ࡱ> MZ&dfhjlnprtv x z | ~ bdfhjlnprtvxz|~bd f!!h""j##l$$n%%  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcefghijklmnopqrstuvwxyz{|}~Root Entry F$ hg[&@ Workbook LMsoDataStore  n0boFMGWIGGT==2 n)oItem PropertiesO3BRKZCQFWG3==2 n0boItem ]& Properties @SummaryInformation( DocumentSummaryInformation8CompObj'l ZO\pVelveenan Ba=  =pq=8X@"1Calibri1Calibri1Calibri1Calibri1Arial1Calibri1Calibri1 Calibri19Calibri1Calibri1Calibri1 Calibri1Calibri14Calibri1 Calibri1Calibri1Calibri1Calibri1,Calibri1Calibri1Calibri1>Calibri14Calibri1<Calibri1?Calibri1hCalibri1Calibri1 Calibri1Arial1Arial1Arial1Arial1Arial1Calibri1Calibri1Calibri1Calibri1Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_) 0.0E+00 0.000                                                                       ff + ) , *     P  P        `            a>      "   "  8 "@ "  " " 1  ! " !  8@ @ " "  h !   h  "|   "| ""8@ ""8 # "" "! $ " %"8! %"8! %"8!! %" &" " "<@ "!8@ ""<@ " "< "!8 ""< " (@ " (        H !   H"  8"   8"@   ( "8 "<   ,  , %"x   (@   ( @ %"x ||{1@}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-} 00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-}  00\);_(*}-} 00\);_(*}-} 00\);_(*}A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef ;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L ;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A}  00\);_(*23;_(@_) }A}! 00\);_(*23 ;_(@_) }A}" 00\);_(*;_(@_) }A}# 00\);_(*;_(@_) }A}$ 00\);_(*;_(@_) }A}% 00\);_(*;_(@_) }A}& 00\);_(*;_(@_) }A}' 00\);_(* ;_(@_) }A}( 00\);_(*;_(@_) }}) }00\);_(*;_(@_)    }}* 00\);_(*;_(@_) ??? ??? ??? ???}-}+ 00\);_(*}-}, 00\);_(*}-}- 00\);_(*}-}. 00\);_(*}-}/ 00\);_(*}A}0 a00\);_(*;_(@_) }A}1 00\);_(*;_(@_) }A}2 00\);_(*?;_(@_) }A}3 00\);_(*23;_(@_) }-}4 00\);_(*}}5 ??v00\);_(*̙;_(@_)    }A}6 }00\);_(*;_(@_) }A}7 W00\);_(*;_(@_) }}8 00\);_(*;_(@_)    }}9 ???00\);_(*;_(@_) ??? ??? ??? ???}-}: 00\);_(*}-}; 00\);_(*}U}< 00\);_(*;_(@_)  }-}= 00\);_(*}(}> 00\);_(*}(}? 00\);_(*}(}@ 00\);_(*}(}A 00\);_(*}(}B 00\);_(*}d}C 00\);_(*;_( ??? }(}D 00\);_(*}(}E 00\);_(*}(}F 00\);_(*}(}G 00\);_(*}(}H 00\);_(*}(}I 00\);_(*}(}J 00\);_(*}<}K 00\);_(*;_(}(}L 00\);_(*}(}M 00\);_(*}P}N 00\);_(*;_( }(}O 00\);_(*}P}P 00\);_(*U;_(U }(}Q 00\);_(*}P}R 00\);_(*P;_(P }(}S 00\);_(*}P}T 00\);_(*;_( }d}U 00\);_(*;_(  ??? }x}V 00\);_(*;_( ??? ???}(}W 00\);_(*}(}X 00\);_(*}(}Y 00\);_(*}(}Z 00\);_(*}(}[ 00\);_(*}x}\ 00\);_(*;_( ??? ???}x}] 00\);_(*;_( ??? ???}x}^ 00\);_(*;_( ??? ???}(}_ 00\);_(*}(}` 00\);_(*}d}a 00\);_(*;_(  ??? }d}b 00\);_(*;_(  ??? }d}c 00\);_(*;_(  ??? }x}d 00\);_(*;_( ??? ???}x}e 00\);_(*;_( ??? ???}x}f 00\);_(*;_( ??? ???}d}g 00\);_(*;_(  ??? }x}h 00\);_(*;_( ??? ???}(}i 00\);_(*}(}j 00\);_(*}(}k 00\);_(*}P}l 00\);_(*;_( }(}m 00\);_(*}P}n 00\);_(*X;_(U }-}o 00\);_(*}d}p 00\);_(*;_( ??? }P}q 00\);_(*;_( }(}r 00\);_(*}(}s 00\);_(*}(}t 00\);_(*}(}u 00\);_(*}(}v 00\);_(*}}w 00\);_(*;_( ??? ??? ???}<}x00\);_(*;_(}P}y00\);_(*;_(  }}z 00\);_(*P;_(P ??? ??? ??? 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L˭ % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  L % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23 % 60% - Accent3M( 60% - Accent3 23 % 60% - Accent4M, 60% - Accent4 23f % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23Ў % "Accent1AAccent1 Dr % #Accent2A!Accent2 }1 % $Accent3A%Accent3  % %Accent4A)Accent4  % &Accent5A-Accent5 [ % 'Accent6A1Accent6  pG %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 %Dr2 Heading 2G Heading 2 %?3 Heading 3G Heading 3 %234 Heading 49 Heading 4 % 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  W%3Normal % 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title % <TotalMTotal %DrDr= Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`5 Table S4a-) Table S4b5 Table S4c7 Table S4d]= Table S4e3B Table S4fV2C Table S4g8F Table S4hxI Table S4i#J Table S4j'K Table S4k 5 o8 UniProtIdsGenes ProteinGroups ProteinNamesProteinDescriptionsValidComparison (group1/group2)Condition NumeratorCondition Denominator # of RatiosGroupAVG Group Quantity DenominatorAVG Group Quantity NumeratorAVG Log2 RatioAbsolute AVG Log2 Ratio% ChangeRatioEPRECATED] AVG Log2 Ratio$[DEPRECATED] Absolute AVG Log2 Ratio[DEPRECATED] % Change[DEPRECATED] RatioStandard DeviationPvalueQvalueDegrees Of FreedomStandard Error OrganismsGO Biological ProcessGO Molecular FunctionGO Cellular ComponentDatabaseProtein ExistenceSequence Version FASTAName FASTAHeader# Unique Total Peptides# Unique Total EG.IdA0A024R571;Q9H4M9EHD1A0A024R571_HUMAN;EHD1_HUMANEH domain-containing protein 1 Old / YoungOldYoung Homo sapiens;intracellular protein transport,endocytosis,blood coagulation,positive regulation of cholesterol storage,neuron projection development,endocytic recycling,low-density lipoprotein particle clearance,cholesterol homeostasis,protein homooligomerization,cilium morphogenesis,protein localization to cilium,positive regulation of myoblast fusion,cellular response to nerve growth factor stimulus,positive regulation of endocytic recycling`;calcium ion binding,protein binding,ATP binding,GTP binding,Rab GTPase binding,cadherin binding;lipid particle,plasma membrane,endosome membrane,membrane,ciliary pocket membrane,platelet dense tubular network membrane,early endosome membrane,recycling endosome membrane,extracellular exosometr;sp1;2uniprot_human_proteome>tr|A0A024R571|A0A024R571_HUMAN EH domain-containing protein 1 OS=Homo sapiens GN=EHD1 PE=1 SV=1;>sp|Q9H4M9|EHD1_HUMAN EH domain-containing protein 1 OS=Homo sapiens GN=EHD1 PE=1 SV=2.A0A024RCR6;A0A0G2JK23;P46379;P46379-2;P46379-3BAT3;BAG6;BAG6;BAG6;BAG6BA0A024RCR6_HUMAN;A0A0G2JK23_HUMAN;BAG6_HUMAN;BAG6_HUMAN;BAG6_HUMANHLA-B associated transcript 3, isoform CRA_a;Large proline-rich protein BAG6;Large proline-rich protein BAG6;Isoform 2 of Large proline-rich protein BAG6;Isoform 3 of Large proline-rich protein BAG6F;;kidney development,immune response-activating cell surface receptor signaling pathway,ubiquitin-dependent protein catabolic process,transport,apoptotic process,synaptonemal complex assembly,spermatogenesis,brain development,embryo development,chromatin modification,internal peptidyl-lysine acetylation,natural killer cell activation,cell differentiation,lung development,ER-associated ubiquitin-dependent protein catabolic process,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,regulation of cell proliferation,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,negative regulation of apoptotic process,negative regulation of proteolysis,protein stabilization,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,ER-associated misfolded protein catabolic process,tail-anchored membrane protein insertion into ER membrane,positive regulation of ERAD pathway,maintenance of unfolded protein involved in ERAD pathway,protein localization to cytosolic proteasome complex involved in ERAD pathway;;;;receptor binding,protein binding,toxic substance binding,Hsp70 protein binding,polyubiquitin binding,ubiquitin protein ligase binding,ribosome binding,misfolded protein binding,proteasome binding,ubiquitin-specific protease binding;;~;;nucleus,nucleoplasm,cytoplasm,cytosol,membrane,intracellular membrane-bounded organelle,extracellular exosome,BAT3 complex;;tr;tr;sp;sp;sp1;1;1;;1;1;2;;>tr|A0A024RCR6|A0A024RCR6_HUMAN HLA-B associated transcript 3, isoform CRA_a OS=Homo sapiens GN=BAT3 PE=1 SV=1;>tr|A0A0G2JK23|A0A0G2JK23_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens GN=BAG6 PE=1 SV=1;>sp|P46379|BAG6_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens GN=BAG6 PE=1 SV=2;>sp|P46379-2|BAG6_HUMAN Isoform 2 of Large proline-rich protein BAG6 OS=Homo sapiens GN=BAG6;>sp|P46379-3|BAG6_HUMAN Isoform 3 of Large proline-rich protein BAG6 OS=Homo sapiens GN=BAG6 A0A075B6I0IGLV8-61A0A075B6I0_HUMANProtein IGLV8-61 (Fragment)Badaptive immune response,immunoglobulin production,immune responseantigen binding#extracellular space,plasma membranetra>tr|A0A075B6I0|A0A075B6I0_HUMAN Protein IGLV8-61 (Fragment) OS=Homo sapiens GN=IGLV8-61 PE=1 SV=7 A0A075B6K5IGLV3-9A0A075B6K5_HUMANHCG2043239 (Fragment))immunoglobulin production,immune responseextracellular spaceZ>tr|A0A075B6K5|A0A075B6K5_HUMAN HCG2043239 (Fragment) OS=Homo sapiens GN=IGLV3-9 PE=1 SV=1A0A075B6K9;P0CG05IGLC2A0A075B6K9_HUMAN;LAC2_HUMANBIg lambda-2 chain C regions (Fragment);Ig lambda-2 chain C regions;proteolysis,receptor-mediated endocytosis,phagocytosis, recognition,phagocytosis, engulfment,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,regulation of immune response,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migrationS;antigen binding,serine-type endopeptidase activity,immunoglobulin receptor binding;extracellular region,extracellular space,plasma membrane,external side of plasma membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticle4;1>tr|A0A075B6K9|A0A075B6K9_HUMAN Ig lambda-2 chain C regions (Fragment) OS=Homo sapiens GN=IGLC2 PE=4 SV=1;>sp|P0CG05|LAC2_HUMAN Ig lambda-2 chain C regions OS=Homo sapiens GN=IGLC2 PE=1 SV=1A0A087WUZ3;Q01082SPTBN1A0A087WUZ3_HUMAN;SPTB2_HUMANOSpectrin beta chain, non-erythrocytic 1;Spectrin beta chain, non-erythrocytic 1;MAPK cascade,mitotic cytokinesis,ER to Golgi vesicle-mediated transport,plasma membrane organization,cytoskeleton organization,common-partner SMAD protein phosphorylation,SMAD protein import into nucleus,axon guidance,Golgi to plasma membrane protein transport,positive regulation of GTPase activity,actin filament capping,membrane assembly,protein targeting to plasma membrane,positive regulation of interleukin-2 secretion,regulation of protein localization to plasma membrane,positive regulation of protein localization to plasma membrane;RNA binding,actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,calmodulin binding,phospholipid binding,ankyrin binding,protein complex binding,cadherin binding,GTPase binding;nucleolus,cytoplasm,cytosol,spectrin,postsynaptic density,spectrin-associated cytoskeleton,axolemma,M band,cuticular plate,protein complex,extracellular exosome>tr|A0A087WUZ3|A0A087WUZ3_HUMAN Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=1;>sp|Q01082|SPTB2_HUMAN Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=2A0A087WVQ6;Q00610;Q00610-2CLTC&A0A087WVQ6_HUMAN;CLH1_HUMAN;CLH1_HUMANOClathrin heavy chain;Clathrin heavy chain 1;Isoform 2 of Clathrin heavy chain 1:;osteoblast differentiation,intracellular protein transport,receptor-mediated endocytosis,autophagy,microtubule-based movement,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,receptor internalization,transferrin transport,retrograde transport, endosome to Golgi,cell division,Wnt signaling pathway, planar cell polarity pathway,regulation of mitotic spindle organization,membrane organization,negative regulation of hyaluronan biosynthetic process,negative regulation of protein localization to plasma membrane;;RNA binding,double-stranded RNA binding,structural molecule activity,protein binding,protein kinase binding,clathrin light chain binding;;lysosome,endosome,spindle,cytosol,plasma membrane,focal adhesion,membrane,clathrin coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,clathrin-coated vesicle,clathrin-coated endocytic vesicle membrane,extracellular matrix,trans-Golgi network membrane,endolysosome membrane,melanosome,protein complex,extracellular exosome,clathrin c< omplex,extracellular vesicle,mitotic spindle microtubule;tr;sp;sp1;1;1;5;>tr|A0A087WVQ6|A0A087WVQ6_HUMAN Clathrin heavy chain OS=Homo sapiens GN=CLTC PE=1 SV=1;>sp|Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC PE=1 SV=5;>sp|Q00610-2|CLH1_HUMAN Isoform 2 of Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC!A0A087WYS1;E7EUC7;Q16851;Q16851-2UGP23A0A087WYS1_HUMAN;E7EUC7_HUMAN;UGPA_HUMAN;UGPA_HUMANUTP--glucose-1-phosphate uridylyltransferase;UTP--glucose-1-phosphate uridylyltransferase;UTP--glucose-1-phosphate uridylyltransferase;Isoform 2 of UTP--glucose-1-phosphate uridylyltransferase;;glycogen metabolic process,glycogen biosynthetic process,UDP-glucose metabolic process,UDP-glucuronate biosynthetic process,glucose 1-phosphate metabolic process;;;UTP:glucose-1-phosphate uridylyltransferase activity,protein binding,glucose binding,pyrimidine ribonucleotide binding,identical protein binding,metal ion binding;2;;nucleus,cytoplasm,cytosol,extracellular exosome; tr;tr;sp;sp1;1;1;1;1;5;>tr|A0A087WYS1|A0A087WYS1_HUMAN UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens GN=UGP2 PE=1 SV=1;>tr|E7EUC7|E7EUC7_HUMAN UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens GN=UGP2 PE=1 SV=1;>sp|Q16851|UGPA_HUMAN UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens GN=UGP2 PE=1 SV=5;>sp|Q16851-2|UGPA_HUMAN Isoform 2 of UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens GN=UGP2 A0A087X0Q4IGKV2-40A0A087X0Q4_HUMAN#Immunoglobulin kappa variable 2D-40i>tr|A0A087X0Q4|A0A087X0Q4_HUMAN Immunoglobulin kappa variable 2D-40 OS=Homo sapiens GN=IGKV2-40 PE=1 SV=1A0A087X188;Q9UBW5;S4R418BIN2(A0A087X188_HUMAN;BIN2_HUMAN;S4R418_HUMANLBridging integrator 2;Bridging integrator 2;Bridging integrator 2 (Fragment)i;phagocytosis, engulfment,neutrophil degranulation,cell chemotaxis,podosome assembly,membrane tubulation;&;protein binding,phospholipid binding;;podosome,extracellular region,cell cortex,cell junction,secretory granule lumen,cell projection,ficolin-1-rich granule lumen,phagocytic cup;tr;sp;tr1;3;2>tr|A0A087X188|A0A087X188_HUMAN Bridging integrator 2 OS=Homo sapiens GN=BIN2 PE=1 SV=1;>sp|Q9UBW5|BIN2_HUMAN Bridging integrator 2 OS=Homo sapiens GN=BIN2 PE=1 SV=3;>tr|S4R418|S4R418_HUMAN Bridging integrator 2 (Fragment) OS=Homo sapiens GN=BIN2 PE=1 SV=2 A0A096LPE2 SAA2-SAA4A0A096LPE2_HUMANProtein SAA2-SAA4#positive chemotaxis,cell chemotaxischemoattractant activityX>tr|A0A096LPE2|A0A096LPE2_HUMAN Protein SAA2-SAA4 OS=Homo sapiens GN=SAA2-SAA4 PE=4 SV=1A0A0A0MRE5;Q9ULH1ASAP1A0A0A0MRE5_HUMAN;ASAP1_HUMANArf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1;Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1;positive regulation of GTPase activity,cilium morphogenesis,negative regulation of dendritic spine development,positive regulation of podosome assembly,positive regulation of membrane tubulation;phosphatidylserine binding,GTPase activator activity,protein binding,phosphatidylinositol-4,5-bisphosphate binding,phosphatidylinositol-3,4,5-trisphosphate binding,cadherin binding,metal ion binding:;podosome,cytosol,cell projection membrane,dendritic spine1;4 >tr|A0A0A0MRE5|A0A0A0MRE5_HUMAN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ASAP1 PE=1 SV=1;>sp|Q9ULH1|ASAP1_HUMAN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ASAP1 PE=1 SV=4A0A0A0MRJ7;P12259F5A0A0A0MRJ7_HUMAN;FA5_HUMANCoagulation factor V;platelet degranulation,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,blood circulation,platelet activation,response to vitamin K,COPII vesicle coatingF;serine-type endopeptidase activity,copper ion binding,protein binding;Golgi membrane,extracellular region,extracellular space,endoplasmic reticulum lumen,plasma membrane,membrane,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular vesicle>tr|A0A0A0MRJ7|A0A0A0MRJ7_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=1;>sp|P12259|FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4A0A0A0MS08;P01857IGHG1A0A0A0MS08_HUMAN;IGHG1_HUMAN>Ig gamma-1 chain C region (Fragment);Ig gamma-1 chain C region;;proteolysis,phagocytosis, recognition,phagocytosis, engulfment,complement activation,complement activation, classical pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activationc;antigen binding,serine-type endopeptidase activity,protein binding,immunoglobulin receptor binding;extracellular region,extracellular space,external side of plasma membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticle>tr|A0A0A0MS08|A0A0A0MS08_HUMAN Ig gamma-1 chain C region (Fragment) OS=Homo sapiens GN=IGHG1 PE=1 SV=1;>sp|P01857|IGHG1_HUMAN Ig gamma-1 chain C region OS=Homo sapiens GN=IGHG1 PE=1 SV=1uA0A0A0MS52;A0A0A0MT11;Q13555;Q13555-10;Q13555-2;Q13555-3;Q13555-4;Q13555-5;Q13555-6;Q13555-7;Q13555-8;Q13555-9;Q5SWX3CAMK2GA0A0A0MS52_HUMAN;A0A0A0MT11_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;Q5SWX3_HUMANCalcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, isoform CRA_a;Calcium/calmodulin-dependent protein kinase type II subunit gamma;Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 10 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 2 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 3 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 4 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 5 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 6 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 7 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 8 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 9 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, isoform CRA_n<;;G1/S transition of mitotic cell cycle,MAPK cascade,protein dephosphorylation,calcium ion transport,nervous system development,regulation of skeletal muscle adaptation,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,insulin secretion,cell differentiation,intracellular signal transduction,positive regulation of GTPase activity,protein autophosphorylation,protein oligomerization,regulation of calcium ion transport,interferon-gamma-mediated signaling pathway,regulation of cellular response to heat,regulation of relaxation of cardiac muscle;;;;;;;;;;!;;protein serine/threonine kinase activity,calmodulin-dependent protein kinase activity,calcium-dependent protein serine/threonine phosphatase activity,Ras guanyl-nucleotide exchange factor activity,protein binding,calmodulin binding,ATP binding,protein homodimerization activity;;;;;;;;;;;;nucleoplasm,cytoplasm,cytosol,plasma membrane,postsynaptic density,membrane,endocytic vesicle membrane,sarcoplasmic reticulum membrane,neuron projection;;;;;;;;;;&tr;tr;sp;sp;sp;sp;sp;sp;sp;sp;sp;sp;tr1;1;1;;;;;;;;;;11;1;3;;;;;;;;;;1>tr|A0A0A0MS52|A0A0A0MS52_HUMAN Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, isoform CRA_a OS=Homo sapiens GN=CAMK2G PE=1 SV=1;>tr|A0A0A0MT11|A0A0A0MT11_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G PE=1 SV=1;>sp|Q13555|KCC2G_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G PE=1 SV=3;>sp|Q13555-10|KCC2G_HUMAN Isoform 10 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-2|KCC2G_HUMAN Isoform 2 of Calcium/calmodulin-dependent protein kinase typ< e II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-3|KCC2G_HUMAN Isoform 3 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-4|KCC2G_HUMAN Isoform 4 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-5|KCC2G_HUMAN Isoform 5 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-6|KCC2G_HUMAN Isoform 6 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-7|KCC2G_HUMAN Isoform 7 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-8|KCC2G_HUMAN Isoform 8 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>sp|Q13555-9|KCC2G_HUMAN Isoform 9 of Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G;>tr|Q5SWX3|Q5SWX3_HUMAN Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, isoform CRA_n OS=Homo sapiens GN=CAMK2G PE=1 SV=1A0A0A0MSD0;Q4LDE5SVEP1A0A0A0MSD0_HUMAN;SVEP1_HUMANSushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1;Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1;cell adhesion&;chromatin binding,calcium ion binding';extracellular space,cytoplasm,membrane1;3">tr|A0A0A0MSD0|A0A0A0MSD0_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=1;>sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 A0A0A0MSV6C1QBA0A0A0MSV6_HUMAN0Complement C1q subcomponent subunit B (Fragment)r>tr|A0A0A0MSV6|A0A0A0MSV6_HUMAN Complement C1q subcomponent subunit B (Fragment) OS=Homo sapiens GN=C1QB PE=1 SV=6!A0A0A0MT22;P08575;P08575-2;X6R433PTPRC5A0A0A0MT22_HUMAN;PTPRC_HUMAN;PTPRC_HUMAN;X6R433_HUMANProtein tyrosine phosphatase, receptor type, C, isoform CRA_d;Receptor-type tyrosine-protein phosphatase C;Isoform 2 of Receptor-type tyrosine-protein phosphatase C;Receptor-type tyrosine-protein phosphatase C";negative regulation of T cell mediated cytotoxicity,negative regulation of cytokine-mediated signaling pathway,hematopoietic progenitor cell differentiation,immunoglobulin biosynthetic process,negative regulation of protein kinase activity,protein dephosphorylation,negative regulation of cell adhesion involved in substrate-bound cell migration,cell surface receptor signaling pathway,dephosphorylation,T cell differentiation,positive regulation of B cell proliferation,peptidyl-tyrosine dephosphorylation,B cell proliferation,positive regulation of T cell proliferation,neutrophil degranulation,cell cycle phase transition,positive regulation of protein kinase activity,bone marrow development,stem cell development,T cell receptor signaling pathway,B cell receptor signaling pathway,positive regulation of antigen receptor-mediated signaling pathway,release of sequestered calcium ion into cytosol,defense response to virus,regulation of cell cycle,positive regulation of hematopoietic stem cell migration,positive regulation of stem cell proliferation;;;protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,protein kinase binding;;;plasma membrane,integral component of plasma membrane,focal adhesion,external side of plasma membrane,cell surface,membrane,secretory granule membrane,membrane raft,extracellular exosome;; tr;sp;sp;tr1;1;;11;2;;1>tr|A0A0A0MT22|A0A0A0MT22_HUMAN Protein tyrosine phosphatase, receptor type, C, isoform CRA_d OS=Homo sapiens GN=PTPRC PE=1 SV=1;>sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2;>sp|P08575-2|PTPRC_HUMAN Isoform 2 of Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC;>tr|X6R433|X6R433_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=1A0A0A0MTH3;Q13418ILKA0A0A0MTH3_HUMAN;ILK_HUMANIntegrin-linked protein kinaseH;MAPK cascade,branching involved in ureteric bud morphogenesis,positive regulation of cell-matrix adhesion,outflow tract morphogenesis,protein phosphorylation,negative regulation of protein kinase activity,cell cycle arrest,cell-matrix adhesion,integrin-mediated signaling pathway,multicellular organism development,cell aging,cell proliferation,positive regulation of cell proliferation,negative regulation of cardiac muscle cell apoptotic process,fibroblast migration,negative regulation of smooth muscle cell migration,peptidyl-serine phosphorylation,nerve development,myelination in peripheral nervous system,positive regulation of cell migration,positive regulation of BMP signaling pathway,myelin assembly,regulation of actin cytoskeleton organization,cell junction assembly,substrate adhesion-dependent cell spreading,positive regulation of phosphorylation,positive regulation of MAP kinase activity,protein kinase B signaling,negative regulation of neuron apoptotic process,establishment or maintenance of epithelial cell apical/basal polarity,positive regulation of myoblast differentiation,positive regulation of osteoblast differentiation,positive regulation of axon extension,positive regulation of transcription, DNA-templated,negative regulation of smooth muscle cell proliferation,neuron projection morphogenesis,positive regulation of dendrite morphogenesis,protein heterooligomerization,positive regulation of protein kinase B signaling,platelet aggregation,positive regulation of canonical Wnt signaling pathway,fibril organization,negative regulation of neural precursor cell proliferation;protein serine/threonine kinase activity,signal transducer activity,integrin binding,protein binding,ATP binding,SH3 domain binding,protein kinase binding;nucleoplasm,cytoplasm,cytosol,plasma membrane,cell-cell junction,focal adhesion,membrane,sarcomere,lamellipodium,cell junction,neuronal cell body,costamere,terminal bouton,dendritic shaft,protein complex,stress fiber>tr|A0A0A0MTH3|A0A0A0MTH3_HUMAN Integrin-linked protein kinase OS=Homo sapiens GN=ILK PE=1 SV=1;>sp|Q13418|ILK_HUMAN Integrin-linked protein kinase OS=Homo sapiens GN=ILK PE=1 SV=2 A0A0B4J1Y9IGHV3-72A0A0B4J1Y9_HUMANProtein IGHV3-72 (Fragment)phagocytosis, recognition,phagocytosis, engulfment,complement activation, classical pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation/antigen binding,immunoglobulin receptor bindingXexternal side of plasma membrane,immunoglobulin complex, circulating,blood microparticlea>tr|A0A0B4J1Y9|A0A0B4J1Y9_HUMAN Protein IGHV3-72 (Fragment) OS=Homo sapiens GN=IGHV3-72 PE=1 SV=1 A0A0B4J2B5 IGHV3OR16-9A0A0B4J2B5_HUMANProtein IGHV3OR16-9 (Fragment)g>tr|A0A0B4J2B5|A0A0B4J2B5_HUMAN Protein IGHV3OR16-9 (Fragment) OS=Homo sapiens GN=IGHV3OR16-9 PE=1 SV=1A0A0C4DFX3;Q9Y6C2EMILIN1A0A0C4DFX3_HUMAN;EMIL1_HUMANEMILIN-1a;protein binding,extracellular matrix constituent conferring elasticity,identical protein binding;extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,extracellular matrix,extracellular exosome>tr|A0A0C4DFX3|A0A0C4DFX3_HUMAN EMILIN-1 OS=Homo sapiens GN=EMILIN1 PE=1 SV=1;>sp|Q9Y6C2|EMIL1_HUMAN EMILIN-1 OS=Homo sapiens GN=EMILIN1 PE=1 SV=2*A0A075B7C0;A0A0C4DGQ5;K7EIV0;P04632;U3KQE2CAPNS1GA0A075B7C0_HUMAN;A0A0C4DGQ5_HUMAN;K7EIV0_HUMAN;CPNS1_HUMAN;U3KQE2_HUMANCalpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1 (Fragment);;;proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly,cornification;u;;;endopeptidase activity,calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding;:;;;cytosol,plasma membrane,membrane,extracellular exosome;tr;tr;tr;sp;tr 1;1;2;1;1>tr|A0A075B7C0|A0A075B7C0_HUMAN Calpa< in small subunit 1 (Fragment) OS=Homo sapiens GN=CAPNS1 PE=1 SV=1;>tr|A0A0C4DGQ5|A0A0C4DGQ5_HUMAN Calpain small subunit 1 OS=Homo sapiens GN=CAPNS1 PE=1 SV=1;>tr|K7EIV0|K7EIV0_HUMAN Calpain small subunit 1 (Fragment) OS=Homo sapiens GN=CAPNS1 PE=1 SV=2;>sp|P04632|CPNS1_HUMAN Calpain small subunit 1 OS=Homo sapiens GN=CAPNS1 PE=1 SV=1;>tr|U3KQE2|U3KQE2_HUMAN Calpain small subunit 1 (Fragment) OS=Homo sapiens GN=CAPNS1 PE=1 SV=1A0A0C4DGV4;E9PLX3;O43504;R4GMU8LAMTOR56A0A0C4DGV4_HUMAN;E9PLX3_HUMAN;LTOR5_HUMAN;R4GMU8_HUMANHepatitis B virus x interacting protein;Ragulator complex protein LAMTOR5;Ragulator complex protein LAMTOR5;Ragulator complex protein LAMTOR5;;cell cycle arrest,regulation of cell size,response to virus,macroautophagy,viral genome replication,positive regulation of TOR signaling,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of GTPase activity,protein localization to lysosome,cellular response to amino acid stimulus;V;;protein binding,guanyl-nucleotide exchange factor activity,protein complex scaffold;8;;lysosome,lysosomal membrane,cytosol,Ragulator complex; tr;tr;sp;tr>tr|A0A0C4DGV4|A0A0C4DGV4_HUMAN Hepatitis B virus x interacting protein OS=Homo sapiens GN=LAMTOR5 PE=1 SV=1;>tr|E9PLX3|E9PLX3_HUMAN Ragulator complex protein LAMTOR5 OS=Homo sapiens GN=LAMTOR5 PE=1 SV=1;>sp|O43504|LTOR5_HUMAN Ragulator complex protein LAMTOR5 OS=Homo sapiens GN=LAMTOR5 PE=1 SV=1;>tr|R4GMU8|R4GMU8_HUMAN Ragulator complex protein LAMTOR5 OS=Homo sapiens GN=LAMTOR5 PE=1 SV=1,A0A0D9SFK2;Q92614;Q92614-2;Q92614-4;Q92614-5MYO18A@A0A0D9SFK2_HUMAN;MY18A_HUMAN;MY18A_HUMAN;MY18A_HUMAN;MY18A_HUMANUnconventional myosin-XVIIIa;Unconventional myosin-XVIIIa;Isoform 2 of Unconventional myosin-XVIIIa;Isoform 4 of Unconventional myosin-XVIIIa;Isoform 5 of Unconventional myosin-XVIIIaF;DNA metabolic process,Golgi organization,cell migration,actomyosin structure organization,regulation of macrophage activation,negative regulation of apoptotic process,Golgi vesicle budding,positive regulation of protein secretion,Golgi ribbon formation,asymmetric Golgi ribbon formation,positive regulation of opsonization;;;j;DNA binding,RNA binding,protein binding,ATP binding,ADP binding,actin filament binding,ATPase activity;;;;Golgi membrane,endoplasmic reticulum-Golgi intermediate compartment,trans-Golgi network,cell surface,membrane,myosin complex,actomyosin;;;tr;sp;sp;sp;sp1;1;;;1;3;;;>tr|A0A0D9SFK2|A0A0D9SFK2_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens GN=MYO18A PE=1 SV=1;>sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens GN=MYO18A PE=1 SV=3;>sp|Q92614-2|MY18A_HUMAN Isoform 2 of Unconventional myosin-XVIIIa OS=Homo sapiens GN=MYO18A;>sp|Q92614-4|MY18A_HUMAN Isoform 4 of Unconventional myosin-XVIIIa OS=Homo sapiens GN=MYO18A;>sp|Q92614-5|MY18A_HUMAN Isoform 5 of Unconventional myosin-XVIIIa OS=Homo sapiens GN=MYO18AA0A0U1RR22;Q9UNF0;Q9UNF0-2PACSIN2(A0A0U1RR22_HUMAN;PACN2_HUMAN;PACN2_HUMANProtein kinase C and casein kinase substrate in neurons protein 2 (Fragment);Protein kinase C and casein kinase substrate in neurons protein 2;Isoform 2 of Protein kinase C and casein kinase substrate in neurons protein 2;actin cytoskeleton organization,regulation of endocytosis,protein localization to endosome,negative regulation of endocytosis,cell projection morphogenesis,membrane organization,caveola assembly,caveolin-mediated endocytosis,membrane tubulation;;transporter activity,protein binding,cytoskeletal protein binding,identical protein binding,cadherin binding,phosphatidic acid binding;;cytoplasm,early endosome,cytosol,cytoskeleton,plasma membrane,caveola,cell-cell junction,focal adhesion,nuclear speck,extrinsic component of membrane,cytoplasmic vesicle membrane,ruffle membrane,intracellular membrane-bounded organelle,recycling endosome membrane,extracellular exosome;1;2;>tr|A0A0U1RR22|A0A0U1RR22_HUMAN Protein kinase C and casein kinase substrate in neurons protein 2 (Fragment) OS=Homo sapiens GN=PACSIN2 PE=1 SV=1;>sp|Q9UNF0|PACN2_HUMAN Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens GN=PACSIN2 PE=1 SV=2;>sp|Q9UNF0-2|PACN2_HUMAN Isoform 2 of Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens GN=PACSIN2=A0A140T913;A0A140T933;A0A140T955;A0A140T9I0;A0A140T9X5;P01892HLA-A_A0A140T913_HUMAN;A0A140T933_HUMAN;A0A140T955_HUMAN;A0A140T9I0_HUMAN;A0A140T9X5_HUMAN;1A02_HUMANpHLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain (Fragment);HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain (Fragment);HLA class I histocompatibility antigen, A-3 alpha chain (Fragment);HLA class I histocompatibility antigen, A-2 alpha chain;;;;;tr;tr;tr;tr;tr;sp>tr|A0A140T913|A0A140T913_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A140T933|A0A140T933_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain (Fragment) OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A140T955|A0A140T955_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A140T9I0|A0A140T9I0_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain (Fragment) OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A140T9X5|A0A140T9X5_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain (Fragment) OS=Homo sapiens GN=HLA-A PE=1 SV=1;>sp|P01892|1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1,A0A1B0GTW1;Q9UDY2;Q9UDY2-3;Q9UDY2-6;Q9UDY2-7TJP28A0A1B0GTW1_HUMAN;ZO2_HUMAN;ZO2_HUMAN;ZO2_HUMAN;ZO2_HUMANTight junction protein ZO-2;Tight junction protein ZO-2;Isoform C1 of Tight junction protein ZO-2;Isoform 6 of Tight junction protein ZO-2;Isoform 7 of Tight junction protein ZO-2;hippo signaling,GMP metabolic process,GDP metabolic process,intestinal absorption,TNFSF11-mediated signaling pathway,establishment of endothelial intestinal barrier,regulation of membrane permeability,negative regulation of osteoclast development;;;;guanylate kinase activity,protein binding,protein C-terminus binding,protein domain specific binding,protein binding, bridging,cadherin binding;;;a;nucleoplasm,cytosol,plasma membrane,adherens junction,bicellular tight junction,cell junction;;;1;2;;;>tr|A0A1B0GTW1|A0A1B0GTW1_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=1;>sp|Q9UDY2|ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2;>sp|Q9UDY2-3|ZO2_HUMAN Isoform C1 of Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2;>sp|Q9UDY2-6|ZO2_HUMAN Isoform 6 of Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2;>sp|Q9UDY2-7|ZO2_HUMAN Isoform 7 of Tight junction protein ZO-2 OS=Homo sapiens GN=TJP22A0A1B0GV23;A0A1B0GVD5;A0A1B0GW44;A0A1B0GWE8;P07339CTSDNA0A1B0GV23_HUMAN;A0A1B0GVD5_HUMAN;A0A1B0GW44_HUMAN;A0A1B0GWE8_HUMAN;CATD_HUMAN Cathepsin D;;;;proteolysis,autophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein catabolic process,collagen catabolic process,neutrophil degranulation;;;;aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein binding;;;;extracellular region,extracellular space,lysosome,specific granule lumen,melanosome,lysosomal lumen,membrane raft,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumen,extracellular matrixtr;tr;tr;tr;sp{>tr|A0A1B0GV23|A0A1B0GV23_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1;>tr|A0A1B0GVD5|A0A1B0GVD5_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1;>tr|A0A1B0GW44|A0A1B0GW44_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1;>tr|A0A1B0GWE8|A0A1B0GWE8_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1;>sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1A0M8Q6IGLC7 LAC7_HUMANIg lambda-7 chain C regionproteolysis,receptor-mediated endocytosis,phagocytosis, recognition,phagocytosis, engu< lfment,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,regulation of immune response,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migrationRantigen binding,serine-type endopeptidase activity,immunoglobulin receptor binding}extracellular region,plasma membrane,external side of plasma membrane,immunoglobulin complex, circulating,blood microparticlespS>sp|A0M8Q6|LAC7_HUMAN Ig lambda-7 chain C region OS=Homo sapiens GN=IGLC7 PE=4 SV=2A1L4H1SSC5D SRCRL_HUMANHSoluble scavenger receptor cysteine-rich domain-containing protein SSC5Dreceptor-mediated endocytosis,multicellular organism development,detection of bacterial lipoprotein,innate immune response,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,negative regulation of interleukin-8 secretionlfibronectin binding,scavenger receptor activity,protein binding,laminin binding,extracellular matrix bindingIextracellular space,intracellular,cytoplasm,membrane,extracellular matrix>sp|A1L4H1|SRCRL_HUMAN Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D OS=Homo sapiens GN=SSC5D PE=1 SV=3$B3KW70;F5GYX4;H0YG03;Q13361;Q13361-2MFAP5>B3KW70_HUMAN;F5GYX4_HUMAN;H0YG03_HUMAN;MFAP5_HUMAN;MFAP5_HUMANMicrofibrillar-associated protein 5;Microfibrillar-associated protein 5;Microfibrillar-associated protein 5 (Fragment);Microfibrillar-associated protein 5;Isoform 2 of Microfibrillar-associated protein 5P;;;extracellular matrix organization,definitive hemopoiesis,fibril organization;/;;;extracellular matrix structural constituent;[;;;microfibril,extracellular region,proteinaceous extracellular matrix,extracellular space;tr;tr;tr;sp;sp1;1;1;1;>tr|B3KW70|B3KW70_HUMAN Microfibrillar-associated protein 5 OS=Homo sapiens GN=MFAP5 PE=1 SV=1;>tr|F5GYX4|F5GYX4_HUMAN Microfibrillar-associated protein 5 OS=Homo sapiens GN=MFAP5 PE=1 SV=1;>tr|H0YG03|H0YG03_HUMAN Microfibrillar-associated protein 5 (Fragment) OS=Homo sapiens GN=MFAP5 PE=1 SV=1;>sp|Q13361|MFAP5_HUMAN Microfibrillar-associated protein 5 OS=Homo sapiens GN=MFAP5 PE=1 SV=1;>sp|Q13361-2|MFAP5_HUMAN Isoform 2 of Microfibrillar-associated protein 5 OS=Homo sapiens GN=MFAP5B4DPQ0C1R B4DPQ0_HUMANComplement C1r subcomponentT>tr|B4DPQ0|B4DPQ0_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=1vB4DV12;F5GXK7;F5GYU3;F5H265;F5H2Z3;F5H388;F5H6Q2;F5H747;J3QKN0;J3QS39;J3QTR3;P0CG47;P0CG48;P62979;P62987;Q5PY61;Q96C32KUBB;UBC;UBC;UBC;UBC;UBC;UBC;UBC;UBB;UBB;RPS27A;UBB;UBC;RPS27A;UBA52;UBC;UBCB4DV12_HUMAN;F5GXK7_HUMAN;F5GYU3_HUMAN;F5H265_HUMAN;F5H2Z3_HUMAN;F5H388_HUMAN;F5H6Q2_HUMAN;F5H747_HUMAN;J3QKN0_HUMAN;J3QS39_HUMAN;J3QTR3_HUMAN;UBB_HUMAN;UBC_HUMAN;RS27A_HUMAN;RL40_HUMAN;Q5PY61_HUMAN;Q96C32_HUMANPolyubiquitin-B;Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-B (Fragment);Polyubiquitin-B (Fragment);Ubiquitin-40S ribosomal protein S27a (Fragment);Polyubiquitin-B;Polyubiquitin-C;Ubiquitin-40S ribosomal protein S27a;Ubiquitin-60S ribosomal protein L40;Polyubiquitin-C;Polyubiquitin-C9;;;;;;;;;;;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,protein folding,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,viral life cycle,virion assembly,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,positive regulation of protein ubiquitination,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,mitochondrion transport along microtubule,neuron projection morphogenesis,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of mitochondrial membrane potential,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of neuron death,regulation of signal transduction by p53 class mediator,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,positive regulation of protein monoubiquitination,endoplasmic reticulum mannose trimming;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,protein folding,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling< pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,ubiquitin homeostasis,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,viral life cycle,virion assembly,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator,endoplasmic reticulum mannose trimming;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translation,translational initiation,protein folding,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator,endoplasmic reticulum mannose trimming;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translational initiation,protein folding,cellular protein modification process,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,response to insecticide,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstran< d cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator,endoplasmic reticulum mannose trimming;;;;;;;;;;;;;protein binding;protease binding,RNA binding,protein binding;RNA binding,structural constituent of ribosome,protein binding,metal ion binding;structural constituent of ribosome,protein binding;;E;;;;;;;;;;;extracellular space,nucleus,nucleoplasm,mitochondrion,mitochondrial outer membrane,cytosol,plasma membrane,endosome membrane,endocytic vesicle membrane,neuron projection,neuronal cell body,endoplasmic reticulum quality control compartment,extracellular exosome;extracellular space,nucleus,nucleoplasm,mitochondrial outer membrane,cytosol,plasma membrane,endosome membrane,endocytic vesicle membrane,myelin sheath,endoplasmic reticulum quality control compartment,extracellular exosome;extracellular space,nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrial outer membrane,cytosol,plasma membrane,endosome membrane,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,endocytic vesicle membrane,myelin sheath,endoplasmic reticulum quality control compartment,extracellular exosome;extracellular space,nucleus,nucleoplasm,mitochondrial outer membrane,lysosomal membrane,endoplasmic reticulum,cytosol,plasma membrane,endosome membrane,cytosolic large ribosomal subunit,endocytic vesicle membrane,endoplasmic reticulum quality control compartment,extracellular exosome;;2tr;tr;tr;tr;tr;tr;tr;tr;tr;tr;tr;sp;sp;sp;sp;tr;tr!1;2;1;1;1;1;8;8;1;1;1;1;3;2;2;1;1>tr|B4DV12|B4DV12_HUMAN Polyubiquitin-B OS=Homo sapiens GN=UBB PE=1 SV=1;>tr|F5GXK7|F5GXK7_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=2;>tr|F5GYU3|F5GYU3_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=1;>tr|F5H265|F5H265_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=1;>tr|F5H2Z3|F5H2Z3_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=1;>tr|F5H388|F5H388_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=1;>tr|F5H6Q2|F5H6Q2_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=8;>tr|F5H747|F5H747_HUMAN Polyubiquitin-C (Fragment) OS=Homo sapiens GN=UBC PE=1 SV=8;>tr|J3QKN0|J3QKN0_HUMAN Polyubiquitin-B (Fragment) OS=Homo sapiens GN=UBB PE=1 SV=1;>tr|J3QS39|J3QS39_HUMAN Polyubiquitin-B (Fragment) OS=Homo sapiens GN=UBB PE=1 SV=1;>tr|J3QTR3|J3QTR3_HUMAN Ubiquitin-40S ribosomal protein S27a (Fragment) OS=Homo sapiens GN=RPS27A PE=1 SV=1;>sp|P0CG47|UBB_HUMAN Polyubiquitin-B OS=Homo sapiens GN=UBB PE=1 SV=1;>sp|P0CG48|UBC_HUMAN Polyubiquitin-C OS=Homo sapiens GN=UBC PE=1 SV=3;>sp|P62979|RS27A_HUMAN Ubiquitin-40S ribosomal protein S27a OS=Homo sapiens GN=RPS27A PE=1 SV=2;>sp|P62987|RL40_HUMAN Ubiquitin-60S ribosomal protein L40 OS=Homo sapiens GN=UBA52 PE=1 SV=2;>tr|Q5PY61|Q5PY61_HUMAN Polyubiquitin-C OS=Homo sapiens GN=UBC PE=1 SV=1;>tr|Q96C32|Q96C32_HUMAN Polyubiquitin-C OS=Homo sapiens GN=UBC PE=1 SV=1B4E1Z4NaN B4E1Z4_HUMANUncharacterized protein proteolysis"serine-type endopeptidase activityI>tr|B4E1Z4|B4E1Z4_HUMAN Uncharacterized protein OS=Homo sapiens PE=1 SV=1 B5MDF5;P62826RANB5MDF5_HUMAN;RAN_HUMANGTP-binding nuclear protein Ran ;ribosomal large subunit export from nucleus,ribosomal small subunit export from nucleus,protein import into nucleus, translocation,DNA metabolic process,tRNA export from nucleus,protein import into nucleus,protein export from nucleus,mitotic spindle organization,mitotic nuclear division,small GTPase mediated signal transduction,spermatid development,viral process,hippocampus development,actin cytoskeleton organization,androgen receptor signaling pathway,gene silencing by RNA,positive regulation of protein binding,cellular protein complex localization,pre-miRNA export from nucleus,positive regulation of transcription, DNA-templated,cell division,cellular response to mineralocorticoid stimulus,protein transmembrane transport,intracellular transport of virus,protein localization to nucleolus;chromatin binding,transcription coactivator activity,RNA binding,GTPase activity,protein binding,GTP binding,GDP binding,protein domain specific binding,protein complex binding,cadherin binding,dynein intermediate chain binding,androgen receptor binding,importin-alpha family protein binding,protein transmembrane transporter activity,pre-miRNA binding,pre-miRNA transporter activity;male germ cell nucleus,manchette,nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,centriole,cytosol,membrane,midbody,extracellular matrix,sperm flagellum,melanosome,RNA nuclear export complex,recycling endosome,extracellular exosome,Flemming body,chromatin>tr|B5MDF5|B5MDF5_HUMAN GTP-binding nuclear protein Ran OS=Homo sapiens GN=RAN PE=1 SV=1;>sp|P62826|RAN_HUMAN GTP-binding nuclear protein Ran OS=Homo sapiens GN=RAN PE=1 SV=3 C9J4A7;Q8TD55;PLEKHO2C9J4A7_HUMAN;PKHO2_HUMANZUncharacterized protein (Fragment);Pleckstrin homology domain-containing family O member 2;neutrophil degranulation;2;extracellular region,ficolin-1-rich granule lumen>tr|C9J4A7|C9J4A7_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=1;>sp|Q8TD55|PKHO2_HUMAN Pleckstrin homology domain-containing family O member 2 OS=Homo sapiens GN=PLEKHO2 PE=1 SV=1!A0A087X0A8;D6RGG3;Q99715;Q99715-2COL12A15A0A087X0A8_HUMAN;D6RGG3_HUMAN;COCA1_HUMAN;COCA1_HUMAN|Collagen alpha-1(XII) chain;Collagen alpha-1(XII) chain;Collagen alpha-1(XII) chain;Isoform 2 of Collagen alpha-1(XII) chain;;skeletal system development,cell adhesion,collagen fibril organization,collagen catabolic process,endodermal cell differentiation;J;;extracellular matrix structural constituent conferring tensile strength;;;extracellular region,collagen type XII trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome,extracellular vesicle;1;1;2;n>tr|A0A087X0A8|A0A087X0A8_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=1;>tr|D6RGG3|D6RGG3_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=1;>sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2;>sp|Q99715-2|COCA1_HUMAN Isoform 2 of Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1E7EPV7;P37840;P37840-2SNCA"E7EPV7_HUMAN;SYUA_HUMAN;SYUA_HUMAN>Alpha-synuclein;Alpha-synuclein;Isoform 2-4 of Alpha-synuclein ;negative regulation of transcription from RNA polymerase II promoter,microglial cell activation,positive regulation of receptor recycling,negative regulation of protein phosphorylation,positive regulation of neurotransmitter secretion,fatty acid metabolic proce< ss,neutral lipid metabolic process,phospholipid metabolic process,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,mitochondrial membrane organization,aging,adult locomotory behavior,response to iron(II) ion,regulation of phospholipase activity,negative regulation of platelet-derived growth factor receptor signaling pathway,regulation of glutamate secretion,regulation of dopamine secretion,negative regulation of microtubule polymerization,receptor internalization,protein destabilization,response to magnesium ion,negative regulation of transporter activity,response to lipopolysaccharide,negative regulation of monooxygenase activity,positive regulation of peptidyl-serine phosphorylation,response to interferon-gamma,cellular response to oxidative stress,negative regulation of histone acetylation,regulation of locomotion,dopamine biosynthetic process,response to drug,mitochondrial ATP synthesis coupled electron transport,regulation of macrophage activation,positive regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of neuron apoptotic process,cellular protein metabolic process,cellular response to fibroblast growth factor stimulus,positive regulation of endocytosis,negative regulation of exocytosis,negative regulation of dopamine metabolic process,behavioral response to cocaine,regulation of long-term neuronal synaptic plasticity,synaptic vesicle endocytosis,synapse organization,regulation of acyl-CoA biosynthetic process,positive regulation of release of sequestered calcium ion into cytosol,dopamine uptake involved in synaptic transmission,negative regulation of dopamine uptake involved in synaptic transmission,negative regulation of serotonin uptake,negative regulation of norepinephrine uptake,oxidation-reduction process,excitatory postsynaptic potential,long-term synaptic potentiation,positive regulation of inositol phosphate biosynthetic process,negative regulation of thrombin-activated receptor signaling pathway,response to interleukin-1,cellular response to copper ion,cellular response to epinephrine stimulus,positive regulation of protein serine/threonine kinase activity,fibril organization,negative regulation of neuron death,negative regulation of mitochondrial electron transport, NADH to ubiquinone,positive regulation of glutathione peroxidase activity,positive regulation of hydrogen peroxide catabolic process,regulation of synaptic vesicle recycling,regulation of reactive oxygen species biosynthetic process,negative regulation of chaperone-mediated autophagy,Requires Ontology,calcium ion homeostasis;\;magnesium ion binding,copper ion binding,calcium ion binding,protein binding,phospholipid binding,microtubule binding,ferrous iron binding,zinc ion binding,oxidoreductase activity,kinesin binding,protein domain specific binding,histone binding,identical protein binding,alpha-tubulin binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,phospholipase binding,transcription regulatory region DNA binding,protein N-terminus binding,tau protein binding,beta-tubulin binding,phosphoprotein binding,dynein complex binding,fatty acid binding,phospholipase D inhibitor activity;;extracellular region,extracellular space,nucleus,nuclear outer membrane,cytoplasm,mitochondrion,lysosome,rough endoplasmic reticulum,Golgi apparatus,cytosol,ribosome,plasma membrane,cell cortex,synaptic vesicle,actin cytoskeleton,membrane,inclusion body,cell junction,axon,growth cone,neuronal cell body,terminal bouton,perinuclear region of cytoplasm,postsynapse,supramolecular fiber,mitochondrial respiratory chain complex I,platelet alpha granule membrane;>tr|E7EPV7|E7EPV7_HUMAN Alpha-synuclein OS=Homo sapiens GN=SNCA PE=1 SV=1;>sp|P37840|SYUA_HUMAN Alpha-synuclein OS=Homo sapiens GN=SNCA PE=1 SV=1;>sp|P37840-2|SYUA_HUMAN Isoform 2-4 of Alpha-synuclein OS=Homo sapiens GN=SNCA E7EQR4;P15311EZRE7EQR4_HUMAN;EZRI_HUMANEzrinf;negative regulation of transcription from RNA polymerase II promoter,intestinal D-glucose absorption,sphingosine-1-phosphate signaling pathway,cytoskeletal anchoring at plasma membrane,leukocyte cell-cell adhesion,axon guidance,regulation of cell shape,positive regulation of gene expression,protein kinase A signaling,membrane to membrane docking,microvillus assembly,astral microtubule organization,actin cytoskeleton reorganization,receptor internalization,regulation of microvillus length,cellular protein complex localization,positive regulation of multicellular organism growth,cortical microtubule organization,filopodium assembly,phosphatidylinositol-mediated signaling,positive regulation of protein secretion,negative regulation of T cell receptor signaling pathway,actin filament bundle assembly,establishment of centrosome localization,establishment of endothelial barrier,negative regulation of ERK1 and ERK2 cascade,cellular response to cAMP,protein localization to cell cortex,establishment of protein localization to plasma membrane,positive regulation of establishment of protein localization to plasma membrane,negative regulation of interleukin-2 secretion,regulation of organelle assembly,terminal web assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,negative regulation of p38MAPK cascade,positive regulation of early endosome to late endosome transport,regulation of cell size,gland morphogenesis,regulation of actin cytoskeleton organization,establishment of epithelial cell apical/basal polarity,regulation of NIK/NF-kappaB signaling ;RNA binding,actin binding,protein binding,microtubule binding,protein domain specific binding,protein kinase A catalytic subunit binding,protein kinase A regulatory subunit binding,S100 protein binding,cadherin binding,cell adhesion molecule binding,actin filament binding,ATPase binding;fibrillar center,ruffle,immunological synapse,uropod,extracellular space,cytoplasm,endosome,cytosol,actin filament,plasma membrane,microvillus,brush border,focal adhesion,actin cytoskeleton,membrane,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,T-tubule,cortical cytoskeleton,microvillus membrane,vesicle,ruffle membrane,ciliary basal body,cell projection,myelin sheath,cell body,microspike,plasma membrane raft,apical part of cell,perinuclear region of cytoplasm,cell tip,extracellular exosome,cell periphery,astrocyte projection,Schwann cell microvillus,cytoplasmic side of apical plasma membrane,TCR signalosome3;4{>tr|E7EQR4|E7EQR4_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 SV=3;>sp|P15311|EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 SV=4 E7EU05;P16671CD36E7EU05_HUMAN;CD36_HUMAN:Platelet glycoprotein 4 (Fragment);Platelet glycoprotein 4s ;negative regulation of transcription from RNA polymerase II promoter,positive regulation of cell-matrix adhesion,toll-like receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,platelet degranulation,MyD88-dependent toll-like receptor signaling pathway,lipid metabolic process,receptor-mediated endocytosis,phagocytosis, recognition,cell adhesion,cell surface receptor signaling pathway,positive regulation of cytosolic calcium ion concentration,nitric oxide mediated signal transduction,blood coagulation,positive regulation of macrophage derived foam cell differentiation,positive regulation of cholesterol storage,lipid storage,cGMP-mediated signaling,positive regulation of blood coagulation,intestinal cholesterol absorption,cholesterol transport,receptor internalization,positive regulation of interleukin-12 production,positive regulation of interleukin-6 production,positive regulation of tumor necrosis factor production,response to lipid,triglyceride transport,plasma lipoprotein particle clearance,low-density lipoprotein particle clearance,response to stilbenoid,toll-like receptor TLR6:TLR2 signaling pathway,lipoprotein transport,negative regulation of transcription factor import into nucleus,positive regulat< ion of I-kappaB kinase/NF-kappaB signaling,apoptotic cell clearance,neutrophil degranulation,negative regulation of growth of symbiont in host,long-chain fatty acid import,interleukin-1 beta secretion,positive regulation of peptidyl-tyrosine phosphorylation,defense response to Gram-positive bacterium,intestinal absorption,sensory perception of taste,low-density lipoprotein particle mediated signaling,positive regulation of phagocytosis, engulfment,positive regulation of macrophage cytokine production,positive regulation of ERK1 and ERK2 cascade,cholesterol import,response to fatty acid,response to linoleic acid,cellular response to lipopolysaccharide,cellular response to lipoteichoic acid,cellular response to low-density lipoprotein particle stimulus,cellular response to hydroperoxide,cellular response to diacyl bacterial lipopeptide,positive regulation of NLRP3 inflammasome complex assembly,amyloid fibril formation,regulation of removal of superoxide radicals,positive regulation of blood microparticle formation,positive regulation of reactive oxygen species metabolic process,regulation of energy homeostasis%;low-density lipoprotein receptor activity,protein binding,high-density lipoprotein particle binding,lipid binding,low-density lipoprotein particle binding,transforming growth factor beta binding,thrombospondin receptor activity,lipoteichoic acid receptor activity,lipoprotein particle binding4;extracellular space,Golgi apparatus,plasma membrane,integral component of plasma membrane,external side of plasma membrane,cell surface,membrane,apical plasma membrane,endocytic vesicle membrane,platelet alpha granule membrane,brush border membrane,specific granule membrane,membrane raft,phagocytic vesicle>tr|E7EU05|E7EU05_HUMAN Platelet glycoprotein 4 (Fragment) OS=Homo sapiens GN=CD36 PE=1 SV=2;>sp|P16671|CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 E9PBF6;P20700LMNB1E9PBF6_HUMAN;LMNB1_HUMANLamin-B1C;structural molecule activity,protein binding,phospholipase bindingl;nuclear envelope,nuclear inner membrane,lamin filament,nucleoplasm,membrane,nuclear matrix,nuclear membrane>tr|E9PBF6|E9PBF6_HUMAN Lamin-B1 OS=Homo sapiens GN=LMNB1 PE=1 SV=1;>sp|P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens GN=LMNB1 PE=1 SV=2F5GYQ1;J3QL14;P61421;R4GN72ATP6V0D12F5GYQ1_HUMAN;J3QL14_HUMAN;VA0D1_HUMAN;R4GN72_HUMANV-type proton ATPase subunit d 1;V-type proton ATPase subunit d 1 (Fragment);V-type proton ATPase subunit d 1;V-type proton ATPase subunit d 1;;brain development,insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,IRE1-mediated unfolded protein response,cilium morphogenesis,phagosome acidification;h;;protein binding,hydrogen-exporting ATPase activity, phosphorylative mechanism,protein complex binding;;;lysosomal membrane,early endosome,synaptic vesicle,endosome membrane,membrane,apical plasma membrane,vacuolar proton-transporting V-type ATPase complex,phagocytic vesicle membrane,proton-transporting V-type ATPase, V0 domain,axon terminus,extracellular exosome,centrosome;>tr|F5GYQ1|F5GYQ1_HUMAN V-type proton ATPase subunit d 1 OS=Homo sapiens GN=ATP6V0D1 PE=1 SV=1;>tr|J3QL14|J3QL14_HUMAN V-type proton ATPase subunit d 1 (Fragment) OS=Homo sapiens GN=ATP6V0D1 PE=1 SV=1;>sp|P61421|VA0D1_HUMAN V-type proton ATPase subunit d 1 OS=Homo sapiens GN=ATP6V0D1 PE=1 SV=1;>tr|R4GN72|R4GN72_HUMAN V-type proton ATPase subunit d 1 OS=Homo sapiens GN=ATP6V0D1 PE=1 SV=1 F8VPD4;P27708CADF8VPD4_HUMAN;PYR1_HUMAN CAD proteinW;liver development,'de novo' pyrimidine nucleobase biosynthetic process,UTP biosynthetic process,glutamine metabolic process,heart development,female pregnancy,lactation,response to amine,drug metabolic process,peptidyl-threonine phosphorylation,citrulline biosynthetic process,response to caffeine,animal organ regeneration,response to insulin,response to testosterone,cellular response to drug,response to starvation,'de novo' UMP biosynthetic process,pyrimidine nucleoside biosynthetic process,protein autophosphorylation,response to cortisol,cellular response to epidermal growth factor stimulus;aspartate carbamoyltransferase activity,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,dihydroorotase activity,protein kinase activity,ATP binding,zinc ion binding,enzyme binding,identical protein binding,aspartate binding;nucleus,nucleoplasm,cytosol,membrane,nuclear matrix,cell projection,neuronal cell body,terminal bouton,protein complex,extracellular exosome>tr|F8VPD4|F8VPD4_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=1;>sp|P27708|PYR1_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=3F8VXU5;Q9UBQ0;Q9UBQ0-2VPS29$F8VXU5_HUMAN;VPS29_HUMAN;VPS29_HUMANVacuolar protein sorting-associated protein 29;Vacuolar protein sorting-associated protein 29;Isoform 2 of Vacuolar protein sorting-associated protein 29;protein transport,Wnt signaling pathway,retrograde transport, endosome to Golgi,retrograde transport, endosome to plasma membrane,regulation of autophagy;#;protein binding,metal ion binding;;endosome,early endosome,late endosome,cytosol,endosome membrane,retromer complex,retromer, cargo-selective complex,intracellular membrane-bounded organelle,extracellular exosome;@>tr|F8VXU5|F8VXU5_HUMAN Vacuolar protein sorting-associated protein 29 OS=Homo sapiens GN=VPS29 PE=1 SV=1;>sp|Q9UBQ0|VPS29_HUMAN Vacuolar protein sorting-associated protein 29 OS=Homo sapiens GN=VPS29 PE=1 SV=1;>sp|Q9UBQ0-2|VPS29_HUMAN Isoform 2 of Vacuolar protein sorting-associated protein 29 OS=Homo sapiens GN=VPS290F8WCA0;J3QRU4;K7EKX0;K7ENK9;L7N2F9;P63027;Q15836$VAMP2;VAMP2;VAMP3;VAMP2;;VAMP2;VAMP3XF8WCA0_HUMAN;J3QRU4_HUMAN;K7EKX0_HUMAN;K7ENK9_HUMAN;L7N2F9_HUMAN;VAMP2_HUMAN;VAMP3_HUMANVesicle-associated membrane protein 2;Vesicle-associated membrane protein 2;Vesicle-associated membrane protein 3;Vesicle-associated membrane protein 2;Uncharacterized protein (Fragment);Vesicle-associated membrane protein 2;Vesicle-associated membrane protein 3u;;;;exocytosis,vesicle fusion;protein complex assembly,exocytosis,post-Golgi vesicle-mediated transport,vesicle fusion,neurotransmitter secretion,response to glucose,glutamate secretion,protein transport,synaptic vesicle exocytosis,vesicle-mediated transport,calcium ion regulated exocytosis,regulation of exocytosis,cellular response to insulin stimulus,Golgi to plasma membrane protein transport,eosinophil degranulation,long-term synaptic potentiation,regulation of vesicle-mediated transport,membrane organization,membrane fusion,positive regulation of intracellular protein transport,regulation of delayed rectifier potassium channel activity,neutrophil degranulation,natural killer cell degranulation,mucus secretion,regulation of histamine secretion by mast cell;positive regulation of receptor recycling,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,protein complex assembly,exocytosis,vesicle docking involved in exocytosis,vesicle fusion,vesicle-mediated transport,calcium ion regulated exocytosis,substrate adhesion-dependent cell spreading,SNARE complex assembly,retrograde transport, endosome to Golgi,Golgi to plasma membrane protein transport,membrane organization,membrane fusion,negative regulation of secretion by cell,positive regulation of immunoglobulin secretion,mucus secretion,regulation of histamine secretion by mast cell/;;;;SNAP receptor activity,syntaxin binding;SNARE binding,SNAP receptor activity,protein binding,calmodulin binding,phospholipid binding,syntaxin-1 binding,syntaxin binding,protein self-association,calcium-dependent protein binding;SNARE binding,SNAP receptor activity,protein binding,syntaxin-1 binding&;;;;integral component of membrane,SNARE complex;trans-Golgi network,cytosol,plasma membrane,integral component of plasma membrane,synaptic vesicle,membrane,cell junction,clathrin-coated vesicle,secretory granule,clathrin-coated vesicle membrane,secretory granule membrane,synaptic vesicle membrane,SNARE complex,cytoplasmic vesicle,vesicle,zymogen granule membrane,neuro< n projection,intracellular membrane-bounded organelle,neuron projection terminus,synapse,perinuclear region of cytoplasm,clathrin-sculpted glutamate transport vesicle membrane,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,synaptobrevin 2-SNAP-25-syntaxin-1a complex,extracellular exosome,clathrin-sculpted monoamine transport vesicle membrane,voltage-gated potassium channel complex;intracellular,cytosol,plasma membrane,cell surface,integral component of membrane,apical plasma membrane,cell junction,transport vesicle,clathrin-coated vesicle,secretory granule,clathrin-coated vesicle membrane,phagocytic vesicle membrane,SNARE complex,trans-Golgi network membrane,neuron projection,intracellular membrane-bounded organelle,synapse,perinuclear region of cytoplasm,recycling endosome,recycling endosome membranetr;tr;tr;tr;tr;sp;sp 4;4;4;4;4;1;1 1;2;1;1;1;3;3>tr|F8WCA0|F8WCA0_HUMAN Vesicle-associated membrane protein 2 OS=Homo sapiens GN=VAMP2 PE=4 SV=1;>tr|J3QRU4|J3QRU4_HUMAN Vesicle-associated membrane protein 2 OS=Homo sapiens GN=VAMP2 PE=4 SV=2;>tr|K7EKX0|K7EKX0_HUMAN Vesicle-associated membrane protein 3 OS=Homo sapiens GN=VAMP3 PE=4 SV=1;>tr|K7ENK9|K7ENK9_HUMAN Vesicle-associated membrane protein 2 OS=Homo sapiens GN=VAMP2 PE=4 SV=1;>tr|L7N2F9|L7N2F9_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=1;>sp|P63027|VAMP2_HUMAN Vesicle-associated membrane protein 2 OS=Homo sapiens GN=VAMP2 PE=1 SV=3;>sp|Q15836|VAMP3_HUMAN Vesicle-associated membrane protein 3 OS=Homo sapiens GN=VAMP3 PE=1 SV=3 F8WCF6;P59998ARPC4-TTLL3;ARPC4F8WCF6_HUMAN;ARPC4_HUMAN+Actin-related protein 2/3 complex subunit 4;actin filament polymerization,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,actin nucleation,ephrin receptor signaling pathway,membrane organizationw;structural constituent of cytoskeleton,protein binding,enzyme binding,protein binding, bridging,actin filament bindingE;cytosol,Arp2/3 protein complex,cell projection,extracellular exosome3;1>tr|F8WCF6|F8WCF6_HUMAN Actin-related protein 2/3 complex subunit 4 OS=Homo sapiens GN=ARPC4-TTLL3 PE=3 SV=1;>sp|P59998|ARPC4_HUMAN Actin-related protein 2/3 complex subunit 4 OS=Homo sapiens GN=ARPC4 PE=1 SV=3 G3V2W1;Q9UK55 SERPINA10G3V2W1_HUMAN;ZPI_HUMAN&Protein Z-dependent protease inhibitorp;blood coagulation,bioluminescence,negative regulation of endopeptidase activity,regulation of acrosome reaction=;serine-type endopeptidase inhibitor activity,heparin binding*;extracellular space,extracellular exosome>tr|G3V2W1|G3V2W1_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1;>sp|Q9UK55|ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 G3XAI2;P07942LAMB1G3XAI2_HUMAN;LAMB1_HUMANLaminin subunit beta-1W;cell adhesion,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,extracellular matrix organization,positive regulation of cell migration,neuron projection development,substrate adhesion-dependent cell spreading,endodermal cell differentiation,odontogenesis,positive regulation of epithelial cell proliferationI;structural molecule activity,extracellular matrix structural constituent;extracellular region,basement membrane,laminin-1 complex,laminin-2 complex,extracellular space,extracellular matrix,laminin-8 complex,laminin-10 complex,perinuclear region of cytoplasm,extracellular exosome>tr|G3XAI2|G3XAI2_HUMAN Laminin subunit beta-1 OS=Homo sapiens GN=LAMB1 PE=1 SV=1;>sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens GN=LAMB1 PE=1 SV=2CG8JLD5;O00429;O00429-2;O00429-3;O00429-4;O00429-5;O00429-6;O00429-8DNM1L`G8JLD5_HUMAN;DNM1L_HUMAN;DNM1L_HUMAN;DNM1L_HUMAN;DNM1L_HUMAN;DNM1L_HUMAN;DNM1L_HUMAN;DNM1L_HUMANDynamin-1-like protein;Dynamin-1-like protein;Isoform 4 of Dynamin-1-like protein;Isoform 2 of Dynamin-1-like protein;Isoform 3 of Dynamin-1-like protein;Isoform 5 of Dynamin-1-like protein;Isoform 6 of Dynamin-1-like protein;Isoform 8 of Dynamin-1-like protein;mitochondrial fission,release of cytochrome c from mitochondria,dynamin family protein polymerization involved in mitochondrial fission,endocytosis,mitochondrion organization,regulation of mitochondrion organization,peroxisome fission,regulation of protein oligomerization,positive regulation of apoptotic process,positive regulation of GTPase activity,mitochondrial fragmentation involved in apoptotic process,intracellular distribution of mitochondria,positive regulation of protein secretion,protein oligomerization,protein homotetramerization,heart contraction,positive regulation of dendritic spine morphogenesis,membrane fusion,necroptotic process,mitochondrion morphogenesis,protein localization to mitochondrion,positive regulation of mitochondrial fission,mitochondrial membrane fission,positive regulation of release of cytochrome c from mitochondria,cellular response to oxygen-glucose deprivation,execution phase of apoptosis,regulation of peroxisome organization,regulation of mitophagy,regulation of ATP metabolic process,cellular response to thapsigargin,response to flavonoid,response to hypobaric hypoxia,positive regulation of intrinsic apoptotic signaling pathway,endoplasmic reticulum organization;;;;;;;GTPase activity,GTPase activator activity,protein binding,GTP binding,microtubule binding,lipid binding,Rab GTPase binding,GTP-dependent protein binding,ubiquitin protein ligase binding,protein homodimerization activity;;;;;;w;Golgi membrane,cytoplasm,mitochondrion,mitochondrial outer membrane,peroxisome,endoplasmic reticulum,endoplasmic reticulum membrane,Golgi apparatus,cytosol,brush border,clathrin-coated pit,membrane,cell junction,synaptic vesicle membrane,intracellular membrane-bounded organelle,protein complex,perinuclear region of cytoplasm,microtubule,mitochondrion-derived vesicle;;;;;;tr;sp;sp;sp;sp;sp;sp;sp 1;1;;;;;; 1;2;;;;;;>tr|G8JLD5|G8JLD5_HUMAN Dynamin-1-like protein OS=Homo sapiens GN=DNM1L PE=1 SV=1;>sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens GN=DNM1L PE=1 SV=2;>sp|O00429-2|DNM1L_HUMAN Isoform 4 of Dynamin-1-like protein OS=Homo sapiens GN=DNM1L;>sp|O00429-3|DNM1L_HUMAN Isoform 2 of Dynamin-1-like protein OS=Homo sapiens GN=DNM1L;>sp|O00429-4|DNM1L_HUMAN Isoform 3 of Dynamin-1-like protein OS=Homo sapiens GN=DNM1L;>sp|O00429-5|DNM1L_HUMAN Isoform 5 of Dynamin-1-like protein OS=Homo sapiens GN=DNM1L;>sp|O00429-6|DNM1L_HUMAN Isoform 6 of Dynamin-1-like protein OS=Homo sapiens GN=DNM1L;>sp|O00429-8|DNM1L_HUMAN Isoform 8 of Dynamin-1-like protein OS=Homo sapiens GN=DNM1L H0YAC1;P03952KLKB1H0YAC1_HUMAN;KLKB1_HUMAN.Plasma kallikrein (Fragment);Plasma kallikrein;Factor XII activation,proteolysis,blood coagulation, intrinsic pathway,extracellular matrix disassembly,zymogen activation,plasminogen activation,fibrinolysis,positive regulation of fibrinolysis3;serine-type endopeptidase activity,protein bindingO;extracellular region,extracellular space,plasma membrane,extracellular exosome>tr|H0YAC1|H0YAC1_HUMAN Plasma kallikrein (Fragment) OS=Homo sapiens GN=KLKB1 PE=1 SV=1;>sp|P03952|KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1H7BY64;Q96NZ9;Q96NZ9-4ZNF511-PRAP1;PRAP1;PRAP1$H7BY64_HUMAN;PRAP1_HUMAN;PRAP1_HUMANhProtein ZNF511-PRAP1 (Fragment);Proline-rich acidic protein 1;Isoform 4 of Proline-rich acidic protein 1;;7nucleic acid binding,metal ion binding;protein binding;;extracellular region;4;1;2;2;>tr|H7BY64|H7BY64_HUMAN Protein ZNF511-PRAP1 (Fragment) OS=Homo sapiens GN=ZNF511-PRAP1 PE=4 SV=2;>sp|Q96NZ9|PRAP1_HUMAN Proline-rich acidic protein 1 OS=Homo sapiens GN=PRAP1 PE=1 SV=2;>sp|Q96NZ9-4|PRAP1_HUMAN Isoform 4 of Proline-rich acidic protein 1 OS=Homo sapiens GN=PRAP1&I3L0A1;J3KPA1;P54108;P54108-2;P54108-3CRISP3=I3L0A1_HUMAN;J3KPA1_HUMAN;CRIS3_HUMAN;CRIS3_HUMAN;CRIS3_HUMANCysteine-rich secretory protein 3 (Fragment);Cysteine-rich secretory protein 3;Cysteine-rich secretory protein 3;Isoform 2 of < Cysteine-rich secretory protein 3;Isoform 3 of Cysteine-rich secretory protein 3D;;defense response,neutrophil degranulation,innate immune response;;;;molecular_function;;;;extracellular region,proteinaceous extracellular matrix,extracellular space,specific granule lumen,specific granule,extracellular exosome,tertiary granule lumen;;>tr|I3L0A1|I3L0A1_HUMAN Cysteine-rich secretory protein 3 (Fragment) OS=Homo sapiens GN=CRISP3 PE=1 SV=1;>tr|J3KPA1|J3KPA1_HUMAN Cysteine-rich secretory protein 3 OS=Homo sapiens GN=CRISP3 PE=1 SV=1;>sp|P54108|CRIS3_HUMAN Cysteine-rich secretory protein 3 OS=Homo sapiens GN=CRISP3 PE=1 SV=1;>sp|P54108-2|CRIS3_HUMAN Isoform 2 of Cysteine-rich secretory protein 3 OS=Homo sapiens GN=CRISP3;>sp|P54108-3|CRIS3_HUMAN Isoform 3 of Cysteine-rich secretory protein 3 OS=Homo sapiens GN=CRISP3J3KQ66;P78509;P78509-2;P78509-3RELN-J3KQ66_HUMAN;RELN_HUMAN;RELN_HUMAN;RELN_HUMAN5Reelin;Reelin;Isoform 2 of Reelin;Isoform 3 of Reelin;cell morphogenesis involved in differentiation,neuron migration,proteolysis,cell adhesion,axon guidance,central nervous system development,brain development,long-term memory,associative learning,glial cell differentiation,positive regulation of neuron projection development,positive regulation of phosphatidylinositol 3-kinase signaling,dendrite development,peptidyl-tyrosine phosphorylation,spinal cord patterning,ventral spinal cord development,hippocampus development,cerebral cortex tangential migration,layer formation in cerebral cortex,positive regulation of TOR signaling,positive regulation of CREB transcription factor activity,protein localization to synapse,reelin-mediated signaling pathway,positive regulation of protein kinase activity,response to pain,positive regulation of peptidyl-tyrosine phosphorylation,regulation of behavior,modulation of synaptic transmission,positive regulation of small GTPase mediated signal transduction,positive regulation of synaptic transmission, glutamatergic,long-term synaptic potentiation,positive regulation of dendritic spine morphogenesis,positive regulation of protein tyrosine kinase activity,positive regulation of synapse maturation,NMDA glutamate receptor clustering,postsynaptic density protein 95 clustering,receptor localization to synapse,lateral motor column neuron migration,positive regulation of long-term synaptic potentiation,positive regulation of lateral motor column neuron migration,regulation of N-methyl-D-aspartate selective glutamate receptor activity,positive regulation of excitatory postsynaptic potential,positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity;;;protein serine/threonine/tyrosine kinase activity,serine-type peptidase activity,metal ion binding,lipoprotein particle receptor binding,very-low-density lipoprotein particle receptor binding;;q;extracellular region,proteinaceous extracellular matrix,extracellular space,cytoplasm,plasma membrane,dendrite;; tr;sp;sp;sp1;1;;1;3;;>tr|J3KQ66|J3KQ66_HUMAN Reelin OS=Homo sapiens GN=RELN PE=1 SV=1;>sp|P78509|RELN_HUMAN Reelin OS=Homo sapiens GN=RELN PE=1 SV=3;>sp|P78509-2|RELN_HUMAN Isoform 2 of Reelin OS=Homo sapiens GN=RELN;>sp|P78509-3|RELN_HUMAN Isoform 3 of Reelin OS=Homo sapiens GN=RELNK7ER74 APOC4-APOC2 K7ER74_HUMANProtein APOC4-APOC2T>tr|K7ER74|K7ER74_HUMAN Protein APOC4-APOC2 OS=Homo sapiens GN=APOC4-APOC2 PE=1 SV=1O00187MASP2 MASP2_HUMAN'Mannan-binding lectin serine protease 2pcomplement activation, lectin pathway,proteolysis,complement activation,complement activation, classical pathwaycomplement component C4b binding,serine-type endopeptidase activity,calcium ion binding,protein binding,peptidase activity,calcium-dependent protein binding>extracellular region,extracellular space,extracellular exosomea>sp|O00187|MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4O00264PGRMC1 PGRC1_HUMAN5Membrane-associated progesterone receptor component 1neutrophil degranulation,steroid binding,protein binding,heme bindingendoplasmic reticulum membrane,plasma membrane,endomembrane system,membrane,integral component of membrane,specific granule membrane,extracellular exosomep>sp|O00264|PGRC1_HUMAN Membrane-associated progesterone receptor component 1 OS=Homo sapiens GN=PGRMC1 PE=1 SV=3O00299CLIC1 CLIC1_HUMAN(Chloride intracellular channel protein 1chloride transport,signal transduction,regulation of ion transmembrane transport,positive regulation of osteoblast differentiation,regulation of cell cycle,regulation of mitochondrial membrane potential,platelet aggregation,chloride transmembrane transport]voltage-gated ion channel activity,chloride channel activity,protein binding,cadherin bindingextracellular space,nucleus,nuclear envelope,cytoplasm,mitochondrion,plasma membrane,brush border,membrane,nuclear membrane,vesicle,chloride channel complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticleb>sp|O00299|CLIC1_HUMAN Chloride intracellular channel protein 1 OS=Homo sapiens GN=CLIC1 PE=1 SV=4O00592;O00592-2PODXL PODXL_HUMAN$Podocalyxin;Isoform 2 of PodocalyxinRcell adhesion,negative regulation of cell adhesion,cell migration,negative regulation of cell-cell adhesion,positive regulation of cell migration,regulation of microvillus assembly,positive regulation of cell-cell adhesion mediated by integrin,leukocyte migration,glomerular visceral epithelial cell development,epithelial tube formation;protein binding;.ruffle,extracellular space,nucleolus,cytoplasm,microtubule organizing center,plasma membrane,integral component of plasma membrane,apical plasma membrane,lamellipodium,filopodium,microvillus membrane,slit diaphragm,intracellular membrane-bounded organelle,cell body,membrane raft,extracellular exosome;1;2;>sp|O00592|PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2;>sp|O00592-2|PODXL_HUMAN Isoform 2 of Podocalyxin OS=Homo sapiens GN=PODXLO00602FCN1 FCN1_HUMAN Ficolin-1mcomplement activation, lectin pathway,cell surface pattern recognition receptor signaling pathway,proteolysis,complement activation,G-protein coupled receptor signaling pathway,protein localization to cell surface,neutrophil degranulation,recognition of apoptotic cell,negative regulation of viral entry into host cell,positive regulation of interleukin-8 secretionG-protein coupled receptor binding,serine-type endopeptidase activity,protein binding,signaling pattern recognition receptor activity,carbohydrate binding,sialic acid binding,metal ion bindingextracellular region,collagen trimer,extrinsic component of external side of plasma membrane,secretory granule lumen,ficolin-1-rich granule lumenA>sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens GN=FCN1 PE=1 SV=2O14745SLC9A3R1 NHRF1_HUMAN/Na(+)/H(+) exchange regulatory cofactor NHE-RF1_renal sodium ion transport,protein complex assembly,adenylate cyclase-activating dopamine receptor signaling pathway,sensory perception of sound,negative regulation of cell proliferation,regulation of cell shape,regulation of cell size,negative regulation of platelet-derived growth factor receptor signaling pathway,negative regulation of phosphatidylinositol 3-kinase signaling,Wnt signaling pathway,cAMP-mediated signaling,gland morphogenesis,microvillus assembly,actin cytoskeleton organization,negative regulation of cell migration,cellular phosphate ion homeostasis,regulation of sodium:proton antiporter activity,negative regulation of sodium:proton antiporter activity,bile acid secretion,glutathione transport,negative regulation of catenin import into nucleus,establishment of nucleus localization,regulation of excretion,establishment of epithelial cell apical/basal polarity,regulation of protein kinase activity,negative regulation of mitotic cell cycle,establishment of Golgi localization,negative regulation of protein kinase B signaling,auditory receptor cell stereocilium organization,phospholipase C-activating dopamine receptor signaling pathway,renal absorption,negative regulation of ERK1 and ERK2 cascade,establishment of protein localization< to plasma membrane,renal phosphate ion absorption,positive regulation of intrinsic apoptotic signaling pathway&receptor binding,protein binding,beta-catenin binding,chloride channel regulator activity,phosphatase binding,PDZ domain binding,beta-2 adrenergic receptor binding,protein complex binding,protein complex scaffold,protein self-association,dopamine receptor binding,growth factor receptor bindingruffle,cytoplasm,microvillus,endomembrane system,actin cytoskeleton,membrane,apical plasma membrane,filopodium,brush border membrane,microvillus membrane,vesicle,stereocilium tip,membrane raft,perinuclear region of cytoplasm,extracellular exosome,cell periphery,sperm midpiece,nucleusl>sp|O14745|NHRF1_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF1 OS=Homo sapiens GN=SLC9A3R1 PE=1 SV=4O14791;O14791-2APOL1 APOL1_HUMAN0Apolipoprotein L1;Isoform 2 of Apolipoprotein L1lipid transport,receptor-mediated endocytosis,cholesterol metabolic process,cytolysis,killing of cells of other organism,lipoprotein metabolic process,innate immune response,chloride transmembrane transport;8chloride channel activity,protein binding,lipid binding;extracellular region,extracellular space,intrinsic component of membrane,very-low-density lipoprotein particle,high-density lipoprotein particle,blood microparticle;5;>sp|O14791|APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5;>sp|O14791-2|APOL1_HUMAN Isoform 2 of Apolipoprotein L1 OS=Homo sapiens GN=APOL1O15143ARPC1B ARC1B_HUMAN,Actin-related protein 2/3 complex subunit 1Bmovement of cell or subcellular component,response to estradiol,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,response to estrogen,ephrin receptor signaling pathway=structural constituent of cytoskeleton,actin filament bindingkcytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,tubulobulbar complex,extracellular exosomeg>sp|O15143|ARC1B_HUMAN Actin-related protein 2/3 complex subunit 1B OS=Homo sapiens GN=ARPC1B PE=1 SV=3O15144ARPC2 ARPC2_HUMAN+Actin-related protein 2/3 complex subunit 28movement of cell or subcellular component,positive regulation of lamellipodium assembly,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,membrane organization,positive regulation of substrate adhesion-dependent cell spreadingMstructural constituent of cytoskeleton,protein binding,actin filament bindingendosome,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,cell leading edge,muscle cell projection membrane,neuron projection,synapse,extracellular exosomee>sp|O15144|ARPC2_HUMAN Actin-related protein 2/3 complex subunit 2 OS=Homo sapiens GN=ARPC2 PE=1 SV=1O43150;O43150-2ASAP2 ASAP2_HUMANArf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2;Isoform 2 of Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2'positive regulation of GTPase activity;<GTPase activator activity,protein binding,metal ion binding;(plasma membrane,Golgi cisterna membrane;3;>sp|O43150|ASAP2_HUMAN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=ASAP2 PE=1 SV=3;>sp|O43150-2|ASAP2_HUMAN Isoform 2 of Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=ASAP2 O43790;P78385 KRT86;KRT83KRT86_HUMAN;KRT83_HUMAN=Keratin, type II cuticular Hb6;Keratin, type II cuticular Hb3`keratinization,cornification;aging,epidermis development,keratinization,hair cycle,cornificationYstructural molecule activity,protein binding;structural molecule activity,protein bindingoextracellular space,cytosol,keratin filament,extracellular exosome;extracellular space,cytosol,keratin filament>sp|O43790|KRT86_HUMAN Keratin, type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1;>sp|P78385|KRT83_HUMAN Keratin, type II cuticular Hb3 OS=Homo sapiens GN=KRT83 PE=1 SV=2O43866CD5L CD5L_HUMANCD5 antigen-likeuimmune system process,receptor-mediated endocytosis,apoptotic process,inflammatory response,cellular defense responsescavenger receptor activityeextracellular region,extracellular space,cytoplasm,membrane,extracellular exosome,blood microparticleH>sp|O43866|CD5L_HUMAN CD5 antigen-like OS=Homo sapiens GN=CD5L PE=1 SV=1O75083WDR1 WDR1_HUMANWD repeat-containing protein 1Sneutrophil mediated immunity,platelet degranulation,sensory perception of sound,regulation of cell shape,actin filament fragmentation,platelet formation,regulation of actin filament depolymerization,positive regulation of actin filament depolymerization,cortical cytoskeleton organization,locomotion,establishment of planar polarity of follicular epithelium,apical junction assembly,maintenance of epithelial cell apical/basal polarity,sarcomere organization,regulation of oligodendrocyte differentiation,regulation of ventricular cardiac muscle cell membrane repolarization,neutrophil migrationactin filament bindingpodosome,extracellular region,cytosol,cell-cell junction,cortical actin cytoskeleton,actomyosin, actin portion,cell projection,myelin sheath,extracellular exosomeV>sp|O75083|WDR1_HUMAN WD repeat-containing protein 1 OS=Homo sapiens GN=WDR1 PE=1 SV=4O75116ROCK2 ROCK2_HUMANRho-associated protein kinase 2`cytokinesis,positive regulation of protein phosphorylation,protein phosphorylation,smooth muscle contraction,I-kappaB kinase/NF-kappaB signaling,Rho protein signal transduction,positive regulation of endothelial cell migration,positive regulation of gene expression,positive regulation of centrosome duplication,negative regulation of angiogenesis,regulation of cell adhesion,cortical actin cytoskeleton organization,regulation of actin cytoskeleto      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdeghijklmnopqrstuvwxyz{|}~n organization,negative regulation of myosin-light-chain-phosphatase activity,viral RNA genome replication,regulation of circadian rhythm,regulation of keratinocyte differentiation,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,rhythmic process,centrosome duplication,regulation of stress fiber assembly,regulation of focal adhesion assembly,cellular response to testosterone stimulus,establishment of protein localization to plasma membrane,regulation of establishment of endothelial barrier,negative regulation of bicellular tight junction assembly,regulation of establishment of cell polarity,regulation of cell motilityRNA binding,protein serine/threonine kinase activity,structural molecule activity,protein binding,ATP binding,Rho GTPase binding,metal ion binding,Rho-dependent protein serine/threonine kinase activityPnucleus,centrosome,cytosol,plasma membrane,cytoplasmic ribonucleoprotein granuleY>sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4O75882;O75882-2ATRN ATRN_HUMAN Attractin;Isoform 2 of Attractininflammatory response,response to oxidative stress,cerebellum development,regulation of multicellular organism growth,myelination,pigmentation;'receptor activity,carbohydrate binding;jextracellular space,cytoplasm,plasma membrane,integral component of plasma membrane,extracellular exosome;>sp|O75882|ATRN_HUMAN Attractin OS=Homo sapiens GN=ATRN PE=1 SV=2;>sp|O75882-2|ATRN_HUMAN Isoform 2 of Attractin OS=Homo sapiens GN=ATRNO95445APOM APOM_HUMANApolipoprotein Mvretinoid metabolic process,response to glucose,cholesterol efflux,high-density lipoprotein particle remodeling,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,negative regulation of plasma lipoprotein particle oxidation,lipoprotein metabolic process,cholesterol homeostasis,reverse cholesterol transport,cellular oxidant detoxificationDlipid transporter activity,phospholipid binding,antioxidant activityextracellular region,integral component of plasma membrane,very-low-density lipoprotein particle,low-density lipoprotein particle,high-density lipoprotein particle,discoidal high-density lipoprotein particle,spherical high-density lipoprotein particle,extracellular exosome< H>sp|O95445|APOM_HUMAN Apolipoprotein M OS=Homo sapiens GN=APOM PE=1 SV=2P00387;P00387-2;P00387-3CYB5R3 NB5R3_HUMANvNADH-cytochrome b5 reductase 3;Isoform 2 of NADH-cytochrome b5 reductase 3;Isoform 3 of NADH-cytochrome b5 reductase 3cholesterol biosynthetic process,xenobiotic metabolic process,blood circulation,L-ascorbic acid metabolic process,neutrophil degranulation,oxidation-reduction process;;cytochrome-b5 reductase activity, acting on NAD(P)H,AMP binding,oxidoreductase activity,ADP binding,flavin adenine dinucleotide binding,NAD binding;;extracellular region,cytoplasm,mitochondrion,mitochondrial outer membrane,mitochondrial inner membrane,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,hemoglobin complex,membrane,azurophil granule lumen,extracellular exosome;;1;;3;;>sp|P00387|NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3;>sp|P00387-2|NB5R3_HUMAN Isoform 2 of NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3;>sp|P00387-3|NB5R3_HUMAN Isoform 3 of NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3P00450CP CERU_HUMAN CeruloplasminNcopper ion transport,cellular iron ion homeostasis,oxidation-reduction process9ferroxidase activity,copper ion binding,chaperone bindingeextracellular region,extracellular space,lysosomal membrane,extracellular exosome,blood microparticleC>sp|P00450|CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1P00451F8 FA8_HUMANCoagulation factor VIIIplatelet degranulation,proteolysis,ER to Golgi vesicle-mediated transport,acute-phase response,blood coagulation,blood coagulation, intrinsic pathway,platelet activation,COPII vesicle coating,oxidation-reduction process]serine-type endopeptidase activity,copper ion binding,protein binding,oxidoreductase activityGolgi membrane,extracellular region,extracellular space,endoplasmic reticulum lumen,plasma membrane,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membraneL>sp|P00451|FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1P00488F13A1 F13A_HUMANCoagulation factor XIII A chaingplatelet degranulation,blood coagulation,peptide cross-linking,blood coagulation, fibrin clot formationFprotein-glutamine gamma-glutamyltransferase activity,metal ion bindingEextracellular region,platelet alpha granule lumen,blood microparticleX>sp|P00488|F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4P00738HP HPT_HUMAN HaptoglobinDreceptor-mediated endocytosis,defense response,acute-phase response,positive regulation of cell death,response to hydrogen peroxide,defense response to bacterium,neutrophil degranulation,negative regulation of oxidoreductase activity,cellular oxidant detoxification,negative regulation of hydrogen peroxide catabolic process7protein binding,antioxidant activity,hemoglobin bindingextracellular region,extracellular space,haptoglobin-hemoglobin complex,specific granule lumen,extracellular exosome,endocytic vesicle lumen,blood microparticle,tertiary granule lumen@>sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens GN=HP PE=1 SV=1P00747PLG PLMN_HUMAN Plasminogenwplatelet degranulation,proteolysis,blood coagulation,negative regulation of cell proliferation,negative regulation of cell-substrate adhesion,extracellular matrix disassembly,fibrinolysis,cellular protein metabolic process,tissue remodeling,negative regulation of fibrinolysis,positive regulation of fibrinolysis,negative regulation of cell-cell adhesion mediated by cadherinserine-type endopeptidase activity,receptor binding,protein binding,serine-type peptidase activity,protein domain specific binding,apolipoprotein bindingextracellular region,extracellular space,plasma membrane,cell surface,platelet alpha granule lumen,extrinsic component of external side of plasma membrane,extracellular exosome,blood microparticleB>sp|P00747|PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2P00748F12 FA12_HUMANCoagulation factor XIITplasma kallikrein-kinin cascade,Factor XII activation,blood coagulation, intrinsic pathway,positive regulation of plasminogen activation,protein processing,protein autoprocessing,positive regulation of blood coagulation,zymogen activation,fibrinolysis,innate immune response,response to misfolded protein,positive regulation of fibrinolysis`serine-type endopeptidase activity,calcium ion binding,protein binding,misfolded protein bindingNextracellular region,extracellular space,plasma membrane,extracellular exosomeM>sp|P00748|FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3P01008SERPINC1 ANT3_HUMANAntithrombin-IIIacute inflammatory response to antigenic stimulus,response to nutrient,lactation,blood coagulation,negative regulation of endopeptidase activity,regulation of blood coagulation, intrinsic pathway]protease binding,serine-type endopeptidase inhibitor activity,protein binding,heparin bindingbextracellular region,extracellular space,plasma membrane,extracellular exosome,blood microparticleL>sp|P01008|ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1P01009SERPINA1 A1AT_HUMANAlpha-1-antitrypsinplatelet degranulation,ER to Golgi vesicle-mediated transport,acute-phase response,blood coagulation,negative regulation of endopeptidase activity,neutrophil degranulation,COPII vesicle coating|glycoprotein binding,protease binding,serine-type endopeptidase inhibitor activity,protein binding,identical protein bindingqGolgi membrane,extracellular region,proteinaceous extracellular matrix,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,Golgi apparatus,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,intracellular membrane-bounded organelle,extracellular exosome,ficolin-1-rich granule lumenO>sp|P01009|A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3P01011SERPINA3 AACT_HUMANAlpha-1-antichymotrypsinplatelet degranulation,acute-phase response,inflammatory response,negative regulation of endopeptidase activity,regulation of lipid metabolic process,maintenance of gastrointestinal epithelium,neutrophil degranulationHDNA binding,serine-type endopeptidase inhibitor activity,protein bindingextracellular region,extracellular space,intracellular,nucleus,platelet alpha granule lumen,secretory granule lumen,azurophil granule lumen,extracellular exosome,blood microparticleT>sp|P01011|AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2P01023A2M A2MG_HUMANAlpha-2-macroglobulin@negative regulation of complement activation, lectin pathway,platelet degranulation,blood coagulation, intrinsic pathway,negative regulation of endopeptidase activity,extracellular matrix disassembly,positive regulation of GTPase activity,stem cell differentiation,regulation of small GTPase mediated signal transduction protease binding,serine-type endopeptidase inhibitor activity,GTPase activator activity,receptor binding,protein binding,growth factor binding,enzyme binding,interleukin-8 binding,interleukin-1 binding,tumor necrosis factor binding,calcium-dependent protein bindingcextracellular region,cytosol,platelet alpha granule lumen,extracellular exosome,blood microparticleL>sp|P01023|A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3P01024C3 CO3_HUMAN Complement C3positive regulation of type IIa hypersensitivity,positive regulation of protein phosphorylation,positive regulation of activation of membrane attack complex,proteolysis,fatty acid metabolic process,inflammatory response,immune response,complement activation,complement activation, alternative pathway,complement activation, classical pathway,signal transduction,G-protein coupled receptor signaling pathway,positive regulation of vascular endothelial growth factor production,positive regulation of glucose transport,regulation of triglyceride biosynthetic process,positive regulation of lipid storage,negative regulation of endopeptidase activi< ty,regulation of complement activation,neutrophil degranulation,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of angiogenesis,regulation of immune response,positive regulation of apoptotic cell clearanceserine-type endopeptidase activity,endopeptidase inhibitor activity,receptor binding,protein binding,C5L2 anaphylatoxin chemotactic receptor bindingextracellular region,extracellular space,plasma membrane,secretory granule lumen,azurophil granule lumen,extracellular exosome,blood microparticleB>sp|P01024|CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2P01031C5 CO5_HUMAN Complement C5Zactivation of MAPK activity,in utero embryonic development,chemotaxis,response to stress,inflammatory response,complement activation,complement activation, alternative pathway,complement activation, classical pathway,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway,positive regulation of vascular endothelial growth factor production,negative regulation of macrophage chemotaxis,negative regulation of endopeptidase activity,cytolysis,regulation of complement activation,positive regulation of angiogenesis,cell chemotaxis,positive regulation of chemokine secretionTendopeptidase inhibitor activity,receptor binding,protein binding,chemokine activityVextracellular region,membrane attack complex,extracellular space,extracellular exosomeB>sp|P01031|CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4P01042KNG1 KNG1_HUMAN Kininogen-1aplatelet degranulation,inflammatory response,negative regulation of cell adhesion,positive regulation of cytosolic calcium ion concentration,blood coagulation, intrinsic pathway,negative regulation of endopeptidase activity,negative regulation of blood coagulation,vasodilation,positive regulation of apoptotic process,negative regulation of proteolysispcysteine-type endopeptidase inhibitor activity,receptor binding,protein binding,heparin binding,zinc ion bindingextracellular region,extracellular space,plasma membrane,platelet alpha granule lumen,extracellular exosome,blood microparticleC>sp|P01042|KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2P01137TGFB1 TGFB1_HUMAN!Transforming growth factor beta-18protein import into nucleus, translocation,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,vasculogenesis,ureteric bud development,response to hypoxia,epithelial to mesenchymal transition,neural tube closure,negative regulation of protein phosphorylation,positive regulation of protein phosphorylation,regulation of sodium ion transport,chondrocyte differentiation,hematopoietic progenitor cell differentiation,connective tissue replacement involved in inflammatory response wound healing,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,tolerance induction to self antigen,platelet degranulation,heart valve morphogenesis,protein phosphorylation,protein export from nucleus,ATP biosynthetic process,phosphate-containing compound metabolic process,cellular calcium ion homeostasis,inflammatory response,cell cycle arrest,mitotic cell cycle checkpoint,epidermal growth factor receptor signaling pathway,transforming growth factor beta receptor signaling pathway,common-partner SMAD protein phosphorylation,SMAD protein complex assembly,SMAD protein import into nucleus,Notch signaling pathway,negative regulation of neuroblast proliferation,salivary gland morphogenesis,endoderm development,heart development,female pregnancy,aging,negative regulation of DNA replication,positive regulation of cell proliferation,negative regulation of cell proliferation,germ cell migration,response to wounding,response to glucose,defense response to fungus, incompatible interaction,positive regulation of vascular endothelial growth factor production,positive regulation of gene expression,negative regulation of gene expression,negative regulation of extracellular matrix disassembly,positive regulation of epithelial to mesenchymal transition,macrophage derived foam cell differentiation,positive regulation of fibroblast migration,positive regulation of peptidyl-threonine phosphorylation,positive regulation of pathway-restricted SMAD protein phosphorylation,negative regulation of macrophage cytokine production,oligodendrocyte development,cell growth,regulation of striated muscle tissue development,cell migration,regulation of transforming growth factor beta receptor signaling pathway,evasion or tolerance of host defenses by virus,neural tube development,negative regulation of cell-cell adhesion,hyaluronan catabolic process,negative regulation of ossification,negative regulation of cell growth,regulation of cell migration,positive regulation of cell migration,positive regulation of bone mineralization,BMP signaling pathway,negative regulation of transforming growth factor beta receptor signaling pathway,positive regulation of histone deacetylation,membrane protein intracellular domain proteolysis,positive regulation of protein complex assembly,positive regulation of exit from mitosis,lipopolysaccharide-mediated signaling pathway,positive regulation of cellular protein metabolic process,response to estradiol,response to progesterone,regulation of interleukin-23 production,negative regulation of interleukin-17 production,positive regulation of interleukin-17 production,receptor catabolic process,positive regulation of superoxide anion generation,mononuclear cell proliferation,positive regulation of collagen biosynthetic process,positive regulation of peptidyl-serine phosphorylation,response to vitamin D,response to laminar fluid shear stress,positive regulation of histone acetylation,positive regulation of protein dephosphorylation,response to immobilization stress,negative regulation of T cell proliferation,regulation of protein import into nucleus,positive regulation of protein import into nucleus,positive regulation of odontogenesis,response to drug,myelination,regulation of apoptotic process,myeloid dendritic cell differentiation,T cell homeostasis,positive regulation of apoptotic process,positive regulation of vascular permeability,positive regulation of MAP kinase activity,protein kinase B signaling,positive regulation of blood vessel endothelial cell migration,negative regulation of blood vessel endothelial cell migration,positive regulation of phosphatidylinositol 3-kinase activity,ossification involved in bone remodeling,regulatory T cell differentiation,cell-cell junction organization,positive regulation of regulatory T cell differentiation,negative regulation of cell differentiation,negative regulation of fat cell differentiation,negative regulation of myoblast differentiation,negative regulation of cell cycle,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,negative regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,active induction of host immune response by virus,positive regulation of fibroblast proliferation,positive regulation of isotype switching to IgA isotypes,cell development,lymph node development,digestive tract development,negative regulation of skeletal muscle tissue development,inner ear development,positive regulation of epithelial cell proliferation,negative regulation of epithelial cell proliferation,positive regulation of protein secretion,positive regulation of peptidyl-tyrosine phosphorylation,negative regulation of phagocytosis,leukocyte migration,positive regulation of chemotaxis,positive regulation of NF-kappaB transcription factor activity,regulation of binding,regulation of DNA binding,positive regulation of smooth muscle cell differentiation,negative regulation of release of sequestered calcium ion into cytosol,positive regulation of cell division,positive regulation of protein kinase B signaling,ventricular cardiac muscle tissue morphogenesis,regulation of blood vessel remodeling,face morphogenesis,frontal suture morphogenesis,pathway-restricted SMAD protein phosphorylation,regulation of SMAD protein import into< nucleus,positive regulation of SMAD protein import into nucleus,SMAD protein signal transduction,mammary gland branching involved in thelarche,branch elongation involved in mammary gland duct branching,regulation of branching involved in mammary gland duct morphogenesis,negative regulation of gene silencing by miRNA,regulation of cartilage development,lens fiber cell differentiation,positive regulation of ERK1 and ERK2 cascade,response to cholesterol,positive regulation of cell cycle arrest,cellular response to mechanical stimulus,cellular response to organic cyclic compound,cellular response to ionizing radiation,cellular response to dexamethasone stimulus,cellular response to transforming growth factor beta stimulus,positive regulation of mononuclear cell migration,extracellular matrix assembly,positive regulation of branching involved in ureteric bud morphogenesis,extrinsic apoptotic signaling pathway,liver regeneration,negative regulation of hyaluronan biosynthetic process,positive regulation of extracellular matrix assembly,positive regulation of NAD+ ADP-ribosyltransferase activity,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,negative regulation of protein localization to plasma membrane,negative regulation of production of miRNAs involved in gene silencing by miRNA,positive regulation of receptor clustering,transforming growth factor beta receptor signaling pathway involved in heart development,cellular response to insulin-like growth factor stimulus,embryonic liver development,regulation of actin cytoskeleton reorganization,positive regulation of transcription regulatory region DNA binding,positive regulation of cardiac muscle cell differentiation,regulation of epithelial to mesenchymal transition involved in endocardial cushion formationglycoprotein binding,antigen binding,type II transforming growth factor beta receptor binding,cytokine activity,transforming growth factor beta receptor binding,protein binding,growth factor activity,enzyme binding,type I transforming growth factor beta receptor binding,type III transforming growth factor beta receptor binding,protein homodimerization activity,protein serine/threonine kinase activator activity,protein heterodimerization activity,protein N-terminus bindingextracellular region,proteinaceous extracellular matrix,extracellular space,nucleus,cytoplasm,Golgi lumen,plasma membrane,cell surface,axon,extracellular matrix,platelet alpha granule lumen,neuronal cell body,blood microparticle,microvillus[>sp|P01137|TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2P01591JCHAIN IGJ_HUMANImmunoglobulin J chainretina homeostasis,adaptive immune response,glomerular filtration,receptor-mediated endocytosis,immune response,antibacterial humoral response,positive regulation of protein oligomerization,innate immune response,leukocyte migration,positive regulation of respiratory burstantigen binding,IgA binding,protein binding, bridging,protein homodimerization activity,single-stranded DNA binding,phosphatidylcholine binding,immunoglobulin receptor binding,peptidoglycan binding7extracellular region,extracellular space,extracellular exosome,monomeric IgA immunoglobulin complex,dimeric IgA immunoglobulin complex,secretory IgA immunoglobulin complex,secretory dimeric IgA immunoglobulin complex,pentameric IgM immunoglobulin complex,blood microparticle,hexameric IgM immunoglobulin complexO>sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens GN=JCHAIN PE=1 SV=4P01602IGKV1-5 KV105_HUMAN!Immunoglobulin kappa variable 1-5'immunoglobulin production,proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response,leukocyte migration2antigen binding,serine-type endopeptidase activityNextracellular region,plasma membrane,extracellular exosome,blood microparticle]>sp|P01602|KV105_HUMAN Immunoglobulin kappa variable 1-5 OS=Homo sapiens GN=IGKV1-5 PE=1 SV=2P01701IGLV1-51 LV151_HUMAN#Immunoglobulin lambda variable 1-51 proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response,leukocyte migration:extracellular region,plasma membrane,extracellular exosome`>sp|P01701|LV151_HUMAN Immunoglobulin lambda variable 1-51 OS=Homo sapiens GN=IGLV1-51 PE=1 SV=2P01705IGLV2-23 LV223_HUMAN#Immunoglobulin lambda variable 2-23$extracellular region,plasma membrane`>sp|P01705|LV223_HUMAN Immunoglobulin lambda variable 2-23 OS=Homo sapiens GN=IGLV2-23 PE=1 SV=2P01709IGLV2-8 LV208_HUMAN"Immunoglobulin lambda variable 2-8^>sp|P01709|LV208_HUMAN Immunoglobulin lambda variable 2-8 OS=Homo sapiens GN=IGLV2-8 PE=1 SV=2P01766IGHV3-13 HV313_HUMAN"Immunoglobulin heavy variable 3-13_>sp|P01766|HV313_HUMAN Immunoglobulin heavy variable 3-13 OS=Homo sapiens GN=IGHV3-13 PE=1 SV=2P01772IGHV3-33 HV333_HUMAN"Immunoglobulin heavy variable 3-33_>sp|P01772|HV333_HUMAN Immunoglobulin heavy variable 3-33 OS=Homo sapiens GN=IGHV3-33 PE=1 SV=2P01780IGHV3-7 HV307_HUMAN!Immunoglobulin heavy variable 3-7]>sp|P01780|HV307_HUMAN Immunoglobulin heavy variable 3-7 OS=Homo sapiens GN=IGHV3-7 PE=1 SV=2P01833PIGR PIGR_HUMAN!Polymeric immunoglobulin receptor<detection of chemical stimulus involved in sensory perception of bitter taste,retina homeostasis,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,epidermal growth factor receptor signaling pathway,Fc receptor signaling pathway,receptor clustering,neutrophil degranulation*polymeric immunoglobulin receptor activityextracellular space,plasma membrane,integral component of plasma membrane,azurophil granule membrane,receptor complex,extracellular exosomeY>sp|P01833|PIGR_HUMAN Polymeric immunoglobulin receptor OS=Homo sapiens GN=PIGR PE=1 SV=4P02042HBD HBD_HUMANHemoglobin subunit delta"blood coagulation,oxygen transportXoxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding.cytosol,hemoglobin complex,blood microparticleN>sp|P02042|HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2P02549SPTA1 SPTA1_HUMAN$Spectrin alpha chain, erythrocytic 1zMAPK cascade,lymphocyte homeostasis,porphyrin-containing compound biosynthetic process,ER to Golgi vesicle-mediated transport,plasma membrane organization,actin filament organization,axon guidance,regulation of cell shape,hemopoiesis,positive regulation of protein binding,positive regulation of T cell proliferation,positive regulation of GTPase activity,actin filament cappingRas guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,calcium ion binding,protein binding,protein heterodimerization activity,actin filament bindingcytosol,spectrin,spectrin-associated cytoskeleton,actin cytoskeleton,axon,intrinsic component of the cytoplasmic side of the plasma membrane,cuticular plate^>sp|P02549|SPTA1_HUMAN Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens GN=SPTA1 PE=1 SV=5P02649APOE APOE_HUMANApolipoprotein EJ response to reactive oxygen species,retinoid metabolic process,negative regulation of endothelial cell proliferation,response to dietary excess,regulation of transcription from RNA polymerase II promoter,triglyceride metabolic process,cholesterol catabolic process,cellular calcium ion homeostasis,receptor-mediated endocytosis,cytoskeleton organization,G-protein coupled receptor signaling pathway,nitric oxide mediated signal transduction,synaptic transmission, cholinergic,cholesterol metabolic process,negative regulation of platelet activation,positive regulation of cholesterol esterification,positive regulation of cholesterol efflux,lipid transport involved in lipid storage,positive regulation of neuron projection development,negative regulation of neuron projec< tion development,long-chain fatty acid transport,protein import,virion assembly,triglyceride catabolic process,cGMP-mediated signaling,negative regulation of blood coagulation,regulation of axon extension,positive regulation of cGMP biosynthetic process,neuron projection regeneration,negative regulation of cellular protein metabolic process,regulation of Cdc42 protein signal transduction,positive regulation of low-density lipoprotein particle receptor catabolic process,cholesterol efflux,phospholipid efflux,very-low-density lipoprotein particle remodeling,low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,high-density lipoprotein particle assembly,chylomicron remnant clearance,high-density lipoprotein particle clearance,very-low-density lipoprotein particle clearance,lipoprotein metabolic process,lipoprotein biosynthetic process,lipoprotein catabolic process,vasodilation,cholesterol homeostasis,negative regulation of MAP kinase activity,negative regulation of neuron apoptotic process,negative regulation of blood vessel endothelial cell migration,reverse cholesterol transport,positive regulation by host of viral process,negative regulation of cholesterol biosynthetic process,positive regulation of endocytosis,positive regulation of lipid biosynthetic process,intracellular transport,regulation of neuronal synaptic plasticity,artery morphogenesis,negative regulation of inflammatory response,positive regulation of nitric-oxide synthase activity,positive regulation of membrane protein ectodomain proteolysis,maintenance of location in cell,fatty acid homeostasis,positive regulation of dendritic spine development,triglyceride homeostasis,negative regulation of canonical Wnt signaling pathway,negative regulation of triglyceride metabolic process,AMPA glutamate receptor clustering,NMDA glutamate receptor clustering,cellular oxidant detoxification,regulation of beta-amyloid clearance,negative regulation of long-term synaptic potentiation,negative regulation of neuron death,positive regulation of postsynaptic membrane organization,negative regulation of presynaptic membrane organization,negative regulation of beta-amyloid formation,positive regulation of dendritic spine maintenance,positive regulation of phospholipid efflux,positive regulation of lipid transport across blood brain barrier,Requires Ontologybeta-amyloid binding,lipid transporter activity,protein binding,phospholipid binding,heparin binding,lipid binding,cholesterol binding,antioxidant activity,cholesterol transporter activity,identical protein binding,protein homodimerization activity,metal chelating activity,tau protein binding,low-density lipoprotein particle receptor binding,phosphatidylcholine-sterol O-acyltransferase activator activity,very-low-density lipoprotein particle receptor binding,lipoprotein particle bindingextracellular region,extracellular space,nucleus,cytoplasm,early endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,membrane,dendrite,extracellular matrix,very-low-density lipoprotein particle,low-density lipoprotein particle,intermediate-density lipoprotein particle,high-density lipoprotein particle,chylomicron,neuronal cell body,extracellular exosome,endocytic vesicle lumen,blood microparticle,extracellular vesicleH>sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 P02652;V9GYM3APOA2APOA2_HUMAN;V9GYM3_HUMANApolipoprotein A-IIretinoid metabolic process,acute inflammatory response,negative regulation of cytokine secretion involved in immune response,triglyceride metabolic process,phosphatidylcholine biosynthetic process,cholesterol metabolic process,phospholipid catabolic process,response to glucose,positive regulation of cholesterol esterification,negative regulation of very-low-density lipoprotein particle remodeling,viral process,protein oxidation,peptidyl-methionine modification,regulation of intestinal cholesterol absorption,animal organ regeneration,regulation of protein stability,negative regulation of cholesterol transport,cholesterol efflux,phospholipid efflux,triglyceride-rich lipoprotein particle remodeling,low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,lipoprotein metabolic process,lipoprotein biosynthetic process,response to drug,cholesterol homeostasis,positive regulation of catalytic activity,response to estrogen,reverse cholesterol transport,positive regulation of interleukin-8 biosynthetic process,diacylglycerol catabolic process,negative regulation of lipid catabolic process,positive regulation of lipid catabolic process,response to glucocorticoid,negative regulation of lipase activity,negative regulation of cholesterol import,negative regulation of cholesterol transporter activity;lipid transporter activity,protein binding,phospholipid binding,high-density lipoprotein particle binding,lipid binding,cholesterol binding,phosphatidylcholine binding,apolipoprotein receptor binding,protein homodimerization activity,protein heterodimerization activity,lipase inhibitor activity,phosphatidylcholine-sterol O-acyltransferase activator activity,high-density lipoprotein particle receptor binding,cholesterol transporter activity;extracellular region,early endosome,endoplasmic reticulum lumen,cytosol,very-low-density lipoprotein particle,high-density lipoprotein particle,spherical high-density lipoprotein particle,chylomicron,extracellular exosome,blood microparticle;sp;tr>sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1;>tr|V9GYM3|V9GYM3_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1P02671FGA FIBA_HUMANFibrinogen alpha chaintoll-like receptor signaling pathway,adaptive immune response,platelet degranulation,protein complex assembly,cell-matrix adhesion,blood coagulation,extracellular matrix organization,plasminogen activation,positive regulation of heterotypic cell-cell adhesion,fibrinolysis,induction of bacterial agglutination,cellular protein complex assembly,cellular protein metabolic process,innate immune response,positive regulation of vasoconstriction,positive regulation of exocytosis,positive regulation of protein secretion,protein polymerization,response to calcium ion,positive regulation of ERK1 and ERK2 cascade,platelet aggregation,blood coagulation, common pathway,blood coagulation, fibrin clot formation,positive regulation of peptide hormone secretion,positive regulation of substrate adhesion-dependent cell spreading,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of endothelial cell apoptotic processstructural molecule activity,protein binding,protein binding, bridging,metal ion binding,receptor binding,cell adhesion molecule bindingextracellular region,fibrinogen complex,extracellular space,plasma membrane,cell cortex,external side of plasma membrane,cell surface,platelet alpha granule,platelet alpha granule lumen,extracellular exosome,blood microparticle,extracellular vesicleM>sp|P02671|FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2P02675FGB FIBB_HUMANFibrinogen beta chaintoll-like receptor signaling pathway,adaptive immune response,platelet degranulation,cell-matrix adhesion,blood coagulation,extracellular matrix organization,plasminogen activation,positive regulation of heterotypic cell-cell adhesion,fibrinolysis,induction of bacterial agglutination,cellular protein complex assembly,cellular response to leptin stimulus,innate immune response,positive regulation of vasoconstriction,positive regulation of exocytosis,positive regulation of protein secretion,protein polymerization,response to calcium ion,positive regulation of ERK1 and ERK2 cascade,platelet aggregation,cellular response to interleukin-1,blood coagulation, fibrin clot formation,positive regulation of peptide hormone secretion,positive regulation of substrate adhesion-dependent cell spreading,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of endothelial cell apoptoti< c processstructural molecule activity,protein binding,protein binding, bridging,chaperone binding,receptor binding,cell adhesion molecule bindingL>sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2P02679FGG FIBG_HUMANFibrinogen gamma chaintoll-like receptor signaling pathway,platelet degranulation,cell-matrix adhesion,blood coagulation,protein secretion,extracellular matrix organization,plasminogen activation,positive regulation of heterotypic cell-cell adhesion,platelet maturation,fibrinolysis,cellular protein complex assembly,positive regulation of vasoconstriction,positive regulation of exocytosis,positive regulation of protein secretion,protein polymerization,response to calcium ion,positive regulation of ERK1 and ERK2 cascade,platelet aggregation,cellular response to interleukin-1,cellular response to interleukin-6,blood coagulation, fibrin clot formation,positive regulation of peptide hormone secretion,negative regulation of platelet aggregation,positive regulation of substrate adhesion-dependent cell spreading,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of endothelial cell apoptotic processreceptor binding,structural molecule activity,protein binding,protein binding, bridging,protein homodimerization activity,metal ion binding,cell adhesion molecule bindingextracellular region,fibrinogen complex,extracellular space,plasma membrane,cell cortex,external side of plasma membrane,cell surface,platelet alpha granule,platelet alpha granule lumen,extracellular exosome,blood microparticleM>sp|P02679|FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3P02745C1QA C1QA_HUMAN%Complement C1q subcomponent subunit Aproteolysis,complement activation,complement activation, classical pathway,cell-cell signaling,response to iron ion,innate immune response2serine-type endopeptidase activity,protein bindingZextracellular region,collagen trimer,complement component C1 complex,extracellular exosome]>sp|P02745|C1QA_HUMAN Complement C1q subcomponent subunit A OS=Homo sapiens GN=C1QA PE=1 SV=2P02747C1QC C1QC_HUMAN%Complement C1q subcomponent subunit Cproteolysis,immune response,complement activation,complement activation, classical pathway,negative regulation of granulocyte differentiation,innate immune response,negative regulation of macrophage differentiationbextracellular region,collagen trimer,extracellular space,extracellular exosome,blood microparticle]>sp|P02747|C1QC_HUMAN Complement C1q subcomponent subunit C OS=Homo sapiens GN=C1QC PE=1 SV=3P02748C9 CO9_HUMANComplement component C9cell killing,complement activation, alternative pathway,complement activation, classical pathway,hemolysis by symbiont of host erythrocytes,regulation of complement activation,protein homooligomerizationextracellular region,membrane attack complex,extracellular space,cytosol,plasma membrane,integral component of plasma membrane,other organism cell membrane,extracellular exosome,blood microparticleL>sp|P02748|CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2P02749APOH APOH_HUMANBeta-2-glycoprotein 1Jnegative regulation of endothelial cell proliferation,platelet degranulation,triglyceride metabolic process,blood coagulation, intrinsic pathway,negative regulation of endothelial cell migration,negative regulation of angiogenesis,positive regulation of blood coagulation,negative regulation of blood coagulation,plasminogen activation,negative regulation of myeloid cell apoptotic process,triglyceride transport,negative regulation of smooth muscle cell apoptotic process,positive regulation of lipoprotein lipase activity,regulation of fibrinolysis,negative regulation of fibrinolysisglycoprotein binding,protein binding,phospholipid binding,heparin binding,lipid binding,identical protein binding,lipoprotein lipase activator activityextracellular region,extracellular space,cell surface,platelet dense granule lumen,very-low-density lipoprotein particle,high-density lipoprotein particle,chylomicron,extracellular exosome,extracellular matrixM>sp|P02749|APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3P02750LRG1 A2GL_HUMAN!Leucine-rich alpha-2-glycoproteinpositive regulation of endothelial cell proliferation,biological_process,positive regulation of transforming growth factor beta receptor signaling pathway,neutrophil degranulation,positive regulation of angiogenesis,brown fat cell differentiationCmolecular_function,transforming growth factor beta receptor bindingextracellular region,extracellular space,membrane,specific granule lumen,intracellular membrane-bounded organelle,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenY>sp|P02750|A2GL_HUMAN Leucine-rich alpha-2-glycoprotein OS=Homo sapiens GN=LRG1 PE=1 SV=2P02751FN1 FINC_HUMAN FibronectinMangiogenesis,regulation of protein phosphorylation,platelet degranulation,acute-phase response,cell-substrate junction assembly,cell adhesion,calcium-independent cell-matrix adhesion,positive regulation of cell proliferation,regulation of cell shape,response to wounding,positive regulation of gene expression,positive regulation of peptidase activity,peptide cross-linking,extracellular matrix disassembly,extracellular matrix organization,integrin activation,substrate adhesion-dependent cell spreading,endodermal cell differentiation,wound healing,positive regulation of axon extension,positive regulation of fibroblast proliferation,leukocyte migration,regulation of ERK1 and ERK2 cascade,positive regulation of substrate-dependent cell migration, cell attachment to substrate,negative regulation of transforming growth factor-beta secretionprotease binding,integrin binding,protein binding,collagen binding,heparin binding,peptidase activator activity,identical protein bindingextracellular region,fibrinogen complex,proteinaceous extracellular matrix,basal lamina,extracellular space,endoplasmic reticulum-Golgi intermediate compartment,apical plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome,blood microparticleB>sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 P02753;Q5VY30RBP4RET4_HUMAN;Q5VY30_HUMANJRetinol-binding protein 4;Retinol binding protein 4, plasma, isoform CRA_bretinoid metabolic process,eye development,gluconeogenesis,heart development,visual perception,maintenance of gastrointestinal epithelium,lung development,positive regulation of insulin secretion,response to retinoic acid,retinol transport,retinol metabolic process,glucose homeostasis,response to ethanol,embryonic organ morphogenesis,embryonic skeletal system development,cardiac muscle tissue development,female genitalia morphogenesis,positive regulation of immunoglobulin secretion,negative regulation of cardiac muscle cell proliferation,embryonic retina morphogenesis in camera-type eye,uterus development,vagina development,urinary bladder development,heart trabecula formation;qprotein binding,retinal binding,retinol binding,retinol transporter activity,protein heterodimerization activity;Wextracellular region,extracellular space,cytosol,protein complex,extracellular exosome;3;2>sp|P02753|RET4_HUMAN Retinol-binding protein 4 OS=Homo sapiens GN=RBP4 PE=1 SV=3;>tr|Q5VY30|Q5VY30_HUMAN Retinol binding protein 4, plasma, isoform CRA_b OS=Homo sapiens GN=RBP4 PE=1 SV=2P02760AMBP AMBP_HUMAN Protein AMBPreceptor-mediated endocytosis,cell adhesion,female pregnancy,negative regulation of endopeptidase activity,viral process,protein-chromophore linkage,protein catabolic process,heme catabolic process,negative regulation of JNK cascade,negative regulation of immune responseserine-type endopeptidase inhibitor activity,protein binding,calcium channel inhibitor activity,IgA binding,heme binding,small molecule binding,protein homodimerization activity,calcium oxalate bindingextracellular region,extracellular space,plasma membrane,cell surface,intracellular membrane-bounded organelle,extracellular exosome,blood microparticleD>sp|P02760|AMBP_H< UMAN Protein AMBP OS=Homo sapiens GN=AMBP PE=1 SV=1P02768ALB ALBU_HUMAN Serum albuminretina homeostasis,platelet degranulation,transport,receptor-mediated endocytosis,cellular response to starvation,bile acid and bile salt transport,hemolysis by symbiont of host erythrocytes,lipoprotein metabolic process,negative regulation of apoptotic process,negative regulation of programmed cell death,sodium-independent organic anion transport,maintenance of mitochondrion location,cellular oxidant detoxificationDNA binding,fatty acid binding,copper ion binding,protein binding,drug binding,toxic substance binding,antioxidant activity,pyridoxal phosphate binding,identical protein binding,chaperone binding,oxygen bindingextracellular region,extracellular space,nucleus,endoplasmic reticulum,Golgi apparatus,platelet alpha granule lumen,myelin sheath,protein complex,extracellular exosome,blood microparticleD>sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2P02786TFRC TFR1_HUMANTransferrin receptor protein 1cellular iron ion homeostasis,osteoclast differentiation,positive regulation of B cell proliferation,receptor internalization,transferrin transport,cellular response to drug,positive regulation of T cell proliferation,positive regulation of bone resorption,positive regulation of isotype switching,viral entry into host cell,membrane organization,iron ion import,regulation of cell growth,regulation of cell proliferationvirus receptor activity,glycoprotein binding,RNA binding,double-stranded RNA binding,transferrin receptor activity,protein binding,transferrin transmembrane transporter activity,identical protein binding,protein homodimerization activityextracellular region,extracellular space,endosome,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,cell surface,membrane,basolateral plasma membrane,clathrin-coated vesicle membrane,cytoplasmic vesicle,melanosome,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,blood microparticle,extracellular vesicle,HFE-transferrin receptor complexV>sp|P02786|TFR1_HUMAN Transferrin receptor protein 1 OS=Homo sapiens GN=TFRC PE=1 SV=2P02787TF TRFE_HUMANSerotransferrinretina homeostasis,platelet degranulation,cellular iron ion homeostasis,regulation of protein stability,transferrin transport,positive regulation of receptor-mediated endocytosis,iron ion homeostasis,membrane organization,cellular response to iron ion,ferrous iron import into cellprotein binding,ferrous iron binding,ferric iron binding,ferric iron transmembrane transporter activity,transferrin receptor bindingextracellular region,extracellular space,early endosome,late endosome,clathrin-coated pit,basal plasma membrane,cell surface,endosome membrane,apical plasma membrane,endocytic vesicle,clathrin-coated vesicle membrane,extrinsic component of external side of plasma membrane,cytoplasmic vesicle,vesicle,secretory granule lumen,basal part of cell,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,blood microparticle,HFE-transferrin receptor complexE>sp|P02787|TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3P02790HPX HEMO_HUMAN Hemopexinpositive regulation of immunoglobulin production,positive regulation of humoral immune response mediated by circulating immunoglobulin,cellular iron ion homeostasis,receptor-mediated endocytosis,heme transport,viral process,hemoglobin metabolic process,heme metabolic process,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of interferon-gamma-mediated signaling pathway;protein binding,heme transporter activity,metal ion bindingjextracellular region,extracellular space,extracellular exosome,endocytic vesicle lumen,blood microparticle@>sp|P02790|HEMO_HUMAN Hemopexin OS=Homo sapiens GN=HPX PE=1 SV=2P03951F11 FA11_HUMANCoagulation factor XIqblood coagulation,blood coagulation, intrinsic pathway,plasminogen activation,positive regulation of fibrinolysisfserine-type endopeptidase activity,protein binding,heparin binding,serine-type aminopeptidase activityWextracellular region,extracellular space,plasma membrane,membrane,extracellular exosomeL>sp|P03951|FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1P04003C4BPA C4BPA_HUMANC4b-binding protein alpha chaincomplement activation, classical pathway,regulation of complement activation,innate immune response,positive regulation of protein catabolic process,negative regulation of complement activation, classical pathway,regulation of opsonizationRNA binding,protein binding`extracellular region,extracellular space,plasma membrane,other organism cell,blood microparticleY>sp|P04003|C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2P04075ALDOA ALDOA_HUMAN Fructose-bisphosphate aldolase AUplatelet degranulation,fructose metabolic process,gluconeogenesis,glycolytic process,ATP biosynthetic process,striated muscle contraction,actin filament organization,regulation of cell shape,fructose 1,6-bisphosphate metabolic process,neutrophil degranulation,muscle cell cellular homeostasis,protein homotetramerization,canonical glycolysisRNA binding,actin binding,fructose-bisphosphate aldolase activity,protein binding,cytoskeletal protein binding,tubulin binding,identical protein binding,cadherin binding,fructose bindingextracellular region,extracellular space,nucleus,cytosol,actin cytoskeleton,membrane,platelet alpha granule lumen,M band,I band,secretory granule lumen,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenZ>sp|P04075|ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2P04114APOB APOB_HUMANApolipoprotein B-100retinoid metabolic process,in utero embryonic development,toll-like receptor signaling pathway,triglyceride mobilization,receptor-mediated endocytosis,spermatogenesis,nervous system development,cholesterol metabolic process,fertilization,response to virus,response to carbohydrate,post-embryonic development,response to selenium ion,positive regulation of gene expression,positive regulation of macrophage derived foam cell differentiation,positive regulation of lipid storage,positive regulation of cholesterol storage,triglyceride catabolic process,cholesterol transport,flagellated sperm motility,response to estradiol,response to lipopolysaccharide,cholesterol efflux,low-density lipoprotein particle remodeling,very-low-density lipoprotein particle assembly,low-density lipoprotein particle clearance,lipoprotein metabolic process,lipoprotein biosynthetic process,lipoprotein catabolic process,cholesterol homeostasis,lipoprotein transport,cellular protein catabolic process,regulation of cholesterol biosynthetic process,artery morphogenesis,leukocyte migration,membrane organization,cellular response to tumor necrosis factor,cellular response to prostaglandin stimulusprotein binding,phospholipid binding,heparin binding,cholesterol transporter activity,lipase binding,low-density lipoprotein particle receptor binding;extracellular region,extracellular space,cytoplasm,early endosome,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,cytosol,plasma membrane,endosome membrane,clathrin-coated endocytic vesicle membrane,endosome lumen,mature chylomicron,chylomicron remnant,very-low-density lipoprotein particle,low-density lipoprotein particle,intermediate-density lipoprotein particle,chylomicron,neuronal cell body,lysosomal lumen,intracellular membrane-bounded organelle,extracellular exosome,endoplasmic reticulum exit site,endocytic vesicle lumenL>sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2P04196HRG HRG_HUMANHistidine-rich glycoprotein(angiogenesis,platelet degranulation,positive regulation of immune response to tumor cell,chemotaxis,negative regulation of cell adhesion,negative regulation of cell proliferation,regulation of gene expression,regulation of platelet activation,negative regulation of lamellipodium assembly,negative regulation of e< ndopeptidase activity,heme transport,negative regulation of angiogenesis,platelet activation,regulation of blood coagulation,negative regulation of cell growth,regulation of actin cytoskeleton organization,negative regulation of cell adhesion mediated by integrin,fibrinolysis,positive regulation of apoptotic process,regulation of protein complex assembly,negative regulation of blood vessel endothelial cell migration,regulation of peptidyl-tyrosine phosphorylation,defense response to fungus,positive regulation of focal adhesion assembly,negative regulation of fibrinolysis,negative regulation of vascular endothelial growth factor signaling pathway,positive regulation of blood vessel remodeling,negative regulation of endothelial cell chemotaxisserine-type endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,receptor binding,protein binding,heparin binding,zinc ion binding,immunoglobulin binding,heme binding,heparan sulfate proteoglycan binding,metal ion bindingxextracellular region,plasma membrane,platelet alpha granule lumen,endolysosome,extracellular exosome,blood microparticleQ>sp|P04196|HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1P04220 MUCB_HUMAN!Ig mu heavy chain disease protein)extracellular exosome,blood microparticleQ>sp|P04220|MUCB_HUMAN Ig mu heavy chain disease protein OS=Homo sapiens PE=1 SV=1P04275VWF VWF_HUMANvon Willebrand factorplatelet degranulation,cell adhesion,blood coagulation,blood coagulation, intrinsic pathway,hemostasis,response to wounding,platelet activation,extracellular matrix organization,cell-substrate adhesion,protein homooligomerizationglycoprotein binding,protease binding,integrin binding,protein binding,collagen binding,immunoglobulin binding,identical protein binding,protein homodimerization activity,protein N-terminus binding,chaperone bindingextracellular region,proteinaceous extracellular matrix,endoplasmic reticulum,extracellular matrix,platelet alpha granule,platelet alpha granule lumen,Weibel-Palade body,extracellular exosomeK>sp|P04275|VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4P04406GAPDH G3P_HUMAN(Glyceraldehyde-3-phosphate dehydrogenasemicrotubule cytoskeleton organization,gluconeogenesis,regulation of macroautophagy,negative regulation of translation,peptidyl-cysteine S-trans-nitrosylation,protein stabilization,neuron apoptotic process,canonical glycolysis,cellular response to interferon-gammaglyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,protein binding,microtubule binding,peptidyl-cysteine S-nitrosylase activity,identical protein binding,NADP binding,NAD bindingnucleus,cytoplasm,lipid particle,cytosol,plasma membrane,microtubule cytoskeleton,membrane,intracellular ribonucleoprotein complex,extracellular matrix,nuclear membrane,vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,GAIT complex`>sp|P04406|G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3P04433IGKV3-11 KV311_HUMAN"Immunoglobulin kappa variable 3-11_>sp|P04433|KV311_HUMAN Immunoglobulin kappa variable 3-11 OS=Homo sapiens GN=IGKV3-11 PE=1 SV=1P04899GNAI2 GNAI2_HUMAN7Guanine nucleotide-binding protein G(i) subunit alpha-2Qactivation of MAPKK activity,adenosine receptor signaling pathway,protein folding,cell cycle,signal transduction,G-protein coupled receptor signaling pathway,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,negative regulation of adenylate cyclase activity,G-protein coupled acetylcholine receptor signaling pathway,gamma-aminobutyric acid signaling pathway,response to nutrient,cell proliferation,positive regulation of cell proliferation,intracellular signal transduction,negative regulation of synaptic transmission,cell division,regulation of calcium ion transportG-protein coupled receptor binding,GTPase activity,signal transducer activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,metal ion bindingnucleoplasm,cytoplasm,centrosome,cytosol,heterotrimeric G-protein complex,plasma membrane,membrane,dendrite,midbody,cell body,membrane raft,extracellular exosome,extracellular vesicleq>sp|P04899|GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit alpha-2 OS=Homo sapiens GN=GNAI2 PE=1 SV=3P05023;P05023-4ATP1A1 AT1A1_HUMANvSodium/potassium-transporting ATPase subunit alpha-1;Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-1Xregulation of the force of heart contraction,regulation of sodium ion transport,cellular sodium ion homeostasis,regulation of blood pressure,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,dephosphorylation,cellular potassium ion homeostasis,negative regulation of glucocorticoid biosynthetic process,ion transmembrane transport,sodium ion export from cell,response to drug,negative regulation of heart contraction,positive regulation of heart contraction,positive regulation of striated muscle contraction,relaxation of cardiac muscle,membrane hyperpolarization,cellular response to mechanical stimulus,cellular response to steroid hormone stimulus,cardiac muscle cell action potential involved in contraction,regulation of cardiac muscle cell contraction,membrane repolarization,membrane repolarization during cardiac muscle cell action potential,cell communication by electrical coupling involved in cardiac conduction,ATP hydrolysis coupled transmembrane transport,response to glycoside,regulation of cardiac conduction,potassium ion import across plasma membrane;)sodium:potassium-exchanging ATPase activity,protein binding,ATP binding,phosphatase activity,protein kinase binding,protein domain specific binding,ankyrin binding,potassium ion binding,sodium ion binding,ADP binding,phosphatidylinositol 3-kinase binding,chaperone binding,steroid hormone binding;]endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,sodium:potassium-exchanging ATPase complex,caveola,postsynaptic density,intercalated disc,membrane,integral component of membrane,basolateral plasma membrane,apical plasma membrane,T-tubule,sarcolemma,melanosome,myelin sheath,protein complex,extracellular exosome,extracellular vesicle;>sp|P05023|AT1A1_HUMAN Sodium/potassium-transporting ATPase subunit alpha-1 OS=Homo sapiens GN=ATP1A1 PE=1 SV=1;>sp|P05023-4|AT1A1_HUMAN Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-1 OS=Homo sapiens GN=ATP1A1+P05067;P05067-11;P05067-7;P05067-8;P05067-9APPA4_HUMANAmyloid beta A4 protein;Isoform 11 of Amyloid beta A4 protein;Isoform L-APP733 of Amyloid beta A4 protein;Isoform APP751 of Amyloid beta A4 protein;Isoform L-APP752 of Amyloid beta A4 proteinvpositive regulation of protein phosphorylation,suckling behavior,platelet degranulation,mRNA polyadenylation,regulation of translation,protein phosphorylation,cellular copper ion homeostasis,endocytosis,response to oxidative stress,cell adhesion,regulation of epidermal growth factor-activated receptor activity,Notch signaling pathway,axonogenesis,learning or memory,mating behavior,locomotory behavior,axo-dendritic transport,cholesterol metabolic process,adult locomotory behavior,visual learning,cellular process,response to lead ion,negative regulation of endopeptidase activity,positive regulation of peptidase activity,positive regulation of G2/M transition of mitotic cell cycle,axon midline choice point recognition,neuron remodeling,dendrite development,extracellular matrix organization,forebrain development,neuron projection development,ionotropic glutamate receptor signaling pathway,regulation of multicellular organism growth,regulation of protein binding,cellular protein metabolic process,innate immune response,negative regulation of neuron differentiation,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,collateral sprouting in absence of injury,regulation of synapse structure or activity,synapse organization,neuromuscular process controlling balance,synaptic growth at neuromuscular junction,p< ositive regulation of protein metabolic process,neuron apoptotic process,smooth endoplasmic reticulum calcium ion homeostasis,cellular response to cAMP,cellular response to norepinephrine stimulus,amyloid fibril formation,cellular response to nerve growth factor stimulus;;;;DNA binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding,heparin binding,peptidase activator activity,enzyme binding,identical protein binding,transition metal ion binding,PTB domain binding,growth factor receptor binding;;;;extracellular region,extracellular space,nuclear envelope lumen,cytoplasm,endosome,smooth endoplasmic reticulum,rough endoplasmic reticulum,Golgi apparatus,Golgi lumen,cytosol,plasma membrane,integral component of plasma membrane,clathrin-coated pit,cell-cell junction,cell surface,integral component of membrane,ER to Golgi transport vesicle,axon,platelet alpha granule lumen,neuromuscular junction,endosome lumen,trans-Golgi network membrane,ciliary rootlet,terminal bouton,dendritic spine,dendritic shaft,receptor complex,main axon,membrane raft,apical part of cell,synapse,perinuclear region of cytoplasm,spindle midzone,extracellular exosome,astrocyte projection,growth cone lamellipodium,growth cone filopodium;;;;1;;;;3;;;;>sp|P05067|A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3;>sp|P05067-11|A4_HUMAN Isoform 11 of Amyloid beta A4 protein OS=Homo sapiens GN=APP;>sp|P05067-7|A4_HUMAN Isoform L-APP733 of Amyloid beta A4 protein OS=Homo sapiens GN=APP;>sp|P05067-8|A4_HUMAN Isoform APP751 of Amyloid beta A4 protein OS=Homo sapiens GN=APP;>sp|P05067-9|A4_HUMAN Isoform L-APP752 of Amyloid beta A4 protein OS=Homo sapiens GN=APPP05109S100A8 S10A8_HUMANProtein S100-A8cytokine production,toll-like receptor signaling pathway,leukocyte migration involved in inflammatory response,acute inflammatory response,chronic inflammatory response,positive regulation of peptide secretion,autophagy,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,inflammatory response,response to zinc ion,astrocyte development,peptidyl-cysteine S-nitrosylation,antimicrobial humoral response,positive regulation of cell growth,neutrophil chemotaxis,sequestering of zinc ion,response to lipopolysaccharide,chemokine production,wound healing,defense response to bacterium,neutrophil degranulation,innate immune response,response to ethanol,positive regulation of inflammatory response,defense response to fungus,positive regulation of NF-kappaB transcription factor activity,regulation of cytoskeleton organization,neutrophil aggregation,positive regulation of intrinsic apoptotic signaling pathwaycalcium ion binding,protein binding,microtubule binding,zinc ion binding,Toll-like receptor 4 binding,arachidonic acid binding,RAGE receptor bindingextracellular region,extracellular space,nucleus,cytosol,cytoskeleton,plasma membrane,secretory granule lumen,intermediate filament cytoskeleton,extracellular exosomeJ>sp|P05109|S10A8_HUMAN Protein S100-A8 OS=Homo sapiens GN=S100A8 PE=1 SV=1P05155;P05155-3SERPING1 IC1_HUMANFPlasma protease C1 inhibitor;Isoform 3 of Plasma protease C1 inhibitor negative regulation of complement activation, lectin pathway,platelet degranulation,complement activation, classical pathway,aging,blood coagulation, intrinsic pathway,blood circulation,negative regulation of endopeptidase activity,fibrinolysis,innate immune response;=serine-type endopeptidase inhibitor activity,protein binding;pextracellular region,extracellular space,platelet alpha granule lumen,extracellular exosome,blood microparticle;>sp|P05155|IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2;>sp|P05155-3|IC1_HUMAN Isoform 3 of Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1P05160F13B F13B_HUMANCoagulation factor XIII B chainblood coagulationextracellular regionW>sp|P05160|F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3P05556ITGB1 ITB1_HUMANIntegrin beta-1G1/S transition of mitotic cell cycle,in utero embryonic development,cell fate specification,cell migration involved in sprouting angiogenesis,cellular defense response,homophilic cell adhesion via plasma membrane adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,calcium-independent cell-matrix adhesion,integrin-mediated signaling pathway,positive regulation of cell proliferation,germ cell migration,visual learning,regulation of collagen catabolic process,cell migration,formation of radial glial scaffolds,B cell differentiation,extracellular matrix organization,cell-substrate adhesion,receptor internalization,cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,heterotypic cell-cell adhesion,negative regulation of Rho protein signal transduction,positive regulation of apoptotic process,positive regulation of GTPase activity,sarcomere organization,negative regulation of cell differentiation,viral entry into host cell,mesodermal cell differentiation,axon extension,dendrite morphogenesis,regulation of immune response,leukocyte migration,leukocyte tethering or rolling,regulation of cell cycle,cardiac muscle cell differentiation,cellular response to low-density lipoprotein particle stimulus,positive regulation of establishment of protein localization to plasma membrane,negative regulation of anoikis,transforming growth factor beta receptor signaling pathway,stress fiber assemblyXvirus receptor activity,fibronectin binding,protease binding,actin binding,integrin binding,protein binding,coreceptor activity,protein complex binding,laminin binding,cadherin binding,metal ion binding,protein heterodimerization activity,cell adhesion molecule binding,collagen binding involved in cell-matrix adhesion,C-X3-C chemokine bindingruffle,cytoplasm,plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,intercalated disc,membrane,lamellipodium,filopodium,neuromuscular junction,cleavage furrow,ruffle membrane,integrin alpha1-beta1 complex,integrin alpha2-beta1 complex,integrin alpha3-beta1 complex,integrin alpha7-beta1 complex,integrin alpha8-beta1 complex,integrin alpha10-beta1 complex,integrin alpha11-beta1 complex,myelin sheath abaxonal region,sarcolemma,melanosome,dendritic spine,receptor complex,membrane raft,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,invadopodium membrane,synaptic membraneH>sp|P05556|ITB1_HUMAN Integrin beta-1 OS=Homo sapiens GN=ITGB1 PE=1 SV=2P06276BCHE CHLE_HUMANCholinesteraselearning,negative regulation of cell proliferation,neuroblast differentiation,choline metabolic process,response to drug,response to alkaloid,cocaine metabolic process,negative regulation of synaptic transmission,response to glucocorticoid,response to folic acidbeta-amyloid binding,catalytic activity,acetylcholinesterase activity,cholinesterase activity,hydrolase activity, acting on ester bonds,enzyme binding,choline binding,identical protein bindingdextracellular region,nuclear envelope lumen,endoplasmic reticulum lumen,membrane,blood microparticleF>sp|P06276|CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1P06396GSN GELS_HUMANGelsolinphagocytosis, engulfment,aging,positive regulation of gene expression,oligodendrocyte development,striated muscle atrophy,actin filament polymerization,protein destabilization,tissue regeneration,sequestering of actin monomers,neutrophil degranulation,cellular protein metabolic process,actin nucleation,response to ethanol,negative regulation of viral entry into host cell,phosphatidylinositol-mediated signaling,actin filament severing,barbed-end actin filament capping,positive regulation of actin nucleation,response to folic acid,actin filament capping,cilium morphogenesis,cellular response to cadmium ion,regulation of podosome assembly,actin filament reorganization,renal protein absorption,hepatocyte apoptotic process,positive regulation of keratinocyte apoptotic process,regulation of wound healing, spreading of epidermal cells,regulation of establishment of T cell polarity,regulatio< n of plasma membrane raft polarization,regulation of receptor clustering,positive regulation of protein processing in phagocytic vesicle,amyloid fibril formation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,extracellular matrix disassemblycactin binding,calcium ion binding,protein binding,protein domain specific binding,myosin II bindingPruffle,podosome,extracellular region,extracellular space,cytoplasm,cytosol,plasma membrane,focal adhesion,actin cytoskeleton,sarcoplasm,lamellipodium,actin cap,cortical actin cytoskeleton,secretory granule lumen,myelin sheath,perinuclear region of cytoplasm,extracellular exosome,blood microparticle,ficolin-1-rich granule lumen,nucleus?>sp|P06396|GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1P06396-2Isoform 2 of GelsolinD>sp|P06396-2|GELS_HUMAN Isoform 2 of Gelsolin OS=Homo sapiens GN=GSNP06681C2 CO2_HUMAN Complement C2proteolysis,complement activation,complement activation, classical pathway,response to nutrient,regulation of complement activation,innate immune response,positive regulation of apoptotic cell clearanceDserine-type endopeptidase activity,protein binding,metal ion bindingB>sp|P06681|CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2P06727APOA4 APOA4_HUMANApolipoprotein A-IVretinoid metabolic process,innate immune response in mucosa,cholesterol biosynthetic process,lipid transport,response to lipid hydroperoxide,leukocyte cell-cell adhesion,cholesterol metabolic process,positive regulation of cholesterol esterification,positive regulation of triglyceride catabolic process,removal of superoxide radicals,regulation of intestinal cholesterol absorption,neuron projection regeneration,regulation of cholesterol transport,cholesterol efflux,phospholipid efflux,chylomicron remodeling,very-low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,chylomicron assembly,high-density lipoprotein particle assembly,negative regulation of plasma lipoprotein particle oxidation,response to stilbenoid,lipoprotein metabolic process,lipoprotein biosynthetic process,cholesterol homeostasis,hydrogen peroxide catabolic process,reverse cholesterol transport,multicellular organism lipid catabolic process,cellular protein metabolic process,positive regulation of fatty acid biosynthetic process,phosphatidylcholine metabolic process,positive regulation of lipoprotein lipase activity,lipid homeostasis,protein-lipid complex assembly,triglyceride homeostasislipid transporter activity,copper ion binding,protein binding,lipid binding,cholesterol binding,antioxidant activity,cholesterol transporter activity,phosphatidylcholine binding,protein homodimerization activity,phosphatidylcholine-sterol O-acyltransferase activator activityextracellular region,extracellular space,early endosome,endoplasmic reticulum lumen,cytosol,very-low-density lipoprotein particle,high-density lipoprotein particle,chylomicron,extracellular exosome,blood microparticle,cell surfaceM>sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3P06733ENO1 ENOA_HUMAN Alpha-enolasegluconeogenesis,transcription, DNA-templated,response to virus,negative regulation of cell growth,negative regulation of transcription, DNA-templated,canonical glycolysismagnesium ion binding,DNA binding,RNA binding,phosphopyruvate hydratase activity,protein binding,cadherin binding,GTPase bindingphosphopyruvate hydratase complex,extracellular space,nucleus,cytoplasm,cytosol,plasma membrane,membrane,M band,extracellular exosomeE>sp|P06733|ENOA_HUMAN Alpha-enolase OS=Homo sapiens GN=ENO1 PE=1 SV=2P07225PROS1 PROS_HUMANVitamin K-dependent protein Splatelet degranulation,signal peptide processing,ER to Golgi vesicle-mediated transport,blood coagulation,negative regulation of endopeptidase activity,peptidyl-glutamic acid carboxylation,regulation of complement activation,fibrinolysis,leukocyte migration4endopeptidase inhibitor activity,calcium ion bindingGolgi membrane,extracellular region,extracellular space,endoplasmic reticulum membrane,Golgi lumen,plasma membrane,platelet alpha granule lumen,extracellular exosome,blood microparticleV>sp|P07225|PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1P07237P4HB PDIA1_HUMANProtein disulfide-isomerasefresponse to reactive oxygen species,protein folding,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,response to endoplasmic reticulum stress,lipoprotein biosynthetic process,cell redox homeostasis,positive regulation of viral entry into host cell,cellular response to hypoxia,regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayRNA binding,protein disulfide isomerase activity,integrin binding,protein binding,enzyme binding,protein heterodimerization activity,procollagen-proline 4-dioxygenase activity3extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,focal adhesion,external side of plasma membrane,procollagen-proline 4-dioxygenase complex,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,extracellular exosomeT>sp|P07237|PDIA1_HUMAN Protein disulfide-isomerase OS=Homo sapiens GN=P4HB PE=1 SV=3P07357C8A CO8A_HUMAN#Complement component C8 alpha chainimmune response,complement activation,complement activation, alternative pathway,complement activation, classical pathway,cytolysis,regulation of complement activation*complement binding,protein complex bindingsextracellular region,membrane attack complex,extracellular space,membrane,extracellular exosome,blood microparticleZ>sp|P07357|CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2P07358C8B CO8B_HUMAN"Complement component C8 beta chainprotein complex bindinguextracellular region,membrane attack complex,extracellular space,membrane,extracellular exosome,extracellular vesicleY>sp|P07358|CO8B_HUMAN Complement component C8 beta chain OS=Homo sapiens GN=C8B PE=1 SV=3P08519LPA APOA_HUMANApolipoprotein(a)proteolysis,lipid metabolic process,lipid transport,blood circulation,negative regulation of endopeptidase activity,lipoprotein metabolic processfibronectin binding,serine-type endopeptidase activity,endopeptidase inhibitor activity,protein binding,heparin binding,apolipoprotein binding0extracellular region,plasma lipoprotein particleH>sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1P08603CFH CFAH_HUMANComplement factor Hdcomplement activation,complement activation, alternative pathway,regulation of complement activationDprotein binding,heparin binding,heparan sulfate proteoglycan bindingRextracellular region,extracellular space,extracellular exosome,blood microparticleJ>sp|P08603|CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4P08697SERPINF2 A2AP_HUMANAlpha-2-antiplasminregulation of blood vessel size by renin-angiotensin,platelet degranulation,acute-phase response,response to organic substance,negative regulation of plasminogen activation,negative regulation of endopeptidase activity,collagen fibril organization,positive regulation of collagen biosynthetic process,fibrinolysis,positive regulation of cell differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of JNK cascade,blood vessel morphogenesis,positive regulation of smooth muscle cell proliferation,positive regulation of stress fiber assembly,negative regulation of fibrinolysis,positive regulation of ERK1 and ERK2 cascade,positive regulation of transforming growth factor beta production,positive regulation of cell-cell adhesion mediated by cadherinprotease binding,endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity,protein binding,protein homodimerization activityextracellular region,fibrinogen complex,extracellular space,cell surface,platelet alpha granule lumen,extracellular exosome,blood microparticleO>sp|P08697|A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF< 2 PE=1 SV=3P09525;P09525-2;Q6P452ANXA4$ANXA4_HUMAN;ANXA4_HUMAN;Q6P452_HUMAN*Annexin A4;Isoform 2 of Annexin A4;AnnexinJregulation of transcription from RNA polymerase II promoter,signal transduction,Notch signaling pathway,epithelial cell differentiation,negative regulation of NF-kappaB transcription factor activity,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of interleukin-8 secretion;;phospholipase inhibitor activity,calcium ion binding,protein binding,calcium-dependent phospholipid binding,identical protein binding,calcium-dependent protein binding,NF-kappaB binding;;nucleus,cytoplasm,plasma membrane,cell surface,vesicle membrane,nuclear membrane,perinuclear region of cytoplasm,extracellular exosome;;sp;sp;tr1;;14;;1>sp|P09525|ANXA4_HUMAN Annexin A4 OS=Homo sapiens GN=ANXA4 PE=1 SV=4;>sp|P09525-2|ANXA4_HUMAN Isoform 2 of Annexin A4 OS=Homo sapiens GN=ANXA4;>tr|Q6P452|Q6P452_HUMAN Annexin OS=Homo sapiens GN=ANXA4 PE=1 SV=1P09871C1S C1S_HUMANComplement C1s subcomponent`serine-type endopeptidase activity,calcium ion binding,protein binding,identical protein binding>extracellular region,extracellular exosome,blood microparticleQ>sp|P09871|C1S_HUMAN Complement C1s subcomponent OS=Homo sapiens GN=C1S PE=1 SV=1P0C0L5C4B CO4B_HUMANComplement C4-B0proteolysis,inflammatory response,complement activation,complement activation, classical pathway,opsonization,negative regulation of endopeptidase activity,regulation of complement activation,detection of molecule of bacterial origin,innate immune response,positive regulation of apoptotic cell clearancekcomplement binding,serine-type endopeptidase activity,endopeptidase inhibitor activity,carbohydrate bindingextracellular region,extracellular space,plasma membrane,cell junction,axon,dendrite,other organism cell,synapse,extracellular exosome,blood microparticleF>sp|P0C0L5|CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=2P10599TXN THIO_HUMAN Thioredoxinnegative regulation of transcription from RNA polymerase II promoter,response to reactive oxygen species,transcription, DNA-templated,glycerol ether metabolic process,movement of cell or subcellular component,signal transduction,cell-cell signaling,cell proliferation,response to radiation,nucleobase-containing small molecule interconversion,protein repair,activation of protein kinase B activity,positive regulation of peptidyl-serine phosphorylation,regulation of protein import into nucleus, translocation,positive regulation of DNA binding,cell redox homeostasis,negative regulation of protein export from nucleus,positive regulation of protein kinase B signaling,oxidation-reduction process,cellular oxidant detoxification,negative regulation of hydrogen peroxide-induced cell deathRNA binding,thioredoxin-disulfide reductase activity,protein binding,protein disulfide oxidoreductase activity,peptide disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,protein-disulfide reductase activity=nucleus,cytoplasm,mitochondrion,cytosol,extracellular exosomeB>sp|P10599|THIO_HUMAN Thioredoxin OS=Homo sapiens GN=TXN PE=1 SV=3P10643C7 CO7_HUMANComplement component C7cellular sodium ion homeostasis,complement activation,complement activation, alternative pathway,complement activation, classical pathway,cytolysis,regulation of complement activationBextracellular region,membrane attack complex,extracellular exosomeL>sp|P10643|CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2P10644PRKAR1A KAP0_HUMAN=cAMP-dependent protein kinase type I-alpha regulatory subunitmesoderm formation,renal water homeostasis,regulation of transcription from RNA polymerase II promoter,female meiotic division,blood coagulation,activation of protein kinase A activity,intracellular signal transduction,sarcomere organization,negative regulation of meiotic nuclear division,negative regulation of activated T cell proliferation,cardiac muscle cell proliferation,cellular response to glucagon stimulus,negative regulation of cAMP-dependent protein kinase activitycAMP-dependent protein kinase inhibitor activity,protein binding,cAMP-dependent protein kinase regulator activity,cAMP binding,ubiquitin protein ligase binding,protein kinase A catalytic subunit bindingcytoplasm,cytosol,cAMP-dependent protein kinase complex,membrane,nucleotide-activated protein kinase complex,neuromuscular junction,protein complex,plasma membrane raft,ciliary base,immunological synapsex>sp|P10644|KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1!P10909;P10909-2;P10909-4;P10909-5CLU CLUS_HUMANNClusterin;Isoform 2 of Clusterin;Isoform 4 of Clusterin;Isoform 5 of Clusterin8cell morphogenesis,microglial cell activation,release of cytochrome c from mitochondria,platelet degranulation,lipid metabolic process,complement activation,complement activation, classical pathway,response to virus,protein import,antimicrobial humoral response,central nervous system myelin maintenance,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,negative regulation of protein homooligomerization,positive regulation of protein homooligomerization,positive regulation of tumor necrosis factor production,reverse cholesterol transport,innate immune response,positive regulation of nitric oxide biosynthetic process,protein stabilization,positive regulation of NF-kappaB transcription factor activity,chaperone-mediated protein complex assembly,response to misfolded protein,negative regulation of cell death,chaperone-mediated protein folding,microglial cell proliferation,negative regulation of release of cytochrome c from mitochondria,regulation of beta-amyloid clearance,regulation of neuron death,positive regulation of neuron death,positive regulation of beta-amyloid formation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,negative regulation of beta-amyloid formation,regulation of neuronal signal transduction,positive regulation of tau-protein kinase activity,positive regulation of neurofibrillary tangle assembly,negative regulation of response to endoplasmic reticulum stress,Requires Ontology,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;;;oprotein binding,ubiquitin protein ligase binding,chaperone binding,misfolded protein binding,ATPase activity;;;extracellular region,extracellular space,nucleus,cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,cell surface,extracellular matrix,platelet alpha granule lumen,mitochondrial membrane,spherical high-density lipoprotein particle,chromaffin granule,protein complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle,neurofibrillary tangle,apical dendrite,cell periphery;;;1;;;>sp|P10909|CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU PE=1 SV=1;>sp|P10909-2|CLUS_HUMAN Isoform 2 of Clusterin OS=Homo sapiens GN=CLU;>sp|P10909-4|CLUS_HUMAN Isoform 4 of Clusterin OS=Homo sapiens GN=CLU;>sp|P10909-5|CLUS_HUMAN Isoform 5 of Clusterin OS=Homo sapiens GN=CLUP11021HSPA5 GRP78_HUMAN 78 kDa glucose-regulated proteineER overload response,activation of signaling protein activity involved in unfolded protein response,response to radiation,positive regulation of neuron projection development,cerebellum structural organization,cerebellar Purkinje cell layer development,substantia nigra development,neuron differentiation,positive regulation of cell migration,ER-associated ubiquitin-dependent protein catabolic process,negative regulation of transforming growth factor beta receptor signaling pathway,endoplasmic reticulum unfolded protein response,positive regulation of protein ubiquitination,protein folding in endoplasmic reticulum,maintenance of protein localization in endoplasmic reticulum,cellular response to drug,IRE1-mediated unfolded protein response,PERK-mediated unfolded protein response,ATF6-mediated unfolded protein response,cellular response < to glucose starvation,response to cocaine,negative regulation of apoptotic process,neuron apoptotic process,regulation of protein folding in endoplasmic reticulum,cellular response to antibiotic,cellular response to calcium ion,cellular response to manganese ion,cellular response to cAMP,cellular response to interleukin-4,negative regulation of protein homodimerization activity,stress response to metal ion,toxin transport,regulation of ATF6-mediated unfolded protein response,regulation of IRE1-mediated unfolded protein response,regulation of PERK-mediated unfolded protein response,response to methamphetamine hydrochloride,cellular response to nerve growth factor stimulus,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress glycoprotein binding,calcium ion binding,protein binding,ATP binding,ATPase activity,enzyme binding,protein domain specific binding,ubiquitin protein ligase binding,ribosome binding,cadherin binding,unfolded protein binding,chaperone binding,misfolded protein bindingnucleus,mitochondrion,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,focal adhesion,cell surface,membrane,integral component of endoplasmic reticulum membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,myelin sheath,extracellular exosome,COP9 signalosomeZ>sp|P11021|GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens GN=HSPA5 PE=1 SV=2P11169SLC2A3 GTR3_HUMANASolute carrier family 2, facilitated glucose transporter member 3carbohydrate metabolic process,glucose transport,L-ascorbic acid metabolic process,neutrophil degranulation,dehydroascorbic acid transport,glucose transmembrane transportglucose transmembrane transporter activity,glucose binding,dehydroascorbic acid transporter activity,D-glucose transmembrane transporter activityplasma membrane,integral component of plasma membrane,integral component of membrane,secretory granule membrane,specific granule membrane,extracellular exosome,tertiary granule membrane,ficolin-1-rich granule membrane{>sp|P11169|GTR3_HUMAN Solute carrier family 2, facilitated glucose transporter member 3 OS=Homo sapiens GN=SLC2A3 PE=1 SV=1P11171;P11171-2;P11171-3;Q4VB86EPB41'41_HUMAN;41_HUMAN;41_HUMAN;Q4VB86_HUMANKProtein 4.1;Isoform 2 of Protein 4.1;Isoform 3 of Protein 4.1;EPB41 proteinprotein complex assembly,actin cytoskeleton organization,cortical actin cytoskeleton organization,actomyosin structure organization,positive regulation of protein binding;;;actin binding,structural constituent of cytoskeleton,protein binding,calmodulin binding,1-phosphatidylinositol binding,spectrin binding;;;nucleus,cytosol,plasma membrane,cytoplasmic side of plasma membrane,postsynaptic density,spectrin-associated cytoskeleton,extrinsic component of membrane,cell junction,cortical cytoskeleton,protein complex;;; sp;sp;sp;tr1;;;14;;;2>sp|P11171|41_HUMAN Protein 4.1 OS=Homo sapiens GN=EPB41 PE=1 SV=4;>sp|P11171-2|41_HUMAN Isoform 2 of Protein 4.1 OS=Homo sapiens GN=EPB41;>sp|P11171-3|41_HUMAN Isoform 3 of Protein 4.1 OS=Homo sapiens GN=EPB41;>tr|Q4VB86|Q4VB86_HUMAN EPB41 protein OS=Homo sapiens GN=EPB41 PE=1 SV=2P11226MBL2 MBL2_HUMANMannose-binding protein Ccomplement activation, lectin pathway,proteolysis,acute-phase response,complement activation,complement activation, classical pathway,response to oxidative stress,opsonization,defense response to bacterium,negative regulation of growth of symbiont in host,innate immune response,negative regulation of viral process,positive regulation of phagocytosis,defense response to Gram-positive bacterium,killing by host of symbiont cellsserine-type endopeptidase activity,receptor binding,calcium ion binding,protein binding,mannose binding,calcium-dependent protein bindingEextracellular region,collagen trimer,extracellular space,cell surfaceQ>sp|P11226|MBL2_HUMAN Mannose-binding protein C OS=Homo sapiens GN=MBL2 PE=1 SV=2P11277-2SPTB SPTB1_HUMAN.Isoform 2 of Spectrin beta chain, erythrocytic_>sp|P11277-2|SPTB1_HUMAN Isoform 2 of Spectrin beta chain, erythrocytic OS=Homo sapiens GN=SPTBP11413;P11413-2;P11413-3G6PD G6PD_HUMANGlucose-6-phosphate 1-dehydrogenase;Isoform Long of Glucose-6-phosphate 1-dehydrogenase;Isoform 3 of Glucose-6-phosphate 1-dehydrogenasejglucose metabolic process,pentose-phosphate shunt,lipid metabolic process,cholesterol biosynthetic process,NADP metabolic process,NADPH regeneration,glutathione metabolic process,pentose-phosphate shunt, oxidative branch,response to iron(III) ion,negative regulation of protein glutathionylation,response to organic cyclic compound,pentose biosynthetic process,substantia nigra development,response to food,cellular response to oxidative stress,erythrocyte maturation,regulation of neuron apoptotic process,response to ethanol,ribose phosphate biosynthetic process,glucose 6-phosphate metabolic process,oxidation-reduction process,negative regulation of cell growth involved in cardiac muscle cell development,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,negative regulation of reactive oxygen species metabolic process;;glucose-6-phosphate dehydrogenase activity,protein binding,glucose binding,identical protein binding,protein homodimerization activity,NADP binding;;^nucleus,cytoplasm,cytosol,cytoplasmic side of plasma membrane,membrane,extracellular exosome;;4;; >sp|P11413|G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4;>sp|P11413-2|G6PD_HUMAN Isoform Long of Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD;>sp|P11413-3|G6PD_HUMAN Isoform 3 of Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PDP12109COL6A1 CO6A1_HUMANCollagen alpha-1(VI) chainosteoblast differentiation,cell adhesion,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,protein heterotrimerization,cellular response to amino acid stimulus&platelet-derived growth factor bindingextracellular region,proteinaceous extracellular matrix,collagen type VI trimer,extracellular space,lysosomal membrane,endoplasmic reticulum lumen,membrane,extracellular matrix,sarcolemma,protein complex,extracellular exosomeU>sp|P12109|CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3P12110COL6A2 CO6A2_HUMANCollagen alpha-2(VI) chainzcell adhesion,response to glucose,extracellular matrix organization,collagen catabolic process,protein heterotrimerizationprotein bindingextracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,sarcolemma,protein complex,extracellular exosome,extracellular vesicleU>sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4P12111COL6A3 CO6A3_HUMANCollagen alpha-3(VI) chaincell adhesion,muscle organ development,negative regulation of endopeptidase activity,extracellular matrix organization,collagen catabolic process,serine-type endopeptidase inhibitor activityextracellular region,proteinaceous extracellular matrix,collagen type VI trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,sarcolemma,extracellular exosome,extracellular vesicleU>sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5P13224;P13224-2GP1BB GP1BB_HUMANTPlatelet glycoprotein Ib beta chain;Isoform 2 of Platelet glycoprotein Ib beta chaincell adhesion,cell surface receptor signaling pathway,blood coagulation,blood coagulation, intrinsic pathway,platelet activation;Ttransmembrane signaling receptor activity,protein binding,identical protein binding;6plasma membrane,integral component of plasma membrane;>sp|P13224|GP1BB_HUMAN Platelet glycoprotein Ib beta chain OS=Homo sapiens GN=GP1BB PE=1 SV=1;>sp|P13224-2|GP1BB_HUMAN Isoform 2 of Platelet glycoprotein Ib beta chain OS=Homo sapiens GN=GP1BBP13611-2< VCAN CSPG2_HUMAN#Isoform V1 of Versican core proteinT>sp|P13611-2|CSPG2_HUMAN Isoform V1 of Versican core protein OS=Homo sapiens GN=VCANP02538KRT6A K2C6A_HUMAN Keratin, type II cytoskeletal 6Amorphogenesis of an epithelium,cytoskeleton organization,positive regulation of cell proliferation,cell differentiation,keratinization,wound healing,cornification6structural constituent of cytoskeleton,protein binding?nucleus,cytosol,membrane,keratin filament,extracellular exosomeZ>sp|P02538|K2C6A_HUMAN Keratin, type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3P13647KRT5 K2C5_HUMANKeratin, type II cytoskeletal 5ccytoskeleton organization,epidermis development,keratinization,hemidesmosome assembly,cornificationOstructural constituent of cytoskeleton,protein binding,scaffold protein binding}nucleus,cytoplasm,mitochondrion,cytosol,intermediate filament,plasma membrane,membrane,keratin filament,extracellular exosomeW>sp|P13647|K2C5_HUMAN Keratin, type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3P13671C6 CO6_HUMANComplement component C6in utero embryonic development,positive regulation of activation of membrane attack complex,complement activation,complement activation, classical pathway,cytolysis,regulation of complement activation,innate immune response,positive regulation of angiogenesisL>sp|P13671|CO6_HUMAN Complement component C6 OS=Homo sapiens GN=C6 PE=1 SV=3P14543NID1 NID1_HUMAN Nidogen-1cell-matrix adhesion,positive regulation of cell-substrate adhesion,extracellular matrix disassembly,extracellular matrix organization,glomerular basement membrane development,basement membrane organization[calcium ion binding,collagen binding,laminin binding,laminin-1 binding,proteoglycan bindingextracellular region,basement membrane,basal lamina,extracellular space,extracellular matrix,extracellular exosome,cell peripheryA>sp|P14543|NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3P15144ANPEP AMPN_HUMANAminopeptidase Nangiogenesis,proteolysis,signal transduction,cell-cell signaling,regulation of blood pressure,cell differentiation,peptide catabolic process,neutrophil degranulation,viral entry into host cellvirus receptor activity,aminopeptidase activity,receptor activity,metallopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activityextracellular space,nucleus,lysosomal membrane,endoplasmic reticulum-Golgi intermediate compartment,cytosol,plasma membrane,external side of plasma membrane,integral component of membrane,secretory granule membrane,extracellular exosomeI>sp|P15144|AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4P63000;P63000-2RAC1 RAC1_HUMANbRas-related C3 botulinum toxin substrate 1;Isoform B of Ras-related C3 botulinum toxin substrate 1& positive regulation of protein phosphorylation,auditory receptor cell morphogenesis,mast cell chemotaxis,epithelial cell morphogenesis,movement of cell or subcellular component,inflammatory response,hyperosmotic response,cell adhesion,cell-matrix adhesion,G-protein coupled receptor signaling pathway,axon guidance,blood coagulation,cell proliferation,regulation of cell size,response to wounding,anatomical structure morphogenesis,regulation of hydrogen peroxide metabolic process,positive regulation of lamellipodium assembly,regulation of fibroblast migration,positive regulation of cell-substrate adhesion,regulation of neuron maturation,Rac protein signal transduction,cerebral cortex radially oriented cell migration,embryonic olfactory bulb interneuron precursor migration,cerebral cortex GABAergic interneuron development,lamellipodium assembly,actin cytoskeleton organization,actin filament polymerization,platelet activation,regulation of cell migration,positive regulation of actin filament polymerization,T cell costimulation,ruffle organization,negative regulation of interleukin-23 production,substrate adhesion-dependent cell spreading,positive regulation of Rho protein signal transduction,intracellular signal transduction,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of apoptotic process,neutrophil degranulation,positive regulation of phosphatidylinositol 3-kinase activity,engulfment of apoptotic cell,cell-cell junction organization,bone resorption,positive regulation of DNA replication,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,regulation of neuronal synaptic plasticity,negative regulation of receptor-mediated endocytosis,anatomical structure arrangement,dendrite morphogenesis,cell motility,homeostasis of number of cells within a tissue,regulation of defense response to virus by virus,regulation of small GTPase mediated signal transduction,positive regulation of stress fiber assembly,localization within membrane,positive regulation of focal adhesion assembly,synaptic transmission, GABAergic,Wnt signaling pathway, planar cell polarity pathway,regulation of respiratory burst,positive regulation of dendritic spine development,cellular response to mechanical stimulus,semaphorin-plexin signaling pathway,protein localization to plasma membrane,positive regulation of neutrophil chemotaxis,cochlea morphogenesis,ruffle assembly,positive regulation of substrate adhesion-dependent cell spreading,midbrain dopaminergic neuron differentiation;GTPase activity,protein binding,GTP binding,Rab GTPase binding,enzyme binding,protein kinase binding,GTP-dependent protein binding,thioesterase binding,histone deacetylase binding,Rho GDP-dissociation inhibitor binding,ATPase binding;Golgi membrane,pericentriolar material,phagocytic cup,nucleus,cytoplasm,endoplasmic reticulum membrane,trans-Golgi network,cytosol,plasma membrane,focal adhesion,membrane,extrinsic component of plasma membrane,lamellipodium,secretory granule membrane,extracellular matrix,early endosome membrane,ruffle membrane,cytoplasmic ribonucleoprotein granule,melanosome,dendritic spine,kinocilium,extracellular exosome,ficolin-1-rich granule membrane,actin filament;>sp|P63000|RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1;>sp|P63000-2|RAC1_HUMAN Isoform B of Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1P15924DSP DESP_HUMAN Desmoplakindesmosome organization,ventricular compact myocardium morphogenesis,epidermis development,peptide cross-linking,keratinocyte differentiation,keratinization,adherens junction organization,wound healing,neutrophil degranulation,intermediate filament organization,cornification,protein localization to adherens junction,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,regulation of heart rate by cardiac conduction,regulation of ventricular cardiac muscle cell action potential&RNA binding,protein kinase C binding,structural molecule activity,structural constituent of cytoskeleton,protein binding,protein binding, bridging,cell adhesion molecule binding,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,scaffold protein bindingcornified envelope,nucleus,plasma membrane,fascia adherens,intercalated disc,basolateral plasma membrane,desmosome,extracellular matrix,extracellular exosome,ficolin-1-rich granule membrane,intermediate filamentB>sp|P15924|DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 P16109;Q5R349SELPLYAM3_HUMAN;Q5R349_HUMAN P-selectin;P-selectin (Fragment)platelet degranulation,positive regulation of leukocyte migration,inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,positive regulation of platelet activation,positive regulation of phosphatidylinositol 3-kinase signaling,response to lipopolysaccharide,regulation of integrin activation,calcium-mediated signaling using intracellular calcium source,defense response to Gram-negative bacterium,leukocyte migration,leukocyte tethering or rolling;lipopolysaccharide binding,glycoprotein binding,protein binding,heparin binding,sialic acid binding,fucose binding,gl< ycosphingolipid binding,calcium-dependent protein binding,oligosaccharide binding;extracellular space,plasma membrane,integral component of plasma membrane,external side of plasma membrane,platelet dense granule membrane,platelet alpha granule membrane;>sp|P16109|LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3;>tr|Q5R349|Q5R349_HUMAN P-selectin (Fragment) OS=Homo sapiens GN=SELP PE=1 SV=2IP16157;P16157-10;P16157-12;P16157-14;P16157-16;P16157-3;P16157-5;P16157-8ANK1 ANK1_HUMANAnkyrin-1;Isoform Er9 of Ankyrin-1;Isoform Er11 of Ankyrin-1;Isoform Er13 of Ankyrin-1;Isoform Er15 of Ankyrin-1;Isoform Er5 of Ankyrin-1;Isoform Er3 of Ankyrin-1;Isoform Er7 of Ankyrin-1exocytosis,ER to Golgi vesicle-mediated transport,cytoskeleton organization,signal transduction,positive regulation of organelle organization,maintenance of epithelial cell apical/basal polarity,protein targeting to plasma membrane;;;;;;;structural molecule activity,structural constituent of cytoskeleton,protein binding,cytoskeletal adaptor activity,enzyme binding,spectrin binding,ATPase binding;;;;;;;nucleus,cytosol,cytoskeleton,plasma membrane,spectrin-associated cytoskeleton,basolateral plasma membrane,sarcoplasmic reticulum,Z disc,axolemma,M band,sarcolemma,postsynaptic membrane;;;;;;;1;;;;;;;3;;;;;;;G>sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3;>sp|P16157-10|ANK1_HUMAN Isoform Er9 of Ankyrin-1 OS=Homo sapiens GN=ANK1;>sp|P16157-12|ANK1_HUMAN Isoform Er11 of Ankyrin-1 OS=Homo sapiens GN=ANK1;>sp|P16157-14|ANK1_HUMAN Isoform Er13 of Ankyrin-1 OS=Homo sapiens GN=ANK1;>sp|P16157-16|ANK1_HUMAN Isoform Er15 of Ankyrin-1 OS=Homo sapiens GN=ANK1;>sp|P16157-3|ANK1_HUMAN Isoform Er5 of Ankyrin-1 OS=Homo sapiens GN=ANK1;>sp|P16157-5|ANK1_HUMAN Isoform Er3 of Ankyrin-1 OS=Homo sapiens GN=ANK1;>sp|P16157-8|ANK1_HUMAN Isoform Er7 of Ankyrin-1 OS=Homo sapiens GN=ANK1P16284;P16284-2;P16284-3PECAM1 PECA1_HUMANPlatelet endothelial cell adhesion molecule;Isoform Delta12 of Platelet endothelial cell adhesion molecule;Isoform Delta13 of Platelet endothelial cell adhesion moleculeplatelet degranulation,phagocytosis,cell adhesion,signal transduction,cell recognition,extracellular matrix organization,neutrophil degranulation,leukocyte migration,diapedesis,glomerular endothelium development;;protein binding;;extracellular space,plasma membrane,integral component of membrane,cell junction,secretory granule membrane,platelet alpha granule membrane,membrane raft,extracellular exosome;;J>sp|P16284|PECA1_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1;>sp|P16284-2|PECA1_HUMAN Isoform Delta12 of Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1;>sp|P16284-3|PECA1_HUMAN Isoform Delta13 of Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1P16452;P16452-2;P16452-3EPB42 EPB42_HUMANErythrocyte membrane protein band 4.2;Isoform Long of Erythrocyte membrane protein band 4.2;Isoform 3 of Erythrocyte membrane protein band 4.2cell morphogenesis,cytoskeleton organization,regulation of cell shape,peptide cross-linking,hemoglobin metabolic process,erythrocyte maturation,spleen development,iron ion homeostasis;;yprotein-glutamine gamma-glutamyltransferase activity,structural constituent of cytoskeleton,protein binding,ATP binding;;4cytoskeleton,plasma membrane,cortical cytoskeleton;;,>sp|P16452|EPB42_HUMAN Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42 PE=1 SV=3;>sp|P16452-2|EPB42_HUMAN Isoform Long of Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42;>sp|P16452-3|EPB42_HUMAN Isoform 3 of Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42P17301ITGA2 ITA2_HUMANIntegrin alpha-2response to hypoxia,positive regulation of leukocyte migration,substrate-dependent cell migration,hypotonic response,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,female pregnancy,blood coagulation,cell proliferation,animal organ morphogenesis,positive regulation of epithelial cell migration,positive regulation of alkaline phosphatase activity,response to amine,response to muscle activity,positive regulation of smooth muscle cell migration,extracellular matrix organization,mammary gland development,positive regulation of cell projection organization,cell-substrate adhesion,positive regulation of collagen biosynthetic process,positive regulation of collagen binding,response to L-ascorbic acid,cell adhesion mediated by integrin,collagen-activated signaling pathway,response to drug,positive regulation of DNA binding,skin morphogenesis,establishment of protein localization,positive regulation of translation,positive regulation of cell adhesion,positive regulation of smooth muscle contraction,viral entry into host cell,focal adhesion assembly,mesodermal cell differentiation,positive regulation of smooth muscle cell proliferation,positive regulation of inflammatory response,positive regulation of positive chemotaxis,detection of mechanical stimulus involved in sensory perception of pain,positive regulation of transmission of nerve impulse,positive regulation of phagocytosis, engulfment,hepatocyte differentiation,response to parathyroid hormone,cellular response to mechanical stimulus,cellular response to estradiol stimulusvirus receptor activity,integrin binding,protein binding,collagen binding,protein complex binding,collagen receptor activity,laminin binding,metal ion binding,protein heterodimerization activity,collagen binding involved in cell-matrix adhesionnucleus,plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,axon,integrin alpha2-beta1 complex,axon terminus,basal part of cell,perinuclear region of cytoplasmI>sp|P17301|ITA2_HUMAN Integrin alpha-2 OS=Homo sapiens GN=ITGA2 PE=1 SV=1P17987TCP1 TCPA_HUMAN!T-complex protein 1 subunit alphadprotein folding,'de novo' protein folding,tubulin complex assembly,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,translocation of peptides or proteins into host cell cytoplasm,protein stabilization,positive regulation of telomerase activity,chaperone-mediated protein folding,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body,regulation of macrophage apoptotic processRNA binding,protein binding,ATP binding,ubiquitin protein ligase binding,protein binding involved in protein folding,unfolded protein bindingpericentriolar material,acrosomal vesicle,zona pellucida receptor complex,nuclear heterochromatin,Golgi apparatus,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosomeY>sp|P17987|TCPA_HUMAN T-complex protein 1 subunit alpha OS=Homo sapiens GN=TCP1 PE=1 SV=1P18054ALOX12 LOX12_HUMAN&Arachidonate 12-lipoxygenase, 12S-typenmovement of cell or subcellular component,aging,positive regulation of cell proliferation,positive regulation of endothelial cell migration,positive regulation of gene expression,negative regulation of muscle cell apoptotic process,arachidonic acid metabolic process,lipoxygenase pathway,fatty acid oxidation,positive regulation of cell growth,positive regulation of cell migration,superoxide anion generation,negative regulation of apoptotic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,linoleic acid metabolic process,positive regulation of endothelial cell differentiation,positive regulation of angiogenesis,positive regulation of cell adhesion,positive regulation of smooth muscle cell proliferation,hepoxilin metabolic process,hepoxilin biosynthetic process,positive regulation of mitochondrial depolarization,establishment of skin barrier,cellular response to lipid,reactive oxygen species metabolic process,negative regulation of platelet aggregation,leukotriene A4 metabolic process,lipoxin metabolic process,lipoxin A4 biosynthetic process,lipoxin B4 biosyn< thetic process,arachidonate 12-lipoxygenase activity,iron ion binding,protein binding,linoleate 13S-lipoxygenase activity,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,hepoxilin-epoxide hydrolase activity,hepoxilin A3 synthase activity;cytoplasm,cytosol,membrane,sarcolemma,extracellular exosomea>sp|P18054|LOX12_HUMAN Arachidonate 12-lipoxygenase, 12S-type OS=Homo sapiens GN=ALOX12 PE=1 SV=4P18206;P18206-2VCL VINC_HUMANVinculin;Isoform 1 of Vinculinmorphogenesis of an epithelium,platelet degranulation,movement of cell or subcellular component,muscle contraction,cell adhesion,cell-matrix adhesion,lamellipodium assembly,negative regulation of cell migration,adherens junction assembly,protein localization to cell surface,apical junction assembly,neutrophil degranulation,axon extension,platelet aggregation,epithelial cell-cell adhesion;dystroglycan binding,actin binding,structural molecule activity,protein binding,beta-catenin binding,ubiquitin protein ligase binding,alpha-catenin binding,cadherin binding;Mpodosome,extracellular region,cytosol,cytoskeleton,plasma membrane,cell-cell junction,adherens junction,cell-cell adherens junction,fascia adherens,focal adhesion,cell-substrate junction,secretory granule lumen,specific granule lumen,costamere,protein complex,extracellular exosome,extracellular vesicle,ficolin-1-rich granule lumen;4;>sp|P18206|VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=1 SV=4;>sp|P18206-2|VINC_HUMAN Isoform 1 of Vinculin OS=Homo sapiens GN=VCLP18428LBP LBP_HUMAN"Lipopolysaccharide-binding proteintoll-like receptor signaling pathway,leukocyte chemotaxis involved in inflammatory response,macrophage activation involved in immune response,acute-phase response,cellular defense response,opsonization,lipopolysaccharide transport,lipopolysaccharide-mediated signaling pathway,detection of molecule of bacterial origin,response to lipopolysaccharide,negative regulation of tumor necrosis factor production,positive regulation of chemokine production,positive regulation of interleukin-6 production,positive regulation of interleukin-8 production,positive regulation of tumor necrosis factor production,toll-like receptor 4 signaling pathway,positive regulation of toll-like receptor 4 signaling pathway,positive regulation of tumor necrosis factor biosynthetic process,positive regulation of macrophage activation,negative regulation of growth of symbiont in host,innate immune response,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,positive regulation of respiratory burst involved in inflammatory response,cellular response to lipopolysaccharide,cellular response to lipoteichoic acid,positive regulation of neutrophil chemotaxisUlipopolysaccharide binding,receptor binding,protein binding,lipoteichoic acid bindingTextracellular region,extracellular space,cell surface,membrane,extracellular exosomeX>sp|P18428|LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3P19652ORM2 A1AG2_HUMANAlpha-1-acid glycoprotein 2hplatelet degranulation,regulation of immune system process,acute-phase response,neutrophil degranulationextracellular region,extracellular space,platelet alpha granule lumen,azurophil granule lumen,specific granule lumen,extracellular exosome,blood microparticleT>sp|P19652|A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 P19823;Q5T985ITIH2ITIH2_HUMAN;Q5T985_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H2Knegative regulation of endopeptidase activity,hyaluronan metabolic process;Nendopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity;?extracellular region,extracellular exosome,blood microparticle;2;1>sp|P19823|ITIH2_HUMAN Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens GN=ITIH2 PE=1 SV=2;>tr|Q5T985|Q5T985_HUMAN Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens GN=ITIH2 PE=1 SV=1P20851;P20851-2C4BPB C4BPB_HUMANJC4b-binding protein beta chain;Isoform 2 of C4b-binding protein beta chaincomplement activation, classical pathway,blood coagulation,regulation of complement activation,innate immune response,positive regulation of protein catabolic process,negative regulation of complement activation, classical pathway,regulation of opsonization;Mextracellular region,extracellular space,plasma membrane,other organism cell;>sp|P20851|C4BPB_HUMAN C4b-binding protein beta chain OS=Homo sapiens GN=C4BPB PE=1 SV=1;>sp|P20851-2|C4BPB_HUMAN Isoform 2 of C4b-binding protein beta chain OS=Homo sapiens GN=C4BPBP21333;P21333-2FLNA FLNA_HUMAN Filamin-A;Isoform 2 of Filamin-Aplatelet degranulation,adenylate cyclase-inhibiting dopamine receptor signaling pathway,negative regulation of transcription from RNA polymerase I promoter,formation of radial glial scaffolds,cerebral cortex development,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,cell junction assembly,protein localization to cell surface,negative regulation of protein catabolic process,mRNA transcription from RNA polymerase II promoter,positive regulation of transcription factor import into nucleus,negative regulation of apoptotic process,receptor clustering,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of sequence-specific DNA binding transcription factor activity,wound healing, spreading of cells,establishment of protein localization,protein stabilization,cytoplasmic sequestering of protein,actin crosslink formation,cilium morphogenesis,platelet aggregation,semaphorin-plexin signaling pathway,protein localization to plasma membrane,mitotic spindle assembly,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of potassium ion transmembrane transport,regulation of membrane repolarization during atrial cardiac muscle cell action potential,regulation of membrane repolarization during cardiac muscle cell action potential,positive regulation of neural precursor cell proliferation,positive regulation of integrin-mediated signaling pathway,positive regulation of neuron migration;G-protein coupled receptor binding,glycoprotein binding,RNA binding,signal transducer activity,protein binding,transcription factor binding,potassium channel regulator activity,Rho GTPase binding,Ral GTPase binding,kinase binding,small GTPase binding,mu-type opioid receptor binding,Fc-gamma receptor I complex binding,protein homodimerization activity,ion channel binding,cadherin binding,SMAD binding,Rac GTPase binding,actin filament binding,GTPase binding;@extracellular region,nucleus,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell junction,focal adhesion,actin cytoskeleton,membrane,Z disc,cortical cytoskeleton,extracellular matrix,Myb complex,neuronal cell body,dendritic shaft,perinuclear region of cytoplasm,extracellular exosome,apical dendrite,filamentous actin;>sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4;>sp|P21333-2|FLNA_HUMAN Isoform 2 of Filamin-A OS=Homo sapiens GN=FLNAP21980TGM2 TGM2_HUMAN-Protein-glutamine gamma-glutamyltransferase 2blood vessel remodeling,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,negative regulation of endoplasmic reticulum calcium ion concentration,positive regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,apoptotic cell clearance,positive regulation of cell adhesion,positive regulation of smooth muscle cell proliferation,positive regulation of inflammatory response,protein homooligomerization,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of mitochondrial calcium ion concentration,branching involved in salivary gland morphogenesis,salivary gland cavitationprotein-glutamine gamma-glutamyltransferase activity,protein binding,GTP binding,protein domain specific binding,metal ion bindingmitochondrion,endoplasmic reticulum,cytosol,focal adhesion,extracellular matrix,intrinsic component of plas< ma membrane,extracellular exosomee>sp|P21980|TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2P22234;P22234-2PAICS PUR6_HUMANFMultifunctional protein ADE2;Isoform 2 of Multifunctional protein ADE2'de novo' IMP biosynthetic process,purine nucleobase biosynthetic process,purine ribonucleoside monophosphate biosynthetic process;phosphoribosylaminoimidazole carboxylase activity,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,protein binding,ATP binding,identical protein binding,cadherin binding;1cytoplasm,cytosol,membrane,extracellular exosome;>sp|P22234|PUR6_HUMAN Multifunctional protein ADE2 OS=Homo sapiens GN=PAICS PE=1 SV=3;>sp|P22234-2|PUR6_HUMAN Isoform 2 of Multifunctional protein ADE2 OS=Homo sapiens GN=PAICSP22792CPN2 CPN2_HUMANCarboxypeptidase N subunit 26regulation of catalytic activity,protein stabilizationenzyme regulator activityT>sp|P22792|CPN2_HUMAN Carboxypeptidase N subunit 2 OS=Homo sapiens GN=CPN2 PE=1 SV=3<P23229;P23229-2;P23229-3;P23229-4;P23229-5;P23229-6;P23229-9ITGA6 ITA6_HUMANIntegrin alpha-6;Isoform Alpha-6X1A of Integrin alpha-6;Isoform Alpha-6X1B of Integrin alpha-6;Isoform Alpha-6X2A of Integrin alpha-6;Isoform Alpha-6X2B of Integrin alpha-6;Isoform Alpha-6X1X2A of Integrin alpha-6;Isoform 9 of Integrin alpha-6cell-substrate junction assembly,cell-matrix adhesion,integrin-mediated signaling pathway,ectodermal cell differentiation,positive regulation of cell-substrate adhesion,single organismal cell-cell adhesion,positive regulation of cell-cell adhesion,extracellular matrix organization,positive regulation of cell migration,hemidesmosome assembly,cell-substrate adhesion,cellular response to extracellular stimulus,cell adhesion mediated by integrin,nail development,positive regulation of phosphorylation,positive regulation of apoptotic process,positive regulation of GTPase activity,skin development,positive regulation of transcription from RNA polymerase II promoter,filopodium assembly,digestive tract development,brown fat cell differentiation,leukocyte migration,cellular response to organic cyclic compound,renal system development,amelogenesis,negative regulation of extrinsic apoptotic signaling pathway;;;;;;integrin binding,protein binding,laminin binding,cadherin binding,metal ion binding,insulin-like growth factor I binding,neuregulin binding;;;;;;basement membrane,plasma membrane,cell-cell adherens junction,focal adhesion,external side of plasma membrane,basal plasma membrane,cell surface,hemidesmosome,filopodium,integrin alpha6-beta4 complex;;;;;;1;;;;;;5;;;;;;R>sp|P23229|ITA6_HUMAN Integrin alpha-6 OS=Homo sapiens GN=ITGA6 PE=1 SV=5;>sp|P23229-2|ITA6_HUMAN Isoform Alpha-6X1A of Integrin alpha-6 OS=Homo sapiens GN=ITGA6;>sp|P23229-3|ITA6_HUMAN Isoform Alpha-6X1B of Integrin alpha-6 OS=Homo sapiens GN=ITGA6;>sp|P23229-4|ITA6_HUMAN Isoform Alpha-6X2A of Integrin alpha-6 OS=Homo sapiens GN=ITGA6;>sp|P23229-5|ITA6_HUMAN Isoform Alpha-6X2B of Integrin alpha-6 OS=Homo sapiens GN=ITGA6;>sp|P23229-6|ITA6_HUMAN Isoform Alpha-6X1X2A of Integrin alpha-6 OS=Homo sapiens GN=ITGA6;>sp|P23229-9|ITA6_HUMAN Isoform 9 of Integrin alpha-6 OS=Homo sapiens GN=ITGA6P23284PPIB PPIB_HUMAN%Peptidyl-prolyl cis-trans isomerase B?protein peptidyl-prolyl isomerization,positive regulation of multicellular organism growth,positive regulation by host of viral process,positive regulation by host of viral genome replication,protein stabilization,bone development,chaperone-mediated protein folding,regulation of post-translational protein modificationRNA binding,peptidyl-prolyl cis-trans isomerase activity,protein binding,protein complex binding,unfolded protein binding,RNA polymerase binding,collagen bindingnucleus,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,focal adhesion,membrane,macromolecular complex,endoplasmic reticulum chaperone complex,melanosome,perinuclear region of cytoplasm,extracellular exosome]>sp|P23284|PPIB_HUMAN Peptidyl-prolyl cis-trans isomerase B OS=Homo sapiens GN=PPIB PE=1 SV=2P23467-3PTPRB PTPRB_HUMAN<Isoform 3 of Receptor-type tyrosine-protein phosphatase betan>sp|P23467-3|PTPRB_HUMAN Isoform 3 of Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRBP23471;P23471-2PTPRZ1 PTPRZ_HUMANlReceptor-type tyrosine-protein phosphatase zeta;Isoform 2 of Receptor-type tyrosine-protein phosphatase zetahematopoietic progenitor cell differentiation,protein dephosphorylation,axonogenesis,central nervous system development,learning or memory,peptidyl-tyrosine dephosphorylation,oligodendrocyte differentiation,regulation of oligodendrocyte progenitor proliferation;sprotein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding;proteinaceous extracellular matrix,integral component of plasma membrane,intrinsic component of plasma membrane,perineuronal net;>sp|P23471|PTPRZ_HUMAN Receptor-type tyrosine-protein phosphatase zeta OS=Homo sapiens GN=PTPRZ1 PE=1 SV=4;>sp|P23471-2|PTPRZ_HUMAN Isoform 2 of Receptor-type tyrosine-protein phosphatase zeta OS=Homo sapiens GN=PTPRZ1P23528CFL1 COF1_HUMAN Cofilin-1*protein import into nucleus,cytoskeleton organization,negative regulation of cell adhesion,Rho protein signal transduction,response to virus,positive regulation of lamellipodium assembly,negative regulation of lamellipodium assembly,response to organic cyclic compound,response to activity,hippocampus development,regulation of cell morphogenesis,cell projection organization,actin cytoskeleton organization,actin filament depolymerization,positive regulation of synaptic plasticity,negative regulation of actin filament bundle assembly,negative regulation of apoptotic process,positive regulation by host of viral process,negative regulation of cell size,positive regulation of proteolysis,negative regulation of unidimensional cell growth,positive regulation of focal adhesion assembly,positive regulation of dendritic spine development,regulation of dendritic spine morphogenesis,cellular response to hydrogen peroxide,cellular response to interleukin-1,cellular response to interleukin-6,cellular response to tumor necrosis factor,cellular response to ether,cellular response to epidermal growth factor stimulus,postsynaptic density assembly,negative regulation of dendritic spine maintenance,positive regulation of protein localization to cell periphery,positive regulation of NMDA glutamate receptor activity,cellular response to insulin-like growth factor stimulus,negative regulation of cell motility,positive regulation of cell motility,positive regulation of establishment of cell polarity regulating cell shape,positive regulation of barbed-end actin filament cappinglprotein binding,protein phosphatase binding,actin filament binding,phosphatidylinositol bisphosphate binding extracellular space,nucleus,cytoplasm,focal adhesion,actin cytoskeleton,membrane,nuclear matrix,filopodium,growth cone,extracellular matrix,lamellipodium membrane,mitochondrial membrane,vesicle,ruffle membrane,neuronal cell body,dendritic spine,extracellular exosomeA>sp|P23528|COF1_HUMAN Cofilin-1 OS=Homo sapiens GN=CFL1 PE=1 SV=3P24043LAMA2 LAMA2_HUMANLaminin subunit alpha-2 cell adhesion,axon guidance,muscle organ development,Schwann cell differentiation,regulation of cell adhesion,extracellular matrix organization,regulation of cell migration,positive regulation of synaptic transmission, cholinergic,regulation of embryonic development-receptor binding,structural molecule activityextracellular region,basement membrane,basal lamina,extracellular space,sarcolemma,dendritic spine,extracellular exosome,extracellular matrixQ>sp|P24043|LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4P24821TNC TENA_HUMANTenascinosteoblast differentiation,cell adhesion,negative regulation of cell adhesion,neuromuscular junction development,positive regulation of cell proliferation,response to wounding,response to mechanical stimulus,positive regulation of gene expression,peripheral nervo< us system axon regeneration,extracellular matrix organization,wound healing,odontogenesis of dentin-containing tooth,response to ethanol,bud outgrowth involved in lung branching,mesenchymal-epithelial cell signaling involved in prostate gland development,prostate gland epithelium morphogenesis,cellular response to retinoic acid,cellular response to vitamin D,response to fibroblast growth factor,cellular response to prostaglandin D stimulussyndecan binding{extracellular region,basement membrane,interstitial matrix,extracellular space,focal adhesion,membrane,extracellular matrix?>sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3P25311AZGP1 ZA2G_HUMANZinc-alpha-2-glycoproteindetection of chemical stimulus involved in sensory perception of bitter taste,retina homeostasis,cell adhesion,negative regulation of cell proliferation,antigen processing and presentation,transmembrane transport,protein transmembrane transport,RNA phosphodiester bond hydrolysisuglycoprotein binding,antigen binding,ribonuclease activity,protein binding,protein transmembrane transporter activityVextracellular region,extracellular space,nucleus,plasma membrane,extracellular exosomeR>sp|P25311|ZA2G_HUMAN Zinc-alpha-2-glycoprotein OS=Homo sapiens GN=AZGP1 PE=1 SV=2P25398RPS12 RS12_HUMAN40S ribosomal protein S12nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription.RNA binding,structural constituent of ribosome>nucleoplasm,cytosol,membrane,cytosolic small ribosomal subunitR>sp|P25398|RS12_HUMAN 40S ribosomal protein S12 OS=Homo sapiens GN=RPS12 PE=1 SV=3P25786;P25786-2PSMA1 PSA1_HUMANOProteasome subunit alpha type-1;Isoform Long of Proteasome subunit alpha type-1MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;BRNA binding,threonine-type endopeptidase activity,protein binding;proteasome complex,nucleus,nucleoplasm,centrosome,cytosol,proteasome core complex,polysome,proteasome core complex, alpha-subunit complex,extracellular exosome;>sp|P25786|PSA1_HUMAN Proteasome subunit alpha type-1 OS=Homo sapiens GN=PSMA1 PE=1 SV=1;>sp|P25786-2|PSA1_HUMAN Isoform Long of Proteasome subunit alpha type-1 OS=Homo sapiens GN=PSMA1P26038MSN MOES_HUMANMoesinmovement of cell or subcellular component,cytoskeleton organization,leukocyte cell-cell adhesion,regulation of cell shape,regulation of cell size,positive regulation of gene expression,gland morphogenesis,membrane to membrane docking,establishment of epithelial cell apical/basal polarity,leukocyte migration,establishment of endothelial barrier,cellular response to testosterone stimulus,positive regulation of podosome assembly,regulation of organelle assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,regulation of lymphocyte migration,positive regulation of early endosome to late endosome transportdouble-stranded RNA binding,actin binding,receptor binding,structural constituent of cytoskeleton,protein binding,protein kinase binding,cell adhesion molecule bindingouropod,extracellular space,nucleus,cytoplasm,cytosol,cytoskeleton,plasma membrane,microvillus,focal adhesion,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,pseudopodium,microvillus membrane,vesicle,myelin sheath,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,cell periphery,blood microparticle=>sp|P26038|MOES_HUMAN Moesin OS=Homo sapiens GN=MSN PE=1 SV=3P26447S100A4 S10A4_HUMANProtein S100-A4_epithelial to mesenchymal transition,positive regulation of I-kappaB kinase/NF-kappaB signalingRNA binding,actin binding,calcium ion binding,protein binding,identical protein binding,transition metal ion binding,calcium-dependent protein binding,RAGE receptor bindingcextracellular space,nucleus,neuron projection,perinuclear region of cytoplasm,extracellular exosomeJ>sp|P26447|S10A4_HUMAN Protein S100-A4 OS=Homo sapiens GN=S100A4 PE=1 SV=1P27797CALR CALR_HUMAN Calretic      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefgijklmnopqrstuvwxyz{|}~ulinnegative regulation of transcription from RNA polymerase II promoter,antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,peptide antigen assembly with MHC class I protein complex,regulation of transcription, DNA-templated,protein folding,protein export from nucleus,cellular calcium ion homeostasis,receptor-mediated endocytosis,spermatogenesis,positive regulation of cell proliferation,positive regulation of gene expression,negative regulation of translation,protein maturation by protein folding,cortical actin cytoskeleton organization,response to estradiol,negative regulation of intracellular steroid hormone receptor signaling pathway,response to testosterone,protein localization to nucleus,protein folding in endoplasmic reticulum,ATF6-mediated unfolded protein response,regulation of meiotic nuclear division,response to drug,glucocorticoid receptor signaling pathway,regulation of apoptotic process,negative regulation of neuron differentiation,positive regulation of DNA replication,positive regulation of cell cycle,negative regulation of transcription, DNA-templated,negative regulation of retinoic acid receptor signaling pathway,positive regulation of phagocytosis,protein stabilization,sequestering of calcium ion,cardiac muscle cell differentiation,chaperone-mediated protein folding,negative regulation of cell cycle arrest,cellular response to lithium ion,cellular senescence,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,positive regulation of dendritic cell chemotaxisxcomplement component C1q binding,glycoprotein binding,DNA binding,RNA binding,mRNA binding,integrin binding,iron ion binding,calcium ion binding,protein binding,zinc ion binding,carbohydrate binding,ubiquitin protein ligase binding,peptide binding,hormone binding,protein binding involved in protein folding,androgen receptor binding,unfolded protein binding,chaperone bindingaacrosomal vesicle,extracellular region,proteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,Golgi apparatus,cytosol,polysome,focal adhesion,external side of plasma membrane,cell surface,membrane,phagocytic vesicle membrane,sarcoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,MHC class I peptide loading complex,perinuclear region of cytoplasm,extracellular exosome,integral component of lumenal side of endoplasmic reticulum membrane,endocytic vesicle lumenD>sp|P27797|CALR_HUMAN Calreticulin OS=Homo sapiens GN=CALR PE=1 SV=1P28838;P28838-2LAP3 AMPL_HUMAN:Cytosol aminopeptidase;Iso< form 2 of Cytosol aminopeptidase proteolysis;Kaminopeptidase activity,metalloexopeptidase activity,manganese ion binding;knucleus,nucleoplasm,mitochondrion,trans-Golgi network,cytosol,focal adhesion,midbody,extracellular exosome;>sp|P28838|AMPL_HUMAN Cytosol aminopeptidase OS=Homo sapiens GN=LAP3 PE=1 SV=3;>sp|P28838-2|AMPL_HUMAN Isoform 2 of Cytosol aminopeptidase OS=Homo sapiens GN=LAP3P29144TPP2 TPP2_HUMANTripeptidyl-peptidase 2&protein polyubiquitination,proteolysisendopeptidase activity,aminopeptidase activity,serine-type endopeptidase activity,protein binding,tripeptidyl-peptidase activity*nucleoplasm,cytoplasm,cytosol,nuclear bodyO>sp|P29144|TPP2_HUMAN Tripeptidyl-peptidase 2 OS=Homo sapiens GN=TPP2 PE=1 SV=4P30479HLA-B 1B41_HUMAN8HLA class I histocompatibility antigen, B-41 alpha chainq>sp|P30479|1B41_HUMAN HLA class I histocompatibility antigen, B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1P33151CDH5 CADH5_HUMAN Cadherin-5blood vessel maturation,cell-cell junction assembly,homophilic cell adhesion via plasma membrane adhesion molecules,transforming growth factor beta receptor signaling pathway,negative regulation of cell proliferation,single organismal cell-cell adhesion,adherens junction organization,positive regulation of establishment of endothelial barrier,regulation of establishment of cell polarityyreceptor binding,calcium ion binding,protein binding,beta-catenin binding,protein phosphatase binding,ion channel bindingplasma membrane,cell-cell junction,adherens junction,bicellular tight junction,external side of plasma membrane,cell surface,membrane,integral component of membrane,cell junctionC>sp|P33151|CADH5_HUMAN Cadherin-5 OS=Homo sapiens GN=CDH5 PE=1 SV=5P35241;P35241-5RDX RADI_HUMANRadixin;Isoform 5 of Radixin;regulation of cell shape,regulation of cell size,positive regulation of gene expression,protein kinase A signaling,microvillus assembly,positive regulation of cell migration,regulation of actin filament bundle assembly,regulation of Rap protein signal transduction,negative regulation of homotypic cell-cell adhesion,negative regulation of GTPase activity,cellular response to platelet-derived growth factor stimulus,regulation of GTPase activity,apical protein localization,establishment of protein localization,negative regulation of cell size,barbed-end actin filament capping,establishment of endothelial barrier,establishment of protein localization to plasma membrane,cellular response to thyroid hormone stimulus,regulation of ruffle assembly,positive regulation of G1/S transition of mitotic cell cycle,regulation of organelle assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,negative regulation of adherens junction organization,positive regulation of early endosome to late endosome transport;RNA binding,actin binding,protein binding,protein domain specific binding,protein homodimerization activity,cadherin binding,protein kinase A binding,ATPase binding;8ruffle,extracellular space,plasma membrane,microvillus,cell-cell adherens junction,focal adhesion,apical plasma membrane,extrinsic component of membrane,lamellipodium,filopodium,T-tubule,midbody,cortical actin cytoskeleton,cleavage furrow,stereocilium,myelin sheath,cell tip,extracellular exosome,cell periphery;>sp|P35241|RADI_HUMAN Radixin OS=Homo sapiens GN=RDX PE=1 SV=1;>sp|P35241-5|RADI_HUMAN Isoform 5 of Radixin OS=Homo sapiens GN=RDXP35442THBS2 TSP2_HUMANThrombospondin-2Ycell adhesion,negative regulation of angiogenesis,positive regulation of synapse assembly3calcium ion binding,protein binding,heparin bindingQextracellular region,basement membrane,extracellular space,platelet alpha granuleI>sp|P35442|TSP2_HUMAN Thrombospondin-2 OS=Homo sapiens GN=THBS2 PE=1 SV=2P35443THBS4 TSP4_HUMANThrombospondin-4positive regulation of endothelial cell proliferation,response to unfolded protein,negative regulation of angiogenesis,regulation of tissue remodeling,response to endoplasmic reticulum stress,behavioral response to pain,tissue remodeling,positive regulation of peptidyl-tyrosine phosphorylation,myoblast migration,positive regulation of cell division,endothelial cell-cell adhesion,positive regulation of neutrophil chemotaxis[integrin binding,calcium ion binding,protein binding,growth factor activity,heparin bindingextracellular region,basement membrane,extracellular space,endoplasmic reticulum,sarcoplasmic reticulum,extracellular matrix,extracellular exosomeI>sp|P35443|TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2P35555FBN1 FBN1_HUMAN Fibrillin-1qskeletal system development,metanephros development,heart development,extracellular matrix disassembly,extracellular matrix organization,cell adhesion mediated by integrin,sequestering of BMP in extracellular matrix,sequestering of TGFbeta in extracellular matrix,camera-type eye development,negative regulation of osteoclast differentiation,embryonic eye morphogenesis,post-embryonic eye morphogenesis,cellular response to transforming growth factor beta stimulus,regulation of cellular response to growth factor stimulus,cellular response to insulin-like growth factor stimulus,negative regulation of osteoclast developmentintegrin binding,hormone activity,extracellular matrix structural constituent,calcium ion binding,protein binding,heparin binding,extracellular matrix constituent conferring elasticity,protein complex bindingmicrofibril,extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular matrix,extracellular exosomeC>sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3P35579MYH9 MYH9_HUMANMyosin-9meiotic spindle organization,cytokinesis,angiogenesis,in utero embryonic development,establishment of T cell polarity,membrane protein ectodomain proteolysis,phagocytosis, engulfment,integrin-mediated signaling pathway,myoblast fusion,regulation of cell shape,protein transport,actin filament-based movement,platelet formation,monocyte differentiation,actomyosin structure organization,actin cytoskeleton reorganization,uropod organization,blood vessel endothelial cell migration,leukocyte migration,establishment of meiotic spindle localization,platelet aggregation,negative regulation of actin filament severing,positive regulation of protein processing in phagocytic vesicle)microfilament motor activity,RNA binding,motor activity,actin binding,protein binding,calmodulin binding,ATP binding,ATPase activity,protein domain specific binding,actin-dependent ATPase activity,protein homodimerization activity,protein anchor,ADP binding,cadherin binding,actin filament bindingstress fiber,ruffle,uropod,nucleus,cytoplasm,spindle,actomyosin contractile ring,cytosol,plasma membrane,brush border,cell-cell adherens junction,actin cytoskeleton,membrane,myosin II complex,extracellular matrix,cell leading edge,neuromuscular junction,cleavage furrow,actomyosin,protein complex,extracellular exosome,myosin II filament,immunological synapse,focal adhesion,COP9 signalosome,integrin complex@>sp|P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4P35858;P35858-2IGFALS ALS_HUMANInsulin-like growth factor-binding protein complex acid labile subunit;Isoform 2 of Insulin-like growth factor-binding protein complex acid labile subunitEcell adhesion,signal transduction,cellular protein metabolic process;#insulin-like growth factor binding;vextracellular region,extracellular space,nucleoplasm,insulin-like growth factor ternary complex,extracellular exosome;>sp|P35858|ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALS PE=1 SV=1;>sp|P35858-2|ALS_HUMAN Isoform 2 of Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALSP37837TALDO1 TALDO_HUMAN Transaldolasecarbohydrate metabolic process,xylulose biosynthetic process,fructose 6-phosphate metabolic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch{sedoheptulose-7-ph< osphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,protein binding,monosaccharide binding/nucleus,cytoplasm,cytosol,extracellular exosomeH>sp|P37837|TALDO_HUMAN Transaldolase OS=Homo sapiens GN=TALDO1 PE=1 SV=2P39060;P39060-1;P39060-2COL18A1 COIA1_HUMANsCollagen alpha-1(XVIII) chain;Isoform 2 of Collagen alpha-1(XVIII) chain;Isoform 3 of Collagen alpha-1(XVIII) chainangiogenesis,endothelial cell morphogenesis,cell adhesion,visual perception,positive regulation of cell proliferation,negative regulation of cell proliferation,animal organ morphogenesis,extracellular matrix organization,positive regulation of cell migration,collagen catabolic process,response to drug,response to hydrostatic pressure,positive regulation of endothelial cell apoptotic process;;0structural molecule activity,metal ion binding;;extracellular region,collagen trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome;;5;;>sp|P39060|COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5;>sp|P39060-1|COIA1_HUMAN Isoform 2 of Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1;>sp|P39060-2|COIA1_HUMAN Isoform 3 of Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1P43652AFM AFAM_HUMANAfaminvitamin transportvitamin E binding=>sp|P43652|AFAM_HUMAN Afamin OS=Homo sapiens GN=AFM PE=1 SV=1P46531NOTCH1 NOTC1_HUMAN(Neurogenic locus notch homolog protein 1negative regulation of transcription from RNA polymerase II promoter,in utero embryonic development,cell fate specification,epithelial to mesenchymal transition,liver development,heart looping,sprouting angiogenesis,positive regulation of neuroblast proliferation,inflammatory response to antigenic stimulus,endocardium development,endocardium morphogenesis,atrioventricular node development,coronary vein morphogenesis,aortic valve morphogenesis,atrioventricular valve morphogenesis,pulmonary valve morphogenesis,mitral valve formation,epithelial to mesenchymal transition involved in endocardial cushion formation,endocardial cushion morphogenesis,cardiac chamber formation,cardiac ventricle morphogenesis,cardiac atrium morphogenesis,cardiac right atrium morphogenesis,cardiac left ventricle morphogenesis,cardiac right ventricle formation,ventricular trabecula myocardium morphogenesis,growth involved in heart morphogenesis,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,cell migration involved in endocardial cushion formation,pericardium morphogenesis,regulation of transcription, DNA-templated,transcription initiation from RNA polymerase II promoter,immune response,humoral immune response,Notch signaling pathway,positive regulation of transcription of Notch receptor target,spermatogenesis,determination of left/right symmetry,compartment pattern specification,axonogenesis,foregut morphogenesis,endoderm development,heart development,positive regulation of cell proliferation,negative regulation of cell proliferation,auditory receptor cell fate commitment,positive regulation of epithelial to mesenchymal transition,negative regulation of cell-substrate adhesion,negative regulation of myotube differentiation,mesenchymal cell development,regulation of somitogenesis,cell differentiation in spinal cord,neural tube development,keratinocyte differentiation,negative regulation of ossification,lung development,positive regulation of cell migration,positive regulation of BMP signaling pathway,negative regulation of BMP signaling pathway,forebrain development,hair follicle morphogenesis,animal organ regeneration,response to corticosteroid,response to muramyl dipeptide,response to lipopolysaccharide,embryonic hindlimb morphogenesis,tube formation,skeletal muscle cell differentiation,cellular response to vascular endothelial growth factor stimulus,tissue regeneration,positive regulation of apoptotic process,negative regulation of catalytic activity,positive regulation of viral genome replication,positive regulation of endothelial cell differentiation,negative regulation of auditory receptor cell differentiation,positive regulation of keratinocyte differentiation,negative regulation of myoblast differentiation,negative regulation of osteoblast differentiation,positive regulation of Notch signaling pathway,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,negative regulation of calcium ion-dependent exocytosis,positive regulation of JAK-STAT cascade,negative regulation of photoreceptor cell differentiation,somatic stem cell division,astrocyte differentiation,oligodendrocyte differentiation,positive regulation of astrocyte differentiation,negative regulation of oligodendrocyte differentiation,branching morphogenesis of an epithelial tube,positive regulation of epithelial cell proliferation,negative regulation of neurogenesis,cardiac muscle tissue morphogenesis,cardiac muscle cell proliferation,positive regulation of cardiac muscle cell proliferation,negative regulation of glial cell proliferation,cilium morphogenesis,cardiac epithelial to mesenchymal transition,cardiac septum morphogenesis,ventricular septum morphogenesis,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,prostate gland epithelium morphogenesis,regulation of epithelial cell proliferation involved in prostate gland development,arterial endothelial cell differentiation,venous endothelial cell differentiation,cardiac vascular smooth muscle cell development,endocardial cell differentiation,vasculogenesis involved in coronary vascular morphogenesis,coronary artery morphogenesis,Notch signaling involved in heart development,heart trabecula morphogenesis,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,left/right axis specification,cellular response to follicle-stimulating hormone stimulus,distal tubule development,collecting duct development,glomerular mesangial cell development,interleukin-4 secretion,negative regulation of cell migration involved in sprouting angiogenesis,negative regulation of canonical Wnt signaling pathway,neuronal stem cell population maintenance,regulation of extracellular matrix assembly,apoptotic process involved in embryonic digit morphogenesis,positive regulation of aorta morphogenesis,negative regulation of stem cell differentiation,negative regulation of anoikis,negative regulation of pro-B cell differentiation,negative regulation of endothelial cell chemotaxisjcore promoter binding,transcriptional activator activity, RNA polymerase II transcription factor binding,transcription factor activity, sequence-specific DNA binding,enzyme inhibitor activity,receptor activity,Notch binding,calcium ion binding,protein binding,enzyme binding,chromatin DNA binding,sequence-specific DNA binding,protein heterodimerization activityGolgi membrane,acrosomal vesicle,MAML1-RBP-Jkappa- ICN1 complex,extracellular region,nucleus,nucleoplasm,endoplasmic reticulum membrane,cytosol,plasma membrane,adherens junction,cell surface,integral component of membrane,apical plasma membrane,receptor complexc>sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens GN=NOTCH1 PE=1 SV=4P48059LIMS1 LIMS1_HUMAN?LIM and senescent cell antigen-like-containing domain protein 1cell aging,positive regulation of gene expression,positive regulation of cell-substrate adhesion,cell junction assembly,positive regulation of GTPase activity,establishment of protein localization,negative regulation of transcription, DNA-templated,positive regulation of focal adhesion assembly,cellular response to transforming growth factor beta stimulus,positive regulation of substrate adhesion-dependent cell spreading,epithelial to mesenchymal transition,regulation of epithelial cell proliferation7protein binding,zinc ion binding,protein kinase bindingYcytosol,plasma mem< brane,cell-cell junction,focal adhesion,perinuclear region of cytoplasmy>sp|P48059|LIMS1_HUMAN LIM and senescent cell antigen-like-containing domain protein 1 OS=Homo sapiens GN=LIMS1 PE=1 SV=4P48426;P48426-2PIP4K2A PI42A_HUMANzPhosphatidylinositol 5-phosphate 4-kinase type-2 alpha;Isoform 2 of Phosphatidylinositol 5-phosphate 4-kinase type-2 alphaphospholipid metabolic process,phosphatidylinositol biosynthetic process,regulation of autophagy,regulation of phosphatidylinositol 3-kinase signaling,megakaryocyte development,phosphatidylinositol phosphorylation,positive regulation of autophagosome assembly;ATP binding,1-phosphatidylinositol-4-phosphate 5-kinase activity,1-phosphatidylinositol-5-phosphate 4-kinase activity,1-phosphatidylinositol-3-phosphate 4-kinase activity;Ecellular_component,nucleoplasm,autophagosome,cytosol,plasma membrane;>sp|P48426|PI42A_HUMAN Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Homo sapiens GN=PIP4K2A PE=1 SV=2;>sp|P48426-2|PI42A_HUMAN Isoform 2 of Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Homo sapiens GN=PIP4K2AP48740-2MASP1 MASP1_HUMAN4Isoform 2 of Mannan-binding lectin serine protease 1f>sp|P48740-2|MASP1_HUMAN Isoform 2 of Mannan-binding lectin serine protease 1 OS=Homo sapiens GN=MASP1P49247RPIA RPIA_HUMANRibose-5-phosphate isomerase`D-ribose metabolic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branchfribose-5-phosphate isomerase activity,protein binding,identical protein binding,monosaccharide binding0cytosol,intracellular membrane-bounded organelleT>sp|P49247|RPIA_HUMAN Ribose-5-phosphate isomerase OS=Homo sapiens GN=RPIA PE=1 SV=3P49755TMED10 TMEDA_HUMAN0Transmembrane emp24 domain-containing protein 10kidney development,intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,Golgi organization,cargo loading into vesicle,COPI-coated vesicle budding,response to alkaloid,regulated exocytosis,vesicle targeting, to, from or within Golgi,COPI coating of Golgi vesicle,COPII vesicle coating,protein oligomerization,regulation of beta-amyloid formation8protein binding,syntaxin binding,protein complex bindingGolgi membrane,endoplasmic reticulum,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cis-Golgi network,plasma membrane,ER to Golgi transport vesicle membrane,integral component of membrane,transport vesicle,COPI-coated vesicle,trans-Golgi network transport vesicle,secretory granule membrane,endoplasmic reticulum-Golgi intermediate compartment membrane,melanosome,zymogen granule membrane,extracellular exosome,gamma-secretase complexk>sp|P49755|TMEDA_HUMAN Transmembrane emp24 domain-containing protein 10 OS=Homo sapiens GN=TMED10 PE=1 SV=2P50552VASP VASP_HUMAN%Vasodilator-stimulated phosphoproteinneural tube closure,axon guidance,actin polymerization or depolymerization,positive regulation of actin filament polymerization,cell junction assembly,protein homotetramerizationRactin binding,protein binding,profilin binding,SH3 domain binding,cadherin bindingcytosol,plasma membrane,bicellular tight junction,focal adhesion,actin cytoskeleton,lamellipodium membrane,filopodium membrane,extracellular exosome]>sp|P50552|VASP_HUMAN Vasodilator-stimulated phosphoprotein OS=Homo sapiens GN=VASP PE=1 SV=3 P51124;U3KQV5GZMMGRAM_HUMAN;U3KQV5_HUMAN Granzyme MJproteolysis,apoptotic process,cell death,cytolysis,innate immune response;Rserine-type endopeptidase activity,protein binding,serine-type peptidase activity;extracellular region,membrane;>sp|P51124|GRAM_HUMAN Granzyme M OS=Homo sapiens GN=GZMM PE=1 SV=2;>tr|U3KQV5|U3KQV5_HUMAN Granzyme M OS=Homo sapiens GN=GZMM PE=1 SV=2P51570;P51570-2GALK1 GALK1_HUMAN(Galactokinase;Isoform 2 of Galactokinasegalactose metabolic process,galactose catabolic process,galactitol metabolic process,carbohydrate phosphorylation,glycolytic process from galactose;5galactokinase activity,ATP binding,galactose binding;>sp|P51570|GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1;>sp|P51570-2|GALK1_HUMAN Isoform 2 of Galactokinase OS=Homo sapiens GN=GALK1P52209;P52209-2PGD 6PGD_HUMANp6-phosphogluconate dehydrogenase, decarboxylating;Isoform 2 of 6-phosphogluconate dehydrogenase, decarboxylatingpentose-phosphate shunt,pentose-phosphate shunt, oxidative branch,pentose biosynthetic process,D-gluconate metabolic process,oxidation-reduction process;:phosphogluconate dehydrogenase (decarboxylating) activity;&nucleus,cytosol,extracellular exosome;>sp|P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens GN=PGD PE=1 SV=3;>sp|P52209-2|6PGD_HUMAN Isoform 2 of 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens GN=PGDP52566ARHGDIB GDIR2_HUMAN Rho GDP-dissociation inhibitor 2movement of cell or subcellular component,negative regulation of cell adhesion,multicellular organism development,regulation of Rho protein signal transduction,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,cellular response to redox state,negative regulation of trophoblast cell migration,regulation of actin cytoskeleton reorganizationtGTPase activity,Rho GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,Rac GTPase bindingQcytoplasm,cytosol,cytoskeleton,membrane,cytoplasmic vesicle,extracellular exosome\>sp|P52566|GDIR2_HUMAN Rho GDP-dissociation inhibitor 2 OS=Homo sapiens GN=ARHGDIB PE=1 SV=3P55072VCP TERA_HUMAN)Transitional endoplasmic reticulum ATPaseDNA repair,double-strand break repair,protein folding,protein methylation,NADH metabolic process,ER to Golgi vesicle-mediated transport,autophagy,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to DNA damage stimulus,positive regulation of mitochondrial membrane potential,protein ubiquitination,protein deubiquitination,protein N-linked glycosylation via asparagine,viral genome replication,translesion synthesis,ER-associated ubiquitin-dependent protein catabolic process,endoplasmic reticulum unfolded protein response,retrograde protein transport, ER to cytosol,positive regulation of protein complex assembly,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,protein hexamerization,ERAD pathway,regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,establishment of protein localization,positive regulation of protein catabolic process,ATP metabolic process,protein homooligomerization,transmembrane transport,aggresome assembly,error-free translesion synthesis,ER-associated misfolded protein catabolic process,flavin adenine dinucleotide catabolic process,autophagosome maturation,positive regulation of protein K63-linked deubiquitination,positive regulation of Lys63-specific deubiquitinase activity,regulation of aerobic respiration,positive regulation of oxidative phosphorylation,positive regulation of ubiquitin-specific protease activity,positive regulation of ATP biosynthetic processRNA binding,protein binding,ATP binding,lipid binding,ATPase activity,protein phosphatase binding,protein domain specific binding,polyubiquitin binding,ubiquitin protein ligase binding,deubiquitinase activator activity,K48-linked polyubiquitin binding,MHC class I protein binding,identical protein binding,ADP binding,ubiquitin-like protein ligase binding,BAT3 complex binding,ubiquitin-specific protease bindingproteasome complex,extracellular region,nucleus,nucleoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,cytosol,VCP-NPL4-UFD1 AAA ATPase complex,secretory granule lumen,azurophil granule lumen,site of double-strand break,Derlin-1 retrotranslocation complex,myelin sheath,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,ficolin-1-rich granule lumen,VCP-NSFL1C complex`>sp|P55072|TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens < GN=VCP PE=1 SV=4P55103INHBC INHBC_HUMANInhibin beta C chainpositive regulation of pathway-restricted SMAD protein phosphorylation,regulation of apoptotic process,regulation of MAPK cascade,cell development,SMAD protein signal transductionjcytokine activity,transforming growth factor beta receptor binding,hormone activity,growth factor activityN>sp|P55103|INHBC_HUMAN Inhibin beta C chain OS=Homo sapiens GN=INHBC PE=2 SV=1 E9PBP6;P55157MTTPE9PBP6_HUMAN;MTP_HUMAN6Microsomal triglyceride transfer protein large subunit;lipid metabolic process,phospholipid transport,triglyceride transport,plasma lipoprotein particle assembly,lipoprotein biosynthetic process;lipid transporter activity,protein binding,phospholipid transporter activity,lipid binding,protein heterodimerization activityC;endoplasmic reticulum,endoplasmic reticulum lumen,receptor complex>tr|E9PBP6|E9PBP6_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1;>sp|P55157|MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1P55268LAMB2 LAMB2_HUMANLaminin subunit beta-2`cell adhesion,axon guidance,neuromuscular junction development,visual perception,astrocyte development,Schwann cell development,extracellular matrix organization,axon extension involved in regeneration,retina development in camera-type eye,metanephric glomerular visceral epithelial cell development,metanephric glomerular basement membrane development-integrin binding,structural molecule activityextracellular region,basement membrane,basal lamina,laminin-3 complex,extracellular space,synaptic cleft,laminin-11 complex,extracellular exosome,extracellular matrixP>sp|P55268|LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2P60953CDC42 CDC42_HUMAN(Cell division control protein 42 homolog sprouting angiogenesis,cardiac conduction system development,keratinocyte development,Golgi organization,regulation of mitotic nuclear division,nuclear migration,establishment or maintenance of cell polarity,blood coagulation,positive regulation of gene expression,negative regulation of gene expression,protein ubiquitination,substantia nigra development,actin cytoskeleton organization,macrophage differentiation,positive regulation of cell growth,hair follicle morphogenesis,positive regulation of pseudopodium assembly,T cell costimulation,negative regulation of protein complex assembly,keratinization,regulation of protein stability,positive regulation of cytokinesis,Cdc42 protein signal transduction,positive regulation of peptidyl-serine phosphorylation,adherens junction organization,cellular protein localization,establishment or maintenance of apical/basal cell polarity,multicellular organism growth,dendritic cell migration,Fc-gamma receptor signaling pathway involved in phagocytosis,viral RNA genome replication,negative regulation of epidermal growth factor receptor signaling pathway,regulation of protein catabolic process,regulation of protein heterodimerization activity,positive regulation of neuron apoptotic process,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of DNA replication,regulation of protein kinase activity,positive regulation of JNK cascade,filopodium assembly,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,neuron fate determination,actin filament bundle assembly,regulation of small GTPase mediated signal transduction,positive regulation of muscle cell differentiation,regulation of filopodium assembly,positive regulation of filopodium assembly,establishment of Golgi localization,positive regulation of synapse structural plasticity,regulation of attachment of spindle microtubules to kinetochore,heart contraction,canonical Wnt signaling pathway,Wnt signaling pathway, planar cell polarity pathway,positive regulation of epithelial cell proliferation involved in lung morphogenesis,submandibular salivary gland formation,epithelial-mesenchymal cell signaling,hair follicle placode formation,dendritic spine morphogenesis,positive regulation of hair follicle cell proliferation,organelle transport along microtubule,actin filament branching,epithelial cell-cell adhesion,positive regulation of intracellular protein transport,modification of synaptic structure,positive regulation of substrate adhesion-dependent cell spreading3GTPase activity,protein binding,GTP binding,protein kinase binding,GTP-dependent protein binding,mitogen-activated protein kinase kinase kinase binding,thioesterase binding,apolipoprotein A-I receptor binding,identical protein binding,Rho GDP-dissociation inhibitor binding,ubiquitin protein ligase activityGolgi membrane,storage vacuole,cytoplasm,endoplasmic reticulum membrane,microtubule organizing center,cytosol,plasma membrane,cell-cell junction,focal adhesion,membrane,secretory granule,filopodium,midbody,leading edge membrane,cytoplasmic ribonucleoprotein granule,neuron projection,neuronal cell body,dendritic spine,myelin sheath,apical part of cell,spindle midzone,extracellular exosome,mitotic spindleb>sp|P60953|CDC42_HUMAN Cell division control protein 42 homolog OS=Homo sapiens GN=CDC42 PE=1 SV=2P61224RAP1B RAP1B_HUMANRas-related protein Rap-1bQcell proliferation,Rap protein signal transduction,neutrophil degranulation,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to cAMP,regulation of cell junction assembly,regulation of establishment of cell polarity,negative regulation of synaptic vesicle exocytosis,microvillus assemblyOGTPase activity,protein binding,GTP binding,GDP binding,protein complex bindingintracellular,lipid particle,cytosol,plasma membrane,cell-cell junction,membrane,azurophil granule membrane,extracellular exosome,membrane raftT>sp|P61224|RAP1B_HUMAN Ras-related protein Rap-1b OS=Homo sapiens GN=RAP1B PE=1 SV=1P61769B2M B2MG_HUMANBeta-2-microglobulin,retina homeostasis,positive regulation of T cell mediated cytotoxicity,antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,positive regulation of T cell cytokine production,regulation of membrane depolarization,negative regulation of neuron projection development,antibacterial humoral response,antigen processing and presentation of endogenous peptide antigen via MHC class I,positive regulation of protein binding,T cell differentiation in thymus,ferric iron import,protein refolding,response to drug,neutrophil degranulation,cellular protein metabolic process,innate immune response,regulation of erythrocyte differentiation,response to cadmium ion,positive regulation of receptor-mediated endocytosis,regulation of defense response to virus by virus,regulation of immune response,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,iron ion homeostasis,interferon-gamma-mediated signaling pathway,cellular response to lipopolysaccharide,cellular response to iron ion,cellular response to iron(III) ion,negative regulation of receptor binding,positive regulation of receptor binding,positive regulation of ferrous iron import into cell,positive regulation of ferrous iron binding,positive regulation of transferrin receptor binding>glycoprotein binding,protein binding,identical protein bindingGolgi membrane,extracellular region,extracellular space,endoplasmic reticulum lumen,Golgi apparatus,cytosol,plasma membrane,focal adhesion,external side of plasma membrane,ER to Golgi transport vesicle membrane,membrane,phagocytic vesicle membrane,early endosome membrane,early endosome lumen,specific granule lumen,MHC class I protein complex,recycling endosome membrane,extracellular exosome,tertiary granule lumen,HFE-transferrin receptor complexK>sp|P61769|B2MG_HUMAN Beta-2-microglobulin OS=Homo sapiens GN=B2M PE=1 SV=1< P61978;P61978-2;P61978-3;Q5T6W2HNRNPK0HNRPK_HUMAN;HNRPK_HUMAN;HNRPK_HUMAN;Q5T6W2_HUMANHeterogeneous nuclear ribonucleoprotein K;Isoform 2 of Heterogeneous nuclear ribonucleoprotein K;Isoform 3 of Heterogeneous nuclear ribonucleoprotein K;Heterogeneous nuclear ribonucleoprotein K (Fragment)mRNA splicing, via spliceosome,transcription from RNA polymerase II promoter,RNA processing,signal transduction,gene expression,regulation of low-density lipoprotein particle clearance,viral process,negative regulation of apoptotic process,positive regulation of low-density lipoprotein particle receptor biosynthetic process,positive regulation of transcription from RNA polymerase II promoter,negative regulation of mRNA splicing, via spliceosome,positive regulation of receptor-mediated endocytosis,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;;;RNA polymerase II core promoter proximal region sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,single-stranded DNA binding,RNA binding,protein binding,cadherin binding;;;nuclear chromatin,podosome,nucleus,nucleoplasm,cytoplasm,focal adhesion,membrane,extracellular matrix,cell projection,extracellular exosome,catalytic step 2 spliceosome;;;>sp|P61978|HNRPK_HUMAN Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens GN=HNRNPK PE=1 SV=1;>sp|P61978-2|HNRPK_HUMAN Isoform 2 of Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens GN=HNRNPK;>sp|P61978-3|HNRPK_HUMAN Isoform 3 of Heterogeneous nuclear ribonucleoprotein K OS=Homo sapiens GN=HNRNPK;>tr|Q5T6W2|Q5T6W2_HUMAN Heterogeneous nuclear ribonucleoprotein K (Fragment) OS=Homo sapiens GN=HNRNPK PE=1 SV=1P62993GRB2 GRB2_HUMAN&Growth factor receptor-bound protein 2-MAPK cascade,epidermal growth factor receptor signaling pathway,Ras protein signal transduction,cell-cell signaling,axon guidance,aging,insulin receptor signaling pathway,fibroblast growth factor receptor signaling pathway,positive regulation of signal transduction,regulation of phosphatidylinositol 3-kinase signaling,viral process,cell migration,cell differentiation,positive regulation of actin filament polymerization,T cell costimulation,receptor internalization,entry of bacterium into host cell,phosphatidylinositol-3-phosphate biosynthetic process,peptidyl-tyrosine autophosphorylation,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,regulation of cell proliferation,signal transduction in response to DNA damage,regulation of MAPK cascade,positive regulation of GTPase activity,innate immune response,phosphatidylinositol phosphorylation,phosphatidylinositol-mediated signaling,anatomical structure formation involved in morphogenesis,leukocyte migration,protein heterooligomerization,branching involved in labyrinthine layer morphogenesis,membrane organization,cellular response to ionizing radiation,positive regulation of reactive oxygen species metabolic processphosphotyrosine binding,RNA binding,non-membrane spanning protein tyrosine kinase activity,SH3/SH2 adaptor activity,Ras guanyl-nucleotide exchange factor activity,epidermal growth factor receptor binding,neurotrophin TRKA receptor binding,protein binding,1-phosphatidylinositol-3-kinase activity,SH3 domain binding,protein kinase binding,protein phosphatase binding,identical protein binding,insulin receptor substrate binding,ephrin receptor binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activitynucleus,nucleoplasm,nucleolus,cytoplasm,endosome,Golgi apparatus,cytosol,plasma membrane,cell-cell junction,COP9 signalosome,vesicle membrane,extrinsic component of cytoplasmic side of plasma membrane,extracellular exosome,Grb2-EGFR complex^>sp|P62993|GRB2_HUMAN Growth factor receptor-bound protein 2 OS=Homo sapiens GN=GRB2 PE=1 SV=1P63104YWHAZ 1433Z_HUMAN14-3-3 protein zeta/delta7protein targeting,signal transduction,platelet activation,negative regulation of apoptotic process,regulation of mRNA stability,establishment of Golgi localization,membrane organization,Golgi reassembly,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathwayRNA binding,protein binding,transcription factor binding,protein kinase binding,protein domain specific binding,ubiquitin protein ligase binding,identical protein binding,cadherin bindingextracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,focal adhesion,cytoplasmic vesicle membrane,melanosome,extracellular exosome,blood microparticleS>sp|P63104|1433Z_HUMAN 14-3-3 protein zeta/delta OS=Homo sapiens GN=YWHAZ PE=1 SV=1 P67870;Q5SRQ6CSNK2BCSK2B_HUMAN;Q5SRQ6_HUMANCasein kinase II subunit betaprotein folding,protein phosphorylation,phosphatidylcholine biosynthetic process,signal transduction,negative regulation of cell proliferation,positive regulation of pathway-restricted SMAD protein phosphorylation,Wnt signaling pathway,positive regulation of activin receptor signaling pathway,adiponectin-activated signaling pathway,response to testosterone,neutrophil degranulation,negative regulation of blood vessel endothelial cell migration,cellular protein complex assembly,regulation of protein kinase activity,regulation of DNA binding,endothelial tube morphogenesis,liver regeneration,regulation of signal transduction by p53 class mediator; chromatin binding,receptor binding,protein binding,transcription factor binding,protein kinase regulator activity,protein domain specific binding,identical protein binding,ribonucleoprotein complex binding,metal ion binding,protein serine/threonine kinase activity;chromatin,extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,cilium,protein kinase CK2 complex,nuclear matrix,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen,plasma membrane,PcG protein complex;>sp|P67870|CSK2B_HUMAN Casein kinase II subunit beta OS=Homo sapiens GN=CSNK2B PE=1 SV=1;>tr|Q5SRQ6|Q5SRQ6_HUMAN Casein kinase II subunit beta OS=Homo sapiens GN=CSNK2B PE=1 SV=2P67936TPM4 TPM4_HUMANTropomyosin alpha-4 chainosteoblast differentiation,movement of cell or subcellular component,muscle contraction,actin filament organization,muscle filament sliding[calcium ion binding,protein binding,structural constituent of muscle,actin filament bindingstress fiber,podosome,cytosol,cytoskeleton,muscle thin filament tropomyosin,actin filament,focal adhesion,membrane,cortical cytoskeleton,filamentous actin,extracellular exosomeQ>sp|P67936|TPM4_HUMAN Tropomyosin alpha-4 chain OS=Homo sapiens GN=TPM4 PE=1 SV=3P68371TUBB4B TBB4B_HUMANTubulin beta-4B chainG2/M transition of mitotic cell cycle,movement of cell or subcellular component,cytoskeleton organization,microtubule-based process,natural killer cell mediated cytotoxicity,neutrophil degranulation,ciliary basal body dockingdouble-stranded RNA binding,GTPase activity,structural constituent of cytoskeleton,GTP binding,MHC class I protein binding,unfolded protein bindingextracellular region,nucleus,cytosol,cytoskeleton,microtubule,microtubule cytoskeleton,extracellular matrix,azurophil granule lumen,myelin sheath,extracellular exosome,extracellular vesicleP>sp|P68371|TBB4B_HUMAN Tubulin beta-4B chain OS=Homo sapiens GN=TUBB4B PE=1 SV=1P69891HBG1 HBG1_HUMANHemoglobin subunit gamma-1Hoxygen transporter activity,iron ion binding,oxygen binding,heme bindingcytosol,hemoglobin complexR>sp|P69891|HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2P69905HBA1 HBA_HUMANHemoglobin subunit alphareceptor-mediated endocytosis,positive regulation of cell death,oxygen transport,bicarbonate transport,response to hydrogen peroxide,hydrogen peroxide catabolic process,protein heterooligomerization,cellular oxidant detoxificationoxygen transporter activity,iron ion binding,protein bind< ing,oxygen binding,heme binding,peroxidase activity,haptoglobin bindingextracellular region,cytosol,hemoglobin complex,membrane,cytosolic small ribosomal subunit,haptoglobin-hemoglobin complex,extracellular exosome,endocytic vesicle lumen,blood microparticleO>sp|P69905|HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2P78417GSTO1 GSTO1_HUMAN!Glutathione S-transferase omega-1regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,L-ascorbic acid metabolic process,methylation,xenobiotic catabolic process,oxidation-reduction process,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,cellular response to arsenic-containing substance,cellular oxidant detoxification,glutathione derivative biosynthetic processglutathione transferase activity,protein binding,oxidoreductase activity,glutathione dehydrogenase (ascorbate) activity,methylarsonate reductase activity'cytoplasm,cytosol,extracellular exosome[>sp|P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens GN=GSTO1 PE=1 SV=2P80108GPLD1 PHLD_HUMAN4Phosphatidylinositol-glycan-specific phospholipase Dossification,cell migration involved in sprouting angiogenesis,chondrocyte differentiation,complement receptor mediated signaling pathway,C-terminal protein lipidation,GPI anchor release,negative regulation of cell proliferation,insulin receptor signaling pathway,response to glucose,positive regulation of endothelial cell migration,positive regulation of alkaline phosphatase activity,positive regulation of triglyceride biosynthetic process,negative regulation of triglyceride catabolic process,positive regulation of glucose metabolic process,positive regulation of high-density lipoprotein particle clearance,cellular response to insulin stimulus,cellular response to drug,hematopoietic stem cell migration,positive regulation of insulin secretion involved in cellular response to glucose stimulus,positive regulation of apoptotic process,positive regulation of cytolysis,phosphatidylcholine metabolic process,positive regulation of membrane protein ectodomain proteolysis,positive regulation of secretion,transepithelial transport,cellular response to calcium ion,cellular response to cholesterol,cellular response to triglyceride,cellular response to pH,hematopoietic stem cell migration to bone marrow,regulation of cellular response to insulin stimuluspglycosylphosphatidylinositol phospholipase D activity,phospholipase D activity,sodium channel regulator activityextracellular region,proteinaceous extracellular matrix,extracellular space,intracellular,cytoplasm,lysosomal membrane,intracellular membrane-bounded organelle,extracellular exosomem>sp|P80108|PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3P80748IGLV3-21 LV321_HUMAN#Immunoglobulin lambda variable 3-21`>sp|P80748|LV321_HUMAN Immunoglobulin lambda variable 3-21 OS=Homo sapiens GN=IGLV3-21 PE=1 SV=2P84095RHOG RHOG_HUMAN$Rho-related GTP-binding protein RhoGRho protein signal transduction,positive regulation of cell proliferation,Rac protein signal transduction,actin cytoskeleton organization,platelet activation,neutrophil degranulation,positive regulation of transcription, DNA-templated,regulation of small GTPase mediated signal transduction,cell chemotaxis,positive regulation of establishment of protein localization to plasma membrane,activation of GTPase activity,regulation of ruffle assembly+GTPase activity,protein binding,GTP bindingvendoplasmic reticulum membrane,cytosol,plasma membrane,focal adhesion,secretory granule membrane,extracellular exosome\>sp|P84095|RHOG_HUMAN Rho-related GTP-binding protein RhoG OS=Homo sapiens GN=RHOG PE=1 SV=1P98160HSPG2 PGBM_HUMANDBasement membrane-specific heparan sulfate proteoglycan core proteinretinoid metabolic process,angiogenesis,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,cellular protein metabolic process>calcium ion binding,protein binding,protein C-terminus bindingextracellular region,basement membrane,extracellular space,Golgi lumen,plasma membrane,focal adhesion,extracellular matrix,lysosomal lumen,extracellular exosome}>sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4P98161;P98161-3PKD1 PKD1_HUMAN&Polycystin-1;Isoform 3 of Polycystin-1cartilage condensation,in utero embryonic development,kidney development,liver development,embryonic placenta development,protein export from nucleus,nitrogen compound metabolic process,cell cycle arrest,homophilic cell adhesion via plasma membrane adhesion molecules,cell-matrix adhesion,calcium-independent cell-matrix adhesion,positive regulation of cytosolic calcium ion concentration,JAK-STAT cascade,heart development,anatomical structure morphogenesis,single organismal cell-cell adhesion,peptidyl-serine phosphorylation,spinal cord development,neural tube development,establishment of cell polarity,regulation of cell adhesion,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,positive regulation of protein binding,response to fluid shear stress,lymph vessel morphogenesis,cytoplasmic sequestering of transcription factor,skin development,positive regulation of transcription from RNA polymerase II promoter,digestive tract development,branching morphogenesis of an epithelial tube,genitalia development,detection of mechanical stimulus,cartilage development,regulation of mitotic spindle organization,lung epithelium development,placenta blood vessel development,regulation of proteasomal protein catabolic process,calcium ion transmembrane transport,mesonephric tubule development,mesonephric duct development,metanephric collecting duct development,metanephric ascending thin limb development,metanephric proximal tubule development,metanephric distal tubule morphogenesis;calcium channel activity,protein binding,protein kinase binding,protein domain specific binding,carbohydrate binding,ion channel binding;(Golgi membrane,polycystin complex,nucleus,cytoplasm,plasma membrane,integral component of plasma membrane,cilium,cell surface,integral component of membrane,basolateral plasma membrane,lateral plasma membrane,Golgi-associated vesicle membrane,motile cilium,ciliary membrane,extracellular exosome;>sp|P98161|PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3;>sp|P98161-3|PKD1_HUMAN Isoform 3 of Polycystin-1 OS=Homo sapiens GN=PKD1Q00577PURA PURA_HUMAN+Transcriptional activator protein Pur-alphaNDNA unwinding involved in DNA replication,DNA replication initiation,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,nervous system development,positive regulation of cell proliferation,negative regulation of translation,cell differentiation,negative regulation of transcription, DNA-templatedGtranslation repressor activity, nucleic acid binding,double-stranded telomeric DNA binding,single-stranded DNA binding,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,RNA binding,protein binding,transcription factor binding,purine-rich negative regulatory element binding,SMAD bindingsnuclear chromosome, telomeric region,nucleus,DNA replication factor A complex,cytoplasm,dendrite,neuronal cell bodyc>sp|Q00577|PURA_HUMAN Transcriptional activator protein Pur-alpha OS=Homo sapiens GN=PURA PE=1 SV=2Q01518;Q01518-2CAP1 CAP1_HUMANXAdenylyl cyclase-associated protein 1;Isoform 2 of Adenylyl cyclase-associated protein 1cell morphogenesis,ameboidal-type cell migration,receptor-mediated endocytosis,establishment or mainte< nance of cell polarity,signal transduction,activation of adenylate cyclase activity,actin polymerization or depolymerization,neutrophil degranulation;(actin binding,adenylate cyclase binding;extracellular region,extracellular space,plasma membrane,focal adhesion,cortical actin cytoskeleton,azurophil granule lumen,extracellular exosome;>sp|Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5;>sp|Q01518-2|CAP1_HUMAN Isoform 2 of Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1Q01813PFKP PFKAP_HUMAN2ATP-dependent 6-phosphofructokinase, platelet type;fructose 6-phosphate metabolic process,canonical glycolysise6-phosphofructokinase activity,ATP binding,protein complex binding,cadherin binding,metal ion bindingMnucleus,cytoplasm,cytosol,membrane,extracellular matrix,extracellular exosomek>sp|Q01813|PFKAP_HUMAN ATP-dependent 6-phosphofructokinase, platelet type OS=Homo sapiens GN=PFKP PE=1 SV=2P02533KRT14 K1C14_HUMANKeratin, type I cytoskeletal 14aging,epidermis development,response to zinc ion,response to ionizing radiation,keratinization,hemidesmosome assembly,hair cycle,intermediate filament bundle assembly,cornificationOstructural constituent of cytoskeleton,protein binding,keratin filament bindingxnucleus,cytoplasm,cytosol,intermediate filament,keratin filament,basal part of cell,extracellular exosome,cell peripheryY>sp|P02533|K1C14_HUMAN Keratin, type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4Q04756HGFAC HGFA_HUMAN"Hepatocyte growth factor activatorAserine-type endopeptidase activity,serine-type peptidase activity0extracellular region,extracellular space,cytosol[>sp|Q04756|HGFA_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1Q06033;Q06033-2ITIH3 ITIH3_HUMANfInter-alpha-trypsin inhibitor heavy chain H3;Isoform 2 of Inter-alpha-trypsin inhibitor heavy chain H3bplatelet degranulation,negative regulation of endopeptidase activity,hyaluronan metabolic process;Hextracellular region,platelet dense granule lumen,extracellular exosome;>sp|Q06033|ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2;>sp|Q06033-2|ITIH3_HUMAN Isoform 2 of Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3Q07954LRP1 LRP1_HUMAN5Prolow-density lipoprotein receptor-related protein 1mretinoid metabolic process,receptor-mediated endocytosis,protein kinase C-activating G-protein coupled receptor signaling pathway,aging,cell proliferation,regulation of extracellular matrix disassembly,positive regulation of cholesterol efflux,negative regulation of neuron projection development,negative regulation of smooth muscle cell migration,cerebral cortex development,negative regulation of Wnt signaling pathway,positive regulation of lipid transport,regulation of cholesterol transport,regulation of phospholipase A2 activity,regulation of actin cytoskeleton organization,aorta morphogenesis,lipoprotein metabolic process,lipoprotein transport,apoptotic cell clearance,negative regulation of neuron apoptotic process,positive regulation of protein transport,beta-amyloid clearance,negative regulation of platelet-derived growth factor receptor-beta signaling pathwayprotease binding,RNA binding,receptor activity,low-density lipoprotein receptor activity,calcium ion binding,protein binding,protein complex binding,apolipoprotein binding,lipoprotein transporter activity,lipoprotein particle receptor bindingnucleolus,lysosomal membrane,endosome,cytosol,plasma membrane,integral component of plasma membrane,clathrin-coated pit,focal adhesion,clathrin-coated vesicle,dendrite,endocytic vesicle membrane,neuronal cell body,receptor complexm>sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2Q07960ARHGAP1 RHG01_HUMANRho GTPase-activating protein 1small GTPase mediated signal transduction,Rho protein signal transduction,positive regulation of signal transduction,positive regulation of GTPase activity,regulation of small GTPase mediated signal transductionfSH3/SH2 adaptor activity,GTPase activator activity,protein binding,SH3 domain binding,cadherin bindingGcytoplasm,cytosol,perinuclear region of cytoplasm,extracellular exosome[>sp|Q07960|RHG01_HUMAN Rho GTPase-activating protein 1 OS=Homo sapiens GN=ARHGAP1 PE=1 SV=1Q08188TGM3 TGM3_HUMAN-Protein-glutamine gamma-glutamyltransferase Ecellular protein modification process,peptide cross-linking,keratinocyte differentiation,hair follicle morphogenesis,keratinization,cell envelope organization,protein tetramerizationprotein-glutamine gamma-glutamyltransferase activity,catalytic activity,calcium ion binding,transferase activity, transferring acyl groupsZcytoplasm,extrinsic component of cytoplasmic side of plasma membrane,extracellular exosomee>sp|Q08188|TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4Q08380LGALS3BP LG3BP_HUMANGalectin-3-binding proteinpplatelet degranulation,receptor-mediated endocytosis,cellular defense response,cell adhesion,signal transductionextracellular region,proteinaceous extracellular matrix,extracellular space,membrane,platelet dense granule lumen,extracellular exosome,blood microparticle,extracellular matrixW>sp|Q08380|LG3BP_HUMAN Galectin-3-binding protein OS=Homo sapiens GN=LGALS3BP PE=1 SV=1Q08431MFGE8 MFGM_HUMAN Lactadherinangiogenesis,phagocytosis, recognition,phagocytosis, engulfment,cell adhesion,single fertilization,viral process,cellular protein metabolic process,positive regulation of apoptotic cell clearanceLphosphatidylserine binding,integrin binding,phosphatidylethanolamine bindingextracellular region,extracellular space,external side of plasma membrane,membrane,extrinsic component of plasma membrane,extracellular exosome,extracellular vesicle,extracellular matrixD>sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens GN=MFGE8 PE=1 SV=2Q13093PLA2G7 PAFA_HUMAN*Platelet-activating factor acetylhydrolaselipid catabolic process,low-density lipoprotein particle remodeling,lipid oxidation,plasma lipoprotein particle oxidation,platelet activating factor metabolic process,positive regulation of inflammatory response,positive regulation of monocyte chemotaxis1-alkyl-2-acetylglycerophosphocholine esterase activity,phospholipid binding,hydrolase activity, acting on ester bonds,calcium-independent phospholipase A2 activity?extracellular region,cytoplasm,low-density lipoprotein particled>sp|Q13093|PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1Q13201MMRN1 MMRN1_HUMAN Multimerin-16platelet degranulation,cell adhesion,blood coagulation#calcium ion binding,protein bindingFextracellular region,extracellular matrix,platelet alpha granule lumenF>sp|Q13201|MMRN1_HUMAN Multimerin-1 OS=Homo sapiens GN=MMRN1 PE=1 SV=3Q13576IQGAP2 IQGA2_HUMAN)Ras GTPase-activating-like protein IQGAP2signal transduction,negative regulation of GTPase activity,Arp2/3 complex-mediated actin nucleation,neutrophil degranulation,thrombin-activated receptor signaling pathwayactin binding,GTPase inhibitor activity,calmodulin binding,phosphatidylinositol-3,4,5-trisphosphate binding,Rho GTPase binding,Rac GTPase binding,actin filament binding,Arp2/3 complex bindingcytoplasm,cytosol,plasma membrane,microvillus,cell surface,actin cytoskeleton,lamellipodium,filopodium,secretory granule membrane,extracellular exosome,filamentous actind>sp|Q13576|IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4Q13642-1;Q13642-4;Q13642-5FHL1 FHL1_HUMANIsoform 1 of Four and a half LIM domains protein 1;Isoform 4 of Four and a half LIM domains protein 1;Isoform 5 of Four and a half LIM domains protein 1(>sp|Q13642-1|FHL1_HUMAN Isoform 1 of Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1;>sp|Q13642-4|FHL1_HUMAN Isoform 4 of Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1;>sp|Q13642-5|FHL1_HUMAN Isoform 5 of Four and a half LIM domains protein< 1 OS=Homo sapiens GN=FHL1Q14008;Q14008-2;Q14008-3CKAP5 CKAP5_HUMANCytoskeleton-associated protein 5;Isoform 2 of Cytoskeleton-associated protein 5;Isoform 3 of Cytoskeleton-associated protein 52G2/M transition of mitotic cell cycle,spindle organization,sister chromatid cohesion,mitotic nuclear division,establishment or maintenance of microtubule cytoskeleton polarity,microtubule polymerization,RNA transport,centrosome organization,centrosome duplication,cell division,ciliary basal body docking;;?protein binding,cadherin binding,microtubule plus-end binding;;kinetochore,condensed chromosome kinetochore,spindle pole,centrosome,cytosol,membrane,protein complex,gamma-tubulin complex,microtubule cytoskeleton,microtubule plus-end;;>sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens GN=CKAP5 PE=1 SV=3;>sp|Q14008-2|CKAP5_HUMAN Isoform 2 of Cytoskeleton-associated protein 5 OS=Homo sapiens GN=CKAP5;>sp|Q14008-3|CKAP5_HUMAN Isoform 3 of Cytoskeleton-associated protein 5 OS=Homo sapiens GN=CKAP5Q14126DSG2 DSG2_HUMAN Desmoglein-2desmosome organization,Purkinje myocyte development,cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,keratinization,response to progesterone,maternal process involved in female pregnancy,cornification,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,regulation of heart rate by cardiac conduction,regulation of ventricular cardiac muscle cell action potentialcalcium ion binding,cell adhesion molecule binding,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communicationcornified envelope,plasma membrane,cell-cell junction,cell surface,intercalated disc,integral component of membrane,apical plasma membrane,lateral plasma membrane,desmosome,extracellular exosomeD>sp|Q14126|DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2Q14314FGL2 FGL2_HUMAN Fibroleukin$proteolysis,neutrophil degranulationpeptidase activityZextracellular region,fibrinogen complex,extracellular exosome,ficolin-1-rich granule lumenC>sp|Q14314|FGL2_HUMAN Fibroleukin OS=Homo sapiens GN=FGL2 PE=1 SV=1Q14624ITIH4 ITIH4_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H4platelet degranulation,acute-phase response,negative regulation of endopeptidase activity,hyaluronan metabolic process,response to cytokine]endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity,protein bindingkextracellular region,plasma membrane,platelet dense granule lumen,extracellular exosome,blood microparticlef>sp|Q14624|ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4Q14697;Q14697-2GANAB GANAB_HUMANFNeutral alpha-glucosidase AB;Isoform 2 of Neutral alpha-glucosidase AB/carbohydrate metabolic process,protein folding;GRNA binding,carbohydrate binding,glucan 1,3-alpha-glucosidase activity;endoplasmic reticulum lumen,Golgi apparatus,membrane,glucosidase II complex,extracellular matrix,melanosome,extracellular exosome;>sp|Q14697|GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo sapiens GN=GANAB PE=1 SV=3;>sp|Q14697-2|GANAB_HUMAN Isoform 2 of Neutral alpha-glucosidase AB OS=Homo sapiens GN=GANABQ14766;Q14766-4LTBP1 LTBP1_HUMAN~Latent-transforming growth factor beta-binding protein 1;Isoform 4 of Latent-transforming growth factor beta-binding protein 1ventricular septum development,transmembrane receptor protein serine/threonine kinase signaling pathway,sequestering of TGFbeta in extracellular matrix,aorta development,coronary vasculature development;transforming growth factor beta-activated receptor activity,calcium ion binding,protein binding,transforming growth factor beta binding,microfibril binding;}microfibril,extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,protein complex;>sp|Q14766|LTBP1_HUMAN Latent-transforming growth factor beta-binding protein 1 OS=Homo sapiens GN=LTBP1 PE=1 SV=4;>sp|Q14766-4|LTBP1_HUMAN Isoform 4 of Latent-transforming growth factor beta-binding protein 1 OS=Homo sapiens GN=LTBP1Q15063-3POSTN POSTN_HUMANIsoform 3 of PeriostinH>sp|Q15063-3|POSTN_HUMAN Isoform 3 of Periostin OS=Homo sapiens GN=POSTNQ15075EEA1 EEA1_HUMANEarly endosome antigen 1endocytosis,vesicle fusion,synaptic vesicle to endosome fusion,viral RNA genome replication,early endosome to late endosome transportprotein binding,calmodulin binding,1-phosphatidylinositol binding,zinc ion binding,GTP-dependent protein binding,protein homodimerization activitycytoplasm,early endosome,cytosol,serine-pyruvate aminotransferase complex,membrane,extrinsic component of plasma membrane,early endosome membrane,axonal spine,recycling endosome,extracellular exosome,presynapseP>sp|Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens GN=EEA1 PE=1 SV=2NQ15149;Q15149-2;Q15149-3;Q15149-4;Q15149-5;Q15149-6;Q15149-7;Q15149-8;Q15149-9PLEC PLEC_HUMANPlectin;Isoform 2 of Plectin;Isoform 3 of Plectin;Isoform 4 of Plectin;Isoform 5 of Plectin;Isoform 6 of Plectin;Isoform 7 of Plectin;Isoform 8 of Plectin;Isoform 9 of Plectinhemidesmosome assembly;;;;;;;;sRNA binding,actin binding,protein binding,structural constituent of muscle,ankyrin binding,cadherin binding;;;;;;;;cytosol,plasma membrane,brush border,focal adhesion,sarcoplasm,hemidesmosome,extracellular matrix,sarcolemma,costamere,intermediate filament cytoskeleton,extracellular exosome;;;;;;;; 1;;;;;;;; 3;;;;;;;;g>sp|Q15149|PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3;>sp|Q15149-2|PLEC_HUMAN Isoform 2 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-3|PLEC_HUMAN Isoform 3 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-4|PLEC_HUMAN Isoform 4 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-5|PLEC_HUMAN Isoform 5 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-6|PLEC_HUMAN Isoform 6 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-7|PLEC_HUMAN Isoform 7 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-8|PLEC_HUMAN Isoform 8 of Plectin OS=Homo sapiens GN=PLEC;>sp|Q15149-9|PLEC_HUMAN Isoform 9 of Plectin OS=Homo sapiens GN=PLECQ15848ADIPOQ ADIPO_HUMAN Adiponectin response to hypoxia,positive regulation of protein phosphorylation,glucose metabolic process,generation of precursor metabolites and energy,fatty acid beta-oxidation,response to nutrient,circadian rhythm,response to sucrose,response to glucose,positive regulation of signal transduction,negative regulation of platelet-derived growth factor receptor signaling pathway,positive regulation of protein kinase A signaling,negative regulation of macrophage derived foam cell differentiation,negative regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of cholesterol efflux,regulation of glucose metabolic process,response to activity,negative regulation of smooth muscle cell migration,fatty acid oxidation,negative regulation of cell migration,negative regulation of granulocyte differentiation,negative regulation of protein autophosphorylation,positive regulation of cellular protein metabolic process,negative regulation of tumor necrosis factor production,positive regulation of interleukin-8 production,cellular response to insulin stimulus,positive regulation of myeloid cell apoptotic process,adiponectin-activated signaling pathway,negative regulation of heterotypic cell-cell adhesion,low-density lipoprotein particle clearance,response to tumor necrosis factor,cellular response to drug,regulation of fatty acid biosynthetic process,glucose homeostasis,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of MAP kinase activity,response to ethanol,negative regulation of fat cell differentiation,negative regulation of macrophage differentiation,negative regulation of low-density lipoprotein particle receptor biosynthetic process,negative regulation of gluconeogenesis,negative regulation of blood pressure,positive regulation of blood pressure,negative regulation of transcription, DNA-templated,positive regulation of fatty acid metabolic process,positiv< e regulation of glucose import,negative regulation of hormone secretion,negative regulation of smooth muscle cell proliferation,negative regulation of inflammatory response,positive regulation of peptidyl-tyrosine phosphorylation,negative regulation of phagocytosis,negative regulation of synaptic transmission,brown fat cell differentiation,protein homooligomerization,response to glucocorticoid,membrane depolarization,membrane hyperpolarization,protein heterotrimerization,negative regulation of ERK1 and ERK2 cascade,response to linoleic acid,detection of oxidative stress,cellular response to cAMP,positive regulation of monocyte chemotactic protein-1 production,cellular response to epinephrine stimulus,protein localization to plasma membrane,negative regulation of intracellular protein transport,negative regulation of receptor binding,negative regulation of DNA biosynthetic process,positive regulation of glycogen (starch) synthase activity,positive regulation of metanephric glomerular visceral epithelial cell development,positive regulation of cAMP-dependent protein kinase activity,positive regulation of renal albumin absorption,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,negative regulation of metanephric mesenchymal cell migrationreceptor binding,cytokine activity,hormone activity,protein binding,sialic acid binding,identical protein binding,protein homodimerization activityqextracellular region,collagen trimer,extracellular space,endoplasmic reticulum,cell surface,extracellular exosomeF>sp|Q15848|ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1Q15911;Q15911-2ZFHX3 ZFHX3_HUMANJZinc finger homeobox protein 3;Isoform B of Zinc finger homeobox protein 3negative regulation of transcription from RNA polymerase II promoter,regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,cell cycle arrest,brain development,muscle organ development,circadian regulation of gene expression,regulation of neuron differentiation,positive regulation of transcription, DNA-templated,response to transforming growth factor beta,regulation of locomotor rhythm;core promoter sequence-specific DNA binding,transcription factor activity, sequence-specific DNA binding,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,protein binding,zinc ion binding,enzyme binding;Hnucleus,nucleoplasm,transcription factor complex,cytoplasm,nuclear body;>sp|Q15911|ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2;>sp|Q15911-2|ZFHX3_HUMAN Isoform B of Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3Q27J81;Q27J81-2INF2 INF2_HUMAN0Inverted formin-2;Isoform 2 of Inverted formin-2Dactin cytoskeleton organization,regulation of mitochondrial fission;!actin binding,Rho GTPase binding; perinuclear region of cytoplasm;>sp|Q27J81|INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2;>sp|Q27J81-2|INF2_HUMAN Isoform 2 of Inverted formin-2 OS=Homo sapiens GN=INF2Q4KMQ2;Q4KMQ2-2;Q4KMQ2-3ANO6 ANO6_HUMAN=Anoctamin-6;Isoform 2 of Anoctamin-6;Isoform 3 of Anoctamin-6&dendritic cell chemotaxis,activation of blood coagulation via clotting cascade,cation transport,chloride transport,lipid transport,blood coagulation,phospholipid scrambling,positive regulation of bone mineralization,bleb assembly,ion transmembrane transport,positive regulation of ion transmembrane transport,purinergic nucleotide receptor signaling pathway,bone mineralization involved in bone maturation,sodium ion transmembrane transport,positive regulation of apoptotic process,neutrophil degranulation,negative regulation of cell volume,pore complex assembly,positive regulation of phagocytosis, engulfment,calcium activated phosphatidylserine scrambling,calcium activated phosphatidylcholine scrambling,calcium activated galactosylceramide scrambling,calcium ion transmembrane transport,positive regulation of monocyte chemotaxis,phosphatidylserine exposure on blood platelet,positive regulation of potassium ion export,chloride transmembrane transport,regulation of anion transmembrane transport,positive regulation of endothelial cell apoptotic process;;calcium activated cation channel activity,intracellular calcium activated chloride channel activity,voltage-gated ion channel activity,voltage-gated chloride channel activity,protein binding,phospholipid scramblase activity,protein homodimerization activity;;intracellular,cytosol,plasma membrane,cell surface,membrane,chloride channel complex,specific granule membrane,extracellular exosome,tertiary granule membrane;;2;;>sp|Q4KMQ2|ANO6_HUMAN Anoctamin-6 OS=Homo sapiens GN=ANO6 PE=1 SV=2;>sp|Q4KMQ2-2|ANO6_HUMAN Isoform 2 of Anoctamin-6 OS=Homo sapiens GN=ANO6;>sp|Q4KMQ2-3|ANO6_HUMAN Isoform 3 of Anoctamin-6 OS=Homo sapiens GN=ANO6!Q5T4S7;Q5T4S7-2;Q5T4S7-3;Q5T4S7-4UBR4 UBR4_HUMANE3 ubiquitin-protein ligase UBR4;Isoform 2 of E3 ubiquitin-protein ligase UBR4;Isoform 3 of E3 ubiquitin-protein ligase UBR4;Isoform 4 of E3 ubiquitin-protein ligase UBR4zviral process,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,neutrophil degranulation;;;]ubiquitin-protein transferase activity,protein binding,calmodulin binding,zinc ion binding;;;nucleoplasm,centrosome,cytosol,plasma membrane,membrane,integral component of membrane,specific granule membrane,tertiary granule membrane,ficolin-1-rich granule membrane;;;r>sp|Q5T4S7|UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4 PE=1 SV=1;>sp|Q5T4S7-2|UBR4_HUMAN Isoform 2 of E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4;>sp|Q5T4S7-3|UBR4_HUMAN Isoform 3 of E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4;>sp|Q5T4S7-4|UBR4_HUMAN Isoform 4 of E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4Q6UY14;Q6UY14-2;Q6UY14-3ADAMTSL4 ATL4_HUMAN[ADAMTS-like protein 4;Isoform 2 of ADAMTS-like protein 4;Isoform 3 of ADAMTS-like protein 4epithelial cell development,proteolysis,apoptotic process,extracellular matrix organization,protein O-linked fucosylation,positive regulation of apoptotic process;;@protease binding,metalloendopeptidase activity,protein binding;;Xcellular_component,interstitial matrix,extracellular space,endoplasmic reticulum lumen;;>sp|Q6UY14|ATL4_HUMAN ADAMTS-like protein 4 OS=Homo sapiens GN=ADAMTSL4 PE=1 SV=2;>sp|Q6UY14-2|ATL4_HUMAN Isoform 2 of ADAMTS-like protein 4 OS=Homo sapiens GN=ADAMTSL4;>sp|Q6UY14-3|ATL4_HUMAN Isoform 3 of ADAMTS-like protein 4 OS=Homo sapiens GN=ADAMTSL4Q6V0I7;Q6V0I7-3FAT4 FAT4_HUMAN4Protocadherin Fat 4;Isoform 3 of Protocadherin Fat 4Wbranching involved in ureteric bud morphogenesis,heart morphogenesis,plasma membrane organization,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,Notch signaling pathway,fibroblast growth factor receptor signaling pathway,cerebral cortex development,neurogenesis,hippo signaling,ossification involved in bone maturation,digestive tract development,inner ear receptor stereocilium organization,condensed mesenchymal cell proliferation,regulation of metanephric nephron tubule epithelial cell differentiation;$calcium ion binding,protein binding;gintracellular,plasma membrane,integral component of membrane,apical part of cell,extracellular exosome;>sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=1 SV=2;>sp|Q6V0I7-3|FAT4_HUMAN Isoform 3 of Protocadherin Fat 4 OS=Homo sapiens GN=FAT4Q6YHK3CD109 CD109_HUMAN CD109 antigennegative regulation of protein phosphorylation,hair follicle development,platelet degranulation,C-terminal protein lipidation,negative regulation of keratinocyte proliferation,negative regulation of endopeptidase activity,negative regulation of transforming growth factor beta receptor signaling pathway,regulation of keratinocyte differentiation,negative regulation of wound healing,osteoclast fusionTserine-type endopeptidase inhibitor activity,transforming growth factor beta bindingextracellular region,extracellular space,plasma membrane,cell sur< face,platelet alpha granule membrane,anchored component of membraneG>sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2Q7L576CYFIP1 CYFP1_HUMAN&Cytoplasmic FMR1-interacting protein 1regulation of cell shape,Rac protein signal transduction,lamellipodium assembly,ruffle organization,cellular response to insulin stimulus,Fc-gamma receptor signaling pathway involved in phagocytosis,neutrophil degranulation,positive regulation of axon extension,vascular endothelial growth factor receptor signaling pathway,axon extension,cognition,positive regulation of neurotrophin TRK receptor signaling pathway,response to electrical stimulus,dendrite extension,positive regulation of dendrite development,positive regulation of ruffle assembly,negative regulation of synaptic vesicle recycling,positive regulation of Arp2/3 complex-mediated actin nucleationsRNA 7-methylguanosine cap binding,protein binding,protein complex binding,Rac GTPase binding,actin filament bindingruffle,extracellular region,cytosol,mRNA cap binding complex,focal adhesion,lamellipodium,SCAR complex,filopodium tip,secretory granule lumen,specific granule lumen,neuron projection,neuronal cell body,terminal bouton,dendritic spine,dendritic growth cone,axonal growth cone,perinuclear region of cytoplasm,excitatory synapse,extracellular exosome,Requires Ontology,tertiary granule lumena>sp|Q7L576|CYFP1_HUMAN Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens GN=CYFIP1 PE=1 SV=1Q7LDG7;Q7LDG7-4RASGRP2 GRP2_HUMANJRAS guanyl-releasing protein 2;Isoform 4 of RAS guanyl-releasing protein 2regulation of cell growth,signal transduction,Ras protein signal transduction,positive regulation of GTPase activity,cellular response to calcium ion;dguanyl-nucleotide exchange factor activity,calcium ion binding,lipid binding,diacylglycerol binding;Pcytosol,plasma membrane,cell junction,ruffle membrane,neuron projection,synapse;>sp|Q7LDG7|GRP2_HUMAN RAS guanyl-releasing protein 2 OS=Homo sapiens GN=RASGRP2 PE=1 SV=1;>sp|Q7LDG7-4|GRP2_HUMAN Isoform 4 of RAS guanyl-releasing protein 2 OS=Homo sapiens GN=RASGRP2Q7Z7M0;Q7Z7M0-2MEGF8 MEGF8_HUMAN|Multiple epidermal growth factor-like domains protein 8;Isoform 2 of Multiple epidermal growth factor-like domains protein 8kembryonic heart tube morphogenesis,regulation of gene expression,embryonic limb morphogenesis,BMP signaling pathway,limb morphogenesis,cell migration involved in gastrulation,embryonic skeletal system morphogenesis,positive regulation of axon extension involved in axon guidance,epiboly involved in gastrulation with mouth forming second,embryonic heart tube left/right pattern formation,left/right pattern formation,coronary vasculature development,determination of heart left/right asymmetry,determination of digestive tract left/right asymmetry,craniofacial suture morphogenesis,fasciculation of sensory neuron axon;=nucleus,integral component of membrane,extracellular exosome;>sp|Q7Z7M0|MEGF8_HUMAN Multiple epidermal growth factor-like domains protein 8 OS=Homo sapiens GN=MEGF8 PE=1 SV=2;>sp|Q7Z7M0-2|MEGF8_HUMAN Isoform 2 of Multiple epidermal growth factor-like domains protein 8 OS=Homo sapiens GN=MEGF8Q86UX7;Q86UX7-2FERMT3 URP2_HUMAN@Fermitin family homolog 3;Isoform 2 of Fermitin family homolog 3 platelet degranulation,leukocyte cell-cell adhesion,integrin-mediated signaling pathway,positive regulation of cell migration,integrin activation,regulation of cell-cell adhesion mediated by integrin,substrate adhesion-dependent cell spreading,platelet aggregation;integrin binding;xpodosome,extracellular region,membrane,cell junction,platelet alpha granule lumen,cell projection,extracellular exosome;>sp|Q86UX7|URP2_HUMAN Fermitin family homolog 3 OS=Homo sapiens GN=FERMT3 PE=1 SV=1;>sp|Q86UX7-2|URP2_HUMAN Isoform 2 of Fermitin family homolog 3 OS=Homo sapiens GN=FERMT3Q86WI1PKHD1L1 PKHL1_HUMAN Fibrocystin-Limmune responsereceptor activityAextracellular space,cytosol,cilium,integral component of membraneI>sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2Q8IZ83ALDH16A1 A16A1_HUMAN*Aldehyde dehydrogenase family 16 member A1oxidation-reduction process%aldehyde dehydrogenase (NAD) activitymembrane,extracellular exosomeg>sp|Q8IZ83|A16A1_HUMAN Aldehyde dehydrogenase family 16 member A1 OS=Homo sapiens GN=ALDH16A1 PE=1 SV=2Q8NBM8PCYOX1L PCYXL_HUMANPrenylcysteine oxidase-likexplatelet degranulation,prenylated protein catabolic process,prenylcysteine catabolic process,oxidation-reduction processprenylcysteine oxidase activityLextracellular region,vacuolar membrane,membrane,platelet alpha granule lumenW>sp|Q8NBM8|PCYXL_HUMAN Prenylcysteine oxidase-like OS=Homo sapiens GN=PCYOX1L PE=1 SV=2Q8NBP7PCSK9 PCSK9_HUMAN-Proprotein convertase subtilisin/kexin type 9tkidney development,liver development,negative regulation of receptor recycling,positive regulation of receptor internalization,triglyceride metabolic process,phospholipid metabolic process,receptor-mediated endocytosis,apoptotic process,lysosomal transport,cholesterol metabolic process,cellular response to starvation,regulation of receptor activity,negative regulation of low-density lipoprotein particle clearance,protein autoprocessing,neurogenesis,neuron differentiation,low-density lipoprotein particle receptor catabolic process,positive regulation of low-density lipoprotein particle receptor catabolic process,cellular response to insulin stimulus,lipoprotein metabolic process,cholesterol homeostasis,regulation of neuron apoptotic process,positive regulation of neuron apoptotic process,Requires Ontology,negative regulation of sodium ion transmembrane transporter activityRNA binding,serine-type endopeptidase activity,protein binding,sodium channel inhibitor activity,low-density lipoprotein particle binding,receptor inhibitor activity,apolipoprotein binding,very-low-density lipoprotein particle binding,apolipoprotein receptor binding,protein self-association,low-density lipoprotein particle receptor binding,very-low-density lipoprotein particle receptor binding}extracellular region,extracellular space,cytoplasm,lysosome,lysosomal membrane,early endosome,late endosome,endoplasmic reticulum,rough endoplasmic reticulum,Golgi apparatus,plasma membrane,cell surface,ER to Golgi transport vesicle,extrinsic component of external side of plasma membrane,endolysosome membrane,perinuclear region of cytoplasm,PCSK9-LDLR complex,PCSK9-AnxA2 complexg>sp|Q8NBP7|PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3Q8NDA2HMCN2 HMCN2_HUMAN Hemicentin-2Tsmooth muscle contraction,positive regulation of cell migration,response to stimuluscalcium ion binding;basement membrane,cell cortex,cell junction,cleavage furrowF>sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens GN=HMCN2 PE=2 SV=3Q8NI99ANGPTL6 ANGL6_HUMANAngiopoietin-related protein 6!angiogenesis,cell differentiation'secretory granule,extracellular exosomeZ>sp|Q8NI99|ANGL6_HUMAN Angiopoietin-related protein 6 OS=Homo sapiens GN=ANGPTL6 PE=1 SV=12G3V234;G3V2G6;H0YIZ8;H0YJ10;H0YJ46;Q8TC12;Q8TC12-2RDH11;RDH11;;;RDH11;RDH11;RDH11XG3V234_HUMAN;G3V2G6_HUMAN;H0YIZ8_HUMAN;H0YJ10_HUMAN;H0YJ46_HUMAN;RDH11_HUMAN;RDH11_HUMANRetinol dehydrogenase 11 (Fragment);Retinol dehydrogenase 11 (Fragment);Uncharacterized protein (Fragment);Uncharacterized protein (Fragment);Retinol dehydrogenase 11 (Fragment);Retinol dehydrogenase 11;Isoform 2 of Retinol dehydrogenase 11;;oxidation-reduction process;;;retinoid metabolic process,adaptation of rhodopsin mediated signaling,retinol metabolic process,retinal metabolic process,oxidation-reduction process;;;oxidoreductase activity;;;retinol dehydrogenase activity,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,NADP-retinol dehydrogenase activity;m;;;;;photoreceptor inner segment,intracellular,endoplasmic reticulum membrane,integral component of membrane; 1;1;4;4;1;1; 8;1;1;1;1;2;q>tr|G3V234|G3V234_HUMAN Retinol dehydrogenase 11 (Fragment) OS=Homo sapiens GN=RDH11< PE=1 SV=8;>tr|G3V2G6|G3V2G6_HUMAN Retinol dehydrogenase 11 (Fragment) OS=Homo sapiens GN=RDH11 PE=1 SV=1;>tr|H0YIZ8|H0YIZ8_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=1;>tr|H0YJ10|H0YJ10_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=1;>tr|H0YJ46|H0YJ46_HUMAN Retinol dehydrogenase 11 (Fragment) OS=Homo sapiens GN=RDH11 PE=1 SV=1;>sp|Q8TC12|RDH11_HUMAN Retinol dehydrogenase 11 OS=Homo sapiens GN=RDH11 PE=1 SV=2;>sp|Q8TC12-2|RDH11_HUMAN Isoform 2 of Retinol dehydrogenase 11 OS=Homo sapiens GN=RDH11!Q8TER0;Q8TER0-3;Q8TER0-4;Q8TER0-5SNED1 SNED1_HUMANSushi, nidogen and EGF-like domain-containing protein 1;Isoform 2 of Sushi, nidogen and EGF-like domain-containing protein 1;Isoform 3 of Sushi, nidogen and EGF-like domain-containing protein 1;Isoform 4 of Sushi, nidogen and EGF-like domain-containing protein 1cell-matrix adhesion;;;calcium ion binding;;;extracellular exosome;;;2;;;>sp|Q8TER0|SNED1_HUMAN Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1 PE=2 SV=2;>sp|Q8TER0-3|SNED1_HUMAN Isoform 2 of Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1;>sp|Q8TER0-4|SNED1_HUMAN Isoform 3 of Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1;>sp|Q8TER0-5|SNED1_HUMAN Isoform 4 of Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1Q8WUA8TSKU TSK_HUMAN Tsukushin adenylate cyclase-modulating G-protein coupled receptor signaling pathway,regulation of gene expression,corpus callosum morphogenesis,lateral ventricle development,anterior commissure morphogenesis,negative regulation of Wnt signaling pathway,ciliary body morphogenesis#G-protein coupled receptor activity@>sp|Q8WUA8|TSK_HUMAN Tsukushin OS=Homo sapiens GN=TSKU PE=2 SV=3Q8WUW1;Q8WUW1-2BRK1 BRK1_HUMAN*Protein BRICK1;Isoform 2 of Protein BRICK1in utero embryonic development,actin filament organization,positive regulation of cell proliferation,positive regulation of lamellipodium assembly,Rac protein signal transduction,Fc-gamma receptor signaling pathway involved in phagocytosis,vascular endothelial growth factor receptor signaling pathway,cell motility,protein homotrimerization,positive regulation of Arp2/3 complex-mediated actin nucleation;;protein binding,protein complex binding,Rac GTPase binding;Fcytosol,cytoskeleton,lamellipodium,SCAR complex,extracellular exosome;>sp|Q8WUW1|BRK1_HUMAN Protein BRICK1 OS=Homo sapiens GN=BRK1 PE=1 SV=1;>sp|Q8WUW1-2|BRK1_HUMAN Isoform 2 of Protein BRICK1 OS=Homo sapiens GN=BRK1Q92626PXDN PXDN_HUMANPeroxidasin homolognegative regulation of cytokine-mediated signaling pathway,immune response,response to oxidative stress,extracellular matrix organization,hydrogen peroxide catabolic process,oxidation-reduction process,cellular oxidant detoxificationperoxidase activity,interleukin-1 receptor antagonist activity,extracellular matrix structural constituent,heme binding,metal ion bindingwproteinaceous extracellular matrix,extracellular space,endoplasmic reticulum,extracellular matrix,extracellular exosomeK>sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens GN=PXDN PE=1 SV=2Q969P0;Q969P0-3IGSF8 IGSF8_HUMANTImmunoglobulin superfamily member 8;Isoform 3 of Immunoglobulin superfamily member 8movement of cell or subcellular component,single fertilization,nervous system development,skeletal muscle tissue development,cell proliferation;Nplasma membrane,membrane,integral component of membrane,extracellular exosome;>sp|Q969P0|IGSF8_HUMAN Immunoglobulin superfamily member 8 OS=Homo sapiens GN=IGSF8 PE=1 SV=1;>sp|Q969P0-3|IGSF8_HUMAN Isoform 3 of Immunoglobulin superfamily member 8 OS=Homo sapiens GN=IGSF8Q96RW7;Q96RW7-2HMCN1 HMCN1_HUMAN&Hemicentin-1;Isoform 2 of Hemicentin-1@cell cycle,visual perception,response to stimulus,cell division;calcium ion binding;gbasement membrane,cell cortex,cell junction,cleavage furrow,extracellular exosome,extracellular matrix;>sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2;>sp|Q96RW7-2|HMCN1_HUMAN Isoform 2 of Hemicentin-1 OS=Homo sapiens GN=HMCN1 K7ELW0;Q99497PARK7K7ELW0_HUMAN;PARK7_HUMANProtein deglycase DJ-1O;negative regulation of protein phosphorylation,positive regulation of acute inflammatory response to antigenic stimulus,negative regulation of protein kinase activity,proteolysis,protein deglycosylation,autophagy,inflammatory response,mitochondrion organization,Ras protein signal transduction,single fertilization,adult locomotory behavior,methylglyoxal metabolic process,detoxification of copper ion,positive regulation of gene expression,negative regulation of gene expression,enzyme active site formation via L-cysteine sulfinic acid,lactate biosynthetic process,negative regulation of protein ubiquitination,negative regulation of protein binding,activation of protein kinase B activity,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of interleukin-8 production,positive regulation of peptidyl-serine phosphorylation,negative regulation of protein sumoylation,positive regulation of NAD(P)H oxidase activity,cellular response to oxidative stress,cellular response to glyoxal,peptidyl-cysteine deglycation,peptidyl-arginine deglycation,peptidyl-lysine deglycation,protein deglycation, glyoxal removal,protein deglycation, methylglyoxal removal,glutathione deglycation,hydrogen peroxide metabolic process,negative regulation of apoptotic process,regulation of neuron apoptotic process,negative regulation of neuron apoptotic process,positive regulation of transcription from RNA polymerase II promoter,glycolate biosynthetic process,negative regulation of protein export from nucleus,regulation of inflammatory response,detoxification of mercury ion,protein stabilization,positive regulation of sequence-specific DNA binding transcription factor activity,negative regulation of ubiquitin-protein transferase activity,dopamine uptake involved in synaptic transmission,regulation of mitochondrial membrane potential,positive regulation of protein kinase B signaling,membrane depolarization,membrane hyperpolarization,negative regulation of cell death,regulation of androgen receptor signaling pathway,cellular response to hydrogen peroxide,positive regulation of protein homodimerization activity,cellular oxidant detoxification,positive regulation of protein localization to nucleus,negative regulation of neuron death,positive regulation of superoxide dismutase activity,negative regulation of protein acetylation,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,regulation of fibril organization,positive regulation of mitochondrial electron transport, NADH to ubiquinone,negative regulation of death-inducing signaling complex assembly,negative regulation of protein K48-linked deubiquitination,negative regulation of TRAIL-activated apoptotic signaling pathway,positive regulation of pyrroline-5-carboxylate reductase activity,positive regulation of tyrosine 3-monooxygenase activity,positive regulation of dopamine biosynthetic process,glyoxal metabolic process,positive regulation of L-dopa biosynthetic process,positive regulation of L-dopa decarboxylase activity,negative regulation of oxidative stress-induced cell death,negative regulation of hydrogen peroxide-induced cell death,negative regulation of hydrogen peroxide-induced neuron death,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,positive regulation of reactive oxygen species biosynthetic process,positive regulation of mitophagy,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,negative regulation of ubiquitin-specific protease activity,positive regulation of oxidative phosphorylation uncoupler activity,positive regulation of transcription regulatory region DNA binding,positive re< gulation of androgen receptor activity,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,regulation of TRAIL receptor biosynthetic process_;transcription coactivator activity,mRNA binding,receptor binding,copper ion binding,protein binding,transcription factor binding,peptidase activity,superoxide dismutase copper chaperone activity,oxidoreductase activity, acting on peroxide as acceptor,enzyme binding,kinase binding,cytokine binding,tyrosine 3-monooxygenase activator activity,L-dopa decarboxylase activator activity,protein deglycase activity,identical protein binding,protein homodimerization activity,small protein activating enzyme binding,ubiquitin-like protein conjugating enzyme binding,cadherin binding,mercury ion binding,androgen receptor binding,peroxiredoxin activity,repressing transcription factor binding,scaffold protein binding,cupric ion binding,cuprous ion binding,ubiquitin-specific protease binding,core promoter binding,double-stranded DNA binding,single-stranded DNA binding<;chromatin,nucleus,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,endoplasmic reticulum,cytosol,plasma membrane,cell-cell adherens junction,PML body,axon,cell body,membrane raft,perinuclear region of cytoplasm,extracellular exosome,presynapse,mitochondrial respiratory chain complex I>tr|K7ELW0|K7ELW0_HUMAN Protein deglycase DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=1;>sp|Q99497|PARK7_HUMAN Protein deglycase DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2Q99832CCT7 TCPH_HUMANT-complex protein 1 subunit etaprotein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodyzprotein binding,ATP binding,identical protein binding,protein binding involved in protein folding,unfolded protein bindingzona pellucida receptor complex,cytoplasm,mitochondrion,cytosol,chaperonin-containing T-complex,microtubule,cell body,extracellular exosomeW>sp|Q99832|TCPH_HUMAN T-complex protein 1 subunit eta OS=Homo sapiens GN=CCT7 PE=1 SV=2Q99969RARRES2 RARR2_HUMAN*Retinoic acid receptor responder protein 2retinoid metabolic process,in utero embryonic development,positive regulation of protein phosphorylation,platelet degranulation,chemotaxis,inflammatory response,positive regulation of macrophage chemotaxis,positive regulation of fat cell differentiation,embryonic digestive tract development,brown fat cell differentiation,positive regulation of chemotaxis,regulation of lipid catabolic process,positive regulation of glucose import in response to insulin stimulus receptor binding,protein bindingpextracellular region,extracellular space,extracellular matrix,platelet dense granule lumen,extracellular exosomef>sp|Q99969|RARR2_HUMAN Retinoic acid receptor responder protein 2 OS=Homo sapiens GN=RARRES2 PE=1 SV=1Q9BUN1MENT MENT_HUMAN Protein MENTD>sp|Q9BUN1|MENT_HUMAN Protein MENT OS=Homo sapiens GN=MENT PE=2 SV=1XQ9BWP8;Q9BWP8-10;Q9BWP8-2;Q9BWP8-3;Q9BWP8-4;Q9BWP8-5;Q9BWP8-6;Q9BWP8-7;Q9BWP8-8;Q9BWP8-9COLEC11 COL11_HUMANCollectin-11;Isoform 10 of Collectin-11;Isoform 2 of Collectin-11;Isoform 3 of Collectin-11;Isoform 4 of Collectin-11;Isoform 5 of Collectin-11;Isoform 6 of Collectin-11;Isoform 7 of Collectin-11;Isoform 8 of Collectin-11;Isoform 9 of Collectin-11proteolysis,receptor-mediated endocytosis,complement activation,multicellular organism development,developmental process;;;;;;;;;;serine-type endopeptidase activity,mannose binding;;;;;;;;;-extracellular region,collagen trimer;;;;;;;;; 1;;;;;;;;;>sp|Q9BWP8|COL11_HUMAN Collectin-11 OS=Homo sapiens GN=COLEC11 PE=1 SV=1;>sp|Q9BWP8-10|COL11_HUMAN Isoform 10 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-2|COL11_HUMAN Isoform 2 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-3|COL11_HUMAN Isoform 3 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-4|COL11_HUMAN Isoform 4 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-5|COL11_HUMAN Isoform 5 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-6|COL11_HUMAN Isoform 6 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-7|COL11_HUMAN Isoform 7 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-8|COL11_HUMAN Isoform 8 of Collectin-11 OS=Homo sapiens GN=COLEC11;>sp|Q9BWP8-9|COL11_HUMAN Isoform 9 of Collectin-11 OS=Homo sapiens GN=COLEC11Q9BXN1ASPN ASPN_HUMANAsporin negative regulation of protein kinase activity,cytokine-mediated signaling pathway,bone mineralization,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of JAK-STAT cascade,negative regulation of tooth mineralizationFprotein kinase inhibitor activity,calcium ion binding,collagen bindingAproteinaceous extracellular matrix,cytoplasm,extracellular matrix?>sp|Q9BXN1|ASPN_HUMAN Asporin OS=Homo sapiens GN=ASPN PE=1 SV=2Q9H0U4RAB1B RAB1B_HUMANRas-related protein Rab-1BPER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,autophagy,small GTPase mediated signal transduction,protein transport,virion assembly,COPII vesicle coating,positive regulation of glycoprotein metabolic process,regulation of autophagosome assembly,establishment of endothelial intestinal barrierprotein binding,GTP bindingGolgi membrane,mitochondrion,endoplasmic reticulum membrane,Golgi apparatus,cytosol,transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,pre-autophagosomal structure membrane,extracellular exosomeT>sp|Q9H0U4|RAB1B_HUMAN Ras-related protein Rab-1B OS=Homo sapiens GN=RAB1B PE=1 SV=1Q9HCL0;Q9HCL0-2PCDH18 PCD18_HUMAN.Protocadherin-18;Isoform 2 of Protocadherin-18cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,cell-cell signaling,nervous system development,brain development;&integral component of plasma membrane;>sp|Q9HCL0|PCD18_HUMAN Protocadherin-18 OS=Homo sapiens GN=PCDH18 PE=2 SV=3;>sp|Q9HCL0-2|PCD18_HUMAN Isoform 2 of Protocadherin-18 OS=Homo sapiens GN=PCDH18Q9HCM3;Q9HCM3-2KIAA1549 K1549_HUMAN>UPF0606 protein KIAA1549;Isoform 2 of UPF0606 protein KIAA1549/plasma membrane,integral component of membrane;>sp|Q9HCM3|K1549_HUMAN UPF0606 protein KIAA1549 OS=Homo sapiens GN=KIAA1549 PE=1 SV=4;>sp|Q9HCM3-2|K1549_HUMAN Isoform 2 of UPF0606 protein KIAA1549 OS=Homo sapiens GN=KIAA1549Q9NZP8C1RL C1RL_HUMAN(Complement C1r subcomponent-like proteinKproteolysis,complement activation, classical pathway,innate immune response)extracellular space,extracellular exosome`>sp|Q9NZP8|C1RL_HUMAN Complement C1r subcomponent-like protein OS=Homo sapiens GN=C1RL PE=1 SV=21Q9UFM8;Q9Y639;Q9Y639-1;Q9Y639-3;Q9Y639-4;Q9Y639-5&DKFZp566H1924;NPTN;NPTN;NPTN;NPTN;NPTNCQ9UFM8_HUMAN;NPTN_HUMAN;NPTN_HUMAN;NPTN_HUMAN;NPTN_HUMAN;NPTN_HUMANNeuroplastin (Fragment);Neuroplastin;Isoform 1 of Neuroplastin;Isoform 3 of Neuroplastin;Isoform 4 of Neuroplastin;Isoform 5 of Neuroplastin;positive regulation of protein phosphorylation,homophilic cell adhesion via plasma membrane adhesion molecules,transmembrane receptor protein tyrosine kinase signaling pathway,positive regulation of cytosolic calcium ion concentration,visual learning,positive regulation of neuron projection development,peptidyl-tyrosine phosphorylation,positive regulation of fibroblast growth factor receptor signaling pathway,positive regulation of long-term neuronal synaptic plasticity,long-term synaptic potentiation,positive regulation of ERK1 and ERK2 cascade,positive regulation of long-term synaptic potentiation,regulation of receptor localization to synapse,positive regulation of cellular protein localization,excitatory synapse assembly;;;;;transmembrane receptor protein tyrosine kinase activity,type 1 fibroblast growth factor receptor binding,i< on channel binding,cell adhesion molecule binding;;;;v;cell surface,postsynaptic density,integral component of membrane,dendrite,presynaptic membrane,inhibitory synapse;;;;tr;sp;sp;sp;sp;sp1;1;;;;2;2;;;;>tr|Q9UFM8|Q9UFM8_HUMAN Neuroplastin (Fragment) OS=Homo sapiens GN=DKFZp566H1924 PE=1 SV=2;>sp|Q9Y639|NPTN_HUMAN Neuroplastin OS=Homo sapiens GN=NPTN PE=1 SV=2;>sp|Q9Y639-1|NPTN_HUMAN Isoform 1 of Neuroplastin OS=Homo sapiens GN=NPTN;>sp|Q9Y639-3|NPTN_HUMAN Isoform 3 of Neuroplastin OS=Homo sapiens GN=NPTN;>sp|Q9Y639-4|NPTN_HUMAN Isoform 4 of Neuroplastin OS=Homo sapiens GN=NPTN;>sp|Q9Y639-5|NPTN_HUMAN Isoform 5 of Neuroplastin OS=Homo sapiens GN=NPTNQ9UHG3PCYOX1 PCYOX_HUMANPrenylcysteine oxidase 1prenylated protein catabolic process,prenylcysteine catabolic process,prenylcysteine metabolic process,oxidation-reduction process,Requires Ontology,chloride transmembrane transportEprenylcysteine oxidase activity,chloride-transporting ATPase activityflysosome,vacuolar membrane,plasma membrane,very-low-density lipoprotein particle,extracellular exosomeS>sp|Q9UHG3|PCYOX_HUMAN Prenylcysteine oxidase 1 OS=Homo sapiens GN=PCYOX1 PE=1 SV=3*Q9UJY5;Q9UJY5-2;Q9UJY5-3;Q9UJY5-4;Q9UJY5-6GGA1 GGA1_HUMANADP-ribosylation factor-binding protein GGA1;Isoform 2 of ADP-ribosylation factor-binding protein GGA1;Isoform 3 of ADP-ribosylation factor-binding protein GGA1;Isoform 4 of ADP-ribosylation factor-binding protein GGA1;Isoform 6 of ADP-ribosylation factor-binding protein GGA1intracellular protein transport,vesicle-mediated transport,cellular protein metabolic process,positive regulation of protein catabolic process,membrane organization,toxin transport;;;;&molecular_function,protein binding;;;;nucleoplasm,Golgi apparatus,endosome membrane,membrane,clathrin adaptor complex,early endosome membrane,intracellular membrane-bounded organelle;;;; >sp|Q9UJY5|GGA1_HUMAN ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1 PE=1 SV=1;>sp|Q9UJY5-2|GGA1_HUMAN Isoform 2 of ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1;>sp|Q9UJY5-3|GGA1_HUMAN Isoform 3 of ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1;>sp|Q9UJY5-4|GGA1_HUMAN Isoform 4 of ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1;>sp|Q9UJY5-6|GGA1_HUMAN Isoform 6 of ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1Q9ULV4;Q9ULV4-2;Q9ULV4-3CORO1C COR1C_HUMAN:Coronin-1C;Isoform 2 of Coronin-1C;Isoform 3 of Coronin-1Cneural crest cell migration,regulation of protein phosphorylation,negative regulation of protein phosphorylation,phagocytosis,signal transduction,regulation of epithelial cell migration,negative regulation of epithelial cell migration,regulation of fibroblast migration,actin cytoskeleton organization,negative regulation of protein kinase activity by regulation of protein phosphorylation,establishment of protein localization,regulation of focal adhesion assembly,negative regulation of focal adhesion assembly,activation of GTPase activity,regulation of substrate adhesion-dependent cell spreading,negative regulation of substrate adhesion-dependent cell spreading,regulation of ruffle assembly,positive regulation of lamellipodium morphogenesis;;;protein binding,Rac GTPase binding,actin filament binding;;mcytoplasm,focal adhesion,actin cytoskeleton,lateral plasma membrane,flotillin complex,lamellipodium,vesicle;;>sp|Q9ULV4|COR1C_HUMAN Coronin-1C OS=Homo sapiens GN=CORO1C PE=1 SV=1;>sp|Q9ULV4-2|COR1C_HUMAN Isoform 2 of Coronin-1C OS=Homo sapiens GN=CORO1C;>sp|Q9ULV4-3|COR1C_HUMAN Isoform 3 of Coronin-1C OS=Homo sapiens GN=CORO1C E9PPM8;Q9Y315DERAE9PPM8_HUMAN;DEOC_HUMANDeoxyribose-phosphate aldolase;pentose-phosphate shunt,deoxyribonucleotide catabolic process,carbohydrate catabolic process,neutrophil degranulation,deoxyribonucleoside catabolic process,deoxyribose phosphate catabolic process(;deoxyribose-phosphate aldolase activityp;extracellular region,nucleus,cytosol,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen>tr|E9PPM8|E9PPM8_HUMAN Deoxyribose-phosphate aldolase OS=Homo sapiens GN=DERA PE=1 SV=1;>sp|Q9Y315|DEOC_HUMAN Deoxyribose-phosphate aldolase OS=Homo sapiens GN=DERA PE=1 SV=2Q9Y490TLN1 TLN1_HUMANTalin-1.platelet degranulation,movement of cell or subcellular component,muscle contraction,cytoskeletal anchoring at plasma membrane,cell-cell junction assembly,cell-substrate junction assembly,viral process,cortical actin cytoskeleton organization,IRE1-mediated unfolded protein response,platelet aggregationintegrin binding,structural constituent of cytoskeleton,protein binding,vinculin binding,LIM domain binding,cadherin binding,actin filament bindingruffle,extracellular region,cytosol,cytoskeleton,cell-cell junction,focal adhesion,cell surface,ruffle membrane,extracellular exosome?>sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens GN=TLN1 PE=1 SV=3Q9Y6R7FCGBP FCGBP_HUMANIgGFc-binding proteinextracellular exosomeO>sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3Q9Y6Z7COLEC10 COL10_HUMAN Collectin-10!proteolysis,complement activation2serine-type endopeptidase activity,mannose binding.extracellular region,collagen trimer,cytoplasmH>sp|Q9Y6Z7|COL10_HUMAN Collectin-10 OS=Homo sapiens GN=COLEC10 PE=2 SV=2A0A024RA52;P25787PSMA2A0A024RA52_HUMAN;PSA2_HUMAN=Proteasome subunit alpha type;Proteasome subunit alpha type-2;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,response to virus,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway6;threonine-type endopeptidase activity,protein binding;proteasome complex,cytoplasmic mRNA processing body,extracellular region,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen>tr|A0A024RA52|A0A024RA52_HUMAN Proteasome subunit alpha type OS=Homo sapiens GN=PSMA2 PE=1 SV=1;>sp|P25787|PSA2_HUMAN Proteasome subunit alpha type-2 OS=Homo sapiens GN=PSMA2 PE=1 SV=2 A0A075B6R2IGHV4-4A0A075B6R2_HUMANProtein IGHV4-4 (Fragment)_>tr|A0A075B6R2|A0A075B6R2_HUMAN Protein IGHV4-4 (Fragment) OS=Homo sapiens GN=IGHV4-4 PE=1 SV=2A0A087WTA8;P08123COL1A2A0A087WTA8_HUMAN;CO1A2_HUMANCollagen alpha-2(I) chain;skeletal system development,blood vessel development,transforming growth factor beta receptor signaling pathway,Rho protein signal transduction,blood coagulation,regulation of blood pressure,platelet activation,extracellular matrix organization,collagen fibril organization,collagen catabolic process,odontogenesis,skin morphogenesis,regulation of immune response,leukocyte migration,protein heterotrimerization,cellular response to amino acid stimulus;extracellular matrix structural constituent,protein binding,protein binding, bridging,identical protein binding,SMAD binding,metal ion binding,platelet-derived growth factor binding;extracellular region,collagen type I trimer,extracellular space,endopla< smic reticulum,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome1;7>tr|A0A087WTA8|A0A087WTA8_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=1;>sp|P08123|CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7A0A087WVP1;Q14517FAT1A0A087WVP1_HUMAN;FAT1_HUMANProtocadherin Fat 1;actin filament organization,cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,establishment or maintenance of cell polarity,cell-cell signaling,anatomical structure morphogenesis,single organismal cell-cell adhesion,cell migration$;calcium ion binding,protein binding;nucleus,plasma membrane,integral component of plasma membrane,cell-cell junction,focal adhesion,lamellipodium,filopodium,perinuclear region of cytoplasm,extracellular exosome>tr|A0A087WVP1|A0A087WVP1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=1;>sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=2A0A087X1T7;E7EX88;H0YM81ACAN*A0A087X1T7_HUMAN;E7EX88_HUMAN;H0YM81_HUMANAggrecan core protein1;2;1>tr|A0A087X1T7|A0A087X1T7_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=1;>tr|E7EX88|E7EX88_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2;>tr|H0YM81|H0YM81_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=1 A0A0A0MS14IGHV1-45 HV145_HUMAN"Immunoglobulin heavy variable 1-45c>sp|A0A0A0MS14|HV145_HUMAN Immunoglobulin heavy variable 1-45 OS=Homo sapiens GN=IGHV1-45 PE=3 SV=1SA0A0A0MTS7;Q8WZ42;Q8WZ42-11;Q8WZ42-12;Q8WZ42-13;Q8WZ42-2;Q8WZ42-4;Q8WZ42-7;Q8WZ42-8TTNpA0A0A0MTS7_HUMAN;TITIN_HUMAN;TITIN_HUMAN;TITIN_HUMAN;TITIN_HUMAN;TITIN_HUMAN;TITIN_HUMAN;TITIN_HUMAN;TITIN_HUMANTitin;Titin;Isoform 11 of Titin;Isoform 12 of Titin;Isoform 13 of Titin;Isoform 2 of Titin;Isoform 4 of Titin;Isoform 7 of Titin;Isoform 8 of Titin6;platelet degranulation,cardiac muscle hypertrophy,muscle contraction,striated muscle contraction,mitotic chromosome condensation,peptidyl-tyrosine phosphorylation,muscle filament sliding,skeletal muscle thin filament assembly,skeletal muscle myosin thick filament assembly,detection of muscle stretch,sarcomere organization,regulation of protein kinase activity,cardiac muscle fiber development,sarcomerogenesis,regulation of catalytic activity,response to calcium ion,cardiac myofibril assembly,cardiac muscle tissue morphogenesis,cardiac muscle contraction;;;;;;;;protease binding,protein serine/threonine kinase activity,protein tyrosine kinase activity,calcium ion binding,protein binding,calmodulin binding,ATP binding,structural constituent of muscle,enzyme binding,protein kinase binding,telethonin binding,identical protein binding,actinin binding,protein self-association,actin filament binding,muscle alpha-actinin binding,structural molecule activity conferring elasticity;;;;;;;;condensed nuclear chromosome,extracellular region,cytosol,muscle myosin complex,Z disc,M band,I band,extracellular exosome;;;;;;;tr;sp;sp;sp;sp;sp;sp;sp;sp 1;1;;;;;;; 1;4;;;;;;;_>tr|A0A0A0MTS7|A0A0A0MTS7_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=1;>sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=4;>sp|Q8WZ42-11|TITIN_HUMAN Isoform 11 of Titin OS=Homo sapiens GN=TTN;>sp|Q8WZ42-12|TITIN_HUMAN Isoform 12 of Titin OS=Homo sapiens GN=TTN;>sp|Q8WZ42-13|TITIN_HUMAN Isoform 13 of Titin OS=Homo sapiens GN=TTN;>sp|Q8WZ42-2|TITIN_HUMAN Isoform 2 of Titin OS=Homo sapiens GN=TTN;>sp|Q8WZ42-4|TITIN_HUMAN Isoform 4 of Titin OS=Homo sapiens GN=TTN;>sp|Q8WZ42-7|TITIN_HUMAN Isoform 7 of Titin OS=Homo sapiens GN=TTN;>sp|Q8WZ42-8|TITIN_HUMAN Isoform 8 of Titin OS=Homo sapiens GN=TTNA0A0C4DFY0;Q14242;Q14242-2SELPLG(A0A0C4DFY0_HUMAN;SELPL_HUMAN;SELPL_HUMANoP-selectin glycoprotein ligand 1;P-selectin glycoprotein ligand 1;Isoform 2 of P-selectin glycoprotein ligand 1;cell adhesion,viral entry into host cell,leukocyte migration,leukocyte adhesive activation,cellular response to interleukin-6;:;virus receptor activity,receptor binding,protein binding;f;uropod,plasma membrane,integral component of plasma membrane,membrane,integral component of membrane;!>tr|A0A0C4DFY0|A0A0C4DFY0_HUMAN P-selectin glycoprotein ligand 1 OS=Homo sapiens GN=SELPLG PE=1 SV=1;>sp|Q14242|SELPL_HUMAN P-selectin glycoprotein ligand 1 OS=Homo sapiens GN=SELPLG PE=1 SV=1;>sp|Q14242-2|SELPL_HUMAN Isoform 2 of P-selectin glycoprotein ligand 1 OS=Homo sapiens GN=SELPLGA0A0C4DGZ8;P07359GP1BAA0A0C4DGZ8_HUMAN;GP1BA_HUMANRGlycoprotein Ib (Platelet), alpha polypeptide;Platelet glycoprotein Ib alpha chain;cell morphogenesis,negative regulation of protein kinase activity,cell adhesion,cell surface receptor signaling pathway,blood coagulation,blood coagulation, intrinsic pathway,cytokine-mediated signaling pathway,platelet activation,regulation of blood coagulation,fibrinolysis,negative regulation of JAK-STAT cascade,thrombin-activated receptor signaling pathway,platelet aggregationW;protein kinase inhibitor activity,protein binding,thrombin-activated receptor activity;cytoplasm,plasma membrane,integral component of plasma membrane,cell surface,membrane,extracellular exosome,anchored component of external side of plasma membrane>tr|A0A0C4DGZ8|A0A0C4DGZ8_HUMAN Glycoprotein Ib (Platelet), alpha polypeptide OS=Homo sapiens GN=GP1BA PE=1 SV=1;>sp|P07359|GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=2 A0A0C4DH35IGHV3-35A0A0C4DH35_HUMANProtein IGHV3-35 (Fragment)a>tr|A0A0C4DH35|A0A0C4DH35_HUMAN Protein IGHV3-35 (Fragment) OS=Homo sapiens GN=IGHV3-35 PE=1 SV=1 A0A0C4DH38IGHV5-51A0A0C4DH38_HUMANProtein IGHV5-51 (Fragment)a>tr|A0A0C4DH38|A0A0C4DH38_HUMAN Protein IGHV5-51 (Fragment) OS=Homo sapiens GN=IGHV5-51 PE=1 SV=1 A0A0C4DH68IGKV2-24A0A0C4DH68_HUMANProtein IGKV2-24 (Fragment)a>tr|A0A0C4DH68|A0A0C4DH68_HUMAN Protein IGKV2-24 (Fragment) OS=Homo sapiens GN=IGKV2-24 PE=1 SV=1A0A0G2JIW1;P0DMV8;P0DMV9HSPA1B;HSPA1A;HSPA1B(A0A0G2JIW1_HUMAN;HS71A_HUMAN;HS71B_HUMANVHeat shock 70 kDa protein 1B;Heat shock 70 kDa protein 1A;Heat shock 70 kDa protein 1B ;positive regulation of gene expression,negative regulation of transforming growth factor beta receptor signaling pathway,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,neutrophil degranulation,regulation of mRNA stability,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,positive regulation of microtubule nucleation,negative regulation of inclusion body assembly,negative regulation of transcription from RNA polymerase II promoter in response to stress,regulation of cellular response to heat,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,regulation of mitotic spindle assembly,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,positive regulation of endoribonuclease activity,positive regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death;positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,neutrophil degranulation,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-bi< nding oligomerization domain containing 2 signaling pathway,positive regulation of microtubule nucleation,negative regulation of inclusion body assembly,regulation of cellular response to heat,regulation of mitotic spindle assembly,positive regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death ;RNA polymerase II transcription corepressor activity,virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,cadherin binding,unfolded protein binding,C3HC4-type RING finger domain binding;virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding;extracellular region,nucleoplasm,cytoplasm,mitochondrion,centrosome,centriole,cytosol,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ficolin-1-rich granule lumen,ubiquitin ligase complex;extracellular region,nucleoplasm,cytoplasm,centrosome,centriole,cytosol,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ficolin-1-rich granule lumen,ubiquitin ligase complex>tr|A0A0G2JIW1|A0A0G2JIW1_HUMAN Heat shock 70 kDa protein 1B OS=Homo sapiens GN=HSPA1B PE=1 SV=1;>sp|P0DMV8|HS71A_HUMAN Heat shock 70 kDa protein 1A OS=Homo sapiens GN=HSPA1A PE=1 SV=1;>sp|P0DMV9|HS71B_HUMAN Heat shock 70 kDa protein 1B OS=Homo sapiens GN=HSPA1B PE=1 SV=1A0A0G2JM87;A0A0G2JR65MUC2!A0A0G2JM87_HUMAN;A0A0G2JR65_HUMANMucin-2>tr|A0A0G2JM87|A0A0G2JM87_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=1;>tr|A0A0G2JR65|A0A0G2JR65_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=1 A0A0G2JMB2IGHA2A0A0G2JMB2_HUMAN$Ig alpha-2 chain C region (Fragment)g>tr|A0A0G2JMB2|A0A0G2JMB2_HUMAN Ig alpha-2 chain C region (Fragment) OS=Homo sapiens GN=IGHA2 PE=1 SV=1A0A0U1RR20;Q92954-6PRG4A0A0U1RR20_HUMAN;PRG4_HUMAN*Proteoglycan 4;Isoform F of Proteoglycan 4>tr|A0A0U1RR20|A0A0U1RR20_HUMAN Proteoglycan 4 OS=Homo sapiens GN=PRG4 PE=1 SV=1;>sp|Q92954-6|PRG4_HUMAN Isoform F of Proteoglycan 4 OS=Homo sapiens GN=PRG4 B0YIW2;P02656APOC3B0YIW2_HUMAN;APOC3_HUMANApolipoprotein C-III5;retinoid metabolic process,triglyceride metabolic process,G-protein coupled receptor signaling pathway,negative regulation of triglyceride catabolic process,negative regulation of very-low-density lipoprotein particle remodeling,negative regulation of very-low-density lipoprotein particle clearance,negative regulation of high-density lipoprotein particle clearance,negative regulation of low-density lipoprotein particle clearance,triglyceride catabolic process,regulation of Cdc42 protein signal transduction,cholesterol efflux,phospholipid efflux,high-density lipoprotein particle remodeling,very-low-density lipoprotein particle assembly,chylomicron remnant clearance,lipoprotein metabolic process,cholesterol homeostasis,reverse cholesterol transport,negative regulation of fatty acid biosynthetic process,negative regulation of lipid metabolic process,negative regulation of receptor-mediated endocytosis,negative regulation of lipid catabolic process,negative regulation of lipoprotein lipase activity,negative regulation of cholesterol import,triglyceride homeostasis;phospholipid binding,cholesterol binding,enzyme regulator activity,lipase inhibitor activity,high-density lipoprotein particle receptor binding;extracellular region,extracellular space,early endosome,very-low-density lipoprotein particle,intermediate-density lipoprotein particle,spherical high-density lipoprotein particle,chylomicron,extracellular exosome>tr|B0YIW2|B0YIW2_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1;>sp|P02656|APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1B4DQI4;F8W9U3;Q96IU4ABHD14B%B4DQI4_HUMAN;F8W9U3_HUMAN;ABHEB_HUMANProtein ABHD14B~;;positive regulation of transcription from RNA polymerase II promoter,3'-phosphoadenosine 5'-phosphosulfate metabolic process$;;protein binding,hydrolase activity1;;nucleus,nucleolus,cytosol,extracellular exosometr;tr;sp>tr|B4DQI4|B4DQI4_HUMAN Protein ABHD14B OS=Homo sapiens GN=ABHD14B PE=1 SV=1;>tr|F8W9U3|F8W9U3_HUMAN Protein ABHD14B OS=Homo sapiens GN=ABHD14B PE=1 SV=1;>sp|Q96IU4|ABHEB_HUMAN Protein ABHD14B OS=Homo sapiens GN=ABHD14B PE=1 SV=1B5MCX3;Q15019;Q15019-2SEPT2$B5MCX3_HUMAN;SEPT2_HUMAN;SEPT2_HUMAN'Septin-2;Septin-2;Isoform 2 of Septin-2;mitotic nuclear division,smoothened signaling pathway,spermatogenesis,neuron projection development,cell division,cilium morphogenesis;.;protein binding,GTP binding,cadherin binding;+;exocyst,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,cytosol,axoneme,actin cytoskeleton,midbody,septin complex,cleavage furrow,photoreceptor connecting cilium,perinuclear region of cytoplasm,ciliary membrane,extracellular exosome,sperm annulus,Requires Ontology,cell cortex;>tr|B5MCX3|B5MCX3_HUMAN Septin-2 OS=Homo sapiens GN=SEPT2 PE=1 SV=1;>sp|Q15019|SEPT2_HUMAN Septin-2 OS=Homo sapiens GN=SEPT2 PE=1 SV=1;>sp|Q15019-2|SEPT2_HUMAN Isoform 2 of Septin-2 OS=Homo sapiens GN=SEPT2 C9J2C0;Q9NY65TUBA8C9J2C0_HUMAN;TBA8_HUMAN4Tubulin alpha chain (Fragment);Tubulin alpha-8 chain4;cytoskeleton organization,microtubule-based processC;GTPase activity,structural constituent of cytoskeleton,GTP binding/;cytoplasm,microtubule,microtubule cytoskeleton>tr|C9J2C0|C9J2C0_HUMAN Tubulin alpha chain (Fragment) OS=Homo sapiens GN=TUBA8 PE=1 SV=1;>sp|Q9NY65|TBA8_HUMAN Tubulin alpha-8 chain OS=Homo sapiens GN=TUBA8 PE=1 SV=1D6RER5;D6RGI3;Q9NVA2SEPT11%D6RER5_HUMAN;D6RGI3_HUMAN;SEP11_HUMAN,Septin-11;Septin 11, isoform CRA_b;Septin-118;;cell cycle,protein heterooligomerization,cell division;;protein binding,GTP bindingQ;;stress fiber,cytoplasm,cell junction,axon,dendritic spine,extracellular exosome1;1;3>tr|D6RER5|D6RER5_HUMAN Septin-11 OS=Homo sapiens GN=SEPT11 PE=1 SV=1;>tr|D6RGI3|D6RGI3_HUMAN Septin 11, isoform CRA_b OS=Homo sapiens GN=SEPT11 PE=1 SV=1;>sp|Q9NVA2|SEP11_HUMAN Septin-11 OS=Homo sapiens GN=SEPT11 PE=1 SV=3E7EMK3;J3QLD9;Q14254FLOT2%E7EMK3_HUMAN;J3QLD9_HUMAN;FLOT2_HUMAN Flotillin-2;;membrane raft assembly,cell adhesion,epidermis development,negative regulation of gene expression,protein localization to plasma membrane raft,regulation of myoblast differentiation,protein stabilization,establishment of protein localization to plasma membrane,negative regulation of amyloid precursor protein catabolic process,positive regulation of establishment of T cell polarity,regulation of heterotypic cell-cell adhesion,regulation of toll-like receptor 3 signaling pathwayl;;protease binding,protein binding,ionotropic glutamate receptor binding,protein heterodimerization activityZ;;uropod,acrosomal membrane,endosome,plasma membrane,caveola,cell-cell adherens junction,focal adhesion,membrane,basolateral plasma membrane,flotillin complex,lamellipodium,endocytic vesicle,cytoplasmic vesicle,vesicle,cell-cell contact zone,perinuclear region of cytoplasm,extracellular exosome,apical plasma membrane,cortical actin cytoskeleton1;1;2>tr|E7EMK3|E7EMK3_HUMAN Flotillin-2 OS=Homo sapiens GN=FLOT2 PE=1 SV=1;>tr|J3QLD9|J3QLD9_HUMAN Flotillin-2 OS=Homo sapiens GN=FLOT2 PE=1 SV=1;>sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens GN=FLOT2 PE=1 SV=2E7EQB2;E7ER44;P02788;P02788-2LTF/E7EQB2_HUMAN;E7ER44_HUMAN;TRFL_HUMAN;TRFL_HUMANaLactotransferrin (Fragment);Lactotransferrin;Lactotransferrin;Isoform DeltaLf of Lactotransferrinv;;ossification,regulation of cytokine production,retina homeostasis,innate immune response in mucosa,transcription, DNA-templated,proteolysis,ion transport,humoral immune respons< e,antimicrobial humoral response,antibacterial humoral response,antifungal humoral response,negative regulation of lipopolysaccharide-mediated signaling pathway,regulation of tumor necrosis factor production,negative regulation of ATPase activity,iron assimilation by chelation and transport,positive regulation of osteoblast proliferation,positive regulation of toll-like receptor 4 signaling pathway,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,neutrophil degranulation,cellular protein metabolic process,negative regulation by host of viral process,negative regulation of viral genome replication,positive regulation of osteoblast differentiation,negative regulation of viral process,positive regulation of NF-kappaB transcription factor activity,bone morphogenesis,positive regulation of protein serine/threonine kinase activity,positive regulation of bone mineralization involved in bone maturation,negative regulation of single-species biofilm formation in or on host organism,positive regulation of chondrocyte proliferation,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,negative regulation of osteoclast development;;;DNA binding,serine-type endopeptidase activity,iron ion binding,protein binding,heparin binding,protein serine/threonine kinase activator activity;;;extracellular region,extracellular space,nucleus,cytoplasm,cell surface,secretory granule,specific granule lumen,specific granule,protein complex,extracellular exosome,phagocytic vesicle lumen,tertiary granule lumen;1;1;6;9>tr|E7EQB2|E7EQB2_HUMAN Lactotransferrin (Fragment) OS=Homo sapiens GN=LTF PE=1 SV=1;>tr|E7ER44|E7ER44_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=1;>sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=6;>sp|P02788-2|TRFL_HUMAN Isoform DeltaLf of Lactotransferrin OS=Homo sapiens GN=LTFE7ETH0;G3XAM2;P05156CFI$E7ETH0_HUMAN;G3XAM2_HUMAN;CFAI_HUMANComplement factor I;;proteolysis,receptor-mediated endocytosis,complement activation, classical pathway,regulation of complement activation,innate immune responseb;;serine-type endopeptidase activity,scavenger receptor activity,protein binding,metal ion bindingI;;extracellular region,extracellular space,membrane,extracellular exosome>tr|E7ETH0|E7ETH0_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=1;>tr|G3XAM2|G3XAM2_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=1;>sp|P05156|CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2+E9PMT7;E9PN59;E9PPV1;E9PQG1;O60667;O60667-3FCMRKE9PMT7_HUMAN;E9PN59_HUMAN;E9PPV1_HUMAN;E9PQG1_HUMAN;FAIM3_HUMAN;FAIM3_HUMANFas apoptotic inhibitory molecule 3 (Fragment);Fas apoptotic inhibitory molecule 3 (Fragment);Fas apoptotic inhibitory molecule 3 (Fragment);Fas apoptotic inhibitory molecule 3;Fas apoptotic inhibitory molecule 3;Isoform 3 of Fas apoptotic inhibitory molecule 3];;;;immune system process,cellular defense response,negative regulation of apoptotic process;8;;;;extracellular region,integral component of membrane;tr;tr;tr;tr;sp;sp 1;1;1;1;1;W>tr|E9PMT7|E9PMT7_HUMAN Fas apoptotic inhibitory molecule 3 (Fragment) OS=Homo sapiens GN=FCMR PE=1 SV=1;>tr|E9PN59|E9PN59_HUMAN Fas apoptotic inhibitory molecule 3 (Fragment) OS=Homo sapiens GN=FCMR PE=1 SV=1;>tr|E9PPV1|E9PPV1_HUMAN Fas apoptotic inhibitory molecule 3 (Fragment) OS=Homo sapiens GN=FCMR PE=1 SV=1;>tr|E9PQG1|E9PQG1_HUMAN Fas apoptotic inhibitory molecule 3 OS=Homo sapiens GN=FCMR PE=1 SV=1;>sp|O60667|FAIM3_HUMAN Fas apoptotic inhibitory molecule 3 OS=Homo sapiens GN=FCMR PE=1 SV=1;>sp|O60667-3|FAIM3_HUMAN Isoform 3 of Fas apoptotic inhibitory molecule 3 OS=Homo sapiens GN=FCMR2B7Z9C2;F5H4R6;F8VV59;F8W0J6;H0YIV4;P55209;P55209-2NAP1L1XB7Z9C2_HUMAN;F5H4R6_HUMAN;F8VV59_HUMAN;F8W0J6_HUMAN;H0YIV4_HUMAN;NP1L1_HUMAN;NP1L1_HUMANNucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1 (Fragment);Nucleosome assembly protein 1-like 1;Isoform 2 of Nucleosome assembly protein 1-like 1S;;;;;DNA replication,nucleosome assembly,positive regulation of cell proliferation;!;;;;;RNA binding,protein binding;!;;;;;nucleus,membrane,melanosome; 1;1;1;1;1;1;>tr|B7Z9C2|B7Z9C2_HUMAN Nucleosome assembly protein 1-like 1 OS=Homo sapiens GN=NAP1L1 PE=1 SV=1;>tr|F5H4R6|F5H4R6_HUMAN Nucleosome assembly protein 1-like 1 OS=Homo sapiens GN=NAP1L1 PE=1 SV=1;>tr|F8VV59|F8VV59_HUMAN Nucleosome assembly protein 1-like 1 OS=Homo sapiens GN=NAP1L1 PE=1 SV=1;>tr|F8W0J6|F8W0J6_HUMAN Nucleosome assembly protein 1-like 1 OS=Homo sapiens GN=NAP1L1 PE=1 SV=1;>      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghiklmnopqrstuvwxyz{|}~tr|H0YIV4|H0YIV4_HUMAN Nucleosome assembly protein 1-like 1 (Fragment) OS=Homo sapiens GN=NAP1L1 PE=1 SV=1;>sp|P55209|NP1L1_HUMAN Nucleosome assembly protein 1-like 1 OS=Homo sapiens GN=NAP1L1 PE=1 SV=1;>sp|P55209-2|NP1L1_HUMAN Isoform 2 of Nucleosome assembly protein 1-like 1 OS=Homo sapiens GN=NAP1L1+F8VUA6;G3V203;H0YHA7;J3QQ67;Q07020;Q07020-2RPL18IF8VUA6_HUMAN;G3V203_HUMAN;H0YHA7_HUMAN;J3QQ67_HUMAN;RL18_HUMAN;RL18_HUMAN60S ribosomal protein L18 (Fragment);60S ribosomal protein L18;60S ribosomal protein L18 (Fragment);60S ribosomal protein L18 (Fragment);60S ribosomal protein L18;Isoform 2 of 60S ribosomal protein L18;;;;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription;3;;;;RNA binding,structural constituent of ribosome;n;;;;nucleus,nucleolus,endoplasmic reticulum,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit; 1;1;1;1;2;>tr|F8VUA6|F8VUA6_HUMAN 60S ribosomal protein L18 (Fragment) OS=Homo sapiens GN=RPL18 PE=1 SV=1;>tr|G3V203|G3V203_HUMAN 60S ribosomal protein L18 OS=Homo sapiens GN=RPL18 PE=1 SV=1;>tr|H0YHA7|H0YHA7_HUMAN 60S ribosomal protein L18 (Fragment) OS=Homo sapiens GN=RPL18 PE=1 SV=1;>tr|J3QQ67|J3QQ67_HUMAN 60S ribosomal protein L18 (Fragment) OS=Homo sapiens GN=RPL18 PE=1 SV=1;>sp|Q07020|RL18_HUMAN 60S ribosomal protein L18 OS=Homo sapiens GN=RPL18 PE=1 SV=2;>sp|Q07020-2|RL18_HUMAN Isoform 2 of 60S ribosomal protein L18 OS=Homo sapiens GN=RPL18 F8WB16;Q8WZ74CTTNBP2F8WB16_HUMAN;CTTB2_HUMANCortactin-binding protein 2;brain development;SH3 domain binding-;cell cortex,synaptic vesicle,dendritic spine>tr|F8WB16|F8WB16_HUMAN Cortactin-binding protein 2 OS=Homo sapiens GN=CTTNBP2 PE=1 SV=1;>sp|Q8WZ74|CTTB2_HUMAN Cortactin-binding protein 2 OS=Homo sapiens GN=CTTNBP2 PE=1 SV=1 G3V4I0;O75356ENTPD5G3V4I0_HUMAN;ENTP5_HUMAN0Ectonucleoside triphosphate diphosphohydrolase 5;protein N-linked glycosylation,cell proliferation,regulation of phosphatidylinositol 3-kinase signaling,cell growth,positive regulation of glycolytic process,ATP metabolic process,'de novo' posttranslational protein folding,nucleobase-containing small molecule metabolic processr;guanosine-diphosphatase activity,protein binding,nucleoside-diphosphatase activity,uridine-diphosphatase activityA;extracellular region,endoplasmic reticulum,extracellular exosome>tr|G3V4I0|G3V4I0_HUMAN Ectonucleoside triphosphate diphosphohydrolase 5 OS=Homo sapiens GN=ENTPD5 PE=1 SV=1;>sp|O75356|ENTP5_HUMAN Ectonucleoside triphosphate diphosphohydrolase 5 OS=Homo sapiens GN=ENTPD5 PE=1 SV=1 G3XAK1;P26927MST1G3XAK1_HUMAN;HGFL_HUMAN%Hepatocyte growth factor-like protein;proteolysis,biological_process,negative regulation of gluconeogenesis,hepatocyte growth factor receptor signaling pathway,regulation of cAMP-dependent protein kinase activityg;molecular_function,serine-type endopeptidase activity,protein binding,receptor tyrosine kinase binding?;extracellular region,extracellular space,extracellular exosome>tr|G3XAK1|G3XAK1_HUMAN Hepatocyte growth factor-like protein OS=Homo sapiens GN=MST1 PE=1 SV=1;>sp|P26927|HGFL_HUMAN Hepatocyte growth factor-like protein OS=Homo sapiens GN=MST1 PE=1 SV=2H0Y755;M9MML0;P08637FCGR3A%H0Y755_HUMAN;M9MML0_HUMAN;FCG3A_HUMANLow affinity immunoglobulin gamma Fc region receptor I< II-A (Fragment);Fc of IgG low affinity IIIa receptor isoform 1;Low affinity immunoglobulin gamma Fc region receptor III-Al;;immune response,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response ;;IgG bindingg;;plasma membrane,external side of plasma membrane,integral component of membrane,extracellular exosomeb>tr|H0Y755|H0Y755_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A (Fragment) OS=Homo sapiens GN=FCGR3A PE=1 SV=1;>tr|M9MML0|M9MML0_HUMAN Fc of IgG low affinity IIIa receptor isoform 1 OS=Homo sapiens GN=FCGR3A PE=1 SV=1;>sp|P08637|FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 H0YH15;O60306AQRH0YH15_HUMAN;AQR_HUMANGAquarius homolog (Mouse), isoform CRA_a;Intron-binding protein aquariusP;mRNA splicing, via spliceosome,transcription-coupled nucleotide-excision repair;RNA binding,protein binding2;nucleoplasm,membrane,catalytic step 2 spliceosome>tr|H0YH15|H0YH15_HUMAN Aquarius homolog (Mouse), isoform CRA_a OS=Homo sapiens GN=AQR PE=1 SV=1;>sp|O60306|AQR_HUMAN Intron-binding protein aquarius OS=Homo sapiens GN=AQR PE=1 SV=4H0YMD1;J3KMZ9;P01130;P01130-5LDLR/H0YMD1_HUMAN;J3KMZ9_HUMAN;LDLR_HUMAN;LDLR_HUMANLow-density lipoprotein receptor;Low-density lipoprotein receptor (Fragment);Low-density lipoprotein receptor;Isoform 5 of Low-density lipoprotein receptor';;lipid metabolic process,endocytosis,receptor-mediated endocytosis,cholesterol metabolic process,positive regulation of gene expression,negative regulation of gene expression,positive regulation of triglyceride biosynthetic process,regulation of phosphatidylcholine catabolic process,phospholipid transport,intestinal cholesterol absorption,cholesterol transport,low-density lipoprotein particle clearance,lipoprotein catabolic process,cholesterol homeostasis,viral entry into host cell,positive regulation of inflammatory response,membrane organization,cholesterol import,cellular response to fatty acid,cellular response to low-density lipoprotein particle stimulus,receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport,regulation of cholesterol homeostasis;&;;virus receptor activity,glycoprotein binding,protease binding,low-density lipoprotein receptor activity,calcium ion binding,protein binding,low-density lipoprotein particle binding,very-low-density lipoprotein particle receptor activity,clathrin heavy chain binding,identical protein binding;;;lysosome,early endosome,late endosome,Golgi apparatus,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,cell surface,endosome membrane,membrane,basolateral plasma membrane,clathrin-coated endocytic vesicle membrane,low-density lipoprotein particle,endolysosome membrane,receptor complex,apical part of cell,sorting endosome,PCSK9-LDLR complex;w>tr|H0YMD1|H0YMD1_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1;>tr|J3KMZ9|J3KMZ9_HUMAN Low-density lipoprotein receptor (Fragment) OS=Homo sapiens GN=LDLR PE=1 SV=1;>sp|P01130|LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1;>sp|P01130-5|LDLR_HUMAN Isoform 5 of Low-density lipoprotein receptor OS=Homo sapiens GN=LDLRH0YN42;P07355;P07355-2ANXA2$H0YN42_HUMAN;ANXA2_HUMAN;ANXA2_HUMAN5Annexin (Fragment);Annexin A2;Isoform 2 of Annexin A2U;angiogenesis,membrane raft assembly,positive regulation of receptor recycling,positive regulation of protein phosphorylation,membrane budding,body fluid secretion,collagen fibril organization,positive regulation of vesicle fusion,negative regulation of low-density lipoprotein particle receptor catabolic process,osteoclast development,fibrinolysis,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of fibroblast proliferation,protein heterotetramerization,protein targeting to plasma membrane,response to thyroid hormone,cell-cell adhesion,Requires Ontology;n;protease binding,RNA binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal protein binding,Rab GTPase binding,phospholipase A2 inhibitor activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion,receptor activator activity;';ruffle,extracellular region,basement membrane,extracellular space,nucleus,lysosomal membrane,endosome,early endosome,lipid particle,cytosol,plasma membrane,cell-cell adherens junction,cell cortex,cell surface,membrane,basolateral plasma membrane,extrinsic component of plasma membrane,midbody,late endosome membrane,vesicle,azurophil granule lumen,myelin sheath adaxonal region,sarcolemma,melanosome,Schmidt-Lanterman incisure,macropinosome,perinuclear region of cytoplasm,extracellular exosome,PCSK9-AnxA2 complex,extracellular matrix,membrane raft;>tr|H0YN42|H0YN42_HUMAN Annexin (Fragment) OS=Homo sapiens GN=ANXA2 PE=1 SV=1;>sp|P07355|ANXA2_HUMAN Annexin A2 OS=Homo sapiens GN=ANXA2 PE=1 SV=2;>sp|P07355-2|ANXA2_HUMAN Isoform 2 of Annexin A2 OS=Homo sapiens GN=ANXA2 J3KNB4;P49913CAMPJ3KNB4_HUMAN;CAMP_HUMAN"Cathelicidin antimicrobial peptide&;innate immune response in mucosa,antimicrobial humoral response,antibacterial humoral response,defense response to bacterium,neutrophil degranulation,negative regulation of growth of symbiont on or near host surface,defense response to Gram-positive bacterium,killing by host of symbiont cells~;extracellular region,extracellular space,specific granule lumen,specific granule,extracellular exosome,tertiary granule lumen>tr|J3KNB4|J3KNB4_HUMAN Cathelicidin antimicrobial peptide OS=Homo sapiens GN=CAMP PE=1 SV=1;>sp|P49913|CAMP_HUMAN Cathelicidin antimicrobial peptide OS=Homo sapiens GN=CAMP PE=1 SV=1J3KTF8;J3QQX2;P52565ARHGDIA%J3KTF8_HUMAN;J3QQX2_HUMAN;GDIR1_HUMANmRho GDP-dissociation inhibitor 1 (Fragment);Rho GDP-dissociation inhibitor 1;Rho GDP-dissociation inhibitor 1;;movement of cell or subcellular component,negative regulation of cell adhesion,regulation of Rho protein signal transduction,negative regulation of apoptotic process,positive regulation of GTPase activity,negative regulation of axonogenesis,positive regulation of axonogenesis,regulation of small GTPase mediated signal transduction,semaphorin-plexin signaling pathway,regulation of actin cytoskeleton reorganizationS;;Rho GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,;;cytosol,cytoskeleton,extracellular exosome8;1;3#>tr|J3KTF8|J3KTF8_HUMAN Rho GDP-dissociation inhibitor 1 (Fragment) OS=Homo sapiens GN=ARHGDIA PE=1 SV=8;>tr|J3QQX2|J3QQX2_HUMAN Rho GDP-dissociation inhibitor 1 OS=Homo sapiens GN=ARHGDIA PE=1 SV=1;>sp|P52565|GDIR1_HUMAN Rho GDP-dissociation inhibitor 1 OS=Homo sapiens GN=ARHGDIA PE=1 SV=3 K7EQ48;P06744GPIK7EQ48_HUMAN;G6PI_HUMANGlucose-6-phosphate isomerase;angiogenesis,in utero embryonic development,mesoderm formation,carbohydrate metabolic process,gluconeogenesis,humoral immune response,hemostasis,learning or memory,methylglyoxal biosynthetic process,response to estradiol,response to progesterone,response to testosterone,erythrocyte homeostasis,response to immobilization stress,response to muscle stretch,glucose homeostasis,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to morphine,neutrophil degranulation,negative regulation of neuron apoptotic process,aldehyde catabolic process,response to cadmium ion,glucose 6-phosphate metabolic process,canonical glycolysis;glucose-6-phosphate isomerase activity,cytokine activity,growth factor activity,intramolecular transferase activity,ubiquitin protein ligase binding,monosaccharide binding;extracellular region,extracellular space,nucleoplasm,cytosol,plasma membrane,membrane,secretory granule lumen,neuron projection,myelin sheath,ciliary membrane,extracellular exosome,ficolin-1-rich granule lumen2;4>tr|K7EQ48|K7EQ48_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=2;>sp|P06744|G6PI_HUMAN Glucose-6-phosphate isomerase < OS=Homo sapiens GN=GPI PE=1 SV=4 K7ERG9;P00746CFDK7ERG9_HUMAN;CFAD_HUMANComplement factor D};platelet degranulation,proteolysis,complement activation,complement activation, alternative pathway,neutrophil degranulationB;serine-type endopeptidase activity,serine-type peptidase activity};extracellular region,platelet alpha granule lumen,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen1;5>tr|K7ERG9|K7ERG9_HUMAN Complement factor D OS=Homo sapiens GN=CFD PE=1 SV=1;>sp|P00746|CFAD_HUMAN Complement factor D OS=Homo sapiens GN=CFD PE=1 SV=5M0R081;Q9Y240;V9H0X6CLEC11A%M0R081_HUMAN;CLC11_HUMAN;V9H0X6_HUMAN'C-type lectin domain family 11 member A+;positive regulation of cell proliferation;-;growth factor activity,carbohydrate binding;4;extracellular region,extracellular space,cytoplasm;->tr|M0R081|M0R081_HUMAN C-type lectin domain family 11 member A OS=Homo sapiens GN=CLEC11A PE=1 SV=1;>sp|Q9Y240|CLC11_HUMAN C-type lectin domain family 11 member A OS=Homo sapiens GN=CLEC11A PE=1 SV=1;>tr|V9H0X6|V9H0X6_HUMAN C-type lectin domain family 11 member A OS=Homo sapiens GN=CLEC11A PE=1 SV=1 M0R1L7;O43633CHMP2AM0R1L7_HUMAN;CHM2A_HUMANXCharged multivesicular body protein 2a (Fragment);Charged multivesicular body protein 2a;cell separation after cytokinesis,nucleus organization,vacuolar transport,mitotic metaphase plate congression,membrane invagination,exit from mitosis,regulation of centrosome duplication,protein transport,endosomal transport,macroautophagy,viral life cycle,nuclear envelope reassembly,multivesicular body assembly,viral budding via host ESCRT complex,establishment of protein localization,regulation of viral process,protein polymerization,protein homooligomerization,protein heterooligomerization,negative regulation of cell death,regulation of mitotic spindle assembly,positive regulation of viral release from host cell,positive regulation of exosomal secretion,negative regulation of centriole elongation,ESCRT III complex disassemblyL;protein binding,protein domain specific binding,phosphatidylcholine bindingo;ESCRT III complex,nuclear envelope,cytosol,membrane,membrane coat,late endosome membrane,extracellular exosome>tr|M0R1L7|M0R1L7_HUMAN Charged multivesicular body protein 2a (Fragment) OS=Homo sapiens GN=CHMP2A PE=1 SV=1;>sp|O43633|CHM2A_HUMAN Charged multivesicular body protein 2a OS=Homo sapiens GN=CHMP2A PE=1 SV=1O00194RAB27B RB27B_HUMANRas-related protein Rab-27Bplatelet degranulation,small GTPase mediated signal transduction,melanosome transport,positive regulation of exocytosis,multivesicular body sorting pathwayhGTPase activity,protein binding,GTP binding,GDP binding,protein domain specific binding,myosin V bindingGolgi stack,plasma membrane,apical plasma membrane,trans-Golgi network transport vesicle,secretory granule,platelet dense granule membrane,multivesicular body membrane,melanosome,zymogen granule membrane,extracellular exosomeV>sp|O00194|RB27B_HUMAN Ras-related protein Rab-27B OS=Homo sapiens GN=RAB27B PE=1 SV=4O00391QSOX1 QSOX1_HUMANSulfhydryl oxidase 1platelet degranulation,negative regulation of macroautophagy,neutrophil degranulation,cell redox homeostasis,oxidation-reduction processNprotein disulfide isomerase activity,flavin-linked sulfhydryl oxidase activityextracellular region,extracellular space,Golgi apparatus,integral component of Golgi membrane,platelet alpha granule lumen,specific granule lumen,intracellular membrane-bounded organelle,intercellular bridge,extracellular exosome,tertiary granule lumenN>sp|O00391|QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3O75636FCN3 FCN3_HUMAN Ficolin-3complement activation, lectin pathway,proteolysis,complement activation,recognition of apoptotic cell,negative regulation of viral entry into host cell,defense response to virus,negative regulation of RNA biosynthetic processiantigen binding,serine-type endopeptidase activity,protein binding,carbohydrate binding,metal ion binding8extracellular region,collagen trimer,blood microparticleA>sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens GN=FCN3 PE=1 SV=2O75955FLOT1 FLOT1_HUMAN Flotillin-1lmembrane raft assembly,positive regulation of cytokine production,positive regulation of protein phosphorylation,regulation of receptor internalization,axonogenesis,extracellular matrix disassembly,positive regulation of protein binding,positive regulation of synaptic transmission, dopaminergic,positive regulation of interferon-beta production,dsRNA transport,positive regulation of heterotypic cell-cell adhesion,positive regulation of toll-like receptor 3 signaling pathway,response to endoplasmic reticulum stress,regulation of Rho protein signal transduction,plasma membrane raft assembly,positive regulation of endocytosis,positive regulation of skeletal muscle tissue development,protein homooligomerization,positive regulation of cell adhesion molecule production,protein kinase C signaling,cellular response to exogenous dsRNA,establishment of protein localization to plasma membrane,positive regulation of myoblast fusion,positive regulation of cell junction assembly,protein localization to membrane raft,positive regulation of cell-cell adhesion mediated by cadherin,regulation of toll-like receptor 4 signaling pathwayjprotease binding,protein binding,ionotropic glutamate receptor binding,protein heterodimerization activityuropod,lysosomal membrane,endosome,early endosome,microtubule organizing center,plasma membrane,caveola,cell-cell junction,cell-cell adherens junction,focal adhesion,membrane,integral component of membrane,basolateral plasma membrane,flotillin complex,lamellipodium,cytoplasmic vesicle,centriolar satellite,sarcolemma,melanosome,cell-cell contact zone,membrane raft,extracellular exosome,apical plasma membrane,COP9 signalosome,cortical actin cytoskeletonE>sp|O75955|FLOT1_HUMAN Flotillin-1 OS=Homo sapiens GN=FLOT1 PE=1 SV=3O95810SDPR SDPR_HUMAN"Serum deprivation-response proteinXphosphatidylserine binding,protein kinase C binding,protein binding,phospholipid binding'cytoplasm,cytosol,caveola,membrane raftZ>sp|O95810|SDPR_HUMAN Serum deprivation-response protein OS=Homo sapiens GN=SDPR PE=1 SV=3P00558PGK1 PGK1_HUMANPhosphoglycerate kinase 1Tgluconeogenesis,phosphorylation,epithelial cell differentiation,canonical glycolysis<phosphoglycerate kinase activity,protein binding,ATP binding4cytosol,membrane,membrane raft,extracellular exosomeQ>sp|P00558|PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3P00734F2 THRB_HUMAN Prothrombinpositive regulation of protein phosphorylation,signal peptide processing,proteolysis,ER to Golgi vesicle-mediated transport,acute-phase response,cell surface receptor signaling pathway,multicellular organism development,blood coagulation,blood coagulation, intrinsic pathway,positive regulation of cell proliferation,regulation of cell shape,response to wounding,regulation of gene expression,negative regulation of platelet activation,positive regulation of phosphatidylinositol 3-kinase signaling,peptidyl-glutamic acid carboxylation,platelet activation,regulation of blood coagulation,positive regulation of blood coagulation,positive regulation of cell growth,positive regulation of collagen biosynthetic process,fibrinolysis,cellular protein metabolic process,negative regulation of proteolysis,negative regulation of astrocyte differentiation,leukocyte migration,positive regulation of release of sequestered calcium ion into cytosol,regulation of cytosolic calcium ion concentration,negative regulation of fibrinolysis,positive regulation of lipid kinase activity,positive regulation of protein localization to nucleus,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,positive regulation of reactive oxygen species metabolic processserine-type endopeptidase activity,receptor binding,calcium ion binding,protein binding,growth factor activity,thrombospondin receptor activityextracellular region,extracellular space,endoplasmic reticulum lumen,Golgi lumen,plasma< membrane,extracellular exosome,blood microparticleA>sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2P00740F9 FA9_HUMANCoagulation factor IXsignal peptide processing,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,blood coagulation, intrinsic pathway,blood coagulation, extrinsic pathway,peptidyl-glutamic acid carboxylation,zymogen activationMendopeptidase activity,serine-type endopeptidase activity,calcium ion bindingvextracellular region,extracellular space,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,extracellular exosomeJ>sp|P00740|FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2P01042-2Isoform LMW of Kininogen-1J>sp|P01042-2|KNG1_HUMAN Isoform LMW of Kininogen-1 OS=Homo sapiens GN=KNG1P01706IGLV2-11 LV211_HUMAN#Immunoglobulin lambda variable 2-11`>sp|P01706|LV211_HUMAN Immunoglobulin lambda variable 2-11 OS=Homo sapiens GN=IGLV2-11 PE=1 SV=2P01714IGLV3-19 LV319_HUMAN#Immunoglobulin lambda variable 3-19`>sp|P01714|LV319_HUMAN Immunoglobulin lambda variable 3-19 OS=Homo sapiens GN=IGLV3-19 PE=1 SV=2P01742IGHV1-69 HV169_HUMAN"Immunoglobulin heavy variable 1-69_>sp|P01742|HV169_HUMAN Immunoglobulin heavy variable 1-69 OS=Homo sapiens GN=IGHV1-69 PE=1 SV=2P01854IGHE IGHE_HUMANIg epsilon chain C regionphagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activationmextracellular region,external side of plasma membrane,immunoglobulin complex, circulating,blood microparticleQ>sp|P01854|IGHE_HUMAN Ig epsilon chain C region OS=Homo sapiens GN=IGHE PE=1 SV=1P01859IGHG2 IGHG2_HUMANIg gamma-2 chain C region:proteolysis,phagocytosis, recognition,phagocytosis, engulfment,complement activation,complement activation, classical pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activationbantigen binding,serine-type endopeptidase activity,protein binding,immunoglobulin receptor bindingextracellular region,extracellular space,external side of plasma membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticleS>sp|P01859|IGHG2_HUMAN Ig gamma-2 chain C region OS=Homo sapiens GN=IGHG2 PE=1 SV=2P01871IGHM IGHM_HUMANIg mu chain C region5adaptive immune response,phagocytosis, recognition,phagocytosis, engulfment,complement activation, classical pathway,antibacterial humoral response,innate immune response,defense response to Gram-negative bacterium,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migrationantigen binding,protein binding,single-stranded DNA binding,phosphatidylcholine binding,immunoglobulin receptor binding,peptidoglycan bindingextracellular space,plasma membrane,external side of plasma membrane,cell surface,integral component of membrane,extracellular exosome,pentameric IgM immunoglobulin complex,hexameric IgM immunoglobulin complex,blood microparticleL>sp|P01871|IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3P02452COL1A1 CO1A1_HUMANCollagen alpha-1(I) chainskeletal system development,blood vessel development,osteoblast differentiation,intramembranous ossification,endochondral ossification,blood coagulation,visual perception,sensory perception of sound,positive regulation of epithelial to mesenchymal transition,negative regulation of cell-substrate adhesion,protein transport,platelet activation,extracellular matrix organization,collagen fibril organization,positive regulation of cell migration,collagen catabolic process,response to corticosteroid,response to estradiol,collagen biosynthetic process,protein localization to nucleus,tooth mineralization,collagen-activated tyrosine kinase receptor signaling pathway,response to drug,response to hydrogen peroxide,response to peptide hormone,skin morphogenesis,cellular response to fibroblast growth factor stimulus,tooth eruption,positive regulation of transcription, DNA-templated,embryonic skeletal system development,regulation of immune response,leukocyte migration,response to cAMP,response to hyperoxia,face morphogenesis,bone trabecula formation,cartilage development involved in endochondral bone morphogenesis,protein heterotrimerization,cellular response to amino acid stimulus,cellular response to mechanical stimulus,cellular response to retinoic acid,cellular response to vitamin E,cellular response to tumor necrosis factor,cellular response to epidermal growth factor stimulus,cellular response to transforming growth factor beta stimulus,positive regulation of canonical Wnt signaling pathway,cellular response to fluorideextracellular matrix structural constituent,protein binding,identical protein binding,metal ion binding,platelet-derived growth factor bindingextracellular region,collagen type I trimer,extracellular space,endoplasmic reticulum lumen,Golgi apparatus,secretory granule,extracellular matrixT>sp|P02452|CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5P02647APOA1 APOA1_HUMANApolipoprotein A-Iretinoid metabolic process,regulation of protein phosphorylation,endothelial cell proliferation,platelet degranulation,negative regulation of cytokine secretion involved in immune response,phosphatidylcholine biosynthetic process,cholesterol biosynthetic process,receptor-mediated endocytosis,G-protein coupled receptor signaling pathway,integrin-mediated signaling pathway,response to nutrient,cholesterol metabolic process,glucocorticoid metabolic process,negative regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of cholesterol esterification,positive regulation of triglyceride catabolic process,negative regulation of very-low-density lipoprotein particle remodeling,peripheral nervous system axon regeneration,protein oxidation,peptidyl-methionine modification,triglyceride catabolic process,lipid storage,regulation of intestinal cholesterol absorption,cholesterol transport,adrenal gland development,animal organ regeneration,neuron projection regeneration,regulation of Cdc42 protein signal transduction,cholesterol efflux,phospholipid efflux,negative regulation of heterotypic cell-cell adhesion,high-density lipoprotein particle remodeling,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,positive regulation of Rho protein signal transduction,lipoprotein metabolic process,lipoprotein biosynthetic process,response to drug,cholesterol homeostasis,blood vessel endothelial cell migration,response to estrogen,reverse cholesterol transport,cellular protein metabolic process,positive regulation of fatty acid biosynthetic process,negative regulation of interleukin-1 beta secretion,negative regulation of inflammatory response,protein stabilization,negative chemotaxis,positive regulation of lipoprotein lipase activity,vitamin transport,positive regulation of hydrolase activity,positive regulation of stress fiber assembly,transmembrane transport,phospholipid homeostasis,negative regulation of lipase activity,negative regulation of cell adhesion molecule production,negative regulation of response to cytokine stimulus,triglyceride homeostasis,cholesterol import,positive regulation of substrate adhesion-dependent cell spreading,transforming growth factor beta receptor signaling pathway,ERK1 and ERK2 cascadebeta-amyloid binding,protein binding,phospholipid binding,phospholipid transporter activity,high-density lipoprotein particle binding,cholesterol binding,cholesterol transporter activity,enzyme binding,phosphatidylcholine binding,apolipoprotein receptor binding,apolipoprotein A-I receptor binding,identical protein binding,chemorepellent activity,lipase inhibitor activity,phosphatidylcholine-sterol O-acyltransferase activator activity,high-density lipoprotein particle receptor bindingextracellular region,extracel< lular space,nucleus,early endosome,endoplasmic reticulum lumen,cytosol,plasma membrane,cell surface,endocytic vesicle,cytoplasmic vesicle,very-low-density lipoprotein particle,high-density lipoprotein particle,discoidal high-density lipoprotein particle,spherical high-density lipoprotein particle,secretory granule lumen,chylomicron,extracellular exosome,endocytic vesicle lumen,blood microparticle,extracellular vesicleL>sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1P02654APOC1 APOC1_HUMANApolipoprotein C-Ilipid metabolic process,triglyceride metabolic process,cholesterol metabolic process,positive regulation of cholesterol esterification,negative regulation of phosphatidylcholine catabolic process,negative regulation of very-low-density lipoprotein particle clearance,regulation of cholesterol transport,negative regulation of cholesterol transport,cholesterol efflux,phospholipid efflux,plasma lipoprotein particle remodeling,high-density lipoprotein particle remodeling,very-low-density lipoprotein particle assembly,chylomicron remnant clearance,very-low-density lipoprotein particle clearance,lipoprotein metabolic process,positive regulation of catalytic activity,negative regulation of fatty acid biosynthetic process,negative regulation of lipid metabolic process,negative regulation of receptor-mediated endocytosis,negative regulation of lipid catabolic process,negative regulation of lipoprotein lipase activityphospholipase inhibitor activity,fatty acid binding,phosphatidylcholine binding,lipase inhibitor activity,phosphatidylcholine-sterol O-acyltransferase activator activityextracellular region,endoplasmic reticulum,very-low-density lipoprotein particle,high-density lipoprotein particle,chylomicron,extracellular exosomeL>sp|P02654|APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1P02730SLC4A1 B3AT_HUMANBand 3 anion transport proteinanion transport,chloride transport,cellular ion homeostasis,bicarbonate transport,regulation of intracellular pH,chloride transmembrane transportinorganic anion exchanger activity,protein binding,anion transmembrane transporter activity,bicarbonate transmembrane transporter activity,chloride transmembrane transporter activity,anion:anion antiporter activity,ankyrin binding,protein homodimerization activity,protein anchorplasma membrane,integral component of plasma membrane,integral component of membrane,basolateral plasma membrane,Z disc,cortical cytoskeleton,extracellular exosome,blood microparticleX>sp|P02730|B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3P02763ORM1 A1AG1_HUMANAlpha-1-acid glycoprotein 1platelet degranulation,regulation of immune system process,acute-phase response,inflammatory response,negative regulation of interleukin-6 production,negative regulation of tumor necrosis factor production,neutrophil degranulationextracellular region,extracellular space,platelet alpha granule lumen,specific granule lumen,extracellular exosome,blood microparticle,tertiary granule lumenT>sp|P02763|A1AG1_HUMAN Alpha-1-acid glycoprotein 1 OS=Homo sapiens GN=ORM1 PE=1 SV=1P02766TTR TTHY_HUMAN Transthyretinretinoid metabolic process,transport,extracellular matrix organization,retinol metabolic process,neutrophil degranulation,cellular protein metabolic process,thyroid hormone transport,purine nucleobase metabolic processvhormone activity,protein binding,identical protein binding,protein heterodimerization activity,thyroid hormone bindingfextracellular region,extracellular space,azurophil granule lumen,protein complex,extracellular exosomeD>sp|P02766|TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1P02794FTH1 FRIH_HUMANFerritin heavy chaincellular iron ion homeostasis,intracellular sequestering of iron ion,immune response,negative regulation of cell proliferation,neutrophil degranulation,negative regulation of fibroblast proliferation,oxidation-reduction process,iron ion importIferroxidase activity,iron ion binding,protein binding,ferric iron bindingextracellular region,nucleus,mitochondrion,cytosol,intracellular ferritin complex,autolysosome,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenL>sp|P02794|FRIH_HUMAN Ferritin heavy chain OS=Homo sapiens GN=FTH1 PE=1 SV=2P04040CAT CATA_HUMANCatalase^response to reactive oxygen species,osteoblast differentiation,ureteric bud development,response to hypoxia,purine nucleotide catabolic process,triglyceride metabolic process,aging,cholesterol metabolic process,aerobic respiration,response to light intensity,UV protection,response to ozone,response to lead ion,positive regulation of phosphatidylinositol 3-kinase signaling,response to activity,response to inactivity,hemoglobin metabolic process,negative regulation of NF-kappaB transcription factor activity,response to estradiol,response to insulin,response to vitamin A,response to vitamin E,response to L-ascorbic acid,response to drug,response to hydrogen peroxide,hydrogen peroxide catabolic process,negative regulation of apoptotic process,neutrophil degranulation,response to ethanol,response to cadmium ion,positive regulation of NF-kappaB transcription factor activity,protein tetramerization,protein homotetramerization,positive regulation of cell division,response to hyperoxia,response to fatty acid,cellular response to growth factor stimulus,response to phenylpropanoid,cellular oxidant detoxificationaminoacylase activity,catalase activity,receptor binding,antioxidant activity,oxidoreductase activity, acting on peroxide as acceptor,enzyme binding,heme binding,protein homodimerization activity,metal ion binding,NADP binding^extracellular region,extracellular space,mitochondrion,mitochondrial intermembrane space,lysosome,peroxisome,peroxisomal membrane,peroxisomal matrix,endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,focal adhesion,membrane,secretory granule lumen,intracellular membrane-bounded organelle,extracellular exosome,ficolin-1-rich granule lumen?>sp|P04040|CATA_HUMAN Catalase OS=Homo sapiens GN=CAT PE=1 SV=3P04792HSPB1 HSPB1_HUMANHeat shock protein beta-1retina homeostasis,regulation of protein phosphorylation,regulation of translational initiation,negative regulation of protein kinase activity,movement of cell or subcellular component,response to unfolded protein,response to virus,regulation of autophagy,positive regulation of interleukin-1 beta production,intracellular signal transduction,cellular response to vascular endothelial growth factor stimulus,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,positive regulation of tumor necrosis factor biosynthetic process,negative regulation of apoptotic process,regulation of I-kappaB kinase/NF-kappaB signaling,regulation of mRNA stability,positive regulation of blood vessel endothelial cell migration,positive regulation of angiogenesis,vascular endothelial growth factor receptor signaling pathway,chaperone-mediated protein folding,platelet aggregation,negative regulation of protein serine/threonine kinase activity,anterograde axonal protein transport,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,positive regulation of endothelial cell chemotaxisRNA binding,protein kinase C binding,protein binding,protein kinase C inhibitor activity,protein kinase binding,identical protein binding,ubiquitin binding,protein binding involved in protein foldingproteasome complex,extracellular space,nucleus,cytoplasm,spindle,cytosol,cytoskeleton,plasma membrane,focal adhesion,Z disc,extracellular matrix,extracellular exosome,axon cytoplasmS>sp|P04792|HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2P05090APOD APOD_HUMANApolipoprotein Dresponse to reactive oxygen species,angiogenesis,glucose metabolic process,lipid metabolic process,lipid transport,brain development,aging,negative regulation of platelet-derived growth factor receptor signaling pathway,peripheral nervous system axon regeneration,tissue regene< ration,negative regulation of protein import into nucleus,response to drug,negative regulation of smooth muscle cell proliferation,response to axon injury,negative regulation of focal adhesion assembly,negative regulation of lipoprotein lipid oxidation,negative regulation of monocyte chemotactic protein-1 production,negative regulation of cytokine production involved in inflammatory response,negative regulation of smooth muscle cell-matrix adhesion,negative regulation of T cell migration>lipid transporter activity,protein binding,cholesterol bindingextracellular region,extracellular space,endoplasmic reticulum,cytosolic ribosome,dendrite,neuronal cell body,perinuclear region of cytoplasm,extracellular exosomeH>sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1P05106ITGB3 ITB3_HUMANIntegrin beta-32positive regulation of protein phosphorylation,positive regulation of endothelial cell proliferation,platelet degranulation,cell-substrate junction assembly,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,blood coagulation,positive regulation of endothelial cell migration,negative regulation of macrophage derived foam cell differentiation,negative regulation of lipid storage,smooth muscle cell migration,cell growth,cell migration,platelet activation,extracellular matrix organization,positive regulation of vascular endothelial growth factor receptor signaling pathway,cell-substrate adhesion,activation of protein kinase activity,negative regulation of lipid transport,cell adhesion mediated by integrin,heterotypic cell-cell adhesion,substrate adhesion-dependent cell spreading,tube development,apolipoprotein A-I-mediated signaling pathway,wound healing,regulation of bone resorption,negative regulation of low-density lipoprotein particle receptor biosynthetic process,viral entry into host cell,vascular endothelial growth factor receptor signaling pathway,mesodermal cell differentiation,positive regulation of peptidyl-tyrosine phosphorylation,negative regulation of lipoprotein metabolic process,leukocyte migration,negative chemotaxis,angiogenesis involved in wound healing,platelet aggregationvirus receptor activity,fibronectin binding,protease binding,protein disulfide isomerase activity,platelet-derived growth factor receptor binding,protein binding,coreceptor activity,enzyme binding,identical protein binding,vascular endothelial growth factor receptor 2 binding,cell adhesion molecule binding,extracellular matrix binding,fibroblast growth factor binding,C-X3-C chemokine binding,insulin-like growth factor I binding,neuregulin binding~nucleus,plasma membrane,integral component of plasma membrane,focal adhesion,integrin complex,cell surface,platelet alpha granule membrane,lamellipodium membrane,filopodium membrane,microvillus membrane,ruffle membrane,integrin alphav-beta3 complex,alphav-beta3 integrin-IGF-1-IGF1R complex,melanosome,receptor complex,extracellular exosome,alphav-beta3 integrin-vitronectin complexH>sp|P05106|ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2P05771-2PRKCB KPCB_HUMAN-Isoform Beta-II of Protein kinase C beta type^>sp|P05771-2|KPCB_HUMAN Isoform Beta-II of Protein kinase C beta type OS=Homo sapiens GN=PRKCBP06310IGKV2-30 KV230_HUMAN"Immunoglobulin kappa variable 2-30_>sp|P06310|KV230_HUMAN Immunoglobulin kappa variable 2-30 OS=Homo sapiens GN=IGKV2-30 PE=3 SV=2P06312IGKV4-1 KV401_HUMAN!Immunoglobulin kappa variable 4-18extracellular region,plasma membrane,blood microparticle]>sp|P06312|KV401_HUMAN Immunoglobulin kappa variable 4-1 OS=Homo sapiens GN=IGKV4-1 PE=1 SV=1P06702S100A9 S10A9_HUMANProtein S100-A9cytokine production,toll-like receptor signaling pathway,leukocyte migration involved in inflammatory response,positive regulation of peptide secretion,regulation of translation,autophagy,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,inflammatory response,cell-cell signaling,astrocyte development,antimicrobial humoral response,positive regulation of blood coagulation,positive regulation of cell growth,neutrophil chemotaxis,actin cytoskeleton reorganization,sequestering of zinc ion,chemokine production,peptidyl-cysteine S-trans-nitrosylation,defense response to bacterium,neutrophil degranulation,innate immune response,regulation of integrin biosynthetic process,positive regulation of inflammatory response,defense response to fungus,positive regulation of NF-kappaB transcription factor activity,regulation of cytoskeleton organization,neutrophil aggregation,cellular oxidant detoxification,positive regulation of intrinsic apoptotic signaling pathwaysignal transducer activity,calcium ion binding,protein binding,microtubule binding,zinc ion binding,antioxidant activity,Toll-like receptor 4 binding,arachidonic acid binding,RAGE receptor bindingextracellular region,extracellular space,nucleus,nucleoplasm,cytosol,cytoskeleton,plasma membrane,cell junction,extracellular matrix,secretory granule lumen,extracellular exosomeJ>sp|P06702|S10A9_HUMAN Protein S100-A9 OS=Homo sapiens GN=S100A9 PE=1 SV=1P06753-2TPM3 TPM3_HUMAN&Isoform 2 of Tropomyosin alpha-3 chainV>sp|P06753-2|TPM3_HUMAN Isoform 2 of Tropomyosin alpha-3 chain OS=Homo sapiens GN=TPM3P07737PFN1 PROF1_HUMAN Profilin-1neural tube closure,positive regulation of epithelial cell migration,actin cytoskeleton organization,negative regulation of actin filament polymerization,positive regulation of actin filament polymerization,negative regulation of actin filament bundle assembly,positive regulation of actin filament bundle assembly,positive regulation of ATPase activity,positive regulation of transcription from RNA polymerase II promoter,positive regulation of viral transcription,protein stabilization,positive regulation of DNA metabolic process,positive regulation of stress fiber assembly,negative regulation of stress fiber assembly,Wnt signaling pathway, planar cell polarity pathway,cellular response to growth factor stimulus,positive regulation of ruffle assemblyadenyl-nucleotide exchange factor activity,RNA binding,actin binding,actin monomer binding,receptor binding,protein binding,phosphatidylinositol-4,5-bisphosphate binding,Rho GTPase binding,cadherin binding,proline-rich region bindingnucleus,cytoplasm,cytosol,cytoskeleton,focal adhesion,cell cortex,membrane,neuron projection,synapse,extracellular exosome,blood microparticleC>sp|P07737|PROF1_HUMAN Profilin-1 OS=Homo sapiens GN=PFN1 PE=1 SV=2P07948-2LYN LYN_HUMAN(Isoform 2 of Tyrosine-protein kinase LynV>sp|P07948-2|LYN_HUMAN Isoform 2 of Tyrosine-protein kinase Lyn OS=Homo sapiens GN=LYNP07996THBS1 TSP1_HUMANThrombospondin-1Q activation of MAPK activity,response to hypoxia,negative regulation of endothelial cell proliferation,negative regulation of cell-matrix adhesion,sprouting angiogenesis,chronic inflammatory response,platelet degranulation,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,negative regulation of dendritic cell antigen processing and presentation,inflammatory response,immune response,response to unfolded protein,cell cycle arrest,cell adhesion,positive regulation of cell proliferation,response to mechanical stimulus,response to glucose,positive regulation of endothelial cell migration,negative regulation of endothelial cell migration,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of nitric oxide mediated signal transduction,negative regulation of cGMP-mediated signaling,negative regulation of plasminogen activation,positive regulation of macrophage chemotaxis,positive regulation of fibroblast migration,cell migration,negative regulation of angiogenesis,peptide cross-linking,positive regulation of blood coagulation,extracellular matrix organization,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,regulation of cGMP metabolic process,response to magnesium ion,response to progesterone,negative regulation of interleukin-< 12 production,positive regulation of transforming growth factor beta1 production,response to testosterone,cellular response to heat,response to endoplasmic reticulum stress,protein O-linked fucosylation,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of phosphorylation,response to drug,positive regulation of tumor necrosis factor biosynthetic process,positive regulation of macrophage activation,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of blood vessel endothelial cell migration,negative regulation of blood vessel endothelial cell migration,engulfment of apoptotic cell,positive regulation of translation,positive regulation of angiogenesis,behavioral response to pain,positive regulation of smooth muscle cell proliferation,positive regulation of chemotaxis,response to calcium ion,negative regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of fibrinolysis,cellular response to tumor necrosis factor,cellular response to growth factor stimulus,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of endothelial cell apoptotic process,positive regulation of reactive oxygen species metabolic process,negative regulation of endothelial cell chemotaxis,negative regulation of extrinsic apoptotic signaling pathway_phosphatidylserine binding,glycoprotein binding,fibronectin binding,integrin binding,calcium ion binding,protein binding,heparin binding,fibroblast growth factor binding,low-density lipoprotein particle binding,identical protein binding,laminin binding,proteoglycan binding,transforming growth factor beta binding,fibrinogen binding,collagen V binding#extracellular region,fibrinogen complex,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,external side of plasma membrane,cell surface,sarcoplasmic reticulum,secretory granule,extracellular matrix,platelet alpha granule,platelet alpha granule lumen,extracellular exosomeI>sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens GN=THBS1 PE=1 SV=2P08473MME NEP_HUMAN Neprilysin1kidney development,angiotensin maturation,proteolysis,peptide metabolic process,sensory perception of pain,neutrophil degranulation,creatinine metabolic process,beta-amyloid metabolic process,cellular response to cytokine stimulus,cellular response to UV-A,cellular response to UV-B,replicative senescenceendopeptidase activity,metalloendopeptidase activity,protein binding,metallopeptidase activity,exopeptidase activity,zinc ion binding,peptide bindingcytoplasm,plasma membrane,integral component of plasma membrane,brush border,focal adhesion,synaptic vesicle,integral component of membrane,axon,dendrite,secretory granule membrane,neuron projection terminus,synapse,extracellular exosome@>sp|P08473|NEP_HUMAN Neprilysin OS=Homo sapiens GN=MME PE=1 SV=2P08567PLEK PLEK_HUMAN Pleckstrinhematopoietic progenitor cell differentiation,platelet degranulation,vesicle docking involved in exocytosis,integrin-mediated signaling pathway,positive regulation of platelet activation,negative regulation of inositol phosphate biosynthetic process,positive regulation of inositol-polyphosphate 5-phosphatase activity,cell projection organization,positive regulation of actin filament depolymerization,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,cortical actin cytoskeleton organization,ruffle organization,actin cytoskeleton reorganization,positive regulation of actin filament bundle assembly,positive regulation of integrin activation,negative regulation of G-protein coupled receptor protein signaling pathway,phosphatidylinositol metabolic process,negative regulation of calcium-mediated signaling,regulation of cell diameter,thrombin-activated receptor signaling pathway,platelet aggregation,protein kinase C signaling,protein secretion by plateletxprotein kinase C binding,protein binding,protein homodimerization activity,phosphatidylinositol-3,4-bisphosphate binding?extracellular region,cytoplasm,cytosol,membrane,ruffle membraneB>sp|P08567|PLEK_HUMAN Pleckstrin OS=Homo sapiens GN=PLEK PE=1 SV=3 B0YJC4;P08670VIMB0YJC4_HUMAN;VIME_HUMANVimentinF;movement of cell or subcellular component,positive regulation of gene expression,negative regulation of neuron projection development,astrocyte development,viral process,muscle filament sliding,intermediate filament organization,Bergmann glial cell differentiation,SMAD protein signal transduction,lens fiber cell development;glycoprotein binding,double-stranded RNA binding,structural constituent of cytoskeleton,structural constituent of eye lens,protein binding,protein C-terminus binding,identical protein binding,scaffold protein binding,keratin filament binding;cytoplasm,peroxisome,cytosol,cytoskeleton,intermediate filament,focal adhesion,extracellular matrix,cell leading edge,neuron projection,extracellular exosome,plasma membrane>tr|B0YJC4|B0YJC4_HUMAN Vimentin OS=Homo sapiens GN=VIM PE=1 SV=1;>sp|P08670|VIME_HUMAN Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4P08758ANXA5 ANXA5_HUMAN Annexin A5platelet degranulation,signal transduction,blood coagulation,response to organic substance,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of coagulationphospholipase inhibitor activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid bindingextracellular region,intracellular,cytoplasm,cytosol,focal adhesion,external side of plasma membrane,membrane,extracellular exosome,endothelial microparticleD>sp|P08758|ANXA5_HUMAN Annexin A5 OS=Homo sapiens GN=ANXA5 PE=1 SV=2P09172DBH DOPO_HUMANDopamine beta-hydroxylaseIcytokine production,blood vessel remodeling,response to amphetamine,leukocyte mediated immunity,octopamine biosynthetic process,chemical synaptic transmission,memory,locomotory behavior,visual learning,regulation of cell proliferation,homoiothermy,dopamine catabolic process,norepinephrine biosynthetic process,catecholamine biosynthetic process,glucose homeostasis,fear response,maternal behavior,positive regulation of vasoconstriction,behavioral response to ethanol,response to pain,leukocyte migration,oxidation-reduction process,regulation of extrinsic apoptotic signaling pathwaybcatalytic activity,dopamine beta-monooxygenase activity,copper ion binding,L-ascorbic acid bindingextracellular region,extracellular space,cytoplasm,membrane,integral component of membrane,transport vesicle membrane,secretory granule membrane,chromaffin granule lumen,secretory granule lumen,chromaffin granule membrane,intracellular membrane-bounded organelleP>sp|P09172|DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3P10646TFPI TFPI1_HUMANTissue factor pathway inhibitorblood coagulation,blood coagulation, extrinsic pathway,negative regulation of endopeptidase activity,response to estradiol,cellular response to lipopolysaccharide,cellular response to interleukin-1Mendopeptidase inhibitor activity,serine-type endopeptidase inhibitor activityextracellular region,extracellular space,endoplasmic reticulum,plasma membrane,cell surface,organelle membrane,anchored component of membraneX>sp|P10646|TFPI1_HUMAN Tissue factor pathway inhibitor OS=Homo sapiens GN=TFPI PE=1 SV=1P11047LAMC1 LAMC1_HUMANLaminin subunit gamma-13protein complex assembly,cell adhesion,endoderm development,cell migration,extracellular matrix disassembly,extracellular matrix organization,hemidesmosome assembly,substrate adhesion-dependent cell spreading,system development,positive regulation of epithelial cell proliferation,basement membrane assembly+extracellular matrix structural constituentextracellular region,basement membrane,laminin-1 complex,extracellular space,extracellular matrix,laminin-10 complex,laminin-11 complex,extracellular exosomeQ>sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 SV=3P11150LIPC LIPC_HUMAN< Hepatic triacylglycerol lipasefatty acid biosynthetic process,cholesterol metabolic process,triglyceride catabolic process,very-low-density lipoprotein particle remodeling,intermediate-density lipoprotein particle remodeling,low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,chylomicron remnant clearance,phosphatidylcholine catabolic process,cholesterol homeostasis,reverse cholesterol transport,lipid digestion,triglyceride homeostasisphospholipase activity,triglyceride lipase activity,heparin binding,low-density lipoprotein particle binding,apolipoprotein bindingfextracellular region,extracellular space,endoplasmic reticulum lumen,high-density lipoprotein particleV>sp|P11150|LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3P11166SLC2A1 GTR1_HUMANASolute carrier family 2, facilitated glucose transporter member 1 lactose biosynthetic process,protein complex assembly,response to osmotic stress,glucose transport,L-ascorbic acid metabolic process,cellular response to glucose starvation,xenobiotic transport,regulation of insulin secretion,dehydroascorbic acid transport,glucose transmembrane transportglucose transmembrane transporter activity,protein binding,kinase binding,dehydroascorbic acid transporter activity,identical protein binding,xenobiotic transporter activity,protein self-association,D-glucose transmembrane transporter activityGolgi membrane,female pronucleus,cytosol,plasma membrane,integral component of plasma membrane,caveola,cell-cell junction,membrane,basolateral plasma membrane,apical plasma membrane,midbody,cortical actin cytoskeleton,melanosome,extracellular exosome,blood microparticle{>sp|P11166|GTR1_HUMAN Solute carrier family 2, facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2P11234;P11234-2;P11234-3RALB RALB_HUMANgRas-related protein Ral-B;Isoform 2 of Ras-related protein Ral-B;Isoform 3 of Ras-related protein Ral-Bcytokinesis,regulation of exocyst assembly,positive regulation of protein phosphorylation,apoptotic process,signal transduction,Ras protein signal transduction,cellular response to starvation,negative regulation of protein binding,positive regulation of protein binding,regulation of exocyst localization,cellular response to exogenous dsRNA,positive regulation of protein serine/threonine kinase activity,positive regulation of autophagosome assembly;;iGTPase activity,protein binding,GTP binding,GDP binding,ubiquitin protein ligase binding,ATPase binding;;Eplasma membrane,midbody,extracellular exosome,exocyst,autophagosome;;>sp|P11234|RALB_HUMAN Ras-related protein Ral-B OS=Homo sapiens GN=RALB PE=1 SV=1;>sp|P11234-2|RALB_HUMAN Isoform 2 of Ras-related protein Ral-B OS=Homo sapiens GN=RALB;>sp|P11234-3|RALB_HUMAN Isoform 3 of Ras-related protein Ral-B OS=Homo sapiens GN=RALBP11766ADH5 ADHX_HUMANAlcohol dehydrogenase class-3retinoid metabolic process,respiratory system process,ethanol oxidation,peptidyl-cysteine S-nitrosylation,response to lipopolysaccharide,positive regulation of blood pressure,formaldehyde catabolic process,response to nitrosative stress,response to redox statealcohol dehydrogenase (NAD) activity,fatty acid binding,zinc ion binding,electron carrier activity,formaldehyde dehydrogenase activity,protein homodimerization activity,S-(hydroxymethyl)glutathione dehydrogenase activity+mitochondrion,cytosol,extracellular exosomeU>sp|P11766|ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Homo sapiens GN=ADH5 PE=1 SV=4P12814;P12814-2;P12814-3ACTN1 ACTN1_HUMANIAlpha-actinin-1;Isoform 2 of Alpha-actinin-1;Isoform 3 of Alpha-actinin-1platelet degranulation,actin filament organization,platelet formation,platelet morphogenesis,regulation of apoptotic process,focal adhesion assembly,actin filament bundle assembly,negative regulation of cellular component movement,actin filament network formation,actin crosslink formation,regulation of nucleic acid-templated transcription,platelet activation,platelet aggregation;;double-stranded RNA binding,integrin binding,calcium ion binding,protein binding,vinculin binding,ligand-dependent nuclear receptor transcription coactivator activity,protein homodimerization activity,ion channel binding,actin filament binding;;stress fiber,ruffle,extracellular region,extracellular space,intracellular,cytoplasm,cytosol,plasma membrane,brush border,cell-cell junction,fascia adherens,focal adhesion,Z disc,platelet alpha granule lumen,pseudopodium,cell projection,extracellular exosome,actin filament;;>sp|P12814|ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2;>sp|P12814-2|ACTN1_HUMAN Isoform 2 of Alpha-actinin-1 OS=Homo sapiens GN=ACTN1;>sp|P12814-3|ACTN1_HUMAN Isoform 3 of Alpha-actinin-1 OS=Homo sapiens GN=ACTN1P13727PRG2 PRG2_HUMANBone marrow proteoglycandefense response to nematode,negative regulation of interleukin-10 production,positive regulation of interleukin-4 production,regulation of cytokine biosynthetic process,defense response to bacterium,neutrophil degranulation$heparin binding,carbohydrate bindingYextracellular region,transport vesicle,extracellular exosome,ficolin-1-rich granule lumenP>sp|P13727|PRG2_HUMAN Bone marrow proteoglycan OS=Homo sapiens GN=PRG2 PE=1 SV=2P13796LCP1 PLSL_HUMAN Plastin-2eT cell activation involved in immune response,protein kinase A signaling,cell migration,extracellular matrix disassembly,animal organ regeneration,regulation of intracellular protein transport,actin filament bundle assembly,actin filament network formation,actin crosslink formation,positive regulation of podosome assembly,wound healing, spreading of cellsaactin binding,calcium ion binding,identical protein binding,actin filament binding,GTPase bindingruffle,phagocytic cup,podosome,extracellular space,cytoplasm,cytosol,actin filament,plasma membrane,focal adhesion,actin cytoskeleton,filopodium,actin filament bundle,ruffle membrane,extracellular exosome,stress fiberA>sp|P13796|PLSL_HUMAN Plastin-2 OS=Homo sapiens GN=LCP1 PE=1 SV=6P14618PKM KPYM_HUMANPyruvate kinase PKMiprogrammed cell death,cellular response to insulin stimulus,neutrophil degranulation,canonical glycolysismagnesium ion binding,RNA binding,pyruvate kinase activity,protein binding,ATP binding,kinase activity,MHC class II protein complex binding,potassium ion binding,cadherin bindingextracellular region,nucleus,cytoplasm,mitochondrion,cytosol,cilium,extracellular matrix,vesicle,secretory granule lumen,myelin sheath,extracellular exosome,extracellular vesicle,ficolin-1-rich granule lumenJ>sp|P14618|KPYM_HUMAN Pyruvate kinase PKM OS=Homo sapiens GN=PKM PE=1 SV=4P14625HSP90B1 ENPL_HUMAN Endoplasminresponse to hypoxia,toll-like receptor signaling pathway,receptor-mediated endocytosis,protein transport,ER-associated ubiquitin-dependent protein catabolic process,retrograde protein transport, ER to cytosol,actin rod assembly,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,ATF6-mediated unfolded protein response,negative regulation of apoptotic process,regulation of phosphoprotein phosphatase activity,sequestering of calcium ion,cellular response to ATPRNA binding,calcium ion binding,protein binding,ATP binding,protein phosphatase binding,virion binding,low-density lipoprotein particle receptor binding,unfolded protein binding;extracellular region,nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,cytosol,plasma membrane,focal adhesion,membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,perinuclear region of cytoplasm,extracellular exosome,endocytic vesicle lumenF>sp|P14625|ENPL_HUMAN Endoplasmin OS=Homo sapiens GN=HSP90B1 PE=1 SV=1P18669PGAM1 PGAM1_HUMANPhosphoglycerate mutase 1gluconeogenesis,glycolytic process,regulation of glycolytic process,neutrophil degranulation,regulation of pentose-phosphate shunt,respiratory burst,canonical glycolysisbisphosphoglycerate mutase activity,phosphoglycerate mutase activity,protein binding,hydrolase activity,protein kinase bi< nding,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activityextracellular region,nucleus,cytoplasm,cytosol,membrane,secretory granule lumen,myelin sheath,extracellular exosome,ficolin-1-rich granule lumenS>sp|P18669|PGAM1_HUMAN Phosphoglycerate mutase 1 OS=Homo sapiens GN=PGAM1 PE=1 SV=2P19320;P19320-3VCAM1 VCAM1_HUMANNVascular cell adhesion protein 1;Isoform 3 of Vascular cell adhesion protein 1Xresponse to hypoxia,acute inflammatory response,chronic inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,aging,response to nutrient,amine metabolic process,response to zinc ion,response to ionizing radiation,viral process,membrane to membrane docking,B cell differentiation,extracellular matrix organization,response to lipopolysaccharide,response to nicotine,calcium-mediated signaling using intracellular calcium source,cellular response to vascular endothelial growth factor stimulus,positive regulation of T cell proliferation,response to ethanol,regulation of immune response,leukocyte tethering or rolling,oxidation-reduction process,cell chemotaxis,interferon-gamma-mediated signaling pathway,cellular response to tumor necrosis factor;Ointegrin binding,primary amine oxidase activity,cell adhesion molecule binding;;podosome,extracellular space,early endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,microvillus,external side of plasma membrane,cell surface,integral component of membrane,filopodium,sarcolemma,apical part of cell,extracellular exosome,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;>sp|P19320|VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1;>sp|P19320-3|VCAM1_HUMAN Isoform 3 of Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1P19827ITIH1 ITIH1_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H1Jnegative regulation of endopeptidase activity,hyaluronan metabolic process@serine-type endopeptidase inhibitor activity,calcium ion bindingf>sp|P19827|ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 OS=Homo sapiens GN=ITIH1 PE=1 SV=3P20618PSMB1 PSB1_HUMANProteasome subunit beta type-1MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway5threonine-type endopeptidase activity,protein bindingproteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome core complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenW>sp|P20618|PSB1_HUMAN Proteasome subunit beta type-1 OS=Homo sapiens GN=PSMB1 PE=1 SV=2P20742PZP PZP_HUMANPregnancy zone protein>female pregnancy,negative regulation of endopeptidase activityL>sp|P20742|PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4P22392-2;Q32Q12NME2;NME1-NME2NDKB_HUMAN;Q32Q12_HUMANJIsoform 3 of Nucleoside diphosphate kinase B;Nucleoside diphosphate kinase;1>sp|P22392-2|NDKB_HUMAN Isoform 3 of Nucleoside diphosphate kinase B OS=Homo sapiens GN=NME2;>tr|Q32Q12|Q32Q12_HUMAN Nucleoside diphosphate kinase OS=Homo sapiens GN=NME1-NME2 PE=1 SV=1P22748CA4 CAH4_HUMANCarbonic anhydrase 42one-carbon metabolic process,bicarbonate transport?carbonate dehydratase activity,protein binding,zinc ion bindingrough endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,trans-Golgi network,plasma membrane,cell surface,membrane,apical plasma membrane,transport vesicle membrane,secretory granule membrane,anchored component of external side of plasma membrane,brush border membrane,perinuclear region of cytoplasm,extracellular exosome,basolateral plasma membraneK>sp|P22748|CAH4_HUMAN Carbonic anhydrase 4 OS=Homo sapiens GN=CA4 PE=1 SV=2P22891;P22891-2PROZ PROZ_HUMANHVitamin K-dependent protein Z;Isoform 2 of Vitamin K-dependent protein Zsignal peptide processing,ER to Golgi vesicle-mediated transport,blood coagulation,peptidyl-glutamic acid carboxylation,negative regulation of blood coagulation;7serine-type endopeptidase activity,calcium ion binding;Rextracellular space,endoplasmic reticulum lumen,Golgi lumen,extracellular exosome;>sp|P22891|PROZ_HUMAN Vitamin K-dependent protein Z OS=Homo sapiens GN=PROZ PE=1 SV=2;>sp|P22891-2|PROZ_HUMAN Isoform 2 of Vitamin K-dependent protein Z OS=Homo sapiens GN=PROZP23142-4FBLN1 FBLN1_HUMANIsoform C of Fibulin-1H>sp|P23142-4|FBLN1_HUMAN Isoform C of Fibulin-1 OS=Homo sapiens GN=FBLN1P26641;P26641-2EEF1G EF1G_HUMAN@Elongation factor 1-gamma;Isoform 2 of Elongation factor 1-gamma+translational elongation,response to virus;Htranslation elongation factor activity,protein binding,cadherin binding;Onucleus,cytoplasm,cytosol,membrane,extracellular exosome,endoplasmic reticulum;>sp|P26641|EF1G_HUMAN Elongation factor 1-gamma OS=Homo sapiens GN=EEF1G PE=1 SV=3;>sp|P26641-2|EF1G_HUMAN Isoform 2 of Elongation factor 1-gamma OS=Homo sapiens GN=EEF1GP27169PON1 PON1_HUMAN Serum paraoxonase/arylesterase 1cholesterol metabolic process,response to external stimulus,response to toxic substance,positive regulation of cholesterol efflux,dephosphorylation,lipoxygenase pathway,aromatic compound catabolic process,response to nutrient levels,positive regulation of transporter activity,carboxylic acid catabolic process,organophosphate catabolic process,phosphatidylcholine metabolic process,positive regulation of binding,response to fatty acid,response to fluoride,negative regulation of plasma lipoprotein particle oxidationaryldialkylphosphatase activity,arylesterase activity,calcium ion binding,phospholipid binding,protein homodimerization activity,acyl-L-homoserine-lactone lactonohydrolase activityextracellular region,extracellular space,high-density lipoprotein particle,spherical high-density lipoprotein particle,intracellular membrane-bounded organelle,extracellular exosome,blood microparticleX>sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=3P29401;P29401-2TKT TKT_HUMAN(Transketolase;Isoform 2 of Transketolasexylulose biosynthetic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch,regulation of growth,glyceraldehyde-3-phosphate biosynthetic process;ltransketolase activity,protein binding,protein homodimerization activity,metal ion binding,cofactor binding;fnucleoplasm,peroxisome,cytosol,nuclear body,nuclear speck,vesicle,myelin sheath,extracellular exosome;>sp|P29401|TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3;>sp|P29401-2|TKT_HUMAN Isoform 2 of Transketolase OS=Homo sapiens GN=TKTP29622SERPINA4 KAIN_HUMAN KallistatinDplatelet degranulation,negative regulation of endopeptidase activity[extracellular region,extracellular space,platelet dense granule lumen,extracellular exosomeG>sp|P29622|KAIN_HUMAN Kallistatin OS=Homo sapiens GN=SERPINA4 PE=1 SV=3P30041PRDX6 PRDX6_HUMANPeroxiredoxin-6response to reactive oxygen species,lipid cata< bolic process,hydrogen peroxide catabolic process,neutrophil degranulation,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxificationglutathione peroxidase activity,protein binding,hydrolase activity,ubiquitin protein ligase binding,cadherin binding,peroxiredoxin activityqextracellular region,extracellular space,cytoplasm,cytosol,membrane,azurophil granule lumen,extracellular exosomeI>sp|P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapiens GN=PRDX6 PE=1 SV=3P30043BLVRB BLVRB_HUMANFlavin reductase (NADPH)2heme catabolic process,oxidation-reduction processCbiliverdin reductase activity,riboflavin reductase (NADPH) activityInucleoplasm,cytosol,plasma membrane,terminal bouton,extracellular exosomeR>sp|P30043|BLVRB_HUMAN Flavin reductase (NADPH) OS=Homo sapiens GN=BLVRB PE=1 SV=3P31949S100A11 S10AB_HUMANProtein S100-A11signal transduction,negative regulation of DNA replication,negative regulation of cell proliferation,neutrophil degranulation,cell-cell adhesioncalcium ion binding,protein binding,protein homodimerization activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesionruffle,extracellular region,extracellular space,nucleus,cytoplasm,cell-cell adherens junction,secretory granule lumen,extracellular exosomeL>sp|P31949|S10AB_HUMAN Protein S100-A11 OS=Homo sapiens GN=S100A11 PE=1 SV=2P35908KRT2 K22E_HUMAN)Keratin, type II cytoskeletal 2 epidermalkeratinocyte development,epidermis development,keratinization,keratinocyte activation,keratinocyte proliferation,intermediate filament organization,keratinocyte migration,cornificationSstructural constituent of cytoskeleton,protein binding,cytoskeletal protein bindingiextracellular space,nucleus,cytosol,intermediate filament,membrane,keratin filament,extracellular exosomea>sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2P35998PSMC2 PRS7_HUMAN!26S protease regulatory subunit 7MAPK cascade,protein polyubiquitination,osteoblast differentiation,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic processkprotein binding,ATP binding,ATPase activity,TBP-class protein binding,proteasome-activating ATPase activity1proteasome complex,cytoplasmic mRNA processing body,extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,secretory granule lumen,ficolin-1-rich granule lumenZ>sp|P35998|PRS7_HUMAN 26S protease regulatory subunit 7 OS=Homo sapiens GN=PSMC2 PE=1 SV=3P36955SERPINF1 PEDF_HUMAN!Pigment epithelium-derived factorkidney development,multicellular organism development,aging,short-term memory,cell proliferation,response to acidic pH,negative regulation of endothelial cell migration,negative regulation of gene expression,negative regulation of endopeptidase activity,positive regulation of neuron projection development,negative regulation of angiogenesis,ovulation cycle,response to arsenic-containing substance,negative regulation of inflammatory response,positive regulation of neurogenesis,retina development in camera-type eye,negative regulation of epithelial cell proliferation involved in prostate gland development,cellular response to cobalt ion,cellular response to retinoic acid,cellular response to glucose stimulus,cellular response to dexamethasone stimulus,negative regulation of neuron death<serine-type endopeptidase inhibitor activity,protein bindingextracellular region,basement membrane,extracellular space,melanosome,axon hillock,perinuclear region of cytoplasm,extracellular exosome,extracellular matrix]>sp|P36955|PEDF_HUMAN Pigment epithelium-derived factor OS=Homo sapiens GN=SERPINF1 PE=1 SV=4P37802TAGLN2 TAGL2_HUMAN Transgelin-26platelet degranulation,epithelial cell differentiation protein binding,cadherin binding:extracellular region,cytosol,vesicle,extracellular exosomeG>sp|P37802|TAGL2_HUMAN Transgelin-2 OS=Homo sapiens GN=TAGLN2 PE=1 SV=3P40197GP5 GPV_HUMANPlatelet glycoprotein Vecell adhesion,axonogenesis,blood coagulation,blood coagulation, intrinsic pathway,platelet activationproteinaceous extracellular matrix,extracellular space,plasma membrane,integral component of plasma membrane,extracellular exosomeM>sp|P40197|GPV_HUMAN Platelet glycoprotein V OS=Homo sapiens GN=GP5 PE=1 SV=1P48740'Mannan-binding lectin serine protease 1ecomplement activation, lectin pathway,proteolysis,receptor-mediated endocytosis,complement activationserine-type endopeptidase activity,calcium ion binding,protein binding,peptidase activity,protein homodimerization activity,calcium-dependent protein binding<extracellular region,extracellular space,nucleoplasm,cytosola>sp|P48740|MASP1_HUMAN Mannan-binding lectin serine protease 1 OS=Homo sapiens GN=MASP1 PE=1 SV=3P49368CCT3 TCPG_HUMAN!T-complex protein 1 subunit gammaaprotein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodylRNA binding,protein binding,ATP binding,protein binding involved in protein folding,unfolded protein bindingzona pellucida receptor complex,cytosol,chaperonin-containing T-complex,cytoskeleton,microtubule,plasma membrane,myelin sheath,cell body,extracellular exosomeY>sp|P49368|TCPG_HUMAN T-complex protein 1 subunit gamma OS=Homo sapiens GN=CCT3 PE=1 SV=4P50991CCT4 TCPD_HUMAN!T-complex protein 1 subunit deltaprotein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,positive regulation of telomerase activity,chaperone-mediated protein folding,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodyzona pellucida receptor complex,nucleoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,melanosome,cell projection,cell body,extracellular exosomeY>sp|P50991|TCPD_HUMAN T-complex protein 1 subunit delta OS=Homo sapiens GN=CCT4 PE=1 SV=4P53396;P53396-2ACLY ACLY_HUMAN6ATP-citrate synthase;Isoform 2 of ATP-citrate synthase/acetyl-CoA biosynthetic process,citrate metabolic process,oxaloacetate metabolic process,fatty acid biosynthetic process,cholesterol biosynthetic process,lipid biosynthetic proc< ess,positive regulation of cellular metabolic process,long-chain fatty-acyl-CoA biosynthetic process,neutrophil degranulation;]ATP citrate synthase activity,protein binding,ATP binding,metal ion binding,cofactor binding;extracellular region,nucleoplasm,cytosol,plasma membrane,citrate lyase complex,membrane,azurophil granule lumen,extracellular exosome,ficolin-1-rich granule lumen;>sp|P53396|ACLY_HUMAN ATP-citrate synthase OS=Homo sapiens GN=ACLY PE=1 SV=3;>sp|P53396-2|ACLY_HUMAN Isoform 2 of ATP-citrate synthase OS=Homo sapiens GN=ACLYP59665DEFA1 DEF1_HUMANNeutrophil defensin 1_innate immune response in mucosa,chemotaxis,immune response,antimicrobial humoral response,antibacterial humoral response,intracellular estrogen receptor signaling pathway,killing of cells of other organism,neutrophil degranulation,innate immune response,defense response to Gram-positive bacterium,defense response to fungus,defense response to viruswextracellular region,extracellular space,Golgi lumen,azurophil granule lumen,extracellular exosome,extracellular matrixN>sp|P59665|DEF1_HUMAN Neutrophil defensin 1 OS=Homo sapiens GN=DEFA1 PE=1 SV=1P60709ACTB ACTB_HUMANActin, cytoplasmic 1retina homeostasis,movement of cell or subcellular component,protein deubiquitination,substantia nigra development,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,ATP-dependent chromatin remodeling,positive regulation of gene expression, epigenetic,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,membrane organization,platelet aggregation,postsynaptic actin cytoskeleton organization~structural constituent of cytoskeleton,protein binding,ATP binding,kinesin binding,Tat protein binding,identical protein binding,nitric-oxide synthase binding,structural constituent of postsynaptic actin cytoskeleton,RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,nucleosomal DNA bindingVnuclear chromatin,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,intracellular ribonucleoprotein complex,cortical cytoskeleton,NuA4 histone acetyltransferase complex,cytoplasmic ribonucleoprotein granule,myelin sheath,protein complex,extracellular exosome,blood microparticle,dense bodyL>sp|P60709|ACTB_HUMAN Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1P61088UBE2N UBE2N_HUMAN!Ubiquitin-conjugating enzyme E2 Nactivation of MAPK activity,double-strand break repair via homologous recombination,DNA double-strand break processing,stimulatory C-type lectin receptor signaling pathway,regulation of DNA repair,postreplication repair,double-strand break repair via nonhomologous end joining,cellular protein modification process,proteolysis,ubiquitin-dependent protein catabolic process,JNK cascade,protein ubiquitination,histone ubiquitination,positive regulation of histone modification,regulation of histone ubiquitination,Fc-epsilon receptor signaling pathway,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of DNA repair,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,positive regulation of ubiquitin-protein transferase activity,nucleotide-binding oligomerization domain containing signaling pathway,protein K63-linked ubiquitination,global genome nucleotide-excision repairRNA binding,ubiquitin-protein transferase activity,protein binding,ATP binding,ubiquitin protein ligase binding,ubiquitin binding,ubiquitin protein ligase activity,ubiquitin conjugating enzyme activityubiquitin ligase complex,fibrillar center,nucleus,nucleoplasm,cytoplasm,cytosol,UBC13-MMS2 complex,UBC13-UEV1A complex,protein complex,extracellular exosome[>sp|P61088|UBE2N_HUMAN Ubiquitin-conjugating enzyme E2 N OS=Homo sapiens GN=UBE2N PE=1 SV=1P61952GNG11 GBG11_HUMANBGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11gsignal transduction,G-protein coupled receptor signaling pathway,cellular response to glucagon stimulus*GTPase activity,signal transducer activity0heterotrimeric G-protein complex,plasma membrane|>sp|P61952|GBG11_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 OS=Homo sapiens GN=GNG11 PE=1 SV=1P62136PPP1CA PP1A_HUMAN@Serine/threonine-protein phosphatase PP1-alpha catalytic subunitglycogen metabolic process,regulation of glycogen biosynthetic process,regulation of glycogen catabolic process,protein dephosphorylation,cell cycle,dephosphorylation,lung development,negative regulation of protein binding,circadian regulation of gene expression,regulation of translational initiation by eIF2 alpha dephosphorylation,regulation of circadian rhythm,entrainment of circadian clock by photoperiod,branching morphogenesis of an epithelial tube,cell division,regulation of canonical Wnt signaling pathway,cell-cell adhesion,beta-catenin destruction complex disassembly,positive regulation of extrinsic apoptotic signaling pathway in absence of ligandphosphoprotein phosphatase activity,protein serine/threonine phosphatase activity,protein binding,protein phosphatase 1 binding,phosphatase activity,protein complex binding,ribonucleoprotein complex binding,metal ion binding,cadherin binding involved in cell-cell adhesionprotein phosphatase type 1 complex,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,glycogen granule,dendritic spine,perikaryon,extracellular exosome,PTW/PP1 phosphatase complex,nuclear chromosome, telomeric regionz>sp|P62136|PP1A_HUMAN Serine/threonine-protein phosphatase PP1-alpha catalytic subunit OS=Homo sapiens GN=PPP1CA PE=1 SV=1J3QQM1;P62195;P62195-2PSMC5"J3QQM1_HUMAN;PRS8_HUMAN;PRS8_HUMAN}26S protease regulatory subunit 8 (Fragment);26S protease regulatory subunit 8;Isoform 2 of 26S protease regulatory subunit 8t;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,transcription from RNA polymerase II promoter,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,negative regulation of programmed cell death,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,modulation of synaptic transmission,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of inclusion body assembly,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process;;transcription cofactor activity,protein binding,ATP binding,transcription factor binding,ATPase activity,TBP-class protein binding,thyrotropin-releasing hormone receptor binding,proteasome-activating ATPase activity;!;proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,inclusion body,proteasome accessory complex,cytoplasmic vesicle,nuclear proteasome complex,cytosolic proteasome complex,extracellular exosome,blood microparticle,postsynapse;">tr|J3QQM1|J3QQM1_HUMAN 26S protease < regulatory subunit 8 (Fragment) OS=Homo sapiens GN=PSMC5 PE=1 SV=1;>sp|P62195|PRS8_HUMAN 26S protease regulatory subunit 8 OS=Homo sapiens GN=PSMC5 PE=1 SV=1;>sp|P62195-2|PRS8_HUMAN Isoform 2 of 26S protease regulatory subunit 8 OS=Homo sapiens GN=PSMC5P62328TMSB4X TYB4_HUMANThymosin beta-4Oplatelet degranulation,actin filament organization,regulation of cell migration1RNA binding,actin monomer binding,protein bindingbextracellular region,extracellular space,nucleus,cytosol,cytoskeleton,platelet alpha granule lumenI>sp|P62328|TYB4_HUMAN Thymosin beta-4 OS=Homo sapiens GN=TMSB4X PE=1 SV=2P62805HIST1H4AH4_HUMAN Histone H4Ochromatin silencing at rDNA,double-strand break repair via nonhomologous end joining,nucleosome assembly,DNA replication-dependent nucleosome assembly,DNA replication-independent nucleosome assembly,DNA-templated transcription, initiation,telomere capping,gene silencing by RNA,telomere organization,CENP-A containing nucleosome assembly,cellular protein metabolic process,negative regulation of megakaryocyte differentiation,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic,protein heterotetramerization,beta-catenin-TCF complex assembly{DNA binding,RNA binding,protein binding,protein domain specific binding,histone binding,protein heterodimerization activitynuclear chromosome,nuclear chromosome, telomeric region,nucleosome,nuclear nucleosome,extracellular region,nucleus,nucleoplasm,membrane,extracellular matrix,protein complex,extracellular exosomeD>sp|P62805|H4_HUMAN Histone H4 OS=Homo sapiens GN=HIST1H4A PE=1 SV=2P62937PPIA PPIA_HUMAN%Peptidyl-prolyl cis-trans isomerase Aprotein peptidyl-prolyl isomerization,RNA-dependent DNA biosynthetic process,protein folding,viral life cycle,uncoating of virus,fusion of virus membrane with host plasma membrane,virion assembly,viral release from host cell,entry into host cell,lipid particle organization,neutrophil degranulation,regulation of viral genome replication,positive regulation of viral genome replication,positive regulation of protein secretion,leukocyte migration,establishment of integrated proviral latencypRNA binding,peptidyl-prolyl cis-trans isomerase activity,protein binding,virion binding,unfolded protein bindingextracellular region,extracellular space,nucleus,cytosol,focal adhesion,membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen]>sp|P62937|PPIA_HUMAN Peptidyl-prolyl cis-trans isomerase A OS=Homo sapiens GN=PPIA PE=1 SV=2P63218GNG5 GBG5_HUMANAGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5signal transduction,G-protein coupled receptor signaling pathway,cellular response to glucagon stimulus,positive regulation of secondary heart field cardioblast proliferation,positive regulation of neural precursor cell proliferationMGTPase activity,signal transducer activity,protein binding,PDZ domain binding]mitochondrion,heterotrimeric G-protein complex,plasma membrane,membrane,extracellular exosomey>sp|P63218|GBG5_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 OS=Homo sapiens GN=GNG5 PE=1 SV=3P68036;P68036-2;P68036-3UBE2L3 UB2L3_HUMANUbiquitin-conjugating enzyme E2 L3;Isoform 2 of Ubiquitin-conjugating enzyme E2 L3;Isoform 3 of Ubiquitin-conjugating enzyme E2 L3rprotein polyubiquitination,transcription, DNA-templated,regulation of transcription, DNA-templated,cellular protein modification process,ubiquitin-dependent protein catabolic process,cell proliferation,protein ubiquitination,positive regulation of protein ubiquitination,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,cell cycle phase transition,positive regulation of ubiquitin-protein transferase activity,protein K11-linked ubiquitination,cellular response to steroid hormone stimulus,cellular response to glucocorticoid stimulus,positive regulation of protein targeting to mitochondrion;;transcription coactivator activity,RNA binding,ubiquitin-protein transferase activity,protein binding,ATP binding,enzyme binding,ubiquitin protein ligase binding,ubiquitin conjugating enzyme activity,ubiquitin-protein transferase activator activity;;Vubiquitin ligase complex,nucleus,nucleoplasm,cytoplasm,cytosol,extracellular exosome;;#>sp|P68036|UB2L3_HUMAN Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens GN=UBE2L3 PE=1 SV=1;>sp|P68036-2|UB2L3_HUMAN Isoform 2 of Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens GN=UBE2L3;>sp|P68036-3|UB2L3_HUMAN Isoform 3 of Ubiquitin-conjugating enzyme E2 L3 OS=Homo sapiens GN=UBE2L3 P68104;Q5VTE0EEF1A1;EEF1A1P5EF1A1_HUMAN;EF1A3_HUMANEElongation factor 1-alpha 1;Putative elongation factor 1-alpha-like 3transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,protein methylation,neutrophil degranulation,cellular response to epidermal growth factor stimulus,regulation of chaperone-mediated autophagy;translational elongation,biological_processtRNA binding,RNA binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,protein kinase binding;molecular_function,translation elongation factor activity,GTPase activity,GTP bindingpextracellular region,extracellular space,nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,membrane,cortical actin cytoskeleton,ruffle membrane,secretory granule lumen,myelin sheath,extracellular exosome,cytoplasmic side of lysosomal membrane,ficolin-1-rich granule lumen;extracellular space,nucleus,cytoplasm,extracellular exosome>sp|P68104|EF1A1_HUMAN Elongation factor 1-alpha 1 OS=Homo sapiens GN=EEF1A1 PE=1 SV=1;>sp|Q5VTE0|EF1A3_HUMAN Putative elongation factor 1-alpha-like 3 OS=Homo sapiens GN=EEF1A1P5 PE=5 SV=1P68363TUBA1B TBA1B_HUMANTubulin alpha-1B chainmicrotubule cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division,cellular response to interleukin-4double-stranded RNA binding,GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,ubiquitin protein ligase binding`microtubule,cytoplasmic microtubule,microtubule cytoskeleton,myelin sheath,extracellular exosomeQ>sp|P68363|TBA1B_HUMAN Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1Q02818NUCB1 NUCB1_HUMANNucleobindin-15response to cisplatin,regulation of protein targetingOG-protein alpha-subunit binding,DNA binding,calcium ion binding,protein binding6extracellular space,nucleus,early endosome,rough endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi-associated vesicle,cis-Golgi network,trans-Golgi network,membrane,Golgi cisterna membrane,extracellular exosome,extrinsic component of Golgi membrane,lumenal side of Golgi membraneH>sp|Q02818|NUCB1_HUMAN Nucleobindin-1 OS=Homo sapiens GN=NUCB1 PE=1 SV=4Q04721NOTCH2 NOTC2_HUMAN(Neurogenic locus notch homolog protein 2cell fate determination,marginal zone B cell differentiation,pulmonary valve morphogenesis,regulation of transcription, DNA-templated,transcription initiation from RNA polymerase II promoter,apoptotic process,cell cycle arrest,Notch signaling pathway,multicellular organism development,nervous system development,negative regulation of cell proliferation,animal organ morphogenesis,cell growth,stem cell population maintenance,hemopoiesis,intracellular receptor signaling pathway,negative regulation of apoptotic process,positive regulation of Ras protein signal transduction,bone remodeling,regulation of developmental process,atrial septum morphogenesis,Notch signaling involved in heart developmentreceptor activity,calcium ion binding,protein binding,transcription factor activity, ligand-activated RNA polymerase II transcription factor bindingGolgi membrane,extracellular region,nucleus,nucleoplasm,endoplasmic reticulum membrane,plasma membrane,integral component of plasma membrane,cell surface,membrane,receptor complexc>sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens GN=NOTCH2 PE=1 SV=3< Q08495;Q08495-2DMTN DEMA_HUMANDematin;Isoform 2 of Dematinprotein complex assembly,cytoskeleton organization,regulation of cell shape,regulation of lamellipodium assembly,positive regulation of fibroblast migration,negative regulation of peptidyl-threonine phosphorylation,negative regulation of cell-substrate adhesion,actin cytoskeleton organization,positive regulation of blood coagulation,regulation of actin cytoskeleton organization,negative regulation of peptidyl-serine phosphorylation,calcium-mediated signaling using intracellular calcium source,calcium-mediated signaling using extracellular calcium source,erythrocyte development,negative regulation of peptidyl-tyrosine phosphorylation,actin filament bundle assembly,regulation of filopodium assembly,actin filament capping,negative regulation of focal adhesion assembly,transmembrane transport,protein secretion by platelet,cellular response to calcium ion,cellular response to cAMP,positive regulation of wound healing,negative regulation of protein targeting to membrane,actin filament reorganization,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of platelet aggregation,positive regulation of integrin-mediated signaling pathway;Yactin binding,receptor binding,protein binding,spectrin binding,protein self-association;cytosol,actin filament,plasma membrane,endomembrane system,postsynaptic density,spectrin-associated cytoskeleton,actin cytoskeleton,cortical cytoskeleton,platelet dense tubular network membrane,cell projection membrane,cytoplasmic vesicle,perinuclear region of cytoplasm;>sp|Q08495|DEMA_HUMAN Dematin OS=Homo sapiens GN=DMTN PE=1 SV=3;>sp|Q08495-2|DEMA_HUMAN Isoform 2 of Dematin OS=Homo sapiens GN=DMTNQ12846STX4 STX4_HUMAN Syntaxin-4intracellular protein transport,post-Golgi vesicle-mediated transport,positive regulation of cell proliferation,regulation of exocytosis,positive regulation of cell migration,synaptic vesicle fusion to presynaptic active zone membrane,response to hydroperoxide,SNARE complex assembly,positive regulation of insulin secretion involved in cellular response to glucose stimulus,positive regulation of catalytic activity,positive regulation of eosinophil degranulation,positive regulation of cell adhesion,vesicle docking,organelle fusion,positive regulation of chemotaxis,positive regulation of immunoglobulin secretion,long-term synaptic potentiation,positive regulation of establishment of protein localization to plasma membrane,regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of protein localization to plasma membrane,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,positive regulation of protein localization to cell surfacegSNARE binding,SNAP receptor activity,protein binding,sphingomyelin phosphodiesterase activator activitystorage vacuole,extracellular space,intracellular,endosome,vacuole,trans-Golgi network,cytosol,plasma membrane,synaptic vesicle,cell surface,membrane,integral component of membrane,basolateral plasma membrane,lamellipodium,phagocytic vesicle membrane,SNARE complex,myelin sheath adaxonal region,somatodendritic compartment,specific granule,dendritic spine,lateral loop,synapse,perinuclear region of cytoplasm,extracellular exosomeB>sp|Q12846|STX4_HUMAN Syntaxin-4 OS=Homo sapiens GN=STX4 PE=1 SV=2Q13232NME3 NDK3_HUMANNucleoside diphosphate kinase 3nucleoside diphosphate phosphorylation,GTP biosynthetic process,UTP biosynthetic process,CTP biosynthetic process,apoptotic processTnucleoside diphosphate kinase activity,protein binding,ATP binding,metal ion binding#mitochondrion,extracellular exosomeW>sp|Q13232|NDK3_HUMAN Nucleoside diphosphate kinase 3 OS=Homo sapiens GN=NME3 PE=1 SV=2Q13561;Q13561-2;Q13561-3DCTN2 DCTN2_HUMANRDynactin subunit 2;Isoform 2 of Dynactin subunit 2;Isoform 3 of Dynactin subunit 2<G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,mitotic spindle organization,mitotic nuclear division,cell proliferation,antigen processing and presentation of exogenous peptide antigen via MHC class II,melanosome transport,protein localization to centrosome,ciliary basal body docking;;Kmotor activity,protein binding,spectrin binding,identical protein binding;;kinetochore,cytoplasm,centrosome,cytosol,dynactin complex,microtubule,membrane,dynein complex,growth cone,vesicle,extracellular exosome;;>sp|Q13561|DCTN2_HUMAN Dynactin subunit 2 OS=Homo sapiens GN=DCTN2 PE=1 SV=4;>sp|Q13561-2|DCTN2_HUMAN Isoform 2 of Dynactin subunit 2 OS=Homo sapiens GN=DCTN2;>sp|Q13561-3|DCTN2_HUMAN Isoform 3 of Dynactin subunit 2 OS=Homo sapiens GN=DCTN2Q14019COTL1 COTL1_HUMANCoactosin-like proteinFbiological_process,neutrophil degranulation,defense response to fungus,actin binding,protein binding,enzyme bindingtextracellular region,nucleus,cytoskeleton,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenP>sp|Q14019|COTL1_HUMAN Coactosin-like protein OS=Homo sapiens GN=COTL1 PE=1 SV=3Q14204DYNC1H1 DYHC1_HUMAN"Cytoplasmic dynein 1 heavy chain 1rG2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,microtubule-based movement,mitotic spindle organization,antigen processing and presentation of exogenous peptide antigen via MHC class II,cytoplasmic mRNA processing body assembly,stress granule assembly,neutrophil degranulation,establishment of spindle localization,ciliary basal body dockingRNA binding,protein binding,ATP binding,dynein light intermediate chain binding,ATP-dependent microtubule motor activity, minus-end-directedextracellular region,centrosome,cytosol,cytoplasmic dynein complex,microtubule,membrane,filopodium,extracellular matrix,azurophil granule lumen,extracellular exosome^>sp|Q14204|DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5Q14520;Q14520-2HABP2 HABP2_HUMANFHyaluronan-binding protein 2;Isoform 2 of Hyaluronan-binding protein 2proteolysis,cell adhesion;Qserine-type endopeptidase activity,calcium ion binding,glycosaminoglycan binding;)extracellular region,extracellular space;>sp|Q14520|HABP2_HUMAN Hyaluronan-binding protein 2 OS=Homo sapiens GN=HABP2 PE=1 SV=1;>sp|Q14520-2|HABP2_HUMAN Isoform 2 of Hyaluronan-binding protein 2 OS=Homo sapiens GN=HABP2Q14623IHH IHH_HUMANIndian hedgehog protein(skeletal system development,heart looping,smoothened signaling pathway,cell-cell signaling,negative regulation of signal transduction,intein-mediated protein splicing,positive regulation of chondrocyte differentiation,response to estradiol,negative regulation of T cell differentiation in thymus,negative regulation of immature T cell proliferation in thymus,positive regulation of T cell differentiation in thymus,negative regulation of apoptotic process,positive regulation of smoothened signaling pathway,positive regulation of transcription from RNA polymerase II promoter,positive regulation of alpha-beta T cell differentiation,negative regulation of alpha-beta T cell differentiation,positive regulation of epithelial cell proliferation,maternal process involved in female pregnancy,somite development6patched binding,calcium ion binding,peptidase activityM>sp|Q14623|IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4Q15008;Q15008-4PSMD6 PSMD6_HUMANj26S proteasome non-ATPase regulatory subunit 6;Isoform 4 of 26S proteasome non-ATPase regulatory subunit 6MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,proteolysis,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling path< way,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway; protein binding,ATPase activity;proteasome complex,extracellular region,nucleoplasm,cytosol,proteasome regulatory particle,proteasome accessory complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;>sp|Q15008|PSMD6_HUMAN 26S proteasome non-ATPase regulatory subunit 6 OS=Homo sapiens GN=PSMD6 PE=1 SV=1;>sp|Q15008-4|PSMD6_HUMAN Isoform 4 of 26S proteasome non-ATPase regulatory subunit 6 OS=Homo sapiens GN=PSMD6!Q15555;Q15555-3;Q15555-4;Q15555-5MAPRE2 MARE2_HUMANMicrotubule-associated protein RP/EB family member 2;Isoform 3 of Microtubule-associated protein RP/EB family member 2;Isoform 4 of Microtubule-associated protein RP/EB family member 2;Isoform 5 of Microtubule-associated protein RP/EB family member 2Pmitotic nuclear division,signal transduction,cell proliferation,cell division;;;@protein binding,microtubule binding,identical protein binding;;;:cytoplasm,microtubule cytoskeleton,microtubule plus-end;;;>sp|Q15555|MARE2_HUMAN Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens GN=MAPRE2 PE=1 SV=1;>sp|Q15555-3|MARE2_HUMAN Isoform 3 of Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens GN=MAPRE2;>sp|Q15555-4|MARE2_HUMAN Isoform 4 of Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens GN=MAPRE2;>sp|Q15555-5|MARE2_HUMAN Isoform 5 of Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens GN=MAPRE2Q15582TGFBI BGH3_HUMAN5Transforming growth factor-beta-induced protein ig-h3angiogenesis,chondrocyte differentiation,cell adhesion,negative regulation of cell adhesion,visual perception,cell proliferation,extracellular matrix organization,cellular protein metabolic process,response to stimulusNintegrin binding,protein binding,collagen binding,extracellular matrix bindingextracellular region,basement membrane,extracellular space,trans-Golgi network,plasma membrane,extracellular matrix,extracellular exosomen>sp|Q15582|BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1OQ15746;Q15746-11;Q15746-2;Q15746-3;Q15746-4;Q15746-5;Q15746-6;Q15746-7;Q15746-9MYLK MYLK_HUMANMyosin light chain kinase, smooth muscle;Isoform 9 of Myosin light chain kinase, smooth muscle;Isoform 2 of Myosin light chain kinase, smooth muscle;Isoform 3A of Myosin light chain kinase, smooth muscle;Isoform 3B of Myosin light chain kinase, smooth muscle;Isoform 4 of Myosin light chain kinase, smooth muscle;Isoform Del-1790 of Myosin light chain kinase, smooth muscle;Isoform 5 of Myosin light chain kinase, smooth muscle;Isoform 7 of Myosin light chain kinase, smooth muscle7protein phosphorylation,muscle contraction,smooth muscle contraction,tonic smooth muscle contraction,positive regulation of cell migration,bleb assembly,positive regulation of calcium ion transport,aorta smooth muscle tissue morphogenesis,cellular hypotonic response,positive regulation of wound healing;;;;;;;;yactin binding,myosin light chain kinase activity,protein binding,calmodulin binding,ATP binding,metal ion binding;;;;;;;;Zstress fiber,cytoplasm,cytosol,lamellipodium,cleavage furrow,extracellular exosome;;;;;;;; 4;;;;;;;;>sp|Q15746|MYLK_HUMAN Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4;>sp|Q15746-11|MYLK_HUMAN Isoform 9 of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-2|MYLK_HUMAN Isoform 2 of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-3|MYLK_HUMAN Isoform 3A of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-4|MYLK_HUMAN Isoform 3B of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-5|MYLK_HUMAN Isoform 4 of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-6|MYLK_HUMAN Isoform Del-1790 of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-7|MYLK_HUMAN Isoform 5 of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK;>sp|Q15746-9|MYLK_HUMAN Isoform 7 of Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLKQ16706MAN2A1 MA2A1_HUMANAlpha-mannosidase 2?in utero embryonic development,liver development,mannose metabolic process,protein glycosylation,N-glycan processing,protein deglycosylation,mitochondrion organization,vacuole organization,respiratory gaseous exchange,lung alveolus development,positive regulation of neurogenesis,retina morphogenesis in camera-type eyealpha-mannosidase activity,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,zinc ion binding,hydrolase activity, hydrolyzing N-glycosyl compounds,carbohydrate bindingrGolgi membrane,extracellular space,cis-Golgi network,membrane,integral component of membrane,extracellular exosomeN>sp|Q16706|MA2A1_HUMAN Alpha-mannosidase 2 OS=Homo sapiens GN=MAN2A1 PE=1 SV=2Q3ZCW2LGALSL LEGL_HUMANGalectin-related protein$protein binding,carbohydrate binding intracellularR>sp|Q3ZCW2|LEGL_HUMAN Galectin-related protein OS=Homo sapiens GN=LGALSL PE=1 SV=2Q5TDH0;Q5TDH0-3DDI2 DDI2_HUMAN:Protein DDI1 homolog 2;Isoform 3 of Protein DDI1 homolog 2%aspartic-type endopeptidase activity;nucleoplasm,cytosol;>sp|Q5TDH0|DDI2_HUMAN Protein DDI1 homolog 2 OS=Homo sapiens GN=DDI2 PE=1 SV=1;>sp|Q5TDH0-3|DDI2_HUMAN Isoform 3 of Protein DDI1 homolog 2 OS=Homo sapiens GN=DDI2Q6UX71PLXDC2 PXDC2_HUMAN"Plexin domain-containing protein 24integral component of membrane,extracellular exosome]>sp|Q6UX71|PXDC2_HUMAN Plexin domain-containing protein 2 OS=Homo sapiens GN=PLXDC2 PE=1 SV=1Q76LX8;Q76LX8-2ADAMTS13 ATS13_HUMANA disintegrin and metalloproteinase with thrombospondin motifs 13;Isoform 2 of A disintegrin and metalloproteinase with thrombospondin motifs 13proteolysis,cell-matrix adhesion,integrin-mediated signaling pathway,glycoprotein metabolic process,response to toxic substance,response to amine,protein processing,platelet activation,response to potassium ion,protein O-linked fucosylation,peptide catabolic process,cellular response to lipopolysaccharide,cellular response to interferon-gamma,cellular response to interleukin-4,cellular response to tumor necrosis factor;~metalloendopeptidase activity,integrin binding,calcium ion binding,protein binding,metallopeptidase activity,zinc ion binding;`proteinaceous extracellular matrix,extracellular space,endoplasmic reticulum lumen,cell surface;>sp|Q76LX8|ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1;>sp|Q76LX8-2|ATS13_HUMAN Isoform 2 of A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13Q86SQ4;Q86SQ4-3ADGRG6 AGRG6_HUMANZAdhesion G-protein coupled receptor G6;Isoform 3 of Adhesion G-protein coupled receptor G6_mitochondrion organization,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,Schwann cell differentiation,cAMP-mediated signaling,myelination in peripheral nervous system,myelination,heart trabecula formation;bG-protein coupled receptor activity,collagen binding,laminin binding,extracellular matrix binding;=intracellular,plasma membrane,integral component of membrane;>sp|Q86SQ4|AGRG6_HUMAN Adhesion G-protein coupled receptor G6 OS=Homo sapiens GN=ADGRG6 PE=1 SV=3;>sp|Q86SQ4-3|AGRG6_HUMAN Isoform 3 of Adhesion G-protein coupled receptor G6 OS=Homo sapiens GN=ADGRG6< Q86U17 SERPINA11 SPA11_HUMAN Serpin A11-negative regulation of endopeptidase activityH>sp|Q86U17|SPA11_HUMAN Serpin A11 OS=Homo sapiens GN=SERPINA11 PE=2 SV=2Q8IUK5PLXDC1 PLDX1_HUMAN"Plexin domain-containing protein 1$angiogenesis,spinal cord developmentextracellular region,cytoplasm,plasma membrane,bicellular tight junction,integral component of membrane,dendrite,neuronal cell body,receptor complex]>sp|Q8IUK5|PLDX1_HUMAN Plexin domain-containing protein 1 OS=Homo sapiens GN=PLXDC1 PE=1 SV=2Q8IZF2;Q8IZF2-2ADGRF5 AGRF5_HUMANZAdhesion G protein-coupled receptor F5;Isoform 2 of Adhesion G protein-coupled receptor F5 energy reserve metabolic process,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway,glucose homeostasis,negative regulation of macrophage activation,surfactant homeostasis,fat cell differentiation,positive regulation of phospholipid biosynthetic process;$G-protein coupled receptor activity;dplasma membrane,cell surface,integral component of membrane,cytoplasmic vesicle,apical part of cell;>sp|Q8IZF2|AGRF5_HUMAN Adhesion G protein-coupled receptor F5 OS=Homo sapiens GN=ADGRF5 PE=1 SV=3;>sp|Q8IZF2-2|AGRF5_HUMAN Isoform 2 of Adhesion G protein-coupled receptor F5 OS=Homo sapiens GN=ADGRF5Q8NBS9;Q8NBS9-2TXNDC5 TXND5_HUMAN\Thioredoxin domain-containing protein 5;Isoform 2 of Thioredoxin domain-containing protein 5protein folding,response to endoplasmic reticulum stress,negative regulation of apoptotic process,apoptotic cell clearance,neutrophil degranulation,cell redox homeostasis;5protein disulfide isomerase activity,protein binding;extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,azurophil granule lumen,lysosomal lumen,extracellular exosome;>sp|Q8NBS9|TXND5_HUMAN Thioredoxin domain-containing protein 5 OS=Homo sapiens GN=TXNDC5 PE=1 SV=2;>sp|Q8NBS9-2|TXND5_HUMAN Isoform 2 of Thioredoxin domain-containing protein 5 OS=Homo sapiens GN=TXNDC5Q92619HMHA1 HMHA1_HUMAN%Minor histocompatibility protein HA-1intracellular signal transduction,neutrophil degranulation,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction;GTPase activator activity,protein binding,metal ion bindingUextracellular region,cytosol,membrane,secretory granule lumen,azurophil granule lumen_>sp|Q92619|HMHA1_HUMAN Minor histocompatibility protein HA-1 OS=Homo sapiens GN=HMHA1 PE=1 SV=2Q93008;Q93008-1USP9X USP9X_HUMANvProbable ubiquitin carboxyl-terminal hydrolase FAF-X;Isoform 2 of Probable ubiquitin carboxyl-terminal hydrolase FAF-Xnegative regulation of transcription from RNA polymerase II promoter,neuron migration,ubiquitin-dependent protein catabolic process,chromosome segregation,mitotic nuclear division,transforming growth factor beta receptor signaling pathway,female gamete generation,protein ubiquitination,protein deubiquitination,BMP signaling pathway,cellular protein metabolic process,axon extension,cell division;cysteine-type endopeptidase activity,protein binding,cysteine-type peptidase activity,thiol-dependent ubiquitinyl hydrolase activity,co-SMAD binding;'cytoplasm,cytosol,membrane,growth cone;>sp|Q93008|USP9X_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-X OS=Homo sapiens GN=USP9X PE=1 SV=3;>sp|Q93008-1|USP9X_HUMAN Isoform 2 of Probable ubiquitin carboxyl-terminal hydrolase FAF-X OS=Homo sapiens GN=USP9X<Q93084;Q93084-2;Q93084-3;Q93084-4;Q93084-5;Q93084-6;Q93084-7ATP2A3 AT2A3_HUMANSarcoplasmic/endoplasmic reticulum calcium ATPase 3;Isoform SERCA3A of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3;Isoform SERCA3C of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3;Isoform SERCA3G of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3;Isoform SERCA3E of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3;Isoform SERCA3D of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3;Isoform SERCA3F of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3transport,calcium ion transport,ion transmembrane transport,calcium ion transmembrane transport,Requires Ontology,regulation of cardiac conduction;;;;;;Hcalcium-transporting ATPase activity,ATP binding,metal ion binding;;;;;;endoplasmic reticulum,endoplasmic reticulum membrane,integral component of membrane,sarcoplasmic reticulum,platelet dense tubular network membrane,nuclear membrane,sarcoplasmic reticulum membrane;;;;;;2;;;;;;J>sp|Q93084|AT2A3_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3 PE=1 SV=2;>sp|Q93084-2|AT2A3_HUMAN Isoform SERCA3A of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3;>sp|Q93084-3|AT2A3_HUMAN Isoform SERCA3C of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3;>sp|Q93084-4|AT2A3_HUMAN Isoform SERCA3G of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3;>sp|Q93084-5|AT2A3_HUMAN Isoform SERCA3E of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3;>sp|Q93084-6|AT2A3_HUMAN Isoform SERCA3D of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3;>sp|Q93084-7|AT2A3_HUMAN Isoform SERCA3F of Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3Q96HC4PDLIM5 PDLI5_HUMANPDZ and LIM domain protein 5regulation of synapse assembly,regulation of dendritic spine morphogenesis,cell growth involved in cardiac muscle cell development,cell-cell adhesionactin binding,protein kinase C binding,protein binding,zinc ion binding,actinin binding,protein N-terminus binding,cadherin binding involved in cell-cell adhesion|cytosol,cell-cell adherens junction,postsynaptic density,actin cytoskeleton,membrane,neuron projection,postsynaptic membraneW>sp|Q96HC4|PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5Q96KN2CNDP1 CNDP1_HUMANBeta-Ala-His dipeptidase<proteolysis,regulation of cellular protein metabolic processZcarboxypeptidase activity,metallopeptidase activity,dipeptidase activity,metal ion bindingextracellular region,cytosolR>sp|Q96KN2|CNDP1_HUMAN Beta-Ala-His dipeptidase OS=Homo sapiens GN=CNDP1 PE=1 SV=4Q9BXJ4-3C1QTNF3 C1QT3_HUMANCIsoform 3 of Complement C1q tumor necrosis factor-related protein 3w>sp|Q9BXJ4-3|C1QT3_HUMAN Isoform 3 of Complement C1q tumor necrosis factor-related protein 3 OS=Homo sapiens GN=C1QTNF3Q9C0H2;Q9C0H2-2TTYH3 TTYH3_HUMAN>Protein tweety homolog 3;Isoform 2 of Protein tweety homolog 3Pchloride transport,ion transmembrane transport,chloride transmembrane transport;Tintracellular calcium activated chloride channel activity,chloride channel activity;?plasma membrane,chloride channel complex,extracellular exosome;>sp|Q9C0H2|TTYH3_HUMAN Protein tweety homolog 3 OS=Homo sapiens GN=TTYH3 PE=1 SV=3;>sp|Q9C0H2-2|TTYH3_HUMAN Isoform 2 of Protein tweety homolog 3 OS=Homo sapiens GN=TTYH3Q9HC84MUC5B MUC5B_HUMANMucin-5Bstimulatory C-type lectin receptor signaling pathway,O-glycan processing,defense response to bacterium,regulation of macrophage activationzextracellular space,Golgi lumen,plasma membrane,intracellular membrane-bounded organelle,extracellular exosome,mucus layerB>sp|Q9HC84|MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3Q9HDC9APMAP APMAP_HUMAN,Adipocyte plasma membrane-associated protein'biological_process,biosynthetic process5arylesterase activity,strictosidine synthase activity`endoplasmic reticulum,cell surface,membrane,integral component of membrane,extracellular exosomef>sp|Q9HDC9|APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens GN=APMAP PE=1 SV=2Q9NR12;Q9NR12-2PDLIM7 PDLI7_HUMANFPDZ and LIM domain protein 7;Isoform 2 of PDZ and LIM domain protein 7ossification,receptor-mediated endocytosis,axon guidance,actin cytoskeleton organization,positive regulation of osteoblast differentiation;!protein binding,zinc ion binding;bstress fiber,ruffle,nucleus,cytosol,cell-cell adherens junction,focal adhesion,actin cytoskeleton;>sp|Q9NR12|PDLI7_HUMAN PDZ and LIM domain protein 7 OS=Homo sapiens GN=PDLIM7 PE=1 SV< =1;>sp|Q9NR12-2|PDLI7_HUMAN Isoform 2 of PDZ and LIM domain protein 7 OS=Homo sapiens GN=PDLIM7Q9NSC7 ST6GALNAC1 SIA7A_HUMAN;Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1protein glycosylation,oligosaccharide metabolic process,oligosaccharide biosynthetic process,protein N-linked glycosylation via asparagine,sialylation]alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,sialyltransferase activity-Golgi membrane,integral component of membranez>sp|Q9NSC7|SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Homo sapiens GN=ST6GALNAC1 PE=2 SV=1Q9NT22;Q9NT22-2EMILIN3 EMIL3_HUMANEMILIN-3;Isoform 2 of EMILIN-3Bproteinaceous extracellular matrix,cytoplasm,extracellular matrix;>sp|Q9NT22|EMIL3_HUMAN EMILIN-3 OS=Homo sapiens GN=EMILIN3 PE=2 SV=2;>sp|Q9NT22-2|EMIL3_HUMAN Isoform 2 of EMILIN-3 OS=Homo sapiens GN=EMILIN3Q9NY97;Q9NY97-2B3GNT2 B3GN2_HUMANN-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2;Isoform 2 of N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2axon guidance,sensory perception of smell,O-glycan processing,keratan sulfate biosynthetic process,poly-N-acetyllactosamine biosynthetic process;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity;DGolgi membrane,integral component of membrane,extracellular exosome;>sp|Q9NY97|B3GN2_HUMAN N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 OS=Homo sapiens GN=B3GNT2 PE=1 SV=2;>sp|Q9NY97-2|B3GN2_HUMAN Isoform 2 of N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 OS=Homo sapiens GN=B3GNT2Q9NZZ3;Q9NZZ3-2CHMP5 CHMP5_HUMANXCharged multivesicular body protein 5;Isoform 2 of Charged multivesicular body protein 5cell separation after cytokinesis,regulation of receptor recycling,nucleus organization,lysosome organization,mitotic metaphase plate congression,endosome to lysosome transport,regulation of centrosome duplication,protein transport,endosomal transport,viral life cycle,multivesicular body assembly,viral budding,multivesicular body sorting pathway,regulation of mitotic spindle assembly,ESCRT III complex disassembly;!protein binding,cadherin binding;8nucleus,cytosol,endosome membrane,extracellular exosome;>sp|Q9NZZ3|CHMP5_HUMAN Charged multivesicular body protein 5 OS=Homo sapiens GN=CHMP5 PE=1 SV=1;>sp|Q9NZZ3-2|CHMP5_HUMAN Isoform 2 of Charged multivesicular body protein 5 OS=Homo sapiens GN=CHMP5Q9UEW3;Q9UEW3-2MARCO MARCO_HUMAN@Macrophage receptor MARCO;Isoform 2 of Macrophage receptor MARCOpattern recognition receptor signaling pathway,receptor-mediated endocytosis,cell surface receptor signaling pathway,apoptotic cell clearance,innate immune response;vtransmembrane signaling receptor activity,scavenger receptor activity,signaling pattern recognition receptor activity;acollagen trimer,plasma membrane,integral component of plasma membrane,endocytic vesicle membrane;>sp|Q9UEW3|MARCO_HUMAN Macrophage receptor MARCO OS=Homo sapiens GN=MARCO PE=1 SV=1;>sp|Q9UEW3-2|MARCO_HUMAN Isoform 2 of Macrophage receptor MARCO OS=Homo sapiens GN=MARCOQ9UIQ6;Q9UIQ6-2;Q9UIQ6-3LNPEP LCAP_HUMANvLeucyl-cystinyl aminopeptidase;Isoform 2 of Leucyl-cystinyl aminopeptidase;Isoform 3 of Leucyl-cystinyl aminopeptidaseKprotein polyubiquitination,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,proteolysis,signal transduction,cell-cell signaling,female pregnancy,regulation of blood pressure,protein catabolic process,peptide catabolic process,SMAD protein signal transduction,membrane organization;;aminopeptidase activity,protein binding,metallopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity;;extracellular region,intracellular,lysosomal membrane,cytosol,plasma membrane,integral component of plasma membrane,membrane,cytoplasmic vesicle membrane,early endosome lumen,perinuclear region of cytoplasm;;>sp|Q9UIQ6|LCAP_HUMAN Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP PE=1 SV=3;>sp|Q9UIQ6-2|LCAP_HUMAN Isoform 2 of Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP;>sp|Q9UIQ6-3|LCAP_HUMAN Isoform 3 of Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEPEQ9UKE5;Q9UKE5-2;Q9UKE5-3;Q9UKE5-4;Q9UKE5-5;Q9UKE5-6;Q9UKE5-7;Q9UKE5-8TNIK TNIK_HUMANTRAF2 and NCK-interacting protein kinase;Isoform 2 of TRAF2 and NCK-interacting protein kinase;Isoform 3 of TRAF2 and NCK-interacting protein kinase;Isoform 4 of TRAF2 and NCK-interacting protein kinase;Isoform 5 of TRAF2 and NCK-interacting protein kinase;Isoform 6 of TRAF2 and NCK-interacting protein kinase;Isoform 7 of TRAF2 and NCK-interacting protein kinase;Isoform 8 of TRAF2 and NCK-interacting protein kinase[positive regulation of protein phosphorylation,protein phosphorylation,cytoskeleton organization,activation of JNKK activity,Wnt signaling pathway,microvillus assembly,actin cytoskeleton reorganization,intracellular signal transduction,protein autophosphorylation,regulation of dendrite morphogenesis,protein localization to plasma membrane;;;;;;;protein kinase activity,protein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,protein binding,ATP binding;;;;;;;ynucleus,nucleoplasm,cytoplasm,cytosol,cytoskeleton,apical plasma membrane,recycling endosome,extracellular exosome;;;;;;;*>sp|Q9UKE5|TNIK_HUMAN TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK PE=1 SV=1;>sp|Q9UKE5-2|TNIK_HUMAN Isoform 2 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK;>sp|Q9UKE5-3|TNIK_HUMAN Isoform 3 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK;>sp|Q9UKE5-4|TNIK_HUMAN Isoform 4 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK;>sp|Q9UKE5-5|TNIK_HUMAN Isoform 5 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK;>sp|Q9UKE5-6|TNIK_HUMAN Isoform 6 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK;>sp|Q9UKE5-7|TNIK_HUMAN Isoform 7 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK;>sp|Q9UKE5-8|TNIK_HUMAN Isoform 8 of TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIKQ9UQP3TNN TENN_HUMAN Tenascin-Nosteoblast development,cell-matrix adhesion,axonogenesis,cell growth,cell migration,negative regulation of osteoblast proliferation,negative regulation of osteoblast differentiation,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation=molecular_function,integrin binding,identical protein bindingBcellular_component,proteinaceous extracellular matrix,cell surfaceA>sp|Q9UQP3|TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2Q9Y2I8;Q9Y2I8-2WDR37 WDR37_HUMANLWD repeat-containing protein 37;Isoform 2 of WD repeat-containing protein 37/maturation of 5.8S rRNA,maturation of LSU-rRNA;3preribosome, large subunit precursor,PeBoW complex;>sp|Q9Y2I8|WDR37_HUMAN WD repeat-containing protein 37 OS=Homo sapiens GN=WDR37 PE=1 SV=2;>sp|Q9Y2I8-2|WDR37_HUMAN Isoform 2 of WD repeat-containing protein 37 OS=Homo sapiens GN=WDR37Q9Y6W5WASF2 WASF2_HUMAN0Wiskott-Aldrich syndrome protein family member 2angiogenesis,ameboidal-type cell migration,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,positive regulation of lamellipodium assembly,viral process,Rac protein signal transduction,lamellipodium assembly,actin cytoskeleton organization,actin filament-based movement,megakaryocyte development,Fc-gamma receptor signaling pathway involved in phagocytosis,vascular endothelial growth factor receptor signaling pathway,negative regulation of stress fiber assembly,lamellipodium morphogenesisYactin binding,protein binding,SH3 domain binding,protein complex binding,cadherin bindingruffle,intracellular,early endosome,cytosol,cell-cell junction,actin cytoskeleton,lamellipodium,SCAR complex,extracellular exosomej>sp|Q9Y6W5|WASF2_HUMAN Wiskott-Aldrich syndrome protein family member 2 OS=Homo sapiens GN=WASF2 PE=1 SV=3 A0A075B6K4IGLV3-10A0A075B6K4_H< UMANHCG2043238 (Fragment)[>tr|A0A075B6K4|A0A075B6K4_HUMAN HCG2043238 (Fragment) OS=Homo sapiens GN=IGLV3-10 PE=1 SV=1 A0A087WSY4IGHV4-31A0A087WSY4_HUMANProtein IGHV4-31 (Fragment)a>tr|A0A087WSY4|A0A087WSY4_HUMAN Protein IGHV4-31 (Fragment) OS=Homo sapiens GN=IGHV4-31 PE=4 SV=1HA0A087WT12;A0A087X2I2;K7EJ20;K7EKX7;K7ENB4;K7ERP4;P36969;P36969-2;R4GNE4GPX4xA0A087WT12_HUMAN;A0A087X2I2_HUMAN;K7EJ20_HUMAN;K7EKX7_HUMAN;K7ENB4_HUMAN;K7ERP4_HUMAN;GPX4_HUMAN;GPX4_HUMAN;R4GNE4_HUMANZGlutathione peroxidase;Glutathione peroxidase;Glutathione peroxidase;Glutathione peroxidase (Fragment);Glutathione peroxidase;Glutathione peroxidase (Fragment);Phospholipid hydroperoxide glutathione peroxidase, mitochondrial;Isoform Cytoplasmic of Phospholipid hydroperoxide glutathione peroxidase, mitochondrial;Glutathione peroxidase (Fragment);;;;;;phospholipid metabolic process,response to oxidative stress,multicellular organism development,lipoxygenase pathway,oxidation-reduction process,cellular oxidant detoxification;;b;;;;;;glutathione peroxidase activity,phospholipid-hydroperoxide glutathione peroxidase activity;;G;;;;;;nucleus,nucleoplasm,mitochondrion,cytosol,extracellular exosome;;tr;tr;tr;tr;tr;tr;sp;sp;tr1;1;1;1;1;1;1;;11;1;3;3;2;1;3;;7h>tr|A0A087WT12|A0A087WT12_HUMAN Glutathione peroxidase OS=Homo sapiens GN=GPX4 PE=1 SV=1;>tr|A0A087X2I2|A0A087X2I2_HUMAN Glutathione peroxidase OS=Homo sapiens GN=GPX4 PE=1 SV=1;>tr|K7EJ20|K7EJ20_HUMAN Glutathione peroxidase OS=Homo sapiens GN=GPX4 PE=1 SV=3;>tr|K7EKX7|K7EKX7_HUMAN Glutathione peroxidase (Fragment) OS=Homo sapiens GN=GPX4 PE=1 SV=3;>tr|K7ENB4|K7ENB4_HUMAN Glutathione peroxidase OS=Homo sapiens GN=GPX4 PE=1 SV=2;>tr|K7ERP4|K7ERP4_HUMAN Glutathione peroxidase (Fragment) OS=Homo sapiens GN=GPX4 PE=1 SV=1;>sp|P36969|GPX4_HUMAN Phospholipid hydroperoxide glutathione peroxidase, mitochondrial OS=Homo sapiens GN=GPX4 PE=1 SV=3;>sp|P36969-2|GPX4_HUMAN Isoform Cytoplasmic of Phospholipid hydroperoxide glutathione peroxidase, mitochondrial OS=Homo sapiens GN=GPX4;>tr|R4GNE4|R4GNE4_HUMAN Glutathione peroxidase (Fragment) OS=Homo sapiens GN=GPX4 PE=1 SV=7'A0A087WUL2;A0A087WXQ8;A0A087WY10;P49720PSMB3=A0A087WUL2_HUMAN;A0A087WXQ8_HUMAN;A0A087WY10_HUMAN;PSB3_HUMANProteasome subunit beta type-3 (Fragment);Proteasome subunit beta type-3;Proteasome subunit beta type-3;Proteasome subunit beta type-3;;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway8;;;threonine-type endopeptidase activity,protein binding;;;proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, beta-subunit complex,extracellular exosome tr;tr;tr;sp1;1;1;2>tr|A0A087WUL2|A0A087WUL2_HUMAN Proteasome subunit beta type-3 (Fragment) OS=Homo sapiens GN=PSMB3 PE=1 SV=1;>tr|A0A087WXQ8|A0A087WXQ8_HUMAN Proteasome subunit beta type-3 OS=Homo sapiens GN=PSMB3 PE=1 SV=1;>tr|A0A087WY10|A0A087WY10_HUMAN Proteasome subunit beta type-3 OS=Homo sapiens GN=PSMB3 PE=1 SV=1;>sp|P49720|PSB3_HUMAN Proteasome subunit beta type-3 OS=Hom      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijkmnopqrstuvwxyz{|}~o sapiens GN=PSMB3 PE=1 SV=2%A0A087WUS7;A0A0A0MS09;P01880;P01880-2IGHD7A0A087WUS7_HUMAN;A0A0A0MS09_HUMAN;IGHD_HUMAN;IGHD_HUMANwIg delta chain C region;Ig delta chain C region (Fragment);Ig delta chain C region;Isoform 2 of Ig delta chain C region;;phagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation, classical pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation;2;;antigen binding,immunoglobulin receptor binding;;;plasma membrane,external side of plasma membrane,integral component of membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticle;c>tr|A0A087WUS7|A0A087WUS7_HUMAN Ig delta chain C region OS=Homo sapiens GN=IGHD PE=1 SV=1;>tr|A0A0A0MS09|A0A0A0MS09_HUMAN Ig delta chain C region (Fragment) OS=Homo sapiens GN=IGHD PE=1 SV=1;>sp|P01880|IGHD_HUMAN Ig delta chain C region OS=Homo sapiens GN=IGHD PE=1 SV=2;>sp|P01880-2|IGHD_HUMAN Isoform 2 of Ig delta chain C region OS=Homo sapiens GN=IGHD A0A087X0P6 IGKV2D-29A0A087X0P6_HUMANProtein IGKV2D-29X>tr|A0A087X0P6|A0A087X0P6_HUMAN Protein IGKV2D-29 OS=Homo sapiens GN=IGKV2D-29 PE=1 SV=1A0A087X1J7;P22352GPX3A0A087X1J7_HUMAN;GPX3_HUMAN/Glutathione peroxidase;Glutathione peroxidase 3;response to reactive oxygen species,response to lipid hydroperoxide,hydrogen peroxide catabolic process,protein homotetramerization,oxidation-reduction process,cellular oxidant detoxification^;glutathione peroxidase activity,protein binding,transcription factor binding,selenium binding>tr|A0A087X1J7|A0A087X1J7_HUMAN Glutathione peroxidase OS=Homo sapiens GN=GPX3 PE=1 SV=1;>sp|P22352|GPX3_HUMAN Glutathione peroxidase 3 OS=Homo sapiens GN=GPX3 PE=1 SV=2%A0A0A0MQS9;A0A0A0MTC7;Q16363;Q16363-2LAMA49A0A0A0MQS9_HUMAN;A0A0A0MTC7_HUMAN;LAMA4_HUMAN;LAMA4_HUMANlLaminin subunit alpha-4;Laminin subunit alpha-4;Laminin subunit alpha-4;Isoform 2 of Laminin subunit alpha-4;;cell adhesion,regulation of cell adhesion,extracellular matrix organization,regulation of cell migration,regulation of embryonic development;O;;receptor binding,extracellular matrix structural constituent,protein binding;a;;extracellular region,basement membrane,basal lamina,extracellular exosome,extracellular matrix;1;1;4;^>tr|A0A0A0MQS9|A0A0A0MQS9_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=1;>tr|A0A0A0MTC7|A0A0A0MTC7_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=1;>sp|Q16363|LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4;>sp|Q16363-2|LAMA4_HUMAN Isoform 2 of Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 A0A0B4J1V2IGHV2-26 HV226_HUMAN"Immunoglobulin heavy variable 2-26c>sp|A0A0B4J1V2|HV226_HUMAN Immunoglobulin heavy variable 2-26 OS=Homo sapiens GN=IGHV2-26 PE=3 SV=1 A0A0B4J1V6IGHV3-73A0A0B4J1V6_HUMANProtein IGHV3-73 (Fragment)a>tr|A0A0B4J1V6|A0A0B4J1V6_HUMAN Protein IGHV3-73 (Fragment) OS=Homo sapiens GN=IGHV3-73 PE=1 SV=1 A0A0B4J1Y8IGLV9-49A0A0B4J1Y8_HUMANProtein IGLV9-49V>tr|A0A0B4J1Y8|A0A0B4J1Y8_HUMAN Protein IGLV9-49 OS=Homo sapiens GN=IGLV9-49 PE=1 SV=1A0A0B4J231;B9A064IGLL5A0A0B4J231_HUMAN;IGLL5_HUMAN(Immunoglobulin lambda-like polypeptide 5;phagocytosis, recognition,phagocytosis, engulfment,complement activation, classical pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation0;antigen binding,immunoglobulin receptor bindingo;external side of plasma membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticle>tr|A0A0B4J231|A0A0B4J231_HUMAN Immunoglobulin lambda-like polypeptide 5 OS=Homo sapiens GN=IGLL5 PE=1 SV=1;>sp|B9A064|IGLL5_HUMAN Immunoglobulin lambda-like polypeptide 5 OS=Homo sapiens GN=IGLL5 PE=2 SV=2A0A0C4DFP6;Q9NQ79;Q9NQ79-2CRTAC1(A0A0C4DFP6_HUMAN;CRAC1_HUMAN;CRAC1_HUMAN]Cartilage acidic protein 1;Cartilage acidic protein 1;< Isoform 2 of Cartilage acidic protein 1Y;axonal fasciculation,olfactory bulb development,negative regulation of receptor binding;%;calcium ion binding,protein binding;F;proteinaceous extracellular matrix,growth cone,extracellular exosome;>tr|A0A0C4DFP6|A0A0C4DFP6_HUMAN Cartilage acidic protein 1 OS=Homo sapiens GN=CRTAC1 PE=1 SV=1;>sp|Q9NQ79|CRAC1_HUMAN Cartilage acidic protein 1 OS=Homo sapiens GN=CRTAC1 PE=1 SV=2;>sp|Q9NQ79-2|CRAC1_HUMAN Isoform 2 of Cartilage acidic protein 1 OS=Homo sapiens GN=CRTAC1 A0A0C4DH39IGHV1-58 HV158_HUMAN"Immunoglobulin heavy variable 1-58c>sp|A0A0C4DH39|HV158_HUMAN Immunoglobulin heavy variable 1-58 OS=Homo sapiens GN=IGHV1-58 PE=3 SV=1 A0A0C4DH43A0A0C4DH43_HUMAN"Uncharacterized protein (Fragment)\>tr|A0A0C4DH43|A0A0C4DH43_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=1.A0A0G2JH68;A0A140T8Z0;O60610;O60610-2;O60610-3DIAPH1EA0A0G2JH68_HUMAN;A0A140T8Z0_HUMAN;DIAP1_HUMAN;DIAP1_HUMAN;DIAP1_HUMANProtein diaphanous homolog 1;Protein diaphanous homolog 1;Protein diaphanous homolog 1;Isoform 2 of Protein diaphanous homolog 1;Isoform 3 of Protein diaphanous homolog 1t;;cytoskeleton organization,sensory perception of sound,regulation of cell shape,actin filament polymerization,positive regulation of cell migration,regulation of microtubule-based process,protein localization to microtubule,neutrophil degranulation,regulation of release of sequestered calcium ion into cytosol,cellular response to histamine,regulation of cell motility;;e;;RNA binding,actin binding,receptor binding,protein binding,Rho GTPase binding,ion channel binding;;;;microtubule organizing center,cytosol,plasma membrane,secretory granule membrane,ruffle membrane,mitotic spindle,ficolin-1-rich granule membrane;;>tr|A0A0G2JH68|A0A0G2JH68_HUMAN Protein diaphanous homolog 1 OS=Homo sapiens GN=DIAPH1 PE=1 SV=1;>tr|A0A140T8Z0|A0A140T8Z0_HUMAN Protein diaphanous homolog 1 OS=Homo sapiens GN=DIAPH1 PE=1 SV=1;>sp|O60610|DIAP1_HUMAN Protein diaphanous homolog 1 OS=Homo sapiens GN=DIAPH1 PE=1 SV=2;>sp|O60610-2|DIAP1_HUMAN Isoform 2 of Protein diaphanous homolog 1 OS=Homo sapiens GN=DIAPH1;>sp|O60610-3|DIAP1_HUMAN Isoform 3 of Protein diaphanous homolog 1 OS=Homo sapiens GN=DIAPH1 A0A0J9YXX1A0A0J9YXX1_HUMAN\>tr|A0A0J9YXX1|A0A0J9YXX1_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=1;A0A140T902;A0A140T9C0;A0A140TA33;A0A140TA41;P22105;P22105-3TNXBYA0A140T902_HUMAN;A0A140T9C0_HUMAN;A0A140TA33_HUMAN;A0A140TA41_HUMAN;TENX_HUMAN;TENX_HUMANNTenascin-X;Tenascin-X;Tenascin-X;Tenascin-X;Tenascin-X;Isoform 4 of Tenascin-X;;;;cell adhesion,actin cytoskeleton organization,collagen fibril organization,collagen metabolic process,elastic fiber assembly;5;;;;integrin binding,protein binding,heparin binding;;;;;proteinaceous extracellular matrix,extracellular space,intracellular,extracellular exosome,fibrillar collagen trimer,extracellular matrix; 1;1;1;1;4;>tr|A0A140T902|A0A140T902_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=1;>tr|A0A140T9C0|A0A140T9C0_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=1;>tr|A0A140TA33|A0A140TA33_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=1;>tr|A0A140TA41|A0A140TA41_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=1;>sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=4;>sp|P22105-3|TENX_HUMAN Isoform 4 of Tenascin-X OS=Homo sapiens GN=TNXBA0A140T9L8;O95866-2;O95866-7C6orf25;G6B;G6B$A0A140T9L8_HUMAN;G6B_HUMAN;G6B_HUMAN=Protein G6b;Isoform A of Protein G6b;Isoform G of Protein G6b>tr|A0A140T9L8|A0A140T9L8_HUMAN Protein G6b OS=Homo sapiens GN=C6orf25 PE=1 SV=1;>sp|O95866-2|G6B_HUMAN Isoform A of Protein G6b OS=Homo sapiens GN=G6B;>sp|O95866-7|G6B_HUMAN Isoform G of Protein G6b OS=Homo sapiens GN=G6BA4D1P6;A4D1P6-2;C9J1X0WDR91$WDR91_HUMAN;WDR91_HUMAN;C9J1X0_HUMANlWD repeat-containing protein 91;Isoform 2 of WD repeat-containing protein 91;WD repeat-containing protein 912;;1>sp|A4D1P6|WDR91_HUMAN WD repeat-containing protein 91 OS=Homo sapiens GN=WDR91 PE=1 SV=2;>sp|A4D1P6-2|WDR91_HUMAN Isoform 2 of WD repeat-containing protein 91 OS=Homo sapiens GN=WDR91;>tr|C9J1X0|C9J1X0_HUMAN WD repeat-containing protein 91 OS=Homo sapiens GN=WDR91 PE=1 SV=1A6NNI4;G8JLH6;P21926CD9#A6NNI4_HUMAN;G8JLH6_HUMAN;CD9_HUMAN.Tetraspanin;Tetraspanin (Fragment);CD9 antigen;;platelet degranulation,movement of cell or subcellular component,cell adhesion,cell surface receptor signaling pathway,fusion of sperm to egg plasma membrane,brain development,negative regulation of cell proliferation,response to water deprivation,oligodendrocyte development,platelet activation,paranodal junction assembly,receptor internalization,cellular response to low-density lipoprotein particle stimulus";;integrin binding,protein binding-;;extracellular space,plasma membrane,integral component of plasma membrane,focal adhesion,external side of plasma membrane,membrane,apical plasma membrane,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,platelet alpha granule membrane,extracellular exosome,extracellular vesicle1;1;4>tr|A6NNI4|A6NNI4_HUMAN Tetraspanin OS=Homo sapiens GN=CD9 PE=1 SV=1;>tr|G8JLH6|G8JLH6_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD9 PE=1 SV=1;>sp|P21926|CD9_HUMAN CD9 antigen OS=Homo sapiens GN=CD9 PE=1 SV=42A6XND0;A6XND1;B3KWK7;H0Y485;H0Y5K2;P17936;P17936-2IGFBP3VA6XND0_HUMAN;A6XND1_HUMAN;B3KWK7_HUMAN;H0Y485_HUMAN;H0Y5K2_HUMAN;IBP3_HUMAN;IBP3_HUMANvInsulin-like growth factor binding protein 3;Insulin-like growth factor binding protein 3 isoform b;Insulin-like growth factor binding protein 3, isoform CRA_b;Insulin-like growth factor-binding protein 3 (Fragment);Insulin-like growth factor-binding protein 3 (Fragment);Insulin-like growth factor-binding protein 3;Isoform 2 of Insulin-like growth factor-binding protein 3;;;;;regulation of cell growth,osteoblast differentiation,negative regulation of protein phosphorylation,protein phosphorylation,apoptotic process,negative regulation of cell proliferation,negative regulation of signal transduction,regulation of glucose metabolic process,negative regulation of smooth muscle cell migration,regulation of apoptotic process,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,positive regulation of myoblast differentiation,negative regulation of smooth muscle cell proliferation;;;;;;fibronectin binding,protein binding,insulin-like growth factor binding,protein tyrosine phosphatase activator activity,insulin-like growth factor I binding,insulin-like growth factor II binding,metal ion binding;;;;;;extracellular region,extracellular space,nucleus,insulin-like growth factor binding protein complex,insulin-like growth factor ternary complex,extracellular exosome; 1;1;1;1;1;2;>tr|A6XND0|A6XND0_HUMAN Insulin-like growth factor binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=1;>tr|A6XND1|A6XND1_HUMAN Insulin-like growth factor binding protein 3 isoform b OS=Homo sapiens GN=IGFBP3 PE=1 SV=1;>tr|B3KWK7|B3KWK7_HUMAN Insulin-like growth factor binding protein 3, isoform CRA_b OS=Homo sapiens GN=IGFBP3 PE=1 SV=1;>tr|H0Y485|H0Y485_HUMAN Insulin-like growth factor-binding protein 3 (Fragment) OS=Homo sapiens GN=IGFBP3 PE=1 SV=1;>tr|H0Y5K2|H0Y5K2_HUMAN Insulin-like growth factor-binding protein 3 (Fragment) OS=Homo sapiens GN=IGFBP3 PE=1 SV=1;>sp|P17936|IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2;>sp|P17936-2|IBP3_HUMAN Isoform 2 of Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3B0I1T2MYO1G MYO1G_HUMANUnconventional myosin-IgT cell mediated immunity,exocytosis,cell-substrate adhesion,Fc-gamma receptor signaling pathway involved in phagocytosis,cell gliding,T cell migrationmotor activity,actin binding,calmodulin binding,ATP binding,phosphatidylinositol-4,5-bisphosphate binding,phosphatidylin< ositol-3,4,5-trisphosphate binding,phosphatidylinositol-3,4-bisphosphate bindingphagocytic cup,plasma membrane,microvillus,membrane,myosin complex,lamellipodium,filopodium,leading edge membrane,extracellular exosomeR>sp|B0I1T2|MYO1G_HUMAN Unconventional myosin-Ig OS=Homo sapiens GN=MYO1G PE=1 SV=2B1AMS2;Q14141;Q14141-2;Q14141-4SEPT60B1AMS2_HUMAN;SEPT6_HUMAN;SEPT6_HUMAN;SEPT6_HUMANLSeptin 6, isoform CRA_b;Septin-6;Isoform I of Septin-6;Isoform V of Septin-6A;cytokinesis,spermatogenesis,viral process,cell differentiation;;;protein binding,GTP binding;;;condensed chromosome kinetochore,spindle,septin ring,synaptic vesicle,midbody,septin complex,cleavage furrow,septin collar,axon terminus,sperm annulus;;1;4;;%>tr|B1AMS2|B1AMS2_HUMAN Septin 6, isoform CRA_b OS=Homo sapiens GN=SEPT6 PE=1 SV=1;>sp|Q14141|SEPT6_HUMAN Septin-6 OS=Homo sapiens GN=SEPT6 PE=1 SV=4;>sp|Q14141-2|SEPT6_HUMAN Isoform I of Septin-6 OS=Homo sapiens GN=SEPT6;>sp|Q14141-4|SEPT6_HUMAN Isoform V of Septin-6 OS=Homo sapiens GN=SEPT6(B4DKB2;P42892;P42892-2;P42892-3;P42892-4ECE18B4DKB2_HUMAN;ECE1_HUMAN;ECE1_HUMAN;ECE1_HUMAN;ECE1_HUMANEndothelin-converting enzyme 1;Endothelin-converting enzyme 1;Isoform A of Endothelin-converting enzyme 1;Isoform C of Endothelin-converting enzyme 1;Isoform D of Endothelin-converting enzyme 1;positive regulation of receptor recycling,regulation of systemic arterial blood pressure by endothelin,heart development,substance P catabolic process,bradykinin catabolic process,calcitonin catabolic process,protein processing,peptide hormone processing,regulation of vasoconstriction,endothelin maturation,hormone catabolic process,embryonic digit morphogenesis,ear development,pharyngeal system development;;;;endopeptidase activity,metalloendopeptidase activity,protein binding,zinc ion binding,peptide hormone binding,protein homodimerization activity;;;;lysosomal membrane,endosome,plasma membrane,external side of plasma membrane,membrane,integral component of membrane,intrinsic component of endosome membrane,vesicle,Weibel-Palade body,perinuclear region of cytoplasm,extracellular exosome;;;>tr|B4DKB2|B4DKB2_HUMAN Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1 PE=1 SV=1;>sp|P42892|ECE1_HUMAN Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1 PE=1 SV=2;>sp|P42892-2|ECE1_HUMAN Isoform A of Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1;>sp|P42892-3|ECE1_HUMAN Isoform C of Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1;>sp|P42892-4|ECE1_HUMAN Isoform D of Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1B7Z4G8;F5GZ08;P51693;P51693-2APLP11B7Z4G8_HUMAN;F5GZ08_HUMAN;APLP1_HUMAN;APLP1_HUMANhAmyloid-like protein 1;Amyloid-like protein 1;Amyloid-like protein 1;Isoform 2 of Amyloid-like protein 1 ;;endocytosis,apoptotic process,cell adhesion,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,nervous system development,animal organ morphogenesis,negative regulation of cAMP biosynthetic process,cellular response to norepinephrine stimulus;;;protein binding,heparin binding,alpha-2A adrenergic receptor binding,alpha-2B adrenergic receptor binding,alpha-2C adrenergic receptor binding,identical protein binding,transition metal ion binding;c;;basement membrane,plasma membrane,integral component of membrane,perinuclear region of cytoplasm;1;1;3;J>tr|B7Z4G8|B7Z4G8_HUMAN Amyloid-like protein 1 OS=Homo sapiens GN=APLP1 PE=1 SV=1;>tr|F5GZ08|F5GZ08_HUMAN Amyloid-like protein 1 OS=Homo sapiens GN=APLP1 PE=1 SV=1;>sp|P51693|APLP1_HUMAN Amyloid-like protein 1 OS=Homo sapiens GN=APLP1 PE=1 SV=3;>sp|P51693-2|APLP1_HUMAN Isoform 2 of Amyloid-like protein 1 OS=Homo sapiens GN=APLP1C9JHZ6;F8W6G1;Q9UHY1NRBP1$C9JHZ6_HUMAN;F8W6G1_HUMAN;NRBP_HUMANmNuclear receptor-binding protein (Fragment);Nuclear receptor-binding protein;Nuclear receptor-binding protein;;transcription initiation from RNA polymerase II promoter,protein phosphorylation,ER to Golgi vesicle-mediated transport,intracellular signal transductionh;;protein serine/threonine kinase activity,protein binding,ATP binding,protein homodimerization activityL;;nucleoplasm,cytosol,cell cortex,endomembrane system,membrane,lamellipodium>tr|C9JHZ6|C9JHZ6_HUMAN Nuclear receptor-binding protein (Fragment) OS=Homo sapiens GN=NRBP1 PE=1 SV=1;>tr|F8W6G1|F8W6G1_HUMAN Nuclear receptor-binding protein OS=Homo sapiens GN=NRBP1 PE=1 SV=1;>sp|Q9UHY1|NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens GN=NRBP1 PE=1 SV=1D3YTD1;G3XAG6;Q96QS1;Q96QS1-2TSPAN321D3YTD1_HUMAN;G3XAG6_HUMAN;TSN32_HUMAN;TSN32_HUMANbTetraspanin-32;Tetraspanin 32, isoform CRA_e (Fragment);Tetraspanin-32;Isoform 2 of Tetraspanin-32:;;cytoskeleton organization,cell surface receptor signaling pathway,integrin-mediated signaling pathway,cell-cell signaling,negative regulation of cell proliferation,negative regulation of myeloid dendritic cell activation,defense response to protozoan,regulation of defense response to virus,platelet aggregation;;;molecular_function;c;;intracellular,integral component of plasma membrane,cell surface,integrin alphaIIb-beta3 complex;L>tr|D3YTD1|D3YTD1_HUMAN Tetraspanin-32 OS=Homo sapiens GN=TSPAN32 PE=1 SV=1;>tr|G3XAG6|G3XAG6_HUMAN Tetraspanin 32, isoform CRA_e (Fragment) OS=Homo sapiens GN=TSPAN32 PE=1 SV=1;>sp|Q96QS1|TSN32_HUMAN Tetraspanin-32 OS=Homo sapiens GN=TSPAN32 PE=2 SV=1;>sp|Q96QS1-2|TSN32_HUMAN Isoform 2 of Tetraspanin-32 OS=Homo sapiens GN=TSPAN32:E7EX90;Q14203;Q14203-2;Q14203-3;Q14203-4;Q14203-5;Q14203-6DCTN1TE7EX90_HUMAN;DCTN1_HUMAN;DCTN1_HUMAN;DCTN1_HUMAN;DCTN1_HUMAN;DCTN1_HUMAN;DCTN1_HUMANDynactin subunit 1;Dynactin subunit 1;Isoform p135 of Dynactin subunit 1;Isoform 3 of Dynactin subunit 1;Isoform 4 of Dynactin subunit 1;Isoform 5 of Dynactin subunit 1;Isoform 6 of Dynactin subunit 1D;G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,mitotic nuclear division,nervous system development,centriole-centriole cohesion,transport along microtubule,antigen processing and presentation of exogenous peptide antigen via MHC class II,positive regulation of microtubule polymerization,melanosome transport,microtubule anchoring at centrosome,IRE1-mediated unfolded protein response,retrograde transport, endosome to Golgi,nuclear envelope disassembly,positive regulation of microtubule nucleation,ciliary basal body docking,Requires Ontology;;;;;_;motor activity,protein binding,microtubule binding,tubulin binding,dynein complex binding;;;;;;kinetochore,spindle pole,nuclear envelope,cytoplasm,centrosome,centriole,spindle,cytosol,dynactin complex,microtubule,actin cytoskeleton,membrane,dynein complex,cell leading edge,microtubule plus-end,retromer complex;;;;;tr;sp;sp;sp;sp;sp;sp1;1;;;;;1;3;;;;;7>tr|E7EX90|E7EX90_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=1;>sp|Q14203|DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3;>sp|Q14203-2|DCTN1_HUMAN Isoform p135 of Dynactin subunit 1 OS=Homo sapiens GN=DCTN1;>sp|Q14203-3|DCTN1_HUMAN Isoform 3 of Dynactin subunit 1 OS=Homo sapiens GN=DCTN1;>sp|Q14203-4|DCTN1_HUMAN Isoform 4 of Dynactin subunit 1 OS=Homo sapiens GN=DCTN1;>sp|Q14203-5|DCTN1_HUMAN Isoform 5 of Dynactin subunit 1 OS=Homo sapiens GN=DCTN1;>sp|Q14203-6|DCTN1_HUMAN Isoform 6 of Dynactin subunit 1 OS=Homo sapiens GN=DCTN1H0Y3M0;H0Y5D3;Q13371PDCL$H0Y3M0_HUMAN;H0Y5D3_HUMAN;PHLP_HUMANZPhosducin-like protein (Fragment);Phosducin-like protein (Fragment);Phosducin-like protein;;protein folding,signal transduction,visual perception,regulation of G-protein coupled receptor protein signaling pathway,queuosine biosynthetic process,negative regulation of protein refolding,heterotrimeric G-protein complex assemblyv;;receptor signaling protein activity,protein binding,protein complex binding,queuine tRNA-ribosyltransferase activity;;cytoplasm,cytosol>tr|H0Y3M0|H0Y3M0_HUMAN Phosducin-like protein (Fragment) OS=Homo sapiens GN=PDCL PE=1 SV=1;>tr|H0Y5D3|H0Y5D3_HUMAN Phosducin-like protein (Fragment) OS=Homo sapiens GN=PDCL PE=1 SV=1;>sp|Q13371|PHLP_HUMAN Phosducin-like protein OS=Homo sapiens GN=PDCL PE=1 SV=3$H3BQF1;H3BQZ9;H3BSW3;P< 07741;P07741-2APRT:H3BQF1_HUMAN;H3BQZ9_HUMAN;H3BSW3_HUMAN;APT_HUMAN;APT_HUMANAdenine phosphoribosyltransferase (Fragment);Adenine phosphoribosyltransferase;Adenine phosphoribosyltransferase;Adenine phosphoribosyltransferase;Isoform 2 of Adenine phosphoribosyltransferase;;;adenine salvage,lactation,grooming behavior,cellular response to insulin stimulus,purine-containing compound salvage,neutrophil degranulation,AMP salvage;J;;;adenine binding,adenine phosphoribosyltransferase activity,AMP binding;d;;;extracellular region,nucleoplasm,cytoplasm,cytosol,secretory granule lumen,extracellular exosome;8;1;1;2;>tr|H3BQF1|H3BQF1_HUMAN Adenine phosphoribosyltransferase (Fragment) OS=Homo sapiens GN=APRT PE=1 SV=8;>tr|H3BQZ9|H3BQZ9_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=1;>tr|H3BSW3|H3BSW3_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=1;>sp|P07741|APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2;>sp|P07741-2|APT_HUMAN Isoform 2 of Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT@C9J4W5;C9J7B5;F8WCJ1;I3L397;I3L504;P63241;P63241-2;Q6IS14;Q9GZV4;EIF5A2;EIF5A2;EIF5A2;EIF5A;EIF5A;EIF5A;EIF5A;EIF5AL1;EIF5A2pC9J4W5_HUMAN;C9J7B5_HUMAN;F8WCJ1_HUMAN;I3L397_HUMAN;I3L504_HUMAN;IF5A1_HUMAN;IF5A1_HUMAN;IF5AL_HUMAN;IF5A2_HUMANEukaryotic translation initiation factor 5A (Fragment);Eukaryotic translation initiation factor 5A;Eukaryotic translation initiation factor 5A;Eukaryotic translation initiation factor 5A (Fragment);Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1;Isoform 2 of Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1-like;Eukaryotic translation initiation factor 5A-2H;;;;;mRNA export from nucleus,translational frameshifting,protein export from nucleus,nucleocytoplasmic transport,apoptotic process,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,positive regulation of translational elongation,positive regulation of translational termination;;translational frameshifting,positive regulation of cytosolic calcium ion concentration,aging,positive regulation of cardiac muscle cell apoptotic process,protein transport,negative regulation of apoptotic process,positive regulation of translational elongation,positive regulation of translational termination,mRNA transport,positive regulation of muscle cell differentiation,cellular response to thyroid hormone stimulus,positive regulation of reactive oxygen species metabolic process;translational frameshifting,spermatogenesis,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,polyamine homeostasis,protein transport,positive regulation of translational elongation,positive regulation of translational termination,mRNA transport;;;;;RNA binding,translation elongation factor activity,protein binding,U6 snRNA binding,ribosome binding,protein N-terminus binding;;translation elongation factor activity,ribosome binding;translation elongation factor activity,protein binding,ribosome binding!;;;;;nucleus,annulate lamellae,nuclear pore,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,extracellular exosome;;nuclear pore,endoplasmic reticulum membrane,dendrite,neuronal cell body;nuclear pore,endoplasmic reticulum membrane,cytosol,intracellular membrane-bounded organelletr;tr;tr;tr;tr;sp;sp;sp;sp1;1;1;1;1;1;;2;11;1;1;8;1;2;;2;3>tr|C9J4W5|C9J4W5_HUMAN Eukaryotic translation initiation factor 5A (Fragment) OS=Homo sapiens GN=EIF5A2 PE=1 SV=1;>tr|C9J7B5|C9J7B5_HUMAN Eukaryotic translation initiation factor 5A OS=Homo sapiens GN=EIF5A2 PE=1 SV=1;>tr|F8WCJ1|F8WCJ1_HUMAN Eukaryotic translation initiation factor 5A OS=Homo sapiens GN=EIF5A2 PE=1 SV=1;>tr|I3L397|I3L397_HUMAN Eukaryotic translation initiation factor 5A (Fragment) OS=Homo sapiens GN=EIF5A PE=1 SV=8;>tr|I3L504|I3L504_HUMAN Eukaryotic translation initiation factor 5A-1 OS=Homo sapiens GN=EIF5A PE=1 SV=1;>sp|P63241|IF5A1_HUMAN Eukaryotic translation initiation factor 5A-1 OS=Homo sapiens GN=EIF5A PE=1 SV=2;>sp|P63241-2|IF5A1_HUMAN Isoform 2 of Eukaryotic translation initiation factor 5A-1 OS=Homo sapiens GN=EIF5A;>sp|Q6IS14|IF5AL_HUMAN Eukaryotic translation initiation factor 5A-1-like OS=Homo sapiens GN=EIF5AL1 PE=2 SV=2;>sp|Q9GZV4|IF5A2_HUMAN Eukaryotic translation initiation factor 5A-2 OS=Homo sapiens GN=EIF5A2 PE=1 SV=3O00139-2KIF2A KIF2A_HUMAN'Isoform 2 of Kinesin-like protein KIF2AY>sp|O00139-2|KIF2A_HUMAN Isoform 2 of Kinesin-like protein KIF2A OS=Homo sapiens GN=KIF2AO00186STXBP3 STXB3_HUMANSyntaxin-binding protein 3vesicle docking involved in exocytosis,brain development,glucose transport,protein to membrane docking,insulin secretion,response to insulin,neutrophil degranulation,negative regulation of calcium ion-dependent exocytosis,protein heterooligomerization,platelet aggregation3protein binding,syntaxin-1 binding,syntaxin bindingcytosol,plasma membrane,basolateral plasma membrane,apical plasma membrane,platelet alpha granule,specific granule,extracellular exosome,tertiary granuleU>sp|O00186|STXB3_HUMAN Syntaxin-binding protein 3 OS=Homo sapiens GN=STXBP3 PE=1 SV=2O00560-2SDCBP SDCB1_HUMANIsoform 2 of Syntenin-1I>sp|O00560-2|SDCB1_HUMAN Isoform 2 of Syntenin-1 OS=Homo sapiens GN=SDCBPO00743;O00743-2;O00743-3PPP6C PPP6_HUMANSerine/threonine-protein phosphatase 6 catalytic subunit;Isoform 2 of Serine/threonine-protein phosphatase 6 catalytic subunit;Isoform 3 of Serine/threonine-protein phosphatase 6 catalytic subunitWG1/S transition of mitotic cell cycle,protein dephosphorylation,COPII vesicle coating;;Qprotein serine/threonine phosphatase activity,protein binding,metal ion binding;;Golgi membrane,cytosol;;_>sp|O00743|PPP6_HUMAN Serine/threonine-protein phosphatase 6 catalytic subunit OS=Homo sapiens GN=PPP6C PE=1 SV=1;>sp|O00743-2|PPP6_HUMAN Isoform 2 of Serine/threonine-protein phosphatase 6 catalytic subunit OS=Homo sapiens GN=PPP6C;>sp|O00743-3|PPP6_HUMAN Isoform 3 of Serine/threonine-protein phosphatase 6 catalytic subunit OS=Homo sapiens GN=PPP6CO14818PSMA7 PSA7_HUMANProteasome subunit alpha type-7MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayOthreonine-type endopeptidase activity,protein binding,identical protein bindingproteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome,postsynapseX>sp|O14818|PSA7_HUMAN Proteasome subunit alpha type-7 OS=Homo sapiens GN=PSMA7 PE=1 SV=1O15117-2;O15117-3FYB FYB_HUMANGIsoform FYB-130 of FYN-binding protein;Isoform 3 of FYN-binding protein>sp|O15117-2|FYB_HUMAN Isoform FYB-130 of FYN-binding protein OS=Homo sapiens GN=FYB;>sp|O15117-3|FYB_HUMAN Isoform 3 of FYN-binding protein OS=Homo sapiens GN=FYBO15204;O15204-2ADAMDEC1 ADEC1_HUMAN ADAM DEC1;Isoform 2 of ADAM DEC1Aproteolysis,immune response,negative regulation of cell adhesion;< /metalloendopeptidase activity,zinc ion binding;(cellular_component,extracellular region;>sp|O15204|ADEC1_HUMAN ADAM DEC1 OS=Homo sapiens GN=ADAMDEC1 PE=1 SV=2;>sp|O15204-2|ADEC1_HUMAN Isoform 2 of ADAM DEC1 OS=Homo sapiens GN=ADAMDEC1O15400;O15400-2STX7 STX7_HUMAN"Syntaxin-7;Isoform 2 of Syntaxin-7,positive regulation of T cell mediated cytotoxicity,intracellular protein transport,vesicle fusion,vesicle docking,organelle localization,regulation of molecular function,organelle assembly,positive regulation of receptor localization to synapse,regulation of protein localization to plasma membrane;jSNARE binding,SNAP receptor activity,protein binding,chloride channel inhibitor activity,syntaxin binding;3immunological synapse,lysosome,lysosomal membrane,endosome,early endosome,late endosome,plasma membrane,integral component of membrane,endocytic vesicle,SNARE complex,early endosome membrane,vesicle,azurophil granule,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,tertiary granule;>sp|O15400|STX7_HUMAN Syntaxin-7 OS=Homo sapiens GN=STX7 PE=1 SV=4;>sp|O15400-2|STX7_HUMAN Isoform 2 of Syntaxin-7 OS=Homo sapiens GN=STX7O43707ACTN4 ACTN4_HUMANAlpha-actinin-4response to hypoxia,platelet degranulation,protein transport,vesicle transport along actin filament,positive regulation of cell migration,positive regulation of sodium:proton antiporter activity,peroxisome proliferator activated receptor signaling pathway,regulation of apoptotic process,retinoic acid receptor signaling pathway,positive regulation of pinocytosis,actin filament bundle assembly,negative regulation of cellular component movement,positive regulation of cellular component movement,bicellular tight junction assembly,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,protein localization to bicellular tight junction,regulation of nucleic acid-templated transcriptionRNA polymerase II regulatory region sequence-specific DNA binding,nucleoside binding,RNA binding,actin binding,integrin binding,calcium ion binding,protein binding,ligand-dependent nuclear receptor transcription coactivator activity,chromatin DNA binding,nuclear hormone receptor binding,protein homodimerization activity,retinoic acid receptor binding,ion channel binding,protein N-terminus binding,actin filament bindingsstress fiber,extracellular region,extracellular space,intracellular,nucleus,cytoplasm,cytosol,brush border,cell-cell junction,focal adhesion,nuclear body,Z disc,intracellular ribonucleoprotein complex,cortical cytoskeleton,platelet alpha granule lumen,pseudopodium,neuron projection,protein complex,perinuclear region of cytoplasm,extracellular exosome,actin cytoskeletonI>sp|O43707|ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2O60493;O60493-2;O60493-4SNX3 SNX3_HUMANISorting nexin-3;Isoform 2 of Sorting nexin-3;Isoform 4 of Sorting nexin-3response to bacterium,membrane invagination,positive regulation of neuron projection development,protein transport,Wnt signaling pathway,protein deubiquitination,protein to membrane docking,regulation of Wnt signaling pathway,negative regulation of protein catabolic process,negative regulation of viral entry into host cell,negative regulation of phagocytosis,negative regulation of protein transport,intralumenal vesicle formation,negative regulation of early endosome to late endosome transport;;protein binding,phosphatidylinositol-5-phosphate binding,protein phosphatase binding,phosphatidylinositol-3-phosphate binding,phosphatidylinositol-4-phosphate binding,phosphatidylinositol-3,5-bisphosphate binding;;cytoplasm,early endosome,cytosol,endosome membrane,extrinsic component of membrane,clathrin-coated vesicle,early endosome membrane,early phagosome,extracellular exosome,retromer complex;;>sp|O60493|SNX3_HUMAN Sorting nexin-3 OS=Homo sapiens GN=SNX3 PE=1 SV=3;>sp|O60493-2|SNX3_HUMAN Isoform 2 of Sorting nexin-3 OS=Homo sapiens GN=SNX3;>sp|O60493-4|SNX3_HUMAN Isoform 4 of Sorting nexin-3 OS=Homo sapiens GN=SNX3O95497VNN1 VNN1_HUMAN Pantetheinaseacute inflammatory response,chronic inflammatory response,C-terminal protein lipidation,movement of cell or subcellular component,inflammatory response,response to oxidative stress,pantothenate metabolic process,single organismal cell-cell adhesion,positive regulation of T cell differentiation in thymus,neutrophil degranulation,innate immune response,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwaypantetheine hydrolase activityextracellular region,plasma membrane,integral component of membrane,anchored component of membrane,azurophil granule membrane,extracellular exosomeE>sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2P00338LDHA LDHA_HUMANL-lactate dehydrogenase A chain\response to hypoxia,lactate metabolic process,pyruvate metabolic process,glycolytic process,response to nutrient,response to glucose,NAD metabolic process,response to drug,response to hydrogen peroxide,positive regulation of apoptotic process,response to estrogen,post-embryonic animal organ development,response to cAMP,oxidation-reduction processvL-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,cadherin binding,NAD binding.nucleus,cytosol,membrane,extracellular exosomeW>sp|P00338|LDHA_HUMAN L-lactate dehydrogenase A chain OS=Homo sapiens GN=LDHA PE=1 SV=2P00739HPR HPTR_HUMANHaptoglobin-related proteinreceptor-mediated endocytosishemoglobin bindingjextracellular region,spherical high-density lipoprotein particle,extracellular exosome,blood microparticleR>sp|P00739|HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=2 SV=2P00918CA2 CAH2_HUMANCarbonic anhydrase 2kidney development,morphogenesis of an epithelium,one-carbon metabolic process,response to pH,response to zinc ion,carbon dioxide transport,bicarbonate transport,positive regulation of synaptic transmission, GABAergic,positive regulation of cellular pH reduction,angiotensin-activated signaling pathway,odontogenesis of dentin-containing tooth,response to estrogen,regulation of anion transport,positive regulation of osteoclast differentiation,positive regulation of bone resorption,secretion,response to steroid hormone,regulation of intracellular pH,cellular response to fluid shear stress,positive regulation of dipeptide transmembrane transport,regulation of chloride transportUarylesterase activity,carbonate dehydratase activity,protein binding,zinc ion bindingextracellular space,cytoplasm,cytosol,plasma membrane,microvillus,basolateral plasma membrane,axon,myelin sheath,apical part of cell,extracellular exosomeK>sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2P01019AGT ANGT_HUMANAngiotensinogen9regulation of cell growth,positive regulation of cytokine production,kidney development,blood vessel remodeling,angiotensin maturation,regulation of blood volume by renin-angiotensin,renin-angiotensin regulation of aldosterone production,regulation of renal output by angiotensin,regulation of heart rate,regulation of blood vessel size by renin-angiotensin,renal system process,angiotensin-mediated drinking behavior,positive regulation of extracellular matrix constituent secretion,cellular sodium ion homeostasis,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,phospholipase C-activating G-protein coupled receptor signaling pathway,activation of phospholipase C activity,positive regulation of cytosolic calcium ion concentration,nitric oxide mediated signal transduction,cell-cell signaling,female pregnancy,aging,regulation of blood pressure,positive regulation of activation of JAK2 kinase activity,positive regulation of endothelial cell migration,positive regulation of cardiac muscle hypertrophy,positive regulation of cardiac muscle cell apoptotic process,positive regulation of macrophage derived foam cell differentiation,positive regulation of< cholesterol esterification,negative regulation of endopeptidase activity,regulation of norepinephrine secretion,positive regulation of phosphatidylinositol 3-kinase signaling,artery smooth muscle contraction,response to muscle activity involved in regulation of muscle adaptation,negative regulation of angiogenesis,regulation of vasoconstriction,negative regulation of cell growth,positive regulation of cellular protein metabolic process,positive regulation of superoxide anion generation,positive regulation of NAD(P)H oxidase activity,negative regulation of tissue remodeling,low-density lipoprotein particle remodeling,catenin import into nucleus,regulation of renal sodium excretion,positive regulation of renal sodium excretion,regulation of cell proliferation,vasodilation,positive regulation of nitric oxide biosynthetic process,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of blood pressure,positive regulation of transcription, DNA-templated,fibroblast proliferation,positive regulation of fibroblast proliferation,regulation of long-term neuronal synaptic plasticity,smooth muscle cell proliferation,cytokine secretion,positive regulation of inflammatory response,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of NF-kappaB transcription factor activity,negative regulation of neurotrophin TRK receptor signaling pathway,stress-activated MAPK cascade,regulation of calcium ion transport,regulation of transmission of nerve impulse,cell growth involved in cardiac muscle cell development,positive regulation of protein tyrosine kinase activity,ERK1 and ERK2 cascade,uterine smooth muscle contraction,cellular response to mechanical stimulus,positive regulation of branching involved in ureteric bud morphogenesis,regulation of extracellular matrix assembly,positive regulation of L-arginine import into cell,positive regulation of gap junction assembly,regulation of cardiac conduction,positive regulation of vascular smooth muscle cell proliferation,positive regulation of vascular associated smooth muscle cell migration,positive regulation of L-lysine import into cell,positive regulation of reactive oxygen species metabolic process,positive regulation of extrinsic apoptotic signaling pathway,positive regulation of glucose import in response to insulin stimulusserine-type endopeptidase inhibitor activity,hormone activity,protein binding,growth factor activity,type 1 angiotensin receptor binding,type 2 angiotensin receptor bindingZextracellular region,extracellular space,cytosol,extracellular exosome,blood microparticleF>sp|P01019|ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1P01344;P01344-3IGF2 IGF2_HUMANHInsulin-like growth factor II;Isoform 3 of Insulin-like growth factor IIskeletal system development,ossification,positive regulation of protein phosphorylation,platelet degranulation,glucose metabolic process,regulation of gene expression by genetic imprinting,regulation of transcription, DNA-templated,multicellular organism development,positive regulation of cell proliferation,insulin receptor signaling pathway,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,positive regulation of activated T cell proliferation,positive regulation of catalytic activity,positive regulation of MAPK cascade,cellular protein metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of mitotic nuclear division,positive regulation of insulin receptor signaling pathway,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of cell division,positive regulation of protein kinase B signaling,positive regulation of protein serine/threonine kinase activity,positive regulation of receptor activity,positive regulation of glycogen (starch) synthase activity;insulin receptor binding,insulin-like growth factor receptor binding,hormone activity,protein binding,growth factor activity,receptor activator activity,protein serine/threonine kinase activator activity;lextracellular region,extracellular space,plasma membrane,platelet alpha granule lumen,extracellular exosome;>sp|P01344|IGF2_HUMAN Insulin-like growth factor II OS=Homo sapiens GN=IGF2 PE=1 SV=1;>sp|P01344-3|IGF2_HUMAN Isoform 3 of Insulin-like growth factor II OS=Homo sapiens GN=IGF2P01718IGLV3-27 LV327_HUMAN#Immunoglobulin lambda variable 3-27`>sp|P01718|LV327_HUMAN Immunoglobulin lambda variable 3-27 OS=Homo sapiens GN=IGLV3-27 PE=1 SV=2P01860IGHG3 IGHG3_HUMANIg gamma-3 chain C regionMretina homeostasis,proteolysis,phagocytosis, recognition,phagocytosis, engulfment,complement activation,complement activation, classical pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activationS>sp|P01860|IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sapiens GN=IGHG3 PE=1 SV=2P02765AHSG FETUA_HUMANAlpha-2-HS-glycoproteinskeletal system development,ossification,platelet degranulation,pinocytosis,acute-phase response,negative regulation of endopeptidase activity,regulation of bone mineralization,negative regulation of bone mineralization,negative regulation of phosphorylation,neutrophil degranulation,negative regulation of insulin receptor signaling pathway,regulation of inflammatory response,positive regulation of phagocytosis,negative regulation of biomineral tissue developmentiendopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,kinase inhibitor activityextracellular region,extracellular space,Golgi apparatus,extracellular matrix,platelet alpha granule lumen,secretory granule lumen,extracellular exosome,blood microparticleP>sp|P02765|FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1P02774;P02774-3GC VTDB_HUMAN@Vitamin D-binding protein;Isoform 3 of Vitamin D-binding protein.vitamin D metabolic process,vitamin transport;Oactin binding,vitamin D binding,vitamin transporter activity,calcidiol binding;kextracellular region,extracellular space,cytosol,lysosomal lumen,extracellular exosome,blood microparticle;>sp|P02774|VTDB_HUMAN Vitamin D-binding protein OS=Homo sapiens GN=GC PE=1 SV=1;>sp|P02774-3|VTDB_HUMAN Isoform 3 of Vitamin D-binding protein OS=Homo sapiens GN=GCP02775PPBP CXCL7_HUMANPlatelet basic proteinleukocyte migration involved in inflammatory response,platelet degranulation,inflammatory response,immune response,G-protein coupled receptor signaling pathway,glucose transport,neutrophil chemotaxis,response to lipopolysaccharide,regulation of cell proliferation,defense response to bacterium,neutrophil degranulation,positive regulation of cell division,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis,glucose transmembrane transporttglucose transmembrane transporter activity,chemokine activity,growth factor activity,CXCR chemokine receptor binding\extracellular region,extracellular space,platelet alpha granule lumen,tertiary granule lumenO>sp|P02775|CXCL7_HUMAN Platelet basic protein OS=Homo sapiens GN=PPBP PE=1 SV=3P02776PF4 PLF4_HUMANPlatelet factor 4platelet degranulation,inflammatory response,immune response,G-protein coupled receptor signaling pathway,positive regulation of gene expression,positive regulation of macrophage derived foam cell differentiation,negative regulation of angiogenesis,cytokine-mediated signaling pathway,platelet activation,leukocyte chemotaxis,positive regulation of cAMP metabolic process,response to lipopolysaccharide,positive regulation of tumor necrosis factor production,regulation of cell proliferation,positive regulation of cAMP-mediated signaling,negative regulation of MHC class II biosynthetic process,positive regulation of macrophage differentiation,negative regulation of megakaryocyte differentiation,negative regulation of cytolysis,positive regulation of transcription from RNA polymerase II promoter,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis,negative regulation of extrinsic apoptotic signaling < pathway in absence of ligandSprotein binding,chemokine activity,heparin binding,CXCR3 chemokine receptor bindingEextracellular region,extracellular space,platelet alpha granule lumenH>sp|P02776|PLF4_HUMAN Platelet factor 4 OS=Homo sapiens GN=PF4 PE=1 SV=2P03950ANG ANGI_HUMAN Angiogenin-angiogenesis,ovarian follicle development,oocyte maturation,response to hypoxia,response to yeast,placenta development,positive regulation of endothelial cell proliferation,diacylglycerol biosynthetic process,cell communication,activation of phospholipase C activity,rRNA transcription,response to hormone,cell migration,negative regulation of translation,antibacterial humoral response,antifungal humoral response,actin filament polymerization,activation of protein kinase B activity,activation of phospholipase A2 activity,adherens junction organization,positive regulation of phosphorylation,homeostatic process,innate immune response,negative regulation of smooth muscle cell proliferation,positive regulation of protein secretion,defense response to Gram-positive bacterium,RNA phosphodiester bond hydrolysisDNA binding,actin binding,endonuclease activity,ribonuclease activity,receptor binding,copper ion binding,protein binding,heparin binding,rRNA binding,peptide binding,protein homodimerization activityextracellular region,basal lamina,extracellular space,nucleus,nucleolus,growth cone,cytoplasmic vesicle,angiogenin-PRI complex,neuronal cell body,extracellular exosomeA>sp|P03950|ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1P04004VTN VTNC_HUMAN Vitronectinreceptor-mediated endocytosis,immune response,cell adhesion,cell-matrix adhesion,positive regulation of cell-substrate adhesion,negative regulation of endopeptidase activity,positive regulation of smooth muscle cell migration,negative regulation of blood coagulation,extracellular matrix organization,regulation of complement activation,positive regulation of vascular endothelial growth factor receptor signaling pathway,positive regulation of protein binding,cell adhesion mediated by integrin,endodermal cell differentiation,positive regulation of receptor-mediated endocytosis,oligodendrocyte differentiation,positive regulation of peptidyl-tyrosine phosphorylation,protein polymerization,smooth muscle cell-matrix adhesion,positive regulation of wound healing,liver regenerationscavenger receptor activity,integrin binding,protein binding,collagen binding,heparin binding,polysaccharide binding,identical protein binding,extracellular matrix bindingextracellular region,basement membrane,extracellular space,endoplasmic reticulum,Golgi lumen,extracellular matrix,intracellular membrane-bounded organelle,rough endoplasmic reticulum lumen,extracellular exosome,alphav-beta3 integrin-vitronectin complex,blood microparticleB>sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens GN=VTN PE=1 SV=1P04217A1BG A1BG_HUMANAlpha-1B-glycoproteinBplatelet degranulation,biological_process,neutrophil degranulationmolecular_functionextracellular region,extracellular space,platelet alpha granule lumen,secretory granule lumen,extracellular exosome,blood microparticle,ficolin-1-rich granule lumenM>sp|P04217|A1BG_HUMAN Alpha-1B-glycoprotein OS=Homo sapiens GN=A1BG PE=1 SV=4P04264KRT1 K2C1_HUMANKeratin, type II cytoskeletal 1complement activation, lectin pathway,retina homeostasis,response to oxidative stress,keratinization,fibrinolysis,neutrophil degranulation,regulation of angiogenesis,negative regulation of inflammatory response,establishment of skin barrier,cornificationSreceptor activity,structural molecule activity,protein binding,carbohydrate bindingextracellular region,extracellular space,nucleus,cytosol,cytoskeleton,plasma membrane,membrane,extracellular matrix,keratin filament,extracellular exosome,blood microparticle,ficolin-1-rich granule lumenW>sp|P04264|K2C1_HUMAN Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6P05062ALDOB ALDOB_HUMAN Fructose-bisphosphate aldolase BFfructose metabolic process,gluconeogenesis,glycolytic process,NADH oxidation,fructose 1,6-bisphosphate metabolic process,positive regulation of ATPase activity,canonical glycolysis,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,vacuolar proton-transporting V-type ATPase complex assemblyfructose-bisphosphate aldolase activity,protein binding,cytoskeletal protein binding,identical protein binding,ATPase binding,fructose-1-phosphate aldolase activity,fructose bindingPmicrotubule organizing center,cytosol,centriolar satellite,extracellular exosomeZ>sp|P05062|ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2P05164;P05164-2;P05164-3MPO PERM_HUMANLMyeloperoxidase;Isoform H14 of Myeloperoxidase;Isoform H7 of MyeloperoxidaseCresponse to yeast,hypochlorous acid biosynthetic process,respiratory burst involved in defense response,defense response,response to oxidative stress,aging,response to mechanical stimulus,removal of superoxide radicals,response to food,response to lipopolysaccharide,low-density lipoprotein particle remodeling,defense response to bacterium,hydrogen peroxide catabolic process,negative regulation of apoptotic process,neutrophil degranulation,negative regulation of growth of symbiont in host,defense response to fungus,oxidation-reduction process,response to gold nanoparticle;;Vchromatin binding,peroxidase activity,heparin binding,heme binding,metal ion binding;;extracellular region,extracellular space,nucleus,mitochondrion,lysosome,secretory granule,azurophil granule lumen,azurophil granule,intracellular membrane-bounded organelle,extracellular exosome;;>sp|P05164|PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1;>sp|P05164-2|PERM_HUMAN Isoform H14 of Myeloperoxidase OS=Homo sapiens GN=MPO;>sp|P05164-3|PERM_HUMAN Isoform H7 of Myeloperoxidase OS=Homo sapiens GN=MPOP05546SERPIND1 HEP2_HUMANHeparin cofactor 2Zchemotaxis,blood coagulation,bioluminescence,negative regulation of endopeptidase activity]endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity,heparin bindingN>sp|P05546|HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3NO60814;P57053;P58876;P62807;Q5QNW6;Q5QNW6-2;Q93079;Q99877;Q99879;Q99880;U3KQK0iHIST1H2BK;H2BFS;HIST1H2BD;HIST1H2BC;HIST2H2BF;HIST2H2BF;HIST1H2BH;HIST1H2BN;HIST1H2BM;HIST1H2BL;HIST1H2BNH2B1K_HUMAN;H2BFS_HUMAN;H2B1D_HUMAN;H2B1C_HUMAN;H2B2F_HUMAN;H2B2F_HUMAN;H2B1H_HUMAN;H2B1N_HUMAN;H2B1M_HUMAN;H2B1L_HUMAN;U3KQK0_HUMANHistone H2B type 1-K;Histone H2B type F-S;Histone H2B type 1-D;Histone H2B type 1-C/E/F/G/I;Histone H2B type 2-F;Isoform 2 of Histone H2B type 2-F;Histone H2B type 1-H;Histone H2B type 1-N;Histone H2B type 1-M;Histone H2B type 1-L;Histone H2Binnate immune response in mucosa,nucleosome assembly,protein ubiquitination,antibacterial humoral response,defense response to Gram-positive bacterium;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,substantia nigra development,defense response to Gram-positive bacterium;nucleosome assembly,protein ubiquitination;innate immune response in mucosa,nucleosome assembly,protein ubiquitination,antibacterial humoral response,defense response to Gram-positive bacterium;nucleosome assembly;;nucleosome assembly,protein ubiquitination;nucleosome assembly,protein ubiquitination;nucleosome assembly,protein ubiquitination;nucleosome assembly,protein ubiquitination;molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;6nucleosome,extracellular space,nucleus,nucleoplasm,cytosol;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol;nucleosome,nucleus,nucleopl< asm,cytosol,extracellular exosome;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome; sp;sp;sp;sp;sp;sp;sp;sp;sp;sp;tr1;1;1;1;1;;1;1;1;1;13;2;2;4;3;;3;3;3;3;1>sp|O60814|H2B1K_HUMAN Histone H2B type 1-K OS=Homo sapiens GN=HIST1H2BK PE=1 SV=3;>sp|P57053|H2BFS_HUMAN Histone H2B type F-S OS=Homo sapiens GN=H2BFS PE=1 SV=2;>sp|P58876|H2B1D_HUMAN Histone H2B type 1-D OS=Homo sapiens GN=HIST1H2BD PE=1 SV=2;>sp|P62807|H2B1C_HUMAN Histone H2B type 1-C/E/F/G/I OS=Homo sapiens GN=HIST1H2BC PE=1 SV=4;>sp|Q5QNW6|H2B2F_HUMAN Histone H2B type 2-F OS=Homo sapiens GN=HIST2H2BF PE=1 SV=3;>sp|Q5QNW6-2|H2B2F_HUMAN Isoform 2 of Histone H2B type 2-F OS=Homo sapiens GN=HIST2H2BF;>sp|Q93079|H2B1H_HUMAN Histone H2B type 1-H OS=Homo sapiens GN=HIST1H2BH PE=1 SV=3;>sp|Q99877|H2B1N_HUMAN Histone H2B type 1-N OS=Homo sapiens GN=HIST1H2BN PE=1 SV=3;>sp|Q99879|H2B1M_HUMAN Histone H2B type 1-M OS=Homo sapiens GN=HIST1H2BM PE=1 SV=3;>sp|Q99880|H2B1L_HUMAN Histone H2B type 1-L OS=Homo sapiens GN=HIST1H2BL PE=1 SV=3;>tr|U3KQK0|U3KQK0_HUMAN Histone H2B OS=Homo sapiens GN=HIST1H2BN PE=1 SV=1P07384CAPN1 CAN1_HUMANCalpain-1 catalytic subunitproteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly,receptor catabolic process,neutrophil degranulation,regulation of catalytic activity,mammary gland involution,cornification,self proteolysisqendopeptidase activity,calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein bindingextracellular region,mitochondrion,lysosome,cytosol,plasma membrane,focal adhesion,membrane,extracellular exosome,ficolin-1-rich granule lumenT>sp|P07384|CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens GN=CAPN1 PE=1 SV=1P07900;P07900-2HSP90AA1 HS90A_HUMANLHeat shock protein HSP 90-alpha;Isoform 2 of Heat shock protein HSP 90-alphaG2/M transition of mitotic cell cycle,mitochondrial transport,receptor-mediated endocytosis,response to unfolded protein,telomere maintenance via telomerase,signal transduction,response to heat,response to cold,peptidyl-tyrosine phosphorylation,regulation of protein ubiquitination,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,protein refolding,regulation of protein complex assembly,neutrophil degranulation,protein unfolding,protein import into mitochondrial outer membrane,positive regulation of nitric oxide biosynthetic process,response to antibiotic,vascular endothelial growth factor receptor signaling pathway,protein stabilization,regulation of nitric-oxide synthase activity,chaperone-mediated protein complex assembly,positive regulation of telomerase activity,chaperone-mediated autophagy,ciliary basal body docking,regulation of cellular response to heat,telomerase holoenzyme complex assembly;nucleotide binding,RNA binding,protein tyrosine kinase activity,protein binding,ATP binding,ATPase activity,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,identical protein binding,protein homodimerization activity,histone deacetylase binding,GTPase binding,unfolded protein binding,DNA polymerase binding,protein tyrosine kinase binding;extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,ruffle membrane,secretory granule lumen,melanosome,lysosomal lumen,myelin sheath,extracellular exosome,endocytic vesicle lumen,ficolin-1-rich granule lumen;>sp|P07900|HS90A_HUMAN Heat shock protein HSP 90-alpha OS=Homo sapiens GN=HSP90AA1 PE=1 SV=5;>sp|P07900-2|HS90A_HUMAN Isoform 2 of Heat shock protein HSP 90-alpha OS=Homo sapiens GN=HSP90AA1P08311CTSG CATG_HUMAN Cathepsin Gangiotensin maturation,protein phosphorylation,proteolysis,immune response,protein processing,antimicrobial humoral response,antibacterial humoral response,extracellular matrix disassembly,neutrophil degranulation,negative regulation of growth of symbiont in host,cellular protein metabolic process,positive regulation of immune response,defense response to Gram-negative bacterium,defense response to fungus,neutrophil mediated killing of gram-positive bacterium,cellular response to lipopolysaccharidetserine-type endopeptidase activity,protein binding,heparin binding,peptidase activity,serine-type peptidase activityextracellular region,extracellular space,nucleus,plasma membrane,cell surface,cytoplasmic stress granule,secretory granule,azurophil granule lumen,extracellular exosome,extracellular matrixC>sp|P08311|CATG_HUMAN Cathepsin G OS=Homo sapiens GN=CTSG PE=1 SV=2P08514ITGA2B ITA2B_HUMANIntegrin alpha-IIbplatelet degranulation,positive regulation of leukocyte migration,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,extracellular matrix organization,platelet aggregationkprotein binding,identical protein binding,metal ion binding,extracellular matrix binding,fibrinogen bindingplasma membrane,integral component of plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,platelet alpha granule membrane,extracellular exosome,blood microparticleM>sp|P08514|ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3P08571CD14 CD14_HUMAN%Monocyte differentiation antigen CD14toll-like receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,receptor-mediated endocytosis,phagocytosis,apoptotic process,inflammatory response,cell surface receptor signaling pathway,I-kappaB kinase/NF-kappaB signaling,response to heat,lipopolysaccharide-mediated signaling pathway,response to magnesium ion,positive regulation of type I interferon production,positive regulation of interferon-gamma production,positive regulation of tumor necrosis factor production,negative regulation of MyD88-independent toll-like receptor signaling pathway,toll-like receptor 4 signaling pathway,response to tumor necrosis factor,TRIF-dependent toll-like receptor signaling pathway,toll-like receptor TLR1:TLR2 signaling pathway,toll-like receptor TLR6:TLR2 signaling pathway,neutrophil degranulation,innate immune response,response to ethanol,positive regulation of endocytosis,positive regulation of cytokine secretion,response to electrical stimulus,necroptotic process,cellular response to lipopolysaccharide,cellular response to lipoteichoic acid,cellular response to diacyl bacterial lipopeptide,cellular response to triacyl bacterial lipopeptide,apoptotic signaling pathway~lipopolysaccharide binding,opsonin receptor activity,protein binding,peptidoglycan receptor activity,lipoteichoic acid bindingextracellular region,extracellular space,Golgi apparatus,plasma membrane,endosome membrane,secretory granule membrane,anchored component of external side of plasma membrane,membrane raft,lipopolysaccharide receptor complex,extracellular exosome]>sp|P08571|CD14_HUMAN Monocyte differentiation antigen CD14 OS=Homo sapiens GN=CD14 PE=1 SV=2P08648ITGA5 ITA5_HUMANIntegrin alpha-5angiogenesis,cell-substrate junction assembly,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,integrin-mediated signaling pathway,memory,positive regulation of cell-substrate adhesion,extracellular matrix organization,positive regulation of cell migration,positive regulation of vascular endothelial growth factor receptor signaling pathway,cell-substrate adhesion,cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,heterotypic cell-cell adhesion,wound healing, spreading of epidermal cells,endodermal cell differentiation,viral entry into host cell,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive regulation of sprouting angiogenesis,negative regulation of anoikisvirus receptor< activity,epidermal growth factor receptor binding,platelet-derived growth factor receptor binding,integrin binding,protein binding,vascular endothelial growth factor receptor 2 binding,metal ion bindingruffle,endoplasmic reticulum,Golgi apparatus,plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,cytoplasmic vesicle,synapse,alphav-beta3 integrin-vitronectin complex,cell-cell junction,ruffle membraneI>sp|P08648|ITA5_HUMAN Integrin alpha-5 OS=Homo sapiens GN=ITGA5 PE=1 SV=2 F5GY03;P09486SPARCF5GY03_HUMAN;SPRC_HUMANSPARC (Fragment);SPARC;ossification,negative regulation of endothelial cell proliferation,platelet degranulation,receptor-mediated endocytosis,signal transduction,heart development,response to gravity,response to lead ion,positive regulation of endothelial cell migration,negative regulation of angiogenesis,regulation of cell morphogenesis,extracellular matrix organization,lung development,response to lipopolysaccharide,response to L-ascorbic acid,response to cytokine,wound healing,response to peptide hormone,pigmentation,response to ethanol,response to cadmium ion,inner ear development,response to glucocorticoid,response to cAMP,response to calcium ion,bone development,cellular response to growth factor stimulusR;calcium ion binding,protein binding,collagen binding,extracellular matrix binding;extracellular region,basement membrane,extracellular space,cytoplasm,cell surface,nuclear matrix,platelet alpha granule,platelet alpha granule membrane,platelet alpha granule lumen,endocytic vesicle lumen,mitochondrion,plasma membrane>tr|F5GY03|F5GY03_HUMAN SPARC (Fragment) OS=Homo sapiens GN=SPARC PE=1 SV=1;>sp|P09486|SPRC_HUMAN SPARC OS=Homo sapiens GN=SPARC PE=1 SV=1!P09496;P09496-2;P09496-3;P09496-4CLTA CLCA_HUMANClathrin light chain A;Isoform Non-brain of Clathrin light chain A;Isoform 3 of Clathrin light chain A;Isoform 4 of Clathrin light chain A intracellular protein transport,receptor-mediated endocytosis,microtubule-based movement,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,cell division,membrane organization,clathrin-dependent endocytosis;;;omolecular_function,structural molecule activity,protein binding,clathrin heavy chain binding,peptide binding;;;spindle,cytosol,plasma membrane,membrane,clathrin coat,clathrin vesicle coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,cytoplasmic vesicle,trans-Golgi network membrane,endolysosome membrane,clathrin complex;;;R>sp|P09496|CLCA_HUMAN Clathrin light chain A OS=Homo sapiens GN=CLTA PE=1 SV=1;>sp|P09496-2|CLCA_HUMAN Isoform Non-brain of Clathrin light chain A OS=Homo sapiens GN=CLTA;>sp|P09496-3|CLCA_HUMAN Isoform 3 of Clathrin light chain A OS=Homo sapiens GN=CLTA;>sp|P09496-4|CLCA_HUMAN Isoform 4 of Clathrin light chain A OS=Homo sapiens GN=CLTAP09497;P09497-2CLTB CLCB_HUMANBClathrin light chain B;Isoform Non-brain of Clathrin light chain BUintracellular protein transport,membrane organization,clathrin-dependent endocytosis;Zstructural molecule activity,protein binding,clathrin heavy chain binding,peptide binding;trans-Golgi network,cytosol,plasma membrane,clathrin coat,clathrin vesicle coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,intracellular membrane-bounded organelle,ciliary membrane;>sp|P09497|CLCB_HUMAN Clathrin light chain B OS=Homo sapiens GN=CLTB PE=1 SV=1;>sp|P09497-2|CLCB_HUMAN Isoform Non-brain of Clathrin light chain B OS=Homo sapiens GN=CLTBP11142HSPA8 HSP7C_HUMAN!Heat shock cognate 71 kDa protein2mRNA splicing, via spliceosome,transcription, DNA-templated,protein folding,protein methylation,response to unfolded protein,neurotransmitter secretion,cellular response to starvation,viral process,regulation of protein stability,protein refolding,regulation of protein complex assembly,neutrophil degranulation,regulation of mRNA stability,positive regulation by host of viral genome replication,negative regulation of transcription, DNA-templated,ATP metabolic process,positive regulation of mRNA splicing, via spliceosome,chaperone mediated protein folding requiring cofactor,regulation of cell cycle,membrane organization,regulation of protein complex stability,chaperone-mediated autophagy,late endosomal microautophagy,protein targeting to lysosome involved in chaperone-mediated autophagy,chaperone-mediated protein transport involved in chaperone-mediated autophagy,clathrin coat disassembly,regulation of cellular response to heat,negative regulation of fibril organization,regulation of protein import,chaperone-mediated autophagy translocation complex disassemblyNG-protein coupled receptor binding,phosphatidylserine binding,RNA binding,protein binding,ATP binding,ATPase activity,enzyme binding,MHC class II protein complex binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,cadherin binding,unfolded protein binding,C3HC4-type RING finger domain bindingPrp19 complex,extracellular region,extracellular space,intracellular,nucleus,nucleoplasm,spliceosomal complex,nucleolus,lysosomal membrane,late endosome,cytosol,plasma membrane,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular matrix,secretory granule lumen,melanosome,lysosomal lumen,myelin sheath,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,extracellular exosome,blood microparticle,lumenal side of lysosomal membrane,presynapse,ficolin-1-rich granule lumen,ubiquitin ligase complex[>sp|P11142|HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1P11597CETP CETP_HUMAN"Cholesteryl ester transfer protein[triglyceride metabolic process,lipid transport,receptor-mediated endocytosis,cholesterol metabolic process,negative regulation of macrophage derived foam cell differentiation,regulation of cholesterol efflux,phospholipid transport,cholesterol transport,triglyceride transport,very-low-density lipoprotein particle remodeling,low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,lipoprotein metabolic process,cholesterol homeostasis,reverse cholesterol transport,phosphatidylcholine metabolic process,lipid homeostasis,phospholipid homeostasis,triglyceride homeostasislipid transporter activity,phospholipid transporter activity,lipid binding,cholesterol binding,cholesterol transporter activity,triglyceride binding,phosphatidylcholine bindinghextracellular region,extracellular space,vesicle,high-density lipoprotein particle,extracellular exosomeZ>sp|P11597|CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2P11678EPX PERE_HUMANEosinophil peroxidaseXdefense response to nematode,response to oxidative stress,negative regulation of interleukin-10 production,negative regulation of interleukin-5 production,positive regulation of interleukin-4 production,hydrogen peroxide catabolic process,neutrophil degranulation,oxidation-reduction process,eosinophil migration,cellular oxidant detoxification2peroxidase activity,heme binding,metal ion bindingVextracellular region,extracellular space,secretory granule lumen,extracellular exosomeL>sp|P11678|PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2P11908;P11908-2PRPS2 PRPS2_HUMANVRibose-phosphate pyrophosphokinase 2;Isoform 2 of Ribose-phosphate pyrophosphokinase 25-phosphoribose 1-diphosphate biosynthetic process,nucleobase-containing compound metabolic process,AMP biosynthetic process,phosphorylation,animal organ regeneration;magnesium ion binding,ribose phosphate diphosphokinase activity,protein binding,ATP binding,AMP binding,kinase activity,GDP binding,carbohydrate binding,identical protein binding,protein homodimerization activity,ADP binding;Oribose phosphate diphosphokinase complex,protein complex,extracellular exosome;>sp|P11908|PRPS2_HUMAN Ribose-phosphate pyrophosphokinase 2 OS=Homo sapiens GN=PRPS2 PE=1 SV=2;>sp|P11908-2|PRPS2_HUMAN Isoform 2 of Ribose-phosphate pyrophosphokinase 2 OS=Homo sapiens GN=PRPS2P12110-2*Isoform 2C2A < of Collagen alpha-2(VI) chain]>sp|P12110-2|CO6A2_HUMAN Isoform 2C2A of Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2P13473;P13473-2;P13473-3LAMP2 LAMP2_HUMANLysosome-associated membrane glycoprotein 2;Isoform LAMP-2B of Lysosome-associated membrane glycoprotein 2;Isoform LAMP-2C of Lysosome-associated membrane glycoprotein 2jplatelet degranulation,protein targeting,cellular response to starvation,protein import,regulation of protein stability,neutrophil degranulation,muscle cell cellular homeostasis,protein stabilization,chaperone-mediated autophagy,protein targeting to lysosome involved in chaperone-mediated autophagy,autophagosome maturation,lysosomal protein catabolic process;;@protein binding,enzyme binding,protein domain specific binding;;[extracellular space,lysosome,lysosomal membrane,late endosome,plasma membrane,membrane,phagocytic vesicle membrane,platelet dense granule membrane,late endosome membrane,azurophil granule membrane,lysosomal lumen,autolysosome,extracellular exosome,integral component of autophagosome membrane,ficolin-1-rich granule membrane,membrane microdomain;;G>sp|P13473|LAMP2_HUMAN Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens GN=LAMP2 PE=1 SV=2;>sp|P13473-2|LAMP2_HUMAN Isoform LAMP-2B of Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens GN=LAMP2;>sp|P13473-3|LAMP2_HUMAN Isoform LAMP-2C of Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens GN=LAMP2P13598ICAM2 ICAM2_HUMAN!Intercellular adhesion molecule 2stimulatory C-type lectin receptor signaling pathway,cell adhesion,single organismal cell-cell adhesion,extracellular matrix organization,regulation of immune responseintegrin bindingkuropod,plasma membrane,integral component of plasma membrane,membrane,cleavage furrow,extracellular exosome[>sp|P13598|ICAM2_HUMAN Intercellular adhesion molecule 2 OS=Homo sapiens GN=ICAM2 PE=1 SV=2P13645KRT10 K1C10_HUMANKeratin, type I cytoskeletal 109keratinocyte differentiation,keratinization,cornification#structural constituent of epidermisbextracellular space,nucleus,cytoplasm,cytosol,intermediate filament,membrane,extracellular exosomeY>sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6P13746;P13746-2 1A11_HUMAN~HLA class I histocompatibility antigen, A-11 alpha chain;Isoform 2 of HLA class I histocompatibility antigen, A-11 alpha chain>sp|P13746|1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>sp|P13746-2|1A11_HUMAN Isoform 2 of HLA class I histocompatibility antigen, A-11 alpha chain OS=Homo sapiens GN=HLA-AP14151;P14151-2SELL LYAM1_HUMAN"L-selectin;Isoform 2 of L-selectinicell adhesion,response to ATP,neutrophil degranulation,regulation of immune response,leukocyte migration;protease binding,protein binding,heparin binding,carbohydrate binding,glycosphingolipid binding,cell adhesion molecule binding;rplasma membrane,integral component of plasma membrane,external side of plasma membrane,secretory granule membrane;>sp|P14151|LYAM1_HUMAN L-selectin OS=Homo sapiens GN=SELL PE=1 SV=2;>sp|P14151-2|LYAM1_HUMAN Isoform 2 of L-selectin OS=Homo sapiens GN=SELLP16150SPN LEUK_HUMAN Leukosialin~response to protozoan,negative regulation of type IV hypersensitivity,positive regulation of protein phosphorylation,chemotaxis,immune response,cellular defense response,negative regulation of cell adhesion,establishment or maintenance of cell polarity,signal transduction,cell surface receptor signaling pathway,T cell costimulation,positive regulation of T cell proliferation,negative regulation of T cell proliferation,positive regulation of tumor necrosis factor biosynthetic process,defense response to bacterium,negative thymic T cell selection,regulation of defense response to virus,leukocyte migration,apoptotic signaling pathway)transmembrane signaling receptor activityuropod,basement membrane,extracellular space,plasma membrane,integral component of plasma membrane,external side of plasma membrane,cell surface,membrane,extracellular exosomeB>sp|P16150|LEUK_HUMAN Leukosialin OS=Homo sapiens GN=SPN PE=1 SV=1P20340;P20340-2RAB6A RAB6A_HUMANBRas-related protein Rab-6A;Isoform 2 of Ras-related protein Rab-6Azprotein targeting to Golgi,retrograde vesicle-mediated transport, Golgi to ER,small GTPase mediated signal transduction,viral process,peptidyl-cysteine methylation,antigen processing and presentation,protein localization to Golgi apparatus,early endosome to Golgi transport,neutrophil degranulation,membrane organization,minus-end-directed organelle transport along microtubule;]GTPase activity,protein binding,GTP binding,protein domain specific binding,myosin V binding;Golgi membrane,endoplasmic reticulum membrane,Golgi apparatus,trans-Golgi network,cytosol,plasma membrane,membrane,secretory granule membrane,cytoplasmic vesicle,trans-Golgi network membrane,extracellular exosome,endosome to plasma membrane transport vesicle;>sp|P20340|RAB6A_HUMAN Ras-related protein Rab-6A OS=Homo sapiens GN=RAB6A PE=1 SV=3;>sp|P20340-2|RAB6A_HUMAN Isoform 2 of Ras-related protein Rab-6A OS=Homo sapiens GN=RAB6AP21399ACO1 ACOC_HUMANCytoplasmic aconitate hydratasetricarboxylic acid cycle,citrate metabolic process,regulation of translation,cellular iron ion homeostasis,post-embryonic development,response to iron(II) ion,intestinal absorptionRNA binding,aconitate hydratase activity,protein binding,iron-responsive element binding,metal ion binding,4 iron, 4 sulfur cluster binding[cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,extracellular exosomeW>sp|P21399|ACOC_HUMAN Cytoplasmic aconitate hydratase OS=Homo sapiens GN=ACO1 PE=1 SV=3P21589;P21589-2NT5E 5NTD_HUMAN,5'-nucleotidase;Isoform 2 of 5'-nucleotidase purine nucleotide catabolic process,AMP catabolic process,DNA metabolic process,leukocyte cell-cell adhesion,dephosphorylation,NAD metabolic process,adenosine biosynthetic process,pyrimidine nucleoside catabolic process,negative regulation of inflammatory response;>nucleotide binding,5'-nucleotidase activity,metal ion binding;ccytosol,plasma membrane,cell surface,membrane,anchored component of membrane,extracellular exosome;>sp|P21589|5NTD_HUMAN 5'-nucleotidase OS=Homo sapiens GN=NT5E PE=1 SV=1;>sp|P21589-2|5NTD_HUMAN Isoform 2 of 5'-nucleotidase OS=Homo sapiens GN=NT5E!P22303;P22303-2;P22303-3;P22303-4ACHE ACES_HUMANzAcetylcholinesterase;Isoform H of Acetylcholinesterase;Isoform 4 of Acetylcholinesterase;Isoform R of Acetylcholinesterase{acetylcholine catabolic process in synaptic cleft,regulation of receptor recycling,osteoblast development,DNA replication,acetylcholine catabolic process,phosphatidylcholine biosynthetic process,cell adhesion,nervous system development,synapse assembly,muscle organ development,cell proliferation,response to wounding,receptor internalization,negative regulation of synaptic transmission, cholinergic,neurotransmitter biosynthetic process,amyloid precursor protein metabolic process,neurotransmitter receptor biosynthetic process,positive regulation of protein secretion,protein tetramerization,retina development in camera-type eye;;;beta-amyloid binding,acetylcholinesterase activity,cholinesterase activity,protein binding,collagen binding,hydrolase activity,serine hydrolase activity,acetylcholine binding,protein homodimerization activity,laminin binding,protein self-association;;;extracellular region,basal lamina,extracellular space,nucleus,Golgi apparatus,plasma membrane,cell surface,membrane,cell junction,anchored component of membrane,neuromuscular junction,synaptic cleft,synapse,perinuclear region of cytoplasm;;;B>sp|P22303|ACES_HUMAN Acetylcholinesterase OS=Homo sapiens GN=ACHE PE=1 SV=1;>sp|P22303-2|ACES_HUMAN Isoform H of Acetylcholinesterase OS=Homo sapiens GN=ACHE;>sp|P22303-3|ACES_HUMAN Isoform 4 of Acetylcholinesterase OS=Homo sapiens GN=ACHE;>sp|P22303-4|ACES_HUMAN Isoform R of Acetylcholinesterase OS=Homo sapiens GN=ACHEP17612;P17612-2PRKACA KAPCA_HUMANxcAMP-dependent protein kinase catalytic subunit alp< ha;Isoform 2 of cAMP-dependent protein kinase catalytic subunit alphaG2/M transition of mitotic cell cycle,mesoderm formation,neural tube closure,regulation of heart rate,stimulatory C-type lectin receptor signaling pathway,renal water homeostasis,mRNA processing,protein phosphorylation,blood coagulation,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of macroautophagy,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,activation of protein kinase A activity,cellular response to heat,calcium-mediated signaling using intracellular calcium source,lipoprotein metabolic process,regulation of protein binding,regulation of osteoblast differentiation,protein autophosphorylation,positive regulation of protein export from nucleus,sperm capacitation,modulation of synaptic transmission,regulation of cytosolic calcium ion concentration,regulation of cardiac muscle contraction,regulation of ryanodine-sensitive calcium-release channel activity,regulation of proteasomal protein catabolic process,regulation of protein processing,positive regulation of cell cycle arrest,cellular response to glucose stimulus,cellular response to parathyroid hormone stimulus,cellular response to glucagon stimulus,cellular response to epinephrine stimulus,cell communication by electrical coupling involved in cardiac conduction,ciliary basal body docking,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,regulation of cardiac conduction,regulation of bicellular tight junction assembly;protein serine/threonine kinase activity,cAMP-dependent protein kinase activity,protein serine/threonine/tyrosine kinase activity,protein binding,ATP binding,protein kinase binding,ubiquitin protein ligase binding,protein kinase A regulatory subunit binding;Jacrosomal vesicle,nucleus,nucleoplasm,cytoplasm,mitochondrion,centrosome,cytosol,cAMP-dependent protein kinase complex,nuclear speck,neuromuscular junction,calcium channel complex,sperm flagellum,dendritic spine,plasma membrane raft,intercellular bridge,perinuclear region of cytoplasm,extracellular exosome,ciliary base,membrane;>sp|P17612|KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens GN=PRKACA PE=1 SV=2;>sp|P17612-2|KAPCA_HUMAN Isoform 2 of cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens GN=PRKACAP23142 Fibulin-1negative regulation of protein phosphorylation,negative regulation of cell adhesion,embryo implantation,positive regulation of peptidase activity,viral process,extracellular matrix organization,negative regulation of ERK1 and ERK2 cascade,blood coagulation, fibrin clot formation,negative regulation of substrate adhesion-dependent cell spreading,negative regulation of cell motility,negative regulation of stem cell proliferation,integrin-mediated signaling pathwayfibronectin binding,extracellular matrix structural constituent,calcium ion binding,protein C-terminus binding,peptidase activator activity,protein complex binding,identical protein binding,fibrinogen bindingextracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular exosome,elastic fiber,fibrinogen complex,extracellular matrixC>sp|P23142|FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN1 PE=1 SV=4P23381;P23381-2WARS SYWC_HUMANVTryptophan--tRNA ligase, cytoplasmic;Isoform 2 of Tryptophan--tRNA ligase, cytoplasmicangiogenesis,translation,tRNA aminoacylation for protein translation,tryptophanyl-tRNA aminoacylation,negative regulation of cell proliferation,regulation of angiogenesis;<tryptophan-tRNA ligase activity,protein binding,ATP binding;0nucleus,cytoplasm,cytosol,extracellular exosome;>sp|P23381|SYWC_HUMAN Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens GN=WARS PE=1 SV=2;>sp|P23381-2|SYWC_HUMAN Isoform 2 of Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens GN=WARSP23526;P23526-2AHCY SAHH_HUMAN:Adenosylhomocysteinase;Isoform 2 of Adenosylhomocysteinase+sulfur amino acid metabolic process,response to hypoxia,chronic inflammatory response to antigenic stimulus,one-carbon metabolic process,response to nutrient,S-adenosylhomocysteine catabolic process,methylation,S-adenosylmethionine cycle,circadian sleep/wake cycle,homocysteine biosynthetic process;padenosylhomocysteinase activity,protein binding,adenyl nucleotide binding,identical protein binding,NAD binding;Cnucleus,cytosol,melanosome,neuron projection,extracellular exosome;>sp|P23526|SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4;>sp|P23526-2|SAHH_HUMAN Isoform 2 of Adenosylhomocysteinase OS=Homo sapiens GN=AHCYP27105STOM STOM_HUMAN,Erythrocyte band 7 integral membrane proteinneutrophil degranulation,positive regulation by host of viral genome replication,protein homooligomerization,positive regulation of protein targeting to membrane,regulation of acid-sensing ion channel activityHprotein binding,protein homodimerization activity,RNA polymerase bindingEextracellular space,mitochondrion,endoplasmic reticulum,cytosol,cytoskeleton,plasma membrane,integral component of plasma membrane,membrane,vesicle,azurophil granule membrane,specific granule membrane,melanosome,membrane raft,perinuclear region of cytoplasm,extracellular exosome,tertiary granule membrane,blood microparticled>sp|P27105|STOM_HUMAN Erythrocyte band 7 integral membrane protein OS=Homo sapiens GN=STOM PE=1 SV=3P27348YWHAQ 1433T_HUMAN14-3-3 protein thetaBprotein targeting,small GTPase mediated signal transduction,substantia nigra development,negative regulation of ion transmembrane transport,negative regulation of transcription, DNA-templated,membrane organization,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathwayprotein binding,protein C-terminus binding,protein domain specific binding,ion channel binding,protein N-terminus binding,14-3-3 protein bindingzcytoplasm,mitochondrion,cytosol,focal adhesion,membrane,cytoplasmic vesicle membrane,protein complex,extracellular exosomeN>sp|P27348|1433T_HUMAN 14-3-3 protein theta OS=Homo sapiens GN=YWHAQ PE=1 SV=1P27918CFP PROP_HUMAN Properdinimmune response,complement activation,complement activation, alternative pathway,regulation of complement activation,protein O-linked fucosylation,defense response to bacterium,neutrophil degranulationextracellular region,extracellular space,endoplasmic reticulum lumen,specific granule lumen,tertiary granule lumen,extracellular matrix@>sp|P27918|PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2P28907CD38 CD38_HUMAN1ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1response to hypoxia,signal transduction,positive regulation of cytosolic calcium ion concentration,female pregnancy,NAD metabolic process,positive regulation of cell growth,positive regulation of B cell proliferation,positive regulation of insulin secretion,response to estradiol,response to retinoic acid,response to progesterone,response to hydroperoxide,response to drug,negative regulation of apoptotic process,negative regulation of bone resorption,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of vasoconstriction,B cell receptor signaling pathway,long term synaptic depression,response to interleukin-1,apoptotic signaling pathwayNAD+ nucleosidase activity,transferase activity,phosphorus-oxygen lyase activity,NAD(P)+ nucleosidase activity,Requires Ontologybnucleus,plasma membrane,cell surface,membrane,integral component of membrane,extracellular exosomei>sp|P28907|CD38_HUMAN ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 OS=Homo sapiens GN=CD38 PE=1 SV=2P30101PDIA3 PDIA3_HUMANProtein disulfide-isomerase A3antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,protein folding,proteolysis,protein import into nucleus,protein retention in ER lumen,signal transduction,protein folding in endoplasmic reticul< um,response to endoplasmic reticulum stress,cell redox homeostasis,oxidation-reduction process,positive regulation of extrinsic apoptotic signaling pathwayRNA binding,protein disulfide isomerase activity,cysteine-type endopeptidase activity,phospholipase C activity,protein binding,disulfide oxidoreductase activitynucleus,endoplasmic reticulum,endoplasmic reticulum lumen,focal adhesion,cell surface,melanosome,myelin sheath,phagocytic vesicle,recycling endosome membrane,extracellular exosomeX>sp|P30101|PDIA3_HUMAN Protein disulfide-isomerase A3 OS=Homo sapiens GN=PDIA3 PE=1 SV=4'A0A140T9M0;A0A140T9U0;A0A140T9W2;P04222HLA-C=A0A140T9M0_HUMAN;A0A140T9U0_HUMAN;A0A140T9W2_HUMAN;1C03_HUMANHLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-3 alpha chain;;;>tr|A0A140T9M0|A0A140T9M0_HUMAN HLA class I histocompatibility antigen, Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1;>tr|A0A140T9U0|A0A140T9U0_HUMAN HLA class I histocompatibility antigen, Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1;>tr|A0A140T9W2|A0A140T9W2_HUMAN HLA class I histocompatibility antigen, Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1;>sp|P04222|1C03_HUMAN HLA class I histocompatibility antigen, Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2P30613;P30613-2PKLR KPYR_HUMAN;Pyruvate kinase PKLR;Isoform L-type of Pyruvate kinase PKLR6response to hypoxia,glycolytic process,ATP biosynthetic process,response to nutrient,response to heat,response to glucose,response to lithium ion,cellular response to insulin stimulus,response to ATP,pyruvate biosynthetic process,response to cAMP,canonical glycolysis,cellular response to epinephrine stimulus;amagnesium ion binding,pyruvate kinase activity,ATP binding,kinase activity,potassium ion binding;(cytoplasm,cytosol,extracellular exosome;>sp|P30613|KPYR_HUMAN Pyruvate kinase PKLR OS=Homo sapiens GN=PKLR PE=1 SV=2;>sp|P30613-2|KPYR_HUMAN Isoform L-type of Pyruvate kinase PKLR OS=Homo sapiens GN=PKLRP31146CORO1A COR1A_HUMAN Coronin-1A\phagolysosome assembly,calcium ion transport,phagocytosis,movement of cell or subcellular component,actin filament organization,regulation of cell shape,actin cytoskeleton organization,positive regulation of cell migration,leukocyte chemotaxis,negative regulation of vesicle fusion,cell-substrate adhesion,uropod organization,regulation of actin cytoskeleton organization,nerve growth factor signaling pathway,positive regulation of T cell proliferation,T cell homeostasis,natural killer cell degranulation,negative regulation of neuron apoptotic process,innate immune response,homeostasis of number of cells within a tissue,positive chemotaxis,negative regulation of actin nucleation,regulation of release of sequestered calcium ion into cytosol,early endosome to recycling endosome transport,cellular response to interleukin-4,immunological synapse formationRNA binding,actin binding,actin monomer binding,protein binding,protein C-terminus binding,cytoskeletal protein binding,myosin heavy chain binding,protein homodimerization activity,phosphatidylinositol 3-kinase binding,actin filament binding immunological synapse,phagocytic cup,cytoplasm,early endosome,cytosol,actin filament,plasma membrane,cell-cell junction,membrane,lamellipodium,axon,phagocytic vesicle membrane,cortical actin cytoskeleton,protein complex,phagocytic vesicle,extracellular exosome,nucleusE>sp|P31146|COR1A_HUMAN Coronin-1A OS=Homo sapiens GN=CORO1A PE=1 SV=4P31150GDI1 GDIA_HUMAN$Rab GDP dissociation inhibitor alphaGsignal transduction,protein transport,Rab protein signal transduction,positive regulation of GTPase activity,negative regulation of axonogenesis,regulation of small GTPase mediated signal transduction,response to calcium ion,oxidation-reduction process,membrane organization,negative regulation of protein targeting to membraneGDP-dissociation inhibitor activity,Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,Rab GTPase bindingYcytoplasm,Golgi apparatus,cytosol,midbody,neuron projection,myelin sheath,protein complex\>sp|P31150|GDIA_HUMAN Rab GDP dissociation inhibitor alpha OS=Homo sapiens GN=GDI1 PE=1 SV=2P32119PRDX2 PRDX2_HUMANPeroxiredoxin-2%response to reactive oxygen species,response to oxidative stress,removal of superoxide radicals,cellular response to oxidative stress,hydrogen peroxide catabolic process,regulation of apoptotic process,negative regulation of apoptotic process,cell redox homeostasis,oxidation-reduction process4thioredoxin peroxidase activity,antioxidant activityI>sp|P32119|PRDX2_HUMAN Peroxiredoxin-2 OS=Homo sapiens GN=PRDX2 PE=1 SV=5P33176KIF5B KINH_HUMANKinesin-1 heavy chainmicrotubule-based movement,cytoplasm organization,axon guidance,cytoskeleton-dependent intracellular transport,positive regulation of vesicle fusion,positive regulation of synaptic transmission, GABAergic,stress granule disassembly,positive regulation of insulin secretion involved in cellular response to glucose stimulus,regulation of membrane potential,positive regulation of potassium ion transport,vesicle transport along microtubule,centrosome localization,plus-end-directed vesicle transport along microtubule,positive regulation of establishment of protein localization to plasma membrane,positive regulation of intracellular protein transport,positive regulation of voltage-gated sodium channel activitymicrotubule motor activity,protein binding,ATP binding,microtubule binding,JUN kinase binding,ATP-dependent microtubule motor activity, plus-end-directed,cadherin bindingmicrotubule organizing center,cytosol,kinesin complex,microtubule,membrane,endocytic vesicle,vesicle,ciliary rootlet,axonal growth cone,perinuclear region of cytoplasmN>sp|P33176|KINH_HUMAN Kinesin-1 heavy chain OS=Homo sapiens GN=KIF5B PE=1 SV=1P33908MAN1A1 MA1A1_HUMAN1Mannosyl-oligosaccharide 1,2-alpha-mannosidase IAJprotein glycosylation,N-glycan processing,Golgi apparatus mannose trimming`mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,calcium ion binding,mannosidase activityGolgi membrane,endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cytosol,membrane,integral component of membrane,extracellular exosomel>sp|P33908|MA1A1_HUMAN Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA OS=Homo sapiens GN=MAN1A1 PE=1 SV=3 P41222;Q5SQ11PTGDSPTGDS_HUMAN;Q5SQ11_HUMANDProstaglandin-H2 D-isomerase;Prostaglandin-H2 D-isomerase (Fragment)tprostaglandin biosynthetic process,transport,cyclooxygenase pathway,regulation of circadian sleep/wake cycle, sleep;kprostaglandin-D synthase activity,transporter activity,retinoid binding,fatty acid binding,protein binding;extracellular region,extracellular space,endoplasmic reticulum membrane,rough endoplasmic reticulum,Golgi apparatus,nuclear membrane,perinuclear region of cytoplasm,extracellular exosome;>sp|P41222|PTGDS_HUMAN Prostaglandin-H2 D-isomerase OS=Homo sapiens GN=PTGDS PE=1 SV=1;>tr|Q5SQ11|Q5SQ11_HUMAN Prostaglandin-H2 D-isomerase (Fragment) OS=Homo sapiens GN=PTGDS PE=1 SV=1P41240CSK CSK_HUMANTyrosine-protein kinase CSKregulation of cytokine production,adaptive immune response,protein phosphorylation,transmembrane receptor protein tyrosine kinase signaling pathway,epidermal growth factor receptor signaling pathway,central nervous system development,brain development,negative regulation of cell proliferation,negative regulation of low-density lipoprotein particle clearance,cell differentiation,T cell costimulation,negative regulation of interleukin-6 production,negative regulation of kinase activity,adherens junction organization,peptidyl-tyrosine autophosphorylation,regulation of cell proliferation,negative regulation of Golgi to plasma membrane protein transport,positive regulation of MAP kinase activity,innate immune response,negative regulation of bone resorption,oligodendrocyte differentiation,negative regulation of phago< cytosis,T cell receptor signaling pathway,regulation of Fc receptor mediated stimulatory signaling pathway,negative regulation of ERK1 and ERK2 cascade,cellular response to peptide hormone stimulus>protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,receptor binding,protein binding,ATP binding,protein C-terminus binding,kinase activity,protein phosphatase binding,protein kinase A catalytic subunit binding,identical protein binding,metal ion binding,proline-rich region bindingcytoplasm,cytosol,plasma membrane,cell-cell junction,extrinsic component of cytoplasmic side of plasma membrane,membrane raft,extracellular exosomeQ>sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1P50148GNAQ GNAQ_HUMAN5Guanine nucleotide-binding protein G(q) subunit alphaskeletal system development,action potential,negative regulation of protein kinase activity,adenylate cyclase-activating G-protein coupled receptor signaling pathway,activation of phospholipase C activity,G-protein coupled acetylcholine receptor signaling pathway,glutamate receptor signaling pathway,heart development,blood coagulation,phototransduction, visible light,entrainment of circadian clock,post-embryonic development,neuron remodeling,forebrain neuron development,platelet activation,regulation of catenin import into nucleus,maternal behavior,embryonic digit morphogenesis,positive regulation of GTPase activity,regulation of melanocyte differentiation,developmental pigmentation,protein stabilization,phospholipase C-activating dopamine receptor signaling pathwayGTPase activity,signal transducer activity,GTPase activator activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,type 2A serotonin receptor binding,metal ion bindingphotoreceptor outer segment,cytoplasm,lysosomal membrane,heterotrimeric G-protein complex,plasma membrane,dendrite,nuclear membrane,cell body,extracellular exosomem>sp|P50148|GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit alpha OS=Homo sapiens GN=GNAQ PE=1 SV=4P50395GDI2 GDIB_HUMAN#Rab GDP dissociation inhibitor betasignal transduction,small GTPase mediated signal transduction,protein transport,neutrophil degranulation,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,oxidation-reduction process,membrane organizationRNA binding,Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,small GTPase bindingextracellular region,cytoplasm,Golgi apparatus,cytosol,focal adhesion,membrane,vesicle,secretory granule lumen,azurophil granule lumen,myelin sheath,extracellular exosome[>sp|P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=Homo sapiens GN=GDI2 PE=1 SV=2P50995;P50995-2ANXA11 ANX11_HUMAN$Annexin A11;Isoform 2 of Annexin A11>phagocytosis,cell cycle,cell division,response to calcium ion;RNA binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylethanolamine binding,MHC class II protein complex binding,S100 protein binding,calcium-dependent protein binding;nuclear envelope,nucleoplasm,cytoplasm,spindle,cytosol,membrane,midbody,melanosome,specific granule,azurophil granule,phagocytic vesicle,extracellular exosome;>sp|P50995|ANX11_HUMAN Annexin A11 OS=Homo sapiens GN=ANXA11 PE=1 SV=1;>sp|P50995-2|ANX11_HUMAN Isoform 2 of Annexin A11 OS=Homo sapiens GN=ANXA11P51884LUM LUM_HUMANLumicanvisual perception,response to organic cyclic compound,keratan sulfate biosynthetic process,extracellular matrix organization,collagen fibril organization,positive regulation of transforming growth factor beta1 production,keratan sulfate catabolic process,positive regulation of transcription from RNA polymerase II promoter,cartilage development,response to growth factor,axonogenesisLextracellular matrix structural constituent,protein binding,collagen bindingextracellular region,proteinaceous extracellular matrix,fibrillar collagen trimer,extracellular space,Golgi lumen,lysosomal lumen,extracellular exosome,extracellular matrix=>sp|P51884|LUM_HUMAN Lumican OS=Homo sapiens GN=LUM PE=1 SV=2P52907CAPZA1 CAZA1_HUMAN'F-actin-capping protein subunit alpha-1protein complex assembly,movement of cell or subcellular component,blood coagulation,innate immune response,barbed-end actin filament capping.actin binding,protein binding,cadherin bindingextracellular region,cytosol,cytoskeleton,F-actin capping protein complex,actin cytoskeleton,extracellular exosome,WASH complexb>sp|P52907|CAZA1_HUMAN F-actin-capping protein subunit alpha-1 OS=Homo sapiens GN=CAPZA1 PE=1 SV=3 M0R0Y2;P54920NAPAM0R0Y2_HUMAN;SNAA_HUMAN$Alpha-soluble NSF attachment proteinr;intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,brain development,regulation of synaptic vesicle priming,neuron differentiation,synaptic transmission, glutamatergic,SNARE complex disassembly,apical protein localization,COPII vesicle coating,membrane fusiono;SNARE binding,soluble NSF attachment protein activity,protein binding,syntaxin binding,protein complex binding;Golgi membrane,vacuolar membrane,cytosol,membrane,SNARE complex,terminal bouton,myelin sheath,synaptobrevin 2-SNAP-25-syntaxin-1a complex,extracellular exosome>tr|M0R0Y2|M0R0Y2_HUMAN Alpha-soluble NSF attachment protein OS=Homo sapiens GN=NAPA PE=1 SV=1;>sp|P54920|SNAA_HUMAN Alpha-soluble NSF attachment protein OS=Homo sapiens GN=NAPA PE=1 SV=3P55056APOC4 APOC4_HUMANApolipoprotein C-IVlipid metabolic process,lipid transport,positive regulation of sequestering of triglyceride,lipoprotein metabolic process,triglyceride homeostasislipid transporter activity\extracellular region,very-low-density lipoprotein particle,high-density lipoprotein particleM>sp|P55056|APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1P55058PLTP PLTP_HUMANPhospholipid transfer proteinlipid metabolic process,lipid transport,vitamin E biosynthetic process,positive regulation of cholesterol efflux,flagellated sperm motility,high-density lipoprotein particle remodeling lipid binding(extracellular region,extracellular spaceU>sp|P55058|PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1P60842EIF4A1 IF4A1_HUMAN!Eukaryotic initiation factor 4A-Inuclear-transcribed mRNA poly(A) tail shortening,translational initiation,regulation of gene expression,RNA secondary structure unwinding,viral processRNA cap binding,RNA binding,double-stranded RNA binding,mRNA binding,translation initiation factor activity,ATP-dependent RNA helicase activity,helicase activity,protein binding,ATP binding,translation factor activity, RNA bindingcytoplasm,cytosol,membrane,eukaryotic translation initiation factor 4F complex,extracellular matrix,extracellular exosome,nucleus\>sp|P60842|IF4A1_HUMAN Eukaryotic initiation factor 4A-I OS=Homo sapiens GN=EIF4A1 PE=1 SV=1P60891PRPS1 PRPS1_HUMAN$Ribose-phosphate pyrophosphokinase 1C5-phosphoribose 1-diphosphate biosynthetic process,purine nucleobase metabolic process,purine nucleotide biosynthetic process,AMP biosynthetic process,pyrimidine nucleotide biosynthetic process,nervous system development,phosphorylation,animal organ regeneration,urate biosynthetic process,hypoxanthine biosynthetic processmagnesium ion binding,ribose phosphate diphosphokinase activity,protein binding,ATP binding,AMP binding,kinase activity,GDP binding,carbohydrate binding,identical protein binding,protein homodimerization activity,ADP binding@ribose phosphate diphosphokinase complex,cytosol,protein complex^>sp|P60891|PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2P61006RAB8A RAB8A_HUMANRas-related protein Rab-8AG2/M transition of mitotic cell cycle,vesicle docking involved in exocytosis,small GTPase mediated signal transduction,axonogenesis,protein secretion,cellular response to insulin stimulus,regulation of long-term neuronal synaptic pla< sticity,Golgi vesicle fusion to target membrane,regulation of protein transport,cilium morphogenesis,membrane organization,protein localization to plasma membrane,ciliary basal body docking,neurotransmitter receptor transport to postsynaptic membranerGTPase activity,protein binding,GTP binding,Rab GTPase binding,GDP binding,protein kinase binding,myosin V bindingGolgi membrane,centrosome,centriole,cytosol,plasma membrane,cilium,synaptic vesicle,postsynaptic density,trans-Golgi network transport vesicle,cytoplasmic vesicle membrane,phagocytic vesicle membrane,extracellular matrix,trans-Golgi network membrane,ciliary basal body,neuronal cell body,dendritic spine,phagocytic vesicle,recycling endosome membrane,extracellular exosome,ciliary base,Requires OntologyT>sp|P61006|RAB8A_HUMAN Ras-related protein Rab-8A OS=Homo sapiens GN=RAB8A PE=1 SV=1P61158ACTR3 ARP3_HUMANActin-related protein 3}movement of cell or subcellular component,establishment or maintenance of cell polarity,asymmetric cell division,meiotic chromosome movement towards spindle pole,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,spindle localization,cilium morphogenesis,membrane organizationYstructural constituent of cytoskeleton,protein binding,ATP binding,actin filament bindingcytosol,Arp2/3 protein complex,brush border,cell-cell junction,focal adhesion,actin cytoskeleton,membrane,lamellipodium,extracellular exosomeP>sp|P61158|ARP3_HUMAN Actin-related protein 3 OS=Homo sapiens GN=ACTR3 PE=1 SV=3P61160ACTR2 ARP2_HUMANActin-related protein 2Nmovement of cell or subcellular component,establishment or maintenance of cell polarity,associative learning,asymmetric cell division,meiotic chromosome movement towards spindle pole,cytosolic transport,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,response to immobilization stress,cellular response to trichostatin A,Fc-gamma receptor signaling pathway involved in phagocytosis,neutrophil degranulation,response to ethanol,ephrin receptor signaling pathway,spindle localization,cilium morphogenesis,positive regulation of dendritic spine morphogenesis,membrane organizationIstructural constituent of cytoskeleton,ATP binding,actin filament bindingpodosome,extracellular region,cytoplasm,cytosol,Arp2/3 protein complex,focal adhesion,postsynaptic density,actin cytoskeleton,membrane,lamellipodium,actin cap,azurophil granule lumen,extracellular exosome,invadopodium,ficolin-1-rich granule lumenP>sp|P61160|ARP2_HUMAN Actin-related protein 2 OS=Homo sapiens GN=ACTR2 PE=1 SV=1P69892HBG2 HBG2_HUMANHemoglobin subunit gamma-2R>sp|P69892|HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2P80511S100A12 S10AC_HUMANProtein S100-A12monocyte chemotaxis,xenobiotic metabolic process,inflammatory response,neutrophil chemotaxis,killing of cells of other organism,defense response to bacterium,positive regulation of I-kappaB kinase/NF-kappaB signaling,neutrophil degranulation,positive regulation of MAP kinase activity,innate immune response,mast cell activation,cytokine secretion,positive regulation of inflammatory response,defense response to fungus,positive regulation of NF-kappaB transcription factor activity]copper ion binding,calcium ion binding,protein binding,zinc ion binding,RAGE receptor bindingcextracellular region,nucleus,cytoplasm,cytosol,cytoskeleton,plasma membrane,secretory granule lumenL>sp|P80511|S10AC_HUMAN Protein S100-A12 OS=Homo sapiens GN=S100A12 PE=1 SV=2Q00765REEP5 REEP5_HUMAN'Receptor expression-enhancing protein 5biological_process"molecular_function,protein bindingZintegral component of membrane,extracellular exosome,endoplasmic reticulum tubular networka>sp|Q00765|REEP5_HUMAN Receptor expression-enhancing protein 5 OS=Homo sapiens GN=REEP5 PE=1 SV=3Q00796SORD DHSO_HUMANSorbitol dehydrogenaseglucose metabolic process,sorbitol catabolic process,response to osmotic stress,response to hormone,glucuronate catabolic process to xylulose 5-phosphate,flagellated sperm motility,response to nutrient levels,response to drug,fructose biosynthetic process,response to cadmium ion,response to copper ion,L-xylitol catabolic process,L-xylitol metabolic process,oxidation-reduction processL-iditol 2-dehydrogenase activity,zinc ion binding,carbohydrate binding,identical protein binding,D-xylulose reductase activity,NAD binding_extracellular space,cytosol,membrane,motile cilium,mitochondrial membrane,extracellular exosomeN>sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens GN=SORD PE=1 SV=4Q02809;Q02809-2PLOD1 PLOD1_HUMANpProcollagen-lysine,2-oxoglutarate 5-dioxygenase 1;Isoform 2 of Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1response to hypoxia,cellular protein modification process,epidermis development,hydroxylysine biosynthetic process,oxidation-reduction process;uiron ion binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding,protein homodimerization activity;Zendoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome;>sp|Q02809|PLOD1_HUMAN Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2;>sp|Q02809-2|PLOD1_HUMAN Isoform 2 of Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1Q02985;Q02985-2CFHR3 FHR3_HUMANXComplement factor H-related protein 3;Isoform 2 of Complement factor H-related protein 3>extracellular space,extracellular exosome,blood microparticle;>sp|Q02985|FHR3_HUMAN Complement factor H-related protein 3 OS=Homo sapiens GN=CFHR3 PE=1 SV=2;>sp|Q02985-2|FHR3_HUMAN Isoform 2 of Complement factor H-related protein 3 OS=Homo sapiens GN=CFHR3Q04917YWHAH 1433F_HUMAN14-3-3 protein etaBregulation of sodium ion transport,glucocorticoid catabolic process,intracellular protein transport,substantia nigra development,glucocorticoid receptor signaling pathway,regulation of neuron differentiation,positive regulation of transcription, DNA-templated,regulation of synaptic plasticity,negative regulation of dendrite morphogenesis,membrane organization,membrane depolarization during action potential,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of sodium ion transmembrane transporter activityactin binding,insulin-like growth factor receptor binding,protein binding,sodium channel regulator activity,enzyme binding,protein domain specific binding,glucocorticoid receptor binding,ion channel binding,protein heterodimerization activitytcytoplasm,mitochondrion,cytosol,plasma membrane,intercalated disc,cytoplasmic vesicle membrane,extracellular exosomeL>sp|Q04917|1433F_HUMAN 14-3-3 protein eta OS=Homo sapiens GN=YWHAH PE=1 SV=4Q05655;Q05655-2PRKCD KPCD_HUMANDProtein kinase C delta type;Isoform 2 of Protein kinase C delta typestimulatory C-type lectin receptor signaling pathway,protein phosphorylation,apoptotic process,cell cycle,signal transduction,activation of phospholipase C activity,intrinsic apoptotic signaling pathway in response to oxidative stress,regulation of receptor activity,immunoglobulin mediated immune response,histone phosphorylation,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,peptidyl-tyrosine phosphorylation,termination of signal transduction,platelet activation,negative regulation of actin filament polymerization,positive regulation of endodeoxyribonuclease activity,negative regulation of protein binding,activation of protein kinase activity,interleukin-10 production,interleukin-12 production,positive regulation of superoxide anion generation,regulation of actin cytoskeleton organization,negative regulation of glial cell apoptotic process,positive regulation of protein dephosphorylation,Fc-gamma receptor signaling pathway involved in phagocytosis,B cell proliferation,neutrophil activation,positive regulation of protein import into nucleus,defense response to bacterium,neutrophil degranulation,negative regulation of MAP kinase activity,regulation< of mRNA stability,negative regulation of insulin receptor signaling pathway,negative regulation of inflammatory response,negative regulation of peptidyl-tyrosine phosphorylation,protein stabilization,negative regulation of filopodium assembly,cell chemotaxis,interferon-gamma-mediated signaling pathway,cellular response to hydrogen peroxide,cellular response to hydroperoxide,negative regulation of platelet aggregation,cellular senescence,execution phase of apoptosis,positive regulation of phospholipid scramblase activity,cellular response to angiotensin,positive regulation of ceramide biosynthetic process,positive regulation of glucosylceramide catabolic process,positive regulation of sphingomyelin catabolic process,positive regulation of response to DNA damage stimulus,positive regulation of apoptotic signaling pathway;`protein kinase activity,protein serine/threonine kinase activity,protein kinase C activity,calcium-independent protein kinase C activity,non-membrane spanning protein tyrosine kinase activity,protein binding,ATP binding,enzyme activator activity,enzyme binding,kinase binding,protein kinase binding,insulin receptor substrate binding,metal ion binding;extracellular region,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,cytosol,plasma membrane,cell-cell junction,nuclear matrix,azurophil granule lumen,perinuclear region of cytoplasm,extracellular exosome;>sp|Q05655|KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2;>sp|Q05655-2|KPCD_HUMAN Isoform 2 of Protein kinase C delta type OS=Homo sapiens GN=PRKCDQ06323PSME1 PSME1_HUMAN&Proteasome activator complex subunit 1!MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycle0protein binding,endopeptidase activator activitycproteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,extracellular exosome`>sp|Q06323|PSME1_HUMAN Proteasome activator complex subunit 1 OS=Homo sapiens GN=PSME1 PE=1 SV=1Q08830FGL1 FGL1_HUMANFibrinogen-like protein 1(fibrinogen complex,extracellular exosomeQ>sp|Q08830|FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3Q13753;Q13753-2LAMC2 LAMC2_HUMAN@Laminin subunit gamma-2;Isoform Short of Laminin subunit gamma-2cell adhesion,positive regulation of cell proliferation,epidermis development,extracellular matrix disassembly,extracellular matrix organization,positive regulation of cell migration,hemidesmosome assembly,system development,basement membrane assembly;heparin binding;pextracellular region,laminin-2 complex,extracellular space,cell cortex,membrane,perinuclear region of cytoplasm;>sp|Q13753|LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2;>sp|Q13753-2|LAMC2_HUMAN Isoform Short of Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2Q13813;Q13813-3SPTAN1 SPTN1_HUMAN^Spectrin alpha chain, non-erythrocytic 1;Isoform 3 of Spectrin alpha chain, non-erythrocytic 1MAPK cascade,ER to Golgi vesicle-mediated transport,cytoskeleton organization,axon guidance,neutrophil degranulation,positive regulation of GTPase activity,actin filament capping;actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,calcium ion binding,protein binding,calmodulin binding,cadherin binding;extracellular region,cytosol,spectrin,microtubule cytoskeleton,membrane,specific granule lumen,intracellular membrane-bounded organelle,extracellular exosome,extracellular vesicle,tertiary granule lumen;>sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTAN1 PE=1 SV=3;>sp|Q13813-3|SPTN1_HUMAN Isoform 3 of Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTAN1Q14247;Q14247-3CTTN SRC8_HUMAN<Src substrate cortactin;Isoform 3 of Src substrate cortactinintracellular protein transport,receptor-mediated endocytosis,substrate-dependent cell migration, cell extension,actin filament polymerization,regulation of axon extension,positive regulation of actin filament polymerization,actin cytoskeleton reorganization,positive regulation of smooth muscle contraction,focal adhesion assembly,neuron projection morphogenesis,cell motility,membrane organization,dendritic spine maintenance,lamellipodium organization,regulation of mitophagy,negative regulation of extrinsic apoptotic signaling pathway;2protein binding,profilin binding,cadherin binding;Lruffle,podosome,cytoplasm,Golgi apparatus,cytosol,cytoskeleton,plasma membrane,clathrin-coated pit,focal adhesion,cell cortex,lamellipodium,cortical cytoskeleton,dendritic spine,intracellular membrane-bounded organelle,extracellular exosome,mitotic spindle midzone,actin filament,voltage-gated potassium channel complex,growth cone;>sp|Q14247|SRC8_HUMAN Src substrate cortactin OS=Homo sapiens GN=CTTN PE=1 SV=2;>sp|Q14247-3|SRC8_HUMAN Isoform 3 of Src substrate cortactin OS=Homo sapiens GN=CTTNQ14644RASA3 RASA3_HUMANRas GTPase-activating protein 3MAPK cascade,signal transduction,positive regulation of GTPase activity,negative regulation of Ras protein signal transduction,release of sequestered calcium ion into cytosolLGTPase activator activity,calcium-release channel activity,metal ion bindingTcytoplasm,cytosol,intrinsic component of the cytoplasmic side of the plasma membraneY>sp|Q14644|RASA3_HUMAN Ras GTPase-activating protein 3 OS=Homo sapiens GN=RASA3 PE=1 SV=3Q15166PON3 PON3_HUMANSerum paraoxonase/lactonase 3response to external stimulus,response to toxic substance,phenylacetate catabolic process,dephosphorylation,lipoxygenase pathway,aromatic compound catabolic process,negative regulation of superoxide anion generation,coumarin catabolic process,carboxylic acid catabolic processaryldialkylphosphatase activity,arylesterase activity,3,4-dihydrocoumarin hydrolase activity,protein homodimerization activity,metal ion binding,dihydrocoumarin hydrolase activity,acyl-L-homoserine-lactone lactonohydrolase activitygextracellular region,extracellular space,intracellular membrane-bounded organelle,extracellular exosomeU>sp|Q15166|PON3_HUMAN Serum paraoxonase/lactonase 3 OS=Homo sapiens GN=PON3 PE=1 SV=3Q15404RSU1 RSU1_HUMANRas suppressor protein 1signal transduction,positive regulation of cell-substrate adhesion,positive regulation of GTPase activity,regulation of cell-substrate adhesion,cytosol,focal adhesion,extracellular exosomeP>sp|Q15404|RSU1_HUMAN Ras suppressor protein 1 OS=Homo sapiens GN=RSU1 PE=1 SV=3Q15485FCN2 FCN2_HUMAN Ficolin-2complement activation, lectin pathway,proteolysis,complement activation,opsonization,recognition of apoptotic cell,defense response to Gram-negative bacterium,defense response to Gram-positive bacteriumantigen binding,serine-type endopeptidase activity,protein binding,proteoglycan binding,metal ion binding,calcium-dependent protein binding,mannan bindingNextracellular region,collagen trimer,ex< tracellular exosome,blood microparticleA>sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens GN=FCN2 PE=1 SV=2Q15833STXBP2 STXB2_HUMANSyntaxin-binding protein 2leukocyte mediated cytotoxicity,platelet degranulation,vesicle docking involved in exocytosis,protein transport,regulation of mast cell degranulation,neutrophil degranulation5protein binding,syntaxin-1 binding,syntaxin-3 bindingextracellular region,cytosol,plasma membrane,apical plasma membrane,specific granule,azurophil granule,zymogen granule membrane,cytolytic granule,extracellular exosome,tertiary granule,SNARE complexU>sp|Q15833|STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2Q16181SEPT7 SEPT7_HUMANSeptin-7cytokinesis,mitotic nuclear division,spermatogenesis,regulation of embryonic cell shape,cell differentiation,protein heterooligomerization,cilium morphogenesis,positive regulation of nonmotile primary cilium assemblycstructural molecule activity,protein binding,GTP binding,identical protein binding,cadherin bindingcondensed chromosome kinetochore,stress fiber,nucleus,spindle,cytosol,axoneme,midbody,septin complex,cleavage furrow,extracellular exosome,sperm annulus,Requires Ontology,apical plasma membraneB>sp|Q16181|SEPT7_HUMAN Septin-7 OS=Homo sapiens GN=SEPT7 PE=1 SV=2Q16610ECM1 ECM1_HUMANExtracellular matrix protein 1ossification,angiogenesis,positive regulation of endothelial cell proliferation,negative regulation of cytokine-mediated signaling pathway,platelet degranulation,regulation of type 2 immune response,regulation of transcription from RNA polymerase II promoter,inflammatory response,signal transduction,negative regulation of peptidase activity,negative regulation of bone mineralization,biomineral tissue development,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of angiogenesis,regulation of T cell migrationprotease binding,signal transducer activity,interleukin-2 receptor binding,protein binding,protein C-terminus binding,enzyme binding,laminin bindingextracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,platelet dense granule lumen,extracellular exosomeV>sp|Q16610|ECM1_HUMAN Extracellular matrix protein 1 OS=Homo sapiens GN=ECM1 PE=1 SV=2Q6Q788APOA5 APOA5_HUMANApolipoprotein A-Vtriglyceride metabolic process,cholesterol biosynthetic process,lipid transport,positive regulation of cholesterol esterification,positive regulation of triglyceride catabolic process,positive regulation of very-low-density lipoprotein particle remodeling,triglyceride catabolic process,regulation of intestinal cholesterol absorption,neuron projection regeneration,cholesterol efflux,phospholipid efflux,triglyceride-rich lipoprotein particle remodeling,high-density lipoprotein particle assembly,lipoprotein metabolic process,tissue regeneration,cholesterol homeostasis,reverse cholesterol transport,positive regulation of fatty acid biosynthetic process,phosphatidylcholine metabolic process,positive regulation of receptor-mediated endocytosis,positive regulation of lipid catabolic process,positive regulation of lipoprotein lipase activity,acylglycerol homeostasis,triglyceride homeostasisphospholipid binding,enzyme activator activity,heparin binding,lipid binding,cholesterol binding,cholesterol transporter activity,enzyme binding,phosphatidylcholine binding,lipase binding,low-density lipoprotein particle receptor binding,phosphatidylcholine-sterol O-acyltransferase activator activity,lipase activator activity,lipoprotein lipase activator activity,lipoprotein particle receptor bindingextracellular region,extracellular space,cytosol,very-low-density lipoprotein particle,high-density lipoprotein particle,chylomicron,blood microparticle,low-density lipoprotein particleL>sp|Q6Q788|APOA5_HUMAN Apolipoprotein A-V OS=Homo sapiens GN=APOA5 PE=1 SV=1Q6UXB8;Q6UXB8-2PI16 PI16_HUMAN:Peptidase inhibitor 16;Isoform 2 of Peptidase inhibitor 16*negative regulation of peptidase activity;peptidase inhibitor activity;extracellular exosome;>sp|Q6UXB8|PI16_HUMAN Peptidase inhibitor 16 OS=Homo sapiens GN=PI16 PE=1 SV=1;>sp|Q6UXB8-2|PI16_HUMAN Isoform 2 of Peptidase inhibitor 16 OS=Homo sapiens GN=PI16Q6UXH0ANGPTL8 ANGL8_HUMANAngiopoietin-like protein 8!positive regulation of protein processing,regulation of lipid metabolic process,lipoprotein metabolic process,cellular lipid metabolic process,type B pancreatic cell proliferation,fat cell differentiation,cell maturation,regulation of lipoprotein metabolic process,triglyceride homeostasis hormone activity,protein bindingW>sp|Q6UXH0|ANGL8_HUMAN Angiopoietin-like protein 8 OS=Homo sapiens GN=ANGPTL8 PE=1 SV=1Q70J99UNC13D UN13D_HUMANProtein unc-13 homolog DMgranuloma formation,germinal center formation,phagocytosis,regulation of mast cell degranulation,neutrophil degranulation,natural killer cell degranulation,positive regulation of exocytosis,defense response to virus,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of regulated secretory pathway"protein binding,Rab GTPase bindingextracellular region,lysosome,late endosome,endoplasmic reticulum,cytosol,membrane,Weibel-Palade body,azurophil granule lumen,recycling endosome,exocytic vesicleS>sp|Q70J99|UN13D_HUMAN Protein unc-13 homolog D OS=Homo sapiens GN=UNC13D PE=1 SV=1Q7L7X3TAOK1 TAOK1_HUMAN$Serine/threonine-protein kinase TAO1]DNA repair,protein phosphorylation,cellular response to DNA damage stimulus,sister chromatid cohesion,signal transduction by protein phosphorylation,G2 DNA damage checkpoint,positive regulation of stress-activated MAPK cascade,positive regulation of JNK cascade,regulation of cytoskeleton organization,execution phase of apoptosis,spindle checkpointprotein kinase activity,protein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,protein binding,ATP binding,kinase activity,transferase activity^>sp|Q7L7X3|TAOK1_HUMAN Serine/threonine-protein kinase TAO1 OS=Homo sapiens GN=TAOK1 PE=1 SV=1Q86YZ3HRNR HORN_HUMANHornerin`keratinization,cell envelope organization,neutrophil degranulation,establishment of skin barrier0calcium ion binding,transition metal ion bindingcornified envelope,extracellular region,nucleus,cytoplasm,cell envelope,azurophil granule lumen,keratohyalin granule,perinuclear region of cytoplasm,extracellular exosome@>sp|Q86YZ3|HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2Q8WWA0ITLN1 ITLN1_HUMAN Intelectin-1positive regulation of protein phosphorylation,response to nematode,antimicrobial humoral response,positive regulation of glucose import,protein homotrimerization+calcium ion binding,oligosaccharide binding~extracellular region,anchored component of membrane,brush border membrane,receptor complex,membrane raft,extracellular exosomeF>sp|Q8WWA0|ITLN1_HUMAN Intelectin-1 OS=Homo sapiens GN=ITLN1 PE=1 SV=1Q92496;Q92496-2CFHR4 FHR4_HUMANXComplement factor H-related protein 4;Isoform 2 of Complement factor H-related protein 4lipid transport;lipid transporter activity;extracellular region;>sp|Q92496|FHR4_HUMAN Complement factor H-related protein 4 OS=Homo sapiens GN=CFHR4 PE=1 SV=3;>sp|Q92496-2|FHR4_HUMAN Isoform 2 of Complement factor H-related protein 4 OS=Homo sapiens GN=CFHR4O75886;O75886-2;Q92783;Q92783-2STAM2;STAM2;STAM;STAM/STAM2_HUMAN;STAM2_HUMAN;STAM1_HUMAN;STAM1_HUMANSignal transducing adapter molecule 2;Isoform 2 of Signal transducing adapter molecule 2;Signal transducing adapter molecule 1;Isoform 2 of Signal transducing adapter molecule 1Iintracellular protein transport,endosomal transport,macroautophagy,protein deubiquitination,multivesicular body assembly,negative regulation of epidermal growth factor receptor signaling pathway,membrane organization;;intracellular protein transport,signal transduction,positive regulation of signal transduction,endosomal transport,macroautophagy,protein deubiquitination,multivesicular body assembly,negative regulation of epidermal growth factor receptor signaling< pathway,membrane organization,positive regulation of exosomal secretion,regulation of extracellular exosome assembly;:protein binding;;SH3/SH2 adaptor activity,protein binding;nucleoplasm,cytoplasm,cytosol,early endosome membrane,ESCRT-0 complex,intracellular membrane-bounded organelle;;cytosol,early endosome membrane,ESCRT-0 complex;1;;1;1;;3;>sp|O75886|STAM2_HUMAN Signal transducing adapter molecule 2 OS=Homo sapiens GN=STAM2 PE=1 SV=1;>sp|O75886-2|STAM2_HUMAN Isoform 2 of Signal transducing adapter molecule 2 OS=Homo sapiens GN=STAM2;>sp|Q92783|STAM1_HUMAN Signal transducing adapter molecule 1 OS=Homo sapiens GN=STAM PE=1 SV=3;>sp|Q92783-2|STAM1_HUMAN Isoform 2 of Signal transducing adapter molecule 1 OS=Homo sapiens GN=STAMQ96PD5;Q96PD5-2PGLYRP2 PGRP2_HUMANRN-acetylmuramoyl-L-alanine amidase;Isoform 2 of N-acetylmuramoyl-L-alanine amidasepeptide amidation,pattern recognition receptor signaling pathway,peptidoglycan catabolic process,detection of bacterium,antimicrobial humoral response,negative regulation of interferon-gamma production,negative regulation of natural killer cell differentiation involved in immune response,growth of symbiont in host,innate immune response,regulation of inflammatory response,defense response to Gram-positive bacterium;szinc ion binding,N-acetylmuramoyl-L-alanine amidase activity,peptidoglycan receptor activity,peptidoglycan binding;Bextracellular region,intracellular,membrane,extracellular exosome;>sp|Q96PD5|PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1;>sp|Q96PD5-2|PGRP2_HUMAN Isoform 2 of N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2Q9BX97PLVAP PLVAP_HUMAN&Plasmalemma vesicle-associated proteinMAPK cascade,positive regulation of cellular extravasation,tumor necrosis factor-mediated signaling pathway,protein kinase C signaling1protein binding,protein homodimerization activityicaveola,cell surface,integral component of membrane,perinuclear region of cytoplasm,extracellular exosome`>sp|Q9BX97|PLVAP_HUMAN Plasmalemma vesicle-associated protein OS=Homo sapiens GN=PLVAP PE=2 SV=1Q9BYJ0FGFBP2 FGFP2_HUMAN*Fibroblast growth factor-binding protein 2growth factor bindinge>sp|Q9BYJ0|FGFP2_HUMAN Fibroblast growth factor-binding protein 2 OS=Homo sapiens GN=FGFBP2 PE=1 SV=1Q9H4B7TUBB1 TBB1_HUMANTubulin beta-1 chainspindle assemblyBGTPase activity,structural constituent of cytoskeleton,GTP bindingDcytoplasm,microtubule,microtubule cytoskeleton,extracellular exosomeM>sp|Q9H4B7|TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens GN=TUBB1 PE=1 SV=1Q9H939PSTPIP2 PPIP2_HUMAN:Proline-serine-threonine phosphatase-interacting protein 2(cytoskeleton organization,cell migration actin bindingcytosol,cytoskeleton,membranev>sp|Q9H939|PPIP2_HUMAN Proline-serine-threonine phosphatase-interacting protein 2 OS=Homo sapiens GN=PSTPIP2 PE=1 SV=4Q9HCU0CD248 CD248_HUMAN Endosialinbiological_process,positive regulation of cell proliferation,cell migration,lymph node development,anatomical structure regression,positive regulation of endothelial cell apoptotic processXmolecular_function,calcium ion binding,carbohydrate binding,extracellular matrix bindingaproteinaceous extracellular matrix,cytoplasm,integral component of membrane,extracellular exosomeD>sp|Q9HCU0|CD248_HUMAN Endosialin OS=Homo sapiens GN=CD248 PE=1 SV=1Q9NPG4PCDH12 PCD12_HUMANProtocadherin-12glycogen metabolic process,cell adhesion,homophilic cell adhesion via plasma membrane adhesion mole      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmopqrstuvwxyz{|}~cules,cell-cell signaling,neuron recognition,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,labyrinthine layer development^plasma membrane,integral component of plasma membrane,cell-cell junction,extracellular exosomeK>sp|Q9NPG4|PCD12_HUMAN Protocadherin-12 OS=Homo sapiens GN=PCDH12 PE=1 SV=1 H0YEA7;Q9UJJ9GNPTGH0YEA7_HUMAN;GNPTG_HUMANxN-acetylglucosamine-1-phosphotransferase subunit gamma (Fragment);N-acetylglucosamine-1-phosphotransferase subunit gamma=;N-glycan processing to lysosome,carbohydrate phosphorylationz;UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,protein homodimerization activity5;Golgi membrane,Golgi apparatus,extracellular exosome8;1>tr|H0YEA7|H0YEA7_HUMAN N-acetylglucosamine-1-phosphotransferase subunit gamma (Fragment) OS=Homo sapiens GN=GNPTG PE=1 SV=8;>sp|Q9UJJ9|GNPTG_HUMAN N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Homo sapiens GN=GNPTG PE=1 SV=1Q9ULI3HEG1 HEG1_HUMANProtein HEG homolog 1vasculogenesis,in utero embryonic development,endothelial cell morphogenesis,lymph vessel development,lymph circulation,cardiac atrium morphogenesis,ventricular trabecula myocardium morphogenesis,ventricular septum development,cell-cell junction assembly,post-embryonic development,lung development,multicellular organism growth,venous blood vessel morphogenesis,regulation of body fluid levels,cardiac muscle tissue growth,pericardium development,positive regulation of fibroblast growth factor productiongextracellular region,cell-cell junction,external side of plasma membrane,integral component of membraneM>sp|Q9ULI3|HEG1_HUMAN Protein HEG homolog 1 OS=Homo sapiens GN=HEG1 PE=1 SV=3Q9Y287;Q9Y287-2ITM2B ITM2B_HUMANFIntegral membrane protein 2B;Isoform 2 of Integral membrane protein 2Bnervous system development,negative regulation of amyloid precursor protein biosynthetic process,cellular protein metabolic process;1beta-amyloid binding,protein binding,ATP binding;Golgi membrane,extracellular region,extracellular space,Golgi apparatus,plasma membrane,endosome membrane,membrane,Golgi-associated vesicle membrane,integral component of organelle membrane,intracellular membrane-bounded organelle,extracellular exosome;>sp|Q9Y287|ITM2B_HUMAN Integral membrane protein 2B OS=Homo sapiens GN=ITM2B PE=1 SV=1;>sp|Q9Y287-2|ITM2B_HUMAN Isoform 2 of Integral membrane protein 2B OS=Homo sapiens GN=ITM2BQ9Y303;Q9Y303-2;Q9Y303-3AMDHD2 NAGA_HUMANN-acetylglucosamine-6-phosphate deacetylase;Isoform 2 of N-acetylglucosamine-6-phosphate deacetylase;Isoform 3 of N-acetylglucosamine-6-phosphate deacetylasecarbohydrate metabolic process,N-acetylglucosamine metabolic process,UDP-N-acetylglucosamine biosynthetic process,N-acetylneuraminate catabolic process;;Xprotein binding,N-acetylglucosamine-6-phosphate deacetylase activity,metal ion binding;;nucleus,cytosol;;;>sp|Q9Y303|NAGA_HUMAN N-acetylglucosamine-6-phosphate deacetylase OS=Homo sapiens GN=AMDHD2 PE=1 SV=2;>sp|Q9Y303-2|NAGA_HUMAN Isoform 2 of N-acetylglucosamine-6-phosphate deacetylase OS=Homo sapiens GN=AMDHD2;>sp|Q9Y303-3|NAGA_HUMAN Isoform 3 of N-acetylglucosamine-6-phosphate deacetylase OS=Homo sapiens GN=AMDHD2 A0A075B6H9IGLV4-69A0A075B6H9_HUMANProtein IGLV4-69 (Fragment)a>tr|A0A075B6H9|A0A075B6H9_HUMAN Protein IGLV4-69 (Fragment) OS=Homo sapiens GN=IGLV4-69 PE=1 SV=1 A0A075B6I4 IGLV10-54A0A075B6I4_HUMANProtein IGLV10-54 (Fragment)c>tr|A0A075B6I4|A0A075B6I4_HUMAN Protein IGLV10-54 (Fragment) OS=Homo sapiens GN=IGLV10-54 PE=1 SV=1 A0A075B6K0IGLV3-16A0A075B6K0_HUMANHCG2041221 (Fragment)[>tr|A0A075B6K0|A0A075B6K0_HUMAN HCG2041221 (Fragment) OS=Homo sapiens GN=IGLV3-16 PE=1 SV=1 A0A075B6R9 IGKV2D-24A0A075B6R9_HUMANProtein IGKV2D-24 (Fragment)c>tr|A0A075B6R9|A0A075B6R9_HUMAN Protein IGKV2D-24 (Fragment) OS=Homo sapiens GN=IGKV2D-24 PE=4 SV=1 A0A075B7B8 IGHV3OR16-12A0A075B7B8_HUMANProtein IGHV3OR16-12 (Fragment)i>tr|A0A075B7B8|A0A075B7B8_HUMAN Protein IGHV3OR16-12 (Fragment) OS=Homo sapiens GN=IGHV3OR16-12 PE=1 SV=1 A0A075B7D8 IGHV3OR15-7A0A075B7D8_HUMANProtein IGHV3OR15-7 (Fragment)g>tr|A0A075B7D8|A0A075B7D8_HUMAN Protein IGHV3OR15-7 (Fragment) OS=Homo sapiens GN=IGHV3OR15-7 PE=1 SV=1 A0A087WWA5A0A087WWA5_HUMAN Tenascin-XL>tr|A0A087WWA5|A0A087WWA5_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=1OA0A087WWC0;A0A087WXC9;A0A087X0U8;A0A087X1F1;A0A087X1M5;Q13477;Q13477-2;Q13477-3MADCAM1xA0A087WWC0_HUMAN;A0A087WXC9_HUMAN;A0A087X0U8_HUMAN;A0A087X1F1< _HUMAN;A0A087X1M5_HUMAN;MADCA_HUMAN;MADCA_HUMAN;MADCA_HUMANqMucosal addressin cell adhesion molecule 1;Mucosal addressin cell adhesion molecule 1;Mucosal addressin cell adhesion molecule 1;Mucosal addressin cell adhesion molecule 1;Mucosal addressin cell adhesion molecule 1;Mucosal addressin cell adhesion molecule 1;Isoform 2 of Mucosal addressin cell adhesion molecule 1;Isoform 3 of Mucosal addressin cell adhesion molecule 14;;;;;positive regulation of leukocyte migration,immune response,cell adhesion,cell-matrix adhesion,signal transduction,integrin-mediated signaling pathway,aging,extracellular matrix organization,heterotypic cell-cell adhesion,receptor clustering,regulation of immune response,leukocyte tethering or rolling;;8;;;;;integrin binding involved in cell-matrix adhesion;;>;;;;;plasma membrane,membrane,integral component of membrane;;tr;tr;tr;tr;tr;sp;sp;sp 1;1;1;1;1;1;; 1;1;1;1;1;2;;n>tr|A0A087WWC0|A0A087WWC0_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=1;>tr|A0A087WXC9|A0A087WXC9_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=1;>tr|A0A087X0U8|A0A087X0U8_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=1;>tr|A0A087X1F1|A0A087X1F1_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=1;>tr|A0A087X1M5|A0A087X1M5_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=1;>sp|Q13477|MADCA_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=2;>sp|Q13477-2|MADCA_HUMAN Isoform 2 of Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1;>sp|Q13477-3|MADCA_HUMAN Isoform 3 of Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1*A0A087WWI4;A0A087X054;E9PJ21;K7EQK2;Q9Y4L1HYOU1GA0A087WWI4_HUMAN;A0A087X054_HUMAN;E9PJ21_HUMAN;K7EQK2_HUMAN;HYOU1_HUMANHypoxia up-regulated protein 1;Hypoxia up-regulated protein 1;Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1;Hypoxia up-regulated protein 1;;;;response to ischemia,ER to Golgi vesicle-mediated transport,receptor-mediated endocytosis,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,cellular response to hypoxia,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway!;;;;ATP binding,chaperone binding;;;;extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,focal adhesion,membrane,endoplasmic reticulum chaperone complex,extracellular exosome,endocytic vesicle lumen>tr|A0A087WWI4|A0A087WWI4_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens GN=HYOU1 PE=1 SV=1;>tr|A0A087X054|A0A087X054_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens GN=HYOU1 PE=1 SV=1;>tr|E9PJ21|E9PJ21_HUMAN Hypoxia up-regulated protein 1 (Fragment) OS=Homo sapiens GN=HYOU1 PE=1 SV=1;>tr|K7EQK2|K7EQK2_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens GN=HYOU1 PE=1 SV=1;>sp|Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens GN=HYOU1 PE=1 SV=1A0A087X2I1;P62333PSMC6A0A087X2I1_HUMAN;PRS10_HUMAN#26S protease regulatory subunit 10B;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process;protein binding,ATP binding,ATPase activity,TBP-class protein binding,protein binding, bridging,proteasome-activating ATPase activity,identical protein binding;proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,extracellular exosome>tr|A0A087X2I1|A0A087X2I1_HUMAN 26S protease regulatory subunit 10B OS=Homo sapiens GN=PSMC6 PE=1 SV=1;>sp|P62333|PRS10_HUMAN 26S protease regulatory subunit 10B OS=Homo sapiens GN=PSMC6 PE=1 SV=1(A0A0A0MRJ6;F6S8N6;H7BY58;P22061;P22061-2PCMT1@A0A0A0MRJ6_HUMAN;F6S8N6_HUMAN;H7BY58_HUMAN;PIMT_HUMAN;PIMT_HUMAN Protein-L-isoaspartate O-methyltransferase;Protein-L-isoaspartate(D-aspartate) O-methyltransferase;Protein-L-isoaspartate O-methyltransferase;Protein-L-isoaspartate(D-aspartate) O-methyltransferase;Isoform 2 of Protein-L-isoaspartate(D-aspartate) O-methyltransferase&;;;protein methylation,protein repair;f;;;protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,protein binding,cadherin binding;A;;;cytoplasm,cytosol,extracellular exosome,extracellular vesicle;1;1;1;4;->tr|A0A0A0MRJ6|A0A0A0MRJ6_HUMAN Protein-L-isoaspartate O-methyltransferase OS=Homo sapiens GN=PCMT1 PE=1 SV=1;>tr|F6S8N6|F6S8N6_HUMAN Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens GN=PCMT1 PE=1 SV=1;>tr|H7BY58|H7BY58_HUMAN Protein-L-isoaspartate O-methyltransferase OS=Homo sapiens GN=PCMT1 PE=1 SV=1;>sp|P22061|PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens GN=PCMT1 PE=1 SV=4;>sp|P22061-2|PIMT_HUMAN Isoform 2 of Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens GN=PCMT1 A0A0B4J1U7IGHV6-1A0A0B4J1U7_HUMANProtein IGHV6-1 (Fragment)_>tr|A0A0B4J1U7|A0A0B4J1U7_HUMAN Protein IGHV6-1 (Fragment) OS=Homo sapiens GN=IGHV6-1 PE=1 SV=1 A0A0B4J1X5IGHV3-74A0A0B4J1X5_HUMANProtein IGHV3-74 (Fragment)a>tr|A0A0B4J1X5|A0A0B4J1X5_HUMAN Protein IGHV3-74 (Fragment) OS=Homo sapiens GN=IGHV3-74 PE=1 SV=1A0A0B4J2C3;P13693;Q5W0H4TPT1(A0A0B4J2C3_HUMAN;TCTP_HUMAN;Q5W0H4_HUMAN(Translationally-controlled tumor protein;calcium ion transport,cellular calcium ion homeostasis,response to virus,cell differentiation,regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;E;RNA binding,calcium ion binding,protein binding,microtubule binding;i;extracellular space,nucleus,cytoplasm,multivesicular body,cytosol,extracellular exosome,tubulin complex;.>tr|A0A0B4J2C3|A0A0B4J2C3_HUMAN Translationally-controlled tumor protein OS=Homo sapiens GN=TPT1 PE=1 SV=1;>sp|P13693|TCTP_HUMAN Translationally-controlled tumor protein OS=Homo sapiens GN=TPT1 PE=1 SV=1;>tr|Q5W0H4|Q5W0H4_HUMAN Translationally-controlled tumor protein OS=Homo sapiens GN=TPT1 PE=1 SV=1 A0A0C4DH34IGHV4-28A0A0C4DH34_HUMANProtein IGHV4-28 (Fragment)a>tr|A0A0C4DH34|A0A0C4DH34_HUMAN Protein IGHV4-28 (Fragment) OS=Homo sapiens GN=IGHV4-28 PE=1 SV=1A0A0C4DH73;P01611IGKV1-12;IGKV1D-12KV112_HUMAN;KVD12_HUMANFImmunoglobulin kappa variable 1-12;Immunoglobulin kappa variable 1D-125immunoglobulin production,proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling path< way involved in phagocytosis,regulation of immune response,leukocyte migration;proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response,leukocyte migrationeantigen binding,serine-type endopeptidase activity;antigen binding,serine-type endopeptidase activityextracellular region,extracellular space,plasma membrane;extracellular region,plasma membrane,extracellular exosome,blood microparticle>sp|A0A0C4DH73|KV112_HUMAN Immunoglobulin kappa variable 1-12 OS=Homo sapiens GN=IGKV1-12 PE=3 SV=1;>sp|P01611|KVD12_HUMAN Immunoglobulin kappa variable 1D-12 OS=Homo sapiens GN=IGKV1D-12 PE=1 SV=2A0A182DWH7;P49908 SELENOP;SEPP1A0A182DWH7_HUMAN;SEPP1_HUMAN*Protein SELENOP (Fragment);Selenoprotein P;selenium compound metabolic process,platelet degranulation,response to oxidative stress,brain development,locomotory behavior,post-embryonic development,sexual reproduction,growth;selenium binding\;extracellular region,extracellular space,platelet dense granule lumen,extracellular exosome>tr|A0A182DWH7|A0A182DWH7_HUMAN Protein SELENOP (Fragment) OS=Homo sapiens GN=SELENOP PE=1 SV=1;>sp|P49908|SEPP1_HUMAN Selenoprotein P OS=Homo sapiens GN=SEPP1 PE=1 SV=37B4DEB1;K7EK07;K7EMV3;K7ES00;P68431;P84243;Q16695;Q71DI37H3F3A;H3F3B;H3F3B;H3F3B;HIST1H3A;H3F3A;HIST3H3;HIST2H3A\B4DEB1_HUMAN;K7EK07_HUMAN;K7EMV3_HUMAN;K7ES00_HUMAN;H31_HUMAN;H33_HUMAN;H31T_HUMAN;H32_HUMANxHistone H3;Histone H3 (Fragment);Histone H3;Histone H3.3 (Fragment);Histone H3.1;Histone H3.3;Histone H3.1t;Histone H3.2P;;;;chromatin silencing at rDNA,chromatin organization,nucleosome assembly,DNA replication-dependent nucleosome assembly,blood coagulation,gene silencing by RNA,telomere organization,cellular protein metabolic process,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic,protein heterotetramerization,regulation of gene silencing;chromatin silencing at rDNA,osteoblast differentiation,nucleosome assembly,DNA replication-independent nucleosome assembly,nucleus organization,spermatid development,single fertilization,brain development,embryo implantation,blood coagulation,cell proliferation,male gonad development,response to hormone,positive regulation of cell growth,gene silencing by RNA,pericentric heterochromatin assembly,telomeric heterochromatin assembly,telomere organization,multicellular organism growth,muscle cell differentiation,cellular protein metabolic process,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic,oogenesis,regulation of centromere complex assembly,negative regulation of chromosome condensation;double-strand break repair via nonhomologous end joining,nucleosome assembly,telomere capping,negative regulation of protein oligomerization,protein heterotetramerization;negative regulation of transcription from RNA polymerase II promoter,chromatin silencing at rDNA,chromatin organization,nucleosome assembly,blood coagulation,gene silencing by RNA,cellular protein metabolic process,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic;;;;DNA binding,protein binding,histone binding,cadherin binding,protein heterodimerization activity;RNA polymerase II core promoter sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,protein binding,nucleosomal DNA binding,histone binding,protein heterodimerization activity;DNA binding,protein binding,histone binding,protein heterodimerization activity;DNA binding,chromatin binding,protein binding,histone binding,protein heterodimerization activity;;;;nuclear chromosome,nuclear chromosome, telomeric region,nucleosome,nuclear nucleosome,extracellular region,nucleus,nucleoplasm,membrane,protein complex,extracellular exosome;nuclear chromosome,nuclear chromosome, telomeric region,nucleosome,nuclear nucleosome,Barr body,extracellular region,nucleus,nucleoplasm,protein complex,extracellular exosome;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,extracellular exosome;nucleosome,extracellular region,nucleus,nucleoplasm,extracellular exosometr;tr;tr;tr;sp;sp;sp;sp1;1;1;1;2;2;3;3M>tr|B4DEB1|B4DEB1_HUMAN Histone H3 OS=Homo sapiens GN=H3F3A PE=1 SV=1;>tr|K7EK07|K7EK07_HUMAN Histone H3 (Fragment) OS=Homo sapiens GN=H3F3B PE=1 SV=1;>tr|K7EMV3|K7EMV3_HUMAN Histone H3 OS=Homo sapiens GN=H3F3B PE=1 SV=1;>tr|K7ES00|K7ES00_HUMAN Histone H3.3 (Fragment) OS=Homo sapiens GN=H3F3B PE=1 SV=1;>sp|P68431|H31_HUMAN Histone H3.1 OS=Homo sapiens GN=HIST1H3A PE=1 SV=2;>sp|P84243|H33_HUMAN Histone H3.3 OS=Homo sapiens GN=H3F3A PE=1 SV=2;>sp|Q16695|H31T_HUMAN Histone H3.1t OS=Homo sapiens GN=HIST3H3 PE=1 SV=3;>sp|Q71DI3|H32_HUMAN Histone H3.2 OS=Homo sapiens GN=HIST2H3A PE=1 SV=3C9J0K6;P30626;P30626-2;P30626-3SRI0C9J0K6_HUMAN;SORCN_HUMAN;SORCN_HUMAN;SORCN_HUMAN5Sorcin;Sorcin;Isoform 2 of Sorcin;Isoform 3 of Sorcin ;action potential,proteolysis,transport,calcium ion transport,intracellular sequestering of iron ion,regulation of striated muscle contraction,signal transduction,heart development,muscle organ development,regulation of heart contraction,negative regulation of heart rate,regulation of cell communication by electrical coupling,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,positive regulation of insulin secretion involved in cellular response to glucose stimulus,cytoplasmic sequestering of transcription factor,positive regulation of release of sequestered calcium ion into cytosol,regulation of calcium ion transport,negative regulation of ryanodine-sensitive calcium-release channel activity,regulation of cardiac muscle cell contraction,regulation of relaxation of muscle,regulation of high voltage-gated calcium channel activity,regulation of cell communication by electrical coupling involved in cardiac conduction,negative regulation of transcription regulatory region DNA binding;;;protease binding,calcium-dependent cysteine-type endopeptidase activity,receptor binding,calcium channel regulator activity,calcium ion binding,protein binding,ion channel binding,protein heterodimerization activity,repressing transcription factor binding;;;nucleoplasm,cytoplasm,mitochondrion,endoplasmic reticulum membrane,smooth endoplasmic reticulum,cytosol,membrane,sarcoplasmic reticulum,Z disc,T-tubule,axon,sarcoplasmic reticulum membrane,axon terminus,dendritic spine neck,extracellular exosome,chromaffin granule membrane;;>tr|C9J0K6|C9J0K6_HUMAN Sorcin OS=Homo sapiens GN=SRI PE=1 SV=1;>sp|P30626|SORCN_HUMAN Sorcin OS=Homo sapiens GN=SRI PE=1 SV=1;>sp|P30626-2|SORCN_HUMAN Isoform 2 of Sorcin OS=Homo sapiens GN=SRI;>sp|P30626-3|SORCN_HUMAN Isoform 3 of Sorcin OS=Homo sapiens GN=SRIE7ENL6;P12111-4E7ENL6_HUMAN;CO6A3_HUMANBCollagen alpha-3(VI) chain;Isoform 4 of Collagen alpha-3(VI) chain>tr|E7ENL6|E7ENL6_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=2;>sp|P12111-4|CO6A3_HUMAN Isoform 4 of Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 F8VYK9;P24592IGFBP6F8VYK9_HUMAN;IBP6_HUMAN,Insulin-like growth factor-binding protein 6;regulation of cell growth,signal transduction,negative regulation of cell proliferation,regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,negative regulation of canonical Wnt signaling pathway\;receptor binding,insulin-like growth factor I binding,insulin-like growth factor II bindingO;extracellular region,extracellular space,Golgi apparatus,extracellular exosome>tr|F8VYK9|F8VYK9_HUMAN Insulin-like growth factor-binding protein 6 OS=Homo sapiens GN=IGFBP6 PE=1 SV=1;>sp|P24592|IBP6_HUMAN Insulin-like growth factor-binding protein 6 OS=Homo sapiens GN=IGFBP6 PE=1 SV=1 G3V5Z7;P60900PSMA6G3V5Z7_HUMAN;PSA6_HUMAN=Proteasome subunit alpha type;Proteasome subunit alpha type-6*;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation< of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,regulation of inflammatory response,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,proteolysis involved in cellular protein catabolic process,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;RNA binding,endopeptidase activity,threonine-type endopeptidase activity,protein binding,purine ribonucleoside triphosphate binding,NF-kappaB binding;proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome core complex,polysome,nuclear matrix,proteasome core complex, alpha-subunit complex,myofibril,sarcomere,extracellular exosome>tr|G3V5Z7|G3V5Z7_HUMAN Proteasome subunit alpha type OS=Homo sapiens GN=PSMA6 PE=1 SV=1;>sp|P60900|PSA6_HUMAN Proteasome subunit alpha type-6 OS=Homo sapiens GN=PSMA6 PE=1 SV=1G3XAH0SEPT5 G3XAH0_HUMANHCG2002594, isoform CRA_cT>tr|G3XAH0|G3XAH0_HUMAN HCG2002594, isoform CRA_c OS=Homo sapiens GN=SEPT5 PE=1 SV=1 H0Y7A7;P62158 CALM2;CALM1H0Y7A7_HUMAN;CALM_HUMAN Calmodulin (Fragment);Calmodulin;MAPK cascade,response to amphetamine,regulation of heart rate,platelet degranulation,detection of calcium ion,glycogen catabolic process,protein methylation,muscle contraction,G-protein coupled receptor signaling pathway,activation of adenylate cyclase activity,Wnt signaling pathway, calcium modulating pathway,positive regulation of peptidyl-threonine phosphorylation,negative regulation of peptidyl-threonine phosphorylation,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,substantia nigra development,regulation of rhodopsin mediated signaling pathway,positive regulation of cyclic nucleotide metabolic process,positive regulation of protein autophosphorylation,regulation of cytokinesis,positive regulation of phosphoprotein phosphatase activity,ion transmembrane transport,positive regulation of protein dephosphorylation,Fc-epsilon receptor signaling pathway,positive regulation of GTPase activity,inositol phosphate metabolic process,regulation of nitric-oxide synthase activity,positive regulation of nitric-oxide synthase activity,positive regulation of cyclic-nucleotide phosphodiesterase activity,response to corticosterone,response to calcium ion,regulation of cardiac muscle contraction,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of protein serine/threonine kinase activity,regulation of high voltage-gated calcium channel activity,regulation of cell communication by electrical coupling involved in cardiac conduction;Ras guanyl-nucleotide exchange factor activity,calcium ion binding,protein binding,adenylate cyclase binding,inositol-1,4,5-trisphosphate 3-kinase activity,ligand-gated ion channel activity,protein kinase binding,protein domain specific binding,nitric-oxide synthase regulator activity,titin binding,type 3 metabotropic glutamate receptor binding,thioesterase binding,N-terminal myristoylation domain binding,phospholipase binding,protein serine/threonine kinase activator activity,phosphatidylinositol 3-kinase binding,ion channel binding,calcium-dependent protein binding,nitric-oxide synthase binding,protein phosphatase activator activity;spindle pole,extracellular region,nucleus,nucleoplasm,cytoplasm,centrosome,cytosol,spindle microtubule,plasma membrane,postsynaptic density,sarcomere,growth cone,vesicle,extracellular exosome,calcium channel complex>tr|H0Y7A7|H0Y7A7_HUMAN Calmodulin (Fragment) OS=Homo sapiens GN=CALM2 PE=1 SV=1;>sp|P62158|CALM_HUMAN Calmodulin OS=Homo sapiens GN=CALM1 PE=1 SV=2H0YNH8;Q9BZF9;Q9BZF9-2UACA"H0YNH8_HUMAN;UACA_HUMAN;UACA_HUMANUveal autoantigen with coiled-coil domains and ankyrin repeats;Uveal autoantigen with coiled-coil domains and ankyrin repeats;Isoform 2 of Uveal autoantigen with coiled-coil domains and ankyrin repeatsV;biological_process,apoptotic signaling pathway,regulation of NIK/NF-kappaB signaling;$;molecular_function,protein binding;I;extracellular region,nucleus,cytosol,cytoskeleton,extracellular exosome;k>tr|H0YNH8|H0YNH8_HUMAN Uveal autoantigen with coiled-coil domains and ankyrin repeats OS=Homo sapiens GN=UACA PE=1 SV=1;>sp|Q9BZF9|UACA_HUMAN Uveal autoantigen with coiled-coil domains and ankyrin repeats OS=Homo sapiens GN=UACA PE=1 SV=2;>sp|Q9BZF9-2|UACA_HUMAN Isoform 2 of Uveal autoantigen with coiled-coil domains and ankyrin repeats OS=Homo sapiens GN=UACA H3BLU7;O43488AKR7A2H3BLU7_HUMAN;ARK72_HUMAN\Aflatoxin B1 aldehyde reductase member 2 (Fragment);Aflatoxin B1 aldehyde reductase member 2;carbohydrate metabolic process,cellular aldehyde metabolic process,xenobiotic metabolic process,daunorubicin metabolic process,doxorubicin metabolic process,oxidation-reduction process;alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,protein binding,electron carrier activity,phenanthrene-9,10-epoxide hydrolase activity.;Golgi apparatus,cytosol,extracellular exosome>tr|H3BLU7|H3BLU7_HUMAN Aflatoxin B1 aldehyde reductase member 2 (Fragment) OS=Homo sapiens GN=AKR7A2 PE=1 SV=1;>sp|O43488|ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 H3BSM5;P60520 GABARAPL2H3BSM5_HUMAN;GBRL2_HUMAN:Gamma-aminobutyric acid receptor-associated protein-like 2;intra-Golgi vesicle-mediated transport,autophagy,protein transport,macroautophagy,positive regulation of ATPase activity,membrane organization,autophagosome maturation,negative regulation of proteasomal protein catabolic process;SNARE binding,protein binding,microtubule binding,ubiquitin protein ligase binding,beta-tubulin binding,GABA receptor binding,ATPase bindingx;Golgi membrane,autophagosome membrane,intracellular,cytoplasm,autophagosome,Golgi apparatus,cytosol,cytoplasmic vesicle>tr|H3BSM5|H3BSM5_HUMAN Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Homo sapiens GN=GABARAPL2 PE=1 SV=1;>sp|P60520|GBRL2_HUMAN Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Homo sapiens GN=GABARAPL2 PE=1 SV=1 I3L145;P04278SHBGI3L145_HUMAN;SHBG_HUMANSex hormone-binding globulin!;steroid binding,androgen binding+;extracellular region,extracellular exosome>tr|I3L145|I3L145_HUMAN Sex hormone-binding globulin OS=Homo sapiens GN=SHBG PE=1 SV=1;>sp|P04278|SHBG_HUMAN Sex hormone-binding globulin OS=Homo sapiens GN=SHBG PE=1 SV=2 J3QRU1;P07947YES1J3QRU1_HUMAN;YES_HUMAN3Tyrosine-protein kinase;Tyrosine-protein kinase Yes;cellular protein modification process,transmembrane receptor protein tyrosine kinase signaling pathway,glucose transport,cell migration,cell differentiation,T cell costimulation,cellular response to platelet-derived growth factor stimulus,peptidyl-tyrosine autophosphorylation,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of cell proliferation,regulation of vascular permeability,innate immune response,positive regulation of transcription from RNA polymerase II promoter,ephrin receptor signaling pathway,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,ce< llular response to retinoic acid,cellular response to transforming growth factor beta stimulus;protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,receptor binding,epidermal growth factor receptor binding,protein binding,ATP binding,enzyme binding,ion channel binding;Golgi apparatus,microtubule organizing center,cytosol,actin filament,plasma membrane,focal adhesion,extrinsic component of cytoplasmic side of plasma membrane,extracellular exosome>tr|J3QRU1|J3QRU1_HUMAN Tyrosine-protein kinase OS=Homo sapiens GN=YES1 PE=1 SV=1;>sp|P07947|YES_HUMAN Tyrosine-protein kinase Yes OS=Homo sapiens GN=YES1 PE=1 SV=3K7EK35;P42229;P42229-2;P51692STAT5A;STAT5A;STAT5A;STAT5B0K7EK35_HUMAN;STA5A_HUMAN;STA5A_HUMAN;STA5B_HUMANSignal transducer and activator of transcription;Signal transducer and activator of transcription 5A;Isoform 2 of Signal transducer and activator of transcription 5A;Signal transducer and activator of transcription 5B ;allantoin metabolic process,positive regulation of endothelial cell proliferation,citrate metabolic process,2-oxoglutarate metabolic process,succinate metabolic process,oxaloacetate metabolic process,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,isoleucine metabolic process,valine metabolic process,creatine metabolic process,fatty acid metabolic process,JAK-STAT cascade,lactation,peptidyl-tyrosine phosphorylation,taurine metabolic process,prolactin signaling pathway,regulation of multicellular organism growth,positive regulation of blood vessel endothelial cell migration,creatinine metabolic process,JAK-STAT cascade involved in growth hormone signaling pathway;;allantoin metabolic process,luteinization,natural killer cell differentiation,citrate metabolic process,2-oxoglutarate metabolic process,succinate metabolic process,oxaloacetate metabolic process,regulation of transcription from RNA polymerase II promoter,transcription from RNA polymerase II promoter,isoleucine metabolic process,valine metabolic process,creatine metabolic process,fatty acid metabolic process,JAK-STAT cascade,female pregnancy,lactation,peptidyl-tyrosine phosphorylation,regulation of steroid metabolic process,taurine metabolic process,lipid storage,regulation of epithelial cell differentiation,response to estradiol,positive regulation of natural killer cell proliferation,positive regulation of natural killer cell differentiation,cellular response to hormone stimulus,T cell differentiation in thymus,prolactin signaling pathway,regulation of multicellular organism growth,positive regulation of multicellular organism growth,positive regulation of activated T cell proliferation,progesterone metabolic process,T cell homeostasis,negative regulation of apoptotic process,positive regulation of interleukin-2 biosynthetic process,positive regulation of B cell differentiation,positive regulation of gamma-delta T cell differentiation,negative regulation of erythrocyte differentiation,positive regulation of erythrocyte differentiation,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,positive regulation of natural killer cell mediated cytotoxicity,creatinine metabolic process,development of secondary female sexual characteristics,development of secondary male sexual characteristics,Peyer's patch development,positive regulation of inflammatory response,JAK-STAT cascade involved in growth hormone signaling pathway,response to interleukin-2,response to interleukin-4,response to interleukin-15,cellular response to growth factor stimulus,cellular response to epidermal growth factor stimulus,mast cell migration7;DNA binding,transcription factor activity, sequence-specific DNA binding,protein tyrosine kinase activity,signal transducer activity,protein binding;;RNA polymerase II core promoter sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,chromatin binding,transcription factor activity, sequence-specific DNA binding,protein tyrosine kinase activity,signal transducer activity,protein binding,protein phosphatase binding,glucocorticoid receptor binding,protein dimerization activity;;nucleoplasm,cytosol;;nucleus,nucleoplasm,cytoplasm,cytosol1;1;;2>tr|K7EK35|K7EK35_HUMAN Signal transducer and activator of transcription OS=Homo sapiens GN=STAT5A PE=1 SV=1;>sp|P42229|STA5A_HUMAN Signal transducer and activator of transcription 5A OS=Homo sapiens GN=STAT5A PE=1 SV=1;>sp|P42229-2|STA5A_HUMAN Isoform 2 of Signal transducer and activator of transcription 5A OS=Homo sapiens GN=STAT5A;>sp|P51692|STA5B_HUMAN Signal transducer and activator of transcription 5B OS=Homo sapiens GN=STAT5B PE=1 SV=2O00148;Q13838;Q13838-2;Q5STU3DDX39A;DDX39B;DDX39B;DDX39B0DX39A_HUMAN;DX39B_HUMAN;DX39B_HUMAN;Q5STU3_HUMANATP-dependent RNA helicase DDX39A;Spliceosome RNA helicase DDX39B;Isoform 2 of Spliceosome RNA helicase DDX39B;Spliceosome RNA helicase DDX39BmmRNA splicing, via spliceosome,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,cellular response to DNA damage stimulus,regulation of gene expression,RNA secondary structure unwinding,mRNA 3'-end processing;spliceosomal complex assembly,mRNA splicing, via spliceosome,liver development,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,RNA splicing,RNA secondary structure unwinding,mRNA 3'-end processing,positive regulation of DNA-templated transcription, elongation,positive regulation of translation,viral mRNA export from host cell nucleus,positive regulation of cell growth involved in cardiac muscle cell development,positive regulation of vascular smooth muscle cell proliferation,negative regulation of DNA damage checkpoint,positive regulation of DNA biosynthetic process;;cRNA binding,ATP-dependent RNA helicase activity,protein binding,ATP binding,ATPase activity,identical protein binding;RNA binding,ATP-dependent RNA helicase activity,protein binding,ATP binding,RNA-dependent ATPase activity,ATPase activity,U6 snRNA binding,U4 snRNA binding,protein complex binding,identical protein binding,ATP-dependent protein binding;;nucleus,nucleoplasm,spliceosomal complex,membrane,nuclear speck,cytoplasm;transcription export complex,nucleus,nucleoplasm,spliceosomal complex,nuclear matrix,nuclear speck,U4 snRNP,U6 snRNP,cytoplasm;;2;1;;2s>sp|O00148|DX39A_HUMAN ATP-dependent RNA helicase DDX39A OS=Homo sapiens GN=DDX39A PE=1 SV=2;>sp|Q13838|DX39B_HUMAN Spliceosome RNA helicase DDX39B OS=Homo sapiens GN=DDX39B PE=1 SV=1;>sp|Q13838-2|DX39B_HUMAN Isoform 2 of Spliceosome RNA helicase DDX39B OS=Homo sapiens GN=DDX39B;>tr|Q5STU3|Q5STU3_HUMAN Spliceosome RNA helicase DDX39B OS=Homo sapiens GN=DDX39B PE=1 SV=2O00161SNAP23 SNP23_HUMAN"Synaptosomal-associated protein 23Hantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,histamine secretion by mast cell,post-Golgi vesicle-mediated transport,vesicle targeting,protein transport,synaptic vesicle priming,synaptic vesicle fusion to presynaptic active zone membrane,neutrophil degranulation,membrane fusion7SNAP receptor activity,protein binding,syntaxin bindingnucleoplasm,cytoplasm,plasma membrane,cell-cell adherens junction,focal adhesion,phagocytic vesicle membrane,SNARE complex,specific granule membrane,specific granule,azurophil granule,mast cell granule,neuron projection,extracellular exosome,tertiary granule membrane,presynapse]>sp|O00161|SNP23_HUMAN Synaptosomal-associated protein 23 OS=Homo sapiens GN=SNAP23 PE=1 SV=1GA0A087X208;O00468;O00468-2;O00468-3;O00468-4;O00468-5;O00468-6;O00468-7AGRNdA0A087X208_HUMAN;AGRIN_HUMAN;AGRIN_HUMAN;AGRIN_HUMAN;AGRIN_HUMAN;AGRIN_HUMAN;AGRIN_HUMAN;AGRIN_HUMAN}Agrin;Agrin;Isoform 2 of Agrin;Isoform 3 of Agrin;Isoform 4 of Agrin;Isoform 5 of Agrin;Isoform 6 of Agrin;Isoform 7 of AgrinH;retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,cytoskeleton organization,signal transduction,G-protein coupled acetylcholine receptor s< ignaling pathway,extracellular matrix organization,glycosaminoglycan metabolic process,receptor clustering,positive regulation of GTPase activity,clustering of voltage-gated sodium channels,positive regulation of synaptic growth at neuromuscular junction,positive regulation of transcription from RNA polymerase II promoter,synapse organization,positive regulation of filopodium assembly;;;;;;;dystroglycan binding,structural constituent of cytoskeleton,calcium ion binding,protein binding,sialic acid binding,chondroitin sulfate binding,laminin binding,heparan sulfate proteoglycan binding;;;;;;;extracellular region,basal lamina,Golgi lumen,cytosol,plasma membrane,integral component of membrane,cell junction,extracellular matrix,lysosomal lumen,synapse,extracellular exosome;;;;;; 1;5;;;;;;>tr|A0A087X208|A0A087X208_HUMAN Agrin OS=Homo sapiens GN=AGRN PE=1 SV=1;>sp|O00468|AGRIN_HUMAN Agrin OS=Homo sapiens GN=AGRN PE=1 SV=5;>sp|O00468-2|AGRIN_HUMAN Isoform 2 of Agrin OS=Homo sapiens GN=AGRN;>sp|O00468-3|AGRIN_HUMAN Isoform 3 of Agrin OS=Homo sapiens GN=AGRN;>sp|O00468-4|AGRIN_HUMAN Isoform 4 of Agrin OS=Homo sapiens GN=AGRN;>sp|O00468-5|AGRIN_HUMAN Isoform 5 of Agrin OS=Homo sapiens GN=AGRN;>sp|O00468-6|AGRIN_HUMAN Isoform 6 of Agrin OS=Homo sapiens GN=AGRN;>sp|O00468-7|AGRIN_HUMAN Isoform 7 of Agrin OS=Homo sapiens GN=AGRNO43149ZZEF1 ZZEF1_HUMAN;Zinc finger ZZ-type and EF-hand domain-containing protein 1$calcium ion binding,zinc ion bindingu>sp|O43149|ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6O43157;O43157-2PLXNB1 PLXB1_HUMAN Plexin-B1;Isoform 2 of Plexin-B1Lnegative regulation of cell adhesion,signal transduction,regulation of cell shape,positive regulation of phosphatidylinositol 3-kinase signaling,cell migration,negative regulation of osteoblast proliferation,intracellular signal transduction,regulation of GTPase activity,positive regulation of GTPase activity,ossification involved in bone maturation,axon extension,neuron projection morphogenesis,positive regulation of axonogenesis,regulation of cytoskeleton organization,semaphorin-plexin signaling pathway,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;receptor activity,transmembrane signaling receptor activity,GTPase activator activity,protein binding,semaphorin receptor activity,semaphorin receptor binding,GTPase activating protein binding;usemaphorin receptor complex,extracellular region,intracellular,plasma membrane,integral component of plasma membrane;>sp|O43157|PLXB1_HUMAN Plexin-B1 OS=Homo sapiens GN=PLXNB1 PE=1 SV=3;>sp|O43157-2|PLXB1_HUMAN Isoform 2 of Plexin-B1 OS=Homo sapiens GN=PLXNB1O43242PSMD3 PSMD3_HUMAN.26S proteasome non-ATPase regulatory subunit 3MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway)protein binding,enzyme regulator activityproteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, lid subcomplex,membrane,proteasome accessory complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenh>sp|O43242|PSMD3_HUMAN 26S proteasome non-ATPase regulatory subunit 3 OS=Homo sapiens GN=PSMD3 PE=1 SV=2O75165DNAJC13 DJC13_HUMAN"DnaJ homolog subfamily C member 13osteoblast differentiation,endosome organization,protein transport,neutrophil degranulation,regulation of early endosome to recycling endosome transport,regulation of early endosome to late endosome transportlysosomal membrane,cytosol,plasma membrane,endosome membrane,membrane,secretory granule membrane,early endosome membrane,azurophil granule membrane,intracellular membrane-bounded organelle,extracellular exosome,WASH complex^>sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens GN=DNAJC13 PE=1 SV=58A0A0A0MRV8;O75935;O75935-2;O75935-3;X6RA56;X6RCK5;X6RLR1DCTN3[A0A0A0MRV8_HUMAN;DCTN3_HUMAN;DCTN3_HUMAN;DCTN3_HUMAN;X6RA56_HUMAN;X6RCK5_HUMAN;X6RLR1_HUMANDynactin subunit 3 (Fragment);Dynactin subunit 3;Isoform 2 of Dynactin subunit 3;Isoform 3 of Dynactin subunit 3;Dynactin subunit 3;Dynactin subunit 3 (Fragment);Dynactin subunit 3;G2/M transition of mitotic cell cycle,cytokinesis,ER to Golgi vesicle-mediated transport,microtubule-based process,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,ciliary basal body docking;;;;;2;structural molecule activity,protein binding;;;;;;condensed chromosome kinetochore,nucleolus,centrosome,spindle,cytosol,dynactin complex,midbody,cleavage furrow,perinuclear region of cytoplasm;;;;;tr;sp;sp;sp;tr;tr;tr 1;1;;;1;1;1 6;1;;;1;1;1F>tr|A0A0A0MRV8|A0A0A0MRV8_HUMAN Dynactin subunit 3 (Fragment) OS=Homo sapiens GN=DCTN3 PE=1 SV=6;>sp|O75935|DCTN3_HUMAN Dynactin subunit 3 OS=Homo sapiens GN=DCTN3 PE=1 SV=1;>sp|O75935-2|DCTN3_HUMAN Isoform 2 of Dynactin subunit 3 OS=Homo sapiens GN=DCTN3;>sp|O75935-3|DCTN3_HUMAN Isoform 3 of Dynactin subunit 3 OS=Homo sapiens GN=DCTN3;>tr|X6RA56|X6RA56_HUMAN Dynactin subunit 3 OS=Homo sapiens GN=DCTN3 PE=1 SV=1;>tr|X6RCK5|X6RCK5_HUMAN Dynactin subunit 3 (Fragment) OS=Homo sapiens GN=DCTN3 PE=1 SV=1;>tr|X6RLR1|X6RLR1_HUMAN Dynactin subunit 3 OS=Homo sapiens GN=DCTN3 PE=1 SV=1O76009KRT33A KT33A_HUMANKeratin, type I cuticular Ha3-Ikeratinization,cornificationstructural molecule activity1extracellular space,cytosol,intermediate filamentZ>sp|O76009|KT33A_HUMAN Keratin, type I cuticular Ha3-I OS=Homo sapiens GN=KRT33A PE=2 SV=2O94919ENDOD1 ENDD1_HUMAN(Endonuclease domain-containing 1 proteinBplatelet degranulation,nucleic acid phosphodiester bond hydrolysis<nucleic acid binding,endonuclease activity,metal ion binding;extracellular region,cytosol,membrane,extracellular exosomec>sp|O94919|ENDD1_HUMAN Endonuclease domain-containing 1 protein OS=Homo sapiens GN=ENDOD1 PE=1 SV=2P00441SOD1 SODC_HUMANSuperoxide dismutase [Cu-Zn]lactivation of MAPK activity,response to reactive oxygen species,response to superoxide,ovarian follicle development,positive regulation of cytokine production,placenta development,retina homeostasis,response to amphetamine,myeloid cell homeostasis,platelet degranulation,glutathione metabolic process,superoxide metabolic process,cellular iron ion homeostasis,spermatogenesis,embryo implantation,cell aging,sensory perception of sound,locomotory behavior,anterograde axonal transport,retrograde axonal transport,regulation of blood pressure,response to heat,response to organic substance,transmission of nerve impulse,removal of superoxide radicals,response to nutrient levels,peripheral nervous system myelin maintenance,positive regulation of superoxide anion generation,regulation of T cell differentiation in thymus,response to carbon monoxide,cellular response to potassium ion,regulation of multicellular organism growth,response to drug,response to hydrogen peroxide,superoxide anion generation,positive regulation of apoptotic process,pos< itive regulation of catalytic activity,regulation of GTPase activity,negative regulation of neuron apoptotic process,response to ethanol,negative regulation of cholesterol biosynthetic process,regulation of protein kinase activity,regulation of organ growth,response to antibiotic,response to copper ion,muscle cell cellular homeostasis,thymus development,response to axon injury,hydrogen peroxide biosynthetic process,regulation of mitochondrial membrane potential,oxidation-reduction process,heart contraction,neurofilament cytoskeleton organization,relaxation of vascular smooth muscle,auditory receptor cell stereocilium organization,cellular response to cadmium ion,cellular response to ATP,reactive oxygen species metabolic process,response to antipsychotic drug,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathwaysuperoxide dismutase activity,copper ion binding,protein binding,zinc ion binding,protein phosphatase 2B binding,identical protein binding,protein homodimerization activity,Rac GTPase binding,chaperone binding\extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,lysosome,peroxisome,cytosol,extracellular matrix,dense core granule,cytoplasmic vesicle,dendrite cytoplasm,neuronal cell body,myelin sheath,protein complex,extracellular exosome,axon cytoplasm,plasma membraneT>sp|P00441|SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2P00915CA1 CAH1_HUMANCarbonic anhydrase 1jarylesterase activity,carbonate dehydratase activity,protein binding,zinc ion binding,hydro-lyase activitycytosol,extracellular exosomeK>sp|P00915|CAH1_HUMAN Carbonic anhydrase 1 OS=Homo sapiens GN=CA1 PE=1 SV=2P01116;P01116-2KRAS RASK_HUMAN%GTPase KRas;Isoform 2B of GTPase KRasMAPK cascade,liver development,positive regulation of protein phosphorylation,stimulatory C-type lectin receptor signaling pathway,epidermal growth factor receptor signaling pathway,Ras protein signal transduction,axon guidance,female pregnancy,positive regulation of cell proliferation,visual learning,positive regulation of gene expression,cytokine-mediated signaling pathway,forebrain astrocyte development,actin cytoskeleton organization,regulation of protein stability,regulation of synaptic transmission, GABAergic,positive regulation of Rac protein signal transduction,response to isolation stress,endocrine signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,positive regulation of MAP kinase activity,negative regulation of neuron apoptotic process,negative regulation of cell differentiation,regulation of long-term neuronal synaptic plasticity,homeostasis of number of cells within a tissue,leukocyte migration,positive regulation of nitric-oxide synthase activity,positive regulation of NF-kappaB transcription factor activity,striated muscle cell differentiation,response to glucocorticoid,response to mineralocorticoid,epithelial tube branching involved in lung morphogenesis,positive regulation of cellular senescence;oGTPase activity,protein binding,GTP binding,GMP binding,GDP binding,LRR domain binding,protein complex binding;cytoplasm,mitochondrion,cytosol,plasma membrane,focal adhesion,membrane,extrinsic component of cytoplasmic side of plasma membrane,membrane raft;>sp|P01116|RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1;>sp|P01116-2|RASK_HUMAN Isoform 2B of GTPase KRas OS=Homo sapiens GN=KRASP01700IGLV1-47 LV147_HUMAN#Immunoglobulin lambda variable 1-47`>sp|P01700|LV147_HUMAN Immunoglobulin lambda variable 1-47 OS=Homo sapiens GN=IGLV1-47 PE=1 SV=2P01717IGLV3-25 LV325_HUMAN#Immunoglobulin lambda variable 3-25`>sp|P01717|LV325_HUMAN Immunoglobulin lambda variable 3-25 OS=Homo sapiens GN=IGLV3-25 PE=1 SV=2P02458;P02458-1COL2A1 CO2A1_HUMANBCollagen alpha-1(II) chain;Isoform 1 of Collagen alpha-1(II) chainskeletal system development,cartilage condensation,tissue homeostasis,endochondral ossification,chondrocyte differentiation,heart morphogenesis,proteoglycan metabolic process,central nervous system development,visual perception,sensory perception of sound,regulation of gene expression,extracellular matrix organization,collagen fibril organization,collagen catabolic process,notochord development,inner ear morphogenesis,regulation of immune response,cartilage development,palate development,limb bud formation,embryonic skeletal joint morphogenesis,cartilage development involved in endochondral bone morphogenesis,otic vesicle development,cellular response to BMP stimulus,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;extracellular matrix structural constituent conferring tensile strength,identical protein binding,metal ion binding,platelet-derived growth factor binding;extracellular region,collagen type II trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,extracellular matrix;>sp|P02458|CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3;>sp|P02458-1|CO2A1_HUMAN Isoform 1 of Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1P02743APCS SAMP_HUMANSerum amyloid P-componentYnegative regulation of acute inflammatory response,protein folding,acute-phase response,cellular protein metabolic process,negative regulation by host of viral exo-alpha-sialidase activity,negative regulation by host of viral glycoprotein metabolic process,innate immune response,negative regulation of monocyte differentiation,negative regulation of viral entry into host cell,negative regulation of viral process,chaperone-mediated protein complex assembly,negative regulation of wound healing,negative regulation of exo-alpha-sialidase activity,negative regulation of glycoprotein metabolic processqcomplement component C1q binding,calcium ion binding,carbohydrate binding,virion binding,unfolded protein bindingoextracellular region,extracellular space,nucleus,extracellular exosome,blood microparticle,extracellular matrixQ>sp|P02743|SAMP_HUMAN Serum amyloid P-component OS=Homo sapiens GN=APCS PE=1 SV=2P04439;Q5SRN5;Q5SRN7$1A03_HUMAN;Q5SRN5_HUMAN;Q5SRN7_HUMANHLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chainsp;tr;trV>sp|P04439|1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2;>tr|Q5SRN5|Q5SRN5_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2;>tr|Q5SRN7|Q5SRN7_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2P05154SERPINA5 IPSP_HUMAN Plasma serine protease inhibitorlipid transport,spermatogenesis,fusion of sperm to egg plasma membrane,blood coagulation,negative regulation of endopeptidase activity,negative regulation of hydrolase activity,seminal vesicle developmentretinoic acid binding,protease binding,serine-type endopeptidase inhibitor activity,protein binding,glycosaminoglycan binding,heparin binding,phosphatidylcholine binding,acrosin bindingVacrosomal membrane,extracellular region,extracellular space,external side of plasma membrane,membrane,platelet alpha granule,platelet dense tubular network,protein C inhibitor-TMPRSS7 complex,protein C inhibitor-TMPRSS11E complex,protein C inhibitor-PLAT complex,protein C inhibitor-PLAU complex,protein C inhibitor-thrombin complex,protein C inhibitor-KLK3 complex,protein C inhibitor-plasma kallikrein complex,protein complex,extracellular exosome,protein C inhibitor-coagulation factor V complex,protein C inhibitor-coagulation factor Xa complex,protein C inhibitor-coagulation factor XI complex\>sp|P05154|IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3P05362ICAM1 ICAM1_HUMAN!Intercellular adhesion molecule 1?ovarian follicle development,regulation of leukocyte mediated cytotoxicity,response to amphetamine,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,acute inflammatory respon< se to antigenic stimulus,T cell antigen processing and presentation,positive regulation of cellular extravasation,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell aging,sensory perception of sound,regulation of cell shape,response to ionizing radiation,response to sulfur dioxide,membrane to membrane docking,extracellular matrix organization,positive regulation of actin filament polymerization,cellular response to nutrient levels,response to insulin,cell adhesion mediated by integrin,response to gonadotropin,response to drug,response to amino acid,positive regulation of GTPase activity,adhesion of symbiont to host,positive regulation of nitric oxide biosynthetic process,response to ethanol,positive regulation of vasoconstriction,response to copper ion,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of peptidyl-tyrosine phosphorylation,regulation of immune response,leukocyte migration,positive regulation of NF-kappaB transcription factor activity,negative regulation of calcium ion transport,interferon-gamma-mediated signaling pathway,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to lipopolysaccharide,cellular response to alkaloid,cellular response to glucose stimulus,cellular response to interleukin-1,cellular response to interleukin-6,cellular response to tumor necrosis factor,cellular response to hypoxia,cellular response to dexamethasone stimulus,establishment of endothelial intestinal barrier,establishment of Sertoli cell barrier,regulation of ruffle assembly,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of leukocyte adhesion to vascular endothelial cell,negative regulation of endothelial cell apoptotic processtvirus receptor activity,receptor activity,transmembrane signaling receptor activity,integrin binding,protein bindingimmunological synapse,extracellular space,plasma membrane,integral component of plasma membrane,focal adhesion,external side of plasma membrane,cell surface,membrane,membrane raft,extracellular exosome[>sp|P05362|ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2P05534 1A24_HUMAN8HLA class I histocompatibility antigen, A-24 alpha chainq>sp|P05534|1A24_HUMAN HLA class I histocompatibility antigen, A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2P05543SERPINA7 THBG_HUMANThyroxine-binding globulinGnegative regulation of endopeptidase activity,thyroid hormone transportV>sp|P05543|THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2P08185SERPINA6 CBG_HUMANCorticosteroid-binding globulinXtransport,glucocorticoid metabolic process,negative regulation of endopeptidase activity<serine-type endopeptidase inhibitor activity,steroid bindingZ>sp|P08185|CBG_HUMAN Corticosteroid-binding globulin OS=Homo sapiens GN=SERPINA6 PE=1 SV=1P08779KRT16 K1C16_HUMANKeratin, type I cytoskeletal 16dmorphogenesis of an epithelium,inflammatory response,cytoskeleton organization,aging,cell proliferation,epidermis development,keratinocyte differentiation,negative regulation of cell migration,keratinization,hair cycle,innate immune response,intermediate filament cytoskeleton organization,keratinocyte migration,establishment of skin barrier,cornificationHnucleus,cytosol,cytoskeleton,intermediate filament,extracellular exosomeY>sp|P08779|K1C16_HUMAN Keratin, type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4P09493-8TPM1 TPM1_HUMAN&Isoform 8 of Tropomyosin alpha-1 chainV>sp|P09493-8|TPM1_HUMAN Isoform 8 of Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1P0C7P3;P0C7P3-2SLFN14 SLN14_HUMAN*Protein SLFN14;Isoform 2 of Protein SLFN14mRNA catabolic process,rRNA catabolic process,platelet maturation,cellular response to magnesium ion,cellular response to manganese ion,RNA phosphodiester bond hydrolysis, endonucleolytic;7endoribonuclease activity,ATP binding,ribosome binding;nucleus,cytoplasm;>sp|P0C7P3|SLN14_HUMAN Protein SLFN14 OS=Homo sapiens GN=SLFN14 PE=1 SV=2;>sp|P0C7P3-2|SLN14_HUMAN Isoform 2 of Protein SLFN14 OS=Homo sapiens GN=SLFN14P0CG06IGLC3 LAC3_HUMANIg lambda-3 chain C regionsextracellular region,extracellular space,plasma membrane,external side of plasma membrane,immunoglobulin complex, circulating,blood microparticleT>sp|P0CG06|LAC3_HUMAN Ig lambda-3 chain C regions OS=Homo sapiens GN=IGLC3 PE=1 SV=1P0DJI8SAA1 SAA1_HUMANSerum amyloid A-1 proteinactivation of MAPK activity,receptor-mediated endocytosis,acute-phase response,positive regulation of cytosolic calcium ion concentration,platelet activation,neutrophil chemotaxis,cellular protein metabolic process,innate immune response,positive regulation of cell adhesion,macrophage chemotaxis,lymphocyte chemotaxis,regulation of protein secretion,positive regulation of cytokine secretion,positive regulation of interleukin-1 secretion,negative regulation of inflammatory response,positive chemotaxisKG-protein coupled receptor binding,heparin binding,chemoattractant activityextracellular region,extracellular space,cytoplasmic microtubule,high-density lipoprotein particle,extracellular exosome,endocytic vesicle lumenQ>sp|P0DJI8|SAA1_HUMAN Serum amyloid A-1 protein OS=Homo sapiens GN=SAA1 PE=1 SV=1P0DJI9SAA2 SAA2_HUMANSerum amyloid A-2 protein8acute-phase response,positive chemotaxis,cell chemotaxisKextracellular space,high-density lipoprotein particle,extracellular exosomeQ>sp|P0DJI9|SAA2_HUMAN Serum amyloid A-2 protein OS=Homo sapiens GN=SAA2 PE=1 SV=1P11717IGF2R MPRI_HUMAN/Cation-independent mannose-6-phosphate receptor]liver development,receptor-mediated endocytosis,signal transduction,G-protein coupled receptor signaling pathway,spermatogenesis,post-embryonic development,animal organ regeneration,response to retinoic acid,positive regulation of apoptotic process,neutrophil degranulation,insulin-like growth factor receptor signaling pathway,membrane organizationRglycoprotein binding,G-protein alpha-subunit binding,retinoic acid binding,receptor activity,G-protein coupled receptor activity,insulin-like growth factor-activated receptor activity,transporter activity,protein binding,mannose binding,enzyme binding,insulin-like growth factor II binding,identical protein binding,phosphoprotein bindingextracellular space,nuclear envelope lumen,lysosomal membrane,endosome,early endosome,late endosome,Golgi apparatus,trans-Golgi network,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,membrane,clathrin coat,transport vesicle,endocytic vesicle,trans-Golgi network transport vesicle,clathrin-coated vesicle membrane,secretory granule membrane,trans-Golgi network membrane,perinuclear region of cytoplasm,extracellular exosomeh>sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3P15169CPN1 CBPN_HUMAN"Carboxypeptidase N catalytic chainJbradykinin catabolic process,insulin processing,response to glucocorticoid1metallocarboxypeptidase activity,zinc ion bindingZextracellular space,Golgi apparatus,secretory granule,neuronal cell body,synaptic membraneZ>sp|P15169|CBPN_HUMAN Carboxypeptidase N catalytic chain OS=Homo sapiens GN=CPN1 PE=1 SV=1P15170;P15170-2;P15170-3GSPT1 ERF3A_HUMANEukaryotic peptide chain release factor GTP-binding subunit ERF3A;Isoform 2 of Eukaryotic peptide chain release factor GTP-binding subunit ERF3A;Isoform 3 of Eukaryotic peptide chain release factor GTP-binding subunit ERF3AG1/S transition of mitotic cell cycle,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translational termination,translational termination,protein methylation;;]RNA binding,translation release factor activity,GTPase activity,protein binding,GTP binding;;:intracellular,cytosol,translation release factor complex;;}>sp|P15170|ERF3A_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens GN=GSPT1 PE=1 SV=1;>sp|P1517< 0-2|ERF3A_HUMAN Isoform 2 of Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens GN=GSPT1;>sp|P15170-3|ERF3A_HUMAN Isoform 3 of Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens GN=GSPT1P17931LGALS3 LEG3_HUMAN Galectin-3omonocyte chemotaxis,mRNA processing,RNA splicing,neutrophil chemotaxis,epithelial cell differentiation,regulation of T cell proliferation,neutrophil degranulation,innate immune response,negative regulation of endocytosis,eosinophil chemotaxis,macrophage chemotaxis,negative regulation of T cell receptor signaling pathway,positive chemotaxis,regulation of T cell apoptotic process,mononuclear cell migration,positive regulation of mononuclear cell migration,positive regulation of calcium ion import,regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of immunological synapse formation,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,negative regulation of extrinsic apoptotic signaling pathway,positive regulation of dendritic cell differentiationeRNA binding,protein binding,IgE binding,carbohydrate binding,chemoattractant activity,laminin bindingimmunological synapse,extracellular space,nucleus,spliceosomal complex,cytoplasm,mitochondrial inner membrane,plasma membrane,membrane,secretory granule membrane,extracellular exosome,ficolin-1-rich granule membrane,extracellular matrixD>sp|P17931|LEG3_HUMAN Galectin-3 OS=Homo sapiens GN=LGALS3 PE=1 SV=5P20160AZU1 CAP7_HUMAN Azurocidin7microglial cell activation,proteolysis,inflammatory response,protein kinase C-activating G-protein coupled receptor signaling pathway,glial cell migration,positive regulation of gene expression,positive regulation of peptidyl-threonine phosphorylation,protein processing,antimicrobial humoral response,calcium-mediated signaling using intracellular calcium source,monocyte activation,positive regulation of tumor necrosis factor biosynthetic process,negative regulation of apoptotic process,regulation of vascular permeability,neutrophil degranulation,cellular extravasation,positive regulation of MHC class II biosynthetic process,positive regulation of cell adhesion,positive regulation of protein kinase activity,macrophage chemotaxis,positive regulation of interleukin-1 beta biosynthetic process,positive regulation of fractalkine biosynthetic process,positive regulation of phagocytosis,defense response to Gram-negative bacterium,induction of positive chemotaxis,defense response to virus,cell chemotaxis,protein kinase C signaling,neutrophil mediated killing of bacteriumserine-type endopeptidase activity,protein binding,heparin binding,peptidase activity,toxic substance binding,heparan sulfate proteoglycan bindingextracellular region,extracellular space,extrinsic component of membrane,azurophil granule membrane,azurophil granule lumen,azurophil granule,extracellular exosomeB>sp|P20160|CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 H0YGT2;P20645M6PRH0YGT2_HUMAN;MPRD_HUMANfCation-dependent mannose-6-phosphate receptor (Fragment);Cation-dependent mannose-6-phosphate receptor;receptor-mediated endocytosis,signal transduction,endosome to lysosome transport,mannose transport,secretion of lysosomal enzymes,membrane organization;transmembrane signaling receptor activity,protein binding,mannose binding,mannose transmembrane transporter activity,retromer complex binding;lysosomal membrane,endosome,late endosome,plasma membrane,integral component of plasma membrane,membrane,transport vesicle,clathrin-coated vesicle membrane,trans-Golgi network membrane,perinuclear region of cytoplasm,retromer complex>tr|H0YGT2|H0YGT2_HUMAN Cation-dependent mannose-6-phosphate receptor (Fragment) OS=Homo sapiens GN=M6PR PE=1 SV=1;>sp|P20645|MPRD_HUMAN Cation-dependent mannose-6-phosphate receptor OS=Homo sapiens GN=M6PR PE=1 SV=1EP23634;P23634-2;P23634-3;P23634-4;P23634-5;P23634-6;P23634-7;P23634-8ATP2B4 AT2B4_HUMANPlasma membrane calcium-transporting ATPase 4;Isoform XA of Plasma membrane calcium-transporting ATPase 4;Isoform ZA of Plasma membrane calcium-transporting ATPase 4;Isoform XK of Plasma membrane calcium-transporting ATPase 4;Isoform ZK of Plasma membrane calcium-transporting ATPase 4;Isoform XB of Plasma membrane calcium-transporting ATPase 4;Isoform ZB of Plasma membrane calcium-transporting ATPase 4;Isoform ZD of Plasma membrane calcium-transporting ATPase 4neural retina development,regulation of transcription from RNA polymerase II promoter,cellular calcium ion homeostasis,spermatogenesis,negative regulation of nitric oxide mediated signal transduction,hippocampus development,flagellated sperm motility,positive regulation of peptidyl-serine phosphorylation,ion transmembrane transport,negative regulation of nitric oxide biosynthetic process,negative regulation of nitric-oxide synthase activity,response to hydrostatic pressure,calcium ion transmembrane transport,negative regulation of calcineurin-NFAT signaling cascade,cellular response to epinephrine stimulus,calcium ion transmembrane import into cytosol,calcium ion import across plasma membrane,negative regulation of the force of heart contraction,Requires Ontology,negative regulation of arginine catabolic process,negative regulation of adrenergic receptor signaling pathway involved in heart process,calcium ion export,negative regulation of peptidyl-cysteine S-nitrosylation,regulation of sodium ion transmembrane transport,regulation of cell cycle G1/S phase transition,negative regulation of cardiac muscle hypertrophy in response to stress,negative regulation of citrulline biosynthetic process,regulation of cardiac conduction,positive regulation of cAMP-dependent protein kinase activity;;;;;;;7calcium-transporting ATPase activity,protein binding,calmodulin binding,ATP binding,protein kinase binding,PDZ domain binding,protein phosphatase 2B binding,nitric-oxide synthase inhibitor activity,metal ion binding,nitric-oxide synthase binding,scaffold protein binding,sodium channel regulator activity;;;;;;;plasma membrane,integral component of plasma membrane,caveola,membrane,basolateral plasma membrane,Z disc,T-tubule,sperm flagellum,neuron projection,intracellular membrane-bounded organelle,protein complex,sperm principal piece;;;;;;;2;;;;;;;q>sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4 PE=1 SV=2;>sp|P23634-2|AT2B4_HUMAN Isoform XA of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4;>sp|P23634-3|AT2B4_HUMAN Isoform ZA of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4;>sp|P23634-4|AT2B4_HUMAN Isoform XK of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4;>sp|P23634-5|AT2B4_HUMAN Isoform ZK of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4;>sp|P23634-6|AT2B4_HUMAN Isoform XB of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4;>sp|P23634-7|AT2B4_HUMAN Isoform ZB of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4;>sp|P23634-8|AT2B4_HUMAN Isoform ZD of Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens GN=ATP2B4P26022PTX3 PTX3_HUMANPentraxin-related protein PTX3response to yeast,inflammatory response,opsonization,neutrophil degranulation,negative regulation by host of viral exo-alpha-sialidase activity,negative regulation by host of viral glycoprotein metabolic process,innate immune response,positive regulation of nitric oxide biosynthetic process,negative regulation of viral entry into host cell,positive regulation of phagocytosis,negative regulation of exo-alpha-sialidase activity,negative regulation of glycoprotein metabolic processvcomplement component C1q binding,(1->3)-beta-D-glucan binding,protein binding,identical protein binding,virion bindingVextracellular region,extracellular space,specific granule lumen,tertiary granule lumenV>sp|P26022|PTX3_HUMAN Pentraxin-related protein PTX3 OS=Homo sapiens GN=PTX3 PE=1 SV=3P29122;P29122-2PCSK6 PCSK6_HUMAN< pProprotein convertase subtilisin/kexin type 6;Isoform PACE4A-II of Proprotein convertase subtilisin/kexin type 6Kzygotic determination of anterior/posterior axis, embryo,determination of left/right symmetry,glycoprotein metabolic process,protein processing,peptide hormone processing,regulation of BMP signaling pathway,nerve growth factor processing,nerve growth factor production,secretion by cell,lipoprotein metabolic process,cornification;fendopeptidase activity,serine-type endopeptidase activity,heparin binding,nerve growth factor binding;}extracellular region,extracellular space,endoplasmic reticulum,Golgi lumen,plasma membrane,cell surface,extracellular matrix;>sp|P29122|PCSK6_HUMAN Proprotein convertase subtilisin/kexin type 6 OS=Homo sapiens GN=PCSK6 PE=1 SV=1;>sp|P29122-2|PCSK6_HUMAN Isoform PACE4A-II of Proprotein convertase subtilisin/kexin type 6 OS=Homo sapiens GN=PCSK6P31948;P31948-2;P31948-3STIP1 STIP1_HUMANyStress-induced-phosphoprotein 1;Isoform 2 of Stress-induced-phosphoprotein 1;Isoform 3 of Stress-induced-phosphoprotein 1response to stress;;`RNA binding,protein binding,protein C-terminus binding,Hsp70 protein binding,chaperone binding;;7nucleus,Golgi apparatus,myelin sheath,protein complex;;>sp|P31948|STIP1_HUMAN Stress-induced-phosphoprotein 1 OS=Homo sapiens GN=STIP1 PE=1 SV=1;>sp|P31948-2|STIP1_HUMAN Isoform 2 of Stress-induced-phosphoprotein 1 OS=Homo sapiens GN=STIP1;>sp|P31948-3|STIP1_HUMAN Isoform 3 of Stress-induced-phosphoprotein 1 OS=Homo sapiens GN=STIP1P35527KRT9 K1C9_HUMANKeratin, type I cytoskeletal 9vspermatogenesis,epidermis development,keratinization,skin development,intermediate filament organization,cornification&structural constituent of cytoskeletonXextracellular space,nucleus,cytosol,intermediate filament,membrane,extracellular exosomeV>sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3P35612ADD2 ADDB_HUMAN Beta-adducinprotein complex assembly,actin cytoskeleton organization,hemopoiesis,positive regulation of protein binding,barbed-end actin filament capping,actin filament bundle assembly,transmembrane transportactin binding,structural molecule activity,calmodulin binding,spectrin binding,protein homodimerization activity,protein heterodimerization activity,actin filament binding`cytosol,plasma membrane,F-actin capping protein complex,postsynaptic density,cytoplasmic vesicleD>sp|P35612|ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD2 PE=1 SV=3 I3L3N5;P43034PAFAH1B1I3L3N5_HUMAN;LIS1_HUMANPlatelet-activating factor acetylhydrolase IB subunit alpha (Fragment);Platelet-activating factor acetylhydrolase IB subunit alpha;G2/M transition of mitotic cell cycle,establishment of mitotic spindle orientation,microtubule cytoskeleton organization,ameboidal-type cell migration,acrosome assembly,neuron migration,positive regulation of cytokine-mediated signaling pathway,microtubule-based process,sister chromatid cohesion,mitotic nuclear division,nuclear migration,chemical synaptic transmission,germ cell development,neuroblast proliferation,learning or memory,retrograde axonal transport,adult locomotory behavior,protein secretion,negative regulation of neuron projection development,lipid catabolic process,stem cell division,transmission of nerve impulse,corpus callosum morphogenesis,hippocampus development,layer formation in cerebral cortex,cerebral cortex neuron differentiation,cerebral cortex development,actin cytoskeleton organization,microtubule organizing center organization,osteoclast development,positive regulation of embryonic development,establishment of planar polarity of embryonic epithelium,regulation of GTPase activity,cortical microtubule organization,positive regulation of axon extension,positive regulation of mitotic cell cycle,negative regulation of JNK cascade,platelet activating factor metabolic process,vesicle transport along microtubule,brain morphogenesis,neuromuscular process controlling balance,nuclear envelope disassembly,establishment of centrosome localization,maintenance of centrosome location,auditory receptor cell development,positive regulation of dendritic spine morphogenesis,regulation of microtubule cytoskeleton organization,cochlea development,microtubule cytoskeleton organization involved in establishment of planar polarity,ciliary basal body docking,regulation of microtubule motor activity;phospholipase A2 activity,protein binding,microtubule binding,heparin binding,dynactin binding,protein homodimerization activity,phospholipase binding,dynein intermediate chain binding,phosphoprotein binding,dynein complex binding ;astral microtubule,kinetochore,nuclear envelope,centrosome,cytosol,kinesin complex,microtubule associated complex,cell cortex,growth cone,motile cilium,nuclear membrane,stereocilium,neuronal cell body,perinuclear region of cytoplasm,extracellular exosome,axon cytoplasm,cell leading edge>tr|I3L3N5|I3L3N5_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha (Fragment) OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=1;>sp|P43034|LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2P47756-2CAPZB CAPZB_HUMAN1Isoform 2 of F-actin-capping protein subunit betac>sp|P47756-2|CAPZB_HUMAN Isoform 2 of F-actin-capping protein subunit beta OS=Homo sapiens GN=CAPZBP48643CCT5 TCPE_HUMAN#T-complex protein 1 subunit epsilonprotein folding,'de novo' protein folding,binding of sperm to zona pellucida,response to virus,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodyprotein binding,ATP binding,G-protein beta-subunit binding,protein binding involved in protein folding,beta-tubulin binding,unfolded protein bindingzona pellucida receptor complex,nucleolus,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome[>sp|P48643|TCPE_HUMAN T-complex protein 1 subunit epsilon OS=Homo sapiens GN=CCT5 PE=1 SV=1P49746THBS3 TSP3_HUMANThrombospondin-3ygrowth plate cartilage development,cell-matrix adhesion,ossification involved in bone maturation,bone trabecula formation#calcium ion binding,heparin binding4extracellular region,perinuclear region of cytoplasmI>sp|P49746|TSP3_HUMAN Thrombospondin-3 OS=Homo sapiens GN=THBS3 PE=1 SV=1P50990CCT8 TCPQ_HUMAN!T-complex protein 1 subunit thetaprotein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,neutrophil degranulation,pore complex assembly,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodyprotein binding,ATP binding,ATPase activity, coupled,protein binding involved in protein folding,cadherin binding,unfolded protein binding zona pellucida receptor complex,extracellular region,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,cilium,secretory granule lumen,azurophil granule lumen,cell body,intermediate filament cytoskeleton,extracellular exosome,ficolin-1-rich granule lumenY>sp|P50990|TCPQ_HUMAN T-complex protein 1 subunit theta OS=Homo sapiens GN=CCT8 PE=1 SV=4P51575P2RX1 P2RX1_HUMANP2X purinoceptor 1serotonin secretion by platelet,regulation of vascular smooth muscle contraction,transport,ion transport,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,signal transduction,insemination,blood coagulation,regulation of blood pressure,neuronal action potential,platelet activation,response to ATP,synaptic transmission, glutamatergic,purinergic nucleotide receptor signaling pathway,vasoconstriction,positive regulation of ion tr< ansport,neutrophil degranulation,ceramide biosynthetic process,protein homooligomerization,protein heterooligomerization,regulation of calcium ion transport,excitatory postsynaptic potential,cation transmembrane transportpurinergic nucleotide receptor activity,extracellular ATP-gated cation channel activity,cation channel activity,ATP binding,drug binding,zinc ion bindingintegral component of nuclear inner membrane,plasma membrane,integral component of plasma membrane,secretory granule membrane,specific granule membrane,neuron projection,protein complex,membrane raft,postsynaptic membraneL>sp|P51575|P2RX1_HUMAN P2X purinoceptor 1 OS=Homo sapiens GN=P2RX1 PE=1 SV=1P54136;P54136-2RARS SYRC_HUMANZArginine--tRNA ligase, cytoplasmic;Isoform Monomeric of Arginine--tRNA ligase, cytoplasmicHtRNA aminoacylation for protein translation,arginyl-tRNA aminoacylation;itRNA binding,arginine-tRNA ligase activity,protein binding,ATP binding,arginine binding,cadherin binding;ynucleoplasm,cytoplasm,mitochondrion,cytosol,membrane,aminoacyl-tRNA synthetase multienzyme complex,extracellular exosome;>sp|P54136|SYRC_HUMAN Arginine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=RARS PE=1 SV=2;>sp|P54136-2|SYRC_HUMAN Isoform Monomeric of Arginine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=RARSP55160NCKAP1L NCKPL_HUMANNck-associated protein 1-likeB cell homeostasis,myeloid cell homeostasis,protein complex assembly,chemotaxis,maintenance of cell polarity,neutrophil chemotaxis,positive regulation of actin filament polymerization,cortical actin cytoskeleton organization,positive regulation of B cell proliferation,activation of protein kinase activity,negative regulation of interleukin-17 production,negative regulation of interleukin-6 production,positive regulation of cell adhesion mediated by integrin,erythrocyte homeostasis,negative regulation of myosin-light-chain-phosphatase activity,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of T cell proliferation,positive regulation of phosphorylation,response to drug,T cell homeostasis,negative regulation of apoptotic process,neutrophil degranulation,positive regulation of CD4-positive, alpha-beta T cell differentiation,positive regulation of CD8-positive, alpha-beta T cell differentiation,positive regulation of GTPase activity,positive regulation of B cell differentiation,positive regulation of gamma-delta T cell differentiation,positive regulation of lymphocyte differentiation,positive regulation of erythrocyte differentiation,vascular endothelial growth factor receptor signaling pathway,erythrocyte development,B cell receptor signaling pathway,positive regulation of phagocytosis, engulfment,actin polymerization-dependent cell motility,positive regulation of neutrophil chemotaxiscGTPase activator activity,protein binding,protein kinase activator activity,protein complex bindingcytosol,plasma membrane,integral component of plasma membrane,membrane,secretory granule membrane,SCAR complex,extracellular exosome,ficolin-1-rich granule membraneY>sp|P55160|NCKPL_HUMAN Nck-associated protein 1-like OS=Homo sapiens GN=NCKAP1L PE=1 SV=3P56199ITGA1 ITA1_HUMANIntegrin alpha-1activation of MAPK activity,muscle contraction,cell-matrix adhesion,integrin-mediated signaling pathway,negative regulation of cell proliferation,extracellular matrix organization,neutrophil chemotaxis,positive regulation of phosphoprotein phosphatase activity,negative regulation of epidermal growth factor receptor signaling pathway,vasodilation,positive regulation of neuron apoptotic process,cellular extravasation,neuron projection morphogenesisreceptor binding,protein binding,collagen binding,protein phosphatase binding,metal ion binding,collagen binding involved in cell-matrix adhesionacrosomal vesicle,plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,membrane,integrin alpha1-beta1 complex,neuron projection,perikaryon,membrane raft,basal part of cell,extracellular exosomeI>sp|P56199|ITA1_HUMAN Integrin alpha-1 OS=Homo sapiens GN=ITGA1 PE=1 SV=2P58166INHBE INHBE_HUMANInhibin beta E chainN>sp|P58166|INHBE_HUMAN Inhibin beta E chain OS=Homo sapiens GN=INHBE PE=1 SV=1P58335-4ANTXR2 ANTR2_HUMAN%Isoform 4 of Anthrax toxin receptor 2X>sp|P58335-4|ANTR2_HUMAN Isoform 4 of Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2P60660-2MYL6 MYL6_HUMAN3Isoform Smooth muscle of Myosin light polypeptide 6c>sp|P60660-2|MYL6_HUMAN Isoform Smooth muscle of Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6P61626LYZ LYSC_HUMAN Lysozyme Cretina homeostasis,inflammatory response,antimicrobial humoral response,cytolysis,defense response to bacterium,neutrophil degranulation,cellular protein metabolic process+lysozyme activity,identical protein bindingextracellular region,extracellular space,azurophil granule lumen,specific granule lumen,extracellular exosome,tertiary granule lumenA>sp|P61626|LYSC_HUMAN Lysozyme C OS=Homo sapiens GN=LYZ PE=1 SV=1P61981YWHAG 1433G_HUMAN14-3-3 protein gammaG2/M transition of mitotic cell cycle,negative regulation of protein kinase activity,protein targeting,regulation of signal transduction,cellular response to insulin stimulus,regulation of neuron differentiation,regulation of synaptic plasticity,membrane organization,negative regulation of protein serine/threonine kinase activity,ciliary basal body docking,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathwayRNA binding,protein kinase C binding,insulin-like growth factor receptor binding,protein binding,protein kinase C inhibitor activity,protein domain specific binding,receptor tyrosine kinase bindingnmitochondrion,cytosol,focal adhesion,membrane,cytoplasmic vesicle membrane,myelin sheath,extracellular exosomeN>sp|P61981|1433G_HUMAN 14-3-3 protein gamma OS=Homo sapiens GN=YWHAG PE=1 SV=2P62873;P62873-2GNB1 GBB1_HUMANGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1;Isoform 2 of Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1protein folding,signal transduction,adenylate cyclase-activating dopamine receptor signaling pathway,phospholipase C-activating G-protein coupled receptor signaling pathway,positive regulation of cytosolic calcium ion concentration,G-protein coupled acetylcholine receptor signaling pathway,Wnt signaling pathway, calcium modulating pathway,Ras protein signal transduction,cell proliferation,cardiac muscle cell apoptotic process,rhodopsin mediated signaling pathway,platelet activation,sensory perception of taste,retina development in camera-type eye,protein heterotrimerization,cellular response to glucagon stimulus,cellular response to prostaglandin E stimulus,cellular response to hypoxia,cellular response to catecholamine stimulus;GTPase activity,signal transducer activity,protein binding,spectrin binding,type 1 angiotensin receptor binding,protein complex binding,alkylglycerophosphoethanolamine phosphodiesterase activity,GTPase binding; photoreceptor inner segment,intracellular,lysosomal membrane,cytosol,heterotrimeric G-protein complex,plasma membrane,membrane,dendrite,photoreceptor outer segment membrane,myelin sheath,cell body,extracellular exosome,photoreceptor disc membrane,extracellular vesicle;>sp|P62873|GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Homo sapiens GN=GNB1 PE=1 SV=3;>sp|P62873-2|GBB1_HUMAN Isoform 2 of Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Homo sapiens GN=GNB1P62942FKBP1A FKB1A_HUMAN*Peptidyl-prolyl cis-trans isomerase FKBP1Aprotein peptidyl-prolyl isomerization,heart morphogenesis,protein folding,'de novo' protein folding,transforming growth factor beta receptor signaling pathway,SMAD protein complex assembly,protein maturation by protein folding,positive regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of phosphoprotein phosphatase activity,regulation of protein localization,regulation of activin receptor signaling pathway,protein refoldi< ng,T cell activation,positive regulation of I-kappaB kinase/NF-kappaB signaling,regulation of immune response,ventricular cardiac muscle tissue morphogenesis,regulation of ryanodine-sensitive calcium-release channel activity,heart trabecula formation,chaperone-mediated protein folding,calcium ion transmembrane transport,fibril organization,regulation of amyloid precursor protein catabolic process,amyloid fibril formation,negative regulation of release of sequestered calcium ion into cytosol,negative regulation of ryanodine-sensitive calcium-release channel activity4peptidyl-prolyl cis-trans isomerase activity,signal transducer activity,transforming growth factor beta receptor binding,protein binding,macrolide binding,FK506 binding,type I transforming growth factor beta receptor binding,ion channel binding,SMAD binding,activin binding,calcium channel inhibitor activityIcytoplasm,cytosol,terminal cisterna,membrane,Z disc,extracellular exosomee>sp|P62942|FKB1A_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP1A OS=Homo sapiens GN=FKBP1A PE=1 SV=2P78371;P78371-2CCT2 TCPB_HUMANNT-complex protein 1 subunit beta;Isoform 2 of T-complex protein 1 subunit beta%protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,neutrophil degranulation,protein stabilization,chaperone mediated protein folding independent of cofactor,chaperone-mediated protein complex assembly,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;protein binding,ATP binding,ubiquitin protein ligase binding,protein binding involved in protein folding,unfolded protein binding;zona pellucida receptor complex,extracellular region,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,azurophil granule lumen,myelin sheath,cell body,extracellular exosome;>sp|P78371|TCPB_HUMAN T-complex protein 1 subunit beta OS=Homo sapiens GN=CCT2 PE=1 SV=4;>sp|P78371-2|TCPB_HUMAN Isoform 2 of T-complex protein 1 subunit beta OS=Homo sapiens GN=CCT2)Q04609;Q04609-10;Q04609-6;Q04609-7;Q9HBA9FOLH1;FOLH1;FOLH1;FOLH1;FOLH1B;FOLH1_HUMAN;FOLH1_HUMAN;FOLH1_HUMAN;FOLH1_HUMAN;FOH1B_HUMANGlutamate carboxypeptidase 2;Isoform 10 of Glutamate carboxypeptidase 2;Isoform PSMA' of Glutamate carboxypeptidase 2;Isoform PSMA-7 of Glutamate carboxypeptidase 2;Putative N-acetylated-alpha-linked acidic dipeptidaseproteolysis,folic acid-containing compound metabolic process,cellular amino acid biosynthetic process,C-terminal protein deglutamylation;;;;proteolysis,cellular amino acid biosynthetic process,C-terminal protein deglutamylationmetallocarboxypeptidase activity,peptidase activity,dipeptidase activity,metal ion binding,Ac-Asp-Glu binding,tetrahydrofolyl-poly(glutamate) polymer binding;;;;metallocarboxypeptidase activity,dipeptidase activity,metal ion bindingcytoplasm,plasma membrane,integral component of plasma membrane,cell surface,membrane,extracellular exosome;;;;cytoplasm,plasma membrane,extracellular exosome1;;;;21;;;;1>sp|Q04609|FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1 PE=1 SV=1;>sp|Q04609-10|FOLH1_HUMAN Isoform 10 of Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1;>sp|Q04609-6|FOLH1_HUMAN Isoform PSMA' of Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1;>sp|Q04609-7|FOLH1_HUMAN Isoform PSMA-7 of Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1;>sp|Q9HBA9|FOH1B_HUMAN Putative N-acetylated-alpha-linked acidic dipeptidase OS=Homo sapiens GN=FOLH1B PE=2 SV=1Q04760;Q04760-2GLO1 LGUL_HUMAN>Lactoylglutathione lyase;Isoform 2 of Lactoylglutathione lyasecarbohydrate metabolic process,pyruvate metabolic process,regulation of transcription from RNA polymerase II promoter,glutathione metabolic process,methylglyoxal metabolic process,osteoclast differentiation,negative regulation of apoptotic process;3lactoylglutathione lyase activity,zinc ion binding;@nucleus,cytoplasm,cytosol,plasma membrane,extracellular exosome;>sp|Q04760|LGUL_HUMAN Lactoylglutathione lyase OS=Homo sapiens GN=GLO1 PE=1 SV=4;>sp|Q04760-2|LGUL_HUMAN Isoform 2 of Lactoylglutathione lyase OS=Homo sapiens GN=GLO1Q06830PRDX1 PRDX1_HUMANPeroxiredoxin-1uresponse to reactive oxygen species,skeletal system development,retina homeostasis,cell proliferation,removal of superoxide radicals,regulation of stress-activated MAPK cascade,erythrocyte homeostasis,natural killer cell mediated cytotoxicity,regulation of NF-kappaB import into nucleus,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction processzRNA binding,peroxidase activity,protein binding,thioredoxin peroxidase activity,identical protein binding,cadherin bindingextracellular space,nucleus,cytoplasm,mitochondrion,cytosol,extracellular matrix,melanosome,myelin sheath,extracellular exosomeI>sp|Q06830|PRDX1_HUMAN Peroxiredoxin-1 OS=Homo sapiens GN=PRDX1 PE=1 SV=1Q12913PTPRJ PTPRJ_HUMAN.Receptor-type tyrosine-protein phosphatase eta2negative regulation of cell proliferation,negative regulation of platelet-derived growth factor receptor signaling pathway,regulation of cell adhesion,negative regulation of cell growth,negative regulation of cell migration,peptidyl-tyrosine dephosphorylation,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of vascular permeability,neutrophil degranulation,negative regulation of MAP kinase activity,positive regulation of cell adhesion,platelet-derived growth factor receptor signaling pathway,T cell receptor signaling pathway,negative regulation of T cell receptor signaling pathway,positive chemotaxis,positive regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of protein kinase B signaling,contact inhibitionprotein tyrosine phosphatase activity,platelet-derived growth factor receptor binding,protein binding,beta-catenin binding,phosphatase activity,protein kinase binding,gamma-catenin binding,mitogen-activated protein kinase binding,delta-catenin bindingimmunological synapse,plasma membrane,integral component of plasma membrane,cell-cell junction,cell surface,ruffle membrane,specific granule membrane,extracellular exosomeh>sp|Q12913|PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3*Q13332;Q13332-2;Q13332-3;Q13332-4;Q13332-6PTPRS PTPRS_HUMAN)Receptor-type tyrosine-protein phosphatase S;Isoform PTPS-MEA of Receptor-type tyrosine-protein phosphatase S;Isoform PTPS-MEB of Receptor-type tyrosine-protein phosphatase S;Isoform PTPS-MEC of Receptor-type tyrosine-protein phosphatase S;Isoform 2 of Receptor-type tyrosine-protein phosphatase Sprotein dephosphorylation,cell adhesion,negative regulation of neuron projection development,spinal cord development,cerebellum development,hippocampus development,cerebral cortex development,corpus callosum development,negative regulation of axon extension,negative regulation of interferon-alpha production,negative regulation of interferon-beta production,negative regulation of toll-like receptor 9 signaling pathway,peptidyl-tyrosine dephosphorylation,negative regulation of collateral sprouting,negative regulation of axon regeneration,negative regulation of dendritic spine development,establishment of endothelial intestinal barrier;;;;phosphoprotein phosphatase activity,protein tyrosine phosphatase activity,protein binding,heparin binding,chondroitin sulfate binding,heparan sulfate proteoglycan binding;;;;plasma membrane,integral component of plasma membrane,integral component of synaptic vesicle membrane,axon,extracellular exosome,integral component of postsynaptic density membrane;;;;+>sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRS PE=1 SV=3;>sp|Q13332-2|PTPRS_HUMAN Isoform PTPS-MEA of Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRS;>sp|Q13332-3|PTPRS_HUMAN Isoform PTPS-MEB of < Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRS;>sp|Q13332-4|PTPRS_HUMAN Isoform PTPS-MEC of Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRS;>sp|Q13332-6|PTPRS_HUMAN Isoform 2 of Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRSQ14344GNA13 GNA13_HUMAN3Guanine nucleotide-binding protein subunit alpha-13+patterning of blood vessels,in utero embryonic development,movement of cell or subcellular component,signal transduction,adenylate cyclase-activating G-protein coupled receptor signaling pathway,positive regulation of cytosolic calcium ion concentration,Rho protein signal transduction,regulation of cell shape,cell differentiation,platelet activation,regulation of cell migration,activation of phospholipase D activity,positive regulation of apoptotic process,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction GTPase activity,signal transducer activity,guanyl-nucleotide exchange factor activity,Rho guanyl-nucleotide exchange factor activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,type 1 angiotensin receptor binding,D5 dopamine receptor binding,metal ion bindingnucleus,cytosol,heterotrimeric G-protein complex,plasma membrane,focal adhesion,membrane,brush border membrane,melanosome,extracellular exosomem>sp|Q14344|GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens GN=GNA13 PE=1 SV=2Q14515;Q14515-2SPARCL1 SPRL1_HUMAN6SPARC-like protein 1;Isoform 2 of SPARC-like protein 15signal transduction,anatomical structure development;Bcalcium ion binding,collagen binding,extracellular matrix binding;Mproteinaceous extracellular matrix,extracellular space,extracellular exosome;>sp|Q14515|SPRL1_HUMAN SPARC-like protein 1 OS=Homo sapiens GN=SPARCL1 PE=1 SV=2;>sp|Q14515-2|SPRL1_HUMAN Isoform 2 of SPARC-like protein 1 OS=Homo sapiens GN=SPARCL1Q14554PDIA5 PDIA5_HUMANProtein disulfide-isomerase A5protein folding,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,cell redox homeostasis,oxidation-reduction processLprotein disulfide isomerase activity,protein binding,oxidoreductase activity:endoplasmic reticulum lumen,endoplasmic reticulum membraneX>sp|Q14554|PDIA5_HUMAN Protein disulfide-isomerase A5 OS=Homo sapiens GN=PDIA5 PE=1 SV=1Q14764MVP MVP_HUMANMajor vault proteinprotein transport,negative regulation of signaling,negative regulation of protein autophosphorylation,ERBB signaling pathway,neutrophil degranulation,mRNA transport,negative regulation of protein tyrosine kinase activity\protein binding,protein kinase binding,protein phosphatase binding,identical protein bindingextracellular region,nucleus,nuclear pore,cytoplasm,cytosol,cytoskeleton,membrane,intracellular ribonucleoprotein complex,secretory granule lumen,perinuclear region of cytoplasm,extracellular exosome,ficolin-1-rich granule lumenI>sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens GN=MVP PE=1 SV=4Q14847;Q14847-2LASP1 LASP1_HUMANFLIM and SH3 domain protein 1;Isoform 2 of LIM and SH3 domain protein 1Uion transport,positive regulation of signal transduction,ion transmembrane transport;SH3/SH2 adaptor activity,protein binding,zinc ion binding,ion transmembrane transporter activity,cadherin binding,actin filament binding;Kcytoplasm,focal adhesion,cortical actin cytoskeleton,extracellular exosome;>sp|Q14847|LASP1_HUMAN LIM and SH3 domain protein 1 OS=Homo sapiens GN=LASP1 PE=1 SV=2;>sp|Q14847-2|LASP1_HUMAN Isoform 2 of LIM and SH3 domain protein 1 OS=Homo sapiens GN=LASP1Q15286RAB35 RAB35_HUMANRas-related protein Rab-35Ucytokinesis,small GTPase mediated signal transduction,protein localization,protein transport,endosomal transport,antigen processing and presentation,neuron projection development,endocytic recycling,protein localization to endosome,plasma membrane to endosome transport,membrane organization,cellular response to nerve growth factor stimuluseGTPase activity,protein binding,GTP binding,phosphatidylinositol-4,5-bisphosphate binding,GDP bindingmitochondrion,cytosol,plasma membrane,clathrin-coated pit,endosome membrane,clathrin-coated vesicle membrane,cell projection membrane,melanosome,intercellular bridge,clathrin-coated endocytic vesicle,recycling endosome membrane,extracellular exosomeT>sp|Q15286|RAB35_HUMAN Ras-related protein Rab-35 OS=Homo sapiens GN=RAB35 PE=1 SV=1Q16658FSCN1 FSCN1_HUMANFascincell-cell junction assembly,cell proliferation,anatomical structure morphogenesis,positive regulation of lamellipodium assembly,cell migration,microspike assembly,actin cytoskeleton organization,regulation of microvillus assembly,regulation of actin cytoskeleton organization,establishment of apical/basal cell polarity,cell motility,actin filament bundle assembly,positive regulation of filopodium assembly,positive regulation of podosome assembly,positive regulation of extracellular matrix disassemblyxRNA binding,actin binding,protein binding,drug binding,protein binding, bridging,cadherin binding,actin filament bindingstress fiber,ruffle,podosome,cytoplasm,cytosol,cytoskeleton,microvillus,cell-cell junction,actin cytoskeleton,lamellipodium,filopodium,growth cone,cell projection membrane,filamentous actin,myelin sheath,microspike,extracellular exosome,invadopodium@>sp|Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens GN=FSCN1 PE=1 SV=3Q8NBJ4;Q8NBJ4-2GOLM1 GOLM1_HUMAN>Golgi membrane protein 1;Isoform 2 of Golgi membrane protein 1;nucleus organization,regulation of lipid metabolic process;`extracellular space,Golgi apparatus,integral component of plasma membrane,extracellular exosome;>sp|Q8NBJ4|GOLM1_HUMAN Golgi membrane protein 1 OS=Homo sapiens GN=GOLM1 PE=1 SV=1;>sp|Q8NBJ4-2|GOLM1_HUMAN Isoform 2 of Golgi membrane protein 1 OS=Homo sapiens GN=GOLM1Q8NG06TRIM58 TRI58_HUMAN"E3 ubiquitin-protein ligase TRIM58protein ubiquitination%zinc ion binding,transferase activity]>sp|Q8NG06|TRI58_HUMAN E3 ubiquitin-protein ligase TRIM58 OS=Homo sapiens GN=TRIM58 PE=2 SV=2Q8TD06AGR3 AGR3_HUMANAnterior gradient protein 3Ibiological_process,cell differentiation,negative regulation of cell death$dystroglycan binding,protein binding(cellular_component,endoplasmic reticulumS>sp|Q8TD06|AGR3_HUMAN Anterior gradient protein 3 OS=Homo sapiens GN=AGR3 PE=1 SV=1Q8TDL5BPIFB1 BPIB1_HUMAN%BPI fold-containing family B member 1}innate immune response in mucosa,antimicrobial humoral response,negative regulation of toll-like receptor 4 signaling pathway molecular_function,lipid binding`>sp|Q8TDL5|BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=1 SV=1Q8WUJ3CEMIP CEMIP_HUMAN6Cell migration-inducing and hyaluronan-binding proteinesensory perception of sound,positive regulation of peptidyl-threonine phosphorylation,hyaluronan biosynthetic process,hyaluronan catabolic process,positive regulation of cell migration,positive regulation of release of sequestered calcium ion into cytosol,positive regulation of protein targeting to membrane,positive regulation of protein kinase C activityhyalurononglucosaminidase activity,protein binding,hyaluronic acid binding,clathrin heavy chain binding,ER retention sequence bindingextracellular region,nucleus,cytoplasm,endoplasmic reticulum,plasma membrane,clathrin-coated pit,clathrin-coated vesicle membrane,clathrin-coated endocytic vesiclep>sp|Q8WUJ3|CEMIP_HUMAN Cell migration-inducing and hyaluronan-binding protein OS=Homo sapiens GN=CEMIP PE=1 SV=2Q8WUM4PDCD6IP PDC6I_HUMAN+Programmed cell death 6-interacting proteinactomyosin contractile ring assembly,cell separation after cytokinesis,apoptotic process,regulation of centrosome duplication,protein transport,viral life cycle,multivesicular body assembly,viral budding via host ESCRT complex,maintenance of epithelial cell apical/basal polarity,bicellular tight junction assembly,regulation of membrane permeability,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,positive regula< tion of exosomal secretion,regulation of extracellular exosome assembly,positive regulation of extracellular exosome assembly,nucleus organization,mitotic metaphase plate congression,regulation of mitotic spindle assemblyyprotein binding,proteinase activated receptor binding,protein homodimerization activity,calcium-dependent protein bindingimmunological synapse,microtubule organizing center,cytosol,focal adhesion,membrane,melanosome,actomyosin,myelin sheath,extracellular exosome,endoplasmic reticulum exit site,extracellular vesicleg>sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens GN=PDCD6IP PE=1 SV=1Q8WW52;Q8WW52-2FAM151A F151A_HUMAN,Protein FAM151A;Isoform 2 of Protein FAM151Abiological_process;molecular_function;>membrane,integral component of membrane,extracellular exosome;>sp|Q8WW52|F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2;>sp|Q8WW52-2|F151A_HUMAN Isoform 2 of Protein FAM151A OS=Homo sapiens GN=FAM151AQ92187ST8SIA4 SIA8D_HUMAN8CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferaseganglioside biosynthetic process,cellular protein modification process,protein glycosylation,N-glycan processing,nervous system development,oligosaccharide metabolic process,sialylationRalpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,sialic acid binding3Golgi membrane,integral component of Golgi membranet>sp|Q92187|SIA8D_HUMAN CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Homo sapiens GN=ST8SIA4 PE=1 SV=1Q92686NRGN NEUG_HUMAN Neurograninsignal transduction,nervous system development,associative learning,telencephalon development,positive regulation of long-term synaptic potentiation]calmodulin binding,phosphatidylinositol-3,4,5-trisphosphate binding,phosphatidic acid bindingnucleus,trans-Golgi network transport vesicle membrane,postsynaptic density,axon,mitochondrial membrane,neuronal cell body,dendritic spine headC>sp|Q92686|NEUG_HUMAN Neurogranin OS=Homo sapiens GN=NRGN PE=1 SV=1Q99784;Q99784-3;Q99784-5OLFM1 NOE1_HUMAN.Noelin;Isoform 3 of Noelin;Isoform 5 of Noelin.atrioventricular valve formation,nervous system development,positive regulation of gene expression,negative regulation of gene expression,positive regulation of epithelial to mesenchymal transition,neuronal signal transduction,regulation of axon extension,cardiac epithelial to mesenchymal transition;;|extracellular space,cell,endoplasmic reticulum,cell junction,axon,neuronal cell body,perikaryon,axonal growth cone,synapse;;>sp|Q99784|NOE1_HUMAN Noelin OS=Homo sapiens GN=OLFM1 PE=1 SV=4;>sp|Q99784-3|NOE1_HUMAN Isoform 3 of Noelin OS=Homo sapiens GN=OLFM1;>sp|Q99784-5|NOE1_HUMAN Isoform 5 of Noelin OS=Homo sapiens GN=OLFM1Q99972MYOC MYOC_HUMANMyocilin!osteoblast differentiation,negative regulation of cell-matrix adhesion,positive regulation of phosphatidylinositol 3-kinase signaling,skeletal muscle hypertrophy,myelination in peripheral nervous system,positive regulation of cell migration,neuron projection development,negative regulation of Rho protein signal transduction,non-canonical Wnt signaling pathway via JNK cascade,ERBB2-ERBB3 signaling pathway,regulation of MAPK cascade,clustering of voltage-gated sodium channels,positive regulation of stress fiber assembly,negative regulation of stress fiber assembly,positive regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,positive regulation of mitochondrial depolarization,bone development,positive regulation of substrate adhesion-dependent cell spreadingfibronectin binding,frizzled binding,protein binding,receptor tyrosine kinase binding,myosin light chain binding,metal ion binding*proteinaceous extracellular matrix,extracellular space,mitochondrial outer membrane,mitochondrial inner membrane,mitochondrial intermembrane space,endoplasmic reticulum,rough endoplasmic reticulum,Golgi apparatus,cilium,extracellular matrix,cytoplasmic vesicle,node of Ranvier,extracellular exosome@>sp|Q99972|MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2Q9BR76CORO1B COR1B_HUMAN Coronin-1Bcell migration,actin cytoskeleton organization,ruffle organization,regulation of Arp2/3 complex-mediated actin nucleation,negative regulation of Arp2/3 complex-mediated actin nucleation,endothelial cell chemotaxis,cellular response to platelet-derived growth factor stimulus,wound healing,actin filament bundle assembly,negative regulation of smooth muscle cell chemotaxis,actin filament branching,protein localization to cell leading edge,positive regulation of lamellipodium morphogenesishprotein binding,identical protein binding,cadherin binding,actin filament binding,Arp2/3 complex bindingstress fiber,cytoplasm,cytosol,actin filament,plasma membrane,focal adhesion,lamellipodium,cell leading edge,perinuclear region of cytoplasm,extracellular exosome,cell peripheryE>sp|Q9BR76|COR1B_HUMAN Coronin-1B OS=Homo sapiens GN=CORO1B PE=1 SV=1Q9BRK5SDF4 CAB45_HUMAN45 kDa calcium-binding proteinUV protection,calcium ion regulated exocytosis,cerebellum development,fat cell differentiation,response to ethanol,zymogen granule exocytosis-calcium ion binding,identical protein bindinggcytoplasm,late endosome,Golgi apparatus,Golgi lumen,membrane,bleb,extracellular exosome,plasma membraneW>sp|Q9BRK5|CAB45_HUMAN 45 kDa calcium-binding protein OS=Homo sapiens GN=SDF4 PE=1 SV=1Q9BT09CNPY3 CNPY3_HUMANProtein canopy homolog 3;toll-like receptor signaling pathway,innate immune responsereceptor bindingendoplasmic reticulum lumenR>sp|Q9BT09|CNPY3_HUMAN Protein canopy homolog 3 OS=Homo sapiens GN=CNPY3 PE=1 SV=1Q9BXX0EMILIN2 EMIL2_HUMANEMILIN-2 cell adhesion,biological_processFprotein binding,extracellular matrix constituent conferring elasticitypextracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,extracellular matrixD>sp|Q9BXX0|EMIL2_HUMAN EMILIN-2 OS=Homo sapiens GN=EMILIN2 PE=1 SV=3Q9HBI1;Q9HBI1-2;Q9HBI1-3PARVB PARVB_HUMAN=Beta-parvin;Isoform 2 of Beta-parvin;Isoform 3 of Beta-parvincell adhesion,cell projection assembly,lamellipodium assembly,actin cytoskeleton reorganization,establishment or maintenance of cell polarity regulating cell shape;;actin binding,protein binding;;Jcytosol,cytoskeleton,plasma membrane,focal adhesion,Z disc,lamellipodium;;>sp|Q9HBI1|PARVB_HUMAN Beta-parvin OS=Homo sapiens GN=PARVB PE=1 SV=1;>sp|Q9HBI1-2|PARVB_HUMAN Isoform 2 of Beta-parvin OS=Homo sapiens GN=PARVB;>sp|Q9HBI1-3|PARVB_HUMAN Isoform 3 of Beta-parvin OS=Homo sapiens GN=PARVBQ9HCM2PLXNA4 PLXA4_HUMAN Plexin-A4 facial nerve structural organization,glossopharyngeal nerve morphogenesis,trigeminal nerve structural organization,vagus nerve morphogenesis,postganglionic parasympathetic fiber development,branchiomotor neuron axon guidance,chemorepulsion of branchiomotor axon,anterior commissure morphogenesis,sympathetic nervous system development,regulation of axon extension involved in axon guidance,regulation of negative chemotaxis,semaphorin-plexin signaling pathway,semaphorin-plexin signaling pathway involved in axon guidancesemaphorin receptor activityJsemaphorin receptor complex,plasma membrane,integral component of membraneD>sp|Q9HCM2|PLXA4_HUMAN Plexin-A4 OS=Homo sapiens GN=PLXNA4 PE=1 SV=4!Q9NPH3;Q9NPH3-2;Q9NPH3-3;Q9NPH3-5IL1RAP IL1AP_HUMANInterleukin-1 receptor accessory protein;Isoform 2 of Interleukin-1 receptor accessory protein;Isoform 3 of Interleukin-1 receptor accessory protein;Isoform 4 of Interleukin-1 receptor accessory proteinprotein complex assembly,inflammatory response,immune response,positive regulation of interleukin-13 production,positive regulation of interleukin-5 production,interleukin-33-mediated signaling pathway,interleukin-2 biosynthetic process,innate immune response,positive regulation of NF-kappaB transcription factor activity,positive regulation of synapse assembly,interleukin-4 secretion,positive regulation of dendrite development,positive regulation of interleukin-6 secretion;;;~interleukin-33 receptor activity,signal tran< sducer activity,interleukin-1 receptor activity,protein tyrosine kinase binding;;;Uextracellular space,plasma membrane,integral component of plasma membrane,membrane;;;>sp|Q9NPH3|IL1AP_HUMAN Interleukin-1 receptor accessory protein OS=Homo sapiens GN=IL1RAP PE=1 SV=2;>sp|Q9NPH3-2|IL1AP_HUMAN Isoform 2 of Interleukin-1 receptor accessory protein OS=Homo sapiens GN=IL1RAP;>sp|Q9NPH3-3|IL1AP_HUMAN Isoform 3 of Interleukin-1 receptor accessory protein OS=Homo sapiens GN=IL1RAP;>sp|Q9NPH3-5|IL1AP_HUMAN Isoform 4 of Interleukin-1 receptor accessory protein OS=Homo sapiens GN=IL1RAPQ9NR99MXRA5 MXRA5_HUMAN&Matrix-remodeling-associated protein 5`>sp|Q9NR99|MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3Q9NYU2;Q9NYU2-2UGGT1 UGGG1_HUMANjUDP-glucose:glycoprotein glucosyltransferase 1;Isoform 2 of UDP-glucose:glycoprotein glucosyltransferase 1{protein glycosylation,'de novo' posttranslational protein folding,UDP-glucosylation,endoplasmic reticulum mannose trimming;_UDP-glucose:glycoprotein glucosyltransferase activity,protein binding,unfolded protein binding;endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,endoplasmic reticulum quality control compartment,extracellular exosome;>sp|Q9NYU2|UGGG1_HUMAN UDP-glucose:glycoprotein glucosyltransferase 1 OS=Homo sapiens GN=UGGT1 PE=1 SV=3;>sp|Q9NYU2-2|UGGG1_HUMAN Isoform 2 of UDP-glucose:glycoprotein glucosyltransferase 1 OS=Homo sapiens GN=UGGT1Q9NZN3EHD3 EHD3_HUMANEH domain-containing protein 3receptor recycling,blood coagulation,endocytic recycling,early endosome to Golgi transport,protein homooligomerization,regulation of cardiac muscle contraction,cilium morphogenesis,protein targeting to plasma membrane,regulation of cardiac muscle cell membrane potential,Golgi to lysosome transport,positive regulation of voltage-gated calcium channel activity,regulation of Golgi organization,regulation of cardiac conductionPnucleic acid binding,calcium ion binding,protein binding,ATP binding,GTP bindingnucleus,cytoplasm,cytosol,focal adhesion,endosome membrane,ciliary pocket membrane,endocytic vesicle,myelin sheath,perinuclear region of cytoplasm,recycling endosome membraneV>sp|Q9NZN3|EHD3_HUMAN EH domain-containing protein 3 OS=Homo sapiens GN=EHD3 PE=1 SV=2Q9P1Z2;Q9P1Z2-2;Q9P1Z2-3CALCOCO1 CACO1_HUMANCalcium-binding and coiled-coil domain-containing protein 1;Isoform 2 of Calcium-binding and coiled-coil domain-containing protein 1;Isoform 3 of Calcium-binding and coiled-coil domain-containing protein 1!transcription, DNA-templated,signal transduction,positive regulation of gene expression,Wnt signaling pathway,intracellular steroid hormone receptor signaling pathway,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter;;[core promoter binding,chromatin binding,transcription cofactor activity,transcription coactivator activity,protein binding,beta-catenin binding,protein C-terminus binding,ligand-dependent nuclear receptor transcription coactivator activity,sequence-specific DNA binding,transcription regulatory region DNA binding,armadillo repeat domain binding;;Lnuclear chromatin,nucleus,cytosol,intracellular membrane-bounded organelle;;t>sp|Q9P1Z2|CACO1_HUMAN Calcium-binding and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=CALCOCO1 PE=1 SV=2;>sp|Q9P1Z2-2|CACO1_HUMAN Isoform 2 of Calcium-binding and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=CALCOCO1;>sp|Q9P1Z2-3|CACO1_HUMAN Isoform 3 of Calcium-binding and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=CALCOCO1Q9UL25RAB21 RAB21_HUMANRas-related protein Rab-21Hsmall GTPase mediated signal transduction,anterograde axonal transport,protein transport,regulation of exocytosis,regulation of axon extension,positive regulation of receptor-mediated endocytosis,positive regulation of dendrite morphogenesis,membrane organization,positive regulation of early endosome to late endosome transport7GTPase activity,protein binding,GTP binding,GDP binding5endosome,endoplasmic reticulum membrane,trans-Golgi network,cytosol,focal adhesion,cytoplasmic side of plasma membrane,vesicle membrane,cytoplasmic vesicle membrane,early endosome membrane,cleavage furrow,Golgi cisterna membrane,extracellular exosome,cytoplasmic side of early endosome membrane,axon cytoplasmT>sp|Q9UL25|RAB21_HUMAN Ras-related protein Rab-21 OS=Homo sapiens GN=RAB21 PE=1 SV=3Q9UM47NOTCH3 NOTC3_HUMAN(Neurogenic locus notch homolog protein 3negative regulation of transcription from RNA polymerase II promoter,transcription initiation from RNA polymerase II promoter,Notch signaling pathway,Notch receptor processing,forebrain development,negative regulation of neuron differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of smooth muscle cell proliferation,neuron fate commitment,artery morphogenesis,glomerular capillary formationUreceptor activity,calcium ion binding,protein binding,enzyme binding,cadherin bindingGolgi membrane,extracellular region,nucleoplasm,endoplasmic reticulum membrane,cytosol,plasma membrane,actin cytoskeleton,integral component of membrane,receptor complexc>sp|Q9UM47|NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2Q9Y230RUVBL2 RUVB2_HUMAN RuvB-like 2DDNA repair,DNA recombination,chromatin remodeling,transcription, DNA-templated,protein folding,DNA duplex unwinding,cellular response to UV,positive regulation of histone acetylation,regulation of growth,histone H4 acetylation,histone H2A acetylation,positive regulation of transcription from RNA polymerase II promoter,establishment of protein localization to chromatin,cellular response to estradiol stimulus,transcriptional activation by promoter-enhancer looping,negative regulation of estrogen receptor binding,positive regulation of telomerase RNA localization to Cajal bodyRNA polymerase II core promoter sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,TFIID-class transcription factor binding,DNA helicase activity,ATP-dependent DNA helicase activity,protein binding,ATP binding,chromatin DNA binding,identical protein binding,protein homodimerization activity,ATP-dependent 5'-3' DNA helicase activity,ADP binding,unfolded protein binding,ATPase binding,ATPase activitySwr1 complex,intracellular,nucleus,nucleoplasm,nuclear euchromatin,centrosome,cytosol,membrane,nuclear matrix,intracellular ribonucleoprotein complex,Ino80 complex,NuA4 histone acetyltransferase complex,extracellular exosome,MLL1 complex,R2TP complexF>sp|Q9Y230|RUVB2_HUMAN RuvB-like 2 OS=Homo sapiens GN=RUVBL2 PE=1 SV=3Q9Y2A7;Q9Y2A7-2NCKAP1 NCKP1_HUMAN>Nck-associated protein 1;Isoform 2 of Nck-associated protein 1Lapoptotic process,central nervous system development,positive regulation of lamellipodium assembly,viral process,Rac protein signal transduction,Fc-gamma receptor signaling pathway involved in phagocytosis,vascular endothelial growth factor receptor signaling pathway,positive regulation of Arp2/3 complex-mediated actin nucleation;pcytosol,focal adhesion,integral component of membrane,SCAR complex,lamellipodium membrane,extracellular exosome;>sp|Q9Y2A7|NCKP1_HUMAN Nck-associated protein 1 OS=Homo sapiens GN=NCKAP1 PE=1 SV=1;>sp|Q9Y2A7-2|NCKP1_HUMAN Isoform 2 of Nck-associated protein 1 OS=Homo sapiens GN=NCKAP1Q9Y5C1ANGPTL3 ANGL3_HUMANAngiopoietin-related protein 3angiogenesis,glycerol metabolic process,fatty acid metabolic process,phospholipid metabolic process,cell-matrix adhesion,signal transduction,integrin-mediated signaling pathway,cholesterol metabolic process,phospholipid catabolic process,response to hormone,negative regulation of phospholipase activity,lipid storage,positive regulation of cell migration,lipoprotein metabolic process,cholesterol homeostasis,positive regulation of angiogenesis,artery morphogenesis,positive regulation of lipid catabolic process,negative regulation of lipoprotein lipase activity,lip< id homeostasis,acylglycerol homeostasis,phospholipid homeostasis,triglyceride homeostasisrenzyme inhibitor activity,phospholipase inhibitor activity,integrin binding,growth factor activity,heparin bindingbextracellular region,extracellular space,early endosome,Golgi apparatus,cell surface,lamellipodiumZ>sp|Q9Y5C1|ANGL3_HUMAN Angiopoietin-related protein 3 OS=Homo sapiens GN=ANGPTL3 PE=1 SV=1Q9Y613FHOD1 FHOD1_HUMAN#FH1/FH2 domain-containing protein 1nuclear migration,positive regulation of transcription from RNA polymerase II promoter,positive regulation of stress fiber assembly,establishment of centrosome localization7actin binding,protein binding,identical protein bindingFnucleus,cytoplasm,cytosol,intercalated disc,membrane,bleb,stress fiber]>sp|Q9Y613|FHOD1_HUMAN FH1/FH2 domain-containing protein 1 OS=Homo sapiens GN=FHOD1 PE=1 SV=3Q9Y6Y9LY96 LY96_HUMANLymphocyte antigen 96toll-like receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,inflammatory response,cellular defense response,cell surface receptor signaling pathway,I-kappaB kinase/NF-kappaB signaling,lipopolysaccharide-mediated signaling pathway,positive regulation of lipopolysaccharide-mediated signaling pathway,response to lipopolysaccharide,detection of lipopolysaccharide,positive regulation of tumor necrosis factor production,negative regulation of MyD88-independent toll-like receptor signaling pathway,toll-like receptor 4 signaling pathway,TRIF-dependent toll-like receptor signaling pathway,innate immune response,necroptotic process,apoptotic signaling pathwayHlipopolysaccharide receptor activity,protein binding,coreceptor activityextracellular space,plasma membrane,endosome membrane,intrinsic component of plasma membrane,lipopolysaccharide receptor complexM>sp|Q9Y6Y9|LY96_HUMAN Lymphocyte antigen 96 OS=Homo sapiens GN=LY96 PE=1 SV=2A0A087WYX9;P05997COL5A2A0A087WYX9_HUMAN;CO5A2_HUMANCollagen alpha-2(V) chain;skeletal system development,ossification,extracellular matrix organization,collagen fibril organization,collagen catabolic process,skin development,eye morphogenesis,cellular response to amino acid stimulus,negative regulation of endodermal cell differentiation^;molecular_function,extracellular matrix structural constituent,SMAD binding,metal ion bindingq;extracellular region,collagen type V trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix>tr|A0A087WYX9|A0A087WYX9_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=1;>sp|P05997|CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3A0A087X1S7;P09326CD48A0A087X1S7_HUMAN;CD48_HUMAN CD48 antigenL;regulation of adaptive immune response,defense response,leukocyte migration";receptor activity,protein binding;plasma membrane,integral component of plasma membrane,membrane,anchored component of membrane,membrane raft,extracellular exosome>tr|A0A087X1S7|A0A087X1S7_HUMAN CD48 antigen OS=Homo sapiens GN=CD48 PE=1 SV=1;>sp|P09326|CD48_HUMAN CD48 antigen OS=Homo sapiens GN=CD48 PE=1 SV=2=A0A0A0MSS8;B4DK69;H0Y804;P42330;P42330-2;P52895;Q04828;S4R3Z27AKR1C3;AKR1C2;AKR1C1;AKR1C3;AKR1C3;AKR1C2;AKR1C1;AKR1C3gA0A0A0MSS8_HUMAN;B4DK69_HUMAN;H0Y804_HUMAN;AK1C3_HUMAN;AK1C3_HUMAN;AK1C2_HUMAN;AK1C1_HUMAN;S4R3Z2_HUMANOAldo-keto reductase family 1 member C3;Aldo-keto reductase family 1 member C2;Aldo-keto reductase family 1 member C1 (Fragment);Aldo-keto reductase family 1 member C3;Isoform 2 of Aldo-keto reductase family 1 member C3;Aldo-keto reductase family 1 member C2;Aldo-keto reductase family 1 member C1;Aldo-keto reductase family 1 member C3;;;protein import into nucleus, translocation,retinoid metabolic process,prostaglandin metabolic process,G-protein coupled receptor signaling pathway,response to nutrient,steroid metabolic process,positive regulation of cell proliferation,male gonad development,cellular response to starvation,positive regulation of cell death,farnesol catabolic process,cyclooxygenase pathway,keratinocyte differentiation,cellular response to reactive oxygen species,progesterone metabolic process,retinol metabolic process,retinal metabolic process,multicellular organismal macromolecule metabolic process,daunorubicin metabolic process,doxorubicin metabolic process,regulation of retinoic acid receptor signaling pathway,positive regulation of protein kinase B signaling,oxidation-reduction process,testosterone biosynthetic process,renal absorption,cellular response to cadmium ion,cellular response to calcium ion,cellular response to prostaglandin stimulus,cellular response to corticosteroid stimulus,cellular response to jasmonic acid stimulus,cellular response to prostaglandin D stimulus,negative regulation of retinoic acid biosynthetic process,regulation of testosterone biosynthetic process,positive regulation of endothelial cell apoptotic process,positive regulation of reactive oxygen species metabolic process;;prostaglandin metabolic process,G-protein coupled receptor signaling pathway,digestion,steroid metabolic process,positive regulation of cell proliferation,epithelial cell differentiation,progesterone metabolic process,daunorubicin metabolic process,doxorubicin metabolic process,positive regulation of protein kinase B signaling,oxidation-reduction process,cellular response to jasmonic acid stimulus,cellular response to prostaglandin D stimulus;retinoid metabolic process,xenobiotic metabolic process,digestion,bile acid metabolic process,bile acid and bile salt transport,intestinal cholesterol absorption,epithelial cell differentiation,progesterone metabolic process,retinal metabolic process,cholesterol homeostasis,daunorubicin metabolic process,doxorubicin metabolic process,response to organophosphorus,protein homooligomerization,oxidation-reduction process,cellular response to jasmonic acid stimulus;;;;retinal dehydrogenase activity,alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,retinol dehydrogenase activity,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,phenanthrene 9,10-monooxygenase activity,dihydrotestosterone 17-beta-dehydrogenase activity,prostaglandin H2 endoperoxidase reductase activity,prostaglandin D2 11-ketoreductase activity,geranylgeranyl reductase activity,ketoreductase activity,prostaglandin-F synthase activity,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,androsterone dehydrogenase activity,testosterone dehydrogenase (NAD+) activity,testosterone 17-beta-dehydrogenase (NADP+) activity,ketosteroid monooxygenase activity,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,indanol dehydrogenase activity,delta4-3-oxosteroid 5beta-reductase activity,NADP-retinol dehydrogenase activity;;alditol:NADP+ 1-oxidoreductase activity,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,phenanthrene 9,10-monooxygenase activity,carboxylic acid binding,bile acid binding,ketosteroid monooxygenase activity,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,protein binding,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,phenanthrene 9,10-monooxygenase activity,carboxylic acid binding,bile acid binding,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,androsterone dehydrogenase (B-specific) activity,ketosteroid monooxygenase activity,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,indanol dehydrogenase activity;j;;;intracellular,nucleus,cytoplasm,cytosol,extracellular exosome;;cytoplasm;cytosol,extracellular exosome;tr;tr;tr;sp;sp;sp;sp;tr1;1;1;1;;1;1;11;1;1;4;;3;1;1+>tr|A0A0A0MSS8|A0A0A0MSS8_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=1;>tr|B4DK69|B4DK69_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=1;>tr|H0Y804|H0Y804_HUMAN Aldo-keto reductase family 1 member C1 (Fragment) OS=Homo sapiens GN=AKR1C1 PE=1 SV=1;>sp|P42330|AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapi< ens GN=AKR1C3 PE=1 SV=4;>sp|P42330-2|AK1C3_HUMAN Isoform 2 of Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3;>sp|P52895|AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3;>sp|Q04828|AK1C1_HUMAN Aldo-keto reductase family 1 member C1 OS=Homo sapiens GN=AKR1C1 PE=1 SV=1;>tr|S4R3Z2|S4R3Z2_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=1A0A0C4DGN6;Q9Y2X7;Q9Y2X7-3GIT1&A0A0C4DGN6_HUMAN;GIT1_HUMAN;GIT1_HUMANuARF GTPase-activating protein GIT1;ARF GTPase-activating protein GIT1;Isoform 3 of ARF GTPase-activating protein GIT1;regulation of G-protein coupled receptor protein signaling pathway,regulation of cytokinesis,positive regulation of GTPase activity,ephrin receptor signaling pathway;U;GTPase activator activity,protein binding,protein complex binding,metal ion binding;!;cytosol,focal adhesion,membrane;>tr|A0A0C4DGN6|A0A0C4DGN6_HUMAN ARF GTPase-activating protein GIT1 OS=Homo sapiens GN=GIT1 PE=1 SV=1;>sp|Q9Y2X7|GIT1_HUMAN ARF GTPase-activating protein GIT1 OS=Homo sapiens GN=GIT1 PE=1 SV=2;>sp|Q9Y2X7-3|GIT1_HUMAN Isoform 3 of ARF GTPase-activating protein GIT1 OS=Homo sapiens GN=GIT1 A0A0C4DH24IGKV6-21A0A0C4DH24_HUMANProtein IGKV6-21 (Fragment)a>tr|A0A0C4DH24|A0A0C4DH24_HUMAN Protein IGKV6-21 (Fragment) OS=Homo sapiens GN=IGKV6-21 PE=1 SV=1 A0A0C4DH67IGKV1-8A0A0C4DH67_HUMANProtein IGKV1-8 (Fragment)adaptive immune response_>tr|A0A0C4DH67|A0A0C4DH67_HUMAN Protein IGKV1-8 (Fragment) OS=Homo sapiens GN=IGKV1-8 PE=1 SV=1 A0A0G2JRQ6A0A0G2JRQ6_HUMAN\>tr|A0A0G2JRQ6|A0A0G2JRQ6_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=4FA0A0U1RR32;A0A0U1RRH7;P0C0S8;P20671;Q16777;Q6FI13;Q96KK5;Q99878;Q9BTM1OhCG_2039566;;HIST1H2AG;HIST1H2AD;HIST2H2AC;HIST2H2AA3;HIST1H2AH;HIST1H2AJ;H2AFJsA0A0U1RR32_HUMAN;A0A0U1RRH7_HUMAN;H2A1_HUMAN;H2A1D_HUMAN;H2A2C_HUMAN;H2A2A_HUMAN;H2A1H_HUMAN;H2A1J_HUMAN;H2AJ_HUMANHistone H2A;Histone H2A;Histone H2A type 1;Histone H2A type 1-D;Histone H2A type 2-C;Histone H2A type 2-A;Histone H2A type 1-H;Histone H2A type 1-J;Histone H2A.J;;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;DNA binding,protein heterodimerization activity;DNA binding,protein binding,enzyme binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;nucleosome,nucleus;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrstuvwxyz{|}~nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosometr;tr;sp;sp;sp;sp;sp;sp;sp3;3;1;1;1;1;1;1;11;1;2;2;4;3;3;3;1>tr|A0A0U1RR32|A0A0U1RR32_HUMAN Histone H2A OS=Homo sapiens GN=hCG_2039566 PE=3 SV=1;>tr|A0A0U1RRH7|A0A0U1RRH7_HUMAN Histone H2A OS=Homo sapiens PE=3 SV=1;>sp|P0C0S8|H2A1_HUMAN Histone H2A type 1 OS=Homo sapiens GN=HIST1H2AG PE=1 SV=2;>sp|P20671|H2A1D_HUMAN Histone H2A type 1-D OS=Homo sapiens GN=HIST1H2AD PE=1 SV=2;>sp|Q16777|H2A2C_HUMAN Histone H2A type 2-C OS=Homo sapiens GN=HIST2H2AC PE=1 SV=4;>sp|Q6FI13|H2A2A_HUMAN Histone H2A type 2-A OS=Homo sapiens GN=HIST2H2AA3 PE=1 SV=3;>sp|Q96KK5|H2A1H_HUMAN Histone H2A type 1-H OS=Homo sapiens GN=HIST1H2AH PE=1 SV=3;>sp|Q99878|H2A1J_HUMAN Histone H2A type 1-J OS=Homo sapiens GN=HIST1H2AJ PE=1 SV=3;>sp|Q9BTM1|H2AJ_HUMAN Histone H2A.J OS=Homo sapiens GN=H2AFJ PE=1 SV=1A6NMZ7COL6A6 CO6A6_HUMANCollagen alpha-6(VI) chain(cell adhesion,collagen catabolic processGextracellular region,proteinaceous extracellular matrix,collagen trimerU>sp|A6NMZ7|CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2-A8MTC6;A8MZI4;B7Z3L0;Q96AX2;Q96AX2-3;Q96AX2-4RAB37JA8MTC6_HUMAN;A8MZI4_HUMAN;B7Z3L0_HUMAN;RAB37_HUMAN;RAB37_HUMAN;RAB37_HUMANRAB37, member RAS oncogene family, isoform CRA_a;Ras-related protein Rab-37;Ras-related protein Rab-37;Ras-related protein Rab-37;Isoform 3 of Ras-related protein Rab-37;Isoform 4 of Ras-related protein Rab-37;;;vesicle docking involved in exocytosis,small GTPase mediated signal transduction,protein secretion,neutrophil degranulation,protein localization to plasma membrane;; ;;;protein binding,GTP binding;;;;;endosome,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,synaptic vesicle,azurophil granule membrane,specific granule membrane;;tr;tr;tr;sp;sp;sp 1;1;1;1;; 1;1;1;3;; >tr|A8MTC6|A8MTC6_HUMAN RAB37, member RAS oncogene family, isoform CRA_a OS=Homo sapiens GN=RAB37 PE=1 SV=1;>tr|A8MZI4|A8MZI4_HUMAN Ras-related protein Rab-37 OS=Homo sapiens GN=RAB37 PE=1 SV=1;>tr|B7Z3L0|B7Z3L0_HUMAN Ras-related protein Rab-37 OS=Homo sapiens GN=RAB37 PE=1 SV=1;>sp|Q96AX2|RAB37_HUMAN Ras-related protein Rab-37 OS=Homo sapiens GN=RAB37 PE=1 SV=3;>sp|Q96AX2-3|RAB37_HUMAN Isoform 3 of Ras-related protein Rab-37 OS=Homo sapiens GN=RAB37;>sp|Q96AX2-4|RAB37_HUMAN Isoform 4 of Ras-related protein Rab-37 OS=Homo sapiens GN=RAB37QB1AP13;H3BLV0;H7BY55;P08174;P08174-2;P08174-3;P08174-4;P08174-5;P08174-6;P08174-7CD55lB1AP13_HUMAN;H3BLV0_HUMAN;H7BY55_HUMAN;DAF_HUMAN;DAF_HUMAN;DAF_HUMAN;DAF_HUMAN;DAF_HUMAN;DAF_HUMAN;DAF_HUMANComplement decay-accelerating factor;Complement decay-accelerating factor (Fragment);Complement decay-accelerating factor;Complement decay-accelerating factor;Isoform 1 of Complement decay-accelerating factor;Isoform 3 of Complement decay-accelerating factor;Isoform 4 of Complement decay-accelerating factor;Isoform 5 of Complement decay-accelerating factor;Isoform 6 of Complement decay-accelerating factor;Isoform 7 of Complement decay-accelerating factor8;;;ER to Golgi vesicle-mediated transport,complement activation, classical pathway,positive regulation of cytosolic calcium ion concentration,regulation of complement activation,regulation of lipopolysaccharide-mediated signaling pathway,CD4-positive, alpha-beta T cell cytokine production,neutrophil degranulation,innate immune response,respiratory burst,negative regulation of complement activation,viral entry into host cell,positive regulation of CD4-positive, alpha-beta T cell activation,positive regulation of CD4-positive, alpha-beta T cell proliferation;;;;;;>;;;virus receptor activity,protein binding,lipid binding;;;;;;=;;;Golgi membrane,extracellular region,plasma membrane,integral component of plasma membrane,cell surface,transport vesicle,secretory granule membrane,anchored component of membrane,endoplasmic reticulum-Golgi intermediate compartment membrane,membrane raft,extracellular exosome,ficolin-1-rich granule membrane;;;;;;tr;tr;tr;sp;sp;sp;sp;sp;sp;sp 1;1;1;1;;;;;; 1;1;2;4;;;;;;>tr|B1AP13|B1AP13_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=1;>tr|H3BLV0|H3BLV0_HUMAN Complement decay-accelerating factor (Fragment) OS=Homo sapiens GN=CD55 PE=1 SV=1;>tr|H7BY55|H7BY55_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=2;>sp|P08174|DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4;>sp|P08174-2|DAF_HUMAN Isoform 1 of Complement decay-accelerating factor OS=Homo sapiens GN=CD55;>sp|P08174-3|DAF_HUMAN Isoform 3 of Complement decay-accelerating factor OS=Homo sapiens GN=CD55;>sp|P08174-4|DAF_HUMAN Isoform 4 of Complement decay-accelerating factor OS=Homo sapiens GN=CD55;>sp|P08174-5|DAF_HUMAN Isoform 5 of Complement decay-accelerating factor OS=Homo sapiens GN=CD55;>sp|P08174-6|DAF_HUMAN Isoform 6 of Comple< ment decay-accelerating factor OS=Homo sapiens GN=CD55;>sp|P08174-7|DAF_HUMAN Isoform 7 of Complement decay-accelerating factor OS=Homo sapiens GN=CD55B4DDF4;B4DUT8;Q99439CNN2$B4DDF4_HUMAN;B4DUT8_HUMAN;CNN2_HUMANCalponin;Calponin;Calponin-2;;cytoskeleton organization,actomyosin structure organization,regulation of actin filament-based process,neutrophil degranulation,cellular response to mechanical stimulus3;;actin binding,calmodulin binding,cadherin binding;;stress fiber,extracellular region,cytoskeleton,cell-cell junction,focal adhesion,membrane,specific granule lumen,extracellular exosome,tertiary granule lumen>tr|B4DDF4|B4DDF4_HUMAN Calponin OS=Homo sapiens GN=CNN2 PE=1 SV=1;>tr|B4DUT8|B4DUT8_HUMAN Calponin OS=Homo sapiens GN=CNN2 PE=1 SV=1;>sp|Q99439|CNN2_HUMAN Calponin-2 OS=Homo sapiens GN=CNN2 PE=1 SV=4 D3DX19;O00501CLDN5D3DX19_HUMAN;CLD5_HUMANClaudin;Claudin-51;outflow tract morphogenesis,cell-cell junction assembly,transforming growth factor beta receptor signaling pathway,learning,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,palate development,face morphogenesis,positive regulation of establishment of endothelial barrier7;structural molecule activity,identical protein binding;cell-cell junction,bicellular tight junction,integral component of membrane,apicolateral plasma membrane,extracellular exosome,cortical actin cytoskeleton>tr|D3DX19|D3DX19_HUMAN Claudin OS=Homo sapiens GN=CLDN5 PE=1 SV=1;>sp|O00501|CLD5_HUMAN Claudin-5 OS=Homo sapiens GN=CLDN5 PE=2 SV=1/E7ENY0;E7EV99;P35611;P35611-2;P35611-3;P35611-6ADD1EE7ENY0_HUMAN;E7EV99_HUMAN;ADDA_HUMAN;ADDA_HUMAN;ADDA_HUMAN;ADDA_HUMANzAlpha-adducin;Alpha-adducin;Alpha-adducin;Isoform 2 of Alpha-adducin;Isoform 3 of Alpha-adducin;Isoform 6 of Alpha-adducin;;cell morphogenesis,in utero embryonic development,cell volume homeostasis,hemoglobin metabolic process,actin cytoskeleton organization,erythrocyte differentiation,positive regulation of protein binding,multicellular organism growth,IRE1-mediated unfolded protein response,homeostasis of number of cells within a tissue,barbed-end actin filament capping,actin filament bundle assembly,transmembrane transport;;;;;RNA binding,actin binding,structural molecule activity,calmodulin binding,transcription factor binding,spectrin binding,protein homodimerization activity,cadherin binding,protein heterodimerization activity,actin filament binding;;;l;;nucleus,nucleoplasm,cytosol,plasma membrane,focal adhesion,F-actin capping protein complex,nuclear body;;;tr;tr;sp;sp;sp;sp1;1;1;;;1;1;2;;;>tr|E7ENY0|E7ENY0_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=1;>tr|E7EV99|E7EV99_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=1;>sp|P35611|ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2;>sp|P35611-2|ADDA_HUMAN Isoform 2 of Alpha-adducin OS=Homo sapiens GN=ADD1;>sp|P35611-3|ADDA_HUMAN Isoform 3 of Alpha-adducin OS=Homo sapiens GN=ADD1;>sp|P35611-6|ADDA_HUMAN Isoform 6 of Alpha-adducin OS=Homo sapiens GN=ADD1F5H442;Q99816;Q99816-2TSG101$F5H442_HUMAN;TS101_HUMAN;TS101_HUMAN~Tumor susceptibility gene 101 protein;Tumor susceptibility gene 101 protein;Isoform 2 of Tumor susceptibility gene 101 protein;regulation of cell growth,protein monoubiquitination,cell cycle arrest,negative regulation of cell proliferation,endosome to lysosome transport,protein transport,endosomal transport,macroautophagy,viral life cycle,keratinocyte differentiation,multivesicular body assembly,viral budding via host ESCRT complex,negative regulation of epidermal growth factor receptor signaling pathway,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,regulation of MAP kinase activity,negative regulation of transcription, DNA-templated,viral budding,positive regulation of viral process,cell division,intracellular transport of virus,autophagosome maturation,positive regulation of viral release from host cell,positive regulation of exosomal secretion,regulation of extracellular exosome assembly,regulation of viral budding via host ESCRT complex,positive regulation of viral budding via host ESCRT complex,exosomal secretion,positive regulation of ubiquitin-dependent endocytosis,regulation of viral release from host cell; ;DNA binding,transcription corepressor activity,protein binding,ligand-dependent nuclear receptor transcription coactivator activity,ubiquitin protein ligase binding,protein homodimerization activity,ubiquitin binding,virion binding,calcium-dependent protein binding;;ESCRT I complex,nucleolus,cytoplasm,endosome,early endosome,late endosome,multivesicular body,cytosol,plasma membrane,endosome membrane,late endosome membrane,extracellular exosome;(>tr|F5H442|F5H442_HUMAN Tumor susceptibility gene 101 protein OS=Homo sapiens GN=TSG101 PE=1 SV=1;>sp|Q99816|TS101_HUMAN Tumor susceptibility gene 101 protein OS=Homo sapiens GN=TSG101 PE=1 SV=2;>sp|Q99816-2|TS101_HUMAN Isoform 2 of Tumor susceptibility gene 101 protein OS=Homo sapiens GN=TSG101 G3XAP6;P49747COMPG3XAP6_HUMAN;COMP_HUMAN#Cartilage oligomeric matrix protein;skeletal system development,growth plate cartilage development,apoptotic process,cell adhesion,animal organ morphogenesis,extracellular matrix organization,negative regulation of apoptotic process,limb development;protease binding,extracellular matrix structural constituent,calcium ion binding,protein binding,collagen binding,heparin binding,heparan sulfate proteoglycan bindingw;extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome,extracellular matrix>tr|G3XAP6|G3XAP6_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=1;>sp|P49747|COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=21H0Y360;Q01433;Q01433-2;Q01433-3;Q01433-4;Q01433-5AMPD2HH0Y360_HUMAN;AMPD2_HUMAN;AMPD2_HUMAN;AMPD2_HUMAN;AMPD2_HUMAN;AMPD2_HUMANAMP deaminase 2 (Fragment);AMP deaminase 2;Isoform Ex1A-2-3 of AMP deaminase 2;Isoform Ex1A-3 of AMP deaminase 2;Isoform Ex1B-3 of AMP deaminase 2;Isoform 5 of AMP deaminase 2;IMP biosynthetic process,IMP salvage,cholesterol homeostasis,purine-containing compound salvage,AMP metabolic process,ATP metabolic process,GTP metabolic process,cyclic purine nucleotide metabolic process,glomerular visceral epithelial cell development,energy homeostasis;;;;=;AMP deaminase activity,protein binding,metal ion binding;;;;;cellular_component,cytosol;;;;1;2;;;;>tr|H0Y360|H0Y360_HUMAN AMP deaminase 2 (Fragment) OS=Homo sapiens GN=AMPD2 PE=1 SV=1;>sp|Q01433|AMPD2_HUMAN AMP deaminase 2 OS=Homo sapiens GN=AMPD2 PE=1 SV=2;>sp|Q01433-2|AMPD2_HUMAN Isoform Ex1A-2-3 of AMP deaminase 2 OS=Homo sapiens GN=AMPD2;>sp|Q01433-3|AMPD2_HUMAN Isoform Ex1A-3 of AMP deaminase 2 OS=Homo sapiens GN=AMPD2;>sp|Q01433-4|AMPD2_HUMAN Isoform Ex1B-3 of AMP deaminase 2 OS=Homo sapiens GN=AMPD2;>sp|Q01433-5|AMPD2_HUMAN Isoform 5 of AMP deaminase 2 OS=Homo sapiens GN=AMPD28H0Y8B3;O43865;O43865-2;Q96HN2;Q96HN2-2;Q96HN2-3;Q96HN2-40AHCYL2;AHCYL1;AHCYL1;AHCYL2;AHCYL2;AHCYL2;AHCYL2TH0Y8B3_HUMAN;SAHH2_HUMAN;SAHH2_HUMAN;SAHH3_HUMAN;SAHH3_HUMAN;SAHH3_HUMAN;SAHH3_HUMANAdenosylhomocysteinase (Fragment);Adenosylhomocysteinase 2;Isoform 2 of Adenosylhomocysteinase 2;Adenosylhomocysteinase 3;Isoform 2 of Adenosylhomocysteinase 3;Isoform 3 of Adenosylhomocysteinase 3;Isoform 4 of Adenosylhomocysteinase 3;mRNA polyadenylation,protein export from nucleus,one-carbon metabolic process,biological_process,positive regulation of sodium ion transport,regulation of mRNA 3'-end processing,regulation of ion transmembrane transporter activity,S-adenosylmethionine cycle,angiotensin-activated signaling pathway,epithelial fluid transport,regulation of anion transport,response to calcium ion,regulation of cardiac conduction;;one-carbon metabolic process,S-adenosylmethionine cycle;;;;RNA binding,protein binding,identical protein binding,adenosylhomocysteinase activity;;protein binding,adenosylhomocysteinase activity;;;;cytoplasm,endoplasmic reticulum membrane,cytosol,apical plasma membrane,extracellular exosome;;endoplasmic < reticulum,cytosol,neuron projection;;; 1;1;;1;;; 1;2;;1;;;i>tr|H0Y8B3|H0Y8B3_HUMAN Adenosylhomocysteinase (Fragment) OS=Homo sapiens GN=AHCYL2 PE=1 SV=1;>sp|O43865|SAHH2_HUMAN Adenosylhomocysteinase 2 OS=Homo sapiens GN=AHCYL1 PE=1 SV=2;>sp|O43865-2|SAHH2_HUMAN Isoform 2 of Adenosylhomocysteinase 2 OS=Homo sapiens GN=AHCYL1;>sp|Q96HN2|SAHH3_HUMAN Adenosylhomocysteinase 3 OS=Homo sapiens GN=AHCYL2 PE=1 SV=1;>sp|Q96HN2-2|SAHH3_HUMAN Isoform 2 of Adenosylhomocysteinase 3 OS=Homo sapiens GN=AHCYL2;>sp|Q96HN2-3|SAHH3_HUMAN Isoform 3 of Adenosylhomocysteinase 3 OS=Homo sapiens GN=AHCYL2;>sp|Q96HN2-4|SAHH3_HUMAN Isoform 4 of Adenosylhomocysteinase 3 OS=Homo sapiens GN=AHCYL2H7BY83;Q5JSH3;Q5JSH3-2;Q5JSH3-3WDR440H7BY83_HUMAN;WDR44_HUMAN;WDR44_HUMAN;WDR44_HUMANWD repeat-containing protein 44 (Fragment);WD repeat-containing protein 44;Isoform 2 of WD repeat-containing protein 44;Isoform 3 of WD repeat-containing protein 44L;Golgi apparatus,cytosol,endosome membrane,perinuclear region of cytoplasm;;}>tr|H7BY83|H7BY83_HUMAN WD repeat-containing protein 44 (Fragment) OS=Homo sapiens GN=WDR44 PE=1 SV=1;>sp|Q5JSH3|WDR44_HUMAN WD repeat-containing protein 44 OS=Homo sapiens GN=WDR44 PE=1 SV=1;>sp|Q5JSH3-2|WDR44_HUMAN Isoform 2 of WD repeat-containing protein 44 OS=Homo sapiens GN=WDR44;>sp|Q5JSH3-3|WDR44_HUMAN Isoform 3 of WD repeat-containing protein 44 OS=Homo sapiens GN=WDR44J3KS94;J3QQK6;P02686;P02686-2MBP-J3KS94_HUMAN;J3QQK6_HUMAN;MBP_HUMAN;MBP_HUMANkMyelin basic protein (Fragment);Myelin basic protein;Myelin basic protein;Isoform 2 of Myelin basic protein;;immune response,chemical synaptic transmission,central nervous system development,sensory perception of sound,axon ensheathment,response to toxic substance,substantia nigra development,myelination,membrane organization;K;;protease binding,protein binding,structural constituent of myelin sheath;T;;nucleus,plasma membrane,internode region of axon,neuronal cell body,myelin sheath;A>tr|J3KS94|J3KS94_HUMAN Myelin basic protein (Fragment) OS=Homo sapiens GN=MBP PE=1 SV=1;>tr|J3QQK6|J3QQK6_HUMAN Myelin basic protein OS=Homo sapiens GN=MBP PE=1 SV=1;>sp|P02686|MBP_HUMAN Myelin basic protein OS=Homo sapiens GN=MBP PE=1 SV=3;>sp|P02686-2|MBP_HUMAN Isoform 2 of Myelin basic protein OS=Homo sapiens GN=MBPO14672ADAM10 ADA10_HUMAN>Disintegrin and metalloproteinase domain-containing protein 10in utero embryonic development,protein phosphorylation,membrane protein ectodomain proteolysis,negative regulation of cell adhesion,Notch signaling pathway,Notch receptor processing,integrin-mediated signaling pathway,cell-cell signaling,positive regulation of cell proliferation,positive regulation of T cell chemotaxis,protein processing,extracellular matrix disassembly,positive regulation of cell growth,positive regulation of cell migration,response to tumor necrosis factor,monocyte activation,neutrophil degranulation,ephrin receptor signaling pathway,PMA-inducible membrane protein ectodomain proteolysis,constitutive protein ectodomain proteolysisendopeptidase activity,metalloendopeptidase activity,receptor binding,integrin binding,protein binding,metallopeptidase activity,SH3 domain binding,protein kinase binding,protein homodimerization activity,metal ion bindingSGolgi membrane,extracellular space,nucleus,cytoplasm,Golgi apparatus,Golgi-associated vesicle,plasma membrane,focal adhesion,cell surface,postsynaptic density,membrane,integral component of membrane,specific granule membrane,extracellular exosome,tertiary granule membrane,perinuclear endoplasmic reticulum,tetraspanin-enriched microdomainy>sp|O14672|ADA10_HUMAN Disintegrin and metalloproteinase domain-containing protein 10 OS=Homo sapiens GN=ADAM10 PE=1 SV=1O15145ARPC3 ARPC3_HUMAN+Actin-related protein 2/3 complex subunit 3movement of cell or subcellular component,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,membrane organization,cellular response to nerve growth factor stimuluscytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,membrane,lamellipodium,growth cone,filamentous actin,extracellular exosomee>sp|O15145|ARPC3_HUMAN Actin-related protein 2/3 complex subunit 3 OS=Homo sapiens GN=ARPC3 PE=1 SV=3O15230LAMA5 LAMA5_HUMANLaminin subunit alpha-53angiogenesis,branching involved in ureteric bud morphogenesis,morphogenesis of a polarized epithelium,neural crest cell migration,hair follicle development,cytoskeleton organization,integrin-mediated signaling pathway,muscle organ development,cell recognition,cell proliferation,embryo development,morphogenesis of embryonic epithelium,cell migration,cell differentiation,regulation of cell adhesion,extracellular matrix organization,lung development,regulation of cell migration,substrate adhesion-dependent cell spreading,regulation of cell proliferation,odontogenesis of dentin-containing tooth,endothelial cell differentiation,regulation of embryonic development,focal adhesion assembly,cilium morphogenesis,branching involved in salivary gland morphogenesis,establishment of protein localization to plasma membraneextracellular region,basement membrane,basal lamina,laminin-5 complex,extracellular space,nucleus,extracellular matrix,synaptic cleft,laminin-10 complex,laminin-11 complex,extracellular exosomeQ>sp|O15230|LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8O43294;O43294-2TGFB1I1 TGFI1_HUMANTransforming growth factor beta-1-induced transcript 1 protein;Isoform 2 of Transforming growth factor beta-1-induced transcript 1 proteintranscription from RNA polymerase II promoter,cell adhesion,negative regulation of cell proliferation,response to heat,positive regulation of epithelial to mesenchymal transition,Wnt signaling pathway,morphogenesis of embryonic epithelium,positive regulation of transforming growth factor beta receptor signaling pathway,negative regulation of transforming growth factor beta receptor signaling pathway,androgen receptor signaling pathway,ubiquitin-dependent SMAD protein catabolic process,epithelial cell differentiation,cell fate commitment,negative regulation of fat cell differentiation,positive regulation of transcription, DNA-templated;transcription coactivator activity,protein binding,zinc ion binding,Roundabout binding,androgen receptor binding,I-SMAD binding;Xintracellular,cytoplasm,cytoskeleton,focal adhesion,nuclear matrix,extracellular matrix;>sp|O43294|TGFI1_HUMAN Transforming growth factor beta-1-induced transcript 1 protein OS=Homo sapiens GN=TGFB1I1 PE=1 SV=2;>sp|O43294-2|TGFI1_HUMAN Isoform 2 of Transforming growth factor beta-1-induced transcript 1 protein OS=Homo sapiens GN=TGFB1I1O75695RP2 XRP2_HUMAN Protein XRP2cell morphogenesis,protein folding,post-Golgi vesicle-mediated transport,cytoskeleton organization,visual perception,protein transport,positive regulation of GTPase activity,post-chaperonin tubulin folding pathway\actin binding,GTPase activator activity,protein binding,GTP binding,unfolded protein bindingnucleoplasm,cytoplasm,Golgi apparatus,centriole,plasma membrane,cilium,nuclear body,cytoplasmic vesicle,ciliary basal body,extracellular exosome,periciliary membrane compartmentC>sp|O75695|XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4*P00390;P00390-2;P00390-3;P00390-4;P00390-5GSR GSHR_HUMANGlutathione reductase, mitochondrial;Isoform Cytoplasmic of Glutathione reductase, mitochondrial;Isoform 2 of Glutathione reductase, mitochondrial;Isoform 3 of Glutathione reductase, mitochondrial;Isoform 4 of Glutathione reductase, mitochondrialresponse to reactive oxygen species,glutathione metabolic process,nucleobase-containing small molecule interconversion,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification;;;;wglutathione-disulfide reductase activity,electron carrier activity,flavin adenine dinucleotide binding,NADP binding;;;;Wmitochondrial matrix,cytosol,external side of plasma membrane,extracellular exosome;;;;2;;;;>sp|P00390|GSHR_HUMAN Glutathione reductase, mitochondrial OS=Homo sapiens G< N=GSR PE=1 SV=2;>sp|P00390-2|GSHR_HUMAN Isoform Cytoplasmic of Glutathione reductase, mitochondrial OS=Homo sapiens GN=GSR;>sp|P00390-3|GSHR_HUMAN Isoform 2 of Glutathione reductase, mitochondrial OS=Homo sapiens GN=GSR;>sp|P00390-4|GSHR_HUMAN Isoform 3 of Glutathione reductase, mitochondrial OS=Homo sapiens GN=GSR;>sp|P00390-5|GSHR_HUMAN Isoform 4 of Glutathione reductase, mitochondrial OS=Homo sapiens GN=GSRP01599IGKV1-17 KV117_HUMAN"Immunoglobulin kappa variable 1-17_>sp|P01599|KV117_HUMAN Immunoglobulin kappa variable 1-17 OS=Homo sapiens GN=IGKV1-17 PE=1 SV=2P01817IGHV2-5 HV205_HUMAN!Immunoglobulin heavy variable 2-5]>sp|P01817|HV205_HUMAN Immunoglobulin heavy variable 2-5 OS=Homo sapiens GN=IGHV2-5 PE=1 SV=2P01834IGKC IGKC_HUMANIg kappa chain C regionretina homeostasis,proteolysis,receptor-mediated endocytosis,phagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,regulation of immune response,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migrationextracellular region,extracellular space,plasma membrane,external side of plasma membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticleO>sp|P01834|IGKC_HUMAN Ig kappa chain C region OS=Homo sapiens GN=IGKC PE=1 SV=1P01861IGHG4 IGHG4_HUMANIg gamma-4 chain C regionS>sp|P01861|IGHG4_HUMAN Ig gamma-4 chain C region OS=Homo sapiens GN=IGHG4 PE=1 SV=1P02741CRP CRP_HUMANC-reactive protein^acute-phase response,inflammatory response,opsonization,positive regulation of gene expression,negative regulation of macrophage derived foam cell differentiation,negative regulation of lipid storage,positive regulation of superoxide anion generation,defense response to Gram-positive bacterium,Requires Ontology,regulation of interleukin-8 secretioncomplement component C1q binding,calcium ion binding,protein binding,low-density lipoprotein particle binding,choline binding,low-density lipoprotein particle receptor binding,virion bindingH>sp|P02741|CRP_HUMAN C-reactive protein OS=Homo sapiens GN=CRP PE=1 SV=1P04211IGLV7-43 LV743_HUMAN#Immunoglobulin lambda variable 7-43`>sp|P04211|LV743_HUMAN Immunoglobulin lambda variable 7-43 OS=Homo sapiens GN=IGLV7-43 PE=3 SV=2P06239;P06239-3;Q573B4LCK LCK_HUMAN;LCK_HUMAN;Q573B4_HUMAN\Tyrosine-protein kinase Lck;Isoform 3 of Tyrosine-protein kinase Lck;Tyrosine-protein kinaseprotein phosphorylation,protein dephosphorylation,cellular zinc ion homeostasis,activation of cysteine-type endopeptidase activity involved in apoptotic process,transmembrane receptor protein tyrosine kinase signaling pathway,regulation of phosphatidylinositol 3-kinase signaling,viral process,cell migration,hemopoiesis,platelet activation,T cell differentiation,T cell costimulation,peptidyl-tyrosine autophosphorylation,regulation of cell proliferation,response to drug,innate immune response,phosphatidylinositol phosphorylation,phosphatidylinositol-mediated signaling,regulation of defense response to virus by virus,T cell receptor signaling pathway,B cell receptor signaling pathway,positive regulation of T cell receptor signaling pathway,positive regulation of T cell activation,leukocyte migration,release of sequestered calcium ion into cytosol,regulation of lymphocyte activation,positive regulation of intrinsic apoptotic signaling pathway;;glycoprotein binding,protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,protein serine/threonine phosphatase activity,protein binding,ATP binding,protein C-terminus binding,kinase activity,protein kinase binding,protein phosphatase binding,SH2 domain binding,CD4 receptor binding,CD8 receptor binding,identical protein binding,phosphatidylinositol 3-kinase binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,ATPase binding;;pericentriolar material,immunological synapse,cytosol,plasma membrane,extrinsic component of cytoplasmic side of plasma membrane,membrane raft,extracellular exosome;;6;;1>sp|P06239|LCK_HUMAN Tyrosine-protein kinase Lck OS=Homo sapiens GN=LCK PE=1 SV=6;>sp|P06239-3|LCK_HUMAN Isoform 3 of Tyrosine-protein kinase Lck OS=Homo sapiens GN=LCK;>tr|Q573B4|Q573B4_HUMAN Tyrosine-protein kinase OS=Homo sapiens GN=LCK PE=1 SV=1P07360C8G CO8G_HUMAN#Complement component C8 gamma chaincomplement activation, alternative pathway,complement activation, classical pathway,cytolysis,regulation of complement activation:complement binding,retinol binding,protein complex bindingVextracellular region,membrane attack complex,extracellular exosome,blood microparticleZ>sp|P07360|CO8G_HUMAN Complement component C8 gamma chain OS=Homo sapiens GN=C8G PE=1 SV=3P09543;P09543-2CNP CN37_HUMANi2',3'-cyclic-nucleotide 3'-phosphodiesterase;Isoform CNPI of 2',3'-cyclic-nucleotide 3'-phosphodiesteraseVmicrotubule cytoskeleton organization,chemical synaptic transmission,axonogenesis,aging,adult locomotory behavior,cyclic nucleotide catabolic process,response to toxic substance,substantia nigra development,forebrain development,response to lipopolysaccharide,regulation of mitochondrial membrane permeability,oligodendrocyte differentiation;\RNA binding,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,cyclic nucleotide binding;extracellular space,cytoplasm,mitochondrial outer membrane,mitochondrial inner membrane,plasma membrane,microvillus,membrane,pseudopodium,myelin sheath abaxonal region,myelin sheath adaxonal region,melanosome,perinuclear region of cytoplasm,extracellular exosome;>sp|P09543|CN37_HUMAN 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens GN=CNP PE=1 SV=2;>sp|P09543-2|CN37_HUMAN Isoform CNPI of 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens GN=CNPP11216PYGB PYGB_HUMAN"Glycogen phosphorylase, brain form3glycogen catabolic process,neutrophil degranulationKprotein binding,glycogen phosphorylase activity,pyridoxal phosphate bindingUextracellular region,cytoplasm,membrane,azurophil granule lumen,extracellular exosomeZ>sp|P11216|PYGB_HUMAN Glycogen phosphorylase, brain form OS=Homo sapiens GN=PYGB PE=1 SV=5P12532;P12532-2CKMT1A KCRU_HUMANXCreatine kinase U-type, mitochondrial;Isoform 2 of Creatine kinase U-type, mitochondrial+creatine metabolic process,phosphorylation;%creatine kinase activity,ATP binding;Amitochondrion,mitochondrial inner membrane,extracellular exosome;>sp|P12532|KCRU_HUMAN Creatine kinase U-type, mitochondrial OS=Homo sapiens GN=CKMT1A PE=1 SV=1;>sp|P12532-2|KCRU_HUMAN Isoform 2 of Creatine kinase U-type, mitochondrial OS=Homo sapiens GN=CKMT1AP14770GP9 GPIX_HUMANPlatelet glycoprotein IXXcell adhesion,blood coagulation,blood coagulation, intrinsic pathway,platelet activation5plasma membrane,integral component of plasma membraneO>sp|P14770|GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3(P20023;P20023-2;P20023-3;P20023-4;Q5SR47CR24CR2_HUMAN;CR2_HUMAN;CR2_HUMAN;CR2_HUMAN;Q5SR47_HUMANComplement receptor type 2;Isoform B of Complement receptor type 2;Isoform C of Complement receptor type 2;Isoform D of Complement receptor type 2;Complement receptor type 2complement receptor mediated signaling pathway,immune response,complement activation, classical pathway,B cell differentiation,B cell proliferation,innate immune response,viral entry into host cell;;;;virus receptor activity,complement binding,DNA binding,complement receptor activity,transmembrane signaling receptor activity,protein homodimerization activity;;;;Yplasma membrane,integral component of membrane,receptor complex,extracellular exosome;;;;sp;sp;sp;sp;tr2;;;;1>sp|P20023|CR2_HUMAN Complement receptor type 2 OS=Homo sapiens GN=CR2 PE=1 SV=2;>sp|P20023-2|CR2_HUMAN Isoform B of Complement receptor type 2 OS=Homo sapiens GN=CR2;>sp|P20023-3|CR2_HUMAN Isoform C of Complement receptor type 2 OS=Homo sapiens GN=CR2;>sp|P20023-4|CR2_H< UMAN Isoform D of Complement receptor type 2 OS=Homo sapiens GN=CR2;>tr|Q5SR47|Q5SR47_HUMAN Complement receptor type 2 OS=Homo sapiens GN=CR2 PE=1 SV=1P21439;P21439-2;P21439-3ABCB4 MDR3_HUMANPhosphatidylcholine translocator ABCB4;Isoform 2 of Phosphatidylcholine translocator ABCB4;Isoform 3 of Phosphatidylcholine translocator ABCB4aresponse to hypoxia,placenta development,lipid metabolic process,transport,drug transmembrane transport,brain development,lactation,circadian rhythm,hormone transport,positive regulation of cholesterol transport,bile acid secretion,response to vitamin A,carbohydrate export,response to vitamin D,maintenance of blood-brain barrier,cellular response to mycotoxin,response to drug,xenobiotic transport,daunorubicin transport,response to morphine,phospholipid translocation,drug export,response to cadmium ion,intestinal absorption,transmembrane transport,lipid homeostasis,negative regulation of cell death,establishment of blood-brain barrier,positive regulation of phospholipid translocation,cellular response to external biotic stimulus,cellular response to antibiotic,cellular response to alkaloid,cellular response to estradiol stimulus,cellular hyperosmotic salinity response,cellular response to dexamethasone stimulus,response to thyroxine,response to antineoplastic agent,response to fenofibrate,cellular response to bile acid,response to glycoside,cellular response to borneol,cellular response to L-glutamate,response to codeine,response to quercetin,response to cyclosporin A,drug transport across blood-brain barrier,establishment of blood-retinal barrier,positive regulation of response to drug,positive regulation of phospholipid transport,ceramide translocation;;*protein binding,ATP binding,phospholipid transporter activity,phosphatidylcholine transporter activity,xenobiotic-transporting ATPase activity,ATPase activity, coupled to transmembrane movement of substances,phosphatidylcholine-translocating ATPase activity,ceramide-translocating ATPase activity;;nucleoplasm,cytoplasm,cytosol,plasma membrane,integral component of plasma membrane,focal adhesion,actin cytoskeleton,membrane,apical plasma membrane,clathrin-coated vesicle,brush border membrane,membrane raft,intercellular canaliculus,extracellular exosome;;)>sp|P21439|MDR3_HUMAN Phosphatidylcholine translocator ABCB4 OS=Homo sapiens GN=ABCB4 PE=1 SV=2;>sp|P21439-2|MDR3_HUMAN Isoform 2 of Phosphatidylcholine translocator ABCB4 OS=Homo sapiens GN=ABCB4;>sp|P21439-3|MDR3_HUMAN Isoform 3 of Phosphatidylcholine translocator ABCB4 OS=Homo sapiens GN=ABCB4P27487DPP4 DPP4_HUMANDipeptidyl peptidase 4behavioral fear response,response to hypoxia,proteolysis,cell adhesion,positive regulation of cell proliferation,negative regulation of extracellular matrix disassembly,T cell costimulation,regulation of cell-cell adhesion mediated by integrin,locomotory exploration behavior,psychomotor behavior,T cell activation,endothelial cell migration,viral entry into host cell,regulation of insulin secretionvirus receptor activity,protease binding,serine-type endopeptidase activity,receptor binding,protein binding,serine-type peptidase activity,dipeptidyl-peptidase activity,identical protein binding,protein homodimerization activityextracellular region,lysosomal membrane,plasma membrane,focal adhesion,cell surface,membrane,integral component of membrane,apical plasma membrane,lamellipodium,endocytic vesicle,lamellipodium membrane,membrane raft,intercellular canaliculus,extracellular exosome,invadopodium membraneN>sp|P27487|DPP4_HUMAN Dipeptidyl peptidase 4 OS=Homo sapiens GN=DPP4 PE=1 SV=2P27824;P27824-2;P27824-3CANX CALX_HUMAN4Calnexin;Isoform 2 of Calnexin;Isoform 3 of CalnexinJantigen processing and presentation of peptide antigen via MHC class I,protein folding,aging,protein secretion,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein folding in endoplasmic reticulum,synaptic vesicle endocytosis,chaperone-mediated protein folding,clathrin-dependent endocytosis;;glycoprotein binding,RNA binding,calcium ion binding,protein binding,carbohydrate binding,apolipoprotein binding,ionotropic glutamate receptor binding,unfolded protein binding;;endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,rough endoplasmic reticulum,ribosome,membrane,axon,extracellular matrix,dendrite cytoplasm,melanosome,neuronal cell body,dendritic spine,myelin sheath,protein complex,ER-mitochondrion membrane contact site,extracellular exosome,integral component of lumenal side of endoplasmic reticulum membrane;;>sp|P27824|CALX_HUMAN Calnexin OS=Homo sapiens GN=CANX PE=1 SV=2;>sp|P27824-2|CALX_HUMAN Isoform 2 of Calnexin OS=Homo sapiens GN=CANX;>sp|P27824-3|CALX_HUMAN Isoform 3 of Calnexin OS=Homo sapiens GN=CANXP28072PSMB6 PSB6_HUMANProteasome subunit beta type-6Mendopeptidase activity,threonine-type endopeptidase activity,cadherin binding\proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,extracellular exosomeW>sp|P28072|PSB6_HUMAN Proteasome subunit beta type-6 OS=Homo sapiens GN=PSMB6 PE=1 SV=41G5E973;P30203;P30203-2;P30203-3;P30203-4;P30203-5CD6>G5E973_HUMAN;CD6_HUMAN;CD6_HUMAN;CD6_HUMAN;CD6_HUMAN;CD6_HUMAN CD6 antigen, isoform CRA_d;T-cell differentiation antigen CD6;Isoform CD6B of T-cell differentiation antigen CD6;Isoform CD6C of T-cell differentiation antigen CD6;Isoform CD6D of T-cell differentiation antigen CD6;Isoform CD6E of T-cell differentiation antigen CD6;immunological synapse formation,adaptive immune response,acute inflammatory response to antigenic stimulus,receptor-mediated endocytosis,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,lipopolysaccharide-mediated signaling pathway,response to lipopolysaccharide,positive regulation of T cell proliferation,innate immune response,positive regulation of cytokine production involved in inflammatory response;;;;e;lipopolysaccharide binding,scavenger receptor activity,protein binding,lipoteichoic acid binding;;;;;immunological synapse,extracellular region,integral component of plasma membrane,intrinsic component of plasma membrane,T cell receptor complex;;;;1;3;;;;0>tr|G5E973|G5E973_HUMAN CD6 antigen, isoform CRA_d OS=Homo sapiens GN=CD6 PE=1 SV=1;>sp|P30203|CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3;>sp|P30203-2|CD6_HUMAN Isoform CD6B of T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6;>sp|P30203-3|CD6_HUMAN Isoform CD6C of T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6;>sp|P30203-4|CD6_HUMAN Isoform CD6D of T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6;>sp|P30203-5|CD6_HUMAN Isoform CD6E of T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6P31151S100A7 S10A7_HUMANProtein S100-A7response to reactive oxygen species,angiogenesis,epidermis development,positive regulation of T cell chemotaxis,antimicrobial humoral response,keratinocyte differentiation,response to lipopolysaccharide,neutrophil degranulation,innate immune response,defense response to Gram-negative bacterium,sequestering of metal ion,positive regulation of ERK1 and ERK2 cascade,positive regulation of granulocyte chemotaxis,positive regulation of monocyte chemotaxisJcalcium ion binding,protein binding,zinc ion binding,RAGE receptor bindingextracellular region,nucleus,cytoplasm,endoplasmic reticulum,cytosol,focal adhesion,azurophil granule lumen,extracellular exosomeJ>sp|P31151|S10A7_HUMAN Protein S100-A7 OS=Homo sapiens GN=S100A7 PE=1 SV=4P40227CCT6A TCPZ_HUMAN T-complex protein 1 subunit zetaaprotein folding,'de novo' protein folding,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone-mediated protein folding,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodyRNA binding,protein binding,ATP binding,protein binding involved in protein folding,unfolded protein binding,WD40-repeat domain binding< hcytoplasm,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,extracellular exosomeY>sp|P40227|TCPZ_HUMAN T-complex protein 1 subunit zeta OS=Homo sapiens GN=CCT6A PE=1 SV=3P41250GARS SYG_HUMANGlycine--tRNA ligasevtRNA aminoacylation for protein translation,glycyl-tRNA aminoacylation,diadenosine tetraphosphate biosynthetic processbis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,glycine-tRNA ligase activity,ATP binding,protein dimerization activityScytoplasm,mitochondrial matrix,cytosol,secretory granule,axon,extracellular exosomeK>sp|P41250|SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3P43121;P43121-2MCAM MUC18_HUMANLCell surface glycoprotein MUC18;Isoform 2 of Cell surface glycoprotein MUC18angiogenesis,glomerular filtration,cell adhesion,anatomical structure morphogenesis,positive regulation of cell migration,vascular wound healing;{extracellular space,nucleus,plasma membrane,focal adhesion,external side of plasma membrane,integral component of membrane;>sp|P43121|MUC18_HUMAN Cell surface glycoprotein MUC18 OS=Homo sapiens GN=MCAM PE=1 SV=2;>sp|P43121-2|MUC18_HUMAN Isoform 2 of Cell surface glycoprotein MUC18 OS=Homo sapiens GN=MCAM!P43251;P43251-2;P43251-3;P43251-4BTD BTD_HUMANVBiotinidase;Isoform 2 of Biotinidase;Isoform 3 of Biotinidase;Isoform 4 of Biotinidase>biotin metabolic process,central nervous system development;;;]hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,biotinidase activity;;;Vextracellular region,extracellular space,mitochondrial matrix,extracellular exosome;;;>sp|P43251|BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2;>sp|P43251-2|BTD_HUMAN Isoform 2 of Biotinidase OS=Homo sapiens GN=BTD;>sp|P43251-3|BTD_HUMAN Isoform 3 of Biotinidase OS=Homo sapiens GN=BTD;>sp|P43251-4|BTD_HUMAN Isoform 4 of Biotinidase OS=Homo sapiens GN=BTDP43405;P43405-2SYK KSYK_HUMANHTyrosine-protein kinase SYK;Isoform Short of Tyrosine-protein kinase SYKangiogenesis,lymph vessel development,positive regulation of receptor internalization,stimulatory C-type lectin receptor signaling pathway,adaptive immune response,macrophage activation involved in immune response,neutrophil activation involved in immune response,leukocyte activation involved in immune response,serotonin secretion by platelet,protein phosphorylation,inflammatory response,leukocyte cell-cell adhesion,transmembrane receptor protein tyrosine kinase signaling pathway,integrin-mediated signaling pathway,activation of JUN kinase activity,cell proliferation,animal organ morphogenesis,regulation of platelet activation,regulation of tumor necrosis factor-mediated signaling pathway,viral process,peptidyl-serine phosphorylation,leukotriene biosynthetic process,platelet activation,neutrophil chemotaxis,receptor internalization,positive regulation of type I interferon production,regulation of superoxide anion generation,positive regulation of cell adhesion mediated by integrin,peptidyl-tyrosine autophosphorylation,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,transcription factor import into nucleus,positive regulation of mast cell degranulation,regulation of neutrophil degranulation,beta selection,innate immune response,positive regulation of interleukin-3 biosynthetic process,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,positive regulation of B cell differentiation,positive regulation of gamma-delta T cell differentiation,positive regulation of bone resorption,positive regulation of alpha-beta T cell differentiation,positive regulation of alpha-beta T cell proliferation,blood vessel morphogenesis,positive regulation of cytokine secretion,positive regulation of peptidyl-tyrosine phosphorylation,regulation of phagocytosis,positive regulation of calcium-mediated signaling,B cell receptor signaling pathway,regulation of sequence-specific DNA binding transcription factor activity,regulation of ERK1 and ERK2 cascade,cellular response to molecule of fungal origin,cellular response to low-density lipoprotein particle stimulus,regulation of arachidonic acid secretion,regulation of platelet aggregation;@protein kinase activity,protein serine/threonine kinase activity,protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,receptor signaling protein tyrosine kinase activity,integrin binding,protein binding,ATP binding,protein kinase binding,phosphatase binding,Toll-like receptor binding;nucleus,cytoplasm,cytosol,plasma membrane,B cell receptor complex,extrinsic component of cytoplasmic side of plasma membrane,early phagosome,T cell receptor complex,protein complex;>sp|P43405|KSYK_HUMAN Tyrosine-protein kinase SYK OS=Homo sapiens GN=SYK PE=1 SV=1;>sp|P43405-2|KSYK_HUMAN Isoform Short of Tyrosine-protein kinase SYK OS=Homo sapiens GN=SYKP50570-3;P50570-4DNM2 DYN2_HUMAN-Isoform 3 of Dynamin-2;Isoform 4 of Dynamin-2>sp|P50570-3|DYN2_HUMAN Isoform 3 of Dynamin-2 OS=Homo sapiens GN=DNM2;>sp|P50570-4|DYN2_HUMAN Isoform 4 of Dynamin-2 OS=Homo sapiens GN=DNM2P51153RAB13 RAB13_HUMANRas-related protein Rab-13small GTPase mediated signal transduction,protein kinase A signaling,protein transport,endosomal transport,cortical actin cytoskeleton organization,neuron projection development,endocytic recycling,cellular response to insulin stimulus,endothelial cell chemotaxis,trans-Golgi network to recycling endosome transport,membrane organization,bicellular tight junction assembly,establishment of protein localization to plasma membrane,establishment of Sertoli cell barrier,protein localization to cell leading edgeVGTPase activity,protein binding,GTP binding,protein kinase A catalytic subunit bindingBtrans-Golgi network,cytosol,plasma membrane,bicellular tight junction,lateral plasma membrane,lamellipodium,cell junction,endocytic vesicle,cytoplasmic vesicle membrane,cytoplasmic vesicle,insulin-responsive compartment,neuron projection,recycling endosome,recycling endosome membrane,extracellular exosome,Golgi apparatusT>sp|P51153|RAB13_HUMAN Ras-related protein Rab-13 OS=Homo sapiens GN=RAB13 PE=1 SV=1P51659HSD17B4 DHB4_HUMAN)Peroxisomal multifunctional enzyme type 2very long-chain fatty acid metabolic process,osteoblast differentiation,fatty acid beta-oxidation,bile acid biosynthetic process,androgen metabolic process,estrogen metabolic process,fatty acid beta-oxidation using acyl-CoA oxidase,alpha-linolenic acid metabolic process,very long-chain fatty-acyl-CoA metabolic process,medium-chain fatty-acyl-CoA metabolic process,Sertoli cell development3-hydroxyacyl-CoA dehydrogenase activity,receptor binding,long-chain-enoyl-CoA hydratase activity,isomerase activity,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,protein homodimerization activity,17-beta-hydroxysteroid dehydrogenase (NAD+) activityImitochondrion,peroxisome,peroxisomal membrane,peroxisomal matrix,membraned>sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3P53618COPB1 COPB_HUMANCoatomer subunit betaintracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,viral process,neutrophil degranulation,structural molecule activity,protein bindingNGolgi membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,Golgi-associated vesicle,cytosol,plasma membrane,membrane,COPI vesicle coat,transport vesicle,secretory granule membrane,intracellular membrane-bounded organelle,tertiary granule membrane,ficolin-1-rich granule membraneN>sp|P53618|COPB_HUMAN Coatomer subunit beta OS=Homo sapiens GN=COPB1 PE=1 SV=3P59768GNG2 GBG2_HUMANAGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2*protein folding,adenylate cyclase-activating dopamine receptor signaling pathway,Wnt signaling pathway, calcium modulating pathway,cell proliferation,platelet activation,cellular re< sponse to glucagon stimulus,cellular response to prostaglandin E stimulus,cellular response to catecholamine stimulus9signal transducer activity,G-protein beta-subunit bindingOheterotrimeric G-protein complex,plasma membrane,membrane,extracellular exosomey>sp|P59768|GBG2_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 OS=Homo sapiens GN=GNG2 PE=1 SV=2P60174;P60174-1TPI1 TPIS_HUMAN@Triosephosphate isomerase;Isoform 2 of Triosephosphate isomerasegluconeogenesis,glycolytic process,pentose-phosphate shunt,multicellular organism development,glycerol catabolic process,glyceraldehyde-3-phosphate biosynthetic process,canonical glycolysis;Utriose-phosphate isomerase activity,protein binding,ubiquitin protein ligase binding;:extracellular space,nucleus,cytosol,extracellular exosome;>sp|P60174|TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3;>sp|P60174-1|TPIS_HUMAN Isoform 2 of Triosephosphate isomerase OS=Homo sapiens GN=TPI1P60981DSTN DEST_HUMANDestrinactin polymerization or depolymerization,actin filament depolymerization,actin filament fragmentation,positive regulation of actin filament depolymerization,actin filament severing&protein binding,actin filament bindingDactin cytoskeleton,cortical actin cytoskeleton,extracellular exosome?>sp|P60981|DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=3P62258YWHAE 1433E_HUMAN14-3-3 protein epsilonG2/M transition of mitotic cell cycle,MAPK cascade,neuron migration,regulation of heart rate by hormone,protein targeting,viral process,substantia nigra development,hippocampus development,cerebral cortex development,cellular response to heat,hippo signaling,intracellular signal transduction,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of GTPase activity,positive regulation of protein export from nucleus,regulation of membrane repolarization,membrane organization,membrane repolarization during cardiac muscle cell action potential,regulation of heart rate by cardiac conduction,ciliary basal body docking,regulation of cellular response to heat,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of potassium ion transmembrane transporter activity,negative regulation of peptidyl-serine dephosphorylationvRNA binding,protein binding,potassium channel regulator activity,Rab guanyl-nucleotide exchange factor activity,enzyme binding,protein domain specific binding,MHC class II protein complex binding,ubiquitin protein ligase binding,histone deacetylase binding,ion channel binding,cadherin binding,protein heterodimerization activity,phosphoserine binding,phosphoprotein bindingnucleus,cytoplasm,mitochondrion,cytosol,kinesin complex,focal adhesion,membrane,axon,cytoplasmic vesicle membrane,melanosome,extracellular exosomeP>sp|P62258|1433E_HUMAN 14-3-3 protein epsilon OS=Homo sapiens GN=YWHAE PE=1 SV=1<A0A0A0MR13;P63092;P63092-2;P63092-3;P63092-4;Q5JWF2;Q5JWF2-2GNASXA0A0A0MR13_HUMAN;GNAS2_HUMAN;GNAS2_HUMAN;GNAS2_HUMAN;GNAS2_HUMAN;GNAS1_HUMAN;GNAS1_HUMANGuanine nucleotide-binding protein G(s) subunit alpha isoforms short;Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;Isoform Gnas-2 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;Isoform 3 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;Isoform 4 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas;Isoform XLas-2 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas;;;;;tissue homeostasis,endochondral ossification,energy reserve metabolic process,DNA methylation,adenylate cyclase-activating G-protein coupled receptor signaling pathway,adenylate cyclase-activating dopamine receptor signaling pathway,sensory perception of chemical stimulus,embryonic hindlimb morphogenesis,multicellular organism growth,post-embryonic body morphogenesis,response to drug,positive regulation of osteoblast differentiation,positive regulation of osteoclast differentiation,developmental growth,embryonic cranial skeleton morphogenesis,cognition,cartilage development,bone development,hair follicle placode formation,platelet aggregation,genetic imprinting,regulation of parathyroid hormone secretion;p;;;;;GTPase activity,signal transducer activity,insulin-like growth factor receptor binding,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,beta-2 adrenergic receptor binding,D1 dopamine receptor binding,mu-type opioid receptor binding,ionotropic glutamate receptor binding,metal ion binding,corticotropin-releasing hormone receptor 1 binding;m;;;;;cytosol,heterotrimeric G-protein complex,membrane,apical plasma membrane,dendrite,extracellular exosome; 1;1;;;;1; 1;1;;;;2;>tr|A0A0A0MR13|A0A0A0MR13_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1;>sp|P63092|GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1;>sp|P63092-2|GNAS2_HUMAN Isoform Gnas-2 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS;>sp|P63092-3|GNAS2_HUMAN Isoform 3 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS;>sp|P63092-4|GNAS2_HUMAN Isoform 4 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS;>sp|Q5JWF2|GNAS1_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens GN=GNAS PE=1 SV=2;>sp|Q5JWF2-2|GNAS1_HUMAN Isoform XLas-2 of Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens GN=GNASP68366TUBA4A TBA4A_HUMANTubulin alpha-4A chainG2/M transition of mitotic cell cycle,platelet degranulation,cytoskeleton organization,microtubule-based process,ciliary basal body dockingaGTPase activity,structural constituent of cytoskeleton,protein binding,GTP binding,enzyme bindingWextracellular region,cytosol,microtubule,microtubule cytoskeleton,extracellular exosomeQ>sp|P68366|TBA4A_HUMAN Tubulin alpha-4A chain OS=Homo sapiens GN=TUBA4A PE=1 SV=1P78527;P78527-2PRKDC PRKDC_HUMANjDNA-dependent protein kinase catalytic subunit;Isoform 2 of DNA-dependent protein kinase catalytic subunitsomitogenesis,negative regulation of protein phosphorylation,B cell lineage commitment,pro-B cell differentiation,T cell lineage commitment,negative regulation of immunoglobulin production,positive regulation of immune system process,double-strand break repair,double-strand break repair via nonhomologous end joining,cellular protein modification process,brain development,heart development,cell proliferation,intrinsic apoptotic signaling pathway in response to DNA damage,response to gamma radiation,response to activity,telomere capping,protein ubiquitination,peptidyl-serine phosphorylation,protein destabilization,positive regulation of type I interferon production,cellular response to insulin stimulus,T cell differentiation in thymus,immunoglobulin V(D)J recombination,T cell receptor V(D)J recombination,ectopic germ cell programmed cell death,regulation of circadian rhythm,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of transcription from RNA polymerase II promoter,positive regulation of fibroblast proliferation,rhythmic process,spleen development,thymus development,positive regulation of developmental growth,regulation of smooth muscle cell proliferation,signal transduction involved in mitotic G1 DNA damage checkpoint,double-strand break repair via alternative nonhomologous end joining,negative regulation of cellular senescence,negative regulation of response to gamma radiation;double-stranded DNA binding,RNA binding,protein kinase activity,protein serine/threonine kinase activity,DNA-dependent protein kinase activity,protein binding,ATP binding,transcription factor binding,enzyme binding;nuclear chromosome, telomeric region,nucleoplasm,tr< anscription factor complex,nucleolus,cytosol,DNA-dependent protein kinase-DNA ligase 4 complex,membrane,extracellular matrix,nonhomologous end joining complex;>sp|P78527|PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3;>sp|P78527-2|PRKDC_HUMAN Isoform 2 of DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDCQ03591CFHR1 FHR1_HUMAN%Complement factor H-related protein 1complement activation=extracellular space,extracellular exosome,blood microparticle^>sp|Q03591|FHR1_HUMAN Complement factor H-related protein 1 OS=Homo sapiens GN=CFHR1 PE=1 SV=2Q0VD83;Q0VD83-3;Q0VD83-4APOBR APOBR_HUMANgApolipoprotein B receptor;Isoform 3 of Apolipoprotein B receptor;Isoform 4 of Apolipoprotein B receptortriglyceride metabolic process,lipid transport,receptor-mediated endocytosis,cholesterol metabolic process,lipoprotein metabolic process;;9very-low-density lipoprotein particle receptor activity;;mplasma membrane,membrane,very-low-density lipoprotein particle,low-density lipoprotein particle,chylomicron;;>sp|Q0VD83|APOBR_HUMAN Apolipoprotein B receptor OS=Homo sapiens GN=APOBR PE=1 SV=2;>sp|Q0VD83-3|APOBR_HUMAN Isoform 3 of Apolipoprotein B receptor OS=Homo sapiens GN=APOBR;>sp|Q0VD83-4|APOBR_HUMAN Isoform 4 of Apolipoprotein B receptor OS=Homo sapiens GN=APOBRQ13103SPP2 SPP24_HUMANSecreted phosphoprotein 24pskeletal system development,platelet degranulation,negative regulation of endopeptidase activity,bone remodeling endopeptidase inhibitor activityGextracellular region,platelet dense granule lumen,extracellular exosomeS>sp|Q13103|SPP24_HUMAN Secreted phosphoprotein 24 OS=Homo sapiens GN=SPP2 PE=1 SV=1Q15599;Q15599-2SLC9A3R2 NHRF2_HUMANlNa(+)/H(+) exchange regulatory cofactor NHE-RF2;Isoform 2 of Na(+)/H(+) exchange regulatory cofactor NHE-RF2protein complex assembly;receptor binding,protein binding,beta-catenin binding,protein C-terminus binding,phosphatase binding,protein complex scaffold,cadherin binding;hnucleus,plasma membrane,focal adhesion,endomembrane system,apical plasma membrane,extracellular exosome;>sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens GN=SLC9A3R2 PE=1 SV=2;>sp|Q15599-2|NHRF2_HUMAN Isoform 2 of Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens GN=SLC9A3R2Q31610 1B81_HUMAN8HLA class I histocompatibility antigen, B-81 alpha chainq>sp|Q31610|1B81_HUMAN HLA class I histocompatibility antigen, B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1Q53RD9;Q53RD9-2;Q53RD9-4FBLN7 FBLN7_HUMAN7Fibulin-7;Isoform 2 of Fibulin-7;Isoform 4 of Fibulin-7cell adhesion;;%calcium ion binding,heparin binding;;Iproteinaceous extracellular matrix,focal adhesion,extracellular exosome;;>sp|Q53RD9|FBLN7_HUMAN Fibulin-7 OS=Homo sapiens GN=FBLN7 PE=2 SV=1;>sp|Q53RD9-2|FBLN7_HUMAN Isoform 2 of Fibulin-7 OS=Homo sapiens GN=FBLN7;>sp|Q53RD9-4|FBLN7_HUMAN Isoform 4 of Fibulin-7 OS=Homo sapiens GN=FBLN7Q60FE5 Q60FE5_HUMAN Filamin AC>tr|Q60FE5|Q60FE5_HUMAN Filamin A OS=Homo sapiens GN=FLNA PE=1 SV=1FQ6E0U4;Q6E0U4-16;Q6E0U4-2;Q6E0U4-3;Q6E0U4-4;Q6E0U4-5;Q6E0U4-6;Q6E0U4-7DMKN DMKN_HUMANDermokine;Isoform 16 of Dermokine;Isoform 2 of Dermokine;Isoform 3 of Dermokine;Isoform 4 of Dermokine;Isoform 5 of Dermokine;Isoform 6 of Dermokine;Isoform 7 of Dermokine"cornified envelope assembly;;;;;;;protein binding;;;;;;;extracellular exosome;;;;;;;4>sp|Q6E0U4|DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3;>sp|Q6E0U4-16|DMKN_HUMAN Isoform 16 of Dermokine OS=Homo sapiens GN=DMKN;>sp|Q6E0U4-2|DMKN_HUMAN Isoform 2 of Dermokine OS=Homo sapiens GN=DMKN;>sp|Q6E0U4-3|DMKN_HUMAN Isoform 3 of Dermokine OS=Homo sapiens GN=DMKN;>sp|Q6E0U4-4|DMKN_HUMAN Isoform 4 of Dermokine OS=Homo sapiens GN=DMKN;>sp|Q6E0U4-5|DMKN_HUMAN Isoform 5 of Dermokine OS=Homo sapiens GN=DMKN;>sp|Q6E0U4-6|DMKN_HUMAN Isoform 6 of Dermokine OS=Homo sapiens GN=DMKN;>sp|Q6E0U4-7|DMKN_HUMAN Isoform 7 of Dermokine OS=Homo sapiens GN=DMKNQ6UX06OLFM4 OLFM4_HUMANOlfactomedin-4 cell adhesion,neutrophil degranulation,protein homooligomerization,positive regulation of substrate adhesion-dependent cell spreading,regulation of necrotic cell death,regulation of apoptotic process,regulation of phagocytosis,regulation of neutrophil extravasationUcatalytic activity,protein binding,protein homodimerization activity,cadherin bindingextracellular region,extracellular space,mitochondrion,plasma membrane,specific granule lumen,specific granule,perinuclear region of cytoplasm,extracellular exosome,tertiary granule lumen,secretory granule,azurophil granuleH>sp|Q6UX06|OLFM4_HUMAN Olfactomedin-4 OS=Homo sapiens GN=OLFM4 PE=1 SV=1Q6ZNJ1;Q6ZNJ1-2;Q6ZNJ1-3NBEAL2 NBEL2_HUMANmNeurobeachin-like protein 2;Isoform 2 of Neurobeachin-like protein 2;Isoform 3 of Neurobeachin-like protein 2-platelet formation,neutrophil degranulation;;aendoplasmic reticulum,plasma membrane,tertiary granule membrane,ficolin-1-rich granule membrane;;>sp|Q6ZNJ1|NBEL2_HUMAN Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2 PE=1 SV=2;>sp|Q6ZNJ1-2|NBEL2_HUMAN Isoform 2 of Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2;>sp|Q6ZNJ1-3|NBEL2_HUMAN Isoform 3 of Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2Q7Z304MAMDC2 MAMC2_HUMANMAM domain-containing protein 2Aproteinaceous extracellular matrix,endoplasmic reticulum,membraneZ>sp|Q7Z304|MAMC2_HUMAN MAM domain-containing protein 2 OS=Homo sapiens GN=MAMDC2 PE=2 SV=3 D3YTG3;Q7Z7G0ABI3BPD3YTG3_HUMAN;TARSH_HUMANTarget of Nesh-SH3Q;positive regulation of cell-substrate adhesion,extracellular matrix organization!;collagen binding,heparin binding=;interstitial matrix,extracellular space,extracellular matrix>tr|D3YTG3|D3YTG3_HUMAN Target of Nesh-SH3 OS=Homo sapiens GN=ABI3BP PE=1 SV=1;>sp|Q7Z7G0|TARSH_HUMAN Target of Nesh-SH3 OS=Homo sapiens GN=ABI3BP PE=1 SV=1Q8N392ARHGAP18 RHG18_HUMAN Rho GTPase-activating protein 18small GTPase mediated signal transduction,regulation of cell shape,regulation of actin filament polymerization,regulation of actin cytoskeleton organization,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,regulation of cell motility*GTPase activator activity,cadherin binding/cytoplasm,cytosol,plasma membrane,nuclear speck]>sp|Q8N392|RHG18_HUMAN Rho GTPase-activating protein 18 OS=Homo sapiens GN=ARHGAP18 PE=1 SV=3Q8NET6CHST13 CHSTD_HUMAN Carbohydrate sulfotransferase 13Jcarbohydrate biosynthetic process,chondroitin sulfate biosynthetic process[N-acetylgalactosamine 4-O-sulfotransferase activity,chondroitin 4-sulfotransferase activity[>sp|Q8NET6|CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens GN=CHST13 PE=1 SV=1Q96C24SYTL4 SYTL4_HUMANSynaptotagmin-like protein 4Aplatelet degranulation,intracellular protein transport,vesicle fusion,regulation of calcium ion-dependent exocytosis,positive regulation of exocytosis,negative regulation of insulin secretion,calcium ion-regulated exocytosis of neurotransmitter,positive regulation of protein secretion,multivesicular body sorting pathwaycalcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding,Rab GTPase binding,syntaxin binding,clathrin binding,neurexin family protein bindingnucleoplasm,endosome,microtubule organizing center,cytosol,plasma membrane,extrinsic component of membrane,transport vesicle membrane,platelet alpha granule membrane,exocytic vesicle,presynapseV>sp|Q96C24|SYTL4_HUMAN Synaptotagmin-like protein 4 OS=Homo sapiens GN=SYTL4 PE=1 SV=2Q9BXR6CFHR5 FHR5_HUMAN%Complement factor H-related protein 5*complement activation, alternative pathway^>sp|Q9BXR6|FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1Q9HAV0GNB4 GBB4_HUMAN1Guanine nucleotide-binding protein subunit beta-4gprotein folding,signal transduction,substantia nigra development,cellular response to glucagon stimulus2signal transducer activity,protein complex bindingNlysosomal membrane,cytosol,pla< sma membrane,myelin sheath,extracellular exosomei>sp|Q9HAV0|GBB4_HUMAN Guanine nucleotide-binding protein subunit beta-4 OS=Homo sapiens GN=GNB4 PE=1 SV=3Q9NQ75;Q9NQ75-2CASS4 CASS4_HUMAN\Cas scaffolding protein family member 4;Isoform 2 of Cas scaffolding protein family member 4cell adhesion;&cytoplasm,cytoskeleton,focal adhesion;>sp|Q9NQ75|CASS4_HUMAN Cas scaffolding protein family member 4 OS=Homo sapiens GN=CASS4 PE=1 SV=2;>sp|Q9NQ75-2|CASS4_HUMAN Isoform 2 of Cas scaffolding protein family member 4 OS=Homo sapiens GN=CASS4Q9UGM5FETUB FETUB_HUMANFetuin-Bxsingle fertilization,binding of sperm to zona pellucida,biological_process,negative regulation of endopeptidase activityimolecular_function,cysteine-type endopeptidase inhibitor activity,metalloendopeptidase inhibitor activityB>sp|Q9UGM5|FETUB_HUMAN Fetuin-B OS=Homo sapiens GN=FETUB PE=1 SV=2Q9UKX5;Q9UKX5-2ITGA11 ITA11_HUMAN0Integrin alpha-11;Isoform 2 of Integrin alpha-11osteoblast differentiation,substrate-dependent cell migration,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,muscle organ development,extracellular matrix organization,cell adhesion mediated by integrin,collagen-activated signaling pathway;pcollagen binding,collagen receptor activity,metal ion binding,collagen binding involved in cell-matrix adhesion;Xplasma membrane,focal adhesion,integrin complex,membrane,integrin alpha11-beta1 complex;>sp|Q9UKX5|ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2;>sp|Q9UKX5-2|ITA11_HUMAN Isoform 2 of Integrin alpha-11 OS=Homo sapiens GN=ITGA11 A0A075B6K6IGLV4-3A0A075B6K6_HUMANProtein IGLV4-3T>tr|A0A075B6K6|A0A075B6K6_HUMAN Protein IGLV4-3 OS=Homo sapiens GN=IGLV4-3 PE=4 SV=1 A0A075B6N7A0A075B6N7_HUMANg>tr|A0A075B6N7|A0A075B6N7_HUMAN Ig alpha-2 chain C region (Fragment) OS=Homo sapiens GN=IGHA2 PE=1 SV=1 A0A075B6Q5IGHV3-64 HV364_HUMAN"Immunoglobulin heavy variable 3-64c>sp|A0A075B6Q5|HV364_HUMAN Immunoglobulin heavy variable 3-64 OS=Homo sapiens GN=IGHV3-64 PE=3 SV=1A0A087X1Z3;H0YM70;Q9UL46PSME2)A0A087X1Z3_HUMAN;H0YM70_HUMAN;PSME2_HUMAN&Proteasome activator complex subunit 2#;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycleL;;protein binding,identical protein binding,endopeptidase activator activityn;;proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,membrane,extracellular exosome,>tr|A0A087X1Z3|A0A087X1Z3_HUMAN Proteasome activator complex subunit 2 OS=Homo sapiens GN=PSME2 PE=1 SV=1;>tr|H0YM70|H0YM70_HUMAN Proteasome activator complex subunit 2 OS=Homo sapiens GN=PSME2 PE=1 SV=1;>sp|Q9UL46|PSME2_HUMAN Proteasome activator complex subunit 2 OS=Homo sapiens GN=PSME2 PE=1 SV=4(A0A0A0MR07;F5H5P4;P15498;P15498-2;Q96D37VAV1>A0A0A0MR07_HUMAN;F5H5P4_HUMAN;VAV_HUMAN;VAV_HUMAN;Q96D37_HUMANkProto-oncogene vav;Proto-oncogene vav;Proto-oncogene vav;Isoform 2 of Proto-oncogene vav;Proto-oncogene vav;;regulation of transcription, DNA-templated,immune response,G-protein coupled receptor signaling pathway,integrin-mediated signaling pathway,small GTPase mediated signal transduction,regulation of cell size,regulation of phosphatidylinositol 3-kinase signaling,platelet activation,T cell differentiation,neutrophil chemotaxis,T cell costimulation,regulation of Rho protein signal transduction,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of apoptotic process,regulation of GTPase activity,positive regulation of GTPase activity,positive regulation of natural killer cell mediated cytotoxicity,phosphatidylinositol phosphorylation,vascular endothelial growth factor receptor signaling pathway,phosphatidylinositol-mediated signaling,regulation of small GTPase mediated signal transduction,reactive oxygen species metabolic process;;#;;transcription factor activity, sequence-specific DNA binding,guanyl-nucleotide exchange factor activity,Rho guanyl-nucleotide exchange factor activity,protein binding,Rac guanyl-nucleotide exchange factor activity,metal ion binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activity;;.;;cytosol,plasma membrane,cell-cell junction;;tr;tr;sp;sp;tr1;1;1;;11;2;4;;2>tr|A0A0A0MR07|A0A0A0MR07_HUMAN Proto-oncogene vav OS=Homo sapiens GN=VAV1 PE=1 SV=1;>tr|F5H5P4|F5H5P4_HUMAN Proto-oncogene vav OS=Homo sapiens GN=VAV1 PE=1 SV=2;>sp|P15498|VAV_HUMAN Proto-oncogene vav OS=Homo sapiens GN=VAV1 PE=1 SV=4;>sp|P15498-2|VAV_HUMAN Isoform 2 of Proto-oncogene vav OS=Homo sapiens GN=VAV1;>tr|Q96D37|Q96D37_HUMAN Proto-oncogene vav OS=Homo sapiens GN=VAV1 PE=1 SV=2jA0A0A0MRT6;B6VEX4;Q8IZP0;Q8IZP0-10;Q8IZP0-2;Q8IZP0-3;Q8IZP0-4;Q8IZP0-5;Q8IZP0-6;Q8IZP0-7;Q8IZP0-8;Q8IZP0-9ABI1A0A0A0MRT6_HUMAN;B6VEX4_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMANAAbl interactor 1;Abl interactor 1;Abl interactor 1;Isoform 10 of Abl interactor 1;Isoform 2 of Abl interactor 1;Isoform 3 of Abl interactor 1;Isoform 4 of Abl interactor 1;Isoform 5 of Abl interactor 1;Isoform 6 of Abl interactor 1;Isoform 7 of Abl interactor 1;Isoform 8 of Abl interactor 1;Isoform 9 of Abl interactor 1;;somitogenesis,movement of cell or subcellular component,transmembrane receptor protein tyrosine kinase signaling pathway,actin polymerization or depolymerization,negative regulation of cell proliferation,viral process,peptidyl-tyrosine phosphorylation,megakaryocyte development,Fc-gamma receptor signaling pathway involved in phagocytosis,vascular endothelial growth factor receptor signaling pathway,dendrite morphogenesis,positive regulation of protein tyrosine kinase activity,lamellipodium morphogenesis;;;;;;;;;;;protein binding,cytoskeletal protein binding,SH3 domain binding,protein tyrosine kinase activator activity,protein complex binding,cadherin binding;;;;;;;;;;;intracellular,nucleus,endoplasmic reticulum,cytosol,cytoskeleton,postsynaptic density,lamellipodium,cell junction,filopodium,growth cone,SCAR complex,postsynaptic membrane,extracellular exosome;;;;;;;;;#tr;tr;sp;sp;sp;sp;sp;sp;sp;sp;sp;sp1;1;1;;;;;;;;;1;1;4;;;;;;;;;>tr|A0A0A0MRT6|A0A0A0MRT6_HUMAN Abl interactor 1 OS=Homo sapiens GN=ABI1 PE=1 SV=1;>tr|B6VEX4|B6VEX4_HUMAN Abl interactor 1 OS=Homo sapiens GN=ABI1 PE=1 SV=1;>sp|Q8IZP0|ABI1_HUMAN Abl interactor 1 OS=Homo sapiens GN=ABI1 PE=1 SV=4;>sp|Q8IZP0-10|ABI1_HUMAN Isoform 10 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-2|ABI1_HUMAN Isoform 2 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-3|ABI1_HUMAN Isoform 3 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-4|ABI1_HUMAN Isoform 4 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-5|ABI1_HUMAN Isoform 5 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-6|ABI1_HUMAN Isoform 6 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-7|ABI1_HUMAN Isoform 7 of Abl interactor< 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-8|ABI1_HUMAN Isoform 8 of Abl interactor 1 OS=Homo sapiens GN=ABI1;>sp|Q8IZP0-9|ABI1_HUMAN Isoform 9 of Abl interactor 1 OS=Homo sapiens GN=ABI1 A0A0B4J1V0IGHV3-15 HV315_HUMAN"Immunoglobulin heavy variable 3-15c>sp|A0A0B4J1V0|HV315_HUMAN Immunoglobulin heavy variable 3-15 OS=Homo sapiens GN=IGHV3-15 PE=3 SV=1 A0A0C4DH32IGHV3-20A0A0C4DH32_HUMANProtein IGHV3-20 (Fragment)a>tr|A0A0C4DH32|A0A0C4DH32_HUMAN Protein IGHV3-20 (Fragment) OS=Homo sapiens GN=IGHV3-20 PE=1 SV=1%A0A0D9SFE4;A0A0U1RQP1;Q05193;Q05193-3DNM17A0A0D9SFE4_HUMAN;A0A0U1RQP1_HUMAN;DYN1_HUMAN;DYN1_HUMAN4Dynamin-1;Dynamin-1;Dynamin-1;Isoform 3 of Dynamin-1;;mitochondrial fission,G-protein coupled receptor internalization,dynamin family protein polymerization involved in mitochondrial fission,endocytosis,receptor-mediated endocytosis,endosome organization,sensory perception of sound,adult locomotory behavior,synaptic vesicle budding from presynaptic endocytic zone membrane,ephrin receptor signaling pathway,protein tetramerization,synaptic transmission, GABAergic,membrane fusion,toxin transport,positive regulation of synaptic vesicle recycling; ;;RNA binding,GTPase activity,protein binding,GTP binding,microtubule binding,protein C-terminus binding,protein kinase binding,D2 dopamine receptor binding,protein complex binding,identical protein binding,protein dimerization activity,nitric-oxide synthase binding;;;photoreceptor inner segment,Golgi apparatus,microtubule,plasma membrane,synaptic vesicle,membrane coat,mitochondrial membrane,varicosity,myelin sheath,extracellular exosome; >tr|A0A0D9SFE4|A0A0D9SFE4_HUMAN Dynamin-1 OS=Homo sapiens GN=DNM1 PE=1 SV=1;>tr|A0A0U1RQP1|A0A0U1RQP1_HUMAN Dynamin-1 OS=Homo sapiens GN=DNM1 PE=1 SV=1;>sp|Q05193|DYN1_HUMAN Dynamin-1 OS=Homo sapiens GN=DNM1 PE=1 SV=2;>sp|Q05193-3|DYN1_HUMAN Isoform 3 of Dynamin-1 OS=Homo sapiens GN=DNM1A0A0G2JN42;A0A0G2JNJ8;Q6W4X9MUC6,A0A0G2JN42_HUMAN;A0A0G2JNJ8_HUMAN;MUC6_HUMANMucin-6u;;stimulatory C-type lectin receptor signaling pathway,O-glycan processing,maintenance of gastrointestinal epithelium-;;extracellular matrix structural constituent2;;extracellular region,Golgi lumen,plasma membrane>tr|A0A0G2JN42|A0A0G2JN42_HUMAN Mucin-6 OS=Homo sapiens GN=MUC6 PE=1 SV=1;>tr|A0A0G2JNJ8|A0A0G2JNJ8_HUMAN Mucin-6 OS=Homo sapiens GN=MUC6 PE=1 SV=1;>sp|Q6W4X9|MUC6_HUMAN Mucin-6 OS=Homo sapiens GN=MUC6 PE=1 SV=3 A0A0G2JSC0IGLV5-45A0A0G2JSC0_HUMANProtein IGLV5-45 (Fragment)a>tr|A0A0G2JSC0|A0A0G2JSC0_HUMAN Protein IGLV5-45 (Fragment) OS=Homo sapiens GN=IGLV5-45 PE=1 SV=1 A0A1B0GTC6FLJ22763A0A1B0GTC6_HUMANProtein FLJ22763V>tr|A0A1B0GTC6|A0A1B0GTC6_HUMAN Protein FLJ22763 OS=Homo sapiens GN=FLJ22763 PE=1 SV=1A0A1C7CYX9;Q16555;Q16555-2DPYSL2(A0A1C7CYX9_HUMAN;DPYL2_HUMAN;DPYL2_HUMAN~Dihydropyrimidinase-related protein 2;Dihydropyrimidinase-related protein 2;Isoform 2 of Dihydropyrimidinase-related protein 2;nucleobase-containing compound metabolic process,endocytosis,cytoskeleton organization,signal transduction,nervous system development,axon guidance,brain development,regulation of axon extension;\;dihydropyrimidinase activity,protein binding,microtubule binding,identical protein binding;D;cytosol,plasma membrane,extracellular exosome,microtubule,membrane;0>tr|A0A1C7CYX9|A0A1C7CYX9_HUMAN Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1;>sp|Q16555|DPYL2_HUMAN Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1;>sp|Q16555-2|DPYL2_HUMAN Isoform 2 of Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2B7ZKJ8 B7ZKJ8_HUMAN ITIH4 proteinH>tr|B7ZKJ8|B7ZKJ8_HUMAN ITIH4 protein OS=Homo sapiens GN=ITIH4 PE=1 SV=1 C9JIF9;P13798APEHC9JIF9_HUMAN;ACPH_HUMANAcylamino-acid-releasing enzyme^;translational termination,proteolysis,neutrophil degranulation,beta-amyloid metabolic processr;RNA binding,serine-type endopeptidase activity,protein binding,omega peptidase activity,identical protein bindinga;extracellular region,cytosol,nuclear membrane,extracellular exosome,ficolin-1-rich granule lumen>tr|C9JIF9|C9JIF9_HUMAN Acylamino-acid-releasing enzyme OS=Homo sapiens GN=APEH PE=1 SV=1;>sp|P13798|ACPH_HUMAN Acylamino-acid-releasing enzyme OS=Homo sapiens GN=APEH PE=1 SV=4C9JPQ9 C9JPQ9_HUMAN!Fibrinogen gamma chain (Fragment)Z>tr|C9JPQ9|C9JPQ9_HUMAN Fibrinogen gamma chain (Fragment) OS=Homo sapiens GN=FGG PE=1 SV=1E5RJ11;G3V114;O60496DOK2$E5RJ11_HUMAN;G3V114_HUMAN;DOK2_HUMAN@Docking protein 2 (Fragment);Docking protein 2;Docking protein 2;;signal transduction,cell surface receptor signaling pathway,transmembrane receptor protein tyrosine kinase signaling pathway,Ras protein signal transduction,axon guidance,leukocyte migration;;receptor signaling protein activity,transmembrane receptor protein tyrosine kinase adaptor activity,insulin receptor binding,protein binding ;;cytosol>tr|E5RJ11|E5RJ11_HUMAN Docking protein 2 (Fragment) OS=Homo sapiens GN=DOK2 PE=1 SV=1;>tr|G3V114|G3V114_HUMAN Docking protein 2 OS=Homo sapiens GN=DOK2 PE=1 SV=1;>sp|O60496|DOK2_HUMAN Docking protein 2 OS=Homo sapiens GN=DOK2 PE=1 SV=2E7END6;P04070;P04070-2PROC"E7END6_HUMAN;PROC_HUMAN;PROC_HUMANfVitamin K-dependent protein C;Vitamin K-dependent protein C;Isoform 2 of Vitamin K-dependent protein C;liver development,signal peptide processing,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,peptidyl-glutamic acid carboxylation,negative regulation of blood coagulation,negative regulation of apoptotic process,regulation of circulating fibrinogen levels,negative regulation of inflammatory response,negative regulation of coagulation,leukocyte migration,positive regulation of establishment of endothelial barrier;H;serine-type endopeptidase activity,calcium ion binding,protein binding;x;extracellular region,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,Golgi apparatus,Golgi lumen;>tr|E7END6|E7END6_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1;>sp|P04070|PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1;>sp|P04070-2|PROC_HUMAN Isoform 2 of Vitamin K-dependent protein C OS=Homo sapiens GN=PROCE7EMB6;E7ETB3;Q9ULA0DNPEP%E7EMB6_HUMAN;E7ETB3_HUMAN;DNPEP_HUMANAspartyl aminopeptidase';;proteolysis,peptide metabolic processs;;aminopeptidase activity,protein binding,zinc ion binding,identical protein binding,metalloaminopeptidase activity/;;nucleus,cytoplasm,cytosol,blood microparticle2;2;1>tr|E7EMB6|E7EMB6_HUMAN Aspartyl aminopeptidase OS=Homo sapiens GN=DNPEP PE=1 SV=2;>tr|E7ETB3|E7ETB3_HUMAN Aspartyl aminopeptidase OS=Homo sapiens GN=DNPEP PE=1 SV=2;>sp|Q9ULA0|DNPEP_HUMAN Aspartyl aminopeptidase OS=Homo sapiens GN=DNPEP PE=1 SV=1&F8WAQ1;H3BLV4;Q6UWL2;Q6UWL2-2;Q6UWL2-3SUSD1=F8WAQ1_HUMAN;H3BLV4_HUMAN;SUSD1_HUMAN;SUSD1_HUMAN;SUSD1_HUMANSushi domain-containing protein 1;Sushi domain-containing protein 1 (Fragment);Sushi domain-containing protein 1;Isoform 2 of Sushi domain-containing protein 1;Isoform 3 of Sushi domain-containing protein 1;;;;;;calcium ion binding;;";;integral component of membrane;;>tr|F8WAQ1|F8WAQ1_HUMAN Sushi domain-containing protein 1 OS=Homo sapiens GN=SUSD1 PE=1 SV=1;>tr|H3BLV4|H3BLV4_HUMAN Sushi domain-containing protein 1 (Fragment) OS=Homo sapiens GN=SUSD1 PE=1 SV=1;>sp|Q6UWL2|SUSD1_HUMAN Sushi domain-containing protein 1 OS=Homo sapiens GN=SUSD1 PE=1 SV=1;>sp|Q6UWL2-2|SUSD1_HUMAN Isoform 2 of Sushi domain-containing protein 1 OS=Homo sapiens GN=SUSD1;>sp|Q6UWL2-3|SUSD1_HUMAN Isoform 3 of Sushi domain-containing protein 1 OS=Homo sapiens GN=SUSD1H7BXD5;H7C2Z6;P28676GCA$H7BXD5_HUMAN;H7C2Z6_HUMAN;GRAN_HUMAN+Grancalcin;Grancalcin (Fragment);Grancalcin6;;proteolysis,neutrophil degranulation,membrane fusion;;calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding,protein homodimerization activity,protein heterodimerization activityf;;extracellular region,cytoplasm,cytosol,plasma membrane,azurophil granule lumen,extracellular exosome>tr|H7BXD5|H7BXD5_HU< MAN Grancalcin OS=Homo sapiens GN=GCA PE=1 SV=1;>tr|H7C2Z6|H7C2Z6_HUMAN Grancalcin (Fragment) OS=Homo sapiens GN=GCA PE=1 SV=1;>sp|P28676|GRAN_HUMAN Grancalcin OS=Homo sapiens GN=GCA PE=1 SV=2K7ES70;P55083;P55083-2MFAP4$K7ES70_HUMAN;MFAP4_HUMAN;MFAP4_HUMAN~Microfibril-associated glycoprotein 4;Microfibril-associated glycoprotein 4;Isoform 2 of Microfibril-associated glycoprotein 4;cell adhesion,UV protection,regulation of collagen metabolic process,elastic fiber assembly,cellular response to UV-B,fibril organization;;microfibril,extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome,elastic fiber;%>tr|K7ES70|K7ES70_HUMAN Microfibril-associated glycoprotein 4 OS=Homo sapiens GN=MFAP4 PE=1 SV=1;>sp|P55083|MFAP4_HUMAN Microfibril-associated glycoprotein 4 OS=Homo sapiens GN=MFAP4 PE=1 SV=2;>sp|P55083-2|MFAP4_HUMAN Isoform 2 of Microfibril-associated glycoprotein 4 OS=Homo sapiens GN=MFAP4!O00182;O00182-2;O00182-3;O00182-6LGALS9 LEG9_HUMANRGalectin-9;Isoform 2 of Galectin-9;Isoform 3 of Galectin-9;Isoform 6 of Galectin-9 natural killer cell tolerance induction,chemotaxis,inflammatory response,female pregnancy,positive regulation of gene expression,negative regulation of gene expression,response to lipopolysaccharide,negative regulation of chemokine production,negative regulation of interferon-gamma production,negative regulation of tumor necrosis factor production,positive regulation of interleukin-4 production,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,p38MAPK cascade,positive regulation of NF-kappaB import into nucleus,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of mast cell degranulation,negative regulation of natural killer cell mediated cytotoxicity,negative regulation of activated T cell proliferation,positive regulation of viral entry into host cell,positive regulation of interleukin-1 beta secretion,positive regulation of NF-kappaB transcription factor activity,maternal process involved in female pregnancy,positive regulation of activated T cell autonomous cell death,ERK1 and ERK2 cascade,positive regulation of ERK1 and ERK2 cascade,response to interleukin-1,cellular response to interferon-gamma,positive regulation of transforming growth factor beta production,positive regulation of monocyte chemotactic protein-1 production,cellular response to virus,positive regulation of interferon-gamma secretion,positive regulation of tumor necrosis factor secretion,positive regulation of interleukin-8 secretion,positive regulation of dendritic cell chemotaxis,negative regulation of CD4-positive, alpha-beta T cell proliferation,positive regulation of CD4-positive, alpha-beta T cell proliferation,positive regulation of interleukin-13 secretion,positive regulation of dendritic cell apoptotic process,positive regulation of interleukin-6 secretion,positive regulation of interleukin-10 secretion,positive regulation of interleukin-12 secretion,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,positive regulation of dendritic cell differentiation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,regulation of interleukin-4 production,regulation of interleukin-5 production,toll-like receptor 2 signaling pathway,toll-like receptor 4 signaling pathway,mature conventional dendritic cell differentiation,regulation of p38MAPK cascade;;;hsignal transducer activity,galactose binding,enzyme binding,carbohydrate binding,disaccharide binding;;;Textracellular space,intracellular,nucleus,cytoplasm,cytosol,extracellular exosome;;;">sp|O00182|LEG9_HUMAN Galectin-9 OS=Homo sapiens GN=LGALS9 PE=1 SV=2;>sp|O00182-2|LEG9_HUMAN Isoform 2 of Galectin-9 OS=Homo sapiens GN=LGALS9;>sp|O00182-3|LEG9_HUMAN Isoform 3 of Galectin-9 OS=Homo sapiens GN=LGALS9;>sp|O00182-6|LEG9_HUMAN Isoform 6 of Galectin-9 OS=Homo sapiens GN=LGALS9O00533;O00533-2CHL1 NCHL1_HUMANhNeural cell adhesion molecule L1-like protein;Isoform 2 of Neural cell adhesion molecule L1-like proteinneuron migration,cell adhesion,signal transduction,axon guidance,adult locomotory behavior,axon regeneration,exploration behavior,negative regulation of neuron apoptotic process,cognition;protease binding;proteinaceous extracellular matrix,plasma membrane,integral component of membrane,dendrite,apical part of cell,extracellular exosome;>sp|O00533|NCHL1_HUMAN Neural cell adhesion molecule L1-like protein OS=Homo sapiens GN=CHL1 PE=1 SV=4;>sp|O00533-2|NCHL1_HUMAN Isoform 2 of Neural cell adhesion molecule L1-like protein OS=Homo sapiens GN=CHL1O15194;O15194-2CTDSPL CTDSL_HUMANRCTD small phosphatase-like protein;Isoform 2 of CTD small phosphatase-like proteinnegative regulation of protein phosphorylation,protein dephosphorylation,biological_process,negative regulation of G1/S transition of mitotic cell cycle;Imolecular_function,phosphoprotein phosphatase activity,metal ion binding;nucleus,extracellular exosome;>sp|O15194|CTDSL_HUMAN CTD small phosphatase-like protein OS=Homo sapiens GN=CTDSPL PE=1 SV=2;>sp|O15194-2|CTDSL_HUMAN Isoform 2 of CTD small phosphatase-like protein OS=Homo sapiens GN=CTDSPLO75339CILP CILP1_HUMAN&Cartilage intermediate layer protein 1Lnegative regulation of insulin-like growth factor receptor signaling pathway?alkaline phosphatase activity,nucleotide diphosphatase activityaproteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome_>sp|O75339|CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4P00491PNP PNPH_HUMANPurine nucleoside phosphorylasenucleobase-containing compound metabolic process,inosine catabolic process,purine nucleotide catabolic process,nicotinamide riboside catabolic process,immune response,NAD biosynthesis via nicotinamide riboside salvage pathway,urate biosynthetic process,positive regulation of T cell proliferation,response to drug,purine-containing compound salvage,neutrophil degranulation,positive regulation of alpha-beta T cell differentiation,interleukin-2 secretionxnucleoside binding,purine nucleobase binding,purine-nucleoside phosphorylase activity,drug binding,phosphate ion bindingextracellular region,intracellular,nucleus,cytoplasm,cytosol,cytoskeleton,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenV>sp|P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2P01768IGHV3-30 HV330_HUMAN"Immunoglobulin heavy variable 3-308extracellular region,extracellular space,plasma membrane_>sp|P01768|HV330_HUMAN Immunoglobulin heavy variable 3-30 OS=Homo sapiens GN=IGHV3-30 PE=1 SV=2P01782IGHV3-9 HV309_HUMAN!Immunoglobulin heavy variable 3-9]>sp|P01782|HV309_HUMAN Immunoglobulin heavy variable 3-9 OS=Homo sapiens GN=IGHV3-9 PE=1 SV=2P02792FTL FRIL_HUMANFerritin light chainiron ion transport,cellular iron ion homeostasis,intracellular sequestering of iron ion,neutrophil degranulation,iron ion homeostasisNiron ion binding,protein binding,ferric iron binding,identical protein bindingextracellular region,cytosol,intracellular ferritin complex,membrane,azurophil granule lumen,autolysosome,extracellular exosomeK>sp|P02792|FRIL_HUMAN Ferritin light chain OS=Homo sapiens GN=FTL PE=1 SV=2P04180LCAT LCAT_HUMAN*Phosphatidylcholine-sterol acyltransferasephospholipid metabolic process,phosphatidylcholine biosynthetic process,cholesterol metabolic process,cholesterol transport,very-low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,cholesterol esterification,lipoprotein metabolic process,lipoprotein biosynthetic process,cholesterol homeostasis,reverse cholesterol transport,phosphatidylcholine metabolic process,regulation of high-density lipoprotein particle assembly`phosphatidylcholine-sterol O-acyltransferase activity,protein binding,apolipoprotein A-I binding`extracellular region,extracel< lular space,high-density lipoprotein particle,extracellular exosomeb>sp|P04180|LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1P04745AMY1A AMY1_HUMANAlpha-amylase 1(carbohydrate metabolic process,digestion8alpha-amylase activity,protein binding,metal ion bindingH>sp|P04745|AMY1_HUMAN Alpha-amylase 1 OS=Homo sapiens GN=AMY1A PE=1 SV=2P06241;P06241-2;P06241-3FYN FYN_HUMANmTyrosine-protein kinase Fyn;Isoform 2 of Tyrosine-protein kinase Fyn;Isoform 3 of Tyrosine-protein kinase FynwMAPK cascade,neuron migration,stimulatory C-type lectin receptor signaling pathway,adaptive immune response,protein phosphorylation,calcium ion transport,transmembrane receptor protein tyrosine kinase signaling pathway,axon guidance,central nervous system development,blood coagulation,learning,feeding behavior,regulation of cell shape,negative regulation of gene expression,positive regulation of neuron projection development,regulation of phosphatidylinositol 3-kinase signaling,positive regulation of phosphatidylinositol 3-kinase signaling,viral process,cell migration,peptidyl-tyrosine phosphorylation,cell differentiation,platelet activation,forebrain development,T cell costimulation,negative regulation of protein ubiquitination,intracellular signal transduction,cellular response to platelet-derived growth factor stimulus,peptidyl-tyrosine autophosphorylation,Fc-gamma receptor signaling pathway involved in phagocytosis,T cell activation,regulation of cell proliferation,negative regulation of protein catabolic process,response to drug,positive regulation of tyrosine phosphorylation of Stat5 protein,regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of neuron apoptotic process,positive regulation of GTPase activity,innate immune response,response to ethanol,phosphatidylinositol phosphorylation,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,phosphatidylinositol-mediated signaling,dendrite morphogenesis,regulation of defense response to virus by virus,activated T cell proliferation,T cell receptor signaling pathway,leukocyte migration,detection of mechanical stimulus involved in sensory perception of pain,cellular response to peptide hormone stimulus,cellular response to transforming growth factor beta stimulus,positive regulation of protein targeting to membrane,positive regulation of protein localization to nucleus,positive regulation of neuron death,negative regulation of dendritic spine maintenance,response to beta-amyloid,Requires Ontology,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;;NG-protein coupled receptor binding,glycoprotein binding,protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,signal transducer activity,Ras guanyl-nucleotide exchange factor activity,protein binding,ATP binding,tubulin binding,enzyme binding,T cell receptor binding,CD4 receptor binding,CD8 receptor binding,identical protein binding,phosphatidylinositol 3-kinase binding,ion channel binding,metal ion binding,ephrin receptor binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,peptide hormone receptor binding,growth factor receptor binding;;nucleus,mitochondrion,endosome,cytosol,actin filament,plasma membrane,postsynaptic density,dendrite,extrinsic component of cytoplasmic side of plasma membrane,membrane raft;;>sp|P06241|FYN_HUMAN Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYN PE=1 SV=3;>sp|P06241-2|FYN_HUMAN Isoform 2 of Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYN;>sp|P06241-3|FYN_HUMAN Isoform 3 of Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYNP07195LDHB LDHB_HUMANL-lactate dehydrogenase B chaincarbohydrate metabolic process,lactate metabolic process,pyruvate metabolic process,NAD metabolic process,oxidation-reduction processeL-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD bindingZcytoplasm,mitochondrion,cytosol,membrane,myelin sheath,membrane raft,extracellular exosomeW>sp|P07195|LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2P0C0L4C4A CO4A_HUMANComplement C4-Aproteolysis,inflammatory response,complement activation,complement activation, classical pathway,negative regulation of endopeptidase activity,regulation of complement activation,innate immune response,positive regulation of apoptotic cell clearancedcomplement component C1q binding,serine-type endopeptidase activity,endopeptidase inhibitor activityextracellular region,extracellular space,plasma membrane,cell junction,axon,dendrite,neuronal cell body,synapse,extracellular exosome,blood microparticleF>sp|P0C0L4|CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=2P11215;P11215-2ITGAM ITAM_HUMAN.Integrin alpha-M;Isoform 2 of Integrin alpha-Mcell adhesion,integrin-mediated signaling pathway,ectodermal cell differentiation,extracellular matrix organization,toll-like receptor 4 signaling pathway,neutrophil degranulation,leukocyte migration;[glycoprotein binding,protein binding,metal ion binding,protein heterodimerization activity;extracellular space,plasma membrane,integrin complex,cell surface,specific granule membrane,extracellular exosome,tertiary granule membrane;>sp|P11215|ITAM_HUMAN Integrin alpha-M OS=Homo sapiens GN=ITGAM PE=1 SV=2;>sp|P11215-2|ITAM_HUMAN Isoform 2 of Integrin alpha-M OS=Homo sapiens GN=ITGAMP17858PFKL PFKAL_HUMAN/ATP-dependent 6-phosphofructokinase, liver typefructose 6-phosphate metabolic process,glycolytic process,response to glucose,fructose 1,6-bisphosphate metabolic process,neutrophil degranulation,negative regulation of insulin secretion,protein oligomerization,protein homotetramerization,canonical glycolysis6-phosphofructokinase activity,protein binding,ATP binding,kinase binding,identical protein binding,metal ion binding,fructose binding,fructose-6-phosphate bindingextracellular region,cytosol,6-phosphofructokinase complex,membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenh>sp|P17858|PFKAL_HUMAN ATP-dependent 6-phosphofructokinase, liver type OS=Homo sapiens GN=PFKL PE=1 SV=6P18462 1A25_HUMAN8HLA class I histocompatibility antigen, A-25 alpha chainq>sp|P18462|1A25_HUMAN HLA class I histocompatibility antigen, A-25 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1P23083IGHV1-2 HV102_HUMAN!Immunoglobulin heavy variable 1-2]>sp|P23083|HV102_HUMAN Immunoglobulin heavy variable 1-2 OS=Homo sapiens GN=IGHV1-2 PE=1 SV=2 P24158;U3KPS2PRTN3PRTN3_HUMAN;U3KPS2_HUMAN Myeloblastinproteolysis,blood coagulation,positive regulation of cell proliferation,antimicrobial humoral response,collagen catabolic process,neutrophil degranulation,negative regulation of phagocytosis,mature conventional dendritic cell differentiation;Qserine-type endopeptidase activity,serine-type peptidase activity,enzyme binding;extracellular region,extracellular space,cytosol,plasma membrane,azurophil granule lumen,extracellular exosome,extracellular matrix;>sp|P24158|PRTN3_HUMAN Myeloblastin OS=Homo sapiens GN=PRTN3 PE=1 SV=3;>tr|U3KPS2|U3KPS2_HUMAN Myeloblastin OS=Homo sapiens GN=PRTN3 PE=1 SV=1P25788;P25788-2PSMA3 PSA3_HUMANLProteasome subunit alpha type-3;Isoform 2 of Proteasome subunit alpha type-3MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase a< ctivity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of endopeptidase activity,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;6threonine-type endopeptidase activity,protein binding;proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,synapse,extracellular exosome;>sp|P25788|PSA3_HUMAN Proteasome subunit alpha type-3 OS=Homo sapiens GN=PSMA3 PE=1 SV=2;>sp|P25788-2|PSA3_HUMAN Isoform 2 of Proteasome subunit alpha type-3 OS=Homo sapiens GN=PSMA3P28062;P28062-2;X5D2R7PSMB8;PSMB8;PSM8"PSB8_HUMAN;PSB8_HUMAN;X5D2R7_HUMANgProteasome subunit beta type-8;Isoform 2 of Proteasome subunit beta type-8;Proteasome subunit beta typeMAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,fat cell differentiation,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of endopeptidase activity,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,type I interferon signaling pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;;7threonine-type endopeptidase activity,protein binding;;qproteasome complex,nucleoplasm,cytosol,proteasome core complex,extracellular exosome,spermatoproteasome complex;;3;;1 >sp|P28062|PSB8_HUMAN Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8 PE=1 SV=3;>sp|P28062-2|PSB8_HUMAN Isoform 2 of Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8;>tr|X5D2R7|X5D2R7_HUMAN Proteasome subunit beta type OS=Homo sapiens GN=PSM8 PE=1 SV=1P29350;P29350-3;P29350-4PTPN6 PTN6_HUMANTyrosine-protein phosphatase non-receptor type 6;Isoform 2 of Tyrosine-protein phosphatase non-receptor type 6;Isoform 4 of Tyrosine-protein phosphatase non-receptor type 63hematopoietic progenitor cell differentiation,negative regulation of humoral immune response mediated by circulating immunoglobulin,protein dephosphorylation,apoptotic process,G-protein coupled receptor signaling pathway,cell proliferation,positive regulation of cell proliferation,negative regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase signaling,peptidyl-tyrosine phosphorylation,cell differentiation,platelet activation,platelet formation,T cell costimulation,abortive mitotic cell cycle,positive regulation of cell adhesion mediated by integrin,peptidyl-tyrosine dephosphorylation,intracellular signal transduction,megakaryocyte development,negative regulation of T cell proliferation,natural killer cell mediated cytotoxicity,neutrophil degranulation,negative regulation of MAP kinase activity,regulation of B cell differentiation,negative regulation of peptidyl-tyrosine phosphorylation,B cell receptor signaling pathway,negative regulation of B cell receptor signaling pathway,negative regulation of T cell receptor signaling pathway,leukocyte migration,regulation of release of sequestered calcium ion into cytosol,regulation of type I interferon-mediated signaling pathway,regulation of ERK1 and ERK2 cascade,platelet aggregation,regulation of G1/S transition of mitotic cell cycle;;phosphotyrosine binding,protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,SH3 domain binding,protein kinase binding,SH2 domain binding,cell adhesion molecule binding;;extracellular region,nucleus,nucleolus,cytoplasm,cytosol,cell-cell junction,membrane,specific granule lumen,alpha-beta T cell receptor complex,extracellular exosome,tertiary granule lumen;;G>sp|P29350|PTN6_HUMAN Tyrosine-protein phosphatase non-receptor type 6 OS=Homo sapiens GN=PTPN6 PE=1 SV=1;>sp|P29350-3|PTN6_HUMAN Isoform 2 of Tyrosine-protein phosphatase non-receptor type 6 OS=Homo sapiens GN=PTPN6;>sp|P29350-4|PTN6_HUMAN Isoform 4 of Tyrosine-protein phosphatase non-receptor type 6 OS=Homo sapiens GN=PTPN6P30086PEBP1 PEBP1_HUMAN*Phosphatidylethanolamine-binding protein 1:MAPK cascade,negative regulation of endopeptidase activityRNA binding,serine-type endopeptidase inhibitor activity,protein binding,ATP binding,phosphatidylethanolamine binding,enzyme binding,protein kinase binding%nucleus,cytosol,extracellular exosomed>sp|P30086|PEBP1_HUMAN Phosphatidylethanolamine-binding protein 1 OS=Homo sapiens GN=PEBP1 PE=1 SV=3P30498 1B78_HUMAN8HLA class I histocompatibility antigen, B-78 alpha chainq>sp|P30498|1B78_HUMAN HLA class I histocompatibility antigen, B-78 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1P30740SERPINB1 ILEU_HUMANLeukocyte elastase inhibitorFnegative regulation of endopeptidase activity,neutrophil degranulation_extracellular region,extracellular space,membrane,secretory granule lumen,extracellular exosomeX>sp|P30740|ILEU_HUMAN Leukocyte elastase inhibitor OS=Homo sapiens GN=SERPINB1 PE=1 SV=1P31946YWHAB 1433B_HUMAN14-3-3 protein beta/alphaMAPK cascade,protein targeting,viral process,negative regulation of protein dephosphorylation,hippo signaling,positive regulation of catalytic activity,regulation of mRNA stability,negative regulation of G-protein coupled receptor protein signaling pathway,negative regulation of transcription, DNA-templated,cytoplasmic sequestering of protein,protein heterooligomerization,membrane organization,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathwaytranscription corepressor activity,protein binding,protein C-terminus binding,enzyme binding,protein domain specific binding,protein complex binding,histone deacetylase binding,cadherin binding,phosphoserine binding,phosphoprotein bindingnucleus,cytoplasm,mitochondrion,cytosol,focal adhesion,membrane,transcriptional repressor complex,cytoplasmic vesicle membrane,melanosome,protein complex,perinuclear region of cytoplasm,extracellular exosomeS>sp|P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sapiens GN=YWHAB PE=1 SV=3P34096RNASE4 RNAS4_HUMANRibonuclease 4AmRNA cleavage,RNA phosphodiester bond hydrolysis, endonucleolyticXnucleic acid binding,endonuclease activity,ribonuclease A activity,ribonuclease activity*extracellular region,extracellular exosomeI>sp|P34096|RNAS4_HUMAN Ribonuclease 4 OS=Homo sapiens GN=RNASE4 PE=1 SV=3P38606;P38606-2ATP6V1A VATA_HUMAN^V-type proton ATPase catalytic subunit A;Isoform 2 of V-type proton ATPase catalytic subunit Atransport,insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,ATP metabolic process,phagosome acidification;FATP binding,proton-transporting ATPase activity, rotational mechanism;mitochondrion,lysosomal membrane,cytosol,plasma membrane,integral component of plasma membrane,microvillus,apical plasma membrane,proton-transporting two-sector ATPase complex,proton-transporting V-type ATPase, V1 domain,myelin sheath,extracellular exosome;>sp|P38606|VATA_HUMAN V-type proton ATPase cataly< tic subunit A OS=Homo sapiens GN=ATP6V1A PE=1 SV=2;>sp|P38606-2|VATA_HUMAN Isoform 2 of V-type proton ATPase catalytic subunit A OS=Homo sapiens GN=ATP6V1A C9J3B7;P42768WASC9J3B7_HUMAN;WASP_HUMANLWiskott-Aldrich syndrome protein (Fragment);Wiskott-Aldrich syndrome protein ;regulation of T cell antigen processing and presentation,protein complex assembly,defense response,immune response,blood coagulation,actin polymerization or depolymerization,epidermis development,endosomal transport,actin filament polymerization,actin filament-based movement,Fc-gamma receptor signaling pathway involved in phagocytosis,T cell activation,regulation of catalytic activity,T cell receptor signaling pathway,negative regulation of cell motility,positive regulation of Arp2/3 complex-mediated actin nucleation;actin binding,protein binding,SH3 domain binding,protein kinase binding,GTPase regulator activity,identical protein binding,phospholipase bindingU;cytosol,cell-cell junction,vesicle membrane,actin cytoskeleton,extracellular exosome8;4>tr|C9J3B7|C9J3B7_HUMAN Wiskott-Aldrich syndrome protein (Fragment) OS=Homo sapiens GN=WAS PE=1 SV=8;>sp|P42768|WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4P46109CRKL CRKL_HUMANCrk-like proteinwactivation of MAPKK activity,blood vessel development,JNK cascade,Ras protein signal transduction,heart development,positive regulation of cell proliferation,animal organ morphogenesis,anterior/posterior pattern specification,intracellular signal transduction,thymus development,parathyroid gland development,positive regulation of substrate adhesion-dependent cell spreading`RNA binding,signal transducer activity,SH3/SH2 adaptor activity,protein binding,cadherin binding&endosome,cytosol,extracellular exosomeH>sp|P46109|CRKL_HUMAN Crk-like protein OS=Homo sapiens GN=CRKL PE=1 SV=1P47755CAPZA2 CAZA2_HUMAN'F-actin-capping protein subunit alpha-2extracellular region,cytosol,brush border,F-actin capping protein complex,actin cytoskeleton,membrane,cortical cytoskeleton,extracellular exosomeb>sp|P47755|CAZA2_HUMAN F-actin-capping protein subunit alpha-2 OS=Homo sapiens GN=CAPZA2 PE=1 SV=3P49721PSMB2 PSB2_HUMANProteasome subunit beta type-2MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,response to organonitrogen compound,negative regulation of G2/M transition of mitotic cell cycle,response to organic cyclic compound,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayeproteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,membrane,extracellular exosomeW>sp|P49721|PSB2_HUMAN Proteasome subunit beta type-2 OS=Homo sapiens GN=PSMB2 PE=1 SV=1P50453SERPINB9 SPB9_HUMAN Serpin B9mast cell mediated immunity,apoptotic process,immune response,response to bacterium,positive regulation of gene expression,negative regulation of endopeptidase activity,negative regulation by symbiont of host apoptotic process,protection from natural killer cell mediated cytotoxicity,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to estrogen stimulusprotease binding,serine-type endopeptidase inhibitor activity,protein binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic processZextracellular space,intracellular,nucleus,cytoplasm,cytosol,membrane,extracellular exosomeE>sp|P50453|SPB9_HUMAN Serpin B9 OS=Homo sapiens GN=SERPINB9 PE=1 SV=1P51148;P51148-2RAB5C RAB5C_HUMANBRas-related protein Rab-5C;Isoform 2 of Ras-related protein Rab-5Csmall GTPase mediated signal transduction,protein transport,regulation of endocytosis,neutrophil degranulation,plasma membrane to endosome transport,membrane organization;8GTPase activity,protein binding,GTP binding,GDP binding;lysosomal membrane,early endosome,lipid particle,plasma membrane,endocytic vesicle,early endosome membrane,azurophil granule membrane,melanosome,extracellular exosome;>sp|P51148|RAB5C_HUMAN Ras-related protein Rab-5C OS=Homo sapiens GN=RAB5C PE=1 SV=2;>sp|P51148-2|RAB5C_HUMAN Isoform 2 of Ras-related protein Rab-5C OS=Homo sapiens GN=RAB5CP61026RAB10 RAB10_HUMANRas-related protein Rab-10Golgi to plasma membrane transport,vesicle docking involved in exocytosis,small GTPase mediated signal transduction,axonogenesis,protein secretion,vesicle-mediated transport,endosomal transport,antigen processing and presentation,polarized epithelial cell differentiation,cellular response to insulin stimulus,Golgi to plasma membrane protein transport,neutrophil degranulation,establishment of neuroblast polarity,membrane organization,basolateral protein localization,endoplasmic reticulum tubular network organization,protein localization to plasma membrane,establishment of protein localization to membrane,establishment of protein localization to endoplasmic reticulum membrane,cell-cell adhesionxGTPase activity,protein binding,GTP binding,GDP binding,myosin V binding,cadherin binding involved in cell-cell adhesionGolgi membrane,endosome,endoplasmic reticulum membrane,Golgi apparatus,trans-Golgi network,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,cilium,cytoplasmic vesicle membrane,secretory granule membrane,phagocytic vesicle membrane,insulin-responsive compartment,recycling endosome,recycling endosome membrane,extracellular exosome,endoplasmic reticulum tubular network,exocystT>sp|P61026|RAB10_HUMAN Ras-related protein Rab-10 OS=Homo sapiens GN=RAB10 PE=1 SV=1P61106RAB14 RAB14_HUMANRas-related protein Rab-14phosphatidylinositol biosynthetic process,Golgi to endosome transport,small GTPase mediated signal transduction,fibroblast growth factor receptor signaling pathway,embryo development,protein transport,vesicle-mediated transport,regulation of endocytosis,endocytic recycling,regulation of protein localization,defense response to bacterium,neutrophil degranulation,intracellular transport,membrane organization,phagosome maturationHGTPase activity,protein binding,GTP binding,GDP binding,myosin V bindingGolgi membrane,intracellular,lysosome,lysosomal membrane,early endosome,late endosome,rough endoplasmic reticulum,Golgi stack,trans-Golgi network,cytosol,plasma membrane,trans-Golgi network transport vesicle,cytoplasmic vesicle membrane,early endosome membrane,nuclear outer membrane-endoplasmic reticulum membrane network,intracellular membrane-bounded organelle,phagocytic vesicle,perinuclear region of cytoplasm,recycling endosome,recycling endosome membrane,extracellular exosome,tertiary granule membrane,ciliumT>sp|P61106|RAB14_HUMAN Ras-related protein Rab-14 OS=Homo sapiens GN=RAB14 PE=1 SV=4P61586RHOA RHOA_HUMANTransforming protein RhoA/transforming growth factor beta receptor signaling pathway,Rho protein signal transduction,viral process,cell migration,protein deubiquitination,substantia nigra development,actin cytoskeleton organization,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,positive regulation of cytokinesis,regulation of actin cytoskeleton organization,regulation of osteob< last proliferation,Roundabout signaling pathway,cleavage furrow formation,apolipoprotein A-I-mediated signaling pathway,positive regulation of NF-kappaB import into nucleus,positive regulation of I-kappaB kinase/NF-kappaB signaling,stress fiber assembly,apical junction assembly,neutrophil degranulation,endothelial cell migration,ossification involved in bone maturation,wound healing, spreading of cells,positive regulation of neuron differentiation,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,phosphatidylinositol-mediated signaling,negative regulation of axonogenesis,positive regulation of axonogenesis,negative chemotaxis,regulation of small GTPase mediated signal transduction,positive regulation of stress fiber assembly,Wnt signaling pathway, planar cell polarity pathway,positive regulation of lipase activity,trabecula morphogenesis,positive regulation of protein serine/threonine kinase activity,negative regulation of cell migration involved in sprouting angiogenesis,mitotic spindle assembly,endothelial tube lumen extension,skeletal muscle satellite cell migration,mitotic cleavage furrow formation,regulation of cell motility:GTPase activity,protein binding,GTP binding,myosin bindingfendosome,endoplasmic reticulum membrane,cytosol,cytoskeleton,plasma membrane,focal adhesion,cell cortex,lamellipodium,cell junction,midbody,secretory granule membrane,extrinsic component of cytoplasmic side of plasma membrane,vesicle,dendritic spine,apical junction complex,extracellular exosome,cell periphery,ficolin-1-rich granule membrane,cleavage furrowQ>sp|P61586|RHOA_HUMAN Transforming protein RhoA OS=Homo sapiens GN=RHOA PE=1 SV=1P68871HBB HBB_HUMANHemoglobin subunit betareceptor-mediated endocytosis,blood coagulation,regulation of blood pressure,positive regulation of cell death,oxygen transport,bicarbonate transport,nitric oxide transport,response to hydrogen peroxide,hydrogen peroxide catabolic process,neutrophil degranulation,positive regulation of nitric oxide biosynthetic process,regulation of blood vessel size,protein heterooligomerization,renal absorption,platelet aggregation,cellular oxidant detoxificationoxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding,hemoglobin binding,peroxidase activity,haptoglobin bindingextracellular region,cytosol,hemoglobin complex,haptoglobin-hemoglobin complex,extracellular exosome,endocytic vesicle lumen,blood microparticle,tertiary granule lumen,ficolin-1-rich granule lumenM>sp|P68871|HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2Q06187;Q06187-2;Q5JY90BTK BTK_HUMAN;BTK_HUMAN;Q5JY90_HUMAN`Tyrosine-protein kinase BTK;Isoform BTK-C of Tyrosine-protein kinase BTK;Tyrosine-protein kinaseppositive regulation of type III hypersensitivity,positive regulation of type I hypersensitivity,negative regulation of cytokine production,adaptive immune response,B cell affinity maturation,histamine secretion by mast cell,regulation of B cell cytokine production,MyD88-dependent toll-like receptor signaling pathway,regulation of B cell apoptotic process,transcription, DNA-templated,protein phosphorylation,transmembrane receptor protein tyrosine kinase signaling pathway,I-kappaB kinase/NF-kappaB signaling,mesoderm development,peptidyl-tyrosine phosphorylation,calcium-mediated signaling,negative regulation of B cell proliferation,cellular response to reactive oxygen species,intracellular signal transduction,peptidyl-tyrosine autophosphorylation,Fc-epsilon receptor signaling pathway,B cell activation,regulation of cell proliferation,innate immune response,positive regulation of B cell differentiation,cell maturation,B cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,cellular response to molecule of fungal origin,apoptotic signaling pathway,cellular response to interleukin-7;;protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,receptor binding,protein binding,ATP binding,phosphatidylinositol-3,4,5-trisphosphate binding,identical protein binding,metal ion binding;;nucleus,cytoplasm,cytosol,plasma membrane,extrinsic component of cytoplasmic side of plasma membrane,cytoplasmic vesicle,mast cell granule,membrane raft,perinuclear region of cytoplasm;;>sp|Q06187|BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3;>sp|Q06187-2|BTK_HUMAN Isoform BTK-C of Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK;>tr|Q5JY90|Q5JY90_HUMAN Tyrosine-protein kinase OS=Homo sapiens GN=BTK PE=1 SV=1Q12907LMAN2 LMAN2_HUMAN)Vesicular integral-membrane protein VIP36hretrograde vesicle-mediated transport, Golgi to ER,protein transport,positive regulation of phagocytosisfglycoprotein binding,mannose binding,carbohydrate binding,heat shock protein binding,metal ion binding Golgi membrane,extracellular space,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,integral component of plasma membrane,cell surface,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosomec>sp|Q12907|LMAN2_HUMAN Vesicular integral-membrane protein VIP36 OS=Homo sapiens GN=LMAN2 PE=1 SV=1Q13162PRDX4 PRDX4_HUMANPeroxiredoxin-4tI-kappaB phosphorylation,spermatogenesis,male gonad development,4-hydroxyproline metabolic process,protein maturation by protein folding,extracellular matrix organization,neutrophil degranulation,cell redox homeostasis,oxidation-reduction process,reactive oxygen species metabolic process,cellular oxidant detoxification,negative regulation of male germ cell proliferationQprotein binding,thioredoxin peroxidase activity,protein homodimerization activityextracellular region,extracellular space,nucleus,mitochondrion,smooth endoplasmic reticulum,cytosol,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenI>sp|Q13162|PRDX4_HUMAN Peroxiredoxin-4 OS=Homo sapiens GN=PRDX4 PE=1 SV=1Q15691MAPRE1 MARE1_HUMAN4Microtubule-associated protein RP/EB family member 1oG2/M transition of mitotic cell cycle,sister chromatid cohesion,mitotic nuclear division,cell proliferation,positive regulation of cell migration,negative regulation of microtubule polymerization,protein localization to microtubule,cell division,ciliary basal body docking,positive regulation of microtubule plus-end binding,negative regulation of microtubule binding~RNA binding,protein binding,protein C-terminus binding,identical protein binding,cadherin binding,microtubule plus-end bindingGolgi apparatus,centrosome,cytosol,microtubule,cytoplasmic microtubule,cortical microtubule cytoskeleton,cell projection membrane,microtubule plus-end,spindleo>sp|Q15691|MARE1_HUMAN Microtubule-associated protein RP/EB family member 1 OS=Homo sapiens GN=MAPRE1 PE=1 SV=3Q15942ZYX ZYX_HUMANZyxincell adhesion,cell-matrix adhesion,signal transduction,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,cell-cell signaling,viral process,stress fiber assembly,regulation of inflammatory response,RNA binding,protein binding,zinc ion binding}stress fiber,nucleus,cytosol,plasma membrane,integral component of plasma membrane,cell-cell adherens junction,focal adhesion;>sp|Q15942|ZYX_HUMAN Zyxin OS=Homo sapiens GN=ZYX PE=1 SV=1 Q5T123;Q9H299SH3BGRL3Q5T123_HUMAN;SH3L3_HUMAN4SH3 domain-binding glutamic acid-rich-like protein 3;regulation of actin filament depolymerization,regulation of actin cytoskeleton organization,regulation of blood vessel endothelial cell migration,positive regulation of GTPase activity,cell redox homeostasis,oxidation-reduction processz;GTPase activator activity,electron carrier activity,protein disulfide oxidoreductase activity,semaphorin receptor binding;;cytoplasm,nuclear body,lamellipodium,extracellular exosome>tr|Q5T123|Q5T123_HUMAN SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens GN=SH3BGRL3 PE=1 SV=1;>sp|Q9H299|SH3L3_HUMAN SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens GN=SH3BGRL3 PE=1 SV=1F2Z3I4;Q5T370;Q5T371;Q8N5I2ARRDC1< 2F2Z3I4_HUMAN;Q5T370_HUMAN;Q5T371_HUMAN;ARRD1_HUMANArrestin domain-containing protein 1;Arrestin domain-containing protein 1 (Fragment);Arrestin domain-containing protein 1 (Fragment);Arrestin domain-containing protein 1;;;protein binding<;;;plasma membrane,cytoplasmic vesicle,extracellular exosome>tr|F2Z3I4|F2Z3I4_HUMAN Arrestin domain-containing protein 1 OS=Homo sapiens GN=ARRDC1 PE=1 SV=1;>tr|Q5T370|Q5T370_HUMAN Arrestin domain-containing protein 1 (Fragment) OS=Homo sapiens GN=ARRDC1 PE=1 SV=1;>tr|Q5T371|Q5T371_HUMAN Arrestin domain-containing protein 1 (Fragment) OS=Homo sapiens GN=ARRDC1 PE=1 SV=1;>sp|Q8N5I2|ARRD1_HUMAN Arrestin domain-containing protein 1 OS=Homo sapiens GN=ARRDC1 PE=1 SV=1Q68D91;Q68D91-2MBLAC2 MBLC2_HUMANrMetallo-beta-lactamase domain-containing protein 2;Isoform 2 of Metallo-beta-lactamase domain-containing protein 28molecular_function,hydrolase activity,metal ion binding;>sp|Q68D91|MBLC2_HUMAN Metallo-beta-lactamase domain-containing protein 2 OS=Homo sapiens GN=MBLAC2 PE=1 SV=3;>sp|Q68D91-2|MBLC2_HUMAN Isoform 2 of Metallo-beta-lactamase domain-containing protein 2 OS=Homo sapiens GN=MBLAC2Q6IAA8LAMTOR1 LTOR1_HUMAN!Ragulator complex protein LAMTOR1regulation of receptor recycling,endosome organization,lysosome organization,cell cycle arrest,regulation of cholesterol esterification,regulation of cholesterol efflux,cell growth,macroautophagy,positive regulation of TOR signaling,lysosome localization,endosome localization,cellular protein localization,cholesterol homeostasis,neutrophil degranulation,positive regulation of MAPK cascade,positive regulation of GTPase activity,regulation of cholesterol import,cellular response to amino acid stimulusSprotein binding,guanyl-nucleotide exchange factor activity,protein complex scaffoldlysosome,lysosomal membrane,plasma membrane,late endosome membrane,azurophil granule membrane,specific granule membrane,membrane raft,extracellular exosome,Ragulator complex,ficolin-1-rich granule membrane]>sp|Q6IAA8|LTOR1_HUMAN Ragulator complex protein LAMTOR1 OS=Homo sapiens GN=LAMTOR1 PE=1 SV=2Q8IU68;Q8IU68-2TMC8 TMC8_HUMANVTransmembrane channel-like protein 8;Isoform 2 of Transmembrane channel-like protein 8regulation of cell growth,ion transport,negative regulation of protein binding,negative regulation of protein oligomerization,zinc ion homeostasis,regulation of extrinsic apoptotic signaling pathway via death domain receptors;!receptor binding,protein binding;extracellular space,cytoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,Golgi apparatus,integral component of membrane,nuclear membrane,extracellular exosome;>sp|Q8IU68|TMC8_HUMAN Transmembrane channel-like protein 8 OS=Homo sapiens GN=TMC8 PE=1 SV=1;>sp|Q8IU68-2|TMC8_HUMAN Isoform 2 of Transmembrane channel-like protein 8 OS=Homo sapiens GN=TMC8Q99523SORT1 SORT_HUMANSortilinossification,Golgi to endosome transport,endocytosis,G-protein coupled receptor signaling pathway,neuropeptide signaling pathway,multicellular organism development,endosome to lysosome transport,extrinsic apoptotic signaling pathway via death domain receptors,regulation of gene expression,myotube differentiation,vesicle organization,endosome transport via multivesicular body sorting pathway,response to insulin,nerve growth factor signaling pathway,negative regulation of fat cell differentiation,glucose import,neurotrophin TRK receptor signaling pathway,plasma membrane to endosome transport,negative regulation of lipoprotein lipase activity,positive regulation of epithelial cell apoptotic processprotein binding,nerve growth factor receptor activity,enzyme binding,neurotensin receptor activity, non-G-protein coupled,nerve growth factor bindinglysosomal membrane,early endosome,endoplasmic reticulum membrane,Golgi apparatus,cytosol,plasma membrane,clathrin-coated pit,cell surface,endosome membrane,integral component of membrane,clathrin-coated vesicle,trans-Golgi network transport vesicle,dendrite,cytoplasmic vesicle membrane,cytoplasmic vesicle,nuclear membrane,Golgi cisterna membrane,neuronal cell body,perinuclear region of cytoplasmA>sp|Q99523|SORT_HUMAN Sortilin OS=Homo sapiens GN=SORT1 PE=1 SV=3Q9BSJ8;Q9BSJ8-2ESYT1 ESYT1_HUMAN>Extended synaptotagmin-1;Isoform 2 of Extended synaptotagmin-14glycosphingolipid metabolic process,lipid transport;0protein binding,lipid binding,metal ion binding;endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,membrane,integral component of endoplasmic reticulum membrane,intracellular membrane-bounded organelle,organelle membrane contact site;>sp|Q9BSJ8|ESYT1_HUMAN Extended synaptotagmin-1 OS=Homo sapiens GN=ESYT1 PE=1 SV=1;>sp|Q9BSJ8-2|ESYT1_HUMAN Isoform 2 of Extended synaptotagmin-1 OS=Homo sapiens GN=ESYT1Q9BWD1;Q9BWD1-2ACAT2 THIC_HUMAN\Acetyl-CoA acetyltransferase, cytosolic;Isoform 2 of Acetyl-CoA acetyltransferase, cytosolicSlipid metabolic process,fatty acid beta-oxidation,cholesterol biosynthetic process;8acetyl-CoA C-acetyltransferase activity,protein binding;Hnucleus,nucleolus,cytoplasm,mitochondrion,cytosol,extracellular exosome;>sp|Q9BWD1|THIC_HUMAN Acetyl-CoA acetyltransferase, cytosolic OS=Homo sapiens GN=ACAT2 PE=1 SV=2;>sp|Q9BWD1-2|THIC_HUMAN Isoform 2 of Acetyl-CoA acetyltransferase, cytosolic OS=Homo sapiens GN=ACAT2Q9BX67;Q9BX67-2JAM3 JAM3_HUMANJJunctional adhesion molecule C;Isoform 2 of Junctional adhesion molecule Cangiogenesis,neutrophil homeostasis,adaptive immune response,myeloid progenitor cell differentiation,leukocyte migration involved in inflammatory response,cell-matrix adhesion,spermatid development,transmission of nerve impulse,establishment of cell polarity,extracellular matrix organization,axon regeneration,myelination,leukocyte migration,regulation of neutrophil chemotaxis,regulation of actin cytoskeleton organization by cell-cell adhesion;gintegrin binding,protein binding,protein homodimerization activity,protein heterodimerization activity;extracellular space,plasma membrane,bicellular tight junction,integral component of membrane,desmosome,paranodal junction,Schmidt-Lanterman incisure,cell-cell contact zone;>sp|Q9BX67|JAM3_HUMAN Junctional adhesion molecule C OS=Homo sapiens GN=JAM3 PE=1 SV=1;>sp|Q9BX67-2|JAM3_HUMAN Isoform 2 of Junctional adhesion molecule C OS=Homo sapiens GN=JAM3Q9H2K8TAOK3 TAOK3_HUMAN$Serine/threonine-protein kinase TAO3jMAPK cascade,DNA repair,protein phosphorylation,negative regulation of protein kinase activity,cellular response to DNA damage stimulus,mitotic G2 DNA damage checkpoint,positive regulation of stress-activated MAPK cascade,positive regulation of JUN kinase activity,negative regulation of JNK cascade,positive regulation of JNK cascade,protein autophosphorylationprotein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,protein kinase inhibitor activity,protein binding,ATP binding,transferase activitycytoplasm,plasma membrane^>sp|Q9H2K8|TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens GN=TAOK3 PE=1 SV=2Q9P126;Q9P126-2CLEC1B CLC1B_HUMANZC-type lectin domain family 1 member B;Isoform 2 of C-type lectin domain family 1 member B`defense response,cell surface receptor signaling pathway,platelet activation,platelet formation;Otransmembrane signaling receptor activity,protein binding,carbohydrate binding;>sp|Q9P126|CLC1B_HUMAN C-type lectin domain family 1 member B OS=Homo sapiens GN=CLEC1B PE=1 SV=2;>sp|Q9P126-2|CLC1B_HUMAN Isoform 2 of C-type lectin domain family 1 member B OS=Homo sapiens GN=CLEC1BQ9P253VPS18 VPS18_HUMAN6Vacuolar protein sorting-associated protein 18 homologintracellular protein transport,vesicle docking involved in exocytosis,autophagy,endosome organization,lysosome organization,endosome to lysosome transport,regulation of SNARE complex assembly,viral entry into host cellZactin binding,protein binding,syntaxin binding,protein binding, bridging,metal ion bindinglysosome,lysosomal membrane,early endosome,late endosome,autophagosome,actin filament,AP-3 adaptor complex,clathrin-coated ve< sicle,HOPS complex,late endosome membrane,CORVET complexp>sp|Q9P253|VPS18_HUMAN Vacuolar protein sorting-associated protein 18 homolog OS=Homo sapiens GN=VPS18 PE=1 SV=2A0A024QZ42;O75340;O75340-2PDCD6(A0A024QZ42_HUMAN;PDCD6_HUMAN;PDCD6_HUMANfHCG1985580, isoform CRA_c;Programmed cell death protein 6;Isoform 2 of Programmed cell death protein 6;angiogenesis,positive regulation of endothelial cell proliferation,proteolysis,intracellular protein transport,activation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of endothelial cell migration,negative regulation of vascular endothelial growth factor receptor signaling pathway,negative regulation of TOR signaling,cellular response to heat,vascular endothelial growth factor receptor-2 signaling pathway,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of angiogenesis,response to calcium ion,negative regulation of protein kinase B signaling,apoptotic signaling pathway;;calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding,identical protein binding,protein homodimerization activity,protein anchor,protein dimerization activity,calcium-dependent protein binding,binding, bridging;;nucleus,cytoplasm,endosome,endoplasmic reticulum,endoplasmic reticulum membrane,cytoplasmic vesicle,nuclear membrane,extracellular exosome,endoplasmic reticulum exit site;>tr|A0A024QZ42|A0A024QZ42_HUMAN HCG1985580, isoform CRA_c OS=Homo sapiens GN=PDCD6 PE=1 SV=1;>sp|O75340|PDCD6_HUMAN Programmed cell death protein 6 OS=Homo sapiens GN=PDCD6 PE=1 SV=1;>sp|O75340-2|PDCD6_HUMAN Isoform 2 of Programmed cell death protein 6 OS=Homo sapiens GN=PDCD6 A0A075B7B6 IGHV4OR15-8A0A075B7B6_HUMANWPutative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 (Fragment)>tr|A0A075B7B6|A0A075B7B6_HUMAN Putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 (Fragment) OS=Homo sapiens GN=IGHV4OR15-8 PE=4 SV=1A0A087WUQ6;P07203GPX1A0A087WUQ6_HUMAN;GPX1_HUMAN/Glutathione peroxidase;Glutathione peroxidase 1%;response to reactive oxygen species,temperature homeostasis,endothelial cell development,negative regulation of inflammatory response to antigenic stimulus,purine nucleotide catabolic process,triglyceride metabolic process,glutathione metabolic process,sensory perception of sound,intrinsic apoptotic signaling       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqstuvwxyz{|}~pathway in response to oxidative stress,response to xenobiotic stimulus,response to symbiotic bacterium,UV protection,response to selenium ion,response to gamma radiation,protein oxidation,lipoxygenase pathway,response to hydroperoxide,regulation of mammary gland epithelial cell proliferation,cellular response to oxidative stress,regulation of gene expression, epigenetic,vasodilation,response to hydrogen peroxide,hydrogen peroxide catabolic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,skeletal muscle tissue regeneration,regulation of neuron apoptotic process,blood vessel endothelial cell migration,fat cell differentiation,cell redox homeostasis,skeletal muscle fiber development,myoblast proliferation,interaction with symbiont,positive regulation of protein kinase B signaling,heart contraction,angiogenesis involved in wound healing,regulation of proteasomal protein catabolic process,negative regulation of release of cytochrome c from mitochondria,cellular oxidant detoxification,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,positive regulation of fibril organization3;glutathione peroxidase activity,SH3 domain bindingU;cytoplasm,mitochondrion,mitochondrial matrix,cytosol,extracellular exosome,Lewy body>tr|A0A087WUQ6|A0A087WUQ6_HUMAN Glutathione peroxidase OS=Homo sapiens GN=GPX1 PE=1 SV=1;>sp|P07203|GPX1_HUMAN Glutathione peroxidase 1 OS=Homo sapiens GN=GPX1 PE=1 SV=4A0A087WW66;Q99460;Q99460-2PSMD1(A0A087WW66_HUMAN;PSMD1_HUMAN;PSMD1_HUMAN26S proteasome non-ATPase regulatory subunit 1;26S proteasome non-ATPase regulatory subunit 1;Isoform 2 of 26S proteasome non-ATPase regulatory subunit 1;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;;enzyme regulator activity;;proteasome complex,extracellular region,nucleoplasm,cytosol,proteasome regulatory particle,membrane,proteasome accessory complex,azurophil granule lumen,extracellular exosome;H>tr|A0A087WW66|A0A087WW66_HUMAN 26S proteasome non-ATPase regulatory subunit 1 OS=Homo sapiens GN=PSMD1 PE=1 SV=1;>sp|Q99460|PSMD1_HUMAN 26S proteasome non-ATPase regulatory subunit 1 OS=Homo sapiens GN=PSMD1 PE=1 SV=2;>sp|Q99460-2|PSMD1_HUMAN Isoform 2 of 26S proteasome non-ATPase regulatory subunit 1 OS=Homo sapiens GN=PSMD1A0A087WZF1;Q93052LPPA0A087WZF1_HUMAN;LPP_HUMANLipoma-preferred partner!;cell adhesion,biological_process!;protein binding,zinc ion binding/;nucleus,cytosol,plasma membrane,focal adhesion>tr|A0A087WZF1|A0A087WZF1_HUMAN Lipoma-preferred partner OS=Homo sapiens GN=LPP PE=1 SV=1;>sp|Q93052|LPP_HUMAN Lipoma-preferred partner OS=Homo sapiens GN=LPP PE=1 SV=1tA0A087WYR8;A0A087X097;A0A0A0MQS6;A0A0A0MS94;B1AVV0;Q8N5B3;Q9H251;Q9H251-2;Q9H251-3;Q9H251-4;Q9H251-6;Q9H251-8;R4GN92CDH23A0A087WYR8_HUMAN;A0A087X097_HUMAN;A0A0A0MQS6_HUMAN;A0A0A0MS94_HUMAN;B1AVV0_HUMAN;Q8N5B3_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMAN;R4GN92_HUMANCadherin-23;Cadherin-23;Cadherin-23;Cadherin-23;Cadherin-23 (Fragment);CDH23 protein;Cadherin-23;Isoform 2 of Cadherin-23;Isoform 3 of Cadherin-23;Isoform 4 of Cadherin-23;Isoform 6 of Cadherin-23;Isoform 8 of Cadherin-23;Cadherin-23 (Fragment);;;;;;calcium ion transport,homophilic cell adhesion via plasma membrane adhesion molecules,visual perception,sensory perception of sound,locomotory behavior,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,photoreceptor cell maintenance,response to stimulus,sensory perception of light stimulus,equilibrioception,regulation of cytosolic calcium ion concentration,inner ear receptor stereocilium organization;;;;;;/;;;;;;calcium ion binding,protein binding;;;;;;P;;;;;;plasma membrane,membrane,integral component of membrane,stereocilium;;;;;;&tr;tr;tr;tr;tr;tr;sp;sp;sp;sp;sp;sp;tr1;1;1;1;1;1;1;;;;;;12;1;2;1;2;1;2;;;;;;1>tr|A0A087WYR8|A0A087WYR8_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=2;>tr|A0A087X097|A0A087X097_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1;>tr|A0A0A0MQS6|A0A0A0MQS6_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=2;>tr|A0A0A0MS94|A0A0A0MS94_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1;>tr|B1AVV0|B1AVV0_HUMAN Cadherin-23 (Fragment) OS=Homo sapiens GN=CDH23 PE=1 SV=2;>tr|Q8N5B3|Q8N5B3_HUMAN CDH23 protein OS=Homo sapiens GN=CDH23 PE=1 SV=1;>sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=2;>sp|Q9H251-2|CAD23_HUMAN Isoform 2 of Cadherin-23 OS=Homo sapiens < GN=CDH23;>sp|Q9H251-3|CAD23_HUMAN Isoform 3 of Cadherin-23 OS=Homo sapiens GN=CDH23;>sp|Q9H251-4|CAD23_HUMAN Isoform 4 of Cadherin-23 OS=Homo sapiens GN=CDH23;>sp|Q9H251-6|CAD23_HUMAN Isoform 6 of Cadherin-23 OS=Homo sapiens GN=CDH23;>sp|Q9H251-8|CAD23_HUMAN Isoform 8 of Cadherin-23 OS=Homo sapiens GN=CDH23;>tr|R4GN92|R4GN92_HUMAN Cadherin-23 (Fragment) OS=Homo sapiens GN=CDH23 PE=1 SV=1.A0A0C4DFU1;A0A0C4DFU2;P04179;P04179-2;P04179-4SOD2BA0A0C4DFU1_HUMAN;A0A0C4DFU2_HUMAN;SODM_HUMAN;SODM_HUMAN;SODM_HUMANSuperoxide dismutase;Superoxide dismutase;Superoxide dismutase [Mn], mitochondrial;Isoform 2 of Superoxide dismutase [Mn], mitochondrial;Isoform 4 of Superoxide dismutase [Mn], mitochondrial;;response to reactive oxygen species,response to superoxide,age-dependent response to reactive oxygen species,release of cytochrome c from mitochondria,vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure,regulation of transcription from RNA polymerase II promoter,superoxide metabolic process,regulation of blood pressure,negative regulation of cell proliferation,removal of superoxide radicals,oxygen homeostasis,negative regulation of neuron apoptotic process,protein homotetramerization,oxidation-reduction process,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;;Q;;superoxide dismutase activity,manganese ion binding,identical protein binding;;<;;mitochondrion,mitochondrial matrix,extracellular exosome;;>tr|A0A0C4DFU1|A0A0C4DFU1_HUMAN Superoxide dismutase OS=Homo sapiens GN=SOD2 PE=1 SV=1;>tr|A0A0C4DFU2|A0A0C4DFU2_HUMAN Superoxide dismutase OS=Homo sapiens GN=SOD2 PE=1 SV=1;>sp|P04179|SODM_HUMAN Superoxide dismutase [Mn], mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2;>sp|P04179-2|SODM_HUMAN Isoform 2 of Superoxide dismutase [Mn], mitochondrial OS=Homo sapiens GN=SOD2;>sp|P04179-4|SODM_HUMAN Isoform 4 of Superoxide dismutase [Mn], mitochondrial OS=Homo sapiens GN=SOD2 A0A0J9YX35A0A0J9YX35_HUMAN\>tr|A0A0J9YX35|A0A0J9YX35_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=1DA6XGL3;E7EQ64;E9PRA0;J3KQC6;P07477;Q9BYE2;Q9BYE2-2;Q9BYE2-3;Q9BYE2-5GPRSS1;PRSS1;TMPRSS13;TMPRSS13;PRSS1;TMPRSS13;TMPRSS13;TMPRSS13;TMPRSS13nA6XGL3_HUMAN;E7EQ64_HUMAN;E9PRA0_HUMAN;J3KQC6_HUMAN;TRY1_HUMAN;TMPSD_HUMAN;TMPSD_HUMAN;TMPSD_HUMAN;TMPSD_HUMANProtease serine 1;Trypsin-1;Transmembrane protease serine 13;Transmembrane protease serine 13;Trypsin-1;Transmembrane protease serine 13;Isoform 2 of Transmembrane protease serine 13;Isoform 3 of Transmembrane protease serine 13;Isoform 5 of Transmembrane protease serine 13;;;;proteolysis,digestion,cobalamin metabolic process,extracellular matrix disassembly;proteolysis,receptor-mediated endocytosis;;;;;;;serine-type endopeptidase activity,serine-type peptidase activity,metal ion binding;serine-type endopeptidase activity,scavenger receptor activity;;;x;;;;extracellular region,extracellular exosome,blood microparticle;integral component of membrane,blood microparticle;;;tr;tr;tr;tr;sp;sp;sp;sp;sp1;1;1;1;1;2;;;1;1;1;1;1;4;;;>tr|A6XGL3|A6XGL3_HUMAN Protease serine 1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1;>tr|E7EQ64|E7EQ64_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1;>tr|E9PRA0|E9PRA0_HUMAN Transmembrane protease serine 13 OS=Homo sapiens GN=TMPRSS13 PE=1 SV=1;>tr|J3KQC6|J3KQC6_HUMAN Transmembrane protease serine 13 OS=Homo sapiens GN=TMPRSS13 PE=1 SV=1;>sp|P07477|TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1;>sp|Q9BYE2|TMPSD_HUMAN Transmembrane protease serine 13 OS=Homo sapiens GN=TMPRSS13 PE=2 SV=4;>sp|Q9BYE2-2|TMPSD_HUMAN Isoform 2 of Transmembrane protease serine 13 OS=Homo sapiens GN=TMPRSS13;>sp|Q9BYE2-3|TMPSD_HUMAN Isoform 3 of Transmembrane protease serine 13 OS=Homo sapiens GN=TMPRSS13;>sp|Q9BYE2-5|TMPSD_HUMAN Isoform 5 of Transmembrane protease serine 13 OS=Homo sapiens GN=TMPRSS13 B5MD23;O75954TSPAN9B5MD23_HUMAN;TSN9_HUMANTetraspanin;Tetraspanin-9;;cell surface receptor signaling pathway,biological_process;molecular_functionf;plasma membrane,integral component of plasma membrane,focal adhesion,tetraspanin-enriched microdomain>tr|B5MD23|B5MD23_HUMAN Tetraspanin OS=Homo sapiens GN=TSPAN9 PE=1 SV=1;>sp|O75954|TSN9_HUMAN Tetraspanin-9 OS=Homo sapiens GN=TSPAN9 PE=1 SV=1D6RF35 D6RF35_HUMANVitamin D-binding proteinQ>tr|D6RF35|D6RF35_HUMAN Vitamin D-binding protein OS=Homo sapiens GN=GC PE=1 SV=1;E7EX60;E9PEP6;O14786;O14786-2;O14786-3;Q5JWQ4;Q5JWQ6;Q5T7F0NRP1aE7EX60_HUMAN;E9PEP6_HUMAN;NRP1_HUMAN;NRP1_HUMAN;NRP1_HUMAN;Q5JWQ4_HUMAN;Q5JWQ6_HUMAN;Q5T7F0_HUMAN{Neuropilin-1;Neuropilin;Neuropilin-1;Isoform 2 of Neuropilin-1;Isoform 3 of Neuropilin-1;Neuropilin-1;Neuropilin;Neuropilin ;;angiogenesis,patterning of blood vessels,neuron migration,positive regulation of endothelial cell proliferation,sprouting angiogenesis,cell migration involved in sprouting angiogenesis,signal transduction,cell-cell signaling,axon guidance,axonal fasciculation,response to wounding,animal organ morphogenesis,positive regulation of endothelial cell migration,positive regulation of smooth muscle cell migration,dendrite development,facial nerve structural organization,trigeminal nerve structural organization,vestibulocochlear nerve structural organization,nerve development,branchiomotor neuron axon guidance,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,retinal ganglion cell axon guidance,cellular response to hepatocyte growth factor stimulus,endothelial cell chemotaxis,cellular response to vascular endothelial growth factor stimulus,ventral trunk neural crest cell migration,VEGF-activated neuropilin signaling pathway,negative regulation of neuron apoptotic process,platelet-derived growth factor receptor signaling pathway,vascular endothelial growth factor receptor signaling pathway,hepatocyte growth factor receptor signaling pathway,positive regulation of axon extension involved in axon guidance,negative regulation of axon extension involved in axon guidance,artery morphogenesis,axon extension involved in axon guidance,positive regulation of peptidyl-tyrosine phosphorylation,positive chemotaxis,positive regulation of cytokine activity,axonogenesis involved in innervation,regulation of vesicle-mediated transport,dichotomous subdivision of terminal units involved in salivary gland branching,angiogenesis involved in coronary vascular morphogenesis,coronary artery morphogenesis,retina vasculature morphogenesis in camera-type eye,renal artery morphogenesis,sympathetic ganglion development,trigeminal ganglion development,positive regulation of ERK1 and ERK2 cascade,semaphorin-plexin signaling pathway,commissural neuron axon guidance,regulation of retinal ganglion cell axon guidance,endothelial tip cell fate specification,sensory neuron axon guidance,sympathetic neuron projection extension,sympathetic neuron projection guidance,neural crest cell migration involved in autonomic nervous system development,toxin transport,semaphorin-plexin signaling pathway involved in neuron projection guidance,semaphorin-plexin signaling pathway involved in axon guidance,positive regulation of retinal ganglion cell axon guidance,VEGF-activated neuropilin signaling pathway involved in axon guidance,protein localization to early endosome,facioacoustic ganglion development,dorsal root ganglion morphogenesis,otic placode development,negative regulation of extrinsic apoptotic signaling pathway;;;;;;;vascular endothelial growth factor-activated receptor activity,protein binding,heparin binding,coreceptor activity,semaphorin receptor activity,growth factor binding,cytokine binding,vascular endothelial growth factor binding,metal ion binding;;;;;;;semaphorin receptor complex,extracellular space,early endosome,cytosol,neurofilament,plasma membrane,focal adhesion,cell surface,integral component of membrane,axon,growth cone,cytoplasmic vesicle,neuronal cell body,receptor complex,sorting endosome;;;;;tr;tr;sp;sp;sp;tr;tr;tr 1;1;1;;;1;1;1 1;2;3;;;2;1;15>tr|E7EX60|E7EX60_HUMAN Neuropilin-1 OS=Homo sapiens GN=NRP1 PE=1 SV=1;>tr|E9PEP6|E9PEP6_HUMAN Neuropilin OS=Homo sapiens GN=NRP1 PE=1 SV=2;>sp|O14786|< NRP1_HUMAN Neuropilin-1 OS=Homo sapiens GN=NRP1 PE=1 SV=3;>sp|O14786-2|NRP1_HUMAN Isoform 2 of Neuropilin-1 OS=Homo sapiens GN=NRP1;>sp|O14786-3|NRP1_HUMAN Isoform 3 of Neuropilin-1 OS=Homo sapiens GN=NRP1;>tr|Q5JWQ4|Q5JWQ4_HUMAN Neuropilin-1 OS=Homo sapiens GN=NRP1 PE=1 SV=2;>tr|Q5JWQ6|Q5JWQ6_HUMAN Neuropilin OS=Homo sapiens GN=NRP1 PE=1 SV=1;>tr|Q5T7F0|Q5T7F0_HUMAN Neuropilin OS=Homo sapiens GN=NRP1 PE=1 SV=1E9PK47;P06737;P06737-2PYGL"E9PK47_HUMAN;PYGL_HUMAN;PYGL_HUMANqAlpha-1,4 glucan phosphorylase;Glycogen phosphorylase, liver form;Isoform 2 of Glycogen phosphorylase, liver form;glycogen metabolic process,glycogen catabolic process,5-phosphoribose 1-diphosphate biosynthetic process,glucose homeostasis,neutrophil degranulation,necroptotic process;;purine nucleobase binding,protein binding,ATP binding,glucose binding,drug binding,glycogen phosphorylase activity,AMP binding,vitamin binding,pyridoxal phosphate binding,bile acid binding,protein homodimerization activity;s;extracellular region,cytoplasm,cytosol,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;1;4;>tr|E9PK47|E9PK47_HUMAN Alpha-1,4 glucan phosphorylase OS=Homo sapiens GN=PYGL PE=1 SV=1;>sp|P06737|PYGL_HUMAN Glycogen phosphorylase, liver form OS=Homo sapiens GN=PYGL PE=1 SV=4;>sp|P06737-2|PYGL_HUMAN Isoform 2 of Glycogen phosphorylase, liver form OS=Homo sapiens GN=PYGLE9PNW4;E9PR17;P13987CD59$E9PNW4_HUMAN;E9PR17_HUMAN;CD59_HUMANCD59 glycoproteinW;;cell activation,negative regulation of activation of membrane attack complex,ER to Golgi vesicle-mediated transport,cell surface receptor signaling pathway,blood coagulation,regulation of complement activation,positive regulation of T cell proliferation,negative regulation of apoptotic process,neutrophil degranulation,COPII vesicle coating$;;complement binding,protein binding;;Golgi membrane,extracellular space,endoplasmic reticulum membrane,plasma membrane,focal adhesion,cell surface,ER to Golgi transport vesicle membrane,membrane,anchored component of external side of plasma membrane,vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,specific granule membrane,sarcolemma,compact myelin,extracellular exosome,tertiary granule membrane>tr|E9PNW4|E9PNW4_HUMAN CD59 glycoprotein OS=Homo sapiens GN=CD59 PE=1 SV=1;>tr|E9PR17|E9PR17_HUMAN CD59 glycoprotein OS=Homo sapiens GN=CD59 PE=1 SV=1;>sp|P13987|CD59_HUMAN CD59 glycoprotein OS=Homo sapiens GN=CD59 PE=1 SV=1F8WE98 F8WE98_HUMANFilamin-A (Fragment)N>tr|F8WE98|F8WE98_HUMAN Filamin-A (Fragment) OS=Homo sapiens GN=FLNA PE=1 SV=2G3V3A0 G3V3A0_HUMANV>tr|G3V3A0|G3V3A0_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=1 M0QYJ8;O60234GMFGM0QYJ8_HUMAN;GMFG_HUMANGlia maturation factor gamma;protein phosphorylation,negative regulation of protein kinase activity,negative regulation of Arp2/3 complex-mediated actin nucleation,positive regulation of catalytic activity,neutrophil degranulation,actin filament debranching,regulation of actin cytoskeleton reorganizationx;actin binding,protein kinase inhibitor activity,enzyme activator activity,growth factor activity,Arp2/3 complex bindingJ;extracellular region,secretory granule lumen,ficolin-1-rich granule lumen>tr|M0QYJ8|M0QYJ8_HUMAN Glia maturation factor gamma OS=Homo sapiens GN=GMFG PE=1 SV=1;>sp|O60234|GMFG_HUMAN Glia maturation factor gamma OS=Homo sapiens GN=GMFG PE=1 SV=1"M0R0P7;M0R117;M0R1A7;M0R3D6;Q02543RPL18A?M0R0P7_HUMAN;M0R117_HUMAN;M0R1A7_HUMAN;M0R3D6_HUMAN;RL18A_HUMAN60S ribosomal protein L18a;60S ribosomal protein L18a;60S ribosomal protein L18a;60S ribosomal protein L18a (Fragment);60S ribosomal protein L18a;;;;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,response to antineoplastic agentB;;;;RNA binding,structural constituent of ribosome,protein binding6;;;;cytosol,membrane,cytosolic large ribosomal subunit 1;1;1;1;2>tr|M0R0P7|M0R0P7_HUMAN 60S ribosomal protein L18a OS=Homo sapiens GN=RPL18A PE=1 SV=1;>tr|M0R117|M0R117_HUMAN 60S ribosomal protein L18a OS=Homo sapiens GN=RPL18A PE=1 SV=1;>tr|M0R1A7|M0R1A7_HUMAN 60S ribosomal protein L18a OS=Homo sapiens GN=RPL18A PE=1 SV=1;>tr|M0R3D6|M0R3D6_HUMAN 60S ribosomal protein L18a (Fragment) OS=Homo sapiens GN=RPL18A PE=1 SV=1;>sp|Q02543|RL18A_HUMAN 60S ribosomal protein L18a OS=Homo sapiens GN=RPL18A PE=1 SV=2O14498ISLR ISLR_HUMANAImmunoglobulin superfamily containing leucine-rich repeat protein$platelet degranulation,cell adhesion[extracellular region,extracellular space,platelet alpha granule lumen,extracellular exosomey>sp|O14498|ISLR_HUMAN Immunoglobulin superfamily containing leucine-rich repeat protein OS=Homo sapiens GN=ISLR PE=2 SV=1O43639NCK2 NCK2_HUMANCytoplasmic protein NCK2Oimmunological synapse formation,actin filament organization,signal transduction,signal complex assembly,epidermal growth factor receptor signaling pathway,regulation of epidermal growth factor-activated receptor activity,negative regulation of cell proliferation,cell migration,lamellipodium assembly,positive regulation of actin filament polymerization,negative regulation of peptidyl-serine phosphorylation,positive regulation of translation in response to endoplasmic reticulum stress,positive regulation of T cell proliferation,T cell activation,positive regulation of transcription from RNA polymerase II promoter,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,dendritic spine development,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,negative regulation of PERK-mediated unfolded protein response,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stressSH3/SH2 adaptor activity,protein binding,cytoskeletal adaptor activity,receptor signaling complex scaffold activity,protein complex binding,scaffold protein bindingMcytoplasm,endoplasmic reticulum,cytosol,vesicle membrane,postsynaptic densityP>sp|O43639|NCK2_HUMAN Cytoplasmic protein NCK2 OS=Homo sapiens GN=NCK2 PE=1 SV=2O75874IDH1 IDHC_HUMAN+Isocitrate dehydrogenase [NADP] cytoplasmic`glyoxylate cycle,tricarboxylic acid cycle,isocitrate metabolic process,2-oxoglutarate metabolic process,NADPH regeneration,glutathione metabolic process,response to oxidative stress,female gonad development,neutrophil degranulation,response to steroid hormone,regulation of phospholipid catabolic process,regulation of phospholipid biosynthetic processmagnesium ion binding,isocitrate dehydrogenase (NADP+) activity,receptor binding,protein homodimerization activity,cadherin binding,NADP binding,NAD binding,(R)-2-hydroxyglutarate dehydrogenase activityextracellular region,cytoplasm,mitochondrion,peroxisome,peroxisomal matrix,cytosol,secretory granule lumen,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenc>sp|O75874|IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2O76074PDE5A PDE5A_HUMAN,cGMP-specific 3',5'-cyclic phosphodiesteraseQsignal transduction,positive regulation of cardiac muscle hypertrophy,regulation of cGMP metabolic process,negative regulation of T cell proliferation,positive regulation of MAP kinase activity,cGMP catabolic process,negative regulation of cardiac muscle contraction,relaxation of cardiac muscle,positive regulation of oocyte development}3',5'-cyclic-nucleotide phosphodiesterase activity,cGMP binding,metal ion binding,3',5'-cyclic-GMP phosphodiesterase activitycellular_component,cytosolf>sp|O76074|PDE5A_HUMAN cGMP-specific 3',5'-cyclic phosphodiesterase OS=Homo sapiens GN=PDE5A PE=1 SV=2O94804STK10 STK10_HUMAN"Serine/threonine-protein kinase 10protein phosphorylation,cell cycle,signal transduction by protein phosphorylation,neutrophil degranulation,protein autophosphorylation,lymphocyte aggregat< ion,regulation of lymphocyte migrationprotein serine/threonine kinase activity,protein binding,ATP binding,polo kinase kinase activity,identical protein binding,protein homodimerization activityIcytoplasm,plasma membrane,specific granule membrane,extracellular exosome\>sp|O94804|STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1O95865DDAH2 DDAH2_HUMAN3N(G),N(G)-dimethylarginine dimethylaminohydrolase 2citrulline metabolic process,arginine catabolic process,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,negative regulation of apoptotic process,positive regulation of nitric oxide biosynthetic process,regulation of nitric-oxide synthase activityQcatalytic activity,protein binding,dimethylargininase activity,amino acid bindingImitochondrion,microtubule organizing center,cytosol,extracellular exosomem>sp|O95865|DDAH2_HUMAN N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 OS=Homo sapiens GN=DDAH2 PE=1 SV=1P00742F10 FA10_HUMANCoagulation factor Xsignal peptide processing,ER to Golgi vesicle-mediated transport,blood coagulation,blood coagulation, intrinsic pathway,blood coagulation, extrinsic pathway,peptidyl-glutamic acid carboxylation,positive regulation of cell migration,positive regulation of protein kinase B signaling[serine-type endopeptidase activity,calcium ion binding,protein binding,phospholipid bindingextracellular region,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,intrinsic component of external side of plasma membraneK>sp|P00742|FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2P00966ASS1 ASSY_HUMANArgininosuccinate synthase"urea cycle,citrulline metabolic process,argininosuccinate metabolic process,arginine biosynthetic process,aspartate metabolic process,positive regulation of nitric oxide biosynthetic process,cellular response to laminar fluid shear stress,negative regulation of leukocyte cell-cell adhesionxRNA binding,argininosuccinate synthase activity,protein binding,ATP binding,amino acid binding,identical protein bindingCcytoplasm,mitochondrion,cytosol,myelin sheath,extracellular exosomeR>sp|P00966|ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2P06729CD2 CD2_HUMANT-cell surface antigen CD2membrane raft polarization,apoptotic process,cell surface receptor signaling pathway,single organismal cell-cell adhesion,natural killer cell activation,positive regulation of myeloid dendritic cell activation,positive regulation of tumor necrosis factor production,heterotypic cell-cell adhesion,T cell activation,regulation of T cell differentiation,leukocyte migration,positive regulation of interferon-gamma secretion,positive regulation of interleukin-8 secretionTreceptor activity,receptor binding,protein binding,protein homodimerization activityextracellular region,plasma membrane,integral component of plasma membrane,cell-cell junction,external side of plasma membrane,cytoplasmic side of plasma membrane,cell surface,anchored component of plasma membraneP>sp|P06729|CD2_HUMAN T-cell surface antigen CD2 OS=Homo sapiens GN=CD2 PE=1 SV=2P12931;P12931-2SRC SRC_HUMANbProto-oncogene tyrosine-protein kinase Src;Isoform 2 of Proto-oncogene tyrosine-protein kinase Srcstimulatory C-type lectin receptor signaling pathway,cell cycle,signal transduction,signal complex assembly,epidermal growth factor receptor signaling pathway,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,axon guidance,central nervous system development,cell proliferation,response to mechanical stimulus,response to virus,response to acidic pH,regulation of epithelial cell migration,positive regulation of epithelial cell migration,positive regulation of platelet-derived growth factor receptor signaling pathway,positive regulation of glucose metabolic process,positive regulation of protein processing,positive regulation of smooth muscle cell migration,single organismal cell-cell adhesion,peptidyl-serine phosphorylation,peptidyl-tyrosine phosphorylation,regulation of cell-cell adhesion,platelet activation,intracellular estrogen receptor signaling pathway,forebrain development,T cell costimulation,protein destabilization,response to nutrient levels,positive regulation of protein autophosphorylation,activation of protein kinase B activity,negative regulation of telomere maintenance via telomerase,negative regulation of protein homooligomerization,cellular response to insulin stimulus,regulation of intracellular estrogen receptor signaling pathway,positive regulation of integrin activation,adherens junction organization,substrate adhesion-dependent cell spreading,cellular response to reactive oxygen species,intracellular signal transduction,entry of bacterium into host cell,osteoclast development,cellular response to platelet-derived growth factor stimulus,peptidyl-tyrosine autophosphorylation,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,regulation of cell proliferation,response to drug,response to hydrogen peroxide,positive regulation of apoptotic process,negative regulation of apoptotic process,regulation of vascular permeability,stress fiber assembly,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,regulation of protein binding,positive regulation of MAP kinase activity,positive regulation of phosphatidylinositol 3-kinase activity,transcytosis,innate immune response,regulation of bone resorption,bone resorption,positive regulation of cyclin-dependent protein serine/threonine kinase activity,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of insulin receptor signaling pathway,protein autophosphorylation,platelet-derived growth factor receptor signaling pathway,vascular endothelial growth factor receptor signaling pathway,neurotrophin TRK receptor signaling pathway,ephrin receptor signaling pathway,oogenesis,positive regulation of cytokine secretion,positive regulation of peptidyl-tyrosine phosphorylation,progesterone receptor signaling pathway,leukocyte migration,positive regulation of small GTPase mediated signal transduction,response to mineralocorticoid,response to electrical stimulus,regulation of cell cycle,negative regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of mitochondrial depolarization,negative regulation of telomerase activity,uterus development,branching involved in mammary gland duct morphogenesis,regulation of cell projection assembly,positive regulation of ERK1 and ERK2 cascade,response to interleukin-1,cellular response to lipopolysaccharide,cellular response to peptide hormone stimulus,cellular response to progesterone stimulus,cellular response to fatty acid,cellular response to hypoxia,cellular response to fluid shear stress,regulation of podosome assembly,positive regulation of podosome assembly,positive regulation of protein serine/threonine kinase activity,angiotensin-activated signaling pathway involved in heart process,positive regulation of canonical Wnt signaling pathway,positive regulation of protein localization to nucleus,positive regulation of lamellipodium morphogenesis,positive regulation of DNA biosynthetic process,regulation of early endosome to late endosome transport,negative regulation of anoikis,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of intrinsic apoptotic signaling pathway,regulation of caveolin-mediated endocytosis;Bprotein kinase activity,protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,SH3/SH2 adaptor activity,protein kinase C binding,receptor binding,insulin receptor binding,integrin binding,protein binding,ATP binding,protein C-terminus binding,kinase activity,enzyme binding,kinase binding,heme binding,estrogen receptor binding,ubiquitin protein ligase binding,SH2 domain binding,ion channel binding,cadherin binding,ephrin receptor binding,phosphoprotein binding,hormone receptor binding,growth factor receptor binding,scaf< fold protein binding;4podosome,nucleus,cytoplasm,mitochondrion,mitochondrial inner membrane,lysosome,late endosome,cytosol,actin filament,plasma membrane,caveola,postsynaptic density,extrinsic component of cytoplasmic side of plasma membrane,ruffle membrane,neuron projection,perinuclear region of cytoplasm,extracellular exosome;>sp|P12931|SRC_HUMAN Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens GN=SRC PE=1 SV=3;>sp|P12931-2|SRC_HUMAN Isoform 2 of Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens GN=SRCP13612ITGA4 ITA4_HUMANIntegrin alpha-4cell-matrix adhesion involved in ameboidal cell migration,leukocyte cell-cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,B cell differentiation,extracellular matrix organization,heterotypic cell-cell adhesion,substrate adhesion-dependent cell spreading,endodermal cell differentiation,receptor clustering,regulation of immune response,leukocyte migration,leukocyte tethering or rolling,diapedesis,cellular response to cytokine stimulus,negative regulation of protein homodimerization activity,import into cell,positive regulation of leukocyte tethering or rolling,clathrin-dependent extracellular exosome endocytosis,positive regulation of T cell migrationfibronectin binding,protein binding,coreceptor activity,metal ion binding,cell adhesion molecule binding,protein antigen binding,C-X3-C chemokine bindinghplasma membrane,focal adhesion,cell surface,membrane,integrin alpha4-beta7 complex,extracellular exosomeI>sp|P13612|ITA4_HUMAN Integrin alpha-4 OS=Homo sapiens GN=ITGA4 PE=1 SV=3P16070;P16070-10;P16070-11;P16070-12;P16070-13;P16070-14;P16070-16;P16070-17;P16070-18;P16070-3;P16070-4;P16070-5;P16070-6;P16070-7;P16070-8CD44 CD44_HUMANCD44 antigen;Isoform 10 of CD44 antigen;Isoform 11 of CD44 antigen;Isoform 12 of CD44 antigen;Isoform 13 of CD44 antigen;Isoform 14 of CD44 antigen;Isoform 16 of CD44 antigen;Isoform 17 of CD44 antigen;Isoform 18 of CD44 antigen;Isoform 3 of CD44 antigen;Isoform 4 of CD44 antigen;Isoform 5 of CD44 antigen;Isoform 6 of CD44 antigen;Isoform 7 of CD44 antigen;Isoform 8 of CD44 antigencell-matrix adhesion,single organismal cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,hyaluronan catabolic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of heterotypic cell-cell adhesion,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,neutrophil degranulation,negative regulation of DNA damage response, signal transduction by p53 class mediator,cellular response to fibroblast growth factor stimulus,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,cartilage development,interferon-gamma-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,monocyte aggregation,positive regulation of monocyte aggregation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;;;;;;;;;;;;;;aprotein binding,collagen binding,hyaluronic acid binding,cytokine receptor activity;;;;;;;;;;;;;;Golgi apparatus,cytosol,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,secretory granule membrane,macrophage migration inhibitory factor receptor complex,extracellular exosome;;;;;;;;;;;;;;1;;;;;;;;;;;;;;3;;;;;;;;;;;;;;`>sp|P16070|CD44_HUMAN CD44 antigen OS=Homo sapiens GN=CD44 PE=1 SV=3;>sp|P16070-10|CD44_HUMAN Isoform 10 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-11|CD44_HUMAN Isoform 11 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-12|CD44_HUMAN Isoform 12 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-13|CD44_HUMAN Isoform 13 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-14|CD44_HUMAN Isoform 14 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-16|CD44_HUMAN Isoform 16 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-17|CD44_HUMAN Isoform 17 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-18|CD44_HUMAN Isoform 18 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-3|CD44_HUMAN Isoform 3 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-4|CD44_HUMAN Isoform 4 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-5|CD44_HUMAN Isoform 5 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-6|CD44_HUMAN Isoform 6 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-7|CD44_HUMAN Isoform 7 of CD44 antigen OS=Homo sapiens GN=CD44;>sp|P16070-8|CD44_HUMAN Isoform 8 of CD44 antigen OS=Homo sapiens GN=CD44P19397CD53 CD53_HUMANLeukocyte surface antigen CD53{signal transduction,cell surface receptor signaling pathway,neutrophil degranulation,positive regulation of myoblast fusionimmunological synapse,plasma membrane,integral component of plasma membrane,cell-cell junction,cell surface,specific granule membrane,extracellular exosome,tertiary granule membraneV>sp|P19397|CD53_HUMAN Leukocyte surface antigen CD53 OS=Homo sapiens GN=CD53 PE=1 SV=1P20073;P20073-2ANXA7 ANXA7_HUMAN"Annexin A7;Isoform 2 of Annexin A78cellular calcium ion homeostasis,autophagy,hemostasis,cell proliferation,regulation of cell shape,response to salt stress,cellular water homeostasis,negative regulation of gene expression,response to organic cyclic compound,epithelial cell differentiation,social behavior,response to calcium ion,membrane fusion;RNA binding,integrin binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,calcium-dependent protein binding;nucleus,nuclear envelope,endoplasmic reticulum membrane,cytosol,plasma membrane,membrane,extracellular exosome,chromaffin granule membrane;>sp|P20073|ANXA7_HUMAN Annexin A7 OS=Homo sapiens GN=ANXA7 PE=1 SV=3;>sp|P20073-2|ANXA7_HUMAN Isoform 2 of Annexin A7 OS=Homo sapiens GN=ANXA7P23141;P23141-2;P23141-3CES1 EST1_HUMANdLiver carboxylesterase 1;Isoform 2 of Liver carboxylesterase 1;Isoform 3 of Liver carboxylesterase 1cholesterol biosynthetic process,xenobiotic metabolic process,metabolic process,response to toxic substance,epithelial cell differentiation,medium-chain fatty acid metabolic process,cholesterol ester hydrolysis involved in cholesterol transport;;nsterol esterase activity,methylumbelliferyl-acetate deacetylase activity,carboxylic ester hydrolase activity;;;endoplasmic reticulum,endoplasmic reticulum lumen,cytosol;;>sp|P23141|EST1_HUMAN Liver carboxylesterase 1 OS=Homo sapiens GN=CES1 PE=1 SV=2;>sp|P23141-2|EST1_HUMAN Isoform 2 of Liver carboxylesterase 1 OS=Homo sapiens GN=CES1;>sp|P23141-3|EST1_HUMAN Isoform 3 of Liver carboxylesterase 1 OS=Homo sapiens GN=CES1P28482;P28482-2MAPK1 MK01_HUMANRMitogen-activated protein kinase 1;Isoform 2 of Mitogen-activated protein kinase 1 MAPK cascade,activation of MAPK activity,MAPK import into nucleus,transcription, DNA-templated,protein phosphorylation,apoptotic process,chemotaxis,response to stress,cellular response to DNA damage stimulus,cell cycle,signal transduction,chemical synaptic transmission,axon guidance,learning or memory,positive regulation of cell proliferation,fibroblast growth factor receptor signaling pathway,response to toxic substance,regulation of gene expression,positive regulation of peptidyl-threonine phosphorylation,regulation of phosphatidylinositol 3-kinase signaling,viral process,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,sensory perception of pain,cytosine metabolic process,platelet activation,regulation of ossification,positive regulation of cell migration,thyroid gland development,regulation of protein stability,lipopolysaccharide-mediated signaling pathway,positive regulation of telomere maintenance via telomerase,regulation of stress-activated MAPK cascade,mammary gland epithelial cell proliferation,response to nicotine,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB signaling pathway,outer ear morphogenesis,neutrophil degranulation,response to exogenous dsRNA,response to estrogen,negative regulation of cell differentiation,positive regulation of translation,positive regulation of transcription, DNA-templated< ,thymus development,T cell receptor signaling pathway,B cell receptor signaling pathway,regulation of sequence-specific DNA binding transcription factor activity,regulation of cytoskeleton organization,positive regulation of telomerase activity,Bergmann glial cell differentiation,long-term synaptic potentiation,face development,JAK-STAT cascade involved in growth hormone signaling pathway,lung morphogenesis,trachea formation,labyrinthine layer blood vessel development,cardiac neural crest cell development involved in heart development,ERK1 and ERK2 cascade,response to epidermal growth factor,cellular response to organic substance,caveolin-mediated endocytosis,regulation of Golgi inheritance,cellular response to granulocyte macrophage colony-stimulating factor stimulus,regulation of cellular response to heat,positive regulation of telomere capping,regulation of early endosome to late endosome transport;Iphosphotyrosine binding,DNA binding,protein serine/threonine kinase activity,MAP kinase activity,protein binding,ATP binding,transcription factor binding,RNA polymerase II carboxy-terminal domain kinase activity,kinase activity,phosphatase binding,mitogen-activated protein kinase kinase kinase binding,identical protein binding;Sextracellular region,nucleus,nucleoplasm,cytoplasm,mitochondrion,early endosome,late endosome,Golgi apparatus,microtubule organizing center,cytosol,cytoskeleton,caveola,focal adhesion,axon,pseudopodium,dendrite cytoplasm,azurophil granule lumen,perikaryon,protein complex,extracellular exosome,mitotic spindle,ficolin-1-rich granule lumen;>sp|P28482|MK01_HUMAN Mitogen-activated protein kinase 1 OS=Homo sapiens GN=MAPK1 PE=1 SV=3;>sp|P28482-2|MK01_HUMAN Isoform 2 of Mitogen-activated protein kinase 1 OS=Homo sapiens GN=MAPK1P31323PRKAR2B KAP3_HUMAN=cAMP-dependent protein kinase type II-beta regulatory subunittG2/M transition of mitotic cell cycle,renal water homeostasis,fatty acid metabolic process,blood coagulation,learning,activation of protein kinase A activity,intracellular signal transduction,cellular response to glucagon stimulus,response to antipsychotic drug,response to clozapine,ciliary basal body docking,negative regulation of cAMP-dependent protein kinase activitycAMP-dependent protein kinase inhibitor activity,protein binding,cAMP-dependent protein kinase regulator activity,protein domain specific binding,cAMP binding,ubiquitin protein ligase binding,protein kinase A catalytic subunit bindingcytoplasm,mitochondrial inner membrane,centrosome,cytosol,plasma membrane,cAMP-dependent protein kinase complex,neuronal cell body,dendritic spine,dendritic shaft,membrane raft,perinuclear region of cytoplasm,extracellular exosome,ciliary basex>sp|P31323|KAP3_HUMAN cAMP-dependent protein kinase type II-beta regulatory subunit OS=Homo sapiens GN=PRKAR2B PE=1 SV=3P36959GMPR GMPR1_HUMANGMP reductase 1purine nucleobase metabolic process,nucleotide metabolic process,response to cold,purine-containing compound salvage,oxidation-reduction process(GMP reductase activity,metal ion bindingcytosol,GMP reductase complexH>sp|P36959|GMPR1_HUMAN GMP reductase 1 OS=Homo sapiens GN=GMPR PE=1 SV=1P47972NPTX2 NPTX2_HUMANNeuronal pentraxin-23chemical synaptic transmission,associative learning9molecular_function,carbohydrate binding,metal ion binding'cellular_component,extracellular regionN>sp|P47972|NPTX2_HUMAN Neuronal pentraxin-2 OS=Homo sapiens GN=NPTX2 PE=1 SV=2A0A0U1RQF0;P49327FASNA0A0U1RQF0_HUMAN;FAS_HUMANFatty acid synthaseN;osteoblast differentiation,acetyl-CoA metabolic process,fatty acid metabolic process,fatty acid biosynthetic process,pantothenate metabolic process,mammary gland development,positive regulation of cellular metabolic process,long-chain fatty-acyl-CoA biosynthetic process,oxidation-reduction process,cellular response to interleukin-4M;RNA binding,fatty acid synthase activity,[acyl-carrier-protein] S-acetyltransferase activity,[acyl-carrier-protein] S-malonyltransferase activity,3-oxoacyl-[acyl-carrier-protein] synthase activity,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,oleoyl-[acyl-carrier-protein] hydrolase activity,protein binding,drug binding,myristoyl-[acyl-carrier-protein] hydrolase activity,palmitoyl-[acyl-carrier-protein] hydrolase activity,phosphopantetheine binding,protein homodimerization activity,cadherin binding,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,NADPH binding,3-oxo-pimeloyl-[acp] methyl ester reductase activityq;mitochondrion,Golgi apparatus,cytosol,plasma membrane,membrane,melanosome,glycogen granule,extracellular exosome>tr|A0A0U1RQF0|A0A0U1RQF0_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=1;>sp|P49327|FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3P51149RAB7A RAB7A_HUMANRas-related protein Rab-7a7protein targeting to lysosome,endocytosis,epidermal growth factor catabolic process,small GTPase mediated signal transduction,endosome to lysosome transport,protein transport,viral release from host cell,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein to membrane docking,retrograde transport, endosome to Golgi,neutrophil degranulation,early endosome to late endosome transport,positive regulation of protein catabolic process,positive regulation of viral process,membrane organization,lipophagy,phagosome maturation,phagosome acidification,phagosome-lysosome fusion,multi-organism intracellular transport,negative regulation of exosomal secretion,positive regulation of exosomal secretion,negative regulation of intralumenal vesicle formation,regulation of autophagosome assemblyPGTPase activity,protein binding,GTP binding,GDP binding,retromer complex bindingtautophagosome membrane,lysosome,lysosomal membrane,late endosome,Golgi apparatus,lipid particle,cytosol,plasma membrane,endosome membrane,secretory granule membrane,phagocytic vesicle membrane,late endosome membrane,extrinsic component of lysosome membrane,melanosome membrane,pre-autophagosomal structure membrane,phagocytic vesicle,extracellular exosome,retromer complexT>sp|P51149|RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1P51452DUSP3 DUS3_HUMAN&Dual specificity protein phosphatase 3rinactivation of MAPK activity,in utero embryonic development,dephosphorylation,peptidyl-tyrosine dephosphorylation,negative regulation of MAPK cascade,positive regulation of mitotic cell cycle,negative regulation of JNK cascade,negative regulation of T cell receptor signaling pathway,negative regulation of T cell activation,negative regulation of ERK1 and ERK2 cascadeprotein tyrosine phosphatase activity,protein tyrosine/serine/threonine phosphatase activity,phosphatase activity,protein kinase binding,MAP kinase phosphatase activityGimmunological synapse,nucleus,nucleoplasm,cytosol,extracellular exosome_>sp|P51452|DUS3_HUMAN Dual specificity protein phosphatase 3 OS=Homo sapiens GN=DUSP3 PE=1 SV=1P61019RAB2A RAB2A_HUMANRas-related protein Rab-2AuGolgi organization,small GTPase mediated signal transduction,protein transport,ER to Golgi vesicle-mediated transportGolgi membrane,nucleus,lysosomal membrane,endoplasmic reticulum membrane,Golgi apparatus,cytosol,endoplasmic reticulum-Golgi intermediate compartment membrane,melanosome,extracellular exosomeT>sp|P61019|RAB2A_HUMAN Ras-related protein Rab-2A OS=Homo sapiens GN=RAB2A PE=1 SV=1P62820RAB1A RAB1A_HUMANRas-related protein Rab-1Aautophagosome assembly,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,endocytosis,autophagy,Golgi organization,small GTPase mediated signal transduction,vesicle-mediated transport,cell migration,virion assembly,growth hormone secretion,melanosome transport,substrate adhesion-dependent cell spreading,defense response to bacterium,vesicle transport along microtubule,COPII vesicle coating,membrane organ< ization,interleukin-8 secretion,cargo loading into COPII-coated vesicle,positive regulation of glycoprotein metabolic process,positive regulation of ubiquitin protein ligase activity,cilium morphogenesis,establishment of endothelial intestinal barrier<GTPase activity,protein binding,GTP binding,cadherin bindingGolgi membrane,early endosome,endoplasmic reticulum membrane,Golgi apparatus,cytosol,transport vesicle membrane,melanosome,extracellular exosomeT>sp|P62820|RAB1A_HUMAN Ras-related protein Rab-1A OS=Homo sapiens GN=RAB1A PE=1 SV=3Q04695KRT17 K1C17_HUMANKeratin, type I cytoskeletal 17signal transduction,epidermis development,positive regulation of cell growth,hair follicle morphogenesis,keratinization,intermediate filament organization,positive regulation of translation,positive regulation of hair follicle development,cornificationrstructural constituent of cytoskeleton,protein binding,MHC class II receptor activity,MHC class II protein bindingecytosol,intermediate filament,intermediate filament cytoskeleton,extracellular exosome,cell peripheryY>sp|Q04695|K1C17_HUMAN Keratin, type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2Q12841FSTL1 FSTL1_HUMANFollistatin-related protein 1,BMP signaling pathway,response to starvationW>sp|Q12841|FSTL1_HUMAN Follistatin-related protein 1 OS=Homo sapiens GN=FSTL1 PE=1 SV=1 F5GX14;Q14165MLECF5GX14_HUMAN;MLEC_HUMANMalectinH;carbohydrate metabolic process,protein folding,neutrophil degranulation$;enzyme binding,carbohydrate binding;endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,membrane,integral component of membrane,specific granule membrane>tr|F5GX14|F5GX14_HUMAN Malectin OS=Homo sapiens GN=MLEC PE=1 SV=1;>sp|Q14165|MLEC_HUMAN Malectin OS=Homo sapiens GN=MLEC PE=1 SV=1Q14392LRRC32 LRC32_HUMAN)Leucine-rich repeat-containing protein 32positive regulation of gene expression,negative regulation of activated T cell proliferation,negative regulation of cytokine secretion%integral component of plasma membraned>sp|Q14392|LRC32_HUMAN Leucine-rich repeat-containing protein 32 OS=Homo sapiens GN=LRRC32 PE=1 SV=1Q14432PDE3A PDE3A_HUMAN/cGMP-inhibited 3',5'-cyclic phosphodiesterase Aoocyte maturation,cAMP catabolic process,lipid metabolic process,diterpenoid metabolic process,cAMP-mediated signaling,cGMP-mediated signaling,regulation of meiotic nuclear division,response to drug,negative regulation of apoptotic process,negative regulation of vascular permeability,positive regulation of vascular permeability,response to cAMP,positive regulation of oocyte development,cellular response to cGMP,cellular response to transforming growth factor beta stimulus3',5'-cyclic-AMP phosphodiesterase activity,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,cAMP binding,metal ion binding,3',5'-cyclic-GMP phosphodiesterase activity&cytosol,integral component of membranei>sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase A OS=Homo sapiens GN=PDE3A PE=1 SV=3Q15113PCOLCE PCOC1_HUMAN&Procollagen C-endopeptidase enhancer 1Xproteolysis,multicellular organism development,positive regulation of peptidase activityMprotein binding,collagen binding,heparin binding,peptidase activator activity>extracellular space,extracellular exosome,extracellular matrixa>sp|Q15113|PCOC1_HUMAN Procollagen C-endopeptidase enhancer 1 OS=Homo sapiens GN=PCOLCE PE=1 SV=2Q5SQ64LY6G6F LY66F_HUMAN.Lymphocyte antigen 6 complex locus protein G6fplatelet degranulationNplasma membrane,integral component of membrane,platelet alpha granule membranei>sp|Q5SQ64|LY66F_HUMAN Lymphocyte antigen 6 complex locus protein G6f OS=Homo sapiens GN=LY6G6F PE=1 SV=2Q658P3;Q658P3-2;Q658P3-3STEAP3 STEA3_HUMANaMetalloreductase STEAP3;Isoform 2 of Metalloreductase STEAP3;Isoform 3 of Metalloreductase STEAP3apoptotic process,cell cycle,protein secretion,copper ion import,transferrin transport,regulation of apoptotic process,iron ion homeostasis,oxidation-reduction process,ferric iron import into cell;;protein binding,cupric reductase activity,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,metal ion binding,ferric-chelate reductase (NADPH) activity;;Wcytoplasm,multivesicular body,integral component of plasma membrane,endosome membrane;;>sp|Q658P3|STEA3_HUMAN Metalloreductase STEAP3 OS=Homo sapiens GN=STEAP3 PE=1 SV=2;>sp|Q658P3-2|STEA3_HUMAN Isoform 2 of Metalloreductase STEAP3 OS=Homo sapiens GN=STEAP3;>sp|Q658P3-3|STEA3_HUMAN Isoform 3 of Metalloreductase STEAP3 OS=Homo sapiens GN=STEAP3Q8IWL1;Q8IWL2;Q8IWL2-2SFTPA2;SFTPA1;SFTPA1#SFPA2_HUMAN;SFTA1_HUMAN;SFTA1_HUMANPulmonary surfactant-associated protein A2;Pulmonary surfactant-associated protein A1;Isoform 2 of Pulmonary surfactant-associated protein A1toll-like receptor signaling pathway,respiratory gaseous exchange,cellular protein metabolic process;toll-like receptor signaling pathway,lipid transport,respiratory gaseous exchange,opsonization,cellular protein metabolic process;Ucarbohydrate binding;lipid transporter activity,protein binding,carbohydrate binding;Vextracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,endoplasmic reticulum membrane,lamellar body,clathrin-coated endocytic vesicle;extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,endoplasmic reticulum membrane,lamellar body,clathrin-coated endocytic vesicle;6>sp|Q8IWL1|SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1;>sp|Q8IWL2|SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2;>sp|Q8IWL2-2|SFTA1_HUMAN Isoform 2 of Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1Q8WWZ8OIT3 OIT3_HUMAN(Oncoprotein-induced transcript 3 proteinurate homeostasisnuclear envelope`>sp|Q8WWZ8|OIT3_HUMAN Oncoprotein-induced transcript 3 protein OS=Homo sapiens GN=OIT3 PE=1 SV=2Q92743HTRA1 HTRA1_HUMANSerine protease HTRA1zregulation of cell growth,placenta development,proteolysis,extracellular matrix disassembly,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of BMP signaling pathway,positive regulation of epithelial cell proliferation,negative regulation of defense response to virus,chorionic trophoblast cell differentiation,dentinogenesisdserine-type endopeptidase activity,insulin-like growth factor binding,serine-type peptidase activitykextracellular region,extracellular space,cytosol,plasma membrane,extracellular matrix,extracellular exosomeO>sp|Q92743|HTRA1_HUMAN Serine protease HTRA1 OS=Homo sapiens GN=HTRA1 PE=1 SV=1Q96IY4CPB2 CBPB2_HUMANCarboxypeptidase B2Ipositive regulation of extracellular matrix constituent secretion,proteolysis,blood coagulation,response to heat,negative regulation of plasminogen activation,response to drug,fibrinolysis,negative regulation of fibrinolysis,cellular response to glucose stimulus,liver regeneration,negative regulation of hepatocyte proliferation.extracellular space,cell,extracellular exosomeL>sp|Q96IY4|CBPB2_HUMAN Carboxypeptidase B2 OS=Homo sapiens GN=CPB2 PE=1 SV=2C9J6D1;Q99733;Q99733-2NAP1L4$C9J6D1_HUMAN;NP1L4_HUMAN;NP1L4_HUMANNucleosome assembly protein 1-like 4 (Fragment);Nucleosome assembly protein 1-like 4;Isoform 2 of Nucleosome assembly protein 1-like 4;nucleosome assembly;6;RNA binding,protein binding,unfolded protein binding;;nucleus,cytoplasm;0>tr|C9J6D1|C9J6D1_HUMAN Nucleosome assembly protein 1-like 4 (Fragment) OS=Homo sapiens GN=NAP1L4 PE=1 SV=1;>sp|Q99733|NP1L4_HUMAN Nucleosome assembly protein 1-like 4 OS=Homo sapiens GN=NAP1L4 PE=1 SV=1;>sp|Q99733-2|NP1L4_HUMAN Isoform 2 of Nucleosome assembly protein 1-like 4 OS=Homo sapiens GN=NAP1L4Q9BYG0B3GNT5 B3GN5_HUMAN<Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase~protein glycosylation,central nervous system development,brain development,glycolipid biosynthetic process,O-glycan processingbeta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ce< ramide beta-1,3-acetylglucosaminyltransferase activity,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity;Golgi membrane,intracellular,integral component of membranew>sp|Q9BYG0|B3GN5_HUMAN Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase OS=Homo sapiens GN=B3GNT5 PE=1 SV=1Q9HBW9ADGRL4 AGRL4_HUMAN&Adhesion G protein-coupled receptor L4Tcell surface receptor signaling pathway,G-protein coupled receptor signaling pathwayUG-protein coupled receptor activity,calcium ion binding,protein dimerization activityBplasma membrane,integral component of membrane,cytoplasmic vesiclea>sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens GN=ADGRL4 PE=1 SV=3H7BXK9;Q9NP58;Q9NP58-4ABCB6$H7BXK9_HUMAN;ABCB6_HUMAN;ABCB6_HUMANATP-binding cassette sub-family B member 6, mitochondrial (Fragment);ATP-binding cassette sub-family B member 6, mitochondrial;Isoform 2 of ATP-binding cassette sub-family B member 6, mitochondrial;porphyrin-containing compound biosynthetic process,transport,cellular iron ion homeostasis,brain development,heme transport,skin development,transmembrane transport;;ATP binding,heme transporter activity,heme-transporting ATPase activity,efflux transmembrane transporter activity,heme binding;N;Golgi membrane,nucleoplasm,mitochondrion,mitochondrial envelope,mitochondrial outer membrane,endosome,endoplasmic reticulum,endoplasmic reticulum membrane,Golgi apparatus,cytosol,plasma membrane,endosome membrane,integral component of mitochondrial outer membrane,ATP-binding cassette (ABC) transporter complex,extracellular exosome;l>tr|H7BXK9|H7BXK9_HUMAN ATP-binding cassette sub-family B member 6, mitochondrial (Fragment) OS=Homo sapiens GN=ABCB6 PE=1 SV=1;>sp|Q9NP58|ABCB6_HUMAN ATP-binding cassette sub-family B member 6, mitochondrial OS=Homo sapiens GN=ABCB6 PE=1 SV=1;>sp|Q9NP58-4|ABCB6_HUMAN Isoform 2 of ATP-binding cassette sub-family B member 6, mitochondrial OS=Homo sapiens GN=ABCB6Q9NR31SAR1A SAR1A_HUMANGTP-binding protein SAR1a:intracellular protein transport,vesicle-mediated transport;endoplasmic reticulum,Golgi apparatus,extracellular exosomeS>sp|Q9NR31|SAR1A_HUMAN GTP-binding protein SAR1a OS=Homo sapiens GN=SAR1A PE=1 SV=1Q9UBQ7GRHPR GRHPR_HUMAN.Glyoxylate reductase/hydroxypyruvate reductaseexcretion,metabolic process,dicarboxylic acid metabolic process,glyoxylate metabolic process,protein oligomerization,oxidation-reduction processglycerate dehydrogenase activity,hydroxypyruvate reductase activity,glyoxylate reductase (NADP) activity,carboxylic acid binding,protein homodimerization activity,NAD binding,NADPH binding:cytoplasm,peroxisomal matrix,cytosol,extracellular exosomeh>sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens GN=GRHPR PE=1 SV=1Q9UEU0VTI1B VTI1B_HUMAN>Vesicle transport through interaction with t-SNAREs homolog 1Bplatelet degranulation,protein targeting to vacuole,ER to Golgi vesicle-mediated transport,intra-Golgi vesicle-mediated transport,Golgi to vacuole transport,vesicle docking involved in exocytosis,cell proliferation,vesicle-mediated transport,retrograde transport, endosome to Golgi,vesicle fusion with Golgi apparatus,membrane fusion,regulation of molecular function,regulation of protein localization to plasma membrane,autophagosome maturationXSNARE binding,SNAP receptor activity,protein binding,chloride channel inhibitor activityextracellular region,lysosomal membrane,endoplasmic reticulum membrane,Golgi apparatus,cytosol,synaptic vesicle,ER to Golgi transport vesicle membrane,integral component of membrane,platelet alpha granule lumen,SNARE complex,early endosome membrane,late endosome membrane,vesicle,neuronal cell body,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,recycling endosome,recycling endosome membranex>sp|Q9UEU0|VTI1B_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1B OS=Homo sapiens GN=VTI1B PE=1 SV=3Q9Y646CPQ CBPQ_HUMANCarboxypeptidase QTproteolysis,thyroid hormone generation,tissue regeneration,peptide catabolic processicarboxypeptidase activity,protein homodimerization activity,metal ion binding,metallodipeptidase activitybextracellular space,cytoplasm,lysosome,endoplasmic reticulum,Golgi apparatus,extracellular exosomeI>sp|Q9Y646|CBPQ_HUMAN Carboxypeptidase Q OS=Homo sapiens GN=CPQ PE=1 SV=1A0A024R6X1;O00748CES2A0A024R6X1_HUMAN;EST2_HUMAN+Carboxylic ester hydrolase;Cocaine esterase/;xenobiotic metabolic process,catabolic processT;methylumbelliferyl-acetate deacetylase activity,carboxylic ester hydrolase activity2;endoplasmic reticulum,endoplasmic reticulum lumen>tr|A0A024R6X1|A0A024R6X1_HUMAN Carboxylic ester hydrolase OS=Homo sapiens GN=CES2 PE=1 SV=1;>sp|O00748|EST2_HUMAN Cocaine esterase OS=Homo sapiens GN=CES2 PE=1 SV=1 A0A075B6J9IGLV2-18A0A075B6J9_HUMANHCG1782423 (Fragment)[>tr|A0A075B6J9|A0A075B6J9_HUMAN HCG1782423 (Fragment) OS=Homo sapiens GN=IGLV2-18 PE=1 SV=1A0A087X0K1;Q9Y376CAB39A0A087X0K1_HUMAN;CAB39_HUMANCalcium-binding protein 39p;cell cycle arrest,positive regulation of peptidyl-threonine phosphorylation,peptidyl-serine phosphorylation,signal transduction by protein phosphorylation,activation of protein kinase activity,intracellular signal transduction,neutrophil degranulation,protein heterooligomerization,cellular hypotonic response,positive regulation of protein serine/threonine kinase activity,negative regulation of potassium ion transmembrane transporter activity,negative regulation of potassium ion transmembrane transport,negative regulation of rubidium ion transport,negative regulation of rubidium ion transmembrane transporter activity;protein binding,kinase binding,protein kinase activator activity,protein serine/threonine kinase activator activity,protein serine/threonine kinase activity;extracellular region,cytosol,secretory granule lumen,protein complex,extracellular exosome,serine/threonine protein kinase complex,ficolin-1-rich granule lumen>tr|A0A087X0K1|A0A087X0K1_HUMAN Calcium-binding protein 39 OS=Homo sapiens GN=CAB39 PE=1 SV=1;>sp|Q9Y376|CAB39_HUMAN Calcium-binding protein 39 OS=Homo sapiens GN=CAB39 PE=1 SV=1A0A087X0R6;Q9UMY4;Q9UMY4-2SNX12(A0A087X0R6_HUMAN;SNX12_HUMAN;SNX12_HUMAN?Sorting nexin-12;Sorting nexin-12;Isoform 2 of Sorting nexin-12.;negative regulation of gene expression,negative regulation of protein processing,protein transport,vesicle organization,regulation of endocytosis,negative regulation of protein catabolic process,negative regulation of protein transport,negative regulation of early endosome to late endosome transport;=;protein binding,enzyme binding,phosphatidylinositol binding;F;early endosome,extrinsic component of membrane,extracellular exosome;1;3;>tr|A0A087X0R6|A0A087X0R6_HUMAN Sorting nexin-12 OS=Homo sapiens GN=SNX12 PE=1 SV=1;>sp|Q9UMY4|SNX12_HUMAN Sorting nexin-12 OS=Homo sapiens GN=SNX12 PE=1 SV=3;>sp|Q9UMY4-2|SNX12_HUMAN Isoform 2 of Sorting nexin-12 OS=Homo sapiens GN=SNX12A0A087X2B5;P35613;P35613-2BSG&A0A087X2B5_HUMAN;BASI_HUMAN;BASI_HUMAN/Basigin (Fragment);Basigin;Isoform 2 of Basiginp;pyruvate metabolic process,cell surface receptor signaling pathway,embryo implantation,monocarboxylic acid transport,extracellular matrix disassembly,extracellular matrix organization,odontogenesis of dentin-containing tooth,response to peptide hormone,response to mercury ion,decidualization,leukocyte migration,response to cAMP,protein targeting to plasma membrane;i;protein binding,mannose binding,monocarboxylic acid transmembrane transporter activity,cadherin binding;;Golgi membrane,acrosomal membrane,mitochondrion,plasma membrane,integral component of plasma membrane,focal adhesion,membrane,sarcolemma,melanosome,intracellular membrane-bounded organelle,membrane raft,extracellular exosome;>tr|A0A087X2B5|A0A087X2B5_HUMAN Basigin (Fragment) OS=Homo sapiens GN=BSG PE=1 SV=1;>sp|P35613|BASI_HUMAN Basigin OS=Homo sapiens GN=BSG PE=1 SV=2;>sp|P35613-2|BASI_HUMAN Isof< orm 2 of Basigin OS=Homo sapiens GN=BSG A0A0A0MRZ9IGLV5-52A0A0A0MRZ9_HUMANProtein IGLV5-52 (Fragment)a>tr|A0A0A0MRZ9|A0A0A0MRZ9_HUMAN Protein IGLV5-52 (Fragment) OS=Homo sapiens GN=IGLV5-52 PE=1 SV=1 A0A0C4DH30IGHV3-16A0A0C4DH30_HUMANProtein IGHV3-16 (Fragment)a>tr|A0A0C4DH30|A0A0C4DH30_HUMAN Protein IGHV3-16 (Fragment) OS=Homo sapiens GN=IGHV3-16 PE=4 SV=1 A0A0C4DH36IGHV3-38A0A0C4DH36_HUMANProtein IGHV3-38 (Fragment)a>tr|A0A0C4DH36|A0A0C4DH36_HUMAN Protein IGHV3-38 (Fragment) OS=Homo sapiens GN=IGHV3-38 PE=1 SV=1A0A140T958;P13761;Q9TQE0HLA-DRB1&A0A140T958_HUMAN;2B17_HUMAN;2B19_HUMANHLA class II histocompatibility antigen, DRB1-16 beta chain (Fragment);HLA class II histocompatibility antigen, DRB1-7 beta chain;HLA class II histocompatibility antigen, DRB1-9 beta chainz>tr|A0A140T958|A0A140T958_HUMAN HLA class II histocompatibility antigen, DRB1-16 beta chain (Fragment) OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1;>sp|P13761|2B17_HUMAN HLA class II histocompatibility antigen, DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1;>sp|Q9TQE0|2B19_HUMAN HLA class II histocompatibility antigen, DRB1-9 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1A8MVM1;C9JXR7;P42574CASP3%A8MVM1_HUMAN;C9JXR7_HUMAN;CASP3_HUMAN(Caspase-3;Caspase-3 (Fragment);Caspase-3;;response to hypoxia,B cell homeostasis,apoptotic DNA fragmentation,proteolysis,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to DNA damage stimulus,heart development,sensory perception of sound,learning or memory,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,response to UV,response to glucose,response to X-ray,regulation of macroautophagy,protein processing,hippocampus development,neuron differentiation,keratinocyte differentiation,erythrocyte differentiation,platelet formation,negative regulation of B cell proliferation,response to cobalt ion,response to estradiol,response to lipopolysaccharide,glial cell apoptotic process,response to tumor necrosis factor,response to nicotine,hippo signaling,wound healing,response to drug,response to hydrogen peroxide,T cell homeostasis,negative regulation of apoptotic process,response to amino acid,positive regulation of neuron apoptotic process,cell fate commitment,negative regulation of cyclin-dependent protein serine/threonine kinase activity,negative regulation of activated T cell proliferation,response to antibiotic,neurotrophin TRK receptor signaling pathway,response to glucocorticoid,neuron apoptotic process,cellular response to organic cyclic compound,apoptotic signaling pathway,extrinsic apoptotic signaling pathway in absence of ligand,execution phase of apoptosis;;protease binding,aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,cyclin-dependent protein serine/threonine kinase inhibitor activity,death receptor binding,protein binding,peptidase activity,cysteine-type endopeptidase activator activity involved in apoptotic process,phospholipase A2 activator activity,protein complex binding,cysteine-type endopeptidase activity involved in apoptotic process,cysteine-type endopeptidase activity involved in execution phase of apoptosis\;;nucleus,nucleoplasm,cytosol,plasma membrane,death-inducing signaling complex,membrane raft>tr|A8MVM1|A8MVM1_HUMAN Caspase-3 OS=Homo sapiens GN=CASP3 PE=1 SV=2;>tr|C9JXR7|C9JXR7_HUMAN Caspase-3 (Fragment) OS=Homo sapiens GN=CASP3 PE=1 SV=2;>sp|P42574|CASP3_HUMAN Caspase-3 OS=Homo sapiens GN=CASP3 PE=1 SV=2B7WPE2;G3V195;H7C355;Q32P44EML32B7WPE2_HUMAN;G3V195_HUMAN;H7C355_HUMAN;EMAL3_HUMANEchinoderm microtubule associated protein like 3, isoform CRA_e;Echinoderm microtubule associated protein like 3, isoform CRA_c;Echinoderm microtubule-associated protein-like 3 (Fragment);Echinoderm microtubule-associated protein-like 3;;;microtubule binding1;;;cytoplasm,microtubule,microtubule cytoskeleton>tr|B7WPE2|B7WPE2_HUMAN Echinoderm microtubule associated protein like 3, isoform CRA_e OS=Homo sapiens GN=EML3 PE=1 SV=1;>tr|G3V195|G3V195_HUMAN Echinoderm microtubule associated protein like 3, isoform CRA_c OS=Homo sapiens GN=EML3 PE=1 SV=1;>tr|H7C355|H7C355_HUMAN Echinoderm microtubule-associated protein-like 3 (Fragment) OS=Homo sapiens GN=EML3 PE=1 SV=1;>sp|Q32P44|EMAL3_HUMAN Echinoderm microtubule-associated protein-like 3 OS=Homo sapiens GN=EML3 PE=1 SV=1 H0YNE9;Q92930RAB8BH0YNE9_HUMAN;RAB8B_HUMAN@Ras-related protein Rab-8B (Fragment);Ras-related protein Rab-8B;vesicle docking involved in exocytosis,small GTPase mediated signal transduction,protein secretion,antigen processing and presentation,positive regulation of cell projection organization,adherens junction organization,protein import into peroxisome membrane,positive regulation of corticotropin secretion,membrane organization,protein localization to plasma membrane,cilium morphogenesis\;GTPase activity,receptor binding,protein binding,GTP binding,GDP binding,TPR domain binding;nucleoplasm,mitochondrion,endosome,peroxisomal membrane,plasma membrane,synaptic vesicle,nuclear body,phagocytic vesicle membrane,intracellular membrane-bounded organelle,phagocytic vesicle,perinuclear region of cytoplasm,cell tip,recycling endosome membrane,extracellular exosome>tr|H0YNE9|H0YNE9_HUMAN Ras-related protein Rab-8B (Fragment) OS=Homo sapiens GN=RAB8B PE=1 SV=1;>sp|Q92930|RAB8B_HUMAN Ras-related protein Rab-8B OS=Homo sapiens GN=RAB8B PE=1 SV=2(H3BPE1;H3BQK9;Q9UPN3-2;Q9UPN3-3;Q9UPN3-5MACF1=H3BPE1_HUMAN;H3BQK9_HUMAN;MACF1_HUMAN;MACF1_HUMAN;MACF1_HUMANMMicrotubule-actin cross-linking factor 1, isoforms 1/2/3/5;Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5;Isoform 2 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5;Isoform 3 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5;Isoform 4 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5Y>tr|H3BPE1|H3BPE1_HUMAN Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=1;>tr|H3BQK9|H3BQK9_HUMAN Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=1;>sp|Q9UPN3-2|MACF1_HUMAN Isoform 2 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1;>sp|Q9UPN3-3|MACF1_HUMAN Isoform 3 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1;>sp|Q9UPN3-5|MACF1_HUMAN Isoform 4 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 J3KN29;O00233PSMD9J3KN29_HUMAN;PSMD9_HUMAN.26S proteasome non-ATPase regulatory subunit 9h;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,positive regulation of insulin secretion,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of transcription, DNA-templated,negative regulation of insulin secretion,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,proteasome regulatory particle assembly,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayU;transcription coactivator activity,protein binding,bHLH transcription factor bindingu;nucleus,nucleoplasm,cytoplasm,cytosol,protea< some regulatory particle,proteasome regulatory particle, base subcomplex>tr|J3KN29|J3KN29_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens GN=PSMD9 PE=1 SV=1;>sp|O00233|PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens GN=PSMD9 PE=1 SV=3J3QR68 J3QR68_HUMANHaptoglobin (Fragment)N>tr|J3QR68|J3QR68_HUMAN Haptoglobin (Fragment) OS=Homo sapiens GN=HP PE=1 SV=1J3QRS3;O14950;P19105MYL12A;MYL12B;MYL12A$J3QRS3_HUMAN;ML12B_HUMAN;ML12A_HUMANeMyosin regulatory light chain 12A;Myosin regulatory light chain 12B;Myosin regulatory light chain 12Av;muscle contraction,regulation of cell shape;muscle contraction,ephrin receptor signaling pathway,platelet aggregationc;calcium ion binding,protein binding,myosin heavy chain binding;calcium ion binding,protein binding;stress fiber,cytosol,brush border,myosin II complex,Z disc,apical part of cell,extracellular exosome;cytosol,myosin complex,extracellular exosome1;2;2>tr|J3QRS3|J3QRS3_HUMAN Myosin regulatory light chain 12A OS=Homo sapiens GN=MYL12A PE=1 SV=1;>sp|O14950|ML12B_HUMAN Myosin regulatory light chain 12B OS=Homo sapiens GN=MYL12B PE=1 SV=2;>sp|P19105|ML12A_HUMAN Myosin regulatory light chain 12A OS=Homo sapiens GN=MYL12A PE=1 SV=2K7ER15;Q9H0R4;Q9H0R4-2HDHD2$K7ER15_HUMAN;HDHD2_HUMAN;HDHD2_HUMANHaloacid dehalogenase-like hydrolase domain-containing protein 2 (Fragment);Haloacid dehalogenase-like hydrolase domain-containing protein 2;Isoform 2 of Haloacid dehalogenase-like hydrolase domain-containing protein 2&;biological_process,dephosphorylation;G;protein binding,phosphatase activity,enzyme binding,metal ion binding;;extracellular exosome;>tr|K7ER15|K7ER15_HUMAN Haloacid dehalogenase-like hydrolase domain-containing protein 2 (Fragment) OS=Homo sapiens GN=HDHD2 PE=1 SV=1;>sp|Q9H0R4|HDHD2_HUMAN Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Homo sapiens GN=HDHD2 PE=1 SV=1;>sp|Q9H0R4-2|HDHD2_HUMAN Isoform 2 of Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Homo sapiens GN=HDHD2O00339MATN2 MATN2_HUMAN Matrilin-2tneuron migration,axon guidance,biological_process,glial cell migration,dendrite regeneration,response to axon injury6molecular_function,calcium ion binding,protein binding]proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular matrixD>sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4O60884DNAJA2 DNJA2_HUMAN!DnaJ homolog subfamily A member 2spositive regulation of cell proliferation,response to heat,positive regulation of ATPase activity,protein refoldingATPase activator activity,protein binding,ATP binding,heat shock protein binding,metal ion binding,unfolded protein binding,chaperone binding&cytosol,membrane,extracellular exosome\>sp|O60884|DNJA2_HUMAN DnaJ homolog subfamily A member 2 OS=Homo sapiens GN=DNAJA2 PE=1 SV=13O75369;O75369-2;O75369-3;O75369-6;O75369-8;O75369-9FLNB FLNB_HUMAN|Filamin-B;Isoform 2 of Filamin-B;Isoform 3 of Filamin-B;Isoform 6 of Filamin-B;Isoform 8 of Filamin-B;Isoform 9 of Filamin-Bkeratinocyte development,epithelial cell morphogenesis,cytoskeletal anchoring at plasma membrane,signal transduction,skeletal muscle tissue development,actin cytoskeleton organization;;;;;YRNA binding,actin binding,protein binding,identical protein binding,cadherin binding;;;;;stress fiber,cytoplasm,cytosol,plasma membrane,brush border,focal adhesion,cell cortex,actin cytoskeleton,integral component of membrane,Z disc,extracellular matrix,extracellular exosome;;;;;1;;;;;2;;;;;>sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2;>sp|O75369-2|FLNB_HUMAN Isoform 2 of Filamin-B OS=Homo sapiens GN=FLNB;>sp|O75369-3|FLNB_HUMAN Isoform 3 of Filamin-B OS=Homo sapiens GN=FLNB;>sp|O75369-6|FLNB_HUMAN Isoform 6 of Filamin-B OS=Homo sapiens GN=FLNB;>sp|O75369-8|FLNB_HUMAN Isoform 8 of Filamin-B OS=Homo sapiens GN=FLNB;>sp|O75369-9|FLNB_HUMAN Isoform 9 of Filamin-B OS=Homo sapiens GN=FLNBO75531BANF1 BAF_HUMAN!Barrier-to-autointegration factormitotic nuclear envelope disassembly,mitotic nuclear envelope reassembly,response to virus,DNA integration,nuclear transport,establishment of integrated proviral latencyDNA binding,protein binding,protein C-terminus binding,enzyme binding,protein homodimerization activity,protein N-terminus binding,LEM domain bindingPcondensed chromosome,nucleus,nucleoplasm,cytoplasm,cytosol,extracellular exosomeY>sp|O75531|BAF_HUMAN Barrier-to-autointegration factor OS=Homo sapiens GN=BANF1 PE=1 SV=1O75558STX11 STX11_HUMAN Syntaxin-11{intracellular protein transport,synaptic vesicle fusion to presynaptic active zone membrane,vesicle docking,membrane fusion4SNARE binding,SNAP receptor activity,protein binding]Golgi apparatus,plasma membrane,synaptic vesicle,integral component of membrane,SNARE complexE>sp|O75558|STX11_HUMAN Syntaxin-11 OS=Homo sapiens GN=STX11 PE=1 SV=1O95445-2Isoform 2 of Apolipoprotein MM>sp|O95445-2|APOM_HUMAN Isoform 2 of Apolipoprotein M OS=Homo sapiens GN=APOMP01876IGHA1 IGHA1_HUMANIg alpha-1 chain C regionretina homeostasis,glomerular filtration,receptor-mediated endocytosis,phagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation, classical pathway,protein-chromophore linkage,antibacterial humoral response,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migration,positive regulation of respiratory burstextracellular region,extracellular space,external side of plasma membrane,extracellular exosome,monomeric IgA immunoglobulin complex,secretory IgA immunoglobulin complex,secretory dimeric IgA immunoglobulin complex,blood microparticleS>sp|P01876|IGHA1_HUMAN Ig alpha-1 chain C region OS=Homo sapiens GN=IGHA1 PE=1 SV=2 P06703;R4GN98S100A6S10A6_HUMAN;R4GN98_HUMAN'Protein S100-A6;Protein S100 (Fragment)msignal transduction,axonogenesis,ion transmembrane transport,positive regulation of fibroblast proliferation;calcium ion binding,protein binding,tropomyosin binding,zinc ion binding,ion transmembrane transporter activity,protein homodimerization activity,S100 protein binding,calcium-dependent protein binding;ruffle,nucleus,nuclear envelope,cytoplasm,cytosol,extrinsic component of cytoplasmic side of plasma membrane,perinuclear region of cytoplasm,extracellular exosome;>sp|P06703|S10A6_HUMAN Protein S100-A6 OS=Homo sapiens GN=S100A6 PE=1 SV=1;>tr|R4GN98|R4GN98_HUMAN Protein S100 (Fragment) OS=Homo sapiens GN=S100A6 PE=1 SV=1P06756;P06756-2;P06756-3ITGAV ITAV_HUMANLIntegrin alpha-V;Isoform 2 of Integrin alpha-V;Isoform 3 of Integrin alpha-Vangiogenesis,vasculogenesis,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,cell adhesion,cell-matrix adhesion,positive regulation of cytosolic calcium ion concentration,integrin-mediated signaling pathway,positive regulation of cell proliferation,negative regulation of macrophage derived foam cell differentiation,negative regulation of lipid storage,cell growth,cell migration,extracellular matrix organization,positive regulation of cell migration,cell-substrate adhesion,negative regulation of lipid transport,cell adhesion mediated by integrin,positive regulation of osteoblast proliferation,heterotypic cell-cell adhesion,substrate adhesion-dependent cell spreading,endodermal cell differentiation,apolipoprotein A-I-mediated signaling pathway,apoptotic cell clearance,neutrophil degranulation,positive regulation of MAPK cascade,negative regulation of low-density lipoprotein particle receptor biosynthetic process,positive regulation of cell adhesion,viral entry into host cell,vascular endothelial growth factor receptor signaling pathway,negative regulation of lipoprotein metabolic process,regulation of phagocytosis,leukocyte migration,negative chemotaxis,entry of symbiont into host cell by promotion of host phagocytosis,ERK1 and ERK2 cascade,calcium ion transmembrane transport,extrinsic apoptotic signaling pathway in absence of ligand,regulation of apoptotic cell clea< rance,negative regulation of entry of bacterium into host cell,negative regulation of extrinsic apoptotic signaling pathway;;virus receptor activity,fibronectin binding,protease binding,receptor binding,voltage-gated calcium channel activity,protein binding,coreceptor activity,peptide binding,metal ion binding,transforming growth factor beta binding,extracellular matrix binding,extracellular matrix protein binding,opsonin binding,protein kinase C binding,fibroblast growth factor binding,C-X3-C chemokine binding,insulin-like growth factor I binding,neuregulin binding;;cytosol,plasma membrane,integral component of plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,membrane,lamellipodium membrane,filopodium membrane,microvillus membrane,ruffle membrane,integrin alphav-beta3 complex,integrin alphav-beta5 complex,integrin alphav-beta8 complex,specific granule membrane,alphav-beta3 integrin-IGF-1-IGF1R complex,phagocytic vesicle,extracellular exosome;;>sp|P06756|ITAV_HUMAN Integrin alpha-V OS=Homo sapiens GN=ITGAV PE=1 SV=2;>sp|P06756-2|ITAV_HUMAN Isoform 2 of Integrin alpha-V OS=Homo sapiens GN=ITGAV;>sp|P06756-3|ITAV_HUMAN Isoform 3 of Integrin alpha-V OS=Homo sapiens GN=ITGAVH0Y6Z7;P10586;P10586-2PTPRF$H0Y6Z7_HUMAN;PTPRF_HUMAN;PTPRF_HUMANReceptor-type tyrosine-protein phosphatase F (Fragment);Receptor-type tyrosine-protein phosphatase F;Isoform 2 of Receptor-type tyrosine-protein phosphatase F;cell adhesion,transmembrane receptor protein tyrosine phosphatase signaling pathway,cell migration,neuron projection regeneration,peptidyl-tyrosine dephosphorylation,regulation of axon regeneration,negative regulation of receptor binding;;protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,heparin binding,protein complex binding,chondroitin sulfate proteoglycan binding;r;plasma membrane,integral component of plasma membrane,neuron projection,neuronal cell body,extracellular exosome;E>tr|H0Y6Z7|H0Y6Z7_HUMAN Receptor-type tyrosine-protein phosphatase F (Fragment) OS=Homo sapiens GN=PTPRF PE=1 SV=1;>sp|P10586|PTPRF_HUMAN Receptor-type tyrosine-protein phosphatase F OS=Homo sapiens GN=PTPRF PE=1 SV=2;>sp|P10586-2|PTPRF_HUMAN Isoform 2 of Receptor-type tyrosine-protein phosphatase F OS=Homo sapiens GN=PTPRFP12955;P12955-2;P12955-3PEPD PEPD_HUMANUXaa-Pro dipeptidase;Isoform 2 of Xaa-Pro dipeptidase;Isoform 3 of Xaa-Pro dipeptidaseNproteolysis,cellular amino acid metabolic process,collagen catabolic process;;}aminopeptidase activity,metallocarboxypeptidase activity,protein binding,manganese ion binding,proline dipeptidase activity;;extracellular exosome;;>sp|P12955|PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3;>sp|P12955-2|PEPD_HUMAN Isoform 2 of Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD;>sp|P12955-3|PEPD_HUMAN Isoform 3 of Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPDP15529;P15529-10;P15529-11;P15529-12;P15529-13;P15529-14;P15529-15;P15529-16;P15529-2;P15529-3;P15529-4;P15529-5;P15529-6;P15529-7;P15529-8;P15529-9CD46 MCP_HUMANbMembrane cofactor protein;Isoform 2 of Membrane cofactor protein;Isoform C of Membrane cofactor protein;Isoform E of Membrane cofactor protein;Isoform G of Membrane cofactor protein;Isoform I of Membrane cofactor protein;Isoform K of Membrane cofactor protein;Isoform 3 of Membrane cofactor protein;Isoform B of Membrane cofactor protein;Isoform D of Membrane cofactor protein;Isoform F of Membrane cofactor protein;Isoform H of Membrane cofactor protein;Isoform J of Membrane cofactor protein;Isoform L of Membrane cofactor protein;Isoform M of Membrane cofactor protein;Isoform N of Membrane cofactor proteinadaptive immune response,T cell mediated immunity,proteolysis,complement activation, classical pathway,single fertilization,regulation of Notch signaling pathway,positive regulation of gene expression,negative regulation of gene expression,regulation of complement activation,interleukin-10 production,positive regulation of interleukin-10 production,sequestering of extracellular ligand from receptor,positive regulation of T cell proliferation,negative regulation of catalytic activity,positive regulation of memory T cell differentiation,innate immune response,positive regulation of regulatory T cell differentiation,negative regulation of complement activation,viral entry into host cell,positive regulation of transforming growth factor beta production;;;;;;;;;;;;;;;virus receptor activity,complement binding,endopeptidase activity,enzyme inhibitor activity,receptor activity,protein binding,cadherin binding;;;;;;;;;;;;;;;inner acrosomal membrane,Golgi apparatus,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,basolateral plasma membrane,extracellular exosome;;;;;;;;;;;;;;;1;;;;;;;;;;;;;;;3;;;;;;;;;;;;;;;a>sp|P15529|MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3;>sp|P15529-10|MCP_HUMAN Isoform 2 of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-11|MCP_HUMAN Isoform C of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-12|MCP_HUMAN Isoform E of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-13|MCP_HUMAN Isoform G of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-14|MCP_HUMAN Isoform I of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-15|MCP_HUMAN Isoform K of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-16|MCP_HUMAN Isoform 3 of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-2|MCP_HUMAN Isoform B of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-3|MCP_HUMAN Isoform D of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-4|MCP_HUMAN Isoform F of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-5|MCP_HUMAN Isoform H of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-6|MCP_HUMAN Isoform J of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-7|MCP_HUMAN Isoform L of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-8|MCP_HUMAN Isoform M of Membrane cofactor protein OS=Homo sapiens GN=CD46;>sp|P15529-9|MCP_HUMAN Isoform N of Membrane cofactor protein OS=Homo sapiens GN=CD46P19086GNAZ GNAZ_HUMAN5Guanine nucleotide-binding protein G(z) subunit alphaprotein folding,G-protein coupled receptor signaling pathway,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathwayG-protein coupled receptor binding,GTPase activity,receptor signaling protein activity,GTP binding,G-protein beta/gamma-subunit complex binding,G-protein coupled serotonin receptor binding,metal ion bindingnuclear envelope,endoplasmic reticulum,cytosol,heterotrimeric G-protein complex,plasma membrane,dendrite,cell body,extracellular exosomem>sp|P19086|GNAZ_HUMAN Guanine nucleotide-binding protein G(z) subunit alpha OS=Homo sapiens GN=GNAZ PE=2 SV=3P19440GGT1 GGT1_HUMANGamma-glutamyltranspeptidase 1regulation of immune system process,cellular amino acid metabolic process,glutamate metabolic process,leukotriene metabolic process,glutathione metabolic process,glutathione biosynthetic process,glutathione catabolic process,xenobiotic metabolic process,spermatogenesis,cysteine biosynthetic process,leukotriene biosynthetic process,zymogen activation,regulation of inflammatory responseQgamma-glutamyltransferase activity,protein binding,glutathione hydrolase activityextracellular space,plasma membrane,integral component of membrane,anchored component of external side of plasma membrane,extracellular exosomeV>sp|P19440|GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2P24844MYL9 MYL9_HUMAN%Myosin regulatory light polypeptide 9Hmuscle contraction,regulation of muscle contraction,platelet aggregationOcalcium ion binding,structural constituent of muscle,myosin heavy chain binding1stress fiber,cytosol,muscle myosin complex,Z disc]>sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens GN=MYL9 PE=1 SV=4P30153PPP2R1A 2AAA_HUMAN< QSerine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoformG2/M transition of mitotic cell cycle,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,inactivation of MAPK activity,regulation of DNA replication,regulation of transcription, DNA-templated,protein complex assembly,protein dephosphorylation,ceramide metabolic process,apoptotic process,chromosome segregation,mitotic nuclear envelope reassembly,female meiotic division,RNA splicing,response to organic substance,second-messenger-mediated signaling,regulation of Wnt signaling pathway,regulation of cell adhesion,negative regulation of cell growth,regulation of growth,negative regulation of tyrosine phosphorylation of Stat3 protein,regulation of cell differentiation,meiotic spindle elongation,mitotic sister chromatid separation,meiotic sister chromatid cohesion, centromeric,peptidyl-serine dephosphorylation,ciliary basal body docking,regulation of meiotic cell cycle process involved in oocyte maturation,positive regulation of extrinsic apoptotic signaling pathway in absence of ligandantigen binding,protein serine/threonine phosphatase activity,protein binding,protein phosphatase regulator activity,protein heterodimerization activityprotein phosphatase type 2A complex,chromosome, centromeric region,nucleus,mitochondrion,cytosol,microtubule cytoskeleton,membrane,extracellular exosome>sp|P30153|2AAA_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform OS=Homo sapiens GN=PPP2R1A PE=1 SV=4P30273FCER1G FCERG_HUMAN;High affinity immunoglobulin epsilon receptor subunit gammaxpositive regulation of type IIa hypersensitivity,positive regulation of type III hypersensitivity,positive regulation of type I hypersensitivity,stimulatory C-type lectin receptor signaling pathway,neutrophil activation involved in immune response,T cell differentiation involved in immune response,Fc receptor mediated stimulatory signaling pathway,serotonin secretion by platelet,phagocytosis, engulfment,integrin-mediated signaling pathway,blood coagulation,regulation of platelet activation,immunoglobulin mediated immune response,antigen processing and presentation of exogenous peptide antigen via MHC class II,platelet activation,neutrophil chemotaxis,receptor internalization,positive regulation of interleukin-10 production,positive regulation of interleukin-6 production,positive regulation of tumor necrosis factor production,positive regulation of mast cell cytokine production,negative regulation of mast cell apoptotic process,Fc-gamma receptor signaling pathway,Fc-epsilon receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I,defense response to bacterium,positive regulation of mast cell degranulation,neutrophil degranulation,innate immune response,mast cell activation,positive regulation of phagocytosis,leukocyte migration,cellular response to low-density lipoprotein particle stimulus,protein localization to plasma membrane=protein binding,IgE receptor activity,IgE binding,IgG bindingplasma membrane,integral component of plasma membrane,external side of plasma membrane,cell surface,Fc-epsilon receptor I complex,tertiary granule membrane,ficolin-1-rich granule membranev>sp|P30273|FCERG_HUMAN High affinity immunoglobulin epsilon receptor subunit gamma OS=Homo sapiens GN=FCER1G PE=1 SV=1P30481 1B44_HUMAN8HLA class I histocompatibility antigen, B-44 alpha chainq>sp|P30481|1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1P31944CASP14 CASPE_HUMAN Caspase-14[proteolysis,epidermis development,keratinization,cornification,execution phase of apoptosisendopeptidase activity,cysteine-type endopeptidase activity,protein binding,cysteine-type endopeptidase activity involved in execution phase of apoptosisUnucleus,cytoplasm,cytosol,extracellular matrix,keratin filament,extracellular exosomeE>sp|P31944|CASPE_HUMAN Caspase-14 OS=Homo sapiens GN=CASP14 PE=1 SV=2P35247SFTPD SFTPD_HUMAN)Pulmonary surfactant-associated protein Dregulation of cytokine production,toll-like receptor signaling pathway,receptor-mediated endocytosis,respiratory gaseous exchange,negative regulation of T cell proliferation,defense response to bacterium,surfactant homeostasis,cellular protein metabolic process,negative regulation of interleukin-2 biosynthetic process,innate immune response,macrophage chemotaxis,lung alveolus development,positive regulation of phagocytosis,regulation of immune response,reactive oxygen species metabolic processextracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,lysosome,endoplasmic reticulum membrane,endocytic vesicle,lamellar body,clathrin-coated endocytic vesiclec>sp|P35247|SFTPD_HUMAN Pulmonary surfactant-associated protein D OS=Homo sapiens GN=SFTPD PE=1 SV=3P40925;P40925-2;P40925-3MDH1 MDHC_HUMANMalate dehydrogenase, cytoplasmic;Isoform 2 of Malate dehydrogenase, cytoplasmic;Isoform 3 of Malate dehydrogenase, cytoplasmicygluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,NADH metabolic process;;{malic enzyme activity,protein binding,L-malate dehydrogenase activity,diiodophenylpyruvate reductase activity,NAD binding;;Oextracellular space,mitochondrion,cytosol,myelin sheath,extracellular exosome;;>sp|P40925|MDHC_HUMAN Malate dehydrogenase, cytoplasmic OS=Homo sapiens GN=MDH1 PE=1 SV=4;>sp|P40925-2|MDHC_HUMAN Isoform 2 of Malate dehydrogenase, cytoplasmic OS=Homo sapiens GN=MDH1;>sp|P40925-3|MDHC_HUMAN Isoform 3 of Malate dehydrogenase, cytoplasmic OS=Homo sapiens GN=MDH1 P50502;Q3KNR6ST13F10A1_HUMAN;Q3KNR6_HUMANHsc70-interacting proteinprotein folding,protein homooligomerization,negative regulation of protein refolding,chaperone cofactor-dependent protein refolding;protein binding,protein domain specific binding,Hsp70 protein binding,protein binding, bridging,protein complex binding,dATP binding,identical protein binding,unfolded protein binding,chaperone binding;8cytoplasm,cytosol,protein complex,extracellular exosome;>sp|P50502|F10A1_HUMAN Hsc70-interacting protein OS=Homo sapiens GN=ST13 PE=1 SV=2;>tr|Q3KNR6|Q3KNR6_HUMAN Hsc70-interacting protein OS=Homo sapiens GN=ST13 PE=1 SV=1P51809;P51809-3VAMP7 VAMP7_HUMANXVesicle-associated membrane protein 7;Isoform 3 of Vesicle-associated membrane protein 7ER to Golgi vesicle-mediated transport,post-Golgi vesicle-mediated transport,endocytosis,vesicle fusion,phagocytosis, engulfment,endosome to lysosome transport,vesicle-mediated transport,calcium ion regulated exocytosis,triglyceride transport,SNARE complex assembly,Golgi to plasma membrane protein transport,eosinophil degranulation,neutrophil degranulation,natural killer cell degranulation,vesicle transport along microtubule,vesicle fusion with Golgi apparatus,positive regulation of dendrite morphogenesis,membrane organization,regulation of protein targeting to vacuolar membrane,positive regulation of histamine secretion by mast cell,autophagosome maturation;FSNARE binding,SNAP receptor activity,protein binding,syntaxin binding;(cytoplasm,lysosomal membrane,endoplasmic reticulum membrane,trans-Golgi network,plasma membrane,cell surface,membrane,lamellipodium,cell junction,secretory granule,integral component of synaptic vesicle membrane,clathrin-coated vesicle membrane,secretory granule membrane,phagocytic vesicle membrane,platelet alpha granule,pseudopodium,SNARE complex,late endosome membrane,azurophil granule membrane,neuron projection,intracellular membrane-bounded organelle,apical part of cell,phagocytic vesicle,perinuclear region of cytoplasm,extracellular exosome;>sp|P51809|VAMP7_HUMAN Vesicle-associated membrane protein 7 OS=Homo sapiens GN=VAMP7 PE=1 SV=3;>sp|P51809-3|VAMP7_HUMAN Isoform 3 of Vesicle-associated membrane protein 7 OS=Homo sapiens GN=VAMP7P61163ACTR1A ACTZ_HUMANAlpha-centractinG2/M transition of mitotic cell cycle,spermatogenesis,vesicle-mediated transport,antigen processing and presentation of exogenous peptide antigen via MHC < class II,ciliary basal body docking ATP bindingmanchette,cytoplasm,centrosome,centriole,cytosol,dynactin complex,microtubule associated complex,microtubule cytoskeleton,COPI-coated vesicle,myelin sheath,extracellular exosomeJ>sp|P61163|ACTZ_HUMAN Alpha-centractin OS=Homo sapiens GN=ACTR1A PE=1 SV=1 P63167;Q96FJ2 DYNLL1;DYNLL2DYL1_HUMAN;DYL2_HUMANCDynein light chain 1, cytoplasmic;Dynein light chain 2, cytoplasmicG2/M transition of mitotic cell cycle,transcription, DNA-templated,regulation of transcription, DNA-templated,ER to Golgi vesicle-mediated transport,apoptotic process,viral process,macroautophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,substantia nigra development,intraciliary retrograde transport,intraciliary transport involved in cilium morphogenesis,negative regulation of phosphorylation,neutrophil degranulation,motile cilium assembly,ciliary basal body docking,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,positive regulation of nonmotile primary cilium assembly;ER to Golgi vesicle-mediated transport,synaptic target recognition,macroautophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,intraciliary transport involved in cilium morphogenesis,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathwaymotor activity,protein binding,protein C-terminus binding,protein domain specific binding,dynein intermediate chain binding;motor activity,protein binding,cytoskeletal protein bindingkinetochore,nucleus,cytoplasm,mitochondrion,centrosome,cytosol,cytoplasmic dynein complex,microtubule,plasma membrane,cilium,membrane,extracellular exosome,tertiary granule membrane,mitotic spindle,ciliary tip,ficolin-1-rich granule membrane,COP9 signalosome;nucleus,mitochondrion,centrosome,cytosol,cytoplasmic dynein complex,microtubule,plasma membrane,cilium,membrane,myosin complex,ciliary tip>sp|P63167|DYL1_HUMAN Dynein light chain 1, cytoplasmic OS=Homo sapiens GN=DYNLL1 PE=1 SV=1;>sp|Q96FJ2|DYL2_HUMAN Dynein light chain 2, cytoplasmic OS=Homo sapiens GN=DYNLL2 PE=1 SV=1!Q08722;Q08722-2;Q08722-3;Q08722-4CD47 CD47_HUMANLeukocyte surface antigen CD47;Isoform OA3-293 of Leukocyte surface antigen CD47;Isoform OA3-305 of Leukocyte surface antigen CD47;Isoform OA3-312 of Leukocyte surface antigen CD47tcell adhesion,integrin-mediated signaling pathway,opsonization,positive regulation of cell proliferation,response to bacterium,positive regulation of cell-cell adhesion,extracellular matrix organization,neutrophil degranulation,positive regulation of inflammatory response,positive regulation of phagocytosis,positive regulation of T cell activation,leukocyte migration;;;3protein binding,thrombospondin receptor activity;;;plasma membrane,integral component of plasma membrane,specific granule membrane,extracellular exosome,tertiary granule membrane;;;|>sp|Q08722|CD47_HUMAN Leukocyte surface antigen CD47 OS=Homo sapiens GN=CD47 PE=1 SV=1;>sp|Q08722-2|CD47_HUMAN Isoform OA3-293 of Leukocyte surface antigen CD47 OS=Homo sapiens GN=CD47;>sp|Q08722-3|CD47_HUMAN Isoform OA3-305 of Leukocyte surface antigen CD47 OS=Homo sapiens GN=CD47;>sp|Q08722-4|CD47_HUMAN Isoform OA3-312 of Leukocyte surface antigen CD47 OS=Homo sapiens GN=CD47Q10567;Q10567-2;Q10567-3AP1B1 AP1B1_HUMANmAP-1 complex subunit beta-1;Isoform B of AP-1 complex subunit beta-1;Isoform C of AP-1 complex subunit beta-1intracellular protein transport,determination of left/right symmetry,heart development,vesicle-mediated transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,regulation of defense response to virus by virus;;Ztransporter activity,protein binding,protein transporter activity,protein kinase binding;;Golgi membrane,lysosomal membrane,Golgi apparatus,cytosol,clathrin adaptor complex,cytoplasmic vesicle membrane,clathrin-coated endocytic vesicle membrane,trans-Golgi network membrane,intracellular membrane-bounded organelle;; >sp|Q10567|AP1B1_HUMAN AP-1 complex subunit beta-1 OS=Homo sapiens GN=AP1B1 PE=1 SV=2;>sp|Q10567-2|AP1B1_HUMAN Isoform B of AP-1 complex subunit beta-1 OS=Homo sapiens GN=AP1B1;>sp|Q10567-3|AP1B1_HUMAN Isoform C of AP-1 complex subunit beta-1 OS=Homo sapiens GN=AP1B15A0A0U1RQV3;Q12805;Q12805-2;Q12805-3;Q12805-4;Q12805-5EFEMP1LA0A0U1RQV3_HUMAN;FBLN3_HUMAN;FBLN3_HUMAN;FBLN3_HUMAN;FBLN3_HUMAN;FBLN3_HUMANEGF-containing fibulin-like extracellular matrix protein 1 (Fragment);EGF-containing fibulin-like extracellular matrix protein 1;Isoform 2 of EGF-containing fibulin-like extracellular matrix protein 1;Isoform 3 of EGF-containing fibulin-like extracellular matrix protein 1;Isoform 4 of EGF-containing fibulin-like extracellular matrix protein 1;Isoform 5 of EGF-containing fibulin-like extracellular matrix protein 1";regulation of transcription, DNA-templated,epidermal growth factor receptor signaling pathway,visual perception,peptidyl-tyrosine phosphorylation,negative regulation of chondrocyte differentiation,camera-type eye development,embryonic eye morphogenesis,post-embryonic eye morphogenesis;;;;;epidermal growth factor-activated receptor activity,epidermal growth factor receptor binding,calcium ion binding,protein binding,growth factor activity;;;;{;extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome,extracellular matrix;;;;>tr|A0A0U1RQV3|A0A0U1RQV3_HUMAN EGF-containing fibulin-like extracellular matrix protein 1 (Fragment) OS=Homo sapiens GN=EFEMP1 PE=1 SV=1;>sp|Q12805|FBLN3_HUMAN EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1 PE=1 SV=2;>sp|Q12805-2|FBLN3_HUMAN Isoform 2 of EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1;>sp|Q12805-3|FBLN3_HUMAN Isoform 3 of EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1;>sp|Q12805-4|FBLN3_HUMAN Isoform 4 of EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1;>sp|Q12805-5|FBLN3_HUMAN Isoform 5 of EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1Q13790APOF APOF_HUMANApolipoprotein FElipid metabolic process,lipid transport,cholesterol metabolic process?receptor binding,lipid transporter activity,cholesterol bindingWextracellular region,low-density lipoprotein particle,high-density lipoprotein particleH>sp|Q13790|APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=2Q15063-2Isoform 2 of PeriostinH>sp|Q15063-2|POSTN_HUMAN Isoform 2 of Periostin OS=Homo sapiens GN=POSTN*Q15084;Q15084-2;Q15084-3;Q15084-4;Q15084-5PDIA6 PDIA6_HUMANProtein disulfide-isomerase A6;Isoform 2 of Protein disulfide-isomerase A6;Isoform 3 of Protein disulfide-isomerase A6;Isoform 4 of Protein disulfide-isomerase A6;Isoform 5 of Protein disulfide-isomerase A6protein folding,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,apoptotic cell clearance,cell redox homeostasis;;;;8protein disulfide isomerase activity,protein binding;;;;endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,cytosol,plasma membrane,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome;;;;>sp|Q15084|PDIA6_HUMAN Protein disulfide-isomerase A6 OS=Homo sapiens GN=PDIA6 PE=1 SV=1;>sp|Q15084-2|PDIA6_HUMAN Isoform 2 of Protein disulfide-isomerase A6 OS=Homo sapiens GN=PDIA6;>sp|Q15084-3|PDIA6_HUMAN Isoform 3 of Protein disulfide-isomerase A6 OS=Homo sapiens GN=PDIA6;>sp|Q15084-4|PDIA6_HUMAN Isoform 4 of Protein disulfide-isomerase A6 OS=Homo sapiens GN=PDIA6;>sp|Q15084-5|PDIA6_HUMAN Isoform 5 of Protein disulfide-isomerase A6 OS=Homo sapiens GN=PDIA6Q15907RAB11B RB11B_HUMANRas-related protein Rab-11Breceptor recycling,small GTPase mediated signal transduction,melanosome transport,transferrin transport,insulin secretion involved in cellular response to glucose stimulus,regulation of anion transport,constitutive se< cretory pathway,regulated exocytosis,membrane organization,cellular response to acidic pH,establishment of protein localization to membrane,retrograde transport, endosome to plasma membrane,regulation of protein localization to cell surface,regulation of endocytic recyclingYGTPase activity,protein binding,GTP binding,GDP binding,myosin V binding,cadherin bindingmitochondrion,cytosol,synaptic vesicle,cell junction,phagocytic vesicle membrane,phagocytic vesicle,recycling endosome,recycling endosome membrane,extracellular exosome,anchored component of synaptic vesicle membraneV>sp|Q15907|RB11B_HUMAN Ras-related protein Rab-11B OS=Homo sapiens GN=RAB11B PE=1 SV=4Q2UY09COL28A1 COSA1_HUMANCollagen alpha-1(XXVIII) chain;cell adhesion,negative regulation of endopeptidase activityRextracellular region,collagen trimer,basement membrane,endoplasmic reticulum lumenZ>sp|Q2UY09|COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2Q6UVK1CSPG4 CSPG4_HUMAN"Chondroitin sulfate proteoglycan 4activation of MAPK activity,angiogenesis,transmembrane receptor protein tyrosine kinase signaling pathway,cell proliferation,glial cell migration,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,intracellular signal transduction,tissue remodeling,positive regulation of peptidyl-tyrosine phosphorylation1signal transducer activity,protein kinase bindingextracellular region,Golgi lumen,integral component of plasma membrane,focal adhesion,cell surface,apical plasma membrane,lamellipodium membrane,lysosomal lumen,extracellular exosome\>sp|Q6UVK1|CSPG4_HUMAN Chondroitin sulfate proteoglycan 4 OS=Homo sapiens GN=CSPG4 PE=1 SV=2Q8N1N4KRT78 K2C78_HUMAN Keratin, type II cytoskeletal 78Bextracellular space,cytosol,keratin filament,extracellular exosomeZ>sp|Q8N1N4|K2C78_HUMAN Keratin, type II cytoskeletal 78 OS=Homo sapiens GN=KRT78 PE=2 SV=2 E5RJH0;Q93088BHMTE5RJH0_HUMAN;BHMT1_HUMAN+Betaine--homocysteine S-methyltransferase 1;sulfur amino acid metabolic process,protein methylation,amino-acid betaine metabolic process,amino-acid betaine catabolic process,choline catabolic process,regulation of homocysteine metabolic process,L-methionine salvage,S-adenosylmethionine metabolic processC;zinc ion binding,betaine-homocysteine S-methyltransferase activity;cytosol,extracellular exosome>tr|E5RJH0|E5RJH0_HUMAN Betaine--homocysteine S-methyltransferase 1 OS=Homo sapiens GN=BHMT PE=1 SV=1;>sp|Q93088|BHMT1_HUMAN Betaine--homocysteine S-methyltransferase 1 OS=Homo sapiens GN=BHMT PE=1 SV=2Q96AP7ESAM ESAM_HUMAN,Endothelial cell-selective adhesion moleculexhomophilic cell adhesion via plasma membrane adhesion molecules,single organismal cell-cell adhesion,leukocyte migrationpplasma membrane,adherens junction,bicellular tight junction,integral component of membrane,extracellular exosomed>sp|Q96AP7|ESAM_HUMAN Endothelial cell-selective adhesion molecule OS=Homo sapiens GN=ESAM PE=1 SV=1Q96FZ7CHMP6 CHMP6_HUMAN%Charged multivesicular body protein 61cell separation after cytokinesis,nucleus organization,vacuolar transport,mitotic metaphase plate congression,protein transport,endosomal transport,macroautophagy,viral life cycle,multivesicular body assembly,viral budding via host ESCRT complex,ESCRT III complex assembly,regulation of exosomal secretion*protein binding,protein N-terminus bindingaESCRT III complex,cytosol,endosome membrane,membrane,late endosome membrane,extracellular exosome_>sp|Q96FZ7|CHMP6_HUMAN Charged multivesicular body protein 6 OS=Homo sapiens GN=CHMP6 PE=1 SV=3Q99436PSMB7 PSB7_HUMANProteasome subunit beta type-7MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of protein targeting to mitochondrionW>sp|Q99436|PSB7_HUMAN Proteasome subunit beta type-7 OS=Homo sapiens GN=PSMB7 PE=1 SV=1Q9H3U1-2UNC45A UN45A_HUMAN%Isoform 2 of Protein unc-45 homolog AX>sp|Q9H3U1-2|UN45A_HUMAN Isoform 2 of Protein unc-45 homolog A OS=Homo sapiens GN=UNC45AQ9H6X2;Q9H6X2-5ANTXR1 ANTR1_HUMAN>Anthrax toxin receptor 1;Isoform 5 of Anthrax toxin receptor 1blood vessel development,signal transduction,reproductive process,actin cytoskeleton reorganization,substrate adhesion-dependent cell spreading,negative regulation of extracellular matrix assembly,positive regulation of metallopeptidase activity;ttransmembrane signaling receptor activity,protein binding,collagen binding,metal ion binding,actin filament binding;plasma membrane,external side of plasma membrane,cell surface,endosome membrane,integral component of membrane,lamellipodium membrane,filopodium membrane,extracellular exosome;>sp|Q9H6X2|ANTR1_HUMAN Anthrax toxin receptor 1 OS=Homo sapiens GN=ANTXR1 PE=1 SV=2;>sp|Q9H6X2-5|ANTR1_HUMAN Isoform 5 of Anthrax toxin receptor 1 OS=Homo sapiens GN=ANTXR1Q9H7M9C10orf54 VISTA_HUMANGV-type immunoglobulin domain-containing suppressor of T-cell activation.plasma membrane,integral component of membrane>sp|Q9H7M9|VISTA_HUMAN V-type immunoglobulin domain-containing suppressor of T-cell activation OS=Homo sapiens GN=C10orf54 PE=1 SV=3Q9HBH0;Q9HBH0-2RHOF RHOF_HUMANVRho-related GTP-binding protein RhoF;Isoform 2 of Rho-related GTP-binding protein RhoFactin filament organization,small GTPase mediated signal transduction,neutrophil degranulation,regulation of small GTPase mediated signal transduction;GTPase activity,GTP binding;Vcytosol,cytoskeleton,plasma membrane,secretory granule membrane,extracellular exosome;>sp|Q9HBH0|RHOF_HUMAN Rho-related GTP-binding protein RhoF OS=Homo sapiens GN=RHOF PE=1 SV=1;>sp|Q9HBH0-2|RHOF_HUMAN Isoform 2 of Rho-related GTP-binding protein RhoF OS=Homo sapiens GN=RHOFQ9NZT1CALML5 CALL5_HUMANCalmodulin-like protein 5Bsignal transduction,epidermis development,neutrophil degranulationGextracellular region,extracellular exosome,ficolin-1-rich granule lumenT>sp|Q9NZT1|CALL5_HUMAN Calmodulin-like protein 5 OS=Homo sapiens GN=CALML5 PE=1 SV=2Q9P1F3ABRACL ABRAL_HUMANCostars family protein ABRACLX>sp|Q9P1F3|ABRAL_HUMAN Costars family protein ABRACL OS=Homo sapiens GN=ABRACL PE=1 SV=1Q9Y4D1;Q9Y4D1-2DAAM1 DAAM1_HUMANrDisheveled-associated activator of morphogenesis 1;Isoform 2 of Disheveled-associated activator of morphogenesis 1Tactin cytoskeleton organization,Wnt signaling pathway, planar cell polarity pathway;Kactin binding,protein binding,Rho GTPase binding,identical protein binding;Ostress fiber,cytosol,plasma membrane,membrane,motile cilium,ciliary basal body;>sp|Q9Y4D1|DAAM1_HUMAN Disheveled-associated activator of morphogenesis 1 OS=Homo sapiens GN=DAAM1 PE=1 SV=2;>sp|Q9Y4D1-2|DAAM1_HUMAN Isoform 2 of Disheveled-associated activator of morphogenesis 1 OS=Homo sapiens GN=DAAM1Q9Y624F11R JAM1_HUMANJunctional adhesion molecule Asregulation of cytokine production,inflammatory response,cell adh< esion,transforming growth factor beta receptor signaling pathway,response to radiation,extracellular matrix organization,actomyosin structure organization,negative regulation of GTPase activity,positive regulation of GTPase activity,positive regulation of blood pressure,viral entry into host cell,intestinal absorption,leukocyte migration,bicellular tight junction assembly,establishment of protein localization to plasma membrane,establishment of endothelial intestinal barrier,regulation of membrane permeability,regulation of actin cytoskeleton reorganizationKvirus receptor activity,protein binding,PDZ domain binding,cadherin bindingplasma membrane,cell-cell junction,bicellular tight junction,integral component of membrane,cell junction,cytoplasmic vesicle,slit diaphragm,extracellular exosomeV>sp|Q9Y624|JAM1_HUMAN Junctional adhesion molecule A OS=Homo sapiens GN=F11R PE=1 SV=1Q9Y696CLIC4 CLIC4_HUMAN(Chloride intracellular channel protein 4 angiogenesis,endothelial cell morphogenesis,chloride transport,vacuolar acidification,fertilization,cell differentiation,keratinocyte differentiation,negative regulation of cell migration,regulation of ion transmembrane transport,establishment or maintenance of apical/basal cell polarity,multicellular organism growth,branching morphogenesis of an epithelial tube,regulation of cytoskeleton organization,retina vasculature morphogenesis in camera-type eye,cellular response to calcium ion,chloride transmembrane transportLvoltage-gated ion channel activity,chloride channel activity,protein binding7intracellular,cytoplasm,mitochondrion,centrosome,cytosol,plasma membrane,microvillus,cell-cell junction,cell surface,actin cytoskeleton,nuclear matrix,midbody,cytoplasmic vesicle membrane,chloride channel complex,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,microtubule cytoskeletonb>sp|Q9Y696|CLIC4_HUMAN Chloride intracellular channel protein 4 OS=Homo sapiens GN=CLIC4 PE=1 SV=4B4DR80;Q9Y6E0;Q9Y6E0-2STK24$B4DR80_HUMAN;STK24_HUMAN;STK24_HUMANuSerine/threonine-protein kinase 24;Serine/threonine-protein kinase 24;Isoform A of Serine/threonine-protein kinase 24?;protein phosphorylation,signal transduction,intrinsic apoptotic signaling pathway in response to oxidative stress,signal transduction by protein phosphorylation,negative regulation of cell migration,response to hydrogen peroxide,protein autophosphorylation,regulation of axon regeneration,execution phase of apoptosis;;protein kinase activity,protein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,protein binding,ATP binding,cadherin binding,metal ion binding;P;nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,membrane,extracellular exosome;>tr|B4DR80|B4DR80_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1;>sp|Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1;>sp|Q9Y6E0-2|STK24_HUMAN Isoform A of Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 A0A075B6I1IGLV4-60A0A075B6I1_HUMANProtein IGLV4-60 (Fragment)a>tr|A0A075B6I1|A0A075B6I1_HUMAN Protein IGLV4-60 (Fragment) OS=Homo sapiens GN=IGLV4-60 PE=1 SV=1 A0A075B6I9IGLV7-46A0A075B6I9_HUMANProtein IGLV7-46 (Fragment)a>tr|A0A075B6I9|A0A075B6I9_HUMAN Protein IGLV7-46 (Fragment) OS=Homo sapiens GN=IGLV7-46 PE=1 SV=4,A0A087X0V8;Q59EK9;Q59EK9-2;Q59EK9-3;Q59EK9-4RUNDC3A@A0A087X0V8_HUMAN;RUN3A_HUMAN;RUN3A_HUMAN;RUN3A_HUMAN;RUN3A_HUMANRUN domain-containing protein 3A;RUN domain-containing protein 3A;Isoform 2 of RUN domain-containing protein 3A;Isoform 3 of RUN domain-containing protein 3A;Isoform 4 of RUN domain-containing protein 3A_;small GTPase mediated signal transduction,positive regulation of guanylate cyclase activity;;;s;protein binding,guanylate cyclase activator activity,GTPase regulator activity,peptide hormone receptor binding;;;;cytosol,plasma membrane;;;>tr|A0A087X0V8|A0A087X0V8_HUMAN RUN domain-containing protein 3A OS=Homo sapiens GN=RUNDC3A PE=1 SV=1;>sp|Q59EK9|RUN3A_HUMAN RUN domain-containing protein 3A OS=Homo sapiens GN=RUNDC3A PE=1 SV=2;>sp|Q59EK9-2|RUN3A_HUMAN Isoform 2 of RUN domain-containing protein 3A OS=Homo sapiens GN=RUNDC3A;>sp|Q59EK9-3|RUN3A_HUMAN Isoform 3 of RUN domain-containing protein 3A OS=Homo sapiens GN=RUNDC3A;>sp|Q59EK9-4|RUN3A_HUMAN Isoform 4 of RUN domain-containing protein 3A OS=Homo sapiens GN=RUNDC3A!A0A0A6YYL2;P0DMM9;P0DMM9-3;P0DMN0SULT1A4;SULT1A3;SULT1A3;SULT1A44A0A0A6YYL2_HUMAN;ST1A3_HUMAN;ST1A3_HUMAN;ST1A4_HUMAN\Sulfotransferase;Sulfotransferase 1A3;Isoform 3 of Sulfotransferase 1A3;Sulfotransferase 1A4;catecholamine metabolic process,xenobiotic metabolic process,steroid metabolic process,flavonoid metabolic process,IRE1-mediated unfolded protein response,3'-phosphoadenosine 5'-phosphosulfate metabolic process,sulfation;;catecholamine metabolic process,steroid metabolic processi;aryl sulfotransferase activity,protein binding,sulfotransferase activity;;aryl sulfotransferase activity;cytosol;;cytoplasmM>tr|A0A0A6YYL2|A0A0A6YYL2_HUMAN Sulfotransferase OS=Homo sapiens GN=SULT1A4 PE=1 SV=1;>sp|P0DMM9|ST1A3_HUMAN Sulfotransferase 1A3 OS=Homo sapiens GN=SULT1A3 PE=1 SV=1;>sp|P0DMM9-3|ST1A3_HUMAN Isoform 3 of Sulfotransferase 1A3 OS=Homo sapiens GN=SULT1A3;>sp|P0DMN0|ST1A4_HUMAN Sulfotransferase 1A4 OS=Homo sapiens GN=SULT1A4 PE=1 SV=1A0A1B0GTU8;A0A1B0GU12;A0A1B0GUT7;A0A1B0GUV3;A0A1B0GVB9;A0A1B0GVC7;A0A1B0GVI9;A0A1B0GVW0;A0A1B0GWD6;A0A1C7CYW4;B7Z1I9;B7Z413;O75787;O75787-2ATP6AP2A0A1B0GTU8_HUMAN;A0A1B0GU12_HUMAN;A0A1B0GUT7_HUMAN;A0A1B0GUV3_HUMAN;A0A1B0GVB9_HUMAN;A0A1B0GVC7_HUMAN;A0A1B0GVI9_HUMAN;A0A1B0GVW0_HUMAN;A0A1B0GWD6_HUMAN;A0A1C7CYW4_HUMAN;B7Z1I9_HUMAN;B7Z413_HUMAN;RENR_HUMAN;RENR_HUMANRenin receptor;Renin receptor;Renin receptor;Renin receptor (Fragment);Renin receptor;Renin receptor;Renin receptor;Renin receptor;Renin receptor (Fragment);Renin receptor;Renin receptor;Renin receptor;Renin receptor;Isoform 2 of Renin receptor;;;;;;;;;;;;angiotensin maturation,rostrocaudal neural tube patterning,positive regulation of Wnt signaling pathway,positive regulation of transforming growth factor beta1 production,neutrophil degranulation,regulation of MAPK cascade,eye pigmentation,head morphogenesis;=;;;;;;;;;;;;receptor activity,protein binding,enzyme binding;;;;;;;;;;;;;plasma membrane,external side of plasma membrane,integral component of membrane,neuron projection,cell body,extracellular exosome,tertiary granule membrane,ficolin-1-rich granule membrane;)tr;tr;tr;tr;tr;tr;tr;tr;tr;tr;tr;tr;sp;sp1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;2;>tr|A0A1B0GTU8|A0A1B0GTU8_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GU12|A0A1B0GU12_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GUT7|A0A1B0GUT7_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GUV3|A0A1B0GUV3_HUMAN Renin receptor (Fragment) OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GVB9|A0A1B0GVB9_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GVC7|A0A1B0GVC7_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GVI9|A0A1B0GVI9_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GVW0|A0A1B0GVW0_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1B0GWD6|A0A1B0GWD6_HUMAN Renin receptor (Fragment) OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|A0A1C7CYW4|A0A1C7CYW4_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|B7Z1I9|B7Z1I9_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>tr|B7Z413|B7Z413_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=1;>sp|O75787|RENR_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=2;>sp|O75787-2|RENR_HUMAN Isoform 2 of Renin receptor OS=Homo sapiens GN=ATP6AP2A8MWX0;A8MXN1;Q96HR9REEP6%A8MWX0_HUMAN;A8MXN1_HUMAN;REEP6_HUMANReceptor expression-enhancing protein (Fragment);Receptor expression-enhancing protein (Fragment);Receptor expression-enhancing protein 6:;;biological_process,regulation of intracellular transport$;;molecular_function,protein binding~;;nucleus,endoplasmic reticulum,< endoplasmic reticulum membrane,integral component of membrane,rod spherule,apical part of cell9>tr|A8MWX0|A8MWX0_HUMAN Receptor expression-enhancing protein (Fragment) OS=Homo sapiens GN=REEP6 PE=1 SV=2;>tr|A8MXN1|A8MXN1_HUMAN Receptor expression-enhancing protein (Fragment) OS=Homo sapiens GN=REEP6 PE=1 SV=2;>sp|Q96HR9|REEP6_HUMAN Receptor expression-enhancing protein 6 OS=Homo sapiens GN=REEP6 PE=1 SV=1&B7ZAN3;M0QZP6;P11049;P11049-2;P11049-3CD37:B7ZAN3_HUMAN;M0QZP6_HUMAN;CD37_HUMAN;CD37_HUMAN;CD37_HUMANTetraspanin;Leukocyte antigen CD37 (Fragment);Leukocyte antigen CD37;Isoform 2 of Leukocyte antigen CD37;Isoform 3 of Leukocyte antigen CD37+;;cell surface receptor signaling pathway;;;;protein binding;;^;;immunological synapse,integral component of plasma membrane,membrane,extracellular exosome;;>tr|B7ZAN3|B7ZAN3_HUMAN Tetraspanin OS=Homo sapiens GN=CD37 PE=1 SV=1;>tr|M0QZP6|M0QZP6_HUMAN Leukocyte antigen CD37 (Fragment) OS=Homo sapiens GN=CD37 PE=1 SV=1;>sp|P11049|CD37_HUMAN Leukocyte antigen CD37 OS=Homo sapiens GN=CD37 PE=1 SV=2;>sp|P11049-2|CD37_HUMAN Isoform 2 of Leukocyte antigen CD37 OS=Homo sapiens GN=CD37;>sp|P11049-3|CD37_HUMAN Isoform 3 of Leukocyte antigen CD37 OS=Homo sapiens GN=CD37C9JGI3;P19971;P19971-2TYMP"C9JGI3_HUMAN;TYPH_HUMAN;TYPH_HUMAN_Thymidine phosphorylase (Fragment);Thymidine phosphorylase;Isoform 2 of Thymidine phosphorylase;angiogenesis,pyrimidine nucleobase metabolic process,chemotaxis,cell differentiation,pyrimidine nucleoside salvage,pyrimidine nucleoside catabolic process;;phosphorylase activity,growth factor activity,thymidine phosphorylase activity,pyrimidine-nucleoside phosphorylase activity,transferase activity, transferring pentosyl groups; ;cytosol;>tr|C9JGI3|C9JGI3_HUMAN Thymidine phosphorylase (Fragment) OS=Homo sapiens GN=TYMP PE=1 SV=1;>sp|P19971|TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2;>sp|P19971-2|TYPH_HUMAN Isoform 2 of Thymidine phosphorylase OS=Homo sapiens GN=TYMP/F5GZS6;J3KPF3;P08195;P08195-2;P08195-3;P08195-4SLC3A2AF5GZS6_HUMAN;J3KPF3_HUMAN;4F2_HUMAN;4F2_HUMAN;4F2_HUMAN;4F2_HUMAN4F2 cell-surface antigen heavy chain;4F2 cell-surface antigen heavy chain;4F2 cell-surface antigen heavy chain;Isoform 2 of 4F2 cell-surface antigen heavy chain;Isoform 3 of 4F2 cell-surface antigen heavy chain;Isoform 4 of 4F2 cell-surface antigen heavy chain;;carbohydrate metabolic process,tryptophan catabolic process,calcium ion transport,amino acid transport,tryptophan transport,cell growth,sodium ion transmembrane transport,response to exogenous dsRNA,leukocyte migration,leucine import;;;;;RNA binding,double-stranded RNA binding,catalytic activity,calcium:sodium antiporter activity,protein binding,neutral amino acid transmembrane transporter activity,cadherin binding;;;;;nucleus,cytosol,plasma membrane,cell surface,membrane,integral component of membrane,apical plasma membrane,melanosome,extracellular exosome;;;1;1;3;;;H>tr|F5GZS6|F5GZS6_HUMAN 4F2 cell-surface antigen heavy chain OS=Homo sapiens GN=SLC3A2 PE=1 SV=1;>tr|J3KPF3|J3KPF3_HUMAN 4F2 cell-surface antigen heavy chain OS=Homo sapiens GN=SLC3A2 PE=1 SV=1;>sp|P08195|4F2_HUMAN 4F2 cell-surface antigen heavy chain OS=Homo sapiens GN=SLC3A2 PE=1 SV=3;>sp|P08195-2|4F2_HUMAN Isoform 2 of 4F2 cell-surface antigen heavy chain OS=Homo sapiens GN=SLC3A2;>sp|P08195-3|4F2_HUMAN Isoform 3 of 4F2 cell-surface antigen heavy chain OS=Homo sapiens GN=SLC3A2;>sp|P08195-4|4F2_HUMAN Isoform 4 of 4F2 cell-surface antigen heavy chain OS=Homo sapiens GN=SLC3A2 F5H6I7;Q6DD88ATL3F5H6I7_HUMAN;ATLA3_HUMAN Atlastin-3y;endoplasmic reticulum organization,Golgi organization,protein homooligomerization,ER to Golgi vesicle-mediated transportF;GTPase activity,protein binding,GTP binding,identical protein binding;endoplasmic reticulum,endoplasmic reticulum membrane,membrane,integral component of membrane,endoplasmic reticulum tubular network>tr|F5H6I7|F5H6I7_HUMAN Atlastin-3 OS=Homo sapiens GN=ATL3 PE=1 SV=1;>sp|Q6DD88|ATLA3_HUMAN Atlastin-3 OS=Homo sapiens GN=ATL3 PE=1 SV=1G3V1N2HBA2 G3V1N2_HUMANHCG1745306, isoform CRA_aS>tr|G3V1N2|G3V1N2_HUMAN HCG1745306, isoform CRA_a OS=Homo sapiens GN=HBA2 PE=1 SV=1H0YL69;H0YMZ1;P25789PSMA4$H0YL69_HUMAN;H0YMZ1_HUMAN;PSA4_HUMANqProteasome subunit alpha type (Fragment);Proteasome subunit alpha type (Fragment);Proteasome subunit alpha type-4;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway7;;threonine-type endopeptidase activity,protein binding;;proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,intracellular membrane-bounded organelle,extracellular exosome1;8;1 >tr|H0YL69|H0YL69_HUMAN Proteasome subunit alpha type (Fragment) OS=Homo sapiens GN=PSMA4 PE=1 SV=1;>tr|H0YMZ1|H0YMZ1_HUMAN Proteasome subunit alpha type (Fragment) OS=Homo sapiens GN=PSMA4 PE=1 SV=8;>sp|P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=Homo sapiens GN=PSMA4 PE=1 SV=1 H3BM89;P36578RPL4H3BM89_HUMAN;RL4_HUMAN60S ribosomal protein L4;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription?;RNA binding,structural constituent of ribosome,protein binding;nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome>tr|H3BM89|H3BM89_HUMAN 60S ribosomal protein L4 OS=Homo sapiens GN=RPL4 PE=1 SV=1;>sp|P36578|RL4_HUMAN 60S ribosomal protein L4 OS=Homo sapiens GN=RPL4 PE=1 SV=5J3KNB3;Q9UN19;Q9UN19-2DAPP1$J3KNB3_HUMAN;DAPP1_HUMAN;DAPP1_HUMANDual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide;Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide;Isoform 2 of Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide/;protein dephosphorylation,signal transduction;;protein binding,phospholipid binding,phosphatidylinositol-3,4,5-trisphosphate binding,PDZ domain binding,phosphatidylinositol-3,4-bisphosphate binding;#;cytoplasm,cytosol,plasma membrane;>tr|J3KNB3|J3KNB3_HUMAN Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Homo sapiens GN=DAPP1 PE=1 SV=1;>sp|Q9UN19|DAPP1_HUMAN Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Homo sapiens GN=DAPP1 PE=1 SV=1;>sp|Q9UN19-2|DAPP1_HUMAN Isoform 2 of Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Homo sapiens GN=DAPP1O00151PDLIM1 PDLI1_HUMANPDZ and LIM domain protein 1nresponse to hypoxia,regulation of transcription, DNA-templated,response to oxidative stress,cell-cell adhesionctranscription coactivator activity,zinc ion binding,cadherin binding involved in cell-cell adhesion^transcription factor complex,cytoplasm,cytoskeleton,cell-cell adherens junction,focal adhesi< onW>sp|O00151|PDLI1_HUMAN PDZ and LIM domain protein 1 OS=Homo sapiens GN=PDLIM1 PE=1 SV=4O15031PLXNB2 PLXB2_HUMAN Plexin-B2neural tube closure,regulation of protein phosphorylation,homophilic cell adhesion via plasma membrane adhesion molecules,negative regulation of cell adhesion,neuroblast proliferation,brain development,regulation of cell shape,positive regulation of neuron projection development,regulation of GTPase activity,positive regulation of axonogenesis,semaphorin-plexin signaling pathway,regulation of neuron migration,protein binding,semaphorin receptor activityHintegral component of plasma membrane,cell surface,extracellular exosomeD>sp|O15031|PLXB2_HUMAN Plexin-B2 OS=Homo sapiens GN=PLXNB2 PE=1 SV=3O15511ARPC5 ARPC5_HUMAN+Actin-related protein 2/3 complex subunit 5movement of cell or subcellular component,smooth muscle cell migration,cell migration,orbitofrontal cortex development,maintenance of cell polarity,actin cytoskeleton organization,microtubule organizing center organization,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,neutrophil degranulation,ephrin receptor signaling pathway,actin filament network formation,membrane organization,lamellipodium organizationextracellular region,cytoplasm,endosome,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,lamellipodium,growth cone,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumene>sp|O15511|ARPC5_HUMAN Actin-related protein 2/3 complex subunit 5 OS=Homo sapiens GN=ARPC5 PE=1 SV=3O60256PRPSAP2 KPRB_HUMAN:Phosphoribosyl pyrophosphate synthase-associated protein 2nucleobase-containing compound metabolic process,nucleoside metabolic process,nucleotide biosynthetic process,negative regulation of catalytic activity,bone developmentimagnesium ion binding,ribose pho      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrsuvwxyz{|}~sphate diphosphokinase activity,enzyme inhibitor activity,protein binding8ribose phosphate diphosphokinase complex,protein complexu>sp|O60256|KPRB_HUMAN Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Homo sapiens GN=PRPSAP2 PE=1 SV=1O95336PGLS 6PGL_HUMAN6-phosphogluconolactonase`carbohydrate metabolic process,pentose-phosphate shunt,pentose-phosphate shunt, oxidative branch2protein binding,6-phosphogluconolactonase activityQ>sp|O95336|6PGL_HUMAN 6-phosphogluconolactonase OS=Homo sapiens GN=PGLS PE=1 SV=2 P00568;Q5T9B7AK1KAD1_HUMAN;Q5T9B7_HUMANAdenylate kinase isoenzyme 1nucleoside diphosphate phosphorylation,nucleoside triphosphate biosynthetic process,nucleobase-containing small molecule interconversion,ATP metabolic process;Madenylate kinase activity,nucleoside diphosphate kinase activity,ATP binding;cytosol,extracellular exosome;>sp|P00568|KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=3;>tr|Q5T9B7|Q5T9B7_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=1P02461COL3A1 CO3A1_HUMANCollagen alpha-1(III) chainskeletal system development,cell-matrix adhesion,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,heart development,aging,response to radiation,response to mechanical stimulus,peptide cross-linking,cerebral cortex development,platelet activation,extracellular matrix organization,collagen fibril organization,collagen catabolic process,response to cytokine,positive regulation of Rho protein signal transduction,wound healing,skin development,digestive tract development,regulation of immune response,negative regulation of immune response,aorta smooth muscle tissue morphogenesis,cellular response to amino acid stimulus,fibril organization,negative regulation of neuron migrationintegrin binding,extracellular matrix structural constituent,protein binding,SMAD binding,metal ion binding,platelet-derived growth factor bindingrextracellular region,collagen type III trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrixV>sp|P02461|CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4P04083ANXA1 ANXA1_HUMAN Annexin A1DNA strand renaturation,neutrophil homeostasis,adaptive immune response,monocyte chemotaxis,regulation of leukocyte migration,phagocytosis,inflammatory response,signal transduction,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,regulation of cell shape,response to X-ray,myoblast migration involved in skeletal muscle regeneration,peptide cross-linking,insulin secretion,keratinocyte differentiation,prostate gland development,endocrine pancreas development,positive regulation of vesicle fusion,positive regulation of prostaglandin biosynthetic process,actin cytoskeleton reorganization,response to estradiol,DNA duplex unwinding,regulation of interleukin-1 production,positive regulation of interleukin-2 production,positive regulation of neutrophil apoptotic process,DNA rewinding,gliogenesis,positive regulation of T cell proliferation,response to drug,negative regulation of apoptotic process,response to peptide hormone,estrous cycle,innate immune response,positive regulation of T-helper 1 cell differentiation,negative regulation of T-helper 2 cell differentiation,negative regulation of exocytosis,alpha-beta T cell differentiation,regulation of hormone secretion,arachidonic acid secretion,regulation of inflammatory response,cellular response to hydrogen peroxide,hepatocyte differentiation,prolactin secretion,response to interleukin-1,cellular response to glucocorticoid stimulus,granulocyte chemotaxis,positive regulation of wound healing,neutrophil clearance,cell-cell adhesion,positive regulation of G1/S transition of mitotic cell cycle,negative regulation of phospholipase A2 activity,negative regulation of interleukin-8 secretionsingle-stranded DNA binding,single-stranded RNA binding,helicase activity,receptor binding,structural molecule activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,protein binding, bridging,double-stranded DNA-dependent ATPase activity,annealing helicase activity,protein homodimerization activity,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion2cornified envelope,phagocytic cup,extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endosome,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,basolateral plasma membrane,apical plasma membrane,lateral plasma membrane,extrinsic component of membrane,cytoplasmic vesicle membrane,extrinsic component of external side of plasma membrane,extrinsic component of endosome membrane,motile cilium,early endosome membrane,mitochondrial membrane,vesicle,sarcolemma,mast cell granule,protein complex,extracellular exosomeD>sp|P04083|ANXA1_HUMAN Annexin A1 OS=Homo sapiens GN=ANXA1 PE=1 SV=2P06331IGHV4-34 HV434_HUMAN"Immunoglobulin heavy variable 4-34_>sp|P06331|HV434_HUMAN Immunoglobulin heavy variable 4-34 OS=Homo sapiens GN=IGHV4-34 PE=1 SV=2 P08134;Q5JR08RHOCRHOC_HUMAN;Q5JR08_HUMANTRho-related GTP-binding protein RhoC;Rho-related GTP-binding protein RhoC (Fragment)4cytokinesis,small GTPase mediated signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,apical junction assembly,wound healing, spreading of cells,regulation of small GTPase mediated signal transduction,positive regulation of lipase activity,skeletal muscle satellite cell migration;7signal transducer activity,protein binding,GTP binding;Fnucleus,cytosol,plasma membrane,cleavage furrow,extracellular exosome;1;8>sp|P08134|RHOC_HUMAN Rho-related GTP-binding protein RhoC OS=Homo sapiens GN=RHOC PE=1 SV=1;>tr|Q5JR08|Q5JR08_HUMAN Rho-related GTP-binding protein RhoC (Fragment) OS=Homo sapiens GN=RHOC PE=1 SV=8P08238HSP90AB1 HS90B_HUMANHeat shock protein HSP 90-betaplacenta development,protein folding,xenobiotic metabolic process,response to unfolded protein,telomere maintenance via telomerase,response to salt stress,virion attachment to host cell,positive< regulation of transforming growth factor beta receptor signaling pathway,regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of phosphoprotein phosphatase activity,positive regulation of protein import into nucleus, translocation,cellular response to drug,Fc-gamma receptor signaling pathway involved in phagocytosis,response to cocaine,neutrophil degranulation,negative regulation of neuron apoptotic process,positive regulation of nitric oxide biosynthetic process,positive regulation of cell differentiation,positive regulation of cell size,protein stabilization,positive regulation of telomerase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,negative regulation of cell cycle arrest,cellular response to interleukin-4,cellular response to organic cyclic compound,positive regulation of protein serine/threonine kinase activity,fibril organization,regulation of cellular response to heat,negative regulation of complement-dependent cytotoxicity,telomerase holoenzyme complex assembly,positive regulation of protein localization to cell surface)glycoprotein binding,UTP binding,CTP binding,RNA binding,double-stranded RNA binding,protein binding,ATP binding,GTP binding,drug binding,sulfonylurea receptor binding,protein kinase regulator activity,kinase binding,protein kinase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,heat shock protein binding,dATP binding,histone deacetylase binding,ion channel binding,cadherin binding,protein dimerization activity,unfolded protein binding,DNA polymerase binding,histone methyltransferase bindinguextracellular region,nucleus,nucleoplasm,cytoplasm,mitochondrion,lysosomal membrane,cytosol,cell surface,membrane,inclusion body,basolateral plasma membrane,apical plasma membrane,brush border membrane,aryl hydrocarbon receptor complex,secretory granule lumen,melanosome,extracellular exosome,ficolin-1-rich granule lumen,sperm head plasma membrane,ooplasm,COP9 signalosome[>sp|P08238|HS90B_HUMAN Heat shock protein HSP 90-beta OS=Homo sapiens GN=HSP90AB1 PE=1 SV=4P10301RRAS RRAS_HUMANRas-related protein R-Rasleukocyte differentiation,Ras protein signal transduction,negative regulation of cell migration,positive regulation of angiogenesis,regulation of protein kinase B signaling,face morphogenesis,regulation of ERK1 and ERK2 cascadeBintracellular,plasma membrane,focal adhesion,extracellular exosomeQ>sp|P10301|RRAS_HUMAN Ras-related protein R-Ras OS=Homo sapiens GN=RRAS PE=1 SV=1P10720PF4V1 PF4V_HUMANPlatelet factor 4 variant inflammatory response,immune response,G-protein coupled receptor signaling pathway,platelet activation,leukocyte chemotaxis,response to lipopolysaccharide,regulation of cell proliferation,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxisBchemokine activity,heparin binding,CXCR chemokine receptor bindingR>sp|P10720|PF4V_HUMAN Platelet factor 4 variant OS=Homo sapiens GN=PF4V1 PE=1 SV=1P14868;P14868-2DARS SYDC_HUMANTAspartate--tRNA ligase, cytoplasmic;Isoform 2 of Aspartate--tRNA ligase, cytoplasmicntranslation,tRNA aminoacylation for protein translation,aspartyl-tRNA aminoacylation,protein complex assembly;]RNA binding,aminoacylase activity,aspartate-tRNA ligase activity,protein binding,ATP binding;>sp|P14868|SYDC_HUMAN Aspartate--tRNA ligase, cytoplasmic OS=Homo sapiens GN=DARS PE=1 SV=2;>sp|P14868-2|SYDC_HUMAN Isoform 2 of Aspartate--tRNA ligase, cytoplasmic OS=Homo sapiens GN=DARSP16930;P16930-2FAH FAAA_HUMAN4Fumarylacetoacetase;Isoform 2 of FumarylacetoacetaseXarginine catabolic process,L-phenylalanine catabolic process,tyrosine catabolic process;?fumarylacetoacetase activity,protein binding,metal ion binding;>sp|P16930|FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2;>sp|P16930-2|FAAA_HUMAN Isoform 2 of Fumarylacetoacetase OS=Homo sapiens GN=FAHF5GX88;P17813;P17813-2ENG"F5GX88_HUMAN;EGLN_HUMAN;EGLN_HUMAN+Endoglin;Endoglin;Isoform Short of Endoglinp;chronological cell aging,patterning of blood vessels,vasculogenesis,positive regulation of protein phosphorylation,heart looping,outflow tract septum morphogenesis,epithelial to mesenchymal transition involved in endocardial cushion formation,endocardial cushion morphogenesis,cardiac ventricle morphogenesis,cardiac atrium morphogenesis,ventricular trabecula myocardium morphogenesis,cell migration involved in endocardial cushion formation,regulation of transcription, DNA-templated,cell adhesion,negative regulation of gene expression,positive regulation of pathway-restricted SMAD protein phosphorylation,regulation of transforming growth factor beta receptor signaling pathway,central nervous system vasculogenesis,negative regulation of cell migration,BMP signaling pathway,positive regulation of BMP signaling pathway,negative regulation of protein autophosphorylation,response to corticosteroid,positive regulation of collagen biosynthetic process,dorsal aorta morphogenesis,response to drug,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,smooth muscle tissue development,artery morphogenesis,venous blood vessel morphogenesis,atrial cardiac muscle tissue morphogenesis,bone development,extracellular matrix constituent secretion,cellular response to mechanical stimulus,response to transforming growth factor beta,vascular smooth muscle cell development,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,positive regulation of vascular smooth muscle cell differentiation,atrioventricular canal morphogenesis,sprouting angiogenesis,regulation of cardiac muscle cell apoptotic process,endocardial cushion to mesenchymal transition,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,regulation of cell proliferation involved in heart morphogenesis;;transmembrane signaling receptor activity,transforming growth factor beta receptor, cytoplasmic mediator activity,type II transforming growth factor beta receptor binding,protein binding,galactose binding,glycosaminoglycan binding,type I transforming growth factor beta receptor binding,protein homodimerization activity,activin binding,transforming growth factor beta binding,BMP binding;;extracellular space,focal adhesion,external side of plasma membrane,receptor complex,transforming growth factor beta receptor homodimeric complex,endothelial microparticle;>tr|F5GX88|F5GX88_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=1;>sp|P17813|EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2;>sp|P17813-2|EGLN_HUMAN Isoform Short of Endoglin OS=Homo sapiens GN=ENGP32942ICAM3 ICAM3_HUMAN!Intercellular adhesion molecule 3stimulatory C-type lectin receptor signaling pathway,phagocytosis,cell adhesion,single organismal cell-cell adhesion,extracellular matrix organization,regulation of immune response1receptor binding,integrin binding,protein bindingKplasma membrane,integral component of plasma membrane,extracellular exosome[>sp|P32942|ICAM3_HUMAN Intercellular adhesion molecule 3 OS=Homo sapiens GN=ICAM3 PE=1 SV=2P41091EIF2S3 IF2G_HUMAN4Eukaryotic translation initiation factor 2 subunit 30translational initiation,transmembrane transporttranslation initiation factor activity,GTPase activity,protein binding,GTP binding,translation factor activity, RNA binding,cadherin bindingbcytoplasm,cytosol,eukaryotic translation initiation factor 2 complex,extracellular exosome,nucleusn>sp|P41091|IF2G_HUMAN Eukaryotic translation initiation factor 2 subunit 3 OS=Homo sapiens GN=EIF2S3 PE=1 SV=3P54577YARS SYYC_HUMAN"Tyrosine--tRNA ligase, cytoplasmicmtRNA aminoacylation for protein translation,tyrosyl-tRNA aminoacylation,apoptotic process,signal transductiontRNA binding,RNA binding,tyrosine-tRNA ligase activity,signal transducer activity,interleukin-8 receptor binding,protein binding,ATP binding< extracellular space,cytoplasm,cytosol,nuclear body,aminoacyl-tRNA synthetase multienzyme complex,methionyl glutamyl tRNA synthetase complexZ>sp|P54577|SYYC_HUMAN Tyrosine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=YARS PE=1 SV=4E9PKU4;E9PKZ0;E9PP36;P62917RPL80E9PKU4_HUMAN;E9PKZ0_HUMAN;E9PP36_HUMAN;RL8_HUMANy60S ribosomal protein L8 (Fragment);60S ribosomal protein L8 (Fragment);60S ribosomal protein L8;60S ribosomal protein L8;;;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,cellular response to nerve growth factor stimulusC;;;RNA binding,structural constituent of ribosome,5.8S rRNA bindingD;;;cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit^>tr|E9PKU4|E9PKU4_HUMAN 60S ribosomal protein L8 (Fragment) OS=Homo sapiens GN=RPL8 PE=1 SV=1;>tr|E9PKZ0|E9PKZ0_HUMAN 60S ribosomal protein L8 (Fragment) OS=Homo sapiens GN=RPL8 PE=1 SV=1;>tr|E9PP36|E9PP36_HUMAN 60S ribosomal protein L8 OS=Homo sapiens GN=RPL8 PE=1 SV=1;>sp|P62917|RL8_HUMAN 60S ribosomal protein L8 OS=Homo sapiens GN=RPL8 PE=1 SV=2Q00013;Q00013-3MPP1 EM55_HUMANT55 kDa erythrocyte membrane protein;Isoform 3 of 55 kDa erythrocyte membrane proteindsignal transduction,GMP metabolic process,GDP metabolic process,regulation of neutrophil chemotaxis;*guanylate kinase activity,protein binding;`intracellular,integral component of plasma membrane,membrane,cortical cytoskeleton,stereocilium;>sp|Q00013|EM55_HUMAN 55 kDa erythrocyte membrane protein OS=Homo sapiens GN=MPP1 PE=1 SV=2;>sp|Q00013-3|EM55_HUMAN Isoform 3 of 55 kDa erythrocyte membrane protein OS=Homo sapiens GN=MPP1Q02413DSG1 DSG1_HUMAN Desmoglein-1dcell-cell junction assembly,homophilic cell adhesion via plasma membrane adhesion molecules,single organismal cell-cell adhesion,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,keratinization,response to progesterone,neutrophil degranulation,protein stabilization,maternal process involved in female pregnancy,cornificationQcalcium ion binding,protein binding,toxic substance binding,gamma-catenin bindingcornified envelope,cytosol,plasma membrane,cytoplasmic side of plasma membrane,integral component of membrane,apical plasma membrane,lateral plasma membrane,desmosome,extracellular matrix,extracellular exosome,ficolin-1-rich granule membrane,cell-cell junctionD>sp|Q02413|DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2Q13347EIF3I EIF3I_HUMAN4Eukaryotic translation initiation factor 3 subunit Itranslational initiation6translation initiation factor activity,protein bindingcytosol,eukaryotic translation initiation factor 3 complex,extracellular exosome,eukaryotic translation initiation factor 3 complex, eIF3mn>sp|Q13347|EIF3I_HUMAN Eukaryotic translation initiation factor 3 subunit I OS=Homo sapiens GN=EIF3I PE=1 SV=1Q5T447HECTD3 HECD3_HUMAN"E3 ubiquitin-protein ligase HECTD3Xprotein ubiquitination,proteasome-mediated ubiquitin-dependent protein catabolic processGubiquitin-protein transferase activity,protein binding,syntaxin bindingperinuclear region of cytoplasm]>sp|Q5T447|HECD3_HUMAN E3 ubiquitin-protein ligase HECTD3 OS=Homo sapiens GN=HECTD3 PE=1 SV=1 Q5VVH5;U3KQ34IRAK1BP1IKBP1_HUMAN;U3KQ34_HUMAN<Interleukin-1 receptor-associated kinase 1-binding protein 1|transcription, DNA-templated,regulation of transcription, DNA-templated,immune response,I-kappaB kinase/NF-kappaB signaling;>sp|Q5VVH5|IKBP1_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens GN=IRAK1BP1 PE=1 SV=1;>tr|U3KQ34|U3KQ34_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens GN=IRAK1BP1 PE=4 SV=1Q6UWD8C16orf54 CP054_HUMANTransmembrane protein C16orf54integral component of membrane[>sp|Q6UWD8|CP054_HUMAN Transmembrane protein C16orf54 OS=Homo sapiens GN=C16orf54 PE=1 SV=1Q8TF42UBASH3B UBS3B_HUMAN8Ubiquitin-associated and SH3 domain-containing protein B@negative regulation of protein kinase activity,negative regulation of signal transduction,peptidyl-tyrosine dephosphorylation,negative regulation of osteoclast differentiation,negative regulation of bone resorption,regulation of release of sequestered calcium ion into cytosol,negative regulation of platelet aggregationpprotein tyrosine phosphatase activity,protein binding,ubiquitin protein ligase binding,identical protein bindingnucleus,cytoplasmt>sp|Q8TF42|UBS3B_HUMAN Ubiquitin-associated and SH3 domain-containing protein B OS=Homo sapiens GN=UBASH3B PE=1 SV=2Q8WWI5SLC44A1 CTL1_HUMAN"Choline transporter-like protein 1lphosphatidylcholine biosynthetic process,choline transport,choline catabolic process,transmembrane transport*choline transmembrane transporter activitynucleoplasm,mitochondrion,mitochondrial outer membrane,plasma membrane,membrane,integral component of membrane,extracellular exosome]>sp|Q8WWI5|CTL1_HUMAN Choline transporter-like protein 1 OS=Homo sapiens GN=SLC44A1 PE=1 SV=1Q96CX2KCTD12 KCD12_HUMAN(BTB/POZ domain-containing protein KCTD12protein homooligomerization%RNA binding,identical protein bindingNcell junction,presynaptic membrane,postsynaptic membrane,extracellular exosomec>sp|Q96CX2|KCD12_HUMAN BTB/POZ domain-containing protein KCTD12 OS=Homo sapiens GN=KCTD12 PE=1 SV=1Q9H8L6MMRN2 MMRN2_HUMAN Multimerin-2angiogenesis,negative regulation of vascular endothelial growth factor receptor signaling pathway,negative regulation of cell migration involved in sprouting angiogenesisPbasement membrane,extracellular space,extracellular matrix,extracellular exosomeF>sp|Q9H8L6|MMRN2_HUMAN Multimerin-2 OS=Homo sapiens GN=MMRN2 PE=1 SV=2Q9NY15STAB1 STAB1_HUMAN Stabilin-1receptor-mediated endocytosis,inflammatory response,cell adhesion,cell-cell signaling,negative regulation of angiogenesis,defense response to bacterium,oxidation-reduction processlow-density lipoprotein receptor activity,scavenger receptor activity,calcium ion binding,protein binding,hyaluronic acid binding,protein disulfide oxidoreductase activity,low-density lipoprotein particle bindingPplasma membrane,integral component of plasma membrane,endocytic vesicle membraneD>sp|Q9NY15|STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3Q9UJU6;Q9UJU6-2;Q9UJU6-3DBNL DBNL_HUMANXDrebrin-like protein;Isoform 2 of Drebrin-like protein;Isoform 3 of Drebrin-like proteinadaptive immune response,receptor-mediated endocytosis,activation of JUN kinase activity,synapse assembly,Rac protein signal transduction,neutrophil degranulation,neuron projection morphogenesis,podosome assembly,ruffle assembly;;actin binding,protein binding,protein C-terminus binding,enzyme activator activity,protein domain specific binding,cadherin binding,actin filament binding;;/Golgi membrane,ruffle,podosome,extracellular region,cytoplasm,early endosome,cytosol,plasma membrane,cell cortex,postsynaptic density,lamellipodium,cell junction,dendrite,clathrin-coated vesicle membrane,secretory granule lumen,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumen;;>sp|Q9UJU6|DBNL_HUMAN Drebrin-like protein OS=Homo sapiens GN=DBNL PE=1 SV=1;>sp|Q9UJU6-2|DBNL_HUMAN Isoform 2 of Drebrin-like protein OS=Homo sapiens GN=DBNL;>sp|Q9UJU6-3|DBNL_HUMAN Isoform 3 of Drebrin-like protein OS=Homo sapiens GN=DBNLQ9UKU9ANGPTL2 ANGL2_HUMANAngiopoietin-related protein 2"multicellular organism developmentZ>sp|Q9UKU9|ANGL2_HUMAN Angiopoietin-related protein 2 OS=Homo sapiens GN=ANGPTL2 PE=2 SV=1Q9Y3I0RTCB RTCB_HUMAN!tRNA-splicing ligase RtcB homologlin utero embryonic development,placenta development,tRNA splicing, via endonucleolytic cleavage and ligationdRNA binding,RNA ligase (ATP) activity,protein binding,ATP binding,vinculin binding,metal ion bindingnucleus,nuclear envelope,nucleoplasm,cytoplasm,endoplasmic reticulum membrane,cytosol,intracellular membrane-bounded organelle,tRNA-splicing ligase complex< Y>sp|Q9Y3I0|RTCB_HUMAN tRNA-splicing ligase RtcB homolog OS=Homo sapiens GN=RTCB PE=1 SV=1Q9Y5S2CDC42BPB MRCKB_HUMAN)Serine/threonine-protein kinase MRCK betaprotein phosphorylation,cytoskeleton organization,establishment or maintenance of cell polarity,signal transduction,cell migration,actomyosin structure organization,actin cytoskeleton reorganization,intracellular signal transductionumagnesium ion binding,protein kinase activity,protein serine/threonine kinase activity,ATP binding,Rho GTPase bindinglcytoplasm,cytoskeleton,plasma membrane,cell-cell junction,cell leading edge,actomyosin,extracellular exosomef>sp|Q9Y5S2|MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 A0A075B6H7IGKV3-7A0A075B6H7_HUMANProtein IGKV3-7 (Fragment)_>tr|A0A075B6H7|A0A075B6H7_HUMAN Protein IGKV3-7 (Fragment) OS=Homo sapiens GN=IGKV3-7 PE=1 SV=1A0A087WXB8;C9IZL6;C9J480;Q9Y274ST3GAL66A0A087WXB8_HUMAN;C9IZL6_HUMAN;C9J480_HUMAN;SIA10_HUMANST3 beta-galactoside alpha-2,3-sialyltransferase 6, isoform CRA_b;Type 2 lactosamine alpha-2,3-sialyltransferase (Fragment);Type 2 lactosamine alpha-2,3-sialyltransferase (Fragment);Type 2 lactosamine alpha-2,3-sialyltransferase;;;cellular protein modification process,glycolipid metabolic process,oligosaccharide metabolic process,keratan sulfate biosynthetic process,protein N-linked glycosylation via asparagine,cellular response to interleukin-6,sialylationt;;;beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,beta-galactoside alpha-2,3-sialyltransferase activityk;;;Golgi membrane,integral component of membrane,integral component of Golgi membrane,extracellular exosome>tr|A0A087WXB8|A0A087WXB8_HUMAN ST3 beta-galactoside alpha-2,3-sialyltransferase 6, isoform CRA_b OS=Homo sapiens GN=ST3GAL6 PE=1 SV=1;>tr|C9IZL6|C9IZL6_HUMAN Type 2 lactosamine alpha-2,3-sialyltransferase (Fragment) OS=Homo sapiens GN=ST3GAL6 PE=1 SV=1;>tr|C9J480|C9J480_HUMAN Type 2 lactosamine alpha-2,3-sialyltransferase (Fragment) OS=Homo sapiens GN=ST3GAL6 PE=1 SV=1;>sp|Q9Y274|SIA10_HUMAN Type 2 lactosamine alpha-2,3-sialyltransferase OS=Homo sapiens GN=ST3GAL6 PE=1 SV=1A0A087WXM8;P50895BCAMA0A087WXM8_HUMAN;BCAM_HUMANBasal cell adhesion molecule7;cell adhesion,cell-matrix adhesion,signal transduction;transmembrane signaling receptor activity,laminin receptor activity,protein binding,protein C-terminus binding,laminin bindingm;plasma membrane,integral component of plasma membrane,external side of plasma membrane,extracellular exosome>tr|A0A087WXM8|A0A087WXM8_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=1;>sp|P50895|BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=25A0A087X296;P23219;P23219-2;P23219-3;P23219-5;P23219-6PTGS1GA0A087X296_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMANProstaglandin G/H synthase 1;Prostaglandin G/H synthase 1;Isoform 2 of Prostaglandin G/H synthase 1;Isoform 3 of Prostaglandin G/H synthase 1;Isoform 5 of Prostaglandin G/H synthase 1;Isoform 6 of Prostaglandin G/H synthase 1 ;prostaglandin biosynthetic process,lipid metabolic process,xenobiotic metabolic process,inflammatory response,response to oxidative stress,regulation of blood pressure,cyclooxygenase pathway,regulation of cell proliferation,oxidation-reduction process,cellular oxidant detoxification;;;;y;peroxidase activity,prostaglandin-endoperoxide synthase activity,heme binding,metal ion binding,dioxygenase activity;;;;;photoreceptor outer segment,nucleus,cytoplasm,endoplasmic reticulum membrane,Golgi apparatus,organelle membrane,intracellular membrane-bounded organelle,extracellular exosome;;;;!>tr|A0A087X296|A0A087X296_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=1;>sp|P23219|PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2;>sp|P23219-2|PGH1_HUMAN Isoform 2 of Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1;>sp|P23219-3|PGH1_HUMAN Isoform 3 of Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1;>sp|P23219-5|PGH1_HUMAN Isoform 5 of Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1;>sp|P23219-6|PGH1_HUMAN Isoform 6 of Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1A0A0A0MT60;Q5T1M5FKBP15A0A0A0MT60_HUMAN;FKB15_HUMAN<FK506-binding protein 15 (Fragment);FK506-binding protein 158;endocytosis,negative regulation of phosphatase activity;actin binding,protein binding8;early endosome,actin filament,membrane,axon,growth cone>tr|A0A0A0MT60|A0A0A0MT60_HUMAN FK506-binding protein 15 (Fragment) OS=Homo sapiens GN=FKBP15 PE=1 SV=1;>sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens GN=FKBP15 PE=1 SV=2A0A0A0MT80;Q9Y2W3SLC45A1A0A0A0MT80_HUMAN;S45A1_HUMAN=HCG21815, isoform CRA_b;Proton-associated sugar transporter A/;carbohydrate transport,transmembrane transport;symporter activity;integral component of membrane4;2>tr|A0A0A0MT80|A0A0A0MT80_HUMAN HCG21815, isoform CRA_b OS=Homo sapiens GN=SLC45A1 PE=4 SV=1;>sp|Q9Y2W3|S45A1_HUMAN Proton-associated sugar transporter A OS=Homo sapiens GN=SLC45A1 PE=2 SV=4.A0A0G2JI36;A0A0G2JIF2;A0A0G2JL56;P30443;P30455HA0A0G2JI36_HUMAN;A0A0G2JIF2_HUMAN;A0A0G2JL56_HUMAN;1A01_HUMAN;1A36_HUMANHLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-1 alpha chain;HLA class I histocompatibility antigen, A-36 alpha chainS>tr|A0A0G2JI36|A0A0G2JI36_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A0G2JIF2|A0A0G2JIF2_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A0G2JL56|A0A0G2JL56_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>sp|P30443|1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>sp|P30455|1A36_HUMAN HLA class I histocompatibility antigen, A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1A0A1C7CYY4;I3L1K6;P12829MYL4(A0A1C7CYY4_HUMAN;I3L1K6_HUMAN;MYL4_HUMANTMyosin light chain 4 (Fragment);Myosin light chain 4 (Fragment);Myosin light chain 4;;regulation of the force of heart contraction,muscle filament sliding,positive regulation of ATPase activity,cardiac muscle contraction`;;actin monomer binding,calcium ion binding,myosin II heavy chain binding,actin filament binding;;cytosol,myosin complex,A band>tr|A0A1C7CYY4|A0A1C7CYY4_HUMAN Myosin light chain 4 (Fragment) OS=Homo sapiens GN=MYL4 PE=1 SV=1;>tr|I3L1K6|I3L1K6_HUMAN Myosin light chain 4 (Fragment) OS=Homo sapiens GN=MYL4 PE=1 SV=1;>sp|P12829|MYL4_HUMAN Myosin light chain 4 OS=Homo sapiens GN=MYL4 PE=1 SV=3A6NHG4;B5MC82;P30046;P30046-2DDTL;DDT;DDT;DDT-DDTL_HUMAN;B5MC82_HUMAN;DOPD_HUMAN;DOPD_HUMAND-dopachrome decarboxylase-like protein;D-dopachrome decarboxylase;D-dopachrome decarboxylase;Isoform 2 of D-dopachrome decarboxylase;;melanin biosynthetic process;Rlyase activity;;dopachrome isomerase activity,D-dopachrome decarboxylase activity;Acytoplasm,extracellular exosome;;cytoplasm,extracellular exosome; sp;tr;sp;sp2;4;1;1;2;3;\>sp|A6NHG4|DDTL_HUMAN D-dopachrome decarboxylase-like protein OS=Homo sapiens GN=DDTL PE=2 SV=1;>tr|B5MC82|B5MC82_HUMAN D-dopachrome decarboxylase OS=Homo sapiens GN=DDT PE=4 SV=2;>sp|P30046|DOPD_HUMAN D-dopachrome decarboxylase OS=Homo sapiens GN=DDT PE=1 SV=3;>sp|P30046-2|DOPD_HUMAN Isoform 2 of D-dopachrome decarboxylase OS=Homo sapiens GN=DDTA8TX70;A8TX70-2;E9PAL5COL6A5$CO6A5_HUMAN;CO6A5_HUMAN;E9PAL5_HUMAN]Collagen alpha-5(VI) chain;Isoform 2 of Collagen alpha-5(VI) chain;Collagen alpha-5(VI) chain*cell adhesion,collagen catabolic process;;^extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular matrix;;1;;3>sp|A8TX70|CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1;>sp|A8TX70-2|CO6A5_HUMAN Isoform 2 of Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5;>tr|E9PAL5|E9PAL5_HUMAN Collagen alpha-5(VI) chai< n OS=Homo sapiens GN=COL6A5 PE=1 SV=3B1AMW1;P19256;P19256-2;P19256-3CD58-B1AMW1_HUMAN;LFA3_HUMAN;LFA3_HUMAN;LFA3_HUMANCD58 antigen, (Lymphocyte function-associated antigen 3), isoform CRA_c;Lymphocyte function-associated antigen 3;Isoform 2 of Lymphocyte function-associated antigen 3;Isoform 3 of Lymphocyte function-associated antigen 3;cell adhesion,single organismal cell-cell adhesion,heterotypic cell-cell adhesion,neutrophil degranulation,leukocyte migration,cellular response to interferon-gamma,cellular response to tumor necrosis factor,positive regulation of interleukin-8 secretion;;#;receptor binding,protein binding;;;plasma membrane,integral component of plasma membrane,cell surface,membrane,secretory granule membrane,anchored component of membrane,extracellular exosome,ficolin-1-rich granule membrane;;>tr|B1AMW1|B1AMW1_HUMAN CD58 antigen, (Lymphocyte function-associated antigen 3), isoform CRA_c OS=Homo sapiens GN=CD58 PE=1 SV=1;>sp|P19256|LFA3_HUMAN Lymphocyte function-associated antigen 3 OS=Homo sapiens GN=CD58 PE=1 SV=1;>sp|P19256-2|LFA3_HUMAN Isoform 2 of Lymphocyte function-associated antigen 3 OS=Homo sapiens GN=CD58;>sp|P19256-3|LFA3_HUMAN Isoform 3 of Lymphocyte function-associated antigen 3 OS=Homo sapiens GN=CD58E7EVJ5;H7C229;Q96F07-2CYFIP2%E7EVJ5_HUMAN;H7C229_HUMAN;CYFP2_HUMANCytoplasmic FMR1-interacting protein 2;Cytoplasmic FMR1-interacting protein 2;Isoform 2 of Cytoplasmic FMR1-interacting protein 2,>tr|E7EVJ5|E7EVJ5_HUMAN Cytoplasmic FMR1-interacting protein 2 OS=Homo sapiens GN=CYFIP2 PE=1 SV=1;>tr|H7C229|H7C229_HUMAN Cytoplasmic FMR1-interacting protein 2 OS=Homo sapiens GN=CYFIP2 PE=1 SV=2;>sp|Q96F07-2|CYFP2_HUMAN Isoform 2 of Cytoplasmic FMR1-interacting protein 2 OS=Homo sapiens GN=CYFIP2 E9PHK0;P05452CLEC3BE9PHK0_HUMAN;TETN_HUMAN Tetranectin;ossification,platelet degranulation,positive regulation of plasminogen activation,bone mineralization,cellular response to organic substance,cellular response to transforming growth factor beta stimulusP;calcium ion binding,heparin binding,carbohydrate binding,kringle domain binding;granular component,extracellular region,extracellular space,cytoplasm,platelet dense granule lumen,extracellular exosome,extracellular matrix>tr|E9PHK0|E9PHK0_HUMAN Tetranectin OS=Homo sapiens GN=CLEC3B PE=1 SV=1;>sp|P05452|TETN_HUMAN Tetranectin OS=Homo sapiens GN=CLEC3B PE=1 SV=3 E9PK01;P29692EEF1DE9PK01_HUMAN;EF1D_HUMAN>Elongation factor 1-delta (Fragment);Elongation factor 1-delta;transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,cellular response to ionizing radiation;DNA binding,translation elongation factor activity,signal transducer activity,protein binding,translation factor activity, RNA binding,cadherin bindingt;fibrillar center,nucleus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,endoplasmic reticulum>tr|E9PK01|E9PK01_HUMAN Elongation factor 1-delta (Fragment) OS=Homo sapiens GN=EEF1D PE=1 SV=1;>sp|P29692|EF1D_HUMAN Elongation factor 1-delta OS=Homo sapiens GN=EEF1D PE=1 SV=5E9PMR4;E9PRJ3;P48509CD151%E9PMR4_HUMAN;E9PRJ3_HUMAN;CD151_HUMAN0Tetraspanin;Tetraspanin (Fragment);CD151 antigenr;;cell adhesion,cell surface receptor signaling pathway,cell migration,hemidesmosome assembly,T cell proliferationi;;basement membrane,cytosol,plasma membrane,integral component of plasma membrane,focal adhesion,membrane>tr|E9PMR4|E9PMR4_HUMAN Tetraspanin OS=Homo sapiens GN=CD151 PE=1 SV=1;>tr|E9PRJ3|E9PRJ3_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD151 PE=1 SV=1;>sp|P48509|CD151_HUMAN CD151 antigen OS=Homo sapiens GN=CD151 PE=1 SV=3H0Y300 H0Y300_HUMANC>tr|H0Y300|H0Y300_HUMAN Haptoglobin OS=Homo sapiens GN=HP PE=1 SV=4H7BZV8;H7C0C0;Q9Y5Q9GTF3C3%H7BZV8_HUMAN;H7C0C0_HUMAN;TF3C3_HUMANGeneral transcription factor 3C polypeptide 3 (Fragment);General transcription factor 3C polypeptide 3 (Fragment);General transcription factor 3C polypeptide 3;;transcription, DNA-templated,regulation of transcription from RNA polymerase III promoter,transcription from RNA polymerase III promoter,5S class rRNA transcription from RNA polymerase III type 1 promoter,tRNA transcription from RNA polymerase III promoter\;;protein binding,transcription factor activity, core RNA polymerase III binding,DNA bindingT;;transcription factor TFIIIC complex,nucleus,nucleoplasm,nucleolus,nuclear membraneR>tr|H7BZV8|H7BZV8_HUMAN General transcription factor 3C polypeptide 3 (Fragment) OS=Homo sapiens GN=GTF3C3 PE=1 SV=1;>tr|H7C0C0|H7C0C0_HUMAN General transcription factor 3C polypeptide 3 (Fragment) OS=Homo sapiens GN=GTF3C3 PE=1 SV=1;>sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens GN=GTF3C3 PE=1 SV=1B0QYK8;E9PM95;J3KQL8;Q9BQE5APOL22B0QYK8_HUMAN;E9PM95_HUMAN;J3KQL8_HUMAN;APOL2_HUMAN]Apolipoprotein L2 (Fragment);Apolipoprotein L2 (Fragment);Apolipoprotein L2;Apolipoprotein L2;;;lipid metabolic process,lipid transport,acute-phase response,multicellular organism development,cholesterol metabolic process,lipoprotein metabolic process,maternal process involved in female pregnancyK;;;receptor binding,high-density lipoprotein particle binding,lipid binding?;;;extracellular region,endoplasmic reticulum membrane,membrane1;1;2;1H>tr|B0QYK8|B0QYK8_HUMAN Apolipoprotein L2 (Fragment) OS=Homo sapiens GN=APOL2 PE=1 SV=1;>tr|E9PM95|E9PM95_HUMAN Apolipoprotein L2 (Fragment) OS=Homo sapiens GN=APOL2 PE=1 SV=1;>tr|J3KQL8|J3KQL8_HUMAN Apolipoprotein L2 OS=Homo sapiens GN=APOL2 PE=1 SV=2;>sp|Q9BQE5|APOL2_HUMAN Apolipoprotein L2 OS=Homo sapiens GN=APOL2 PE=1 SV=1K7EKE8;Q92692;Q92692-2NECTIN2$K7EKE8_HUMAN;NECT2_HUMAN;NECT2_HUMAN6Nectin-2 (Fragment);Nectin-2;Isoform Alpha of Nectin-2;acrosome assembly,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,positive regulation of immunoglobulin mediated immune response,cytoskeleton organization,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,signal transduction,spermatid development,spermatid nucleus differentiation,cell recognition,fertilization,fusion of virus membrane with host plasma membrane,sperm mitochondrion organization,cell part morphogenesis,positive regulation of mast cell activation,adherens junction organization,susceptibility to natural killer cell mediated cytotoxicity,adhesion of symbiont to host,cilium organization,positive regulation of natural killer cell mediated cytotoxicity,regulation of viral entry into host cell,coreceptor-mediated virion attachment to host cell,regulation of immune response,establishment of mitochondrion localization,susceptibility to T cell mediated cytotoxicity;;virus receptor activity,receptor binding,protein binding,coreceptor activity,identical protein binding,protein homodimerization activity,protein heterodimerization activity,cell adhesion molecule binding;;plasma membrane,integral component of plasma membrane,cell-cell junction,cell-cell adherens junction,zonula adherens,focal adhesion,cell surface,integral component of membrane,cell-cell contact zone,extracellular exosome;>tr|K7EKE8|K7EKE8_HUMAN Nectin-2 (Fragment) OS=Homo sapiens GN=NECTIN2 PE=1 SV=1;>sp|Q92692|NECT2_HUMAN Nectin-2 OS=Homo sapiens GN=NECTIN2 PE=1 SV=1;>sp|Q92692-2|NECT2_HUMAN Isoform Alpha of Nectin-2 OS=Homo sapiens GN=NECTIN2O15551CLDN3 CLD3_HUMAN Claudin-3 response to hypoxia,epithelial cell morphogenesis,signal transduction,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,response to ethanol,protein homooligomerization,protein heterooligomerization,bicellular tight junction assembly`transmembrane signaling receptor activity,structural molecule activity,identical protein bindingcytoplasm,integral component of plasma membrane,bicellular tight junction,integral component of membrane,apicolateral plasma membrane,lateral plasma membrane,extracellular exosomeB>sp|O15551|CLD3_HUMAN Claudi< n-3 OS=Homo sapiens GN=CLDN3 PE=1 SV=1O76013;O76013-2KRT36 KRT36_HUMANHKeratin, type I cuticular Ha6;Isoform 2 of Keratin, type I cuticular Ha6[biological_process,keratinization,regulation of keratinocyte differentiation,cornification;$structural constituent of epidermis;4cytosol,intermediate filament,extracellular exosome;>sp|O76013|KRT36_HUMAN Keratin, type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=2 SV=1;>sp|O76013-2|KRT36_HUMAN Isoform 2 of Keratin, type I cuticular Ha6 OS=Homo sapiens GN=KRT36P00492HPRT1 HPRT_HUMAN.Hypoxanthine-guanine phosphoribosyltransferase:response to amphetamine,purine nucleotide biosynthetic process,purine ribonucleoside salvage,adenine salvage,guanine salvage,grooming behavior,locomotory behavior,cytolysis,striatum development,cerebral cortex neuron differentiation,central nervous system neuron development,IMP salvage,dopamine metabolic process,purine-containing compound salvage,hypoxanthine salvage,positive regulation of dopamine metabolic process,GMP catabolic process,IMP metabolic process,hypoxanthine metabolic process,lymphocyte proliferation,dendrite morphogenesis,protein homotetramerizationnucleotide binding,magnesium ion binding,hypoxanthine phosphoribosyltransferase activity,protein binding,identical protein binding,protein homodimerization activity,guanine phosphoribosyltransferase activityg>sp|P00492|HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2P01619IGKV3-20 KV320_HUMAN"Immunoglobulin kappa variable 3-20_>sp|P01619|KV320_HUMAN Immunoglobulin kappa variable 3-20 OS=Homo sapiens GN=IGKV3-20 PE=1 SV=2P06576ATP5B ATPB_HUMAN(ATP synthase subunit beta, mitochondrialiangiogenesis,osteoblast differentiation,generation of precursor metabolites and energy,lipid metabolic process,ATP biosynthetic process,negative regulation of cell adhesion involved in substrate-bound cell migration,mitochondrion organization,proton transport,mitochondrial ATP synthesis coupled proton transport,regulation of intracellular pH,Requires Ontologytransporter activity,protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism,ATPase activity-nucleus,mitochondrion,mitochondrial proton-transporting ATP synthase complex,mitochondrial proton-transporting ATP synthase, catalytic core,mitochondrial matrix,plasma membrane,cell surface,membrane,extracellular matrix,mitochondrial membrane,mitochondrial nucleoid,myelin sheath,extracellular exosomea>sp|P06576|ATPB_HUMAN ATP synthase subunit beta, mitochondrial OS=Homo sapiens GN=ATP5B PE=1 SV=3P06858LPL LIPL_HUMANLipoprotein lipaseretinoid metabolic process,fatty acid biosynthetic process,triglyceride metabolic process,phospholipid metabolic process,response to cold,response to glucose,positive regulation of macrophage derived foam cell differentiation,positive regulation of cholesterol storage,positive regulation of sequestering of triglyceride,triglyceride biosynthetic process,triglyceride catabolic process,chylomicron remodeling,very-low-density lipoprotein particle remodeling,lipoprotein metabolic process,response to drug,cholesterol homeostasis,positive regulation of inflammatory response,low-density lipoprotein particle mediated signaling,triglyceride homeostasis,positive regulation of chemokine secretionlipoprotein lipase activity,phospholipase activity,triglyceride lipase activity,receptor binding,protein binding,heparin binding,triglyceride binding,apolipoprotein bindingextracellular region,extracellular space,plasma membrane,cell surface,extracellular matrix,anchored component of membrane,very-low-density lipoprotein particle,chylomicron,extracellular exosomeI>sp|P06858|LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 B2RNN3;P0C862C1QTNF9B;C1QTNF9C1T9B_HUMAN;C1T9A_HUMANwComplement C1q and tumor necrosis factor-related protein 9B;Complement C1q and tumor necrosis factor-related protein 9AJprotein binding;hormone activity,protein binding,identical protein bindingJcollagen trimer,extracellular exosome;extracellular region,collagen trimer>sp|B2RNN3|C1T9B_HUMAN Complement C1q and tumor necrosis factor-related protein 9B OS=Homo sapiens GN=C1QTNF9B PE=1 SV=1;>sp|P0C862|C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens GN=C1QTNF9 PE=1 SV=1P11233RALA RALA_HUMANRas-related protein Ral-Acytokinesis,neural tube closure,exocytosis,chemotaxis,signal transduction,Ras protein signal transduction,viral process,regulation of exocytosis,actin cytoskeleton reorganization,positive regulation of filopodium assembly,membrane raft localization,membrane organizationGTPase activity,protein binding,GTP binding,myosin binding,GDP binding,ubiquitin protein ligase binding,Edg-2 lysophosphatidic acid receptor binding,ATPase bindingplasma membrane,focal adhesion,cell surface,midbody,cytoplasmic vesicle membrane,cleavage furrow,myelin sheath,extracellular exosome,endocytic vesicleQ>sp|P11233|RALA_HUMAN Ras-related protein Ral-A OS=Homo sapiens GN=RALA PE=1 SV=1P12429ANXA3 ANXA3_HUMAN Annexin A3phagocytosis,positive regulation of endothelial cell migration,hippocampus development,animal organ regeneration,defense response to bacterium,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of angiogenesis,positive regulation of DNA metabolic process,positive regulation of sequence-specific DNA binding transcription factor activity,response to glucocorticoid,response to growth factorcalcium ion binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,calcium-dependent protein bindingcytoplasm,cytosol,plasma membrane,membrane,axon,dendrite,phagocytic vesicle membrane,specific granule,neuronal cell body,extracellular exosomeD>sp|P12429|ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANXA3 PE=1 SV=3P13497BMP1 BMP1_HUMANBone morphogenetic protein 1skeletal system development,cartilage condensation,ossification,proteolysis,multicellular organism development,extracellular matrix disassembly,cell differentiation,lipoprotein metabolic process,positive regulation of cartilage developmentmetalloendopeptidase activity,serine-type endopeptidase activity,cytokine activity,calcium ion binding,protein binding,growth factor activity,peptidase activity,metallopeptidase activity,zinc ion bindingcextracellular region,proteinaceous extracellular matrix,extracellular space,Golgi apparatus,vesicleT>sp|P13497|BMP1_HUMAN Bone morphogenetic protein 1 OS=Homo sapiens GN=BMP1 PE=1 SV=2P13639EEF2 EF2_HUMANElongation factor 2Uhematopoietic progenitor cell differentiation,response to ischemia,skeletal muscle contraction,translational elongation,protein methylation,aging,glial cell proliferation,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,response to estradiol,response to endoplasmic reticulum stress,skeletal muscle cell differentiation,response to drug,response to hydrogen peroxide,neutrophil degranulation,response to ethanol,positive regulation of translation,response to folic acid,cellular response to brain-derived neurotrophic factor stimulus,positive regulation of cytoplasmic translationp53 binding,RNA binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,5S rRNA binding,protein kinase binding,ribosome binding,cadherin binding,actin filament bindingextracellular region,nucleus,cytoplasm,cytosol,plasma membrane,membrane,aggresome,intracellular ribonucleoprotein complex,extracellular matrix,secretory granule lumen,polysomal ribosome,membrane raft,extracellular exosome,ficolin-1-rich granule lumenJ>sp|P13639|EF2_HUMAN Elongation factor 2 OS=Homo sapiens GN=EEF2 PE=1 SV=41H7C5W9;P16615;P16615-2;P16615-3;P16615-4;P16615-5ATP2A2HH7C5W9_HUMAN;AT2A2_HUMAN;AT2A2_HUMAN;AT2A2_HUMAN;AT2A2_HUMAN;AT2A2_HUMANvSarcoplasmic/endoplasmic reticulum calcium ATPase 2 (Fragment);Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;Isoform < 2 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;Isoform 3 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;Isoform 4 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2;Isoform 5 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2A;regulation of the force of heart contraction,ER-nucleus signaling pathway,organelle organization,cell adhesion,epidermis development,positive regulation of heart rate,regulation of cardiac muscle contraction by calcium ion signaling,transition between fast and slow fiber,cardiac muscle hypertrophy in response to stress,endoplasmic reticulum calcium ion homeostasis,positive regulation of endoplasmic reticulum calcium ion concentration,T-tubule organization,ion transmembrane transport,cellular response to oxidative stress,response to endoplasmic reticulum stress,negative regulation of heart contraction,relaxation of cardiac muscle,sarcoplasmic reticulum calcium ion transport,calcium ion transmembrane transport,regulation of cardiac muscle cell membrane potential,regulation of cardiac muscle cell action potential involved in regulation of contraction,Requires Ontology,regulation of calcium ion-dependent exocytosis of neurotransmitter,calcium ion transport from cytosol to endoplasmic reticulum,regulation of cardiac conduction,calcium ion import into sarcoplasmic reticulum;;;;;calcium-transporting ATPase activity,calcium ion binding,protein binding,ATP binding,enzyme binding,lutropin-choriogonadotropic hormone receptor binding,S100 protein binding,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential;;;;^;nucleoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,integral component of plasma membrane,vesicle membrane,membrane,sarcoplasmic reticulum,platelet dense tubular network membrane,extrinsic component of cytoplasmic side of plasma membrane,sarcoplasmic reticulum membrane,protein complex,perinuclear region of cytoplasm,ribbon synapse;;;;>tr|H7C5W9|H7C5W9_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (Fragment) OS=Homo sapiens GN=ATP2A2 PE=1 SV=1;>sp|P16615|AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1;>sp|P16615-2|AT2A2_HUMAN Isoform 2 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2;>sp|P16615-3|AT2A2_HUMAN Isoform 3 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2;>sp|P16615-4|AT2A2_HUMAN Isoform 4 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2;>sp|P16615-5|AT2A2_HUMAN Isoform 5 of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2E9PDY4;P17927;Q5SR44CR1#E9PDY4_HUMAN;CR1_HUMAN;Q5SR44_HUMANComplement receptor type 1;complement receptor mediated signaling pathway,complement activation, classical pathway,regulation of complement activation,neutrophil degranulation,innate immune response,negative regulation of complement activation, alternative pathway,negative regulation of complement activation, classical pathway,viral entry into host cell,negative regulation of serine-type endopeptidase activity,positive regulation of serine-type endopeptidase activity;;virus receptor activity,complement component C3b binding,complement component C4b binding,complement component C4b receptor activity,complement component C3b receptor activity;;plasma membrane,integral component of plasma membrane,cell surface,secretory granule membrane,extracellular exosome,ficolin-1-rich granule membrane;1;3;1>tr|E9PDY4|E9PDY4_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=1;>sp|P17927|CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3;>tr|Q5SR44|Q5SR44_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=1P20701;P20701-2;P20701-3ITGAL ITAL_HUMANLIntegrin alpha-L;Isoform 2 of Integrin alpha-L;Isoform 3 of Integrin alpha-LT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,phagocytosis,movement of cell or subcellular component,inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,signal transduction,integrin-mediated signaling pathway,extracellular matrix organization,receptor clustering,neutrophil degranulation,regulation of immune response,leukocyte migration;;protein binding,ICAM-3 receptor activity,protein complex binding,metal ion binding,protein heterodimerization activity,cell adhesion molecule binding;;plasma membrane,integrin complex,cell surface,membrane,integrin alphaL-beta2 complex,specific granule membrane,extracellular exosome;;>sp|P20701|ITAL_HUMAN Integrin alpha-L OS=Homo sapiens GN=ITGAL PE=1 SV=3;>sp|P20701-2|ITAL_HUMAN Isoform 2 of Integrin alpha-L OS=Homo sapiens GN=ITGAL;>sp|P20701-3|ITAL_HUMAN Isoform 3 of Integrin alpha-L OS=Homo sapiens GN=ITGALP28070PSMB4 PSB4_HUMANProteasome subunit beta type-4MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,negative regulation of inflammatory response to antigenic stimulus,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayPlipopolysaccharide binding,threonine-type endopeptidase activity,protein bindingW>sp|P28070|PSB4_HUMAN Proteasome subunit beta type-4 OS=Homo sapiens GN=PSMB4 PE=1 SV=4P02462;P02462-2COL4A1 CO4A1_HUMANBCollagen alpha-1(IV) chain;Isoform 2 of Collagen alpha-1(IV) chainpatterning of blood vessels,brain development,neuromuscular junction development,extracellular matrix organization,collagen catabolic process,epithelial cell differentiation,collagen-activated tyrosine kinase receptor signaling pathway,blood vessel morphogenesis,retinal blood vessel morphogenesis,renal tubule morphogenesis,cellular response to amino acid stimulus,basement membrane organization;extracellular matrix structural constituent,protein binding,extracellular matrix constituent conferring elasticity,platelet-derived growth factor binding;extracellular region,collagen type IV trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,extracellular matrix;>sp|P02462|CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3;>sp|P02462-2|CO4A1_HUMAN Isoform 2 of Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 P30085;Q5T0D2CMPK1KCY_HUMAN;Q5T0D2_HUMANUMP-CMP kinase/nucleoside diphosphate phosphorylation,'de novo' pyrimidine nucleobase biosynthetic process,UMP biosynthetic process,nucleoside triphosphate biosynthetic process,pyrimidine ribonucleotide biosynthetic process,nucleobase-containing small molecule interconversion,nucleoside monophosphate phosphorylation;cytidylate kinase activity,nucleoside diphosphate kinase activity,uridine kinase activity,ATP binding,uridylate kinase activity,nucleoside phosphate kinase activity;:nucleus,nucleolus,cytoplasm,cytosol,extracellular exosome;>sp|P30085|KCY_HUMAN UMP-CMP kinase OS=Homo sapiens GN=CMPK1 PE=1 SV=3;>tr|Q5T0D2|Q5T0D2_HUMAN UMP-CMP kinase OS=Homo sapiens GN=CMPK1 PE=1 SV=1P49257LMAN1 LMAN1_HUMA< NProtein ERGIC-53:protein folding,ER to Golgi vesicle-mediated transport,endoplasmic reticulum organization,Golgi organization,blood coagulation,positive regulation of organelle organization,protein N-linked glycosylation via asparagine,COPII vesicle coating,protein exit from endoplasmic reticulum,early endosome to Golgi transportJprotein binding,mannose binding,metal ion binding,unfolded protein binding9Golgi membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,ER to Golgi transport vesicle membrane,membrane,integral component of membrane,sarcomere,endoplasmic reticulum-Golgi intermediate compartment membrane,host cell perinuclear region of cytoplasm,extracellular exosomeJ>sp|P49257|LMAN1_HUMAN Protein ERGIC-53 OS=Homo sapiens GN=LMAN1 PE=1 SV=2H3BNT7;H3BTM8;P51665PSMD7%H3BNT7_HUMAN;H3BTM8_HUMAN;PSMD7_HUMAN.26S proteasome non-ATPase regulatory subunit 7;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway3;;protein binding,protein homodimerization activity;;proteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen<>tr|H3BNT7|H3BNT7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens GN=PSMD7 PE=1 SV=1;>tr|H3BTM8|H3BTM8_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens GN=PSMD7 PE=1 SV=1;>sp|P51665|PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens GN=PSMD7 PE=1 SV=2P60985KRTDAP KTDAP_HUMAN/Keratinocyte differentiation-associated proteincell differentiationj>sp|P60985|KTDAP_HUMAN Keratinocyte differentiation-associated protein OS=Homo sapiens GN=KRTDAP PE=1 SV=1P61225RAP2B RAP2B_HUMANRas-related protein Rap-2bBsignal transduction,platelet activation,negative regulation of cell migration,positive regulation of protein autophosphorylation,Rap protein signal transduction,neutrophil degranulation,regulation of protein tyrosine kinase activity,platelet aggregation,microvillus assembly,establishment of endothelial intestinal barrierGprotein binding,GTP binding,GDP binding,protein domain specific bindingcytosol,plasma membrane,bicellular tight junction,membrane,specific granule membrane,cell-cell contact zone,membrane raft,recycling endosome membrane,extracellular exosome,tertiary granule membraneT>sp|P61225|RAP2B_HUMAN Ras-related protein Rap-2b OS=Homo sapiens GN=RAP2B PE=1 SV=1P81605DCD DCD_HUMAN Dermcidinproteolysis,antimicrobial humoral response,killing of cells of other organism,defense response to bacterium,defense response to fungus.RNA binding,protein binding,peptidase activity?extracellular region,extracellular matrix,extracellular exosome?>sp|P81605|DCD_HUMAN Dermcidin OS=Homo sapiens GN=DCD PE=1 SV=2Q13200PSMD2 PSMD2_HUMAN.26S proteasome non-ATPase regulatory subunit 2MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayproteasome complex,extracellular region,nucleoplasm,cytosol,proteasome regulatory particle,membrane,proteasome accessory complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenh>sp|Q13200|PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens GN=PSMD2 PE=1 SV=3Q13464ROCK1 ROCK1_HUMANRho-associated protein kinase 1apical constriction,protein phosphorylation,smooth muscle contraction,leukocyte cell-cell adhesion,signal transduction,I-kappaB kinase/NF-kappaB signaling,Rho protein signal transduction,negative regulation of angiogenesis,membrane to membrane docking,actin cytoskeleton organization,regulation of cell adhesion,cortical actin cytoskeleton organization,bleb assembly,negative regulation of protein binding,regulation of actin cytoskeleton organization,negative regulation of myosin-light-chain-phosphatase activity,neutrophil degranulation,negative regulation of neuron apoptotic process,regulation of keratinocyte differentiation,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,leukocyte migration,leukocyte tethering or rolling,myoblast migration,regulation of stress fiber assembly,regulation of focal adhesion assembly,positive regulation of focal adhesion assembly,establishment of protein localization to plasma membrane,execution phase of apoptosis,regulation of establishment of endothelial barrier,negative regulation of bicellular tight junction assembly,regulation of establishment of cell polarity,regulation of cell motility~protein kinase activity,protein serine/threonine kinase activity,protein binding,ATP binding,GTP-Rho binding,metal ion bindingGolgi membrane,ruffle,extracellular region,centriole,cytosol,cytoskeleton,plasma membrane,lamellipodium,bleb,secretory granule lumenY>sp|Q13464|ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1Q13637RAB32 RAB32_HUMANRas-related protein Rab-32mitochondrion organization,small GTPase mediated signal transduction,vesicle-mediated transport,antigen processing and presentation,endosome to melanosome transport,membrane organization,protein localization to membrane,phagosome maturation,melanosome assemblyGTPase activity,protein binding,GTP binding,GTP-dependent protein binding,AP-1 adaptor complex binding,AP-3 adaptor complex binding,BLOC-2 complex binding,AP-2 adaptor complex bindingmitochondrion,mitochondrial outer membrane,early endosome,endoplasmic reticulum,trans-Golgi network,cytosol,membrane,phagocytic vesicle membrane,melanosome membrane,melanosome,ER-mitochondrion membrane contact site,phagocytic vesicle,early endosome lumenT>sp|Q13637|RAB32_HUMAN Ras-related protein Rab-32 OS=Homo sapiens GN=RAB32 PE=1 SV=3Q14974KPNB1 IMB1_HUMANImportin subunit beta-1protein import into nucleus, translocation,apoptotic DNA fragmentation,protein import into nucleus,NLS-bearing protein im< port into nucleus,ribosomal protein import into nucleus,mitotic chromosome movement towards spindle pole,mitotic metaphase plate congression,modulation by virus of host process,astral microtubule organization,Ran protein signal transduction,establishment of mitotic spindle localization,neutrophil degranulation,establishment of protein localization,intracellular transport of virus,mitotic spindle assemblyRNA binding,protein binding,nuclear localization sequence binding,zinc ion binding,Ran GTPase binding,protein transporter activity,enzyme binding,protein domain specific binding,Hsp90 protein bindingextracellular region,nuclear envelope,nuclear pore,nucleoplasm,cytoplasm,cytosol,membrane,nuclear membrane,nuclear periphery,specific granule lumen,extracellular exosome,endoplasmic reticulum tubular network,ficolin-1-rich granule lumenP>sp|Q14974|IMB1_HUMAN Importin subunit beta-1 OS=Homo sapiens GN=KPNB1 PE=1 SV=2Q15389;Q15389-2ANGPT1 ANGP1_HUMAN*Angiopoietin-1;Isoform 2 of Angiopoietin-1IMAPK cascade,in utero embryonic development,negative regulation of protein phosphorylation,sprouting angiogenesis,positive regulation of receptor internalization,negative regulation of cytokine secretion involved in immune response,negative regulation of cell adhesion,activation of transmembrane receptor protein tyrosine kinase activity,positive regulation of endothelial cell migration,positive regulation of phosphatidylinositol 3-kinase signaling,regulation of skeletal muscle satellite cell proliferation,hemopoiesis,cell differentiation,heparin biosynthetic process,positive regulation of protein ubiqu itination,cell-substrate adhesion,regulation of tumor necrosis factor production,positive regulation of peptidyl-serine phosphorylation,protein localization to cell surface,negative regulation of protein import into nucleus,negative regulation of apoptotic process,negative regulation of vascular permeability,regulation of I-kappaB kinase/NF-kappaB signaling,regulation of protein binding,negative regulation of neuron apoptotic process,positive regulation of blood vessel endothelial cell migration,positive regulation of GTPase activity,positive regulation of cell adhesion,Tie signaling pathway,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive chemotaxis,positive regulation of protein kinase B signaling,positive regulation of ERK1 and ERK2 cascade,glomerulus vasculature development,negative regulation of endothelial cell apoptotic process,regulation of macrophage migration inhibitory factor signaling pathway,regulation of endothelial cell proliferation;PRas guanyl-nucleotide exchange factor activity,receptor tyrosine kinase binding;wextracellular region,extracellular space,intracellular,plasma membrane,microvillus,membrane raft,extracellular exosome;>sp|Q15389|ANGP1_HUMAN Angiopoietin-1 OS=Homo sapiens GN=ANGPT1 PE=1 SV=2;>sp|Q15389-2|ANGP1_HUMAN Isoform 2 of Angiopoietin-1 OS=Homo sapiens GN=ANGPT1Q15843NEDD8 NEDD8_HUMAN_regulation of transcription from RNA polymerase II promoter,cellular protein modification process,proteolysis,ubiquitin-dependent protein catabolic process,transforming growth factor beta receptor signaling pathway,protein localization,anatomical structure morphogenesis,response to organic cyclic compound,protein deubiquitination,protein neddylation0protein binding,ubiquitin protein ligase binding?>sp|Q15843|NEDD8_HUMAN NEDD8 OS=Homo sapiens GN=NEDD8 PE=1 SV=1 A6QRJ1;Q15904ATP6AP1A6QRJ1_HUMAN;VAS1_HUMANJV-type proton ATPase subunit S1 (Fragment);V-type proton ATPase subunit S1;insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,transferrin transport,ion transmembrane transport,positive regulation of osteoblast differentiation,positive regulation of bone resorption,pH reduction,positive regulation of exocytosis,establishment of organelle localization,positive regulation of ERK1 and ERK2 cascade,positive regulation of osteoclast development;transporter activity,ATP binding,Rab GTPase binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism;endoplasmic reticulum membrane,endosome membrane,integral component of membrane,proton-transporting two-sector ATPase complex,endoplasmic reticulum-Golgi intermediate compartment membrane,proton-transporting V-type ATPase, V1 domain,extracellular exosome>tr|A6QRJ1|A6QRJ1_HUMAN V-type proton ATPase subunit S1 (Fragment) OS=Homo sapiens GN=ATP6AP1 PE=1 SV=1;>sp|Q15904|VAS1_HUMAN V-type proton ATPase subunit S1 OS=Homo sapiens GN=ATP6AP1 PE=1 SV=2K7EL47;K7EQZ5;Q16853;Q16853-3AOC3/K7EL47_HUMAN;K7EQZ5_HUMAN;AOC3_HUMAN;AOC3_HUMAN|Amine oxidase (Fragment);Amine oxidase (Fragment);Membrane primary amine oxidase;Isoform 3 of Membrane primary amine oxidase;;xenobiotic metabolic process,inflammatory response,cell adhesion,amine metabolic process,response to antibiotic,oxidation-reduction process;|;;copper ion binding,calcium ion binding,protein binding,primary amine oxidase activity,protein homodimerization activity,protein heterodimerization activity,quinone binding,tryptamine:oxygen oxidoreductase (deaminating) activity,aminoacetone:oxygen oxidoreductase(deaminating) activity,aliphatic-amine oxidase activity,phenethylamine:oxygen oxidoreductase (deaminating) activity;;;cytoplasm,early endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,microvillus,cell surface,integral component of membrane;X>tr|K7EL47|K7EL47_HUMAN Amine oxidase (Fragment) OS=Homo sapiens GN=AOC3 PE=1 SV=1;>tr|K7EQZ5|K7EQZ5_HUMAN Amine oxidase (Fragment) OS=Homo sapiens GN=AOC3 PE=1 SV=1;>sp|Q16853|AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3;>sp|Q16853-3|AOC3_HUMAN Isoform 3 of Membrane primary amine oxidase OS=Homo sapiens GN=AOC3Q5T749KPRP KPRP_HUMAN!Keratinocyte proline-rich proteincytoplasm,extracellular exosomeY>sp|Q5T749|KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1Q5VY43PEAR1 PEAR1_HUMAN+Platelet endothelial aggregation receptor 1Lrecognition of apoptotic cell,negative regulation of Notch signaling pathway-phagocytic cup,integral component of membranee>sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens GN=PEAR1 PE=1 SV=1Q71U36;Q71U36-2TUBA1A TBA1A_HUMAN:Tubulin alpha-1A chain;Isoform 2 of Tubulin alpha-1A chainG2/M transition of mitotic cell cycle,cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division,ciliary basal body docking;GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,protein domain specific binding;nucleus,cytosol,microtubule,cytoplasmic microtubule,microtubule cytoskeleton,cytoplasmic ribonucleoprotein granule,myelin sheath,recycling endosome,extracellular exosome;>sp|Q71U36|TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1;>sp|Q71U36-2|TBA1A_HUMAN Isoform 2 of Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1AQ7Z434;Q7Z434-2;Q7Z434-5MAVS MAVS_HUMANMitochondrial antiviral-signaling protein;Isoform 2 of Mitochondrial antiviral-signaling protein;Isoform 5 of Mitochondrial antiviral-signaling proteinpositive regulation of protein phosphorylation,activation of innate immune response,positive regulation of defense response to virus by host,signal transduction,protein deubiquitination,negative regulation of type I interferon production,positive regulation of interferon-alpha production,positive regulation of interferon-beta production,positive regulation of interleukin-8 production,positive regulation of tumor necrosis factor production,positive regulation of protein import into nucleus, translocation,RIG-I signaling pathway,defense response to bacterium,positive regulation of transcription factor import into nucleus,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of viral genome replication,innate immune response,positive regulation of transcription from RNA polymerase II promoter,positive regulation of se< quence-specific DNA binding transcription factor activity,defense response to virus,positive regulation of type I interferon-mediated signaling pathway,cellular response to exogenous dsRNA,positive regulation of chemokine (C-C motif) ligand 5 production,positive regulation of IP-10 production,regulation of peroxisome organization;;Wsignal transducer activity,protein binding,protein kinase binding,CARD domain binding;;wmitochondrion,mitochondrial outer membrane,peroxisomal membrane,integral component of membrane,mitochondrial membrane;;/>sp|Q7Z434|MAVS_HUMAN Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS PE=1 SV=2;>sp|Q7Z434-2|MAVS_HUMAN Isoform 2 of Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS;>sp|Q7Z434-5|MAVS_HUMAN Isoform 5 of Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVSQ86UP2;Q86UP2-2;Q86UP2-4KTN1 KTN1_HUMAN4Kinectin;Isoform 2 of Kinectin;Isoform 4 of Kinectinmicrotubule-based movement;;>RNA binding,protein binding,kinesin binding,cadherin binding;;endoplasmic reticulum,endoplasmic reticulum membrane,integral component of plasma membrane,membrane,integral component of membrane;;>sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens GN=KTN1 PE=1 SV=1;>sp|Q86UP2-2|KTN1_HUMAN Isoform 2 of Kinectin OS=Homo sapiens GN=KTN1;>sp|Q86UP2-4|KTN1_HUMAN Isoform 4 of Kinectin OS=Homo sapiens GN=KTN1Q86X55;Q86X55-1CARM1 CARM1_HUMAN^Histone-arginine methyltransferase CARM1;Isoform 1 of Histone-arginine methyltransferase CARM1regulation of growth plate cartilage chondrocyte proliferation,transcription, DNA-templated,regulation of transcription, DNA-templated,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,aging,positive regulation of cell proliferation,viral process,histone methylation,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,intracellular estrogen receptor signaling pathway,negative regulation of protein binding,regulation of intracellular estrogen receptor signaling pathway,histone H3-R2 methylation,histone H3-R17 methylation,cellular lipid metabolic process,positive regulation of fat cell differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of NF-kappaB transcription factor activity,response to cAMP,endochondral bone morphogenesis,protein localization to chromatin,regulation of mRNA binding,negative regulation of dendrite development;HRNA polymerase II transcription coactivator activity,transcription coactivator activity,protein binding,beta-catenin binding,protein methyltransferase activity,histone-arginine N-methyltransferase activity,protein-arginine N-methyltransferase activity,ligand-dependent nuclear receptor transcription coactivator activity,protein-arginine omega-N asymmetric methyltransferase activity,histone methyltransferase activity (H3-R17 specific),histone methyltransferase activity,protein homodimerization activity,transcription regulatory region DNA binding,lysine-acetylated histone binding;Unucleus,nucleoplasm,cytoplasm,cytosol,RNA polymerase II transcription factor complex;>sp|Q86X55|CARM1_HUMAN Histone-arginine methyltransferase CARM1 OS=Homo sapiens GN=CARM1 PE=1 SV=3;>sp|Q86X55-1|CARM1_HUMAN Isoform 1 of Histone-arginine methyltransferase CARM1 OS=Homo sapiens GN=CARM1Q9BV40VAMP8 VAMP8_HUMAN%Vesicle-associated membrane protein 8antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,post-Golgi vesicle-mediated transport,vesicle fusion,protein transport,autophagosome docking,neutrophil degranulation,viral entry into host cell,membrane organization,regulation of molecular function,mucus secretion,autophagosome maturation,regulation of protein localization to plasma membrane,negative regulation of secretion by cell,positive regulation of histamine secretion by mast cell,eosinophil degranulationcytoplasm,lysosomal membrane,early endosome,cytosol,plasma membrane,membrane,integral component of membrane,clathrin-coated vesicle membrane,secretory granule membrane,phagocytic vesicle membrane,SNARE complex,early endosome membrane,late endosome membrane,vesicle,azurophil granule membrane,specific granule membrane,perinuclear region of cytoplasm,recycling endosome,recycling endosome membrane,extracellular exosome,tertiary granule membrane,mucin granule_>sp|Q9BV40|VAMP8_HUMAN Vesicle-associated membrane protein 8 OS=Homo sapiens GN=VAMP8 PE=1 SV=1Q9UHA4LAMTOR3 LTOR3_HUMAN!Ragulator complex protein LAMTOR3MAPK cascade,activation of MAPKK activity,cell cycle arrest,macroautophagy,positive regulation of TOR signaling,cellular protein localization,neutrophil degranulation,positive regulation of GTPase activity,cellular response to amino acid stimulusmprotein binding,kinase activator activity,guanyl-nucleotide exchange factor activity,protein complex scaffoldlysosomal membrane,plasma membrane,focal adhesion,endosome membrane,specific granule membrane,extracellular exosome,tertiary granule membrane,Ragulator complex]>sp|Q9UHA4|LTOR3_HUMAN Ragulator complex protein LAMTOR3 OS=Homo sapiens GN=LAMTOR3 PE=1 SV=1 K7EQB1;Q9UNK0STX8K7EQB1_HUMAN;STX8_HUMAN Syntaxin-8;transport,intracellular protein transport,vesicle fusion,endosome to lysosome transport,early endosome to late endosome transport,vesicle docking,regulation of molecular function,regulation of protein localization to plasma membrane};SNAP receptor activity,protein binding,chloride channel inhibitor activity,syntaxin binding,ubiquitin protein ligase binding;lysosomal membrane,endosome,early endosome,late endosome,endoplasmic reticulum,trans-Golgi network,cytosol,integral component of plasma membrane,SNARE complex,late endosome membrane,vesicle,perinuclear region of cytoplasm,recycling endosome>tr|K7EQB1|K7EQB1_HUMAN Syntaxin-8 OS=Homo sapiens GN=STX8 PE=1 SV=1;>sp|Q9UNK0|STX8_HUMAN Syntaxin-8 OS=Homo sapiens GN=STX8 PE=1 SV=2Q9Y5Y7LYVE1 LYVE1_HUMAN7Lymphatic vessel endothelial hyaluronic acid receptor 1transport,movement of cell or subcellular component,cell-matrix adhesion,signal transduction,response to wounding,anatomical structure morphogenesis,hyaluronan catabolic processcreceptor activity,transmembrane signaling receptor activity,protein binding,hyaluronic acid bindingTplasma membrane,integral component of plasma membrane,membrane,extracellular exosomeq>sp|Q9Y5Y7|LYVE1_HUMAN Lymphatic vessel endothelial hyaluronic acid receptor 1 OS=Homo sapiens GN=LYVE1 PE=1 SV=2A0A024QZX5;A0A087X1N8;P35237SERPINB6,A0A024QZX5_HUMAN;A0A087X1N8_HUMAN;SPB6_HUMAN Serpin B6;;sensory perception of sound,negative regulation of endopeptidase activity,neutrophil degranulation,cellular response to osmotic stress?;;protease binding,serine-type endopeptidase inhibitor activity;;extracellular space,cytoplasm,cytosol,plasma membrane,secretory granule membrane,protein complex,extracellular exosome,tertiary granule membrane,ficolin-1-rich granule membrane,nucleus>tr|A0A024QZX5|A0A024QZX5_HUMAN Serpin B6 OS=Homo sapiens GN=SERPINB6 PE=1 SV=1;>tr|A0A087X1N8|A0A087X1N8_HUMAN Serpin B6 OS=Homo sapiens GN=SERPINB6 PE=1 SV=1;>sp|P35237|SPB6_HUMAN Serpin B6 OS=Homo sapiens GN=SERPINB6 PE=1 SV=3 A0A087WSY6 IGKV3D-15A0A087WSY6_HUMANProtein IGKV3D-15 (Fragment)c>tr|A0A087WSY6|A0A087WSY6_HUMAN Protein IGKV3D-15 (Fragment) OS=Homo sapiens GN=IGKV3D-15 PE=1 SV=6>A0A087WU43;A0A087WX17;A0A087WXI5;H3BNC6;H3BVI7;P12830;P12830-2CDH1dA0A087WU43_HUMAN;A0A087WX17_HUMAN;A0A087WXI5_HUMAN;H3BNC6_HUMAN;H3BVI7_HUMAN;CADH1_HUMAN;CADH1_HUMANYCadherin-1;Cadherin-1;Cadherin-1;Cadherin-1;Cadherin-1;Cadherin-1;Isoform 2 of Cadherin-1;;;;;homophilic cell adhesion via plasma membrane adhesion molecules,synapse assembly,response to toxic substance,single organismal cell-cell adhesion,pituitary gland development,negative regulation of cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,neuron projection development,adherens junction organization,entry of bacterium into host cell,response to drug,positive regulation of transcription factor import into nucleus,positive r< egulation of transcription, DNA-templated,cellular response to lithium ion,cellular response to indole-3-methanol,protein localization to plasma membrane,establishment of protein localization to plasma membrane;;;;;;glycoprotein binding,calcium ion binding,protein binding,beta-catenin binding,ankyrin binding,GTPase activating protein binding,gamma-catenin binding,cadherin binding,cell adhesion molecule binding;y;;;;;extracellular region,endosome,trans-Golgi network,plasma membrane,cell-cell adherens junction,cytoplasmic side of plasma membrane,actin cytoskeleton,integral component of membrane,lateral plasma membrane,catenin complex,flotillin complex,lamellipodium,cell junction,apical junction complex,perinuclear region of cytoplasm,extracellular exosome,cortical actin cytoskeleton; 1;1;1;1;1;3;>tr|A0A087WU43|A0A087WU43_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=1;>tr|A0A087WX17|A0A087WX17_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=1;>tr|A0A087WXI5|A0A087WXI5_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=1;>tr|H3BNC6|H3BNC6_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=1;>tr|H3BVI7|H3BVI7_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=1;>sp|P12830|CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3;>sp|P12830-2|CADH1_HUMAN Isoform 2 of Cadherin-1 OS=Homo sapiens GN=CDH1!A0A0A0MS45;J3KNI1;Q9H9E3;Q9H9E3-3COG43A0A0A0MS45_HUMAN;J3KNI1_HUMAN;COG4_HUMAN;COG4_HUMANConserved oligomeric Golgi complex subunit 4;Conserved oligomeric Golgi complex subunit 4;Conserved oligomeric Golgi complex subunit 4;Isoform 3 of Conserved oligomeric Golgi complex subunit 4;;retrograde transport, vesicle recycling within Golgi,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,Golgi organization,protein transport,Golgi vesicle prefusion complex stabilization;;;protein binding;F;;Golgi membrane,Golgi transport complex,trans-Golgi network membrane;>tr|A0A0A0MS45|A0A0A0MS45_HUMAN Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens GN=COG4 PE=1 SV=1;>tr|J3KNI1|J3KNI1_HUMAN Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens GN=COG4 PE=1 SV=1;>sp|Q9H9E3|COG4_HUMAN Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens GN=COG4 PE=1 SV=3;>sp|Q9H9E3-3|COG4_HUMAN Isoform 3 of Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens GN=COG4 A0A0A0MT36 IGKV6D-21A0A0A0MT36_HUMANProtein IGKV6D-21 (Fragment)c>tr|A0A0A0MT36|A0A0A0MT36_HUMAN Protein IGKV6D-21 (Fragment) OS=Homo sapiens GN=IGKV6D-21 PE=4 SV=1A0A0D9SFB5;P08319;P08319-2ADH4&A0A0D9SFB5_HUMAN;ADH4_HUMAN;ADH4_HUMANTAlcohol dehydrogenase 4;Alcohol dehydrogenase 4;Isoform 2 of Alcohol dehydrogenase 4;retinoid metabolic process,alcohol metabolic process,ethanol oxidation,cellular aldehyde metabolic process,retinol metabolic process,alcohol catabolic process,quinone metabolic process;;NADPH:quinone reductase activity,alcohol dehydrogenase (NAD) activity,alcohol dehydrogenase activity, zinc-dependent,alditol:NADP+ 1-oxidoreductase activity,retinol dehydrogenase activity,all-trans retinal binding,zinc ion binding,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,benzaldehyde dehydrogenase activity,retinol binding,ethanol binding,NAD binding;;nucleus,cytosol;>tr|A0A0D9SFB5|A0A0D9SFB5_HUMAN Alcohol dehydrogenase 4 OS=Homo sapiens GN=ADH4 PE=1 SV=1;>sp|P08319|ADH4_HUMAN Alcohol dehydrogenase 4 OS=Homo sapiens GN=ADH4 PE=1 SV=5;>sp|P08319-2|ADH4_HUMAN Isoform 2 of Alcohol dehydrogenase 4 OS=Homo sapiens GN=ADH4!A0A0G2JJA7;A2ACR1;P28065;P28065-2PSMB93A0A0G2JJA7_HUMAN;A2ACR1_HUMAN;PSB9_HUMAN;PSB9_HUMANProteasome subunit beta type;Proteasome subunit beta type;Proteasome subunit beta type-9;Isoform LMP2.S of Proteasome subunit beta type-9;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of cysteine-type endopeptidase activity;8;;threonine-type endopeptidase activity,protein binding;r;;proteasome complex,nucleoplasm,cytosol,proteasome core complex,extracellular exosome,spermatoproteasome complex;q>tr|A0A0G2JJA7|A0A0G2JJA7_HUMAN Proteasome subunit beta type OS=Homo sapiens GN=PSMB9 PE=1 SV=1;>tr|A2ACR1|A2ACR1_HUMAN Proteasome subunit beta type OS=Homo sapiens GN=PSMB9 PE=1 SV=1;>sp|P28065|PSB9_HUMAN Proteasome subunit beta type-9 OS=Homo sapiens GN=PSMB9 PE=1 SV=2;>sp|P28065-2|PSB9_HUMAN Isoform LMP2.S of Proteasome subunit beta type-9 OS=Homo sapiens GN=PSMB9 A0A0J9YY99A0A0J9YY99_HUMAN\>tr|A0A0J9YY99|A0A0J9YY99_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=1 A8MXQ1;P53801PTTG1IPA8MXQ1_HUMAN;PTTG_HUMAN?Pituitary tumor-transforming gene 1 protein-interacting protein-;protein import into nucleus,positive regulation of protein ubiquitination,negative regulation of DNA damage response, signal transduction by p53 class mediator,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,positive regulation of cellular protein catabolic process/;p53 binding,molecular_function,protein binding\;nucleus,nucleoplasm,cytoplasm,membrane,integral component of membrane,extracellular exosome>tr|A8MXQ1|A8MXQ1_HUMAN Pituitary tumor-transforming gene 1 protein-interacting protein OS=Homo sapiens GN=PTTG1IP PE=1 SV=1;>sp|P53801|PTTG_HUMAN Pituitary tumor-transforming gene 1 protein-interacting protein OS=Homo sapiens GN=PTTG1IP PE=1 SV=1B1AJZ9;B1AJZ9-4;H0YE38;Q5JYW6FHAD11FHAD1_HUMAN;FHAD1_HUMAN;H0YE38_HUMAN;Q5JYW6_HUMANForkhead-associated domain-containing protein 1;Isoform 4 of Forkhead-associated domain-containing protein 1;Forkhead-associated domain-containing protein 1 (Fragment);Forkhead-associated domain-containing protein 1 (Fragment) sp;sp;tr;tr2;;1;1>sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens GN=FHAD1 PE=2 SV=2;>sp|B1AJZ9-4|FHAD1_HUMAN Isoform 4 of Forkhead-associated domain-containing protein 1 OS=Homo sapiens GN=FHAD1;>tr|H0YE38|H0YE38_HUMAN Forkhead-associated domain-containing protein 1 (Fragment) OS=Homo sapiens GN=FHAD1 PE=1 SV=1;>tr|Q5JYW6|Q5JYW6_HUMAN Forkhead-associated domain-containing protein 1 (Fragment) OS=Homo sapiens GN=FHAD1 PE=1 SV=1C9JEU5 C9JEU5_HUMANO>tr|C9JEU5|C9JEU5_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=1F5H081;I3L2R4;P14672;P14672-2SLC2A4/F5H081_HUMAN;I3L2R4_HUMAN;GTR4_HUMAN;GTR4_HUMAN%Solute carrier family 2, facilitated glucose transporter member 4;Solute carrier family 2 (Facilitated glucose transporter), member 4, isoform CRA_b;Solute carrier family 2, facilitated glucose transporter member 4;Isoform 2 of Solute carrier family 2, facilitated glucose transporter member 4;;carbohydrate metabolic process,amylopectin biosynthetic process,glucose transport,cellular response to insulin stimulus,glucose homeostasis,glucose import in response to insulin stimulus,response to ethanol,glucose import,brown fat cell differentiation,cellular response to tumor necrosis factor,cellular response to hypoxia,cellular response to osmotic stress,glucose transmembra< ne transport;j;;glucose transmembrane transporter activity,protein binding,D-glucose transmembrane transporter activity;~;;multivesicular body,cytosol,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,endomembrane system,vesicle membrane,membrane,clathrin-coated vesicle,trans-Golgi network transport vesicle,T-tubule,cytoplasmic vesicle membrane,insulin-responsive compartment,membrane raft,perinuclear region of cytoplasm,extracellular exosome; >tr|F5H081|F5H081_HUMAN Solute carrier family 2, facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1;>tr|I3L2R4|I3L2R4_HUMAN Solute carrier family 2 (Facilitated glucose transporter), member 4, isoform CRA_b OS=Homo sapiens GN=SLC2A4 PE=1 SV=1;>sp|P14672|GTR4_HUMAN Solute carrier family 2, facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1;>sp|P14672-2|GTR4_HUMAN Isoform 2 of Solute carrier family 2, facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4F5H6E2;O00159;O00159-2;O00159-3MYO1C0F5H6E2_HUMAN;MYO1C_HUMAN;MYO1C_HUMAN;MYO1C_HUMAN}Unconventional myosin-Ic;Unconventional myosin-Ic;Isoform 2 of Unconventional myosin-Ic;Isoform 3 of Unconventional myosin-IcY;protein targeting,protein targeting to membrane,positive regulation of cell migration,positive regulation of actin filament polymerization,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of gene expression, epigenetic,mRNA transport,positive regulation of protein targeting to membrane,positive regulation of cellular response to insulin stimulus,positive regulation of vascular endothelial growth factor signaling pathway,regulation of bicellular tight junction assembly;;;microfilament motor activity,receptor binding,protein binding,calmodulin binding,ATP binding,protein C-terminus binding,Ral GTPase binding,actin-dependent ATPase activity,actin filament binding;;P;nuclear pore,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,microvillus,brush border,basal plasma membrane,membrane,lateral plasma membrane,unconventional myosin complex,nuclear body,cytoplasmic vesicle,filamentous actin,ruffle membrane,membrane raft,myosin I complex,stereocilium membrane,extracellular exosome,stress fiber;;V>tr|F5H6E2|F5H6E2_HUMAN Unconventional myosin-Ic OS=Homo sapiens GN=MYO1C PE=1 SV=1;>sp|O00159|MYO1C_HUMAN Unconventional myosin-Ic OS=Homo sapiens GN=MYO1C PE=1 SV=4;>sp|O00159-2|MYO1C_HUMAN Isoform 2 of Unconventional myosin-Ic OS=Homo sapiens GN=MYO1C;>sp|O00159-3|MYO1C_HUMAN Isoform 3 of Unconventional myosin-Ic OS=Homo sapiens GN=MYO1CF5H8B0;P08709;P08709-2F7 F5H8B0_HUMAN;FA7_HUMAN;FA7_HUMANQCoagulation factor VII;Coagulation factor VII;Isoform B of Coagulation factor VII;response to hypoxia,positive regulation of leukocyte chemotaxis,signal peptide processing,ER to Golgi vesicle-mediated transport,blood coagulation,blood coagulation, extrinsic pathway,circadian rhythm,response to carbon dioxide,positive regulation of platelet-derived growth factor receptor signaling pathway,protein processing,peptidyl-glutamic acid carboxylation,positive regulation of blood coagulation,positive regulation of cell migration,animal organ regeneration,response to estradiol,response to vitamin K,response to genistein,response to estrogen,positive regulation of positive chemotaxis,positive regulation of protein kinase B signaling,response to growth hormone,response to anticoagulant,response to cholesterol,response to thyroxine,response to Thyroid stimulating hormone,response to 2,3,7,8-tetrachlorodibenzodioxine,response to astaxanthin,response to thyrotropin-releasing hormone;;glycoprotein binding,receptor binding,calcium ion binding,protein binding,serine-type peptidase activity,serine-type endopeptidase activity;;extracellular region,extracellular space,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,vesicle,serine-type peptidase complex;2;1;>tr|F5H8B0|F5H8B0_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=2;>sp|P08709|FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1;>sp|P08709-2|FA7_HUMAN Isoform B of Coagulation factor VII OS=Homo sapiens GN=F7 H0YDV5;Q8N699MYCT1H0YDV5_HUMAN;MYCT1_HUMAN4Myc target protein 1 (Fragment);Myc target protein 15;nucleoplasm,intracellular membrane-bounded organelle>tr|H0YDV5|H0YDV5_HUMAN Myc target protein 1 (Fragment) OS=Homo sapiens GN=MYCT1 PE=1 SV=1;>sp|Q8N699|MYCT1_HUMAN Myc target protein 1 OS=Homo sapiens GN=MYCT1 PE=1 SV=1H0YFH1 H0YFH1_HUMAN Alpha-2-macroglobulin (Fragment)Y>tr|H0YFH1|H0YFH1_HUMAN Alpha-2-macroglobulin (Fragment) OS=Homo sapiens GN=A2M PE=1 SV=1O75460ERN1 ERN1_HUMAN5Serine/threonine-protein kinase/endoribonuclease IRE1.endothelial cell proliferation,transcription, DNA-templated,regulation of transcription, DNA-templated,mRNA cleavage,mRNA catabolic process,protein phosphorylation,activation of signaling protein activity involved in unfolded protein response,cell cycle arrest,activation of JUN kinase activity,regulation of macroautophagy,positive regulation of RNA splicing,response to endoplasmic reticulum stress,cellular response to vascular endothelial growth factor stimulus,peptidyl-serine autophosphorylation,IRE1-mediated unfolded protein response,protein autophosphorylation,mRNA splicing, via endonucleolytic cleavage and ligation,mRNA endonucleolytic cleavage involved in unfolded protein response,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,cellular response to glucose stimulus,RNA phosphodiester bond hydrolysis, endonucleolytic,positive regulation of endoplasmic reticulum unfolded protein response,insulin metabolic process,positive regulation of vascular smooth muscle cell proliferation,peptidyl-serine trans-autophosphorylation'magnesium ion binding,endoribonuclease activity,protein serine/threonine kinase activity,platelet-derived growth factor receptor binding,protein binding,ATP binding,enzyme binding,Hsp70 protein binding,identical protein binding,protein homodimerization activity,ADP binding,Hsp90 protein bindingnuclear inner membrane,cytoplasm,mitochondrion,endoplasmic reticulum,endoplasmic reticulum membrane,integral component of endoplasmic reticulum membrane,Ire1 complex,AIP1-IRE1 complex,IRE1-TRAF2-ASK1 complex,IRE1-RACK1-PP2A complexm>sp|O75460|ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2O94769ECM2 ECM2_HUMANExtracellular matrix protein 2rcell-matrix adhesion,positive regulation of cell-substrate adhesion,extracellular matrix organization,axonogenesis3integrin binding,heparin binding,collagen V bindingJproteinaceous extracellular matrix,interstitial matrix,extracellular spaceV>sp|O94769|ECM2_HUMAN Extracellular matrix protein 2 OS=Homo sapiens GN=ECM2 PE=2 SV=1P01624IGKV3-15 KV315_HUMAN"Immunoglobulin kappa variable 3-15_>sp|P01624|KV315_HUMAN Immunoglobulin kappa variable 3-15 OS=Homo sapiens GN=IGKV3-15 PE=1 SV=2P05107ITGB2 ITB2_HUMANIntegrin beta-2sleukocyte migration involved in inflammatory response,phagocytosis,apoptotic process,inflammatory response,cell adhesion,leukocyte cell-cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,cell-cell signaling,aging,regulation of cell shape,natural killer cell activation,extracellular matrix organization,neutrophil chemotaxis,receptor internalization,heterotypic cell-cell adhesion,toll-like receptor 4 signaling pathway,endodermal cell differentiation,receptor clustering,neutrophil degranulation,endothelial cell migration,cellular extravasation,positive regulation of nitric oxide biosynthetic process,positive regulation of angiogenesis,regulation of peptidyl-tyrosine phosphorylation,regulation of immune response,leukocyte migration,positive regulation of NF-kappaB transcription factor activity,cellular response to low-density lipoprotein particle stimulusglycoprotein binding,protein binding,protein kinase binding,ICAM-3 receptor activity,protein complex binding,m< etal ion binding,protein heterodimerization activity,cell adhesion molecule bindingplasma membrane,integrin complex,cell surface,membrane,integrin alphaL-beta2 complex,specific granule membrane,receptor complex,extracellular exosome,tertiary granule membrane,ficolin-1-rich granule membrane,extracellular vesicleH>sp|P05107|ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2P08133;P08133-2ANXA6 ANXA6_HUMAN"Annexin A6;Isoform 2 of Annexin A6calcium ion transport,regulation of muscle contraction,ion transmembrane transport,protein homooligomerization,mitochondrial calcium ion homeostasis,apoptotic signaling pathway;calcium ion binding,protein binding,GTP binding,calcium-dependent phospholipid binding,lipid binding,ligand-gated ion channel activity,cholesterol binding,protein homodimerization activity,calcium-dependent protein binding;mitochondrion,lysosomal membrane,focal adhesion,membrane,late endosome membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome;>sp|P08133|ANXA6_HUMAN Annexin A6 OS=Homo sapiens GN=ANXA6 PE=1 SV=3;>sp|P08133-2|ANXA6_HUMAN Isoform 2 of Annexin A6 OS=Homo sapiens GN=ANXA6(P09104;P09104-2;P13929;P13929-2;P13929-3ENO2;ENO2;ENO3;ENO3;ENO36ENOG_HUMAN;ENOG_HUMAN;ENOB_HUMAN;ENOB_HUMAN;ENOB_HUMANiGamma-enolase;Isoform 2 of Gamma-enolase;Beta-enolase;Isoform 2 of Beta-enolase;Isoform 3 of Beta-enolasegluconeogenesis,canonical glycolysis;;gluconeogenesis,aging,response to drug,skeletal muscle tissue regeneration,canonical glycolysis;;magnesium ion binding,phosphopyruvate hydratase activity,protein binding;;magnesium ion binding,phosphopyruvate hydratase activity,protein homodimerization activity,protein heterodimerization activity;;phosphopyruvate hydratase complex,photoreceptor inner segment,extracellular space,cytosol,plasma membrane,perikaryon,myelin sheath,extracellular exosome;;phosphopyruvate hydratase complex,extracellular space,cytosol,plasma membrane,extracellular exosome;;1;;1;;3;;5;;i>sp|P09104|ENOG_HUMAN Gamma-enolase OS=Homo sapiens GN=ENO2 PE=1 SV=3;>sp|P09104-2|ENOG_HUMAN Isoform 2 of Gamma-enolase OS=Homo sapiens GN=ENO2;>sp|P13929|ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=ENO3 PE=1 SV=5;>sp|P13929-2|ENOB_HUMAN Isoform 2 of Beta-enolase OS=Homo sapiens GN=ENO3;>sp|P13929-3|ENOB_HUMAN Isoform 3 of Beta-enolase OS=Homo sapiens GN=ENO3P10124SRGN SRGN_HUMAN Serglycinplatelet degranulation,granzyme-mediated apoptotic signaling pathway,protein processing,negative regulation of bone mineralization,biomineral tissue development,mast cell secretory granule organization,protease localization to mast cell secretory granule,T cell secretory granule organization,maintenance of protease location in mast cell secretory granule,maintenance of granzyme B location in T cell secretory granule,negative regulation of cytokine secretion protein binding,collagen bindingGolgi membrane,extracellular region,extracellular space,Golgi apparatus,platelet alpha granule lumen,zymogen granule,mast cell granuleA>sp|P10124|SRGN_HUMAN Serglycin OS=Homo sapiens GN=SRGN PE=1 SV=3P13716ALAD HEM2_HUMAN%Delta-aminolevulinic acid dehydrataseresponse to hypoxia,protoporphyrinogen IX biosynthetic process,heme biosynthetic process,response to oxidative stress,response to herbicide,response to iron ion,response to zinc ion,response to aluminum ion,response to ionizing radiation,response to vitamin B1,response to selenium ion,response to activity,response to cobalt ion,response to lipopolysaccharide,response to vitamin E,response to drug,response to amino acid,neutrophil degranulation,response to ethanol,response to arsenic-containing substance,response to cadmium ion,response to mercury ion,protein homooligomerization,response to glucocorticoid,response to methylmercury,response to platinum ion,response to fatty acid,cellular response to lead ion,cellular response to interleukin-4pcatalytic activity,porphobilinogen synthase activity,zinc ion binding,lead ion binding,identical protein bindingextracellular region,extracellular space,nucleus,cytosol,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen]>sp|P13716|HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1P25705;P25705-2;P25705-3ATP5A1 ATPA_HUMANATP synthase subunit alpha, mitochondrial;Isoform 2 of ATP synthase subunit alpha, mitochondrial;Isoform 3 of ATP synthase subunit alpha, mitochondrialnegative regulation of endothelial cell proliferation,lipid metabolic process,ATP biosynthetic process,embryo development,mitochondrial ATP synthesis coupled proton transport,Requires Ontology;;RNA binding,protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,proton-transporting ATP synthase activity, rotational mechanism,ATPase activity;;mitochondrion,mitochondrial inner membrane,mitochondrial proton-transporting ATP synthase complex,mitochondrial matrix,plasma membrane,membrane,extracellular matrix,myelin sheath,proton-transporting ATP synthase complex, catalytic core F(1),extracellular exosome,COP9 signalosome;;5>sp|P25705|ATPA_HUMAN ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1 SV=1;>sp|P25705-2|ATPA_HUMAN Isoform 2 of ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1;>sp|P25705-3|ATPA_HUMAN Isoform 3 of ATP synthase subunit alpha, mitochondrial OS=Homo sapiens GN=ATP5A1P28799GRN GRN_HUMAN Granulins,signal transduction,neutrophil degranulationDRNA binding,cytokine activity,protein binding,growth factor activity~extracellular region,extracellular space,lysosome,endosome,endoplasmic reticulum,azurophil granule lumen,extracellular exosome?>sp|P28799|GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2P30566;P30566-2ADSL PUR8_HUMAN:Adenylosuccinate lyase;Isoform 2 of Adenylosuccinate lyaseGresponse to hypoxia,purine nucleotide biosynthetic process,AMP biosynthetic process,'de novo' IMP biosynthetic process,response to nutrient,aerobic respiration,purine ribonucleoside monophosphate biosynthetic process,response to muscle activity,response to starvation,'de novo' AMP biosynthetic process,protein tetramerization;N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity;mitochondrion,cytosol;>sp|P30566|PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2;>sp|P30566-2|PUR8_HUMAN Isoform 2 of Adenylosuccinate lyase OS=Homo sapiens GN=ADSL&F5H0N7;J3KP58;P30622;P30622-1;P30622-2CLIP1=F5H0N7_HUMAN;J3KP58_HUMAN;CLIP1_HUMAN;CLIP1_HUMAN;CLIP1_HUMANCAP-Gly domain-containing linker protein 1;CAP-Gly domain-containing linker protein 1;CAP-Gly domain-containing linker protein 1;Isoform 2 of CAP-Gly domain-containing linker protein 1;Isoform 3 of CAP-Gly domain-containing linker protein 1;;microtubule bundle formation,sister chromatid cohesion,mitotic nuclear division,positive regulation of microtubule polymerization,protein transport into plasma membrane raft;;;;protein binding,microtubule binding,zinc ion binding,tubulin binding,protein homodimerization activity,metal ion binding,microtubule plus-end binding;;;;kinetochore,ruffle,nuclear envelope,endosome,centrosome,cytosol,microtubule,cytoplasmic microtubule,intermediate filament,microtubule cytoskeleton,cytoplasmic vesicle membrane,microtubule plus-end,macropinosome;;1;2;2;;>tr|F5H0N7|F5H0N7_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=1;>tr|J3KP58|J3KP58_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2;>sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2;>sp|P30622-1|CLIP1_HUMAN Isoform 2 of CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1;>sp|P30622-2|CLIP1_HUMAN Isoform 3 of CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1H7C1S2;P31939;P31939-2ATIC"H7C1S2_HUMAN;PUR9_HUMAN;PUR9_HUMANBifunctional purine biosynthesis protein PURH (Fragment);Bifunctional purine biosynth< esis protein PURH;Isoform 2 of Bifunctional purine biosynthesis protein PURHt;brainstem development,nucleobase-containing compound metabolic process,'de novo' IMP biosynthetic process,nucleoside metabolic process,purine ribonucleoside monophosphate biosynthetic process,response to inorganic substance,cerebellum development,cerebral cortex development,animal organ regeneration,dihydrofolate metabolic process,tetrahydrofolate biosynthetic process;;IMP cyclohydrolase activity,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,protein homodimerization activity,cadherin binding;6;mitochondrion,cytosol,membrane,extracellular exosome;C>tr|H7C1S2|H7C1S2_HUMAN Bifunctional purine biosynthesis protein PURH (Fragment) OS=Homo sapiens GN=ATIC PE=1 SV=1;>sp|P31939|PUR9_HUMAN Bifunctional purine biosynthesis protein PURH OS=Homo sapiens GN=ATIC PE=1 SV=3;>sp|P31939-2|PUR9_HUMAN Isoform 2 of Bifunctional purine biosynthesis protein PURH OS=Homo sapiens GN=ATIC"P13688;P13688-10;P13688-2;P13688-8CEACAM1 CEAM1_HUMANCarcinoembryonic antigen-related cell adhesion molecule 1;Isoform 10 of Carcinoembryonic antigen-related cell adhesion molecule 1;Isoform 2 of Carcinoembryonic antigen-related cell adhesion molecule 1;Isoform 8 of Carcinoembryonic antigen-related cell adhesion molecule 1gangiogenesis,regulation of cell growth,blood vessel development,negative regulation of T cell mediated cytotoxicity,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,negative regulation of protein kinase activity,cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,integrin-mediated signaling pathway,regulation of endothelial cell migration,regulation of phosphatidylinositol 3-kinase signaling,bile acid and bile salt transport,cell migration,regulation of cell migration,negative regulation of granulocyte differentiation,negative regulation of interleukin-1 production,cellular response to insulin stimulus,common myeloid progenitor cell proliferation,insulin receptor internalization,granulocyte colony-stimulating factor signaling pathway,regulation of epidermal growth factor receptor signaling pathway,negative regulation of vascular permeability,neutrophil degranulation,negative regulation of cytotoxic T cell degranulation,wound healing, spreading of cells,regulation of endothelial cell differentiation,negative regulation of fatty acid biosynthetic process,negative regulation of T cell receptor signaling pathway,leukocyte migration,negative regulation of lipid biosynthetic process,regulation of blood vessel remodeling,regulation of ERK1 and ERK2 cascade,negative regulation of platelet aggregation,cell-cell adhesion via plasma-membrane adhesion molecules,insulin catabolic process,regulation of homophilic cell adhesion,regulation of sprouting angiogenesis,negative regulation of hepatocyte proliferation,positive regulation of vasculogenesis;;;molecular_function,actin binding,protein binding,bile acid transmembrane transporter activity,kinase binding,protein phosphatase binding,filamin binding,protein homodimerization activity,protein dimerization activity,protein tyrosine kinase binding;;;wplasma membrane,integral component of plasma membrane,cell-cell junction,adherens junction,basal plasma membrane,cell surface,membrane,integral component of membrane,apical plasma membrane,lateral plasma membrane,cell junction,transport vesicle membrane,microvillus membrane,specific granule membrane,extracellular exosome,tertiary granule membrane,T cell receptor complex;;;>sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1 PE=1 SV=2;>sp|P13688-10|CEAM1_HUMAN Isoform 10 of Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1;>sp|P13688-2|CEAM1_HUMAN Isoform 2 of Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1;>sp|P13688-8|CEAM1_HUMAN Isoform 8 of Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1 P49591;Q5T5C7SARSSYSC_HUMAN;Q5T5C7_HUMANASerine--tRNA ligase, cytoplasmic;Serine--tRNA ligase, cytoplasmictranslation,tRNA aminoacylation for protein translation,seryl-tRNA aminoacylation,tRNA processing,selenocysteine metabolic process,selenocysteinyl-tRNA(Sec) biosynthetic process;XRNA binding,serine-tRNA ligase activity,ATP binding,selenocysteine-tRNA ligase activity;>sp|P49591|SYSC_HUMAN Serine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=SARS PE=1 SV=3;>tr|Q5T5C7|Q5T5C7_HUMAN Serine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=SARS PE=1 SV=1P68402PAFAH1B2 PA1B2_HUMAN:Platelet-activating factor acetylhydrolase IB subunit betalipid metabolic process,spermatogenesis,brain development,lipid catabolic process,positive regulation of macroautophagy,neutrophil degranulation1-alkyl-2-acetylglycerophosphocholine esterase activity,phospholipase A2 activity,protein binding,protein homodimerization activity,protein heterodimerization activity,platelet-activating factor acetyltransferase activityfibrillar center,extracellular region,nucleolus,cytoplasm,cytosol,plasma membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenw>sp|P68402|PA1B2_HUMAN Platelet-activating factor acetylhydrolase IB subunit beta OS=Homo sapiens GN=PAFAH1B2 PE=1 SV=1Q02952;Q02952-2;Q02952-3AKAP12 AKA12_HUMANjA-kinase anchor protein 12;Isoform 2 of A-kinase anchor protein 12;Isoform 3 of A-kinase anchor protein 12protein targeting,G-protein coupled receptor signaling pathway,positive regulation of protein kinase A signaling,positive regulation of cAMP biosynthetic process,regulation of protein kinase C signaling;;Dprotein binding,adenylate cyclase binding,protein kinase A binding;;Kcytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,cell cortex;; >sp|Q02952|AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4;>sp|Q02952-2|AKA12_HUMAN Isoform 2 of A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12;>sp|Q02952-3|AKA12_HUMAN Isoform 3 of A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12Q05209PTPN12 PTN12_HUMAN1Tyrosine-protein phosphatase non-receptor type 12dprotein dephosphorylation,peptidyl-tyrosine dephosphorylation,ERBB2 signaling pathway,regulation of epidermal growth factor receptor signaling pathway,tissue regeneration,cellular response to epidermal growth factor stimulus,negative regulation of ERBB signaling pathway,negative regulation of platelet-derived growth factor receptor-beta signaling pathwayphosphoprotein phosphatase activity,protein tyrosine phosphatase activity,non-membrane spanning protein tyrosine phosphatase activity,protein binding,SH3 domain binding9podosome,cytoplasm,cytosol,focal adhesion,cell projectionl>sp|Q05209|PTN12_HUMAN Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens GN=PTPN12 PE=1 SV=3F5H5B4;Q13043;Q13043-2STK4"F5H5B4_HUMAN;STK4_HUMAN;STK4_HUMANrSerine/threonine-protein kinase 4;Serine/threonine-protein kinase 4;Isoform 2 of Serine/threonine-protein kinase 4S;cell morphogenesis,patterning of blood vessels,neural tube formation,positive regulation of protein phosphorylation,endocardium development,protein phosphorylation,apoptotic process,signal transduction,central nervous system development,negative regulation of cell proliferation,peptidyl-serine phosphorylation,signal transduction by protein phosphorylation,keratinocyte differentiation,positive regulation of protein binding,positive regulation of peptidyl-serine phosphorylation,hippo signaling,intracellular signal transduction,positive regulation of apoptotic process,positive regulation of fat cell differentiation,negative regulation of organ growth,protein autophosphorylation,protein stabilization,primitive hemopoiesis,cell differentiation involved in embryonic placenta development,regulation of cell differentiation involved in embryonic placenta development,positive regulation of protein serine/threonine kinase activity,negative regulation of canonical Wnt signaling pathway,hepatocyte apoptotic process,positive regulation of extrinsic apoptotic < signaling pathway via death domain receptors;Z;magnesium ion binding,protein kinase activity,protein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,protein binding,ATP binding,transcription factor binding,identical protein binding,protein homodimerization activity,protein serine/threonine kinase activator activity,protein dimerization activity;D;nucleus,nucleoplasm,cytoplasm,cytosol,nuclear body,protein complex;>tr|F5H5B4|F5H5B4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=1;>sp|Q13043|STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2;>sp|Q13043-2|STK4_HUMAN Isoform 2 of Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4Q13884;Q13884-2SNTB1 SNTB1_HUMAN0Beta-1-syntrophin;Isoform 2 of Beta-1-syntrophinmuscle contraction;aactin binding,structural molecule activity,protein binding,calmodulin binding,PDZ domain binding;tcytoplasm,cytoskeleton,focal adhesion,dystrophin-associated glycoprotein complex,sarcolemma,protein complex,synapse;>sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens GN=SNTB1 PE=1 SV=3;>sp|Q13884-2|SNTB1_HUMAN Isoform 2 of Beta-1-syntrophin OS=Homo sapiens GN=SNTB1Q14677;Q14677-2;Q14677-3CLINT1 EPN4_HUMAN[Clathrin interactor 1;Isoform 2 of Clathrin interactor 1;Isoform 3 of Clathrin interactor 1$endocytosis,clathrin coat assembly;;Aprotein binding,lipid binding,clathrin binding,cadherin binding;;nucleoplasm,Golgi apparatus,cytosol,membrane,clathrin-coated vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm;;>sp|Q14677|EPN4_HUMAN Clathrin interactor 1 OS=Homo sapiens GN=CLINT1 PE=1 SV=1;>sp|Q14677-2|EPN4_HUMAN Isoform 2 of Clathrin interactor 1 OS=Homo sapiens GN=CLINT1;>sp|Q14677-3|EPN4_HUMAN Isoform 3 of Clathrin interactor 1 OS=Homo sapiens GN=CLINT1Q14761PTPRCAP PTCA_HUMAN?Protein tyrosine phosphatase receptor type C-associated proteindefense responsez>sp|Q14761|PTCA_HUMAN Protein tyrosine phosphatase receptor type C-associated protein OS=Homo sapiens GN=PTPRCAP PE=1 SV=1Q86UD1OAF OAF_HUMANOut at first protein homologR>sp|Q86UD1|OAF_HUMAN Out at first protein homolog OS=Homo sapiens GN=OAF PE=2 SV=1UB4DIP2;Q96RT1;Q96RT1-2;Q96RT1-3;Q96RT1-4;Q96RT1-5;Q96RT1-6;Q96RT1-7;Q96RT1-8;Q96RT1-9ERBINxB4DIP2_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMAN;ERBIN_HUMANErbin;Erbin;Isoform 2 of Erbin;Isoform 3 of Erbin;Isoform 4 of Erbin;Isoform 5 of Erbin;Isoform 6 of Erbin;Isoform 7 of Erbin;Isoform 8 of Erbin;Isoform 9 of Erbin;protein targeting,cell cycle,cell adhesion,signal transduction,epidermal growth factor receptor signaling pathway,integrin-mediated signaling pathway,cell growth,negative regulation of NF-kappaB transcription factor activity,response to muramyl dipeptide,response to lipopolysaccharide,ERBB2 signaling pathway,intermediate filament cytoskeleton organization,basal protein localization,establishment or maintenance of epithelial cell apical/basal polarity,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,cellular response to tumor necrosis factor,negative regulation of monocyte chemotactic protein-1 production;;;;;;;;;receptor binding,ErbB-2 class receptor binding,integrin binding,structural constituent of cytoskeleton,protein binding;;;;;;;;;basement membrane,nucleus,cytoplasm,plasma membrane,basal plasma membrane,basolateral plasma membrane,nuclear speck,cell junction,hemidesmosome,nuclear membrane;;;;;;;;tr;sp;sp;sp;sp;sp;sp;sp;sp;sp 1;1;;;;;;;; 1;2;;;;;;;;>tr|B4DIP2|B4DIP2_HUMAN Erbin OS=Homo sapiens GN=ERBIN PE=1 SV=1;>sp|Q96RT1|ERBIN_HUMAN Erbin OS=Homo sapiens GN=ERBIN PE=1 SV=2;>sp|Q96RT1-2|ERBIN_HUMAN Isoform 2 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-3|ERBIN_HUMAN Isoform 3 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-4|ERBIN_HUMAN Isoform 4 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-5|ERBIN_HUMAN Isoform 5 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-6|ERBIN_HUMAN Isoform 6 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-7|ERBIN_HUMAN Isoform 7 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-8|ERBIN_HUMAN Isoform 8 of Erbin OS=Homo sapiens GN=ERBIN;>sp|Q96RT1-9|ERBIN_HUMAN Isoform 9 of Erbin OS=Homo sapiens GN=ERBINH0YA47;Q96T51;Q96T51-2RUFY1$H0YA47_HUMAN;RUFY1_HUMAN;RUFY1_HUMANRUN and FYVE domain-containing protein 1 (Fragment);RUN and FYVE domain-containing protein 1;Isoform 2 of RUN and FYVE domain-containing protein 1c;phosphatidylinositol biosynthetic process,endocytosis,protein transport,regulation of endocytosis;M;protein binding,zinc ion binding,lipid binding,protein transporter activity;X;cytosol,nuclear speck,early endosome membrane,intracellular membrane-bounded organelle;9>tr|H0YA47|H0YA47_HUMAN RUN and FYVE domain-containing protein 1 (Fragment) OS=Homo sapiens GN=RUFY1 PE=1 SV=1;>sp|Q96T51|RUFY1_HUMAN RUN and FYVE domain-containing protein 1 OS=Homo sapiens GN=RUFY1 PE=1 SV=2;>sp|Q96T51-2|RUFY1_HUMAN Isoform 2 of RUN and FYVE domain-containing protein 1 OS=Homo sapiens GN=RUFY1Q9HCU4CELSR2 CELR2_HUMAN-Cadherin EGF LAG seven-pass G-type receptor 2Iregulation of transcription, DNA-templated,homophilic cell adhesion via plasma membrane adhesion molecules,G-protein coupled receptor signaling pathway,Wnt signaling pathway,neural plate anterior/posterior regionalization,regulation of cell-cell adhesion,dendrite morphogenesis,Wnt signaling pathway, planar cell polarity pathway7G-protein coupled receptor activity,calcium ion binding8cytoplasm,plasma membrane,integral component of membraneh>sp|Q9HCU4|CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=1 SV=1Q9UBV8PEF1 PEF1_HUMANPeflin#proteolysis,response to calcium ionRNA binding,calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding,protein heterodimerization activity,protein dimerization activity(cytoplasm,membrane,extracellular exosome>>sp|Q9UBV8|PEF1_HUMAN Peflin OS=Homo sapiens GN=PEF1 PE=1 SV=1(A0A087WTT1;E7ERJ7;P11940;P11940-2;Q9H361"PABPC1;PABPC1;PABPC1;PABPC1;PABPC3AA0A087WTT1_HUMAN;E7ERJ7_HUMAN;PABP1_HUMAN;PABP1_HUMAN;PABP3_HUMANPolyadenylate-binding protein;Polyadenylate-binding protein;Polyadenylate-binding protein 1;Isoform 2 of Polyadenylate-binding protein 1;Polyadenylate-binding protein 3x;;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,nuclear-transcribed mRNA poly(A) tail shortening,mRNA splicing, via spliceosome,mRNA polyadenylation,translational initiation,gene silencing by RNA,regulation of mRNA stability,positive regulation of viral genome replication,positive regulation of translation,mRNA stabilization,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;;mRNA metabolic process;;nucleotide binding,RNA binding,mRNA 3'-UTR binding,protein binding,protein C-terminus binding,poly(A) binding,poly(U) RNA binding,translation activator activity;;nucleotide binding,poly(A) binding;;nucleus,cytoplasm,cytosol,focal adhesion,cytoplasmic stress granule,membrane,intracellular ribonucleoprotein complex,cytoplasmic ribonucleoprotein granule,extracellular exosome,catalytic step 2 spliceosome;;cytoplasm,cytosol,extracellular exosome1;1;2;;2>tr|A0A087WTT1|A0A087WTT1_HUMAN Polyadenylate-binding protein OS=Homo sapiens GN=PABPC1 PE=1 SV=1;>tr|E7ERJ7|E7ERJ7_HUMAN Polyadenylate-binding protein OS=Homo sapiens GN=PABPC1 PE=1 SV=1;>sp|P11940|PABP1_HUMAN Polyadenylate-binding protein 1 OS=Homo sapiens GN=PABPC1 PE=1 SV=2;>sp|P11940-2|PABP1_HUMAN Isoform 2 of Polyadenylate-binding protein 1 OS=Homo sapiens GN=PABPC1;>sp|Q9H361|PABP3_HUMAN Polyadenylate-binding protein 3 OS=Homo sapiens GN=PABPC3 PE=1 SV=2A0A087WVN2;Q96L08;Q96L08-2SUSD3(A0A087WVN2_HUMAN;SUSD3_HUMAN;SUSD3_HUMANrSushi domain-containing protein 3;Sushi domain-containing protein 3;Isoform 2 of Sushi< domain-containing protein 30;plasma membrane,integral component of membrane;!>tr|A0A087WVN2|A0A087WVN2_HUMAN Sushi domain-containing protein 3 OS=Homo sapiens GN=SUSD3 PE=1 SV=1;>sp|Q96L08|SUSD3_HUMAN Sushi domain-containing protein 3 OS=Homo sapiens GN=SUSD3 PE=2 SV=1;>sp|Q96L08-2|SUSD3_HUMAN Isoform 2 of Sushi domain-containing protein 3 OS=Homo sapiens GN=SUSD3 A0A0A0MS15IGHV3-49 HV349_HUMAN"Immunoglobulin heavy variable 3-49c>sp|A0A0A0MS15|HV349_HUMAN Immunoglobulin heavy variable 3-49 OS=Homo sapiens GN=IGHV3-49 PE=1 SV=1#A0A0B4J1S2;Q8WWV6;Q8WWV6-3;Q8WWV6-4FCAMR4A0A0B4J1S2_HUMAN;FCAMR_HUMAN;FCAMR_HUMAN;FCAMR_HUMAN-High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;Isoform 3 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;Isoform 4 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor/;adaptive immune response,leukocyte migration;;1;plasma membrane,integral component of membrane;;>tr|A0A0B4J1S2|A0A0B4J1S2_HUMAN High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor OS=Homo sapiens GN=FCAMR PE=1 SV=1;>sp|Q8WWV6|FCAMR_HUMAN High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor OS=Homo sapiens GN=FCAMR PE=1 SV=1;>sp|Q8WWV6-3|FCAMR_HUMAN Isoform 3 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor OS=Homo sapiens GN=FCAMR;>sp|Q8WWV6-4|FCAMR_HUMAN Isoform 4 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor OS=Homo sapiens GN=FCAMRA0A0B4J269;Q13509;TUBB3A0A0B4J269_HUMAN;TBB3_HUMAN,Uncharacterized protein;Tubulin beta-3 chaincytoskeleton organization,microtubule-based process,G-protein coupled receptor signaling pathway;cytoskeleton organization,microtubule-based process,mitotic nuclear division,axon guidanceGTPase activity,G-protein coupled receptor activity,structural constituent of cytoskeleton,GTP binding;GTPase activity,structural constituent of cytoskeleton,protein binding,GTP binding,peptide bindingmicrotubule,microtubule cytoskeleton,integral component of membrane;nucleus,cytoplasm,microtubule,microtubule cytoskeleton,axon,dendrite,neuronal cell body,extracellular exosome,cell periphery>tr|A0A0B4J269|A0A0B4J269_HUMAN Uncharacterized protein OS=Homo sapiens PE=1 SV=1;>sp|Q13509|TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 A0A0C4DH29IGHV1-3 HV103_HUMAN!Immunoglobulin heavy variable 1-3a>sp|A0A0C4DH29|HV103_HUMAN Immunoglobulin heavy variable 1-3 OS=Homo sapiens GN=IGHV1-3 PE=3 SV=1 B2RUZ4;H3BS66SMIM1SMIM1_HUMAN;H3BS66_HUMAN!Small integral membrane protein 1Eplasma membrane,integral component of membrane,extracellular exosome;>sp|B2RUZ4|SMIM1_HUMAN Small integral membrane protein 1 OS=Homo sapiens GN=SMIM1 PE=1 SV=1;>tr|H3BS66|H3BS66_HUMAN Small integral membrane protein 1 OS=Homo sapiens GN=SMIM1 PE=1 SV=1B7Z596;F5H7S3;H7BYY1&B7Z596_HUMAN;F5H7S3_HUMAN;H7BYY1_HUMANXTropomyosin alpha-1 chain;Tropomyosin alpha-1 chain;Tropomyosin 1 (Alpha), isoform CRA_m>tr|B7Z596|B7Z596_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=1;>tr|F5H7S3|F5H7S3_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2;>tr|H7BYY1|H7BYY1_HUMAN Tropomyosin 1 (Alpha), isoform CRA_m OS=Homo sapiens GN=TPM1 PE=1 SV=1 B8ZZ54;P61604HSPE1B8ZZ54_HUMAN;CH10_HUMANQ10 kDa heat shock protein, mitochondrial;10 kDa heat shock protein, mitochondrial;osteoblast differentiation,protein folding,activation of cysteine-type endopeptidase activity involved in apoptotic process,response to unfolded protein,chaperone mediated protein folding requiring cofactore;RNA binding,protein binding,ATP binding,metal ion binding,unfolded protein binding,chaperone bindingB;mitochondrion,mitochondrial matrix,membrane,extracellular exosome>tr|B8ZZ54|B8ZZ54_HUMAN 10 kDa heat shock protein, mitochondrial OS=Homo sapiens GN=HSPE1 PE=1 SV=1;>sp|P61604|CH10_HUMAN 10 kDa heat shock protein, mitochondrial OS=Homo sapiens GN=HSPE1 PE=1 SV=2G8JLG2;Q15517;Q2L6G8CDSN$G8JLG2_HUMAN;CDSN_HUMAN;Q2L6G8_HUMANCorneodesmosin;cell adhesion,epidermis development,single organismal cell-cell adhesion,keratinocyte differentiation,skin morphogenesis,cornification;#;protein homodimerization activity;W;cornified envelope,plasma membrane,cell-cell junction,desmosome,extracellular exosome;>tr|G8JLG2|G8JLG2_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=1;>sp|Q15517|CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3;>tr|Q2L6G8|Q2L6G8_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=1/H7BXZ5;J3QSW6;O60229;O60229-4;O60229-5;O60229-6KALRNIH7BXZ5_HUMAN;J3QSW6_HUMAN;KALRN_HUMAN;KALRN_HUMAN;KALRN_HUMAN;KALRN_HUMANaKalirin (Fragment);Kalirin;Kalirin;Isoform 4 of Kalirin;Isoform 5 of Kalirin;Isoform 6 of Kalirin;;behavioral fear response,protein phosphorylation,signal transduction,Rho protein signal transduction,nervous system development,neuromuscular junction development,lactation,memory,adult locomotory behavior,response to mechanical stimulus,smooth muscle cell migration,vesicle-mediated transport,regulation of Rho protein signal transduction,social behavior,intracellular signal transduction,maternal behavior,positive regulation of apoptotic process,positive regulation of GTPase activity,habituation,ephrin receptor signaling pathway,behavioral response to cocaine,regulation of neuronal synaptic plasticity,smooth muscle cell proliferation,regulation of small GTPase mediated signal transduction,regulation of synaptic transmission, glutamatergic,negative regulation of growth hormone secretion,maternal process involved in parturition,positive regulation of dendritic spine morphogenesis,behavioral response to formalin induced pain,positive regulation of long-term synaptic potentiation,regulation of protein localization to plasma membrane;;;;;protein serine/threonine kinase activity,guanyl-nucleotide exchange factor activity,Rho guanyl-nucleotide exchange factor activity,GTPase activator activity,ATP binding,Rac guanyl-nucleotide exchange factor activity,metal ion binding;;;V;;nucleoplasm,cytosol,postsynaptic density,actin cytoskeleton,extracellular exosome;;;>tr|H7BXZ5|H7BXZ5_HUMAN Kalirin (Fragment) OS=Homo sapiens GN=KALRN PE=1 SV=1;>tr|J3QSW6|J3QSW6_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=1;>sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2;>sp|O60229-4|KALRN_HUMAN Isoform 4 of Kalirin OS=Homo sapiens GN=KALRN;>sp|O60229-5|KALRN_HUMAN Isoform 5 of Kalirin OS=Homo sapiens GN=KALRN;>sp|O60229-6|KALRN_HUMAN Isoform 6 of Kalirin OS=Homo sapiens GN=KALRN(K7N7A8;P29972;P29972-2;P29972-3;P29972-4;AQP1;AQP1;AQP1;AQP18K7N7A8_HUMAN;AQP1_HUMAN;AQP1_HUMAN;AQP1_HUMAN;AQP1_HUMANyUncharacterized protein (Fragment);Aquaporin-1;Isoform 2 of Aquaporin-1;Isoform 3 of Aquaporin-1;Isoform 4 of Aquaporin-1water transport,carbon dioxide transmembrane transport,ammonium transmembrane transport;renal water homeostasis,renal water transport,cGMP biosynthetic process,potassium ion transport,water transport,cell volume homeostasis,carbon dioxide transport,ammonium transport,bicarbonate transport,glycerol transport,cellular homeostasis,lateral ventricle development,pancreatic juice secretion,nitric oxide transport,establishment or maintenance of actin cytoskeleton polarity,cerebrospinal fluid secretion,cellular response to stress,cellular response to UV,transepithelial water transport,carbon dioxide transmembrane transport,odontogenesis,response to drug,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of angiogenesis,positive regulation of saliva secretion,positive regulation of fibroblast proliferation,multicellular organismal water homeostasis,cellular response to hydrogen peroxide,cellular response to inorganic substance,cellular response to mechanical stimulus,cellular response to copper ion,cellular response to mercury ion,cellular response to retinoic acid,cellular response to cAMP,cellular response to hypoxia,cellular response to salt stress,< cellular hyperosmotic response,cellular response to dexamethasone stimulus,cellular response to nitric oxide,potassium ion transmembrane transport,ammonium transmembrane transport,maintenance of symbiont-containing vacuole by host;;;%ammonium transmembrane transporter activity,water channel activity,carbon dioxide transmembrane transporter activity;intracellular cGMP activated cation channel activity,potassium channel activity,water transmembrane transporter activity,protein binding,ammonium transmembrane transporter activity,potassium ion transmembrane transporter activity,glycerol transmembrane transporter activity,water channel activity,transmembrane transporter activity,nitric oxide transmembrane transporter activity,carbon dioxide transmembrane transporter activity;;;plasma membrane,integral component of plasma membrane,basolateral plasma membrane;nucleus,cytoplasm,plasma membrane,integral component of plasma membrane,brush border,basal plasma membrane,basolateral plasma membrane,apical plasma membrane,symbiont-containing vacuole,brush border membrane,nuclear membrane,sarcolemma,apical part of cell,extracellular exosome,symbiont-containing vacuole membrane;;;3;1;;;2;3;;;s>tr|K7N7A8|K7N7A8_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=3 SV=2;>sp|P29972|AQP1_HUMAN Aquaporin-1 OS=Homo sapien                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u w x y z { | } ~  s GN=AQP1 PE=1 SV=3;>sp|P29972-2|AQP1_HUMAN Isoform 2 of Aquaporin-1 OS=Homo sapiens GN=AQP1;>sp|P29972-3|AQP1_HUMAN Isoform 3 of Aquaporin-1 OS=Homo sapiens GN=AQP1;>sp|P29972-4|AQP1_HUMAN Isoform 4 of Aquaporin-1 OS=Homo sapiens GN=AQP1O75636-2Isoform 2 of Ficolin-3F>sp|O75636-2|FCN3_HUMAN Isoform 2 of Ficolin-3 OS=Homo sapiens GN=FCN3!P02545;P02545-2;P02545-3;P02545-6LMNA LMNA_HUMANaPrelamin-A/C;Isoform C of Prelamin-A/C;Isoform ADelta10 of Prelamin-A/C;Isoform 6 of Prelamin-A/C}mitotic nuclear envelope disassembly,mitotic nuclear envelope reassembly,regulation of cell migration,establishment or maintenance of microtubule cytoskeleton polarity,protein localization to nucleus,sterol regulatory element binding protein import into nucleus,IRE1-mediated unfolded protein response,ventricular cardiac muscle cell development,cellular response to hypoxia,negative regulation of mesenchymal cell proliferation,negative regulation of release of cytochrome c from mitochondria,positive regulation of cell aging,regulation of protein localization to nucleus,negative regulation of extrinsic apoptotic signaling pathway;;;/structural molecule activity,protein binding;;;rnucleus,nuclear envelope,lamin filament,nucleoplasm,cytosol,nuclear speck,extracellular matrix,nuclear membrane;;;)>sp|P02545|LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1;>sp|P02545-2|LMNA_HUMAN Isoform C of Prelamin-A/C OS=Homo sapiens GN=LMNA;>sp|P02545-3|LMNA_HUMAN Isoform ADelta10 of Prelamin-A/C OS=Homo sapiens GN=LMNA;>sp|P02545-6|LMNA_HUMAN Isoform 6 of Prelamin-A/C OS=Homo sapiens GN=LMNAP04259KRT6B K2C6B_HUMAN Keratin, type II cytoskeletal 6BKcytoskeleton organization,ectoderm development,keratinization,cornification.cytosol,keratin filament,extracellular exosomeZ>sp|P04259|K2C6B_HUMAN Keratin, type II cytoskeletal 6B OS=Homo sapiens GN=KRT6B PE=1 SV=5P04430IGKV1-16 KV116_HUMAN"Immunoglobulin kappa variable 1-16_>sp|P04430|KV116_HUMAN Immunoglobulin kappa variable 1-16 OS=Homo sapiens GN=IGKV1-16 PE=1 SV=2P22314;P22314-2UBA1 UBA1_HUMANdUbiquitin-like modifier-activating enzyme 1;Isoform 2 of Ubiquitin-like modifier-activating enzyme 1@cellular response to DNA damage stimulus,protein ubiquitination;MRNA binding,ubiquitin activating enzyme activity,protein binding,ATP binding;nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome,heterochromatin,lysosomal membrane,endosome membrane,desmosome,rough endoplasmic reticulum membrane;>sp|P22314|UBA1_HUMAN Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens GN=UBA1 PE=1 SV=3;>sp|P22314-2|UBA1_HUMAN Isoform 2 of Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens GN=UBA1K7EIS0;K7EKE5;P23258;Q9NRH3TUBG1;TUBG1;TUBG1;TUBG2/K7EIS0_HUMAN;K7EKE5_HUMAN;TBG1_HUMAN;TBG2_HUMAN`Tubulin gamma chain (Fragment);Tubulin gamma-1 chain;Tubulin gamma-1 chain;Tubulin gamma-2 chain;;G2/M transition of mitotic cell cycle,meiotic spindle organization,microtubule cytoskeleton organization,microtubule nucleation,cytoplasmic microtubule organization,ciliary basal body docking;microtubule nucleation,cytoplasmic microtubule organization;;GTPase activity,structural constituent of cytoskeleton,protein binding,GTP binding;GTPase activity,structural molecule activity,GTP binding;;pericentriolar material,condensed nuclear chromosome,gamma-tubulin complex,cytoplasm,centrosome,centriole,polar microtubule,cytosol,cytoplasmic microtubule,cell leading edge,ciliary basal body,apical part of cell,recycling endosome,Requires Ontology;pericentriolar material,gamma-tubulin complex,cytosol,microtubule,spindle microtubule,cytoplasmic microtubule,microtubule cytoskeleton1;4;1;2H>tr|K7EIS0|K7EIS0_HUMAN Tubulin gamma chain (Fragment) OS=Homo sapiens GN=TUBG1 PE=1 SV=1;>tr|K7EKE5|K7EKE5_HUMAN Tubulin gamma-1 chain OS=Homo sapiens GN=TUBG1 PE=4 SV=1;>sp|P23258|TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens GN=TUBG1 PE=1 SV=2;>sp|Q9NRH3|TBG2_HUMAN Tubulin gamma-2 chain OS=Homo sapiens GN=TUBG2 PE=2 SV=1P23470;P23470-2PTPRG PTPRG_HUMANnReceptor-type tyrosine-protein phosphatase gamma;Isoform 2 of Receptor-type tyrosine-protein phosphatase gammatransmembrane receptor protein tyrosine kinase signaling pathway,brain development,negative regulation of epithelial cell migration,negative regulation of neuron projection development,peptidyl-tyrosine dephosphorylation,regulation of homophilic cell adhesion;protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,identical protein binding;Pextracellular space,integral component of plasma membrane,extracellular exosome;>sp|P23470|PTPRG_HUMAN Receptor-type tyrosine-protein phosphatase gamma OS=Homo sapiens GN=PTPRG PE=1 SV=4;>sp|P23470-2|PTPRG_HUMAN Isoform 2 of Receptor-type tyrosine-protein phosphatase gamma OS=Homo sapiens GN=PTPRGH0YJM8;P28074;P28074-2PSMB5"H0YJM8_HUMAN;PSB5_HUMAN;PSB5_HUMANtProteasome subunit beta type-5 (Fragment);Proteasome subunit beta type-5;Isoform 2 of Proteasome subunit beta type-5;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,proteolysis,regulation of cellular amino acid metabolic process,response to oxidative stress,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;J;threonine-type endopeptidase activity,protein binding,peptidase activity;i;proteasome complex,nucleus,nucleoplasm,centrosome,cytosol,proteasome core complex,extracellular exosome;>tr|H0YJM8|H0YJM8_HUMAN Proteasome subunit beta type-5 (Fragment) OS=Homo sapiens GN=PSMB5 PE=1 SV=1;>sp|P28074|PSB5_HUMAN Proteasome subunit beta type-5 OS=Homo sapiens GN=PSMB5 PE=1 SV=3;>sp|P28074-2|PSB5_HUMAN Isoform 2 of Proteasome subunit beta type-5 OS=Homo sapiens GN=PSMB5 P28906;Q5JTA5CD34CD34_HUMAN;Q5JTA5_HUMAN*Hematopoietic< progenitor cell antigen CD34Qtissue homeostasis,endothelial cell proliferation,glomerular filtration,endothelium development,cell-matrix adhesion,signal transduction,regulation of blood pressure,cell proliferation,positive regulation of gene expression,negative regulation of gene expression,single organismal cell-cell adhesion,hemopoiesis,negative regulation of blood coagulation,negative regulation of tumor necrosis factor production,positive regulation of interleukin-10 production,mesangial cell-matrix adhesion,paracrine signaling,positive regulation of odontogenesis,negative regulation of nitric oxide biosynthetic process,positive regulation of angiogenesis,cell motility,regulation of immune response,leukocyte migration,transdifferentiation,vascular wound healing,hematopoietic stem cell proliferation,positive regulation of transforming growth factor beta production,positive regulation of granulocyte colony-stimulating factor production,extracellular exosome assembly,glomerular endothelium development,stem cell proliferation,metanephric glomerular mesangial cell differentiation,negative regulation of cellular response to heat,negative regulation of cellular response to hypoxia,negative regulation of interleukin-2 secretion,positive regulation of glial cell-derived neurotrophic factor secretion,negative regulation of neuron death,positive regulation of vasculogenesis;Btranscription factor binding,carbohydrate binding,sulfate binding;cytoplasm,lysosome,plasma membrane,integral component of plasma membrane,external side of plasma membrane,basal plasma membrane,apical plasma membrane,glomerular endothelium fenestra,intercellular bridge,perinuclear region of cytoplasm;>sp|P28906|CD34_HUMAN Hematopoietic progenitor cell antigen CD34 OS=Homo sapiens GN=CD34 PE=1 SV=2;>tr|Q5JTA5|Q5JTA5_HUMAN Hematopoietic progenitor cell antigen CD34 OS=Homo sapiens GN=CD34 PE=1 SV=1P30044;P30044-2PRDX5 PRDX5_HUMAN`Peroxiredoxin-5, mitochondrial;Isoform Cytoplasmic+peroxisomal of Peroxiredoxin-5, mitochondrialresponse to reactive oxygen species,apoptotic process,inflammatory response,response to oxidative stress,negative regulation of transcription from RNA polymerase III promoter,cellular response to reactive oxygen species,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification;RNA polymerase III regulatory region DNA binding,peroxidase activity,receptor binding,thioredoxin peroxidase activity,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,protein dimerization activity;extracellular space,nucleus,cytoplasm,mitochondrion,mitochondrial matrix,peroxisome,cytosol,cytoplasmic vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome;>sp|P30044|PRDX5_HUMAN Peroxiredoxin-5, mitochondrial OS=Homo sapiens GN=PRDX5 PE=1 SV=4;>sp|P30044-2|PRDX5_HUMAN Isoform Cytoplasmic+peroxisomal of Peroxiredoxin-5, mitochondrial OS=Homo sapiens GN=PRDX5P62701RPS4X RS4X_HUMAN#40S ribosomal protein S4, X isoform8nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,multicellular organism development,positive regulation of cell proliferation,viral transcription,positive regulation of translationKRNA binding,structural constituent of ribosome,protein binding,rRNA bindingnucleoplasm,cytosol,ribosome,polysome,focal adhesion,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,cytoplasmic ribonucleoprotein granule,extracellular exosome\>sp|P62701|RS4X_HUMAN 40S ribosomal protein S4, X isoform OS=Homo sapiens GN=RPS4X PE=1 SV=2Q13131;Q13131-2PRKAA1 AAPK1_HUMAN5'-AMP-activated protein kinase catalytic subunit alpha-1;Isoform 2 of 5'-AMP-activated protein kinase catalytic subunit alpha-1activation of MAPK activity,response to hypoxia,glucose metabolic process,transcription, DNA-templated,regulation of transcription, DNA-templated,protein phosphorylation,fatty acid biosynthetic process,cholesterol biosynthetic process,cell cycle arrest,signal transduction,positive regulation of cell proliferation,lipid biosynthetic process,response to UV,cold acclimation,response to gamma radiation,positive regulation of autophagy,positive regulation of gene expression,response to activity,Wnt signaling pathway,macroautophagy,fatty acid oxidation,response to caffeine,cellular response to nutrient levels,negative regulation of TOR signaling,regulation of peptidyl-serine phosphorylation,histone-serine phosphorylation,intracellular signal transduction,cellular response to glucose starvation,glucose homeostasis,regulation of circadian rhythm,negative regulation of apoptotic process,positive regulation of cholesterol biosynthetic process,positive regulation of glycolytic process,negative regulation of glucosylceramide biosynthetic process,rhythmic process,positive regulation of skeletal muscle tissue development,negative regulation of lipid catabolic process,protein heterooligomerization,fatty acid homeostasis,regulation of vesicle-mediated transport,CAMKK-AMPK signaling cascade,cellular response to hydrogen peroxide,cellular response to ethanol,cellular response to prostaglandin E stimulus,cellular response to organonitrogen compound,cellular response to hypoxia,response to camptothecin,regulation of signal transduction by p53 class mediator,regulation of energy homeostasis,negative regulation of glucose import in response to insulin stimulus;qchromatin binding,protein kinase activity,AMP-activated protein kinase activity,cAMP-dependent protein kinase activity,protein binding,ATP binding,protein C-terminus binding,kinase binding,histone serine kinase activity,metal ion binding,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,tau-protein kinase activity,[acetyl-CoA carboxylase] kinase activity;intracellular,nucleus,nucleoplasm,cytoplasm,cytosol,apical plasma membrane,nuclear speck,nucleotide-activated protein kinase complex;>sp|Q13131|AAPK1_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens GN=PRKAA1 PE=1 SV=4;>sp|Q13131-2|AAPK1_HUMAN Isoform 2 of 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens GN=PRKAA1Q13404;Q13404-8UBE2V1 UB2V1_HUMAN`Ubiquitin-conjugating enzyme E2 variant 1;Isoform 6 of Ubiquitin-conjugating enzyme E2 variant 1Gactivation of MAPK activity,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,regulation of DNA repair,postreplication repair,regulation of transcription, DNA-templated,JNK cascade,cell differentiation,Fc-epsilon receptor signaling pathway,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of transcription, DNA-templated,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,nucleotide-binding oligomerization domain containing signaling pathway,protein K63-linked ubiquitination;Sprotein binding,ubiquitin protein ligase binding,ubiquitin protein ligase activity;ubiquitin ligase complex,nucleus,nucleoplasm,cytoplasm,cytosol,ubiquitin conjugating enzyme complex,UBC13-UEV1A complex,protein complex,extracellular exosome;>sp|Q13404|UB2V1_HUMAN Ubiquitin-conjugating enzyme E2 variant 1 OS=Homo sapiens GN=UBE2V1 PE=1 SV=2;>sp|Q13404-8|UB2V1_HUMAN Isoform 6 of Ubiquitin-conjugating enzyme E2 variant 1 OS=Homo sapiens GN=UBE2V1Q9H4G4GLIPR2 GAPR1_HUMAN5Golgi-associated plant pathogenesis-related protein 1positive regulation of epithelial cell migration,positive regulation of epithelial to mesenchymal transition,positive regulation of ERK1 and ERK2 cascade!protein homodimerization activity$Golgi membrane,extracellular exosomep>sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens GN=GLIPR2 PE=1 SV=3P62879GNB2 GBB2_HUMAN@Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit bet< a-2protein folding,G-protein coupled receptor signaling pathway,regulation of molecular function,cellular response to glucagon stimulusGTPase activity,signal transducer activity,calcium channel regulator activity,protein binding,protein complex binding,GTPase bindingextracellular space,lysosomal membrane,cytosol,plasma membrane,focal adhesion,membrane,vesicle,myelin sheath,protein complex,cell body,perinuclear region of cytoplasm,extracellular exosomex>sp|P62879|GBB2_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 OS=Homo sapiens GN=GNB2 PE=1 SV=3Q9NP72RAB18 RAB18_HUMANRas-related protein Rab-18eye development,small GTPase mediated signal transduction,brain development,protein transport,lipid particle organization,neutrophil degranulation,membrane organization,endoplasmic reticulum tubular network organization,single-organism nuclear importintracellular,endoplasmic reticulum membrane,cytosol,plasma membrane,secretory granule membrane,extracellular exosome,endoplasmic reticulum tubular networkT>sp|Q9NP72|RAB18_HUMAN Ras-related protein Rab-18 OS=Homo sapiens GN=RAB18 PE=1 SV=1Q9Y6N6LAMC3 LAMC3_HUMANLaminin subunit gamma-3cell morphogenesis involved in differentiation,cell adhesion,visual perception,astrocyte development,extracellular matrix organization,retina development in camera-type eyeRextracellular region,proteinaceous extracellular matrix,basement membrane,membraneQ>sp|Q9Y6N6|LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3.A0A087WU05;A0A087WY48;Q8IY22;Q8IY22-2;Q8IY22-3CMIPBA0A087WU05_HUMAN;A0A087WY48_HUMAN;CMIP_HUMAN;CMIP_HUMAN;CMIP_HUMANC-Maf-inducing protein;C-Maf-inducing protein;C-Maf-inducing protein;Isoform 2 of C-Maf-inducing protein;Isoform 3 of C-Maf-inducing protein;;nucleoplasm,cytosol;;1;1;3;;>tr|A0A087WU05|A0A087WU05_HUMAN C-Maf-inducing protein OS=Homo sapiens GN=CMIP PE=1 SV=1;>tr|A0A087WY48|A0A087WY48_HUMAN C-Maf-inducing protein OS=Homo sapiens GN=CMIP PE=1 SV=1;>sp|Q8IY22|CMIP_HUMAN C-Maf-inducing protein OS=Homo sapiens GN=CMIP PE=1 SV=3;>sp|Q8IY22-2|CMIP_HUMAN Isoform 2 of C-Maf-inducing protein OS=Homo sapiens GN=CMIP;>sp|Q8IY22-3|CMIP_HUMAN Isoform 3 of C-Maf-inducing protein OS=Homo sapiens GN=CMIP(A0A0C4DFY5;A8MXZ4;J9JIE0;Q9NQ84;Q9NQ84-2GPRC5CBA0A0C4DFY5_HUMAN;A8MXZ4_HUMAN;J9JIE0_HUMAN;GPC5C_HUMAN;GPC5C_HUMAN G-protein-coupled receptor family C group 5 member C;G-protein-coupled receptor family C group 5 member C (Fragment);G-protein-coupled receptor family C group 5 member C;G-protein coupled receptor family C group 5 member C;Isoform 2 of G-protein coupled receptor family C group 5 member C0;;;G-protein coupled receptor signaling pathway;';;;G-protein coupled receptor activity;u;;;integral component of plasma membrane,cytoplasmic vesicle membrane,vesicle,receptor complex,extracellular exosome;1;2;1;2;J>tr|A0A0C4DFY5|A0A0C4DFY5_HUMAN G-protein-coupled receptor family C group 5 member C OS=Homo sapiens GN=GPRC5C PE=1 SV=1;>tr|A8MXZ4|A8MXZ4_HUMAN G-protein-coupled receptor family C group 5 member C (Fragment) OS=Homo sapiens GN=GPRC5C PE=1 SV=2;>tr|J9JIE0|J9JIE0_HUMAN G-protein-coupled receptor family C group 5 member C OS=Homo sapiens GN=GPRC5C PE=1 SV=1;>sp|Q9NQ84|GPC5C_HUMAN G-protein coupled receptor family C group 5 member C OS=Homo sapiens GN=GPRC5C PE=1 SV=2;>sp|Q9NQ84-2|GPC5C_HUMAN Isoform 2 of G-protein coupled receptor family C group 5 member C OS=Homo sapiens GN=GPRC5C#A0A0C4DGS1;P39656;P39656-2;P39656-3DDOST4A0A0C4DGS1_HUMAN;OST48_HUMAN;OST48_HUMAN;OST48_HUMANQDolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Isoform 2 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Isoform 3 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;protein glycosylation,protein N-linked glycosylation,protein N-linked glycosylation via asparagine,response to cytokine,T cell activation,neutrophil degranulation;;z;protein binding,oligosaccharyl transferase activity,dolichyl-diphosphooligosaccharide-protein glycotransferase activity;;;endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,oligosaccharyltransferase complex,membrane,integral component of membrane,azurophil granule membrane,intracellular membrane-bounded organelle,protein complex;;2>tr|A0A0C4DGS1|A0A0C4DGS1_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens GN=DDOST PE=1 SV=1;>sp|P39656|OST48_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens GN=DDOST PE=1 SV=4;>sp|P39656-2|OST48_HUMAN Isoform 2 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens GN=DDOST;>sp|P39656-3|OST48_HUMAN Isoform 3 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens GN=DDOST A0A0C4DH25 IGKV3D-20 KVD20_HUMANd>sp|A0A0C4DH25|KVD20_HUMAN Immunoglobulin kappa variable 3-20 OS=Homo sapiens GN=IGKV3D-20 PE=3 SV=1A0A0J9YXN7;Q96Q06;Q96Q06-2PLIN4(A0A0J9YXN7_HUMAN;PLIN4_HUMAN;PLIN4_HUMAN0Perilipin-4;Perilipin-4;Isoform 2 of Perilipin-4Q;lipid particle,cytosol,plasma membrane,intracellular membrane-bounded organelle;>tr|A0A0J9YXN7|A0A0J9YXN7_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=1 SV=1;>sp|Q96Q06|PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=1 SV=2;>sp|Q96Q06-2|PLIN4_HUMAN Isoform 2 of Perilipin-4 OS=Homo sapiens GN=PLIN4B3KWE1;P12081;P12081-4HARS"B3KWE1_HUMAN;SYHC_HUMAN;SYHC_HUMANxHistidine--tRNA ligase, cytoplasmic;Histidine--tRNA ligase, cytoplasmic;Isoform 4 of Histidine--tRNA ligase, cytoplasmicp;translation,tRNA aminoacylation for protein translation,histidyl-tRNA aminoacylation,mitochondrial translation;,;histidine-tRNA ligase activity,ATP binding;!;cytoplasm,mitochondrion,cytosol;>tr|B3KWE1|B3KWE1_HUMAN Histidine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=HARS PE=1 SV=1;>sp|P12081|SYHC_HUMAN Histidine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=HARS PE=1 SV=2;>sp|P12081-4|SYHC_HUMAN Isoform 4 of Histidine--tRNA ligase, cytoplasmic OS=Homo sapiens GN=HARS*A0A0J9YXB8;C9JIZ6;P07602;P07602-2;P07602-3PSAP;A0A0J9YXB8_HUMAN;C9JIZ6_HUMAN;SAP_HUMAN;SAP_HUMAN;SAP_HUMANiProsaposin (Fragment);Prosaposin;Prosaposin;Isoform Sap-mu-6 of Prosaposin;Isoform Sap-mu-9 of Prosaposin;;platelet degranulation,glycosphingolipid metabolic process,lipid transport,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,regulation of autophagy,regulation of lipid metabolic process,positive regulation of catalytic activity,neutrophil degranulation,positive regulation of MAPK cascade,prostate gland growth,epithelial cell differentiation involved in prostate gland development,cellular response to organic substance,negative regulation of hydrogen peroxide-induced cell death;;^;;G-protein coupled receptor binding,protein binding,enzyme activator activity,lipid binding;;;;extracellular region,extracellular space,mitochondrion,lysosome,lysosomal membrane,plasma membrane,integral component of membrane,azurophil granule membrane,lysosomal lumen,intracellular membrane-bounded organelle,extracellular exosome;;z>tr|A0A0J9YXB8|A0A0J9YXB8_HUMAN Prosaposin (Fragment) OS=Homo sapiens GN=PSAP PE=1 SV=1;>tr|C9JIZ6|C9JIZ6_HUMAN Prosaposin OS=Homo sapiens GN=PSAP PE=1 SV=2;>sp|P07602|SAP_HUMAN Prosaposin OS=Homo sapiens GN=PSAP PE=1 SV=2;>sp|P07602-2|SAP_HUMAN Isoform Sap-mu-6 of Prosaposin OS=Homo sapiens GN=PSAP;>sp|P07602-3|SAP_HUMAN Isoform Sap-mu-9 of Prosaposin OS=Homo sapiens GN=PSAPC9JNR0;P27930;P27930-2IL1R2$C9JNR0_HUMAN;IL1R2_HUMAN;IL1R2_HUMANuInterleukin-1 receptor type 2 (Fragment);Interleukin-1 receptor type 2;Isoform Short of Interleukin-1 receptor type 2!;immune response,negative regulation of protein processing,cytokine-mediated signaling pathway,negative regulation of interleukin-1 alpha secretion,negative regulation of cytokine production involved in inflammatory response,negative regulation of interleukin-1-mediated signaling pa< thway;z;interleukin-1 receptor activity,interleukin-1, Type II, blocking receptor activity,protein binding,interleukin-1 binding;O;extracellular region,cytoplasm,plasma membrane,integral component of membrane;>tr|C9JNR0|C9JNR0_HUMAN Interleukin-1 receptor type 2 (Fragment) OS=Homo sapiens GN=IL1R2 PE=1 SV=1;>sp|P27930|IL1R2_HUMAN Interleukin-1 receptor type 2 OS=Homo sapiens GN=IL1R2 PE=1 SV=1;>sp|P27930-2|IL1R2_HUMAN Isoform Short of Interleukin-1 receptor type 2 OS=Homo sapiens GN=IL1R2E5RH77;H0YB22;P62263RPS14$E5RH77_HUMAN;H0YB22_HUMAN;RS14_HUMANX40S ribosomal protein S14;40S ribosomal protein S14 (Fragment);40S ribosomal protein S14;;ribosomal small subunit assembly,negative regulation of transcription from RNA polymerase II promoter,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,regulation of translation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,erythrocyte differentiation,maturation of SSU-rRNA;;RNA binding,structural constituent of ribosome,protein binding,translation regulator activity,mRNA 5'-UTR binding,small ribosomal subunit rRNA binding;;nucleoplasm,nucleolus,mitochondrion,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome>tr|E5RH77|E5RH77_HUMAN 40S ribosomal protein S14 OS=Homo sapiens GN=RPS14 PE=1 SV=1;>tr|H0YB22|H0YB22_HUMAN 40S ribosomal protein S14 (Fragment) OS=Homo sapiens GN=RPS14 PE=1 SV=1;>sp|P62263|RS14_HUMAN 40S ribosomal protein S14 OS=Homo sapiens GN=RPS14 PE=1 SV=3$E5RHG6;E5RIW3;E5RJD8;O75347;O75347-2TBCA<E5RHG6_HUMAN;E5RIW3_HUMAN;E5RJD8_HUMAN;TBCA_HUMAN;TBCA_HUMANTubulin-specific chaperone A;Tubulin-specific chaperone A;Tubulin-specific chaperone A;Tubulin-specific chaperone A;Isoform 2 of Tubulin-specific chaperone AT;;;protein folding,tubulin complex assembly,post-chaperonin tubulin folding pathway;F;;;RNA binding,protein binding,beta-tubulin binding,chaperone binding;R;;;nucleolus,cytoplasm,microtubule,microtubule cytoskeleton,extracellular exosome;2;1;1;3;>tr|E5RHG6|E5RHG6_HUMAN Tubulin-specific chaperone A OS=Homo sapiens GN=TBCA PE=1 SV=2;>tr|E5RIW3|E5RIW3_HUMAN Tubulin-specific chaperone A OS=Homo sapiens GN=TBCA PE=1 SV=1;>tr|E5RJD8|E5RJD8_HUMAN Tubulin-specific chaperone A OS=Homo sapiens GN=TBCA PE=1 SV=1;>sp|O75347|TBCA_HUMAN Tubulin-specific chaperone A OS=Homo sapiens GN=TBCA PE=1 SV=3;>sp|O75347-2|TBCA_HUMAN Isoform 2 of Tubulin-specific chaperone A OS=Homo sapiens GN=TBCAE5RHG8;Q15369;Q15369-2;R4GMY8TCEB1/E5RHG8_HUMAN;ELOC_HUMAN;ELOC_HUMAN;R4GMY8_HUMANTranscription elongation factor B polypeptide 1 (Fragment);Transcription elongation factor B polypeptide 1;Isoform 2 of Transcription elongation factor B polypeptide 1;Transcription elongation factor B polypeptide 1;regulation of transcription from RNA polymerase II promoter,transcription from RNA polymerase II promoter,transcription elongation from RNA polymerase II promoter,viral process,positive regulation of transcription elongation from RNA polymerase II promoter,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia;;9;protein binding,ubiquitin-protein transferase activity;;&;nucleoplasm,cytosol,elongin complex;;>tr|E5RHG8|E5RHG8_HUMAN Transcription elongation factor B polypeptide 1 (Fragment) OS=Homo sapiens GN=TCEB1 PE=1 SV=1;>sp|Q15369|ELOC_HUMAN Transcription elongation factor B polypeptide 1 OS=Homo sapiens GN=TCEB1 PE=1 SV=1;>sp|Q15369-2|ELOC_HUMAN Isoform 2 of Transcription elongation factor B polypeptide 1 OS=Homo sapiens GN=TCEB1;>tr|R4GMY8|R4GMY8_HUMAN Transcription elongation factor B polypeptide 1 OS=Homo sapiens GN=TCEB1 PE=1 SV=1E9PEM5;P50851;P50851-2LRBA"E9PEM5_HUMAN;LRBA_HUMAN;LRBA_HUMANLipopolysaccharide-responsive and beige-like anchor protein;Lipopolysaccharide-responsive and beige-like anchor protein;Isoform 2 of Lipopolysaccharide-responsive and beige-like anchor protein;biological_process;;molecular_function;h;lysosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,membrane,integral component of membrane;b>tr|E9PEM5|E9PEM5_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=1;>sp|P50851|LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4;>sp|P50851-2|LRBA_HUMAN Isoform 2 of Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA"F5GYJ8;F5GYN4;F5H6Q1;J3KR44;Q96FW1OTUB1?F5GYJ8_HUMAN;F5GYN4_HUMAN;F5H6Q1_HUMAN;J3KR44_HUMAN;OTUB1_HUMANUbiquitin thioesterase OTUB1;Ubiquitin thioesterase OTUB1;Ubiquitin thioesterase;Ubiquitin thioesterase;Ubiquitin thioesterase OTUB1;;;;adaptive immune response,DNA repair,cellular response to DNA damage stimulus,protein deubiquitination,protein K48-linked deubiquitination,cellular response to interleukin-1,negative regulation of histone H2A K63-linked ubiquitination,negative regulation of double-strand break repair;;;;thiol-dependent ubiquitin-specific protease activity,protein binding,NEDD8-specific protease activity,ubiquitin protein ligase binding,ubiquitin binding5;;;;nucleus,nucleoplasm,cytosol,extracellular exosome 1;1;1;2;2>tr|F5GYJ8|F5GYJ8_HUMAN Ubiquitin thioesterase OTUB1 OS=Homo sapiens GN=OTUB1 PE=1 SV=1;>tr|F5GYN4|F5GYN4_HUMAN Ubiquitin thioesterase OTUB1 OS=Homo sapiens GN=OTUB1 PE=1 SV=1;>tr|F5H6Q1|F5H6Q1_HUMAN Ubiquitin thioesterase OS=Homo sapiens GN=OTUB1 PE=1 SV=1;>tr|J3KR44|J3KR44_HUMAN Ubiquitin thioesterase OS=Homo sapiens GN=OTUB1 PE=1 SV=2;>sp|Q96FW1|OTUB1_HUMAN Ubiquitin thioesterase OTUB1 OS=Homo sapiens GN=OTUB1 PE=1 SV=2 P01597;P04432IGKV1-39;IGKV1D-39KV139_HUMAN;KVD39_HUMANFImmunoglobulin kappa variable 1-39;Immunoglobulin kappa variable 1D-39proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response,leukocyte migration;proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response,leukocyte migrationsextracellular region,plasma membrane,extracellular exosome,blood microparticle;extracellular region,plasma membrane>sp|P01597|KV139_HUMAN Immunoglobulin kappa variable 1-39 OS=Homo sapiens GN=IGKV1-39 PE=1 SV=2;>sp|P04432|KVD39_HUMAN Immunoglobulin kappa variable 1D-39 OS=Homo sapiens GN=IGKV1D-39 PE=3 SV=2P01703IGLV1-40 LV140_HUMAN#Immunoglobulin lambda variable 1-40`>sp|P01703|LV140_HUMAN Immunoglobulin lambda variable 1-40 OS=Homo sapiens GN=IGLV1-40 PE=1 SV=2(P05019;P05019-2;P05019-3;P05019-4;Q13429IGF1;IGF1;IGF1;IGF1;IGF-I8IGF1_HUMAN;IGF1_HUMAN;IGF1_HUMAN;IGF1_HUMAN;Q13429_HUMANInsulin-like growth factor I;Isoform 2 of Insulin-like growth factor I;Isoform 3 of Insulin-like growth factor I;Isoform 4 of Insulin-like growth factor I;Insulin-like growth factor I (Fragment) activation of MAPK activity,skeletal system development,cell activation,platelet degranulation,DNA replication,movement of cell or subcellular component,signal transduction,Ras protein signal transduction,muscle organ development,cell proliferation,positive regulation of cell proliferation,response to heat,glycolate metabolic process,regulation of gene expression,positive regulation of glycoprotein biosynthetic process,positive regulation of cardiac muscle hypertrophy,phosphatidylinositol 3-kinase signaling,positive regulation of phosphatidylinositol 3-kinase signaling,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,muscle hypertrophy,myotube cell development,positive regulation of smooth muscle cell migration,proteoglycan biosynthetic process,positive regulation of cell mi< gration,activation of protein kinase B activity,positive regulation of protein import into nucleus, translocation,negative regulation of smooth muscle cell apoptotic process,bone mineralization involved in bone maturation,regulation of multicellular organism growth,positive regulation of activated T cell proliferation,positive regulation of tyrosine phosphorylation of Stat5 protein,negative regulation of apoptotic process,positive regulation of DNA binding,positive regulation of MAPK cascade,protein kinase B signaling,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,myoblast differentiation,positive regulation of osteoblast differentiation,positive regulation of glycogen biosynthetic process,positive regulation of DNA replication,positive regulation of glycolytic process,positive regulation of mitotic nuclear division,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,positive regulation of glucose import,positive regulation of Ras protein signal transduction,insulin-like growth factor receptor signaling pathway,phosphatidylinositol-mediated signaling,positive regulation of fibroblast proliferation,positive regulation of smooth muscle cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of protein secretion,positive regulation of peptidyl-tyrosine phosphorylation,protein stabilization,myoblast proliferation,negative regulation of oocyte development,positive regulation of cell growth involved in cardiac muscle cell development,ERK1 and ERK2 cascade,positive regulation of calcineurin-NFAT signaling cascade,negative regulation of release of cytochrome c from mitochondria,positive regulation of trophectodermal cell proliferation,positive regulation of transcription regulatory region DNA binding,negative regulation of extrinsic apoptotic signaling pathway;;;;insulin receptor binding,insulin-like growth factor receptor binding,integrin binding,hormone activity,protein binding,growth factor activity;;;;extracellular region,extracellular space,plasma membrane,insulin-like growth factor binding protein complex,platelet alpha granule lumen,alphav-beta3 integrin-IGF-1-IGF1R complex,insulin-like growth factor ternary complex,exocytic vesicle;;;;>sp|P05019|IGF1_HUMAN Insulin-like growth factor I OS=Homo sapiens GN=IGF1 PE=1 SV=1;>sp|P05019-2|IGF1_HUMAN Isoform 2 of Insulin-like growth factor I OS=Homo sapiens GN=IGF1;>sp|P05019-3|IGF1_HUMAN Isoform 3 of Insulin-like growth factor I OS=Homo sapiens GN=IGF1;>sp|P05019-4|IGF1_HUMAN Isoform 4 of Insulin-like growth factor I OS=Homo sapiens GN=IGF1;>tr|Q13429|Q13429_HUMAN Insulin-like growth factor I (Fragment) OS=Homo sapiens GN=IGF-I PE=1 SV=1P08572COL4A2 CO4A2_HUMANCollagen alpha-2(IV) chain&angiogenesis,transcription, DNA-templated,negative regulation of angiogenesis,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,collagen-activated tyrosine kinase receptor signaling pathway,cellular response to transforming growth factor beta stimulus;extracellular matrix structural constituent,protein bindingextracellular region,collagen type IV trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosomeU>sp|P08572|CO4A2_HUMAN Collagen alpha-2(IV) chain OS=Homo sapiens GN=COL4A2 PE=1 SV=4P10809HSPD1 CH60_HUMAN(60 kDa heat shock protein, mitochondrialresponse to hypoxia,detection of misfolded protein,B cell cytokine production,MyD88-dependent toll-like receptor signaling pathway,positive regulation of T cell mediated immune response to tumor cell,response to ischemia,regulation of transcription from RNA polymerase II promoter,'de novo' protein folding,activation of cysteine-type endopeptidase activity involved in apoptotic process,response to unfolded protein,apoptotic mitochondrial changes,response to heat,response to cold,response to activity,viral process,response to lipopolysaccharide,positive regulation of interferon-alpha production,positive regulation of interferon-gamma production,positive regulation of interleukin-10 production,positive regulation of interleukin-12 production,positive regulation of interleukin-6 production,response to ATP,protein refolding,B cell proliferation,T cell activation,B cell activation,response to cocaine,response to drug,response to hydrogen peroxide,positive regulation of macrophage activation,positive regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of neuron apoptotic process,response to estrogen,protein import into mitochondrial intermembrane space,isotype switching to IgG isotypes,positive regulation of inflammatory response,protein stabilization,positive regulation of T cell activation,chaperone mediated protein folding requiring cofactor,chaperone-mediated protein complex assembly,response to glucocorticoid,protein maturation,chaperone-mediated protein folding,negative regulation of apoptotic process in bone marrow,negative regulation of reactive oxygen species biosynthetic process,positive regulation of tumor necrosis factor secretion,positive regulation of interleukin-6 secretionlipopolysaccharide binding,protease binding,p53 binding,DNA replication origin binding,single-stranded DNA binding,RNA binding,double-stranded RNA binding,protein binding,ATP binding,ATPase activity,ubiquitin protein ligase binding,protein complex binding,insulin binding,protein binding involved in protein folding,protein heterodimerization activity,unfolded protein binding,chaperone binding,misfolded protein bindingextracellular space,cytoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,early endosome,peroxisomal matrix,rough endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,clathrin-coated pit,cell surface,membrane,mitochondrial crista,coated vesicle,secretory granule,extracellular matrix,zymogen granule,myelin sheath,protein complex,membrane raft,lipopolysaccharide receptor complex,extracellular exosome,cyclin-dependent protein kinase activating kinase holoenzyme complexa>sp|P10809|CH60_HUMAN 60 kDa heat shock protein, mitochondrial OS=Homo sapiens GN=HSPD1 PE=1 SV=2P14174MIF MIF_HUMAN&Macrophage migration inhibitory factorprostaglandin biosynthetic process,negative regulation of mature B cell apoptotic process,inflammatory response,cell surface receptor signaling pathway,cell aging,cell proliferation,negative regulation of gene expression,positive regulation of protein kinase A signaling,carboxylic acid metabolic process,DNA damage response, signal transduction by p53 class mediator,positive regulation of B cell proliferation,positive regulation of lipopolysaccharide-mediated signaling pathway,negative regulation of cellular protein metabolic process,negative regulation of myeloid cell apoptotic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of phosphorylation,regulation of macrophage activation,negative regulation of apoptotic process,neutrophil degranulation,positive regulation of MAP kinase activity,negative regulation of DNA damage response, signal transduction by p53 class mediator,innate immune response,positive regulation of fibroblast proliferation,positive regulation of cytokine secretion,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive chemotaxis,positive regulation of prostaglandin secretion involved in immune response,positive regulation of myeloid leukocyte cytokine production involved in immune response,protein homotrimerization,positive regulation of ERK1 and ERK2 cascade,negative regulation of cell cycle arrest,positive regulation of arachidonic acid secretion,negative regulation of cell aging,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,positive regulation of chemokine (C-X-C motif) ligand 2 productiondopachrome isomerase activity,receptor binding,cytokine activity,cytokine receptor binding,protein binding,chemoattractant activity,phenylpyruvate tautomerase activityextracellular< region,extracellular space,nucleoplasm,cytosol,cell surface,vesicle,secretory granule lumen,myelin sheath,extracellular exosome,ficolin-1-rich granule lumen\>sp|P14174|MIF_HUMAN Macrophage migration inhibitory factor OS=Homo sapiens GN=MIF PE=1 SV=4P15153RAC2 RAC2_HUMAN*Ras-related C3 botulinum toxin substrate 2 chemotaxis,actin filament organization,signal transduction,G-protein coupled receptor signaling pathway,small GTPase mediated signal transduction,positive regulation of cell proliferation,regulation of hydrogen peroxide metabolic process,positive regulation of lamellipodium assembly,regulation of cell-substrate adhesion,cell projection assembly,platelet activation,regulation of T cell proliferation,regulation of mast cell degranulation,bone resorption,regulation of protein kinase activity,regulation of small GTPase mediated signal transduction,regulation of respiratory burst,regulation of mast cell chemotaxis,lymphocyte aggregation,positive regulation of neutrophil chemotaxis,regulation of neutrophil migration,positive regulation of protein targeting to mitochondrion=GTPase activity,GTP binding,protein kinase regulator activitynuclear envelope,cytosol,plasma membrane,focal adhesion,lamellipodium,phagocytic vesicle membrane,extracellular exosome,actin filamentb>sp|P15153|RAC2_HUMAN Ras-related C3 botulinum toxin substrate 2 OS=Homo sapiens GN=RAC2 PE=1 SV=1 H3BNI9;P19784CSNK2A2H3BNI9_HUMAN;CSK22_HUMANJCasein kinase II subunit alpha' (Fragment);Casein kinase II subunit alpha';transcription, DNA-templated,regulation of transcription, DNA-templated,protein folding,protein phosphorylation,phosphatidylcholine biosynthetic process,apoptotic process,spermatogenesis,Wnt signaling pathway,cerebral cortex development,mitotic spindle checkpoint,liver regeneration,regulation of signal transduction by p53 class mediator,regulation of mitophagy,positive regulation of protein targeting to mitochondrion`;protein serine/threonine kinase activity,protein binding,ATP binding,protein N-terminus binding\;chromatin,acrosomal vesicle,nucleus,nucleoplasm,cytosol,plasma membrane,PcG protein complex>tr|H3BNI9|H3BNI9_HUMAN Casein kinase II subunit alpha' (Fragment) OS=Homo sapiens GN=CSNK2A2 PE=1 SV=1;>sp|P19784|CSK22_HUMAN Casein kinase II subunit alpha' OS=Homo sapiens GN=CSNK2A2 PE=1 SV=1P36980;P36980-2CFHR2 FHR2_HUMAN\Complement factor H-related protein 2;Isoform Short of Complement factor H-related protein 2>sp|P36980|FHR2_HUMAN Complement factor H-related protein 2 OS=Homo sapiens GN=CFHR2 PE=1 SV=1;>sp|P36980-2|FHR2_HUMAN Isoform Short of Complement factor H-related protein 2 OS=Homo sapiens GN=CFHR2P49407;P49407-2ARRB1 ARRB1_HUMAN-Beta-arrestin-1;Isoform 1B of Beta-arrestin-1activation of MAPK activity,positive regulation of protein phosphorylation,G-protein coupled receptor internalization,positive regulation of receptor internalization,transcription from RNA polymerase II promoter,apoptotic process,phototransduction,protein transport,protein ubiquitination,platelet activation,negative regulation of protein ubiquitination,positive regulation of protein ubiquitination,negative regulation of NF-kappaB transcription factor activity,positive regulation of protein binding,negative regulation of interleukin-6 production,negative regulation of interleukin-8 production,positive regulation of peptidyl-serine phosphorylation,negative regulation of GTPase activity,positive regulation of smooth muscle cell apoptotic process,positive regulation of Rho protein signal transduction,positive regulation of histone acetylation,positive regulation of insulin secretion involved in cellular response to glucose stimulus,response to drug,follicle-stimulating hormone signaling pathway,stress fiber assembly,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of GTPase activity,positive regulation of transcription from RNA polymerase II promoter,membrane organization,negative regulation of ERK1 and ERK2 cascade,positive regulation of ERK1 and ERK2 cascade,positive regulation of histone H4 acetylation;enzyme inhibitor activity,GTPase activator activity,insulin-like growth factor receptor binding,protein binding,transcription factor binding,estrogen receptor binding,mitogen-activated protein kinase kinase binding,ubiquitin protein ligase binding,alpha-1A adrenergic receptor binding,alpha-1B adrenergic receptor binding,angiotensin receptor binding,follicle-stimulating hormone receptor binding,V2 vasopressin receptor binding,AP-2 adaptor complex binding,clathrin adaptor activity,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,transcription regulatory region DNA binding,ion channel binding,protein phosphorylated amino acid binding,histone acetyltransferase activity;9Golgi membrane,chromatin,nucleus,nucleoplasm,cytoplasm,lysosomal membrane,cytosol,plasma membrane,clathrin-coated pit,postsynaptic density,basolateral plasma membrane,nuclear body,cytoplasmic vesicle membrane,pseudopodium,cytoplasmic vesicle,dendritic spine,postsynaptic membrane,heterotrimeric G-protein complex;>sp|P49407|ARRB1_HUMAN Beta-arrestin-1 OS=Homo sapiens GN=ARRB1 PE=1 SV=2;>sp|P49407-2|ARRB1_HUMAN Isoform 1B of Beta-arrestin-1 OS=Homo sapiens GN=ARRB1 P62241;Q5JR95RPS8RS8_HUMAN;Q5JR95_HUMAN40S ribosomal protein S8"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription;/RNA binding,structural constituent of ribosome;nucleus,nucleoplasm,endoplasmic reticulum,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome;>sp|P62241|RS8_HUMAN 40S ribosomal protein S8 OS=Homo sapiens GN=RPS8 PE=1 SV=2;>tr|Q5JR95|Q5JR95_HUMAN 40S ribosomal protein S8 OS=Homo sapiens GN=RPS8 PE=1 SV=1P67936-2&Isoform 2 of Tropomyosin alpha-4 chainV>sp|P67936-2|TPM4_HUMAN Isoform 2 of Tropomyosin alpha-4 chain OS=Homo sapiens GN=TPM4Q15819UBE2V2 UB2V2_HUMAN)Ubiquitin-conjugating enzyme E2 variant 2Aprotein polyubiquitination,DNA double-strand break processing,regulation of DNA repair,postreplication repair,double-strand break repair via nonhomologous end joining,cell proliferation,positive regulation of neuron projection development,protein ubiquitination,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,error-free postreplication DNA repair,negative regulation of neuron apoptotic process,positive regulation of DNA repair,positive regulation of synapse assembly,protein K63-linked ubiquitination,global genome nucleotide-excision repairxprotein binding,ubiquitin protein ligase binding,ubiquitin protein ligase activity,ubiquitin conjugating enzyme activityFnucleus,nucleoplasm,cytoplasm,UBC13-MMS2 complex,extracellular exosomed>sp|Q15819|UB2V2_HUMAN Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens GN=UBE2V2 PE=1 SV=4Q6IBS0TWF2 TWF2_HUMAN Twinfilin-2positive regulation of lamellipodium assembly,positive regulation of neuron projection development,cell projection organization,negative regulation of actin filament polymerization,regulation of microvillus length,regulation of actin cytoskeleton organization,sequestering of actin monomers,positive regulation of axon extension,barbed-end actin filament capping,cellular response to retinoic acid,cellular response to growth factor stimulusRNA binding,actin monomer binding,protein kinase C binding,protein binding,ATP binding,phosphatidylinositol-4,5-bisphosphate binding,cadherin bindingcytoplasm,cytoskeleton,myofibril,lamellipodium,filopodium,growth cone,stereocilium,perinuclear region of cytoplasm,extracellular exosomeC>sp|Q6IBS0|TWF2_HUMAN Twinfilin-2 OS=Homo sapiens GN=TWF2 PE=1 SV=2Q7KZF4SND1< SND1_HUMAN3Staphylococcal nuclease domain-containing protein 1osteoblast differentiation,transcription, DNA-templated,regulation of transcription, DNA-templated,RNA catabolic process,viral process,gene silencing by RNA,nucleic acid phosphodiester bond hydrolysis^transcription cofactor activity,RNA binding,nuclease activity,protein binding,cadherin bindinginucleus,cytoplasm,mitochondrion,cytosol,membrane,RISC complex,melanosome,extracellular exosome,dense bodyk>sp|Q7KZF4|SND1_HUMAN Staphylococcal nuclease domain-containing protein 1 OS=Homo sapiens GN=SND1 PE=1 SV=1&B7Z2A9;B7Z641;Q93050;Q93050-1;Q93050-3ATP6V0A1:B7Z2A9_HUMAN;B7Z641_HUMAN;VPP1_HUMAN;VPP1_HUMAN;VPP1_HUMANV-type proton ATPase subunit a;V-type proton ATPase subunit a;V-type proton ATPase 116 kDa subunit a isoform 1;Isoform 2 of V-type proton ATPase 116 kDa subunit a isoform 1;Isoform 3 of V-type proton ATPase 116 kDa subunit a isoform 1X;;vacuolar acidification,insulin receptor signaling pathway,ATP synthesis coupled proton transport,ATP hydrolysis coupled proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,neutrophil degranulation,vacuolar proton-transporting V-type ATPase complex assembly,phagosome acidification,toxin transport;;\;;protein binding,proton-transporting ATPase activity, rotational mechanism,ATPase binding;;;;vacuolar proton-transporting V-type ATPase, V0 domain,lysosomal membrane,Golgi apparatus,cytosol,plasma membrane,endosome membrane,integral component of membrane,vacuolar proton-transporting V-type ATPase complex,nuclear speck,secretory granule membrane,phagocytic vesicle membrane,melanosome,intracellular membrane-bounded organelle,extracellular exosome,ficolin-1-rich granule membrane;; >tr|B7Z2A9|B7Z2A9_HUMAN V-type proton ATPase subunit a OS=Homo sapiens GN=ATP6V0A1 PE=1 SV=1;>tr|B7Z641|B7Z641_HUMAN V-type proton ATPase subunit a OS=Homo sapiens GN=ATP6V0A1 PE=1 SV=1;>sp|Q93050|VPP1_HUMAN V-type proton ATPase 116 kDa subunit a isoform 1 OS=Homo sapiens GN=ATP6V0A1 PE=1 SV=3;>sp|Q93050-1|VPP1_HUMAN Isoform 2 of V-type proton ATPase 116 kDa subunit a isoform 1 OS=Homo sapiens GN=ATP6V0A1;>sp|Q93050-3|VPP1_HUMAN Isoform 3 of V-type proton ATPase 116 kDa subunit a isoform 1 OS=Homo sapiens GN=ATP6V0A1Q96QK1VPS35 VPS35_HUMAN.Vacuolar protein sorting-associated protein 35Glysosome organization,positive regulation of gene expression,negative regulation of gene expression,regulation of mitochondrion organization,Wnt signaling pathway,regulation of macroautophagy,regulation of protein stability,protein destabilization,regulation of cellular protein metabolic process,negative regulation of protein homooligomerization,protein localization to organelle,retrograde transport, endosome to Golgi,mitochondrial fragmentation involved in apoptotic process,transcytosis,voluntary musculoskeletal movement,positive regulation of dopamine receptor signaling pathway,positive regulation of Wnt protein secretion,positive regulation of mitochondrial fission,positive regulation of canonical Wnt signaling pathway,positive regulation of locomotion involved in locomotory behavior,mitochondrion to lysosome transport,neurotransmitter receptor transport, endosome to plasma membrane,negative regulation of neuron death,negative regulation of late endosome to lysosome transport,regulation of dendritic spine maintenance,positive regulation of dopamine biosynthetic process,positive regulation of cellular protein catabolic process,negative regulation of cellular protein localization,negative regulation of lysosomal protein catabolic process,retrograde transport, endosome to plasma membrane,regulation of terminal button organizationIprotein binding,protein transporter activity,D1 dopamine receptor binding;lysosome,lysosomal membrane,endosome,early endosome,late endosome,cytosol,endosome membrane,postsynaptic density,retromer complex,retromer, cargo-selective complex,neuron projection,neuronal cell body,perinuclear region of cytoplasm,extracellular exosome,tubular endosome,mitochondrion-derived vesicle,mitochondrionh>sp|Q96QK1|VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2Q9BUL8PDCD10 PDC10_HUMAN Programmed cell death protein 10angiogenesis,positive regulation of cell proliferation,positive regulation of gene expression,negative regulation of gene expression,positive regulation of cell migration,positive regulation of stress-activated MAPK cascade,positive regulation of peptidyl-serine phosphorylation,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,response to hydrogen peroxide,negative regulation of apoptotic process,positive regulation of MAP kinase activity,wound healing, spreading of cells,positive regulation of Notch signaling pathway,protein stabilization,establishment of Golgi localization,positive regulation of protein serine/threonine kinase activity,negative regulation of cell migration involved in sprouting angiogenesis,Golgi reassembly,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,regulation of Rho protein signal transduction,stress fiber assemblycprotein binding,protein kinase binding,protein homodimerization activity,protein N-terminus bindingVGolgi membrane,cytoplasm,Golgi apparatus,cytosol,plasma membrane,extracellular exosome[>sp|Q9BUL8|PDC10_HUMAN Programmed cell death protein 10 OS=Homo sapiens GN=PDCD10 PE=1 SV=1Q9BYE9CDHR2 CDHR2_HUMAN Cadherin-related family member 2homophilic cell adhesion via plasma membrane adhesion molecules,epithelial cell differentiation,regulation of microvillus length,cell-cell adhesion mediated by cadherin,negative regulation of cell growth involved in contact inhibition,intermicrovillar adhesionBcalcium ion binding,protein binding,cell adhesion molecule bindingbrush border,apical plasma membrane,cell junction,brush border membrane,microvillus membrane,spanning component of plasma membrane,extracellular exosomeZ>sp|Q9BYE9|CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2Q9NSB4KRT82 KRT82_HUMANKeratin, type II cuticular Hb2/biological_process,keratinization,cornificationcytosol,keratin filamentX>sp|Q9NSB4|KRT82_HUMAN Keratin, type II cuticular Hb2 OS=Homo sapiens GN=KRT82 PE=3 SV=3Q9NVJ2ARL8B ARL8B_HUMAN'ADP-ribosylation factor-like protein 8Bocell cycle,chromosome segregation,small GTPase mediated signal transduction,lysosome localization,cell divisionbGTPase activity,protein binding,GTP binding,GDP binding,alpha-tubulin binding,beta-tubulin bindingjcytoplasm,membrane,midbody,late endosome membrane,spindle midzone,extracellular exosome,lysosomal membranea>sp|Q9NVJ2|ARL8B_HUMAN ADP-ribosylation factor-like protein 8B OS=Homo sapiens GN=ARL8B PE=1 SV=1Q9UBI6GNG12 GBG12_HUMANBGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12signal transduction,G-protein coupled receptor signaling pathway,cerebral cortex development,response to lipopolysaccharide,cellular response to glucagon stimulusSsignal transducer activity,protein binding,PDZ domain binding,phosphate ion bindingUheterotrimeric G-protein complex,actin filament,plasma membrane,extracellular exosome|>sp|Q9UBI6|GBG12_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 OS=Homo sapiens GN=GNG12 PE=1 SV=3SK7EK18;K7EL40;Q9UHD8;Q9UHD8-2;Q9UHD8-3;Q9UHD8-4;Q9UHD8-5;Q9UHD8-7;Q9UHD8-8;Q9UHD8-9SEPT9yK7EK18_HUMAN;K7EL40_HUMAN;SEPT9_HUMAN;SEPT9_HUMAN;SEPT9_HUMAN;SEPT9_HUMAN;SEPT9_HUMAN;SEPT9_HUMAN;SEPT9_HUMAN;SEPT9_HUMANSeptin-9 (Fragment);Septin-9 (Fragment);Septin-9;Isoform 2 of Septin-9;Isoform 3 of Septin-9;Isoform 4 of Septin-9;Isoform 5 of Septin-9;Isoform 7 of Septin-9;Isoform 8 of Septin-9;Isoform 9 of Septin-9x;;cell cycle,protein heterooligomerization,cell division,positive regulation of nonmotile primary cilium assembly;;;;;;;E;;GTPase activity,protein binding,GTP binding,cadherin binding;;;;;;;;;stress fiber,cytoplasm,microtubule,axoneme,actin cytoskeleton,septin complex,perinuclear region of cytoplasm,Requires Ontology;;;;;;;tr;tr;sp;sp;< sp;sp;sp;sp;sp;sp 1;1;1;;;;;;; 1;1;2;;;;;;;>tr|K7EK18|K7EK18_HUMAN Septin-9 (Fragment) OS=Homo sapiens GN=SEPT9 PE=1 SV=1;>tr|K7EL40|K7EL40_HUMAN Septin-9 (Fragment) OS=Homo sapiens GN=SEPT9 PE=1 SV=1;>sp|Q9UHD8|SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2;>sp|Q9UHD8-2|SEPT9_HUMAN Isoform 2 of Septin-9 OS=Homo sapiens GN=SEPT9;>sp|Q9UHD8-3|SEPT9_HUMAN Isoform 3 of Septin-9 OS=Homo sapiens GN=SEPT9;>sp|Q9UHD8-4|SEPT9_HUMAN Isoform 4 of Septin-9 OS=Homo sapiens GN=SEPT9;>sp|Q9UHD8-5|SEPT9_HUMAN Isoform 5 of Septin-9 OS=Homo sapiens GN=SEPT9;>sp|Q9UHD8-7|SEPT9_HUMAN Isoform 7 of Septin-9 OS=Homo sapiens GN=SEPT9;>sp|Q9UHD8-8|SEPT9_HUMAN Isoform 8 of Septin-9 OS=Homo sapiens GN=SEPT9;>sp|Q9UHD8-9|SEPT9_HUMAN Isoform 9 of Septin-9 OS=Homo sapiens GN=SEPT9Q9ULL4;Q9ULL4-2PLXNB3 PLXB3_HUMAN Plexin-B3;Isoform 2 of Plexin-B3positive regulation of endothelial cell proliferation,homophilic cell adhesion via plasma membrane adhesion molecules,negative regulation of cell adhesion,regulation of cell shape,negative regulation of lamellipodium assembly,positive regulation of neuron projection development,negative regulation of cell migration,negative regulation of GTPase activity,axon extension,positive regulation of axonogenesis,positive chemotaxis,cell chemotaxis,semaphorin-plexin signaling pathway;protein binding,semaphorin receptor activity,protein domain specific binding,Rho GDP-dissociation inhibitor binding,protein binding involved in cell-cell adhesion;<plasma membrane,cell surface,integral component of membrane;>sp|Q9ULL4|PLXB3_HUMAN Plexin-B3 OS=Homo sapiens GN=PLXNB3 PE=1 SV=2;>sp|Q9ULL4-2|PLXB3_HUMAN Isoform 2 of Plexin-B3 OS=Homo sapiens GN=PLXNB3Q9Y3F4;Q9Y3F4-2STRAP STRAP_HUMANtSerine-threonine kinase receptor-associated protein;Isoform 2 of Serine-threonine kinase receptor-associated proteinnegative regulation of transcription from RNA polymerase II promoter,spliceosomal snRNP assembly,negative regulation of epithelial cell migration,negative regulation of epithelial to mesenchymal transition,maintenance of gastrointestinal epithelium,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of epithelial cell proliferation,negative regulation of pathway-restricted SMAD protein phosphorylation;-RNA binding,receptor binding,protein binding;Anucleoplasm,cytoplasm,cytosol,SMN complex,SMN-Sm protein complex;>sp|Q9Y3F4|STRAP_HUMAN Serine-threonine kinase receptor-associated protein OS=Homo sapiens GN=STRAP PE=1 SV=1;>sp|Q9Y3F4-2|STRAP_HUMAN Isoform 2 of Serine-threonine kinase receptor-associated protein OS=Homo sapiens GN=STRAP A0A075B6I7IGLV5-48A0A075B6I7_HUMANProtein IGLV5-48V>tr|A0A075B6I7|A0A075B6I7_HUMAN Protein IGLV5-48 OS=Homo sapiens GN=IGLV5-48 PE=1 SV=2>A0A087WU31;A0A0A0MTB7;E9PE15;P51790;P51790-2;P51790-4;P51790-5CLCN3^A0A087WU31_HUMAN;A0A0A0MTB7_HUMAN;E9PE15_HUMAN;CLCN3_HUMAN;CLCN3_HUMAN;CLCN3_HUMAN;CLCN3_HUMANChloride channel protein;Chloride channel protein;Chloride channel protein (Fragment);H(+)/Cl(-) exchange transporter 3;Isoform 2 of H(+)/Cl(-) exchange transporter 3;Isoform 3 of H(+)/Cl(-) exchange transporter 3;Isoform 4 of H(+)/Cl(-) exchange transporter 3;;;transport,regulation of pH,negative regulation of cell volume,endosomal lumen acidification,chloride transmembrane transport,regulation of anion transmembrane transport;;;;;;voltage-gated chloride channel activity,chloride channel activity,protein binding,ATP binding,antiporter activity,PDZ domain binding,protein homodimerization activity,protein heterodimerization activity,volume-sensitive chloride channel activity;;;;;;Golgi membrane,early endosome,late endosome,Golgi apparatus,plasma membrane,integral component of plasma membrane,synaptic vesicle,external side of plasma membrane,cell surface,vesicle membrane,membrane,integral component of membrane,secretory granule,transport vesicle membrane,cytoplasmic vesicle,early endosome membrane,late endosome membrane,specific granule,phagocytic vesicle;;;tr;tr;tr;sp;sp;sp;sp 1;1;1;1;;; 1;1;1;2;;;>tr|A0A087WU31|A0A087WU31_HUMAN Chloride channel protein OS=Homo sapiens GN=CLCN3 PE=1 SV=1;>tr|A0A0A0MTB7|A0A0A0MTB7_HUMAN Chloride channel protein OS=Homo sapiens GN=CLCN3 PE=1 SV=1;>tr|E9PE15|E9PE15_HUMAN Chloride channel protein (Fragment) OS=Homo sapiens GN=CLCN3 PE=1 SV=1;>sp|P51790|CLCN3_HUMAN H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens GN=CLCN3 PE=1 SV=2;>sp|P51790-2|CLCN3_HUMAN Isoform 2 of H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens GN=CLCN3;>sp|P51790-4|CLCN3_HUMAN Isoform 3 of H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens GN=CLCN3;>sp|P51790-5|CLCN3_HUMAN Isoform 4 of H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens GN=CLCN3A0A087WZZ4;A0A0A0MQS8;Q02094RHAG,A0A087WZZ4_HUMAN;A0A0A0MQS8_HUMAN;RHAG_HUMANAmmonium transporter Rh type A);;cellular ion homeostasis,carbon dioxide transport,monovalent inorganic cation transport,organic cation transport,ammonium transport,bicarbonate transport,carbon dioxide transmembrane transport,erythrocyte development,multicellular organismal iron ion homeostasis,ammonium transmembrane transport;;ammonium transmembrane transporter activity,leak channel activity,ankyrin binding,carbon dioxide transmembrane transporter activity@;;plasma membrane,integral component of plasma membrane,membrane>tr|A0A087WZZ4|A0A087WZZ4_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=1;>tr|A0A0A0MQS8|A0A0A0MQS8_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=1;>sp|Q02094|RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2E9PL40;H0YB98;Q96SJ8TSPAN18%E9PL40_HUMAN;H0YB98_HUMAN;TSN18_HUMAN?Tetraspanin-18 (Fragment);Tetraspanin (Fragment);Tetraspanin-18);;cell surface receptor signaling pathway';;integral component of plasma membrane>tr|E9PL40|E9PL40_HUMAN Tetraspanin-18 (Fragment) OS=Homo sapiens GN=TSPAN18 PE=1 SV=1;>tr|H0YB98|H0YB98_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=TSPAN18 PE=1 SV=1;>sp|Q96SJ8|TSN18_HUMAN Tetraspanin-18 OS=Homo sapiens GN=TSPAN18 PE=2 SV=1F8W914;Q9NQC3;Q9NQC3-2;Q9NQC3-5RTN4-F8W914_HUMAN;RTN4_HUMAN;RTN4_HUMAN;RTN4_HUMANGReticulon;Reticulon-4;Isoform 2 of Reticulon-4;Isoform 5 of Reticulon-4;apoptotic process,axonal fasciculation,cerebral cortex radial glia guided migration,negative regulation of cell growth,negative regulation of axon extension,regulation of apoptotic process,negative regulation of axonogenesis,nuclear pore complex assembly,cardiac epithelial to mesenchymal transition,endoplasmic reticulum tubular network organization,endoplasmic reticulum tubular network assembly,regulation of branching morphogenesis of a nerve;;/;RNA binding,protein binding,cadherin binding;;;intracellular,nuclear envelope,endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,postsynaptic density,integral component of endoplasmic reticulum membrane,cell projection,extracellular exosome;;1;2;;>tr|F8W914|F8W914_HUMAN Reticulon OS=Homo sapiens GN=RTN4 PE=1 SV=1;>sp|Q9NQC3|RTN4_HUMAN Reticulon-4 OS=Homo sapiens GN=RTN4 PE=1 SV=2;>sp|Q9NQC3-2|RTN4_HUMAN Isoform 2 of Reticulon-4 OS=Homo sapiens GN=RTN4;>sp|Q9NQC3-5|RTN4_HUMAN Isoform 5 of Reticulon-4 OS=Homo sapiens GN=RTN48H3BU86;O14662;O14662-2;O14662-3;O14662-4;O14662-5;Q96NX80STX16-NPEPL1;STX16;STX16;STX16;STX16;STX16;STX16UH3BU86_HUMAN;STX16_HUMAN;STX16_HUMAN;STX16_HUMAN;STX16_HUMAN;STX16_HUMAN;Q96NX8_HUMANProtein STX16-NPEPL1;Syntaxin-16;Isoform A of Syntaxin-16;Isoform C of Syntaxin-16;Isoform D of Syntaxin-16;Isoform E of Syntaxin-16;Syntaxin-16intracellular protein transport,vesicle fusion,vesicle docking;intracellular protein transport,vesicle fusion,retrograde transport, endosome to Golgi,vesicle docking,Golgi ribbon formation;;;;;aSNARE binding,SNAP receptor activity;SNAP receptor activity,protein binding,syntaxin binding;;;;;;endomembrane system,integral component of membrane,SNARE complex;Golgi membrane,cytoplasm,Golgi apparatus,trans-Golgi network,cytosol,focal adhesion,integral component of membrane,SNARE complex,Golgi cisterna,trans-Golgi network membrane,in< tracellular membrane-bounded organelle,perinuclear region of cytoplasm;;;;;tr;sp;sp;sp;sp;sp;tr 3;1;;;;;1 1;3;;;;;1>tr|H3BU86|H3BU86_HUMAN Protein STX16-NPEPL1 OS=Homo sapiens GN=STX16-NPEPL1 PE=3 SV=1;>sp|O14662|STX16_HUMAN Syntaxin-16 OS=Homo sapiens GN=STX16 PE=1 SV=3;>sp|O14662-2|STX16_HUMAN Isoform A of Syntaxin-16 OS=Homo sapiens GN=STX16;>sp|O14662-3|STX16_HUMAN Isoform C of Syntaxin-16 OS=Homo sapiens GN=STX16;>sp|O14662-4|STX16_HUMAN Isoform D of Syntaxin-16 OS=Homo sapiens GN=STX16;>sp|O14662-5|STX16_HUMAN Isoform E of Syntaxin-16 OS=Homo sapiens GN=STX16;>tr|Q96NX8|Q96NX8_HUMAN Syntaxin-16 OS=Homo sapiens GN=STX16 PE=1 SV=1C9JTK6;J3KQ32;Q9NTK5;Q9NTK5-3OLA1/C9JTK6_HUMAN;J3KQ32_HUMAN;OLA1_HUMAN;OLA1_HUMAN_Obg-like ATPase 1 (Fragment);Obg-like ATPase 1;Obg-like ATPase 1;Isoform 3 of Obg-like ATPase 1/;;platelet degranulation,ATP metabolic process;];;protein binding,ATP binding,GTP binding,ATPase activity,cadherin binding,metal ion binding;z;;extracellular region,nucleolus,cytoplasm,centrosome,cytosol,membrane,plat elet alpha granule lumen,extracellular exosome;;>tr|C9JTK6|C9JTK6_HUMAN Obg-like ATPase 1 (Fragment) OS=Homo sapiens GN=OLA1 PE=1 SV=1;>tr|J3KQ32|J3KQ32_HUMAN Obg-like ATPase 1 OS=Homo sapiens GN=OLA1 PE=1 SV=1;>sp|Q9NTK5|OLA1_HUMAN Obg-like ATPase 1 OS=Homo sapiens GN=OLA1 PE=1 SV=2;>sp|Q9NTK5-3|OLA1_HUMAN Isoform 3 of Obg-like ATPase 1 OS=Homo sapiens GN=OLA1 J9JIG6;Q96EG1ARSGJ9JIG6_HUMAN;ARSG_HUMANArylsulfatase Gn;glycosphingolipid metabolic process,sulfur compound metabolic process,post-translational protein modification);arylsulfatase activity,metal ion bindingO;extracellular space,lysosome,endoplasmic reticulum,endoplasmic reticulum lumen>tr|J9JIG6|J9JIG6_HUMAN Arylsulfatase G OS=Homo sapiens GN=ARSG PE=1 SV=1;>sp|Q96EG1|ARSG_HUMAN Arylsulfatase G OS=Homo sapiens GN=ARSG PE=1 SV=1$K7EQ86;K7EQR3;Q08E86;Q14667;Q14667-2KIAA0100>K7EQ86_HUMAN;K7EQR3_HUMAN;Q08E86_HUMAN;K0100_HUMAN;K0100_HUMANsKIAA0100, isoform CRA_a;Protein KIAA0100 (Fragment);KIAA0100 protein;Protein KIAA0100;Isoform 2 of Protein KIAA0100;;;extracellular region;1;1;1;3;>tr|K7EQ86|K7EQ86_HUMAN KIAA0100, isoform CRA_a OS=Homo sapiens GN=KIAA0100 PE=1 SV=1;>tr|K7EQR3|K7EQR3_HUMAN Protein KIAA0100 (Fragment) OS=Homo sapiens GN=KIAA0100 PE=1 SV=1;>tr|Q08E86|Q08E86_HUMAN KIAA0100 protein OS=Homo sapiens GN=KIAA0100 PE=1 SV=1;>sp|Q14667|K0100_HUMAN Protein KIAA0100 OS=Homo sapiens GN=KIAA0100 PE=1 SV=3;>sp|Q14667-2|K0100_HUMAN Isoform 2 of Protein KIAA0100 OS=Homo sapiens GN=KIAA0100O00487PSMD14 PSDE_HUMAN/26S proteasome non-ATPase regulatory subunit 14MAPK cascade,protein polyubiquitination,double-strand break repair via homologous recombination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,double-strand break repair via nonhomologous end joining,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,response to ethanol,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,protein K63-linked deubiquitination,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayprotein binding,metallopeptidase activity,metal ion binding,endopeptidase activator activity,Lys63-specific deubiquitinase activity,proteasome bindingproteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, lid subcomplex,proteasome accessory complex,cytosolic proteasome complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumeni>sp|O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory subunit 14 OS=Homo sapiens GN=PSMD14 PE=1 SV=1P01704IGLV2-14 LV214_HUMAN#Immunoglobulin lambda variable 2-14`>sp|P01704|LV214_HUMAN Immunoglobulin lambda variable 2-14 OS=Homo sapiens GN=IGLV2-14 PE=1 SV=2P04908;Q7L7L0;Q93077HIST1H2AB;HIST3H2A;HIST1H2AC"H2A1B_HUMAN;H2A3_HUMAN;H2A1C_HUMAN>Histone H2A type 1-B/E;Histone H2A type 3;Histone H2A type 1-Cchromatin silencing,negative regulation of cell proliferation;nucleosome disassembly,chromatin silencing,UV-damage excision repair;chromatin silencing,negative regulation of cell proliferationDNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activitynucleosome,nuclear chromatin,nucleus,extracellular exosome;nuclear nucleosome,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome2;3;3>sp|P04908|H2A1B_HUMAN Histone H2A type 1-B/E OS=Homo sapiens GN=HIST1H2AB PE=1 SV=2;>sp|Q7L7L0|H2A3_HUMAN Histone H2A type 3 OS=Homo sapiens GN=HIST3H2A PE=1 SV=3;>sp|Q93077|H2A1C_HUMAN Histone H2A type 1-C OS=Homo sapiens GN=HIST1H2AC PE=1 SV=3P09382LGALS1 LEG1_HUMAN Galectin-1^plasma cell differentiation,apoptotic process,signal transduction,negative regulation of cell-substrate adhesion,negative regulation of neuron projection development,T cell costimulation,positive regulation of erythrocyte aggregation,response to isolation stress,response to drug,regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,myoblast differentiation,positive regulation of viral entry into host cell,response to axon injury,cellular response to glucose stimulus,cellular response to organic cyclic compound,positive regulation of dendritic cell differentiationglycoprotein binding,RNA binding,signal transducer activity,protein binding,lactose binding,protein homodimerization activity,laminin bindingproteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,cytosol,cell surface,extracellular matrix,extracellular exosomeD>sp|P09382|LEG1_HUMAN Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2P14209;P14209-3CD99 CD99_HUMAN&CD99 antigen;Isoform 3 of CD99 antigenOcytoplasm,plasma membrane,integral component of plasma membrane,focal adhesion;>sp|P14209|CD99_HUMAN CD99 antigen OS=Homo sapiens GN=CD99 PE=1 SV=1;>sp|P14209-3|CD99_HUMAN Isoform 3 of CD99 antigen OS=Homo sapiens GN=CD99!P18433;P18433-2;P18433-3;P18433-4PTPRA PTPRA_HUMANReceptor-type tyrosine-protein phosphatase alpha;Isoform 2 of Receptor-type tyrosine-protein phosphatase alpha;Isoform 3 of Receptor-type tyrosine-protein phosphatase alpha;Isoform 4 of Receptor-type tyrosine-protein phosphatase alphaMAPK cascade,axon guidance,insulin receptor signaling pathway,peptidyl-tyrosine dephosphorylation,positive regulation of GTPase activity;;;protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,Ras guanyl-nucleotide exchange factor activity,protein binding;;;mintracellular,plasma membrane,integral component of plasma membrane,receptor complex,extracellular exosome;;;>sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens GN=PTPRA PE=1 SV=2;>sp|P18433-2|PTPRA_HUMAN Isoform 2 of Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens GN=PTPRA;>sp|P18433-3|PTPRA_HUMAN Isoform 3 of Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens GN=PTPRA;>sp|P18433-4|PTPRA_HUMAN Isoform 4 of Receptor-type tyrosine-protein phosp< hatase alpha OS=Homo sapiens GN=PTPRAP53621;P53621-2COPA COPA_HUMAN:Coatomer subunit alpha;Isoform 2 of Coatomer subunit alphaintracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,pancreatic juice secretion;.hormone activity,structural molecule activity;Golgi membrane,extracellular space,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,COPI vesicle coat,transport vesicle,extracellular exosome;>sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2;>sp|P53621-2|COPA_HUMAN Isoform 2 of Coatomer subunit alpha OS=Homo sapiens GN=COPAP58546MTPN MTPN_HUMAN MyotrophinVregulation of translation,catecholamine metabolic process,positive regulation of macromolecule biosynthetic process,positive regulation of cardiac muscle hypertrophy,cell growth,regulation of striated muscle tissue development,cerebellar granule cell differentiation,neuron differentiation,positive regulation of cell growth,skeletal muscle tissue regeneration,positive regulation of NF-kappaB transcription factor activity,striated muscle cell differentiation,positive regulation of protein metabolic process,cellular response to mechanical stimulus,regulation of barbed-end actin filament cappingsequence-specific DNA bindingjnucleus,cytosol,F-actin capping protein complex,axon,perinuclear region of cytoplasm,extracellular exosomeB>sp|P58546|MTPN_HUMAN Myotrophin OS=Homo sapiens GN=MTPN PE=1 SV=2P81172HAMP HEPC_HUMANHepcidinnegative regulation of transcription from RNA polymerase II promoter,cellular iron ion homeostasis,acute-phase response,immune response,aging,response to iron ion,response to zinc ion,killing of cells of other organism,response to vitamin A,negative regulation of iron ion transmembrane transport,response to erythropoietin,defense response to bacterium,response to ethanol,defense response to fungus,multicellular organismal iron ion homeostasis,positive regulation of cell growth involved in cardiac muscle cell development,cellular response to lipopolysaccharide,cellular response to interleukin-6,cellular response to tumor necrosis factor,cellular response to X-ray,liver regeneration,cellular response to bile acid,negative regulation of intestinal absorption,response to iron ion starvationhormone activityHextracellular region,extracellular space,intercalated disc,apical cortex@>sp|P81172|HEPC_HUMAN Hepcidin OS=Homo sapiens GN=HAMP PE=1 SV=2Q01970;Q01970-2PLCB3 PLCB3_HUMAN1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3;Isoform 2 of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3regulation of systemic arterial blood pressure,Wnt signaling pathway, calcium modulating pathway,chemical synaptic transmission,lipid catabolic process,intracellular signal transduction,inositol phosphate metabolic process;phosphatidylinositol phospholipase C activity,phospholipase C activity,signal transducer activity,calcium ion binding,calmodulin binding,cadherin binding;-nucleoplasm,cytosol,membrane,protein complex;>sp|Q01970|PLCB3_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 OS=Homo sapiens GN=PLCB3 PE=1 SV=2;>sp|Q01970-2|PLCB3_HUMAN Isoform 2 of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 OS=Homo sapiens GN=PLCB3!Q8N5J2;Q8N5J2-2;Q8N5J2-3;Q8N5J2-4FAM63A FA63A_HUMANUbiquitin carboxyl-terminal hydrolase MINDY-1;Isoform 2 of Ubiquitin carboxyl-terminal hydrolase MINDY-1;Isoform 3 of Ubiquitin carboxyl-terminal hydrolase MINDY-1;Isoform 4 of Ubiquitin carboxyl-terminal hydrolase MINDY-19biological_process,protein K48-linked deubiquitination;;;thiol-dependent ubiquitin-specific protease activity,protein binding,cysteine-type carboxypeptidase activity,Lys48-specific deubiquitinase activity;;;>sp|Q8N5J2|FA63A_HUMAN Ubiquitin carboxyl-terminal hydrolase MINDY-1 OS=Homo sapiens GN=FAM63A PE=1 SV=2;>sp|Q8N5J2-2|FA63A_HUMAN Isoform 2 of Ubiquitin carboxyl-terminal hydrolase MINDY-1 OS=Homo sapiens GN=FAM63A;>sp|Q8N5J2-3|FA63A_HUMAN Isoform 3 of Ubiquitin carboxyl-terminal hydrolase MINDY-1 OS=Homo sapiens GN=FAM63A;>sp|Q8N5J2-4|FA63A_HUMAN Isoform 4 of Ubiquitin carboxyl-terminal hydrolase MINDY-1 OS=Homo sapiens GN=FAM63AQ8NEU8;Q8NEU8-2;Q8NEU8-3APPL2 DP13B_HUMANyDCC-interacting protein 13-beta;Isoform 2 of DCC-interacting protein 13-beta;Isoform 3 of DCC-interacting protein 13-beta3cell cycle,signal transduction,cell proliferation;;`nucleus,cytoplasm,endosome membrane,early endosome membrane,extracellular exosome,NuRD complex;;>sp|Q8NEU8|DP13B_HUMAN DCC-interacting protein 13-beta OS=Homo sapiens GN=APPL2 PE=1 SV=3;>sp|Q8NEU8-2|DP13B_HUMAN Isoform 2 of DCC-interacting protein 13-beta OS=Homo sapiens GN=APPL2;>sp|Q8NEU8-3|DP13B_HUMAN Isoform 3 of DCC-interacting protein 13-beta OS=Homo sapiens GN=APPL2Q92954-3 PRG4_HUMANIsoform C of Proteoglycan 4K>sp|Q92954-3|PRG4_HUMAN Isoform C of Proteoglycan 4 OS=Homo sapiens GN=PRG4Q9UJC5SH3BGRL2 SH3L2_HUMAN4SH3 domain-binding glutamic acid-rich-like protein 2SH3 domain binding<nucleoplasm,cytoplasm,nuclear membrane,extracellular exosomeq>sp|Q9UJC5|SH3L2_HUMAN SH3 domain-binding glutamic acid-rich-like protein 2 OS=Homo sapiens GN=SH3BGRL2 PE=1 SV=2Q9Y265RUVBL1 RUVB1_HUMAN RuvB-like 1DNA repair,DNA recombination,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,mitotic nuclear division,spermatogenesis,protein deubiquitination,DNA duplex unwinding,CENP-A containing nucleosome assembly,regulation of growth,histone H4 acetylation,histone H2A acetylation,cell division,regulation of mitophagy,positive regulation of protein targeting to mitochondrion,beta-catenin-TCF complex assembly,positive regulation of telomerase RNA localization to Cajal body|DNA helicase activity,protein binding,ATP binding,ATPase activity,ATP-dependent 5'-3' DNA helicase activity,cadherin bindingSwr1 complex,nucleus,nucleoplasm,microtubule organizing center,cytosol,membrane,nuclear matrix,Ino80 complex,NuA4 histone acetyltransferase complex,extracellular exosome,MLL1 complex,R2TP complexF>sp|Q9Y265|RUVB1_HUMAN RuvB-like 1 OS=Homo sapiens GN=RUVBL1 PE=1 SV=1A0A075B6P5;P01615IGKV2-28;IGKV2D-28KV228_HUMAN;KVD28_HUMANFImmunoglobulin kappa variable 2-28;Immunoglobulin kappa variable 2D-28>sp|A0A075B6P5|KV228_HUMAN Immunoglobulin kappa variable 2-28 OS=Homo sapiens GN=IGKV2-28 PE=3 SV=1;>sp|P01615|KVD28_HUMAN Immunoglobulin kappa variable 2D-28 OS=Homo sapiens GN=IGKV2D-28 PE=1 SV=2A0A087X1G7;A0A0B4J1S4;O60613SEPT15-A0A087X1G7_HUMAN;A0A0B4J1S4_HUMAN;SEP15_HUMAN15 kDa selenoprotein-;;'de novo' posttranslational protein folding;;selenium binding3;;endoplasmic reticulum lumen,extracellular exosome>tr|A0A087X1G7|A0A087X1G7_HUMAN 15 kDa selenoprotein OS=Homo sapiens GN=SEP15 PE=1 SV=1;>tr|A0A0B4J1S4|A0A0B4J1S4_HUMAN 15 kDa selenoprotein OS=Homo sapiens GN=SEP15 PE=1 SV=1;>sp|O60613|SEP15_HUMAN 15 kDa selenoprotein OS=Homo sapiens GN=SEP15 PE=1 SV=3A0A0A0MQS1;Q53H96;Q53H96-2PYCRL(A0A0A0MQS1_HUMAN;P5CR3_HUMAN;P5CR3_HUMANvPyrroline-5-carboxylate reductase;Pyrroline-5-carboxylate reductase 3;Isoform 2 of Pyrroline-5-carboxylate reductase 3e;cellular amino acid biosynthetic process,oxidation-reduction process,L-proline biosynthetic process;<;pyrroline-5-carboxylate reductase activity,protein binding;%>tr|A0A0A0MQS1|A0A0A0MQS1_HUMAN Pyrroline-5-carboxylate reductase OS=Homo sapiens GN=PYCRL PE=1 SV=1;>sp|Q53H96|P5CR3_HUMAN Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens GN=PYCRL PE=1 SV=3;>sp|Q53H96-2|P5CR3_HUMAN Isoform 2 of Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens GN=PYCRL A0A0B4J2D9 IGKV1D-13A0A0B4J2D9_HUMANProtein IGKV1D-13 (Fragment)c>tr|A0A0B4J2D9|A0A0B4J2D9_HUMAN Protein IGKV1D-13 (Fragment) OS=Homo sapiens GN=IGKV1D-13 PE=1 SV=1*A0A0D9SEU5;Q6VN20;Q6VN20-2;Q6VN20-3;R4GMX8RANBP10AA0A0D9SEU5_HUMAN;RBP10_HUMAN;RBP10_HUMAN;RBP10_HUMAN;R4GMX8_HUMANRan-binding protein 10;Ran-binding protein 10;Isoform 2 of Ran-binding protein 10;Isoform 3 < of Ran-binding protein 10;Ran-binding protein 10;nucleus,cytosol;;;tr;sp;sp;sp;tr1;1;;;1>tr|A0A0D9SEU5|A0A0D9SEU5_HUMAN Ran-binding protein 10 OS=Homo sapiens GN=RANBP10 PE=1 SV=1;>sp|Q6VN20|RBP10_HUMAN Ran-binding protein 10 OS=Homo sapiens GN=RANBP10 PE=1 SV=1;>sp|Q6VN20-2|RBP10_HUMAN Isoform 2 of Ran-binding protein 10 OS=Homo sapiens GN=RANBP10;>sp|Q6VN20-3|RBP10_HUMAN Isoform 3 of Ran-binding protein 10 OS=Homo sapiens GN=RANBP10;>tr|R4GMX8|R4GMX8_HUMAN Ran-binding protein 10 OS=Homo sapiens GN=RANBP10 PE=1 SV=1 A0A0G2JS06A0A0G2JS06_HUMAN\>tr|A0A0G2JS06|A0A0G2JS06_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=4 SV=1C9JMN4;C9JP35;Q92520FAM3C%C9JMN4_HUMAN;C9JP35_HUMAN;FAM3C_HUMAN?Protein FAM3C (Fragment);Protein FAM3C (Fragment);Protein FAM3CN;;platelet degranulation,multicellular organism development,biological_process#;;cytokine activity,protein binding];;extracellular region,extracellular space,platelet dense granule lumen,extracellular exosome>tr|C9JMN4|C9JMN4_HUMAN Protein FAM3C (Fragment) OS=Homo sapiens GN=FAM3C PE=1 SV=1;>tr|C9JP35|C9JP35_HUMAN Protein FAM3C (Fragment) OS=Homo sapiens GN=FAM3C PE=1 SV=1;>sp|Q92520|FAM3C_HUMAN Protein FAM3C OS=Homo sapiens GN=FAM3C PE=1 SV=1 D6RAM3;Q7L591DOK3D6RAM3_HUMAN;DOK3_HUMANDocking protein 39;Ras protein signal transduction,neutrophil degranulation);insulin receptor binding,protein bindingK;plasma membrane,secretory granule membrane,ficolin-1-rich granule membrane>tr|D6RAM3|D6RAM3_HUMAN Docking protein 3 OS=Homo sapiens GN=DOK3 PE=1 SV=1;>sp|Q7L591|DOK3_HUMAN Docking protein 3 OS=Homo sapiens GN=DOK3 PE=1 SV=2MA1A4Z5;E9PJN4;Q70T24;Q70T25;Q9HCX4;Q9HCX4-2;Q9HCX4-3;Q9Y210;Q9Y210-2;Q9Y210-3;TRPC7;TRPC6;TRPC7;TRPC7;TRPC7;TRPC7;TRPC7;TRPC6;TRPC6;TRPC6{A1A4Z5_HUMAN;E9PJN4_HUMAN;Q70T24_HUMAN;Q70T25_HUMAN;TRPC7_HUMAN;TRPC7_HUMAN;TRPC7_HUMAN;TRPC6_HUMAN;TRPC6_HUMAN;TRPC6_HUMANShort transient receptor potential channel 7;Short transient receptor potential channel 6;Short transient receptor potential channel 7;Short transient receptor potential channel 7;Short transient receptor potential channel 7;Isoform 2 of Short transient receptor potential channel 7;Isoform 3 of Short transient receptor potential channel 7;Short transient receptor potential channel 6;Isoform 2 of Short transient receptor potential channel 6;Isoform 3 of Short transient receptor potential channel 6;;;;manganese ion transport,single fertilization,platelet activation,regulation of cytosolic calcium ion concentration,calcium ion transmembrane transport;;;cation transport,manganese ion transport,positive regulation of cytosolic calcium ion concentration,single fertilization,aging,positive regulation of peptidyl-threonine phosphorylation,platelet activation,neuron differentiation,positive regulation of ion transmembrane transporter activity,positive regulation of neuron differentiation,negative regulation of dendrite morphogenesis,regulation of cytosolic calcium ion concentration,positive regulation of calcium ion transport,cellular response to hydrogen peroxide,calcium ion transmembrane transport,cellular response to hypoxia;; ;;;;calcium channel activity,protein binding,store-operated calcium channel activity;;;actin binding,calcium channel activity,protein binding,store-operated calcium channel activity,clathrin binding,actinin binding,ATPase binding,inositol 1,4,5 trisphosphate binding;;;;;;nuclear envelope,cis-Golgi network,plasma membrane,integral component of plasma membrane,perinuclear region of cytoplasm;;;cytoplasm,plasma membrane,integral component of plasma membrane,membrane,slit diaphragm;;tr;tr;tr;tr;sp;sp;sp;sp;sp;sp2;1;2;2;1;;;1;;1;1;1;1;1;;;1;;>tr|A1A4Z5|A1A4Z5_HUMAN Short transient receptor potential channel 7 OS=Homo sapiens GN=TRPC7 PE=2 SV=1;>tr|E9PJN4|E9PJN4_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1;>tr|Q70T24|Q70T24_HUMAN Short transient receptor potential channel 7 OS=Homo sapiens GN=TRPC7 PE=2 SV=1;>tr|Q70T25|Q70T25_HUMAN Short transient receptor potential channel 7 OS=Homo sapiens GN=TRPC7 PE=2 SV=1;>sp|Q9HCX4|TRPC7_HUMAN Short transient receptor potential channel 7 OS=Homo sapiens GN=TRPC7 PE=1 SV=1;>sp|Q9HCX4-2|TRPC7_HUMAN Isoform 2 of Short transient receptor potential channel 7 OS=Homo sapiens GN=TRPC7;>sp|Q9HCX4-3|TRPC7_HUMAN Isoform 3 of Short transient receptor potential channel 7 OS=Homo sapiens GN=TRPC7;>sp|Q9Y210|TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1;>sp|Q9Y210-2|TRPC6_HUMAN Isoform 2 of Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6;>sp|Q9Y210-3|TRPC6_HUMAN Isoform 3 of Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 F5H2F4;P11586MTHFD1F5H2F4_HUMAN;C1TC_HUMANUC-1-tetrahydrofolate synthase, cytoplasmic;C-1-tetrahydrofolate synthase, cytoplasmicV;histidine biosynthetic process,neutrophil homeostasis,neural tube closure,purine nucleotide biosynthetic process,methionine metabolic process,one-carbon metabolic process,heart development,serine family amino acid metabolic process,serine family amino acid biosynthetic process,methionine biosynthetic process,purine nucleobase biosynthetic process,10-formyltetrahydrofolate biosynthetic process,transsulfuration,tetrahydrofolate interconversion,folic acid metabolic process,embryonic neurocranium morphogenesis,embryonic viscerocranium morphogenesis,oxidation-reduction process,somite development";formate-tetrahydrofolate ligase activity,methenyltetrahydrofolate cyclohydrolase activity,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,methylenetetrahydrofolate dehydrogenase (NAD+) activity,methylenetetrahydrofolate dehydrogenase (NADP+) activity,protein binding,ATP binding?;cytoplasm,mitochondrion,cytosol,membrane,extracellular exosome>tr|F5H2F4|F5H2F4_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=1;>sp|P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3F8VZN8;O14974-4PPP1R12AF8VZN8_HUMAN;MYPT1_HUMANqProtein phosphatase 1 regulatory subunit 12A (Fragment);Isoform 4 of Protein phosphatase 1 regulatory subunit 12A>tr|F8VZN8|F8VZN8_HUMAN Protein phosphatase 1 regulatory subunit 12A (Fragment) OS=Homo sapiens GN=PPP1R12A PE=1 SV=1;>sp|O14974-4|MYPT1_HUMAN Isoform 4 of Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens GN=PPP1R12A F8WF32;P04843RPN1F8WF32_HUMAN;RPN1_HUMANHDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1T;cellular protein modification process,protein N-linked glycosylation via asparagine`;RNA binding,protein binding,dolichyl-diphosphooligosaccharide-protein glycotransferase activity;endoplasmic reticulum,endoplasmic reticulum membrane,rough endoplasmic reticulum,cytosol,oligosaccharyltransferase complex,membrane,integral component of membrane,extracellular matrix,melanosome>tr|F8WF32|F8WF32_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Homo sapiens GN=RPN1 PE=1 SV=1;>sp|P04843|RPN1_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Homo sapiens GN=RPN1 PE=1 SV=1G3V583;Q8N128;Q8N128-2FAM177A1$G3V583_HUMAN;F177A_HUMAN;F177A_HUMANJProtein FAM177A1 (Fragment);Protein FAM177A1;Isoform 2 of Protein FAM177A1>tr|G3V583|G3V583_HUMAN Protein FAM177A1 (Fragment) OS=Homo sapiens GN=FAM177A1 PE=1 SV=1;>sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens GN=FAM177A1 PE=1 SV=1;>sp|Q8N128-2|F177A_HUMAN Isoform 2 of Protein FAM177A1 OS=Homo sapiens GN=FAM177A1P01111NRAS RASN_HUMAN GTPase NRas<MAPK cascade,stimulatory C-type lectin receptor signaling pathway,epidermal growth factor receptor signaling pathway,Ras protein signal transduction,axon guidance,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,neutrophil degranulation,leukocyte migration,establishment of protein localization to Golgi#GTP binding,protein complex bindinggGolgi membrane,Golgi apparatus,plasma membrane,membrane,extracellular exosome,tertiary granule membraneC>sp|P01111|RASN_HUMAN GTPase NRas OS=Homo sap< iens GN=NRAS PE=1 SV=1P01601 IGKV1D-16 KVD16_HUMAN.Immunoglobulin kappa variable 1D-16 (Fragment)l>sp|P01601|KVD16_HUMAN Immunoglobulin kappa variable 1D-16 (Fragment) OS=Homo sapiens GN=IGKV1D-16 PE=3 SV=2P05186;P05186-2;P05186-3ALPL PPBT_HUMANAlkaline phosphatase, tissue-nonspecific isozyme;Isoform 2 of Alkaline phosphatase, tissue-nonspecific isozyme;Isoform 3 of Alkaline phosphatase, tissue-nonspecific isozyme]skeletal system development,osteoblast differentiation,endochondral ossification,developmental process involved in reproduction,C-terminal protein lipidation,dephosphorylation,response to lipopolysaccharide,response to vitamin D,response to antibiotic,response to glucocorticoid,cellular response to organic cyclic compound,cementum mineralization;;Zalkaline phosphatase activity,protein binding,pyrophosphatase activity,metal ion binding;;extracellular region,proteinaceous extracellular matrix,extracellular space,plasma membrane,membrane,integral component of membrane,anchored component of membrane,extracellular membrane-bounded organelle,extracellular exosome;;D>sp|P05186|PPBT_HUMAN Alkaline phosphatase, tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4;>sp|P05186-2|PPBT_HUMAN Isoform 2 of Alkaline phosphatase, tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL;>sp|P05186-3|PPBT_HUMAN Isoform 3 of Alkaline phosphatase, tissue-nonspecific isozyme OS=Homo sapiens GN=ALPLP08754GNAI3 GNAI3_HUMAN5Guanine nucleotide-binding protein G(k) subunit alphaprotein folding,transport,vesicle fusion,cell cycle,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,negative regulation of adenylate cyclase activity,dopamine receptor signaling pathway,GTP metabolic process,cell division#G-protein coupled receptor binding,GTPase activity,signal transducer activity,protein binding,GTP binding,GDP binding,protein domain specific binding,G-protein beta/gamma-subunit complex binding,G-protein coupled serotonin receptor binding,GTPase activating protein binding,metal ion bindingnucleus,nucleolus,cytoplasm,lysosomal membrane,Golgi apparatus,centrosome,heterotrimeric G-protein complex,plasma membrane,membrane,midbody,zymogen granule,membrane raft,extracellular exosomeo>sp|P08754|GNAI3_HUMAN Guanine nucleotide-binding protein G(k) subunit alpha OS=Homo sapiens GN=GNAI3 PE=1 SV=3P11217;P11217-2PYGM PYGM_HUMANTGlycogen phosphorylase, muscle form;Isoform 2 of Glycogen phosphorylase, muscle form6glycogen metabolic process,glycogen catabolic process;_nucleotide binding,protein binding,glycogen phosphorylase activity,pyridoxal phosphate binding;6;>sp|P11217|PYGM_HUMAN Glycogen phosphorylase, muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6;>sp|P11217-2|PYGM_HUMAN Isoform 2 of Glycogen phosphorylase, muscle form OS=Homo sapiens GN=PYGMP15104GLUL GLNA_HUMANGlutamine synthetaseneurotransmitter uptake,glutamate catabolic process,glutamine biosynthetic process,cell proliferation,cellular amino acid biosynthetic process,cellular response to starvation,response to glucose,ammonia assimilation cycle,positive regulation of insulin secretion,positive regulation of epithelial cell proliferation,protein homooligomerization,positive regulation of synaptic transmission, glutamatergicmagnesium ion binding,glutamate decarboxylase activity,glutamate-ammonia ligase activity,protein binding,ATP binding,glutamate binding,manganese ion binding,identical protein binding,dynein light chain bindingnucleus,mitochondrion,rough endoplasmic reticulum,cytosol,perikaryon,myelin sheath,protein complex,axon terminus,extracellular exosome,glial cell projectionL>sp|P15104|GLNA_HUMAN Glutamine synthetase OS=Homo sapiens GN=GLUL PE=1 SV=4P23276KEL KELL_HUMANKell blood group glycoproteinproteolysis,cellular calcium ion homeostasis,regulation of cell size,cellular magnesium ion homeostasis,regulation of axon diameter,vasoconstriction,myelination,skeletal muscle fiber development,negative regulation of potassium ion transmembrane transport?metalloendopeptidase activity,protein binding,metal ion bindingT>sp|P23276|KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2P27701;P27701-2CD82 CD82_HUMAN&CD82 antigen;Isoform 2 of CD82 antigen(cell surface receptor signaling pathway;Lplasma membrane,integral component of plasma membrane,extracellular exosome;>sp|P27701|CD82_HUMAN CD82 antigen OS=Homo sapiens GN=CD82 PE=1 SV=1;>sp|P27701-2|CD82_HUMAN Isoform 2 of CD82 antigen OS=Homo sapiens GN=CD82P36871;P36871-2;P36871-3PGM1 PGM1_HUMANXPhosphoglucomutase-1;Isoform 2 of Phosphoglucomutase-1;Isoform 3 of Phosphoglucomutase-1glycogen biosynthetic process,glycogen catabolic process,glucose metabolic process,gluconeogenesis,glycolytic process,galactose catabolic process,neutrophil degranulation;;Cmagnesium ion binding,phosphoglucomutase activity,protein binding;;extracellular region,cytoplasm,cytosol,actin cytoskeleton,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumen;;>sp|P36871|PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3;>sp|P36871-2|PGM1_HUMAN Isoform 2 of Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1;>sp|P36871-3|PGM1_HUMAN Isoform 3 of Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1P41226UBA7 UBA7_HUMAN+Ubiquitin-like modifier-activating enzyme 7cellular protein modification process,protein ubiquitination,modification-dependent protein catabolic process,translesion synthesis,ISG15-protein conjugation,negative regulation of type I interferon productioncubiquitin-protein transferase activity,protein binding,ATP binding,ISG15 activating enzyme activitynucleoplasm,cytosolc>sp|P41226|UBA7_HUMAN Ubiquitin-like modifier-activating enzyme 7 OS=Homo sapiens GN=UBA7 PE=1 SV=2 P61204;P84077 ARF3;ARF1ARF3_HUMAN;ARF1_HUMAN3ADP-ribosylation factor 3;ADP-ribosylation factor 1phosphatidylinositol biosynthetic process,retrograde vesicle-mediated transport, Golgi to ER,small GTPase mediated signal transduction,protein transport;regulation of receptor internalization,phosphatidylinositol biosynthetic process,cellular copper ion homeostasis,post-Golgi vesicle-mediated transport,actin filament organization,small GTPase mediated signal transduction,protein transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,regulation of Arp2/3 complex-mediated actin nucleation,very-low-density lipoprotein particle assembly,positive regulation of catalytic activity,positive regulation of endocytosis,positive regulation of calcium ion-dependent exocytosis,regulation of defense response to virus by virus,positive regulation of protein secretion,Golgi to transport vesicle transport,long term synaptic depression,positive regulation of dendritic spine development,synaptic vesicle budding,dendritic spine organization,lysosomal membrane organization,positive regulation of sodium ion transmembrane transport,positive regulation of late endosome to lysosome transport,positive regulation of ER to Golgi vesicle-mediated transport,regulation of phospholipid metabolic processGTPase activity,GTP binding;magnesium ion binding,RNA binding,GTPase activity,receptor signaling protein activity,protein binding,GTP binding,GDP binding,phospholipase D activator activityTGolgi membrane,perinuclear region of cytoplasm,extracellular exosome;Golgi membrane,late endosome,peroxisomal membrane,trans-Golgi network,cytosol,plasma membrane,focal adhesion,postsynaptic density,sarcomere,COPI-coated vesicle,cell leading edge,neuron projection,postsynaptic membrane,perinuclear region of cytoplasm,extracellular exosome>sp|P61204|ARF3_HUMAN ADP-ribosylation factor 3 OS=Homo sapiens GN=ARF3 PE=1 SV=2;>sp|P84077|ARF1_HUMAN ADP-ribosylation factor 1 OS=Homo sapiens GN=ARF1 PE=1 SV=2 P68032;P68133 ACTC1;ACTA1ACTC_HUMAN;ACTS_HUMAN:Actin, alpha cardiac muscle 1;Actin, alpha skeletal muscleapoptotic process,positive regulation of gene expression,actin filament-based movement,muscle filament sliding,skeletal muscle thin filament assembly,actomyosin structure organization,actin-myosin filament sliding,< response to drug,negative regulation of apoptotic process,response to ethanol,cardiac myofibril assembly,cardiac muscle tissue morphogenesis,heart contraction,cardiac muscle contraction,mesenchyme migration;muscle contraction,response to mechanical stimulus,response to extracellular stimulus,response to lithium ion,positive regulation of gene expression,cell growth,muscle filament sliding,skeletal muscle thin filament assembly,skeletal muscle fiber adaptation,response to steroid hormone,skeletal muscle fiber development,mesenchyme migrationATP binding,ATPase activity,myosin binding;structural constituent of cytoskeleton,protein binding,ATP binding,myosin binding,ADP bindingextracellular space,cytoplasm,cytosol,actin filament,focal adhesion,membrane,sarcomere,lamellipodium,filopodium,I band,actomyosin, actin portion,cell body,extracellular exosome,blood microparticle;stress fiber,extracellular space,cytosol,striated muscle thin filament,actin filament,actin cytoskeleton,sarcomere,lamellipodium,filopodium,cell body,extracellular exosome,blood microparticle>sp|P68032|ACTC_HUMAN Actin, alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1;>sp|P68133|ACTS_HUMAN Actin, alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1Q13724;Q13724-2MOGS MOGS_HUMANVMannosyl-oligosaccharide glucosidase;Isoform 2 of Mannosyl-oligosaccharide glucosidaseQprotein folding,protein N-linked glycosylation,oligosaccharide metabolic process;Cmannosyl-oligosaccharide glucosidase activity,glucosidase activity;sendoplasmic reticulum,endoplasmic reticulum membrane,membrane,integral component of membrane,extracellular exosome;>sp|Q13724|MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5;>sp|Q13724-2|MOGS_HUMAN Isoform 2 of Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS*Q14162;Q14162-2;Q14162-3;Q14162-4;Q14162-5SCARF1 SREC_HUMANScavenger receptor class F member 1;Isoform 2 of Scavenger receptor class F member 1;Isoform 3 of Scavenger receptor class F member 1;Isoform 4 of Scavenger receptor class F member 1;Isoform 5 of Scavenger receptor class F member 1cholesterol catabolic process,receptor-mediated endocytosis,cell adhesion,signal transduction,positive regulation of neuron projection development,neuron remodeling,dendrite development,positive regulation of axon regeneration;;;;rtransmembrane signaling receptor activity,scavenger receptor activity,low-density lipoprotein particle binding;;;;Mplasma membrane,integral component of membrane,endocytic vesicle membrane;;;;>sp|Q14162|SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3;>sp|Q14162-2|SREC_HUMAN Isoform 2 of Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1;>sp|Q14162-3|SREC_HUMAN Isoform 3 of Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1;>sp|Q14162-4|SREC_HUMAN Isoform 4 of Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1;>sp|Q14162-5|SREC_HUMAN Isoform 5 of Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1Q15365PCBP1 PCBP1_HUMANPoly(rC)-binding protein 1mRNA splicing, via spliceosome,gene expression,viral RNA genome replication,positive regulation of transcription from RNA polymerase II promoterRNA polymerase II transcription factor activity, sequence-specific DNA binding,single-stranded DNA binding,RNA binding,mRNA binding,protein binding,cadherin binding,sequence-specific single stranded DNA bindingkcytoplasmic mRNA processing body,nucleoplasm,cytoplasm,cytosol,membrane,nuclear speck,extracellular exosomeT>sp|Q15365|PCBP1_HUMAN Poly(rC)-binding protein 1 OS=Homo sapiens GN=PCBP1 PE=1 SV=2Q16394EXT1 EXT1_HUMAN Exostosin-1skeletal system development,ossification,glycosaminoglycan biosynthetic process,protein glycosylation,signal transduction,gastrulation,axon guidance,endoderm development,mesoderm development,heparan sulfate proteoglycan biosynthetic process,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,olfactory bulb development,cellular polysaccharide biosynthetic process,embryonic skeletal joint developmentacetylglucosaminyltransferase activity,glucuronosyltransferase activity,transferase activity, transferring glycosyl groups,heparan sulfate N-acetylglucosaminyltransferase activity,protein homodimerization activity,metal ion binding,protein heterodimerization activity,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activityGolgi membrane,endoplasmic reticulum,endoplasmic reticulum membrane,Golgi apparatus,integral component of membrane,integral component of endoplasmic reticulum membraneC>sp|Q16394|EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2Q53TN4;Q53TN4-3CYBRD1 CYBR1_HUMAN>Cytochrome b reductase 1;Isoform 3 of Cytochrome b reductase 1Ocellular iron ion homeostasis,response to iron ion,oxidation-reduction process;rferric-chelate reductase activity,protein binding,oxidoreductase activity, oxidizing metal ions,metal ion binding;nlysosomal membrane,plasma membrane,integral component of membrane,brush border membrane,extracellular exosome;>sp|Q53TN4|CYBR1_HUMAN Cytochrome b reductase 1 OS=Homo sapiens GN=CYBRD1 PE=1 SV=1;>sp|Q53TN4-3|CYBR1_HUMAN Isoform 3 of Cytochrome b reductase 1 OS=Homo sapiens GN=CYBRD1A0A0C4DGH5;Q86VP6;Q86VP6-2CAND1(A0A0C4DGH5_HUMAN;CAND1_HUMAN;CAND1_HUMANCullin-associated NEDD8-dissociated protein 1 (Fragment);Cullin-associated NEDD8-dissociated protein 1;Isoform 2 of Cullin-associated NEDD8-dissociated protein 1;SCF complex assembly,protein ubiquitination,cell differentiation,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;+;protein binding,TBP-class protein binding;;ubiquitin ligase complex,extracellular region,nucleus,nucleoplasm,cytoplasm,Golgi apparatus,cytosol,membrane,cullin-RING ubiquitin ligase complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;P>tr|A0A0C4DGH5|A0A0C4DGH5_HUMAN Cullin-associated NEDD8-dissociated protein 1 (Fragment) OS=Homo sapiens GN=CAND1 PE=1 SV=1;>sp|Q86VP6|CAND1_HUMAN Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens GN=CAND1 PE=1 SV=2;>sp|Q86VP6-2|CAND1_HUMAN Isoform 2 of Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens GN=CAND1Q9BXJ0C1QTNF5 C1QT5_HUMAN6Complement C1q tumor necrosis factor-related protein 5=protein secretion,inner ear development,protein trimerizationidentical protein bindingcollagen trimer,extracellular space,bicellular tight junction,apical plasma membrane,lateral plasma membrane,transport vesicle,cell projection,extracellular exosomer>sp|Q9BXJ0|C1QT5_HUMAN Complement C1q tumor necrosis factor-related protein 5 OS=Homo sapiens GN=C1QTNF5 PE=1 SV=1Q9C0C9UBE2O UBE2O_HUMAN0(E3-independent) E2 ubiquitin-conjugating enzymeprotein monoubiquitination,positive regulation of BMP signaling pathway,retrograde transport, endosome to Golgi,protein K63-linked ubiquitinationRNA binding,ubiquitin-protein transferase activity,protein binding,ATP binding,ubiquitin protein ligase binding,ubiquitin protein ligase activity,ubiquitin conjugating enzyme activity&nucleus,cytoplasm,cytosol,nuclear bodyj>sp|Q9C0C9|UBE2O_HUMAN (E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens GN=UBE2O PE=1 SV=3Q9NRW1RAB6B RAB6B_HUMANRas-related protein Rab-6Bretrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,small GTPase mediated signal transduction,protein transport,retrograde transport, endosome to Golgi<GTPase activity,protein binding,GTP binding,myosin V bindingoGolgi membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cytosol,cytoplasmic vesicleT>sp|Q9NRW1|RAB6B_HUMAN Ras-related protein Rab-6B OS=Homo sapiens GN=RAB6B PE=1 SV=1Q9P2B2PTGFRN FPRP_HUMAN,Prostaglandin F2 receptor negative regulatorlipid particle organizationjendoplasmic reticulum membrane,Golgi appar< atus,plasma membrane,cell surface,integral component of membranef>sp|Q9P2B2|FPRP_HUMAN Prostaglandin F2 receptor negative regulator OS=Homo sapiens GN=PTGFRN PE=1 SV=2 A0A075B6J1IGLV5-37A0A075B6J1_HUMANProtein IGLV5-37 (Fragment)a>tr|A0A075B6J1|A0A075B6J1_HUMAN Protein IGLV5-37 (Fragment) OS=Homo sapiens GN=IGLV5-37 PE=1 SV=1 A0A075B6S4 IGKV1D-17A0A075B6S4_HUMANProtein IGKV1D-17 (Fragment)c>tr|A0A075B6S4|A0A075B6S4_HUMAN Protein IGKV1D-17 (Fragment) OS=Homo sapiens GN=IGKV1D-17 PE=4 SV=1A0A087WV46;C9JXA7;Q0VGL1LAMTOR4)A0A087WV46_HUMAN;C9JXA7_HUMAN;LTOR4_HUMAN!Ragulator complex protein LAMTOR4;;cell cycle arrest,regulation of cell size,macroautophagy,positive regulation of TOR signaling,positive regulation of GTPase activity,protein localization to lysosome,cellular response to amino acid stimulusU;;protein binding,guanyl-nucleotide exchange factor activity,protein complex scaffoldX;;lysosome,lysosomal membrane,intracellular membrane-bounded organelle,Ragulator complex#>tr|A0A087WV46|A0A087WV46_HUMAN Ragulator complex protein LAMTOR4 OS=Homo sapiens GN=LAMTOR4 PE=1 SV=1;>tr|C9JXA7|C9JXA7_HUMAN Ragulator complex protein LAMTOR4 OS=Homo sapiens GN=LAMTOR4 PE=1 SV=1;>sp|Q0VGL1|LTOR4_HUMAN Ragulator complex protein LAMTOR4 OS=Homo sapiens GN=LAMTOR4 PE=1 SV=1A0A0C4DFN3;Q99685;Q99685-2MGLL&A0A0C4DFN3_HUMAN;MGLL_HUMAN;MGLL_HUMANKMonoglyceride lipase;Monoglyceride lipase;Isoform 2 of Monoglyceride lipaser;lipid metabolic process,fatty acid biosynthetic process,inflammatory response,regulation of signal transduction,arachidonic acid metabolic process,triglyceride catabolic process,acylglycerol acyl-chain remodeling,acylglycerol catabolic process,regulation of inflammatory response,regulation of sensory perception of pain,regulation of endocannabinoid signaling pathway;[;lysophospholipase activity,protein homodimerization activity,acylglycerol lipase activity;m;nucleoplasm,endoplasmic reticulum membrane,cytosol,plasma membrane,membrane,extrinsic component of membrane;>tr|A0A0C4DFN3|A0A0C4DFN3_HUMAN Monoglyceride lipase OS=Homo sapiens GN=MGLL PE=1 SV=1;>sp|Q99685|MGLL_HUMAN Monoglyceride lipase OS=Homo sapiens GN=MGLL PE=1 SV=2;>sp|Q99685-2|MGLL_HUMAN Isoform 2 of Monoglyceride lipase OS=Homo sapiens GN=MGLL A0A0C4DH31IGHV1-18 HV118_HUMAN"Immunoglobulin heavy variable 1-18c>sp|A0A0C4DH31|HV118_HUMAN Immunoglobulin heavy variable 1-18 OS=Homo sapiens GN=IGHV1-18 PE=3 SV=1 C9JKG1;P21810BGNC9JKG1_HUMAN;PGS1_HUMANBiglycan (Fragment);Biglycan;blood vessel remodeling,negative regulation of protein kinase activity,biological_process,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,negative regulation of JAK-STAT cascade;protein kinase inhibitor activity,extracellular matrix structural constituent,glycosaminoglycan binding,extracellular matrix binding;extracellular region,proteinaceous extracellular matrix,extracellular space,cytoplasm,Golgi lumen,cell surface,transport vesicle,sarcolemma,lysosomal lumen,extracellular exosome,extracellular matrix>tr|C9JKG1|C9JKG1_HUMAN Biglycan (Fragment) OS=Homo sapiens GN=BGN PE=1 SV=1;>sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens GN=BGN PE=1 SV=2E9PKD5;E9PM69;P17980;R4GNH3PSMC32E9PKD5_HUMAN;E9PM69_HUMAN;PRS6A_HUMAN;R4GNH3_HUMAN26S protease regulatory subunit 6A (Fragment);26S protease regulatory subunit 6A;26S protease regulatory subunit 6A;26S protease regulatory subunit 6A;;MAPK cascade,protein polyubiquitination,blastocyst development,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process,negative regulation of nucleic acid-templated transcription;;;transcription coactivator activity,transcription corepressor activity,protein binding,ATP binding,ATPase activity,TBP-class protein binding,proteasome-activating ATPase activity,identical protein binding;*;;proteasome complex,cytoplasmic mRNA processing body,extracellular region,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,secretory granule lumen,ficolin-1-rich granule lumen;2;1;3;1>tr|E9PKD5|E9PKD5_HUMAN 26S protease regulatory subunit 6A (Fragment) OS=Homo sapiens GN=PSMC3 PE=1 SV=2;>tr|E9PM69|E9PM69_HUMAN 26S protease regulatory subunit 6A OS=Homo sapiens GN=PSMC3 PE=1 SV=1;>sp|P17980|PRS6A_HUMAN 26S protease regulatory subunit 6A OS=Homo sapiens GN=PSMC3 PE=1 SV=3;>tr|R4GNH3|R4GNH3_HUMAN 26S protease regulatory subunit 6A OS=Homo sapiens GN=PSMC3 PE=1 SV=1H0YJW9 H0YJW9_HUMANT>tr|H0YJW9|H0YJW9_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=3J3QRQ9;J3QS22;Q5M775;Q5M775-2SPECC11J3QRQ9_HUMAN;J3QS22_HUMAN;CYTSB_HUMAN;CYTSB_HUMANNCytospin-B (Fragment);Cytospin-B (Fragment);Cytospin-B;Isoform 2 of Cytospin-B;;nucleus,membrane;1;8;1;4>tr|J3QRQ9|J3QRQ9_HUMAN Cytospin-B (Fragment) OS=Homo sapiens GN=SPECC1 PE=1 SV=1;>tr|J3QS22|J3QS22_HUMAN Cytospin-B (Fragment) OS=Homo sapiens GN=SPECC1 PE=1 SV=8;>sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens GN=SPECC1 PE=1 SV=1;>sp|Q5M775-2|CYTSB_HUMAN Isoform 2 of Cytospin-B OS=Homo sapiens GN=SPECC1O60268;O60268-3KIAA0513 K0513_HUMANNUncharacterized protein KIAA0513;Isoform 3 of Uncharacterized protein KIAA0513 cytoplasm;>sp|O60268|K0513_HUMAN Uncharacterized protein KIAA0513 OS=Homo sapiens GN=KIAA0513 PE=1 SV=1;>sp|O60268-3|K0513_HUMAN Isoform 3 of Uncharacterized protein KIAA0513 OS=Homo sapiens GN=KIAA0513O75563SKAP2 SKAP2_HUMAN&Src kinase-associated phosphoprotein 2immune response-activating signal transduction,protein complex assembly,signal transduction,negative regulation of cell proliferation,positive regulation of signal transduction,B cell activation(SH3/SH2 adaptor activity,protein binding!cytoplasm,cytosol,plasma membrane`>sp|O75563|SKAP2_HUMAN Src kinase-associated phosphoprotein 2 OS=Homo sapiens GN=SKAP2 PE=1 SV=1P01743IGHV1-46 HV146_HUMAN"Immunoglobulin heavy variable 1-46_>sp|P01743|HV146_HUMAN Immunoglobulin heavy variable 1-46 OS=Homo sapiens GN=IGHV1-46 PE=1 SV=2P01764IGHV3-23 HV323_HUMAN"Immunoglobulin heavy variable 3-23proteolysis,receptor-mediated endocytosis,phagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,regulation of immune response,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migration_>sp|P01764< |HV323_HUMAN Immunoglobulin heavy variable 3-23 OS=Homo sapiens GN=IGHV3-23 PE=1 SV=2 P07437;Q5JP53TUBBTBB5_HUMAN;Q5JP53_HUMANTubulin beta chain'G2/M transition of mitotic cell cycle,movement of cell or subcellular component,microtubule-based process,cellular process,cytoskeleton-dependent intracellular transport,natural killer cell mediated cytotoxicity,neutrophil degranulation,spindle assembly,cell division,ciliary basal body docking;GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,protein domain specific binding,ubiquitin protein ligase binding,protein complex binding,GTPase activating protein binding,MHC class I protein binding;extracellular region,nucleus,nuclear envelope lumen,cytoskeleton,microtubule,microtubule cytoskeleton,extracellular matrix,azurophil granule lumen,cytoplasmic ribonucleoprotein granule,protein complex,cell body,extracellular exosome;>sp|P07437|TBB5_HUMAN Tubulin beta chain OS=Homo sapiens GN=TUBB PE=1 SV=2;>tr|Q5JP53|Q5JP53_HUMAN Tubulin beta chain OS=Homo sapiens GN=TUBB PE=1 SV=1"P10412;P16402;P16403;P22492;Q02539,HIST1H1E;HIST1H1D;HIST1H1C;HIST1H1T;HIST1H1A1H14_HUMAN;H13_HUMAN;H12_HUMAN;H1T_HUMAN;H11_HUMAN?Histone H1.4;Histone H1.3;Histone H1.2;Histone H1t;Histone H1.1negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,nucleosome positioning,histone H3-K4 trimethylation,histone H3-K27 trimethylation;negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,nucleosome positioning,histone H3-K4 trimethylation,histone H3-K27 trimethylation;negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,nucleosome positioning,histone H3-K4 trimethylation,histone H3-K27 trimethylation;nucleosome assembly,multicellular organism development,spermatogenesis,cell differentiation;nucleosome assembly,spermatogenesisRNA binding,protein binding,chromatin DNA binding;RNA binding,chromatin DNA binding;RNA binding,protein binding,chromatin DNA binding;DNA binding;protein binding,chromatin DNA bindingnucleosome,nucleus,nuclear heterochromatin,extracellular exosome;nucleosome,nuclear chromatin,nuclear euchromatin;nucleosome,nucleus,nuclear euchromatin,transcriptionally active chromatin;nucleosome,nucleus;nucleosome,nuclear chromatin,nuclear euchromatin 1;1;1;2;1 2;2;2;4;3f>sp|P10412|H14_HUMAN Histone H1.4 OS=Homo sapiens GN=HIST1H1E PE=1 SV=2;>sp|P16402|H13_HUMAN Histone H1.3 OS=Homo sapiens GN=HIST1H1D PE=1 SV=2;>sp|P16403|H12_HUMAN Histone H1.2 OS=Homo sapiens GN=HIST1H1C PE=1 SV=2;>sp|P22492|H1T_HUMAN Histone H1t OS=Homo sapiens GN=HIST1H1T PE=2 SV=4;>sp|Q02539|H11_HUMAN Histone H1.1 OS=Homo sapiens GN=HIST1H1A PE=1 SV=3P21291CSRP1 CSRP1_HUMAN#Cysteine and glycine-rich protein 1platelet aggregationRNA binding,zinc ion binding,nucleus,focal adhesion,extracellular exosome]>sp|P21291|CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=Homo sapiens GN=CSRP1 PE=1 SV=3P31946-2*Isoform Short of 14-3-3 protein beta/alpha\>sp|P31946-2|1433B_HUMAN Isoform Short of 14-3-3 protein beta/alpha OS=Homo sapiens GN=YWHABP63313TMSB10 TYB10_HUMANThymosin beta-10actin filament organization%actin monomer binding,protein bindingcytoplasm,cytoskeletonK>sp|P63313|TYB10_HUMAN Thymosin beta-10 OS=Homo sapiens GN=TMSB10 PE=1 SV=2Q10589;Q10589-2BST2 BST2_HUMANHBone marrow stromal antigen 2;Isoform 2 of Bone marrow stromal antigen 2negative regulation of plasmacytoid dendritic cell cytokine production,humoral immune response,cell-cell signaling,multicellular organism development,cell proliferation,response to virus,negative regulation of endopeptidase activity,negative regulation of cell growth,negative regulation of cell migration,regulation of actin cytoskeleton organization,response to interferon-gamma,response to interferon-alpha,response to interferon-beta,B cell activation,positive regulation of I-kappaB kinase/NF-kappaB signaling,neutrophil degranulation,negative regulation of viral genome replication,innate immune response,defense response to virus,type I interferon signaling pathway,negative regulation of intracellular transport of viral material;RNA binding,signal transducer activity,protein binding,metalloendopeptidase inhibitor activity,protein homodimerization activity;multivesicular body,Golgi apparatus,cytosol,plasma membrane,integral component of plasma membrane,cell surface,membrane,apical plasma membrane,anchored component of membrane,azurophil granule membrane,membrane raft,extracellular exosome,cytoplasm;>sp|Q10589|BST2_HUMAN Bone marrow stromal antigen 2 OS=Homo sapiens GN=BST2 PE=1 SV=1;>sp|Q10589-2|BST2_HUMAN Isoform 2 of Bone marrow stromal antigen 2 OS=Homo sapiens GN=BST2Q7Z794KRT77 K2C1B_HUMAN Keratin, type II cytoskeletal 1b/molecular_function,structural molecule activity;cytosol,cytoskeleton,keratin filament,extracellular exosomeZ>sp|Q7Z794|K2C1B_HUMAN Keratin, type II cytoskeletal 1b OS=Homo sapiens GN=KRT77 PE=2 SV=3Q8N5C1FAM26E FA26E_HUMANProtein FAM26E:ion transmembrane transport,cation transmembrane transportcation channel activity;integral component of plasma membrane,extracellular exosomeI>sp|Q8N5C1|FA26E_HUMAN Protein FAM26E OS=Homo sapiens GN=FAM26E PE=2 SV=1Q96KP4CNDP2 CNDP2_HUMAN"Cytosolic non-specific dipeptidasePsulfur amino acid metabolic process,proteolysis,glutathione biosynthetic processvcarboxypeptidase activity,metallopeptidase activity,metal ion binding,cytosolic dipeptidase activity,Requires Ontology)nucleoplasm,cytosol,extracellular exosome\>sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens GN=CNDP2 PE=1 SV=2Q96MK2FAM65C FA65C_HUMANProtein FAM65CI>sp|Q96MK2|FA65C_HUMAN Protein FAM65C OS=Homo sapiens GN=FAM65C PE=1 SV=4Q9Y5K6CD2AP CD2AP_HUMANCD2-associated proteinprotein complex assembly,substrate-dependent cell migration, cell extension,cytoskeleton organization,mitotic nuclear division,signal transduction,vesicle organization,single organismal cell-cell adhesion,negative regulation of transforming growth factor beta1 production,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of receptor-mediated endocytosis,cell division,positive regulation of protein localization to nucleus,regulation of actin cytoskeleton reorganizationvascular endothelial growth factor receptor binding,structural constituent of cytoskeleton,protein binding,beta-catenin binding,protein C-terminus binding,SH3 domain binding,protein complex binding,cadherin bindingruffle,cytoplasm,plasma membrane,cell-cell junction,actin cytoskeleton,endocytic vesicle,filamentous actin,perinuclear region of cytoplasm,extracellular exosomeP>sp|Q9Y5K6|CD2AP_HUMAN CD2-associated protein OS=Homo sapiens GN=CD2AP PE=1 SV=1 A0A075B6S9 IGKV1D-37A0A075B6S9_HUMANProtein IGKV1-37 (Fragment)b>tr|A0A075B6S9|A0A075B6S9_HUMAN Protein IGKV1-37 (Fragment) OS=Homo sapiens GN=IGKV1D-37 PE=4 SV=7hA0A087WTE4;A0A087WTF6;A0A087WV75;A0A087WWD4;A0A087WX77;H7BYX6;P13591;P13591-1;P13591-3;P13591-4;P13591-5NCAM1A0A087WTE4_HUMAN;A0A087WTF6_HUMAN;A0A087WV75_HUMAN;A0A087WWD4_HUMAN;A0A087WX77_HUMAN;H7BYX6_HUMAN;NCAM1_HUMAN;NCAM1_HUMAN;NCAM1_HUMAN;NCAM1_HUMAN;NCAM1_HUMANNeural cell adhesion molecule 1;Neural cell adhesion molecule 1;Neural cell adhesion molecule 1;Neural cell adhesion molecule 1;Neural cell adhesion molecule 1;Neural cell adhesion molecule 1;Neural cell adhesion molecule 1;Isoform 2 of Neural cell adhesion molecule 1;Isoform 3 of Neural cell adhesion molecule 1;Isoform 4 of Neural cell adhesion molecule 1;Isoform 5 of Neural cell adhesion molecule 1;;;;;;MAPK cascade,cell adhesion,axon guidance,positive regulation of GTPase activity,viral entry into host cell,interferon-gamma-mediated signaling pathway;;;;P;;;;;;virus receptor activity,Ras guanyl-nucleotide exchange factor activity;;;;;;;;;;Golgi membrane,cytosol,plasma membrane,external side of plasma membrane,cell surface,membrane,integral component of membrane,anchored component of membrane,extracellular ex< osome;;;; tr;tr;tr;tr;tr;tr;sp;sp;sp;sp;sp1;1;1;1;1;1;1;;;;1;1;1;1;1;2;3;;;;>tr|A0A087WTE4|A0A087WTE4_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=1;>tr|A0A087WTF6|A0A087WTF6_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=1;>tr|A0A087WV75|A0A087WV75_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=1;>tr|A0A087WWD4|A0A087WWD4_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=1;>tr|A0A087WX77|A0A087WX77_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=1;>tr|H7BYX6|H7BYX6_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=2;>sp|P13591|NCAM1_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=3;>sp|P13591-1|NCAM1_HUMAN Isoform 2 of Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1;>sp|P13591-3|NCAM1_HUMAN Isoform 3 of Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1;>sp|P13591-4|NCAM1_HUMAN Isoform 4 of Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1;>sp|P13591-5|NCAM1_HUMAN Isoform 5 of Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1A0A087WVJ0;A0A087WWM1;A0A087X2A4;A0A0A0MRB3;A0A0A0MSH4;A0A0C4DGW3;B1AVQ7;P15941;P15941-11;P15941-13;P15941-17;P15941-2;P15941-3;P15941-4;P15941-7;P15941-8MUC1A0A087WVJ0_HUMAN;A0A087WWM1_HUMAN;A0A087X2A4_HUMAN;A0A0A0MRB3_HUMAN;A0A0A0MSH4_HUMAN;A0A0C4DGW3_HUMAN;B1AVQ7_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMAN;MUC1_HUMANMucin-1 (Fragment);Mucin-1;Mucin-1;Mucin-1;Mucin-1;Mucin-1;Mucin-1;Mucin-1;Isoform Y-LSP of Mucin-1;Isoform M6 of Mucin-1;Isoform J13 of Mucin-1;Isoform 2 of Mucin-1;Isoform 3 of Mucin-1;Isoform 4 of Mucin-1;Isoform Y of Mucin-1;Isoform 8 of Mucin-1;;;;;;;stimulatory C-type lectin receptor signaling pathway,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,negative regulation of transcription by competitive promoter binding,O-glycan processing,negative regulation of cell adhesion mediated by integrin,positive regulation of transcription from RNA polymerase II promoter in response to stress,regulation of transcription from RNA polymerase II promoter in response to stress,positive regulation of histone H4 acetylation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;;;;;;;;;;;;;;;RNA polymerase II core promoter proximal region sequence-specific DNA binding,p53 binding,transcription cofactor activity,protein binding;;;;;;;;;;;;;;;nuclear chromatin,extracellular space,Golgi lumen,plasma membrane,integral component of plasma membrane,apical plasma membrane,vesicle,extracellular exosome;;;;;;;;/tr;tr;tr;tr;tr;tr;tr;sp;sp;sp;sp;sp;sp;sp;sp;sp1;1;1;1;1;1;1;1;;;;;;;;1;1;1;1;1;1;1;3;;;;;;;;z>tr|A0A087WVJ0|A0A087WVJ0_HUMAN Mucin-1 (Fragment) OS=Homo sapiens GN=MUC1 PE=1 SV=1;>tr|A0A087WWM1|A0A087WWM1_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=1;>tr|A0A087X2A4|A0A087X2A4_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=1;>tr|A0A0A0MRB3|A0A0A0MRB3_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=1;>tr|A0A0A0MSH4|A0A0A0MSH4_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=1;>tr|A0A0C4DGW3|A0A0C4DGW3_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=1;>tr|B1AVQ7|B1AVQ7_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=1;>sp|P15941|MUC1_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=3;>sp|P15941-11|MUC1_HUMAN Isoform Y-LSP of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-13|MUC1_HUMAN Isoform M6 of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-17|MUC1_HUMAN Isoform J13 of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-2|MUC1_HUMAN Isoform 2 of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-3|MUC1_HUMAN Isoform 3 of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-4|MUC1_HUMAN Isoform 4 of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-7|MUC1_HUMAN Isoform Y of Mucin-1 OS=Homo sapiens GN=MUC1;>sp|P15941-8|MUC1_HUMAN Isoform 8 of Mucin-1 OS=Homo sapiens GN=MUC1#A0A140T941;A0A140T9Z6;B0UXQ0;P305129A0A140T941_HUMAN;A0A140T9Z6_HUMAN;B0UXQ0_HUMAN;1A29_HUMANHLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-29 alpha chain>tr|A0A140T941|A0A140T941_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|A0A140T9Z6|A0A140T9Z6_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>tr|B0UXQ0|B0UXQ0_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1;>sp|P30512|1A29_HUMAN HLA class I histocompatibility antigen, A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 K7EN45;Q13526PIN1K7EN45_HUMAN;PIN1_HUMANePeptidyl-prolyl cis-trans isomerase (Fragment);Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1x;protein peptidyl-prolyl isomerization,positive regulation of protein phosphorylation,cell cycle,regulation of mitotic nuclear division,neuron differentiation,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of protein binding,regulation of cytokinesis,negative regulation of type I interferon production,positive regulation of protein dephosphorylation,negative regulation of protein catabolic process,negative regulation of neuron apoptotic process,positive regulation of neuron apoptotic process,positive regulation of GTPase activity,positive regulation of transcription from RNA polymerase II promoter,synapse organization,protein stabilization,positive regulation of ubiquitin-protein transferase activity,regulation of pathway-restricted SMAD protein phosphorylation,positive regulation of cell growth involved in cardiac muscle cell development,negative regulation of ERK1 and ERK2 cascade,positive regulation of canonical Wnt signaling pathway,regulation of protein localization to nucleus,regulation of signal transduction by p53 class mediator,negative regulation of cell motility;peptidyl-prolyl cis-trans isomerase activity,motor activity,protein binding,beta-catenin binding,mitogen-activated protein kinase kinase binding,GTPase activating protein binding,phosphoserine binding,phosphothreonine bindingR;nucleus,nucleoplasm,mitochondrion,cytosol,nuclear speck,midbody,neuron projection>tr|K7EN45|K7EN45_HUMAN Peptidyl-prolyl cis-trans isomerase (Fragment) OS=Homo sapiens GN=PIN1 PE=1 SV=1;>sp|Q13526|PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 OS=Homo sapiens GN=PIN1 PE=1 SV=1P01715IGLV3-1 LV301_HUMAN"Immunoglobulin lambda variable 3-1^>sp|P01715|LV301_HUMAN Immunoglobulin lambda variable 3-1 OS=Homo sapiens GN=IGLV3-1 PE=1 SV=2P09211GSTP1 GSTP1_HUMANGlutathione S-transferase PQresponse to reactive oxygen species,negative regulation of acute inflammatory response,negative regulation of protein kinase activity,glutathione metabolic process,xenobiotic metabolic process,central nervous system development,negative regulation of biosynthetic process,negative regulation of tumor necrosis factor-mediated signaling pathway,oligodendrocyte development,animal organ regeneration,response to estradiol,negative regulation of interleukin-1 beta production,negative regulation of tumor necrosis factor production,cellular response to insulin stimulus,regulation of stress-activated MAPK cascade,negative regulation of stress-activated MAPK cascade,positive regulation of superoxide anion generation,response to L-ascorbic acid,common myeloid progenitor cell proliferation,nitric oxide storage,negative regulation of apoptotic process,negative regulation of I-kappaB kinase/NF-kappaB signaling,response to amino acid,neutrophil degranulation,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of JUN kinase activity,linoleic acid metabolic process,response to ethanol,negative regulation of fibroblast proliferation,negative regulation of nitric-oxide synthase biosynthetic process,regulati< on of ERK1 and ERK2 cascade,negative regulation of ERK1 and ERK2 cascade,negative regulation of leukocyte proliferation,cellular response to lipopolysaccharide,cellular response to epidermal growth factor stimulus,cellular response to glucocorticoid stimulus,cellular response to cell-matrix adhesion,negative regulation of monocyte chemotactic protein-1 production,negative regulation of smooth muscle cell chemotaxis,cellular oxidant detoxification,glutathione derivative biosynthetic process,negative regulation of vascular smooth muscle cell proliferation,negative regulation of extrinsic apoptotic signaling pathwayglutathione transferase activity,glutathione peroxidase activity,protein binding,drug binding,JUN kinase binding,kinase regulator activity,S-nitrosoglut                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w y z { | } ~  athione binding,dinitrosyl-iron complex binding,glutathione binding,nitric oxide bindingextracellular region,extracellular space,intracellular,nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,vesicle,secretory granule lumen,extracellular exosome,TRAF2-GSTP1 complex,ficolin-1-rich granule lumenU>sp|P09211|GSTP1_HUMAN Glutathione S-transferase P OS=Homo sapiens GN=GSTP1 PE=1 SV=2P11279LAMP1 LAMP1_HUMAN+Lysosome-associated membrane glycoprotein 1granzyme-mediated apoptotic signaling pathway,neutrophil degranulation,positive regulation of natural killer cell degranulation,positive regulation of natural killer cell mediated cytotoxicity,viral entry into host cell,autophagic cell death,protein stabilization,establishment of protein localization to organelle,Golgi to lysosome transport,regulation of organelle transport along microtubuleVvirus receptor activity,protein binding,enzyme binding,protein domain specific bindingcytoplasm,lysosome,lysosomal membrane,late endosome,multivesicular body,cytosol,plasma membrane,integral component of plasma membrane,synaptic vesicle,external side of plasma membrane,endosome membrane,membrane,dendrite,azurophil granule membrane,sarcolemma,melanosome,neuronal cell body,cytolytic granule,autolysosome,perinuclear region of cytoplasm,phagolysosome membrane,extracellular exosome,alveolar lamellar body,ficolin-1-rich granule membranee>sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens GN=LAMP1 PE=1 SV=3P14780MMP9 MMP9_HUMANMatrix metalloproteinase-9skeletal system development,ossification,positive regulation of protein phosphorylation,proteolysis,embryo implantation,extracellular matrix disassembly,macrophage differentiation,positive regulation of cell migration,collagen catabolic process,endodermal cell differentiation,negative regulation of apoptotic process,neutrophil degranulation,positive regulation of DNA binding,positive regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,leukocyte migration,positive regulation of keratinocyte migration,positive regulation of release of cytochrome c from mitochondria,positive regulation of receptor binding,positive regulation of vascular smooth muscle cell proliferation,negative regulation of intrinsic apoptotic signaling pathway,negative regulation of cation channel activity,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathwayendopeptidase activity,metalloendopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,metallopeptidase activity,zinc ion binding,identical protein bindingextracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenR>sp|P14780|MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3P19961;P19961-2AMY2B AMY2B_HUMAN.Alpha-amylase 2B;Isoform 2 of Alpha-amylase 2B)carbohydrate metabolic process,digestion;)alpha-amylase activity,metal ion binding;>sp|P19961|AMY2B_HUMAN Alpha-amylase 2B OS=Homo sapiens GN=AMY2B PE=1 SV=1;>sp|P19961-2|AMY2B_HUMAN Isoform 2 of Alpha-amylase 2B OS=Homo sapiens GN=AMY2BP28289;P28289-2TMOD1 TMOD1_HUMAN*Tropomodulin-1;Isoform 2 of Tropomodulin-1adult locomotory behavior,muscle filament sliding,myofibril assembly,pointed-end actin filament capping,lens fiber cell development;9actin binding,tropomyosin binding,actin filament binding;[cytosol,actin filament,membrane,myofibril,sarcomere,cortical cytoskeleton,COP9 signalosome;>sp|P28289|TMOD1_HUMAN Tropomodulin-1 OS=Homo sapiens GN=TMOD1 PE=1 SV=1;>sp|P28289-2|TMOD1_HUMAN Isoform 2 of Tropomodulin-1 OS=Homo sapiens GN=TMOD1P30825SLC7A1 CTR1_HUMAN/High affinity cationic amino acid transporter 1?transport,amino acid transport,arginine transmembrane transportiprotein binding,amino acid transmembrane transporter activity,arginine transmembrane transporter activity>plasma membrane,integral component of plasma membrane,membranei>sp|P30825|CTR1_HUMAN High affinity cationic amino acid transporter 1 OS=Homo sapiens GN=SLC7A1 PE=1 SV=1Q15762CD226 CD226_HUMAN CD226 antigencytokine production,positive regulation of natural killer cell cytokine production,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,positive regulation of immunoglobulin mediated immune response,cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,signal transduction,cell recognition,positive regulation of interferon-gamma production,positive regulation of mast cell activation,positive regulation of natural killer cell mediated cytotoxicity,regulation of immune response,positive regulation of Fc receptor mediated stimulatory signaling pathwayreceptor activity,integrin binding,protein binding,protein kinase binding,protein homodimerization activity,cell adhesion molecule bindingplasma membrane,integral component of plasma membrane,cell-cell adherens junction,external side of plasma membrane,cell surface,membrane raftG>sp|Q15762|CD226_HUMAN CD226 antigen OS=Homo sapiens GN=CD226 PE=1 SV=2Q9NZB2;Q9NZB2-6FAM120A F120A_HUMANxConstitutive coactivator of PPAR-gamma-like protein 1;Isoform F of Constitutive coactivator of PPAR-gamma-like protein 1 RNA binding;)nucleus,cytosol,plasma membrane,membrane;>sp|Q9NZB2|F120A_HUMAN Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens GN=FAM120A PE=1 SV=2;>sp|Q9NZB2-6|F120A_HUMAN Isoform F of Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens GN=FAM120A A0A075B6S5IGKV1-27A0A075B6S5_HUMANProtein IGKV1-27 (Fragment)a>tr|A0A075B6S5|A0A075B6S5_HUMAN Protein IGKV1-27 (Fragment) OS=Homo sapiens GN=IGKV1-27 PE=1 SV=1 A0A075B738A0A075B738_HUMAN+Platelet endothelial cell adhesion moleculeo>tr|A0A075B738|A0A075B738_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1!A0A087WTQ6;F8W6X9;Q7Z5N4;Q7Z5N4-3SDK13A0A087WTQ6_HUMAN;F8W6X9_HUMAN;SDK1_HUMAN;SDK1_HUMANXProtein sidekick-1;Protein sidekick-1;Protein sidekick-1;Isoform 3 of Protein sidekick-1;;homophilic cell adhesion via plasma membrane adhesion molecules,synapse assembly,retina layer formation,behavioral response to cocaine,regulation of dendritic spine development;;;identical protein binding;];;plasma membrane,integral component of membrane,cell junction,synapse,extracellular exosome;<>tr|A0A087WTQ6|A0A087WTQ6_HUMAN Protein sidekick-1 OS=Homo sapiens GN=SDK1 PE=1 SV=1;>tr|F8W6X9|F8W6X9_HUMAN Protein sidekick-1 OS=Homo sapiens GN=SDK1 PE=1 SV=1;>sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens GN=SDK1 PE=2 SV=3;>sp|Q7Z5N4-3|SDK1_HUMAN Isoform 3 of Protein sidekick-1 OS=Homo sapiens GN=SDK1A0A0D9SGG1;E7ESF6;Q13094LCP2(A0A0D9SGG1_HUMAN;E7ESF6_HUMAN;LCP2_HUMANLymphocyte cytosolic protein 2';;immune response,transmembrane receptor protein tyrosine kinase signaling pathway,platelet activation,intracellular signal transduction,Fc-epsilon receptor signaling pathway,mast cell activation,positive regulation of protein kinase activity,cytokine secretion,T cell receptor signaling pathway;;protein bindingA;;cytosol,cell-cell junction,TCR signalosome,pla< sma membrane raft>tr|A0A0D9SGG1|A0A0D9SGG1_HUMAN Lymphocyte cytosolic protein 2 OS=Homo sapiens GN=LCP2 PE=1 SV=1;>tr|E7ESF6|E7ESF6_HUMAN Lymphocyte cytosolic protein 2 OS=Homo sapiens GN=LCP2 PE=1 SV=1;>sp|Q13094|LCP2_HUMAN Lymphocyte cytosolic protein 2 OS=Homo sapiens GN=LCP2 PE=1 SV=1 A0A0J9YVY3A0A0J9YVY3_HUMAN\>tr|A0A0J9YVY3|A0A0J9YVY3_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens PE=1 SV=1C9J1V9;D6RBD7;O43324;O43324-2#EEF1E1-BLOC1S5;EEF1E1;EEF1E1;EEF1E1/C9J1V9_HUMAN;D6RBD7_HUMAN;MCA3_HUMAN;MCA3_HUMANHCG2043275;Eukaryotic translation elongation factor 1 epsilon-1;Eukaryotic translation elongation factor 1 epsilon-1;Isoform 2 of Eukaryotic translation elongation factor 1 epsilon-1negative regulation of cell proliferation,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of apoptotic signaling pathway;;tRNA aminoacylation for protein translation,negative regulation of cell proliferation,positive regulation of apoptotic process,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of cellular senescence;Ynucleus,cytoplasm;;nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,extracellular exosome;4;4;1;2;1;1;>tr|C9J1V9|C9J1V9_HUMAN HCG2043275 OS=Homo sapiens GN=EEF1E1-BLOC1S5 PE=4 SV=2;>tr|D6RBD7|D6RBD7_HUMAN Eukaryotic translation elongation factor 1 epsilon-1 OS=Homo sapiens GN=EEF1E1 PE=4 SV=1;>sp|O43324|MCA3_HUMAN Eukaryotic translation elongation factor 1 epsilon-1 OS=Homo sapiens GN=EEF1E1 PE=1 SV=1;>sp|O43324-2|MCA3_HUMAN Isoform 2 of Eukaryotic translation elongation factor 1 epsilon-1 OS=Homo sapiens GN=EEF1E1BE9PKK8;E9PNX5;E9PPK9;E9PQ14;G3V180;G3V1D3;Q9NY33;Q9NY33-2;Q9NY33-4DPP3nE9PKK8_HUMAN;E9PNX5_HUMAN;E9PPK9_HUMAN;E9PQ14_HUMAN;G3V180_HUMAN;G3V1D3_HUMAN;DPP3_HUMAN;DPP3_HUMAN;DPP3_HUMANDipeptidyl peptidase 3 (Fragment);Dipeptidyl peptidase 3 (Fragment);Dipeptidyl peptidase 3 (Fragment);Dipeptidyl peptidase 3 (Fragment);Dipeptidyl peptidase 3;Dipeptidyl peptidase 3;Dipeptidyl peptidase 3;Isoform 2 of Dipeptidyl peptidase 3;Isoform 4 of Dipeptidyl peptidase 3;;;;;;proteolysis;;`;;;;;;protein binding,metallopeptidase activity,dipeptidyl-peptidase activity,zinc ion binding;;M;;;;;;cytoplasm,cytosol,plasma membrane,nuclear speck,extracellular exosome;;tr;tr;tr;tr;tr;tr;sp;sp;sp1;1;1;1;1;1;1;;1;1;2;1;1;1;2;;>tr|E9PKK8|E9PKK8_HUMAN Dipeptidyl peptidase 3 (Fragment) OS=Homo sapiens GN=DPP3 PE=1 SV=1;>tr|E9PNX5|E9PNX5_HUMAN Dipeptidyl peptidase 3 (Fragment) OS=Homo sapiens GN=DPP3 PE=1 SV=1;>tr|E9PPK9|E9PPK9_HUMAN Dipeptidyl peptidase 3 (Fragment) OS=Homo sapiens GN=DPP3 PE=1 SV=2;>tr|E9PQ14|E9PQ14_HUMAN Dipeptidyl peptidase 3 (Fragment) OS=Homo sapiens GN=DPP3 PE=1 SV=1;>tr|G3V180|G3V180_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=1;>tr|G3V1D3|G3V1D3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=1;>sp|Q9NY33|DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=2;>sp|Q9NY33-2|DPP3_HUMAN Isoform 2 of Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3;>sp|Q9NY33-4|DPP3_HUMAN Isoform 4 of Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3K7ELL7;P14314;P14314-2PRKCSH$K7ELL7_HUMAN;GLU2B_HUMAN;GLU2B_HUMAN]Glucosidase 2 subunit beta;Glucosidase 2 subunit beta;Isoform 2 of Glucosidase 2 subunit betaG;protein folding,N-glycan processing,intracellular signal transduction;Y;protein kinase C binding,calcium ion binding,ion channel binding,phosphoprotein binding;A;intracellular,endoplasmic reticulum,endoplasmic reticulum lumen;>tr|K7ELL7|K7ELL7_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens GN=PRKCSH PE=1 SV=1;>sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens GN=PRKCSH PE=1 SV=2;>sp|P14314-2|GLU2B_HUMAN Isoform 2 of Glucosidase 2 subunit beta OS=Homo sapiens GN=PRKCSHO00560 Syntenin-1negative regulation of receptor internalization,protein targeting to membrane,substrate-dependent cell migration, cell extension,chemical synaptic transmission,regulation of mitotic cell cycle,positive regulation of cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of pathway-restricted SMAD protein phosphorylation,actin cytoskeleton organization,positive regulation of cell growth,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,intracellular signal transduction,positive regulation of phosphorylation,neutrophil degranulation,positive regulation of JNK cascade,ephrin receptor signaling pathway,positive regulation of exosomal secretion,positive regulation of extracellular exosome assemblyfrizzled binding,interleukin-5 receptor binding,protein binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal adaptor activity,identical protein binding,cadherin binding,syndecan binding,protein heterodimerization activity,protein N-terminus binding~extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum membrane,cytosol,cytoskeleton,plasma membrane,interleukin-5 receptor complex,adherens junction,focal adhesion,membrane,nuclear membrane,azurophil granule lumen,melanosome,intracellular membrane-bounded organelle,membrane raft,extracellular exosome,blood microparticle,extracellular vesicleD>sp|O00560|SDCB1_HUMAN Syntenin-1 OS=Homo sapiens GN=SDCBP PE=1 SV=1O14964;O14964-2HGS HGS_HUMANHepatocyte growth factor-regulated tyrosine kinase substrate;Isoform 2 of Hepatocyte growth factor-regulated tyrosine kinase substrateprotein targeting to lysosome,signal transduction,negative regulation of cell proliferation,membrane invagination,positive regulation of gene expression,endosomal transport,macroautophagy,protein deubiquitination,multivesicular body assembly,negative regulation of epidermal growth factor receptor signaling pathway,regulation of protein catabolic process,regulation of MAP kinase activity,negative regulation of JAK-STAT cascade,membrane organization,protein localization to membrane,positive regulation of exosomal secretion;Bprotein binding,protein domain specific binding,metal ion binding;lysosome,endosome,early endosome,cytosol,early endosome membrane,multivesicular body membrane,ESCRT-0 complex,intracellular membrane-bounded organelle,extracellular exosome;>sp|O14964|HGS_HUMAN Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens GN=HGS PE=1 SV=1;>sp|O14964-2|HGS_HUMAN Isoform 2 of Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens GN=HGS P01593;P01594IGKV1D-33;IGKV1-33KVD33_HUMAN;KV133_HUMANFImmunoglobulin kappa variable 1D-33;Immunoglobulin kappa variable 1-33extracellular region,plasma membrane,extracellular exosome,blood microparticle;extracellular region,plasma membrane,extracellular exosome,blood microparticle>sp|P01593|KVD33_HUMAN Immunoglobulin kappa variable 1D-33 OS=Homo sapiens GN=IGKV1D-33 PE=1 SV=2;>sp|P01594|KV133_HUMAN Immunoglobulin kappa variable 1-33 OS=Homo sapiens GN=IGKV1-33 PE=1 SV=2 P10768;X6RA14ESDESTD_HUMAN;X6RA14_HUMANS-formylglutathione hydrolase^biological_process,formaldehyde catabolic process,glutathione derivative biosynthetic process;protein binding,hydrolase activity, acting on ester bonds,S-formylglutathione hydrolase activity,identical protein binding,methylumbelliferyl-acetate deacetylase activity,carboxylic ester hydrolase activity;Fendoplasmic reticulum lumen,cytoplasmic vesicle,extracellular exosome;>sp|P10768|ESTD_HUMAN S-formylglutathione hydrolase OS=Homo sapiens GN=ESD PE=1 SV=2;>tr|X6RA14|X6RA14_HUMAN S-formylglutathione hydrolase OS=Homo sapiens GN=ESD PE=1 SV=1P13164IFITM1 IFM1_HUMAN*Interferon-induced transmembrane protein 1ossification,cell surface receptor signaling pathway,negative regulation of cell proliferation,response to virus,negative regulation of cell migration,response to interferon-gamma,response to interferon-alpha,response to interferon-beta,negative regulation of viral genome replication,positive regulation of osteobl< ast differentiation,negative regulation of viral entry into host cell,regulation of immune response,defense response to virus,type I interferon signaling pathway3receptor signaling protein activity,protein binding7plasma membrane,membrane,integral component of membraned>sp|P13164|IFM1_HUMAN Interferon-induced transmembrane protein 1 OS=Homo sapiens GN=IFITM1 PE=1 SV=3P15814IGLL1 IGLL1_HUMAN(Immunoglobulin lambda-like polypeptide 1phagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation, classical pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation,leukocyte migrationextracellular region,external side of plasma membrane,membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticleb>sp|P15814|IGLL1_HUMAN Immunoglobulin lambda-like polypeptide 1 OS=Homo sapiens GN=IGLL1 PE=1 SV=1P16152CBR1 CBR1_HUMANCarbonyl reductase [NADPH] 1drug metabolic process,cyclooxygenase pathway,epithelial cell differentiation,vitamin K metabolic process,oxidation-reduction processcarbonyl reductase (NADPH) activity,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,prostaglandin-E2 9-reductase activity3cytosol,extracellular exosome,extracellular vesicleT>sp|P16152|CBR1_HUMAN Carbonyl reductase [NADPH] 1 OS=Homo sapiens GN=CBR1 PE=1 SV=3B0YIW6;P48444;P48444-2ARCN1"B0YIW6_HUMAN;COPD_HUMAN;COPD_HUMANSArchain 1, isoform CRA_a;Coatomer subunit delta;Isoform 2 of Coatomer subunit delta;intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,adult locomotory behavior,cerebellar Purkinje cell layer maturation,pigmentation; ;RNA binding;d;Golgi membrane,endoplasmic reticulum membrane,cytosol,membrane,COPI vesicle coat,transport vesicle;>tr|B0YIW6|B0YIW6_HUMAN Archain 1, isoform CRA_a OS=Homo sapiens GN=ARCN1 PE=1 SV=1;>sp|P48444|COPD_HUMAN Coatomer subunit delta OS=Homo sapiens GN=ARCN1 PE=1 SV=1;>sp|P48444-2|COPD_HUMAN Isoform 2 of Coatomer subunit delta OS=Homo sapiens GN=ARCN1P62140PPP1CB PP1B_HUMAN?Serine/threonine-protein phosphatase PP1-beta catalytic subunitNG2/M transition of mitotic cell cycle,glycogen metabolic process,regulation of glycogen biosynthetic process,regulation of glycogen catabolic process,protein dephosphorylation,regulation of cell adhesion,circadian regulation of gene expression,regulation of circadian rhythm,entrainment of circadian clock by photoperiod,cell divisionprotein binding,phosphatase activity,myosin phosphatase activity,protein kinase binding,metal ion binding,myosin-light-chain-phosphatase activityprotein phosphatase type 1 complex,nucleus,nucleoplasm,nucleolus,cytosol,focal adhesion,glycogen granule,extracellular exosome,PTW/PP1 phosphatase complex,nuclear chromosome, telomeric regiony>sp|P62140|PP1B_HUMAN Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Homo sapiens GN=PPP1CB PE=1 SV=3Q6UWP8SBSN SBSN_HUMAN Suprabasin*extracellular matrix,extracellular exosomeB>sp|Q6UWP8|SBSN_HUMAN Suprabasin OS=Homo sapiens GN=SBSN PE=1 SV=2Q9H479FN3K FN3K_HUMANFructosamine-3-kinasephosphorylation,fructosamine metabolic process,fructoselysine metabolic process,epithelial cell differentiation,post-translational protein modification.kinase activity,fructosamine-3-kinase activityM>sp|Q9H479|FN3K_HUMAN Fructosamine-3-kinase OS=Homo sapiens GN=FN3K PE=1 SV=1Q9HCN6;Q9HCN6-2GP6 GPVI_HUMAN>Platelet glycoprotein VI;Isoform 2 of Platelet glycoprotein VIkenzyme linked receptor protein signaling pathway,blood coagulation,platelet activation,leukocyte migration;]receptor activity,transmembrane signaling receptor activity,protein binding,collagen binding;zplasma membrane,integral component of plasma membrane,cell surface,extracellular exosome,tetraspanin-enriched microdomain;>sp|Q9HCN6|GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4;>sp|Q9HCN6-2|GPVI_HUMAN Isoform 2 of Platelet glycoprotein VI OS=Homo sapiens GN=GP6Q9UKK3PARP4 PARP4_HUMANPoly [ADP-ribose] polymerase 4DNA repair,cellular protein modification process,protein ADP-ribosylation,transport,inflammatory response,cellular response to DNA damage stimulus,cell death,response to drugODNA binding,NAD+ ADP-ribosyltransferase activity,protein binding,enzyme bindingtnucleus,cytoplasm,cytosol,spindle microtubule,membrane,intracellular ribonucleoprotein complex,extracellular exosomeX>sp|Q9UKK3|PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3/H7C189;Q13107;Q13107-2;Q9Y4E8;Q9Y4E8-2;Q9Y4E8-3 USP4;USP4;USP4;USP15;USP15;USP15FH7C189_HUMAN;UBP4_HUMAN;UBP4_HUMAN;UBP15_HUMAN;UBP15_HUMAN;UBP15_HUMAN$Ubiquitin carboxyl-terminal hydrolase 4 (Fragment);Ubiquitin carboxyl-terminal hydrolase 4;Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 4;Ubiquitin carboxyl-terminal hydrolase 15;Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 15;Isoform 3 of Ubiquitin carboxyl-terminal hydrolase 15;spliceosomal tri-snRNP complex assembly,ubiquitin-dependent protein catabolic process,protein deubiquitination,negative regulation of protein ubiquitination,regulation of protein stability,protein localization to cell surface;;ubiquitin-dependent protein catabolic process,transforming growth factor beta receptor signaling pathway,protein deubiquitination,BMP signaling pathway,monoubiquitinated protein deubiquitination,histone H2B conserved C-terminal lysine deubiquitination,pathway-restricted SMAD protein phosphorylation;;;thiol-dependent ubiquitin-specific protease activity,protein binding,adenosine receptor binding,thiol-dependent ubiquitinyl hydrolase activity,identical protein binding,metal ion binding;;cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,transforming growth factor beta receptor binding,protein binding,thiol-dependent ubiquitinyl hydrolase activity,identical protein binding,SMAD binding,ubiquitinated histone binding;;P;nucleus,cytoplasm,lysosome,cytosol,plasma membrane;;nucleus,cytoplasm,cytosol;;1;1;;1;;1;3;;3;;d>tr|H7C189|H7C189_HUMAN Ubiquitin carboxyl-terminal hydrolase 4 (Fragment) OS=Homo sapiens GN=USP4 PE=1 SV=1;>sp|Q13107|UBP4_HUMAN Ubiquitin carboxyl-terminal hydrolase 4 OS=Homo sapiens GN=USP4 PE=1 SV=3;>sp|Q13107-2|UBP4_HUMAN Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 4 OS=Homo sapiens GN=USP4;>sp|Q9Y4E8|UBP15_HUMAN Ubiquitin carboxyl-terminal hydrolase 15 OS=Homo sapiens GN=USP15 PE=1 SV=3;>sp|Q9Y4E8-2|UBP15_HUMAN Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 15 OS=Homo sapiens GN=USP15;>sp|Q9Y4E8-3|UBP15_HUMAN Isoform 3 of Ubiquitin carboxyl-terminal hydrolase 15 OS=Homo sapiens GN=USP15(A0A087X1K9;B4DP64;E5RGR0;O75608;O75608-2LYPLA1BA0A087X1K9_HUMAN;B4DP64_HUMAN;E5RGR0_HUMAN;LYPA1_HUMAN;LYPA1_HUMANAcyl-protein thioesterase 1;Acyl-protein thioesterase 1;Acyl-protein thioesterase 1 (Fragment);Acyl-protein thioesterase 1;Isoform 2 of Acyl-protein thioesterase 1;;;protein depalmitoylation,fatty acid metabolic process,negative regulation of Golgi to plasma membrane protein transport,regulation of nitric-oxide synthase activity;U;;;lysophospholipase activity,palmitoyl-(protein) hydrolase activity,lipase activity;9;;;cytoplasm,mitochondrion,cytosol,extracellular exosome;>tr|A0A087X1K9|A0A087X1K9_HUMAN Acyl-protein thioesterase 1 OS=Homo sapiens GN=LYPLA1 PE=1 SV=1;>tr|B4DP64|B4DP64_HUMAN Acyl-protein thioesterase 1 OS=Homo sapiens GN=LYPLA1 PE=1 SV=1;>tr|E5RGR0|E5RGR0_HUMAN Acyl-protein thioesterase 1 (Fragment) OS=Homo sapiens GN=LYPLA1 PE=1 SV=1;>sp|O75608|LYPA1_HUMAN Acyl-protein thioesterase 1 OS=Homo sapiens GN=LYPLA1 PE=1 SV=1;>sp|O75608-2|LYPA1_HUMAN Isoform 2 of Acyl-protein thioesterase 1 OS=Homo sapiens GN=LYPLA1 A0A0B4J1X8IGHV3-43 HV343_HUMAN"Immunoglobulin heavy variable 3-43c>sp|A0A0B4J1X8|HV343_HUMAN Immunoglobulin heavy variable 3-43 OS=Homo sapiens GN=IGHV3-43 PE=3 SV=1 A0A0C4DH33IGHV1-24 HV124_HUMAN< "Immunoglobulin heavy variable 1-24c>sp|A0A0C4DH33|HV124_HUMAN Immunoglobulin heavy variable 1-24 OS=Homo sapiens GN=IGHV1-24 PE=3 SV=10A6PVH9;B0QZ18;E7ENH5;F2Z2V0;H0Y524;Q5JX45;Q99829CPNE1YA6PVH9_HUMAN;B0QZ18_HUMAN;E7ENH5_HUMAN;F2Z2V0_HUMAN;H0Y524_HUMAN;Q5JX45_HUMAN;CPNE1_HUMAN_Copine-1;Copine-1;Copine-1;Copine-1 (Fragment);Copine-1 (Fragment);Copine-1 (Fragment);Copine-1^;;;;;;transcription, DNA-templated,regulation of transcription, DNA-templated,proteolysis,lipid metabolic process,negative regulation of gene expression,vesicle-mediated transport,regulation of I-kappaB kinase/NF-kappaB signaling,neutrophil degranulation,negative regulation of DNA binding,positive regulation of neuron differentiation,glycerophospholipid biosynthetic process,positive regulation of protein kinase B signaling,cellular response to calcium ion,negative regulation of NIK/NF-kappaB signaling,positive regulation of tumor necrosis factor-mediated signaling pathway,neuron projection extension;;;;;;phosphatidylserine binding,endopeptidase activity,transporter activity,calcium ion binding,protein binding,calcium-dependent phospholipid binding,protein homodimerization activity,NF-kappaB binding;;;;;;nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,nuclear membrane,azurophil granule membrane,extracellular exosometr;tr;tr;tr;tr;tr;sp>tr|A6PVH9|A6PVH9_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1;>tr|B0QZ18|B0QZ18_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1;>tr|E7ENH5|E7ENH5_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1;>tr|F2Z2V0|F2Z2V0_HUMAN Copine-1 (Fragment) OS=Homo sapiens GN=CPNE1 PE=1 SV=1;>tr|H0Y524|H0Y524_HUMAN Copine-1 (Fragment) OS=Homo sapiens GN=CPNE1 PE=1 SV=1;>tr|Q5JX45|Q5JX45_HUMAN Copine-1 (Fragment) OS=Homo sapiens GN=CPNE1 PE=1 SV=1;>sp|Q99829|CPNE1_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1E9PFZ2 E9PFZ2_HUMANE>tr|E9PFZ2|E9PFZ2_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1A6NEC2;E9PLK3;E9PP11;P55786NPEPPSL1;NPEPPS;NPEPPS;NPEPPS.PSAL_HUMAN;E9PLK3_HUMAN;E9PP11_HUMAN;PSA_HUMANPuromycin-sensitive aminopeptidase-like protein;Puromycin-sensitive aminopeptidase;Puromycin-sensitive aminopeptidase (Fragment);Puromycin-sensitive aminopeptidaseproteolysis,peptide catabolic process;;;protein polyubiquitination,proteolysis,peptide catabolic process,cellular response to hypoxia,positive regulation of protein targeting to mitochondrionzinc ion binding,peptide binding,metalloaminopeptidase activity;;;aminopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activityQcytoplasm,extracellular exosome;;;nucleus,cytoplasm,cytosol,extracellular exosome sp;tr;tr;sp2;1;1;13;1;1;2>sp|A6NEC2|PSAL_HUMAN Puromycin-sensitive aminopeptidase-like protein OS=Homo sapiens GN=NPEPPSL1 PE=2 SV=3;>tr|E9PLK3|E9PLK3_HUMAN Puromycin-sensitive aminopeptidase OS=Homo sapiens GN=NPEPPS PE=1 SV=1;>tr|E9PP11|E9PP11_HUMAN Puromycin-sensitive aminopeptidase (Fragment) OS=Homo sapiens GN=NPEPPS PE=1 SV=1;>sp|P55786|PSA_HUMAN Puromycin-sensitive aminopeptidase OS=Homo sapiens GN=NPEPPS PE=1 SV=2J3KSV1 J3KSV1_HUMANN>tr|J3KSV1|J3KSV1_HUMAN Haptoglobin (Fragment) OS=Homo sapiens GN=HP PE=1 SV=1&K7EII6;K7EIK7;O95834;O95834-2;O95834-3EML2=K7EII6_HUMAN;K7EIK7_HUMAN;EMAL2_HUMAN;EMAL2_HUMAN;EMAL2_HUMANEchinoderm microtubule-associated protein-like 2 (Fragment);Echinoderm microtubule-associated protein-like 2;Echinoderm microtubule-associated protein-like 2;Isoform 2 of Echinoderm microtubule-associated protein-like 2;Isoform 3 of Echinoderm microtubule-associated protein-like 2;;visual perception,sensory perception of sound,regulation of microtubule nucleation,negative regulation of microtubule polymerization;;c;;receptor binding,protein binding,microtubule binding,protein C-terminus binding,tubulin binding;;H;;cytoplasm,microtubule,microtubule associated complex,mitotic spindle;;(>tr|K7EII6|K7EII6_HUMAN Echinoderm microtubule-associated protein-like 2 (Fragment) OS=Homo sapiens GN=EML2 PE=1 SV=1;>tr|K7EIK7|K7EIK7_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=1 SV=1;>sp|O95834|EMAL2_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=1 SV=1;>sp|O95834-2|EMAL2_HUMAN Isoform 2 of Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2;>sp|O95834-3|EMAL2_HUMAN Isoform 3 of Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2P05387RPLP2 RLA2_HUMAN60S acidic ribosomal protein P2nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,translational elongation,SRP-dependent cotranslational protein targeting to membrane,viral transcription2structural constituent of ribosome,protein bindingWcytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular exosomeX>sp|P05387|RLA2_HUMAN 60S acidic ribosomal protein P2 OS=Homo sapiens GN=RPLP2 PE=1 SV=1P98095;P98095-2FBLN2 FBLN2_HUMAN Fibulin-2;Isoform 2 of Fibulin-2/positive regulation of cell-substrate adhesion;]extracellular matrix structural constituent,calcium ion binding,extracellular matrix binding;extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome,extracellular vesicle;>sp|P98095|FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2;>sp|P98095-2|FBLN2_HUMAN Isoform 2 of Fibulin-2 OS=Homo sapiens GN=FBLN2Q12860;Q12860-2;Q12860-3CNTN1 CNTN1_HUMAN=Contactin-1;Isoform 2 of Contactin-1;Isoform 3 of Contactin-1cell adhesion,Notch signaling pathway,positive regulation of gene expression,positive regulation of sodium ion transport,positive regulation of neuron projection development,cerebellum development,neuron projection development,positive regulation of peptidyl-tyrosine phosphorylation;;+glycoprotein binding,carbohydrate binding;;kplasma membrane,membrane,anchored component of membrane,myelin sheath,membrane raft,extracellular exosome;;>sp|Q12860|CNTN1_HUMAN Contactin-1 OS=Homo sapiens GN=CNTN1 PE=1 SV=1;>sp|Q12860-2|CNTN1_HUMAN Isoform 2 of Contactin-1 OS=Homo sapiens GN=CNTN1;>sp|Q12860-3|CNTN1_HUMAN Isoform 3 of Contactin-1 OS=Homo sapiens GN=CNTN1Q8IY63;Q8IY63-2AMOTL1 AMOL1_HUMAN@Angiomotin-like protein 1;Isoform 2 of Angiomotin-like protein 1establishment of cell polarity involved in ameboidal cell migration,Wnt signaling pathway,hippo signaling,positive regulation of blood vessel endothelial cell migration;*protein binding,identical protein binding;lcytosol,bicellular tight junction,apical plasma membrane,lamellipodium,cytoplasmic vesicle,COP9 signalosome;>sp|Q8IY63|AMOL1_HUMAN Angiomotin-like protein 1 OS=Homo sapiens GN=AMOTL1 PE=1 SV=1;>sp|Q8IY63-2|AMOL1_HUMAN Isoform 2 of Angiomotin-like protein 1 OS=Homo sapiens GN=AMOTL1Q9P2R3;Q9P2R3-2;Q9P2R3-4ANKFY1 ANFY1_HUMAN@Rabankyrin-5;Isoform 2 of Rabankyrin-5;Isoform 4 of Rabankyrin-5endocytosis,endosome localization,endosomal vesicle fusion,retrograde transport, endosome to Golgi,positive regulation of pinocytosis,Golgi to lysosome transport;;]protein binding,Rab GTPase binding,metal ion binding,phosphatidylinositol phosphate binding;;lysosomal membrane,endosome,early endosome,cytosol,endosome membrane,membrane,intracellular membrane-bounded organelle,macropinosome,extracellular exosome,retromer complex;;>sp|Q9P2R3|ANFY1_HUMAN Rabankyrin-5 OS=Homo sapiens GN=ANKFY1 PE=1 SV=2;>sp|Q9P2R3-2|ANFY1_HUMAN Isoform 2 of Rabankyrin-5 OS=Homo sapiens GN=ANKFY1;>sp|Q9P2R3-4|ANFY1_HUMAN Isoform 4 of Rabankyrin-5 OS=Homo sapiens GN=ANKFY1A0A0C4DH55;A0A0C4DH90IGKV3D-7;IGKV3OR2-268!A0A0C4DH55_HUMAN;A0A0C4DH90_HUMAN;Protein IGKV3D-7 (Fragment);Protein IGKV3OR2-268 (Fragment)ladaptive immune response,immunoglobulin production,immune response;immunoglobulin production,immune responseantigen binding;7extracellular space,plasma membrane;extracellular space>tr|A0A0C4DH55|A0A0C4DH55_HUMAN Protein IGKV3D-7 (Fragment) OS=Homo sapiens GN=IGKV3D-7 PE=4 SV=5;>tr|A0A0C4DH90|A0A0C4DH90_HUMAN Protein IGKV3OR2-268 (Fragment) OS=< Homo sapiens GN=IGKV3OR2-268 PE=4 SV=5(B4DUC8;Q13126;Q13126-2;Q13126-3;Q13126-4MTAP8B4DUC8_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMANS-methyl-5'-thioadenosine phosphorylase;S-methyl-5'-thioadenosine phosphorylase;Isoform 2 of S-methyl-5'-thioadenosine phosphorylase;Isoform 3 of S-methyl-5'-thioadenosine phosphorylase;Isoform 4 of S-methyl-5'-thioadenosine phosphorylase;nucleobase-containing compound metabolic process,purine ribonucleoside salvage,L-methionine biosynthetic process from methylthioadenosine,nicotinamide riboside catabolic process;;;Z;phosphorylase activity,protein binding,S-methyl-5-thioadenosine phosphorylase activity;;;);nucleus,cytosol,extracellular exosome;;;>tr|B4DUC8|B4DUC8_HUMAN S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens GN=MTAP PE=1 SV=1;>sp|Q13126|MTAP_HUMAN S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens GN=MTAP PE=1 SV=2;>sp|Q13126-2|MTAP_HUMAN Isoform 2 of S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens GN=MTAP;>sp|Q13126-3|MTAP_HUMAN Isoform 3 of S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens GN=MTAP;>sp|Q13126-4|MTAP_HUMAN Isoform 4 of S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens GN=MTAP E7EPB3;P50914RPL14E7EPB3_HUMAN;RL14_HUMAN60S ribosomal protein L14;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal large subunit biogenesisP;RNA binding,structural constituent of ribosome,protein binding,cadherin bindingI;cytosol,membrane,cytosolic large ribosomal subunit,extracellular exosome>tr|E7EPB3|E7EPB3_HUMAN 60S ribosomal protein L14 OS=Homo sapiens GN=RPL14 PE=1 SV=1;>sp|P50914|RL14_HUMAN 60S ribosomal protein L14 OS=Homo sapiens GN=RPL14 PE=1 SV=4O00231;O00231-2PSMD11 PSD11_HUMANl26S proteasome non-ATPase regulatory subunit 11;Isoform 2 of 26S proteasome non-ATPase regulatory subunit 11MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,proteasome assembly,neutrophil degranulation,regulation of mRNA stability,stem cell differentiation,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;-structural molecule activity,protein binding;proteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, lid subcomplex,membrane,proteasome accessory complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;>sp|O00231|PSD11_HUMAN 26S proteasome non-ATPase regulatory subunit 11 OS=Homo sapiens GN=PSMD11 PE=1 SV=3;>sp|O00231-2|PSD11_HUMAN Isoform 2 of 26S proteasome non-ATPase regulatory subunit 11 OS=Homo sapiens GN=PSMD110E9PIK5;E9PIM9;E9PLZ3;E9PMA9;E9PMJ3;E9PMN0;P13489RNH1XE9PIK5_HUMAN;E9PIM9_HUMAN;E9PLZ3_HUMAN;E9PMA9_HUMAN;E9PMJ3_HUMAN;E9PMN0_HUMAN;RINI_HUMANRibonuclease inhibitor (Fragment);Ribonuclease inhibitor (Fragment);Ribonuclease inhibitor (Fragment);Ribonuclease inhibitor;Ribonuclease inhibitor (Fragment);Ribonuclease inhibitor;Ribonuclease inhibitora;;;;;;mRNA catabolic process,negative regulation of catalytic activity,regulation of angiogenesis5;;;;;;protein binding,ribonuclease inhibitor activityF;;;;;;nucleoplasm,cytosol,angiogenin-PRI complex,extracellular exosome 1;1;1;1;1;1;2`>tr|E9PIK5|E9PIK5_HUMAN Ribonuclease inhibitor (Fragment) OS=Homo sapiens GN=RNH1 PE=1 SV=1;>tr|E9PIM9|E9PIM9_HUMAN Ribonuclease inhibitor (Fragment) OS=Homo sapiens GN=RNH1 PE=1 SV=1;>tr|E9PLZ3|E9PLZ3_HUMAN Ribonuclease inhibitor (Fragment) OS=Homo sapiens GN=RNH1 PE=1 SV=1;>tr|E9PMA9|E9PMA9_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=1;>tr|E9PMJ3|E9PMJ3_HUMAN Ribonuclease inhibitor (Fragment) OS=Homo sapiens GN=RNH1 PE=1 SV=1;>tr|E9PMN0|E9PMN0_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=1;>sp|P13489|RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2P40189;P40189-3IL6ST IL6RB_HUMANTInterleukin-6 receptor subunit beta;Isoform 3 of Interleukin-6 receptor subunit betapositive regulation of acute inflammatory response,positive regulation of adaptive immune response,glycogen metabolic process,positive regulation of cell proliferation,regulation of Notch signaling pathway,positive regulation of vascular endothelial growth factor production,positive regulation of cardiac muscle hypertrophy,viral process,cytokine-mediated signaling pathway,response to cytokine,interleukin-11-mediated signaling pathway,oncostatin-M-mediated signaling pathway,positive regulation of T cell proliferation,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,negative regulation of apoptotic process,positive regulation of osteoblast differentiation,positive regulation of astrocyte differentiation,leukemia inhibitory factor signaling pathway,interleukin-6-mediated signaling pathway,interleukin-27-mediated signaling pathway,ciliary neurotrophic factor-mediated signaling pathway;ciliary neurotrophic factor receptor activity,interleukin-11 receptor activity,ciliary neurotrophic factor receptor binding,protein binding,growth factor binding,interleukin-11 binding,protein homodimerization activity,interleukin-27 receptor activity,interleukin-6 receptor activity,leukemia inhibitory factor receptor activity,oncostatin-M receptor activity,interleukin-6 receptor binding,interleukin-6 binding;extracellular region,plasma membrane,interleukin-6 receptor complex,oncostatin-M receptor complex,external side of plasma membrane,membrane,dendrite,neuronal cell body,extracellular exosome,ciliary neurotrophic factor receptor complex;>sp|P40189|IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2;>sp|P40189-3|IL6RB_HUMAN Isoform 3 of Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6STP55957;P55957-2BID BID_HUMANVBH3-interacting domain death agonist;Isoform 2 of BH3-interacting domain death agonistrelease of cytochrome c from mitochondria,protein targeting to mitochondrion,activation of cysteine-type endopeptidase activity involved in apoptotic process,brain development,extrinsic apoptotic signaling pathway via death domain receptors,apoptotic mitochondrial changes,positive regulation of mitochondrial membrane potential,response to estradiol,positive regulation of protein oligomerization,positive regulation of protein homooligomerization,glial cell apoptotic process,regulation of cell proliferation,signal transduction in response to DNA damage,mitochondrial ATP synthesis coupled electron transport,regulation of apoptotic process,positive regulation of apoptotic process,protein homooligomerization,neuron apoptotic process,establishment of protein localization to membrane,positive regulation of release of cytochrome c from mitochondria,hepatocyte apoptotic process,mitochondrial outer membrane permeabilization,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling p< athway,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,regulation of G1/S transition of mitotic cell cycle,positive regulation of fibroblast apoptotic process,positive regulation of extrinsic apoptotic signaling pathway,positive regulation of intrinsic apoptotic signaling pathway;ldeath receptor binding,protein binding,ubiquitin protein ligase binding,protein heterodimerization activity;mitochondrion,mitochondrial outer membrane,cytosol,membrane,integral component of mitochondrial membrane,extracellular exosome;>sp|P55957|BID_HUMAN BH3-interacting domain death agonist OS=Homo sapiens GN=BID PE=1 SV=1;>sp|P55957-2|BID_HUMAN Isoform 2 of BH3-interacting domain death agonist OS=Homo sapiens GN=BIDQ14766-3EIsoform 3 of Latent-transforming growth factor beta-binding protein 1w>sp|Q14766-3|LTBP1_HUMAN Isoform 3 of Latent-transforming growth factor beta-binding protein 1 OS=Homo sapiens GN=LTBP1 A0A024R6I7A0A024R6I7_HUMANY>tr|A0A024R6I7|A0A024R6I7_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=1 A0A075B6S6 IGKV2D-30 KVD30_HUMAN#Immunoglobulin kappa variable 2D-30e>sp|A0A075B6S6|KVD30_HUMAN Immunoglobulin kappa variable 2D-30 OS=Homo sapiens GN=IGKV2D-30 PE=3 SV=1P30483 1B45_HUMAN8HLA class I histocompatibility antigen, B-45 alpha chainq>sp|P30483|1B45_HUMAN HLA class I histocompatibility antigen, B-45 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1&A6NEP9;H7BXY6;Q8NG11;Q8NG11-2;Q8NG11-3TSPAN14=A6NEP9_HUMAN;H7BXY6_HUMAN;TSN14_HUMAN;TSN14_HUMAN;TSN14_HUMANiTetraspanin (Fragment);Tetraspanin;Tetraspanin-14;Isoform 2 of Tetraspanin-14;Isoform 3 of Tetraspanin-14;;neutrophil degranulation,positive regulation of Notch signaling pathway,protein maturation,establishment of protein localization to plasma membrane;;;;enzyme binding;;;;plasma membrane,integral component of plasma membrane,cell surface,specific granule membrane,tertiary granule membrane,tetraspanin-enriched microdomain;;2;1;1;;>tr|A6NEP9|A6NEP9_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=TSPAN14 PE=1 SV=2;>tr|H7BXY6|H7BXY6_HUMAN Tetraspanin OS=Homo sapiens GN=TSPAN14 PE=1 SV=1;>sp|Q8NG11|TSN14_HUMAN Tetraspanin-14 OS=Homo sapiens GN=TSPAN14 PE=1 SV=1;>sp|Q8NG11-2|TSN14_HUMAN Isoform 2 of Tetraspanin-14 OS=Homo sapiens GN=TSPAN14;>sp|Q8NG11-3|TSN14_HUMAN Isoform 3 of Tetraspanin-14 OS=Homo sapiens GN=TSPAN14D6RAR4 D6RAR4_HUMAN]>tr|D6RAR4|D6RAR4_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1 F5H5D3;Q9BQE3TUBA1CF5H5D3_HUMAN;TBA1C_HUMAN*Tubulin alpha chain;Tubulin alpha-1C chainq;cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell divisionp;GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding?;nucleus,cytoplasm,microtubule,microtubule cytoskeleton,vesicle>tr|F5H5D3|F5H5D3_HUMAN Tubulin alpha chain OS=Homo sapiens GN=TUBA1C PE=1 SV=1;>sp|Q9BQE3|TBA1C_HUMAN Tubulin alpha-1C chain OS=Homo sapiens GN=TUBA1C PE=1 SV=1O43665;O43665-2;O43665-3RGS10 RGS10_HUMANRegulator of G-protein signaling 10;Isoform 2 of Regulator of G-protein signaling 10;Isoform 3 of Regulator of G-protein signaling 10G-protein coupled acetylcholine receptor signaling pathway,negative regulation of signal transduction,positive regulation of GTPase activity;;;G-protein alpha-subunit binding,GTPase activator activity;;Rnucleus,cytosol,plasma membrane,neuronal cell body,dendritic spine,axon terminus;;#>sp|O43665|RGS10_HUMAN Regulator of G-protein signaling 10 OS=Homo sapiens GN=RGS10 PE=1 SV=2;>sp|O43665-2|RGS10_HUMAN Isoform 2 of Regulator of G-protein signaling 10 OS=Homo sapiens GN=RGS10;>sp|O43665-3|RGS10_HUMAN Isoform 3 of Regulator of G-protein signaling 10 OS=Homo sapiens GN=RGS10O95721SNAP29 SNP29_HUMAN"Synaptosomal-associated protein 29exocytosis,vesicle targeting,protein transport,synaptic vesicle priming,autophagosome docking,synaptic vesicle fusion to presynaptic active zone membrane,neutrophil degranulation,cilium morphogenesis,membrane fusion,autophagosome maturationGolgi membrane,autophagosome membrane,nucleoplasm,cytoplasm,autophagosome,centrosome,cytosol,plasma membrane,ciliary pocket membrane,SNARE complex,azurophil granule membrane,presynapse]>sp|O95721|SNP29_HUMAN Synaptosomal-associated protein 29 OS=Homo sapiens GN=SNAP29 PE=1 SV=1P12273PIP PIP_HUMANProlactin-inducible proteindetection of chemical stimulus involved in sensory perception of bitter taste,retina homeostasis,regulation of immune system process,proteolysis,positive regulation of gene expression,transmembrane transport,negative regulation of T cell apoptotic processglycoprotein binding,actin binding,aspartic-type endopeptidase activity,protein binding,IgG binding,protein dimerization activity]extracellular region,extracellular space,nucleus,apical plasma membrane,extracellular exosomeQ>sp|P12273|PIP_HUMAN Prolactin-inducible protein OS=Homo sapiens GN=PIP PE=1 SV=1 G3XAL0;P40926MDH2G3XAL0_HUMAN;MDHM_HUMAN8Malate dehydrogenase;Malate dehydrogenase, mitochondrial;gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,internal protein amino acid acetylation,NADH metabolic processk;RNA binding,L-malate dehydrogenase activity,protein self-association,malate dehydrogenase (NADP+) activityl;nucleus,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,myelin sheath,extracellular exosome>tr|G3XAL0|G3XAL0_HUMAN Malate dehydrogenase OS=Homo sapiens GN=MDH2 PE=1 SV=1;>sp|P40926|MDHM_HUMAN Malate dehydrogenase, mitochondrial OS=Homo sapiens GN=MDH2 PE=1 SV=3Q04941PLP2 PLP2_HUMANProteolipid protein 2Xion transport,chemotaxis,cytokine-mediated signaling pathway,ion transmembrane transportHprotein binding,ion transmembrane transporter activity,chemokine bindingendoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,membrane,integral component of membrane,extracellular exosomeM>sp|Q04941|PLP2_HUMAN Proteolipid protein 2 OS=Homo sapiens GN=PLP2 PE=1 SV=1(H0YFY6;Q14980;Q14980-2;Q14980-3;Q14980-4NUMA1<H0YFY6_HUMAN;NUMA1_HUMAN;NUMA1_HUMAN;NUMA1_HUMAN;NUMA1_HUMANNuclear mitotic apparatus protein 1 (Fragment);Nuclear mitotic apparatus protein 1;Isoform 2 of Nuclear mitotic apparatus protein 1;Isoform Numa-m of Nuclear mitotic apparatus protein 1;Isoform Numa-s of Nuclear mitotic apparatus protein 1;establishment of mitotic spindle orientation,nucleus organization,mitotic nuclear division,cell division,meiotic cell cycle,lung epithelial cell differentiation;;;D;structural molecule activity,protein binding,microtubule binding;;;;Golgi membrane,spindle pole,nucleus,nucleoplasm,chromosome,centrosome,spindle,cytosol,spindle microtubule,cell cortex,nuclear matrix,dendrite,neuronal cell body,apical part of cell,mitotic spindle astral microtubule,extracellular exosome,mitotic spindle,mitotic spindle pole;;;>tr|H0YFY6|H0YFY6_HUMAN Nuclear mitotic apparatus protein 1 (Fragment) OS=Homo sapiens GN=NUMA1 PE=1 SV=1;>sp|Q14980|NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2;>sp|Q14980-2|NUMA1_HUMAN Isoform 2 of Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1;>sp|Q14980-3|NUMA1_HUMAN Isoform Numa-m of Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1;>sp|Q14980-4|NUMA1_HUMAN Isoform Numa-s of Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1Q5VW32;Q5VW32-2BROX BROX_HUMANTBRO1 domain-containing protein BROX;Isoform 2 of BRO1 domain-containing protein BROXmembrane,extracellular exosome;>sp|Q5VW32|BROX_HUMAN BRO1 domain-containing protein BROX OS=Homo sapiens GN=BROX PE=1 SV=1;>sp|Q5VW32-2|BROX_HUMAN Isoform 2 of BRO1 domain-containing protein BROX OS=Homo sapiens GN=BROXQ86YL5;Q86YL5-2TDRP TDRP_HUMANRTestis development-related protein;Isoform 2 of Testis development-related proteinspermatogenesis;Cnucleus,cytoplasm,cytosol,intracellular membrane-bounded organelle;>sp|Q86YL5|TDRP_HUMAN Testis development-related protein OS=Homo sapiens GN=TDRP PE=1 SV=< 2;>sp|Q86YL5-2|TDRP_HUMAN Isoform 2 of Testis development-related protein OS=Homo sapiens GN=TDRPQ9HD89RETN RETN_HUMANResistinaging,biological_process,response to mechanical stimulus,positive regulation of collagen metabolic process,positive regulation of smooth muscle cell migration,response to insulin,neutrophil degranulation,fat cell differentiation,positive regulation of smooth muscle cell proliferation,positive regulation of synaptic transmission,negative regulation of feeding behavior,positive regulation of progesterone secretionuextracellular region,extracellular space,nucleus,azurophil granule lumen,specific granule lumen,extracellular exosome@>sp|Q9HD89|RETN_HUMAN Resistin OS=Homo sapiens GN=RETN PE=1 SV=1 A0A075B7D0 IGHV1OR15-1A0A075B7D0_HUMANProtein IGHV1OR15-1 (Fragment)g>tr|A0A075B7D0|A0A075B7D0_HUMAN Protein IGHV1OR15-1 (Fragment) OS=Homo sapiens GN=IGHV1OR15-1 PE=1 SV=1jB4E2Q0;H0Y8X9;H0Y9S7;H0Y9V7;P98194;P98194-2;P98194-3;P98194-4;P98194-5;P98194-6;P98194-7;P98194-8;P98194-9ATP2C1B4E2Q0_HUMAN;H0Y8X9_HUMAN;H0Y9S7_HUMAN;H0Y9V7_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMAN;AT2C1_HUMANCalcium-transporting ATPase;Calcium-transporting ATPase type 2C member 1 (Fragment);Calcium-transporting ATPase type 2C member 1 (Fragment);Calcium-transporting ATPase type 2C member 1 (Fragment);Calcium-transporting ATPase type 2C member 1;Isoform 2 of Calcium-transporting ATPase type 2C member 1;Isoform 3 of Calcium-transporting ATPase type 2C member 1;Isoform 4 of Calcium-transporting ATPase type 2C member 1;Isoform 5 of Calcium-transporting ATPase type 2C member 1;Isoform 6 of Calcium-transporting ATPase type 2C member 1;Isoform 7 of Calcium-transporting ATPase type 2C member 1;Isoform 8 of Calcium-transporting ATPase type 2C member 1;Isoform 9 of Calcium-transporting ATPase type 2C member 1;;;;calcium ion transport,cellular calcium ion homeostasis,signal transduction,epidermis development,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,actin cytoskeleton reorganization,Golgi calcium ion homeostasis,Golgi calcium ion transport,ion transmembrane transport,positive regulation of I-kappaB kinase/NF-kappaB signaling,calcium ion transmembrane transport,Requires Ontology;;;;;;;;i;;;;signal transducer activity,calcium-transporting ATPase activity,ATP binding,metal ion binding;;;;;;;;f;;;;Golgi membrane,Golgi apparatus,trans-Golgi network,membrane,integral component of membrane;;;;;;;;&tr;tr;tr;tr;sp;sp;sp;sp;sp;sp;sp;sp;sp1;1;1;1;1;;;;;;;;1;1;1;1;3;;;;;;;;>tr|B4E2Q0|B4E2Q0_HUMAN Calcium-transporting ATPase OS=Homo sapiens GN=ATP2C1 PE=1 SV=1;>tr|H0Y8X9|H0Y8X9_HUMAN Calcium-transporting ATPase type 2C member 1 (Fragment) OS=Homo sapiens GN=ATP2C1 PE=1 SV=1;>tr|H0Y9S7|H0Y9S7_HUMAN Calcium-transporting ATPase type 2C member 1 (Fragment) OS=Homo sapiens GN=ATP2C1 PE=1 SV=1;>tr|H0Y9V7|H0Y9V7_HUMAN Calcium-transporting ATPase type 2C member 1 (Fragment) OS=Homo sapiens GN=ATP2C1 PE=1 SV=1;>sp|P98194|AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3;>sp|P98194-2|AT2C1_HUMAN Isoform 2 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-3|AT2C1_HUMAN Isoform 3 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-4|AT2C1_HUMAN Isoform 4 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-5|AT2C1_HUMAN Isoform 5 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-6|AT2C1_HUMAN Isoform 6 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-7|AT2C1_HUMAN Isoform 7 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-8|AT2C1_HUMAN Isoform 8 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1;>sp|P98194-9|AT2C1_HUMAN Isoform 9 of Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1!O15439;O15439-2;O15439-3;O15439-4ABCC4 MRP4_HUMANMultidrug resistance-associated protein 4;Isoform 2 of Multidrug resistance-associated protein 4;Isoform 3 of Multidrug resistance-associated protein 4;Isoform 4 of Multidrug resistance-associated protein 40platelet degranulation,biological_process,response to organonitrogen compound,response to organic cyclic compound,prostaglandin secretion,response to drug,positive regulation of smooth muscle cell proliferation,transmembrane transport,oxidation-reduction process,cilium morphogenesis,Requires Ontology;;;ATP binding,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,ATPase activity, coupled to transmembrane movement of substances,ATPase-coupled anion transmembrane transporter activity;;;}plasma membrane,integral component of plasma membrane,membrane,basolateral plasma membrane,platelet dense granule membrane;;;3;;;>sp|O15439|MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3;>sp|O15439-2|MRP4_HUMAN Isoform 2 of Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4;>sp|O15439-3|MRP4_HUMAN Isoform 3 of Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4;>sp|O15439-4|MRP4_HUMAN Isoform 4 of Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4O75368SH3BGRL SH3L1_HUMAN2SH3 domain-binding glutamic acid-rich-like protein*positive regulation of signal transduction+SH3/SH2 adaptor activity,SH3 domain binding;extracellular space,nucleus,cytoplasm,extracellular exosomen>sp|O75368|SH3L1_HUMAN SH3 domain-binding glutamic acid-rich-like protein OS=Homo sapiens GN=SH3BGRL PE=1 SV=1O95980RECK RECK_HUMAN:Reversion-inducing cysteine-rich protein with Kazal motifsblood vessel maturation,C-terminal protein lipidation,embryo implantation,extracellular matrix organization,negative regulation of cell migration,embryonic forelimb morphogenesis,negative regulation of metalloendopeptidase activityendopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity,protein binding,metalloendopeptidase inhibitor activityLextracellular region,plasma membrane,membrane,anchored component of membraner>sp|O95980|RECK_HUMAN Reversion-inducing cysteine-rich protein with Kazal motifs OS=Homo sapiens GN=RECK PE=1 SV=1P08493;P08493-2MGP MGP_HUMAN2Matrix Gla protein;Isoform 2 of Matrix Gla protein[cartilage condensation,ossification,cell differentiation,regulation of bone mineralization;oextracellular matrix structural constituent,calcium ion binding,protein binding,structural constituent of bone;Nproteinaceous extracellular matrix,extracellular matrix,extracellular exosome;>sp|P08493|MGP_HUMAN Matrix Gla protein OS=Homo sapiens GN=MGP PE=1 SV=2;>sp|P08493-2|MGP_HUMAN Isoform 2 of Matrix Gla protein OS=Homo sapiens GN=MGPA0A024R161;P50151;Q9H1X3-3DNAJC25-GNG10;GNG10;DNAJC25(A0A024R161_HUMAN;GBG10_HUMAN;DJC25_HUMANGuanine nucleotide-binding protein subunit gamma;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10;Isoform 3 of DnaJ homolog subfamily C member 25G-protein coupled receptor signaling pathway;signal transduction,G-protein coupled receptor signaling pathway,cellular response to glucagon stimulus;Vsignal transducer activity;GTPase activity,signal transducer activity,protein binding;hheterotrimeric G-protein complex;heterotrimeric G-protein complex,plasma membrane,extracellular exosome;3;1;\>tr|A0A024R161|A0A024R161_HUMAN Guanine nucleotide-binding protein subunit gamma OS=Homo sapiens GN=DNAJC25-GNG10 PE=3 SV=1;>sp|P50151|GBG10_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 OS=Homo sapiens GN=GNG10 PE=1 SV=1;>sp|Q9H1X3-3|DJC25_HUMAN Isoform 3 of DnaJ homolog subfamily C member 25 OS=Homo sapiens GN=DNAJC25P55290;P55290-4;P55290-5CDH13 CAD13_HUMAN=Cadherin-13;Isoform 4 of Cadherin-13;Isoform 5 of Cadherin-13mitotic cell cycle,positive regulation of endothelial cell proliferation,positive regulation of cell-matrix adhesion,sprouting angiogenesis,homophil< ic cell adhesion via plasma membrane adhesion molecules,negative regulation of cell adhesion,Rho protein signal transduction,negative regulation of cell proliferation,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,Rac protein signal transduction,lamellipodium assembly,regulation of endocytosis,positive regulation of cell migration,adherens junction organization,regulation of epidermal growth factor receptor signaling pathway,endothelial cell migration,keratinocyte proliferation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of smooth muscle cell proliferation,positive regulation of calcium-mediated signaling,positive regulation of positive chemotaxis,localization within membrane,low-density lipoprotein particle mediated signaling;;calcium ion binding,low-density lipoprotein particle binding,protein homodimerization activity,cadherin binding,adiponectin binding,lipoprotein particle binding;;extracellular space,cytoplasm,plasma membrane,caveola,focal adhesion,external side of plasma membrane,anchored component of membrane,neuron projection,perinuclear region of cytoplasm,extracellular exosome;;>sp|P55290|CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1;>sp|P55290-4|CAD13_HUMAN Isoform 4 of Cadherin-13 OS=Homo sapiens GN=CDH13;>sp|P55290-5|CAD13_HUMAN Isoform 5 of Cadherin-13 OS=Homo sapiens GN=CDH13P61073;P61073-2CXCR4 CXCR4_HUMANLC-X-C chemokine receptor type 4;Isoform 2 of C-X-C chemokine receptor type 4activation of MAPK activity,response to hypoxia,dendritic cell chemotaxis,apoptotic process,inflammatory response,G-protein coupled receptor signaling pathway,positive regulation of cytosolic calcium ion concentration,response to virus,fusion of virus membrane with host plasma membrane,calcium-mediated signaling,entry into host cell,myelin maintenance,positive regulation of oligodendrocyte differentiation,regulation of chemotaxis,chemokine-mediated signaling pathway,cellular response to cytokine stimulus;virus receptor activity,actin binding,G-protein coupled receptor activity,protein binding,coreceptor activity,C-X-C chemokine receptor activity,cytokine binding,ubiquitin protein ligase binding,myosin light chain binding,ubiquitin binding;cytoplasm,lysosome,early endosome,late endosome,plasma membrane,cell surface,integral component of membrane,cell junction,cell leading edge,cytoplasmic vesicle,extracellular exosome;>sp|P61073|CXCR4_HUMAN C-X-C chemokine receptor type 4 OS=Homo sapiens GN=CXCR4 PE=1 SV=1;>sp|P61073-2|CXCR4_HUMAN Isoform 2 of C-X-C chemokine receptor type 4 OS=Homo sapiens GN=CXCR4Q5D862FLG2 FILA2_HUMAN Filaggrin-26neutrophil degranulation,establishment of skin barrierMstructural molecule activity,calcium ion binding,transition metal ion bindingSextracellular region,nucleus,cytoplasm,extracellular exosome,tertiary granule lumenD>sp|Q5D862|FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1M0QZZ9;M0R2S7;M0R2Y5;Q8WXI7MUC162M0QZZ9_HUMAN;M0R2S7_HUMAN;M0R2Y5_HUMAN;MUC16_HUMANDMucin-16 (Fragment);Mucin-16 (Fragment);Mucin-16 (Fragment);Mucin-16Y;;;stimulatory C-type lectin receptor signaling pathway,cell adhesion,O-glycan processing;;;extracellular space,Golgi lumen,plasma membrane,integral component of membrane,extrinsic component of membrane,vesicle,extracellular exosome1;1;1;3/>tr|M0QZZ9|M0QZZ9_HUMAN Mucin-16 (Fragment) OS=Homo sapiens GN=MUC16 PE=1 SV=1;>tr|M0R2S7|M0R2S7_HUMAN Mucin-16 (Fragment) OS=Homo sapiens GN=MUC16 PE=1 SV=1;>tr|M0R2Y5|M0R2Y5_HUMAN Mucin-16 (Fragment) OS=Homo sapiens GN=MUC16 PE=1 SV=1;>sp|Q8WXI7|MUC16_HUMAN Mucin-16 OS=Homo sapiens GN=MUC16 PE=1 SV=3 A0A0C4DH70IGHJ2A0A0C4DH70_HUMANProtein IGHJ2 (Fragment)[>tr|A0A0C4DH70|A0A0C4DH70_HUMAN Protein IGHJ2 (Fragment) OS=Homo sapiens GN=IGHJ2 PE=4 SV=1 A0A0G2JPR0A0A0G2JPR0_HUMANP>tr|A0A0G2JPR0|A0A0G2JPR0_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1aF8VXH9;F8VZX2;F8W0G4;H3BRU6;Q15366;Q15366-2;Q15366-3;Q15366-4;Q15366-5;Q15366-6;Q15366-7;Q15366-8PCBP2F8VXH9_HUMAN;F8VZX2_HUMAN;F8W0G4_HUMAN;H3BRU6_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMANPoly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2;Poly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2;Isoform 2 of Poly(rC)-binding protein 2;Isoform 3 of Poly(rC)-binding protein 2;Isoform 4 of Poly(rC)-binding protein 2;Isoform 5 of Poly(rC)-binding protein 2;Isoform 6 of Poly(rC)-binding protein 2;Isoform 7 of Poly(rC)-binding protein 2;Isoform 8 of Poly(rC)-binding protein 2s;;;;mRNA splicing, via spliceosome,gene expression,mRNA metabolic process,negative regulation of type I interferon production,viral RNA genome replication,proteasome-mediated ubiquitin-dependent protein catabolic process,innate immune response,negative regulation of defense response to virus,defense response to virus,IRES-dependent viral translational initiation;;;;;;;y;;;;RNA binding,protein binding,enzyme binding,ubiquitin protein ligase binding,C-rich single-stranded DNA binding;;;;;;;;;;;nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular exosome;;;;;;;#tr;tr;tr;tr;sp;sp;sp;sp;sp;sp;sp;sp1;1;1;1;1;;;;;;;C>tr|F8VXH9|F8VXH9_HUMAN Poly(rC)-binding protein 2 (Fragment) OS=Homo sapiens GN=PCBP2 PE=1 SV=1;>tr|F8VZX2|F8VZX2_HUMAN Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2 PE=1 SV=1;>tr|F8W0G4|F8W0G4_HUMAN Poly(rC)-binding protein 2 (Fragment) OS=Homo sapiens GN=PCBP2 PE=1 SV=1;>tr|H3BRU6|H3BRU6_HUMAN Poly(rC)-binding protein 2 (Fragment) OS=Homo sapiens GN=PCBP2 PE=1 SV=1;>sp|Q15366|PCBP2_HUMAN Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2 PE=1 SV=1;>sp|Q15366-2|PCBP2_HUMAN Isoform 2 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2;>sp|Q15366-3|PCBP2_HUMAN Isoform 3 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2;>sp|Q15366-4|PCBP2_HUMAN Isoform 4 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2;>sp|Q15366-5|PCBP2_HUMAN Isoform 5 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2;>sp|Q15366-6|PCBP2_HUMAN Isoform 6 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2;>sp|Q15366-7|PCBP2_HUMAN Isoform 7 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2;>sp|Q15366-8|PCBP2_HUMAN Isoform 8 of Poly(rC)-binding protein 2 OS=Homo sapiens GN=PCBP2UH0Y704;O15231;O15231-2;O15231-3;O15231-4;O15231-5;O15231-6;O15231-7;O15231-8;O15231-9ZNF185xH0Y704_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMAN;ZN185_HUMANbZinc finger protein 185 (Fragment);Zinc finger protein 185;Isoform 2 of Zinc finger protein 185;Isoform 3 of Zinc finger protein 185;Isoform 4 of Zinc finger protein 185;Isoform 5 of Zinc finger protein 185;Isoform 6 of Zinc finger protein 185;Isoform 7 of Zinc finger protein 185;Isoform 8 of Zinc finger protein 185;Isoform 9 of Zinc finger protein 185 ;;;;;;;;;;zinc ion binding;;;;;;;;.;cytoplasm,cytoskeleton,focal adhesion;;;;;;;; 2;3;;;;;;;;q>tr|H0Y704|H0Y704_HUMAN Zinc finger protein 185 (Fragment) OS=Homo sapiens GN=ZNF185 PE=1 SV=2;>sp|O15231|ZN185_HUMAN Zinc finger protein 185 OS=Homo sapiens GN=ZNF185 PE=1 SV=3;>sp|O15231-2|ZN185_HUMAN Isoform 2 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-3|ZN185_HUMAN Isoform 3 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-4|ZN185_HUMAN Isoform 4 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-5|ZN185_HUMAN Isoform 5 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-6|ZN185_HUMAN Isoform 6 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-7|ZN185_HUMAN Isoform 7 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-8|ZN185_HUMAN Isoform 8 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185;>sp|O15231-9|ZN185_HUMAN Isoform 9 of Zinc finger protein 185 OS=Homo sapiens GN=ZNF185J3QQQ0;Q9Y5X9;Q9Y5X9-2LIPG"J3QQQ0_HUMAN;LIPE_HUMAN;LIPE_HUMANEEndothelial lipase;Endothelial lipase;Isoform 2 of Endothelial lipase;lipid metabolic process,respons< e to nutrient,cell proliferation,phospholipid catabolic process,positive regulation of high-density lipoprotein particle clearance,positive regulation of cholesterol transport,high-density lipoprotein particle remodeling,cholesterol homeostasis,reverse cholesterol transport,lipid digestion,regulation of lipoprotein metabolic process,phospholipid homeostasis;q;lipoprotein lipase activity,phospholipase activity,heparin binding,phosphatidylcholine 1-acylhydrolase activity;V;extracellular region,extracellular space,early endosome,Golgi apparatus,cell surface;>tr|J3QQQ0|J3QQQ0_HUMAN Endothelial lipase OS=Homo sapiens GN=LIPG PE=1 SV=1;>sp|Q9Y5X9|LIPE_HUMAN Endothelial lipase OS=Homo sapiens GN=LIPG PE=1 SV=1;>sp|Q9Y5X9-2|LIPE_HUMAN Isoform 2 of Endothelial lipase OS=Homo sapiens GN=LIPGP12277CKB KCRB_HUMANCreatine kinase B-typecreatine metabolic process,phosphorylation,cerebellum development,substantia nigra development,cellular chloride ion homeostasisUcreatine kinase activity,protein binding,ATP binding,ubiquitin protein ligase bindingqextracellular space,nucleus,mitochondrion,cytosol,dendrite,neuronal cell body,myelin sheath,extracellular exosomeM>sp|P12277|KCRB_HUMAN Creatine kinase B-type OS=Homo sapiens GN=CKB PE=1 SV=10A0A087WTP2;A0A087WVN4;A0A087X1D8;P14324;P14324-2FDPSHA0A087WTP2_HUMAN;A0A087WVN4_HUMAN;A0A087X1D8_HUMAN;FPPS_HUMAN;FPPS_HUMANFarnesyl pyrophosphate synthase;Farnesyl pyrophosphate synthase (Fragment);Farnesyl pyrophosphate synthase (Fragment);Farnesyl pyrophosphate synthase;Isoform 2 of Farnesyl pyrophosphate synthase;;;cholesterol biosynthetic process,viral process,geranyl diphosphate biosynthetic process,farnesyl diphosphate biosynthetic process;i;;;RNA binding,dimethylallyltranstransferase activity,geranyltranstransferase activity,metal ion binding;!;;;nucleoplasm,cytoplasm,cytosol;>tr|A0A087WTP2|A0A087WTP2_HUMAN Farnesyl pyrophosphate synthase OS=Homo sapiens GN=FDPS PE=1 SV=1;>tr|A0A087WVN4|A0A087WVN4_HUMAN Farnesyl pyrophosphate synthase (Fragment) OS=Homo sapiens GN=FDPS PE=1 SV=1;>tr|A0A087X1D8|A0A087X1D8_HUMAN Farnesyl pyrophosphate synthase (Fragment) OS=Homo sapiens GN=FDPS PE=1 SV=1;>sp|P14324|FPPS_HUMAN Farnesyl pyrophosphate synthase OS=Homo sapiens GN=FDPS PE=1 SV=4;>sp|P14324-2|FPPS_HUMAN Isoform 2 of Farnesyl pyrophosphate synthase OS=Homo sapiens GN=FDPSP28066PSMA5 PSA5_HUMANProteasome subunit alpha type-5proteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumenX>sp|P28066|PSA5_HUMAN Proteasome subunit alpha type-5 OS=Homo sapiens GN=PSMA5 PE=1 SV=3 K7ERT7;Q99536VAT1K7ERT7_HUMAN;VAT1_HUMANjSynaptic vesicle membrane protein VAT-1 homolog (Fragment);Synaptic vesicle membrane protein VAT-1 homologa;negative regulation of mitochondrial fusion,neutrophil degranulation,oxidation-reduction process);zinc ion binding,oxidoreductase activity;extracellular region,mitochondrial outer membrane,integral component of membrane,azurophil granule lumen,extracellular exosome>tr|K7ERT7|K7ERT7_HUMAN Synaptic vesicle membrane protein VAT-1 homolog (Fragment) OS=Homo sapiens GN=VAT1 PE=1 SV=1;>sp|Q99536|VAT1_HUMAN Synaptic vesicle membrane protein VAT-1 homolog OS=Homo sapiens GN=VAT1 PE=1 SV=2Q9BVC6TMEM109 TM109_HUMANTransmembrane protein 109ion transport,regulation of ion transmembrane transport,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,negative regulation of cell death,cellular response to gamma radiation5molecular_function,voltage-gated ion channel activityknuclear outer membrane,integral component of membrane,sarcoplasmic reticulum membrane,extracellular exosomeU>sp|Q9BVC6|TM109_HUMAN Transmembrane protein 109 OS=Homo sapiens GN=TMEM109 PE=1 SV=1A0A087WSZ0;A0A0G2JQJ0IGKV1D-8!A0A087WSZ0_HUMAN;A0A0G2JQJ0_HUMANProtein IGKV1D-8 (Fragment)Cadaptive immune response,immunoglobulin production,immune response;$extracellular space,plasma membrane;6;4>tr|A0A087WSZ0|A0A087WSZ0_HUMAN Protein IGKV1D-8 (Fragment) OS=Homo sapiens GN=IGKV1D-8 PE=1 SV=6;>tr|A0A0G2JQJ0|A0A0G2JQJ0_HUMAN Protein IGKV1D-8 (Fragment) OS=Homo sapiens GN=IGKV1D-8 PE=1 SV=4:A0A0A0MSJ3;E9PFK9;Q3HKR1;Q9UJ41;Q9UJ41-2;Q9UJ41-3;Q9UJ41-4RABGEF1ZA0A0A0MSJ3_HUMAN;E9PFK9_HUMAN;Q3HKR1_HUMAN;RABX5_HUMAN;RABX5_HUMAN;RABX5_HUMAN;RABX5_HUMANRAB guanine nucleotide exchange factor (GEF) 1, isoform CRA_c;Rab5 GDP/GTP exchange factor;RAP1 short isoform;Rab5 GDP/GTP exchange factor;Isoform 2 of Rab5 GDP/GTP exchange factor;Isoform 3 of Rab5 GDP/GTP exchange factor;Isoform 4 of Rab5 GDP/GTP exchange factorB;;;negative regulation of protein phosphorylation,negative regulation of leukocyte migration,protein targeting to membrane,endocytosis,protein ubiquitination,negative regulation of mast cell degranulation,positive regulation of GTPase activity,negative regulation of Ras protein signal transduction,negative regulation of receptor-mediated endocytosis,negative regulation of inflammatory response,regulation of Fc receptor mediated stimulatory signaling pathway,membrane organization,negative regulation of interleukin-6 secretion,negative regulation of Kit signaling pathway;;;;;;DNA binding,protein binding,zinc ion binding,Rab guanyl-nucleotide exchange factor activity,Rab GTPase binding,ubiquitin protein ligase activity;;;Q;;;nucleolus,early endosome,cytosol,early endosome membrane,recycling endosome;;;>tr|A0A0A0MSJ3|A0A0A0MSJ3_HUMAN RAB guanine nucleotide exchange factor (GEF) 1, isoform CRA_c OS=Homo sapiens GN=RABGEF1 PE=1 SV=1;>tr|E9PFK9|E9PFK9_HUMAN Rab5 GDP/GTP exchange factor OS=Homo sapiens GN=RABGEF1 PE=1 SV=1;>tr|Q3HKR1|Q3HKR1_HUMAN RAP1 short isoform OS=Homo sapiens GN=RABGEF1 PE=1 SV=1;>sp|Q9UJ41|RABX5_HUMAN Rab5 GDP/GTP exchange factor OS=Homo sapiens GN=RABGEF1 PE=1 SV=2;>sp|Q9UJ41-2|RABX5_HUMAN Isoform 2 of Rab5 GDP/GTP exchange factor OS=Homo sapiens GN=RABGEF1;>sp|Q9UJ41-3|RABX5_HUMAN Isoform 3 of Rab5 GDP/GTP exchange factor OS=Homo sapiens GN=RABGEF1;>sp|Q9UJ41-4|RABX5_HUMAN Isoform 4 of Rab5 GDP/GTP exchange factor OS=Homo sapiens GN=RABGEF1'A0A140T8Y6;A0A140T920;A0A140T9R5;Q99466NOTCH4>A0A140T8Y6_HUMAN;A0A140T920_HUMAN;A0A140T9R5_HUMAN;NOTC4_HUMAN(Neurogenic locus notch homolog protein 4 ;;;patterning of blood vessels,cell fate determination,morphogenesis of a branching structure,endothelial cell morphogenesis,transcription initiation from RNA polymerase II promoter,Notch signaling pathway,Notch receptor processing,positive regulation of transcription of Notch receptor target,embryo development,hemopoiesis,cell differentiation,mammary gland development,negative regulation of cell differentiation,negative regulation of endothelial cell differentiation,positive regulation of transcription, DNA-templated\;;;receptor activity,calcium ion binding,protein binding,protein heterodimerization activity;;;Golgi membrane,extracellular region,nucleus,nucleoplasm,endoplasmic reticulum membrane,cytosol,plasma membrane,integral component of plasma membrane,cell surface>tr|A0A140T8Y6|A0A140T8Y6_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=1;>tr|A0A140T920|A0A140T920_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=1;>tr|A0A140T9R5|A0A140T9R5_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=1;>sp|Q99466|NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2=A6PVN5;B7ZBQ0;F6WIT2;Q15257;Q15257-2;Q15257-3;Q15257-4;Q68CR89PTPA;PTPA;PTPA;PPP2R4;PPP2R4;PPP2R4;PPP2R4;DKFZp781M17165_A6PVN5_HUMAN;B7ZBQ0_HUMAN;F6WIT2_HUMAN;PTPA_HUMAN;PTPA_HUMAN;PTPA_HUMAN;PTPA_HUMAN;Q68CR8_HUMANSerine/threonine-protein phosphatase 2A activator;Serine/threonine-protein phosphatase 2A activator;Serine/threonine-protein phosphatase 2A activator;Serine/threonine-protein phosphatase 2A activator;Isoform 1 of Serine/threonine-protein phosphatase 2A activator;Isoform 3 of Serine/threonine-protein phosphatase 2A activator;Isoform 4 of Serine/threoni< ne-protein phosphatase 2A activator;Serine/threonine-protein phosphatase 2A activator;;;protein peptidyl-prolyl isomerization,mitotic spindle organization in nucleus,negative regulation of phosphoprotein phosphatase activity,positive regulation of phosphoprotein phosphatase activity,positive regulation of protein dephosphorylation,negative regulation of protein dephosphorylation,positive regulation of apoptotic process,regulation of phosphoprotein phosphatase activity;;;;,;;;peptidyl-prolyl cis-trans isomerase activity,receptor binding,protein binding,ATP binding,protein tyrosine phosphatase activator activity,protein phosphatase regulator activity,protein homodimerization activity,protein heterodimerization activity,protein phosphatase 2A binding,ATPase activity;;;;v;;;protein phosphatase type 2A complex,nucleus,nucleoplasm,cytoplasm,calcium channel complex,extracellular exosome;;;; 1;1;1;1;;;;1 1;1;1;3;;;;1x>tr|A6PVN5|A6PVN5_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PTPA PE=1 SV=1;>tr|B7ZBQ0|B7ZBQ0_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PTPA PE=1 SV=1;>tr|F6WIT2|F6WIT2_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PTPA PE=1 SV=1;>sp|Q15257|PTPA_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4 PE=1 SV=3;>sp|Q15257-2|PTPA_HUMAN Isoform 1 of Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4;>sp|Q15257-3|PTPA_HUMAN Isoform 3 of Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4;>sp|Q15257-4|PTPA_HUMAN Isoform 4 of Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4;>tr|Q68CR8|Q68CR8_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=DKFZp781M17165 PE=1 SV=1D6REL8 D6REL8_HUMANN>tr|D6REL8|D6REL8_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=1H0YKU1;H0YNJ8;Q9NYL9TMOD3%H0YKU1_HUMAN;H0YNJ8_HUMAN;TMOD3_HUMAN7Tropomodulin-3 (Fragment);Tropomodulin-3;Tropomodulin-3;;actin cytoskeleton organization,erythrocyte development,pointed-end actin filament capping,cell-cell adhesion,positive regulation of mitotic cell cycle phase transitionS;;actin binding,tropomyosin binding,cadherin binding involved in cell-cell adhesion;;;striated muscle thin filament,cell-cell adherens junction>tr|H0YKU1|H0YKU1_HUMAN Tropomodulin-3 (Fragment) OS=Homo sapiens GN=TMOD3 PE=1 SV=1;>tr|H0YNJ8|H0YNJ8_HUMAN Tropomodulin-3 OS=Homo sapiens GN=TMOD3 PE=1 SV=1;>sp|Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens GN=TMOD3 PE=1 SV=1M0QXM4;Q15758;Q15758-2;Q15758-3SLC1A5-M0QXM4_HUMAN;AAAT_HUMAN;AAAT_HUMAN;AAAT_HUMANAmino acid transporter;Neutral amino acid transporter B(0);Isoform 2 of Neutral amino acid transporter B(0);Isoform 3 of Neutral amino acid transporter B(0);amino acid transmembrane transport,extracellular amino acid transport,amino acid transport,glutamine transport,neutral amino acid transport,L-serine transport,viral entry into host cell;;;virus receptor activity,receptor activity,protein binding,amino acid transmembrane transporter activity,neutral amino acid transmembrane transporter activity,L-glutamine transmembrane transporter activity,L-serine transmembrane transporter activity,symporter activity;;b;plasma membrane,integral component of plasma membrane,membrane,melanosome,extracellular exosome;;v>tr|M0QXM4|M0QXM4_HUMAN Amino acid transporter OS=Homo sapiens GN=SLC1A5 PE=1 SV=1;>sp|Q15758|AAAT_HUMAN Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5 PE=1 SV=2;>sp|Q15758-2|AAAT_HUMAN Isoform 2 of Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5;>sp|Q15758-3|AAAT_HUMAN Isoform 3 of Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5P49006MARCKSL1 MRP_HUMANMARCKS-related protein)positive regulation of cell proliferation0actin binding,protein binding,calmodulin binding/cytoplasm,plasma membrane,extracellular exosomeQ>sp|P49006|MRP_HUMAN MARCKS-related protein OS=Homo sapiens GN=MARCKSL1 PE=1 SV=2Q07108CD69 CD69_HUMANEarly activation antigen CD69-signal transduction,cellular response to drugbtransmembrane signaling receptor activity,calcium ion binding,protein binding,carbohydrate bindingFintegral component of plasma membrane,external side of plasma membraneU>sp|Q07108|CD69_HUMAN Early activation antigen CD69 OS=Homo sapiens GN=CD69 PE=1 SV=1 A0A087WWT3A0A087WWT3_HUMANN>tr|A0A087WWT3|A0A087WWT3_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=1>A0A0A0MSK3;A0A0C4DH47;P24557;P24557-2;P24557-3;P24557-4;Q53F23TBXAS1ZA0A0A0MSK3_HUMAN;A0A0C4DH47_HUMAN;THAS_HUMAN;THAS_HUMAN;THAS_HUMAN;THAS_HUMAN;Q53F23_HUMANHCG14925, isoform CRA_b;Thromboxane-A synthase;Thromboxane-A synthase;Isoform 2 of Thromboxane-A synthase;Isoform 3 of Thromboxane-A synthase;Isoform 4 of Thromboxane-A synthase;HCG14925, isoform CRA_a (Fragment)T;;icosanoid metabolic process,cyclooxygenase pathway,oxidation-reduction process;;;;;;monooxygenase activity,thromboxane-A synthase activity,iron ion binding,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,heme binding,12-hydroxyheptadecatrienoic acid synthase activity;;;;C;;endoplasmic reticulum membrane,integral component of membrane;;;;tr;tr;sp;sp;sp;sp;tr 1;1;1;;;;1 1;1;3;;;;1h>tr|A0A0A0MSK3|A0A0A0MSK3_HUMAN HCG14925, isoform CRA_b OS=Homo sapiens GN=TBXAS1 PE=1 SV=1;>tr|A0A0C4DH47|A0A0C4DH47_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=1;>sp|P24557|THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3;>sp|P24557-2|THAS_HUMAN Isoform 2 of Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1;>sp|P24557-3|THAS_HUMAN Isoform 3 of Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1;>sp|P24557-4|THAS_HUMAN Isoform 4 of Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1;>tr|Q53F23|Q53F23_HUMAN HCG14925, isoform CRA_a (Fragment) OS=Homo sapiens GN=TBXAS1 PE=1 SV=1C9JEE0 C9JEE0_HUMAN3Immunoglobulin lambda-like polypeptide 1 (Fragment)n>tr|C9JEE0|C9JEE0_HUMAN Immunoglobulin lambda-like polypeptide 1 (Fragment) OS=Homo sapiens GN=IGLL1 PE=1 SV=1F6TLX2;I3L1I0;Q9HC38;Q9HC38-2GLOD41F6TLX2_HUMAN;I3L1I0_HUMAN;GLOD4_HUMAN;GLOD4_HUMANGlyoxalase domain-containing protein 4;Glyoxalase domain-containing protein 4 (Fragment);Glyoxalase domain-containing protein 4;Isoform 2 of Glyoxalase domain-containing protein 4;;cadherin binding;&;;mitochondrion,extracellular exosome;>tr|F6TLX2|F6TLX2_HUMAN Glyoxalase domain-containing protein 4 OS=Homo sapiens GN=GLOD4 PE=1 SV=1;>tr|I3L1I0|I3L1I0_HUMAN Glyoxalase domain-containing protein 4 (Fragment) OS=Homo sapiens GN=GLOD4 PE=1 SV=1;>sp|Q9HC38|GLOD4_HUMAN Glyoxalase domain-containing protein 4 OS=Homo sapiens GN=GLOD4 PE=1 SV=1;>sp|Q9HC38-2|GLOD4_HUMAN Isoform 2 of Glyoxalase domain-containing protein 4 OS=Homo sapiens GN=GLOD4H7C013 H7C013_HUMANSerum albumin (Fragment)Q>tr|H7C013|H7C013_HUMAN Serum albumin (Fragment) OS=Homo sapiens GN=ALB PE=1 SV=1P05198EIF2S1 IF2A_HUMAN4Eukaryotic translation initiation factor 2 subunit 1'translational initiation,aging,negative regulation of translational initiation in response to stress,cellular response to amino acid starvation,cellular response to heat,cellular response to UV,response to endoplasmic reticulum stress,PERK-mediated unfolded protein response,protein autophosphorylation,transmembrane transport,positive regulation of neuron death,negative regulation of guanyl-nucleotide exchange factor activity,response to manganese-induced endoplasmic reticulum stress,positive regulation of type B pancreatic cell apoptotic processSRNA binding,translation initiation factor activity,protein binding,ribosome binding8nucleus,cytosol,ribosome,polysome,eukaryotic translation initiation factor 2 complex,cytoplasmic stress granule,membrane,eukaryotic 48S preinitiation complex,multi-eIF complex,translation initiation ternary complex,extracellular exosome,glial limiting end-foot,eukaryotic translation initiation factor 2B complexn>sp|P05198|IF2A_HUMAN Eukaryotic translation initiation factor 2 subunit 1 OS=Ho< mo sapiens GN=EIF2S1 PE=1 SV=3P18065IGFBP2 IBP2_HUMAN,Insulin-like growth factor-binding protein 2regulation of cell growth,signal transduction,female pregnancy,aging,response to nutrient,response to mechanical stimulus,response to lithium ion,response to estradiol,response to retinoic acid,cellular response to hormone stimulus,positive regulation of activated T cell proliferation,response to drug,regulation of insulin-like growth factor receptor signaling pathway,response to estrogen,cellular protein metabolic process,response to glucocorticoid,negative regulation of canonical Wnt signaling pathwaykreceptor binding,protein binding,insulin-like growth factor I binding,insulin-like growth factor II bindingiextracellular region,extracellular space,apical plasma membrane,cytoplasmic vesicle,extracellular exosomef>sp|P18065|IBP2_HUMAN Insulin-like growth factor-binding protein 2 OS=Homo sapiens GN=IGFBP2 PE=1 SV=2Q6ZUX7LHFPL2 LHPL2_HUMAN*Lipoma HMGIC fusion partner-like 2 protein)platelet degranulation,biological_processacellular_component,plasma membrane,integral component of membrane,platelet alpha granule membranee>sp|Q6ZUX7|LHPL2_HUMAN Lipoma HMGIC fusion partner-like 2 protein OS=Homo sapiens GN=LHFPL2 PE=2 SV=2Q96IJ6;Q96IJ6-2GMPPA GMPPA_HUMANdMannose-1-phosphate guanyltransferase alpha;Isoform 2 of Mannose-1-phosphate guanyltransferase alphabiosynthetic process;0protein binding,nucleotidyltransferase activity; cytoplasm,extracellular exosome;>sp|Q96IJ6|GMPPA_HUMAN Mannose-1-phosphate guanyltransferase alpha OS=Homo sapiens GN=GMPPA PE=1 SV=1;>sp|Q96IJ6-2|GMPPA_HUMAN Isoform 2 of Mannose-1-phosphate guanyltransferase alpha OS=Homo sapiens GN=GMPPAQ96QR1SCGB3A1 SG3A1_HUMAN Secretoglobin family 3A member 1jnegative regulation of cell growth,regulation of cell proliferation,positive regulation of myoblast fusioncytokine activity\>sp|Q96QR1|SG3A1_HUMAN Secretoglobin family 3A member 1 OS=Homo sapiens GN=SCGB3A1 PE=1 SV=2!A0A0A0MRA8;A8K968;Q9Y2J2;Q9Y2J2-2EPB41L35A0A0A0MRA8_HUMAN;A8K968_HUMAN;E41L3_HUMAN;E41L3_HUMANlBand 4.1-like protein 3;Band 4.1-like protein 3;Band 4.1-like protein 3;Isoform 2 of Band 4.1-like protein 3;;regulation of cell growth,protein localization to paranode region of axon,apoptotic process,cytoskeletal anchoring at plasma membrane,biological_process,regulation of cell shape,cortical cytoskeleton organization,cortical actin cytoskeleton organization,paranodal junction assembly,actomyosin structure organization,myelin maintenance,neuron projection morphogenesis,protein localization to juxtaparanode region of axon,protein localization to plasma membrane;G;;actin binding,structural constituent of cytoskeleton,protein binding;;;cytosol,cytoskeleton,plasma membrane,cell-cell junction,postsynaptic density,extrinsic component of membrane,paranode region of axon,juxtaparanode region of axon,axolemma;^>tr|A0A0A0MRA8|A0A0A0MRA8_HUMAN Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 PE=1 SV=1;>tr|A8K968|A8K968_HUMAN Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 PE=1 SV=1;>sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 PE=1 SV=2;>sp|Q9Y2J2-2|E41L3_HUMAN Isoform 2 of Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 A0A0B4J2B8 IGHV1OR15-9A0A0B4J2B8_HUMANProtein IGHV1OR15-9 (Fragment)g>tr|A0A0B4J2B8|A0A0B4J2B8_HUMAN Protein IGHV1OR15-9 (Fragment) OS=Homo sapiens GN=IGHV1OR15-9 PE=4 SV=1-A6NJA2;J3KS55;J3QQT6;P54578;P54578-2;P54578-3USP14JA6NJA2_HUMAN;J3KS55_HUMAN;J3QQT6_HUMAN;UBP14_HUMAN;UBP14_HUMAN;UBP14_HUMAN%Ubiquitin carboxyl-terminal hydrolase 14;Ubiquitin carboxyl-terminal hydrolase 14 (Fragment);Ubiquitin carboxyl-terminal hydrolase 14 (Fragment);Ubiquitin carboxyl-terminal hydrolase 14;Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 14;Isoform 3 of Ubiquitin carboxyl-terminal hydrolase 148;;;ubiquitin-dependent protein catabolic process,chemical synaptic transmission,negative regulation of endopeptidase activity,protein deubiquitination,regulation of chemotaxis,regulation of proteasomal protein catabolic process,negative regulation of ER-associated ubiquitin-dependent protein catabolic process;;;;;cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,endopeptidase inhibitor activity,protein binding,tRNA guanylyltransferase activity,proteasome binding;;n;;;proteasome complex,cytosol,plasma membrane,cell surface,cytoplasmic vesicle,synapse,extracellular exosome;; 2;1;1;3;;t>tr|A6NJA2|A6NJA2_HUMAN Ubiquitin carboxyl-terminal hydrolase 14 OS=Homo sapiens GN=USP14 PE=1 SV=2;>tr|J3KS55|J3KS55_HUMAN Ubiquitin carboxyl-terminal hydrolase 14 (Fragment) OS=Homo sapiens GN=USP14 PE=1 SV=1;>tr|J3QQT6|J3QQT6_HUMAN Ubiquitin carboxyl-terminal hydrolase 14 (Fragment) OS=Homo sapiens GN=USP14 PE=1 SV=1;>sp|P54578|UBP14_HUMAN Ubiquitin carboxyl-terminal hydrolase 14 OS=Homo sapiens GN=USP14 PE=1 SV=3;>sp|P54578-2|UBP14_HUMAN Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 14 OS=Homo sapiens GN=USP14;>sp|P54578-3|UBP14_HUMAN Isoform 3 of Ubiquitin carboxyl-terminal hydrolase 14 OS=Homo sapiens GN=USP14B1AKP1;B1AKP2;O60636;O60636-2TSPAN2/B1AKP1_HUMAN;B1AKP2_HUMAN;TSN2_HUMAN;TSN2_HUMANKTetraspanin;Tetraspanin (Fragment);Tetraspanin-2;Isoform 2 of Tetraspanin-2;;inflammatory response,cell surface receptor signaling pathway,brain development,astrocyte development,microglia development,myelination,oligodendrocyte differentiation,axon development;U;;integral component of plasma membrane,integral component of membrane,myelin sheath;/>tr|B1AKP1|B1AKP1_HUMAN Tetraspanin OS=Homo sapiens GN=TSPAN2 PE=1 SV=1;>tr|B1AKP2|B1AKP2_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=TSPAN2 PE=1 SV=1;>sp|O60636|TSN2_HUMAN Tetraspanin-2 OS=Homo sapiens GN=TSPAN2 PE=1 SV=2;>sp|O60636-2|TSN2_HUMAN Isoform 2 of Tetraspanin-2 OS=Homo sapiens GN=TSPAN2+C9JGV6;C9JJ34;C9JXG8;F6WQW2;P43487;P43487-2RANBP1IC9JGV6_HUMAN;C9JJ34_HUMAN;C9JXG8_HUMAN;F6WQW2_HUMAN;RANG_HUMAN;RANG_HUMANRan-specific GTPase-activating protein (Fragment);Ran-specific GTPase-activating protein (Fragment);Ran-specific GTPase-activating protein (Fragment);Ran-specific GTPase-activating protein;Ran-specific GTPase-activating protein;Isoform 2 of Ran-specific GTPase-activating protein;;;;G1/S transition of mitotic cell cycle,RNA export from nucleus,ubiquitin-dependent protein catabolic process,protein import into nucleus,spindle organization,signal transduction,viral process,positive regulation of GTPase activity,positive regulation of mitotic centrosome separation;v;;;;GDP-dissociation inhibitor activity,protein binding,Ran GTPase binding,cadherin binding,GTPase activator activity;:;;;;nucleus,nuclear envelope,cytoplasm,centrosome,cytosol; 8;1;2;1;1;s>tr|C9JGV6|C9JGV6_HUMAN Ran-specific GTPase-activating protein (Fragment) OS=Homo sapiens GN=RANBP1 PE=1 SV=8;>tr|C9JJ34|C9JJ34_HUMAN Ran-specific GTPase-activating protein (Fragment) OS=Homo sapiens GN=RANBP1 PE=1 SV=1;>tr|C9JXG8|C9JXG8_HUMAN Ran-specific GTPase-activating protein (Fragment) OS=Homo sapiens GN=RANBP1 PE=1 SV=2;>tr|F6WQW2|F6WQW2_HUMAN Ran-specific GTPase-activating protein OS=Homo sapiens GN=RANBP1 PE=1 SV=1;>sp|P43487|RANG_HUMAN Ran-specific GTPase-activating protein OS=Homo sapiens GN=RANBP1 PE=1 SV=1;>sp|P43487-2|RANG_HUMAN Isoform 2 of Ran-specific GTPase-activating protein OS=Homo sapiens GN=RANBP1H0YLX2;Q2KHR2;Q2KHR2-2RFX7"H0YLX2_HUMAN;RFX7_HUMAN;RFX7_HUMANWDNA-binding protein RFX7;DNA-binding protein RFX7;Isoform 2 of DNA-binding protein RFX7=;regulation of transcription from RNA polymerase II promoter;;RNA polymerase II core promoter proximal region sequence-specific DNA binding,transcription factor activity, sequence-specific DNA binding; ;nucleus;>tr|H0YLX2|H0YLX2_HUMAN DNA-binding protein RFX7 OS=Homo sapiens GN=RFX7 PE=1 SV=2;>sp|Q2KHR2|RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens GN=RFX7 PE=1 SV=1;>sp|Q2KHR2-2|RFX7_HUMAN Isoform 2 of DNA-binding protein RFX7 OS=Homo sapiens GN=RFX7P80723BASP1 BASP1_HUMANBrain acid soluble protein 1~thorax and anterior abdomen determination,gonad development< ,substantia nigra development,negative regulation of transcription, DNA-templated,mesenchymal to epithelial transition,positive regulation of heart growth,diaphragm development,metanephric mesenchyme development,glomerular visceral epithelial cell differentiation,positive regulation of metanephric ureteric bud development~transcription corepressor activity,protein binding,protein domain specific binding,transcription regulatory region DNA bindingnucleus,cytoplasm,cytoskeleton,plasma membrane,nuclear speck,cell junction,growth cone,vesicle,extracellular exosome,COP9 signalosomeV>sp|P80723|BASP1_HUMAN Brain acid soluble protein 1 OS=Homo sapiens GN=BASP1 PE=1 SV=2 H3BSW0;Q8N9N7LRRC57H3BSW0_HUMAN;LRC57_HUMAN^Leucine-rich repeat-containing protein 57 (Fragment);Leucine-rich repeat-containing protein 57;membrane,extracellular exosome>tr|H3BSW0|H3BSW0_HUMAN Leucine-rich repeat-containing protein 57 (Fragment) OS=Homo sapiens GN=LRRC57 PE=1 SV=1;>sp|Q8N9N7|LRC57_HUMAN Leucine-rich repeat-containing protein 57 OS=Homo sapiens GN=LRRC57 PE=1 SV=1$M0QYE0;M0R0I3;Q99961;Q99961-3;Q99962"SH3GL1;SH3GL1;SH3GL1;SH3GL1;SH3GL2=M0QYE0_HUMAN;M0R0I3_HUMAN;SH3G1_HUMAN;SH3G1_HUMAN;SH3G2_HUMANhEndophilin-A2 (Fragment);Endophilin-A2 (Fragment);Endophilin-A2;Isoform 3 of Endophilin-A2;Endophilin-A1 ;;signal transduction,central nervous system development,synaptic vesicle uncoating;;regulation of receptor internalization,microtubule-based movement,signal transduction,central nervous system development,synaptic vesicle uncoating,antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection development,negative regulation of epidermal growth factor receptor signaling pathway,membrane organization,dendrite extension,cellular response to brain-derived neurotrophic factor stimulus;;protein binding,lipid binding,phosphatase binding,identical protein binding,cadherin binding,GTPase binding;;protein binding,lipid binding,identical protein binding;;podosome,cytoplasm,cell junction,early endosome membrane,cell projection,synapse;;Golgi membrane,early endosome,cytosol,plasma membrane,clathrin-coated endocytic vesicle membrane,synapse,extracellular exosome8;1;1;;1>tr|M0QYE0|M0QYE0_HUMAN Endophilin-A2 (Fragment) OS=Homo sapiens GN=SH3GL1 PE=1 SV=8;>tr|M0R0I3|M0R0I3_HUMAN Endophilin-A2 (Fragment) OS=Homo sapiens GN=SH3GL1 PE=1 SV=1;>sp|Q99961|SH3G1_HUMAN Endophilin-A2 OS=Homo sapiens GN=SH3GL1 PE=1 SV=1;>sp|Q99961-3|SH3G1_HUMAN Isoform 3 of Endophilin-A2 OS=Homo sapiens GN=SH3GL1;>sp|Q99962|SH3G2_HUMAN Endophilin-A1 OS=Homo sapiens GN=SH3GL2 PE=1 SV=1*A0A0A0MSW7;D6RGF0;Q569H4;Q569H4-2;Q569H4-3PRR16AA0A0A0MSW7_HUMAN;D6RGF0_HUMAN;LARGN_HUMAN;LARGN_HUMAN;LARGN_HUMANoProtein Largen;Protein Largen (Fragment);Protein Largen;Isoform 2 of Protein Largen;Isoform 3 of Protein LargenG;;positive regulation of translation,positive regulation of cell size;;4;4;1;;>tr|A0A0A0MSW7|A0A0A0MSW7_HUMAN Protein Largen OS=Homo sapiens GN=PRR16 PE=4 SV=1;>tr|D6RGF0|D6RGF0_HUMAN Protein Largen (Fragment) OS=Homo sapiens GN=PRR16 PE=4 SV=1;>sp|Q569H4|LARGN_HUMAN Protein Largen OS=Homo sapiens GN=PRR16 PE=1 SV=1;>sp|Q569H4-2|LARGN_HUMAN Isoform 2 of Protein Largen OS=Homo sapiens GN=PRR16;>sp|Q569H4-3|LARGN_HUMAN Isoform 3 of Protein Largen OS=Homo sapiens GN=PRR16B1AH49;P25325;P25325-2MPST"B1AH49_HUMAN;THTM_HUMAN;THTM_HUMAN{3-mercaptopyruvate sulfurtransferase;3-mercaptopyruvate sulfurtransferase;Isoform 2 of 3-mercaptopyruvate sulfurtransferase;kidney development,liver development,cyanate catabolic process,response to toxic substance,transsulfuration,spinal cord development,hydrogen sulfide biosynthetic process;p;thiosulfate sulfurtransferase activity,3-mercaptopyruvate sulfurtransferase activity,identical protein binding;U;mitochondrion,cytosol,cell junction,neuron projection,synapse,extracellular exosome;>tr|B1AH49|B1AH49_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens GN=MPST PE=1 SV=1;>sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens GN=MPST PE=1 SV=3;>sp|P25325-2|THTM_HUMAN Isoform 2 of 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens GN=MPST1B1AN99;P35030;P35030-2;P35030-3;P35030-4;P35030-5PRSS3CB1AN99_HUMAN;TRY3_HUMAN;TRY3_HUMAN;TRY3_HUMAN;TRY3_HUMAN;TRY3_HUMANzTrypsin-3 (Fragment);Trypsin-3;Isoform 2 of Trypsin-3;Isoform 3 of Trypsin-3;Isoform 4 of Trypsin-3;Isoform 5 of Trypsin-3;proteolysis,digestion,cobalamin metabolic process,antimicrobial humoral response,zymogen activation,neutrophil degranulation,endothelial cell migration;;;;j;serine-type endopeptidase activity,calcium ion binding,protein binding,serine-type peptidase activity;;;;Z;extracellular region,extracellular space,extracellular exosome,tertiary granule lumen;;;;8;2;;;;>tr|B1AN99|B1AN99_HUMAN Trypsin-3 (Fragment) OS=Homo sapiens GN=PRSS3 PE=1 SV=8;>sp|P35030|TRY3_HUMAN Trypsin-3 OS=Homo sapiens GN=PRSS3 PE=1 SV=2;>sp|P35030-2|TRY3_HUMAN Isoform 2 of Trypsin-3 OS=Homo sapiens GN=PRSS3;>sp|P35030-3|TRY3_HUMAN Isoform 3 of Trypsin-3 OS=Homo sapiens GN=PRSS3;>sp|P35030-4|TRY3_HUMAN Isoform 4 of Trypsin-3 OS=Homo sapiens GN=PRSS3;>sp|P35030-5|TRY3_HUMAN Isoform 5 of Trypsin-3 OS=Homo sapiens GN=PRSS3P01767IGHV3-53 HV353_HUMAN"Immunoglobulin heavy variable 3-53_>sp|P01767|HV353_HUMAN Immunoglobulin heavy variable 3-53 OS=Homo sapiens GN=IGHV3-53 PE=1 SV=2Q9Y3C5RNF11 RNF11_HUMANRING finger protein 11protein ubiquitination involved in ubiquitin-dependent protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,protein autoubiquitinationuDNA binding,ubiquitin-protein transferase activity,protein binding,zinc ion binding,ubiquitin protein ligase activityXubiquitin ligase complex,nucleus,early endosome,recycling endosome,extracellular exosomeP>sp|Q9Y3C5|RNF11_HUMAN RING finger protein 11 OS=Homo sapiens GN=RNF11 PE=1 SV=1 A0A075B7F0 IGHV3OR16-10A0A075B7F0_HUMANProtein IGHV3OR16-10 (Fragment)i>tr|A0A075B7F0|A0A075B7F0_HUMAN Protein IGHV3OR16-10 (Fragment) OS=Homo sapiens GN=IGHV3OR16-10 PE=1 SV=1 A0A0B4J1V1IGHV3-21 HV321_HUMAN"Immunoglobulin heavy variable 3-21c>sp|A0A0B4J1V1|HV321_HUMAN Immunoglobulin heavy variable 3-21 OS=Homo sapiens GN=IGHV3-21 PE=1 SV=1A0A0C4DH41;P01825IGHV4-61;IGHV4-59A0A0C4DH41_HUMAN;HV459_HUMAN>Protein IGHV4-61 (Fragment);Immunoglobulin heavy variable 4-59phagocytosis, recognition,phagocytosis, engulfment,complement activation, classical pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation;proteolysis,receptor-mediated endocytosis,immune response,complement activation,complement activation, classical pathway,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response,leukocyte migrationbantigen binding,immunoglobulin receptor binding;antigen binding,serine-type endopeptidase activityexternal side of plasma membrane,immunoglobulin complex, circulating,blood microparticle;extracellular region,plasma membrane,extracellular exosome>tr|A0A0C4DH41|A0A0C4DH41_HUMAN Protein IGHV4-61 (Fragment) OS=Homo sapiens GN=IGHV4-61 PE=4 SV=1;>sp|P01825|HV459_HUMAN Immunoglobulin heavy variable 4-59 OS=Homo sapiens GN=IGHV4-59 PE=1 SV=2$F5GX41;F5GXY9;P12318;P12318-2;V9GY83FCGR2A>F5GX41_HUMAN;F5GXY9_HUMAN;FCG2A_HUMAN;FCG2A_HUMAN;V9GY83_HUMAN9Low affinity immunoglobulin gamma Fc region receptor II-a;Low affinity immunoglobulin gamma Fc region receptor II-a;Low affinity immunoglobulin gamma Fc region receptor II-a;Isoform 2 of Low affinity immunoglobulin gamma Fc region receptor II-a;Low affinity immunoglobulin gamma Fc region receptor II-a (Fragment)Y;;Fc-gamma receptor signaling pathway involved in phagocytosis,neutrophil degranulation;;;;protein binding,IgG binding;;c;;plasma membrane,integral component of membrane,secretory granule membrane,extracellular exosome;;1;1;4;;1[>tr|F5GX41|F5GX41_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=1;>tr|F5GXY9|F5GXY9_HU< MAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=1;>sp|P12318|FCG2A_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=4;>sp|P12318-2|FCG2A_HUMAN Isoform 2 of Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A;>tr|V9GY83|V9GY83_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a (Fragment) OS=Homo sapiens GN=FCGR2A PE=1 SV=1K7EKG2;K7EPB7;O43396TXNL1%K7EKG2_HUMAN;K7EPB7_HUMAN;TXNL1_HUMAN[Thioredoxin-like protein 1 (Fragment);Thioredoxin-like protein 1;Thioredoxin-like protein 1z;;cellular response to oxidative stress,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification;;thioredoxin-disulfide reductase activity,protein disulfide oxidoreductase activity,disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,protein-disulfide reductase activityD;;proteasome complex,nucleus,cytoplasm,cytosol,extracellular exosome >tr|K7EKG2|K7EKG2_HUMAN Thioredoxin-like protein 1 (Fragment) OS=Homo sapiens GN=TXNL1 PE=1 SV=1;>tr|K7EPB7|K7EPB7_HUMAN Thioredoxin-like protein 1 OS=Homo sapiens GN=TXNL1 PE=1 SV=1;>sp|O43396|TXNL1_HUMAN Thioredoxin-like protein 1 OS=Homo sapiens GN=TXNL1 PE=1 SV=3P01763IGHV3-48 HV348_HUMAN"Immunoglobulin heavy variable 3-48_>sp|P01763|HV348_HUMAN Immunoglobulin heavy variable 3-48 OS=Homo sapiens GN=IGHV3-48 PE=1 SV=2P62330ARF6 ARF6_HUMANADP-ribosylation factor 6liver development,movement of cell or subcellular component,cell cycle,cell adhesion,small GTPase mediated signal transduction,protein transport,vesicle-mediated transport,positive regulation of actin filament polymerization,cortical actin cytoskeleton organization,ruffle organization,myeloid cell apoptotic process,protein localization to cell surface,regulation of Rac protein signal transduction,protein localization to endosome,negative regulation of receptor-mediated endocytosis,cell division,regulation of filopodium assembly,regulation of dendritic spine development,membrane organization,positive regulation of establishment of protein localization to plasma membrane,establishment of epithelial cell polarity,hepatocyte apoptotic process,negative regulation of dendrite development[GTPase activity,protein binding,GTP binding,thioesterase binding,protein N-terminus bindingruffle,endosome,early endosome,Golgi apparatus,plasma membrane,focal adhesion,cell cortex,membrane,endocytic vesicle,midbody,filopodium membrane,cleavage furrow,myelin sheath,recycling endosome membrane,extracellular exosomeQ>sp|P62330|ARF6_HUMAN ADP-ribosylation factor 6 OS=Homo sapiens GN=ARF6 PE=1 SV=2NQ9UGM3;Q9UGM3-2;Q9UGM3-3;Q9UGM3-4;Q9UGM3-5;Q9UGM3-6;Q9UGM3-7;Q9UGM3-8;Q9UGM3-9DMBT1 DMBT1_HUMANDeleted in malignant brain tumors 1 protein;Isoform 2 of Deleted in malignant brain tumors 1 protein;Isoform 3 of Deleted in malignant brain tumors 1 protein;Isoform 4 of Deleted in malignant brain tumors 1 protein;Isoform 5 of Deleted in malignant brain tumors 1 protein;Isoform 6 of Deleted in malignant brain tumors 1 protein;Isoform 7 of Deleted in malignant brain tumors 1 protein;Isoform 8 of Deleted in malignant brain tumors 1 protein;Isoform 9 of Deleted in malignant brain tumors 1 protein"pattern recognition receptor signaling pathway,receptor-mediated endocytosis,multicellular organism development,protein transport,epithelial cell differentiation,induction of bacterial agglutination,cellular protein metabolic process,innate immune response,defense response to virus;;;;;;;;scavenger receptor activity,protein binding,signaling pattern recognition receptor activity,zymogen binding,calcium-dependent protein binding;;;;;;;;extracellular region,extracellular space,cytoplasm,extrinsic component of membrane,phagocytic vesicle membrane,zymogen granule membrane,extracellular exosome;;;;;;;; 2;;;;;;;;>sp|Q9UGM3|DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2;>sp|Q9UGM3-2|DMBT1_HUMAN Isoform 2 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-3|DMBT1_HUMAN Isoform 3 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-4|DMBT1_HUMAN Isoform 4 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-5|DMBT1_HUMAN Isoform 5 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-6|DMBT1_HUMAN Isoform 6 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-7|DMBT1_HUMAN Isoform 7 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-8|DMBT1_HUMAN Isoform 8 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1;>sp|Q9UGM3-9|DMBT1_HUMAN Isoform 9 of Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1%A0A087WTS8;A0A087WYC1;P34932;P34932-2HSPA49A0A087WTS8_HUMAN;A0A087WYC1_HUMAN;HSP74_HUMAN;HSP74_HUMAN|Heat shock 70 kDa protein 4;Heat shock 70 kDa protein 4;Heat shock 70 kDa protein 4;Isoform 2 of Heat shock 70 kDa protein 4|;;response to unfolded protein,protein import into mitochondrial outer membrane,chaperone-mediated protein complex assembly;;;protein binding,ATP binding; ;;cytosol,extracellular exosome;n>tr|A0A087WTS8|A0A087WTS8_HUMAN Heat shock 70 kDa protein 4 OS=Homo sapiens GN=HSPA4 PE=1 SV=1;>tr|A0A087WYC1|A0A087WYC1_HUMAN Heat shock 70 kDa protein 4 OS=Homo sapiens GN=HSPA4 PE=1 SV=1;>sp|P34932|HSP74_HUMAN Heat shock 70 kDa protein 4 OS=Homo sapiens GN=HSPA4 PE=1 SV=4;>sp|P34932-2|HSP74_HUMAN Isoform 2 of Heat shock 70 kDa protein 4 OS=Homo sapiens GN=HSPA4P01699IGLV1-44 LV144_HUMAN#Immunoglobulin lambda variable 1-44`>sp|P01699|LV144_HUMAN Immunoglobulin lambda variable 1-44 OS=Homo sapiens GN=IGLV1-44 PE=1 SV=2P01762IGHV3-11 HV311_HUMAN"Immunoglobulin heavy variable 3-11_>sp|P01762|HV311_HUMAN Immunoglobulin heavy variable 3-11 OS=Homo sapiens GN=IGHV3-11 PE=1 SV=2P30484 1B46_HUMAN8HLA class I histocompatibility antigen, B-46 alpha chainq>sp|P30484|1B46_HUMAN HLA class I histocompatibility antigen, B-46 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 A0A0B4J1U3IGLV1-36A0A0B4J1U3_HUMANProtein IGLV1-36 (Fragment)a>tr|A0A0B4J1U3|A0A0B4J1U3_HUMAN Protein IGLV1-36 (Fragment) OS=Homo sapiens GN=IGLV1-36 PE=1 SV=5P01721IGLV6-57 LV657_HUMAN#Immunoglobulin lambda variable 6-57`>sp|P01721|LV657_HUMAN Immunoglobulin lambda variable 6-57 OS=Homo sapiens GN=IGLV6-57 PE=1 SV=2P0CF74IGLC6 LAC6_HUMANIg lambda-6 chain C regionS>sp|P0CF74|LAC6_HUMAN Ig lambda-6 chain C region OS=Homo sapiens GN=IGLC6 PE=4 SV=1P24821-2Isoform 2 of TenascinD>sp|P24821-2|TENA_HUMAN Isoform 2 of Tenascin OS=Homo sapiens GN=TNCP01824IGHV4-39 HV439_HUMAN"Immunoglobulin heavy variable 4-39_>sp|P01824|HV439_HUMAN Immunoglobulin heavy variable 4-39 OS=Homo sapiens GN=IGHV4-39 PE=1 SV=20A6NMH8;E9PIF1;E9PJK1;E9PRJ8;H0YDJ9;H0YDL9;P60033CD81XA6NMH8_HUMAN;E9PIF1_HUMAN;E9PJK1_HUMAN;E9PRJ8_HUMAN;H0YDJ9_HUMAN;H0YDL9_HUMAN;CD81_HUMANuTetraspanin;Tetraspanin;Tetraspanin;Tetraspanin (Fragment);Tetraspanin (Fragment);Tetraspanin (Fragment);CD81 antigen;;;;;;activation of MAPK activity,cell surface receptor signaling pathway,protein localization,cell proliferation,positive regulation of cell proliferation,positive regulation of B cell proliferation,receptor internalization,regulation of protein stability,positive regulation of 1-phosphatidylinositol 4-kinase activity,positive regulation of transcription from RNA polymerase II promoter,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of peptidyl-tyrosine phosphorylation,regulation of immune response,protein localization to lysosome,cellular response to low-density lipoprotein particle stimulus,positive regulation of protein catabolic process in the vacuole,regulation of cell motilityW;;;;;;protein binding,MHC class II protein complex binding,transferrin receptor binding;;;;;;immunological synapse,plasma membrane,integral component of< plasma membrane,focal adhesion,membrane,vesicle,extracellular exosome >tr|A6NMH8|A6NMH8_HUMAN Tetraspanin OS=Homo sapiens GN=CD81 PE=1 SV=1;>tr|E9PIF1|E9PIF1_HUMAN Tetraspanin OS=Homo sapiens GN=CD81 PE=1 SV=1;>tr|E9PJK1|E9PJK1_HUMAN Tetraspanin OS=Homo sapiens GN=CD81 PE=1 SV=1;>tr|E9PRJ8|E9PRJ8_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD81 PE=1 SV=1;>tr|H0YDJ9|H0YDJ9_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD81 PE=1 SV=1;>tr|H0YDL9|H0YDL9_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD81 PE=1 SV=1;>sp|P60033|CD81_HUMAN CD81 antigen OS=Homo sapiens GN=CD81 PE=1 SV=1-F8VV56;F8VWK8;F8W022;P08962;P08962-2;P08962-3CD63GF8VV56_HUMAN;F8VWK8_HUMAN;F8W022_HUMAN;CD63_HUMAN;CD63_HUMAN;CD63_HUMAN{CD63 antigen;Tetraspanin (Fragment);Tetraspanin (Fragment);CD63 antigen;Isoform 2 of CD63 antigen;Isoform 3 of CD63 antigen;;;positive regulation of receptor internalization,platelet degranulation,cell-matrix adhesion,protein transport,cell migration,cellular protein localization,endosome to melanosome transport,neutrophil degranulation,pigment granule maturation,regulation of vascular endothelial growth factor signaling pathway,regulation of rubidium ion transport,positive regulation of integrin-mediated signaling pathway;;;;;protein binding;;l;;;extracellular space,lysosomal membrane,plasma membrane,integral component of plasma membrane,cell surface,endosome membrane,platelet dense granule membrane,intrinsic component of plasma membrane,late endosome membrane,endosome lumen,multivesicular body membrane,azurophil granule membrane,melanosome,extracellular exosome,multivesicular body, internal vesicle;; 1;1;1;2;;>tr|F8VV56|F8VV56_HUMAN CD63 antigen OS=Homo sapiens GN=CD63 PE=1 SV=1;>tr|F8VWK8|F8VWK8_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD63 PE=1 SV=1;>tr|F8W022|F8W022_HUMAN Tetraspanin (Fragment) OS=Homo sapiens GN=CD63 PE=1 SV=1;>sp|P08962|CD63_HUMAN CD63 antigen OS=Homo sapiens GN=CD63 PE=1 SV=2;>sp|P08962-2|CD63_HUMAN Isoform 2 of CD63 antigen OS=Homo sapiens GN=CD63;>sp|P08962-3|CD63_HUMAN Isoform 3 of CD63 antigen OS=Homo sapiens GN=CD63H0YFA4;P52943;P52943-2CRIP2$H0YFA4_HUMAN;CRIP2_HUMAN;CRIP2_HUMAN_Cysteine-rich protein 2 (Fragment);Cysteine-rich protein 2;Isoform 2 of Cysteine-rich protein 27;positive regulation of cell proliferation,hemopoiesis;;zinc ion binding;";cell cortex,extracellular matrix;>tr|H0YFA4|H0YFA4_HUMAN Cysteine-rich protein 2 (Fragment) OS=Homo sapiens GN=CRIP2 PE=1 SV=1;>sp|P52943|CRIP2_HUMAN Cysteine-rich protein 2 OS=Homo sapiens GN=CRIP2 PE=1 SV=1;>sp|P52943-2|CRIP2_HUMAN Isoform 2 of Cysteine-rich protein 2 OS=Homo sapiens GN=CRIP2B4DDG0;B4E171;P41732TSPAN7;;TSPAN7$B4DDG0_HUMAN;B4E171_HUMAN;TSN7_HUMAN%Tetraspanin;Tetraspanin;Tetraspanin-7^;cell surface receptor signaling pathway;cell surface receptor signaling pathway,viral process;calcium ion binding;a;extracellular region,integral component of plasma membrane;integral component of plasma membrane>tr|B4DDG0|B4DDG0_HUMAN Tetraspanin OS=Homo sapiens GN=TSPAN7 PE=2 SV=1;>tr|B4E171|B4E171_HUMAN Tetraspanin OS=Homo sapiens PE=2 SV=1;>sp|P41732|TSN7_HUMAN Tetraspanin-7 OS=Homo sapiens GN=TSPAN7 PE=1 SV=2P09972ALDOC ALDOC_HUMAN Fructose-bisphosphate aldolase Cfructose metabolic process,gluconeogenesis,fructose 1,6-bisphosphate metabolic process,epithelial cell differentiation,neutrophil degranulation,canonical glycolysisTfructose-bisphosphate aldolase activity,protein binding,cytoskeletal protein bindingextracellular region,mitochondrion,cytosol,cytoskeleton,secretory granule lumen,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenZ>sp|P09972|ALDOC_HUMAN Fructose-bisphosphate aldolase C OS=Homo sapiens GN=ALDOC PE=1 SV=2P63261ACTG1 ACTG_HUMANActin, cytoplasmic 2jretina homeostasis,movement of cell or subcellular component,response to mechanical stimulus,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,sarcomere organization,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,response to calcium ion,membrane organization,platelet aggregation}structural constituent of cytoskeleton,protein binding,ATP binding,ubiquitin protein ligase binding,identical protein bindingextracellular space,nucleus,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,myofibril,extracellular matrix,filamentous actin,myelin sheath,extracellular exosome,blood microparticle,dense bodyM>sp|P63261|ACTG_HUMAN Actin, cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=154 proteins are up-regulated.54 proteins are up-regulated. 117 proteins are down-regulated.P24821-4Isoform 4 of TenascinP11277MAPK cascade,ER to Golgi vesicle-mediated transport,cytoskeleton organization,axon guidance,positive regulation of GTPase activity,actin filament cappingactin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,ankyrin binding,actin filament bindingGolgi apparatus,cytosol,spectrin,spectrin-associated cytoskeleton,actin cytoskeleton,intrinsic component of the cytoplasmic side of the plasma membrane,protein complexIg delta chain C region;phagocytosis, recognition,phagocytosis, engulfment,immune response,complement activation, classical pathway,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation;plasma membrane,external side of plasma membrane,integral component of membrane,immunoglobulin complex, circulating,extracellular exosome,blood microparticleA6NML5TMEM212 TM212_HUMANTransmembrane protein 212 PTPRF_HUMANfReceptor-type tyrosine-protein phosphatase F;Isoform 2 of Receptor-type tyrosine-protein phosphatase Fcell adhesion,transmembrane receptor protein tyrosine phosphatase signaling pathway,cell migration,neuron projection regeneration,peptidyl-tyrosine dephosphorylation,regulation of axon regeneration,negative regulation of receptor binding;protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,heparin binding,protein complex binding,chondroitin sulfate proteoglycan binding;qplasma membrane,integral component of plasma membrane,neuron projection,neuronal cell body,extracellular exosome;Nodal modulator 1;Nodal modulator 1;Nodal modulator 1;Nodal modulator 1;Nodal modulator 3;Nodal modulator 3;Nodal modulator 1;Nodal modulator 2;Isoform 2 of Nodal modulator 2;Isoform 3 of Nodal modulator 2D;;;;;biological_process;biological_process;protein destabilization;;{;;;;;molecular_function,carbohydrate binding;molecular_function,carbohydrate binding;protein binding,carbohydrate binding;;;;;;;cellular_component,integral component of membrane;membrane,integral component of membrane;endoplasmic reticulum membrane,integral component of membrane;;;DNA repair;ubiquitin-dependent protein catabolic process,apoptotic process,regulation of fibroblast migration,negative regulation of tumor necrosis factor-mediated signaling pathway,regulation of TOR signaling,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,protein K48-linked ubiquitination,negative regulation of signal transduction by p53 class mediator,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;;;DNA binding,ATP binding,DNA-dependent ATPase activity,zinc ion binding;protease binding,p53 binding,protein binding,zinc ion binding,protein kinase binding,ubiquitin protein ligase binding,ubiquitin protein ligase activity;;;;nucleoplasm,cytoplasm,cytosol,plasma membrane,endosome membrane,membrane,recycling endosome membrane,Golgi membrane,lysosome,tumor necrosis factor receptor superfamily complex;;dTenascin-X;Tenascin-X;Tenascin-X;Tenascin-X;Tenascin-X;Tenascin-X;Tenascin-X;Isoform 4 of Tenascin-X;;;;;;cell adhesion,actin cytoskeleton organization,collagen fibril organizat< ion,collagen metabolic process,elastic fiber assembly;7;;;;;;integrin binding,protein binding,heparin binding;;;;;;;proteinaceous extracellular matrix,extracellular space,intracellular,extracellular exosome,fibrillar collagen trimer,extracellular matrix;RNF123uE3 ubiquitin-protein ligase RNF123;E3 ubiquitin-protein ligase RNF123;Isoform 2 of E3 ubiquitin-protein ligase RNF1231;protein ubiquitination,protein deubiquitination;';zinc ion binding,transferase activity;;cytoplasm,cytosol;Platelet glycoprotein VI (Fragment);Platelet glycoprotein VI;Isoform 2 of Platelet glycoprotein VI;Isoform 3 of Platelet glycoprotein VIm;enzyme linked receptor protein signaling pathway,blood coagulation,platelet activation,leukocyte migration;;_;receptor activity,transmembrane signaling receptor activity,protein binding,collagen binding;;|;plasma membrane,integral component of plasma membrane,cell surface,extracellular exosome,tetraspanin-enriched microdomain;;P01814IGHV2-70 HV270_HUMAN"Immunoglobulin heavy variable 2-70;;regulation of receptor recycling,endosome organization,lysosome organization,cell cycle arrest,regulation of cholesterol esterification,regulation of cholesterol efflux,cell growth,macroautophagy,positive regulation of TOR signaling,lysosome localization,endosome localization,cellular protein localization,cholesterol homeostasis,neutrophil degranulation,positive regulation of MAPK cascade,positive regulation of GTPase activity,regulation of cholesterol import,cellular response to amino acid stimulus;;lysosome,lysosomal membrane,plasma membrane,late endosome membrane,azurophil granule membrane,specific granule membrane,membrane raft,extracellular exosome,Ragulator complex,ficolin-1-rich granule membraneMOB kinase activator 1B (Fragment);MOB kinase activator 1B;Isoform 2 of MOB kinase activator 1B;MOB kinase activator 1A;Isoform 2 of MOB kinase activator 1As;regulation of protein autophosphorylation,hippo signaling,positive regulation of phosphorylation;;hippo signaling;o;protein binding,kinase activator activity,kinase binding,metal ion binding;;protein binding,metal ion binding;l;nucleus,nucleolus,cytoplasm,cytosol,extracellular exosome;;nucleus,nucleolus,cytosol,extracellular exosome;<60S ribosomal protein L4 (Fragment);60S ribosomal protein L4=Septin-2;Septin-2;Isoform 2 of Septin-2;Isoform 3 of Septin-2;mitotic nuclear division,smoothened signaling pathway,spermatogenesis,neuron projection development,cell division,cilium morphogenesis;;/;protein binding,GTP binding,cadherin binding;;,;exocyst,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,cytosol,axoneme,actin cytoskeleton,midbody,septin complex,cleavage furrow,photoreceptor connecting cilium,perinuclear region of cytoplasm,ciliary membrane,extracellular exosome,sperm annulus,Requires Ontology,cell cortex;;P12955Xaa-Pro dipeptidaseLproteolysis,cellular amino acid metabolic process,collagen catabolic process{aminopeptidase activity,metallocarboxypeptidase activity,protein binding,manganese ion binding,proline dipeptidase activityRPS340S ribosomal protein S3;40S ribosomal protein S3;40S ribosomal protein S3 (Fragment);40S ribosomal protein S3 (Fragment);40S ribosomal protein S3;Isoform 2 of 40S ribosomal protein S3;;;;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,DNA repair,transcription, DNA-templated,regulation of transcription, DNA-templated,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,apoptotic process,cellular response to DNA damage stimulus,response to oxidative stress,chromosome segregation,mitotic nuclear division,positive regulation of gene expression,negative regulation of translation,viral transcription,positive regulation of microtubule polymerization,negative regulation of protein ubiquitination,positive regulation of endodeoxyribonuclease activity,DNA damage response, detection of DNA damage,regulation of apoptotic process,positive regulation of JUN kinase activity,negative regulation of DNA repair,positive regulation of DNA repair,spindle assembly,cell division,response to TNF agonist,cellular response to hydrogen peroxide,positive regulation of NIK/NF-kappaB signaling,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,positive regulation of DNA N-glycosylase activity,positive regulation of base-excision repair,positive regulation of apoptotic signaling pathway,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;l;;;;DNA binding,damaged DNA binding,RNA binding,mRNA binding,structural constituent of ribosome,DNA-(apurinic or apyrimidinic site) lyase activity,endodeoxyribonuclease activity,protein binding,microtubule binding,transcription factor binding,tubulin binding,enzyme binding,kinase binding,protein kinase binding,Hsp70 protein binding,SUMO binding,oxidized purine DNA binding,oxidized pyrimidine DNA binding,ubiquitin-like protein conjugating enzyme binding,protein kinase A binding,iron-sulfur cluster binding,Hsp90 protein binding,small ribosomal subunit rRNA binding,supercoiled DNA binding,DNA N-glycosylase activity;K;;;;nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrial inner membrane,mitochondrial matrix,endoplasmic reticulum,cytosol,ribosome,polysome,plasma membrane,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,ruffle membrane,extracellular exosome,mitotic spindle; CD6_HUMANT-cell differentiation antigen CD6;Isoform CD6B of T-cell differentiation antigen CD6;Isoform CD6C of T-cell differentiation antigen CD6;Isoform CD6D of T-cell differentiation antigen CD6;Isoform CD6E of T-cell differentiation antigen CD6immunological synapse formation,adaptive immune response,acute inflammatory response to antigenic stimulus,receptor-mediated endocytosis,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,lipopolysaccharide-mediated signaling pathway,response to lipopolysaccharide,positive regulation of T cell proliferation,innate immune response,positive regulation of cytokine production involved in inflammatory response;;;;dlipopolysaccharide binding,scavenger receptor activity,protein binding,lipoteichoic acid binding;;;;immunological synapse,extracellular region,integral component of plasma membrane,intrinsic component of plasma membrane,T cell receptor complex;;;;O43396 TXNL1_HUMANThioredoxin-like protein 1xcellular response to oxidative stress,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxificationthioredoxin-disulfide reductase activity,protein disulfide oxidoreductase activity,disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,protein-disulfide reductase activityBproteasome complex,nucleus,cytoplasm,cytosol,extracellular exosomeCalpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1;Calpain small subunit 1 (Fragment);;;;proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly,cornification;v;;;;endopeptidase activity,calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding;;;;;;cytosol,plasma membrane,membrane,extracellular exosome;@Ig lambda-7 chain C region (Fragment);Ig lambda-7 chain C region~;extracellular region,plasma membrane,external side of plasma membrane,immunoglobulin complex, circulating,blood microparticleAP2B1AP-2 complex subunit beta (Fragment);AP-2 complex subunit beta (Fragment);AP-2 complex subunit beta (Fragment);AP-2 complex subunit beta;AP-2 complex subunit beta;Isoform 2 of AP-2 complex subunit beta;Isoform 3 of AP-2 complex subunit beta;;;;ventricular septum development,intracellular protein transport,receptor-mediated endocytosis,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,aorta development,ephrin receptor signaling pat< hway,clathrin coat assembly,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,coronary vasculature development,membrane organization,clathrin-dependent endocytosis,neurotransmitter receptor internalization;;;;;;signal sequence binding,protein binding,protein transporter activity,clathrin binding,protein complex binding,clathrin adaptor activity;;;;;;trans-Golgi network,cytosol,plasma membrane,membrane,AP-2 adaptor complex,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,endolysosome membrane;;TATA-box-binding protein;TATA-box-binding protein;Isoform 2 of TATA-box-binding protein;TATA-box-binding protein;TATA box-binding protein-like protein 2;TATA-box-binding protein (Fragment);regulation of transcription from RNA polymerase III promoter,transcription initiation from RNA polymerase I promoter,transcription elongation from RNA polymerase I promoter,termination of RNA polymerase I transcription,transcription from RNA polymerase II promoter,transcription initiation from RNA polymerase II promoter,transcription elongation from RNA polymerase II promoter,transcription from RNA polymerase III promoter,spermatogenesis,viral process,snRNA transcription from RNA polymerase II promoter,positive regulation of gene expression, epigenetic,positive regulation of transcription, DNA-templated,regulation of signal transduction by p53 class mediator;;;DNA-templated transcription, initiation,multicellular organism development,negative regulation of transcription, DNA-templated;;RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II core promoter sequence-specific DNA binding,RNA polymerase III transcription factor activity, sequence-specific DNA binding,RNA polymerase II repressing transcription factor binding,protein binding,transcription factor binding,enzyme binding,transcription regulatory region DNA binding,repressing transcription factor binding;;;DNA binding,transcription factor activity, sequence-specific DNA binding;;nuclear chromatin,female pronucleus,male pronucleus,nucleus,nucleoplasm,transcription factor TFIID complex,transcription factor TFIIA complex,nuclear euchromatin,cytoplasm;;;nucleus,cytoplasm;P43034 LIS1_HUMAN;Platelet-activating factor acetylhydrolase IB subunit alphaG2/M transition of mitotic cell cycle,establishment of mitotic spindle orientation,microtubule cytoskeleton organization,ameboidal-type cell migration,acrosome assembly,neuron migration,positive regulation of cytokine-mediated signaling pathway,microtubule-based process,sister chromatid cohesion,mitotic nuclear division,nuclear migration,chemical synaptic transmission,germ cell development,neuroblast proliferation,learning or memory,retrograde axonal transport,adult locomotory behavior,protein secretion,negative regulation of neuron projection development,lipid catabolic process,stem cell division,transmission of nerve impulse,corpus callosum morphogenesis,hippocampus development,layer formation in cerebral cortex,cerebral cortex neuron differentiation,cerebral cortex development,actin cytoskeleton organization,microtubule organizing center organization,osteoclast development,positive regulation of embryonic development,establishment of planar polarity of embryonic epithelium,regulation of GTPase activity,cortical microtubule organization,positive regulation of axon extension,positive regulation of mitotic cell cycle,negative regulation of JNK cascade,platelet activating factor metabolic process,vesicle transport along microtubule,brain morphogenesis,neuromuscular process controlling balance,nuclear envelope disassembly,establishment of centrosome localization,maintenance of centrosome location,auditory receptor cell development,positive regulation of dendritic spine morphogenesis,regulation of microtubule cytoskeleton organization,cochlea development,microtubule cytoskeleton organization involved in establishment of planar polarity,ciliary basal body docking,regulation of microtubule motor activityphospholipase A2 activity,protein binding,microtubule binding,heparin binding,dynactin binding,protein homodimerization activity,phospholipase binding,dynein intermediate chain binding,phosphoprotein binding,dynein complex bindingastral microtubule,kinetochore,nuclear envelope,centrosome,cytosol,kinesin complex,microtubule associated complex,cell cortex,growth cone,motile cilium,nuclear membrane,stereocilium,neuronal cell body,perinuclear region of cytoplasm,extracellular exosome,axon cytoplasm,cell leading edgeyProteasome subunit alpha type;Proteasome subunit alpha type;Proteasome subunit alpha type;Proteasome subunit alpha type-6,;;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,regulation of inflammatory response,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,proteolysis involved in cellular protein catabolic process,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;;;RNA binding,endopeptidase activity,threonine-type endopeptidase activity,protein binding,purine ribonucleoside triphosphate binding,NF-kappaB binding;;;proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome core complex,polysome,nuclear matrix,proteasome core complex, alpha-subunit complex,myofibril,sarcomere,extracellular exosomeP54727RAD23B RD23B_HUMAN*UV excision repair protein RAD23 homolog Bnucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,protein folding,spermatogenesis,protein deubiquitination,regulation of proteasomal ubiquitin-dependent protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,embryonic organ development,global genome nucleotide-excision repairUdamaged DNA binding,single-stranded DNA binding,protein binding,polyubiquitin binding:proteasome complex,nucleus,nucleoplasm,cytosol,XPC complexQ7Z434)Mitochondrial antiviral-signaling proteinpositive regulation of protein phosphorylation,activation of innate immune response,positive regulation of defense response to virus by host,signal transduction,protein deubiquitination,negative regulation of type I interferon production,positive regulation of interferon-alpha production,positive regulation of interferon-beta production,positive regulation of interleukin-8 production,positive regulation of tumor necrosis factor production,positive regulation of protein import into nucleus, translocation,RIG-I signaling pathway,defense response to bacterium,positive regulation of transcription factor import into nucleus,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of viral genome replication,innate immune response,positive regulation of transcription from RNA polymerase II promoter,positive regulation of sequence-specific DNA binding transcription factor activity,defense response to virus,positive regulation of type I interferon-mediated signaling pathway,cellular response to exogenous dsRNA,positive regulation o< f chemokine (C-C motif) ligand 5 production,positive regulation of IP-10 production,regulation of peroxisome organizationUsignal transducer activity,protein binding,protein kinase binding,CARD domain bind                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y { | } ~  ingumitochondrion,mitochondrial outer membrane,peroxisomal membrane,integral component of membrane,mitochondrial membranePoly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2;Poly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2 (Fragment);Poly(rC)-binding protein 2;Isoform 2 of Poly(rC)-binding protein 2;Isoform 3 of Poly(rC)-binding protein 2;Isoform 4 of Poly(rC)-binding protein 2;Isoform 5 of Poly(rC)-binding protein 2;Isoform 6 of Poly(rC)-binding protein 2;Isoform 7 of Poly(rC)-binding protein 2;Isoform 8 of Poly(rC)-binding protein 2t;;;;;mRNA splicing, via spliceosome,gene expression,mRNA metabolic process,negative regulation of type I interferon production,viral RNA genome replication,proteasome-mediated ubiquitin-dependent protein catabolic process,innate immune response,negative regulation of defense response to virus,defense response to virus,IRES-dependent viral translational initiation;;;;;;;z;;;;;RNA binding,protein binding,enzyme binding,ubiquitin protein ligase binding,C-rich single-stranded DNA binding;;;;;;;;;;;;nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular exosome;;;;;;;VWA5AQ8N9U0TC2N TAC2N_HUMAN!Tandem C2 domains nuclear proteinregulation of gene expression,regulation of blood coagulation,calcium ion-regulated exocytosis of neurotransmitter,vesicle fusion,regulation of calcium ion-dependent exocytosisomolecular_function,calcium ion binding,calcium-dependent phospholipid binding,syntaxin binding,clathrin binding5cellular_component,nucleus,plasma membrane,presynapsePTGES3Prostaglandin E synthase 3;Prostaglandin E synthase 3;Isoform 3 of Prostaglandin E synthase 3;Isoform 4 of Prostaglandin E synthase 3v;telomere maintenance,prostaglandin biosynthetic process,xenobiotic metabolic process,telomere maintenance via telomerase,signal transduction,cyclooxygenase pathway,positive regulation of phosphorylation,positive regulation of telomerase activity,chaperone cofactor-dependent protein refolding,regulation of cellular response to heat,telomerase holoenzyme complex assembly;;;telomerase activity,protein binding,prostaglandin-E synthase activity,unfolded protein binding,Hsp90 protein binding,DNA polymerase binding;;o;chromosome, telomeric region,nucleus,nucleoplasm,telomerase holoenzyme complex,cytosol,extracellular exosome;;CD84 SLAF5_HUMANSLAM family member 5;Isoform 2 of SLAM family member 5;Isoform 3 of SLAM family member 5;Isoform 4 of SLAM family member 5;Isoform 5 of SLAM family member 5;Isoform 6 of SLAM family member 5adaptive immune response,defense response,homophilic cell adhesion via plasma membrane adhesion molecules,negative regulation of granulocyte macrophage colony-stimulating factor production,negative regulation of interleukin-18 production,negative regulation of mast cell activation,negative regulation of mast cell degranulation,innate immune response,leukocyte migration,regulation of store-operated calcium entry;;;;;protein binding;;;;;Pplasma membrane,integral component of plasma membrane,extracellular exosome;;;;;P40306PSMB10 PSB10_HUMANProteasome subunit beta type-10MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,humoral immune response,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathwayYproteasome complex,nucleoplasm,cytosol,proteasome core complex,spermatoproteasome complexReticulon;Reticulon (Fragment);Reticulon-4;Isoform 2 of Reticulon-4;Isoform 3 of Reticulon-4;Isoform 4 of Reticulon-4;Isoform 5 of Reticulon-4;Isoform 6 of Reticulon-4;;apoptotic process,axonal fasciculation,cerebral cortex radial glia guided migration,negative regulation of cell growth,negative regulation of axon extension,regulation of apoptotic process,negative regulation of axonogenesis,nuclear pore complex assembly,cardiac epithelial to mesenchymal transition,endoplasmic reticulum tubular network organization,endoplasmic reticulum tubular network assembly,regulation of branching morphogenesis of a nerve;;;;;3;;RNA binding,protein binding,cadherin binding;;;;;;;intracellular,nuclear envelope,endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,postsynaptic density,integral component of endoplasmic reticulum membrane,cell projection,extracellular exosome;;;;;TOR3A TOR3A_HUMAN Torsin-3A;Isoform 2 of Torsin-3AATP binding,ATPase activity;Hendoplasmic reticulum,endoplasmic reticulum lumen,extracellular exosome;Proteasome subunit beta type;Proteasome subunit beta type-9 (Fragment);Proteasome subunit beta type-9 (Fragment);Proteasome subunit beta type;Proteasome subunit beta type-9;Isoform LMP2.S of Proteasome subunit beta type-9;;;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of cysteine-type endopeptidase activity;:;;;;threonine-type endopeptidase activity,protein binding;t;;;;proteasome complex,nucleoplasm,cytosol,proteasome core complex,extracellular exosome,spermatoproteasome complex;Protein C1QTNF3-AMACR;Complement C1q tumor necrosis factor-related protein 3;Isoform 3 of Complement C1q tumor necrosis factor-related protein 3;cellular triglyceride homeostasis,negative regulation of NF-kappaB import into nucleus,fat cell differentiation,negative regulation of gluconeogenesis,positive regulation of cytokine secretion,negative regulation of inflammatory response,positive regulation of adiponectin secretion,protein trimerization,negative regulation of monocyte chemotactic protein-1 production,negative regulation of interleukin-6 secretion;mextracellular region,collagen trimer;collagen trimer,extracellular space,cell,membrane,extracellular exosome;BolA-like protein 2;Uncharacterized protein;Uncharacterized protein (Frag< ment);BolA-like protein 2 (Fragment);Uncharacterized protein (Fragment);BolA-like protein 2;Isoform 2 of BolA-like protein 2R;;;;;[2Fe-2S] cluster assembly,protein maturation by iron-sulfur cluster transfer;;;;;;protein binding;-;;;;;nucleus,cytoplasm,extracellular exosome;Signal transducer and activator of transcription;Signal transducer and activator of transcription 5A;Signal transducer and activator of transcription 5B ;allantoin metabolic process,positive regulation of endothelial cell proliferation,citrate metabolic process,2-oxoglutarate metabolic process,succinate metabolic process,oxaloacetate metabolic process,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,isoleucine metabolic process,valine metabolic process,creatine metabolic process,fatty acid metabolic process,JAK-STAT cascade,lactation,peptidyl-tyrosine phosphorylation,taurine metabolic process,prolactin signaling pathway,regulation of multicellular organism growth,positive regulation of blood vessel endothelial cell migration,creatinine metabolic process,JAK-STAT cascade involved in growth hormone signaling pathway;allantoin metabolic process,luteinization,natural killer cell differentiation,citrate metabolic process,2-oxoglutarate metabolic process,succinate metabolic process,oxaloacetate metabolic process,regulation of transcription from RNA polymerase II promoter,transcription from RNA polymerase II promoter,isoleucine metabolic process,valine metabolic process,creatine metabolic process,fatty acid metabolic process,JAK-STAT cascade,female pregnancy,lactation,peptidyl-tyrosine phosphorylation,regulation of steroid metabolic process,taurine metabolic process,lipid storage,regulation of epithelial cell differentiation,response to estradiol,positive regulation of natural killer cell proliferation,positive regulation of natural killer cell differentiation,cellular response to hormone stimulus,T cell differentiation in thymus,prolactin signaling pathway,regulation of multicellular organism growth,positive regulation of multicellular organism growth,positive regulation of activated T cell proliferation,progesterone metabolic process,T cell homeostasis,negative regulation of apoptotic process,positive regulation of interleukin-2 biosynthetic process,positive regulation of B cell differentiation,positive regulation of gamma-delta T cell differentiation,negative regulation of erythrocyte differentiation,positive regulation of erythrocyte differentiation,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,positive regulation of natural killer cell mediated cytotoxicity,creatinine metabolic process,development of secondary female sexual characteristics,development of secondary male sexual characteristics,Peyer's patch development,positive regulation of inflammatory response,JAK-STAT cascade involved in growth hormone signaling pathway,response to interleukin-2,response to interleukin-4,response to interleukin-15,cellular response to growth factor stimulus,cellular response to epidermal growth factor stimulus,mast cell migration6;DNA binding,transcription factor activity, sequence-specific DNA binding,protein tyrosine kinase activity,signal transducer activity,protein binding;RNA polymerase II core promoter sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,chromatin binding,transcription factor activity, sequence-specific DNA binding,protein tyrosine kinase activity,signal transducer activity,protein binding,protein phosphatase binding,glucocorticoid receptor binding,protein dimerization activity:;nucleoplasm,cytosol;nucleus,nucleoplasm,cytoplasm,cytosolP14868mtranslation,tRNA aminoacylation for protein translation,aspartyl-tRNA aminoacylation,protein complex assembly\RNA binding,aminoacylase activity,aspartate-tRNA ligase activity,protein binding,ATP binding0cytoplasm,cytosol,membrane,extracellular exosomeBCAP31 BAP31_HUMANXB-cell receptor-associated protein 31;Isoform 2 of B-cell receptor-associated protein 31antigen processing and presentation of peptide antigen via MHC class I,intracellular protein transport,ER to Golgi vesicle-mediated transport,positive regulation of cytosolic calcium ion concentration,spermatogenesis,negative regulation of endoplasmic reticulum calcium ion concentration,calcium-mediated signaling using intracellular calcium source,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of mitochondrial calcium ion concentration,protein localization to endoplasmic reticulum exit site,execution phase of apoptosis,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,positive regulation of retrograde protein transport, ER to cytosol,positive regulation of intrinsic apoptotic signaling pathway;Dprotein binding,protein complex binding,MHC class I protein binding;wmitochondrion,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,cytosol,integral component of plasma membrane,membrane,clathrin-coated vesicle,Golgi cisterna membrane,endoplasmic reticulum-Golgi intermediate compartment membrane,integral component of lumenal side of endoplasmic reticulum membrane,perinuclear endoplasmic reticulum,Sec61 translocon complex;ESulfotransferase (Fragment);Sulfotransferase 1A1;Sulfotransferase 1A2;catecholamine metabolic process,xenobiotic metabolic process,estrogen metabolic process,amine metabolic process,flavonoid metabolic process,3'-phosphoadenosine 5'-phosphosulfate metabolic process,sulfation;catecholamine metabolic process,xenobiotic metabolic process,steroid metabolic process,amine biosynthetic process,phenol-containing compound metabolic process,3'-phosphoadenosine 5'-phosphosulfate metabolic process,sulfation;aryl sulfotransferase activity,protein binding,sulfotransferase activity,flavonol 3-sulfotransferase activity,steroid sulfotransferase activity;aryl sulfotransferase activity,protein binding,sulfotransferase activity,flavonol 3-sulfotransferase activity;cytosol;cytosolUnconventional myosin-XVIIIa;Unconventional myosin-XVIIIa;Isoform 2 of Unconventional myosin-XVIIIa;Isoform 3 of Unconventional myosin-XVIIIa;Isoform 4 of Unconventional myosin-XVIIIaSpliceosome RNA helicase DDX39B (Fragment);Spliceosome RNA helicase DDX39B (Fragment);Spliceosome RNA helicase DDX39B (Fragment);ATP-dependent RNA helicase DDX39A;Spliceosome RNA helicase DDX39B;Isoform 2 of Spliceosome RNA helicase DDX39B;Spliceosome RNA helicase DDX39Bp;;;mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,cellular response to DNA damage stimulus,regulation of gene expression,RNA secondary structure unwinding,mRNA 3'-end processing;spliceosomal complex assembly,mRNA splicing, via spliceosome,liver development,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,RNA splicing,RNA secondary structure unwinding,mRNA 3'-end processing,positive regulation of DNA-templated transcription, elongation,positive regulation of translation,viral mRNA export from host cell nucleus,positive regulation of cell growth involved in cardiac muscle cell development,positive regulation of vascular smooth muscle cell proliferation,negative regulation of DNA damage checkpoint,positive regulation of DNA biosynthetic process;;f;;;RNA binding,ATP-dependent RNA helicase activity,protein binding,ATP binding,ATPase activity,identical protein binding;RNA binding,ATP-dependent RNA helicase activity,protein binding,ATP binding,RNA-dependent ATPase activity,ATPase activity,U6 snRNA binding,U4 snRNA binding,protein complex binding,identical protein binding,ATP-dependent protein binding;;;;;nucleus,nucleoplasm,spliceosomal complex,membrane,nuclear speck,cytoplasm;transcription export complex,nucleus,nucleoplasm,spliceosomal complex,nuclear matrix,nuclear speck,U4 snRNP,U6 snRNP,cytoplasm;;STAT3Signal transducer and activator of transcription;Signal transducer and activator of transcription 3;Iso< form Del-701 of Signal transducer and activator of transcription 3;Isoform 3 of Signal transducer and activator of transcription 3 ;negative regulation of transcription from RNA polymerase II promoter,temperature homeostasis,eye photoreceptor cell differentiation,regulation of transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,protein import into nucleus,movement of cell or subcellular component,acute-phase response,inflammatory response,signal transduction,JAK-STAT cascade,nervous system development,aging,cell proliferation,positive regulation of cell proliferation,negative regulation of cell proliferation,positive regulation of gene expression,negative regulation of hydrogen peroxide biosynthetic process,viral process,phosphorylation,cytokine-mediated signaling pathway,sexual reproduction,intracellular receptor signaling pathway,response to estradiol,cellular response to hormone stimulus,leptin-mediated signaling pathway,somatic stem cell population maintenance,miRNA mediated inhibition of translation,regulation of multicellular organism growth,response to drug,positive regulation of tyrosine phosphorylation of Stat3 protein,glucose homeostasis,eating behavior,mRNA transcription from RNA polymerase II promoter,negative regulation of apoptotic process,cellular response to leptin stimulus,response to leptin,response to ethanol,positive regulation of Notch signaling pathway,negative regulation of glycolytic process,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,regulation of mitochondrial membrane permeability,astrocyte differentiation,regulation of cell cycle,radial glial cell differentiation,regulation of feeding behavior,growth hormone receptor signaling pathway,JAK-STAT cascade involved in growth hormone signaling pathway,interleukin-6-mediated signaling pathway,cellular response to organic cyclic compound,T-helper 17 cell lineage commitment,energy homeostasis,negative regulation of neuron death,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,positive regulation of metalloendopeptidase activity,positive regulation of gene silencing by miRNA,negative regulation of stem cell differentiation,positive regulation of ATP biosynthetic process,negative regulation of neuron migration;;h;RNA polymerase II core promoter proximal region sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,RNA polymerase II repressing transcription factor binding,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,DNA binding,transcription factor activity, sequence-specific DNA binding,signal transducer activity,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,protein binding,transcription factor binding,protein kinase binding,protein phosphatase binding,chromatin DNA binding,CCR5 chemokine receptor binding,glucocorticoid receptor binding,identical protein binding,protein homodimerization activity,transcription regulatory region DNA binding,protein dimerization activity;;;nuclear chromatin,nucleus,nucleoplasm,cytoplasm,mitochondrial inner membrane,cytosol,plasma membrane,RNA polymerase II transcription factor complex;;EPS15L1dEpidermal growth factor receptor substrate 15-like 1;Epidermal growth factor receptor substrate 15-like 1;Epidermal growth factor receptor substrate 15-like 1;Isoform 2 of Epidermal growth factor receptor substrate 15-like 1;Isoform 3 of Epidermal growth factor receptor substrate 15-like 1;Isoform 4 of Epidermal growth factor receptor substrate 15-like 1p;;endocytosis,negative regulation of epidermal growth factor receptor signaling pathway,membrane organization;;;9;;calcium ion binding,protein binding,cadherin binding;;;I;;nucleus,cytosol,plasma membrane,membrane,clathrin coat of coated pit;;;<Plexin domain-containing protein 1 (Fragment);Plexin domain-containing protein 1 (Fragment);Plexin domain-containing protein 1 (Fragment);Plexin domain-containing protein 1;Isoform 2 of Plexin domain-containing protein 1;Isoform 3 of Plexin domain-containing protein 1;Isoform 4 of Plexin domain-containing protein 1*;;;angiogenesis,spinal cord development;;;;;;protein binding;;;;;;extracellular region,cytoplasm,plasma membrane,bicellular tight junction,integral component of membrane,dendrite,neuronal cell body,receptor complex;;;bBridging integrator 2;Bridging integrator 2;Bridging integrator 2;Bridging integrator 2 (Fragment)j;;phagocytosis, engulfment,neutrophil degranulation,cell chemotaxis,podosome assembly,membrane tubulation;';;protein binding,phospholipid binding;;;podosome,extracellular region,cell cortex,cell junction,secretory granule lumen,cell projection,ficolin-1-rich granule lumen,phagocytic cup;PROCRHEndothelial protein C receptor (Fragment);Endothelial protein C receptorI;blood coagulation,negative regulation of coagulation,leukocyte migration;extracellular region,centrosome,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,extracellular exosomeARMC8#;;;;;;neutrophil degranulation;;;;;;;;;;;protein binding;;;;;M;;;;;;extracellular region,specific granule lumen,tertiary granule lumen;;;;;Q9H6X2Anthrax toxin receptor 1blood vessel development,signal transduction,reproductive process,actin cytoskeleton reorganization,substrate adhesion-dependent cell spreading,negative regulation of extracellular matrix assembly,positive regulation of metallopeptidase activitystransmembrane signaling receptor activity,protein binding,collagen binding,metal ion binding,actin filament bindingplasma membrane,external side of plasma membrane,cell surface,endosome membrane,integral component of membrane,lamellipodium membrane,filopodium membrane,extracellular exosomeInterleukin-1 receptor accessory protein;Isoform 2 of Interleukin-1 receptor accessory protein;Isoform 4 of Interleukin-1 receptor accessory proteinprotein complex assembly,inflammatory response,immune response,positive regulation of interleukin-13 production,positive regulation of interleukin-5 production,interleukin-33-mediated signaling pathway,interleukin-2 biosynthetic process,innate immune response,positive regulation of NF-kappaB transcription factor activity,positive regulation of synapse assembly,interleukin-4 secretion,positive regulation of dendrite development,positive regulation of interleukin-6 secretion;;}interleukin-33 receptor activity,signal transducer activity,interleukin-1 receptor activity,protein tyrosine kinase binding;;Textracellular space,plasma membrane,integral component of plasma membrane,membrane;; TYPH_HUMAN<Thymidine phosphorylase;Isoform 2 of Thymidine phosphorylaseangiogenesis,pyrimidine nucleobase metabolic process,chemotaxis,cell differentiation,pyrimidine nucleoside salvage,pyrimidine nucleoside catabolic process;phosphorylase activity,growth factor activity,thymidine phosphorylase activity,pyrimidine-nucleoside phosphorylase activity,transferase activity, transferring pentosyl groups;cytosol;;intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,adult locomotory behavior,cerebellar Purkinje cell layer maturation,pigmentation ;RNA bindingc;Golgi membrane,endoplasmic reticulum membrane,cytosol,membrane,COPI vesicle coat,transport vesiclePDZ and LIM domain protein 5;Isoform 4 of PDZ and LIM domain protein 5;Isoform 6 of PDZ and LIM domain protein 5;Isoform 7 of PDZ and LIM domain protein 5regulation of synapse assembly,regulation of dendritic spine morphogenesis,cell growth involved in cardiac muscle cell development,cell-cell adhesion;;;actin binding,protein kinase C binding,protein binding,zinc ion binding,actinin binding,protein N-terminus binding,cadherin binding involved in cell-cell adhesion;;;cytosol,cell-cell adherens junction,postsynaptic density,actin cytos< keleton,membrane,neuron projection,postsynaptic membrane;;;P36871Phosphoglucomutase-1glycogen biosynthetic process,glycogen catabolic process,glucose metabolic process,gluconeogenesis,glycolytic process,galactose catabolic process,neutrophil degranulationAmagnesium ion binding,phosphoglucomutase activity,protein bindingextracellular region,cytoplasm,cytosol,actin cytoskeleton,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumen PRS8_HUMANP26S protease regulatory subunit 8;Isoform 2 of 26S protease regulatory subunit 8sMAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,transcription from RNA polymerase II promoter,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,negative regulation of programmed cell death,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,modulation of synaptic transmission,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of inclusion body assembly,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process;transcription cofactor activity,protein binding,ATP binding,transcription factor binding,ATPase activity,TBP-class protein binding,thyrotropin-releasing hormone receptor binding,proteasome-activating ATPase activity; proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,inclusion body,proteasome accessory complex,cytoplasmic vesicle,nuclear proteasome complex,cytosolic proteasome complex,extracellular exosome,blood microparticle,postsynapse;P62277RPS13 RS13_HUMAN40S ribosomal protein S13nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,negative regulation of RNA splicingRNA binding,mRNA binding,structural constituent of ribosome,protein binding,small ribosomal subunit rRNA binding,5.8S rRNA bindingnucleus,nucleoplasm,nucleolus,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosomeP54920 SNAA_HUMANqintracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,brain development,regulation of synaptic vesicle priming,neuron differentiation,synaptic transmission, glutamatergic,SNARE complex disassembly,apical protein localization,COPII vesicle coating,membrane fusionnSNARE binding,soluble NSF attachment protein activity,protein binding,syntaxin binding,protein complex bindingGolgi membrane,vacuolar membrane,cytosol,membrane,SNARE complex,terminal bouton,myelin sheath,synaptobrevin 2-SNAP-25-syntaxin-1a complex,extracellular exosomeP32320CDA CDD_HUMANCytidine deaminase(cell surface receptor signaling pathway,pyrimidine-containing compound salvage,cytidine deamination,cytosine metabolic process,negative regulation of cell growth,pyrimidine nucleoside salvage,neutrophil degranulation,negative regulation of nucleotide metabolic process,protein homotetramerizationqnucleoside binding,cytidine deaminase activity,protein binding,zinc ion binding,protein homodimerization activityhextracellular region,cytosol,secretory granule lumen,tertiary granule lumen,ficolin-1-rich granule lumenNAPG SNAG_HUMANVGamma-soluble NSF attachment protein;Isoform 2 of Gamma-soluble NSF attachment proteinprotein complex assembly,intracellular protein transport,intra-Golgi vesicle-mediated transport,protein stabilization,membrane fusion;Isoluble NSF attachment protein activity,protein binding,syntaxin binding;Smitochondrion,lysosomal membrane,SNARE complex,myelin sheath,extracellular exosome;OProtein NEDD8-MDP1 (Fragment);Protein NEDD8-MDP1;NEDD8;NEDD8;Protein NEDD8-MDP1tdephosphorylation;;;regulation of transcription from RNA polymerase II promoter,cellular protein modification process,proteolysis,ubiquitin-dependent protein catabolic process,transforming growth factor beta receptor signaling pathway,protein localization,anatomical structure morphogenesis,response to organic cyclic compound,protein deubiquitination,protein neddylation;Hphosphatase activity;;;protein binding,ubiquitin protein ligase binding;);;;nucleus,cytosol,extracellular exosome;*Annexin;Annexin A6;Isoform 2 of Annexin A6;calcium ion transport,regulation of muscle contraction,ion transmembrane transport,protein homooligomerization,mitochondrial calcium ion homeostasis,apoptotic signaling pathway;;calcium ion binding,protein binding,GTP binding,calcium-dependent phospholipid binding,lipid binding,ligand-gated ion channel activity,cholesterol binding,protein homodimerization activity,calcium-dependent protein binding;;mitochondrion,lysosomal membrane,focal adhesion,membrane,late endosome membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome;GAPVD1GTPase-activating protein and VPS9 domain-containing protein 1;GTPase-activating protein and VPS9 domain-containing protein 1;GTPase-activating protein and VPS9 domain-containing protein 1;GTPase-activating protein and VPS9 domain-containing protein 1 (Fragment);GTPase-activating protein and VPS9 domain-containing protein 1;GTPase-activating protein and VPS9 domain-containing protein 1 (Fragment);GTPase-activating protein and VPS9 domain-containing protein 1 (Fragment);GTPase-activating protein and VPS9 domain-containing protein 1;Isoform 2 of GTPase-activating protein and VPS9 domain-containing protein 1;Isoform 3 of GTPase-activating protein and VPS9 domain-containing protein 1;Isoform 4 of GTPase-activating protein and VPS9 domain-containing protein 1;Isoform 5 of GTPase-activating protein and VPS9 domain-containing protein 1;Isoform 6 of GTPase-activating protein and VPS9 domain-containing protein 1;;;;;;;endocytosis,signal transduction,positive regulation of GTPase activity,regulation of protein transport,membrane organization;;;;;;;;;;;;guanyl-nucleotide exchange factor activity,GTPase activator activity,Rab guanyl-nucleotide exchange factor activity,GTPase activating protein binding,cadherin binding;;;;;%;;;;;;;endosome,cytosol,membrane;;;;;SACM1LPhosphatidylinositide phosphatase SAC1;Phosphatidylinositide phosphatase SAC1;Isoform 2 of Phosphatidylinositide phosphatase SAC1e;phosphatidylinositol biosynthetic process,biological_process,phosphatidylinositol dephosphorylation;;phosphatidylinositol-3-phosphatase activity,protein binding,phosphatase activity,phosphatidylinositol bisphosphate phosphatase activity,phosphatidylinositol phosphate 4-phosphatase activity,phosphatidylinositol-4-phosphate phosphatase activity;;Golgi membrane,endoplasmic reticulum membrane,Golgi apparatus,integral component of endoplasmic reticulum membrane,AMPA glutamate receptor complex;HCLS1+Hematopoietic lineage cell-specific protein;negative regulation of transcription from RNA polymerase II promoter,regulation of transcription, DNA-< templated,positive regulation of cell proliferation,response to hormone,positive regulation of phosphatidylinositol 3-kinase signaling,actin filament polymerization,erythrocyte differentiation,regulation of actin filament polymerization,positive regulation of granulocyte differentiation,positive regulation of peptidyl-serine phosphorylation,intracellular signal transduction,positive regulation of tyrosine phosphorylation of STAT protein,positive regulation of transcription factor import into nucleus,positive regulation of macrophage differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling,cellular response to cytokine stimulus,negative regulation of leukocyte apoptotic process,positive regulation of actin cytoskeleton reorganization;RNA polymerase II transcription factor binding,actin binding,protein binding,SH3 domain binding,protein kinase binding,protein complex bindingU;nucleus,transcription factor complex,cytoplasm,mitochondrion,cytosol,plasma membrane CD34_HUMANQ92673SORL1 SORL_HUMANSortilin-related receptor1protein targeting to Golgi,protein targeting,protein targeting to lysosome,lipid transport,post-Golgi vesicle-mediated transport,receptor-mediated endocytosis,signal transduction,cholesterol metabolic process,regulation of smooth muscle cell migration,negative regulation of protein binding,negative regulation of protein oligomerization,negative regulation of MAP kinase activity,cellular protein metabolic process,protein retention in Golgi apparatus,positive regulation of protein catabolic process,negative regulation of neurogenesis,protein maturation,positive regulation of protein exit from endoplasmic reticulum,negative regulation of neuron death,negative regulation of beta-amyloid formation,positive regulation of choline O-acetyltransferase activity,negative regulation of tau-protein kinase activity,positive regulation of ER to Golgi vesicle-mediated transport,positive regulation of early endosome to recycling endosome transport,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,positive regulation of protein localization to early endosome,negative regulation of neurofibrillary tangle assembly,positive regulation of endocytic recyclingbeta-amyloid binding,transmembrane signaling receptor activity,protein binding,low-density lipoprotein particle binding,ADP-ribosylation factor binding%Golgi membrane,extracellular space,nuclear envelope lumen,endosome,early endosome,endoplasmic reticulum,Golgi apparatus,trans-Golgi network,integral component of plasma membrane,endosome membrane,membrane,Golgi cisterna,low-density lipoprotein particle,recycling endosome,extracellular exosomeQ14247-3$Isoform 3 of Src substrate cortactinDynactin subunit 3 (Fragment);Dynactin subunit 3;Isoform 2 of Dynactin subunit 3;Isoform 3 of Dynactin subunit 3;Dynactin subunit 3;Dynactin subunit 3;G2/M transition of mitotic cell cycle,cytokinesis,ER to Golgi vesicle-mediated transport,microtubule-based process,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,ciliary basal body docking;;;;1;structural molecule activity,protein binding;;;;;condensed chromosome kinetochore,nucleolus,centrosome,spindle,cytosol,dynactin complex,midbody,cleavage furrow,perinuclear region of cytoplasm;;;;PSMC4 PRS6B_HUMANR26S protease regulatory subunit 6B;Isoform 2 of 26S protease regulatory subunit 6BMAPK cascade,protein polyubiquitination,blastocyst development,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,proteolysis,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process;lprotein binding,ATP binding,ATPase activity,TBP-class protein binding,proteasome-activating ATPase activity;proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,inclusion body,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,synapse;AP2S1AP-2 complex subunit sigma;AP-2 complex subunit sigma;AP-2 complex subunit sigma;Isoform 2 of AP-2 complex subunit sigma;AP-2 complex subunit sigma;;intracellular protein transport,receptor-mediated endocytosis,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,regulation of endocytosis,ephrin receptor signaling pathway,clathrin coat assembly,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,membrane organization,clathrin-dependent endocytosis;;_;;transporter activity,protein binding,protein transporter activity,clathrin adaptor activity;;;;cytosol,plasma membrane,AP-2 adaptor complex,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,endolysosome membrane;;IST1IST1 homolog (Fragment);IST1 homolog (Fragment);IST1 homolog;Isoform 2 of IST1 homolog;Isoform 3 of IST1 homolog;Isoform 4 of IST1 homolog;Isoform 5 of IST1 homologZ;;cytokinesis,protein localization,abscission,protein transport,viral release from host cell,multivesicular body assembly,neutrophil degranulation,establishment of protein localization,positive regulation of proteolysis,viral capsid secondary envelopment,positive regulation of collateral sprouting,cell division,ESCRT III complex disassembly;;;;q;;protein binding,protein domain specific binding,protein complex binding,cadherin binding,MIT domain binding;;;;;;extracellular region,nuclear envelope,endoplasmic reticulum-Golgi intermediate compartment,centrosome,cytosol,midbody,azurophil granule lumen,intracellular membrane-bounded organelle,extracellular exosome,Flemming body;;;;YSynaptosomal-associated protein 23;Isoform SNAP-23b of Synaptosomal-associated protein 23Iantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,histamine secretion by mast cell,post-Golgi vesicle-mediated transport,vesicle targeting,protein transport,synaptic vesicle priming,synaptic vesicle fusion to presynaptic active zone membrane,neutrophil degranulation,membrane fusion;8SNAP receptor activity,protein binding,syntaxin binding;nucleoplasm,cytoplasm,plasma membrane,cell-cell adherens junction,focal adhesion,phagocytic vesicle membrane,SNARE complex,specific granule membrane,specific granule,azurophil granule,mast cell granule,neuron projection,extracellular exosome,tertiary granule membrane,presynapse;SEC31AProtein transport protein Sec31A;Protein transport protein Sec31A;Isoform 10 of Protein transport protein Sec31A;Isoform 2 of Protein transport protein Sec31A;Isoform 3 of Protein transport protein Sec31A;Isoform 4 of Protein transport protein Sec31A;Isoform 6 of Protein transport protein Sec31A;I< soform 8 of Protein transport protein Sec31A;Isoform 9 of Protein transport protein Sec31A/;antigen processing and presentation of peptide antigen via MHC class I,ER to Golgi vesicle-mediated transport,protein transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,IRE1-mediated unfolded protein response,COPII vesicle coating,response to calcium ion;;;;;;;9;protein binding,calcium-dependent protein binding;;;;;;;+;Golgi membrane,cytoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,cytosol,ER to Golgi transport vesicle membrane,vesicle coat,COPII vesicle coat,ER to Golgi transport vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,endoplasmic reticulum exit site;;;;;;;ALOX5Arachidonate 5-lipoxygenase;Arachidonate 5-lipoxygenase;Isoform 2 of Arachidonate 5-lipoxygenase;Isoform 3 of Arachidonate 5-lipoxygenase;Isoform 4 of Arachidonate 5-lipoxygenase;Isoform 5 of Arachidonate 5-lipoxygenase;leukotriene production involved in inflammatory response,leukotriene metabolic process,leukotriene biosynthetic process,lipoxygenase pathway,neutrophil degranulation,oxidation-reduction process,lipoxin metabolic process;;;;J;arachidonate 5-lipoxygenase activity,iron ion binding,protein binding;;;;;extracellular region,extracellular space,nuclear envelope,nuclear envelope lumen,nucleoplasm,cytosol,nuclear matrix,nuclear membrane,secretory granule lumen,ficolin-1-rich granule lumen;;;;[FYN-binding protein;Isoform FYB-130 of FYN-binding protein;Isoform 3 of FYN-binding proteinprotein phosphorylation,NLS-bearing protein import into nucleus,immune response,signal transduction,biological_process,intracellular signal transduction,T cell receptor signaling pathway,protein localization to plasma membrane;;:receptor binding,protein binding,protein complex binding;;Bnucleus,cytosol,plasma membrane,actin cytoskeleton,cell junction;;P40238-2MPL TPOR_HUMAN$Isoform 2 of Thrombopoietin receptorNRho GTPase-activating protein 18;Isoform 2 of Rho GTPase-activating protein 18small GTPase mediated signal transduction,regulation of cell shape,regulation of actin filament polymerization,regulation of actin cytoskeleton organization,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,regulation of cell motility;+GTPase activator activity,cadherin binding;0cytoplasm,cytosol,plasma membrane,nuclear speck;$Contactin-1;Isoform 2 of Contactin-1cell adhesion,Notch signaling pathway,positive regulation of gene expression,positive regulation of sodium ion transport,positive regulation of neuron projection development,cerebellum development,neuron projection development,positive regulation of peptidyl-tyrosine phosphorylation;*glycoprotein binding,carbohydrate binding;jplasma membrane,membrane,anchored component of membrane,myelin sheath,membrane raft,extracellular exosome;";MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycleK;protein binding,identical protein binding,endopeptidase activator activitym;proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,membrane,extracellular exosomeEukaryotic translation initiation factor 5A (Fragment);Eukaryotic translation initiation factor 5A;Eukaryotic translation initiation factor 5A;Eukaryotic translation initiation factor 5A (Fragment);Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1;Isoform 2 of Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-2a;;;;;mRNA export from nucleus,translational frameshifting,protein export from nucleus,nucleocytoplasmic transport,apoptotic process,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,positive regulation of translational elongation,positive regulation of translational termination;;translational frameshifting,spermatogenesis,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,polyamine homeostasis,protein transport,positive regulation of translational elongation,positive regulation of translational termination,mRNA transport;;;;;RNA binding,translation elongation factor activity,protein binding,U6 snRNA binding,ribosome binding,protein N-terminus binding;;translation elongation factor activity,protein binding,ribosome binding;;;;;nucleus,annulate lamellae,nuclear pore,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,extracellular exosome;;nuclear pore,endoplasmic reticulum membrane,cytosol,intracellular membrane-bounded organelleQ9UBX1CTSF CATF_HUMAN Cathepsin Fproteolysis,antigen processing and presentation of exogenous peptide antigen via MHC class II,proteolysis involved in cellular protein catabolic process$cysteine-type endopeptidase activityXextracellular space,lysosome,lysosomal lumen,extracellular exosome,extracellular vesicleQ6UXB8Peptidase inhibitor 16)negative regulation of peptidase activitypeptidase inhibitor activityP20039 2B1B_HUMANARG1 ARGI1_HUMAN:Arginase-1;Isoform 2 of Arginase-1;Isoform 3 of Arginase-1wurea cycle,liver development,positive regulation of endothelial cell proliferation,arginine catabolic process,aging,response to herbicide,response to manganese ion,response to zinc ion,response to selenium ion,regulation of L-arginine import,response to amine,arginine catabolic process to ornithine,lung development,collagen biosynthetic process,response to vitamin A,response to vitamin E,response to drug,response to amino acid,neutrophil degranulation,response to cadmium ion,response to axon injury,response to methylmercury,mammary gland involution,maternal process involved in female pregnancy,protein homotrimerization,cellular response to hydrogen peroxide,cellular response to lipopolysaccharide,cellular response to interleukin-4,cellular response to glucagon stimulus,cellular response to dexamethasone stimulus,cellular response to transforming growth factor beta stimulus;;)arginase activity,manganese ion binding;;extracellular region,extracellular space,nucleus,cytoplasm,mitochondrial outer membrane,cytosol,azurophil granule lumen,specific granule lumen,neuron projection,neuronal cell body,extracellular exosome;;O14980XPO1 XPO1_HUMAN Exportin-1ribosomal subunit export from nucleus,ribosomal large subunit export from nucleus,ribosomal small subunit export from nucleus,negative regulation of transcription from RNA polymerase II promoter,protein export from nucleus,sister chromatid cohesion,regulation of centrosome duplication,viral process,protein localization to nucleus,regulation of protein catabolic process,response to drug,regulation of mRNA stability,regulation of protein export from nucleus,mRNA transport,intracellular transport of virusRNA binding,nuclear export signal receptor activity,transporter activity,nucleocytoplasmic tr< ansporter activity,protein binding,Ran GTPase binding,protein domain specific bindingkinetochore,nucleus,nuclear envelope,annulate lamellae,nucleoplasm,nucleolus,cytoplasm,cytosol,Cajal body,membrane,intracellular ribonucleoprotein complex,nuclear membrane,intracellular membrane-bounded organelleABCE1*ATP-binding cassette sub-family E member 1;ribosomal subunit export from nucleus,translational initiation,translational termination,viral process,transmembrane transport,negative regulation of endoribonuclease activity;iron ion binding,protein binding,ATP binding,ATPase activity,ribosomal small subunit binding,endoribonuclease inhibitor activityq;cytoplasm,mitochondrion,mitochondrial matrix,cytosol,membrane,eukaryotic translation initiation factor 3 complexCCM2L CCM2L_HUMANCerebral cavernous malformations 2 protein-like;Isoform 2 of Cerebral cavernous malformations 2 protein-like;Isoform 3 of Cerebral cavernous malformations 2 protein-like!cardiac atrium morphogenesis,ventricular trabecula myocardium morphogenesis,biological_process,negative regulation of protein binding,negative regulation of homotypic cell-cell adhesion,wound healing,cardiac muscle tissue growth,positive regulation of fibroblast growth factor production;;molecular_function;;cellular_component;;DCN@Decorin (Fragment);Decorin (Fragment);Decorin (Fragment);Decorin";;;kidney development,placenta development,negative regulation of protein kinase activity,skeletal muscle tissue development,aging,response to mechanical stimulus,animal organ morphogenesis,positive regulation of autophagy,negative regulation of endothelial cell migration,positive regulation of phosphatidylinositol 3-kinase signaling,positive regulation of macroautophagy,negative regulation of angiogenesis,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,response to lipopolysaccharide,wound healing,positive regulation of transcription from RNA polymerase II promoter,negative regulation of JAK-STAT cascade,positive regulation of mitochondrial depolarization,positive regulation of mitochondrial fission,negative regulation of vascular endothelial growth factor signaling pathway;;;RNA binding,protein kinase inhibitor activity,protein binding,collagen binding,glycosaminoglycan binding,protein N-terminus binding,extracellular matrix binding;;;extracellular region,proteinaceous extracellular matrix,collagen type VI trimer,extracellular space,cytoplasm,Golgi lumen,lysosomal lumen,extracellular matrixQ8NBJ4Golgi membrane protein 1:nucleus organization,regulation of lipid metabolic process_extracellular space,Golgi apparatus,integral component of plasma membrane,extracellular exosomeP10646-2/Isoform Beta of Tissue factor pathway inhibitor ANXA2_HUMAN"Annexin A2;Isoform 2 of Annexin A2Tangiogenesis,membrane raft assembly,positive regulation of receptor recycling,positive regulation of protein phosphorylation,membrane budding,body fluid secretion,collagen fibril organization,positive regulation of vesicle fusion,negative regulation of low-density lipoprotein particle receptor catabolic process,osteoclast development,fibrinolysis,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of fibroblast proliferation,protein heterotetramerization,protein targeting to plasma membrane,response to thyroid hormone,cell-cell adhesion,Requires Ontology;mprotease binding,RNA binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal protein binding,Rab GTPase binding,phospholipase A2 inhibitor activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion,receptor activator activity;&ruffle,extracellular region,basement membrane,extracellular space,nucleus,lysosomal membrane,endosome,early endosome,lipid particle,cytosol,plasma membrane,cell-cell adherens junction,cell cortex,cell surface,membrane,basolateral plasma membrane,extrinsic component of plasma membrane,midbody,late endosome membrane,vesicle,azurophil granule lumen,myelin sheath adaxonal region,sarcolemma,melanosome,Schmidt-Lanterman incisure,macropinosome,perinuclear region of cytoplasm,extracellular exosome,PCSK9-AnxA2 complex,extracellular matrix,membrane raft;&CD226 antigen (Fragment);CD226 antigen;cytokine production,positive regulation of natural killer cell cytokine production,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,positive regulation of immunoglobulin mediated immune response,cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,signal transduction,cell recognition,positive regulation of interferon-gamma production,positive regulation of mast cell activation,positive regulation of natural killer cell mediated cytotoxicity,regulation of immune response,positive regulation of Fc receptor mediated stimulatory signaling pathway;receptor activity,integrin binding,protein binding,protein kinase binding,protein homodimerization activity,cell adhesion molecule binding;plasma membrane,integral component of plasma membrane,cell-cell adherens junction,external side of plasma membrane,cell surface,membrane raftJRho GTPase-activating protein 1 (Fragment);Rho GTPase-activating protein 1;small GTPase mediated signal transduction,Rho protein signal transduction,positive regulation of signal transduction,positive regulation of GTPase activity,regulation of small GTPase mediated signal transductiong;SH3/SH2 adaptor activity,GTPase activator activity,protein binding,SH3 domain binding,cadherin bindingH;cytoplasm,cytosol,perinuclear region of cytoplasm,extracellular exosomePeroxisomal multifunctional enzyme type 2;Peroxisomal multifunctional enzyme type 2;Isoform 2 of Peroxisomal multifunctional enzyme type 2;Isoform 3 of Peroxisomal multifunctional enzyme type 2;very long-chain fatty acid metabolic process,osteoblast differentiation,fatty acid beta-oxidation,bile acid biosynthetic process,androgen metabolic process,estrogen metabolic process,fatty acid beta-oxidation using acyl-CoA oxidase,alpha-linolenic acid metabolic process,very long-chain fatty-acyl-CoA metabolic process,medium-chain fatty-acyl-CoA metabolic process,Sertoli cell development;;;3-hydroxyacyl-CoA dehydrogenase activity,receptor binding,long-chain-enoyl-CoA hydratase activity,isomerase activity,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,protein homodimerization activity,17-beta-hydroxysteroid dehydrogenase (NAD+) activity;;L;mitochondrion,peroxisome,peroxisomal membrane,peroxisomal matrix,membrane;;RAB5B RAB5B_HUMANBRas-related protein Rab-5B;Isoform 2 of Ras-related protein Rab-5Bendosome organization,small GTPase mediated signal transduction,protein transport,antigen processing and presentation,regulation of endocytosis,neutrophil degranulation,plasma membrane to endosome transport,membrane organization;VGTPase activity,protein binding,GTP binding,GDP binding,GTP-dependent protein binding;intracellular,endosome,early endosome,plasma membrane,membrane,endocytic vesicle,secretory granule membrane,early endosome membrane,melanosome,intracellular membrane-bounded organelle,extracellular exosome;FCRL5 FCRL5_HUMANjFc receptor-like protein 5;Isoform 3 of Fc receptor-like protein 5;Isoform 4 of Fc receptor-like protein 5Aplasma membrane,integral component of membrane,receptor complex;;RUncharacterized protein;Dual specificity mitogen-activated protein kinase kinase 2Vprotein phosphorylation;MAPK cascade,activation of MAPK activity,negative regulation of gene expression,peptidyl-tyrosine phosphorylation,regulation of stress-activated MAPK cascade,proteolysis in other organism,peptidyl-serine autophosphorylation,< positive regulation of transcription, DNA-templated,ERK1 and ERK2 cascade,positive regulation of ERK1 and ERK2 cascade,positive regulation of protein serine/threonine kinase activity,regulation of Golgi inheritance,positive regulation of production of miRNAs involved in gene silencing by miRNA,regulation of early endosome to late endosome transportprotein kinase activity,ATP binding;protein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,MAP kinase kinase activity,protein serine/threonine/tyrosine kinase activity,protein tyrosine kinase activity,protein binding,ATP binding,PDZ domain binding,protein serine/threonine kinase activator activity,metal ion binding,scaffold protein binding ;extracellular region,nucleus,mitochondrion,early endosome,late endosome,peroxisomal membrane,endoplasmic reticulum,Golgi apparatus,cytosol,microtubule,plasma membrane,cell-cell junction,focal adhesion,cytoplasmic side of plasma membrane,perinuclear region of cytoplasmwAlcohol dehydrogenase 4;Alcohol dehydrogenase 4 (Fragment);Alcohol dehydrogenase 4;Isoform 2 of Alcohol dehydrogenase 4;;retinoid metabolic process,alcohol metabolic process,ethanol oxidation,cellular aldehyde metabolic process,retinol metabolic process,alcohol catabolic process,quinone metabolic process;;;NADPH:quinone reductase activity,alcohol dehydrogenase (NAD) activity,alcohol dehydrogenase activity, zinc-dependent,alditol:NADP+ 1-oxidoreductase activity,retinol dehydrogenase activity,all-trans retinal binding,zinc ion binding,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,benzaldehyde dehydrogenase activity,retinol binding,ethanol binding,NAD binding;;;nucleus,cytosol;ATP1B3Sodium/potassium-transporting ATPase subunit beta-3 (Fragment);Sodium/potassium-transporting ATPase subunit beta-3 (Fragment);Sodium/potassium-transporting ATPase subunit beta-3;Isoform 2 of Sodium/potassium-transporting ATPase subunit beta-3k;;transport,cellular sodium ion homeostasis,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,cellular potassium ion homeostasis,positive regulation of ATPase activity,ion transmembrane transport,sodium ion export from cell,protein stabilization,leukocyte migration,protein localization to plasma membrane,membrane repolarization,ATP hydrolysis coupled transmembrane transport,positive regulation of potassium ion transmembrane transporter activity,positive regulation of sodium ion export from cell,positive regulation of potassium ion import,regulation of cardiac conduction;W;;ATPase activator activity,sodium:potassium-exchanging ATPase activity,ATPase binding;f;;plasma membrane,sodium:potassium-exchanging ATPase complex,caveola,melanosome,extracellular exosome;.Integrin alpha-L;Isoform 2 of Integrin alpha-LT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,phagocytosis,movement of cell or subcellular component,inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,signal transduction,integrin-mediated signaling pathway,extracellular matrix organization,receptor clustering,neutrophil degranulation,regulation of immune response,leukocyte migration;protein binding,ICAM-3 receptor activity,protein complex binding,metal ion binding,protein heterodimerization activity,cell adhesion molecule binding;plasma membrane,integrin complex,cell surface,membrane,integrin alphaL-beta2 complex,specific granule membrane,extracellular exosome;GNG7AGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7;G-protein coupled receptor signaling pathway,regulation of G-protein coupled receptor protein signaling pathway,cellular response to glucagon stimulus;signal transducer activityG;heterotrimeric G-protein complex,plasma membrane,extracellular exosomeC9JZC2ZNF621 C9JZC2_HUMANZinc finger protein 6213Prostaglandin G/H synthase 1;Prostaglandin G/H synthase 1;Isoform 2 of Prostaglandin G/H synthase 1;Isoform 3 of Prostaglandin G/H synthase 1;Isoform 4 of Prostaglandin G/H synthase 1;Isoform 5 of Prostaglandin G/H synthase 1;Isoform 6 of Prostaglandin G/H synthase 1;Prostaglandin G/H synthase 1 (Fragment)";prostaglandin biosynthetic process,lipid metabolic process,xenobiotic metabolic process,inflammatory response,response to oxidative stress,regulation of blood pressure,cyclooxygenase pathway,regulation of cell proliferation,oxidation-reduction process,cellular oxidant detoxification;;;;;;{;peroxidase activity,prostaglandin-endoperoxide synthase activity,heme binding,metal ion binding,dioxygenase activity;;;;;;;photoreceptor outer segment,nucleus,cytoplasm,endoplasmic reticulum membrane,Golgi apparatus,organelle membrane,intracellular membrane-bounded organelle,extracellular exosome;;;;;; Cadherin-1;;;homophilic cell adhesion via plasma membrane adhesion molecules,synapse assembly,response to toxic substance,single organismal cell-cell adhesion,pituitary gland development,negative regulation of cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,neuron projection development,adherens junction organization,entry of bacterium into host cell,response to drug,positive regulation of transcription factor import into nucleus,positive regulation of transcription, DNA-templated,cellular response to lithium ion,cellular response to indole-3-methanol,protein localization to plasma membrane,establishment of protein localization to plasma membrane;;;glycoprotein binding,calcium ion binding,protein binding,beta-catenin binding,ankyrin binding,GTPase activating protein binding,gamma-catenin binding,cadherin binding,cell adhesion molecule bindingv;;;extracellular region,endosome,trans-Golgi network,plasma membrane,cell-cell adherens junction,cytoplasmic side of plasma membrane,actin cytoskeleton,integral component of membrane,lateral plasma membrane,catenin complex,flotillin complex,lamellipodium,cell junction,apical junction complex,perinuclear region of cytoplasm,extracellular exosome,cortical actin cytoskeleton A0A087WZR4FCGR3BA0A087WZR4_HUMAN:Low affinity immunoglobulin gamma Fc region receptor III-BOADP-ribosylation factor-like protein 8A;ADP-ribosylation factor-like protein 8Bchromosome segregation,mitotic nuclear division,small GTPase mediated signal transduction,neutrophil degranulation,cell division;cell cycle,chromosome segregation,small GTPase mediated signal transduction,lysosome localization,cell divisionGTPase activity,protein binding,GTP binding,alpha-tubulin binding,beta-tubulin binding;GTPase activity,protein binding,GTP binding,GDP binding,alpha-tubulin binding,beta-tubulin binding cytoplasm,lysosomal membrane,plasma membrane,membrane,midbody,late endosome membrane,azurophil granule membrane,spindle midzone,extracellular exosome,ficolin-1-rich granule membrane;cytoplasm,membrane,midbody,late endosome membrane,spindle midzone,extracellular exosome,lysosomal membraneA6NCN2KRT87P KR87P_HUMANPutative keratin-87 protein$extracellular space,keratin filamentdProgrammed cell death 6-interacting protein;Isoform 2 of Programmed cell death 6-interacting proteinactomyosin contractile ring assembly,cell separation after cytokinesis,apoptotic process,regulation of centrosome duplication,protein transport,viral life cycle,multivesicular body assembly,viral budding via host ESCRT complex,maintenance of epithelial cell apical/basal polarity,bicellular tight junction assembly,regulation of membrane permeability,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,positive regulation of exosomal secretion,regulation of extracellular exosome assembly,positive regulation of extracellular exosome assembly,nucleus organization,mitotic metaphase plate congression,regulation of mitotic spindle assembly;zprotein binding,proteinase activated receptor binding,protein homodimerization activity, calcium-dependent protein binding;immunological synapse,microtubule organi< zing center,cytosol,focal adhesion,membrane,melanosome,actomyosin,myelin sheath,extracellular exosome,endoplasmic reticulum exit site,extracellular vesicle;Annexin;Annexin A5;platelet degranulation,signal transduction,blood coagulation,response to organic substance,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of coagulation;phospholipase inhibitor activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding;extracellular region,intracellular,cytoplasm,cytosol,focal adhesion,external side of plasma membrane,membrane,extracellular exosome,endothelial microparticleEIF3B EIF3B_HUMANvEukaryotic translation initiation factor 3 subunit B;Isoform 2 of Eukaryotic translation initiation factor 3 subunit Btranslational initiation,regulation of translational initiation,IRES-dependent viral translational initiation,viral translational termination-reinitiation;nucleotide binding,RNA binding,translation initiation factor activity,protein binding,translation initiation factor binding,protein complex scaffold;cytosol,eukaryotic translation initiation factor 3 complex,extracellular exosome,eukaryotic translation initiation factor 3 complex, eIF3m;Guanine nucleotide-binding protein G(i) subunit alpha-2;Isoform sGi2 of Guanine nucleotide-binding protein G(i) subunit alpha-2Ractivation of MAPKK activity,adenosine receptor signaling pathway,protein folding,cell cycle,signal transduction,G-protein coupled receptor signaling pathway,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,negative regulation of adenylate cyclase activity,G-protein coupled acetylcholine receptor signaling pathway,gamma-aminobutyric acid signaling pathway,response to nutrient,cell proliferation,positive regulation of cell proliferation,intracellular signal transduction,negative regulation of synaptic transmission,cell division,regulation of calcium ion transport;G-protein coupled receptor binding,GTPase activity,signal transducer activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,metal ion binding;nucleoplasm,cytoplasm,centrosome,cytosol,heterotrimeric G-protein complex,plasma membrane,membrane,dendrite,midbody,cell body,membrane raft,extracellular exosome,extracellular vesicle; Granulins;Isoform 2 of Granulins-signal transduction,neutrophil degranulation;ERNA binding,cytokine activity,protein binding,growth factor activity;extracellular region,extracellular space,lysosome,endosome,endoplasmic reticulum,azurophil granule lumen,extracellular exosome;SELE E-selectinpositive regulation of receptor internalization,leukocyte migration involved in inflammatory response,inflammatory response,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,activation of phospholipase C activity,calcium-mediated signaling,actin filament-based process,response to lipopolysaccharide,response to tumor necrosis factor,regulation of inflammatory response,leukocyte migration,leukocyte tethering or rolling,response to interleukin-1;;;;transmembrane signaling receptor activity,protein binding,sialic acid binding,phospholipase binding,oligosaccharide binding;;;;extracellular space,plasma membrane,caveola,clathrin-coated pit,integral component of membrane,cortical cytoskeleton,membrane raft,perinuclear region of cytoplasm;;;;BLMHpBleomycin hydrolase (Fragment);Bleomycin hydrolase (Fragment);Bleomycin hydrolase (Fragment);Bleomycin hydrolaseu;;;protein polyubiquitination,proteolysis,response to toxic substance,response to drug,homocysteine catabolic process;;;aminopeptidase activity,carboxypeptidase activity,cysteine-type endopeptidase activity,protein binding,cysteine-type peptidase activity,identical protein binding2;;;nucleus,cytoplasm,cytosol,extracellular exosomeCadherin-23;Cadherin-23;Cadherin-23;Cadherin-23;Isoform 2 of Cadherin-23;Isoform 3 of Cadherin-23;Isoform 4 of Cadherin-23;Isoform 8 of Cadherin-23;;;calcium ion transport,homophilic cell adhesion via plasma membrane adhesion molecules,visual perception,sensory perception of sound,locomotory behavior,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,photoreceptor cell maintenance,response to stimulus,sensory perception of light stimulus,equilibrioception,regulation of cytosolic calcium ion concentration,inner ear receptor stereocilium organization;;;;*;;;calcium ion binding,protein binding;;;;K;;;plasma membrane,membrane,integral component of membrane,stereocilium;;;;FLII FLII_HUMANFProtein flightless-1 homolog;Isoform 2 of Protein flightless-1 homologtranscription, DNA-templated,regulation of transcription, DNA-templated,multicellular organism development,actin cytoskeleton organization,actin filament severing;actin binding,protein binding;Nnucleoplasm,microtubule organizing center,cytosol,brush border,focal adhesion;RPL760S ribosomal protein L7];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),cytoplasmic translation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal large subunit biogenesisz;DNA binding,RNA binding,mRNA binding,structural constituent of ribosome,protein binding,protein homodimerization activity;nucleus,nucleolus,cytoplasm,cytosol,polysome,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosomeATP6V1E1 VATE1_HUMAN|V-type proton ATPase subunit E 1;Isoform 2 of V-type proton ATPase subunit E 1;Isoform 3 of V-type proton ATPase subunit E 1insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,phagosome acidification;;protein binding,hydrogen-exporting ATPase activity, phosphorylative mechanism,proton-transporting ATPase activity, rotational mechanism,ATPase binding;;mitochondrion,lysosomal membrane,endosome,cytosol,microvillus,apical plasma membrane,proton-transporting two-sector ATPase complex,proton-transporting two-sector ATPase complex, catalytic domain,extracellular exosome;;GNB5 GBB5_HUMANGuanine nucleotide-binding protein subunit beta-5;Isoform 2 of Guanine nucleotide-binding protein subunit beta-5;Isoform 3 of Guanine nucleotide-binding protein subunit beta-5protein folding,signal transduction,positive regulation of GTPase activity,negative regulation of voltage-gated calcium channel activity;;GTPase activity,signal transducer activity,GTPase activator activity,protein binding,G-protein gamma-subunit binding,chaperone binding;;cytosol,membrane;;PLS3APlastin-3;Plastin-3;Isoform 2 of Plastin-3;Isoform 3 of Plastin-3m;actin filament bundle assembly,actin filament network formation,actin crosslink formation,bone development;;-;calcium ion binding,actin filament binding;;I;cytoplasm,cytosol,actin filament,plasma membrane,actin filament bundle;;KMT2C KMT2C_HUMANHistone-lysine N-methyltransferase 2C;Isoform 2 of Histone-lysine N-methyltransferase 2C;Isoform 3 of Histone-lysine N-methyltransferase 2Cctranscription, DNA-templated,regulation of transcription, DNA-templated,histone H3-K4 methylation;;DNA binding,RNA binding,protein binding,zinc ion binding,transferase activity, transferring acyl groups,histone-lysine N-methyltransferase activity,histone methyltransferase activity (H3-K4 specific);;Fnucleus,nucleoplasm,histone methyltransferase complex,MLL3/4 complex;;VNN2 VNN2_HUMANVVascular non-inflammatory molecule 2;Isoform 6 of Vascular non-inflammatory molecule 2gC-terminal protein lipidation,movement of cell or subcellular component,pantothenate metabolic process;pantetheine hydrolase activity;Dextracellular region,plasma membrane,anchored component of membrane;FNucleosome assembly protein 1-like 4 (Fragment);Nucleosome assembly protein 1-like 4 (Fragment);Nucleosome assembl< y protein 1-like 4 (Fragment);Nucleosome assembly protein 1-like 4 (Fragment);Nucleosome assembly protein 1-like 4 (Fragment);Nucleosome assembly protein 1-like 4;Isoform 2 of Nucleosome assembly protein 1-like 4;;;;;nucleosome assembly;:;;;;;RNA binding,protein binding,unfolded protein binding;;;;;;nucleus,cytoplasm;Isoform 3 of Membrane cofactor protein;Isoform B of Membrane cofactor protein;Isoform D of Membrane cofactor protein;Isoform F of Membrane cofactor protein;Isoform H of Membrane cofactor protein;Isoform J of Membrane cofactor protein;Isoform L of Membrane cofactor protein;;;;;;Q13509TUBB3 TBB3_HUMANTubulin beta-3 chainZcytoskeleton organization,microtubule-based process,mitotic nuclear division,axon guidancebGTPase activity,structural constituent of cytoskeleton,protein binding,GTP binding,peptide binding|nucleus,cytoplasm,microtubule,microtubule cytoskeleton,axon,dendrite,neuronal cell body,extracellular exosome,cell peripheryA8K7I4CLCA1 CLCA1_HUMAN.Calcium-activated chloride channel regulator 1proteolysis,transport,calcium ion transport,ion transmembrane transport,cellular response to hypoxia,chloride transmembrane transportmetalloendopeptidase activity,intracellular calcium activated chloride channel activity,chloride channel activity,metal ion bindingnextracellular space,plasma membrane,integral component of plasma membrane,microvillus,zymogen granule membraneP07437 TBB5_HUMAN&G2/M transition of mitotic cell cycle,movement of cell or subcellular component,microtubule-based process,cellular process,cytoskeleton-dependent intracellular transport,natural killer cell mediated cytotoxicity,neutrophil degranulation,spindle assembly,cell division,ciliary basal body dockingGTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,protein domain specific binding,ubiquitin protein ligase binding,protein complex binding,GTPase activating protein binding,MHC class I protein bindingextracellular region,nucleus,nuclear envelope lumen,cytoskeleton,microtubule,microtubule cytoskeleton,extracellular matrix,azurophil granule lumen,cytoplasmic ribonucleoprotein granule,protein complex,cell body,extracellular exosomeCCRL2 CCRL2_HUMANHC-C chemokine receptor-like 2;Isoform 2 of C-C chemokine receptor-like 2schemotaxis,inflammatory response,G-protein coupled receptor signaling pathway,chemokine-mediated signaling pathway;Vchemokine receptor activity,chemokine receptor binding,CCR chemokine receptor binding;P30044-2Tyrosine-protein phosphatase non-receptor type 12;Isoform 2 of Tyrosine-protein phosphatase non-receptor type 12;Isoform 3 of Tyrosine-protein phosphatase non-receptor type 12fprotein dephosphorylation,peptidyl-tyrosine dephosphorylation,ERBB2 signaling pathway,regulation of epidermal growth factor receptor signaling pathway,tissue regeneration,cellular response to epidermal growth factor stimulus,negative regulation of ERBB signaling pathway,negative regulation of platelet-derived growth factor receptor-beta signaling pathway;;phosphoprotein phosphatase activity,protein tyrosine phosphatase activity,non-membrane spanning protein tyrosine phosphatase activity,protein binding,SH3 domain binding;;;podosome,cytoplasm,cytosol,focal adhesion,cell projection;; A0A075B6W8TRAJ17A0A075B6W8_HUMANProtein TRAJ17 (Fragment)Q14525KRT33B KT33B_HUMAN-aging,keratinization,hair cycle,cornificationGextracellular space,cytosol,intermediate filament,extracellular exosomeAP2A1 AP2A1_HUMANFAP-2 complex subunit alpha-1;Isoform B of AP-2 complex subunit alpha-1intracellular protein transport,Golgi to endosome transport,endocytosis,receptor-mediated endocytosis,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,ephrin receptor signaling pathway,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,membrane organization,clathrin-dependent endocytosis,negative regulation of hyaluronan biosynthetic process;protein binding,protein C-terminus binding,protein transporter activity,protein kinase binding,protein complex binding,clathrin adaptor activity;cytosol,plasma membrane,membrane,basolateral plasma membrane,apical plasma membrane,AP-2 adaptor complex,clathrin coat of trans-Golgi network vesicle,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,filopodium tip,endolysosome membrane;GRIPAP1xGRIP1-associated protein 1;GRIP1-associated protein 1;GRIP1-associated protein 1;Isoform 4 of GRIP1-associated protein 1;;biological_process,neurotransmitter receptor transport, endosome to postsynaptic membrane,regulation of modification of synaptic structure;%;;molecular_function,protein binding;;;nucleoplasm,early endosome,cytosol,intracellular membrane-bounded organelle,blood microparticle,postsynaptic recycling endosome;S-methyl-5'-thioadenosine phosphorylase;Uncharacterized protein;Purine nucleoside phosphorylase;S-methyl-5'-thioadenosine phosphorylase;Isoform 2 of S-methyl-5'-thioadenosine phosphorylase;Isoform 3 of S-methyl-5'-thioadenosine phosphorylase;Isoform 4 of S-methyl-5'-thioadenosine phosphorylase;Isoform 5 of S-methyl-5'-thioadenosine phosphorylase;Isoform 6 of S-methyl-5'-thioadenosine phosphorylase;Isoform 7 of S-methyl-5'-thioadenosine phosphorylase;nucleoside metabolic process;;nucleobase-containing compound metabolic process,purine ribonucleoside salvage,L-methionine biosynthetic process from methylthioadenosine,nicotinamide riboside catabolic process;;;;;;;S-methyl-5-thioadenosine phosphorylase activity;;phosphorylase activity,protein binding,S-methyl-5-thioadenosine phosphorylase activity;;;;;;.;;;nucleus,cytosol,extracellular exosome;;;;;;PPA1Inorganic pyrophosphataseztRNA aminoacylation for protein translation,phosphate-containing compound metabolic process,diphosphate metabolic process;7magnesium ion binding,inorganic diphosphatase activity;WD repeat-containing protein 44 (Fragment);WD repeat-containing protein 44;Isoform 2 of WD repeat-containing protein 44;Isoform 3 of WD repeat-containing protein 44;Isoform 4 of WD repeat-containing protein 44M;Golgi apparatus,cytosol,endosome membrane,perinuclear region of cytoplasm;;;O75791GRAP2 GRAP2_HUMANGRB2-related adapter protein 2~transmembrane receptor protein tyrosine kinase signaling pathway,Ras protein signal transduction,cell-cell signaling,positive regulation of signal transduction,cell migration,cell differentiation,T cell costimulation,peptidyl-tyrosine autophosphorylation,Fc-epsilon receptor signaling pathway,regulation of cell proliferation,innate immune response,T cell receptor signaling pathwaypnon-membrane spanning protein tyrosine kinase activity,SH3/SH2 adaptor activity,receptor binding,protein binding]nucleus,cytoplasm,endosome,cytosol,extrinsic component of cytoplasmic side of plasma membraneQ96L33RHOV RHOV_HUMAN$Rho-related GTP-binding protein RhoVasmall GTPase mediated signal transduction,regulation of small GTPase mediated signal transduction-protein binding,GTP binding,metal ion binding)cytosol,plasma membrane,endosome membraneRAP1GAP2Rap1 GTPase-activating protein 2;Rap1 GTPase-activating protein 2;Isoform 2 of Rap1 GTPase-activating protein 2;Isoform 3 of Rap1 GTPase-activating protein 2;regulation of cell size,negative regulation of neuron projection development,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction;;,;GTPase activator activity,protein binding;;h;centrosome,cytosol,plasma membrane,nuclear membrane,neuron projection,perinuclear region of cytoplasm;;UPF1 RENT1_HUMANTRegulator of nonsense transcripts 1;Isoform 2 of Regulator of nonsense transcripts 1]nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,telomere maintenance,nuclear-transcribed mRNA catabolic process,DNA replication,DNA repair,mRNA export from nucleus,regulation of translational termination,dosage compensa< tion by inactivation of X chromosome,telomere maintenance via semi-conservative replication,positive regulation of mRNA catabolic process,3'-UTR-mediated mRNA destabilization,histone mRNA catabolic process,cellular response to lipopolysaccharide,cellular response to interleukin-1;chromatin binding,RNA binding,ATP-dependent RNA helicase activity,helicase activity,protein binding,ATP binding,zinc ion binding,telomeric DNA binding;nuclear chromosome, telomeric region,chromatin,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,exon-exon junction complex,supraspliceosomal complex;NMyosin light polypeptide 6;Isoform Smooth muscle of Myosin light polypeptide 6zUncharacterized protein KIAA0513 (Fragment);Uncharacterized protein KIAA0513;Isoform 3 of Uncharacterized protein KIAA0513 ;cytoplasm; A0A075B7E8 IGHV3OR16-13A0A075B7E8_HUMANProtein IGHV3OR16-13 (Fragment)MSRA MSRA_HUMAN<Mitochondrial peptide methionine sulfoxide reductase;Isoform 2 of Mitochondrial peptide methionine sulfoxide reductase;Isoform 3 of Mitochondrial peptide methionine sulfoxide reductase;Isoform 4 of Mitochondrial peptide methionine sulfoxide reductase;Isoform 5 of Mitochondrial peptide methionine sulfoxide reductasecellular protein modification process,methionine metabolic process,response to oxidative stress,protein repair,oxidation-reduction process;;;;5peptide-methionine (S)-S-oxide reductase activity;;;;Wnucleoplasm,mitochondrion,cytosol,actin cytoskeleton,membrane,extracellular exosome;;;;DOCK8Dedicator of cytokinesis protein 8;Dedicator of cytokinesis protein 8;Isoform 2 of Dedicator of cytokinesis protein 8;Isoform 3 of Dedicator of cytokinesis protein 8;Isoform 4 of Dedicator of cytokinesis protein 8;immunological synapse formation,small GTPase mediated signal transduction,blood coagulation,dendritic cell migration,positive regulation of GTPase activity,memory T cell proliferation,negative regulation of T cell apoptotic process;;;>;guanyl-nucleotide exchange factor activity,protein binding;;;&;cytosol,membrane,cell leading edge;;; A0A0B4J2H0 IGHV1-69-2A0A0B4J2H0_HUMANProtein IGHV1-69-2 (Fragment)PTPN11Tyrosine-protein phosphatase non-receptor type 11 (Fragment);Tyrosine-protein phosphatase non-receptor type 11;Isoform 2 of Tyrosine-protein phosphatase non-receptor type 116;DNA damage checkpoint,activation of MAPK activity,triglyceride metabolic process,epidermal growth factor receptor signaling pathway,integrin-mediated signaling pathway,axon guidance,brain development,heart development,fibroblast growth factor receptor signaling pathway,hormone-mediated signaling pathway,regulation of phosphatidylinositol 3-kinase signaling,cerebellar cortex formation,platelet activation,platelet formation,T cell costimulation,microvillus organization,abortive mitotic cell cycle,regulation of cell adhesion mediated by integrin,negative regulation of cell adhesion mediated by integrin,multicellular organism growth,organ growth,peptidyl-tyrosine dephosphorylation,megakaryocyte development,phosphatidylinositol-3-phosphate biosynthetic process,atrioventricular canal development,ERBB signaling pathway,regulation of multicellular organism growth,hormone metabolic process,glucose homeostasis,regulation of protein complex assembly,positive regulation of mitotic cell cycle,negative regulation of insulin secretion,regulation of protein export from nucleus,phosphatidylinositol phosphorylation,positive regulation of hormone secretion,platelet-derived growth factor receptor signaling pathway,neurotrophin TRK receptor signaling pathway,ephrin receptor signaling pathway,phosphatidylinositol-mediated signaling,multicellular organismal reproductive process,genitalia development,inner ear development,homeostasis of number of cells within a tissue,leukocyte migration,negative regulation of cortisol secretion,Bergmann glial cell differentiation,negative regulation of growth hormone secretion,face morphogenesis,regulation of type I interferon-mediated signaling pathway,intestinal epithelial cell migration,positive regulation of ERK1 and ERK2 cascade,positive regulation of glucose import in response to insulin stimulus;;phosphoprotein phosphatase activity,protein tyrosine phosphatase activity,non-membrane spanning protein tyrosine phosphatase activity,SH3/SH2 adaptor activity,insulin receptor binding,protein binding,1-phosphatidylinositol-3-kinase activity,protein domain specific binding,receptor tyrosine kinase binding,D1 dopamine receptor binding,phospholipase binding,insulin receptor substrate binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,cell adhesion molecule binding,peptide hormone receptor binding;9;nucleus,cytoplasm,mitochondrion,cytosol,protein complex;SLC11A2TNatural resistance-associated macrophage protein 2 (Fragment);Natural resistance-associated macrophage protein 2;Natural resistance-associated macrophage protein 2 (Fragment);Natural resistance-associated macrophage protein 2;Natural resistance-associated macrophage protein 2;Isoform 1 of Natural resistance-associated macrophage protein 2;;;;heme biosynthetic process,cobalt ion transport,copper ion transport,manganese ion transport,cellular iron ion homeostasis,learning or memory,response to iron ion,ferrous iron transport,lead ion transport,copper ion transmembrane transport,dendrite morphogenesis,erythrocyte development,multicellular organismal iron ion homeostasis,cadmium ion transmembrane transport,ferrous iron import,manganese ion transmembrane transport,hydrogen ion transmembrane transport,ferrous iron transmembrane transport;,;;;;copper ion transmembrane transporter activity,iron ion transmembrane transporter activity,manganese ion transmembrane transporter activity,protein binding,hydrogen ion transmembrane transporter activity,cadmium ion transmembrane transporter activity,cobalt ion transmembrane transporter activity,ferrous iron transmembrane transporter activity,lead ion transmembrane transporter activity,solute:proton symporter activity,ferrous iron uptake transmembrane transporter activity,cadmium ion binding,transition metal ion transmembrane transporter activity;~;;;;nucleus,cytoplasm,mitochondrion,mitochondrial outer membrane,lysosomal membrane,early endosome,vacuole,plasma membrane,integral component of plasma membrane,cell surface,membrane,apical plasma membrane,cytoplasmic vesicle,brush border membrane,late endosome membrane,apical part of cell,basal part of cell,perinuclear region of cytoplasm,recycling endosome,paraferritin complex;DNAJC3!DnaJ homolog subfamily C member 3negative regulation of protein kinase activity,positive regulation of translation initiation in response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,negative regulation of apoptotic process,neutrophil degranulation,proteolysis involved in cellular protein catabolic process,defense response to virus,cellular response to cold,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation;eprotein kinase inhibitor activity,protein kinase binding,chaperone binding,misfolded protein binding;extracellular region,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,cytosol,membrane,endoplasmic reticulum Sec complex,azurophil granule lumen,extracellular exosome,extracellular vesicle;Q09666AHNAK AHNK_HUMAN3Neuroblast differentiation-associated protein AHNAKgregulation of RNA splicing,protein oligomerization,regulation of voltage-gated calcium channel activitytRNA binding,protein binding,S100 protein binding,cadherin binding,structural molecule activity conferring elasticitynucleus,cytoplasm,lysosomal membrane,cytosol,plasma membrane,focal adhesion,actin cytoskeleton,membrane,T-tubule,vesicle,sarcolemma,costamere,cell-cell contact zone,extracellular exosome,membrane raftQ14165 MLEC_HUMANGcarbohydrate metabolic process,protein folding,neutrophil degranulation#enzyme binding,carbohydrate bindingendoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,membrane,integral component of membrane,specific granule membraneQ86UF1< TSPAN33 TSN33_HUMANTetraspanin-33scell surface receptor signaling pathway,protein maturation,establishment of protein localization to plasma membraneenzyme bindingcplasma membrane,integral component of plasma membrane,cell surface,tetraspanin-enriched microdomainQ9UJU6Drebrin-like proteinadaptive immune response,receptor-mediated endocytosis,activation of JUN kinase activity,synapse assembly,Rac protein signal transduction,neutrophil degranulation,neuron projection morphogenesis,podosome assembly,ruffle assemblyactin binding,protein binding,protein C-terminus binding,enzyme activator activity,protein domain specific binding,cadherin binding,actin filament binding-Golgi membrane,ruffle,podosome,extracellular region,cytoplasm,early endosome,cytosol,plasma membrane,cell cortex,postsynaptic density,lamellipodium,cell junction,dendrite,clathrin-coated vesicle membrane,secretory granule lumen,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumenNucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1 (Fragment);Nucleosome assembly protein 1-like 1 (Fragment);Nucleosome assembly protein 1-like 1;Nucleosome assembly protein 1-like 1 (Fragment);Nucleosome assembly protein 1-like 1 (Fragment);Nucleosome assembly protein 1-like 1 (Fragment);Nucleosome assembly protein 1-like 1;Isoform 2 of Nucleosome assembly protein 1-like 1W;;;;;;;;;DNA replication,nucleosome assembly,positive regulation of cell proliferation;%;;;;;;;;;RNA binding,protein binding;%;;;;;;;;;nucleus,membrane,melanosome; ;;chemotaxis,actin filament organization,signal transduction,G-protein coupled receptor signaling pathway,small GTPase mediated signal transduction,positive regulation of cell proliferation,regulation of hydrogen peroxide metabolic process,positive regulation of lamellipodium assembly,regulation of cell-substrate adhesion,cell projection assembly,platelet activation,regulation of T cell proliferation,regulation of mast cell degranulation,bone resorption,regulation of protein kinase activity,regulation of small GTPase mediated signal transduction,regulation of respiratory burst,regulation of mast cell chemotaxis,lymphocyte aggregation,positive regulation of neutrophil chemotaxis,regulation of neutrophil migration,positive regulation of protein targeting to mitochondrion?;;GTPase activity,GTP binding,protein kinase regulator activity;;nuclear envelope,cytosol,plasma membrane,focal adhesion,lamellipodium,phagocytic vesicle membrane,extracellular exosome,actin filamentPhosphoribosyl pyrophosphate synthase-associated protein 2 (Fragment);Phosphoribosyl pyrophosphate synthase-associated protein 2;Isoform 3 of Phosphoribosyl pyrophosphate synthase-associated protein 2;nucleobase-containing compound metabolic process,nucleoside metabolic process,nucleotide biosynthetic process,negative regulation of catalytic activity,bone development;k;magnesium ion binding,ribose phosphate diphosphokinase activity,enzyme inhibitor activity,protein binding;:;ribose phosphate diphosphokinase complex,protein complex;O00533-2:Isoform 2 of Neural cell adhesion molecule L1-like proteinP26641Elongation factor 1-gamma*translational elongation,response to virusGtranslation elongation factor activity,protein binding,cadherin bindingNnucleus,cytoplasm,cytosol,membrane,extracellular exosome,endoplasmic reticulumQ9Y3C8UFC1 UFC1_HUMAN,Ubiquitin-fold modifier-conjugating enzyme 1Yresponse to endoplasmic reticulum stress,protein ufmylation,protein K69-linked ufmylation)protein binding,UFM1 transferase activity CLIP1_HUMANCAP-Gly domain-containing linker protein 1;Isoform 2 of CAP-Gly domain-containing linker protein 1;Isoform 3 of CAP-Gly domain-containing linker protein 1microtubule bundle formation,sister chromatid cohesion,mitotic nuclear division,positive regulation of microtubule polymerization,protein transport into plasma membrane raft;;protein binding,microtubule binding,zinc ion binding,tubulin binding,protein homodimerization activity,metal ion binding,microtubule plus-end binding;;kinetochore,ruffle,nuclear envelope,endosome,centrosome,cytosol,microtubule,cytoplasmic microtubule,intermediate filament,microtubule cytoskeleton,cytoplasmic vesicle membrane,microtubule plus-end,macropinosome;;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Isoform 2 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Isoform 3 of Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (Fragment);protein glycosylation,protein N-linked glycosylation,protein N-linked glycosylation via asparagine,response to cytokine,T cell activation,neutrophil degranulation;;;{;protein binding,oligosaccharyl transferase activity,dolichyl-diphosphooligosaccharide-protein glycotransferase activity;;;;endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,oligosaccharyltransferase complex,membrane,integral component of membrane,azurophil granule membrane,intracellular membrane-bounded organelle,protein complex;;;HAPLN1`Hyaluronan and proteoglycan link protein 1 (Fragment);Hyaluronan and proteoglycan link protein 1o;skeletal system development,cell adhesion,central nervous system development,extracellular matrix organizationD;extracellular matrix structural constituent,hyaluronic acid bindingM;extracellular region,proteinaceous extracellular matrix,extracellular matrixGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (Fragment);Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2+;protein folding,adenylate cyclase-activating dopamine receptor signaling pathway,Wnt signaling pathway, calcium modulating pathway,cell proliferation,platelet activation,cellular response to glucagon stimulus,cellular response to prostaglandin E stimulus,cellular response to catecholamine stimulus:;signal transducer activity,G-protein beta-subunit bindingP;heterotrimeric G-protein complex,plasma membrane,membrane,extracellular exosomeQ08211DHX9 DHX9_HUMANATP-dependent RNA helicase AmRNA splicing, via spliceosome,osteoblast differentiation,RNA processing,positive regulation of type I interferon production,DNA duplex unwinding,rhythmic process,CRD-mediated mRNA stabilization,protein localization to cytoplasmic stress granuleRNA polymerase II transcription factor binding,DNA binding,RNA binding,RNA helicase activity,ATP-dependent DNA helicase activity,ATP-dependent RNA helicase activity,protein binding,ATP bindingnucleus,nucleoplasm,nucleolus,cytoplasm,centrosome,cytosol,membrane,intracellular ribonucleoprotein complex,cytoplasmic ribonucleoprotein granule,CRD-mediated mRNA stability complex,nuclear stress granuleO00160MYO1F MYO1F_HUMANUnconventional myosin-If;motor activity,actin binding,calmodulin binding,ATP bindingunconventional myosin complex55 kDa erythrocyte membrane protein;Isoform 2 of 55 kDa erythrocyte membrane protein;Isoform 3 of 55 kDa erythrocyte membrane proteinesignal transduction,GMP metabolic process,GDP metabolic process,regulation of neutrophil chemotaxis;;+guanylate kinase activity,protein binding;;aintracellular,integral component of plasma membrane,membrane,cortical cytoskeleton,stereocilium;;Choline transporter-like protein 1;Isoform 2 of Choline transporter-like protein 1;Isoform 3 of Choline transporter-like protein 1nphosphatidylcholine biosynthetic process,choline transport,choline catabolic process,transmembrane transport;;,choline transmembrane transporter activity;;nucleoplasm,mitochondrion,mitochondrial outer membrane,plasma membrane,membrane,integral component of membrane,extracellular exosome;; Nuclear receptor-binding protein;transcription initiation from RNA polymerase II promoter,protein phosphorylation,ER to Golgi vesicle-mediated transport,intracellular signal transduction< g;protein serine/threonine kinase activity,protein binding,ATP binding,protein homodimerization activityK;nucleoplasm,cytosol,cell cortex,endomembrane system,membrane,lamellipodiumPDZ and LIM domain protein 7 (Fragment);PDZ and LIM domain protein 7 (Fragment);PDZ and LIM domain protein 7 (Fragment);PDZ and LIM domain protein 7 (Fragment);PDZ and LIM domain protein 7;Isoform 2 of PDZ and LIM domain protein 7;Isoform 3 of PDZ and LIM domain protein 7;Isoform 4 of PDZ and LIM domain protein 7;Isoform 5 of PDZ and LIM domain protein 7;Isoform 6 of PDZ and LIM domain protein 7;;;;ossification,receptor-mediated endocytosis,axon guidance,actin cytoskeleton organization,positive regulation of osteoblast differentiation;;;;;);;;;protein binding,zinc ion binding;;;;;j;;;;stress fiber,ruffle,nucleus,cytosol,cell-cell adherens junction,focal adhesion,actin cytoskeleton;;;;;Zinc finger protein 90;40S ribosomal protein S16 (Fragment);40S ribosomal protein S16 (Fragment);40S ribosomal protein S16;40S ribosomal protein S16;40S ribosomal protein S16;40S ribosomal protein S16J;;;;;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal small subunit biogenesis;D;;;;;RNA binding,structural constituent of ribosome,protein binding;;;;;;nucleoplasm,cytosol,focal adhesion,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome;P19961^Protein LOC102723996;ICOS ligand;ICOS ligand;Isoform 2 of ICOS ligand;Isoform 3 of ICOS ligand;;adaptive immune response,defense response,hyperosmotic response,signal transduction,T cell costimulation,positive regulation of activated T cell proliferation,T cell activation,B cell activation;;;;receptor binding;;fintegral component of membrane;;plasma membrane,integral component of membrane,extracellular exosome;;;stimulatory C-type lectin receptor signaling pathway,cell adhesion,single organismal cell-cell adhesion,extracellular matrix organization,regulation of immune response;integrin bindingl;uropod,plasma membrane,integral component of plasma membrane,membrane,cleavage furrow,extracellular exosomeP56202CTSW CATW_HUMAN Cathepsin Waplatelet degranulation,immune response,proteolysis involved in cellular protein catabolic processEcysteine-type endopeptidase activity,cysteine-type peptidase activityWextracellular region,extracellular space,lysosome,membrane,platelet dense granule lumenMAGI2 ;;;;;;;;;;;;positive regulation of receptor internalization,planar cell polarity pathway involved in axis elongation,negative regulation of cell proliferation,positive regulation of neuron projection development,negative regulation of cell migration,positive regulation of phosphoprotein phosphatase activity,negative regulation of activin receptor signaling pathway,nerve growth factor signaling pathway,receptor clustering,protein heterooligomerization,negative regulation of protein kinase B signaling,SMAD protein signal transduction,mitotic cell cycle arrest,glomerular visceral epithelial cell development,neuroligin clustering involved in postsynaptic membrane assembly,cellular response to nerve growth factor stimulus,positive regulation of synaptic vesicle clustering;;;;;;;;;;;;;signal transducer activity,protein binding,phosphatase binding,receptor signaling complex scaffold activity,beta-1 adrenergic receptor binding,SMAD binding,type II activin receptor binding;;;;;;;;;;;;;nucleus,cytoplasm,late endosome,plasma membrane,bicellular tight junction,postsynaptic density,dendrite,slit diaphragm,protein complex,synapse,perinuclear region of cytoplasm;b;protein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal bodym;RNA binding,protein binding,ATP binding,protein binding involved in protein folding,unfolded protein binding;zona pellucida receptor complex,cytosol,chaperonin-containing T-complex,cytoskeleton,microtubule,plasma membrane,myelin sheath,cell body,extracellular exosomeCD163dScavenger receptor cysteine-rich type 1 protein M130;Scavenger receptor cysteine-rich type 1 protein M130;Scavenger receptor cysteine-rich type 1 protein M130;Isoform 2 of Scavenger receptor cysteine-rich type 1 protein M130;Isoform 3 of Scavenger receptor cysteine-rich type 1 protein M130;Isoform 4 of Scavenger receptor cysteine-rich type 1 protein M1307;;receptor-mediated endocytosis,acute-phase response;;;0;;scavenger receptor activity,protein binding;;;j;;extracellular region,plasma membrane,integral component of plasma membrane,endocytic vesicle membrane;;;$Protein G6b;Isoform A of Protein G6bP42574 CASP3_HUMAN Caspase-3response to hypoxia,B cell homeostasis,apoptotic DNA fragmentation,proteolysis,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to DNA damage stimulus,heart development,sensory perception of sound,learning or memory,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,response to UV,response to glucose,response to X-ray,regulation of macroautophagy,protein processing,hippocampus development,neuron differentiation,keratinocyte differentiation,erythrocyte differentiation,platelet formation,negative regulation of B cell proliferation,response to cobalt ion,response to estradiol,response to lipopolysaccharide,glial cell apoptotic process,response to tumor necrosis factor,response to nicotine,hippo signaling,wound healing,response to drug,response to hydrogen peroxide,T cell homeostasis,negative regulation of apoptotic process,response to amino acid,positive regulation of neuron apoptotic process,cell fate commitment,negative regulation of cyclin-dependent protein serine/threonine kinase activity,negative regulation of activated T cell proliferation,response to antibiotic,neurotrophin TRK receptor signaling pathway,response to glucocorticoid,neuron apoptotic process,cellular response to organic cyclic compound,apoptotic signaling pathway,extrinsic apoptotic signaling pathway in absence of ligand,execution phase of apoptosisprotease binding,aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,cyclin-dependent protein serine/threonine kinase inhibitor activity,death receptor binding,protein binding,peptidase activity,cysteine-type endopeptidase activator activity involved in apoptotic process,phospholipase A2 activator activity,protein complex binding,cysteine-type endopeptidase activity involved in apoptotic process,cysteine-type endopeptidase activity involved in execution phase of apoptosisZnucleus,nucleoplasm,cytosol,plasma membrane,death-inducing signaling complex,membrane raftCCS)Copper chaperone for superoxide dismutase;response to reactive oxygen species,superoxide metabolic process,intracellular copper ion transport,removal of superoxide radicals,positive regulation of oxidoreductase activity,oxidation-reduction process;superoxide dismutase activity,copper ion binding,protein binding,zinc ion binding,protein disulfide oxidoreductase activity,cadherin binding;nucleus,cytoplasm,cytosolPSMD10/26S proteasome non-ATPase regulatory subunit 10H;;negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,apoptotic process,cytoplasmic sequestering of NF-kappaB,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,positive regulation of cell growth,anaphase-promoting complex-de< pendent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,positive regulation of protein ubiquitination,negative regulation of NF-kappaB transcription factor activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,negative regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,negative regulation of MAPK cascade,regulation of mRNA stability,negative regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of cyclin-dependent protein serine/threonine kinase activity,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,proteasome regulatory particle assembly,negative regulation of canonical Wnt signaling pathway,negative regulation of release of cytochrome c from mitochondria,positive regulation of canonical Wnt signaling pathway.;;protein binding,transcription factor binding;;proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle,intermediate filament cytoskeleton,proteasome regulatory particle, base subcomplexUBL4AUbiquitin-like protein 4Ajcellular protein modification process,transport,tail-anchored membrane protein insertion into ER membrane;Nprotein binding,ubiquitin-like protein transferase activity,chaperone binding;0nucleus,cytoplasm,cytosol,membrane,BAT3 complex;"Matrilin-2;Isoform 3 of Matrilin-2uneuron migration,axon guidance,biological_process,glial cell migration,dendrite regeneration,response to axon injury;7molecular_function,calcium ion binding,protein binding;^proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular matrix;Q13813MAPK cascade,ER to Golgi vesicle-mediated transport,cytoskeleton organization,axon guidance,neutrophil degranulation,positive regulation of GTPase activity,actin filament cappingactin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,calcium ion binding,protein binding,calmodulin binding,cadherin bindingextracellular region,cytosol,spectrin,microtubule cytoskeleton,membrane,specific granule lumen,intracellular membrane-bounded organelle,extracellular exosome,extracellular vesicle,tertiary granule lumenQ15904 VAS1_HUMANV-type proton ATPase subunit S1insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,transferrin transport,ion transmembrane transport,positive regulation of osteoblast differentiation,positive regulation of bone resorption,pH reduction,positive regulation of exocytosis,establishment of organelle localization,positive regulation of ERK1 and ERK2 cascade,positive regulation of osteoclast developmenttransporter activity,ATP binding,Rab GTPase binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanismendoplasmic reticulum membrane,endosome membrane,integral component of membrane,proton-transporting two-sector ATPase complex,endoplasmic reticulum-Golgi intermediate compartment membrane,proton-transporting V-type ATPase, V1 domain,extracellular exosomePRSS1P01889 1B07_HUMANP30453 1A34_HUMANuIsoform 10 of Tropomyosin alpha-1 chain;Isoform 3 of Tropomyosin alpha-1 chain;Isoform 4 of Tropomyosin alpha-1 chainN144 proteins were significantly altered (Qvalue < 0.05 and fold-change > 1.5).Q4LDE5 SVEP1_HUMANRSushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 cell adhesion%chromatin binding,calcium ion binding&extracellular space,cytoplasm,membraneexocytosis,ER to Golgi vesicle-mediated transport,cytoskeleton organization,signal transduction,positive regulation of organelle organization,maintenance of epithelial cell apical/basal polarity,protein targeting to plasma membrane;;;;;;;;;;;;;;structural molecule activity,structural constituent of cytoskeleton,protein binding,cytoskeletal adaptor activity,enzyme binding,spectrin binding,ATPase binding;;;;;;;;;;;;;;nucleus,cytosol,cytoskeleton,plasma membrane,spectrin-associated cytoskeleton,basolateral plasma membrane,sarcoplasmic reticulum,Z disc,axolemma,M band,sarcolemma,postsynaptic membrane;;;;;;;;;;;;;; A0A087WW89A0A087WW89_HUMANProtein IGHV3-72 negative regulation of complement activation, lectin pathway,platelet degranulation,complement activation, classical pathway,aging,blood coagulation, intrinsic pathway,blood circulation,negative regulation of endopeptidase activity,fibrinolysis,innate immune response;;>serine-type endopeptidase inhibitor activity,protein binding;;qextracellular region,extracellular space,platelet alpha granule lumen,extracellular exosome,blood microparticle;;!Spectrin beta chain, erythrocyticMAPK cascade,ER to Golgi vesicle-mediated transport,cytoskeleton organization,axon guidance,positive regulation of GTPase activity,actin filament capping;actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,ankyrin binding,actin filament binding;Golgi apparatus,cytosol,spectrin,spectrin-associated cytoskeleton,actin cytoskeleton,intrinsic component of the cytoplasmic side of the plasma membrane,protein complex;N;retina homeostasis,proteolysis,phagocytosis, recognition,phagocytosis, engulfment,complement activation,complement activation, classical pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,defense response to bacterium,innate immune response,B cell receptor signaling pathway,positive regulation of B cell activation;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;C;RNA binding,threonine-type endopeptidase activity,protein binding;;proteasome complex,nucleus,nucleoplasm,centrosome,cytosol,proteasome core complex,polysome,proteasome core complex, alpha-subunit complex,extracellular exosome;;apoptotic process,cell cycle,protein secretion,copper ion import,transferrin transport,regulation of apoptotic process,iron ion homeostasis,oxidation-reduction process,ferric iron import into cell;;;;protein binding,cupric reductase activity,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,metal ion binding,ferric-chelate reductase (NADPH) activity;;;Y;cytoplasm,multivesicular body,integral component of plasma membrane,endosome membrane;;;;;liver development,signal peptide processing,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,peptidyl-glutamic acid carboxylation,negative regulation of blood coagulation,negative regulation of apoptotic process,regulation of circulating fibrinoge< n levels,negative regulation of inflammatory response,negative regulation of coagulation,leukocyte migration,positive regulation of establishment of endothelial barrier;I;;serine-type endopeptidase activity,calcium ion binding,protein binding;y;;extracellular region,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,Golgi apparatus,Golgi lumen;4;;one-carbon metabolic process,bicarbonate transportl;;arylesterase activity,carbonate dehydratase activity,protein binding,zinc ion binding,hydro-lyase activity;;cytosol,extracellular exosomeQ13939CCIN CALI_HUMANCalicinmulticellular organism development,spermatogenesis,cell differentiation,protein ubiquitination involved in ubiquitin-dependent protein catabolic process4actin binding,ubiquitin-protein transferase activityPnucleus,actin cytoskeleton,Cul3-RING ubiquitin ligase complex,cytoskeletal calyx~;keratinization,cornification;aging,epidermis development,keratinization,hair cycle,cornification;keratinization,cornification;structural molecule activity,protein binding;structural molecule activity,protein binding;structural molecule activity,protein binding;extracellular space,cytosol,keratin filament,extracellular exosome;extracellular space,cytosol,keratin filament;extracellular space,cytosol,keratin filament;;cytokinesis,mitotic nuclear division,spermatogenesis,regulation of embryonic cell shape,cell differentiation,protein heterooligomerization,cilium morphogenesis,positive regulation of nonmotile primary cilium assembly;f;;structural molecule activity,protein binding,GTP binding,identical protein binding,cadherin binding;;;condensed chromosome kinetochore,stress fiber,nucleus,spindle,cytosol,axoneme,midbody,septin complex,cleavage furrow,extracellular exosome,sperm annulus,Requires Ontology,apical plasma membrane;(;;lipid metabolic process,endocytosis,receptor-mediated endocytosis,cholesterol metabolic process,positive regulation of gene expression,negative regulation of gene expression,positive regulation of triglyceride biosynthetic process,regulation of phosphatidylcholine catabolic process,phospholipid transport,intestinal cholesterol absorption,cholesterol transport,low-density lipoprotein particle clearance,lipoprotein catabolic process,cholesterol homeostasis,viral entry into host cell,positive regulation of inflammatory response,membrane organization,cholesterol import,cellular response to fatty acid,cellular response to low-density lipoprotein particle stimulus,receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport,regulation of cholesterol homeostasis;;';;virus receptor activity,glycoprotein binding,protease binding,low-density lipoprotein receptor activity,calcium ion binding,protein binding,low-density lipoprotein particle binding,very-low-density lipoprotein particle receptor activity,clathrin heavy chain binding,identical protein binding;;;;lysosome,early endosome,late endosome,Golgi apparatus,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,cell surface,endosome membrane,membrane,basolateral plasma membrane,clathrin-coated endocytic vesicle membrane,low-density lipoprotein particle,endolysosome membrane,receptor complex,apical part of cell,sorting endosome,PCSK9-LDLR complex;;proteolysis,antimicrobial humoral response,killing of cells of other organism,defense response to bacterium,defense response to fungus;/RNA binding,protein binding,peptidase activity;@extracellular region,extracellular matrix,extracellular exosome;Yresponse to hypoxia,acute inflammatory response,chronic inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,aging,response to nutrient,amine metabolic process,response to zinc ion,response to ionizing radiation,viral process,membrane to membrane docking,B cell differentiation,extracellular matrix organization,response to lipopolysaccharide,response to nicotine,calcium-mediated signaling using intracellular calcium source,cellular response to vascular endothelial growth factor stimulus,positive regulation of T cell proliferation,response to ethanol,regulation of immune response,leukocyte tethering or rolling,oxidation-reduction process,cell chemotaxis,interferon-gamma-mediated signaling pathway,cellular response to tumor necrosis factor;;Pintegrin binding,primary amine oxidase activity,cell adhesion molecule binding;;<podosome,extracellular space,early endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,microvillus,external side of plasma membrane,cell surface,integral component of membrane,filopodium,sarcolemma,apical part of cell,extracellular exosome,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;;extracellular region;;BNC2;;;;;endochondral bone growth,transcription, DNA-templated,regulation of transcription, DNA-templated,tongue development,palate development,mesenchyme development;#;;;;;DNA binding,metal ion binding;%;;;;;nucleus,cytosol,plasma membrane;S;;mitotic nuclear division,signal transduction,cell proliferation,cell division;;;;C;;protein binding,microtubule binding,identical protein binding;;;;=;;cytoplasm,microtubule cytoskeleton,microtubule plus-end;;;;J;positive regulation of extracellular matrix constituent secretion,proteolysis,blood coagulation,response to heat,negative regulation of plasminogen activation,response to drug,fibrinolysis,negative regulation of fibrinolysis,cellular response to glucose stimulus,liver regeneration,negative regulation of hepatocyte proliferation2;metallocarboxypeptidase activity,zinc ion binding/;extracellular space,cell,extracellular exosome;positive regulation of endothelial cell proliferation,response to unfolded protein,negative regulation of angiogenesis,regulation of tissue remodeling,response to endoplasmic reticulum stress,behavioral response to pain,tissue remodeling,positive regulation of peptidyl-tyrosine phosphorylation,myoblast migration,positive regulation of cell division,endothelial cell-cell adhesion,positive regulation of neutrophil chemotaxis\;integrin binding,calcium ion binding,protein binding,growth factor activity,heparin binding;extracellular region,basement membrane,extracellular space,endoplasmic reticulum,sarcoplasmic reticulum,extracellular matrix,extracellular exosome;;;proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,intracellular membrane-bounded organelle,extracellular exosome G2/M transition of mitotic cell cycle,mitochondrial fission,G-protein coupled receptor internalization,ventricular septum development,dynamin family protein polymerization involved in mitochondrial fission,regulation of transcription, DNA-templated,Golgi to plasma membrane transport,endocytosis,receptor-mediated endocytosis,phagocytosis,signal transduction,spermatogenesis,response to light stimulus,positive regulation of lamellipodium assembly,antigen processing and presentation of exogenous peptide antigen via MHC class II,negative regulation of transforming growth factor beta receptor signaling pathway,regulation of axon extension,receptor internalization,transferrin transport,regulation of Rac protein signal transduction,aorta development,response to cocaine,positive regulation of apoptotic process,macropinocytosis,positive regulation of nitric oxide biosynthetic process,positive regulation of transcription, DNA-templated,synaptic vesicle transport,neuron projection morphogenesis,positive regulation of phagocytosis,regulation of nitric-oxide synthase activity,coronary vasculature development,membrane organization,membrane fusion,cellular response to carbon monoxide,cellular response to X-ray,cellular response to nitric oxide,positive regulation of substrate adhesion-dependent cell spreading,negative regulation of nonmotile primary cilium assembly,cellular response to dopamine,regulation of Golgi organization,positive regulation of sodium:potassium-exchanging ATPase activity,negati< ve regulation of membrane tubulation;;;;GTPase activity,protein binding,GTP binding,microtubule binding,SH3 domain binding,enzyme binding,protein kinase binding,D2 dopamine receptor binding,protein complex binding,phosphatidylinositol 3-kinase regulatory subunit binding,WW domain binding,nitric-oxide synthase binding;;;;Golgi membrane,phagocytic cup,photoreceptor inner segment,nucleus,endosome,Golgi apparatus,trans-Golgi network,centrosome,cytosol,microtubule,plasma membrane,clathrin-coated pit,focal adhesion,postsynaptic density,lamellipodium,midbody,endocytic vesicle membrane,phagocytic vesicle membrane,mitochondrial membrane,ruffle membrane,protein complex,postsynaptic membrane,clathrin-coated endocytic vesicle,perinuclear region of cytoplasm,extracellular exosome,growth cone;;;;P;;;zygotic determination of anterior/posterior axis, embryo,determination of left/right symmetry,glycoprotein metabolic process,protein processing,peptide hormone processing,regulation of BMP signaling pathway,nerve growth factor processing,nerve growth factor production,secretion by cell,lipoprotein metabolic process,cornification;;;k;;;endopeptidase activity,serine-type endopeptidase activity,heparin binding,nerve growth factor binding;;;;;;extracellular region,extracellular space,endoplasmic reticulum,Golgi lumen,plasma membrane,cell surface,extracellular matrix;;;cgluconeogenesis,glycolytic process,striated muscle contraction,Notch signaling pathway,spermatogenesis,regulation of pentose-phosphate shunt,response to mercury ion,canonical glycolysis;gluconeogenesis,glycolytic process,regulation of glycolytic process,neutrophil degranulation,regulation of pentose-phosphate shunt,respiratory burst,canonical glycolysismbisphosphoglycerate mutase activity,phosphoglycerate mutase activity,hydrolase activity,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,cofactor binding;bisphosphoglycerate mutase activity,phosphoglycerate mutase activity,protein binding,hydrolase activity,protein kinase binding,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activitynucleus,cytosol,extracellular exosome;extracellular region,nucleus,cytoplasm,cytosol,membrane,secretory granule lumen,myelin sheath,extracellular exosome,ficolin-1-rich granule lumenprotein complex assembly,actin cytoskeleton organization,cortical actin cytoskeleton organization,actomyosin structure organization,positive regulation of protein binding;;;;actin binding,structural constituent of cytoskeleton,protein binding,calmodulin binding,1-phosphatidylinositol binding,spectrin binding;;;;nucleus,cytosol,plasma membrane,cytoplasmic side of plasma membrane,postsynaptic density,spectrin-associated cytoskeleton,extrinsic component of membrane,cell junction,cortical cytoskeleton,protein complex;;;;protein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,positive regulation of telomerase activity,chaperone-mediated protein folding,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;mRNA binding,protein binding,ATP binding,protein binding involved in protein folding,unfolded protein binding;zona pellucida receptor complex,nucleoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,melanosome,cell projection,cell body,extracellular exosome;/;;signal transduction,neutrophil degranulation;G;;RNA binding,cytokine activity,protein binding,growth factor activity;;;extracellular region,extracellular space,lysosome,endosome,endoplasmic reticulum,azurophil granule lumen,extracellular exosome; ;intracellular protein transport,receptor-mediated endocytosis,microtubule-based movement,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,cell division,membrane organization,clathrin-dependent endocytosis;;;p;molecular_function,structural molecule activity,protein binding,clathrin heavy chain binding,peptide binding;;;;spindle,cytosol,plasma membrane,membrane,clathrin coat,clathrin vesicle coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,cytoplasmic vesicle,trans-Golgi network membrane,endolysosome membrane,clathrin complex;;;Q6GTS8PM20D1 P20D1_HUMAN1N-fatty-acyl-amino acid synthase/hydrolase PM20D1proteolysis,cellular amino acid metabolic process,amide biosynthetic process,cellular amide catabolic process,cellular lipid metabolic process,energy homeostasis,negative regulation of neuron death,adaptive thermogenesis,regulation of oxidative phosphorylation uncoupler activitypeptidase activity,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,lyase activity,metal ion bindings;;pyruvate metabolic process,cell surface receptor signaling pathway,embryo implantation,monocarboxylic acid transport,extracellular matrix disassembly,extracellular matrix organization,odontogenesis of dentin-containing tooth,response to peptide hormone,response to mercury ion,decidualization,leukocyte migration,response to cAMP,protein targeting to plasma membrane;;;l;;protein binding,mannose binding,monocarboxylic acid transmembrane transporter activity,cadherin binding;;;;;Golgi membrane,acrosomal membrane,mitochondrion,plasma membrane,integral component of plasma membrane,focal adhesion,membrane,sarcolemma,melanosome,intracellular membrane-bounded organelle,membrane raft,extracellular exosome;;;protein complex assembly,actin cytoskeleton organization,hemopoiesis,positive regulation of protein binding,barbed-end actin filament capping,actin filament bundle assembly,transmembrane transport;;;;;actin binding,structural molecule activity,calmodulin binding,spectrin binding,protein homodimerization activity,protein heterodimerization activity,actin filament binding;;;;;ecytosol,plasma membrane,F-actin capping protein complex,postsynaptic density,cytoplasmic vesicle;;;;;;;fatty acid biosynthetic process,cholesterol metabolic process,triglyceride catabolic process,very-low-density lipoprotein particle remodeling,intermediate-density lipoprotein particle remodeling,low-density lipoprotein particle remodeling,high-density lipoprotein particle remodeling,chylomicron remnant clearance,phosphatidylcholine catabolic process,cholesterol homeostasis,reverse cholesterol transport,lipid digestion,triglyceride homeostasis;;phospholipase activity,triglyceride lipase activity,heparin binding,low-density lipoprotein particle binding,apolipoprotein bindingh;;extracellular region,extracellular space,endoplasmic reticulum lumen,high-density lipoprotein particleplatelet degranulation;Oplasma membrane,integral component of membrane,platelet alpha granule membrane;;;UV protection,calcium ion regulated exocytosis,cerebellum development,fat cell differentiation,response to ethanol,zymogen granule exocytosis;;;;3;;calcium ion binding,identical protein binding;;;;m;;cytoplasm,late endosome,Golgi apparatus,Golgi lumen,membrane,bleb,extracellular exosome,plasma membrane;;;;u;;;cytoskeleton organization,sensory perception of sound,regulation of cell shape,actin filament polymerization,positive regulation of cell migration,regulation of microtubule-based process,protein localization to microtubule,neutrophil degranulation,regulation of release of sequestered calcium ion into cytosol,cellular response to histamine,regulation of cell motility;;f;;;RNA binding,actin binding,receptor binding,protein binding,Rho GTPase binding,ion channel binding;;;;;microtubule organizing center,cytosol,plasma membrane,secretory granule membrane,ruffl                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { } ~  e membrane,mitotic spindle,ficolin-1-rich granule membrane;;;;;cytoskeleton organization,actomyosin structure organization,regulation of actin filament-based process,neutrophil degranulation,cellular response to mechanical stimulus4;;;actin binding,calmodulin binding,cadherin binding;;;stress fiber,extracellular region,cytoskeleton,cell-< cell junction,focal adhesion,membrane,specific granule lumen,extracellular exosome,tertiary granule lumendefense response to nematode,negative regulation of interleukin-10 production,positive regulation of interleukin-4 production,regulation of cytokine biosynthetic process,defense response to bacterium,neutrophil degranulation;%heparin binding,carbohydrate binding;Zextracellular region,transport vesicle,extracellular exosome,ficolin-1-rich granule lumen;4hematopoietic progenitor cell differentiation,negative regulation of humoral immune response mediated by circulating immunoglobulin,protein dephosphorylation,apoptotic process,G-protein coupled receptor signaling pathway,cell proliferation,positive regulation of cell proliferation,negative regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase signaling,peptidyl-tyrosine phosphorylation,cell differentiation,platelet activation,platelet formation,T cell costimulation,abortive mitotic cell cycle,positive regulation of cell adhesion mediated by integrin,peptidyl-tyrosine dephosphorylation,intracellular signal transduction,megakaryocyte development,negative regulation of T cell proliferation,natural killer cell mediated cytotoxicity,neutrophil degranulation,negative regulation of MAP kinase activity,regulation of B cell differentiation,negative regulation of peptidyl-tyrosine phosphorylation,B cell receptor signaling pathway,negative regulation of B cell receptor signaling pathway,negative regulation of T cell receptor signaling pathway,leukocyte migration,regulation of release of sequestered calcium ion into cytosol,regulation of type I interferon-mediated signaling pathway,regulation of ERK1 and ERK2 cascade,platelet aggregation,regulation of G1/S transition of mitotic cell cycle;;;phosphotyrosine binding,protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,SH3 domain binding,protein kinase binding,SH2 domain binding,cell adhesion molecule binding;;;extracellular region,nucleus,nucleolus,cytoplasm,cytosol,cell-cell junction,membrane,specific granule lumen,alpha-beta T cell receptor complex,extracellular exosome,tertiary granule lumen;;;<;toll-like receptor signaling pathway,innate immune response;receptor binding;endoplasmic reticulum lumen`acute-phase response,inflammatory response,opsonization,positive regulation of gene expression,negative regulation of macrophage derived foam cell differentiation,negative regulation of lipid storage,positive regulation of superoxide anion generation,defense response to Gram-positive bacterium,Requires Ontology,regulation of interleukin-8 secretion;;complement component C1q binding,calcium ion binding,protein binding,low-density lipoprotein particle binding,choline binding,low-density lipoprotein particle receptor binding,virion binding;;@extracellular region,extracellular space,extracellular exosome;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;;wthreonine-type endopeptidase activity,protein binding,identical protein binding;threonine-type endopeptidase activity;; proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome,postsynapse;nucleus,cytosol,proteasome core complex, alpha-subunit complex,extracellular exosome,spermatoproteasome complex;;.MAPK cascade,epidermal growth factor receptor signaling pathway,Ras protein signal transduction,cell-cell signaling,axon guidance,aging,insulin receptor signaling pathway,fibroblast growth factor receptor signaling pathway,positive regulation of signal transduction,regulation of phosphatidylinositol 3-kinase signaling,viral process,cell migration,cell differentiation,positive regulation of actin filament polymerization,T cell costimulation,receptor internalization,entry of bacterium into host cell,phosphatidylinositol-3-phosphate biosynthetic process,peptidyl-tyrosine autophosphorylation,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,regulation of cell proliferation,signal transduction in response to DNA damage,regulation of MAPK cascade,positive regulation of GTPase activity,innate immune response,phosphatidylinositol phosphorylation,phosphatidylinositol-mediated signaling,anatomical structure formation involved in morphogenesis,leukocyte migration,protein heterooligomerization,branching involved in labyrinthine layer morphogenesis,membrane organization,cellular response to ionizing radiation,positive regulation of reactive oxygen species metabolic process;phosphotyrosine binding,RNA binding,non-membrane spanning protein tyrosine kinase activity,SH3/SH2 adaptor activity,Ras guanyl-nucleotide exchange factor activity,epidermal growth factor receptor binding,neurotrophin TRKA receptor binding,protein binding,1-phosphatidylinositol-3-kinase activity,SH3 domain binding,protein kinase binding,protein phosphatase binding,identical protein binding,insulin receptor substrate binding,ephrin receptor binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activity;nucleus,nucleoplasm,nucleolus,cytoplasm,endosome,Golgi apparatus,cytosol,plasma membrane,cell-cell junction,COP9 signalosome,vesicle membrane,extrinsic component of cytoplasmic side of plasma membrane,extracellular exosome,Grb2-EGFR complex;toll-like receptor signaling pathway,response to molecule of bacterial origin,MyD88-dependent toll-like receptor signaling pathway,axonogenesis,toll-like receptor 9 signaling pathway,innate immune response,regulation of cytokine secretion,positive regulation of inflammatory response;positive regulation of lamellipodium assembly,positive regulation of neuron projection development,cell projection organization,negative regulation of actin filament polymerization,regulation of microvillus length,regulation of actin cytoskelet< on organization,sequestering of actin monomers,positive regulation of axon extension,barbed-end actin filament capping,cellular response to retinoic acid,cellular response to growth factor stimulusactin binding,transmembrane signaling receptor activity,interleukin-1 receptor binding;RNA binding,actin monomer binding,protein kinase C binding,protein binding,ATP binding,phosphatidylinositol-4,5-bisphosphate binding,cadherin bindingproteinaceous extracellular matrix,extracellular space,intracellular,plasma membrane,integral component of membrane;cytoplasm,cytoskeleton,myofibril,lamellipodium,filopodium,growth cone,stereocilium,perinuclear region of cytoplasm,extracellular exosome;;;;;C-terminal protein lipidation,immune response,neutrophil degranulation;immune response,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of immune response;;;;;IgG binding;IgG binding;;;;;extracellular region,plasma membrane,secretory granule membrane,anchored component of membrane,extracellular exosome;plasma membrane,external side of plasma membrane,integral component of membrane,extracellular exosomeY;external side of plasma membrane,immunoglobulin complex, circulating,blood microparticleW;;ion transport,positive regulation of signal transduction,ion transmembrane transport;;;SH3/SH2 adaptor activity,protein binding,zinc ion binding,ion transmembrane transporter activity,cadherin binding,actin filament binding;M;;cytoplasm,focal adhesion,cortical actin cytoskeleton,extracellular exosome;;;;;intracellular signal transduction,neutrophil degranulation,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction;@;;;;GTPase activator activity,protein binding,metal ion binding;Z;;;;extracellular region,cytosol,membrane,secretory granule lumen,azurophil granule lumen;%;proteolysis,neutrophil degranulation;peptidase activity[;extracellular region,fibrinogen complex,extracellular exosome,ficolin-1-rich granule lumen;cell adhesion;;;;(;calcium ion binding,heparin binding;;;;L;proteinaceous extracellular matrix,focal adhesion,extracellular exosome;;;;^DNA repair,protein phosphorylation,cellular response to DNA damage stimulus,sister chromatid cohesion,signal transduction by protein phosphorylation,G2 DNA damage checkpoint,positive regulation of stress-activated MAPK cascade,positive regulation of JNK cascade,regulation of cytoskeleton organization,execution phase of apoptosis,spindle checkpoint;protein kinase activity,protein serine/threonine kinase activity,receptor signaling protein serine/threonine kinase activity,protein binding,ATP binding,kinase activity,transferase activity;;blood coagulation,blood coagulation, extrinsic pathway,negative regulation of endopeptidase activity,response to estradiol,cellular response to lipopolysaccharide,cellular response to interleukin-1N;endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity;extracellular region,extracellular space,endoplasmic reticulum,plasma membrane,cell surface,organelle membrane,anchored component of membranez;growth plate cartilage development,cell-matrix adhesion,ossification involved in bone maturation,bone trabecula formation$;calcium ion binding,heparin binding5;extracellular region,perinuclear region of cytoplasm;;;;regulation of the force of heart contraction,regulation of sodium ion transport,cellular sodium ion homeostasis,regulation of blood pressure,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,dephosphorylation,cellular potassium ion homeostasis,negative regulation of glucocorticoid biosynthetic process,ion transmembrane transport,sodium ion export from cell,response to drug,negative regulation of heart contraction,positive regulation of heart contraction,positive regulation of striated muscle contraction,relaxation of cardiac muscle,membrane hyperpolarization,cellular response to mechanical stimulus,cellular response to steroid hormone stimulus,cardiac muscle cell action potential involved in contraction,regulation of cardiac muscle cell contraction,membrane repolarization,membrane repolarization during cardiac muscle cell action potential,cell communication by electrical coupling involved in cardiac conduction,ATP hydrolysis coupled transmembrane transport,response to glycoside,regulation of cardiac conduction,potassium ion import across plasma membrane;;;;cellular sodium ion homeostasis,memory,adult locomotory behavior,visual learning,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,cerebral cortex development,cellular potassium ion homeostasis,ion transmembrane transport,ionotropic glutamate receptor signaling pathway,sodium ion export from cell,response to drug,cardiac muscle contraction,cellular response to retinoic acid,cellular response to steroid hormone stimulus,regulation of cardiac muscle cell membrane potential,cell communication by electrical coupling involved in cardiac conduction,ATP hydrolysis coupled transmembrane transport,cellular response to thyroid hormone stimulus,response to glycoside,regulation of cardiac conduction;;;transport,potassium ion transport,sodium ion transport,establishment or maintenance of transmembrane electrochemical gradient,ATP hydrolysis coupled proton transport,ion transmembrane transport;neurotransmitter uptake,regulation of the force of heart contraction,regulation of respiratory gaseous exchange by neurological system process,potassium ion transport,sodium ion transport,cellular sodium ion homeostasis,regulation of smooth muscle contraction,regulation of striated muscle contraction,regulation of blood pressure,adult locomotory behavior,visual learning,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,ATP hydrolysis coupled proton transport,regulation of vasoconstriction,cellular potassium ion homeostasis,ion transmembrane transport,response to nicotine,sodium ion export from cell,locomotion,negative regulation of heart contraction,negative regulation of striated muscle contraction,ATP metabolic process,negative regulation of cytosolic calcium ion concentration,regulation of glutamate uptake involved in transmission of nerve impulse,regulation of synaptic transmission, glutamatergic,relaxation of cardiac muscle,cardiac muscle contraction,cellular response to mechanical stimulus,cellular response to steroid hormone stimulus,regulation of cardiac muscle cell contraction,membrane repolarization,membrane depolarization during cardiac muscle cell action potential,cell communication by electrical coupling involved in cardiac conduction,negative regulation of calcium ion transmembrane transport,negative regulation of calcium:sodium antiporter activity,response to glycoside,regulation of cardiac conduction,potassium ion import across plasma membrane;potassium ion transport,sodium ion transport,regulation of pH,establishment or maintenance of transmembrane electrochemical gradient,ion transmembrane transport,potassium ion homeostasis,Requires Ontology,hydrogen ion transmembrane transport;;potassium ion transport,sodium ion transport,spermatogenesis,fertilization,establishment or maintenance of transmembrane electrochemical gradient,ATP hydrolysis coupled proton transport,flagellated sperm motility,regulation of cellular pH,ion transmembrane transport,regulation of membrane potential,regulation of cardiac conduction`;;;;sodium:potassium-exchanging ATPase activity,protein binding,ATP binding,phosphatase activity,protein kinase binding,protein domain specific binding,ankyrin binding,potassium ion binding,sodium ion binding,ADP binding,phosphatidylinositol 3-kinase binding,chaperone binding,steroid hormone binding;;;;beta-amyloid binding,sodium:potassium-exchanging ATPase activity,ATP binding,D1 dopamine receptor binding,heparan sulfate proteoglycan binding,metal ion binding,chaperone binding,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,steroid hormone binding< ;;;magnesium ion binding,sodium:potassium-exchanging ATPase activity,ATP binding,hydrogen:potassium-exchanging ATPase activity;sodium:potassium-exchanging ATPase activity,protein binding,chaperone binding,steroid hormone binding,ATP binding,drug binding,ATPase activity,potassium ion binding,sodium ion binding;sodium:potassium-exchanging ATPase activity,ATP binding,hydrogen:potassium-exchanging ATPase activity,metal ion binding;;sodium:potassium-exchanging ATPase activity,ATP binding,metal ion binding;;;;endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,sodium:potassium-exchanging ATPase complex,caveola,postsynaptic density,intercalated disc,membrane,integral component of membrane,basolateral plasma membrane,apical plasma membrane,T-tubule,sarcolemma,melanosome,myelin sheath,protein complex,extracellular exosome,extracellular vesicle;;;;nucleus,endoplasmic reticulum,Golgi apparatus,plasma membrane,sodium:potassium-exchanging ATPase complex,integral component of membrane,axon,sarcolemma,myelin sheath,dendritic spine neck,dendritic spine head,synapse,extracellular vesicle;;;extracellular space,plasma membrane,integral component of plasma membrane;cytoplasm,endosome,plasma membrane,sodium:potassium-exchanging ATPase complex,caveola,intercalated disc,membrane,T-tubule,dendritic spine,myelin sheath,extracellular vesicle;plasma membrane,hydrogen:potassium-exchanging ATPase complex,basolateral plasma membrane;;plasma membrane,integral component of plasma membrane,sodium:potassium-exchanging ATPase complexproteolysis,response to biotic stimulus;;;;;;;proteolysis,autophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein catabolic process,collagen catabolic process,neutrophil degranulationaspartic-type endopeptidase activity;;;;;;;aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein bindinglysosome,integral component of membrane;;;;;;;extracellular region,extracellular space,lysosome,specific granule lumen,melanosome,lysosomal lumen,membrane raft,extracellular exosome,tertiary granule lumen,ficolin-1-rich granule lumen,extracellular matrix;;cytokinesis,renal water homeostasis,mitotic metaphase plate congression,small GTPase mediated signal transduction,positive regulation of epithelial cell migration,regulation of multivesicular body size,positive regulation of G2/M transition of mitotic cell cycle,vesicle-mediated transport,astral microtubule organization,neuron projection development,melanosome transport,multivesicular body assembly,positive regulation of axon extension,regulation of long-term neuronal synaptic plasticity,plasma membrane to endosome transport,regulation of protein transport,establishment of vesicle localization,regulation of vesicle-mediated transport,membrane organization,establishment of protein localization to organelle,protein localization to plasma membrane,establishment of protein localization to membrane,mitotic spindle assembly,ciliary basal body docking,neurotransmitter receptor transport, endosome to postsynaptic membrane,positive regulation of protein localization to plasma membrane,exosomal secretion;;receptor recycling,small GTPase mediated signal transduction,melanosome transport,transferrin transport,insulin secretion involved in cellular response to glucose stimulus,regulation of anion transport,constitutive secretory pathway,regulated exocytosis,membrane organization,cellular response to acidic pH,establishment of protein localization to membrane,retrograde transport, endosome to plasma membrane,regulation of protein localization to cell surface,regulation of endocytic recycling;;;GTPase activity,protein binding,GTP binding,microtubule binding,syntaxin binding,myosin V binding;;GTPase activity,protein binding,GTP binding,GDP binding,myosin V binding,cadherin binding;R;;spindle pole,mitochondrion,multivesicular body,Golgi apparatus,trans-Golgi network,cytosol,plasma membrane,transport vesicle,axon,cytoplasmic vesicle membrane,cytoplasmic vesicle,vesicle,cleavage furrow,protein complex,phagocytic vesicle,perinuclear region of cytoplasm,recycling endosome,recycling endosome membrane,extracellular exosome,centrosome,kinetochore microtubule;;mitochondrion,cytosol,synaptic vesicle,cell junction,phagocytic vesicle membrane,phagocytic vesicle,recycling endosome,recycling endosome membrane,extracellular exosome,anchored component of synaptic vesicle membrane;KRT13;cytoskeleton organization,response to radiation,keratinization,tongue morphogenesis,cornification,cellular response to retinoic acid;.;structural molecule activity,protein binding;[;nucleus,cytosol,keratin filament,intermediate filament cytoskeleton,extracellular exosome;negative regulation of protein phosphorylation,hair follicle development,platelet degranulation,C-terminal protein lipidation,negative regulation of keratinocyte proliferation,negative regulation of endopeptidase activity,negative regulation of transforming growth factor beta receptor signaling pathway,regulation of keratinocyte differentiation,negative regulation of wound healing,osteoclast fusion;;Vserine-type endopeptidase inhibitor activity,transforming growth factor beta binding;;extracellular region,extracellular space,plasma membrane,cell surface,platelet alpha granule membrane,anchored component of membrane;;m;membrane raft assembly,positive regulation of cytokine production,positive regulation of protein phosphorylation,regulation of receptor internalization,axonogenesis,extracellular matrix disassembly,positive regulation of protein binding,positive regulation of synaptic transmission, dopaminergic,positive regulation of interferon-beta production,dsRNA transport,positive regulation of heterotypic cell-cell adhesion,positive regulation of toll-like receptor 3 signaling pathway,response to endoplasmic reticulum stress,regulation of Rho protein signal transduction,plasma membrane raft assembly,positive regulation of endocytosis,positive regulation of skeletal muscle tissue development,protein homooligomerization,positive regulation of cell adhesion molecule production,protein kinase C signaling,cellular response to exogenous dsRNA,establishment of protein localization to plasma membrane,positive regulation of myoblast fusion,positive regulation of cell junction assembly,protein localization to membrane raft,positive regulation of cell-cell adhesion mediated by cadherin,regulation of toll-like receptor 4 signaling pathwayk;protease binding,protein binding,ionotropic glutamate receptor binding,protein heterodimerization activity;uropod,lysosomal membrane,endosome,early endosome,microtubule organizing center,plasma membrane,caveola,cell-cell junction,cell-cell adherens junction,focal adhesion,membrane,integral component of membrane,basolateral plasma membrane,flotillin complex,lamellipodium,cytoplasmic vesicle,centriolar satellite,sarcolemma,melanosome,cell-cell contact zone,membrane raft,extracellular exosome,apical plasma membrane,COP9 signalosome,cortical actin cytoskeleton:;;;cell cycle,protein heterooligomerization,cell division;;;;protein binding,GTP binding;S;;;stress fiber,cytoplasm,cell junction,axon,dendritic spine,extracellular exosome;inflammatory response,response to oxidative stress,cerebellum development,regulation of multicellular organism growth,myelination,pigmentation;;(receptor activity,carbohydrate binding;;kextracellular space,cytoplasm,plasma membrane,integral component of plasma membrane,extracellular exosome;;;;;;;angiogenesis,in utero embryonic development,mesoderm formation,carbohydrate metabolic process,gluconeogenesis,humoral immune response,hemostasis,learning or memory,methylglyoxal biosynthetic process,response to estradiol,response to progesterone,response to testosterone,erythrocyte homeostasis,response to immobilization stress,response to muscle stretch,glucose homeostasis,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to morphine,neutrophil degranulation,negative regulation of neuron apoptotic process,aldehyde catabolic process,response to cadmium ion,gluc< ose 6-phosphate metabolic process,canonical glycolysis;;;;;;glucose-6-phosphate isomerase activity,cytokine activity,growth factor activity,intramolecular transferase activity,ubiquitin protein ligase binding,monosaccharide binding;;;;;;extracellular region,extracellular space,nucleoplasm,cytosol,plasma membrane,membrane,secretory granule lumen,neuron projection,myelin sheath,ciliary membrane,extracellular exosome,ficolin-1-rich granule lumen;Q15063-4Isoform 4 of Periostin;;;;;;;;;;;response to ischemia,ER to Golgi vesicle-mediated transport,receptor-mediated endocytosis,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,cellular response to hypoxia,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(;;;;;;;;;;;ATP binding,chaperone binding;;;;;;;;;;;extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,focal adhesion,membrane,endoplasmic reticulum chaperone complex,extracellular exosome,endocytic vesicle lumenF B cell homeostasis,regulation of cytokine production,regulation of protein phosphorylation,negative regulation of protein phosphorylation,stimulatory C-type lectin receptor signaling pathway,adaptive immune response,Fc receptor mediated stimulatory signaling pathway,tolerance induction to self antigen,histamine secretion by mast cell,platelet degranulation,negative regulation of myeloid leukocyte differentiation,immune response-regulating cell surface receptor signaling pathway,Fc receptor mediated inhibitory signaling pathway,regulation of B cell apoptotic process,protein phosphorylation,inflammatory response,cellular response to DNA damage stimulus,response to sterol depletion,signal transduction,transmembrane receptor protein tyrosine kinase signaling pathway,central nervous system development,blood coagulation,positive regulation of cell proliferation,negative regulation of cell proliferation,response to toxic substance,response to hormone,response to carbohydrate,positive regulation of neuron projection development,oligodendrocyte development,response to organic cyclic compound,viral process,peptidyl-tyrosine phosphorylation,signal transduction by protein phosphorylation,platelet activation,erythrocyte differentiation,positive regulation of cell migration,negative regulation of B cell proliferation,neuron projection development,T cell costimulation,lipopolysaccharide-mediated signaling pathway,cellular response to extracellular stimulus,response to insulin,regulation of mast cell activation,regulation of cell adhesion mediated by integrin,negative regulation of toll-like receptor 2 signaling pathway,negative regulation of toll-like receptor 4 signaling pathway,cellular response to heat,peptidyl-tyrosine autophosphorylation,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,response to drug,positive regulation of tyrosine phosphorylation of STAT protein,response to amino acid,regulation of mast cell degranulation,negative regulation of MAP kinase activity,positive regulation of phosphatidylinositol 3-kinase activity,innate immune response,regulation of erythrocyte differentiation,protein autophosphorylation,ephrin receptor signaling pathway,response to axon injury,cytokine secretion,regulation of cytokine secretion,regulation of inflammatory response,negative regulation of immune response,B cell receptor signaling pathway,regulation of B cell receptor signaling pathway,positive regulation of B cell receptor signaling pathway,leukocyte migration,positive regulation of cellular component movement,regulation of release of sequestered calcium ion into cytosol,positive regulation of glial cell proliferation,positive regulation of Fc receptor mediated stimulatory signaling pathway,JAK-STAT cascade involved in growth hormone signaling pathway,positive regulation of stress-activated protein kinase signaling cascade,regulation of ERK1 and ERK2 cascade,negative regulation of ERK1 and ERK2 cascade,positive regulation of oligodendrocyte progenitor proliferation,negative regulation of mast cell proliferation,positive regulation of mast cell proliferation,cellular response to retinoic acid,regulation of monocyte chemotaxis,regulation of platelet aggregation,dendritic cell differentiation,negative regulation of intracellular signal transduction,positive regulation of dendritic cell apoptotic process;protein tyrosine kinase activity,non-membrane spanning protein tyrosine kinase activity,receptor signaling protein tyrosine kinase activity,receptor binding,platelet-derived growth factor receptor binding,integrin binding,protein binding,ATP binding,SH3 domain binding,ubiquitin protein ligase binding,gamma-tubulin binding,glycosphingolipid binding,ion channel binding,phosphoprotein binding;znucleus,cytoplasm,mitochondrial intermembrane space,Golgi apparatus,cytosol,plasma membrane,cell-cell adherens junction,postsynaptic density,mitochondrial crista,extrinsic component of cytoplasmic side of plasma membrane,integrin alpha2-beta1 complex,mast cell granule,intracellular membrane-bounded organelle,membrane raft,perinuclear region of cytoplasm,extracellular exosome;FLNC FLNC_HUMAN0cell junction assembly,muscle fiber development;Tprotein binding,cytoskeletal protein binding,ankyrin binding,actin filament binding;ecytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,sarcoplasm,Z disc,sarcolemma,costamere;M;;;;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,histamine secretion by mast cell,post-Golgi vesicle-mediated transport,vesicle targeting,protein transport,synaptic vesicle priming,synaptic vesicle fusion to presynaptic active zone membrane,neutrophil degranulation,membrane fusion;<;;;;SNAP receptor activity,protein binding,syntaxin binding;;;;;nucleoplasm,cytoplasm,plasma membrane,cell-cell adherens junction,focal adhesion,phagocytic vesicle membrane,SNARE complex,specific granule membrane,specific granule,azurophil granule,mast cell granule,neuron projection,extracellular exosome,tertiary granule membrane,presynapse;;;;;stimulatory C-type lectin receptor signaling pathway,cell adhesion,single organismal cell-cell adhesion,extracellular matrix organization,regulation of immune response;;;;integrin bindingo;;;;uropod,plasma membrane,integral component of plasma membrane,membrane,cleavage furrow,extracellular exosome;glucose metabolic process,sorbitol catabolic process,response to osmotic stress,response to hormone,glucuronate catabolic process to xylulose 5-phosphate,flagellated sperm motility,response to nutrient levels,response to drug,fructose biosynthetic process,response to cadmium ion,response to copper ion,L-xylitol catabolic process,L-xylitol metabolic process,oxidation-reduction process;;L-iditol 2-dehydrogenase activity,zinc ion binding,carbohydrate binding,identical protein binding,D-xylulose reductase activity,NAD binding;a;extracellular space,cytosol,membrane,motile cilium,mitochondrial membrane,extracellular exosome;blood vessel development,signal transduction,reproductive process,actin cytoskeleton reorganization,substrate adhesion-dependent cell spreading,negative regulation of extracellular matrix assembly,positive regulation of metallopeptidase activity;;;;;xtransmembrane signaling receptor activity,protein binding,collagen binding,metal ion binding,actin filament binding;;;;;plasma membrane,external side of plasma membrane,cell surface,endosome membrane,integral component of membrane,lamellipodium membrane,filopodium membrane,extracellular exosome;;;;;fructose 6-phosphate metabolic process,glycolytic process,response to glucose,fructose 1,6-bisphosphate metabolic process,neutrophil degranulation,negative regulation of insulin secretion,protein oligomerization,protein homotetramerization,canonical glycolysis;6-phosphofructokinase activity,protein binding,ATP binding,kinase binding,identical protein binding,metal ion binding,fructose binding,fructose-6-phosphate binding;extracell< ular region,cytosol,6-phosphofructokinase complex,membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;bprotein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;zona pellucida receptor complex,cytosol,chaperonin-containing T-complex,cytoskeleton,microtubule,plasma membrane,myelin sheath,cell body,extracellular exosome;;;;protein folding,'de novo' protein folding,binding of sperm to zona pellucida,response to virus,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;;;;protein binding,ATP binding,G-protein beta-subunit binding,protein binding involved in protein folding,beta-tubulin binding,unfolded protein binding;;;;zona pellucida receptor complex,nucleolus,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome;SEMG1 SEMG1_HUMAN.insemination,antimicrobial humoral response,antibacterial humoral response,cellular protein metabolic process,coagulation,protein heterooligomerization,negative regulation of calcium ion import,positive regulation of serine-type endopeptidase activity,negative regulation of flagellated sperm motility;"protein binding,metal ion binding;Wextracellular region,extracellular space,nucleus,protein complex,extracellular exosome;N ;;;;;;G1/S transition of mitotic cell cycle,MAPK cascade,protein dephosphorylation,calcium ion transport,nervous system development,regulation of skeletal muscle adaptation,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,insulin secretion,cell differentiation,intracellular signal transduction,positive regulation of GTPase activity,protein autophosphorylation,protein oligomerization,regulation of calcium ion transport,interferon-gamma-mediated signaling pathway,regulation of cellular response to heat,regulation of relaxation of cardiac muscle;;;;;;;;;;MAPK cascade,regulation of cell growth,regulation of the force of heart contraction,regulation of membrane depolarization,regulation of transcription from RNA polymerase II promoter,protein phosphorylation,nervous system development,regulation of heart contraction,positive regulation of cardiac muscle hypertrophy,regulation of cell communication by electrical coupling,positive regulation of cardiac muscle cell apoptotic process,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,cell differentiation,endoplasmic reticulum calcium ion homeostasis,positive regulation of GTPase activity,protein autophosphorylation,protein oligomerization,relaxation of cardiac muscle,regulation of ryanodine-sensitive calcium-release channel activity,interferon-gamma-mediated signaling pathway,regulation of cellular localization,cellular response to calcium ion,cardiac muscle cell contraction,regulation of heart rate by cardiac conduction,regulation of cardiac muscle cell action potential,regulation of cardiac muscle cell action potential involved in regulation of contraction,regulation of cellular response to heat,regulation of histone deacetylase activity,regulation of cell communication by electrical coupling involved in cardiac conduction,regulation of relaxation of cardiac muscle,negative regulation of sodium ion transmembrane transport,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,negative regulation of sodium ion transmembrane transporter activity;;;;;;;;;;;;G1/S transition of mitotic cell cycle,MAPK cascade,response to ischemia,protein phosphorylation,calcium ion transport,Wnt signaling pathway, calcium modulating pathway,nervous system development,positive regulation of cardiac muscle cell apoptotic process,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,cell differentiation,intracellular signal transduction,angiotensin-activated signaling pathway,positive regulation of GTPase activity,protein autophosphorylation,regulation of neurotransmitter secretion,regulation of neuronal synaptic plasticity,dendrite morphogenesis,positive regulation of NF-kappaB transcription factor activity,positive regulation of calcium ion transport,interferon-gamma-mediated signaling pathway,regulation of cellular response to heat,regulation of mitochondrial membrane permeability involved in apoptotic process;];;;;;;protein serine/threonine kinase activity,calmodulin-dependent protein kinase activity,calcium-dependent protein serine/threonine phosphatase activity,Ras guanyl-nucleotide exchange factor activity,protein binding,calmodulin binding,ATP binding,protein homodimerization activity;;;;;;;;;;protein serine/threonine kinase activity,calmodulin-dependent protein kinase activity,Ras guanyl-nucleotide exchange factor activity,protein binding,calmodulin binding,ATP binding,sodium channel inhibitor activity,titin binding,protein homodimerization activity,ion channel binding;;;;;;;;;;;;protein serine/threonine kinase activity,calmodulin-dependent protein kinase activity,Ras guanyl-nucleotide exchange factor activity,protein binding,calmodulin binding,ATP binding,kinase activity,glutamate receptor binding,protein homodimerization activity,metal ion binding; ;;;;;;nucleoplasm,cytoplasm,cytosol,plasma membrane,postsynaptic density,membrane,endocytic vesicle membrane,sarcoplasmic reticulum membrane,neuron projection;;;;;;;;;;nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,endocytic vesicle membrane,sarcoplasmic reticulum membrane,sarcolemma,neuron projection,calcium channel complex;;;;;;;;;;;;nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,plasma membrane,postsynaptic density,cell junction,endocytic vesicle membrane,presynaptic membrane,neuron projection;ossification,angiogenesis,positive regulation of endothelial cell proliferation,negative regulation of cytokine-mediated signaling pathway,platelet degranulation,regulation of type 2 immune response,regulation of transcription from RNA polymerase II promoter,inflammatory response,signal transduction,negative regulation of peptidase activity,negative regulation of bone mineralization,biomineral tissue development,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of angiogenesis,regulation of T cell migration;protease binding,signal transducer activity,interleukin-2 receptor binding,protein binding,protein C-terminus binding,enzyme binding,laminin binding;extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,platelet dense granule lumen,extracellular exosome;platelet degranulation,positive regulation of leukocyte migration,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,extracellular matrix organization,platelet aggregation;lprotein binding,identical protein binding,metal ion binding,extracellular matrix binding,fibrinogen binding;plasma membrane,integral component of plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,platelet alpha granule membrane,extracellular exosome,blood microparticle;;;pentose-phosphate shunt,pentose-phosphate shunt, oxidative branch,pentose biosynthetic process,D-gluconate metabolic process,oxidation-reduction process;<;;phosphogluconate dehydrogenase (decarboxylating) activity;(;;nucleus,cytosol,extracellular exosome;;;;angiogenesis,positive regulation of endothelial cell proliferation,proteolysis,intracellular protein transport,activation of cysteine-type endopeptidase activity involved in apoptotic process,positiv< e regulation of endothelial cell migration,negative regulation of vascular endothelial growth factor receptor signaling pathway,negative regulation of TOR signaling,cellular response to heat,vascular endothelial growth factor receptor-2 signaling pathway,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of angiogenesis,response to calcium ion,negative regulation of protein kinase B signaling,apoptotic signaling pathway;;;;calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding,identical protein binding,protein homodimerization activity,protein anchor,protein dimerization activity,calcium-dependent protein binding,binding, bridging;;;;nucleus,cytoplasm,endosome,endoplasmic reticulum,endoplasmic reticulum membrane,cytoplasmic vesicle,nuclear membrane,extracellular exosome,endoplasmic reticulum exit site;;;;negative regulation of protein phosphorylation,protein dephosphorylation,biological_process,negative regulation of G1/S transition of mitotic cell cycle;;negative regulation of protein phosphorylation,regulation of transcription from RNA polymerase II promoter,protein dephosphorylation,negative regulation of neuron differentiation,negative regulation of G1/S transition of mitotic cell cycle;;;;;molecular_function,phosphoprotein phosphatase activity,metal ion binding;;protein binding,CTD phosphatase activity,metal ion binding;;M;;;nucleus,extracellular exosome;;nucleus,nucleoplasm,extracellular exosome;;negative regulation of receptor internalization,protein targeting to membrane,substrate-dependent cell migration, cell extension,chemical synaptic transmission,regulation of mitotic cell cycle,positive regulation of cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of pathway-restricted SMAD protein phosphorylation,actin cytoskeleton organization,positive regulation of cell growth,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,intracellular signal transduction,positive regulation of phosphorylation,neutrophil degranulation,positive regulation of JNK cascade,ephrin receptor signaling pathway,positive regulation of exosomal secretion,positive regulation of extracellular exosome assembly;frizzled binding,interleukin-5 receptor binding,protein binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal adaptor activity,identical protein binding,cadherin binding,syndecan binding,protein heterodimerization activity,protein N-terminus binding;extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum membrane,cytosol,cytoskeleton,plasma membrane,interleukin-5 receptor complex,adherens junction,focal adhesion,membrane,nuclear membrane,azurophil granule lumen,melanosome,intracellular membrane-bounded organelle,membrane raft,extracellular exosome,blood microparticle,extracellular vesicle;*;antigen processing and presentation of exogenous peptide antigen via MHC class II,neutrophil degranulation;G2/M transition of mitotic cell cycle,spermatogenesis,vesicle-mediated transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,ciliary basal body docking;);protein binding,ATP binding;ATP binding;c;extracellular region,cytoplasm,centrosome,cytosol,dynactin complex,microtubule cytoskeleton,membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;manchette,cytoplasm,centrosome,centriole,cytosol,dynactin complex,microtubule associated complex,microtubule cytoskeleton,COPI-coated vesicle,myelin sheath,extracellular exosome;Q9H1D9POLR3F RPC6_HUMAN,DNA-directed RNA polymerase III subunit RPC60regulation of transcription from RNA polymerase III promoter,transcription from RNA polymerase III promoter,positive regulation of type I interferon production,positive regulation of interferon-beta production,innate immune response,positive regulation of innate immune response,defense response to virusPDNA-directed RNA polymerase activity,protein binding,RNA polymerase III activity;nucleoplasm,DNA-directed RNA polymerase III complex,cytosol A0A087WSX0A0A087WSX0_HUMAN;;;;glycogen metabolic process,protein dephosphorylation,sister chromatid cohesion,neuron differentiation,circadian regulation of gene expression,regulation of circadian rhythm,entrainment of circadian clock by photoperiod,regulation of nucleocytoplasmic transport,cell division;;glycogen metabolic process,regulation of glycogen biosynthetic process,regulation of glycogen catabolic process,protein dephosphorylation,cell cycle,dephosphorylation,lung development,negative regulation of protein binding,circadian regulation of gene expression,regulation of translational initiation by eIF2 alpha dephosphorylation,regulation of circadian rhythm,entrainment of circadian clock by photoperiod,branching morphogenesis of an epithelial tube,cell division,regulation of canonical Wnt signaling pathway,cell-cell adhesion,beta-catenin destruction complex disassembly,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;;];;;;RNA binding,phosphoprotein phosphatase activity,protein serine/threonine phosphatase activity,protein binding,lamin binding,protein C-terminus binding,protein phosphatase 1 binding,phosphatase activity,protein kinase binding,protein domain specific binding,protein complex binding,metal ion binding,protein N-terminus binding;;phosphoprotein phosphatase activity,protein serine/threonine phosphatase activity,protein binding,protein phosphatase 1 binding,phosphatase activity,protein complex binding,ribonucleoprotein complex binding,metal ion binding,cadherin binding involved in cell-cell adhesion;;;;;;condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,mitochondrion,mitochondrial outer membrane,cytosol,focal adhesion,nuclear speck,midbody,cleavage furrow,dendritic spine,protein complex,PTW/PP1 phosphatase complex,nuclear chromosome, telomeric region;;protein phosphatase type 1 complex,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,glycogen granule,dendritic spine,perikaryon,extracellular exosome,PTW/PP1 phosphatase complex,nuclear chromosome, telomeric region;;proteolysis,cell-matrix adhesion,integrin-mediated signaling pathway,glycoprotein metabolic process,response to toxic substance,response to amine,protein processing,platelet activation,response to potassium ion,protein O-linked fucosylation,peptide catabolic process,cellular response to lipopolysaccharide,cellular response to interferon-gamma,cellular response to interleukin-4,cellular response to tumor necrosis factor;;metalloendopeptidase activity,integrin binding,calcium ion binding,protein binding,metallopeptidase activity,zinc ion binding;;aproteinaceous extracellular matrix,extracellular space,endoplasmic reticulum lumen,cell surface;;P01730CD4 CD4_HUMANT-cell surface glycoprotein CD4"cytokine production,adaptive immune response,induction by virus of host cell-cell fusion,immune response,cell adhesion,signal transduction,cell surface receptor signaling pathway,enzyme linked receptor protein signaling pathway,transmembrane receptor protein tyrosine kinase signaling pathway,positive regulation of calcium ion transport into cytosol,fusion of virus membrane with host plasma membrane,T cell differentiation,entry into host cell,T cell costimulation,response to estradiol,maintenance of protein location in cell,response to vitamin D,helper T cell enhancement of adaptive immune response,positive regulation of T cell proliferation,T cell selection,positive regulation of interleukin-2 biosynthetic process,positive regulation of protein kinase activity,regulation of defense response to virus by virus,positive regulation of peptidyl-tyrosine phosphorylation,defense response to Gram-negative bacterium,positive regulation of calcium-mediated signaling,T cell receptor signaling pathway,regulation of T cell activation,membrane organization< evirus receptor activity,glycoprotein binding,receptor activity,transmembrane signaling receptor activity,extracellular matrix structural constituent,protein binding,zinc ion binding,coreceptor activity,immunoglobulin binding,enzyme binding,protein kinase binding,MHC class II protein binding,protein homodimerization activity,protein tyrosine kinase bindingearly endosome,endoplasmic reticulum lumen,endoplasmic reticulum membrane,plasma membrane,external side of plasma membrane,integral component of membrane,clathrin-coated vesicle membrane,T cell receptor complex,membrane raftprotein complex assembly,cytoskeleton organization,regulation of cell shape,regulation of lamellipodium assembly,positive regulation of fibroblast migration,negative regulation of peptidyl-threonine phosphorylation,negative regulation of cell-substrate adhesion,actin cytoskeleton organization,positive regulation of blood coagulation,regulation of actin cytoskeleton organization,negative regulation of peptidyl-serine phosphorylation,calcium-mediated signaling using intracellular calcium source,calcium-mediated signaling using extracellular calcium source,erythrocyte development,negative regulation of peptidyl-tyrosine phosphorylation,actin filament bundle assembly,regulation of filopodium assembly,actin filament capping,negative regulation of focal adhesion assembly,transmembrane transport,protein secretion by platelet,cellular response to calcium ion,cellular response to cAMP,positive regulation of wound healing,negative regulation of protein targeting to membrane,actin filament reorganization,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of platelet aggregation,positive regulation of integrin-mediated signaling pathway;;;[actin binding,receptor binding,protein binding,spectrin binding,protein self-association;;;cytosol,actin filament,plasma membrane,endomembrane system,postsynaptic density,spectrin-associated cytoskeleton,actin cytoskeleton,cortical cytoskeleton,platelet dense tubular network membrane,cell projection membrane,cytoplasmic vesicle,perinuclear region of cytoplasm;;;y;platelet degranulation,prenylated protein catabolic process,prenylcysteine catabolic process,oxidation-reduction process ;prenylcysteine oxidase activityM;extracellular region,vacuolar membrane,membrane,platelet alpha granule lumen;;skeletal system development,cell adhesion,collagen fibril organization,collagen catabolic process,endodermal cell differentiation;;K;;extracellular matrix structural constituent conferring tensile strength;;;;extracellular region,collagen type XII trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome,extracellular vesicle;;;cell adhesion,cell-matrix adhesion,signal transduction,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,cell-cell signaling,viral process,stress fiber assembly,regulation of inflammatory response-;RNA binding,protein binding,zinc ion binding~;stress fiber,nucleus,cytosol,plasma membrane,integral component of plasma membrane,cell-cell adherens junction,focal adhesion;carbohydrate metabolic process,cellular aldehyde metabolic process,xenobiotic metabolic process,daunorubicin metabolic process,doxorubicin metabolic process,oxidation-reduction process;xenobiotic metabolic process,oxidation-reduction process;alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,protein binding,electron carrier activity,phenanthrene-9,10-epoxide hydrolase activity;aldo-keto reductase (NADP) activityL;Golgi apparatus,cytosol,extracellular exosome;cytosol,extracellular exosome;;somitogenesis,movement of cell or subcellular component,transmembrane receptor protein tyrosine kinase signaling pathway,actin polymerization or depolymerization,negative regulation of cell proliferation,viral process,peptidyl-tyrosine phosphorylation,megakaryocyte development,Fc-gamma receptor signaling pathway involved in phagocytosis,vascular endothelial growth factor receptor signaling pathway,dendrite morphogenesis,positive regulation of protein tyrosine kinase activity,lamellipodium morphogenesis;;;;;;;;;;;;protein binding,cytoskeletal protein binding,SH3 domain binding,protein tyrosine kinase activator activity,protein complex binding,cadherin binding;;;;;;;;;;;;intracellular,nucleus,endoplasmic reticulum,cytosol,cytoskeleton,postsynaptic density,lamellipodium,cell junction,filopodium,growth cone,SCAR complex,postsynaptic membrane,extracellular exosome;;;;;;;;;;;xylulose biosynthetic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch,regulation of growth,glyceraldehyde-3-phosphate biosynthetic process;m;transketolase activity,protein binding,protein homodimerization activity,metal ion binding,cofactor binding;g;nucleoplasm,peroxisome,cytosol,nuclear body,nuclear speck,vesicle,myelin sheath,extracellular exosome;;negative regulation of myeloid leukocyte differentiation,nucleoside diphosphate phosphorylation,GTP biosynthetic process,UTP biosynthetic process,CTP biosynthetic process,transcription, DNA-templated,regulation of transcription, DNA-templated,cell adhesion,integrin-mediated signaling pathway,nucleoside triphosphate biosynthetic process,positive regulation of neuron projection development,nucleobase-containing small molecule interconversion,peptidyl-histidine phosphorylation,positive regulation of cAMP biosynthetic process,cellular response to oxidative stress,negative regulation of apoptotic process,neutrophil degranulation,positive regulation of keratinocyte differentiation,regulation of epidermis development,positive regulation of transcription from RNA polymerase II promoter,protein autophosphorylation,positive regulation of epithelial cell proliferation,protein oligomerization,response to growth hormone,cellular response to glucose stimulus,cellular response to fatty acid;;8;DNA binding,transcription factor activity, sequence-specific DNA binding,nucleoside diphosphate kinase activity,protein histidine kinase activity,protein serine/threonine kinase activity,fatty acid binding,protein binding,ATP binding,drug binding,intermediate filament binding,enzyme binding,metal ion binding;; ;ruffle,extracellular region,nucleus,cytoplasm,cytosol,intermediate filament,lamellipodium,mitochondrial membrane,secretory granule lumen,myelin sheath,perinuclear region of cytoplasm,extracellular exosome,cell periphery,ficolin-1-rich granule lumen,focal adhesion;;.;;;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,regulation of inflammatory response,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,proteolysis involved in cellular protein catabolic process,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;;;;;RNA binding,endopeptidase activity,threonine-type endopeptidase activity,protein binding,purine ribonucleoside triphosphate binding,NF-kappaB binding;;;;;proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome cor< e complex,polysome,nuclear matrix,proteasome core complex, alpha-subunit complex,myofibril,sarcomere,extracellular exosome;innate immune response in mucosa,nucleosome assembly,protein ubiquitination,antibacterial humoral response,defense response to Gram-positive bacterium;innate immune response in mucosa,nucleosome assembly,protein ubiquitination,antibacterial humoral response,defense response to Gram-positive bacterium;nucleosome assembly,protein ubiquitination;nucleosome assembly,protein ubiquitination;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,substantia nigra development,defense response to Gram-positive bacterium;nucleosome assembly,protein ubiquitination;innate immune response in mucosa,nucleosome assembly,protein ubiquitination,antibacterial humoral response,defense response to Gram-positive bacterium;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium;nucleosome assembly;;nucleosome assembly,protein ubiquitination;nucleosome assembly,nucleosome disassembly,inflammatory response,protein ubiquitination,plasminogen activation,spermatogenesis, exchange of chromosomal proteins,positive regulation of binding,mononuclear cell migration;nucleosome assembly,protein ubiquitination;nucleosome assembly,protein ubiquitination;nucleosome assembly,protein ubiquitination; molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol;nucleosome,nucleus,nucleoplasm,cytosol;nuclear chromosome, telomeric region,nucleosome,nucleus,nucleoplasm,cytosol;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,extracellular space,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nuclear chromosome, telomeric region,nucleosome,nucleus,nucleoplasm,extrinsic component of plasma membrane;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;nucleosome,nucleus,nucleoplasm,cytosol,extracellular exosome;;stimulatory C-type lectin receptor signaling pathway,phagocytosis,cell adhesion,single organismal cell-cell adhesion,extracellular matrix organization,regulation of immune response2;receptor binding,integrin binding,protein bindingL;plasma membrane,integral component of plasma membrane,extracellular exosome8;protein targeting to lysosome,endocytosis,epidermal growth factor catabolic process,small GTPase mediated signal transduction,endosome to lysosome transport,protein transport,viral release from host cell,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein to membrane docking,retrograde transport, endosome to Golgi,neutrophil degranulation,early endosome to late endosome transport,positive regulation of protein catabolic process,positive regulation of viral process,membrane organization,lipophagy,phagosome maturation,phagosome acidification,phagosome-lysosome fusion,multi-organism intracellular transport,negative regulation of exosomal secretion,positive regulation of exosomal secretion,negative regulation of intralumenal vesicle formation,regulation of autophagosome assemblyQ;GTPase activity,protein binding,GTP binding,GDP binding,retromer complex bindingu;autophagosome membrane,lysosome,lysosomal membrane,late endosome,Golgi apparatus,lipid particle,cytosol,plasma membrane,endosome membrane,secretory granule membrane,phagocytic vesicle membrane,late endosome membrane,extrinsic component of lysosome membrane,melanosome membrane,pre-autophagosomal structure membrane,phagocytic vesicle,extracellular exosome,retromer complexWskeletal system development,osteoblast differentiation,cell adhesion,multicellular organism development,central nervous system development,cell recognition,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process;extracellular matrix structural constituent,calcium ion binding,protein binding,glycosaminoglycan binding,hyaluronic acid binding,carbohydrate binding;extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi lumen,membrane,extracellular matrix,lysosomal lumen; ;MAPK cascade,mitotic cytokinesis,ER to Golgi vesicle-mediated transport,plasma membrane organization,cytoskeleton organization,common-partner SMAD protein phosphorylation,SMAD protein import into nucleus,axon guidance,Golgi to plasma membrane protein transport,positive regulation of GTPase activity,actin filament capping,membrane assembly,protein targeting to plasma membrane,positive regulation of interleukin-2 secretion,regulation of protein localization to plasma membrane,positive regulation of protein localization to plasma membrane;;;RNA binding,actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,calmodulin binding,phospholipid binding,ankyrin binding,protein complex binding,cadherin binding,GTPase binding;;;nucleolus,cytoplasm,cytosol,spectrin,postsynaptic density,spectrin-associated cytoskeleton,axolemma,M band,cuticular plate,protein complex,extracellular exosome;;A;;Golgi lumen,plasma membrane,inner mucus layer,outer mucus layer A0A075B7D4 IGKV1OR2-108A0A075B7D4_HUMANProtein IGKV1OR2-108 (Fragment)=;G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,mitotic spindle organization,mitotic nuclear division,cell proliferation,antigen processing and presentation of exogenous peptide antigen via MHC class II,melanosome transport,protein localization to centrosome,ciliary basal body docking;;L;motor activity,protein binding,spectrin binding,identical protein binding;;;kinetochore,cytoplasm,centrosome,cytosol,dynactin complex,microtubule,membrane,dynein complex,growth cone,vesicle,extracellular exosome;;Q;;;;extracellular matrix organization,definitive hemopoiesis,fibril organization;0;;;;extracellular matrix structural constituent;\;;;;microfibril,extracellular region,proteinaceous extracellular matrix,extracellular space;';reproductive process,toxin transport;;6;receptor activity,protein binding,metal ion binding;;;extracellular region,endoplasmic reticulum membrane,plasma membrane,external side of plasma membrane,endosome membrane,integral component of membrane;;0;adaptive immune response,leukocyte migration;;;2;plasma membrane,integral component of membrane;;;Ł protein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,neutrophil degranulation,pore complex assembly,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;;protein binding,ATP binding,ATPase activity, coupled,protein binding involved in protein folding,cadherin binding,unfolded protein binding;;"zona pellucida receptor co< mplex,extracellular region,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,cilium,secretory granule lumen,azurophil granule lumen,cell body,intermediate filament cytoskeleton,extracellular exosome,ficolin-1-rich granule lumen;;;cell adhesion,cell projection assembly,lamellipodium assembly,actin cytoskeleton reorganization,establishment or maintenance of cell polarity regulating cell shape;; ;actin binding,protein binding;;K;cytosol,cytoskeleton,plasma membrane,focal adhesion,Z disc,lamellipodium;; ;;negative regulation of transcription from RNA polymerase II promoter,microglial cell activation,positive regulation of receptor recycling,negative regulation of protein phosphorylation,positive regulation of neurotransmitter secretion,fatty acid metabolic process,neutral lipid metabolic process,phospholipid metabolic process,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,mitochondrial membrane organization,aging,adult locomotory behavior,response to iron(II) ion,regulation of phospholipase activity,negative regulation of platelet-derived growth factor receptor signaling pathway,regulation of glutamate secretion,regulation of dopamine secretion,negative regulation of microtubule polymerization,receptor internalization,protein destabilization,response to magnesium ion,negative regulation of transporter activity,response to lipopolysaccharide,negative regulation of monooxygenase activity,positive regulation of peptidyl-serine phosphorylation,response to interferon-gamma,cellular response to oxidative stress,negative regulation of histone acetylation,regulation of locomotion,dopamine biosynthetic process,response to drug,mitochondrial ATP synthesis coupled electron transport,regulation of macrophage activation,positive regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of neuron apoptotic process,cellular protein metabolic process,cellular response to fibroblast growth factor stimulus,positive regulation of endocytosis,negative regulation of exocytosis,negative regulation of dopamine metabolic process,behavioral response to cocaine,regulation of long-term neuronal synaptic plasticity,synaptic vesicle endocytosis,synapse organization,regulation of acyl-CoA biosynthetic process,positive regulation of release of sequestered calcium ion into cytosol,dopamine uptake involved in synaptic transmission,negative regulation of dopamine uptake involved in synaptic transmission,negative regulation of serotonin uptake,negative regulation of norepinephrine uptake,oxidation-reduction process,excitatory postsynaptic potential,long-term synaptic potentiation,positive regulation of inositol phosphate biosynthetic process,negative regulation of thrombin-activated receptor signaling pathway,response to interleukin-1,cellular response to copper ion,cellular response to epinephrine stimulus,positive regulation of protein serine/threonine kinase activity,fibril organization,negative regulation of neuron death,negative regulation of mitochondrial electron transport, NADH to ubiquinone,positive regulation of glutathione peroxidase activity,positive regulation of hydrogen peroxide catabolic process,regulation of synaptic vesicle recycling,regulation of reactive oxygen species biosynthetic process,negative regulation of chaperone-mediated autophagy,Requires Ontology,calcium ion homeostasis;;^;;magnesium ion binding,copper ion binding,calcium ion binding,protein binding,phospholipid binding,microtubule binding,ferrous iron binding,zinc ion binding,oxidoreductase activity,kinesin binding,protein domain specific binding,histone binding,identical protein binding,alpha-tubulin binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,phospholipase binding,transcription regulatory region DNA binding,protein N-terminus binding,tau protein binding,beta-tubulin binding,phosphoprotein binding,dynein complex binding,fatty acid binding,phospholipase D inhibitor activity;;;;extracellular region,extracellular space,nucleus,nuclear outer membrane,cytoplasm,mitochondrion,lysosome,rough endoplasmic reticulum,Golgi apparatus,cytosol,ribosome,plasma membrane,cell cortex,synaptic vesicle,actin cytoskeleton,membrane,inclusion body,cell junction,axon,growth cone,neuronal cell body,terminal bouton,perinuclear region of cytoplasm,postsynapse,supramolecular fiber,mitochondrial respiratory chain complex I,platelet alpha granule membrane;;BCL6};;;protein import into nucleus, translocation,negative regulation of transcription from RNA polymerase II promoter,cell morphogenesis,negative regulation of cell-matrix adhesion,germinal center formation,regulation of germinal center formation,negative regulation of B cell apoptotic process,transcription, DNA-templated,inflammatory response,cellular response to DNA damage stimulus,Rho protein signal transduction,spermatogenesis,negative regulation of cell proliferation,actin cytoskeleton organization,B cell differentiation,negative regulation of cell growth,positive regulation of B cell proliferation,positive regulation of histone deacetylation,negative regulation of mast cell cytokine production,negative regulation of Rho protein signal transduction,type 2 immune response,regulation of cell proliferation,regulation of apoptotic process,positive regulation of apoptotic process,regulation of GTPase activity,regulation of memory T cell differentiation,negative regulation of T-helper 2 cell differentiation,positive regulation of neuron differentiation,negative regulation of Notch signaling pathway,negative regulation of transcription, DNA-templated,negative regulation of isotype switching to IgE isotypes,erythrocyte development,regulation of inflammatory response,regulation of immune response,positive regulation of cellular component movement,negative regulation of cellular senescence;;;;RNA polymerase II regulatory region sequence-specific DNA binding,intronic transcription regulatory region sequence-specific DNA binding,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,chromatin binding,transcription factor activity, sequence-specific DNA binding,protein binding,chromatin DNA binding,identical protein binding,sequence-specific DNA binding,metal ion binding;8;;;nucleus,nucleoplasm,Golgi apparatus,replication fork;1retrograde vesicle-mediated transport, Golgi to ER,microtubule-based movement,mitotic spindle organization,sister chromatid cohesion,nervous system development,antigen processing and presentation of exogenous peptide antigen via MHC class II,cell differentiation,cell division,mitotic spindle assembly;;;;mmotor activity,microtubule motor activity,protein binding,ATP binding,microtubule binding,ATPase activity;;;;nucleus,nucleolus,centrosome,cytosol,kinesin complex,membrane,nuclear body,sperm principal piece,spindle pole,spindle microtubule;;;;Alpha-amylase 2B(alpha-amylase activity,metal ion bindingOproteolysis,cellular amino acid metabolic process,collagen catabolic process;;;~aminopeptidase activity,metallocarboxypeptidase activity,protein binding,manganese ion binding,proline dipeptidase activity;;;]response to hypoxia,lactate metabolic process,pyruvate metabolic process,glycolytic process,response to nutrient,response to glucose,NAD metabolic process,response to drug,response to hydrogen peroxide,positive regulation of apoptotic process,response to estrogen,post-embryonic animal organ development,response to cAMP,oxidation-reduction process;wL-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,cadherin binding,NAD binding;/nucleus,cytosol,membrane,extracellular exosome;;;protein folding,protein homooligomerization,negative regulation of protein refolding,chaperone cofactor-dependent protein refolding;;;;;protein binding,protein domain specific binding,Hsp70 protein binding,protein binding, bridging,protein complex binding,dATP binding,identical protein binding,unfolded protein binding,ch< aperone binding;;;d;;cytoplasm,cytosol,protein complex,extracellular exosome;;cytoplasm,extracellular exosome;cytoplasm Trypsin-1S;proteolysis,digestion,cobalamin metabolic process,extracellular matrix disassemblyT;serine-type endopeptidase activity,serine-type peptidase activity,metal ion binding?;extracellular region,extracellular exosome,blood microparticle;;;;;proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly,cornification;w;;;;;endopeptidase activity,calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding;<;;;;;cytosol,plasma membrane,membrane,extracellular exosome;G2/M transition of mitotic cell cycle,platelet degranulation,cytoskeleton organization,microtubule-based process,ciliary basal body docking;bGTPase activity,structural constituent of cytoskeleton,protein binding,GTP binding,enzyme binding;Xextracellular region,cytosol,microtubule,microtubule cytoskeleton,extracellular exosome;k;platelet degranulation,protein targeting,cellular response to starvation,protein import,regulation of protein stability,neutrophil degranulation,muscle cell cellular homeostasis,protein stabilization,chaperone-mediated autophagy,protein targeting to lysosome involved in chaperone-mediated autophagy,autophagosome maturation,lysosomal protein catabolic process;;A;protein binding,enzyme binding,protein domain specific binding;;\;extracellular space,lysosome,lysosomal membrane,late endosome,plasma membrane,membrane,phagocytic vesicle membrane,platelet dense granule membrane,late endosome membrane,azurophil granule membrane,lysosomal lumen,autolysosome,extracellular exosome,integral component of autophagosome membrane,ficolin-1-rich granule membrane,membrane microdomain;;9;;;;;;;;;;;;;;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,protein folding,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,viral life cycle,virion assembly,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,positive regulation of protein ubiquitination,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,mitochondrion transport along microtubule,neuron projection morphogenesis,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of mitochondrial membrane potential,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of neuron death,regulation of signal transduction by p53 class mediator,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,positive regulation of protein monoubiquitination,endoplasmic reticulum mannose trimming;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,protein folding,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,ubiquitin homeostasis,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,viral life cycle,virion assembly,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA p< olymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator,endoplasmic reticulum mannose trimming;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translation,translational initiation,protein folding,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator,endoplasmic reticulum mannose trimming;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translational initiation,protein folding,cellular protein modification process,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of G2/M transition of mitotic cell cycle,Wnt signaling pathway,endosomal transport,macroautophagy,protein ubiquitination,protein deubiquitination,response to insecticide,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,entry of bacterium into host cell,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of necroptotic process,membrane organization,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wn< t signaling pathway,regulation of signal transduction by p53 class mediator,endoplasmic reticulum mannose trimming;;;;;;;;;;;;;;;;protein binding;protease binding,RNA binding,protein binding;RNA binding,structural constituent of ribosome,protein binding,metal ion binding;structural constituent of ribosome,protein binding;;H;;;;;;;;;;;;;;extracellular space,nucleus,nucleoplasm,mitochondrion,mitochondrial outer membrane,cytosol,plasma membrane,endosome membrane,endocytic vesicle membrane,neuron projection,neuronal cell body,endoplasmic reticulum quality control compartment,extracellular exosome;extracellular space,nucleus,nucleoplasm,mitochondrial outer membrane,cytosol,plasma membrane,endosome membrane,endocytic vesicle membrane,myelin sheath,endoplasmic reticulum quality control compartment,extracellular exosome;extracellular space,nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrial outer membrane,cytosol,plasma membrane,endosome membrane,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,endocytic vesicle membrane,myelin sheath,endoplasmic reticulum quality control compartment,extracellular exosome;extracellular space,nucleus,nucleoplasm,mitochondrial outer membrane,lysosomal membrane,endoplasmic reticulum,cytosol,plasma membrane,endosome membrane,cytosolic large ribosomal subunit,endocytic vesicle membrane,endoplasmic reticulum quality control compartment,extracellular exosome;;;actin polymerization or depolymerization,actin filament depolymerization,actin filament fragmentation,positive regulation of actin filament depolymerization,actin filament severing';protein binding,actin filament bindingE;actin cytoskeleton,cortical actin cytoskeleton,extracellular exosomecell-matrix adhesion,positive regulation of cell-substrate adhesion,extracellular matrix disassembly,extracellular matrix organization,glomerular basement membrane development,basement membrane organization;\calcium ion binding,collagen binding,laminin binding,laminin-1 binding,proteoglycan binding;extracellular region,basement membrane,basal lamina,extracellular space,extracellular matrix,extracellular exosome,cell periphery;;;nucleobase-containing compound metabolic process,endocytosis,cytoskeleton organization,signal transduction,nervous system development,axon guidance,brain development,regulation of axon extension;];;dihydropyrimidinase activity,protein binding,microtubule binding,identical protein binding;E;;cytosol,plasma membrane,extracellular exosome,microtubule,membrane;-BMP signaling pathway,response to starvation;4calcium ion binding,protein binding,heparin binding;?extracellular region,extracellular space,extracellular exosome;;;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;;DNA binding,protein heterodimerization activity;DNA binding,protein binding,enzyme binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;;nucleosome,nucleus;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome;Mnegative regulation of cell adhesion,signal transduction,regulation of cell shape,positive regulation of phosphatidylinositol 3-kinase signaling,cell migration,negative regulation of osteoblast proliferation,intracellular signal transduction,regulation of GTPase activity,positive regulation of GTPase activity,ossification involved in bone maturation,axon extension,neuron projection morphogenesis,positive regulation of axonogenesis,regulation of cytoskeleton organization,semaphorin-plexin signaling pathway,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;;receptor activity,transmembrane signaling receptor activity,GTPase activator activity,protein binding,semaphorin receptor activity,semaphorin receptor binding,GTPase activating protein binding;;vsemaphorin receptor complex,extracellular region,intracellular,plasma membrane,integral component of plasma membrane;;hematopoietic progenitor cell differentiation,protein dephosphorylation,axonogenesis,central nervous system development,learning or memory,peptidyl-tyrosine dephosphorylation,oligodendrocyte differentiation,regulation of oligodendrocyte progenitor proliferation;;tprotein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding;;proteinaceous extracellular matrix,integral component of plasma membrane,intrinsic component of plasma membrane,perineuronal net;;MAPK cascade,protein polyubiquitination,osteoblast differentiation,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,viral process,protein deubiquitination,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process;2proteasome complex,cytoplasmic mRNA processing body,extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,secretory granule lumen,ficolin-1-rich granule lumen;bprotein folding,'de novo' protein folding,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone-mediated protein folding,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;RNA binding,protein binding,ATP binding,protein binding involved in protein folding,unfolded protein binding,WD40-repeat domain binding;icytoplasm,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,extracellular exosome;;angiogenesis,protein dephosphorylation,phosphate-containing compound metabolic process,dephosphorylation,peptidyl-tyrosine dephosphorylation,neutrophil degranulation;;;P;transmembrane receptor protein tyrosine phosphatase activity,protein binding;;;~;plasma membrane,integral component of plasma membrane,specific granule membrane,receptor complex,tertiary granule membrane;;;s;;intracellular protein transport,ER to Golgi vesicle-mediated transport,retr< ograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,brain development,regulation of synaptic vesicle priming,neuron differentiation,synaptic transmission, glutamatergic,SNARE complex disassembly,apical protein localization,COPII vesicle coating,membrane fusionp;;SNARE binding,soluble NSF attachment protein activity,protein binding,syntaxin binding,protein complex binding;;Golgi membrane,vacuolar membrane,cytosol,membrane,SNARE complex,terminal bouton,myelin sheath,synaptobrevin 2-SNAP-25-syntaxin-1a complex,extracellular exosome;;;;cell-matrix adhesion,single organismal cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,hyaluronan catabolic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of heterotypic cell-cell adhesion,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,neutrophil degranulation,negative regulation of DNA damage response, signal transduction by p53 class mediator,cellular response to fibroblast growth factor stimulus,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,cartilage development,interferon-gamma-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,monocyte aggregation,positive regulation of monocyte aggregation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;;;;;;;;;;;;;;;;g;;;;protein binding,collagen binding,hyaluronic acid binding,cytokine receptor activity;;;;;;;;;;;;;;;;;;;;Golgi apparatus,cytosol,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,secretory granule membrane,macrophage migration inhibitory factor receptor complex,extracellular exosome;;;;;;;;;;;;;;;;E;actin cytoskeleton organization,regulation of mitochondrial fission;";actin binding,Rho GTPase binding;!;perinuclear region of cytoplasm;!;;ribosomal large subunit export from nucleus,ribosomal small subunit export from nucleus,protein import into nucleus, translocation,DNA metabolic process,tRNA export from nucleus,protein import into nucleus,protein export from nucleus,mitotic spindle organization,mitotic nuclear division,small GTPase mediated signal transduction,spermatid development,viral process,hippocampus development,actin cytoskeleton organization,androgen receptor signaling pathway,gene silencing by RNA,positive regulation of protein binding,cellular protein complex localization,pre-miRNA export from nucleus,positive regulation of transcription, DNA-templated,cell division,cellular response to mineralocorticoid stimulus,protein transmembrane transport,intracellular transport of virus,protein localization to nucleolus;;chromatin binding,transcription coactivator activity,RNA binding,GTPase activity,protein binding,GTP binding,GDP binding,protein domain specific binding,protein complex binding,cadherin binding,dynein intermediate chain binding,androgen receptor binding,importin-alpha family protein binding,protein transmembrane transporter activity,pre-miRNA binding,pre-miRNA transporter activity;;male germ cell nucleus,manchette,nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,centriole,cytosol,membrane,midbody,extracellular matrix,sperm flagellum,melanosome,RNA nuclear export complex,recycling endosome,extracellular exosome,Flemming body,chromatinQchloride transport,ion transmembrane transport,chloride transmembrane transport;;Uintracellular calcium activated chloride channel activity,chloride channel activity;;@plasma membrane,chloride channel complex,extracellular exosome;;B cell homeostasis,myeloid cell homeostasis,protein complex assembly,chemotaxis,maintenance of cell polarity,neutrophil chemotaxis,positive regulation of actin filament polymerization,cortical actin cytoskeleton organization,positive regulation of B cell proliferation,activation of protein kinase activity,negative regulation of interleukin-17 production,negative regulation of interleukin-6 production,positive regulation of cell adhesion mediated by integrin,erythrocyte homeostasis,negative regulation of myosin-light-chain-phosphatase activity,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of T cell proliferation,positive regulation of phosphorylation,response to drug,T cell homeostasis,negative regulation of apoptotic process,neutrophil degranulation,positive regulation of CD4-positive, alpha-beta T cell differentiation,positive regulation of CD8-positive, alpha-beta T cell differentiation,positive regulation of GTPase activity,positive regulation of B cell differentiation,positive regulation of gamma-delta T cell differentiation,positive regulation of lymphocyte differentiation,positive regulation of erythrocyte differentiation,vascular endothelial growth factor receptor signaling pathway,erythrocyte development,B cell receptor signaling pathway,positive regulation of phagocytosis, engulfment,actin polymerization-dependent cell motility,positive regulation of neutrophil chemotaxis;dGTPase activator activity,protein binding,protein kinase activator activity,protein complex binding;cytosol,plasma membrane,integral component of plasma membrane,membrane,secretory granule membrane,SCAR complex,extracellular exosome,ficolin-1-rich granule membrane;;protein peptidyl-prolyl isomerization,heart morphogenesis,protein folding,'de novo' protein folding,transforming growth factor beta receptor signaling pathway,SMAD protein complex assembly,protein maturation by protein folding,positive regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of phosphoprotein phosphatase activity,regulation of protein localization,regulation of activin receptor signaling pathway,protein refolding,T cell activation,positive regulation of I-kappaB kinase/NF-kappaB signaling,regulation of immune response,ventricular cardiac muscle tissue morphogenesis,regulation of ryanodine-sensitive calcium-release channel activity,heart trabecula formation,chaperone-mediated protein folding,calcium ion transmembrane transport,fibril organization,regulation of amyloid precursor protein catabolic process,amyloid fibril formation,negative regulation of release of sequestered calcium ion into cytosol,negative regulation of ryanodine-sensitive calcium-release channel activity5;peptidyl-prolyl cis-trans isomerase activity,signal transducer activity,transforming growth factor beta receptor binding,protein binding,macrolide binding,FK506 binding,type I transforming growth factor beta receptor binding,ion channel binding,SMAD binding,activin binding,calcium channel inhibitor activityJ;cytoplasm,cytosol,terminal cisterna,membrane,Z disc,extracellular exosomefsensory perception of sound,positive regulation of peptidyl-threonine phosphorylation,hyaluronan biosynthetic process,hyaluronan catabolic process,positive regulation of cell migration,positive regulation of release of sequestered calcium ion into cytosol,positive regulation of protein targeting to membrane,positive regulation of protein kinase C activity;hyalurononglucosaminidase activity,protein binding,hyaluronic acid binding,clathrin heavy chain binding,ER retention sequence binding;extracellular region,nucleus,cytoplasm,endoplasmic reticulum,plasma membrane,clathrin-coated pit,clathrin-coated vesicle membrane,clathrin-coated endocytic vesicle;cartilage condensation,in utero embryonic development,kidney development,liver development,embryonic placenta development,protein export from nucleus,nitrogen compound metabolic process,cell cycle arrest,homophilic cell adhesion via plasma membrane adhesion molecules,cell-matrix adhesion,calcium-independent cell-matrix adhesion,positive regulation of cytosolic calcium ion concentration,JAK-STAT cascade,heart development,anatomical structure morphogenesis,single organismal cell-cell adhesion,peptidyl-serine phosphorylation,spinal cord development,neural tube development,establishment of cell polarity,regulation of cell adhesion,positive regulation of cyclin-dependent protein serine/threonine kinase acti< vity involved in G1/S transition of mitotic cell cycle,positive regulation of protein binding,response to fluid shear stress,lymph vessel morphogenesis,cytoplasmic sequestering of transcription factor,skin development,positive regulation of transcription from RNA polymerase II promoter,digestive tract development,branching morphogenesis of an epithelial tube,genitalia development,detection of mechanical stimulus,cartilage development,regulation of mitotic spindle organization,lung epithelium development,placenta blood vessel development,regulation of proteasomal protein catabolic process,calcium ion transmembrane transport,mesonephric tubule development,mesonephric duct development,metanephric collecting duct development,metanephric ascending thin limb development,metanephric proximal tubule development,metanephric distal tubule morphogenesis;;calcium channel activity,protein binding,protein kinase binding,protein domain specific binding,carbohydrate binding,ion channel binding;;)Golgi membrane,polycystin complex,nucleus,cytoplasm,plasma membrane,integral component of plasma membrane,cilium,cell surface,integral component of membrane,basolateral plasma membrane,lateral plasma membrane,Golgi-associated vesicle membrane,motile cilium,ciliary membrane,extracellular exosome;;platelet degranulation,positive regulation of leukocyte migration,inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,positive regulation of platelet activation,positive regulation of phosphatidylinositol 3-kinase signaling,response to lipopolysaccharide,regulation of integrin activation,calcium-mediated signaling using intracellular calcium source,defense response to Gram-negative bacterium,leukocyte migration,leukocyte tethering or rolling;;;lipopolysaccharide binding,glycoprotein binding,protein binding,heparin binding,sialic acid binding,fucose binding,glycosphingolipid binding,calcium-dependent protein binding,oligosaccharide binding;;;extracellular space,plasma membrane,integral component of plasma membrane,external side of plasma membrane,platelet dense granule membrane,platelet alpha granule membrane;;;signal transduction,small GTPase mediated signal transduction,protein transport,neutrophil degranulation,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,oxidation-reduction process,membrane organization;RNA binding,Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,small GTPase binding;extracellular region,cytoplasm,Golgi apparatus,cytosol,focal adhesion,membrane,vesicle,secretory granule lumen,azurophil granule lumen,myelin sheath,extracellular exosome;v;response to reactive oxygen species,skeletal system development,retina homeostasis,cell proliferation,removal of superoxide radicals,regulation of stress-activated MAPK cascade,erythrocyte homeostasis,natural killer cell mediated cytotoxicity,regulation of NF-kappaB import into nucleus,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction process{;RNA binding,peroxidase activity,protein binding,thioredoxin peroxidase activity,identical protein binding,cadherin binding;extracellular space,nucleus,cytoplasm,mitochondrion,cytosol,extracellular matrix,melanosome,myelin sheath,extracellular exosomeG;DNA metabolic process,Golgi organization,cell migration,actomyosin structure organization,regulation of macrophage activation,negative regulation of apoptotic process,Golgi vesicle budding,positive regulation of protein secretion,Golgi ribbon formation,asymmetric Golgi ribbon formation,positive regulation of opsonization;;;;k;DNA binding,RNA binding,protein binding,ATP binding,ADP binding,actin filament binding,ATPase activity;;;;;Golgi membrane,endoplasmic reticulum-Golgi intermediate compartment,trans-Golgi network,cell surface,membrane,myosin complex,actomyosin;;;;;;G2/M transition of mitotic cell cycle,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,inactivation of MAPK activity,regulation of DNA replication,regulation of transcription, DNA-templated,protein complex assembly,protein dephosphorylation,ceramide metabolic process,apoptotic process,chromosome segregation,mitotic nuclear envelope reassembly,female meiotic division,RNA splicing,response to organic substance,second-messenger-mediated signaling,regulation of Wnt signaling pathway,regulation of cell adhesion,negative regulation of cell growth,regulation of growth,negative regulation of tyrosine phosphorylation of Stat3 protein,regulation of cell differentiation,meiotic spindle elongation,mitotic sister chromatid separation,meiotic sister chromatid cohesion, centromeric,peptidyl-serine dephosphorylation,ciliary basal body docking,regulation of meiotic cell cycle process involved in oocyte maturation,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand;;antigen binding,protein serine/threonine phosphatase activity,protein binding,protein phosphatase regulator activity,protein heterodimerization activity;;protein phosphatase type 2A complex,chromosome, centromeric region,nucleus,mitochondrion,cytosol,microtubule cytoskeleton,membrane,extracellular exosome ;;regulation of cell growth,regulation of transcription, DNA-templated,membrane protein ectodomain proteolysis,inflammatory response,axon guidance,peptidyl-serine phosphorylation,platelet activation,positive regulation of telomere maintenance via telomerase,positive regulation of interleukin-17 production,positive regulation of interleukin-4 production,intracellular signal transduction,Fc-epsilon receptor signaling pathway,positive regulation of T cell proliferation,positive regulation of interleukin-2 biosynthetic process,negative regulation of insulin receptor signaling pathway,T cell receptor signaling pathway,positive regulation of T cell activation,positive regulation of NF-kappaB transcription factor activity,positive regulation of telomerase activity,cell chemotaxis,negative regulation of T cell apoptotic process,regulation of platelet aggregation,execution phase of apoptosis,positive regulation of telomere capping,positive regulation of T-helper 17 type immune response,positive regulation of T-helper 2 cell activation;;;stimulatory C-type lectin receptor signaling pathway,protein phosphorylation,apoptotic process,cell cycle,signal transduction,activation of phospholipase C activity,intrinsic apoptotic signaling pathway in response to oxidative stress,regulation of receptor activity,immunoglobulin mediated immune response,histone phosphorylation,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,peptidyl-tyrosine phosphorylation,termination of signal transduction,platelet activation,negative regulation of actin filament polymerization,positive regulation of endodeoxyribonuclease activity,negative regulation of protein binding,activation of protein kinase activity,interleukin-10 production,interleukin-12 production,positive regulation of superoxide anion generation,regulation of actin cytoskeleton organization,negative regulation of glial cell apoptotic process,positive regulation of protein dephosphorylation,Fc-gamma receptor signaling pathway involved in phagocytosis,B cell proliferation,neutrophil activation,positive regulation of protein import into nucleus,defense response to bacterium,neutrophil degranulation,negative regulation of MAP kinase activity,regulation of mRNA stability,negative regulation of insulin receptor signaling pathway,negative regulation of inflammatory response,negative regulation of peptidyl-tyrosine phosphorylation,protein stabilization,negative regulation of filopodium assembly,cell chemotaxis,interferon-gamma-mediated signaling pathway,cellular response to hydrogen peroxide,cellular response to hydroperoxide,negative regulation of platelet aggregation,cellular senescence,execution phase of apoptosis,positive regulation of phospholipid scramblase activity,cellular response to angiotensin,positive regulation of ceramide biosynthetic process,positive regulation of glucosylceramide catabol< ic process,positive regulation of sphingomyelin catabolic process,positive regulation of response to DNA damage stimulus,positive regulation of apoptotic signaling pathway;;;protein kinase activity,protein serine/threonine kinase activity,protein kinase C activity,protein binding,ATP binding,metal ion binding;;;protein kinase activity,protein serine/threonine kinase activity,protein kinase C activity,calcium-independent protein kinase C activity,non-membrane spanning protein tyrosine kinase activity,protein binding,ATP binding,enzyme activator activity,enzyme binding,kinase binding,protein kinase binding,insulin receptor substrate binding,metal ion binding;9;;immunological synapse,intracellular,microtubule organizing center,cytosol,plasma membrane,aggresome;;;extracellular region,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,cytosol,plasma membrane,cell-cell junction,nuclear matrix,azurophil granule lumen,perinuclear region of cytoplasm,extracellular exosome;;;;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,negative regulation of G2/M transition of mitotic cell cycle,protein deubiquitination,anaphase-promoting complex-dependent catabolic process,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,neutrophil degranulation,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,transmembrane transport,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway4;;;protein binding,protein homodimerization activity;;;proteasome complex,extracellular region,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumen;response to protozoan,negative regulation of type IV hypersensitivity,positive regulation of protein phosphorylation,chemotaxis,immune response,cellular defense response,negative regulation of cell adhesion,establishment or maintenance of cell polarity,signal transduction,cell surface receptor signaling pathway,T cell costimulation,positive regulation of T cell proliferation,negative regulation of T cell proliferation,positive regulation of tumor necrosis factor biosynthetic process,defense response to bacterium,negative thymic T cell selection,regulation of defense response to virus,leukocyte migration,apoptotic signaling pathway*;transmembrane signaling receptor activity;uropod,basement membrane,extracellular space,plasma membrane,integral component of plasma membrane,external side of plasma membrane,cell surface,membrane,extracellular exosome;positive regulation of epithelial cell migration,positive regulation of epithelial to mesenchymal transition,positive regulation of ERK1 and ERK2 cascade";protein homodimerization activity%;Golgi membrane,extracellular exosomeDNA repair,DNA recombination,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,mitotic nuclear division,spermatogenesis,protein deubiquitination,DNA duplex unwinding,CENP-A containing nucleosome assembly,regulation of growth,histone H4 acetylation,histone H2A acetylation,cell division,regulation of mitophagy,positive regulation of protein targeting to mitochondrion,beta-catenin-TCF complex assembly,positive regulation of telomerase RNA localization to Cajal body;}DNA helicase activity,protein binding,ATP binding,ATPase activity,ATP-dependent 5'-3' DNA helicase activity,cadherin binding;Swr1 complex,nucleus,nucleoplasm,microtubule organizing center,cytosol,membrane,nuclear matrix,Ino80 complex,NuA4 histone acetyltransferase complex,extracellular exosome,MLL1 complex,R2TP complex;l;;;cytokinesis,synaptic vesicle targeting,regulation of exocytosis,regulation of synaptic vesicle exocytosisK;;;GTPase activity,structural molecule activity,protein binding,GTP bindingL;;;cytoskeleton,plasma membrane,cell cortex,synaptic vesicle,terminal boutonY;;;;;angiogenesis,membrane raft assembly,positive regulation of receptor recycling,positive regulation of protein phosphorylation,membrane budding,body fluid secretion,collagen fibril organization,positive regulation of vesicle fusion,negative regulation of low-density lipoprotein particle receptor catabolic process,osteoclast development,fibrinolysis,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of fibroblast proliferation,protein heterotetramerization,protein targeting to plasma membrane,response to thyroid hormone,cell-cell adhesion,Requires Ontology;r;;;;;protease binding,RNA binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal protein binding,Rab GTPase binding,phospholipase A2 inhibitor activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion,receptor activator activity;+;;;;;ruffle,extracellular region,basement membrane,extracellular space,nucleus,lysosomal membrane,endosome,early endosome,lipid particle,cytosol,plasma membrane,cell-cell adherens junction,cell cortex,cell surface,membrane,basolateral plasma membrane,extrinsic component of plasma membrane,midbody,late endosome membrane,vesicle,azurophil granule lumen,myelin sheath adaxonal region,sarcolemma,melanosome,Schmidt-Lanterman incisure,macropinosome,perinuclear region of cytoplasm,extracellular exosome,PCSK9-AnxA2 complex,extracellular matrix,membrane raft;Q29865 1C18_HUMAN9HLA class I histocompatibility antigen, Cw-18 alpha chain4;;negative regulation of cell proliferation,negative regulation of platelet-derived growth factor receptor signaling pathway,regulation of cell adhesion,negative regulation of cell growth,negative regulation of cell migration,peptidyl-tyrosine dephosphorylation,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of vascular permeability,neutrophil degranulation,negative regulation of MAP kinase activity,positive regulation of cell adhesion,platelet-derived growth factor receptor signaling pathway,T cell receptor signaling pathway,negative regulation of T cell receptor signaling pathway,positive chemotaxis,positive regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of protein kinase B signaling,contact inhibition;;protein tyrosine phosphatase activity,platelet-derived growth factor receptor binding,protein binding,beta-catenin binding,phosphatase activity,protein kinase binding,gamma-catenin binding,mitogen-activated protein kinase binding,delta-catenin binding;;immunological synapse,plasma membrane,integral component of plasma membrane,cell-cell junction,cell surface,ruffle membrane,specific granule membrane,extracellular exosome`;renal sodium ion transport,protein complex assembly,adenylate cyclase-activating dopamine receptor signaling pathway,sensory perception of sound,negative regulation of cell proliferation,regulation of cell shape,regulation of cell size,negative regulation of platelet-derived growth factor receptor signaling pathway,negative regulation of phosphatidylinositol 3-kinase signaling,Wnt signaling pathway,cAMP-mediated signaling,gland morphogenesis,microvillus assembly,actin cytoskeleton organization,negative regulation of cell migration,cellular phosphate ion homeostasis,regulation of sodium:proton antiporter activity,negative regulation of sodium:proton antiporter activity,bile acid secretion,glutathione transport,neg< ative regulation of catenin import into nucleus,establishment of nucleus localization,regulation of excretion,establishment of epithelial cell apical/basal polarity,regulation of protein kinase activity,negative regulation of mitotic cell cycle,establishment of Golgi localization,negative regulation of protein kinase B signaling,auditory receptor cell stereocilium organization,phospholipase C-activating dopamine receptor signaling pathway,renal absorption,negative regulation of ERK1 and ERK2 cascade,establishment of protein localization to plasma membrane,renal phosphate ion absorption,positive regulation of intrinsic apoptotic signaling pathway';receptor binding,protein binding,beta-catenin binding,chloride channel regulator activity,phosphatase binding,PDZ domain binding,beta-2 adrenergic receptor binding,protein complex binding,protein complex scaffold,protein self-association,dopamine receptor binding,growth factor receptor binding;ruffle,cytoplasm,microvillus,endomembrane system,actin cytoskeleton,membrane,apical plasma membrane,filopodium,brush border membrane,microvillus membrane,vesicle,stereocilium tip,membrane raft,perinuclear region of cytoplasm,extracellular exosome,cell periphery,sperm midpiece,nucleus)cytoskeleton organization,cell migration;actin binding;cytosol,cytoskeleton,membrane;f;;protein folding,'de novo' protein folding,tubulin complex assembly,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,translocation of peptides or proteins into host cell cytoplasm,protein stabilization,positive regulation of telomerase activity,chaperone-mediated protein folding,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body,regulation of macrophage apoptotic process;;RNA binding,protein binding,ATP binding,ubiquitin protein ligase binding,protein binding involved in protein folding,unfolded protein binding;;pericentriolar material,acrosomal vesicle,zona pellucida receptor complex,nuclear heterochromatin,Golgi apparatus,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome ;;movement of cell or subcellular component,cytoskeleton organization,blood coagulation,regulation of lamellipodium assembly,regulation of cell morphogenesis,actin cytoskeleton organization,barbed-end actin filament capping,negative regulation of filopodium assembly;8;;actin binding,cadherin binding,actin filament binding;;;cytosol,cytoskeleton,actin filament,F-actin capping protein complex,actin cytoskeleton,sarcomere,extracellular exosome,WASH complex;DNA strand renaturation,neutrophil homeostasis,adaptive immune response,monocyte chemotaxis,regulation of leukocyte migration,phagocytosis,inflammatory response,signal transduction,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,regulation of cell shape,response to X-ray,myoblast migration involved in skeletal muscle regeneration,peptide cross-linking,insulin secretion,keratinocyte differentiation,prostate gland development,endocrine pancreas development,positive regulation of vesicle fusion,positive regulation of prostaglandin biosynthetic process,actin cytoskeleton reorganization,response to estradiol,DNA duplex unwinding,regulation of interleukin-1 production,positive regulation of interleukin-2 production,positive regulation of neutrophil apoptotic process,DNA rewinding,gliogenesis,positive regulation of T cell proliferation,response to drug,negative regulation of apoptotic process,response to peptide hormone,estrous cycle,innate immune response,positive regulation of T-helper 1 cell differentiation,negative regulation of T-helper 2 cell differentiation,negative regulation of exocytosis,alpha-beta T cell differentiation,regulation of hormone secretion,arachidonic acid secretion,regulation of inflammatory response,cellular response to hydrogen peroxide,hepatocyte differentiation,prolactin secretion,response to interleukin-1,cellular response to glucocorticoid stimulus,granulocyte chemotaxis,positive regulation of wound healing,neutrophil clearance,cell-cell adhesion,positive regulation of G1/S transition of mitotic cell cycle,negative regulation of phospholipase A2 activity,negative regulation of interleukin-8 secretion;;single-stranded DNA binding,single-stranded RNA binding,helicase activity,receptor binding,structural molecule activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,protein binding, bridging,double-stranded DNA-dependent ATPase activity,annealing helicase activity,protein homodimerization activity,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion;;4cornified envelope,phagocytic cup,extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endosome,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,basolateral plasma membrane,apical plasma membrane,lateral plasma membrane,extrinsic component of membrane,cytoplasmic vesicle membrane,extrinsic component of external side of plasma membrane,extrinsic component of endosome membrane,motile cilium,early endosome membrane,mitochondrial membrane,vesicle,sarcolemma,mast cell granule,protein complex,extracellular exosome;;ABCB9;;;protein transport,peptide transport,oligopeptide transmembrane transport,transmembrane transport,antigen processing and presentation of peptide antigen via MHC class I;;;;;;;;protein binding,ATP binding,oligopeptide-transporting ATPase activity,peptide-transporting ATPase activity,substrate-specific transmembrane transporter activity,protein homodimerization activity;;;;;;;;lysosome,lysosomal membrane,integral component of membrane,integral component of endoplasmic reticulum membrane,intracellular membrane-bounded organelle,early endosome,endoplasmic reticulum;;;;;Ngranuloma formation,germinal center formation,phagocytosis,regulation of mast cell degranulation,neutrophil degranulation,natural killer cell degranulation,positive regulation of exocytosis,defense response to virus,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of regulated secretory pathway;#protein binding,Rab GTPase binding;extracellular region,lysosome,late endosome,endoplasmic reticulum,cytosol,membrane,Weibel-Palade body,azurophil granule lumen,recycling endosome,exocytic vesicle;;lipid metabolic process,spermatogenesis,brain development,lipid catabolic process,positive regulation of macroautophagy,neutrophil degranulation;1-alkyl-2-acetylglycerophosphocholine esterase activity,phospholipase A2 activity,protein binding,protein homodimerization activity,protein heterodimerization activity,platelet-activating factor acetyltransferase activity;fibrillar center,extracellular region,nucleolus,cytoplasm,cytosol,plasma membrane,secretory granule lumen,extracellular exosome,ficolin-1-rich granule lumensignal peptide processing,proteolysis,ER to Golgi vesicle-mediated transpo                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | }  rt,blood coagulation,blood coagulation, intrinsic pathway,blood coagulation, extrinsic pathway,peptidyl-glutamic acid carboxylation,zymogen activation;Nendopeptidase activity,serine-type endopeptidase activity,calcium ion binding;wextracellular region,extracellular space,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,extracellular exosome;;;;microtubule-based movement;;A;;;RNA binding,protein binding,kinesin binding,cadherin binding;;;;;endoplasmic reticulum,endoplasmic reticulum membrane,integral component of plasma membrane,membrane,integral component of membrane;;O;renal water homeostasis,blood coagulation,activation of protein kinase A activity,intracellular signal transduction,cellular response to glucagon stimulus,negative regulation of cAMP-dependent protein kinase activity;;G2/M transition of mitotic cell cycle,renal water homeostasis,fatty acid metabolic process,blood co< agulation,learning,activation of protein kinase A activity,intracellular signal transduction,cellular response to glucagon stimulus,response to antipsychotic drug,response to clozapine,ciliary basal body docking,negative regulation of cAMP-dependent protein kinase activity;cAMP-dependent protein kinase inhibitor activity,protein binding,cAMP-dependent protein kinase regulator activity,cAMP binding,ubiquitin protein ligase binding,protein kinase A catalytic subunit binding;;cAMP-dependent protein kinase inhibitor activity,protein binding,cAMP-dependent protein kinase regulator activity,protein domain specific binding,cAMP binding,ubiquitin protein ligase binding,protein kinase A catalytic subunit binding;cytoplasm,centrosome,cytosol,plasma membrane,focal adhesion,cAMP-dependent protein kinase complex,membrane,nucleotide-activated protein kinase complex,plasma membrane raft,extracellular exosome,ciliary base;;cytoplasm,mitochondrial inner membrane,centrosome,cytosol,plasma membrane,cAMP-dependent protein kinase complex,neuronal cell body,dendritic spine,dendritic shaft,membrane raft,perinuclear region of cytoplasm,extracellular exosome,ciliary base;autophagosome assembly,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,endocytosis,autophagy,Golgi organization,small GTPase mediated signal transduction,vesicle-mediated transport,cell migration,virion assembly,growth hormone secretion,melanosome transport,substrate adhesion-dependent cell spreading,defense response to bacterium,vesicle transport along microtubule,COPII vesicle coating,membrane organization,interleukin-8 secretion,cargo loading into COPII-coated vesicle,positive regulation of glycoprotein metabolic process,positive regulation of ubiquitin protein ligase activity,cilium morphogenesis,establishment of endothelial intestinal barrier;;?;GTPase activity,protein binding,GTP binding,cadherin binding;;;Golgi membrane,early endosome,endoplasmic reticulum membrane,Golgi apparatus,cytosol,transport vesicle membrane,melanosome,extracellular exosome;;Rcell proliferation,Rap protein signal transduction,neutrophil degranulation,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to cAMP,regulation of cell junction assembly,regulation of establishment of cell polarity,negative regulation of synaptic vesicle exocytosis,microvillus assembly;PGTPase activity,protein binding,GTP binding,GDP binding,protein complex binding;intracellular,lipid particle,cytosol,plasma membrane,cell-cell junction,membrane,azurophil granule membrane,extracellular exosome,membrane raft;protein folding,'de novo' protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone-mediated protein folding,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body;{protein binding,ATP binding,identical protein binding,protein binding involved in protein folding,unfolded protein binding;zona pellucida receptor complex,cytoplasm,mitochondrion,cytosol,chaperonin-containing T-complex,microtubule,cell body,extracellular exosome;172 pathways were up-regulated.*Significantly altered upregulated pathwaysp-valueq-value term_goid term_category term_levelpathwaymembers_input_overlapmembers_input_overlap_geneidssizeeffective_sizecountGeneRatio non-corrected GeneRatio GO:0072562cblood microparticle|1; 173; 197; 213; 259; 337; 348; 710; 733; 1356; 2147; 2638; 3040; 3043; 3045; 3240; 3263; 3827; 5340; 6521; 7018; 462; 3039P04217; P02768; P02649; P02760; P02765; P68871; P01042; P02042; P00747; P01008; P02790; P00450; P02787; P02730; P43652; P05155; P02774; P06727; P00734; P07360; P00738; P69905 GO:0006810b transport1; 173; 197; 213; 259; 286; 337; 341; 346; 348; 350; 563; 710; 760; 1277; 1356; 1667; 2147; 2159; 2638; 3040; 3043; 3045; 3240; 3263; 3827; 4018; 4924; 5265; 5340; 5624; 6521; 6708; 6710; 6906; 7018; 7276; 7450; 728358; 462; 284297; 3039; 63893; 116844NP04217; P02768; P02649; P04275; A1L4H1; P02760; P02765; P08519; P02766; P68871; P25311; Q9C0C9; P01042; P02042; P59665; P00747; P01009; P01008; P00742; P02790; P02787; P00450; P00918; P02730; P43652; P16157; P02654; P05155; P02452; P02774; P06727; P00734; P02750; P02549; Q02818; P05543; P00738; E7END6; P55056; P11277; P02749; P69905 GO:0051234establishment of localization GO:0062023(collagen-containing extracellular matrixo1; 197; 259; 337; 348; 350; 563; 710; 1277; 1667; 2147; 3263; 3827; 5176; 5265; 5340; 7450; 728358; 462; 284297P04217; P00734; P02649; P04275; A1L4H1; P02760; P02765; P02452; P05155; P59665; P36955; P00747; P01042; P01009; P01008; P06727; P02790; P02749; P25311 GO:0031983 vesicle lumenr1; 197; 213; 348; 350; 710; 1667; 3040; 3043; 3240; 3263; 3827; 5265; 5340; 7018; 7276; 7450; 728358; 3039; 116844P04217; P02768; P02649; P04275; P00738; P02765; P59665; P05155; P02766; P02790; P00747; P01042; P01009; P02750; P68871; P02787; P02749; P69905 GO:0060205cytoplasmic vesicle lumen GO:0031012extracellular matrix GO:0031838haptoglobin-hemoglobin complex3040; 3043; 3045; 3240; 3039P68871; P69905; P00738; P02042 GO:0019825moxygen binding213; 3040; 3043; 3045; 3039P68871; P02768; P69905; P02042 GO:0031721hemoglobin alpha binding 3043; 3045P68871; P02042 GO:0098869cellular oxidant detoxification+213; 337; 348; 3040; 3043; 3045; 3240; 30396P02768; P02649; P02042; P00738; P06727; P68871; P69905 GO:0007597$blood coagulation, intrinsic pathway350; 710; 2147; 3827; 7450; 462.P00734; P01042; P04275; P05155; P01008; P02749 GO:0005788M197; 213; 337; 348; 1277; 1356; 2147; 2159; 3827; 4924; 5265; 5624; 7018; 462nP00734; P02768; P02649; Q02818; P02765; P02452; E7END6; P01042; P01009; P01008; P06727; P00742; P02787; P00450 GO:0071682endocytic vesicle lumen!348; 3040; 3043; 3240; 3263; 3039&P69905; P68871; P02649; P00738; P02790 GO:1990748cellular detoxification GO:0072378(blood coagulation, fibrin clot formation%350; 710; 2147; 2159; 3827; 7450; 4626P00734; P01042; P04275; P05155; P01008; P00742; P02749 GO:0070327thyroid hormone transport 6906; 7276P05543; P02766 GO:0051801=cytolysis in other organism involved in symbiotic interaction 213; 2147P00734; P02768 GO:0050817 coagulationN348; 350; 710; 1277; 2147; 2159; 3043; 3045; 3827; 5265; 5340; 5624; 7450; 462nP00734; P02649; P04275; P02042; P02452; P05155; E7END6; P00747; P01042; P01009; P01008; P00742; P68871; P02749 GO:0007596 GO:0015669 gas transport760; 3040; 3043; 3045; 3039P00918; P68871; P69905; P02042 GO:0060228?phosphatidylcholine-sterol O-acyltransferase activator activity 337; 341; 348P02649; P02654; P06727 GO:0005344oxygen carrier activity3040; 3043; 3045; 3039P68871; P69905; P02042 GO:0031720haptoglobin binding GO:0052185Mmodification of structure of other organism involved in symbiotic interaction 1667; 728358 GO:0034358plasma lipoprotein particle#337; 341; 346; 348; 350; 4018; 62896P02649; P08519; P0DJI9; P02654; P06727; P02749; P55056 GO:0032994protein-lipid complex GO:1990777lipoprotein particle GO:0035915,pore formation in membrane of other organism GO:1900046regulation of hemostasis*348; 350; 710; 2147; 3827; 5340; 5624; 462>P00734; P01042; E7END6; P05155; P00747; P02649; P01008; P02749 GO:0034382chylomicron remnant clearance341; 348P02649; P02654 GO:0015671oxygen transport GO:0051918#negative regulation of fibrinolysis350; 2147; 5340P00734; P02749; P00747 GO:0006778/porphyrin-containing compound metabolic process259; 3263; 6708P02790; P02760; P02549 GO:0033013tetrapyrrole metabolic process GO:0034379.very-low-density lipoprotein particle assembly341; 346P02654; P55056 GO:0050878regulation of body fluid levels GO:0034364!high-density lipoprotein particle< 337; 341; 346; 348; 350; 6289.P02649; P02654; P0DJI9; P06727; P02749; P55056 GO:0090207,regulation of triglyceride metabolic process337; 348P02649; P06727 GO:0005833hemoglobin complex GO:0051180 173; 2638P43652; P02774 GO:0043233organelle lumen1; 197; 213; 337; 348; 350; 710; 1277; 1356; 1667; 2147; 2159; 2638; 3040; 3043; 3240; 3263; 3827; 4924; 5265; 5340; 5624; 7018; 7276; 7450; 728358; 462; 3039; 63893; 116844P04217; P02768; P02649; P04275; P02765; P02766; P68871; Q9C0C9; P01042; P59665; P00747; P01009; P01008; P00742; P02790; P02750; P00450; P02787; P02452; P05155; P02774; P06727; P00734; Q02818; P00738; E7END6; P02749; P69905 GO:0070013intracellular organelle lumen GO:0071300"cellular response to retinoic acid 1277; 5176P36955; P02452 GO:0010872(regulation of cholesterol esterification GO:0034375,high-density lipoprotein particle remodeling213; 337; 341; 348P02768; P02649; P02654; P06727 GO:0034433steroid esterification GO:00056151; 173; 197; 213; 259; 337; 341; 346; 348; 350; 563; 710; 733; 760; 1277; 1356; 1667; 2147; 2159; 2638; 3040; 3043; 3045; 3240; 3263; 3827; 4018; 4924; 5176; 5265; 5340; 5624; 6289; 6521; 6906; 7018; 7276; 7450; 728358; 462; 284297; 3039; 116844FP04217; P02768; P02649; P04275; A1L4H1; P02760; P02765; P08519; P02766; P36955; P68871; P25311; P01042; P02042; P59665; P0DJI9; P00747; P01009; P01008; P00742; P02790; P02787; P00450; P00734; P02730; P43652; P02654; P05155; P02452; P02774; P06727; P00918; P02750; P07360; P05543; P00738; E7END6; P55056; Q02818; P02749; P69905 GO:0034385-triglyceride-rich plasma lipoprotein particle337; 341; 346; 348; 350&P02749; P02649; P02654; P06727; P55056 GO:0034361%very-low-density lipoprotein particle GO:0051917regulation of fibrinolysis GO:0061134peptidase regulator activity0197; 259; 710; 3827; 4018; 5176; 5265; 6906; 462FP01042; P02760; P05543; P02765; P08519; P05155; P01009; P01008; P36955 GO:0071827(plasma lipoprotein particle organization213; 337; 341; 346; 348; 4018.P02768; P02649; P08519; P02654; P06727; P55056 GO:0051673%membrane disruption in other organism GO:0020037 heme binding259; 3040; 3043; 3045; 3039P68871; P02760; P69905; P02042 GO:0046906tetrapyrrole binding GO:0042744#hydrogen peroxide catabolic process!337; 3040; 3043; 3045; 3240; 3039&P68871; P69905; P00738; P02042; P06727 GO:0065008 regulation of biological quality173; 213; 337; 346; 348; 350; 563; 710; 760; 1277; 1356; 2147; 2159; 3043; 3045; 3263; 3827; 5176; 5265; 5340; 5624; 6521; 6708; 6710; 6906; 7018; 7276; 7450; 462P02768; P02649; P04275; P02766; P68871; P36955; P25311; P01042; P02042; P00747; P01009; P01008; P00742; P02790; P02787; P00450; P00734; P02730; P43652; P02452; P05155; P06727; P00918; P02549; P05543; E7END6; P55056; P11277; P02749 GO:0004857enzyme inhibitor activity5197; 259; 341; 710; 3827; 4018; 5176; 5265; 6906; 462NP01042; P02760; P05543; P02765; P02654; P05155; P08519; P01009; P01008; P36955 GO:00304923043; 3045; 3240P68871; P00738; P02042 GO:0015893drug transport GO:0030234J197; 259; 337; 341; 348; 350; 710; 2147; 3827; 4018; 5176; 5265; 6906; 462nP00734; P02649; P02760; P05543; P02765; P02654; P05155; P08519; P01042; P01009; P01008; P06727; P36955; P02749 GO:0065005protein-lipid complex assembly337; 341; 346; 348P02649; P02654; P06727; P55056 GO:0034774secretory granule lumenU1; 197; 213; 350; 710; 1667; 3240; 3827; 5265; 5340; 7018; 7276; 7450; 728358; 116844nP04217; P02768; P01042; P04275; P00738; P02765; P59665; P05155; P02766; P00747; P01009; P02750; P02787; P02749 GO:0034368 protein-lipid complex remodeling213; 337; 341; 348; 4018&P02768; P02649; P02654; P06727; P08519 GO:0051818Gdisruption of cells of other organism involved in symbiotic interaction213; 1667; 2147; 728358P00734; P02768; P59665 GO:0009636response to toxic substance7213; 337; 348; 1277; 3040; 3043; 3045; 3240; 4924; 3039FQ02818; P02768; P02649; P02042; P00738; P02452; P06727; P68871; P69905 GO:0019842vitamin binding173; 213; 733; 2638P43652; P02768; P07360; P02774 GO:0042627 chylomicron337; 341; 348; 350P02749; P02649; P02654; P06727 GO:0034367%protein-containing complex remodeling GO:0034369&plasma lipoprotein particle remodeling GO:0051187cofactor catabolic process&259; 337; 3040; 3043; 3045; 3240; 3039.P02042; P02760; P00738; P06727; P68871; P69905 GO:0002227 innate immune response in mucosa337; 1667; 728358P59665; P06727 GO:0042832defense response to protozoan GO:0034447/very-low-density lipoprotein particle clearance 341; 346; 348P02649; P02654; P55056 GO:0014731 spectrin-associated cytoskeleton286; 6708; 6710P02549; P11277; P16157 GO:00305201intracellular estrogen receptor signaling pathway GO:0071825*protein-lipid complex subunit organization GO:0042743#hydrogen peroxide metabolic process GO:0030195(negative regulation of blood coagulation%348; 350; 710; 2147; 3827; 5340; 56246P00734; P01042; E7END6; P05155; P00747; P02649; P02749 GO:1900047!negative regulation of hemostasis GO:0009611response to wounding GO:0050819"negative regulation of coagulation GO:0051702interaction with symbiont348; 1667; 2147; 5340; 728358P00734; P00747; P02649; P59665 GO:00970060regulation of plasma lipoprotein particle levels GO:0015748organophosphate ester transport GO:0005796 Golgi lumen1667; 2147; 2159; 5624; 728358P00734; E7END6; P59665; P00742 GO:0034377$plasma lipoprotein particle assembly GO:0017001antibiotic catabolic process GO:0002385mucosal immune response GO:0035821:modification of morphology or physiology of other organism"213; 348; 1667; 2147; 5340; 728358&P00734; P02768; P00747; P02649; P59665 GO:1903035+negative regulation of response to wounding GO:0051852$disruption by host of symbiont cells1667; 2147; 728358P00734; P59665 GO:1900048!positive regulation of hemostasis GO:0030194(positive regulation of blood coagulation GO:0050820"positive regulation of coagulation GO:00518519modification by host of symbiont morphology or physiology GO:0010818T cell chemotaxis GO:0006721terpenoid metabolic process337; 348; 7276P02649; P06727; P02766 GO:0044432endoplasmic reticulum part GO:0005783endoplasmic reticulum]197; 213; 286; 337; 341; 348; 1277; 1356; 2147; 2159; 3827; 4924; 5265; 5624; 7018; 7450; 462P00734; P02768; P02649; P04275; P02765; Q02818; P16157; P02654; P02452; P01042; P01009; P01008; P06727; P00742; P02787; P00450; E7END6 GO:0004601peroxidase activity GO:0043177organic acid binding 213; 341; 3040; 3043; 3045; 3039&P68871; P02768; P69905; P02654; P02042 GO:0055082cellular chemical homeostasis2348; 760; 1356; 2147; 3263; 3827; 5176; 6521; 7018FP00918; P00734; P02649; P02730; P36955; P01042; P02790; P02787; P00450 GO:0006720isoprenoid metabolic process GO:0030193regulation of blood coagulation GO:00166847oxidoreductase activity, acting on peroxide as acceptor GO:00700621; 173; 197; 213; 259; 337; 348; 350; 563; 710; 733; 760; 1356; 1667; 2147; 2638; 3040; 3043; 3240; 3263; 3827; 4924; 5176; 5265; 5340; 6289; 6521; 6906; 7018; 7276; 7450; 728358; 462; 3039; 116844P04217; P02768; P02649; P04275; P02760; P02765; P02766; P36955; P68871; P25311; P01042; P59665; P0DJI9; P00747; P01009; P01008; P02750; P02790; P02787; P00450; P00734; P02730; P43652; P05155; P02774; P06727; P00918; P07360; P05543; P00738; Q02818; P02749; P69905 GO:0010035response to inorganic substance2337; 760; 1277; 3040; 3043; 3240; 5176; 7018; 3039>P00918; P02787; P00738; P02452; P36955; P06727; P68871; P69905 GO:1903561extracellular vesicle GO:0043230extracellular organelle GO:0050818regulation of coagulation GO:0002251(organ or tissue specific immune response GO:0045834.positive regulation of lipid metabolic process337; 341; 348; 2147P00734; P02649; P02654; P06727 GO:0042737drug catabolic process GO:0015711organic anion transport*337; 341; 348; 7< 60; 3040; 3043; 6521; 30396P00918; P02649; P02730; P02654; P06727; P68871; P69905 GO:00440039modification by symbiont of host morphology or physiology213; 1667; 728358P02768; P59665 GO:0072593)reactive oxygen species metabolic process'337; 2147; 3040; 3043; 3045; 3240; 3039.P00734; P02042; P00738; P06727; P68871; P69905 GO:0006639acylglycerol metabolic process GO:0051186cofactor metabolic process2259; 337; 3040; 3043; 3045; 3240; 3263; 6708; 3039>P02042; P02549; P02760; P00738; P02790; P06727; P68871; P69905 GO:0048037cofactor binding 213; 259; 3040; 3043; 3045; 3039&P68871; P02768; P69905; P02042; P02760 GO:0006950response to stress197; 213; 259; 337; 348; 350; 710; 733; 760; 1277; 1667; 2147; 2159; 3040; 3043; 3045; 3240; 3263; 3827; 5176; 5265; 5340; 5624; 6289; 7450; 728358; 462; 284297; 3039P02768; P02649; P04275; A1L4H1; P02760; P02765; P68871; P36955; P01042; P02042; P59665; P0DJI9; P00747; P01009; P01008; P00742; P02790; P00734; P02452; P05155; P06727; P00918; P07360; P00738; E7END6; P02749; P69905 GO:0006638neutral lipid metabolic process GO:0051817\modification of morphology or physiology of other organism involved in symbiotic interaction GO:0004866 GO:0031235Bintrinsic component of the cytoplasmic side of the plasma membrane 6708; 6710P02549; P11277 GO:0030414 GO:0006979response to oxidative stress&337; 348; 1277; 3040; 3043; 3240; 3039.P02649; P00738; P02452; P06727; P68871; P69905 GO:0044092)negative regulation of molecular function@197; 259; 341; 348; 710; 3240; 3827; 4018; 5176; 5265; 6906; 462^P02649; P00738; P02760; P05543; P02765; P02654; P05155; P08519; P01042; P01009; P01008; P36955 GO:0031640"killing of cells of other organism GO:1903034"regulation of response to wounding GO:0031348'negative regulation of defense response348; 710; 2147; 5176; 5624&P00734; P36955; P02649; E7END6; P05155 GO:0043178alcohol binding 337; 348; 733P07360; P02649; P06727 GO:0061135 endopeptidase regulator activity GO:0051087chaperone binding213; 1356; 5340; 7450P02768; P00747; P04275; P00450 GO:0042542response to hydrogen peroxide1277; 3040; 3043; 3240; 3039P68871; P69905; P00738; P02452 GO:0097237$cellular response to toxic substance GO:0000302#response to reactive oxygen species GO:0008289.213; 337; 341; 348; 350; 733; 2147; 2159; 2638FP00734; P02768; P02649; P07360; P02654; P02774; P06727; P00742; P02749 GO:00718300triglyceride-rich lipoprotein particle clearance GO:0001562response to protozoan GO:0006820anion transport GO:0016999antibiotic metabolic process GO:0008091spectrin GO:0044364%disruption of cells of other organism GO:0006888&ER to Golgi vesicle-mediated transport'286; 2147; 2159; 5265; 5624; 6708; 67106P00734; P11277; P02549; P16157; E7END6; P01009; P00742 GO:00321024negative regulation of response to external stimulus+348; 350; 710; 2147; 3827; 5176; 5340; 5624>P00734; P01042; E7END6; P05155; P00747; P02649; P36955; P02749 GO:0007599 hemostasis GO:0051346)negative regulation of hydrolase activity GO:0008201heparin binding348; 350; 2147; 3827; 4018; 462.P00734; P01042; P08519; P02649; P01008; P02749 GO:0006869lipid transport337; 341; 346; 348; 350; 4018.P02649; P08519; P02654; P06727; P02749; P55056 GO:0043062$extracellular structure organization5213; 337; 341; 346; 348; 1277; 4018; 5340; 7276; 7450NP02768; P02649; P04275; P02452; P02654; P00747; P06727; P08519; P02766; P55056 GO:0019725cellular homeostasis GO:0030003cellular cation homeostasis,348; 760; 1356; 2147; 3263; 3827; 6521; 7018>P00918; P00734; P02649; P02730; P01042; P02790; P02787; P00450 GO:0005496steroid binding337; 348; 2638P02649; P02774; P06727 GO:0006873cellular ion homeostasis GO:0051715cytolysis in other organism GO:0042168heme metabolic process 259; 3263P02790; P02760 GO:0048193Golgi vesicle transport GO:0043086)negative regulation of catalytic activity GO:0042060 wound healing GO:0050801ion homeostasis GO:0048878chemical homeostasis<337; 346; 348; 760; 1356; 2147; 3263; 3827; 5176; 6521; 7018VP00918; P00734; P02649; P02730; P00450; P36955; P01042; P06727; P02790; P02787; P55056 GO:0042221response to chemical197; 213; 337; 348; 563; 760; 1277; 1667; 3040; 3043; 3045; 3240; 3263; 4924; 5176; 6289; 6708; 6710; 7018; 728358; 462; 284297; 3039; 63893; 116844Q02818; P02768; P02649; A1L4H1; P02765; P68871; P36955; P25311; Q9C0C9; P02042; P59665; P0DJI9; P02750; P01008; P02790; P02787; P11277; P02452; P06727; P00918; P02549; P00738; P69905 GO:0009605response to external stimulus{197; 213; 348; 350; 710; 733; 1277; 1667; 2147; 3240; 3827; 5176; 5340; 5624; 6289; 6708; 6710; 728358; 462; 284297; 116844P00734; P02768; P02649; A1L4H1; P02549; P00738; P07360; P11277; P02765; P02452; P05155; P59665; P00747; P01042; P02750; P0DJI9; P01008; P36955; P02749; E7END6 GO:0010876lipid localization GO:0006811 ion transport<337; 341; 348; 760; 1356; 2147; 3040; 3043; 6521; 7018; 3039NP00918; P00734; P02649; P02730; P02654; P06727; P68871; P02787; P69905; P00450 GO:00512417negative regulation of multicellular organismal processB197; 337; 341; 348; 350; 710; 2147; 3827; 5176; 5340; 5624; 284297^P00734; P02649; A1L4H1; P02765; P02654; P05155; E7END6; P00747; P01042; P06727; P36955; P02749 GO:0071702organic substance transportd173; 337; 341; 346; 348; 350; 563; 760; 1277; 3040; 3043; 3263; 4018; 4924; 6521; 7018; 284297; 3039P00918; Q02818; P02649; A1L4H1; P02730; P43652; P08519; P02654; P02452; P02790; P06727; P68871; P02787; P02749; P69905; P55056; P25311 GO:0046903 secretionr1; 197; 213; 286; 350; 710; 760; 1667; 3043; 3240; 3827; 5265; 5340; 7018; 7276; 7450; 728358; 462; 284297; 116844P04217; P02768; P01042; P04275; P00738; P02765; P16157; P59665; P05155; P02766; P00918; P00747; P01009; P01008; P02750; P68871; P02787; P02749; A1L4H1 GO:0016192vesicle-mediated transport1; 197; 213; 259; 286; 341; 348; 350; 710; 1667; 2147; 2159; 3040; 3043; 3240; 3263; 3827; 5265; 5340; 5624; 6708; 6710; 7018; 7276; 7450; 728358; 284297; 3039; 63893; 116844P04217; P02768; P02649; P04275; A1L4H1; P02760; P02765; P02766; P68871; Q9C0C9; P01042; P59665; P00747; P01009; P00742; P02790; P02787; P00734; P16157; P02654; P05155; P11277; P02750; P02549; P00738; E7END6; P02749; P69905 GO:0030139endocytic vesicle'348; 3040; 3043; 3240; 3263; 7018; 3039.P02787; P02649; P00738; P02790; P68871; P69905!127 pathways were down-regulated. ,Significantly altered downregulated pathways GO:0003823O3105; 3493; 3495; 3507; 3512; 3514; 3538; 28825; 28870; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942P01709; P01591; A0A0B4J1Y8; A0A0B4J1Y9; P06310; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; A0A0C4DH67; P01602; P23083; A0A0B4J1U7; P01768; P06312; A0A0A0MT36; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; A0A075B6K4; P01876; P01871; P01715; A0A087X0P6; P01619; P01817; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6H9; A0A075B6Q5; P01718; A0A075B6I9 GO:0006956>712; 714; 715; 716; 1369; 1370; 3493; 3495; 3507; 3514; 3538; 3848; 5199; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P06310; P15169; P27918; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P01817; P01834; P0177< 2; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01718 GO:0002250i712; 714; 715; 716; 3105; 3493; 3495; 3507; 3512; 3514; 3538; 7037; 28825; 28870; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942P01709; A0A0C4DH34; A0A0B4J1Y8; A0A0B4J1Y9; P06310; A0A0C4DH31; P05534; P01591; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; A0A0C4DH67; P01602; P23083; A0A0B4J1U7; P01768; P06312; A0A0A0MT36; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; A0A075B6K4; P01876; P01871; P01715; A0A087X0P6; P09871; B4DPQ0; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6H9; P02747; P02745; P01718; A0A075B6I9 GO:0045109"intermediate filament organization3849; 3857; 3861P35527; P35908; P02533 GO:0097205renal filtration3493; 3512; 28912P01876; P01619; P01591 GO:0003094glomerular filtration GO:0072376protein activation cascade GO:0006959humoral immune responseJ712; 714; 715; 716; 1369; 1370; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3853; 5199; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0C4DH34; P01768; A0A0B4J1Y9; P06310; P15169; P27918; P01591; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P02538; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01718 GO:0006958(complement activation, classical pathway&712; 714; 715; 716; 388077; 3493; 3495; 3507; 3514; 3538; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P06310; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; P02747; P02745; P01718 GO:0002455>humoral immune response mediated by circulating immunoglobulin GO:0042571#immunoglobulin complex, circulating3493; 3495; 3507; 3512; 3514; 3538; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28912 P01591; A0A0B4J1Y9; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01619; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5 GO:0019814immunoglobulin complex GO:0019724B cell mediated immunity,712; 714; 715; 716; 3493; 3495; 3507; 3514; 3538; 7037; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P06310; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; P02747; P02745; P01718 GO:0034987immunoglobulin receptor binding388077; 3493; 3495; 3507; 3512; 3514; 3538; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474P01591; A0A0B4J1Y9; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5 GO:0099024plasma membrane invagination3493; 3495; 3507; 3514; 3538; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474A0A0B4J1Y9; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5 GO:0002253activation of immune response GO:0030449#regulation of complement activation712; 714; 715; 716; 1369; 1370; 3514; 5199; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P15169; P27918; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P02747; P02745; P06310 GO:0010324membrane invagination388077; 3493; 3495; 3507; 3514; 3538; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474 GO:2000257(regulation of protein activation cascade712; 714; 715; 716; 1369; 1370; 388077; 3514; 5199; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0002920%regulation of humoral immune response GO:0042113B cell activation388077; 3493; 3495; 3507; 3514; 3538; 7037; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474A0A0B4J1Y9; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P02786; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5 GO:0006910phagocytosis, recognition GO:0006952w183; 335; 712; 714; 715; 716; 922; 1369; 1370; 3105; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3853; 3959; 5005; 5199; 28825; 8542; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; A0A0C4DH34; P01768; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; P01591; A0A0C4DH38; P22792; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P02538; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01782; P01780; P01700; P01718; P01876; P01871; P01715; O14791; P09871; B4DPQ0; P01817; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019 GO:0002764,immune response-regulating signaling pathway3493; 3495; 3507; 3514; 3538; 5284; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937rP01709; A0A0B4J1Y9; P06310; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782< ; P01780; P01876; P01871; P01715; P01619; P01817; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P01718 GO:0006955290; 335; 22931; 712; 714; 715; 716; 1369; 1370; 3105; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3853; 5005; 5199; 5284; 5683; 7037; 7837; 28825; 28870; 8542; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942bO14791; P19652; A0A0C4DH34; A0A024RA52; P01768; A0A0B4J1Y8; A0A0B4J1Y9; A0A087X0P6; P02647; P06310; P15169; P27918; P05534; P01591; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; A0A0C4DH67; P01602; P23083; A0A0B4J1U7; P06312; P02538; P01709; A0A075B6H9; A0A0A0MT36; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; A0A075B6K4; P01876; P01871; P01715; Q92626; P09871; B4DPQ0; P02786; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A0C4DH31; P02747; P02745; P01718; A0A075B6I9; P15144 GO:0002757.immune response-activating signal transduction3493; 3495; 3507; 3514; 3538; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937jP01709; A0A0B4J1Y9; P06310; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01715; P01619; P01817; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P01718 GO:0002460yadaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains2712; 714; 715; 716; 388077; 3105; 3493; 3495; 3507; 3514; 3538; 7037; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P06310; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; P02747; P02745; P01718 GO:0050851+antigen receptor-mediated signaling pathway GO:0002449lymphocyte mediated immunity GO:0042742defense response to bacterium388077; 3493; 3495; 3507; 3512; 3514; 3538; 3853; 5199; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28912P01591; A0A0B4J1Y9; P27918; A0A0C4DH34; A0A0C4DH38; P02538; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01619; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; A0A075B6Q5 GO:0070268 cornification(3848; 3849; 3852; 3853; 3857; 3858; 38616P13645; P35527; P13647; P04264; P02538; P35908; P02533 GO:0004252712; 714; 715; 716; 3250; 3514; 5199; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P27918; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P00739; P02747; P02745; P06310 GO:0008236serine-type peptidase activity712; 714; 715; 716; 388077; 3250; 3514; 5199; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0038096<Fc-gamma receptor signaling pathway involved in phagocytosis388077; 3514; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01743; P01767; P01782; P01780; P01715; P01619; P01817; P01834; P01772; P01717; P01718; P06310 GO:0017171serine hydrolase activity GO:0002768Bimmune response-regulating cell surface receptor signaling pathway388077; 3493; 3495; 3507; 3514; 3538; 5284; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0002429Bimmune response-activating cell surface receptor signaling pathway388077; 3493; 3495; 3507; 3514; 3538; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0002682#regulation of immune system processa335; 712; 714; 715; 716; 1369; 1370; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5005; 5199; 5284; 5573; 7037; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P10644; P09871; B4DPQ0; P02786; P01715; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01718 GO:00024312Fc receptor mediated stimulatory signaling pathway3514; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0002443leukocyte mediated immunity\290; 22931; 712; 714; 715; 716; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5005; 5199; 5284; 5683; 7037; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; A0A024RA52; A0A0B4J1Y9; P06310; P27918; P15144; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A0C4DH31; P02747; P02745; P01718; P05534 GO:0019731antibacterial humoral response3493; 3507; 3512; 28912P01876; P01871; P01591; P01619 GO:0002526acute inflammatory response712; 714; 715; 716; 1369; 1370; 3250; 3514; 5005; 5199; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; P15169; P27918; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P00739; P02747; P02745; P06310 GO:0008037cell recognition GO:0002252immune effector processm290; 335; 22931; 712; 714; 715; 716; 1369; 1370< ; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5005; 5199; 5284; 5683; 7037; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; A0A024RA52; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A0C4DH31; P02747; P02745; P01718; P15144 GO:0098542"defense response to other organism GO:0016485protein processing GO:0002377immunoglobulin production3514; 7037; 28825; 28870; 28299; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942A0A087X0P6; A0A0B4J1Y8; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P01709; P06310; P06312; A0A0A0MT36; A0A075B6K4; A0A0C4DH67; P01715; P02786; P01834; P01619; P01717; P01718; A0A075B6H9; A0A075B6I9 GO:0002697%regulation of immune effector process335; 712; 714; 715; 716; 1369; 1370; 388077; 3105; 3514; 5199; 7037; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P02647; P15169; P27918; P05534; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01817; P01782; P01780; P01715; P09871; B4DPQ0; P02786; P01834; P01772; P01717; P01718; P02747; P02745; P06310 GO:00700113peptidase activity, acting on L-amino acid peptides290; 712; 714; 715; 716; 1369; 1370; 388077; 3250; 3514; 5199; 5683; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937A0A024RA52; P15169; P27918; P15144; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P00739; P02747; P02745; P06310 GO:0004175endopeptidase activity712; 714; 715; 716; 3250; 3514; 5199; 5683; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937A0A024RA52; P27918; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P00739; P02747; P02745; P06310 GO:0008233290; 712; 714; 715; 716; 1369; 1370; 3250; 3514; 5199; 5683; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937183; 335; 714; 715; 716; 922; 1370; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3959; 5005; 5858; 7037; 8542; 28299; 28452; 28793; 28822; 28908; 28912; 28919; 28937O14791; P02647; P19652; P01591; P22792; P01599; O43866; P01602; P06310; P06312; A0A075B6K9; Q08380; A0A087WUS7; P04264; P01780; P01700; P01876; P20742; P09871; B4DPQ0; P02786; P01834; P01619; P01717; P00739; P02747; P01019; P01871 GO:0002433[immune response-regulating cell surface receptor signaling pathway involved in phagocytosis GO:0002696+positive regulation of leukocyte activation3493; 3495; 3507; 3514; 3538; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474 GO:00024403production of molecular mediator of immune response335; 3514; 7037; 28825; 28870; 28299; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942A0A087X0P6; A0A0B4J1Y8; P02647; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P01709; P06310; P06312; A0A0A0MT36; A0A075B6K4; A0A0C4DH67; P01715; P02786; P01834; P01619; P01717; P01718; A0A075B6H9; A0A075B6I9 GO:0051249#regulation of lymphocyte activation3493; 3495; 3507; 3514; 3538; 5573; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474 A0A0B4J1Y9; A0A0C4DH31; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P10644; P02786; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5 GO:0050727#regulation of inflammatory response183; 335; 712; 714; 715; 716; 1369; 1370; 3514; 3848; 5199; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P02647; P06310; P15169; P27918; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P04264; P01782; P01780; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P02747; P02745; P01019 GO:0050867&positive regulation of cell activationZ183; 335; 712; 714; 715; 716; 1369; 1370; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3853; 5199; 5683; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0C4DH34; A0A024RA52; P01768; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P01591; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P02538; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01782; P01780; P01718; P01876; P01871; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019 GO:0009897 external side of plasma membrane290; 3493; 3495; 3507; 3514; 3538; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474 A0A0B4J1Y9; A0A0C4DH31; P15144; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P02786; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5 GO:0051604protein maturation GO:0002694"regulation of leukocyte activation388077; 3493; 3495; 3507; 3514; 3538; 5573; 7037; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474 GO:0050778&positive regulation of immune responseJ712; 714; 715; 716; 1369; 1370; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5199; 7037; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P06310; P15169; P27918; P05534; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01718 GO:0046649lymphocyte activation GO:0050865regulation of cell activation GO:0009617response to bacterium3493; 3495; 3507; 3512; 3514; 3538; 3853; 5199; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 2844< 8; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28912 GO:0009913epidermal cell differentiation183; 290; 335; 712; 714; 715; 716; 922; 1071; 1369; 1370; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3849; 3852; 3853; 3857; 3858; 3861; 3959; 5005; 5199; 5284; 5683; 5858; 7037; 7837; 28825; 28870; 8542; 51449; 8857; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942Q9Y6R7; P11597; P19652; A0A0C4DH34; A0A024RA52; Q9UHG3; A0A0B4J1Y8; A0A0B4J1Y9; P01700; P02647; P06310; P15169; P27918; P15144; P01591; A0A0C4DH38; P22792; P01599; P01703; O43866; P01701; P01706; P01705; A0A0C4DH67; P01602; P23083; A0A0B4J1U7; P06312; A0A075B6I9; P02538; P01709; A0A075B6H9; A0A0A0MT36; P06331; A0A075B6Q5; A0A075B6K9; P02533; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P02786; P01782; P01780; A0A075B6K4; P35527; P01817; P01718; P01876; P01833; P01871; P01715; Q92626; P09871; B4DPQ0; P13645; P13647; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; P01768; A0A0B4J1V2; P00739; O14791; A0A0B4J1V6; A0A0C4DH31; P02747; A0A087X0P6; P02745; P01019; P01619; P35908; P20742 GO:0045087innate immune response712; 714; 715; 716; 3105; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 5199; 8542; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474BO14791; A0A0C4DH34; A0A0B4J1Y9; P27918; P05534; P01591; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6Q5; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01782; P01780; P01876; P01871; P09871; B4DPQ0; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745 GO:0006897 endocytosis:335; 922; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3959; 7037; 28825; 8542; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937O14791; P01591; A0A0B4J1Y9; P02647; P06310; A0A0C4DH31; P01709; A0A0C4DH34; A0A0C4DH38; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6K9; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01700; P01876; P01871; P01715; P01619; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A075B6Q5; P01718 GO:0098657import into cell?183; 335; 922; 388077; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3959; 7037; 28825; 8542; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937O14791; P01591; A0A0B4J1Y9; P02647; P06310; A0A0C4DH31; P01709; A0A0C4DH34; A0A0C4DH38; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6K9; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01700; P01718; P01876; P01871; P01715; P01619; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A075B6Q5; P01019 GO:0051707response to other organism3493; 3495; 3507; 3512; 3514; 3538; 3853; 5199; 5683; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28912&P01591; A0A024RA52; A0A0B4J1Y9; P27918; A0A0C4DH34; A0A0C4DH38; P02538; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; P01619; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; A0A075B6Q5 GO:0043207$response to external biotic stimulus183; 335; 712; 714; 715; 716; 922; 1369; 1370; 3105; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3853; 3959; 5005; 5199; 5573; 7837; 28825; 8542; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 P19652; A0A0C4DH34; P01768; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; P01591; A0A0C4DH38; P22792; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P02538; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01700; P01718; P01876; P01871; P10644; Q92626; P09871; B4DPQ0; O14791; P01715; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019 GO:0009607response to biotic stimulus GO:0098552side of membrane290; 3105; 3493; 3495; 3507; 3514; 3538; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474A0A0B4J1Y9; A0A0C4DH31; P15144; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P02786; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P05534 GO:0050900leukocyte migration3493; 3507; 3512; 3514; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01591; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01743; P01767; P01782; P01780; P01876; P01871; P01715; P01619; P01817; P01834; P01772; P01717; P01718; P06310 GO:0050776regulation of immune responseU335; 712; 714; 715; 716; 1369; 1370; 388077; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5199; 5284; 7037; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01718 GO:0006954inflammatory response183; 335; 712; 714; 715; 716; 922; 1369; 1370; 388077; 3250; 3514; 3848; 5005; 5199; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937&P19652; P02647; P06310; P15169; P27918; P22792; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P04264; P01782; P01780; P01700; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P00739; P02747; P02745; P01019 GO:0048583"regulation of response to stimulus`183; 335; 712; 714; 715; 716; 1369; 1370; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5199; 5284; 7037; 7837; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01718; P01876; P01871; P01715; Q92626; P09871; B4DPQ0; P02786; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V< 2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019 GO:0009986 cell surface290; 335; 3105; 3493; 3495; 3507; 3514; 3538; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474A0A0B4J1Y9; P02647; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P02786; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P15144 GO:0061024membrane organization GO:0140096'catalytic activity, acting on a protein GO:0007166'cell surface receptor signaling pathway.183; 335; 3105; 3493; 3495; 3507; 3514; 3538; 5284; 7837; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P02647; P06310; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01718; P01876; P01871; P01715; Q92626; P01619; P01817; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P01019 GO:0031347regulation of defense response GO:0005886plasma membrane290; 335; 22931; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 3849; 3852; 3858; 5284; 5573; 7037; 28825; 28870; 51449; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942Q9UHG3; P01709; A0A0B4J1Y8; A0A0B4J1Y9; P02647; P06310; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; A0A0C4DH67; P01602; P23083; A0A0B4J1U7; A0A075B6I9; P01768; P06312; A0A0A0MT36; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P02786; P01782; P01780; A0A075B6K4; P01817; P01876; P13647; P01871; P10644; A0A087X0P6; P01619; P13645; P01715; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A075B6H9; A0A075B6Q5; P01718; P35908; P15144 GO:0071944cell periphery290; 335; 22931; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 3849; 3852; 3858; 3861; 5284; 5573; 7037; 28825; 28870; 51449; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28773; 28775; 28784; 28791; 28793; 28803; 28809; 28813; 28816; 28817; 28820; 28822; 28882; 28908; 28912; 28919; 28937; 28942&Q9UHG3; P01709; A0A0B4J1Y8; A0A0B4J1Y9; P02647; P06310; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; A0A0C4DH67; P01602; P23083; A0A0B4J1U7; A0A075B6I9; P01768; P06312; A0A0A0MT36; P06331; A0A075B6K9; P02533; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P02786; P01782; P01780; A0A075B6K4; P01817; P01876; P13647; P01871; P10644; A0A087X0P6; P01619; P13645; P01715; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A075B6H9; A0A075B6Q5; P01718; P35908; P15144 GO:0048518)positive regulation of biological process~183; 335; 712; 714; 715; 716; 1369; 1370; 3105; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3849; 3853; 3858; 5005; 5199; 5573; 7037; 28825; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; A0A0C4DH34; P01768; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; P01591; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P02538; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P02786; P01782; P01780; P01718; P01876; P01817; P01871; P10644; P09871; B4DPQ0; P13645; P01715; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019; P35908 GO:0005102signaling receptor binding183; 335; 3105; 3493; 3495; 3507; 3512; 3514; 3538; 7837; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474"P01591; A0A0B4J1Y9; P02647; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01876; P01871; Q92626; P01817; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P01019 GO:0016787hydrolase activity290; 22931; 712; 714; 715; 716; 1369; 1370; 3250; 3514; 5199; 5573; 5683; 28825; 51449; 51560; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 289372Q9UHG3; A0A024RA52; P15169; P27918; P15144; P10644; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P01834; P09871; B4DPQ0; P01817; Q9NRW1; P01772; P01717; P01718; P00739; Q9NP72; P02747; P02745; P06310 GO:0045321leukocyte activation290; 22931; 3493; 3495; 3507; 3514; 3538; 3848; 5005; 5199; 5284; 5573; 5683; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474FP19652; A0A024RA52; A0A0B4J1Y9; P27918; P15144; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P10644; P02786; P01833; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A0C4DH31; A0A075B6Q5 GO:0019538protein metabolic process~183; 290; 335; 712; 714; 715; 716; 1369; 1370; 3250; 3493; 3495; 3507; 3514; 3538; 3848; 3849; 3858; 5199; 5573; 5683; 5858; 28825; 8542; 51449; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937Q9UHG3; O14791; A0A024RA52; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P15144; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01718; P01876; P20742; P10644; P09871; B4DPQ0; P13645; P01715; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A 0C4DH31; P02747; P02745; P01019; P35908; P01871 GO:0002684,positive regulation of immune system processJ712; 714; 715; 716; 1369; 1370; 388077; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5199; 7037; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0005882intermediate filament GO:0071745IgA immunoglobulin complex GO:0071753IgM immunoglobulin complex3507; 3512; 28912P01871; P01591; P01619 GO:0071746'IgA immunoglobulin complex, circulating GO:0071748$monomeric IgA immunoglobulin complex GO:0071749$polymeric IgA immunoglobulin complex GO:0071754'IgM immunoglobulin complex, circulating GO:0071756%pentameric IgM immunoglobulin complex GO:0032101+regulation of response to external stimulus183; 335; 712; 714; 715; 716; 1369; 1370; 388077; 3514; 3848; 5199; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:0045111"intermediate filam< ent cytoskeleton GO:0080134 regulation of response to stress GO:0001775cell activation290; 22931; 3493; 3495; 3507; 3514; 3538; 3848; 3849; 5005; 5199; 5284; 5573; 5683; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474NP19652; A0A024RA52; A0A0B4J1Y9; P27918; P15144; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01876; P01871; P10644; P02786; P01833; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A0C4DH31; A0A075B6Q5; P35908}183; 290; 335; 22931; 922; 1071; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3959; 5005; 5199; 5284; 5683; 7037; 28825; 8542; 51449; 51560; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P11597; P19652; A0A0C4DH34; A0A024RA52; Q9UHG3; A0A0B4J1Y9; P02647; P06310; P27918; P15144; P01591; A0A0C4DH38; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6K9; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01700; P01718; P01876; P01871; Q9NRW1; O14791; P01619; P02786; P01715; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; Q9NP72; A0A0C4DH31; A0A075B6Q5; P01019 GO:0031424keratinization GO:0048584+positive regulation of response to stimulusT183; 335; 712; 714; 715; 716; 1369; 1370; 388077; 3105; 3493; 3495; 3507; 3514; 3538; 3848; 5199; 7037; 28825; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P05534; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01718; P01876; P01871; P01715; P09871; B4DPQ0; P02786; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019 GO:0048870 cell motility183; 335; 3493; 3507; 3512; 3514; 3849; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P02647; P06310; P01591; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01743; P01767; P01782; P01780; P01876; P01871; P01715; P01619; P01817; P01834; P01772; P01717; P01718; P01019; P35908 GO:0051674localization of cell GO:0006508183; 290; 712; 714; 715; 716; 1369; 1370; 388077; 3250; 3514; 5199; 5683; 5858; 28825; 51449; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937*Q9UHG3; A0A024RA52; P06310; P15169; P27918; P15144; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P20742; P01715; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P00739; P02747; P02745; P01019 GO:0010468regulation of gene expression183; 712; 714; 715; 716; 1369; 1370; 3514; 5199; 5573; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P06310; P15169; P27918; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P01715; P10644; P09871; B4DPQ0; P01817; P01834; P01772; P01717; P01718; P02747; P02745; P01019 GO:0043170macromolecule metabolic process183; 290; 335; 712; 714; 715; 716; 1369; 1370; 3250; 3493; 3495; 3507; 3514; 3538; 3848; 3849; 3858; 5199; 5573; 5683; 5858; 7037; 28825; 8542; 51449; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937Q9UHG3; O14791; A0A024RA52; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P15144; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P02786; P01782; P01780; P01718; P01876; P01817; P20742; P10644; P09871; B4DPQ0; P13645; P01715; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019; P35908; P01871 GO:1901564)organonitrogen compound metabolic process183; 290; 335; 712; 714; 715; 716; 1071; 1369; 1370; 3250; 3493; 3495; 3507; 3514; 3538; 3848; 3849; 3858; 5199; 5573; 5683; 5858; 28825; 8542; 51449; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P11597; O14791; A0A024RA52; Q9UHG3; A0A0B4J1Y9; P02647; P06310; P15169; P27918; P15144; A0A0C4DH34; A0A0C4DH38; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6Q5; A0A075B6K9; P01619; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01718; P01876; P01871; P10644; P09871; B4DPQ0; P13645; P01715; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; A0A0C4DH31; P02747; P02745; P01019; P35908; P20742 GO:0003014renal system process183; 3493; 3512; 5573; 28912&P10644; P01876; P01619; P01591; P01019 GO:0071757$hexameric IgM immunoglobulin complex 3507; 3512P01871; P01591 GO:0007165signal transductionH183; 335; 22931; 3105; 3493; 3495; 3507; 3514; 3538; 3959; 5284; 5573; 7837; 28825; 51560; 388077; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P01709; A0A0B4J1Y9; P02647; P06310; A0A0C4DH31; P05534; A0A0C4DH34; A0A0C4DH38; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P01768; P06312; P06331; A0A075B6K9; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P01782; P01780; P01718; P01876; P01871; P10644; Q92626; P01619; P01817; P01715; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; Q9NP72; A0A075B6Q5; P01019; Q9NRW1 GO:0016477cell migration183; 335; 388077; 3493; 3507; 3512; 3514; 3849; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937 GO:00302803848; 3849; 3858P13645; P35908; P04264 GO:0051246'regulation of protein metabolic process183; 335; 712; 714; 715; 716; 1369; 1370; 3514; 5199; 5573; 5858; 28825; 388077; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P02647; P06310; P15169; P27918; P22792; P01599; P01703; P01700; P01701; P01706; P01705; P01602; P23083; P01709; P01768; P06312; P06331; P01619; P01743; P01767; P01782; P01780; P20742; P10644; P09871; B4DPQ0; P01817; P01715; P01834; P01772; P01717; P01718; P02747; P02745; P01019 GO:0010467gene expression183; 712; 714; 715; 716; 1369; 1370; 388077; 3514; 5199; 5573; 28825; 28299; 28395; 28420; 28434; 28439; 28451; 28452; 28457; 28465; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937k290; 335; 22931; 922; 388077; 3250; 3493; 3495; 3507; 3512; 3514; 3538; 3848; 3959;< 5005; 5199; 5284; 5683; 7037; 28825; 8542; 51560; 28299; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474; 28791; 28793; 28809; 28813; 28816; 28817; 28820; 28822; 28908; 28912; 28919; 28937P19652; A0A0C4DH34; A0A024RA52; A0A0B4J1Y9; P02647; P06310; P27918; P15144; P01591; A0A0C4DH38; P01599; P01703; O43866; P01701; P01706; P01705; P01602; P23083; A0A0B4J1U7; P06312; P01768; P01709; P06331; A0A075B6K9; P01743; Q08380; P01767; A0A0B4J1X5; A0A087WUS7; P04264; P01817; P01782; P01780; P01700; P01876; P01871; Q9NRW1; O14791; P01619; P02786; P01715; P01833; P01834; P01772; P01717; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; P00739; A0A0B4J1V6; Q9NP72; A0A0C4DH31; A0A075B6Q5; P01718 GO:0006928)movement of cell or subcellular component GO:0044459plasma membrane part290; 3105; 3493; 3495; 3507; 3514; 3538; 5284; 5573; 7037; 388077; 28385; 28388; 28395; 28400; 28408; 28409; 28410; 28414; 28420; 28434; 28439; 28444; 28448; 28451; 28452; 28455; 28457; 28465; 28468; 28474"A0A0B4J1Y9; A0A0C4DH31; P15144; A0A0C4DH34; A0A0C4DH38; P23083; A0A0B4J1U7; P01768; P06331; A0A075B6K9; P01743; P01767; A0A0B4J1X5; A0A087WUS7; P01817; P01782; P01780; P01876; P01871; P10644; P02786; P01833; P01834; P01772; A0A0B4J1V1; A0A0B4J1V0; A0A0B4J1V2; A0A0B4J1V6; A0A075B6Q5; P05534 GO:0045103#intermediate filament-based process GO:0045104/intermediate filament cytoskeleton organization1498 proteins were identified.A0A075B6L1;A0M8Q6A0A075B6L1_HUMAN;LAC7_HUMANA0A087X188;F5H0W4;Q9UBW5;S4R4185A0A087X188_HUMAN;F5H0W4_HUMAN;BIN2_HUMAN;S4R418_HUMAN1A0A075B7C0;A0A0C4DGQ5;K7EIV0;K7ELJ7;P04632;U3KQE2TA0A075B7C0_HUMAN;A0A0C4DGQ5_HUMAN;K7EIV0_HUMAN;K7ELJ7_HUMAN;CPNS1_HUMAN;U3KQE2_HUMAN,A0A0D9SFK2;Q92614;Q92614-2;Q92614-3;Q92614-4/C9JHR8;F5GZZ9;Q86VB7;Q86VB7-2;Q86VB7-3;Q86VB7-4IC9JHR8_HUMAN;F5GZZ9_HUMAN;C163A_HUMAN;C163A_HUMAN;C163A_HUMAN;C163A_HUMAN D6R9I9;P61221D6R9I9_HUMAN;ABCE1_HUMANP04899;P04899-4P19971;P19971-2P30487 1B49_HUMAN8HLA class I histocompatibility antigen, B-49 alpha chainP30622;P30622-1;P30622-2A0A1B0GUL7;P36507;MAP2K2A0A1B0GUL7_HUMAN;MP2K2_HUMANQ8NEZ4;Q8NEZ4-2;Q8NEZ4-3:A0A087WZT3;A0A0B4J295;H3BTW0;H3BV85;H3BVE0;Q9H3K6;Q9H3K6-2BOLA2;;;BOLA2B;;BOLA2;BOLA2`A0A087WZT3_HUMAN;A0A0B4J295_HUMAN;H3BTW0_HUMAN;H3BV85_HUMAN;H3BVE0_HUMAN;BOLA2_HUMAN;BOLA2_HUMAN B4DUR8;P49368B4DUR8_HUMAN;TCPG_HUMANMD6REX3;O94979;O94979-10;O94979-2;O94979-3;O94979-4;O94979-6;O94979-8;O94979-9lD6REX3_HUMAN;SC31A_HUMAN;SC31A_HUMAN;SC31A_HUMAN;SC31A_HUMAN;SC31A_HUMAN;SC31A_HUMAN;SC31A_HUMAN;SC31A_HUMANE9PGZ4;Q9NTJ5;Q9NTJ5-2"E9PGZ4_HUMAN;SAC1_HUMAN;SAC1_HUMANP05089;P05089-2;P05089-3P07355;P07355-2 D6RBL5;P08758D6RBL5_HUMAN;ANXA5_HUMAN#Aspartate--tRNA ligase, cytoplasmic+F8VR36;F8VRL7;F8VWB0;F8W1D8;P49281;P49281-2KF8VR36_HUMAN;F8VRL7_HUMAN;F8VWB0_HUMAN;F8W1D8_HUMAN;NRAM2_HUMAN;NRAM2_HUMAN6C9JCL2;C9JWQ3;J3QR40;Q8IUK5;Q8IUK5-2;Q8IUK5-3;Q8IUK5-4VC9JCL2_HUMAN;C9JWQ3_HUMAN;J3QR40_HUMAN;PLDX1_HUMAN;PLDX1_HUMAN;PLDX1_HUMAN;PLDX1_HUMANQ92900;Q92900-2Q96RD9;Q96RD9-3;Q96RD9-4A0A087WUS7;P01880A0A087WUS7_HUMAN;IGHD_HUMANA0A0U1RRI0;Q06124;Q06124-2(A0A0U1RRI0_HUMAN;PTN11_HUMAN;PTN11_HUMANQA0A140T8Y3;A0A140T902;A0A140T9C0;A0A140TA33;A0A140TA41;A0A140TA52;P22105;P22105-3{A0A140T8Y3_HUMAN;A0A140T902_HUMAN;A0A140T9C0_HUMAN;A0A140TA33_HUMAN;A0A140TA41_HUMAN;A0A140TA52_HUMAN;TENX_HUMAN;TENX_HUMAN8HLA class I histocompatibility antigen, A-34 alpha chainA0A140T9L8;O95866-2 C6orf25;G6BA0A140T9L8_HUMAN;G6B_HUMANB1AJY5;B1AJY7;O75832%B1AJY5_HUMAN;B1AJY7_HUMAN;PSD10_HUMAN E7EVW7;P14317E7EVW7_HUMAN;HCLS1_HUMAN+E9PL09;F2Z2S8;H0YCJ7;H0YF32;P23396;P23396-2GE9PL09_HUMAN;F2Z2S8_HUMAN;H0YCJ7_HUMAN;H0YF32_HUMAN;RS3_HUMAN;RS3_HUMAN F8W6G1;Q9UHY1F8W6G1_HUMAN;NRBP_HUMAN H0YE29;Q07960H0YE29_HUMAN;RHG01_HUMAN9C9J4W5;C9J7B5;F8WCJ1;I3L397;I3L504;P63241;P63241-2;Q9GZV43EIF5A2;EIF5A2;EIF5A2;EIF5A;EIF5A;EIF5A;EIF5A;EIF5A2dC9J4W5_HUMAN;C9J7B5_HUMAN;F8WCJ1_HUMAN;I3L397_HUMAN;I3L504_HUMAN;IF5A1_HUMAN;IF5A1_HUMAN;IF5A2_HUMAN J3QRT5;P13598J3QRT5_HUMAN;ICAM2_HUMANO14775;O14775-2;O14775-3O15117;O15117-2;O15117-3 D6RBS1;P10915D6RBS1_HUMAN;HPLN1_HUMAN#A0A087WU43;A0A087WX17;H3BNC6;P12830:A0A087WU43_HUMAN;A0A087WX17_HUMAN;H3BNC6_HUMAN;CADH1_HUMAN*P30203;P30203-2;P30203-3;P30203-4;P30203-57HLA class I histocompatibility antigen, B-7 alpha chainE7EWE5;P51659;P51659-2;P51659-3-E7EWE5_HUMAN;DHB4_HUMAN;DHB4_HUMAN;DHB4_HUMANC9JA36;H7C4L9;P54709;P54709-21C9JA36_HUMAN;H7C4L9_HUMAN;AT1B3_HUMAN;AT1B3_HUMAN(Spectrin alpha chain, non-erythrocytic 1;HLA class II histocompatibility antigen, DRB1-11 beta chainE9PGA6;Q9BXJ4;Q9BXJ4-3C1QTNF3-AMACR;C1QTNF3;C1QTNF3$E9PGA6_HUMAN;C1QT3_HUMAN;C1QT3_HUMANQ9H497;Q9H497-2A0A087X1Z3;Q9UL46A0A087X1Z3_HUMAN;PSME2_HUMAN/A0A1B0GVC6;P20226;P20226-2;Q32MN6;Q6SJ96;Q7Z6S5TBP;TBP;TBP;TBP;TBPL2;TBPJA0A1B0GVC6_HUMAN;TBP_HUMAN;TBP_HUMAN;Q32MN6_HUMAN;TBPL2_HUMAN;Q7Z6S5_HUMANNB7Z9C2;F5H4R6;F8VV59;F8VY35;F8W020;F8W0J6;F8W118;H0YHC3;H0YIV4;P55209;P55209-2B7Z9C2_HUMAN;F5H4R6_HUMAN;F8VV59_HUMAN;F8VY35_HUMAN;F8W020_HUMAN;F8W0J6_HUMAN;F8W118_HUMAN;H0YHC3_HUMAN;H0YIV4_HUMAN;NP1L1_HUMAN;NP1L1_HUMANG3V295;G3V3I1;G3V5Z7;P609001G3V295_HUMAN;G3V3I1_HUMAN;G3V5Z7_HUMAN;PSA6_HUMANG8JLA2;P60660-2G8JLA2_HUMAN;MYL6_HUMANP09493-10;P09493-3;P09493-4O00161;O00161-21A0A0A0MRV8;O75935;O75935-2;O75935-3;X6RA56;X6RLR1NA0A0A0MRV8_HUMAN;DCTN3_HUMAN;DCTN3_HUMAN;DCTN3_HUMAN;X6RA56_HUMAN;X6RLR1_HUMANO95498;O95498-6K7EK35;P42229;P51692STAT5A;STAT5A;STAT5B$K7EK35_HUMAN;STA5A_HUMAN;STA5B_HUMAN Q13217;X6R9L0DNJC3_HUMAN;X6R9L0_HUMAN&D6RCK3;Q7L9L4;Q7L9L4-2;Q9H8S9;Q9H8S9-2MOB1B;MOB1B;MOB1B;MOB1A;MOB1A<D6RCK3_HUMAN;MOB1B_HUMAN;MOB1B_HUMAN;MOB1A_HUMAN;MOB1A_HUMANQ8WUM4;Q8WUM4-2Q9NPH3;Q9NPH3-2;Q9NPH3-53Q9UIB8;Q9UIB8-2;Q9UIB8-3;Q9UIB8-4;Q9UIB8-5;Q9UIB8-68H3BMU1;H3BUI0;P53990;P53990-2;P53990-3;P53990-4;P53990-5PH3BMU1_HUMAN;H3BUI0_HUMAN;IST1_HUMAN;IST1_HUMAN;IST1_HUMAN;IST1_HUMAN;IST1_HUMAN(H7BY83;Q5JSH3;Q5JSH3-2;Q5JSH3-3;Q5JSH3-4<H7BY83_HUMAN;WDR44_HUMAN;WDR44_HUMAN;WDR44_HUMAN;WDR44_HUMANP43686;P43686-2 G3V2C9;P59768G3V2C9_HUMAN;GBG2_HUMANQ00013;Q00013-2;Q00013-3Q8N392;Q8N392-2C9J266;Q5XPI4;Q5XPI4-2$C9J266_HUMAN;RN123_HUMAN;RN123_HUMAN/M0R165;M0R2S2;Q9UBC2;Q9UBC2-2;Q9UBC2-3;Q9UBC2-4IM0R165_HUMAN;M0R2S2_HUMAN;EP15R_HUMAN;EP15R_HUMAN;EP15R_HUMAN;EP15R_HUMANH3BRY5;P50225;P50226SULT1A1;SULT1A1;SULT1A2$H3BRY5_HUMAN;ST1A1_HUMAN;ST1A2_HUMANF5GX19;F5H3Y3;Q6IAA8%F5GX19_HUMAN;F5H3Y3_HUMAN;LTOR1_HUMAN#A0A0G2JH50;A0A0G2JIF0;A2BF26;Q9TNN79A0A0G2JH50_HUMAN;A0A0G2JIF0_HUMAN;A2BF26_HUMAN;1C05_HUMANHLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-5 alpha chainQ99747;Q99747-2KA0A087WYR8;A0A087X097;A0A0A0MQS6;Q9H251;Q9H251-2;Q9H251-3;Q9H251-4;Q9H251-8nA0A087WYR8_HUMAN;A0A087X097_HUMAN;A0A0A0MQS6_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMAN;CAD23_HUMANB5MCX3;Q15019;Q15019-2;Q15019-30B5MCX3_HUMAN;SEPT2_HUMAN;SEPT2_HUMAN;SEPT2_HUMAN$M0QYZ2;M0R0N4;P53680;P53680-2;X6R390>M0QYZ2_HUMAN;M0R0N4_HUMAN;AP2S1_HUMAN;AP2S1_HUMAN;X6R390_HUMAN(B4DHS6;O00534;O00534-2;O00534-3;O00534-4<B4DHS6_HUMAN;VMA5A_HUMAN;VMA5A_HUMAN;VMA5A_HUMAN;VMA5A_HUMANYcDNA FLJ55206, highly similar to Loss of heterozygosity 11 chromosomal region 2 gene A protein;von Willebrand factor A domain-containing protein 5A;Isoform 2 of von Willebrand factor A domain-containing protein 5A;Isoform 3 of von Willebrand factor A domain-containing protein 5A;Isoform 4 of von Willebrand factor A domain-containing protein 5A K7ESC6;O60262K7ESC6_HUMAN;GBG7_HUMAN P11441;Q5HY81UBL4A_HUMAN;Q5HY81_HUMANP51572;P51572-2Q12860;Q12860-2!Q96HC4;Q96HC4-4;Q96HC4-6;Q96HC4-72C9J6D1;E9PJJ2;E9PNJ7;E9PNW0;E9PS34;Q99733;Q99733-2XC9J6D1_HUMAN;E9PJJ2_HUMAN;E9PNJ7_HUMAN;E9PNW0_HUMAN;E9PS34_HUMAN;NP1L4_HUMAN;NP1L4_HUMANQ9NUG4;Q9NUG4-2;Q9NUG4-3#A0A087WYT3;Q15185;Q15185-3< ;Q15185-41A0A087WYT3_HUMAN;TEBP_HUMAN;TEBP_HUMAN;TEBP_HUMANH3BPE1;H3BQK9;Q9UPN3-5%H3BPE1_HUMAN;H3BQK9_HUMAN;MACF1_HUMANMicrotubule-actin cross-linking factor 1, isoforms 1/2/3/5;Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5;Isoform 4 of Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5O00339;O00339-3P10586;P10586-2?P15529-16;P15529-2;P15529-3;P15529-4;P15529-5;P15529-6;P15529-7Q05209;Q05209-2;Q05209-3DA0A087WU93;A0A087WYD1;A0A087WZQ6;A0A087X253;P63010;P63010-2;P63010-3gA0A087WU93_HUMAN;A0A087WYD1_HUMAN;A0A087WZQ6_HUMAN;A0A087X253_HUMAN;AP2B1_HUMAN;AP2B1_HUMAN;AP2B1_HUMANA0A0D9SET0;A0A0D9SEY4;A0A0D9SGF2;A0A0D9SGF8;A0A0D9SGI1;A0A0E3D6M1;A0A1B0GTC0;A0A1B0GTH8;A0A1B0GUF0;A0A1B0GUI9;A0A1B0GUV4;E7EWI0;Q86UL8;Q86UL8-2A0A0D9SET0_HUMAN;A0A0D9SEY4_HUMAN;A0A0D9SGF2_HUMAN;A0A0D9SGF8_HUMAN;A0A0D9SGI1_HUMAN;A0A0E3D6M1_HUMAN;A0A1B0GTC0_HUMAN;A0A1B0GTH8_HUMAN;A0A1B0GUF0_HUMAN;A0A1B0GUI9_HUMAN;A0A1B0GUV4_HUMAN;E7EWI0_HUMAN;MAGI2_HUMAN;MAGI2_HUMAN_Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane associated guanylate kinase, WW and PDZ domain containing 2, isoform CRA_c;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Fragment);Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Fragment);Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2;Isoform 2 of Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2#A0A1B0GV05;Q684P5;Q684P5-2;Q684P5-34A0A1B0GV05_HUMAN;RPGP2_HUMAN;RPGP2_HUMAN;RPGP2_HUMANE7EPA1;O60256;O60256-3"E7EPA1_HUMAN;KPRB_HUMAN;KPRB_HUMAN H3BU31;P36578H3BU31_HUMAN;RL4_HUMANP62195;P62195-2 Keratin, type I cuticular Ha3-IIQ8WWI5;Q8WWI5-2;Q8WWI5-3EA0A087X296;P23219;P23219-2;P23219-3;P23219-4;P23219-5;P23219-6;X6RJD6_A0A087X296_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMAN;PGH1_HUMAN;X6RJD6_HUMANhA0A0A0MQV8;B0QZ65;B4DGD8;C9IZ08;F8W9S7;H0Y4E7;H0Y7I9;Q14C86;Q14C86-2;Q14C86-3;Q14C86-4;Q14C86-5;Q14C86-6A0A0A0MQV8_HUMAN;B0QZ65_HUMAN;B4DGD8_HUMAN;C9IZ08_HUMAN;F8W9S7_HUMAN;H0Y4E7_HUMAN;H0Y7I9_HUMAN;GAPD1_HUMAN;GAPD1_HUMAN;GAPD1_HUMAN;GAPD1_HUMAN;GAPD1_HUMAN;GAPD1_HUMANP20701;P20701-2Q13045;Q13045-2YA0A087WW46;A0A087X117;A0A0G2JN29;A0A0G2JP90;J3KN36;P69849;Q15155;Q5JPE7;Q5JPE7-2;Q5JPE7-3;NOMO1;NOMO1;NOMO1;NOMO1;NOMO3;NOMO3;NOMO1;NOMO2;NOMO2;NOMO2A0A087WW46_HUMAN;A0A087X117_HUMAN;A0A0G2JN29_HUMAN;A0A0G2JP90_HUMAN;J3KN36_HUMAN;NOMO3_HUMAN;NOMO1_HUMAN;NOMO2_HUMAN;NOMO2_HUMAN;NOMO2_HUMAN!A0A0D9SFB5;D6R9K8;P08319;P08319-23A0A0D9SFB5_HUMAN;D6R9K8_HUMAN;ADH4_HUMAN;ADH4_HUMAN3A0A0G2JJA7;A0A0G2JJQ0;A2ACR0;A2ACR1;P28065;P28065-2QA0A0G2JJA7_HUMAN;A0A0G2JJQ0_HUMAN;A2ACR0_HUMAN;A2ACR1_HUMAN;PSB9_HUMAN;PSB9_HUMANP02679-2)Isoform Gamma-A of Fibrinogen gamma chain J3KNF4;O14618J3KNF4_HUMAN;CCS_HUMANE5RK69;P08133;P08133-2$E5RK69_HUMAN;ANXA6_HUMAN;ANXA6_HUMANP28799;P28799-2P30486 1B48_HUMAN8HLA class I histocompatibility antigen, B-48 alpha chainA0A0U1RQQ4;Q9UNN8A0A0U1RQQ4_HUMAN;EPCR_HUMANO95782;O95782-2AIsoform Cytoplasmic+peroxisomal of Peroxiredoxin-5, mitochondrial*A0A0C4DGS1;P39656;P39656-2;P39656-3;U3KQ84AA0A0C4DGS1_HUMAN;OST48_HUMAN;OST48_HUMAN;OST48_HUMAN;U3KQ84_HUMANB1AH77;B1AH80;P15153$B1AH77_HUMAN;B1AH80_HUMAN;RAC2_HUMAN B0YIW6;P48444B0YIW6_HUMAN;COPD_HUMAN/Archain 1, isoform CRA_a;Coatomer subunit delta Q15181;Q5SQT6IPYR_HUMAN;Q5SQT6_HUMAN(A2A369;Q8NF50;Q8NF50-2;Q8NF50-3;Q8NF50-4<A2A369_HUMAN;DOCK8_HUMAN;DOCK8_HUMAN;DOCK8_HUMAN;DOCK8_HUMAN Q96BM9;Q9NVJ2 ARL8A;ARL8BARL8A_HUMAN;ARL8B_HUMAN#A0A0A0MSQ0;P13797;P13797-2;P13797-31A0A0A0MSQ0_HUMAN;PLST_HUMAN;PLST_HUMAN;PLST_HUMANAF8W914;H7C106;Q9NQC3;Q9NQC3-2;Q9NQC3-3;Q9NQC3-4;Q9NQC3-5;Q9NQC3-6[F8W914_HUMAN;H7C106_HUMAN;RTN4_HUMAN;RTN4_HUMAN;RTN4_HUMAN;RTN4_HUMAN;RTN4_HUMAN;RTN4_HUMAN A8MUD9;P18124A8MUD9_HUMAN;RL7_HUMANP55884;P55884-2J3KSD8;K7ES02;K7ESE8;Q138671J3KSD8_HUMAN;K7ES02_HUMAN;K7ESE8_HUMAN;BLMH_HUMAN&J3KSU7;K7EN88;Q8WZ73;Q8WZ73-2;Q8WZ73-3RFFL;hCG_2039718;RFFL;RFFL;RFFL:J3KSU7_HUMAN;K7EN88_HUMAN;RFFL_HUMAN;RFFL_HUMAN;RFFL_HUMANE3 ubiquitin-protein ligase rififylin (Fragment);HCG2039718, isoform CRA_g;E3 ubiquitin-protein ligase rififylin;Isoform 2 of E3 ubiquitin-protein ligase rififylin;Isoform 3 of E3 ubiquitin-protein ligase rififylin5A0A087X109;P09917;P09917-2;P09917-3;P09917-4;P09917-5GA0A087X109_HUMAN;LOX5_HUMAN;LOX5_HUMAN;LOX5_HUMAN;LOX5_HUMAN;LOX5_HUMAN:A0A0G2JJZ9;A0A140T9X3;H0Y400;O00148;Q13838;Q13838-2;Q5STU30DDX39B;DDX39B;DDX39B;DDX39A;DDX39B;DDX39B;DDX39B_A0A0G2JJZ9_HUMAN;A0A140T9X3_HUMAN;H0Y400_HUMAN;DX39A_HUMAN;DX39B_HUMAN;DX39B_HUMAN;Q5STU3_HUMANP04229;Q29974;Q30134 2B11_HUMAN;2B1G_HUMAN;2B18_HUMANHLA class II histocompatibility antigen, DRB1-1 beta chain;HLA class II histocompatibility antigen, DRB1-16 beta chain;HLA class II histocompatibility antigen, DRB1-8 beta chain"E9PL57;E9PS38;F8VSA6;Q15843;S4R3E9,NEDD8-MDP1;NEDD8-MDP1;NEDD8;NEDD8;NEDD8-MDP1?E9PL57_HUMAN;E9PS38_HUMAN;F8VSA6_HUMAN;NEDD8_HUMAN;S4R3E9_HUMAN4A0A087WZ27;M0QX76;M0R1M5;M0R210;M0R3H0;P62249;Q6IPX4)ZNF90;RPS16;RPS16;RPS16;RPS16;RPS16;RPS16\A0A087WZ27_HUMAN;M0QX76_HUMAN;M0R1M5_HUMAN;M0R210_HUMAN;M0R3H0_HUMAN;RS16_HUMAN;Q6IPX4_HUMANOD6RAN1;D6RF83;D6RH06;H7BYK4;Q9NR12;Q9NR12-2;Q9NR12-3;Q9NR12-4;Q9NR12-5;Q9NR12-6{D6RAN1_HUMAN;D6RF83_HUMAN;D6RH06_HUMAN;H7BYK4_HUMAN;PDLI7_HUMAN;PDLI7_HUMAN;PDLI7_HUMAN;PDLI7_HUMAN;PDLI7_HUMAN;PDLI7_HUMAN*Q9UJ68;Q9UJ68-2;Q9UJ68-3;Q9UJ68-4;Q9UJ68-5%A0A075B793;A0A087WT45;Q4V328;Q4V328-49A0A075B793_HUMAN;A0A087WT45_HUMAN;GRAP1_HUMAN;GRAP1_HUMAN*A0A087X1L8;K4DIA0;O75144;O75144-2;O75144-3(LOC102723996;ICOSLG;ICOSLG;ICOSLG;ICOSLGAA0A087X1L8_HUMAN;K4DIA0_HUMAN;ICOSL_HUMAN;ICOSL_HUMAN;ICOSL_HUMAN]B7Z637;C9J8P8;C9JAA7;C9JBY2;G5E9V6;G5E9V7;Q8IUR7;Q8IUR7-2;Q8IUR7-3;Q8IUR7-6;Q8IUR7-7;Q8IUR7-8B7Z637_HUMAN;C9J8P8_HUMAN;C9JAA7_HUMAN;C9JBY2_HUMAN;G5E9V6_HUMAN;G5E9V7_HUMAN;ARMC8_HUMAN;ARMC8_HUMAN;ARMC8_HUMAN;ARMC8_HUMAN;ARMC8_HUMAN;ARMC8_HUMAN>Armadillo repeat containing 8, isoform CRA_g;Armadillo repeat-containing protein 8 (Fragment);Armadillo repeat-containing protein 8 (Fragment);Armadillo repeat-containing protein 8 (Fragment);Armadillo repeat containing 8, isoform CRA_e;Armadillo repeat containing 8, isoform CRA_d;Armadillo repeat-containing protein 8;Isoform 2 of Armadillo repeat-containing protein 8;Isoform 3 of Armadillo repeat-containing protein 8;Isoform 6 of Armadillo repeat-containing protein 8;Isoform 7 of Armadillo repeat-containing protein 8;Isoform 8 of Armadillo repeat-containing protein 8E7ERP7 E7ERP7_HUMANApolipoprotein E (Fragment)F8VUF6;F8VWU0;F8VXZ8;P075851F8VUF6_HUMAN;F8VWU0_HUMAN;F8VXZ8_HUMAN;PGS2_HUMANP36543;P36543-2;P36543-3A0A0J9YW62;A0A0J9YX97!A0A0J9YW62_HUMAN;A0A0J9YX97_HUMAN J3QQW1;Q15762J3QQW1_HUMAN;CD226_HUMAN"P16581;Q5TI72;Q5TI73;Q5TI74;Q5TI75?LYAM2_HUMAN;Q5TI72_HUMAN;Q5TI73_HUMAN;Q5TI74_HUMAN;Q5TI75_HUMANH3BMU3;O60268;O60268-3$H3BMU3_HUMAN;K0513_HUMAN;K0513_HUMANK7EIW7;Q9HCN6;Q9HCN6-2;Q9HCN6-3-K7EIW7_HUMAN;GPVI_HUMAN;GPVI_HUMAN;GPVI_HUMANQB4DUC8;F2Z2F3;J3QSB7;Q13126;Q13126-2;Q13126-3;Q13126-4;Q13126-5;Q13126-6;Q13126-7-MTAP;;MTAP;MTAP;MTAP;MTAP;MTAP;MTAP;MTAP;MTAPsB4DUC8_HUMAN;F2Z2F3_HUMAN;J3QSB7_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMAN;MTAP_HUMAND3DSM0 D3DSM0_HUMAN Integrin betaO00421;O00421-2hF8VXH9;F8VZX2;F8W0G4;F8W1G6;H3BRU6;Q15366;Q15366-2;Q15366-3;Q15366-4;Q15366-5;Q15366-6;Q15366-7;Q15366-8F8VXH9_HUMAN;F8VZX2_H< UMAN;F8W0G4_HUMAN;F8W1G6_HUMAN;H3BRU6_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMAN;PCBP2_HUMANP61020;P61020-2G8JLH9;P40763;P40763-2;P40763-30G8JLH9_HUMAN;STAT3_HUMAN;STAT3_HUMAN;STAT3_HUMANF8W876;P48740-3F8W876_HUMAN;MASP1_HUMAN\Mannan-binding lectin serine protease 1;Isoform 3 of Mannan-binding lectin serine protease 1>1349 proteins were identified with at least 2 unique peptides.52 proteins were up-regulated. 92 proteins were down-regulated.897 proteins were identified.A0A087X106;O43790;P78385;Q14533KRT81;KRT86;KRT83;KRT814A0A087X106_HUMAN;KRT86_HUMAN;KRT83_HUMAN;KRT81_HUMAN{Keratin, type II cuticular Hb1;Keratin, type II cuticular Hb6;Keratin, type II cuticular Hb3;Keratin, type II cuticular Hb1A0A0A0MS52;A0A0A0MT11;D6R938;D6RFJ0;E9PBG7;E9PF82;Q13555;Q13555-10;Q13555-2;Q13555-3;Q13555-4;Q13555-5;Q13555-6;Q13555-7;Q13555-8;Q13555-9;Q13557;Q13557-10;Q13557-11;Q13557-12;Q13557-3;Q13557-4;Q13557-5;Q13557-6;Q13557-8;Q13557-9;Q5SWX3;Q8WU40;Q9UQM7;Q9UQM7-2CAMK2G;CAMK2G;CAMK2D;CAMK2A;CAMK2D;CAMK2D;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2G;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2D;CAMK2G;CAMK2G;CAMK2A;CAMK2AwA0A0A0MS52_HUMAN;A0A0A0MT11_HUMAN;D6R938_HUMAN;D6RFJ0_HUMAN;E9PBG7_HUMAN;E9PF82_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2G_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;KCC2D_HUMAN;Q5SWX3_HUMAN;Q8WU40_HUMAN;KCC2A_HUMAN;KCC2A_HUMANCalcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, isoform CRA_a;Calcium/calmodulin-dependent protein kinase type II subunit gamma;Calcium/calmodulin-dependent protein kinase (CaM kinase) II delta, isoform CRA_e;Calcium/calmodulin-dependent protein kinase type II subunit alpha (Fragment);Calcium/calmodulin-dependent protein kinase type II subunit delta;Calcium/calmodulin-dependent protein kinase type II subunit delta;Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 10 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 2 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 3 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 4 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 5 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 6 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 7 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 8 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Isoform 9 of Calcium/calmodulin-dependent protein kinase type II subunit gamma;Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 10 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 11 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 12 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 3 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 4 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 8 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 9 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 6 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Isoform Delta 7 of Calcium/calmodulin-dependent protein kinase type II subunit delta;Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma, isoform CRA_n;CAMK2G protein (Fragment);Calcium/calmodulin-dependent protein kinase type II subunit alpha;Isoform B of Calcium/calmodulin-dependent protein kinase type II subunit alpha E7ES19;P35443E7ES19_HUMAN;TSP4_HUMANF5GX11;P25786;P25786-2"F5GX11_HUMAN;PSA1_HUMAN;PSA1_HUMANoProteasome subunit alpha type-1;Proteasome subunit alpha type-1;Isoform Long of Proteasome subunit alpha type-1O75882;O75882-2;O75882-37Attractin;Isoform 2 of Attractin;Isoform 3 of AttractinP05155;P05155-2;P05155-3pPlasma protease C1 inhibitor;Isoform 2 of Plasma protease C1 inhibitor;Isoform 3 of Plasma protease C1 inhibitor(P11171;P11171-2;P11171-3;P11171-4;Q4VB86041_HUMAN;41_HUMAN;41_HUMAN;41_HUMAN;Q4VB86_HUMANdProtein 4.1;Isoform 2 of Protein 4.1;Isoform 3 of Protein 4.1;Isoform 4 of Protein 4.1;EPB41 proteinP16157;P16157-10;P16157-11;P16157-12;P16157-13;P16157-14;P16157-15;P16157-16;P16157-3;P16157-4;P16157-5;P16157-6;P16157-7;P16157-8;P16157-9mAnkyrin-1;Isoform Er9 of Ankyrin-1;Isoform Er10 of Ankyrin-1;Isoform Er11 of Ankyrin-1;Isoform Er12 of Ankyrin-1;Isoform Er13 of Ankyrin-1;Isoform Er14 of Ankyrin-1;Isoform Er15 of Ankyrin-1;Isoform Er5 of Ankyrin-1;Isoform Er2 of Ankyrin-1;Isoform Er3 of Ankyrin-1;Isoform Er4 of Ankyrin-1;Isoform Er6 of Ankyrin-1;Isoform Er7 of Ankyrin-1;Isoform Er8 of Ankyrin-1P61224;P61224-3BRas-related protein Rap-1b;Isoform 3 of Ras-related protein Rap-1bP81605;P81605-2 Dermcidin;Isoform 2 of DermcidinQ6YHK3;Q6YHK3-3;Q6YHK3-4CCD109 antigen;Isoform 3 of CD109 antigen;Isoform 4 of CD109 antigenQ99832;Q99832-3LT-complex protein 1 subunit eta;Isoform 3 of T-complex protein 1 subunit eta&A0A087X1T7;E7ENV9;E7EX88;H0YM81;Q6PID9DA0A087X1T7_HUMAN;E7ENV9_HUMAN;E7EX88_HUMAN;H0YM81_HUMAN;Q6PID9_HUMAN`Aggrecan core protein;Aggrecan core protein;Aggrecan core protein;Aggrecan core protein;AggrecanA0A0B4J1R6;P29401;P29401-2$A0A0B4J1R6_HUMAN;TKT_HUMAN;TKT_HUMAN6Transketolase;Transketolase;Isoform 2 of Transketolase C9JBB3;P10646C9JBB3_HUMAN;TFPI1_HUMANJTissue factor pathway inhibitor (Fragment);Tissue factor pathway inhibitor$D6RDU5;D6RER5;D6RGI3;Q9NVA2;Q9NVA2-2>D6RDU5_HUMAN;D6RER5_HUMAN;D6RGI3_HUMAN;SEP11_HUMAN;SEP11_HUMANXSeptin-11 (Fragment);Septin-11;Septin 11, isoform CRA_b;Septin-11;Isoform 2 of Septin-11P07948;P07948-2DTyrosine-protein kinase Lyn;Isoform 2 of Tyrosine-protein kinase LynP11277;P11277-2PSpectrin beta chain, erythrocytic;Isoform 2 of Spectrin beta chain, erythrocyticP13727;P13727-2>Bone marrow proteoglycan;Isoform 2 of Bone marrow proteoglycan P15259;P18669 PGAM2;PGAM1PGAM2_HUMAN;PGAM1_HUMAN3Phosphoglycerate mutase 2;Phosphoglycerate mutase 1Q76LX8;Q76LX8-2;Q76LX8-3A disintegrin and metalloproteinase with thrombospondin motifs 13;Isoform 2 of A disintegrin and metalloproteinase with thrombospondin motifs 13;Isoform 3 of A disintegrin and metalloproteinase with thrombospondin motifs 13A0A075B6N8;P01860A0A075B6N8_HUMAN;IGHG3_HUMAN>Ig gamma-3 chain C region (Fragment);Ig gamma-3 chain C region4A0A087WZR4;H0Y4U3;H0Y755;M9MML0;M9MML6;O75015;P086370FCGR3B;FCGR3B;FCGR3A;FCGR3A;FCGR3B;FCGR3B;FCGR3A\A0A087WZR4_HUMAN;H0Y4U3_HUMAN;H0Y755_HUMAN;M9MML0_HUMAN;M9MML6_HUMAN;FCG3B_HUMAN;FCG3A_HUMANLow affinity immunoglobulin gamma Fc region receptor III-B;Low affinity immunoglobulin gamma Fc region receptor III-B (Fragment);Low affinity immunoglobulin gamma Fc region receptor III-A (Fragment);Fc of IgG low affinity IIIa receptor isoform 1;Low affinity immunoglobulin gamma Fc region receptor III-B;Low affinity immunoglobulin gamma Fc region receptor III-B;Low affinity immunoglobulin gamma Fc region receptor III-A;A0A140T8Y3;A0A140T902;A0A140TA33;A0A140TA52;P22105;P22105-3YA0A140T8Y3_HUMAN;A0A140T902_HUMAN;A0A140TA33_HUMAN;A0A140TA52_HUMAN;TENX_HUMAN;TENX_HUMAN(F8WF69;P09496;P09496-2;P09496-3;P09496-48F8WF69_HUMAN;CLCA_HUMAN;CLCA_HUMAN;CLCA_HUMAN;CLCA_HUMANClathrin light chain A;Clathrin light chain A;Isoform Non-brain of Clathrin light chain A;Isoform 3 of Clathrin light chain A;Isoform 4 of Clathrin light chain A&H0YMD1;J3KMZ9;P01130;P01130-3;P01130-5:H0YMD1_HUMAN;J3KMZ9_HUMAN;LDLR_HUMAN;LDLR_HUMAN;LDLR_HUMANLow-density lipoprotein receptor;Low-density lipoprotein receptor (Fragment);Low-density lipoprotein receptor;Isoform 3 of Low-density lipoprotein receptor;Isoform 5 of Low-density lipoprotein receptor< J3KPD9;P22392;P22392-2;Q32Q12NME1-NME2;NME2;NME2;NME1-NME2/J3KPD9_HUMAN;NDKB_HUMAN;NDKB_HUMAN;Q32Q12_HUMAN|Protein NME1-NME2;Nucleoside diphosphate kinase B;Isoform 3 of Nucleoside diphosphate kinase B;Nucleoside diphosphate kinaseO00560;O00560-2"Syntenin-1;Isoform 2 of Syntenin-1P19320;P19320-2;P19320-3|Vascular cell adhesion protein 1;Isoform 2 of Vascular cell adhesion protein 1;Isoform 3 of Vascular cell adhesion protein 1Q9H939;Q9H939-2Proline-serine-threonine phosphatase-interacting protein 2;Isoform 2 of Proline-serine-threonine phosphatase-interacting protein 2A0A087WTK0;A0A087WVC6;Q12913-A0A087WTK0_HUMAN;A0A087WVC6_HUMAN;PTPRJ_HUMANA0A087WUS7;A0A0A0MS09!A0A087WUS7_HUMAN;A0A0A0MS09_HUMAN:Ig delta chain C region;Ig delta chain C region (Fragment)#A0A087WUZ3;Q01082;Q01082-2;Q01082-34A0A087WUZ3_HUMAN;SPTB2_HUMAN;SPTB2_HUMAN;SPTB2_HUMANSpectrin beta chain, non-erythrocytic 1;Spectrin beta chain, non-erythrocytic 1;Isoform Short of Spectrin beta chain, non-erythrocytic 1;Isoform 2 of Spectrin beta chain, non-erythrocytic 1>A0A087WY68;A0A087WZR0;H0Y3Q0;P29122;P29122-2;P29122-7;P29122-8^A0A087WY68_HUMAN;A0A087WZR0_HUMAN;H0Y3Q0_HUMAN;PCSK6_HUMAN;PCSK6_HUMAN;PCSK6_HUMAN;PCSK6_HUMANProprotein convertase subtilisin/kexin type 6;Proprotein convertase subtilisin/kexin type 6;Proprotein convertase subtilisin/kexin type 6 (Fragment);Proprotein convertase subtilisin/kexin type 6;Isoform PACE4A-II of Proprotein convertase subtilisin/kexin type 6;Isoform PACE4E-I of Proprotein convertase subtilisin/kexin type 6;Isoform PACE4E-II of Proprotein convertase subtilisin/kexin type 6#A0A087WZB5;Q9HBI1;Q9HBI1-2;Q9HBI1-34A0A087WZB5_HUMAN;PARVB_HUMAN;PARVB_HUMAN;PARVB_HUMANIBeta-parvin;Beta-parvin;Isoform 2 of Beta-parvin;Isoform 3 of Beta-parvin5A0A0G2JH68;A0A140T8Z0;H9KV28;O60610;O60610-2;O60610-3RA0A0G2JH68_HUMAN;A0A140T8Z0_HUMAN;H9KV28_HUMAN;DIAP1_HUMAN;DIAP1_HUMAN;DIAP1_HUMANProtein diaphanous homolog 1;Protein diaphanous homolog 1;Protein diaphanous homolog 1;Protein diaphanous homolog 1;Isoform 2 of Protein diaphanous homolog 1;Isoform 3 of Protein diaphanous homolog 1A0A140T9R1;O75955A0A140T9R1_HUMAN;FLOT1_HUMAN"Flotillin-1 (Fragment);Flotillin-1B1AK87;B1AK88;P47756;P47756-21B1AK87_HUMAN;B1AK88_HUMAN;CAPZB_HUMAN;CAPZB_HUMANCapping protein (Actin filament) muscle Z-line, beta, isoform CRA_a;Capping protein (Actin filament) muscle Z-line, beta, isoform CRA_d;F-actin-capping protein subunit beta;Isoform 2 of F-actin-capping protein subunit beta C9JUK7;P16150C9JUK7_HUMAN;LEUK_HUMAN"Leukosialin (Fragment);Leukosialin F5H4Z8;P49746F5H4Z8_HUMAN;TSP3_HUMANF6S2S5;K7ESD6;Q14847;Q14847-21F6S2S5_HUMAN;K7ESD6_HUMAN;LASP1_HUMAN;LASP1_HUMANLIM and SH3 domain protein 1;LIM and SH3 domain protein 1;LIM and SH3 domain protein 1;Isoform 2 of LIM and SH3 domain protein 1+G3V295;G3V3I1;G3V3U4;G3V5Z7;P60900;P60900-2IG3V295_HUMAN;G3V3I1_HUMAN;G3V3U4_HUMAN;G3V5Z7_HUMAN;PSA6_HUMAN;PSA6_HUMANProteasome subunit alpha type;Proteasome subunit alpha type;Proteasome subunit alpha type;Proteasome subunit alpha type;Proteasome subunit alpha type-6;Isoform 2 of Proteasome subunit alpha type-6J3KPY9;P58335;P58335-2;P58335-40J3KPY9_HUMAN;ANTR2_HUMAN;ANTR2_HUMAN;ANTR2_HUMAN}Anthrax toxin receptor 2;Anthrax toxin receptor 2;Isoform 2 of Anthrax toxin receptor 2;Isoform 4 of Anthrax toxin receptor 2qO60814;P06899;P23527;P33778;P57053;P58876;P62807;Q16778;Q5QNW6;Q5QNW6-2;Q93079;Q96A08;Q99877;Q99879;Q99880;U3KQK0HIST1H2BK;HIST1H2BJ;HIST1H2BO;HIST1H2BB;H2BFS;HIST1H2BD;HIST1H2BC;HIST2H2BE;HIST2H2BF;HIST2H2BF;HIST1H2BH;HIST1H2BA;HIST1H2BN;HIST1H2BM;HIST1H2BL;HIST1H2BNH2B1K_HUMAN;H2B1J_HUMAN;H2B1O_HUMAN;H2B1B_HUMAN;H2BFS_HUMAN;H2B1D_HUMAN;H2B1C_HUMAN;H2B2E_HUMAN;H2B2F_HUMAN;H2B2F_HUMAN;H2B1H_HUMAN;H2B1A_HUMAN;H2B1N_HUMAN;H2B1M_HUMAN;H2B1L_HUMAN;U3KQK0_HUMAN[Histone H2B type 1-K;Histone H2B type 1-J;Histone H2B type 1-O;Histone H2B type 1-B;Histone H2B type F-S;Histone H2B type 1-D;Histone H2B type 1-C/E/F/G/I;Histone H2B type 2-E;Histone H2B type 2-F;Isoform 2 of Histone H2B type 2-F;Histone H2B type 1-H;Histone H2B type 1-A;Histone H2B type 1-N;Histone H2B type 1-M;Histone H2B type 1-L;Histone H2BP49368;P49368-2PT-complex protein 1 subunit gamma;Isoform 2 of T-complex protein 1 subunit gammaQ16610;Q16610-4JExtracellular matrix protein 1;Isoform 4 of Extracellular matrix protein 1*A0A087X0A8;D6RGG3;Q99715;Q99715-2;Q99715-4AA0A087X0A8_HUMAN;D6RGG3_HUMAN;COCA1_HUMAN;COCA1_HUMAN;COCA1_HUMANCollagen alpha-1(XII) chain;Collagen alpha-1(XII) chain;Collagen alpha-1(XII) chain;Isoform 2 of Collagen alpha-1(XII) chain;Isoform 4 of Collagen alpha-1(XII) chain(A0A0C4DH53;C9JCS5;C9JL16;P41182;P41182-2@A0A0C4DH53_HUMAN;C9JCS5_HUMAN;C9JL16_HUMAN;BCL6_HUMAN;BCL6_HUMANB-cell lymphoma 6 protein;B-cell lymphoma 6 protein (Fragment);B-cell lymphoma 6 protein (Fragment);B-cell lymphoma 6 protein;Isoform 2 of B-cell lymphoma 6 proteinOA0A0U1RR32;A0A0U1RRH7;P0C0S8;P20671;Q16777;Q6FI13;Q96KK5;Q99878;Q9BTM1;Q9BTM1-2UhCG_2039566;;HIST1H2AG;HIST1H2AD;HIST2H2AC;HIST2H2AA3;HIST1H2AH;HIST1H2AJ;H2AFJ;H2AFJ~A0A0U1RR32_HUMAN;A0A0U1RRH7_HUMAN;H2A1_HUMAN;H2A1D_HUMAN;H2A2C_HUMAN;H2A2A_HUMAN;H2A1H_HUMAN;H2A1J_HUMAN;H2AJ_HUMAN;H2AJ_HUMANHistone H2A;Histone H2A;Histone H2A type 1;Histone H2A type 1-D;Histone H2A type 2-C;Histone H2A type 2-A;Histone H2A type 1-H;Histone H2A type 1-J;Histone H2A.J;Isoform 2 of Histone H2A.J$B7ZAR1;E7ENZ3;E9PCA1;P48643;P48643-2<B7ZAR1_HUMAN;E7ENZ3_HUMAN;E9PCA1_HUMAN;TCPE_HUMAN;TCPE_HUMANT-complex protein 1 subunit epsilon;T-complex protein 1 subunit epsilon;T-complex protein 1 subunit epsilon;T-complex protein 1 subunit epsilon;Isoform 2 of T-complex protein 1 subunit epsilonHF5H0G0;F5H5I5;Q6P2Q0;Q9NP78;Q9NP78-2;Q9NP78-3;Q9NP78-5;Q9NP78-6;Q9NP78-7nF5H0G0_HUMAN;F5H5I5_HUMAN;Q6P2Q0_HUMAN;ABCB9_HUMAN;ABCB9_HUMAN;ABCB9_HUMAN;ABCB9_HUMAN;ABCB9_HUMAN;ABCB9_HUMANATP-binding cassette sub-family B member 9;ATP-binding cassette sub-family B member 9 (Fragment);ABCB9 protein;ATP-binding cassette sub-family B member 9;Isoform 2 of ATP-binding cassette sub-family B member 9;Isoform 3 of ATP-binding cassette sub-family B member 9;Isoform 4 of ATP-binding cassette sub-family B member 9;Isoform 5 of ATP-binding cassette sub-family B member 9;Isoform 6 of ATP-binding cassette sub-family B member 9 F6RFD5;P60981F6RFD5_HUMAN;DEST_HUMAN&F8VSD5;P23467;P23467-3;P23467-4;Q6ZR19=F8VSD5_HUMAN;PTPRB_HUMAN;PTPRB_HUMAN;PTPRB_HUMAN;Q6ZR19_HUMANReceptor-type tyrosine-protein phosphatase beta;Receptor-type tyrosine-protein phosphatase beta;Isoform 3 of Receptor-type tyrosine-protein phosphatase beta;Isoform 4 of Receptor-type tyrosine-protein phosphatase beta;Receptor-type tyrosine-protein phosphatase beta (Fragment)8K7EL66;K7ERD8;Q15555;Q15555-2;Q15555-3;Q15555-4;Q15555-5UK7EL66_HUMAN;K7ERD8_HUMAN;MARE2_HUMAN;MARE2_HUMAN;MARE2_HUMAN;MARE2_HUMAN;MARE2_HUMANMicrotubule-associated protein RP/EB family member 2 (Fragment);Microtubule-associated protein RP/EB family member 2 (Fragment);Microtubule-associated protein RP/EB family member 2;Isoform 2 of Microtubule-associated protein RP/EB family member 2;Isoform 3 of Microtubule-associated protein RP/EB family member 2;Isoform 4 of Microtubule-associated protein RP/EB family member 2;Isoform 5 of Microtubule-associated protein RP/EB family member 2P13611;P13611-29Versican core protein;Isoform V1 of Versican core proteinP14543;P14543-2 Nidogen-1;Isoform 2 of Nidogen-1P40227;P40227-2NT-complex protein 1 subunit zeta;Isoform 2 of T-complex protein 1 subunit zetaP50991;P50991-2PT-complex protein 1 subunit delta;Isoform 2 of T-complex protein 1 subunit deltaP68366;P68366-2:Tubulin alpha-4A chain;Isoform 2 of Tubulin alpha-4A chainP98161;P98161-2;P98161-3@Polycystin-1;Isoform 2 of Polycystin-1;Isoform 3 of Polycystin-1A0A087X271;B4DDF4;B4DUT8;Q994395A0A087X271_HUMAN;B4DDF4_HUMAN;B4DUT8_HUMAN;CNN2_HUMAN0Calponin (Fragment);Calponin;Calponin;Calponin-2!A0A1C7CYX9;E5RFU4;Q16555;Q16555-25A0A1C7CYX9_HUMAN;E5RFU4_HUMAN;DPYL2_HUMAN;DPYL2_HUMANDihydropyrimidinase-related protein 2;Dihydropyrimidinas< e-related protein 2 (Fragment);Dihydropyrimidinase-related protein 2;Isoform 2 of Dihydropyrimidinase-related protein 2E7EQR6;F5H282;P17987$E7EQR6_HUMAN;F5H282_HUMAN;TCPA_HUMAN8G3V1E2;H0Y3T6;Q9BRK5;Q9BRK5-2;Q9BRK5-3;Q9BRK5-4;Q9BRK5-6UG3V1E2_HUMAN;H0Y3T6_HUMAN;CAB45_HUMAN;CAB45_HUMAN;CAB45_HUMAN;CAB45_HUMAN;CAB45_HUMAN45 kDa calcium-binding protein;45 kDa calcium-binding protein (Fragment);45 kDa calcium-binding protein;Isoform 2 of 45 kDa calcium-binding protein;Isoform 3 of 45 kDa calcium-binding protein;Isoform 4 of 45 kDa calcium-binding protein;Isoform 6 of 45 kDa calcium-binding protein H0Y2Y8;Q15942H0Y2Y8_HUMAN;ZYX_HUMANZyxin (Fragment);Zyxin=H7C1Z7;H7C270;H7C2S4;O15194;O15194-2;Q9GZU7;Q9GZU7-2;Q9GZU7-37CTDSP1;CTDSP1;CTDSPL;CTDSPL;CTDSPL;CTDSP1;CTDSP1;CTDSP1bH7C1Z7_HUMAN;H7C270_HUMAN;H7C2S4_HUMAN;CTDSL_HUMAN;CTDSL_HUMAN;CTDS1_HUMAN;CTDS1_HUMAN;CTDS1_HUMAN,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (Fragment);Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (Fragment);CTD small phosphatase-like protein (Fragment);CTD small phosphatase-like protein;Isoform 2 of CTD small phosphatase-like protein;Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1;Isoform 2 of Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1;Isoform 3 of Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 J3QRP6;O14745J3QRP6_HUMAN;NHRF1_HUMANjNa(+)/H(+) exchange regulatory cofactor NHE-RF1 (Fragment);Na(+)/H(+) exchange regulatory cofactor NHE-RF1P02741;P02741-2;Q5VVP7 CRP_HUMAN;CRP_HUMAN;Q5VVP7_HUMANEC-reactive protein;Isoform 2 of C-reactive protein;C-reactive proteinP08514;P08514-22Integrin alpha-IIb;Isoform 2 of Integrin alpha-IIbP17858;P17858-2lATP-dependent 6-phosphofructokinase, liver type;Isoform 2 of ATP-dependent 6-phosphofructokinase, liver typeP62993;P62993-2ZGrowth factor receptor-bound protein 2;Isoform 2 of Growth factor receptor-bound protein 2Q70J99;Q70J99-3>Protein unc-13 homolog D;Isoform 3 of Protein unc-13 homolog D,A0A024QZ42;A0A087WZ38;H0Y9X3;O75340;O75340-2FA0A024QZ42_HUMAN;A0A087WZ38_HUMAN;H0Y9X3_HUMAN;PDCD6_HUMAN;PDCD6_HUMANHCG1985580, isoform CRA_c;Programmed cell death protein 6;Programmed cell death protein 6 (Fragment);Programmed cell death protein 6;Isoform 2 of Programmed cell death protein 6A0A0A0MSI0;Q06830A0A0A0MSI0_HUMAN;PRDX1_HUMAN*Peroxiredoxin-1 (Fragment);Peroxiredoxin-1A0A0C4DFY8;Q9BT09A0A0C4DFY8_HUMAN;CNPY3_HUMAN5A0A0D9SFK2;Q92614;Q92614-2;Q92614-3;Q92614-4;Q92614-5LA0A0D9SFK2_HUMAN;MY18A_HUMAN;MY18A_HUMAN;MY18A_HUMAN;MY18A_HUMAN;MY18A_HUMANUnconventional myosin-XVIIIa;Unconventional myosin-XVIIIa;Isoform 2 of Unconventional myosin-XVIIIa;Isoform 3 of Unconventional myosin-XVIIIa;Isoform 4 of Unconventional myosin-XVIIIa;Isoform 5 of Unconventional myosin-XVIIIa$B7Z596;F5H7S3;H0YK48;H7BYY1;P09493-5>B7Z596_HUMAN;F5H7S3_HUMAN;H0YK48_HUMAN;H7BYY1_HUMAN;TPM1_HUMANTropomyosin alpha-1 chain;Tropomyosin alpha-1 chain;Tropomyosin alpha-1 chain;Tropomyosin 1 (Alpha), isoform CRA_m;Isoform 5 of Tropomyosin alpha-1 chain C9J8S3;P51149C9J8S3_HUMAN;RAB7A_HUMANH0Y5E4;H0YCV9;H0YD13;H0YDW7;P16070;P16070-10;P16070-11;P16070-12;P16070-13;P16070-14;P16070-15;P16070-16;P16070-17;P16070-18;P16070-3;P16070-4;P16070-5;P16070-6;P16070-7;P16070-8;P16070-9H0Y5E4_HUMAN;H0YCV9_HUMAN;H0YD13_HUMAN;H0YDW7_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN;CD44_HUMAN CD44 antigen (Fragment);CD44 antigen (Fragment);CD44 antigen;CD44 antigen (Fragment);CD44 antigen;Isoform 10 of CD44 antigen;Isoform 11 of CD44 antigen;Isoform 12 of CD44 antigen;Isoform 13 of CD44 antigen;Isoform 14 of CD44 antigen;Isoform 15 of CD44 antigen;Isoform 16 of CD44 antigen;Isoform 17 of CD44 antigen;Isoform 18 of CD44 antigen;Isoform 3 of CD44 antigen;Isoform 4 of CD44 antigen;Isoform 5 of CD44 antigen;Isoform 6 of CD44 antigen;Isoform 7 of CD44 antigen;Isoform 8 of CD44 antigen;Isoform 9 of CD44 antigenP23471;P23471-2;P23471-3Receptor-type tyrosine-protein phosphatase zeta;Isoform 2 of Receptor-type tyrosine-protein phosphatase zeta;Isoform 3 of Receptor-type tyrosine-protein phosphatase zeta*P50570;P50570-2;P50570-3;P50570-4;P50570-5eDynamin-2;Isoform 2 of Dynamin-2;Isoform 3 of Dynamin-2;Isoform 4 of Dynamin-2;Isoform 5 of Dynamin-2P50990;P50990-2;P50990-3T-complex protein 1 subunit theta;Isoform 2 of T-complex protein 1 subunit theta;Isoform 3 of T-complex protein 1 subunit thetaQ12841;Q12841-2HFollistatin-related protein 1;Isoform 2 of Follistatin-related protein 1Q5SQ64;Q5SQ64-2jLymphocyte antigen 6 complex locus protein G6f;Isoform 2 of Lymphocyte antigen 6 complex locus protein G6fA0A0A0MT26;B1AKY9;H0Y7C1;M0R116;P05023;P05023-2;P05023-3;P05023-4;P13637;P13637-2;P13637-3;P20648;P50993;P54707;P54707-2;Q13733nATP1A3;ATP1A2;ATP1A2;ATP1A3;ATP1A1;ATP1A1;ATP1A1;ATP1A1;ATP1A3;ATP1A3;ATP1A3;ATP4A;ATP1A2;ATP12A;ATP12A;ATP1A4A0A0A0MT26_HUMAN;B1AKY9_HUMAN;H0Y7C1_HUMAN;M0R116_HUMAN;AT1A1_HUMAN;AT1A1_HUMAN;AT1A1_HUMAN;AT1A1_HUMAN;AT1A3_HUMAN;AT1A3_HUMAN;AT1A3_HUMAN;ATP4A_HUMAN;AT1A2_HUMAN;AT12A_HUMAN;AT12A_HUMAN;AT1A4_HUMANSodium/potassium-transporting ATPase subunit alpha-3;Sodium/potassium-transporting ATPase subunit alpha;Sodium/potassium-transporting ATPase subunit alpha (Fragment);Sodium/potassium-transporting ATPase subunit alpha;Sodium/potassium-transporting ATPase subunit alpha-1;Isoform 2 of Sodium/potassium-transporting ATPase subunit alpha-1;Isoform 3 of Sodium/potassium-transporting ATPase subunit alpha-1;Isoform 4 of Sodium/potassium-transporting ATPase subunit alpha-1;Sodium/potassium-transporting ATPase subunit alpha-3;Isoform 2 of Sodium/potassium-transporting ATPase subunit alpha-3;Isoform 3 of Sodium/potassium-transporting ATPase subunit alpha-3;Potassium-transporting ATPase alpha chain 1;Sodium/potassium-transporting ATPase subunit alpha-2;Potassium-transporting ATPase alpha chain 2;Isoform 2 of Potassium-transporting ATPase alpha chain 2;Sodium/potassium-transporting ATPase subunit alpha-4A0A1B0GVK0;Q14314A0A1B0GVK0_HUMAN;FGL2_HUMANA0A1B0GVS3;P42025;P61163;R4GMT0ACTR1A;ACTR1B;ACTR1A;ACTR1A3A0A1B0GVS3_HUMAN;ACTY_HUMAN;ACTZ_HUMAN;R4GMT0_HUMANBAlpha-centractin;Beta-centractin;Alpha-centractin;Alpha-centractin"J3QQR8;J3QQX6;J3QRQ1;J3QRT5;P13598?J3QQR8_HUMAN;J3QQX6_HUMAN;J3QRQ1_HUMAN;J3QRT5_HUMAN;ICAM2_HUMANIntercellular adhesion molecule 2 (Fragment);Intercellular adhesion molecule 2 (Fragment);Intercellular adhesion molecule 2 (Fragment);Intercellular adhesion molecule 2;Intercellular adhesion molecule 2P00338;P00338-3LL-lactate dehydrogenase A chain;Isoform 3 of L-lactate dehydrogenase A chainP00740;P00740-28Coagulation factor IX;Isoform 2 of Coagulation factor IXP55160;P55160-2HNck-associated protein 1-like;Isoform 2 of Nck-associated protein 1-likeQ14315;Q14315-2 Filamin-C;Isoform 2 of Filamin-CA0A087WSY5;Q96IY4A0A087WSY5_HUMAN;CBPB2_HUMAN+B3KW70;F5GYX4;H0YG03;H0YGS3;Q13361;Q13361-2KB3KW70_HUMAN;F5GYX4_HUMAN;H0YG03_HUMAN;H0YGS3_HUMAN;MFAP5_HUMAN;MFAP5_HUMANMicrofibrillar-associated protein 5;Microfibrillar-associated protein 5;Microfibrillar-associated protein 5 (Fragment);Microfibrillar-associated protein 5 (Fragment);Microfibrillar-associated protein 5;Isoform 2 of Microfibrillar-associated protein 5B4DJ62;C9JM82;G3XAH0;Q997192B4DJ62_HUMAN;C9JM82_HUMAN;G3XAH0_HUMAN;SEPT5_HUMANPHCG2002594, isoform CRA_a;Septin-5 (Fragment);HCG2002594, isoform CRA_c;Septin-5F8W1I6;Q13561;Q13561-2;Q13561-30F8W1I6_HUMAN;DCTN2_HUMAN;DCTN2_HUMAN;DCTN2_HUMANeDynactin subunit 2;Dynactin subunit 2;Isoform 2 of Dynactin subunit 2;Isoform 3 of Dynactin subunit 2H0YL69;H0YMZ1;H0YN18;P257891H0YL69_HUMAN;H0YMZ1_HUMAN;H0YN18_HUMAN;PSA4_HUMANProteasome subunit alpha type (Fragment);Proteasome subunit alpha type (Fragment);Proteasome subunit alpha type-4;Proteasome subunit alpha type-4K7EM49;K7EPF6;P52209;P52209-2/K7EM49_HUMAN;K7EPF6_HUMAN;6PG< D_HUMAN;6PGD_HUMAN6-phosphogluconate dehydrogenase, decarboxylating (Fragment);6-phosphogluconate dehydrogenase, decarboxylating (Fragment);6-phosphogluconate dehydrogenase, decarboxylating;Isoform 2 of 6-phosphogluconate dehydrogenase, decarboxylatingP36980;P36980-2;V9GYE7"FHR2_HUMAN;FHR2_HUMAN;V9GYE7_HUMANComplement factor H-related protein 2;Isoform Short of Complement factor H-related protein 2;Complement factor H-related protein 2B5MDF5;J3KQE5;P62826#B5MDF5_HUMAN;J3KQE5_HUMAN;RAN_HUMANjGTP-binding nuclear protein Ran;GTP-binding nuclear protein Ran (Fragment);GTP-binding nuclear protein RanE5RH81;E5RHP7;P00915$E5RH81_HUMAN;E5RHP7_HUMAN;CAH1_HUMANTCarbonic anhydrase 1 (Fragment);Carbonic anhydrase 1 (Fragment);Carbonic anhydrase 1E7END6;E7ENR9;P04070;P04070-2/E7END6_HUMAN;E7ENR9_HUMAN;PROC_HUMAN;PROC_HUMANVitamin K-dependent protein C;Vitamin K-dependent protein C (Fragment);Vitamin K-dependent protein C;Isoform 2 of Vitamin K-dependent protein CE7END7;P62820;P62820-2;P62820-30E7END7_HUMAN;RAB1A_HUMAN;RAB1A_HUMAN;RAB1A_HUMANRas-related protein Rab-1A;Ras-related protein Rab-1A;Isoform 2 of Ras-related protein Rab-1A;Isoform 3 of Ras-related protein Rab-1AE7EPK1;E7ES33;Q16181;Q16181-21E7EPK1_HUMAN;E7ES33_HUMAN;SEPT7_HUMAN;SEPT7_HUMAN0Septin-7;Septin-7;Septin-7;Isoform 2 of Septin-7-G3V4Y7;G3V5G2;H0YJZ8;Q86UP2;Q86UP2-2;Q86UP2-4GG3V4Y7_HUMAN;G3V5G2_HUMAN;H0YJZ8_HUMAN;KTN1_HUMAN;KTN1_HUMAN;KTN1_HUMANeKinectin;Kinectin (Fragment);Kinectin (Fragment);Kinectin;Isoform 2 of Kinectin;Isoform 4 of KinectinH3BNT7;H3BQV2;H3BTM8;P516652H3BNT7_HUMAN;H3BQV2_HUMAN;H3BTM8_HUMAN;PSMD7_HUMAN3P35612;P35612-2;P35612-3;P35612-4;P35612-8;P35612-9Beta-adducin;Isoform 2 of Beta-adducin;Isoform 3 of Beta-adducin;Isoform 4 of Beta-adducin;Isoform 8 of Beta-adducin;Isoform 9 of Beta-adducin(B8ZZX6;Q658P3;Q658P3-2;Q658P3-3;Q658P3-4<B8ZZX6_HUMAN;STEA3_HUMAN;STEA3_HUMAN;STEA3_HUMAN;STEA3_HUMANMetalloreductase STEAP3;Metalloreductase STEAP3;Isoform 2 of Metalloreductase STEAP3;Isoform 3 of Metalloreductase STEAP3;Isoform 4 of Metalloreductase STEAP3H7C1L0;P13861;P13861-2;P31323PRKAR2A;PRKAR2A;PRKAR2A;PRKAR2B-H7C1L0_HUMAN;KAP2_HUMAN;KAP2_HUMAN;KAP3_HUMANcAMP-dependent protein kinase type II-alpha regulatory subunit (Fragment);cAMP-dependent protein kinase type II-alpha regulatory subunit;Isoform 2 of cAMP-dependent protein kinase type II-alpha regulatory subunit;cAMP-dependent protein kinase type II-beta regulatory subunit J3KNE3;P68402J3KNE3_HUMAN;PA1B2_HUMANPlatelet-activating factor acetylhydrolase IB subunit beta (Fragment);Platelet-activating factor acetylhydrolase IB subunit beta K7ERN2;P32942K7ERN2_HUMAN;ICAM3_HUMANP16109;Q5R341;Q5R345;Q5R3492LYAM3_HUMAN;Q5R341_HUMAN;Q5R345_HUMAN;Q5R349_HUMAN6P-selectin;P-selectin;P-selectin;P-selectin (Fragment)!P29350;P29350-2;P29350-3;P29350-4Tyrosine-protein phosphatase non-receptor type 6;Isoform 3 of Tyrosine-protein phosphatase non-receptor type 6;Isoform 2 of Tyrosine-protein phosphatase non-receptor type 6;Isoform 4 of Tyrosine-protein phosphatase non-receptor type 67A0A087WUV8;A0A087X2B5;P35613;P35613-2;P35613-3;P35613-4MA0A087WUV8_HUMAN;A0A087X2B5_HUMAN;BASI_HUMAN;BASI_HUMAN;BASI_HUMAN;BASI_HUMANaBasigin;Basigin (Fragment);Basigin;Isoform 2 of Basigin;Isoform 3 of Basigin;Isoform 4 of Basigin,A0A0B4J1S2;Q8WWV6;Q8WWV6-2;Q8WWV6-3;Q8WWV6-4@A0A0B4J1S2_HUMAN;FCAMR_HUMAN;FCAMR_HUMAN;FCAMR_HUMAN;FCAMR_HUMANHigh affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;Isoform 2 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;Isoform 3 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;Isoform 4 of High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor+F5H1R4;K7EM85;K7ES92;K7ES98;Q92619;Q92619-2/ARHGAP45;ARHGAP45;ARHGAP45;ARHGAP45;HMHA1;HMHA1KF5H1R4_HUMAN;K7EM85_HUMAN;K7ES92_HUMAN;K7ES98_HUMAN;HMHA1_HUMAN;HMHA1_HUMANProtein ARHGAP45;Protein ARHGAP45;Protein ARHGAP45;Protein ARHGAP45;Minor histocompatibility protein HA-1;Isoform 2 of Minor histocompatibility protein HA-1P04083;Q5T3N0;Q5T3N1%ANXA1_HUMAN;Q5T3N0_HUMAN;Q5T3N1_HUMAN0Annexin A1;Annexin (Fragment);Annexin (Fragment)Q8WUJ3;Q8WUJ3-2zCell migration-inducing and hyaluronan-binding protein;Isoform 2 of Cell migration-inducing and hyaluronan-binding proteinA0A087WZM5;P62942A0A087WZM5_HUMAN;FKB1A_HUMANA0A0G2JM87;A0A0G2JR65;Q02817,A0A0G2JM87_HUMAN;A0A0G2JR65_HUMAN;MUC2_HUMANOA0A1B0GU03;A0A1B0GU92;A0A1B0GV23;A0A1B0GVD5;A0A1B0GW44;A0A1B0GWE8;H7C469;P07339;;CTSD;CTSD;CTSD;CTSD;;CTSD}A0A1B0GU03_HUMAN;A0A1B0GU92_HUMAN;A0A1B0GV23_HUMAN;A0A1B0GVD5_HUMAN;A0A1B0GW44_HUMAN;A0A1B0GWE8_HUMAN;H7C469_HUMAN;CATD_HUMANUncharacterized protein;Uncharacterized protein;Cathepsin D;Cathepsin D;Cathepsin D;Cathepsin D;Uncharacterized protein (Fragment);Cathepsin DDE9PMD7;F8VR82;F8VYE8;F8W0W8;P36873;P36873-2;P62136;P62136-2;P62136-3>PPP1CA;PPP1CC;PPP1CC;PPP1CC;PPP1CC;PPP1CC;PPP1CA;PPP1CA;PPP1CAjE9PMD7_HUMAN;F8VR82_HUMAN;F8VYE8_HUMAN;F8W0W8_HUMAN;PP1G_HUMAN;PP1G_HUMAN;PP1A_HUMAN;PP1A_HUMAN;PP1A_HUMANSerine/threonine-protein phosphatase (Fragment);Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase PP1-gamma catalytic subunit;Isoform Gamma-2 of Serine/threonine-protein phosphatase PP1-gamma catalytic subunit;Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;Isoform 2 of Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;Isoform 3 of Serine/threonine-protein phosphatase PP1-alpha catalytic subunit-H3BMH2;H3BSC1;P62491;P62491-2;Q15907;Q15907-2)RAB11A;RAB11A;RAB11A;RAB11A;RAB11B;RAB11BIH3BMH2_HUMAN;H3BSC1_HUMAN;RB11A_HUMAN;RB11A_HUMAN;RB11B_HUMAN;RB11B_HUMANRas-related protein Rab-11A (Fragment);Ras-related protein Rab-11A;Ras-related protein Rab-11A;Isoform 2 of Ras-related protein Rab-11A;Ras-related protein Rab-11B;Isoform 2 of Ras-related protein Rab-11B*O00139;O00139-1;O00139-2;O00139-4;O00139-5Kinesin-like protein KIF2A;Isoform 1 of Kinesin-like protein KIF2A;Isoform 2 of Kinesin-like protein KIF2A;Isoform 4 of Kinesin-like protein KIF2A;Isoform 5 of Kinesin-like protein KIF2AP28906;P28906-2gHematopoietic progenitor cell antigen CD34;Isoform CD34-T of Hematopoietic progenitor cell antigen CD34Q7L7X3;Q7L7X3-3VSerine/threonine-protein kinase TAO1;Isoform 3 of Serine/threonine-protein kinase TAO1A0A0A0MQU1;Q27J81;Q27J81-2&A0A0A0MQU1_HUMAN;INF2_HUMAN;INF2_HUMANMInverted formin-2 (Fragment);Inverted formin-2;Isoform 2 of Inverted formin-26A0A1B0GX98;B1APH0;F5H586;H0Y6W5;Q06HB9;Q6ZN30;Q6ZN30-2ZA0A1B0GX98_HUMAN;B1APH0_HUMAN;F5H586_HUMAN;H0Y6W5_HUMAN;Q06HB9_HUMAN;BNC2_HUMAN;BNC2_HUMANZinc finger protein basonuclin-2 (Fragment);Zinc finger protein basonuclin-2;Zinc finger protein basonuclin-2;Zinc finger protein basonuclin-2 (Fragment);Basonuclin 2 (Fragment);Zinc finger protein basonuclin-2;Isoform 2 of Zinc finger protein basonuclin-2&E7EPV7;H6UYS7;P37840;P37840-2;P37840-3:E7EPV7_HUMAN;H6UYS7_HUMAN;SYUA_HUMAN;SYUA_HUMAN;SYUA_HUMANmAlpha-synuclein;Alpha-synuclein;Alpha-synuclein;Isoform 2-4 of Alpha-synuclein;Isoform 2-5 of Alpha-synuclein)F6VDH7;H7C3I1;P50502;Q3KNR6;Q8IZP2;Q8NFI4!ST13;ST13;ST13;ST13;ST13P4;ST13P5JF6VDH7_HUMAN;H7C3I1_HUMAN;F10A1_HUMAN;Q3KNR6_HUMAN;ST134_HUMAN;F10A5_HUMANHsc70-interacting protein (Fragment);Hsc70-interacting protein (Fragment);Hsc70-interacting protein;Hsc70-interacting protein;Putative protein FAM10A4;Putative protein FAM10A5/H7BZ65;Q53RD9;Q53RD9-2;Q53RD9-3;Q53RD9-4;Q8IY13IH7BZ65_HUMAN;FBLN7_HUMAN;FBLN7_HUMAN;FBLN7_HUMAN;FBLN7_HUMAN;Q8IY13_HUMAN|Fibulin-7 (Fragment);Fibulin-7;Isoform 2 of Fibulin-7;Isoform 3 of Fibulin-7;Isoform 4 of Fibulin-7;FBLN7 protein (Fragment)!Q08495;Q08495-2;Q08495-3;Q08495-4FDematin;Isoform 2 of Dematin;Isoform 3 of Dematin;Isoform 4 of DematinQ9C0H2;Q9C0H2-2;Q9C0H2-3dProtein tweety homolog 3;Isoform 2 of Protein tweety homolog 3;Isoform 3 of Protein tweety homolog 3H0YCG2;P13473< ;P13473-2;P13473-30H0YCG2_HUMAN;LAMP2_HUMAN;LAMP2_HUMAN;LAMP2_HUMANLysosome-associated membrane glycoprotein 2 (Fragment);Lysosome-associated membrane glycoprotein 2;Isoform LAMP-2B of Lysosome-associated membrane glycoprotein 2;Isoform LAMP-2C of Lysosome-associated membrane glycoprotein 22H0YKS4;H0YMD0;H0YMM1;H0YMU9;H0YN42;P07355;P07355-2XH0YKS4_HUMAN;H0YMD0_HUMAN;H0YMM1_HUMAN;H0YMU9_HUMAN;H0YN42_HUMAN;ANXA2_HUMAN;ANXA2_HUMANvAnnexin (Fragment);Annexin (Fragment);Annexin (Fragment);Annexin;Annexin (Fragment);Annexin A2;Isoform 2 of Annexin A2+H3BM38;H3BNE1;H3BPJ0;H3BR18;O00161;O00161-2KH3BM38_HUMAN;H3BNE1_HUMAN;H3BPJ0_HUMAN;H3BR18_HUMAN;SNP23_HUMAN;SNP23_HUMANSynaptosomal-associated protein (Fragment);Synaptosomal-associated protein 23;Synaptosomal-associated protein 23;Synaptosomal-associated protein (Fragment);Synaptosomal-associated protein 23;Isoform SNAP-23b of Synaptosomal-associated protein 23O14818;Q8TAA3;Q8TAA3-2;Q8TAA3-5PSMA7;PSMA8;PSMA8;PSMA8.PSA7_HUMAN;PSA7L_HUMAN;PSA7L_HUMAN;PSA7L_HUMANProteasome subunit alpha type-7;Proteasome subunit alpha type-7-like;Isoform 2 of Proteasome subunit alpha type-7-like;Isoform 3 of Proteasome subunit alpha type-7-like3Q9H6X2;Q9H6X2-2;Q9H6X2-3;Q9H6X2-4;Q9H6X2-5;Q9H6X2-6Anthrax toxin receptor 1;Isoform 2 of Anthrax toxin receptor 1;Isoform 3 of Anthrax toxin receptor 1;Isoform 4 of Anthrax toxin receptor 1;Isoform 5 of Anthrax toxin receptor 1;Isoform 6 of Anthrax toxin receptor 1:A0A087X0I9;C9K0E3;Q04759;Q04759-2;Q04759-3;Q05655;Q05655-2)PRKCQ;PRKCD;PRKCQ;PRKCQ;PRKCQ;PRKCD;PRKCDTA0A087X0I9_HUMAN;C9K0E3_HUMAN;KPCT_HUMAN;KPCT_HUMAN;KPCT_HUMAN;KPCD_HUMAN;KPCD_HUMANProtein kinase C;Protein kinase C delta type (Fragment);Protein kinase C theta type;Isoform 2 of Protein kinase C theta type;Isoform 3 of Protein kinase C theta type;Protein kinase C delta type;Isoform 2 of Protein kinase C delta typeE7EUJ1;E7EUK6;P11150$E7EUJ1_HUMAN;E7EUK6_HUMAN;LIPC_HUMANK7ERE3;P13646;P13646-3$K7ERE3_HUMAN;K1C13_HUMAN;K1C13_HUMANlKeratin, type I cytoskeletal 13;Keratin, type I cytoskeletal 13;Isoform 3 of Keratin, type I cytoskeletal 13cA0A087WW13;A0A087WWI4;A0A087X054;A0A087X214;E9PJ21;J3KTF1;J3QL06;J3QLE9;J3QQH7;K7EQK2;Q9BST8;Q9Y4L1A0A087WW13_HUMAN;A0A087WWI4_HUMAN;A0A087X054_HUMAN;A0A087X214_HUMAN;E9PJ21_HUMAN;J3KTF1_HUMAN;J3QL06_HUMAN;J3QLE9_HUMAN;J3QQH7_HUMAN;K7EQK2_HUMAN;Q9BST8_HUMAN;HYOU1_HUMANHypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1;Hypoxia up-regulated protein 1;Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1 (Fragment);Hypoxia up-regulated protein 1;HYOU1 protein;Hypoxia up-regulated protein 1P12955;P12955-2;P12955-3;V9GYE4-PEPD_HUMAN;PEPD_HUMAN;PEPD_HUMAN;V9GYE4_HUMANtXaa-Pro dipeptidase;Isoform 2 of Xaa-Pro dipeptidase;Isoform 3 of Xaa-Pro dipeptidase;Xaa-Pro dipeptidase (Fragment)tA0A0A0MRT6;B6VEX4;Q8IZP0;Q8IZP0-10;Q8IZP0-12;Q8IZP0-2;Q8IZP0-3;Q8IZP0-4;Q8IZP0-5;Q8IZP0-6;Q8IZP0-7;Q8IZP0-8;Q8IZP0-9A0A0A0MRT6_HUMAN;B6VEX4_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN;ABI1_HUMAN`Abl interactor 1;Abl interactor 1;Abl interactor 1;Isoform 10 of Abl interactor 1;Isoform 12 of Abl interactor 1;Isoform 2 of Abl interactor 1;Isoform 3 of Abl interactor 1;Isoform 4 of Abl interactor 1;Isoform 5 of Abl interactor 1;Isoform 6 of Abl interactor 1;Isoform 7 of Abl interactor 1;Isoform 8 of Abl interactor 1;Isoform 9 of Abl interactor 18A0A075B7C0;A0A0C4DGQ5;K7EIV0;K7ELJ7;K7EM73;P04632;U3KQE2aA0A075B7C0_HUMAN;A0A0C4DGQ5_HUMAN;K7EIV0_HUMAN;K7ELJ7_HUMAN;K7EM73_HUMAN;CPNS1_HUMAN;U3KQE2_HUMANCalpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1 (Fragment);Calpain small subunit 1;Calpain small subunit 1 (Fragment) D6R9J0;Q8NBM8D6R9J0_HUMAN;PCYXL_HUMAN H0Y858;Q6IBS0;TWF2H0Y858_HUMAN;TWF2_HUMAN.Uncharacterized protein (Fragment);Twinfilin-2BA0A0A0MTS2;A0A0J9YX90;A0A0J9YXP8;A0A0J9YYH3;K7EQ48;P06744;P06744-2fA0A0A0MTS2_HUMAN;A0A0J9YX90_HUMAN;A0A0J9YXP8_HUMAN;A0A0J9YYH3_HUMAN;K7EQ48_HUMAN;G6PI_HUMAN;G6PI_HUMAN Glucose-6-phosphate isomerase (Fragment);Glucose-6-phosphate isomerase (Fragment);Glucose-6-phosphate isomerase (Fragment);Glucose-6-phosphate isomerase (Fragment);Glucose-6-phosphate isomerase;Glucose-6-phosphate isomerase;Isoform 2 of Glucose-6-phosphate isomeraseK7EKL3;K7EMR1;P28799;P28799-2-K7EKL3_HUMAN;K7EMR1_HUMAN;GRN_HUMAN;GRN_HUMANJGranulins (Fragment);Granulins (Fragment);Granulins;Isoform 2 of GranulinsP35998;P35998-2P26S protease regulatory subunit 7;Isoform 2 of 26S protease regulatory subunit 7P50395;P50395-2TRab GDP dissociation inhibitor beta;Isoform 2 of Rab GDP dissociation inhibitor betaM0R0Y2;M0R2M1;P54920$M0R0Y2_HUMAN;M0R2M1_HUMAN;SNAA_HUMANyAlpha-soluble NSF attachment protein;Alpha-soluble NSF attachment protein (Fragment);Alpha-soluble NSF attachment protein Q5VZR0;Q9H4G4Q5VZR0_HUMAN;GAPR1_HUMANQ9Y265;Q9Y265-2$RuvB-like 1;Isoform 2 of RuvB-like 1O43157;O43157-2;O43157-37Plexin-B1;Isoform 2 of Plexin-B1;Isoform 3 of Plexin-B1 Q5SZC9;Q9P1F3Q5SZC9_HUMAN;ABRAL_HUMANH0YKB3;Q00796;Q00796-2"H0YKB3_HUMAN;DHSO_HUMAN;DHSO_HUMANQSorbitol dehydrogenase;Sorbitol dehydrogenase;Isoform 2 of Sorbitol dehydrogenaseM0R1Q1 M0R1Q1_HUMANComplement C3 (Fragment)Q5TFM2 Q5TFM2_HUMANA0A087WYE8;A0A0B4J2B8IGHV1OR21-1;IGHV1OR15-9!A0A087WYE8_HUMAN;A0A0B4J2B8_HUMANvPutative V-set and immunoglobulin domain-containing-like protein IGHV1OR21-1 (Fragment);Protein IGHV1OR15-9 (Fragment)B3KQV6;E9PH38;P30153$B3KQV6_HUMAN;E9PH38_HUMAN;2AAA_HUMANSerine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform;Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Fragment);Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform E7EQ64;P07477E7EQ64_HUMAN;TRY1_HUMANH7C5R1 H7C5R1_HUMANCeruloplasmin (Fragment)H3BLU7;O43488;Q8NHP1AKR7A2;AKR7A2;AKR7L$H3BLU7_HUMAN;ARK72_HUMAN;ARK74_HUMANAflatoxin B1 aldehyde reductase member 2 (Fragment);Aflatoxin B1 aldehyde reductase member 2;Aflatoxin B1 aldehyde reductase member 4P04279;P04279-2(Semenogelin-1;Isoform 2 of Semenogelin-1B4DV12;F5GXK7;F5GYU3;F5GZ39;F5H265;F5H2Z3;F5H388;F5H6Q2;F5H747;J3QKN0;J3QS39;J3QSA3;J3QTR3;M0R1V7;P0CG47;P0CG48;P62979;P62987;Q5PY61;Q96C32YUBB;UBC;UBC;UBC;UBC;UBC;UBC;UBC;UBC;UBB;UBB;UBB;RPS27A;UBA52      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~;UBB;UBC;RPS27A;UBA52;UBC;UBCB4DV12_HUMAN;F5GXK7_HUMAN;F5GYU3_HUMAN;F5GZ39_HUMAN;F5H265_HUMAN;F5H2Z3_HUMAN;F5H388_HUMAN;F5H6Q2_HUMAN;F5H747_HUMAN;J3QKN0_HUMAN;J3QS39_HUMAN;J3QSA3_HUMAN;J3QTR3_HUMAN;M0R1V7_HUMAN;UBB_HUMAN;UBC_HUMAN;RS27A_HUMAN;RL40_HUMAN;Q5PY61_HUMAN;Q96C32_HUMAN Polyubiquitin-B;Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-C (Fragment);Polyubiquitin-B (Fragment);Polyubiquitin-B (Fragment);Polyubiquitin-B (Fragment);Ubiquitin-40S ribosomal protein S27a (Fragment);Ubiquitin-60S ribosomal protein L40 (Fragment);Polyubiquitin-B;Polyubiquitin-C;Ubiquitin-40S ribosomal protein S27a;Ubiquitin-60S ribosomal protein L40;Polyubiquitin-C;Polyubiquitin-C=760 proteins were identified with at least 2 unique peptides.N173 proteins were significantly altered (Qvalue < 0.05 and fold-change > 1.5).53 proteins were up-regulated.!120 proteins were down-regulated.1502 proteins were identified.@1356 proteins were identified with at least two unique peptides.K171 proteins were significantly altered (Qvalue < 0.05, and Abs.FC > 0.58).Supplementary Table 4A. List of all proteins identified in pilot experiment (Old/ young) analysed with the Hybrid spectral library.Supplementary Table 4B. List of all proteins ( e" 2< unique peptides) identified in pilot experiment (Old/ Young) analysed with the Hybrid spectral library.Supplementary Table 4C. List of significantly altered proteins in pilot experiment (Old/Young) analysed with the Hybrid spectral library.Supplementary Table 4D. List of all proteins identified in pilot experiment (Old/ Young) analysed with the deep fractionation DDA spectral library.Supplementary Table 4E. List of all proteins ( e" 2 unique peptides) identified in pilot experiment (Old/Young) analysed with the deep fractionation DDA spectral library.Supplementary Table 4F. List of significantly altered proteins in pilot experiment (Old/Young) analysed with the deep fractionation DDA spectral library.Supplementary Table 4G. List of all proteins identified in pilot experiment (Old/Young) analysed with the directDIA spectral library.Supplementary Table 4H. List of all proteins ( e" 2 unique peptides) identified in pilot experiment (Old/Young) analysed with the directDIA spectral library.Supplementary Table 4I. List of significantly altered proteins in pilot experiment (Old /Young) analysed with the directDIA spectral library.Supplementary Table 4J. List of up-regulated pathways obtained using the significantly altered proteins (Hybrid spectral library).Supplementary Table 4K. List of down-regulated pathways obtained using the significantly altered proteins (Hybrid spectral library).rG k[u A@ 'wZ#/n2y R}~-qw[<~i_}'?*?/$v\fHf?w* >O;K {g M r$ AR t    WY m= \  ?I; ^    6 ]s (  j U+ ]   yN_\ҫ KpZ)zC)8?isƧL6 O!E/V:S  G` AyQnz ެ {=Vt~}   9<Vi Y[cs&Cr}~,   ! %]ݘy^j 4?Vw"(ccF PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V(KɸX#+jg3dy7e Ti6 |XrsFn1Yv"3_AV~U˕ʽM'gG'C(Ff1C;Jv{n2"eb+m訷&[gHj9`ͤZӴѩ{z܍!̴TEN~"ø4'CɝZwpOh$_34 jm0dܕaٕ՞OP{͐0TV=[3#zÁLq}TV pc =\ Ud$lPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!ͳ)theme/theme/theme1.xmlPK-! ѐ'theme/theme/_rels/themeManager.xml.relsPK] ZO {e)i;cK;3[O2zq {R ! I K*!Wr! !"I""3"a"#)j##A#-B$Y$a$?%b%%%:&a&&A'\'''4(|(( ))  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} } I(} )} } } } $ } } } m} m} m } } m } } 3} "} ##m} $$} %m%%h%,%,%,%J@%,%,%,%, %, %, %, %, %,%,%,%,%,%,%,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ >8N?????@@@@@@@@@@@@@@@@@@?????????????$ A8NAAAAABBBBBBBBBBBBBBBBBBAAAAAAAAAAAAA$PAAAAAABBBBBBBBBBBBBBBBBBAAAAAAAAAAAAA$PAAAAAABBBBBBBBBBBBBBBBBBAAAAAAAAAAAAA$ p q q q q q q q q  q  q  q  q  q q q q q q q q q q q q q q q q q q q  q !q! "q" #q# $C$ A% A& A% A' A(A B) B* B+~  Bd@  B% B`2!A~  B  D*N?D*N?DJT1Q@DRC?B 0B 0?B/.BzdRJZ?~ BE1\?FTh=?~ Ad@A$? A, A- A. A/ A0~ A?  A1 !A2 "A3#A?@AF@$ A4 A5 A4 A6 A7A B) B* B+~  B9@  B4 BA BxA D:g??D:g??DJlUN@D^~?B?I̿B?I?B?;,g,BE !t?~ BE|?F ?~ A8@A%CE? A, A8 A9 A: A; A<  A= !A2 "A>#A"@A$@$ A? A@ A? AA ABA B) B* B+~  BA@  B? Bz B  D색7D색7?DtBD ?BB?B+{ BB?~ BE4gnOʧ?F$r?~ AA@AV w4? A, AC AD AE AFA?A@ !A2 "AG#A@A@$ AH AI AH AJ AKA B) B* B+~  BQ@  BH B:fB*m  DrrDrr?D3NPAD?B?IǿB?I?B6@.r['B5 6b5?~ BE2߅?FKh?~ A@Q@AΆc!? A, ALA AM AFA?A? !A2 "AN#A@A,@$ AO AP AO AQ AR A B) B* B+~ Bp@ BO B`|A B A DQi DQi? D%>΢{J Dt?? Bu. Bu.? BbeB BA|9?~ B E5ȳ? FYЍ^G?~ Ap@ A(? A, AS AT AU A0 AV~ A? !A2 "AW #A5@AK@$ AX AY AX AZ A[ A B) B* B+~ B`c@ BX B\ A B a/A D]D'? D]D'? DO'庌V@ DزIn? Bߎh? Bߎh? B1'H<@ BH?~ B Els? F!t&?~ A@c@ A ^1? A, A\ A] A^ A0~ A? A1 !A2 "A_ #AG@AM@$ A` Aa A` Ab Ac A B) B* B+~ B|@ B` B 5A B A D)̿ D)? DhVFJ, D+ m{?D5>{?DY(0@DY?B5?B5?B=\(@BVg?~ BE0,B`?F&-?~ Ae@Af? A, A A AM AFA@A? !A2 "A#A1@AC@$ A A A A AA B) B* B+~  B@P@  B~  Bg B !A D@z(@?D@z(@?D,ԎP@DQ?B_EڿB_E?B 99Ba>IC?~ BE:'9?Fm?~ AP@AKI!ں? A, A A A A0~ A?  A !A2 "A#A.@A1@$ A A A A AA B) B* B+~  Bd@  B B NYBzՁ  D70?D70?DrYC"Q@Dk]?B@?B@?B_R?C@B#=V?~ BEŕ]=F^o=~ A`@Ay`)Ұ? A, A A A A0~ A?  A !A2 "A#Ac@At@$ A A A A AA B) B* B+~  B|@  B B-GB L  DWJMi?DWJMi?DYqU@D?B,?B,?BʥAP7@B@ ?~ BEĠls!?FOM?~ A|@AJ@d? A, A A A A0A?A? !A2 "A#AD@A@Z@$ A A A A AA B) B* B+~  B4@  B BA B6)A D%O?D%O?DKHEOl@DuA @B?B?B(US@B∨?~ BE:^f?FcMo"?~ A3@A;pv/? A, A A A A A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  Bh@  B B@.A~  BC/ DXPA?DXPA?D]"X@D ?BQ?BQ?B@ mP@B $Ճ?~ BEmvXC<F3<~ A`@AŽ д? A, A A A A0~ A?  A !A2 "A#Aa@Ak@$ A A A A AA B) B* B+~  Bo@  B BM`B#<  D>VF>]D>VF>]?D-[tBDW*/%?B ]ԿB ]?BgNF^3Bנ?~ BE[-Y?F ?~ Ao@A2s? A, AAA AFA?A@ !A2 "A#A1@AL@$ A A A A AA B) B* B+~  BQ@  B~  BZ'  B@&MA D33|ۿD33|?DC44ܾ9D<?B?B?B5X@Bz?~ BE,?FZ Gk ?~ A@Q@ALTX? A, A A A A A  A !A2 "A#A4@A;@$ A A A A AA B) B* B+~  Bu@  B B^)Bw'A  DQDQ?DůYKDM \?BvBv?BTr5@BG?~ BEOz]:?F#m?~ Au@Al$8? A, A A A A0~ A?  A1 !A2 "A#AA@AU@$ A A A A AA B) B* B+~  B g@  B BB#  D=R(3D=R(3?D!ǨLDFP?BWBW?BU>gEBls{?~ BEO_>FA)?~ Ag@A=@? A, A A A AFA?A? !A2 "A#A1@AE@$ A A A A AA B) B* B+~  Ba@  B B2fBi  Dw/ϻ;Dw/ϻ;?D|CQD1 ?BϯBϯ?BFmHBT?~ BE&?}>F>~ A`a@A,? A, A A A AFA?A? !A2 "A#A$@A=@$ A A A A AA B) B* B+~  B@`@  B B<A BPA DPYտDPY?D D\4D*N?BNBN?B8xB$e}M?~ BEyr?Fp ?~ A `@Am&? A, A A A A0~ A?  A1 !A2 "A#A>@AC@$ A A A A AA B) B* B+~  BN@  B B hA B`2A D!RpD!Rp?D3GD6a}&?BߘBߘ?Bzy^ GB??~ BEBLZid?~ BE`b6?FڤAg%;@?%;@ A A A A A A B) B* B+~ BF@ B BA B A DV? DV? DY/:}I@ D|(? B? B? B?ze ,@ B~2K?~ B EP#Ot? F%@ $ B6$ B@@$ Bii@$ D?$D?$DD<#@$D?$B-v?$B-v?$B(Yc@$BׂUy?~ $B$Ea<7?$F6^u?~ $A=@$Al4ܼ? $A, $A: $A; $A< $A= $A> $ A> $!A2 $"A?$#A@A$@$ %A@ %AA %A@ %AB %AC%A %B) %B* %B+~ % B@ % B@% BBIB % D{\U%D{\U?%Dc7a4G%D'f8.(&?%B2`%B2`?%B 7[=%BTf*q?~ %B%EQ@H=%Fh>~ %A@%ArkoQ? %A, %AAA %AF%A?A? %!A2 %"AD%#AT@Aj@$ &AE &AF &AE &AG &AH&A &B) &B* &B+~ & B9@ & BE~ & BA& B@& D 7Iֿ&D 7I?&D#0Q6&Dzs5?&Bڿ&B?&B|%W,9&B1?~ &B&E|$,?&Foـ?~ &A8@&AO=c? &A, &AI &AJ &AK &AL~ &A? & AM &!A2 &"AN&#A@A"@$ 'AO 'AP 'AO 'AQ 'AR'A 'B) 'B* 'B+~ ' BȄ@ ' BO' Bˢ(A~ ' B_*lI' D?'D?'Dyrq@'D-@'B?'B?'BYZ4_@'B(@~ 'B'Erlf)<'FAW<1<~ 'A@'Aׇ? 'A, 'AS 'AT'A 'AF'A?A? '!A2 '"AU'#AW@A@c@$ (AV (AW (AV (AX (AY(A (B) (B* (B+~ ( BK@ ( BV( BA( B Y A( DZ?(DZ?(DIGE@(D?~ /B/Eف?/Fk@#a?~ /AC@/A^p+? /A, /A /A /A /A/A?A? /!A2 /"A/#A @A$@$ 0A 0A 0A 0A 0A0A 0B) 0B* 0B+~ 0 BK@ 0 B~ 0 B@0 B@A0 D16Dw?0D16Dw?0DF1F@0D>)ٽ[?0Biȿ0Bi?0B`1g(0B ?~ 0B0E)8x?0F7ك?~ 0AK@0A+? 0A, 0A 0A 0A 0A0~ 0A? 0 A 0!A2 0"A0#A:@A=@$ 1A 1A 1A 1A 1A1A 1B) 1B* 1B+~ 1 B@ 1 B1 B "!@1 B~w@1 DIb.տ1DIb.?1DJ ]41DȔ{?1Bψ?1Bψ?1B|& Ii@1BV@.@~ 1B1EQ{Z&?1F 4ϝ?~ 1A@1A`Nd@ 1A, 1A 1A 1A 1Ag 1Ah 1 Ah 1!A2 1"A1#A?A?$ 2A 2A 2A 2A 2A2A 2B) 2B* 2B+~ 2 B.@ 2 B2 B@A2 B@A2 D2 ut?2D2 ut?2DV?2DL?2BO2BO?2Bd׶ 2Bi9=r?~ 2B2EME?2Fn³?~ 2A,@2A@2? 2A, 2A 2A 2A 2A 2A 2 A 2!A2 2"A2#A@A@$ 3A 3A 3A 3A 3A3A 3B) 3B* 3B+~ 3 BK@ 3 B3 B@~mA3 BA3 DВ(gʿ3DВ(g?3DYP*3D0K?3B?3B?3BM!:@3Be $aA?~ 3B3Ee?3Fz D?~ 3AK@3ATR? 3A, 3A 3A 3A 3A0 3A 3 A 3!A2 3"A3#A&@A.@$ 4A 4A 4A 4A 4A4A 4B) 4B* 4B+~ 4 Bb@ 4 B4 B^zA4 B],A4 D#ʬ?4D#ʬ?4DRg@4D6*iL@4B?4B?4BA2@4BAM?~ 4B4EΙpL?4F+`?~ 4Ab@4AtcSP? 4A, 4A 4A 4A 4A04A?A? 4!A2 4"A4#A7@AC@$ 5A 5A 5A 5A 5A5A 5B) 5B* 5B+~ 5 B@ 5 B~ 5 B!,5 B`$A5 DQ麿5DQ?5D<95DC?5B_̓5B_̓?5B̆5B`u?~ 5B5Eax?5FG0tG?~ 5A؀@5A0Uغ? 5A, 5A 5A 5A 5A0~ 5A? 5 A1 5!A2 5"A5#AU@Ab@$ 6A 6A 6A 6A 6A6A 6B) 6B* 6B+~ 6 BF@ 6 B6 B @6 B`SA6 D4?6D4?6D؁R\@6D>.s0@6BM?6BM?6BEc\U@6B ū?~ 6B6E+钴?6Fކ?~ 6AF@6AeZ#? 6A, 6A 6A 6A 6A 6A 6 A 6!A2 6"A6#A&@A(@$ 7A 7A 7A 7A 7A7A 7B) 7B* 7B+~ 7 By@ 7 B7 BZ^5BJ( 7 Dx# 7Dx# ?7Dh-HC7DF>j?7B`?7B`?7BbǑ8@7BzW]?~ 7B7E/?7F*U?~ 7Ay@7AA9~? 7A, 7A 7A 7A 7A07A?A? 7!A2 7"A7#AK@AX@$ 8A 8A 8A 8A 8A8A 8B) 8B* 8B+~ 8 B4@ 8 B8 BA8 B\ A8 Dީ[?8Dީ[?8D^jH@8DM?8B-8B-?8BInC1Q8Bƹ%p?~ 8B8E(a0~o?8F凗9_?~ 8A3@8A092oo? 8A, 8A 8A 8A 8Ag 8A 8 A 8!A2 8"A8#A@A@$ 9A 9A 9A 9A 9A9A 9B) 9B* 9B+~ 9 B4@ 9 B9 B^QA9 B'a@9 Dm 9Dm ?9D~5K$P9DLS?9B?V9B?V?9B owB9BQ{Y?~ 9B9E.[?9Fn#?~ 9A3@9AC?6!? 9A, 9A 9A 9A 9A; 9A< 9 A< 9!A2 9"A9#A@A@$ :A :A :A :A :A:A :B) :B* :B+~ : BPy@ : B: BA: B=/A: D ?:D ?:D%H[@:D5@:B1~ :A@y@:AJ흺z? :A, :A :A :A :A :A : A :!A2 :"A:#A@S@A[@$ ;A ;A ;A ;A ;A;A ;B) ;B* ;B+~ ; Bo@ ; B; BnA; BxA; Dx?;Dx?;D(2꫾`@;D8[Dx@;B?;B?;Bar~W@;B㩇 ?~ ;B;Exع̩>;FU8ΎK>~ ;Ao@;A+5|? ;A, ;AAA ;AF;A?A? ;!A2 ;"A;#A2@AJ@$ <A <A <A <A <A<A <B) <B* <B+~ < Bq@ < B< B[AB < D%󕱿<D%?<D,<D ?<B<B?<B^<BEOs.?~ <B<EgL?<F:嫴?~ <Aq@<AU&Y? <A, <A <A <A <A,<A?A@ <!A2 <"A<#AF@A@S@$ =A =A  =A =A  =A =A =B) =B* =B+~ = B4@ = B= BRA= B@= D n=D n?=DfWB*D=Dv'?=BB=BB?=B ?f=BZͺ$-?~ =B=Eg&ϝ?=F3I?~ =A3@=Aso4? =A, =A  =A  =A =A,=A?A@ =!A2 ="A=#A@A@$ >A >A >A >A >A>A >B) >B* >B+~ > B\@ > B~ > B[ > B aA> D}>D}?>D;_@>Ds)6C^?>B_ѿ>B_?>B(30>B'7?~ >B>Eԗ ?>Fc7Dg?~ >A\@>Abh? >A, >A >A >A >A,>A?A@ >!A2 >"A>#A3@A:@$ ?A ?A ?A ?A ?A?A ?B) ?B* ?B+~ ? BT@ ? B? B8A~ ? Br? DseMNۿ?DseMN??D7449?DI|??B`gտ?B`g??BGme4?Bx?~ ?B?Ec҇??Fn?~ ?AS@?A|R? ?A, ?A ?A ?A ?A, ?A ? A  ?!A2 ?"A!?#A"@A0@$DGl2,2.$22222(2,.222,.2222,(@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A" @A# @A" @A$ @A%@A @B) @B* @B+~ @ Bd@ @ B"@ B`>.A@ BX>#A@ DFo@DFo?@DD'/B@DU88\?@B2ٿ@B2?@BdQY7@B_?c?~ @B@ElN?@F;H?~ @Ac@@AgY ? @A, @A& @A' @A( @A,@A?A@ @!A2 @"A)@#A7@AC@$ AA* AA+ AA* AA, AA-AA AB) AB* AB+~ A BQ@ A B*A B`*AA B > AA DƖIADƖI?AD6!~CA CB) CB* CB+~ C B@`@ C B;~ C B C B`AC D:~xwCD:~xw?CDP>GCDz/3?CB@[ަ?CB@[ަ?CB' @CB[2ˀ?~ CBCE [?CFtYQ?~ CA `@CA&ώ0? CA, CA? CA@ CAA CA,CA?A@ C!A2 C"ABC#A4@A?@$ DAC DAD DAC DAE DAFDA DB) DB* DB+~ D B@U@ D BCD B AD B AD DVrDDVr?DDUpKDDo>?DB_?DB_?DBi`YG@DBsx?~ DBDEQw [6?DFb' ?~ DAU@DA3b? DA, DAG DAH DAI DA,DA?A? D!A2 D"AJD#A1@A:@$ EAK EAL EAK EAM EANEA EB) EB* EB+~ E B.@ E BKE B@E B@E D(DWBED(DWB?ED3apDEDը0 ?EB; EB; ?EB@EBChL.?~ EBEE7;H!?EF8zY?~ EA,@EAq5'? EA, EAO EAP EAQ EA, EA E AR E!A2 E"ASE#A$@A&@$ FAT FAU FAT FAV FAWFA FB) FB* FB+~ F B@P@ F BTF B,kAF B'AF D5ނ[?FD5ނ[?FDzC2LR@FDIG?FB?FB?FBA%1h@FBv~|@~ FBFE<Y`f?FFH> Α?~ FAP@FAq+? FA, FAX FAY FAZ FA,~ FA? F A1 F!A2 F"A[F#A&@A.@$ GA\ GA] GA\ GA^ GA_GA GB) GB* GB+~ G B@@ G B\G BA~ G BnsG DfGGDfG?GDOLGDɏ?GB GB ?GBYKz[CGBqj@~?~ GBGEqHX>GF`>~ GA8@GA$vtDп? GA, GA` GAa GAb GA,GA?A? G!A2 G"AcG#AE@A[@$ HAd HAe HAd HAf HAgHA HB) HB* HB+~ H Bq@ H BdH B%AH BAH D1ܿHD1?HD]LT :HDMƪw?HBߣU?HBߣU?HB:T$@HBۋ?~ HBHEQ0)I?HF?~ HApq@HAx_? HA, HAh HAi HAj HA,HA?A@ H!A2 H"AkH#AE@A@R@$ IAl IAm IAl IAn IAoIA IB) IB* IB+~ I B`m@ I BlI B AI BAI DltȝIDltȝ?IDထID`\?IBM޿IBM?IBgUA<IB46?~ IBIELc?IFDž?~ IA@m@IAnΟ,hu? IA, IAp IAq IAr IA,IA?A@ I!A2 I"AsI#AK@A@R@$ JAt JAu JAt JAv JAwJA JB) JB* JB+~ J B g@ J BtJ B4 AJ B:AJ Dwɿ]L?JDwɿ]L?JD>ۏB@JDV?JBߏ?JBߏ?JB!< @JB?s|uI?~ JBJEH?JFKh?~ JAg@JA줳6? JA, JAx JAy JAz JA, JA J A  J!A2 J"A{J#AC@AM@$ KA| KA} KA| KA~ KAKA KB) KB* KB+~ K B@o@ K B|K B B2 K D B ?KD B ?KDGk9̱=@KD#ɢI?KB?KB?KB)9G;8@KB%F?~ KBKE߂?KFɉ?~ KA o@KAW~? KA, KA KA KA KA,KA?A@ K!A2 K"AK#A7@AJ@$ LA LA LA LA LALA LB) LB* LB+~ L BA@ L BL B@L B`]@L D<D?LD<D?LDX8@LD{~?LB˾LB˾?LBξy. LBm gp?~ LBLE`N;?LF ?~ LAA@LA4a^so? LA, LA LA LA LA, LA L A L!A2 L"AL#A$@A,@$ MA MA MA MA MAMA MB) MB* MB+~ M BH@ M BM BZB M Dҍ0?MDҍ0?MD e@MDb@MB`f?MB`f?MB3L@MBMUGX3?~ MBME.y } h=MF gW?>~ MA@@MA? MA, MA MA MA MA,MA?A? M!A2 M"AM#AU@Ah@$ NA NA NA NA NANA NB) NB* NB+~ N Bz@ N BN B AN B ߙAN D#|$?ND#|$?NDVBA@NDqcq?NB}?NB}?NBUL@NB{2?~ NBNEr^ѝ>NF+3i4M>~ NAz@NAThT? NA, NA NA NA NA,NA?A? N!A2 N"AN#AU@A`@$ OA OA OA OA OAOA OB) OB* OB+~ O B@z@ O BO BÈ M@QBP v?~ QBQE&\& >QF]`>~ QA@QAN? QA, QA QA QA QA,QA?A@ Q!A2 Q"AQ#A@V@A g@$ RA RA RA RA RARA RB) RB* RB+~ R B`c@ R BR BeB[! R D'CZ#?RD'CZ#?RDmxz1@RD:`?RBG͂RBG͂?RB4ĩoLRB@ ?~ RBREc?RFw=ISFc }>~ SA0u@SAƊ? SA, SA SA SA SA,SA?A? S!A2 S"AS#AF@A@V@$ TA TA TA TA TATA TB) TB* TB+~ T B@@ T BT BpABBB T D }w ?TD }w ?TDU@TDC<?TB?TB?TB]kDC@TB gU?~ TBTE/+Щl>TFƢƐ>~ TA8@TAtW^? TA, TA TA TA TA,TA?A@ T!A2 T"AT#AK@Ac@$ UA UA UA UA UAUA UB) UB* UB+~ U B@o@ U BU B )YA~ U B"ZU Dќ?UDќ?UDq:^H@UDr~?UB?UB?UBC2:@UBO}D?~ UBUESb?UFs5 .?~ UA o@UAqP? UA, UA UA UA UA,UA?A@ U!A2 U"AU#A<@AN@$ VA VA VA VA VAVA VB) VB* VB+~ V Bԧ@ V BV B`FFAV B@WxAV D9fs 2ѿVD9fs 2?VD}0(0VDV&?VBVB?VB\sA VBJKO?~ VBVE ?VF#X9i?~ VAҧ@VA6 ? VA, VA VA VA VA,VA?A@ V!A2 V"AV#Ai@AX@$ WA WA WA WA WAWA WB) WB* WB+~ W B4@ W BW BB# BR W D:g?WD:g?WD )F1@WDD?WB &_?WB &_?WB̪&@WB$"?~ WBWEff;#)S?WFĠIf?~ WA2@WAEէ? WA, WA WA WA WA,WA?A@ W!A2 W"AW#Al@A`@$ XA XA XA XA XAXA XB) XB* XB+~ X B@ X BX BjB" X D_up?XD_up?XDuH1@XD?XB_͢?XB_͢?XBsU骟@XBIi?~ XBXE 4,`?XF z}?~ XA@XA"i?? XA, XA XA XA XA,XA?A@ X!A2 X"AX#AX@Ad@$ YA YA YA YA YAYA YB) YB* YB+~ Y B@@ Y BY B/B 1 Y D 5a?YD 5a?YDdQ@YDkG+!?YB_ ?YB_ ?YBK]A@YB2?~ YBYEgm{?YFYЍ^G?~ YA0@YAmwAS? YA, YA YA YA YA,YA?A@ Y!A2 Y"AY#AL@A\@$ ZA ZA ZA ZA ZAZA ZB) ZB* ZB+~ Z B@Z@ Z BZ BdcAZ B`WAZ D&9?ZD&9?ZDA10@ZDe ]ϫ?ZBF?ZBF?ZB-D;C@ZB.lGS?~ ZBZERH?ZF16?~ ZAZ@ZAg_P? ZA, ZA ZA ZA ZA,ZA?A@ Z!A2 Z"AZ#A2@A>@$ [A [A [A [A [A[A [B) [B* [B+~ [ Bn@ [ B[ BtBd3 [ D^*U[D^*U?[D K[DWtK?[B[B?[B`DBޔe>[BߘE?~ [B[E@T?[Fx)D?~ [Am@[A'vx? [A, [A [A [A [A,[A?A@ [!A2 ["A[#A6@AL@$ \A \A \A \A \A \A \B) \B* \B+~ \ BN@ \ B\ B=*BP \ D-S\D-S?\DЫXQ\D3P?\Bt\Bt?\B0%u!'O\BU+?~ \B\Ervz>\Ftp>~ \AM@\Aa8$t? \A, \A  \A  \A  \A,\A?A@ \!A2 \"A \#A@A*@$ ]A ]A ]A ]A ]A]A ]B) ]B* ]B+~ ] BR@ ] B] BrLB1 ] Db*]Db*?]Dt|Q]DJ(";?]BDm]BDm?]B l7O]B.>+A2?~ ]B]E8vb=]FY4P>~ ]AR@]A%? ]A, ]A ]A  ]A ]A,]A?A@ ]!A2 ]"A]#A@A.@$ ^A ^A ^A ^A ^A^A ^B) ^B* ^B+~ ^ BK@ ^ B^ BZ΄B{-F ^ D1m"P^D1m"P?^Dŷ{Q^D3U?^B^B?^By!ci~Q^B D7?~ ^B^E xf?^FrP@*9?~ ^AK@^Aw bO? ^A, ^A ^A  ^A ^A,^A?A@ ^!A2 ^"A^#A@A(@$ _A _A _A _A _A_A _B) _B* _B+~ _ B@Z@ _ B_ BF@Bf _ D[C_D[C?_DHP_DA?_B N{_B N{?_Bz)I_BaXV?~ _B_Efu.>_F.Դ>~ _AZ@_Aurx'? _A, _A _A  _A _A,_A?A@ _!A2 _"A_#A @A5@$DFGl,,$(,22(,,22,,(((,,`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A  `A! `A  `A" `A#`A `B) `B* `B+~ ` BN@ ` B ` BjzeBHj ` DÁP`DÁP?`Drf yD`D[@?`B B`B B?`BL=E`B 7ί?~ `B`E! ?`Fo(?~ `AM@`A_;(? `A, `A `A  `A `A,`A?A@ `!A2 `"A$`#A@A,@$ aA% aA& aA% aA' aA(aA aB) aB* aB+~ a B l@ a B%a BBf?BH a D?TaD?T?aD+w&PaD))?aBaB?aB-(CaB|rB?~ aBaEVS>aFu#>~ aAl@aA9PԤ[6? aA, aA aA  aA aA,aA?A@ a!A2 a"A)a#A1@AH@$ bA* bA+ bA* bA, bA-bA bB) bB* bB+~ b B@e@ b B*b BB8 BR b DVbDV?bḎĪZQbDKr?bBbB?bB؊n\HbB`Lh?~ bBbE#>bFW2p>~ bA e@bA@-ɸX? bA, bA bA  bA bA,bA?A@ b!A2 b"A.b#A*@AA@$ cA/ cA0 cA/ cA1 cA2cA cB) cB* cB+~ c B0{@ c B/c B&B9 c DFcDF?cDBcDSk?cBcB?cBµ <>cBz65.S?~ cBcE5Bk)?cF"1j^9^?~ cA {@cAW? cA, cA3 cA4 cA5 cA,cA?A@ c!A2 c"A6c#AM@AY@$ dA7 dA8 dA7 dA9 dA:dA dB) dB* dB+~ d Bp@ d B7d BBJ"B6 d D]U?dD]U?dD%sL@dD2X;?dBs?dBs?dBpJD@dBgka~?~ dBdE762?dF`~nC?e?~ dAp@dAY%? dA, dA; dA< dA= dA,dA?A@ d!A2 d"A>d#A6@AJ@$ eA? eA@ eA? eAA eABeA eB) eB* eB+~ e B8@ e B?e BBz@e BAe D40ݩ?eD40ݩ?eD'RU{n@eD% @eB?eB?eBxKS@eB ~n?~ eBeEB8<eFD~M`=~ eA0@eA;]$? eA, eAC eAD eAE eA,eA?A@ e!A2 e"AFe#A@d@A p@$ fAG fAH fAG fAI fAJfA fB) fB* fB+~ f B@@ f BGf BOAf BgAf D2ro?fD2ro?fDB-JKR@fDul:?fB?fB?fBR@fB(?~ fBfE,ޤ.́9fFѳ[\:~ fA<@fA0S? fA, fAK fAL fAM fA,fA?A? f!A2 f"ANf#AS@Ak@$ gAO gAP gAO gAQ gARgA gB) gB* gB+~ g B g@ g BOg B8 Br g D aO[gD aO[?gDKZgD$z"C?gBW?gBW?gBSi@gBҕ"Y?gFG0tG?~ gAg@gA*'? gA, gAS gAT gAU gAVgA?A? g!A2 g"AWg#A2@AD@$ hAX hAY hAX hAZ hA[hA hB) hB* hB+~ h BT@ h BXh B`|pAh B9Ah D ?hD ?hDǿ%@hD\ ?hB?hB?hB"(8:=@hBA?~ hBhE]IT$>hF>{vs>~ hAR@hAX}? hA, hA\ hA] hA^ hA,hA?A@ h!A2 h"A_h#Aa@A|@$ iA` iAa iA` iAb iAciA iB) iB* iB+~ i BL@ i B`i BBXAi B 4Ai DN?iDN?iDk?'@iD&K"?iBR?iBR?iB@|{"@iBD z?~ iBiE0h?iFDJ?~ iAH@iA u? iA, iAd iAe iA^ iA,iA?A@ i!A2 i"Afi#AV@Au@$ jAg jAh jAg jAi jAjjA jB) jB* jB+~ j BL@ j Bgj BAj B6Aj Djo>0?jDjo>0?jD_ @jDAq)k?jB߆?jB߆?jBW @jB Ww[?~ jBjE:ʥ?jF]g#t?~ jAH@jA%8Y? jA, jAk jAl jAm jA,jA?A@ j!A2 j"Anj#A@T@A q@$ kAo kAp kAo kAq kArkA kB) kB* kB+~ k B`h@ k Bok B BR] k D&JkD&J?kD.9PPIkD,F2?kB޿kB?kBR<kByQ?~ kBkEue>kFqn>~ kA@h@kAc$4? kA, kAs kAt kAu kA,kA?A@ k!A2 k"Avk#A0@AJ@$ lAw lAx lAw lAy lAzlA lB) lB* lB+~ l Bl@ l Bwl B;dB6 l D#U8lD#U8?lD`FlD`V?lBt%lBt%?lBz0@@lB z?~ lBlE>lFԾ0?~ lAl@lAI? lA, lA{ lAT lA| lA,lA?A@ l!A2 l"A}l#A5@AH@$ mA~ mA mA~ mA mAmA mB) mB* mB+~ m Bl@ m B~m B/A*,B : m D9o?mD9o?mDxe#U@@mD drV?mB6?mB6?mBn\b[D@mB'gyo?~ mBmEr>'֋?mF^EZǰ?~ mAl@mAP ? mA, mAmA mA mA,mA?A@ m!A2 m"Am#AD@AM@$ nA nA nA nA nAnA nB) nB* nB+~ n B@o@ n B~ n BKIn B \An D'vJ?nD'vJ?nDxda@nDB69z@nB?nB?nB$^Y\@nBg[@~ nBnEwjۯs >nFH)K_>~ nA o@nA~? nA, nA nA nA nA,nA?A@ n!A2 n"An#A<@AM@$ oA oA oA oA oAoA oB) oB* oB+~ o B[@ o Bo BD A~ o B'o DZ?oDZ?oDĝPp@oD.x @oB?oB?oBf@oBPJK(@~ oBoEUD::?oF#m?~ oA@[@oAl? oA, oA oA oA oA,oA?A@ o!A2 o"Ao#A2@A:@$ pA pA pA pA pApA pB) pB* pB+~ p B@ p Bp B_B!k p D1?pD1?pDTi*@pDow;!?pB?pB?pB(_@pB ?~ pBpE%m>?pF#PP[?~ pA@pAP-C? pA, pA pA pA pA,pA?A@ p!A2 p"Ap#Ah@A@$ qA qA qA qA qAqA qB) qB* qB+~ q B[@ q Bq B .Aq B)Aq Dբ5?qDբ5?qDKQl0W@qD:gG?~ xBxESwj?xF}?~ xA@xAʥ? xA, xA xA xA xA,xA?A@ x!A2 x"Ax#AX@Aq@$ yA yA yA yA yAyA yB) yB* yB+~ y Bo@ y B~ y B؃y BU$Ay Dg>[yDg>[?yDkFxryD8?yB+y?yB+y?yB1*s2@yBOɡ?~ yByEg?yF<?~ yAo@yAX呷=? yA, yA yA yA yA,yA?A@ y!A2 y"Ay#AB@AO@$ zA zA zA zA zAzA zB) zB* zB+~ z B@ z Bz B`RAz BAz D>d̿zD>d?zDM`Sˀ,zDNp?zBzB?zBc]uC"zB8E?~ zBzE$>zF>{vs>~ zA@zA0kȰ? zA, zA zA zA zA,zA?A@ z!A2 z"Az#A@A@$ {A {A {A {A {A{A {B) {B* {B+~ { Bw@ { B~ { BH{\A{ B_A{ D1;`Q?{D1;`Q?{Dh}C!@{D.Bzj?{B/?{B/?{BSt1$#@{BK?~ {B{EH2?{F-It<?~ {Aw@{A? {A, {A {A {A {A,{A?A? {!A2 {"A{#AD@AU@$ |A |AP |A |A |A|A |B) |B* |B+~ | B@ | B~ | B$SB| B1A| DR|DR?|DV>RdJ|DDY7?|B`|B`?|BE|B38;?~ |B|E7دܘ;|FjyM <~ |A@|A ? |A,|A |AD |A |A,|A?A? |!A2 |"A|#AG@A c@$ }A }A }A }A }A}A }B) }B* }B+~ } B @ } B} B B } DM?}DM?}D$ |L@}Dl\%?}B?}B?}B޸E@}B"d<?~ }B}Ea|;}F(x ;~ }A@}AٸJـ? }A, }A }A }A }A,}A?A@ }!A2 }"A}#Ai@A@$ ~A ~A ~A ~A ~A~A ~B) ~B* ~B+~ ~ Bn@ ~ B~ BlX7AB ~ D̹Ŀ~D̹?~D21%~Dڛ?~B?~B?~Bsu`*)@~Bd2c?~ ~B~E vI?~FOM?~ ~Am@~A7? ~A, ~A ~A ~A  ~A,~A?A@ ~!A2 ~"A ~#A@@AQ@$ A  A  A  A  AA B) B* B+~  BF@  B  B TB;  D,ӛD,ӛ?DF5۟>~ Ar@Ae]G? A, A6 A7 A8 A, A A  !A2 "A9#A?@AQ@$ A: A; A: A< A=A B) B* B+~ Bv@ B: BŸB_7  DHR$ĿDHR$?D݀$D}\q?BRBR?B -DpVB5?~ BE?FZ v?~ Apv@A܇7OC? A, A>A A? A,A?A@ !A2 "A@#AI@AV@$ AA AB AA AC ADA B) B* B+~ B`m@ BA B #A B`A DNvDNv?DH=Dε:g?BڿB?Bex#8B ?~ BEn:?F4?~ A@m@Aӫ? A, AE AF AG A,A?A@ !A2 "AH#AB@AN@$ AI AJ AI AK ALA B) B* B+~ B[@ BI BClB+  DvݞĿDvݞ?D?P:8%DNآ?B lҿB l?B:l72B-+?~ BE_J?F/,?~ A@[@A˚U? A, AM AN AO A,A?A? !A2 "AP#A4@A=@$ AQ AR AQ AS ATA B) B* B+~ BP~@ BQ BkHB?T  D̗S?D̗S?Di}0@D練?BC?BC?B)@B7R5?~ BE| ?F?~ A@~@AI? A, AU AV AW A,A?A? !A2 "AX#AP@A`@$ AY AR AY AS AZA B) B* B+~ B$@ BY B@@ B ԋA Dא.X?Dא.X?DYZ@D/&~@BFĿBF?Bƪf%BfOh?~ BEf4?Fno3?~ A"@ASsr? A, AAA A, AA !A2 "A[#A@A@$ A\ A] A\ A^ A_A B) B* B+~ BA@ B\ Bff A Bw~A D<%#?D<%#?D#nP D@Duj?B_ٰ?B_ٰ?BX+NT@B'M%?~ BElyނ?FO `?~ AA@AqG? A, A` Aa A A,A?A@ !A2 "Ab#A@A$@$ Ac Ad Ac Ae AfA B) B* B+~ B@ Bc BfBB  DR?DR?DKGKN@Dv?B_?B_?B/gB@Bia?~ BEu%/C>F d?~ A@A6kfA? A, Ag Ah Ai A,A?A@ !A2 "Aj#AT@Af@$ Ak Al Ak Am AnA B) B* B+~ B@`@ Bk B`; A ByA D|ʿD|?D꛶*D5lSI?B_MտB_M?B@R4Bf]rh?~ BEDB?F@AE@$ As At As Au AvA B) B* B+~ Bȉ@ Bs Bf|>BXH  D`($ ?D`($ ?D-2/Hh/@DsjtM1?Bx?Bx?BN 4@Br-XBU?~ BEK,,?F%.`?~ A@A\ɲ? A, Aw Ax Ay A,A?A? !A2 "Az#AS@Ag@$ A{ A| A{ A} A~A B) B* B+~ B`h@ B{ B+A BƓA D*TkɿD*Tk?D"B)Dr?BY¿BY?Brt}"B]ׁ?~ BEd`R?FA s?~ A@h@A% ? A, A A A A,A?A@ !A2 "A#AA@AI@$ A A A A AA B) B* B+~ B g@ B B`>3A B`T0A D#b XοD#b X?D6aN.D+7kd&?B@?B@?B:N@BEp?~ BEŽl?F$ݡ ѕ?~ Ag@A^a`? A, A A A A,A?A@ !A2 "A#A@@AL@$ A A A A AA B) B* B+~ Bn@ B B N/%A B OK+A DXie?DXie?DU `Ҭ<@D_:?B{?B{?B-R;@B~c3y?~ BEdf'{?F]g#t?~ Am@As7?? A, A A A A,A?A@ !A2 "A#AB@AN@$ A A A A AA B) B* B+~ B@ B BrBiK  Dp'hcS?Dp'hcS?D!&_r@DP+@B@2&?B@2&?Bm'`@BQ߹V@~ BEs0zP7F7~ A@A{ 6ӟ? A, A A A A,A?A? !A2 "A#AW@Ap@$ A A A A AA B) B* B+~ B@ B BB2Bo   Dq M?Dq M?D$C@Dd >F?Bq?Bq?BmO 5@B]n?~ BEtPs?F Hg?~ A@AD՟? A, A A A A,A?A@ !A2 "A#A^@Ap@$ A A A A AA B) B* B+~ B g@ B BpAABH@  D7_?D7_?D,@DnyzM?B@^?B@^?Bѥ8i(@B?~ BEӾ?FG3p@?~ Ag@ALb? A, A A A A,A?A@ !A2 "A#A:@AI@$ A A A A AA B) B* B+~ BD@ B BpA BJA DRXo`?DRXo`?D*\vA@D?B@BB@B?B;qFBit|?~ BE7N ?F2{?~ AC@Ajcc? A, A A A A A A !A2 "A#A@A @$ A A A A AA B) B* B+~ B@ B BB^B  D}c!6D}c!6?Dr"ED)#?BL BL ?BM6-@B?C?~ BE > F=F:=~ A@A`;? A, A A A A,A?A? !A2 "A#AQ@Ah@$ A A A A AA B) B* B+~ Bt@ B B2BR2x  D(EuzӿD(Euz?D #0K3DZ>?B_2w?B_2w?BU"@B}?~ BEL#Ԣ?FdS?~ Ap@AUh1? A, A A A A,A?A@ !A2 "A#Ad@Au@$ A A A A AA B) B* B+~ B>@ B~ B3" B`Q2A D}EsпD}Es?Dx-R0Dj?B qB q?B(f3;ABCbJ?~ BEs8Qb?F ?~ A=@A? A, A A A A,A?A@ !A2 "A#A@A"@$ A A A A AA B) B* B+~ Bs@ B~ B 3 Bʲ0A DH;+?DH;+?DaL7@DB*?B!K?B!K?Bx!@B1e?~ BEPN ?F-3Wm?~ As@AKdxP? A, AA A A,A?A@ !A2 "A#AK@AW@$ A A A A AA B) B* B+~ B@U@ B BZDBJ  DQq?DQq?Dq͕<@D??BпB?BcS~0ByA?~ BEϙ?F??~ AU@A{ :]~? A, A A A A,A?A? !A2 "A#A0@A7@$ A A A A AA B) B* B+~ B@ B By"BB  DDz |ϿDDz |?Do{/DDh?B?B?BE3@B 6ޗ?~ BE7洺?F_?~ A@A`/? A, A A A A, A A !A2 "A#AG@A\@$ A A A A AA B) B* B+~ B@u@ B B`*A~ B1 Db6CDb6C?D\!D-dLv$?B_ȿB_?BDb(B\&$?~ BE I3y.?Fw'o?~ A0u@Ac? A, A A A A,A?A@ !A2 "A#AH@AV@$ A A A A AA B) B* B+~ BK@ B~ BE  BoA Do:+:Do:+:?DbDT*M?B2B2?BL^*OaB :?~ BE[lP?F(?~ AK@A8c? A, A A A A,A?A? !A2 "A#A @A(@$ A A A A AA B) B* B+~ Be@ B BvA B ?A DKNꏂ?DKNꏂ?D`*?DߤJ?Bߙ?Bߙ?B =@BޯKҺ?~ BEHi?Fu݁?~ Ae@AԪAQ? A, A A A A A A !A2 "A#A@@AH@$ A A A A AA B) B* B+~ Bd@ B BB  D/5"eD/5"e?D=zY8CDx4?BcBc?B;DB،6?~ BER 7V?F~J?~ Ad@Aϰ"? A, A A A A,A?A@ !A2 "A#A5@AB@$ A A A A  A A B) B* B+~ B@ B B CA B wF(A D'\?D'\?D 6U@D1FR7>~ A@A"&̹? A, AAA A, AA !A2 "A #Ac@A o@$DFl(2.($, ,,,,,2($$((2%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A  A  A  A AA B) B* B+~ BV@ B  B A B`A D׿D?DK#6DF Ю?BfBf?B Bt(i=?~ BEYm?Fh=m6?~ A@V@Aлe? A, A A A A, A A !A2 "A#A6@A;@$ A A A A AA B) B* B+~ Bt@ B~ B. B9k;A DqzDqz?D'^DL;?BG棿BG?BWتCBܭ@&?~ BE0?F@Ѝ?~ At@Atо? A, A A A A,A?A@ !A2 "A#AF@A@S@$ A A A A A A B) B* B+~ Bp@ B B Ʀ5A~ BK D=ϿD=?D:2 /Dn?B+?B+?B{|,@B^ M?~ BE?FU\?~ Ap@A꓂ ? A, A! A" A# A,A?A@ !A2 "A$#AC@AQ@$ A% A& A% A' A(A B) B* B+~ Bl@ B% BB  DBteDBte?DW9!D*t{?B`.B`.?B{s(BR)&c?~ BE&?Fc-s:?~ Ah@Ad*>\? A, A) A* A+ A,A?A@ !A2 "A,#A@f@Aq@$ A- A. A- A/ A0A B) B* B+~ B@P@ B- BrFB0CAA  D=w[l5+ٿD=w[l5+?D6_7DKfp]?B_ =?B_ =?B_$@B )3?~ BE#?F1V^IT?~ AP@Al!? A, A1 A2 A3 A, A A !A2 "A4#A"@A*@$ A5 A6 A5 A7 A8A B) B* B+~ B`m@ B5 B`n %A BZ6"A Dh>&ڟʿDh>&ڟ?D c*D֨7?BtBt?B3\sB x?~ BE"?Fw=I A? A@ A,A?A@ !A2 "AA#AE@AL@$ AB AC AB AD AEA B) B* B+~ Ba@ BB B@Q#A B@ A DfDf?Dq7ODAs?BCBC?BIIBؐq?~ BE2p`<$>Fv9[?~ A`a@AWUm_h? A, AF AG AH A,A?A@ !A2 "AI#A>@AD@$ AJ AK AJ AL AMA B) B* B+~ Bt@ BJ B$3B+b  Dq8Kg?Dq8Kg?DXɶAD@Dr{?B_y0?B_y0?B-θ9@BFs ?~ BElb?FXO?~ At@A_st? A, AN A" A A,A?A@ !A2 "AO#AK@AU@$ AP AQ AP AR ASA B) B* B+~ Bv@ BP B X0A B`s.A Dce Dce ?D''DRQ:?BYBY?B0y[B~b ?~ BEv Z?F~?~ Apv@AJO¾? A, AT AU AV A,A?A@ !A2 "AW#AO@A@X@$ AX AY AX AZ A[A B) B* B+~ Bu@ BX B` +A B A DoRݩDoRݩ?Dca>LDM?B0CֿB0C?B9hl5Bi|$?~ BE6Cނ?FTLO?~ Au@AJ? A, A\ A] A^ A,A?A@ !A2 "A_#AI@AT@$ A` Aa A` Ab AcA B) B* B+~ BR@ B` B̏#AB?$  DDtDDt?D&$7D DC?B@|B@|?BQu8Bbt)C?~ BEZ\/?FIA8 ?~ AR@ALՀ? A, Ad Ae Af A, A A !A2 "Ag#A"@A.@$ Ah Ai Ah Aj AkA B) B* B+~ BK@ Bh B @ BY@ D1뗸D1뗸?DC(^D D?BaHBaH?Bs HB&YZ:?~ BE/?F r?~ AK@As_77? A, Al Am An A,A?A@ !A2 "Ao#A3@A3@$ Ap Aq Ap Ar AsA B) B* B+~ B@`@ Bp B`s;A~ B)/ D{I?D{I?D{w&@Do2?BB?B)n<$PB6d`?~ BEmF(?F[ݤ?~ A `@A+? A, At Au Av AV~ A? A !A2 "Aw#A6@A@@$ Ax Ay Ax Az A{A B) B* B+~ Bp@ Bx B@ BQ[A Di?Di?Dc/j@D> @B`'?B`'?BUl'HP@B+6Zk?~ BE>!>FFo&q>~ Ah@A"N`? A, A| A} A~ A, A A !A2 "A#AS@A`a@$ A A A A AA B) B* B+~ Bi@ B B@"A~ B  D`D`?D/Di֭?B?B?Bd0&@B4U?~ BE5?Frd5J?~ Ah@A_]K$? A, A A A A, A A !A2 "A#AC@AM@$ A A A A AA B) B* B+~ Ba@ B B@>A BA D,ק^?D,ק^?D$ذK@DP?B ?B ?Bw~R@B:ke?~ BETΉ?FPS?~ A`a@A? A, A A A A, A A !A2 "A#A7@A?@$ A A A A AA B) B* B+~ B b@ B B A BnA DIq͓;DIq͓;?D60_CD?B2B2?Bmk3EB h$?~ BEs?Fl0'ኜ?~ Ab@A\R"C? A, A A A A,A?A? !A2 "A#A;@AB@$ A A A A AA B) B* B+~ B@Z@ B B A B@sA D ֊sԿD ֊s?Dpy>3D|f?Bߝ翿Bߝ?Bǫ*H BZ?~ BEf.?Fn?~ AZ@AMc? A, A A A A,A?A? !A2 "A#A9@A?@$ A A A A AA B) B* B+~ BW@ B BwA B@ c@ D1~{^D1~{^?D!+BD'z$?B@ڿB@?B@19B?~ BE̽'?F9jR9?~ AW@A[\*? A, A A A A,A?A@ !A2 "A#A7@A@@$ A A A A AA B) B* B+~ B@@ B B U0A B&A DxDx?DtyѴ5>D`fU?B]ɿB]?B+S)B,ow\?~ BEQl㟥?F}n?~ A8@AHkߢ? A, A A A A, A A !A2 "A#AV@Ad@$ A A A A AA B) B* B+~ B`h@ B~ B?r.2 B|&;A D3uJϿD3uJ?D.DQ[ ?B@B@?B/ ΘCBp"|j?~ BE| ?FfBB?~ A@h@A.0X2? A, A A A A,A?A@ !A2 "A#A8@AG@$ A A A A AA B) B* B+~ B@e@ B BB~  DikHDikH?DiJ_IDNg:?B B ?B*Ҏ6CB1>9o?~ BEwWeP?F7ŽۮB?~ A e@Ak? A, AA A A,A?A@ !A2 "A#A(@AB@$ A A A A AA B) B* B+~ B~@ B BXA~ B*6 D(z0(?D(z0(?D|D@DlT?BM?BM?BKh5@Bt޾Kq?~ BE&-~S?FM)O?~ A}@Aa? A, A A A AV~ A? A !A2 "A#AI@AZ@$ A A A A AA B) B* B+~ Bx@ B B8B?  Drn#?Drn#?DY6DҲ*@D<$"?Bu?Bu?B _ @B=[O?~ BEdS?F|e?~ Ax@A7/? A, A A A A, A A !A2 "A#A9@A\@$ A A A A AA B) B* B+~ B@ B BbBeU  D<&˿D<&?DQX+D;ߟ?BB?ByUv Bk)Q?~ BE(m?FRU1?~ A@A?>נ? A, A A A A, A A !A2 "A#A l@A0{@$ A A A A AA B) B* B+~ BT@ B B A BPmA DzښB˞?DzښB˞?D¿B>?B[/gs#B~:?~ BEroI5?F 4ϝ?~ AS@AD k? A, A A A A,A?A@ !A2 "A#A2@A:@$ A A A A AA B) B* B+~ BD@ B~ B(A BQh@ DUTDUT?D+{GD+o?BB?B(ƜGBN7X?~ BE=CM?FMt?~ AC@A@=Is? A, A A A A, A AR !A2 "A#A"@A&@$ A A A A AA B) B* B+~ B\@ B BlQABpJ  DRK4DRK4?D1U5@Dy/(3?BΒBΒ?B]/GAB(?~ BEu|/2,>Fy ?~ A\@ATO? A, A A A A,A?A@ !A2 "A#A0@A;@$ A A A A AA B) B* B+~ By@ B~ B:i B,A DtDt?Dɓy؝FDj ?B KĿB K?B7 `S%BĀQ?~ BE$çu=|?F~ ?~ Ax@Aib? A, A A A A, A A !A2 "A#AO@AY@$ A A A A AA B) B* B+~ BI@ B B A~ B@ D4h8      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`acdefghijklmnopqrstuvwxyz{|}~D4h8?DStIJD)Y?B_?B_?BDb @B#揄?~ BED7 ~?F|gG?~ AH@Afk? A, A A A A,A?A@ !A2 "A#A,@A2@$ A A A A AA B) B* B+~ Bn@ B B2A BdA D׳5qĿD׳5q?D¤!A%D LBk?BmҿBm?B1B\NkL?~ BE0'?F?~ Am@Aj#i? A, AAA A, AA !A2 "A#AP@A@T@$DrGl2(($ ,,,,$,.2.2,,,2(.$$,..(%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A  A A  A A B) B* B+~ BT@ B B@Zh!A B@.&A DqgO޿DqgO?D&8;DU0}?BժBժ?BVE BUD?~ BEAoa?F@Ѝ?~ AS@A*? A, A  A  A A, A A !A2 "A#A1@A9@$ A A A A AA B) B* B+~ Bi@ B~ B6 B 1o+t?~ BE ލ?Ff`?~ Ai@A.? A, A A A A,A?A@ !A2 "A#A3@AG@$ A A A A AA B) B* B+~ Bh@ B B \--A B@@.A DTVAٱ?DTVAٱ?D}@DF?B1?B1?B"{l~7@Bڡz?~ BE:G>FaW5?~ Ad@A$d*? A, A A A A,A?A@ !A2 "A#Ae@Aq@$ A  A! A  A" A#A B) B* B+~ B@ B  B_xq_B[?  D$zD$z?Dd@D7c@L?B,fֿB,f?Brtt5BL_?~ BE~0p >FXa%>~ A@AEo>? A, A$ A% A& A,A?A@ !A2 "A'#A]@A`j@$ A( A) A( A* A+A B) B* B+~ Bg@ B( B A B3A D~s:;?D~s:;?DERa@D08@B@t?B@t?B)vQ@B*Q,?~ BE;ZaX@?F@$r?~ Ag@A? A, A, A- A. A,A?A@ !A2 "A/#A9@AF@$ A0 A1 A0 A2 A3A B) B* B+~ B$@ B0 B_@ B@@ DѩFDѩF?Do LDtP?BB?BogOCBcMG?~ BEMci6?Fm?~ A"@A^S1|? A, A4 A5 A6 A,A?A@ !A2 "A7#A@A@$ A8 A9 A8 A: A;A B) B* B+~ BD@ B8 B$A B "A Dh3wDh3w?D/trMDpN?B2޿B2?B34}1;BRd?~ BEBc?Fކ?~ AC@Ab:q? A, A< A= A> A, A A !A2 "A?#A @A,@$ A@ AA A@ AB ACA B) B* B+~ Bw@ B@ B@+A BR&A DWxѿDWx?Di8=1Dޗ\{?B_?B_?Bz0)@B9e?~ BEN` ?FA}V?~ Aw@AG.O? A, AD AE AF A,A?A@ !A2 "AG#AI@AW@$ AH AI AH AJ AKA B) B* B+~ BK@ BH BA B pA D&P&ɴD&P&ɴ?DAJDx??BP?BP?BO@@BX ?~ BEˈ?Fm?~ AK@A2~? A, AL AM AN A,A?A? !A2 "AO#A @A,@$ AP AQ AP AR ASA B) B* B+~ BK@ BP B DA BW A Dez^9?Dez^9?Da,APz!@D_a/e?B˿B?B9+Bu>)0?~ BEt"?F:)?~ AK@An5!a=-? A, AT AU AV A,A?A? !A2 "AW#A&@A.@$ AX AY AX AZ A[A B) B* B+~ B9@ BX B`eA B`b@ DìESDìES?DRRGRD]4?BߣBߣ?BP]RB4?!?~ BE-˭b?Fs5 .?~ A8@Aki? A, A\ A] A^ A, A AR !A2 "A_#A"@A"@$ A` Aa A` Ab AcA B) B* B+~ B@p@ B` B@qA~ B9 DZ5X&U?DZ5X&U?DXߖ?D0?B?B?B]'@Bٖ?~ BE[GӶ?FM(/vU?~ A0p@As+9M? A, Ad Ae Af A,A?A@ !A2 "Ag#AL@AT@$ Ah Ai Ah Aj AkA B) B* B+~ Bg@ Bh B`Ɏ1A B`$/A Dj8¿Dj8?Di{@5#D˅,?B׿B?Bp&6B Y?~ BE\:?FnMm?~ Ag@At? A, AAA A,A?A? !A2 "Al#A6@AE@$ Am An Am Ao ApA B) B* B+~ B@P@ Bm BsA B A D{%̿D{%?D`zF,D3a\y?B`ڭ?B`ڭ?Bh@BIn?~ BEo?F)?~ AP@AV˜G\? A, Aq Ar As A,A?A@ !A2 "At#A.@A3@$ Au Av Au Aw AxA B) B* B+~ Bd@ Bu~ BS B`h-A D[D@ƿD[D@?D6Ӑ&DR%R?B?lB?l?BVH}$B{o?~ BE[Ǒu?F r.5:?~ Ad@Ax߰9? A, Ay Az A{ A, A A !A2 "A|#A<@AG@$ A} A~ A} A AA B) B* B+~ B4@ B}~ B(8 BA D[_@ D[_@ @DVDe3~#?B'B'?B ֩EB?2(?~ BE;.D>.?Ddݓ]~QD\b7?B?ڿB??B 68BDc6 ?~ BEt0?F^mh ?~ AF@A՘D\ ? A, A A A A,A?A@ !A2 "A#A$@A*@$ A A A A AA B) B* B+~ B@U@ B B@+a&A B9t,A D ;,?D ;,?D庸$;@DkeW?B ^?B ^?B>S/G@B_A?~ BEQc܌q?F?~ AU@A僧~? A, A A A A, A A !A2 "A#A1@A6@$ A A A A AA B) B* B+~ B`x@ B B f A B`A1A D؜,?D؜,?Dl[@D(c@B?B?BNޛS@BƢ޴?~ BEt}kW>F`>~ APx@A"? A, A A A A,A?A? !A2 "A#AN@A@Y@$ A A A A AA B) B* B+~ B\@ B B kA B A D@οD@?Do緡.D7S?BIBI?B9OIB-?~ BEKU?Fց'_:?~ A\@A? A, A A A A,A?A@ !A2 "A#A6@AA@$ A A A A AA B) B* B+~ B@p@ B BXQ.A~ B DeN:?DeN:?DEa@D5 ?BY¿BY?Bz"#B*q 5?~ BEB}?F_i_V?~ A0p@AV?2S? A, A A A A,A?A@ !A2 "A#A?@AO@$ A A A A AA B) B* B+~ B@P@ B BA B8A DYډ?DYډ?Dlg?DW-=#?B@@B<M?~ BE?FG?~ AP@AQ A,A?A? !A2 "A?#A2@A@@$ A@ AA A@ AB ACA B) B* B+~ B@U@ B@ B?+A B +A DxȬ?DxȬ?D3! @D?̃$?B8?B8?BOjZ(@B>/?~ BEBj?FG0tG?~ AU@A~dXd? A, AD AE AF A,A?A? !A2 "AG#A"@A4@$ AH AI AH AJ AKA B) B* B+~ B4@ BH B vA B )@ DD$DD$?DoTFDcd?B_F}ٿB_F}?B-8B;bG?~ BE2J+?Fm?~ A3@A2H7? A, AL AM AN A A A !A2 "AO#A@A@$ AP AQ AP AR ASA B) B* B+~ BR@ BP B A BA Djj?Djj?Di@Ds?Bl?Bl?B`| aB@Bp?~ BEЭu?FXwz#?~ AR@AT? A, AT AU AV A,A?A? !A2 "AW#A(@A3@$ AX AY AX AZ A[A B) B* B+~ B@o@ BX B&wB  Dr)Dr)?D6QBD-^G?B?P?B?P?B)+@BiK 3?~ BEҀM?F?~ A o@A/e;!? A, A\ A] A^ A,A?A? !A2 "A_#A?@AM@$ A` Aa A` Ab AcA B) B* B+~ B@ B` B@ Bk@ D?5׿D?5?D196D P?B_?ֿB_??B"i5Bfz8%?~ BEJ'?Fd/J%?~ A@A #? A, Ad Ae Af AV~ A? A1 !A2 "Ag#A@A@$ Ah Ai Ah Aj AkA B) B* B+~ B b@ Bh B@0$A B`A DֶDֶ?D.?BD$al?BৼӿBৼ?By>3B!'c?~ BEʩ>?F.?~ Ab@A=? A, Al Am An A,A?A@ !A2 "Ao#A7@AC@$ Ap Aq Ap Ar AsA B) B* B+~ B r@ Bp B!QB @  DoտDo?D .5DkW>?B)?B)?Baz@BZA?~ BEޒ*?Fоl?~ Ar@Al? A, At Au Av A,A?A? !A2 "Aw#A>@AS@$ Ax Ay Ax Az A{A B) B* B+~ B@_@ Bx B$A B@7A DriJ?DriJ?DU`@DJs@Bt0?Bt0?B6Ewp8@BՁ?~ BEuG3?FRU1?~ A_@A)? A, A; A| A} A,A?A@ !A2 "A~#A.@A@@$ A A A A AA B) B* B+~ B`}@ B B4B[  D^3~?D^3~?DUhLm>mR@Dc; ?Bk?Bk?B)%U@B~?~ BEHP=FhJl}p=~ AP}@AVNͼ? A, A A A A,A?A@ !A2 "A#A;@A@Z@$ A A A A AA B) B* B+~ BW@ B Bd-A B@G A D|D|?DHj>,r!DEi5?B?%?B?%?B EW @BUϤ%Y?~ BElSl?F6':?~ AW@A갑Cy? A, A A A A,A?A@ !A2 "A#A.@A6@$ A A A A AA B) B* B+~ Bi@ B Bp2A~ B DVP DVP ?DICDLD)l?B%0B%0?Bp?Br ?~ BEGʧZ?F\ׇ?~ Ah@At? A, A A A A,A?A@ !A2 "A#AB@AL@$ A A A A AA B) B* B+~ BA@ B B)BcH  D |75D |75?D1X|BDǏr ?B@k?B@k?B#.@BP*v?~ BE4#j?FRPA0?~ AA@A?uvF#? A, A A  A  A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~ B>@ B~ B3\& Bm2A DRxEzڿDRxEz?DR% 8Dk`?BYA?BYA?Bn @B]lM?~ BE房%3?F^Ŷ?~ A=@AD ? A, A A A A,A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~ Bs@ B BA B`A D3sy{?D3sy{?DbH@D^n?BԼ?BԼ?B x< @Ḃg֎L?~ BE,a?FZ\s?~ As@A>? A, A A A A,A?A@ !A2 "A#AS@AX@$ A A A A AA B) B* B+~ Bg@ B B mA B@ A DR 2?DR 2?D\EA@Dܰ?B`B`?BXB)¡?~ BEz?F=d?~ Ag@A? A, A A A A, A AR !A2 "A#AH@AM@$ A A A A AA B) B* B+~ B4@ B BZ@ B`@ DEJ@DEJ@?DqED̋9?B?B?B"?GG?B'x?~ BE8??F0pI?~ A3@A;ǶK^+? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~ B@p@ B B^ B#  Dd7d8~¿Dd7d8~?Dg##DP,6?Bi˿Bi?B32,B?V?~ BEĜ?Fh$r?~ A0p@A:{i? A, A A A A, A A9 !A2 "A#AD@AR@$ A A A A AA B) B* B+~ B^@ B B @ B y@ D=)R[D=)R[?DoJDD|?B@(}߿B@(}?BO<Bl8?~ BE`3dk?F \~?~ A]@Atoa? A, A A A A,A?A@ !A2 "A#A=@AB@$ A A A A AA B) B* B+~ B@j@ B Bg!nB^,  DukүDukү?DKMD}怮?B fB f?B;jrSf'ABj"F?~ BEJ/UA^?F^9B?~ A j@AO? A, A A A A,A?A@ !A2 "A#A@@AM@$ A A A A AA B) B* B+~ B`c@ B B Bm+E?~ BEd t?Fno3?~ A@c@A6”? A, AS A A A,A?A? !A2 "A#A6@AC@$ A A A A AA B) B* B+~ Bs@ B B 2A B i:A D{?D{?D# }G@DF6[?Bߓ)?Bߓ)?Bh1Q@B pw?~ BEh>FR8%?~ As@AR,? A, A A A A, A A  !A2 "A#AE@A@U@$ A A A A AA B) B* B+~ B@ B BCBu  D %?D %?D L#T?DL /?BؙBؙ?B0B!kq?~ BE 0?Fso?~ A@Atw? A, A A A A,A?A@ !A2 "A#Aj@Av@$ A A A A AA B) B* B+~ B$@ B B`@ B@z@ DZ9zӿDZ9z?Dg6Φ^3D!C;?B`B`?BR犨j!BUUU.?~ BED F?F[?~ A"@A%H? A, A A A A,A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~ B$@ B B\@ B`@ D[|KD[|K?DF0&CD ?BB?B7Q%@B8bT?~ BEIJvv?F%?~ A"@AklM=? A, A A A A,A?A@ !A2 "A#A@A@$DGl2,,,,,,,2,2,,,((,2,$,(2,%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA B) B* B+~  Bh@  B B]MB+  DaR]>DaR]>?DQǞuIFDf{Z?BB?BR0 Q=B^Y\?~ BELY>F2x>~ A`@A/M? A, A Aa A A,A?A? !A2 "A#AI@A]@$ A A A A AA B) B* B+~  B@Z@  B BVA B A D&3?D&3?D NsB@DmKLu?B!d¹?B!d¹?B)@B)'?~ BE^@$ A  A  A  A  A A B) B* B+~  Bo@  B  B aBk 2  D>q?D>q?DСTk7?@Dx?B_2i?B_2i?B]@B~G;?~ BE1< F ?Fb;I?~ Ao@AШ)Iվ? A, A  A A A,A?A? !A2 "A#A@@AR@$ A A A A AA B) B* B+~  B@  B B+B*  D%{2?D%{2?DЎ%E@Dk9?B[?B[?BK('Q@B}:W?~ BENmو!=F,{`v6>~ A@A8 T\? A, A A A A,A?A@ !A2 "A#A@S@Aa@$ A A A A AA B) B* B+~  BR@  B B`A BA DC1%?DC1%?D練grD@Df?B^пB^?Bޥ0B?~ BEnӄ?F=d?~ AR@A6H'1c? A, A A A A,A?A@ !A2 "A #A6@A9@$ A! A" A! A# A$A B) B* B+~  B@Z@  B! B *A BA Dx,Dx,?DW6dPD"n?B? ſB? ?BAu%B. ō?~ BEOb ?F쨇?~ AZ@Aq? A, A A A A, AA !A2 "A%#A.@A8@$ A& A' A& A( A)A B) B* B+~  B$@  B& B #@~  B42@ D/həD/hə?D"mbID?B:B:?Bʄ~b?PBad]g?~ BEon?F%?~ A"@AFu? A, A* A+ A, A, A  A !A2 "A-#A@A@$ A. A/ A. A0 A1A B) B* B+~  BT@  B. BcA B 9A Do كg?Do كg?DBu|B@DDg'?B S&?B S&?B j1@BUb?~ BEl.?FT4?~ AS@A{ ? A, A2 A3 A4 A,A?A@ !A2 "A5#A8@A<@$ A6 A7 A6 A8 A9A B) B* B+~  BK@  B6 B A B6@ DXDX?DhZhVe@DM{?B?B?Bb04lR@BU&?~ BEVD?Fm?~ AK@A? A, A: A; A< A,A?A? !A2 "A=#A,@A1@$ A> A? A> A@ AA A B) B* B+~  B@@  B>~  B1E  BQ[A  Ddjmٿ Ddjm? D<7 DW74ac? B>x? B>x? BVG?@ Bּ(S?~ B E089? FmRl?~ A8@ A{bT? A, AB AC AD A, A?A@ !A2 "AE #AR@A d@$ AF AG AF AH AI A B) B* B+~  B`h@  BF  B A~  Bk0   D R? D R? D@ Dac;? B?I<п B?I@AG@$ A[ A\ A[ A] A^ A B) B* B+~  B@P@  B[  B@Y&A  BA  DǷ4E? DǷ4E? Dӫ0TL@ D 6/j? Bk Bk? BҠ6! BS ?~ B E-$(~L? F16?~ AP@ A(|l:? A, A_ A` Aa A, A?A@ !A2 "Ab #A9@A?@$ Ac Ad Ac Ae AfA B) B* B+~  B w@  Bc BcA BA DnxDnx?D&ED܍і ?B`Z?B`Z?B?BҒ?~ BE6"0?FK?~ Aw@An? A, Ag Ah Ai A, Aj  Ak !A2 "Al#AZ@A@_@$ Am An Am Ao ApA B) B* B+~  B@U@  Bm~  BҔ B`i?A D÷ͿD÷?Da$͗-D`-C?BܽBܽ?B; oB ƒ?~ BE?~ BEPʫ?F)wM_?~ AF@ACӔ#5? A, A A A A, A  A !A2 "A#A&@A*@$ A A A A AA B) B* B+~  Bg@  B Bf^B  D&~D&~?D;!ADDQ_[ ?BB?BeL!B7pt;?~ BEΐ~?F{?~ Ag@Aiz&? A, A A A A, A  A !A2 "A#AM@AP@$ A A A A AA B) B* B+~  B.@  B B6h@ B`@ D)NR]?D)NR]?D5,@D8ۼA?BDE?BDE?B %I@Boø ?~ BE[Օx`?FѾ'?~ A,@A"}J? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B@Z@  B B@>,A~  Bz1A Dw)&?Dw)&?D.6b8@DVF?B͸B͸?B9 Bհ?~ BE?FJ?~ AZ@AUuc? A, A A A A, A  A  !A2 "A#AD@AH@$ A A A A AA B) B* B+~  BN@  B B"oA B"A DL1?DL1?DbD@D?B?B?Bi H+@B׳5?~ BEF'v?FJR`?~ AM@AdS? A, A A A A,A?A@ !A2 "A#A8@A<@$ A A A A AA B) B* B+~  BT@  B B8A BA DNAqDNAq?D?r@D=@H?B`$g?B`$g?B\~JL@BxK?~ BEKҿ?FULc?~ AS@AvGw? A, A A A A,A?A? !A2 "A#A7@A<@$ A A A A AA B) B* B+~  BW@  B BA B?A Dk~Dk~?DL)TCDvu4P?F 뭞Al?~ AW@AuHx? A, A A A A, A  A !A2 "A#A0@A9@$ A A A A AA B) B* B+~  B>@  B~  B B bA DwƃuۿDwƃu?Dyd59D6oџ?Bi?Bi?B/0F@B?~ BETr?F,RUi?~ A=@A9C`J? A, A A A A, A  A  !A2 "A#A@A @$ A A A A AA B) B* B+~  Bw@  B BwB&B  DY: ߿DY: ?DF(J<D3Z?B>?B>?BQo2@BGBi?~ BErBC]?FO `?~ Aw@A5? A, A A A A, A  A !A2 "A#AJ@AX@$ A A A A AA B) B* B+~  Bn@  B B:A B@)A Du?ԿDu??DOJ4DkRY?Bt>?Bt>?BLu?B>u?%#?~ BE+\?FM$QN?~ An@A?nSI? A, A A A A,A@A@ !A2 "A#AP@AS@$ A A A A AA B) B* B+~  BI@  B~  BtT  B@}A D-p*ܿD-p*?Dj9J:D::?B @B @?Bz!RJB\N1O?~ BE&M^?Fě)R?~ AH@A`+? A, A A A A,A?A@ !A2 "A#A0@A4@$ A A A A AA B) B* B+~  B>@  B B@ BU@ D0J?D0J?DfJ%OH@Dg?Bf?Bf?Bqz@BEљ?~ BEe8u?Frl?~ A=@AKO@? A, A A A A,A?A@ !A2 "A#A @A @$ A A A A AA B) B* B+~  Bn@  B~  B\ B5)A D9D9?DmRz0#5DJtwހ?B ^?B ^?B}4ޙ@BIc/?~ BEeG?F=d?~ An@Ar? A, A A A A,A?A@ !A2 "A#A@@AM@$ A A A A AA B) B* B+~  B@  B B`A BbA DJ-ȿDJ-?DyȊ(DR.?BhȿBh?Bw_(}(Bq?~ BE/Kt"?F^sYi?~ A@A{"l? A, A A A A,A@A@ !A2 "A#A@e@A@m@$DGl,,$.,,(.2 ,2(2$2$2.,,2.$,(,( %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A A A A A A B) B* B+~  Bs@  B  B_Bo'P   Dڪ7Ͽ Dڪ7? D8a/ D$`)%DM>)?%DNT}M%DRVU(.?%B%B?%BqyD%BfA?~ %B%Ed0?%F~N-~D@?~ %A_@%A^>/@ & B& & BQ8@& B<{@& Dޡ?&Dޡ?&D>C@&D[̦C?&BA=?&BA=?&B@QVqF@&BBv8>?~ &B&EWP?&F,Kv?~ &A=@&A~X q? &A, &A* &A &A+ &A, &A & A &!A2 &"A, &#A"@A$@$ 'A- 'A. 'A- 'A/ 'A0 'A 'B) 'B* 'B+~ ' BX@ ' B- ' B A~ ' B' D\Gm?'D\Gm?'D2s!IE2@'D]?'B 1?'B 1?'Bw(j$@'BJ?~ 'B'Esj|?'Fɷ$?~ 'AT@'A,)(? 'A, 'A1 'A2 'A3 'A, 'A ' A  '!A2 '"A4 '#A f@A0p@$ (A5 (A6 (A5 (A7 (A8 (A (B) (B* (B+~ ( BI@ ( B5 ( BخA( B !2@( DT4ۿ(DT4?(D9(D#޳?(B[ܿ(B[?(BGln:(BMb`?~ (B(E\%l`?(Fm?~ (AH@(Aآ? (A, (A9 (A: (A; (A0~ (A? ( A1 (!A2 ("A< (#A"@A&@$ )A= )A> )A= )A? )A@ )A )B) )B* )B+~ ) BR@ ) B= ) B`ϭA) B!A) DJ?)DJ?)D51υq@)Ducm@)Bu?)Bu?)B >.@)BLEw?~ )B)Eby?)FJ?~ )AR@)Aُy? )A, )AA )AB )AC )A,)A?A@ )!A2 )"AD )#A2@A6@$ *AE *AF *AE *AG *AH *A *B) *B* *B+~ * B4@ * BE * B հ@* B@* DT^ݿ*DT^?*DYI _;*D}D=?*B`Ŀ*B`?*BlU /%*B=Z+?~ *B*E` ?*F}?~ *A3@*Ae? *A, *AI *AJ *AK *A,*A?A? *!A2 *"AL *#A@A@$ +AM +AN +AM +AO +AP +A +B) +B* +B+~ + B@U@ + BM + B[/B + DPտ,?+DPտ,?+D}"?@+D?+B?+B?+Bz 7@+BHW?~ +B+E0a?+F?~ +AU@+A{1? +A, +AA +A? +A,+A@A? +!A2 +"AQ +#A&@A4@$ ,AR ,AS ,AR ,AT ,AU ,A ,B) ,B* ,B+~ , Bi@ , BR , B_FZA~ , B q|, D Y=ٿ,D Y=?,DZAKz8,D&*?,B?&ο,B?&?,B.,B2l?~ ,B,ELq?-F;j9:?~ -A@[@-AF? -A, -A_ -A` -Aa -A,-A?A@ -!A2 -"Ab -#A5@A?@$ .Ac .Ad .Ac .Ae .Af .A .B) .B* .B+~ . B@U@ . Bc ~ . B(. BA. D=7ѿ.D=7?.D1.D?f?.B?.B?.B[zq@.BTp?~ .B.E^ꣂ?.F'Z ?~ .AU@.A#Ĺ? .A, .Ag .Ah .Ai .A,.A?A? .!A2 ."Aj .#A2@A;@$ /Ak /Al /Ak /Am /An /A /B) /B* /B+~ / BR@ / Bk / B5F A/ BA/ D\4Aܿ/D\4A?/DC\:/D%R?/B_ix¿/B_ix?/B_EJ #/Bo0E?~ /B/EՆ(-?/F#$C?~ /AR@/A-Vb? /A, /Ao /A2 /Ap /A, /A  / AR /!A2 /"Aq /#A0@A5@$ 0Ar 0As 0Ar 0At 0Au 0A 0B) 0B* 0B+~ 0 BA@ 0 Br 0 BU(A0 B`A0 D$0D$?0DkD0DpuIӥ?0Bݿ0B?0B%Iaд;0BvL"?~ 0B0E|/w?0Fh$r?~ 0AA@0Afh? 0A, 0Ac 0Ac 0Av 0A, 0A 0 A 0!A2 0"Aw 0#A"@A$@$ 1Ax 1Ay 1Ax 1Az 1A{ 1A 1B) 1B* 1B+~ 1 B@P@ 1 Bx 1 B k? A1 B@vA1 DN4Rzȿ1DN4Rz?1Dʶi(1Do*YK?1Bſ1B?1B}&1B Hpu?~ 1B1E;(-?1F 4ϝ?~ 1AP@1A#5϶? 1A, 1A| 1AT 1A} 1A,1A?A@ 1!A2 1"A~ 1#A.@A6@$ 2A 2A 2A 2A 2A 2A 2B) 2B* 2B+~ 2 B$@ 2 B 2 B,@~ 2 B@2 DU)$:?2DU)$:?2DW}c&@2DT?2B 2B ?2BJBM2B%k_?~ 2B2EՁC2?2FSP?~ 2A"@2A93~? 2A, 2A 2A 2A 2A 2A 2 A 2!A2 2"A 2#A@A@$ 3A 3A 3A 3A 3A 3A 3B) 3B* 3B+~ 3 By@ 3 B 3 B^UA~ 3 BW3 DTotd3DTotd?3DATyA3Dտ?3B"T3B"T?3B($K?3BZ^H?~ 3B3Ev]t>3F>|8 >~ 3Ay@3AVN? 3A, 3A 3A 3A 3A,3A?A@ 3!A2 3"A 3#AB@AY@$ 4A 4A 4A 4A 4A 4A 4B) 4B* 4B+~ 4 B$@ 4 B 4 B(@4 B`@4 DO\c޿4DO\c?4DnX<4D?4B_9߿4B_9?4BiZA˱<4BNX?~ 4B4Ea(!?4Fź?~ 4A"@4AWsn? 4A, 4A 4A 4A 4A, 4A' 4 A' 4!A2 4"A 4#A?A@$ 5A 5A 5A 5A 5A 5A 5B) 5B* 5B+~ 5 B`c@ 5 B 5 B#A5 B`GA5 D:ѿ5D:?5DWij15DwIX?5B 05B 0?5BG5B .3?~ 5B5Ea5 !P?5FXzdYw(?~ 5A@c@5AȾ? 5A, 5A 5A 5A 5A, 5A 5 A 5!A2 5"A 5#A:@AC@$ 6A 6A 6A 6A 6A 6A 6B) 6B* 6B+~ 6 BD@ 6 B ~ 6 B{w6 BಀA6 Dg(6Dg(@6D#պDS6Drj\lX?6B 6B ?6BY[E6Bȗ T?~ 6B6EqQ n?6F+e `?~ 6AC@6AG}n? 6A, 6A 6A 6A 6A0~ 6A? 6 A1 6!A2 6"A 6#A @A"@$ 7A 7A 7A 7A 7A 7A 7B) 7B* 7B+~ 7 BH@ 7 B ~ 7 B7 B Ia:A7 D`3w7D`3w?7D:J7D۵b?7B 刺7B ?7BK 7B ,?~ 7B7ELO{?7F7ك?~ 7AD@7A>O˰? 7A, 7A 7A 7A 7A,7A?A@ 7!A2 7"A 7#Aj@Az@$ 8A 8A 8A 8A 8A 8A 8B) 8B* 8B+~ 8 B@ 8 B 8 BB'&B 8 DeO8DeO?8D;ag@8D,V?8B?ؿ8B??8Bal}{78BR,|?~ 8B8Ei *G<8F,E=~ 8A@8Ay.֑? 8A,8A 8A" 8A 8A,8A?A@ 8!A2 8"A 8#Ak@AX@$ 9A 9A 9A 9A 9A 9A 9B) 9B* 9B+~ 9 Bf@ 9 B 9 BKFB6 9 DRv׿9DRv?9DG;^69DEf; ?9B_޿9B_?9B\(G1<9BmE?~ 9B9ENj\,`?9FmIe w?~ 9A`f@9Ambdl? 9A, 9A 9A 9A 9A,9A@A@ 9!A2 9"A 9#A4@AH@$ :A :A :A :A :A :A :B) :B* :B+~ : B4@ : B : BrA~ : B,: D!@?:D!@?:DӀ5q@:DpRP@:BL:BL?:Ba N:B[#Po?~ :B:E?:F͝j?~ :A3@:A? :A, :A :A :A :A0~ :A? : A1 :!A2 :"A :#A @A"@$ ;A ;A ;A ;A ;A ;A ;B) ;B* ;B+~ ; BQ@ ; B ; B" B~ ; Dc~J;Dc~J?;DגN;Dm{2]?;BE?;BE?;BB@;BhAq?~ ;B;E~GJ?;F16?~ ;A@Q@;A=f ? ;A, ;A ;A ;A ;AF;A?A@ ;!A2 ;"A ;#A"@A0@$ <A <A <A <A <A <A <B) <B* <B+~ < B`@ < B < BY BF < Da?<Da?<D<] Z@<Deh̝@<B *?<B *?<BuVA@<Bfm0y?~ <B<E\kF)?<F]÷?~ <A`@<Auuŏ? <A, <A <A <A <A0~ <A? < A <!A2 <"A <#A:@AD@$ =A =A =A =A =A =A =B) =B* =B+~ = By@ = B = B,jA= B  A= D2,%?=D2,%?=D6'8@=D{^?=B@j?=B@j?=BF|^ȉ+@=B.ȭ3?~ =B=EzL T?=F\!1%?~ =Ay@=A>z8? =A, =A =A =A =A0~ =A? = A1 =!A2 ="A =#AX@A`@$ >A >A >A >A >A >A >B) >B* >B+~ > B\@ > B ~ > B~iD> BF$A> Dyֺ>Dyֺ?>DdwCC>D`ޔs?>B䦖?>B䦖?>BKFSظ?>BmI??~ >B>EL T?>F 뭞Al?~ >A\@>Aj&^x? >A, >A >A >A >AF~ >A? > A >!A2 >"A >#A:@A@@$ ?A ?A ?A ?A ?A ?A ?B) ?B* ?B+~ ? B>@ ? B ? B>&A~ ? BV`X? D(n@?D(n@?DDݛx@?D-#@?B 9Ͽ?B 9??Bm;/?B(?~ ?B?E!,r??F2?~ ?A=@?A |? ?A, ?A ?A ?A ?A,?A@A? ?!A2 ?"A ?#A@A@$DGl22,2,2.2,,.,(22,.(22.(.$2.@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A @A @A @A @A @A @B) @B* @B+~ @ B.@ @ B ~ @ B@ B@OA@ DBW& ?@DBW& ?@D1J\R@@Dd?@Bx?@Bx?@B%3-@@BT!?R?~ @B@E)}i?@Fh=m6?~ @A,@@A}ӄ7C? @A, @A @A @A @A @A @ A @!A2 @"A @#A@A@$ AA AA AA AA AA AA AB) AB* AB+~ A B4@ A B A B@/ AA B໌@A DAD?ADKdGIADӲR?AB.AB.?AB$aF"GAByT&z1?~ ABAEjI(Ї?AF%?~ AA3@AA? AA, AA AA AA AAg AAh A Ah A!A2 A"A A#A@A@$ BA BA BA BA BA BA BB) BB* BB+~ B B\@ B B B B^ *B)X B DR߭\jҿBDR߭\j?BDlr2BDLbۿ6?BB`BB`?BBmBB4?~ BBBEx?BF?~ BA\@BA\?? BA, BA BA BA BA0~ BA? B A1 B!A2 B"A B#A4@A>@$ CA CA CA CA CA CA CB) CB* CB+~ C BF@ C B ~ C BZ C BW^AC D#pCD#p?CDFJCDS8?CBCB?CB}ȉFCBvCV?~ CBCEb?xkM?CFB4e?~ CAF@CA鑭? CA, CA CA CA CAFCA?A? C!A2 C"A C#A@A"@$ DA DA DA DA DA DA DB) DB* DB+~ D B@U@ D B D BByB D DtaV|DDtaV|?DDT-ynODDCg?DBDB?DB4mmMDB6ͯ?~ DBDET-{>DFڨW ?~ DAU@DA;u? DA, DA DA DA DAFDA?A? D!A2 D"A D#A"@A6@$ EA EA EA EA EA EA EB) EB* EB+~ E B9@ E B ~ E BT7E B`A=AE DmD ѿEDmD ?ED 0Q1ED{Gpu?EBlEBl?EBy59:ҐGEB?~ EBEEh@J?EFMt?~ EA8@EA98uM[? EA, EAC EAD EAE EAFEA?A? E!A2 E"A E#A@A@$ FA FA FA FA FA FA FB) FB* FB+~ F Bb@ F B F B AF B@AF D&AۿFD&A?FDRn:FDZЬW?FB sjϿFB sj?FB jI/FB s?~ FBFEy?FF+?~ FAb@FAG1+? FA, FA FA FA FAgFA?A? F!A2 F"A F#A;@AD@$ GA GA GA GA GA GA GB) GB* GB+~ G B[@ G B G B`GA~ G B_xzG Ds5~%?GDs5~%?GD/Q]@@GDuaHF%>~ HAPx@HA ? HA, HAAA HAFHA?A? H!A2 H"A$ H#A>@AU@$ IA% IA& IA% IA' IA( IA IB) IB* IB+~ I B@ I B% I BB  I D?ID?ID}95@IDge?IB4Q?IB4Q?IB6X!>@IB"?~ IBIE-c>IF%R6?~ IA@IA`? IA, IAc IAc IAc IA0 IA I A I!A2 I"A) I#AT@A@g@$ JA* JA+ JA* JA, JA- JA JB) JB* JB+~ J B`c@ J B* ~ J B^J B@KAJ Dsמ6?JDsמ6?JDth@JDb?ot@@JB_q$?JB_q$?JB.LU%`@JB0yOUU@~ JBJE#"uE>JFnRG4_>~ JA@c@JAJ[!/? JA, JA. JA/ JA0 JA0JA?A? J!A2 J"A1 J#A(@A@@$ KA2 KA3 KA2 KA4 KA5 KA KB) KB* KB+~ K B@ K B2 ~ K B@K B @K DXYKDXY?KD~InQKDr`?KBlKBl?KBp*oGKBQ,=?~ KBKEr္?KFЙ?~ KA@KAt( \? KA, KA6 KA7 KA8 KA9 KA?A? K!A2 K"A: K#A@A@$ LA; LG< LA; LA= LA> LA LB) LB* LB+~ L B@P@ L B; ~ L B.L B "AL D_Ӯ;ӿLD_Ӯ;?LD}Q2LD+@B?LBp̿LBp?LB6&;,LBn?~ LBLEFI?LFm?~ LAP@LA͏? LA, LA? LA@ LAA LAg LAh L Ah L!A2 L"AB L#A*@A1@$ MAC MAD MAC MAE MAF MA MB) MB* MB+~ M BV@ M BC M B,A~ M B:|M D^Mn?MD^Mn?MD"^@MDR9@MB2T?MB2T?MBde@MBƣO"?~ MBME ?MFhKw_?~ MA@V@MA42? MA, MAG MAH MAI MA0MA?A? M!A2 M"AJ M#A.@A7@$ NAK NGL NAK NAM NAN NA NB) NB* NB+~ N BT@ N BK N B AN B *AN D9.P?ND9.P?ND~WY#?ND1=?NB?HsNB?Hs?NB;WHNBw}1?~ NBNE/h䀏b?NF?~ NAS@NA5\Ɗ9? NA, NAO NAP NAQ NA9 ~ NA? N AR N!A2 N"AS N#A2@A4@$ OAT OAU OAT OAV OAW OA OB) OB* OB+~ O B@_@ O BT O B`ZAO BR8AO D ?OD ?OD.2@OD¿>?OB}%?OB}%?OBȇ?OBKy?~ OBOEW?OF!B?~ OA_@OAVUS|{? OA, OAX OAY OAZ OA9 ~ OA? O A[ O!A2 O"A\ O#A:@AC@$ PA] PA^ PA] PA_ PA` PA PB) PB* PB+~ P Ba@ P B] ~ P B_P B AP Dz[JοPDz[J?PDE8T.PDe]ƪ?PB ?PB ?PBNg1@PB?~ PBPElFò?PF )XO?~ PA`a@PA$>? PA, PAa PAb PAc PAr PAs P Ad P!A2 P"Ae P#A=@AD@$ QAf QAg QAf QAh QAi QA QB) QB* QB+~ Q Be@ Q Bf Q B "A~ Q BQ Dր?QDր?QDu6GZ@QD@QB@?QB@?QB=8x=@@QBc2?~ QBQE]mPFޢ?QFdS?~ QAe@QAɞ? QA, QAj QAk QAl QA9 ~ QA? Q A[ Q!A2 Q"Am Q#A>@AH@$ RAn RAo RAn RAp RAq RA RB) RB* RB+~ R B@ R Bn R BK@R B`F@R D9T|RD9T|?RD#)楙GRDubX?RB `JRB `J@RBk+SRBV?~ RBREZo?RFSP?~ RA@RA &? RA, RAr RA RAs RAt RAu R Au R!A2 R"Av R#A?A?$ SAw SAx SAw SAy SAz SA SB) SB* SB+~ S BD@ S Bw S B A~ S B_ S DЖ.?SDЖ.?SD0'@SD?SBhk?SBhk?SBLu#@SB\F0?~ SBSEtPZ\?SF(ݧo?~ SAC@SA&YA? SA, SA{ SA| SA} SA SA~ S A~ S!A2 S"A S#A@A @$ TA TA TA TA TA TA TB) TB* TB+~ T B.@ T B T B{AT B`@T DTr6TDTr6?TDmJTD ?TB TB ?TBm&\p|HTBh92T?~ TBTE5z466\?TFy?~ TA,@TAXa_'? TA, TA TA TA TAt TAu T A T!A2 T"A T#A@A@$ UA UA UA UA UA UA UB) UB* UB+~ U B@ U B U B@3@U B@U D?~ UA@UAgiQ? UA, UA UA UA UA0UA?A? U!A2 U"A U#A?A?$ VA VA VA VA VA VA VB) VB* VB+~ V B9@ V B V B y*AV B` AV D=rVD=r?VD1ҟFVD?VB$VB$?VBVB?-f?~ VBVEU?VFO?~ VA8@VAnI? VA, VA VA VA VA0VA?A? V!A2 V"A V#A"@A&@$ WA WA WA WA WA WA WB) WB* WB+~ W B@Z@ W B W B@/AW B@MLAW D.x ڿWD.x ?WD7%:8WD^*$?WBi?WBi?WBfn$@WBp|?~ WBWEm??WF60?~ WAZ@WA(Դ%? WA, WA WA WA WA0~ WA? W A1 W!A2 W"A W#A<@AC@$ XA XA XA XA XA XA XB) XB* XB+~ X BD@ X B X BEA~ X BX D(J޿XD(J?XD_+}<XD\/?XB8?XB8?XBGDe6@XB3j?~ XBXE3?XFź?~ XAC@XAoJa? XA, XA XA XA XA9 ~ XA? X A[ X!A2 X"A X#A@A @$ YA YA YA YA YA YA YB) YB* YB+~ Y B$@ Y B Y B=B_`R Y DjvCYDjvC?YD&QYDJ?YB)YB)?YB)W3h"!YB,B?~ YBYE^J?YFOe?~ YA"@YAQ_ni? YA, YA YA YA YA0~ YA? Y A Y!A2 Y"A Y#A?A@$ ZA ZA ZA ZA ZA ZA ZB) ZB* ZB+~ Z Bk@ Z B Z B"'AZ B.AZ D[=?ZD[=?ZD1:n=@ZD-;C?ZBI?ZBI?ZBv>9@ZBdP_y&?~ ZBZEX~މ?ZFPS?~ ZA`k@ZA+nj? ZA, ZA ZA ZA ZAr ZAs Z As Z!A2 Z"A Z#A@@AK@$ [A [A [A [A [A [A [B) [B* [B+~ [ BF@ [ B [ B-A[ B` "A[ DZy?[DZy?[D ҂^b@[Dҕ@[B(:?[B(:?[B963@[B?~ [B[ED|?[FG0tG?~ [AF@[Ar}u? [A, [A [A [A [Ag [Ah [ A  [!A2 ["A [#A"@A&@$ \A \A \A \A \A \A \B) \B* \B+~ \ B@_@ \ B \ B ?\A~ \ B2\ Dig?\Dig?\D\aF6@\D Bi?\B??\B??\BH,|C@\B??~ \B\E[xq؎?\FFV?~ \A_@\AAE(? \A, \A \Ac \A \A0\A?A? \!A2 \"A \#A.@A;@$ ]A ]A ]A ]A ]A ]A ]B) ]B* ]B+~ ] BA@ ] B ] B@A] B`A] DH(]DH(?]Dj];P]Dϟa?]B9ƿ]B9?]BV7k']B@?~ ]B]EhU{8?]F Hg?~ ]AA@]A/]? ]A, ]A ]A ]A ]A9 ~ ]A? ] A ]!A2 ]"A ]#A@A @$ ^A ^A ^A ^A ^A ^A ^B) ^B* ^B+~ ^ BI@ ^ B ^ B@# A^ BA^ D7Q^D7Q?^DVҌxB ^D&1f?^B!@^B!@?^B;z-?^BSl?~ ^B^EUH6p?^F ;eD?~ ^AH@^AHݦ? ^A, ^A ^A ^A ^A0~ ^A? ^ A ^!A2 ^"A ^#A"@A*@$ _A _A _A _A _A _A _B) _B* _B+~ _ B>@ _ B _ B@i@_ B@7@_ DRM5?_DRM5?_DqWm$@_Dw1o?_B#?_B#?_Bb#@_B=?~ _B_EKʝБ?_F Hg?~ _A=@_A[? _A, _A _A _A _A0~ _A? _ A _!A2 _"A _#A@A$@$DGl.2$((,($((.(22..2.2,,2.$22(22`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A `A `A `A `A `A `B) `B* `B+~ ` B$@ ` B ` B@@` BuM@` Dвۖѿ`Dвۖ?`D9jX1`DNLs?`B_^?`B_^?`BӐ'f@`Bv7})}-@~ `B`Ez^?`Fȱ`xv?~ `A"@`Ag? `A, `A `A `A `A`A?A? `!A2 `"A `#A@A@$ aA aA aA aA aA aA aB) aB* aB+~ a B4@ a B a BBc@a B`@a DTaڿaDTa?aDQ9aDm+?aBϿaB?aBnFY/aB ieD$?eBߡ ۿeBߡ ?eBN_c9eB/aZ83?~ eBeE.?{zj?eFDž?~ eA\@eA=m? eA, eA eA eA eA,eA?A@ e!A2 e"A e#A9@AA@$ fA fA fA fA fA fA fB) fB* fB+~ f B b@ f B ~ f B^kf Bi4Af D,ؿfD,?fDYAw7fD'v?fB?KۿfB?K?fB.U9fBK?~ fBfEiq?fFt+1?~ fAb@fAëő? fA,fA fA fA fA,fA?A@ f!A2 f"A f#A8@AB@$ gA gA gA gA gA gA gB) gB* gB+~ g Bd@ g B g B 0Ag BnAg DFP8{?gDFP8{?gDݠyܳtE@gDp2?gB`W?gB`W?gB!8:@gBkF")?~ gBgEbD?gFj3?~ gAc@gA>ze? gA, gA gA gA gA,gA?A@ g!A2 g"A! g#A=@AF@$ hA" hA# hA" hA$ hA% hA hB) hB* hB+~ h Bt@ h B" h BϘ!B!K h D?hD?hD` _@hDFV\:@hB_v?hB_v?hB/jU>@hBjcw?~ hBhEbVm?hF O"?~ hAt@hAr`JcƦ? hA, hA& hA' hA( hA,hA?A@ h!A2 h"A) h#AF@AU@$ iA* iA+ iA* iA, iA- iA iB) iB* iB+~ i BR@ i B* i BTAi Bb3Ai D)Pv0iD)Pv0@iD 3ǂSiD??iBʗǿiBʗ?iBvPG'iB#{)?~ iBiEB{?iF=d?~ iAR@iAl"? iA, iA. iA/ iA0 iA,iA?A@ i!A2 i"A1 i#A*@A2@$ jA2 jA jA2 jA jA3 jA jB) jB* jB+~ j BA@ j B2 j B^\B j D>?jD>?jD}X@jDɽyl?jBQP?jBQP?jB"I+Z׊?@jBy* ?~ jBjE П>?jFa瑶?~ jAA@jA/ n[? jA, jAAA jA, jAA j!A2 j"A4 j#A@A@$ kA5 kA6 kA5 kA7 kA8 kA kB) kB* kB+~ k BY@ k B5 k BABRT k DRڶ2fkDRڶ2f?kD{ PPkD߮L=?kBO'kBO'?kBjzNkB%Ԙ?~ kBkE˨|7>kF d?~ kAX@kA5p8V? kA, kA kA  kA kA,kA?A@ k!A2 k"A9 k#A@A4@$ lA: lA; lA: lA< lA= lA lB) lB* lB+~ l BK@ l B: l B3uBz l D пlD ?lDVy0lD >~?lB_$ĿlB_$?lBp{$lB?~N?~ lBlE) Z?lF7ك?~ lAK@lA? lA, lA lA  lA lA,lA?A@ l!A2 l"A> l#A@A*@$ mA? mA@ mA? mAA mAB mA mB) mB* mB+~ m B@U@ m B? m BҸBږ m DfmDf?mDKmD&Ye6?mB UԿmB U?mB?L3mBQkf?~ mBmE-Q?mFb?~ mAU@mA_:aT? mA, mA mA  mA mA,mA?A@ m!A2 m"AC m#A"@A2@$ nAD nAE nAD nAF nAG nA nB) nB* nB+~ n Bb@ n BD ~ n B{P^n B.~ pA~@pA {? pA, pAW pAX pAY pA,pA?A@ p!A2 p"AZ p#AA@AZ@$ qA[ qA\ qA[ qA] qA^ qA qB) qB* qB+~ q Be@ q B[ q B`#Aq B@*Aq Dɣ?qDɣ?qDܗSQ@qD!R?qB?qB?qB7)L@qBhT!?~ qBqEzr>߉?qFPS?~ qAe@qA>O!~? qA, qA_ qA` qAa qA,qA?A@ q!A2 q"Ab q#A<@AD@$ rAc rAd rAc rAe rAf rA rB) rB* rB+~ r B@ r Bc r B pAr BaiAr D  rD  ?rDESYBrD/A?rB`#rB`#?rBEj>@rB C?~ rBrEt5=rF_ >~ rA@rA3^6? rA, rAg rAh rAi rA,rA?A? r!A2 r"Aj r#AQ@A`h@$ sAk sAl sAk sAm sAn sA sB) sB* sB+~ s Bi@ s Bk s BB)BLA s D?sD?sDA:_b@sD⾩ @sB?sB?sBT%d@sB줜B@~ sBsE A,5>sFɃJ>~ sAh@sAwt? sA, sAo sAp sAq sA,sA?A? s!A2 s"Ar s#A0@AE@$ tAs tAt tAs tAu tAv tA tB) tB* tB+~ t B l@ t Bs t B?ip!BaNA t D[?tD[?tDJf@tD cL@tB?=?tB?=?tB:H@tBxb?~ tBtE`Jh?tFDJ?~ tAl@tAd:E? tA, tAw tAx tAy tA,tA?A@ t!A2 t"Az t#A8@AH@$ uA{ uA| uA{ uA} uA~ uA uB) uB* uB+~ u B@j@ u B{ u BB** u D>#?uD>#?uDvRL@uDە2+?uBd?uBd?uBf:@uBvt+?~ uBuEv?uF1gN}H?~ uA j@uA)J3? uA, uA uA" uA uA,uA?A? u!A2 u"A u#A5@AH@$ vA vA vA vA vA vA vB) vB* vB+~ v Be@ v B v BB v D N,?vD N,?vD0PO@vDAtaY?vBe?vBe?vB>R@vB**U?~ vBvEhS?vFM)O?~ vAe@vA?ˋq8? vA, vA vA vA vA,vA?A? v!A2 v"A v#A1@AD@$ wA wA wA wA wA wA wB) wB* wB+~ w B9@ w B w B`{2@w BhO@w D?wD??wD%1HwDB?wBywBy?wBY:|WPwBSG*?~ wBwEc?wF?~ wA8@wA6"O? wA, wA wA wA wA,wA?A@ w!A2 w"A w#A"@A*@$ xA xA xA xA xA xA xB) xB* xB+~ x Bi@ x B x Bp+ A~ x BFL'x D&嘉?xD&嘉?xD@0Vh5@xD_Xq?xBw?xBw?xB@z*@xB#Xrg?~ xBxEVA?xFoـ?~ xAi@xAܖe? xA, xA xA xA xA,xA?A@ x!A2 x"A x#AB@AL@$ yA yA yA yA yA yA yB) yB* yB+~ y BD@ y B y BPm6A~ y B kZy Dl2ð(K?yDl2ð(K?yD@@ S?yD]k ?yBU?yBU?yBr $@yBr?~ yByE<9?yF ꉶ?~ yAC@yAa a? yA, yA yA yA yA,yA?A@ y!A2 y"A y#A(@A1@$ zA zA zA zA zA zA zB) zB* zB+~ z Bk@ z B z B Bh)A z DL@P3?zDL@P3?zDڊ!1@zD4-??zB_?zB_?zBj[@zBQ?~ zBzE %R?zF?~ zA`k@zAL+? zA, zA zA zA zA,zA?A? z!A2 z"A z#A2@AG@$ {A {A {A {A {A {A {B) {B* {B+~ { B@ { B { B"rUB[`5 { D@$1 {D@$1 ?{D*?B{DG?{B8z{B8z?{B&} {B;?~ {B{EMܴc?{Fj"A?~ {A@{AZ^%]? {A, {A {A {A {A,{A?A@ {!A2 {"A {#AN@A@_@$ |A |A |A |A |A |A |B) |B* |B+~ | B@P@ | B | BA| B A| D# ?|D# ?|D]D@|D̿?|B`<տ|B`}Fv,з>~ }AW@}AZ#iB? }A, }A }A  }A  }A,}A@A@ }!A2 }"A }#A$@A4@$ ~A ~A ~A ~A ~A ~A ~B) ~B* ~B+~ ~ B@Z@ ~ B ~ BDB" ~ D:mʑ~D:mʑ?~DAf`P~Dvit?~B_w~B_w?~B ՃI~B5[?~ ~B~E&y4>~F^*>~ ~AZ@~A"8? ~A, ~A  ~A  ~A ~A,~A?A? ~!A2 ~"A ~#A"@A6@$ A A A A A A B) B* B+~  BV@  B  BZ!A~  Bf  DOV;?DOV;?D5V@DZ]?B?B?Bj=@BzŹ?~ BEۭJG>?Fgh~??~ A@V@Aw_ұ? A, A A A A,A?A? !A2 "A #A&@A4@$DFl,,,($,,(,,,,(( %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A A A B) B* B+~  B l@  B ~  BqT  B = -A DVlt[DVlt[?Dٚ=Dths?B?B?B*c!()@B5?~ BE(BNʣ?F&^?~ Al@AܹË? A, AAA A, AA !A2 "A #A@@AK@$ A A A A A A B) B* B+~  B b@  B  B5ӻ4DA{B~]?B?B?Bj[7#@B`ޑ?~ BEB~?FV22?~ A@AC>`? A, A A A A,A?A@ !A2 "A #A@U@Af@$ A A A A A A B) B* B+~  B@P@  B  B@A B%A Dڂ$¿Dڂ$?D1"Dh?B]޿B]?Bs,<B 7/?~ BE&JV? A, A A A A,A?A@ !A2 "A #A @A @$ A A A A A A B) B* B+~  B@P@  B ~  Bp  B`fe A DMQDMQ?D,4CD}Y.v?B"B"?B z@BrT?~ BE@Aۥ?F]g#t?~ AP@A\? A, A A A A,A?A@ !A2 "A #A0@A5@$ A A A A A A B) B* B+~  BV@  B  B ,0A B Fq.A DepDep?D'{D~[)!?BÿB?B0" i$B67?~ BE_?FKh?~ A8@Ay` p? A, A8 A9 A: A,A?A@ !A2 "A; #A@A@$ A< A= A< A> A? A B) B* B+~  By@  B<  B|A B A Dg|Dg|?D3PPCD+h"?~ Ay@Alj⪔? A, A@ AA AB A, A  A !A2 "AC #AL@AY@$ AD AE AD AF AG A B) B* B+~  B9@  BD  BO7FB  D>etwD>etw@DoɜTD:;?B \{?B \{?BJ 0@B0 C?~ BE@P)O?F)J?~ A8@Alw ? A, AH AI AJ A,A?A@ !A2 "AK #A@A"@$ AL AM AL AN AO A B) B* B+~  B@P@  BL  B?EB{{  DпPX?DпPX?DU L@Db1?B?B?ByAwF72@B;2)?~ BEJeyo?F[T?~ AP@A΀? A, AP AQ AR A,A?A@ !A2 "AS #A1@A4@$ AT AU AT AV AW A B) B* B+~  Br@  BT ~  B& B`W.A DN_zyDN_zy?DR-2CDl>?B??B??BS*cU4@BJ[?~ BEq=?FD?~ Ar@A=p? A, AX AY AZ A,A?A@ !A2 "A[ #AH@AR@$ A\ A] A\ A^ A_ A B) B* B+~  BW@  B\  B@xA BA D$*W/ᢿD$*W/?D$70DIyE1?B?B?BX{}5@B7_Ae`?~ BE2~~?F`:?~ AW@A}? A, A` Aa Ab A,A?A? !A2 "Ac #A4@A:@$ Ad Ae Ad Af Ag A B) B* B+~  BF@  Bd ~  By BA DzG+f˽DzG+f˽?Da_Dh?BĿB?B{5}B&O%B4-?~ BE6D 4|?F%?~ AF@AwC{? A, Ah Ai Aj A,A?A@ !A2 "Ak #A@A$@$ Al Am Al An Ao A B) B* B+~  BW@  Bl ~  BbA BA DA&$ſDA&$?D%Da։?B¿B?B$a4N#B*;?~ BE`H?Fm?~ AW@A7? A, Ap Aq Ar A, A  A !A2 "As #A7@A=@$ At Au At Av Aw A B) B* B+~  B0{@  Bt  Bo.B@  D6G?D6G?DegC@D2jU5?B_?B_?Bec`G@B Z{?~ BE(z>F}.I"?~ A {@A,༿? A, Ax Ay A A,A?A@ !A2 "Az #AK@A\@$ A{ A| A{ A} A~ A B) B* B+~  B9@  B{  B}A B@'o A DTwZ}cпDTwZ}c?DKlpxC0Dc?B (ٿB (?BЦw7B=@^?~ BENjJT?F>?~ A8@Ao$? A, A A A A,A?A@ !A2 "A #A@A"@$ A A A A A A B) B* B+~  B@  B  BB$$IA  D[-:D[-:?DX#QDG) P?B`#B`#?B.R.LB]r}?~ BE;G̴:F9+.;~ A@Af? A, A A A A,A?A@ !A2 "A #AQ@A a@$ A A A A A A B) B* B+~  B@U@  B  B)r$A Bv&A Dn-5b?Dn-5b?D9#@DY\?BD?BD?BX$&@Be\Q?~ BE([@i ?F쨇?~ AU@Apc? A, Ac Ac Ac AV A  A !A2 "A #A&@A2@$ A A A A A A B) B* B+~  BA@  B  BA BA D*'9=4y?D*'9=4y?D2qz?DJ>?B`TB`T?Bn,QBCH?~ BE#?Fdl"Z?~ AA@A? A, A A A A,A?A@ !A2 "A #A@A"@$ A A A A A A B) B* B+~  B4@  B  B @ BR@ D'#u?D'#u?DcA@Dt}?B?B?BaeaJ=@BWؤ?~ BE d?F`X?~ A3@A*? A, A A A A, A  A  !A2 "A #A @A"@$ A A A A A A B) B* B+~  BN@  B  B|1A~  Bo DocпDoc?DW-kC0DK?B@пB@?B@Ư0Bn?~ BE]1E?FrH#?~ AM@A2? A, AAA A, AA !A2 "A #A @A.@$ A A A A A A B) B* B+~  BA@  B  BA B0A D VU?D VU?De^M@Dɥ e?Bγ?Bγ?B>,t @Bߺ*?~ BE^ǫ?Fno3?~ AA@APWBK? A, A A A A, A  AR !A2 "A #A@A @$ A A A A A A B) B* B+~  B@j@  B  BR B  Dy]ٿDy]?D-8D-_SC?B⏺B⏺?BtuB?~ BEJ?Fnb'v?~ A j@Aln4? A, A A A A,A?A@ !A2 "A #A7@AK@$ A A A A A A B) B* B+~  BQ@  B  B@ BS@ DuzUܿDuzU?D#=l:D >?BB?Bw);ihBЁ5k?~ BEf)*[a?F Xȍ?~ A@Q@A%%s? A, A A A A, A  AR !A2 "A #A,@A1@$D:Gl ,,2,(,,(.,2(,(.,2,22%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A A A B) B* B+~  B@e@  B  Bt&(A~  B *A DF?DF?D˿5!f$@DLԡ?B?B?B5+F@B{ڪ9?~ BEj:S?FM)O?~ A e@Aձ(? A, A A* A A,A?A@ !A2 "A #A:@AE@$ A A A A A A B) B* B+~  BY@  B  B JA B`KP A Di0>Di0>?D&33BD:9E      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcefghijklmnopqrstuvwxyz{|}~?B#?B#?B!{<@BV?~ BEݢ?Fei{C"?~ AX@A P'? A, A A A A,A?A@ !A2 "A #A1@A7@$ A A A A A A B) B* B+~  B9@  B  BF@ B2@ Ds,3?Ds,3?Db/@Dxd0鰆?B?$?B?$?B2g4@BWFC?~ BE~.?F-It<?~ A8@ALd? A, A A A A,A?A@ !A2 "A #A@A@$ A A A A A A B) B* B+~  B.@  B ~  B@ B _@ D@,?D@,?DTs@D;U#lv?BF@?BF@?BmO%S@BK;@?~ BEpgMjx?FG0tG?~ A,@A&Y~? A, A A A A,A?A@ !A2 "A #A@A@$ A A A A A A B) B* B+~  Bs@  B ~  B7~E B,A DTShDTSh?DQDv0?BB?BJrlCBtP9zt?~ BE0ե>Fbc>~ As@AGs?F闋#ua?~ A_@A%e? A, A A A A,A?A@ !A2 "A #A7@A?@$ A A A A A A B) B* B+~  B@Z@  B  B A BGA D4O/̿D4O/?DPO,D{pM&Wx?B4?B4?BXx @B+(q?~ BEr匚?F@Ѝ?~ AZ@A+P? A, A A A A,A?A@ !A2 "A #A2@A:@$ A A A A A A B) B* B+~  B^@  B  B_A B@%A D혊D혊?D0 CD=m]?BQ?BQ?B)JAK!@B9f?~ BE s?F=d?~ A]@A<{{^? A, A A" A A,A?A? !A2 "A #A3@A>@$ A A A A A A B) B* B+~  B@  B ~  BY B ^YA Dg$!&ֿDg$!&?D"5D ?B?ͿB??Bh(ַ8-B刪g9?~ BE51sl?F<Ň?~ A@A=kP? A, A A A A,A?A@ !A2 "A #AL@Aa@$ A A A A A A B) B* B+~  BW@  B  BA BA DοD?D_rc:,.DCq?BٴBٴ?B'YB%9_R>?~ BExF?FhKw_?~ AW@ACݸ$? A, A A A A,A?A@ !A2 "A #A7@A@@$ A A A A A A B) B* B+~  B@U@  B  B@WA B@A Db{?Db{?D믝@Dv{?BB?B\vۛlABTJ?~ BE,HJH?FI?~ AU@A? A, A A A A,A?A@ !A2 "A #A5@A9@$ A A A A A A B) B* B+~  Bd@  B  BP@ B>A D:7 ?D:7 ?D}T@Dd:F?BB?BBG?~ BERth?F ~~?~ Ac@AXt? A, A A A A, A  AR !A2 "A #A>@A@@$ A A A A! A" A B) B* B+~  BD@  B  BR_<B2J  DM&.?DM&.?D2u-2`@D6΍]@Bc?Bc?BQ\.Y@BZ7E@~ BE Im>F d?~ AC@AkwOW? A, A# A A$ A,A?A? !A2 "A% #A@A"@$ A& A' A& A( A) A B) B* B+~  B@  B&  B2BR  DBMj,GڿDBMj,G?D"8DK"?BV?BV?B8_V@B /?~ BE1Fu?F%?~ A@A(qB? A, A* A+ A, A,A?A? !A2 "A- #AD@A `@$ A. A/ A. A0 A1 A B) B* B+~  B9@  B.  B@pK@ B@ D.ͫD.ͫ?DF0Dȟ۰?B@LſB@L?B̸G9%BH꤃?~ BElĽ?FS=G?~ A8@A/LG~? A, A2 A3 A4 A,A?A? !A2 "A5 #A@A@$ A6 A7 A6 A8 A9 A B) B* B+~  B>@  B6  B`wi6A B E>A DrK?DrK?DZ%rGA@D?B@?B@?B%]cN@B ?~ BEZB?FV]?~ A=@AM? A, A: A; A< A,A?A? !A2 "A= #A@A&@$ A> A? A> A@ AA A B) B* B+~  B@P@  B>  B1 A BRA DWP?DWP?D9M'}@@D"1-F?BCBC?Bc˗ =Bl?~ BEw-aw?FOZ}?~ AP@Ab? A, AB AC AD A,A?A? !A2 "AE #A,@A5@$ AF AG AF AH AI A B) B* B+~  B4@  BF  B@ B @ D'D]oҿD'D]o?Dxf@2D9(?B@sB@s?BV,PB+xQ?~ BE{zt?Ffc>?~ A3@Aq>3? A, AJ AK AL Ag Ah  Ah !A2 "AM #A@A@$ AN AO AN AP AQ A B) B* B+~  B@U@  BN  BǑ-BBg9  DcpϻDcpϻ?DD T>ȭ?B;?B;?Bf@BXW?~ BE!OP:?Foـ?~ Ab@A&? A, Ab Ac Ad A,A?A@ !A2 "Ae #A.@A@@$ Af Ag Af Ah Ai A B) B* B+~  B>@  Bf  B`A B@ DqܿDq?D(K \:D/Ym?BqݿBq?BI0O;BN/?~ BEJ(h L?F>|?~ A=@A|? A, Aj Ak Al A,A?A@ !A2 "Am #A@A"@$ An Ao An Ap Aq A B) B* B+~  B.@  Bn  B`>@ B @ DaIDaI?DpDR@?B`?B`?B@k1@Bc?~ BEIo?FJ?~ A,@AJ~? A, Ar As At A, A  A !A2 "Au #A@A@$ Av Aw Av Ax Ay A B) B* B+~  BI@  Bv  BѡA BA Dqo1?Dqo1?D^[1@D68A?B$Ϻ?B$Ϻ?BK0@B0_??~ BE]cƵ?F?[a΢?~ AH@A09"? A, Az A{ A| A, A ~  A? !A2 "A} #A&@A1@$ A~ A A~ A A A B) B* B+~  B0v@  B~  B[;B`D  Dya_XS?Dya_XS?DTq/@DkA?B?4?B?4?BQ^+C%@B2t?~ BE s?Fm?~ A v@A_? A, A A A A,A?A? !A2 "A #AD@AU@$ A A A A A A B) B* B+~  B g@  B  BXvA B pA Dց$?Dց$?D[]BS@D}1Iզ?B ?B ?B"C@ByÅPN?~ BEn0i?FI?~ Ag@AG v? A, A A A A,A?A@ !A2 "A #AC@AL@$ A A A A A A B) B* B+~  BV@  B  Bk A BA DCdZݿDCdZ?D[`;;D " H?BԿB?Bl3B\G?~ BEȮ I?FH?~ A@V@AYh? A, A A A A,A?A@ !A2 "A #A2@A8@$ A A A A A A B) B* B+~  BI@  B  B,A B`(A D $ݛͿD $ݛ?DLH-DxX?B?B?Bc9N@Bce4?~ BE&<b?Fs5 .?~ AH@A}S0? A, A A A A, A  AR !A2 "A #A"@A$@$ A A A A A A B) B* B+~  B.@  B  B@ B`'5@ D{Фo?D{Фo?DKUW@Dd]0 ?Bk?Bk?B[{C:@Boc3?~ BE{r}Nh?F7ك?~ A,@A Y? A, A A A A,A?A@ !A2 "A #A@A @$ A A A A A A B) B* B+~  B9@  B  B @ B@$@ DX !?DX !?Dd[? A, A A A A, A  A !A2 "A #A1@A6@$DGl(,,((,,,,(,,2,,,2(,22,,2,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A A A B) B* B+~  B>@  B ~  Bk B@7'A D;|ӿD;|?Dp62DT ?BB?B ACBu2f?~ BEamtl?Fow8U?~ A=@A#+o? A, A A A A,A?A@ !A2 "A #A@A&@$ A A A A A A B) B* B+~  B^@  B  BJA B A DESl!ٿDESl!?DŸ7L7DfI_?B@^z?B@^z?ByWV@B gv|L?~ BEKvpY^?F^9B?~ A]@AKv? A, A A A A,A?A@ !A2 "A #AG@AI@$ A A A A A A B) B* B+~  B`@  B  B A B`X "A D-p1?D-p1?D=MJT@D81?B?B?B Z?dA@BaQR͐?~ BEyaZ?F-O$W?~ A`@A!? A, A A A A, A  A !A2 "A #A9@AD@$ A A A A A A B) B* B+~  B.@  B ~  B1 B-A D?D?Djy5@Dk,w?B5ȯ?B5ȯ?Bt!@Bg?~ BE7 p?FM$QN?~ A,@AdުtF? A, A A AE A,A?A@ !A2 "A #A"@A$@$ A A A A A A B) B* B+~  B$@  B  B `9;@ B4@ D@  B BN#@ B)J@ D*3ֿD*3?DC5DlP?BbpBbp?BrDBb֊?~ BE4z(E?FYt?~ A=@AP°? A, A\ A  A  A, A  A !A2 "A #A"@A$@$ A  A  A  A AA B) B* B+~  Be@  B ~  BfR B 4A DCɉ?BDCɉ?B?D tDBTF?B綿B?B]P B|c?~ BE؊izc?Fh$r?~ Ae@A? A,A A" A A,A?A? !A2 "A#A8@AB@$ A A A A AA B) B* B+~  BK@  B B hA B!A D;Oe?D;Oe?D't;@D#N}d?BB?Bk=X >Bsa?~ BE>I?F9jR9?~ AK@A?wی? A, A A A A, A  A !A2 "A#A$@A(@$ A A A A AA B) B* B+~  BQ@  B~  B  B,A D3?D3?D(F} @D Z?B@aпB@a?Bw0Ba%š?~ BEd?F{?~ A@Q@A? A, A A A  A, A  AR !A2 "A!#A*@A1@$ A" A# A" A$ A%A B) B* B+~  B$@  B" BM@ BB@ Dv5}ɿDv5}?D3Sy*D0C?B`B`?BJHNBq4?~ BE ?FSP?~ A"@A9m~-? A, A& A* AM A,A@A@ !A2 "A'#A@A@$ A( A) A( A* A+A B) B* B+~  B.@  B( B @ B@ D8飗ҿD8飗?Dsv =2D`+)?BN?BN?BrrSM@Bbzb?~ BES?q?FG0tG?~ A,@A? A, A, A" A- A,A?A@ !A2 "A.#A@A@$ A/ A0 A/ A1 A2A B) B* B+~  Bd@  B/ B ;A B N.A DؓDؓ?Dj>DSN-?BX]ٿBX]?Bl1MO8BNu8P?~ BE>] [S?FB4e?~ Ac@A1_ S? A, A3 A4 A5 A, A  AR !A2 "A6#A8@AD@$ A7 A8 A7 A9 A:A B) B* B+~  BK@  B7 BA B@@ DqDq?DUO/EDp?BDBD?B B6j'?~ BEPǵu?F'Z ?~ AK@A,q=? A, A; A< A= A, A  A  !A2 "A>#A.@A1@$ A? A@ A? AA ABA B) B* B+~  BK@  B? B`@ B@@ D7?D7?D{W`7@DqnBS?B_?B_?B;D@B;#{y?~ BEI4\?FaQAU?~ AK@AŠDM-? A, AC AD AE A,A?A@ !A2 "AF#A(@A,@$ AG AH AG AI AJA B) B* B+~  B$@  BG B/&@ B @ D 2?D 2?D O @Dc?B_ؿD$r>?D;7D?|*5?B (B (?BQw ?BH?~ BE\|i?FU`?~ AH@Ay39e? A, AS AT AU A, A  AV !A2 "AW#A0@A2@$ AX AY AX AZ A[A B) B* B+~  B.@  BX B@ B:@ D@>X?D@>X?D; l%@D|FHt?B?B?BZ?B{ 8?~ BE.?yP?Fn#?~ A,@Abh-!5? A, A\ A] A^ A,A?A@ !A2 "A_#A @A"@$ A` Aa A` Ab AcA B) B* B+~  BT@  B` BY7A ByA D`fD`f?D\gX#nIDA>s?B οB ?B .Bz;1?~ BE!b?FS*?~ AS@Av]m? A, Ad Ae Af A,A?A@ !A2 "Ag#A2@A8@$ Ah Ai Ah Aj AkA B) B* B+~  BK@  Bh B`qA B`LEA Ds Ds ?DDV@eGD n)?B?B??B؁׫LBު?~ BEx61?F`~nC?e?~ AK@AlU? A, AAA A, AA !A2 "Al#A@A*@$ Am An Am Ao ApA B) B* B+~  BA@  Bm B+m@ B@OA D?D?DX+@D֒I 5?B B ?Bk8wq!B| /?~ BE-;G?F#?~ AA@Aj#I? A, Aq Ar As A, A  AR !A2 "At#A @A&@$ Au Av Au Aw AxA B) B* B+~  Bx@  Bu B`A B A D27?D27?D,Ok2@DHρi?B^׿B^?B%\6BG ?~ BEC6t0]?Fj=?~ Ax@AH? A, Ay A" Az A,A?A@ !A2 "A{#AP@AW@$ A| A} A| A~ AA B) B* B+~  B@`@  B| B@f&A B ].A D>?D>?D6FaN@@Da57m?B @V6?B @V6?B@?au5#A@B`%{?~ BEEpF?F@t?~ A `@A汳? A, A A A A,A?A@ !A2 "A#A8@AB@$ A A A A AA B) B* B+~  B.@  B B@@ B@ D_1b\Z?D_1b\Z?Dq5[8D@D/Rx?Bm>;пD >m>;?D!2}0D-3d7?BH?BH?Bfp@Bߍ?~ BEvh?Fe.?~ Ae@A 76? A, A A A A,A?A@ !A2 "A#AD@AM@$ A A A A AA B) B* B+~  B@  B B @ B `uB@ DrLtRDrLtR?D[]+CD7I?B `CB `C@B6ɏSBؽ"؛?~ BE_y?F:!M?~ A@AOKk6@ A, A Ac A A, A  A  !A2 "A#A@A@$ A A A A AA B) B* B+~  B9@  B BA B`!uA D\tD\t?Da,D]o+#?B޿B?BtaD<BF?~ BE;?FjqFPC]?~ A`a@Aշch ~? A, A A A Ar As  Am !A2 "A#A5@AA@$ A A A A AA B) B* B+~  BY@  B BB\B*z  D^jaD^ja?D+ OD2|F?E?BB?BDB"5)?~ BE,>FQJ6?~ AX@A JZ+? A, AAA AFA?A? !A2 "A#A$@A6@$ A A A A AA B) B* B+~  BR@  B B`N3A B 02A DD?D_DPJ&?B_7B_7?BT BX~3?~ BEʩ?F=d?~ AR@AIy(? A, A  A  A A0~ A?  A1 !A2 "A #A(@A5@$ A  A  A  A AA B) B* B+~  BI@  B  B`lA~  B  DmEDmE?DD4[?Bȏ?Bȏ?B7+@B<ٛAk-?~ BE,F๎?FJ?~ AH@A>$:? A, A A A Ar As  A !A2 "A#A4@A8@$ A A A A AA B) B* B+~  B[@  B B XA~  B̌ Dި Dި ?D0So -PDن?B+B+?Bg 4PBG7?~ BEpZ=FY4P>~ A@[@A.;*? A, A A A A,A@A? !A2 "A#A&@A8@$ A A A A AA B) B* B+~  Ba@  B Bs#B  Dt6wDt6w?D[/PD5=?B/:B/:?BEBjxF5!?~ BEfte[>F&4{2?~ A`a@A?(m? A, A A A AFA?A? !A2 "A#A&@A@@$ A A  A A! A"A B) B* B+~  BQ@  B B6B?(  Dݮe9;ڿDݮe9;?Dub8D;?B`B`?B 3 ePB ?~ BE_w >F;/?~ A@Q@A?/3? A, AC AD AE AFA?A? !A2 "A##A @A,@$ A$ A% A$ A& A'A B) B* B+~  B@U@  B$ B jA~  BX DOƮhDOƮh?Dˋj[*OD8?BkBk?B)N?yOB! RP?~ BErrwi>Fp>~ AU@A%˜?? A, A( A) A* A0 A1  A1 !A2 "A+#A @A2@$ A, A- A, A. A/A B) B* B+~  Bb@  B, B`A B@A DQ5?DQ5?Daj C@DtXVH?B?B?B}r6@B?G?~ BEWSJÂ?F[~rn?~ Ab@AsYp? A, A0 A1 A2 Ag Ah  A  !A2 "A3#A?@AG@$ A4 A5 A4 A6 A7A B) B* B+~  BA@  B4 B`K.A~  B" DFf?DFf?DnE@D?"kT?B ̿B ?B,a*A,Bitz?~ BE^s?F7,??~ AA@A~OQ? A, A A A A,A@A? !A2 "A8#A@A"@$ A9 AP A9 A: A;A B) B* B+~  Bb@  B9 B.HBZy  DX8|-?DX8|-?D!@va@DP N,@BӿB?Bٴ&3BS3A?~ BE%P?F\!1%?~ Ab@AG^? A, A A A AFA?A? !A2 "A<#A.@AD@$ A= A> A= A? A@A B) B* B+~  Be@  B= BxA BCA D 0"{̿D 0"{?Dq 5,Dn=m?B?B?Bn".@B*}f?~ BER?F?OH?~ Ae@A3? A, AA AB AC A; A<  A= !A2 "AD#A@@AF@$ AE AP AE AF A;A B) B* B+~  BV@  BE BzȔB:?  D?~ BE2A$?F?~ AM@A@c*? A, A A A Ag A  A !A2 "AU#A @A*@$ AV AW AV AX AYA B) B* B+~  B>@  BV B\@ BX@ Di')?Di')?D9B/n;@Dc:T?B۴ͿB۴?B'/ -B/>?~ BEdr5L?F)wM_?~ AM@A5$? A, A` Aa Ab A9 ~ A?  Ac !A2 "Ad#A @A,@$ Ae Af Ae Ag AhA B) B* B+~  BD@  Be B A B0A DI0X,ֿDI0X,?D.J5DjaҪ?B n?B n?B M0Z4@BxhA?~ BE(?FZFM?~ AC@Atid? A, Ai Aj Ak A A~  Al !A2 "Am#A@A"@$ An Ao An Ap AqA B) B* B+~  BA@  Bn BF@~  BlT D1f?D1f?DEb]1Q@DH|?B?B?Bn>c;@Bs?~ BE(rM?F2{?~ AA@Ayxz? A, Ar As At A,A?A@ !A2 "Au#A*@A,@$ Av Gw Av Ax AyA B) B* B+~  BD@  Bv B@A Bu A DE6oDE6o?DIv,c>DO6/2@1?BB?B6\PB}$?~ BEb@I?Fh=?~ AC@A$ӽ(? A, Az A{ A| A A  A} !A2 "A~#A @A(@$ A A A A AA B) B* B+~  BA@  B B@ B`#A Dq(?Dq(?D^뿚Xa@Deɣ@B2?B2?BZ c?B;K?~ BEƷ{z?Fw=I@~ BEߥ?FIN?~ A"@AܶA? A, A A A A9 A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  B9@  B B RA BA DX \Է?DX \Է?DD@Dx?BE˿BE?B\,BVA?~ BE&3z?F ~?~ A8@AmУ[*? A, A A A Ar Am  As !A2 "A#A@A@$ A A A A AA B) B* B+~  BW@  B BA BA D|?D|?D:M>@D?B?B?BE"hZ@B}[4 ?~ BEdI?F(?~ AW@A ? A, A A A A A  A !A2 "A#A2@A8@$ A A A A AA B) B* B+~  B$@  B B@ @ B½@ Dr?Dr?DKu.+@DW] 8?B9?B9?BG<@B3١?~ BE˷2g?F+h͎?~ A"@AL? A, A A A A9 ~ A?  AR !A2 "A#A?A@$ A A A A AA B) B* B+~  B.@  B B`\NA B@ D36`wD36`w?Da(O?Df.k?BֿB?B͵ɹ5B!?: ?~ BE“AH?F`r-V?~ A,@Ak? A, A A A A= A>  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B9@  B BM@ B@ DſD?Dpr $\&Dh 1#l?BE?BE?BT%x E@B،?~ BE`n.V?Fm?~ A8@Axxᖰ? A, A A A A A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BT@  B BA B@vA Du9⺜Du9⺜?D֨8>D6NT?B -?B -?BKX*@B.#?~ BE^Z0?F 4ϝ?~ AS@Ao? A, AAA A, AA !A2 "A#A2@A5@$ A A A A AA B) B* B+~  BA@  B B'e@ B1_@ DdxĿDdx?DT_K%DNyǗ?BōۿBō?Bg 9BZzb?~ BE o?F凗9_?~ AA@A2K+? A, A A A A,A?A@ !A2 "A#A$@A$@$ A A A A AA B) B* B+~  BW@  B BVBn  DQK?DQK?DїLW$@D C?B@ĶB@Ķ?B3ʲB!]?~ BE:Dj~D?Fоl?~ AW@Aɀ? A, AAA A, AA !A2 "A#A3@A<@$ A A A A A A B) B* B+~  B4@  B  BzA  B@@  D?ް͆ D?ް͆@ DČ/S DZkY? Bj? Bj? Bz{2@@ Bz'.?~ B E@,ة? F?~ A3@ A}? A, A A A A, A  A !A2 "A #A@A@$ A A A A A A B) B* B+~  BD@  B  B@A~  BwW  D%pA{xҿ D%pA{x? D9`n!2 D{t2? Bٿ B? B]("=8 Bc0>?~ B E,P? FvxE ?~ AC@ A1@A? A, A A A A, A?A? !A2 "A #A$@A,@$ A A A A A A B) B* B+~  BT@  B  B@P@  B @  DWx? DWx? D:d5@ DGl? B`Ls? B`Ls? BVЃ*4@ BȰT?~ B E-Νi? FH}H?~ AS@ AߴT? A, Ac Ac Ac A, AA !A2 "A #A1@A3@$ A A A A A A B) B* B+~  B>@  B  B# @  B 1@  DěPǿ DěP? D ' DD9P4? Bf_ſ Bf_? B_(% B%?~ B EFt? F%?~ A=@ An#:C? A, A A A A, A  A  !A2 "A #A"@A&@$ A A A A A A B) B* B+~  BQ@  B  B@[A  BA  Dki ? Dki ? D:dC@ Dq]9J? B$Ϳ B$? B]502- BT?~ B EtZh&? Fm?~ A@Q@ AN? A, A A A A, A  A !A2 "A #A*@A0@$ A A A A AA B) B* B+~  B>@  B B@ B@m@ DƁԿDƁ?DM-/ 4DblTa?BB?BW/BBV?~ BEE%@?Fm?~ A=@A\0? A, A A A A,A?A@ !A2 "A#A3@A:@$ A A A A A A B) B* B+~  B.@  B B W@ B W{@ D 0ƙ?D 0ƙ?D1ƮP@D+|_K?B?B?BO~JB?~ BEK%R=FG=~ Au@A\D? A, A" A# A$ A,A@A@ !A2 "A%#A<@A@S@$ A& A' A& A( A)A B) B* B+~  BK@  B& BFA B A D*Ux"D*Ux"?D}~=D ˿?B?B?BlW7 L@BMsY?~ BEBҰ?F )XO?~ AK@AA? A, A* A+ A, A,A?A@ !A2 "A-#A&@A*@$ A. A/ A. A0 A1A B) B* B+~  B@e@  B. B.Bx$  D,D,?D/sO6LD1Wq?B@vWB@vW?Bc%*NB#.c?~ BEάC3К=F9=~ A e@AH? A, A2 A3 A4 A,A?A? !A2 "A5#A3@AA@$ A6 A7 A6 A8 A9A B) B* B+~  B9@  B6 B@)MA B A DIx4?DIx4?Dd05@D c?B`пB`?BW@0B?~ BEE].?FJ?c?~ A8@A,X? A, A: A; A< A, A  A !A2 "A=#A@A@$ A> A? A> A@ AAA B) B* B+~  B>@  B> B>9BO  DD?DALDxl;?BEu BEu @BxuyVBk^ܹ?~ BE P?FS?~ A=@AZ?}? A, A A  A A,A?A@ !A2 "AB#A@A@$ AC AD AC AE AFA B) B* B+~  B@j@  BC BCB   D>l4D>l4?DU axIDDY^-?B{̿B{?By1,BR(}?~ BE[{E?FRU1?~ A j@A*f? A, AG A* AQ A,A?A@ !A2 "AH#A3@AG@$ AI AJ AI AK ALA B) B* B+~  B g@  BI B DJ^A~  BRp D1Ôh?D1Ôh?DXDNW@D/.i?Bnk?Bnk?Bk^@BmK4@~ BE5և ?F=B?~ Ag@AKX? A, AM AN AO A,A?A? !A2 "AP#A2@AD@$ AQ AR AQ AS ATA B) B* B+~  BP~@  BQ BԩBzp@  Db8d߻Db8d߻?DyD򍄬?B!?B!?B+jW@B*5?~ BE0>FS[:~>~ A@~@AsT? A, AU AV AW A, A  A !A2 "AX#AL@A^@$ AY AZ AY A[ A\A B) B* B+~  BN@  BY B`װ*A~  B^X DՄ@DՄ@D>Ls@DZ@B`Ֆ?B`Ֆ?BrQpE@B!8?~ BE" p?FS?~ AM@Ahr&? A, A] A^ A_ A,A?A@ !A2 "A`#A@A*@$ Aa Ab Aa Ac AdA B) B* B+~  BF@  Ba BG;B  D߶ D߶ @DyHRDxx?B?B??BD`_1OBQf?~ BE,OeI`?F򮳌t?~ AF@AؖZS? A, Ae Af Ag A,A?A@ !A2 "Ah#A@A"@$ Ai Aj Ai Ak AlA B) B* B+~  BI@  Bi B@!A B`g+"A Dg#N5?Dg#N5?D!{í @D?B?B?B7[G>@BI?~ BE'o/?F ~?~ AH@A ? A, Am An Ao A,A?A? !A2 "Ap#A @A,@$ Aq Ar Aq As AtA B) B* B+~  Br@  Bq B2 B  DdGpƿDdGp?DވT.&DmF5k3}>~ A@m@A[\Z? A, A} A~ A A,A?A@ !A2 "A#A@@AM@$ A A A A AA B) B* B+~  B|@  B BZB?\G  D[rvD[rv?DQLd4RD2g?B r/B r/?B HBnH?~ BE\S}Tm<F^ɏ<~ A|@AF ? A, A A A A,A?A@ !A2 "A#AM@A@[@$D^Gl,22222 ,2($22,2,,,2($(, %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A A A A A A B) B* B+~  B9@  B  B #@  B@  D˾J? D˾J? DγZ3A@ Dl1? B? B? B1J`@ BцqXL@~ B EWCz&? F>|?~ A8@ AXFpC|? A, A A A A, A?A@ !A2 "A #A @A&@$ !A !A !A !A !A!A !B) !B* !B+~ ! BR@ ! B! B و@! Bɠ A! D~?!D~?!Dj3w+Y@!D,/m @!BM@?!BM@?!B"9zB@!B闵?~ !B!ETg=?!F h{?~ !AR@!Ad(ö? !A, !A !A !A !A, !A ! A !!A2 !"A!#A2@A8@$ "A "A "A "A "A"A "B) "B* "B+~ " B`c@ " B" B(ABS " DKX&$?"DKX&$?"Dn=eN@"D=(?"B_X?"B_X?"BEC6@"BH?~ "B"E1Tx?"F- V?~ "A@c@"A&? "A, "A "A "A "A,"A?A@ "!A2 ""A"#A=@AF@$ #A #A #A #A #A#A #B) #B* #B+~ # BD@ # B# Bs"ABp # D4Wڹ#D4Wڹ?#D]Չ #Di2?#B@ڿ#B@?#B]dCJ8#B1@$?~ #B#Eqȳ?#F[ȮW4?~ #AC@#A$Z ? #A, #A #A #A #A #A # A #!A2 #"A##A@A&@$ $A $A $A $A $A$A $B) $B* $B+~ $ B^@ $ B$ B3A$ B`IJ A$ D[t$D[t?$DOtPE$Dɭ ?$B¿$B?$B39P#$BC?~ $B$EsnA?$Fl ?~ $A]@$A&S? $A, $A $A $A $A,$A?A? $!A2 $"A$#A=@AA@$ %A %A %A %A %A%A %B) %B* %B+~ % B@`@ % B% BqCA% Bख़A% DOX6%DOX6?%DJ*D%D/Я?%BT%BT?%B>|%Bx ?~ %B%EMf3?%F&HǴ?~ %A `@%A,hL+? %A, %A %A %A %A, %A % A9 %!A2 %"A%#A8@AB@$ &A &A &A &A &A&A &B) &B* &B+~ & BT@ & B& B  A& B@}*A& D\Wt)@&D\Wt)@&Dh)ns@&D$g9@&B ?&B ?&BT`@&B[ A@~ &B&E:΅?&F!l۫?~ &AS@&AxRT ? &A, &A &A &A &A,&A?A@ &!A2 &"A&#A0@A7@$ 'A 'A 'A 'A 'A'A 'B) 'B* 'B+~ ' B |@ ' B' BLyBkJ ' DY{'DY{?'DccG'Dc?'B}S'B}S?'B 7A? 7A@ 7A,7A?A? 7!A2 7"AA7#A@A@$ 8AB 8AC 8AB 8AD 8AE8A 8B) 8B* 8B+~ 8 B@P@ 8 BB8 B`A~ 8 BA8 D@7-8D@7-?8DTU=8DTj3?8B`&տ8B`&?8BbAy48B~[r?~ 8B8EU?8F'?~ 8AP@8AA)? 8A, 8AF 8AG 8AH 8A, 8A 8 AR 8!A2 8"AI8#A&@A,@$ 9AJ 9AK 9AJ 9AL 9AM9A 9B) 9B* 9B+~ 9 B$@ 9 BJ9 B@9 B @9 D/m͐9D/m͐?9D\v)L9D Z?9B9B?9BC9B4e9?~ 9B9E,r?9FO `?~ 9A"@9A;(? 9A, 9AN 9AO 9AP 9A,9A?A@ 9!A2 9"AQ9#A@A@$ :AR :AS :AR :AT :AU:A :B) :B* :B+~ : BD@ : BR: BQA: BuA: D *Pݿ:D *P?:DAp >Aq >Ap >Ar >As>A >B) >B* >B+~ > B4@ > Bp> Bc@> B r@> DC?>DC?>D.5@>D_u?>B Á?>B Á?>B!%@>BQ?ů?~ >B>EZmF./M?~ >A3@>Ars? >A, >At >Au >Av >A, >A > A  >!A2 >"Aw>#A@A@$ ?Ax ?Ay ?Ax ?Az ?A{?A ?B) ?B* ?B+~ ? B4@ ? Bx? B @? B @? DdVտ?DdV??Dg5?D%???B??B??BkV@@?Bjwo?~ ?B?E??F⅛?~ ?A3@?A>l-? ?A, ?A| ?A} ?A~ ?A, ?A ? A ?!A2 ?"A?#A@A@$DGl,2$,2,,,(2.((,2 2,(2.(.,2222@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A @A @A @A @A@A @B) @B* @B+~ @ Bd@ @ B@ BOOJB|G @ Dbzk=@Dbzk=?@DR|>@DzJd?@B q?@B q?@BԚdû"@@B?;}?~ @B@E·h?@FKh?~ @Ac@@Aye? @A, @A @A @A @A,@A?A@ @!A2 @"A@#A,@AB@$ AA AA AA AA AAAA AB) AB* AB+~ A B@P@ A BA B` AA B AA DAD?ADU@ADCD7T?ABHzABHz?ABN5ũAB"9?~ ABAEd ?AFh=m6?~ AAP@AA0 Er? AA, AA AA AA AA,AA?A? A!A2 A"AA#A(@A.@$ BA BA BA BA BABA BB) BB* BB+~ B B b@ B B~ B BʛB BWAB D s>BD s>?BD1|7SzEBDskA?BBBB?BBaXFDBB+u?~ BBBE'ܭ|=j>BF E>~ BAb@BA2R5JT? BA, BABA BA BA,BA?A@ B!A2 B"AB#A2@A@@$ CA CA CA CA CACA CB) CB* CB+~ C B$@ C BC B@@C B@AC D%t@CD%t@CDE @CD1H@CB`n?CB`n?CB^ƑJ@CB?~ CBCE17?CF&9?~ CA"@CAчQ[? CA, CA CA CA CA,CA?A@ C!A2 C"AC#A@A@$ DA DA DA DA DADA DB) DB* DB+~ D Bd@ D BD B` AD B@#AD Dq8?DDq8?DDP&ßU@DDC߸K?DB峪DB峪?DBRXg DBTm%?~ DBDEacJ?DFS=G?~ DAd@DAڸY? DA, DA DA DA DA,DA?A@ D!A2 D"AD#AA@AG@$ EA EA EA EA EAEA EB) EB* EB+~ E B4@ E BE B@AE B`{TAE D'?ED'?ED H.:P@EDWaSc?EBEB?EBqgKEBqy?~ EBEE~fm?EFqc`?~ EA3@EAr)? EA, EA EA EA EA~ EA? E A E!A2 E"AE#A@A@$ FA FA FA FA FAFA FB) FB* FB+~ F B9@ F BF B@F B@@F DylFDyl?FD VGQFD"e?FBFB?FB%pJGFB\`m?~ FBFE=?FF%p6X?~ FA8@FAS? FA, FA FA FA FA, FA F A  F!A2 F"AF#A"@A&@$ GA GA GA GA GAGA GB) GB* GB+~ G BY@ G BG B\A~ G BiAG D<*YοGD<*Y?GD;O.GD˅&?GB.ѿGB.?GBR^0GBa̎d)?~ GBGEa?GFzp/?~ GAX@GAz!? GA, GA GA GA GA,GA?A@ G!A2 G"AG#A4@A;@$ HA HA HA HA HAHA HB) HB* HB+~ H BD@ H B~ H B.OH B33AH DWzHDWz?HD{ܿHDnaQFHQa?~ QAX@QA/@? QA, QA QA  QA  QA,QA?A@ Q!A2 Q"A Q#A*@A5@$ RA  RA  RA  RA RARA RB) RB* RB+~ R BD@ R B R B`@A~ R BQR D9x]?RD9x]?RDl3(BW@RD֫?RBz?RBz?RBBv0n[@RB@~ RBREu=j?RF!p?~ RAC@RA|;? RA, RA RA RA RA,RA?A@ R!A2 R"AR#A$@A&@$ SA SA SA SA SASA SB) SB* SB+~ S B@P@ S BS B@AS B@j"AS D#+̿SD#+?SD:4,SDmg?SBSSBS?SBnInASBbK4?~ SBSEƨ3?SF>|?~ SAP@SA0aںX? SA, SA SA SA SA0~ SA? S A S!A2 S"AS#A&@A0@$ TA TA TA TA TATA TB) TB* TB+~ T Ba@ T BT B BBk T DZ?TDZ?TD6X@TD֝e?TB_; ?TB_; ?TBje-K@TB6]?~ TBTE0Wyz`?TFh FЋ?~ TA`a@TAQ&y4_? TA, TA  TA! TA" TA,TA?A? T!A2 T"A#T#A&@A<@$ UA$ UA% UA$ UA& UA'UA UB) UB* UB+~ U B\@ U B$U B7A~ U B=&U DC?UDC?UDFϡ@UD x?UBпUB?UB\ud0UBα=?~ UBUEzO?UF.?~ UA\@UAiHبE? UA, UA( UA) UA* UA,UA?A? U!A2 U"A+U#A0@A=@$ VA, VA- VA, VA. VA/VA VB) VB* VB+~ V BD@ V B,V BvGAV B AV D"?VD"?VDOVQ@VD jc?VB)i?VB)i?VB"W _p4@VB,Q?~ VBVE$Ju?VF Hg?~ VAC@VAcwNv? VA, VA0 VA1 VA2 VA,VA?A? V!A2 V"A3V#A&@A(@$ WA4 WA5 WA4 WA6 WA7WA WB) WB* WB+~ W BF@ W B4W B`-AW BAW Dhl.EwWDhl.Ew?WD*IWDcO\?WB?,?WB?,?WB84N@WBM됁?~ WBWEhTst?WF`:?~ WAF@WA:q? WA, WA8 WA9 WA: WA,WA?A@ W!A2 W"A;W#A"@A&@$ XA< XA= XA< XA> XA?XA XB) XB* XB+~ X BK@ X B<X BY AX B׏AX D/5XD/5?XD35 ?XDƣb?XBؿXB?XB[R7XBk=I?~ XBXEmH:?XF!t&?~ XAK@XA? XA, XA@ XAA XAB XA,XA?A? X!A2 X"ACX#A @A*@$ YAD YAE YAD YAF YAGYA YB) YB* YB+~ Y B[@ Y BDY BW4Bn\ Y D@8-K?YD@8-K?YD[No5@YD;} ?YB??YB??YBha @YB;V?~ YBYE7@$ ZAL ZAM ZAL ZAN ZAOZA ZB) ZB* ZB+~ Z BW@ Z BLZ B 'A~ Z B('AZ D2^ZD2^?ZDqVZD@6{?ZBP˷ZBP˷?ZBž!ZBǓ?~ ZBZEa;?ZFso?~ ZAW@ZA4=P? ZA, ZAP ZAQ ZAR ZA,ZA?A? Z!A2 Z"ASZ#A3@A=@$ [AT [AU [AT [AV [AW[A [B) [B* [B+~ [ B.@ [ BT[ B` @[ BA[ Dk Ǯ@[Dk Ǯ@[DRS 3Dz@[DI|@[Bb?[Bb?[B1=2|C@[Bϳ 9?aF`M?~ aAM@aA!!J? aA, aA aA aA aA,aA?A@ a!A2 a"Aa#A,@A5@$ bA bA bA bA bAbA bB) bB* bB+~ b B9@ b Bb BR-@b B @b Daᯱ)?bDaᯱ)?bD'%N1@bD ?bB?C?bB?C?bB `[@bB ׶@~ bBbE@?bFO `?~ bA8@bAii4? bA, bA bA bA bA, bA b A  b!A2 b"Ab#A"@A"@$ cA cA cA cA cAcA cB) cB* cB+~ c B4@ c Bc B,@c B`#@c D&XcD&X?cDf1bBcD?cBcB?cB}9cB@ g Bg B{vAg BAg Dn"4?gDn"4?gD@gDbס ?gB?gB?gBl+ jB@gB_P~?~ gBgEg ?gF Hg?~ gA=@gAfR:? gA, gA gA gA gA, gA g A  g!A2 g"Ag#A&@A,@$ hA hA hA hA hAhA hB) hB* hB+~ h B`c@ h Bh B`z A~ h B_dh DI?hDI?hDPFcP@hDeA^Z?hB@P?hB@P?hBte\?hB-ݹ*?~ hBhEhӇ?hF e}?~ hA@c@hAQ? hA, hA hA hA hA,hA?A@ h!A2 h"Ah#AA@AF@$ iA iA iA iA iAiA iB) iB* iB+~ i BI@ i Bi B`2 Ai B v%Ai D"?iD"?iDrΫ@@iDiV?iB}?iB}?iBKyP1@iBؘ??~ iBiE9zV?mB)mB)?mB=k @mBnU?~ mBmEn?mF IL?~ mA\@mAr V4? mA, mA mA mA mA,mA?A@ m!A2 m"Am#A5@A>@$ nA nA nA nA nAnA nB) nB* nB+~ n Bb@ n Bn BLAn B!An DL?nDL?nDS B@nD冱?nB 5nB 5?nBL5v#nB:r?~ nBnE$ ?nF& }?~ nAb@nA? nA, nA nA nA nA,nA?A@ n!A2 n"An#A<@AE@$ oA oA oA oA oAoA oB) oB* oB+~ o Ba@ o Bo B0#Ao B`%&Ao D)W\z?oD)W\z?oDLc+@oD@$ uA uA uA uA uAuA uB) uB* uB+~ u B@P@ u B~ u Bu B Au D XuD X?uD BGuD(5?uBAҿuBA?uBـ41uBy~B?~ uBuEG?uF/k?~ uAP@uA\@^?a? uA, uA uA uA  uA,uA?A? u!A2 u"A!u#A,@A4@$ vA" vA# vA" vA$ vA%vA vB) vB* vB+~ v BT@ v B"v B{,B v D`T?vD`T?vDHlO@vDE@Q?vB&?vB&?vBCi S@vB|gW1?~ vBvEx??vF=@/?~ vAS@vA{? vA, vA& vA' vA( vA, vA v AR v!A2 v"A)v#A.@A8@$ wA* wA+ wA* wA, wA-wA wB) wB* wB+~ w B@ w B*w B !@~ w B@w DR?52ۿwDR?52?wDCT9wDjFǗ?wB @?wB @?wBt̓A?YL@wBQ?~ wBwE1",?wFZFM?~ wA@wA\^? wA, wA. wA/ wA0 wA, wA1 w A2 w!A2 w"A3w#A?A?$ xA4 xA5 xA4 xA6 xA7xA xB) xB* xB+~ x B`c@ x B4~ x B Ix B 7Ax Dgf%?xDgf%?xD氬 @@xDv-Ad?xB~H?xB~H?xBs3thC@xB5?~ xBxEt*M?xF8 wK?~ xA@c@xAɋҽ? xA, xA8 xA9 xA: xA, xA x A x!A2 x"A;x#A1@AA@$ yA< yA= yA< yA> yA?yA yB) yB* yB+~ y B9@ y B<y Bs@y B&@y D?ϿyD??yD*k/yD_?yB@ӿyB@?yBPб2yB#?~ yByEye?yFow8U?~ yA8@yA? yA, yA@ yAA yAB yA,yA@A? y!A2 y"ACy#A$@A&@$ zAD zAE zAD zAF zAGzA zB) zB* zB+~ z BN@ z BDz B UKAz B`α'Az D8_9?zD8_9?zDCѪ$P@zDRm@?zB?b ?zB?b ?zBð>FWF@zBg*&?~ zBzEeM ހ?zFw@~?~ zAM@zA4Ӏ? zA,zA zAH zAM zA,zA?A? z!A2 z"AIz#A"@A0@$ {AJ {AK {AJ {AL {AM{A {B) {B* {B+~ { Bv@ { BJ{ B_*fJB(F { Dۻ@{Dۻ@?{D20{DQ6-?{B ^o?{B ^o?{BΔ?{BTI) ?~ {B{EF7ZM?{Fn#?~ {Apv@{A8Ozz? {A, {AN {AO {AP {A,{A?A? {!A2 {"AQ{#A@@AV@$ |AR |AS |AR |AT |AU|A |B) |B* |B+~ | BF@ | BR~ | B,| B`oA| Dz |Dz ?|D߽J|D?|B?|B?|Bi4SD@|B]Xy)?~ |B|Euи?|F_i_V?~ |AF@|Aك\? |A, |AV |AW |AX |A,|A?A@ |!A2 |"AY|#A*@A2@$ }AZ }A[ }AZ }A\ }A]}A }B) }B* }B+~ } BI@ } BZ} B4A} B A} Dr wE}Dr wE?}Dm "C}D?}B?}B?}B1Ҫ~6@}Bc?~ }B}E2|P?}Ftp8:?~ }AH@}A(*LP? }A, }A^ }A_ }A` }A,}A?A? }!A2 }"Aa}#A(@A.@$ ~Ab ~Ac ~Ab ~Ad ~Ae~A ~B) ~B* ~B+~ ~ BA@ ~ Bb~ B A~ B A~ DL?~DL?~D:>Ñ%@~D ?~Bm?~Bm?~B[5J?~Bu ?~ ~B~E~c?~F?~ ~AA@~A2&b? ~A, ~Af ~A ~Ag ~A,~A?A? ~!A2 ~"Ah~#A&@A*@$ Ai Aj Ai Ak AlA B) B* B+~  B$@  Bi B @ BhI@ D}?D}?D[ B@Dq=?Bj?Bj?Bmغ`F@BY1)?~ BE6ɺ?F/Ant?~ A"@AH~s? A, Am An Ao A0~ A?  Ap !A2 "Aq#A?A@$DGl2,2,2$2(,,(,,2(,,,($..,((,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ Ar As Ar At AuA B) B* B+~  B@j@  Br B B/1  D\ L.οD\ L.?D-'.DX,?B@Š?B@Š?BmM>!@B(ya?~ BE?Fm?~ A j@AȋbT? A, Av A Aw A,A?A@ !A2 "Ax#A@@AK@$ Ay Az Ay A{ A|A B) B* B+~  B@  By~  B@ B@ DgҐ?DgҐ?D0ÿo1@DTŒ?BDBD?B!aДJB -?~ BE&%?Fl ?~ A@AVri? A, A} A~ A A, A  A !A2 "A#A?A@$ A A A A AA B) B* B+~  B9@  B B@ڏ@ B H@ D=Wn' D=Wn' ?D_)BKD©xL?BVBV?B q fHBGrb?~ BE ?F-O$W?~ A8@AxL? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BW@  B By B )  D FD F@D[`TDI?BB?B%TVPB Z?~ BEM½[p>FUgeg >~ AW@AFW? A, AC AD AE AFA?A? !A2 "A#A@A3@$ A A A A AA B) B* B+~  B4@  B BOKRB}B(  D0RԀD0RԀ?DYIDoUO?BgSBgS?B,NEB}}?~ BEMTUI?FzCl?~ A3@A^? A, AC AD AE AFA?A? !A2 "A#A@A@$ A A A      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdeghijklmnopqrstuvwxyz{|}~ A AA B) B* B+~  B.@  B B`4A BP A DVDV?D_uF4@De\MԠ?B B ?Bc_WPB<>Iɤ?~ BEF#)?Fm?~ A,@A..w? A, AC AD AE AFA?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  BT@  B B Bp%rA  DG-EYDG-EY?D-.PDyv?B gB g?BtoݠnIBWq_Ker?~ BEZiŷ?FyY ??~ AS@A< ? A, ALA AM AFA@A? !A2 "A#A@A1@$ A A A A AA B) B* B+~  BI@  B BڞBJ7  DjRDjR?D\_OD7G?BdBd?BYFB(L?~ BEm;?F'K0A?~ AH@A0/? A, A A A AFA?A? !A2 "A#A@A$@$ A A A A AA B) B* B+~  BD@  B B; ooB6  DGDG?D:HD '?B B ?B#VEBW?~ BEYme?FU&?~ AC@Aׇ? A, A A A AFA?A? !A2 "A#A@A$@$ A AI A A AA B) B* B+~  B.@  B~  B BEA D<D@  B B A B mA DŰuFn?DŰuFn?DqP3@DDX?BtBt?Bcz@Bvt?~ BEa ?F7%?~ A=@Ar? A, A A A A= A>  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BW@  B B0BUg  DlDl?DcR̫NDɠV.6?BB?B(\IFBC|q?~ BE fz>F%R6?~ AW@AKTR? A, A A A AFA?A? !A2 "A#A&@A3@$ A A A A AA B) B* B+~  B[@  B BBy  DXpDXp?D_ED*C ?BB?BIA՚FBǘe m?~ BE)>F0 ?~ A@[@A[T? A, A A A AFA?A? !A2 "A#A"@A8@$ A A A A AA B) B* B+~  B9@  B B@W A B+(A DfmV >DfmV >?Dr8qBDhk2?B@(ٿB@(?B"7B`7&^?~ BEH p?F>-I?~ A8@A>O*? A, A A A AA?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  BW@  B BB~1   Dq0A]Dq0A]?Da)QDWYw?BE1BE1?B x89 NB(u<ˍ?~ BE#MH">F؍r>~ AW@AR1v? A, A A A AFA?A? !A2 "A#A@A5@$ A A A A AA B) B* B+~  BF@  B BRB  DK6]DK6]?DFŨVED]CmW?B`B`?B-9 FEB:b?~ BEuH=i?Fq2P?~ AF@AR]? A, A A A A, A  A1 !A2 "A#A@A"@$ A A A A AA B) B* B+~  BW@  B B`=A B`?A D~?D~?Dښw@D(9G?B?7B?7?Bg|lB?~ BE7S1 ?F7,??~ AW@AB׋R? A, A A A A0~ A?  A !A2 "A#A*@A5@$ A A A A AA B) B* B+~  B4@  B B@Ce@ B@U@ Dg]?Dg]?DoQ@D_&#|?B_?B_?BxjV@BE?~ BETm ?F!t&?~ A3@AĽ? A, A A A A~ A?  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BA@  B~  BR B@FA D0˿D0?DdU,D2L㋩?B@wѿB@w?B_T<1B]C |?~ BEe?F-D3{?~ AA@AZ>? A, A A A A A  A !A2 "A#A @A"@$ A A& A A  A A B) B* B+~  B$@  B B)y@ B )(@ D*vl?D*vl?DsB@DL09?BB?BB?B'wC;@BHFͼ\?~ BE9#꒧?Fm?~ A"@A/ǟ? A, Ac Ac Ac A0 A  A  !A2 "A #A?A@$ A  A  A  A AA B) B* B+~  B4@  B  B8@ B:%@ D<]ND<]N?DF-~D/ׄ?BWB?BWB?B&;@BQw?~ BEݢ̮?F?~ A3@A4K? A, A A A A0A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  BF@  B~  BY BA DRDR?DuhB>DDP.?B?=B?=?B:GRQ@B7n0?~ BEI>Yb^?F>?~ AF@Axe9B? A, A A A A0A?A? !A2 "A#A,@A3@$ A G A A AA B) B* B+~  BN@  B BMA B A Di8Di8?Dĝ DvRO?B]B]?BԘ?=BA+Wr?~ BE]p`J!?FOM?~ AM@As; ? A, AAA AFA?A? !A2 "A #A(@A.@$ A! A" A! A# A$A B) B* B+~  BK@  B! B7KBf  D8?D8?Dm-@D L1f?B?B?BB H1@B㌸b?~ BEv@  B) B @ B@|@ D-:8D-:8?D5H~XEDOjV"?B B ?BMSlDB>5?~ BE@?F|e?~ A=@Aۍ:? A, A- A. A/ Ag Ah  A  !A2 "A0#A$@A&@$ A1 A2 A1 A3 A4A B) B* B+~  B4@  B1 B bb!A B`Q-A D3;+?D3;+?DWZQ@D4bY?B ?B ?B Ch6@B5^{ݨ?~ BE_?F.gC?~ A3@A^VC? A, A5 A6 A7 A0~ A?  A !A2 "A8#A@A @$ A9 A: A9 A; A<A B) B* B+~  B$@  B9 B@ BY@ DH6DH6?D{ζGD?BxDBxD?B+ABw A? A0A?A? !A2 "A@#A@A@$ AA AB AA AC ADA B) B* B+~  BN@  BA B| A~  Bg. DmЁ@DmЁ@Db7@D{Ie!@B?B?BRR@Bg,?~ BEuA+e?FW{w?~ AM@AHA? A, Ac AE AF A0~ A?  A1 !A2 "AG#A*@A.@$ AH AI AH AJ AKA B) B* B+~  BN@  BH BpA BA D<8iD<8i?D]pN@D7ׇU?B_*{ԿB_*{?B*3BًI?~ BEOj '?F;}?~ AM@Aq8lL? A, AL AM AN A0~ A?  A !A2 "AO#A,@A0@$DnGl.2,2,,2,$22.2,($22,.%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ AP AQ AP AR ASA B) B* B+~  B.@  BP B@x@ B}\A DWF?DWF?D"Nsf@D n@Bo?Bo?B36@B @??~ BEw?F`X?~ A,@A{N6? A, AT AU AV A A  AW !A2 "AX#A@A@$ AY AZ AY A[ A\A B) B* B+~  B$@  BY B @ B@ D.D.?D%#!DzA?B ?B ?Bc2ֆ@BIN'?~ BEF2?F[ݤ?~ A"@AW? A, A] A^ A_ A A  A` !A2 "Aa#A@A@$ Ab Ac Ab Ad AeA B) B* B+~  BA@  Bb B`umA B@]A DPYDPY?DZ=DkA?B [aݿB [a?B\'A;B|RG?~ BE0ֈ?F`X?~ AA@AQ|? A, Af Ag Ah A,A?A? !A2 "Ai#A"@A&@$ Aj Ak Aj Al AmA B) B* B+~  B@_@  Bj BI$A B@L#A D/PuD/Pu?D@)Dfp?B_ ?B_ ?B6I@B}?~ BE)o?Fg,?~ A_@Aj$? A, An Ao Ap A A  Aq !A2 "Ar#A9@A<@$ As At As Au AvA B) B* B+~  BD@  Bs BA B %@ D̿^D̿^?D}QDQDL?B@߿B@?B$W<BvM\?~ BEu@?F/k?~ AC@Ap8E? A,A AwA A,A?A@ !A2 "Ax#A3@A3@$ Ay Az Ay A{ A|A B) B* B+~  B9@  By B.@~  B`"A DP0?DP0?DZ—U@D d?B`?B`?BT+@BFX[ɻ3?~ BE T!V?F`X?~ A8@A?b? A, A} A~ A A, A  AR !A2 "A#A&@A*@$ A A A A AA B) B* B+~  B9@  B B@ B`hA D`@D`@D&jVa|@Dp)@B\?B\?Bjp { J@Ba;V?~ BE^l?FVL?~ A8@A_4W? A, A A A A,A?A@ !A2 "A#A @A&@$ A A A A AA B) B* B+~  B@  B B @ BG@ D V]?D V]?Du#m@D~L @B@9@B@9@Bٟ@Be^©>@~ BEz+;?F C?~ A@A@ A, A A" A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B9@  B BBjȭ  Dku@Dku@DӺ@Dh~hU@BsBs?BABa5-?~ BE.Q-4?FĤ ?~ A8@AxbO%? A, A A A A A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BA@  B B` A B@<{"A Due?Due?Df^8N@D?B"B"?B$cT?BOo?~ BEkH(%?FZFM?~ AA@A3? A, A A A A,A@A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B$@  B Bd@ Bͥ@ DvhU+DvhU+?DV3D~6+?BiؿBi?B73;7B"j?~ BEt?FKh?~ A"@AwUp? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  BA@  B~  Bs  B fA Dx6C߿Dx6C?D"=DV(?B~QڿB~Q?B.8B2C?~ BE]h?F\?~ AA@A#? A, A A A A,A?A@ !A2 "A#A@A @$ A A A A AA B) B* B+~  BR@  B B`4A~  B& D&?D&?Ddo@DmA @Bo?Bo?Bf G@BpK?~ BEӾ&Τ?FJb%kU?~ AR@A$? A, A A A A,A?A@ !A2 "A#A2@A9@$ A A A A AA B) B* B+~  BA@  B BA B 'A DMtEz?DMtEz?DrFLUT@D d?B ?B ?BV -@BK>R?~ BEۣh?F?ȓQ?~ AA@Ah? A, A A A A, A  A !A2 "A#A@A&@$ A A A A AA B) B* B+~  BQ@  B B"qBb  D2D2?D|PDyn?B?uB?u?BQۑKBz,?~ BE)M>F%>~ A@Q@Ax? A, A A  A  A,A?A@ !A2 "A#A@A,@$ A A A A AA B) B* B+~  BF@  B B*`B  Ds;`Ds;`?DlA$ED;`;,@BO?=J?~ BET?`B>?FOM?~ A8@AdR? A, A A A A, A  AR !A2 "A#A@A@$ A A A A AA B) B* B+~  BT@  B B:ABkeS  D/t?D/t?DL><@DS?B9?B9?B3>s!@B>P]?~ BE 6"?FA?~ AS@Af4? A, A A A A,A?A@ !A2 "A#A*@A1@$ A A  A A AA B) B* B+~  BV@  B B A~  B6 D>M?D>M?D\?C1S@DfH?B/?B/?B_O8@B?~ BEU*?Fm?~ A@V@AԆ? A, A A A AA?A@ !A2 "A#A"@A5@$ A A A A AA B) B* B+~  BQ@  B B@ӬA Bz A DtCg?DtCg?DW2oq3@DOEf?Bt?Bt?BmĒQ@Bt?~ BEYޅҟ?Fgn2?~ A@Q@AA[^#? A, A A A A,A?A@ !A2 "A#A,@A1@$ A A A A AA B) B* B+~  BD@  B B @ Bݮ@ Du?Du?Dzüƃ/@D8?B?B?BC@Bѫ?~ BEt~?BL?BL?B7>.@B n?~ BE/ӠP?F 뭞Al?~ AC@A&@? A, A) A* A A,A?A? !A2 "A#A@A(@$ A A A A AA B) B* B+~  B[@  B B ;a_A~  B:O DD?DUiټDKv?B?K?B?K?BrV0@BlIKB?~ BEDwkCo?F7ك?~ A@[@A+⤫? A, A  A! A" A,A?A? !A2 "A##A(@A9@$ A$ A% A$ A& A'A B) B* B+~  BF@  B$ Bq0A Bs*A DKmԿDKm?Df4Dd~U?BDпBD?B0BCIHң?~ BEcB?FJ?~ AF@Aeɨ? A, A( A A) A,A?A? !A2 "A*#A@A(@$ A+ A, A+ A- A.A B) B* B+~  BR@  B+ B^A BA D4@G?D4@G?D՞G7?Dˮn;?BֿB?BQL%F45BǢ6?~ BEY.!?Ff箮?~ AR@A? A, A/ A0 A1 A,A?A@ !A2 "A2#A8@A<@$ A3 A4 A3 A5 A6A B) B* B+~  Bd@  B3 B`W>A B2A Dc"pDc"p?D秗vCD-k$?BuֿBu?Br&֒5BEY?~ BErt&?FPS?~ Ad@A? A, A7 A8 A9 A,A?A? !A2 "A:#A8@AE@$DGl22,2$.,,$,,((22(,,(,, 2(,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A; A< A; A= A>A B) B* B+~  B.@  B; B@ Bފ@ DۋDۋ?D0FFDWk?B`B`?BZήKBn4-h?~ BEpT?FOZ}?~ A,@AGR0? A, A? A@ AA A, A  A !A2 "AB#A@A@$ AC AD AC AE AFA B) B* B+~  B.@  BC B`@ B@ D Oo?D Oo?D["SqQ@DZO)?B&A D3͚?D3͚?DuLlP@D?BJBJ?B&g!B>7b?7?~ BEm ٚ?F@Ѝ?~ AM@AsD? A, Ah Ai Aj A,A?A@ !A2 "Ak#A$@A2@$ Al Am Al An AoA B) B* B+~  BR@  Bl B A BA D|oӿD|o?DRo3D[?Bޥ?Bޥ?B<$1<@Bݏ$]]?~ BE|G_?FO?~ AR@Ar~_? A, Ap Aq Ar A, A  A !A2 "As#A,@A2@$ At Au At Av AwA B) B* B+~  B>@  Bt Bm@ Bm-A Dwh0?Dwh0?Ds_>KN@Dg\t?B @`ѿB @`?BPS0Bxuޜ?~ BEf)w?F%?~ A=@A2F? A, Ax Ay Az A, A  A !A2 "A{#A @A&@$ A| A} A| A~ AA B) B* B+~  Bt@  B|~  B̿MA B #A DлR-DлR-@DpևTTD: n?BA"BA"?BͦK CB9@?~ BE'^eKV>FÑ>~ At@AƓJ`? A, A A A A,A?A@ !A2 "A#AF@A@T@$ A A A A AA B) B* B+~  BK@  B B A BɨA Dr?Dr?DcG@DL?B\ ?B\ ?B)gVNUF@B%ǧ%?~ BE) ?F)2 ?~ AK@A nIp? A, A A A A,A?A@ !A2 "A#A.@A1@$ A A A A AA B) B* B+~  B@  B B@@ B౲@ D8vpD8vp?DPRD5n?B_ B_ @BBEVVB%?F6G>? ?~ A@AM^'@ A, A A A A0~ A?  A1 !A2 "A#A?A?$ A A A A AA B) B* B+~  BW@  B~  B@JA B~^A D\}ĿD\}?DL%Dx硣?B?6t?B?6t?BĂ)4@BmRwMT?~ BE~?FTC^9u?~ AW@A5-Չ? A, AAA A, AA !A2 "A#A6@A@@$ A A A A AA B) B* B+~  BQ@  B B @ B`A D 2X?D 2X?DNho\Q@Dla?B?B?BCRMiJ@BA}?~ BEUʵ?F#PP[?~ A@Q@AW? A, A A A A,A?A? !A2 "A#A4@A9@$ A A A A AA B) B* B+~  Bd@  B BB~:A BD3A DP#'ۿDP#'?Dݞez9D=?B2ʿB2?BX03+BJ ?~ BEG"?Fݓ?~ Ad@AioW? A, A A A A,A?A? !A2 "A#A6@AD@$ A A A A AA B) B* B+~  B^@  B BuA B A Dek?Dek?DfBI@DAHR2?B@9@  B B ;4A B@A DMD\?DMD\?D9+|$@D H?B?*C?B?*C?B/OLE@BhKˡ?~ BEK@/?Fq/?~ A=@Ajѝ3E? A, A A A A,A?A@ !A2 "A#A@A&@$ A A A A AA B) B* B+~  B@U@  B B@?A BH A D=]?D=]?D5@ B@@ D0iD0i?DI DDh^>?B?B?Bqj&@B=۝?~ BE%r?Fno3?~ A,@A:? A, A  A  A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B$@  B BG@ B`܀@ Dr͊8޿Dr͊8?D+;;D&CSNQ?BB?Bw7BcivD?~ BEkkQYv?Fe}#x?~ A"@A_? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B@U@  B BOh?Bc3  D}3y6ӿD}3y6?D f J3Dcӣ?B_ۿB_?B-:Bne?~ BE$rz- ?FcL^M?~ AU@AfJ? A, A A A  A,A?A? !A2 "A!#A1@A7@$ A" A# A" A$ A%A B) B* B+~  B@_@  B" B@ _A BIA D!bYo?D!bYo?D _C@Dn[B??BȿB?By)')B?~ BE10 ?F 4ϝ?~ A_@AHfa? A, A& A' A( A,A?A@ !A2 "A)#A@@AB@$ A* A+ A* A, A-A B) B* B+~  B$@  B* B@ B3@ D`{ͿD`{?D.-Dz+G?B@B@BXEZ@Bv/@~ BEn!?F A? A@ A, A  A  !A2 "AA#A0@A9@$ AB AC AB AD AEA B) B* B+~  B$@  BB B~@ B@ DS/FѠ?DS/FѠ?D1Gl@DRZS^?B1B1?B BpF?~ BE$7Ty?FUvC?~ A"@A ? A, AF AG AH A,A?A? !A2 "AI#A@A@$ AJ AK AJ AL AMA B) B* B+~  Bd@  BJ B? A B A DGtaR#ÿDGtaR#?Dbo$D? A, AN AO AP A,A?A@ !A2 "AQ#AA@AF@$ AR AS AR AT AUA B) B* B+~  BA@  BR B <@ B`"A D<ÅG @D<ÅG @D=g0 w@DP{@B_4R@B_4R@BtɦQx@B@j@~ BEc?FH!?~ AA@A(t? A, AV AW AX A, A  A  !A2 "AY#A @A$@$ AZ A[ AZ A\ A]A B) B* B+~  B9@  BZ B@~  Bh@ DG"aEDG"aE?D4=D}~?BB?BD8ABB['^#Q?~ BEvK] ?FEo];&?~ A8@A? A, A^ A_ A` A,A?A? !A2 "Aa#A@A @$ Ab Ac Ab Ad AeA B) B* B+~  B$@  Bb B@ Bu@ Dm%?Dm%?D(r]@D?QΈ@B?B?By_U@B˭_2?~ BE#Wdr=?F ꉶ?~ A"@A?~,}? A, Af Ag Ah A,A?A@ !A2 "Ai#A @A @$ Aj Ak Aj Al AmA B) B* B+~  BI@  Bj B@uA BY5A D/h'?D/h'?D?;RJ@DtGQl?B?B??BB-?~ BE/ us?FѮ?~ AH@Aޒ? A, An A Ao A, A  A !A2 "Ap#A&@A.@$ Aq Ar Aq As AtA B) B* B+~  B@P@  Bq B A B UA DR("QӿDR("Q?D2D"Ä?B_*uտB_*u?Bp񆜼4BvI#>]?~ BEN`?F6G>? ?~ AP@A _X? A, Au Av A A,A@A@ !A2 "Aw#A*@A0@$ Ax Ay Ax Az A{A B) B* B+~  BD@  Bx BE)A~  B?, D3I؟?D3I؟?D*nn@DDO@Y?B?B?BIEߟ;@B;k?~ BEJR6?FSP?~ AC@AA=? A, A| A} A~ A,A?A? !A2 "A#A @A&@$ A A A A AA B) B* B+~  BA@  B~  BOd  B+A D[ܹڿD[ܹ?Dv"{#9De]?BuпBu?BȽߪ,T0BՅ=X?~ BE;Rv?F%?~ BEx4?FtYQ?~ A@[@AD)c? A, A A A A,A?A@ !A2 "A#A@@AG@$ A A A A AA B) B* B+~  B`@  B B@%@~  B7 D{?D{?D [E S]@D"hb@Bl$?Bl$?B!?B0V-?~ BEwvY?F 뭞Al?~ A`@A:( ? A, A A A A,A?A? !A2 "A#A@@AG@$ A A A A AA B) B* B+~  B>@  B B@A B A DG !?DG !?D+lpL@D 7?B?B??Bl@B∫?~ BE.v?FSP?~ A=@A1 ? A, A A A A, A   A  !A2 "A#A@A$@$ A A A A AA B) B* B+~  BA@  B B@G3A B@A D7e?D7e?DT#ЋP@Dhc?BgBg?B %oIB_q?~ BE)?F HOQ?~ AA@A~ѷ? A, A A A A,A?A? !A2 "A#A"@A$@$ A A A A AA B) B* B+~  B4@  B BkA B `@ DӂDӂ?DJ=BI)-%?~ BEU?F;0?~ A8@AkY? A, A A A A,A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  BN@  B B@@ B7A DLz\?DLz\?D,sK@D:ݞO?B R$?B R$?B^pƸ@BZ&?~ BE)?F(?~ AM@A>fC? A, A A A A,A?A? !A2 "A#A.@A5@$ A A A A AA B) B* B+~  B4@  B B.m@ B;]@ D!ЦͿD!Ц?Ds;-D);?BؿB?B,Gw7Bwm}?~ BEy\YM?F>?~ A3@AG>R? A, A A A A,A?A? !A2 "A#A"@A$@$ A A A A AA B) B* B+~  B>@  B B@ A~  BJ@ D:fD:f@Dߟ4/SD/쁭?B>?B>?BHN@B2.?~ BE xl?F./M?~ A=@AS? A, A A A A,A?A@ !A2 "A#A"@A&@$ A A A A AA B) B* B+~  B[@  B B#A B@EA DEJti׿DEJti?D-6D7c?BĿB?B:ҍ}$B4G{?~ BE ~v?F{?~ A@[@Awhm? A, A A A A, A  A !A2 "A#A.@A<@$ A A A A AA B) B* B+~  B>@  B B$'@~  B@ D[ ?D[ ?D/Ϧ@DO`Zp?BX?BX?BWi&L@BɌ .?~ BEBz[GL?F`r-V?~ A=@A1z? A, A A A A,A?A@ !A2 "A#A&@A&@$ A A A A AA B) B* B+~  B>@  B B2@ B@ DWʿDW?D1+D ?B窰?B窰?B_*w@B~ӆ?~ BEػb8?F16?~ A=@A!j]? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B>@  B Be@ Bq@ DcCӿDcC?D dDc3Do'?BeⲿBe?BZ` @B? g?~ BEty ?F1gC?~ A=@A ? A, Ae A~ A A,A@A@ !A2 "A#A$@A&@$ A A A A AA B) B* B+~  BY@  B~  BH B@P@ D iD i?D3`DD'q?B =ͿB =?B}I6J-B;IP?~ BEԛ?F:!M?~ AX@A~t :u? A, A A A A, A  AR !A2 "A#AD@AG@$ A A A A AA B) B* B+~  Bb@  B BWڡ BoX  Dt<S׿Dt<S?DqpR6DE?B?B?B@  B  BA B~.@ DfWDfW?Dj BDĜ'?BB?B5GB9z3%?~ BEֶ2R?F~ ?~ A=@AgY? A, A A A A, A  A !A2 "A#A"@A$@$ A A A A AA B) B* B+~  BK@  B~  B4A BA DͶ8[?DͶ8[?DavP@DVH?B?B?BJ-=Q@BzEA?~ BE -?F?~ AK@AbPa? A, A A A A,A?A@ !A2 "A#A"@A(@$ A A A A AA B) B* B+~  B b@  B~  B B@_A D'>D'>?DqD?B?B?B`m@BL?~ BEJz ?F}?~ Ab@AT? A, A A  A! A,A?A@ !A2 "A"#AA@AF@$ A# A$ A# A% A&A B) B* B+~  BF@  B# BҘBֿ  D` :D` :?D&"@D$E'J?B¼տB¼?BNx4BuCI?~ BE$[uG?F`r-V?~ AF@A['w!? A, A' A( A) A,A?A@ !A2 "A*#A*@A.@$DGl(.,,2(,2,(((2,,2,,,,(2(2,.2((%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A+ A, A+ A- A.A B) B* B+~  B9@  B+ B+@ Ba@ D.kD.k?D^Z?D`NReI?BB?Bx`SABx?~ BE͏?Fm?~ A8@A6i? A, A/ A A0 A, A  A !A2 "A1#A&@A(@$ A2 A3 A2 A4 A5A B) B* B+~  BI@  B2 BA@ B@ D@.?D@.?D#_a7@D-?BZD?BZD?B{IQ@B#x|?~ BEW?F(?~ AH@A5!? A, A6 A7 A8 A,A?A? !A2 "A9#A,@A5@$ A: A; A: A< A=A B) B* B+~  BR@  B:~  B6H B O8A DRްV?DRްV?DSN`@@DZ)?BvʿBv?B[аD*B%Wo ?~ BE[b?FJ?~ AR@AW˪5? A, A> A? A@ A,A?A@ !A2 "AA#A0@A5@$ AB AC AB AD AEA B) B* B+~  B$@  BB B"@ B`Y@ D6{D6{?DʺHD@}l1?~ BE S?F_|By ?~ A"@AAO@ A, AN AO AP A0~ A?  A !A2 "AQ#A@A@$ AR AS AR AT AUA B) B* B+~  B.@  BR B@8m@ B`h@ DrFN?DrFN?DsQkA7@DD ?B `\?B `\?B.&T7@B%j?~ BE &?FZ\s?~ A,@AA٢? A, AV AW AX A0~ A?  A1 !A2 "AY#A@A@$ AZ A[ AZ A\ A]A B) B* B+~  B@  BZ B C@ B@9@ D?Fso?~ A8@At? A, Ai Aj Ak Ag Ah  A  !A2 "Al#A@A@$ Am An Am Ao ApA B) B* B+~  B$@  Bm B H@ Bڅ@ D?D?DBy>@D8 ?BYĿBY?BC_$BL)?~ BECUsx?F(w?~ A"@A; F);>~ AP@ AŨ ? A, Av AD A AF A?A? !A2 "Aw #A@A.@$ Ax AP Ax Ay A; A B) B* B+~  BD@  Bx  B#fYB q   D/A&H D/A&H? DrMI Dkfw? B B? BL9G B d?~ B Ef7s? Fs?~ AC@ Aw1u? A, AL A AM AF A?A@ !A2 "Az #A@A"@$ A{ A| A{ A} A~ A B) B* B+~  B>@  B{  BA  BKA  Dm@F Dm@F? D:\ Da$G? B? B? B1Լu@ B\BT?~ B Ejyj=`? FTh=?~ A=@ A? A, A A A A A  A !A2 "A #A@A @$ A A A A A A B) B* B+~  BI@  B  BA  B`A  D1)k D1)k? D&b"M Dcw#? B?Tɫ? B?Tɫ? B2Fƪ@ BV)?~ B EÛ? F? ?~ AH@ A?? A, A A A A, A?A@ !A2 "A #A1@A4@$ A A A A A A B) B* B+~  B.@  B  Bb@  BE@  D"-%? D"-%? D>+wW@ D)C? Bx\? Bx\? B|,kH@ BQ`?~ B EQ? FA}V?~ A,@ Ak? A, A A A A A  A !A2 "A #A@A@$ A A A A AA B) B* B+~  BA@  B B-'A BA DjcDjc?D$)/]CDn;7HH?B@B@?B?B^i?~ BE쯟?F޿Jpј?B @?B @?By_˨D@BE j?~ BE:;?F?~ BE .9|?Fi п?~ Aq@Aa3"߿? A, A A A A0~ A?  A1 !A2 "A#AC@A@Q@$ A A A A AA B) B* B+~  B9@  B B`1A~  BOv DqjmֿDqjm?Dl˪ 5D/bN?B jB j?B(h0r@Bk[zy?~ BEr-d?Fz D?~ A8@As$? A, A A A A A  A !A2 "A#A$@A$@$ A A A A AA B) B* B+~  B@  B BФ@ B /@ DZ(?DZ(?D(;f@DIM3:@B`Z?B`Z?B4Ir@BX@~ BE iz?F kT?~ A@A? A, A A A A A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B4@  B~  Bg B ]@ D D @Db ƯrWD_eȯ?BB@BB@?BBRBhB?~ BEifb?F5&?~ A3@A ? A, A A A A A  A !A2 "A#A @A @$ A A A A AA B) B* B+~  B$@  B Bh@ B '@ D@n?D@n?DJ.9@DZr\?B?b˿B?b?B ,BF5?~ BEC?F&ED?~ A"@AȆg? A, A A A Ar As  A !A2 "A#A?A@$ A A A A AA B) B* B+~  B g@  B~  B BA D+;]}ҿD+;]}?DbpV@%2D֨[1?B׿B?B5M6B_WȮ?~ BEI7 ?FpRd?~ Ag@Ab? A, A A A A,A?A? !A2 "A#A:@AF@$ A A A A AA B) B* B+~  BK@  B B௉ A B` A DcYDcY?DI'ёBD.Q?B;ſB;?B7|&B dvy?~ BE{5?F?~ AK@AN( C? A, A AH A A,A?A@ !A2 "A#A @A(@$ A A A A AA B) B* B+~  BW@  B B 3@ Bস@ D Ǎdq˿D Ǎdq?Dq~+D{?BѿB?B f1B`p$n?~ BEDZB?F <,?~ AW@Aq|? A, A A- A A,A?A @ !A2 "A#A<@A>@$ A A A A AA B) B* B+~  B>@  B B A B ?@ D ]4D ]4?DeK0>D99?B@E?B@E?BROf4@B޺J?~ BEo6z?F{?~ A=@A1D? A, A  A  A  A, A  A  !A2 "A #A"@A$@$ A  A A  A AA B) B* B+~  B4@  B  B@ BP A D.]f?D.]f?Dp@D* @B?B?B67CH@Bh0Uq?~ BEݘO?F/X?~ A3@A4ZV? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B>@  B B`sA~  B_ DUBDUB?DBC DiɯEke?B¿B?B3d"BΓ(?~ BEY?FVi?~ A=@AM&NJ? A, A A A A, A'  A !A2 "A#A@A@$ A A A A  A!A B) B* B+~  BN@  B BOBFd  D!\mD!\m?D-k~KDuiY?BB?BԳKBٙ~?~ BE؏?FQn aJ?~ AM@AYt? A, A A  A  A,A?A@ !A2 "A"#A@A*@$ A# A$ A# A% A&A B) B* B+~  B^@  B# B69BOf_  D"4D"4?DHD䀢#?BhlBhl?B˔Y=BUIk?~ BE5 s?Fl0'ኜ?~ A]@AXe,? A, A A  A A,A?A@ !A2 "A'#A&@A>@$DGl2,(,.222,2(22$2$2$.2.2(,,2,. %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A( A) A( A* A+ A B) B* B+~  Bp@  B(  BcA  B A  DI DI? D AՍ=E D!%g? B@$  B@$ ? BKZLB Bf|J?~ B E1^a? F_(Q?~ Ap@ AaW? A, A, A* A- A, A?A? !A2 "A. #A5@AL@$ !A/ !A0 !A/ !A1 !A2!A !B) !B* !B+~ ! B`c@ ! B/~ ! B*! BMTA! DJN?!DJN?!Dg:Z1@!DN?!Br?!Br?!BԓbR@!BĦ5?~ !B!E 0P^?!F`'Q?~ !A@c@!A Fd? !A, !AO !A* !AQ !A,!A?A? !!A2 !"A3!#A1@AD@$ "A4 "A5 "A4 "A6 "A7"A "B) "B* "B+~ " B>@ " B4" B3@~ " Bl@" DԦG?"DԦG?"DwJ;@"D34&x]?"B"B?"B L"B $m?~ "B"E+?"Fn#?~ "A=@"A΅"? "A, "A8 "A9 "A "A,"A?A? "!A2 ""A:"#A@A@$ #A; #A< #A; #A= #A>#A #B) #B* #B+~ # BF@ # B;# BrC B3 # DEu[#DEu[?#D@*N#DC?#B#B?#B0K#BA?#FZhtp?~ #AF@#Ar? #A, #A #A  #A #A,#A@A@ #!A2 #"A?##A@A"@$ $A@ $AA $A@ $AB $AC$A $B) $B* $B+~ $ B@ $ B@$ Bo@$ B@N/@$ D"?$D"?$D(P+"@$D^N?$Bи?$Bи?$B|C"*S@$B_>?~ $B$EgIf?$FG0tG?~ $A@$AWykK? $A, $AD $AE $AF $A $A $ AG $!A2 $"AH$#A?A?$ %AI %AJ %AI %AK %AL%A %B) %B* %B+~ % BW@ % BI% B @%B,{D?~ %B%Enh?%Fzg?~ %AW@%A? %A, %AM %AN %AO %A,%A?A@ %!A2 %"AP%#A(@A6@$ &AQ &AR &AQ &AS &AT&A &B) &B* &B+~ & B4@ & BQ& BAA& BA& DDP?&DDP?&DqqK1E@&Dl$?&B i?&B i?&BƠC>@&B`H?~ &B&E5v?&F60?~ &A3@&A8a`J? &A, &AU &AV &AW &A, &A & A  &!A2 &"AX&#A@A@$ 'AY 'AZ 'AY 'A[ 'A\'A 'B) 'B* 'B+~ ' BF@ ' BY' B^@' B A' D?@'D?@'D~-!@'D@'BC?'BC?'B(G0@'B?К?~ 'B'EԶ?'FJ?~ 'AF@'AE ʼV? 'A, 'A] 'A^ 'A_ 'A,'A?A@ '!A2 '"A`'#A*@A*@$ (Aa (Ab (Aa (Ac (Ad(A (B) (B* (B+~ ( B>@ ( Ba( B@/A~ ( B.( DqBֿ(DqB?(DdF6=5(D &)?(B߶׿(B߶?(B6(BYQ`?~ (B(EMv?(F)wM_?~ (A=@(ASkY!? (A, (Ae (Af (Ag (A, (A ( A (!A2 ("Ah(#A@A@$ )Ai )Aj )Ai )Ak )Al)A )B) )B* )B+~ ) BI@ ) Bi~ ) B7[-) B5X5A) D cܿ)D c?)D&&x:)Dxsܥ?)B?y?)B?y?)B9P`J@)BAf?~ )B)EiKP?)Fh+a?~ )AH@)At0=Ea? )A, )Am )A" )An )A,)A?A@ )!A2 )"Ao)#A@A$@$ *Ap *Aq *Ap *Ar *As*A *B) *B* *B+~ * B4@ * Bp* B @* B`_8@* D/l*D/l?*D$G*D0a?*B>*B>?*B`7I*Bַ> ?~ *B*E/*?*FWF?~ *A3@*AjΒj? *A, *At *Au *Av *Aw *A * Ax *!A2 *"Ay*#A&@A&@$ +Az +A{ +Az +A| +A}+A +B) +B* +B+~ + B$@ + Bz+ Bf@+ B@"@+ DqObq8+DqObq8?+DvE+D.ztC?+Bf+Bf?+BQ+B$L?~ +B+Ew?+FPS?~ +A"@+A:r? +A, +A~ +A +A +A, +A + A +!A2 +"A+#A@A@$ ,A ,A ,A ,A ,A,A ,B) ,B* ,B+~ , BK@ , B, B MA, Bo A, Dfb<,DfbHͿ.B@>H?.BS-.BVeN?~ .B.E"E ?.F1gC?~ .A3@.A+? .A, .A .A .A .A,.A?A@ .!A2 ."A.#A@A@$ /A /A /A /A /A/A /B) /B* /B+~ / B4@ / B/ BH@/ BA/ D9W8@/D9W8@/DWM@/Dm=m@/Bt,?/Bt,?/B+V@/BA?~ /B/E3#?/F)_?~ /A3@/A&ΗX? /A, /A /A /A /A /A / A /!A2 /"A/#A@A@$ 0A 0A 0A 0A 0A0A 0B) 0B* 0B+~ 0 B9@ 0 B0 B ^@0 B e@0 D0D?0D!^M0D!y4?0BH0BH?0B;1P0BL]eYg?~ 0B0EkIDM?0FJXY?~ 0A8@0A$Zc? 0A, 0A 0A 0A 0A,0A?A@ 0!A2 0"A0#A@A @$ 1A 1A 1A 1A 1A1A 1B) 1B* 1B+~ 1 BV@ 1 B1 B`A1 BA1 D?1D?1DAގ39@1D;??1B?1B?1B[*&'@1Bs!J?~ 1B1EgUA?1FKh?~ 1A@V@1AQ &Н? 1A, 1A 1A 1A 1A,1A?A@ 1!A2 1"A1#A1@A8@$ 2A 2A 2A 2A 2A2A 2B) 2B* 2B+~ 2 B@ 2 B2 B@2 B@iR@2 D}vYc?2D}vYc?2Dp( NE@2Dk!V?2B??2B??2B$ @2B@@3W?~ 2B2Eڦ?2F3I?~ 2A@2A1}? 2A, 2A 2A 2A 2A,2A?A@ 2!A2 2"A2#A@A@$ 3A 3A 3A 3A 3A3A 3B) 3B* 3B+~ 3 B$@ 3 B3 B@@3 B` @3 D!V3D!V?3D;E3D͋Qš?3BͿ3B?3B,P-3B*Ō9?~ 3B3E=?3Fn?~ 3A"@3Am? 3A, 3A 3Ac 3A 3A, 3A 3 A  3!A2 3"A3#A@A@$ 4A 4A 4A 4A 4A4A 4B) 4B* 4B+~ 4 B.@ 4 B4 By@4 Br>@4 D}0z?4D}0z?4DMQO\@4D`0$@4BZ@4BZ@4B5%Fu@4BUV|@~ 4B4Ewf?4F^nˮl?~ 4A,@4AXz? 4A, 4A 4A 4A 4A, 4A 4 A 4!A2 4"A4#A@A@$ 5A 5A 5A 5A 5A5A 5B) 5B* 5B+~ 5 B9@ 5 B5 B=A5 BA5 D'f  ο5D'f  ?5Dh .?9D,E$?9B,9B,?9BoM0I9B|+?~ 9B9E>?9F?~ 9A3@9A} (g? 9A, 9A 9A 9A 9A,9A?A@ 9!A2 9"A9#A@A"@$ :A :A :A :A :A:A :B) :B* :B+~ : B.@ : B: B[B : DC)[߽:DC)[߽?:D 8@O:D0C~?:B @<߿:B @@$ <A <A <A <A <A<A <B) <B* <B+~ < BD@ < B< B`"A< BjuA< Dq)*<Dq)*?<D ߳L4L<D|8?<B<B?<BEfA >A >A >A >A>A >B) >B* >B+~ > B4@ > B> B@AA> B A> D>0tѿ>D>0t?>D%W߃1>Do.(e?>B ?>B ?>B/+gl@>Blm @~ >B>EZg?>F%p6X?~ >A3@>A[,#G!? >A, >A >A >A >A >A > A >!A2 >"A>#A@A@$ ?A ?A ?A ?A ?A?A ?B) ?B* ?B+~ ? B^@ ? B? BG{2Bw7 ? DY>ܱ??DY>ܱ??D;_ό$@?DTx??B_8?B_8??B³+U!?BŜ&?~ ?B?Eˤ??F*?~ ?A]@?Aza8? ?A, ?A ?A ?A ?A,?A?A? ?!A2 ?"A?#A*@A:@$DGl,((22,.(22,2,2,,,222$,,,$,(2@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A  @A! @A  @A" @A#@A @B) @B* @B+~ @ B$@ @ B @ BL@@ B @@ D CO?@D CO?@DXA@@Dxý?@B@΀?@B@΀?@B2@@BHm|?~ @B@Ey7AXA?@FAA B @ C B7C B > A~ C BWRC D7.;G?CD7.;G?CDkzQ]#E@CD_Z?CB@%?CB@%?CB JnB@CBu G?~ CBCE6k۟?CFgn2?~ CA=@CA$|C#A@A@$ DA? DA@ DA? DAA DABDA DB) DB* DB+~ D B.@ D B?D B@D Bs@D D?DD?DDa78@DDeW?DB׿DB?DB(H]pHD*h>p?HDy.AHDۋ?HBulHBul?HBDgοHBy(K?~ HBHE!`W?HF?~@?~ HA3@HAj8,? HA, HA[ HA\ HA] HA, HA H A H!A2 H"A^H#A@A@$ IA_ IA` IA_ IAa IAbIA IB) IB* IB+~ I B.@ I B_I B8f@I B {@I Dt6a?IBÿIB?IB>ˣqc$IBaߓ?~ IBIE~55d?IF(ݧo?~ IA,@IA.n\? IA, IAc IAd IAe IA,IA?A? I!A2 I"AfI#A$@A$@$ JAg JAh JAg JAi JAjJA JB) JB* JB+~ J BF@ J BgJ B@@J B f@J DpT }JDpT }?JD$i-JDKX?JB?P?JB?P?JB. wC$@JB6sY?~ JBJES@ K BnK B+@K B`@K D#;\?KD#;\?KDwf=:@KD{_a*?KB?KB?KB1B FC@KBWq*?~ KBKEVEx ?KF)_?~ KA=@KAlGxw? KA, KAA KAr KA,KA@A@ K!A2 K"AsK#A*@A,@$ LAt LAu LAt LAv LAwLA LB) LB* LB+~ L Be@ L BtL BZN$AL B`-*AL DA_V?LDA_V?LDO*)m<@LDp?LB!?LB!?LBVjn3@LBA ?~ LBLE$C?LF#^9?~ LAe@LAB7? LA, LAx LAy LAz LA0LA?A? L!A2 L"A{L#A9@AC@$ MA| MA} MA| MA~ MAMA MB) MB* MB+~ M B@P@ M B|M BkC@M BA0@M Dr*4MDr*4?MDsQMDo6?MB߅1?MB߅1?MBotA@MB0lz?~ MBME#EJ%?MFYÚ?~ MAP@MAz6 WY? MA, MA MA MA MA,MA?A@ M!A2 M"AM#A3@A8@$ NA NA NA NA NANA NB) NB* NB+~ N B$@ N BN B z@N B@N DuݿNDu?NDSѷC;ND`&?NB޿NB?NBZ;l<NBT]f?~ NBNE݆`?NF~ ?~ NA"@NA30)? NA, NA NA NA NA,NA?A? N!A2 N"AN#A@A@$ OA OA OA OA OAOA OB) OB* OB+~ O BN@ O BO B@O B`z@O DH?ODH?OD؜^M@OD02p?OBQ?OBQ?OBQY*@OBN'?~ OBOE{oh>?OF`r-V?~ OAM@OAB? W? OA, OA OA OA OA,OA?A@ O!A2 O"AO#A*@A0@$ PA PA PA PA PAPA PB) PB* PB+~ P B@_@ P BP B@' AP B VAP Dz@ Q BQ B0gAQ B%AQ DSu=ҿQDSu=?QDlU/2QDv.?QB@QB@?QB+1!QBfnwb?~ QBQE1"OO?QFiz?~ QA=@QAï?/? QA, QA QA QA QA,QA?A@ Q!A2 Q"AQ#A@A"@$ RA RA RA RA RARA RB) RB* RB+~ R B9@ R BR B AR B @R D:ݿRD:?RD;RD?ɐ9#?RB`8?RB`8?RBO-53@RBpTa?~ RBREEƒ?RFJ ž'?~ RA8@RA۵ԓi? RA, RA RAc RA RA, RA R A  R!A2 R"AR#A@A@$ SA SA SA SA SASA SB) SB* SB+~ S BD@ S BS By AS B AS DR%(p?SDR%(p?SD?SD̽2 ?SB!SB!?SB,HSB:nh ?~ SBSEk%?SFc%,b?~ SAC@SA{l0? SA, SA SA SA SA,SA?A@ S!A2 S"AS#A"@A(@$ TA TA TA TA TATA TB) TB* TB+~ T BR@ T BT B@AT B:AT DܿTD?TDc;-:TDy[|b?TBTB?TBjUATB}Q1{ ?~ TBTE:ϩ?TF˸ ?~ TAR@TA3xD? TA, TA TA TA TA, TA T A  T!A2 T"AT#A:@A@@$ UA UA UA UA UAUA UB) UB* UB+~ U BQ@ U BU B ;A~ U B`5AU D+sؿUD+s?UD D`7UDЄ?UBUB?UB3~ZJUB:T?~ UBUEj9rCA?UFJr?~ UA@Q@UA8pT? UA, UAC UAD UAE UAFUA@A? U!A2 U"AU#A @A1@$ VA VA! VA VA VA# VA VB) VB* VB+~ V B[@ V BV B^xB" V DPChFſVDPChF?VD.So%VD)i!{?VBFVBF?VBўIVB(r ?~ VBVEL(I.4?VF盲9g?~ VA@[@VA2$? VA, VAAA VAFVA?A? V!A2 V"AV#A@A9@$ WA WA WA WA WAWA WB) WB* WB+~ W B\@ W BW BB%B2| W DF1 WDF1 ?WDEs9PWDE9 ?WB`WB`?WB#w!FWB;n ?~ WBWEt />WFUgeg >~ WA\@WA[=3? WA, WA WA WA WA,WA@A? W!A2 W"AW#A"@A;@$ XA XA XA XA XAXA XB) XB* XB+~ X B$@ X BX B @X B@5@X D-qXD-q?XDdXDhb?XB^K?XB^K?XB^#@XBm#?~ XBXEeu1?XF(?~ XA"@XA}^? XA, XA XA XA XA9 ~ XA? X Ac X!A2 X"AX#A@A@$ YA YA YA YA YAYA YB) YB* YB+~ Y B$@ Y BY B@O@Y B@Y D{ȉ?YD{ȉ?YD.O@YDی;?YBۿYB?YB#:YBpo ?~ YBYE]rb6?YF 4ϝ?~ YA"@YA7j3f? YA, YA YA YA YA YA Y A Y!A2 Y"AY#A@A@$ ZA ZA ZA ZA ZAZA ZB) ZB* ZB+~ Z BF@ Z B~ Z BK Z B3AZ D\W<ֿZD\W~ [A `@[A y? [A, [A [A [A [A,[A@A? [!A2 ["A[#A$@A>@$ \A \A \A \A \A\A \B) \B* \B+~ \ BF@ \ B~ \ B;\ B*ѿ\B|>?\B.) 1\Bm?~ \B\EЧ]#?\F:!M?~ \AF@\AʭM? \A, \A \A \A \AF\A?A? \!A2 \"A\#A@A$@$ ]A ]A ]A ]A ]A]A ]B) ]B* ]B+~ ] BF@ ] B] BA] B@@] DE3]DE3?]D\UbC]DT;\?]B್п]B್?]B%ҷi0]BAs?~ ]B]EN?]FШU?~ ]AF@]AJB!? ]A, ]A ]A ]A ]Ar ]As ] Am ]!A2 ]"A]#A(@A(@$ ^A ^A ^A ^A ^A^A ^B) ^B* ^B+~ ^ B$@ ^ B^ B`c@^ B`@^ Dox?^Dox?^D kN@^DEl'?^BUT?^BUT?^BcG*]M@^B qe?~ ^B^EQ s,?^F ?~ ^A"@^A{~@)? ^A, ^A ^A ^A ^A9 ~ ^A? ^ AR ^!A2 ^"A^#A@A @$ _A _A _A _A _A_A _B) _B* _B+~ _ BK@ _ B~ _ Bu_ B[A_ D;dB_D;dB?_D1G@D_Dq ?_B5_B5?_B4L@_BQڑ?~ _B_Eiyѥ?_F]g#t?~ _AK@_A>.`? _A, _AAA _AF_A?A? _!A2 _"A_#A"@A,@$DGl2(2(22.,2,,,,,,2,2(22.(22`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A `A `A `A `A`A `B) `B* `B+~ ` B$@ ` B` B7 @` B@@` Dy3eAֿ`Dy3eA?`D8撝-k5`D61 b%?`B $?`B $?`B?Hja@`BF L%@~ `B`EX?`FT4?~ `A"@`AO5X,? `A, `AAA `AF`A?A? `!A2 `"A`#A@A@$ aA aA aA aA aA aA aB) aB* aB+~ a BF@ a Ba B35Aa B Aa D|CTN?aD|CTN?aD_ؑ &@aD$g?aBaB?aB%#i!aBn76?~ aBaE~6@cDRFSR?cB6?cB6?cB`\I@cBQDA?~ cBcE}vyY?cFC?~ cAF@cA`,*? cA, cA cA cA cA0~ cA? c A c!A2 c"Ac#A&@A&@$ dA dAh dA dA dAdA dB) dB* dB+~ d B4@ d B~ d Bv8d B ?Ad DAȿdDA?dD-FYqf(dDF?dBġdBġ?dBmdBrI=?~ dBdE}F?dFѾ'?~ dA3@dA!<]? dA, dAAA dAFdA?A? d!A2 d"Ad#A@A@$ eA eA eA eA  eA!eA eB) eB* eB+~ e B$@ e Be B@/@e Bs@e DtTeDtT?eD$O.PeD̛?eB_VeB_V?eB@]IeB2ˬO?~ eBeE8X?eF|[?~ eA"@eAԃ? eA, eA" eA# eA$ eA9 ~ eA? e A[ e!A2 e"A%e#A@A@$ fA& fA' fA& fA( fA)fA fB) fB* fB+~ f B4@ f B&f B @f Bh@f DKӇ?fDKӇ?fDs@fDY?fBH?fBH?fBHz5;-S@fBdE?~ fBfE O?fFH?~ fA3@fA,u? fA, fA* fA+ fA, fAg fAh f Ah f!A2 f"A-f#A@A @$ gA. gA/ gA. gA0 gA1gA gB) gB* gB+~ g B$@ g B.g B`H[@g B`Y[@g DlŠ=ֿgDlŠ=?gD@6g5gDh&?gBgB@gB{xdtRgBX0?~ gBgE짲?gF\] ?~ gA"@gA-? gA, gA2 gA3 gA4 gA9 ~ gA? g A5 g!A2 g"A6g#A@A@$ hA7 hA8 hA7 hA9 hA:hA hB) hB* hB+~ h BI@ h B7h B@[@h Bգ@h Dj#^?hDj#^?hDiX7@hDPo?hB ;?hB ;?hB^h@hBRh6W?~ hBhEs?hFUT+?~ hAH@hAU)? hA, hA; hA< hA= hA;       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefgijklmnopqrstuvwxyz{|}~hA< h A< h!A2 h"A>h#A(@A*@$ iA? iA@ iA? iAA iABiA iB) iB* iB+~ i B.@ i B?i BPh@i B @i D)BNԿiD)BN?iDY3iDicY?iB{iB{?iBߚ+GiB*~m?~ iBiEqUDw?iFXwz#?~ iA,@iAp? iA, iAC iAD iAE iA9 ~ iA? i A[ i!A2 i"AFi#A@A@$ jAG jAH jAG jAI jAJjA jB) jB* jB+~ j B.@ j BGj B`_u&Aj B%Aj D[_F?jD[_F??jDkigjD44 ?jBLi?jBLi?jB]3d@jB%^:[@~ jBjE>&?jFN-I?~ jA,@jAjz? jA, jAK jA. jAL jAg jAh j A  j!A2 j"AMj#A@A@$ kAN kAO kAN kAP kAQkA kB) kB* kB+~ k B$@ k BNk Bx̶@k B@k DE*a\?kDE*a\?kD/ZK@kDyj?kBI?kBI?kBbƉM@kBW!!?~ kBkEMDN?kF`X?~ kA"@kA >)? kA, kAR kAS kAT kA, kA k A k!A2 k"AUk#A@A@$ lAV lAW lAV lAX lAYlA lB) lB* lB+~ l BN@ l BV~ l B` -Al B-Al D>?lD>?lD{HpF%R6?~ pA\@pAZųo? pA, pA pA  pAz pA,pA?A@ p!A2 p"A{p#A @A8@$ qA| qA} qA| qA~ qAqA qB) qB* qB+~ q BV@ q B|q BꢕB  q D%ZpbqD%Zpb?qDd {tKqD?Au?qB-޿qB-?qB͵FF<qBeJ?~ qBqE ӑ?qF1ǪK?~ qA@V@qAlYE/? qA, qA qA  qA qA,qA?A@ q!A2 q"Aq#A"@A7@$ rA rA rA rA rArA rB) rB* rB+~ r B4@ r Br B 9Ar BmfAr D8'?rD8'?rDMãKM@rD]4L?rBi?rBi?rBኙ"J@rBR\?~ rBrEn3?rF)2 ?~ rA3@rArŸ? rA, rA rA rA rA,rA?A@ r!A2 r"Ar#A@A@$ sA sA sA sA sAsA sB) sB* sB+~ s BK@ s Bs BAs BlAs D ˰¿sD ˰?sDEbC#sD?sBIƿsBI?sB"Ƃ'sB5[O?~ sBsEK1?sFRGz?~ sAK@sAgDP? sA, sA sA sA sA,sA?A? s!A2 s"As#A*@A0@$ tA tA tA tA tAtA tB) tB* tB+~ t BR@ t Bt BTAt BAt D1?tD1?tDMhk&@tDM1E?tBtB?tB}htBnQ!?~ tBtE Q%s?tFw=Iren?yF'Z ?~ yAS@yA]N+? yA, yA yA yA yA,yA?A@ y!A2 y"Ay#A6@A:@$ zA zA  zA zA zAzA zB) zB* zB+~ z B>@ z Bz B@Az B`wAz DJDzDJD?zD @ozDQ4?zBBؿzBB?zBQ47zBX"?~ zBzENjH?zFXZ?~ zA=@zAM܆? zA, zAAA zA,zA?A? z!A2 z"Az#A@A@$ {A {A {A {A {A{A {B) {B* {B+~ { BV@ { B{ B&ABFe { Dlb{Dlb?{DktPF{Dik?{B{B?{BE3B{BA?~ {B{Ee2(?{FFV?~ {A@V@{AaTZ? {A, {A {A  {A {A,{A?A@ {!A2 {"A{#A@A3@$ |A |A |A |A |A|A |B) |B* |B+~ | B.@ | B| B@'@| BM@| D M?|D M?|D~%6O@|D{z ~?|B?|B?|Bd3Q@|B; sd?~ |B|Elq>?|F r?~ |A,@|A^*ȸ? |A, |A |A |A |AV~ |A? | A |!A2 |"A|#A@A@$ }A }A }A }A }A}A }B) }B* }B+~ } B>@ } B} B@eA} BJ@} D&QH!}D&QH!?}Dޱ}M}DO?}B?}B??}BI}BPC?~ }B}E?撸Ɉ?}F ?~ }A=@}AdgL? }A, }A }A }A }A, }A } A  }!A2 }"A}#A@A"@$ ~A ~A ~A ~A ~A~A ~B) ~B* ~B+~ ~ B.@ ~ B~ BA~ Bm@~ D4~D4@~Dl9V~Di?~B~B?~BlR~B0<7F?~ ~B~EX?~F4,?~ ~A,@~A(SH m? ~A, ~A ~A ~A ~A ~A ~ A ~!A2 ~"A~#A@A@$ A A A A AA B) B* B+~  BN@  B B@A BA DdDd?Dϱ1?FF6?~ AM@A>? A, A A A A, A  A !A2 "A#A.@A0@$DGl222222222.2,,,,,2(2222%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA B) B* B+~  B9@  B B&@ B`@ D2=ÿD2=?DY"xbK$DX ?B`?B`?Bqkx% @B {?~ BE5 ?FtYQ?~ A8@Aa'? A, A A A A,A?A@ !A2 "A#A@A@$ A Ai A A AA B) B* B+~  BN@  B~  BGG  B'#A D!)?D!)?Dl.v/@D1U?B3?B3?BSqq9@Bb\+?~ BE;Ճ?F1?~ AM@Ajvg? A, AAA A,A?A? !A2 "A#A$@A3@$ A A A A AA B) B* B+~  BR@  B B@A~  BW D.껎?D.껎?DfAQ@DqZRA B) B* B+~  BD@  B; B A B#A D}?D}?D3lY$G@D&&?BȿB?B4!)Bor\?~ BE?F?~ AC@A` \ ? A, A? A@ AA A, A  A  !A2 "AB#A @A$@$ AC AD AC AE AFA B) B* B+~  BF@  BC~  Bg3  BA DڿD?DǨ 8DPF9:#?B>ÿB>?B F#B)Yy?B?A>?Bˉ_;3@B@h?~ BEPMdDk?F[T?~ A@Q@Au]? A, AW AX AY A,A?A? !A2 "AZ#A(@A0@$ A[ A\ A[ A] A^A B) B* B+~  Bn@  B[ B7+B6G  D T?D T?Dy`˜O@D=;Bg?Buf?Buf?B&aF@B]^S?~ BE%VLfx>FIV?~ An@A—? A, A_ A` Aa A,A?A@ !A2 "Ab#A0@AJ@$ Ac Ad Ac Ae AfA B) B* B+~  B>@  Bc B)u@ B@ D6 D6 ?D@cD.?BaֿBa?BLjņ5BYY?~ BEjv?F2{?~ A=@AqiXR2? A, Ag Ah Ai A A  A !A2 "Aj#A@A@$ Ak Al Ak Am AnA B) B* B+~  B9@  Bk B` }A B` A D`"D`"?D?~ BEdk?Fn?~ A3@A=4? A, Aw Ax Ay A,A?A? !A2 "Az#A@A@$ A{ A| A{ A} A~A B) B* B+~  BD@  B{ B@A~  B?n DEKx?DEKx?DIkU@DE#?BͿB?B~-B942E?~ BEȕC' ?F?~ AC@AU C? A, A A A A,A?A@ !A2 "A#A@A"@$ A A A A AA B) B* B+~  BY@  B B*B7  DtP¿DtP?Db*W"Di?BҿB?Bɂj{2B]:w?~ BEċ6?Fm?~ AX@A٬<5? A, A A A A,A?A? !A2 "A#A3@A:@$ A A A A AA B) B* B+~  B9@  B B"A BA D_fxUD_fxU?DQ,[ID-&׊?Bk?Bk?B4_@B90~?~ BE}j?Fk@#a?~ A8@Aý-? A, A A A A0A?A? !A2 "A#A@A @$ A A A A AA B) B* B+~  B.@  B B@ B A DJm^x5?DJm^x5?DsOm@D? F=' @BX?BX?B\Y@B\P=@~ BEP~5?Fq/?~ A,@A#? A, A A A AA?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  B$@  B BP@ Bv@ DTjVDTjV?Dw?JD@\hü?B ڿB ?B,U9B'4e?~ BEw?FJ?~ A"@Aaãg/? A, A A A A, A  AR !A2 "A#A@A@$ A A A A AA B) B* B+~  B4@  B Bwb@ B@ Dh8zp?Dh8zp?D"@Dh*\}?BClBCl?BRzo?B@ۈ?~ BE+K?Fc%,b?~ A3@AXj? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B.@  B BHA BOA DwȚݿDwȚ?D#:DLX_?B ÿB ?BS9$+$Bw[?~ BEw`?FEڕ0?~ A,@A%c? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BK@  B BK@ B``A D{ tT?D{ tT?D$0O@D8hr?B?\ƿB?\?BbBb'B$B?~ BEc?w|?FJ?~ AK@AE0? A, A A A A,A?A@ !A2 "A#A&@A,@$ A A A A AA B) B* B+~  B4@  B BA BA D?D?DbI>C@Dp}]?B?-?B?-?B1mV@@Bl7FYQ?~ BE\1&?F&ED?~ A3@Al/? A, A A A A, A  A !A2 "A#A$@A&@$ A A A A AA B) B* B+~  B@  B B @ Btf@ Dvk?Dvk?D}Ii2@DH?B`6?B`6?BnR*M@B*FWJU?~ BEL"?Fm?~ A@Aq? A, A A A A, A  A  !A2 "A#A@A@$ A A A A AA B) B* B+~  B9@  B B`+@ BQ@ DD?Dj2wIHDj'A u?B﴿B?BOS B mtU? A, A A  A  A0A?A? !A2 "A #A@A@$ A  A  A  A AA B) B* B+~  B.@  B  B@A~  B/w DqGJݡZDqGJݡZ?D |lKDK?BB?B28ڤ@BzF Y?~ BE?1v?F^nˮl?~ A,@AF.l ? A, A A A A A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B4@  B B@ B @ D#p?D#p?DCD@D] ?B?B?B Il@Bt9k @~ BEaU?F{ %?~ A3@A !b? A, A A A A; A<  A= !A2 "A#A@A@$ A AP A A  A;A B) B* B+~  B@P@  B~  B B IUA DYDY?DY;1KDx=n0?B@$B@$?B D̃BBuE}O?~ BEW7mBp?F?~ AP@AH2? A, AAA AFA?A? !A2 "A!#A@A,@$ A" A# A" A$ A%A B) B* B+~  B@  B" B fA B&A Dr޿Dr?Dc+V<DEw?BB?BlBB7q\?~ BEL2e?Fo:?~ A@Aڴ ? A, A& A' A( A) A*  A+ !A2 "A,#A?A?$ A- A. A- A/ A0A B) B* B+~  B>@  B- B%A B`KZA D}K ^R׿D}K ^R?D6(R6D6x?B 9B 9?BէBA) ?~ BEK?F}!K*?~ A=@A"[b? A, A1 A2 A3 A0A?A? !A2 "A4#A@A@$ A5 AR A5 A6 A7A B) B* B+~  B9@  B5 B֪%A B`?A Ddh?Ddh?De%Uh@Daƻ0/@B`?B`?BP0rG@BǮ?~ BE)ZC?FiU?~ A8@AW? A, AAA AFA?A? !A2 "A8#A@A@$ A9 A: A9 A; A<A B) B* B+~  B@  B9 B@ B@ D{3<_DD{3<_D?D[ ICPD]?BoBo?BݑqQBk9C%?~ BE ?Fw?~ A@A:|H^O? A, A= A> A? A@ AA  AB !A2 "AC#A?A?$ AD AE AD AF AGA B) B* B+~  BN@  BD BV@ B$@ D͡?D͡?DmźV@DK c?Bܧ?Bܧ?B8&cR@B5)?~ BEV}J-s?Fj=?~ AM@ANu? A, AH AI AJ Ag Ah  AK !A2 "AL#A0@A2@$ AM AN AM AO APA B) B* B+~  BF@  BM BA B@o!A D!|?~ A"@A(B5OCF?~ BE+?F&9?~ A3@AH? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  BQ@  B B@  B B}# A~  Bb  D%??D%??DJ8M@DoY?BB?B @BU ?~ BE?F|k|?~ A=@A>? A, A A A A,A?A? !A2 "A#A.@A1@$ A A A A AA B) B* B+~  B.@  B B@A B}@ DvCgDvCg?Ds:BD ?BzDԿBzD?Bl[3B3|?~ BE\D?F_TA?~ A,@Ag>? A, A A A A,A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  BT@  B B@ A BA D~?D~?D^@DS@Bo?Bo?BSTĿPK@B@>?~ BE2 /T?F!%G?~ AS@A8C? A, A A A A,A?A@ !A2 "A#A3@A7@$ A A A A AA B) B* B+~  B>@  B Bp A B A De~0..?De~0..?DA0-5@Dcc{?BkaBka?Be$ABb\?~ BE̟]?FL?z?~ A=@Ae? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B@  B B ʑ@ BMM@ DYDY?D!VDD+|x?BWBW?B+CBL?~ BE3tU?FZ{xa?~ A@A? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  BV@  B B :A~  Bg?9 D+ ?D+ ?D{ॺC@Df5P?B@W?B@W?Baޱ@B"{1?~ BEH?Fi?~ A@V@A*6@k? A, A A A A, A  AR !A2 "A#A2@A;@$ A A A A AA B) B* B+~  B9@  B B@@ B`@ D0?D0?De0@Dד?B,]?B,]?Bj/<@B3c?~ BEu4?F )XO?~ A8@AoQ? A, A A A A,A?A@ !A2 "A#A"@A&@$ A A A A AA B) B* B+~  BD@  B B2A B@6(A DS!PbDS!Pb?D ÿD3!\P?B j㓿B j?BWJDeBdt?~ BE+A}_?FM$QN?~ AC@AO? A, A A A A, A  A !A2 "A#A @A$@$ A A A A AA B) B* B+~  B$@  B B@ Bp@ Dѵ(;Dѵ(;?D>WY EDц?B?B??B.eRBBm ?~ BE]?Fȱ`xv?~ A"@A !? A, A A" A A,A?A? !A2 "A#A@A@$DGl,2..,.22,22,,2(,,,(,,,,.,2%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA B) B* B+~  B@U@  B BHA BTA D+̏⦿D+̏?D=gD?BB?B"B@ D< >nؿD< >n?D[&@7D޾O?B`&ۿB`&?B5X":B?~ BEWz?F;?~ AX@A5.W"? A, A A A A, A  A !A2 "A#A7@A<@$ A A A A AA B) B* B+~  B>@  B B@ B@ DA}R?DA}R?Dĉ?D/>I?B]?B]?B|{g@BG[@~ BE ?F;?~ A3@AFm? A, A A A A,A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  B@  B Bhd@ B g@ DD@D6KvUD $i?B-B-@B>@{XBŏ?~ BEж?F~rr?~ A@A3ZY? A, A A A A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B>@  B B@4A B@j2A DrǾ6?DrǾ6?D%.登@D}q&j?B p?B p?Bކ۹""@B &^}?~ BEFSe?Fb?~ A=@A^`p? A, A  A  A  A0~ A?  A !A2 "A #A@A@$ A  A A  A AA B) B* B+~  B@P@  B  BbnBh  D,9)WɿD,9)W?D[%*Di ?BͿB?B޿-B螙6?~ BEVtr?Fc?~ AP@Amg? A, A A A A,A?A? !A2 "A#A*@A1@$ A A A A AA B) B* B+~  B.@  B B mA B@OA Dw)Dw)?D/LD Eq?B `jvB `jv?B@RB:?~ BE0?F )XO?~ A,@A^(? A, A A A A,A?A? !A2 "A#A@A@$ A A A A A A B) B* B+~  BA@  B B A Br A D0IL?D0IL?D}3A@Dy'?B}B?B}B?BJI@BiH?~ BEKh;:d?Fz D?~ AA@AҤg&? A, A! A A" A,A?A? !A2 "A##A"@A*@$ A$ A% A$ A& A'A B) B* B+~  BD@  B$ B@A B"A DQ?DQ?D p3E@Dj]?BeBe?B_B>W BB' Ct?~ BEԀKF?FbZHA?~ AC@Al&J0? A, A( A) A* A,A?A@ !A2 "A+#A"@A,@$ A, A- A, A. A/A B) B* B+~  BA@  B, B@A Bt&A DЍ @?DЍ @?D1FQ@DH5?B_g:?B_g:?B*U@BO}?~ BE}"?FbGh?~ AA@Asj? A, A0 A1 A2 A,A?A@ !A2 "A3#A(@A,@$ A4 A5 A4 A6 A7A B) B* B+~  BK@  B4 B`qA B "H@ D;&D;&?DYÑDDz?B ԿB ?BeX\%4B}d[?~ BEHJ?F1?~ AK@As۰*? A, A8 A A A,A?A? !A2 "A9#A.@A5@$ A: A; A: A< A=A B) B* B+~  B@  B: B ᅐ@ B`ed@ D:\zD:\z?D/4DDC?B-B-?Bt݉t@KB㝒&#?~ BEnb?FEs?~ A@AF@ A, A> A? A@ A0A?A? !A2 "AA#A?A?$ AB AC AB AD AEA B) B* B+~  B>@  BB~  BpG A B.A DpQ3'DpQ3'?D5OѢNDm"j0?Bvm?Bvm?B Ϋ@Bt /?~ BEˆt?F$zd?~ A=@A!? A, AFA AG A,A?A? !A2 "AH#A"@A$@$ AI AJ AI AK ALA B) B* B+~  B.@  BI B3@ Bs@ Dqu˿Dqu?DCQ,Dկ{ށ?BgؿBg?B?~:7B3{RjQDJ)@?BӿB?B5#5m3BՒ?~ BEKQ?F&HǴ?~ AH@AԵ|~? A, A]A A^ A,A?A@ !A2 "A_#A @A&@$ A` Aa A` Ab AcA B) B* B+~  BN@  B` BA B`T A D]ƩӿD]Ʃ?DDwc.3DSos?B@eB@e?B 닂nNBS?~ BE>Gi?Fۛjw?~ AM@A1Kl]? A, Ad Ae Af A, A  A !A2 "Ag#A"@A.@$ Ah Ai Ah Aj AkA B) B* B+~  BF@  Bh BjWB  DhiDhi?Dg_DD3?B?ޑB?ޑ?BV<Bd2?~ BEy?FUvC?~ AF@A}HX-? A, Al Am An A, Ah  A  !A2 "Ao#A$@A,@$ Ap Aq Ap Ar AsA B) B* B+~  B\@  Bp B -,A~  B D=hl.ʿD=hl.?Do*DG/?BտB?BӠ4BzO?~ BE맠@Y?FRU1?~ A\@AI1B8? A, At A Au A,A?A@ !A2 "Av#A8@AA@$ Aw Ax Aw Ay AzA B) B* B+~  B9@  Bw B@@ B?@ Dt.p}ݿDt.p}?Du%:W;DKUZV?@?B_ne¿B_ne?BHj"B??~ BEa?Foـ?~ A8@AXpP$? A, A{ A| A} A,A?A? !A2 "A~#A @A$@$ A A A A AA B) B* B+~  BQ@  B B ,a A BA DОɿDО?Dk)D~?B x?B x?BtZs@@Bl1_?~ BEa)3?F_']?~ A@Q@AP? A, A A8 A A,A?A@ !A2 "A#A*@A1@$ A A A A AA B) B* B+~  BK@  B BA B`A Dȓ}&?Dȓ}&?DئD@D\ 6k?B_pB_p?Bp7WMCB x憊?~ BE+UIC?F[qx?~ AK@A;u,1? A, A A A Ag Ah  Ah !A2 "A#A"@A.@$ A A A A AA B) B* B+~  B9@  B B`EA B@ A D#l޿D#l?D gAL;D2?B ,ϿB ,?BUpP/BlN?x?~ BEQ\?B!6?B!6?BQrx8@BgO?~ BEb?FTb?~ A@Ai5? A, A A A Ag Ah  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BD@  B B A B@A Dp?Dp?DV. G@Dw⚿``?Bj?Bj?Br}2L?BֱM?~ BEQM?FO?~ AC@AEN:? A, A A A Ag Ah  A  !A2 "A#A@A$@$ A A A A AA B) B* B+~  B9@  B B A B@ DD?D#\RD [$?B`\B`\?Bñ#*JRBa-?~ BE6j!6=?F4wBp?~ A8@A0IG? A, AC AD AE AFA?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  BF@  B B2OXA~  B+X D%KaD%Ka?DZDDz6?Bu׿Bu?Brh'p6BuY ?~ BEYƟ?FO `?~ AF@A)q'y? A, A A A AFA@A? !A2 "A#A@A&@$ A A A A AA B) B* B+~  BT@  B BkhBG  D }jD }j?Dm?DOq?B ߿B ?BB2Id<BLe?~ BEcX?F>?~ AS@A,B? A, A A A AFA?A? !A2 "A#A@A1@$ A A A A AA B) B* B+~  B.@  B~  B<A B@fA D??D??DjeAڢc@Dkw/@Bk鷱?~ BE{l]?FȬ?~ A"@A? A, A A A A9 A?A@ !A2 "A#A@A@$ A A A A  A A B) B* B+~  B@  B Bq@ B;R@ DZ?DZ?DLB>S@DsdS\P?BmZBmZ?B~?FYt?~ A,@A? A, A; A; A; A; A  A !A2 "A#A @A @$ A A A A AA B) B* B+~  B.@  B B@ 8@ B™@ Djq|?Djq|?D<@(4@D̕V?B`B`?BBB?~ BEw?F7ك?~ A,@Ao;v? A, A A  A! A0~ A?  A !A2 "A"#A@A@$ A# A A# A$ A%A B) B* B+~  B4@  B# BB6-  DCr- ?DCr- ?D{@DG?BHy?BHy?B̫yB0c@ByYb H@~ BEA  D6apCпD6apC?DZF/D$?B_#B_#?Bs@4@BMO?~ BE$؞u:?FEkE5?~ AC@AZz? A, A+ A, A- Ag~ A?  A. !A2 "A/#A@A&@$ A0 A1 A0 A2 A3A B) B* B+~  B$@  B0 B @ B @ DkhF8޿DkhF8?D򝧾\<DLqxם?B0?B0?B1@Bay؂?~ BEn7?F`MK?~ A"@A3? A, A4 A5 A6 Ag Ah  Ah !A2 "A7#A@A@$ A8 A9 A8 A: A;A B) B* B+~  BF@  B8 B`JIA~  BO2  D{gSu4?D{gSu4?D&qĶ/ '@Dj?BZĿBZ?B< $B՟?~ BE^?@?FOM?~ AF@Araңh? A, A< A= A> A,A?A@ !A2 "A?#A2@A4@$ A@ AA A@ AB ACA B) B* B+~  B$@  B@ Bi`@ B@>@ Dn@._?Dn@._?D@A@D[ k?B[?B[?B4@B*r$8O?~ BEOτh?F`X?~ A"@A` ? A, AD AE AF A,A?A? !A2 "AG#A@A@$ AH AI AH AJ AKA B) B* B+~  B@  BH BD@ B `Oœ@ DzIC2?DzIC2?D([s @D\ɹP?B@`@B@`@Bov@Bz[@~ BE՛?Fm?~ A@A;u? A, AL AM AN A, AO  AP !A2 "AQ#A@A@$ AR AS AR AT AUA B) B* B+~  B.@  BR BS@ Bj@ Dݧ$ڿDݧ$?D1>IC8D?BKܿBK?BYJe:B|ɺ?~ BE ?FSP?~ A,@A x0!? A, AV AW AX A,A?A? !A2 "AY#A@A@$ AZ A[ AZ A\ A]A B) B* B+~  BN@  BZ B@w.A B G3A Dfc{?Dfc{?D8@D b E?B'?B'?BO:?@B7/?~ BE D u?FXa?~ AM@AEk? A, A^ A_ A` A,A?A? !A2 "Aa#A"@A,@$ Ab A} Ab A~ AcA B) B* B+~  B@  Bb B@ B @ D\]z?D\]z?D%6-$dB@DN?B ?B ?B'.J@B'}ղ?~ BE8^)?F\?~ A@AKä1? A, AAA A, AA !A2 "Ad#A?A?$ Ae Af Ae Ag AhA B) B* B+~  B`c@  Be BתA~  B.Z DWp*DWp*?D GD|k?B pB p?Btx /KBB`'+J?~ BEd2k>Fbþ?~ A@c@Am0)? A, Ai A Aj A,A?A@ !A2 "Ak#A*@A@@$ Al Am Al An AoA B) B* B+~  B@  Bl B>@ B@b@ D={hD={h?D 4KDRS?BiBi?B9@BYV?~ BEg?Fw?~ A@A ? A, Ap Aq Ar AVA?A? !A2 "As#A@A@$ At Au At Av AwA B) B* B+~  B4@  Bt B@ B@@ DytB?DytB?D݄$H@D+zS|5?Bߢ?Bߢ?B})uT@Bi$*?~ BE[E?Fm?~ A3@AFo>? A, Ax Ay Az A, A  A !A2 "A{#A&@A(@$ A| A} A| A~ AA B) B* B+~  BD@  B| B dA B@,A D'oJ8?D'oJ8?D(J@D!^0?B3?B3?B&6t:Q@B?~ BEEH?F4f?~ AC@A“zl? A, A A A Ag Ah  A  !A2 "A#A @A @$ A A A A AA B) B* B+~  B4@  B B@=@ B VA DaY?DaY?DF'J@D?B ~4?B ~4?B'@BC~?~ BE7*}?Fso?~ A3@A q? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  B@  B B@ B"@ D隋տD隋?Dc4D >W?B `G?B `G?B\i3)@BͰ?~ BEh?F tA?~ A@AC? A, A A A A, A  A !A2 "A#A@A@$ A A A A AA B) B* B+~  BD@  B B A B`%A DW*9?DW*9?Dk5 R@D1)#A?BIt?BIt?BK%Q,@B2_C?~ BEA-)?FE?~ AC@A4i\E>? A, A A A A,A@A@ !A2 "A#A*@A0@$ A A A A AA B) B* B+~  BD@  B B A B"A D~Ͻ-?D~Ͻ-?Dz4t4e@D_(6@B@?B@?ByZ@B]x0|@~ BEl\f?FTLO?~ AC@AA|~? A, A A A A,A?A@ !A2 "A#A @A"@$ A A A A AA B) B* B+~  BV@  B BD5A~  BB Dj5SٿDj5S?D"s7DR?Ba?Ba?BWF@B?~ BEt?F>'?~ A@V@A||? A, A A A A,A?A@ !A2 "A#A(@A6@$ A A A A AA B) B* B+~  B>@  B BM A B@H%A D?D?D+ >@DP*?B?B?Bb+˝@Bv?~ BEkȔ?F)?~ A=@A,ke? A, A A A A,A?A@ !A2 "A#A"@A"@$DGl,22,((,,222$2(,2,, (,2222,,(%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA B) B* B+~  B4@  B BcA B&@ DԸ<߿DԸ@  B B 4@ Bi<@ DP+MDP+M?D`sy D)+?B7B7?BoEB d8?~ BE9}Y?FMt?~ A=@AYY? A, A A A A,A?A@ !A2 "A#A"@A&@$ A A A A AA B) B* B+~  BD@  B Bj>A~  Bغ D?D?DX^*D@Da(_?B ?B ?Byۮ,IQ@B1?~ BEJdk?F(sr6?~ AC@Am W? A, A A A A,A?A@ !A2 "A#A"@A(@$ A A A A AA B) B* B+~  B4@  B BR@ B@$@ D32l?D32l?D{dx3@D{[?Be|?Be|?Be4S\@BIW@~ BE=ytE>?FfH?~ A3@AoE? A, A A A A, A  A !A2 "A#A@A @$ A A A A AA B) B* B+~  B>@  B B'2 A BA DQ~-t?DQ~-t?D R5ҭcR@D" ?Be$?Be$?BIZJrE9@B?~ BE1jٴ|?F`X?~ A=@Ai{G? A, A A A AV~ A?  A !A2 "A#A@A&@$ A A A A AA B) B* B+~  B.@  B B`@ B*h@ DBMTDBMT?D})-5QDXX0?B,YB,Y?B"@n!kJB9f^1/?~ BEdF?F?ש?~ A,@AH;s? A, A A A A, A  AR !A2 "A#A@A@$ A A A A AA B) B* B+~  BD@  B BA B@ D A D@x?D@x?D* :"@D\Us?B B ?Bh BrS?~ BEC ?F[?~ AC@AjTM%? A, A A A A,A?A? !A2 "A#A&@A*@$ A A A A AA B) B* B+~  B$@  B B`@ B@#@ DjDj?DNBDf)?B?B?BA B) B* B+~  B4@  B; B@&A B@A Dd?yDd?y?D&}VGDO8 /?B۰B۰?B] <B.Ǫx?~ BEjN?F 뭞Al?~ A3@AR3? A, A A A? A,A@A@ !A2 "A@#A@A@$ AA AB AA AC ADA B) B* B+~  B$@  BA B@ @ B`@ D=B%D=B%?DD4FD,z?B ɿB ?BcV?[)B/pL?~ BEZ?F(?~ A"@Au? A, AE AF AG A0~ A?  A1 !A2 "AH#A@A@$ AI AJ AI AK ALA B) B* B+~  B4@  BI BwA B`A DAc:?DAc:?DLg@Dv' X@Br\?Br\?B =@B 1*ia?~ BE ѱ?FpC9?~ A3@Ag? A, AMA AN A,A?A? !A2 "AO#A @A&@$ AP AQ AP AR ASA B) B* B+~  B.@  BP B@l@ Bj@ DY 4E?DY 4E?DΌMZ@DX@B?B?BsKcǻQ@BD^uY?~ BEi8Z?F:嫴?~ A,@A? A, AT AU AV A,A?A@ !A2 "AW#A@A@$ AX AY AX AZ A[A B) B* B+~  B@  BX B`@~  B ¸@ DsۿDs?D}Y:D5e^?B{B{?B&`6JJ>BPN?~ BEOxN?Fd7W?~ A@AQ*8? A, A\ A A A,A?A? !A2 "A]#A@A@$ A^ A_ A^ A` AaA B) B* B+~  B.@  B^ B@ Bԓ@ D=9*'D=9*'?DCEn1LDٲ?Ba.Ba.?BaOGBiF{?~ BE"C?FS?~ A,@A8[? A, AAA A, AA !A2 "Ab#A @A @$ Ac Ad Ac Ae AfA B) B* B+~  BD@  Bc B K A~  BkG DƗ?DƗ?D5h@D/5je~@B?Η?B?Η?B?oJ@BY=su?~ BE{?FO `?~ AC@Aʴ? A, Ag Ah Ai A, A  A  !A2 "Aj#A$@A&@$ Ak Al Ak Am AnA B) B* B+~  B$@  Bk By[@ B<@ DF4~DF4~?D&HGD]a?B.B.?BRPLB*wx\2@D>E=?B? ٿB? ?BC9B77Bz<@`?~ BEbߥ?FF/S?~ A3@ASQ? A, Au Av Aw A, A  A !A2 "Ax#A@A@$ Ay Az Ay A{ A|A B) B* B+~  B$@  By B`HA B@ D2d#.D2d#.?DV2ODr?B LGB LG?B%_#OBZ{ȈX?~ BEW3Kf?FDЭ?~ A"@A=/? A, A} A A~ A,A?A@ !A2 "A#A@A@$ A A A A AA B) B* B+~  B.@  B B`B@ Bj @ D9\vzϿD9\vz?Dac'/D?B_=B_=?BBuX^?~ BESbDQ?Fn#?~ A,@A7IG? A, AAA A,A?A? !A2 "A#A@A@$ A A A A AA B) B* B+~  B9@  B BA B@N%A Diu?Diu?DU5"q@DxY @B `!ٿB `!?B &8B9E?~ BEj+?F 4ϝ?~ A8@AaN+? A, A A A A, A  A  !A2 "A#A*@A*@$ A A A A AA B) B* B+~  B@U@  B B A B|A D7)l̿D7)l?DZ ,Dy`o?BǿB?BxH+A(B^QXo?~ BEU#[?Fm?~ AU@AyJf? A, A A A A,A?A? !A2 "A#A0@A8@$ A A A A AA B) B* B+~  B9@  B~  B[ш B  A DQƿDQ?D{VGa2'DI?B_B_?B,EM|HB/(e?~ BEAP?Fn#?~ A8@Api? A, A A A A,A?A@ !A2 "A#A$@A*@$DGl,,(222,,222 2,,(,2(,( .2,2, %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A A A A A A B) B* B+~  B4@  B  B]@  BpE@  D8¯ D8¯? DnK D|*Y? Bܿ B? Bz": BSr?~ B EH? F-D3{?~ A3@ Ad"2? A, A A A Ag Ah  Ah !A2 "A #A@A@$ !A !A !A !A !A!A !B) !B* !B+~ ! BT@ ! B! B:A! Be-A! D`^!D`^?!D9ZE!D a?!BfԿ!Bf?!B#3!B$?~ !B!Ebeja?"Ff?~ "A8@"A<<\r? "A, "AC "AD "AE "AF"A?A@ "!A2 ""A"#A@A@$ #A #A #A #A #A#A #B) #B* #B+~ # B@ # B# B !@# B`&A# D"9\?#D"9\?#Df7Z\E@#DlF?#B?W{?#B?W{?#B9(`G@#BTJR]?~ #B#E#?#F/ؿ?~ #A@#A4:m$? #A, #A #A #A #A #A # A #!A2 #"A##A?A?$ $A $A $A $A $A$A $B) $B* $B+~ $ B.@ $ B$ BN@$ Br@$ DjYɌ?$DjYɌ?$D!8@$D8q5?$B >?$B >?$BRi,'@$B9ė?~ $B$EjLQ ?$FIA8 ?~ $A,@$Arb? $A, $A $A $A $A $A $ A $!A2 $"A$#A@A@$ %A %A %A %A %A%A %B) %B* %B+~ % B@ % B% B`@~ % B@% D6(%D6(?%D< ?%Dfg?%B9%B9?%B̛rA%B}^?~ %B%EGj?%Ftpv?~ %A@%AZO,.? %A, %A %A %A %A %A % A %!A2 %"A%#A?A?$ &A &A &A &A &A&A &B) &B* &B+~ & B@ & B& B `@& B ඵ@& D_?&D_?&D'cS\:@&Dd`7?&Bˢ?&Bˢ?&Bcu;J@&B5 :F{?~ &B&E1?&Fh$r?~ &A@&AI0k? &A, &A &A &A &A9 ~ &A? & A5 &!A2 &"A&#A?A?$ 'A 'A 'A 'A 'A'A 'B) 'B* 'B+~ ' B9@ ' B' B>A' B M:A' Dz ̿'Dz ?'Dg|),'D~Rk~?'B ߿'B ?'Bͦ1='Bj?~ 'B'EX4x#?'F?~ 'A8@'AE0? 'A, 'A 'A 'A 'A; 'A< ' A= '!A2 '"A'#A@A@$ (A (A (A (A (A(A (B) (B* (B+~ ( BD@ ( B( B@` A( B8@( D_(D_?(Duzw]F(D~ܛ?(B%ʿ(B%?(BgAg*(Bli?~ (B(E ?(F]{?~ (AC@(Aޞ? (A, (A (A (A (Ag (Ah ( A  (!A2 ("A(#A @A$@$ )A )A )A )A )A)A )B) )B* )B+~ ) B9@ ) B~ ) B@) B@) DE宫)DE宫?)D\m )D\?)Bi?)Bi?)B1IA1@)B 4R?~ )B)Er:i?)Fc9?~ )A8@)A}? )A, )A )A )A )A )A ) A )!A2 )"A)#A(@A*@$ *A *A *A *A *A*A *B) *B* *B+~ * B@ * B~ * BȺ@* Bӷ@* D:GZq*D:GZq?*Dfz Q*D8Z?*B@*B@?*Bj-Q*Br?~ *B*EgA>^?*Fp˕G?~ *A@*Aa? *A, *A *A *A *A0*A?A? *!A2 *"A*#A@A@$ +A +A +A +A +A+A +B) +B* +B+~ + B@ + B+ Bg"@+ BF@+ Dc)?+Dc)?+Dհ[@+D3$B@+B|?+B|?+B kR@+B::3?~ +B+E,+]?+Fj3?~ +A@+A'Jo? +A, +AAA +AF+A?A? +!A2 +"A+#A?A?$ ,A ,A ,A ,A ,A,A ,B) ,B* ,B+~ , B.@ , B, Bŕ@, B:@, D3.3>,D3.3>?,D}z@,Dy|lm?,B0f,B0f?,BuD,Btl?~ ,B,E6Ӟ?,F]D @?~ ,A,@,AX n? ,A, ,A ,A ,A ,A9 ~ ,A? , A ,!A2 ,"A ,#A@A@$ -A -A -A -A -A -A -B) -B* -B+~ - B$@ - B - B@"A- B`@- De-De?-Dl^Q-D[iNW?-B? ~?-B? ~?-B :^@-BK1@~ -B-E.Pc?-F^mh ?~ -A"@-A!b? -A, -A -A -A -A0~ -A? - A -!A2 -"A -#A@A@$ .A .A .A .A .A .A .B) .B* .B+~ . B.@ . B . BC-A~ . Be?. DAt.DAt?.D3`ƃrB.Dec?.B@D.B@D?.B#Wy.B Kd?~ .B.EJ? ?.Fno3?~ .A,@.AzG ? .A, .A .A .A .Ag .Ah . Ah .!A2 ."A .#A@A@$ /A /A /A /A /A /A /B) /B* /B+~ / BA@ / B / BpA/ B _""A/ D>V?/D>V?/D5e~.j@/D~@/Be?/Be?/B?6V:@/BT6?~ /B/Eh9t?/FKh?~ /AA@/ASl? /A, /A /A /A /A,/A?A@ /!A2 /"A /#A"@A*@$ 0A 0A 0A 0A 0A 0A 0B) 0B* 0B+~ 0 BA@ 0 B ~ 0 BkU0 BA0 Dhw 0Dhw ?0Dzō 0D# ?0Bؕ0Bؕ?0B\Zo0BG?~ 0B0E*1>?0F(?~ 0AA@0A L? 0A, 0A 0A 0A 0A,0A?A@ 0!A2 0"A 0#A0@A3@$ 1A! 1A" 1A! 1A# 1A$ 1A 1B) 1B* 1B+~ 1 B>@ 1 B! 1 Bi A1 B(A1 D?1D?1DsϼRq@1Dxv,@1B..1B..?1BTF@1Bdie?~ 1B1E&>?1FOM?~ 1A=@1AFT? 1A, 1A% 1AH 1A& 1A,1A?A@ 1!A2 1"A' 1#A@A@$ 2A( 2A) 2A( 2A* 2A+ 2A 2B) 2B* 2B+~ 2 B>@ 2 B( ~ 2 Bq2 B /A2 D9?3ɿ2D9?3?2Dǃ)2D~)C?2B2B?2BW$2B}?~ 2B2EF?2F^ld\?~ 2A=@2A]? 2A, 2A, 2A- 2A. 2A,2A?A? 2!A2 2"A/ 2#A@A@$ 3A0 3A1 3A0 3A2 3A3 3A 3B) 3B* 3B+~ 3 B$@ 3 B0 3 B}o@3 B`i@3 D#˿3D#?3D U+3DzT?3E)%3E)%?3Bk`f3Bnx_?~ 3B3Ea)=?3F!B?~ 3A"@3A+? 3A, 3A4 3A5 3A 3A,3A?A@ 3!A2 3"A6 3#A@A@$ 4A7 4A8 4A7 4A9 4A: 4A 4B) 4B* 4B+~ 4 B4@ 4 B7 4 B@ A4 B A4 Dnj ?4Dnj ?4D@V7S@4D\/-?4B`?4B`?4BGcɐV@4B۷$q?~ 4B4ExNm?4F]6?~ 4A3@4Aenk? 4A, 4A; 4A< 4A= 4AV~ 4A? 4 A 4!A2 4"A> 4#A@A @$ 5A? 5A@ 5A? 5AA 5AB 5A 5B) 5B* 5B+~ 5 B>@ 5 B? 5 B@qA5 B@4 A5 DYy1p?5DYy1p?5D̸2a?@5DFdk?5B?5B?5B dA+@5B~߉6?~ 5B5EHwU?5F*?~ 5A=@5A``mx? 5A, 5AC 5AD 5AE 5A,5A?A@ 5!A2 5"AF 5#A*@A1@$ 6AG 6AH 6AG 6AI 6AJ 6A 6B) 6B* 6B+~ 6 B>@ 6 BG 6 B ' A6 B c A6 D@M1L6D@M1L?6D5?M6D"C_?6B SX?6B SX?6B/LD$@6BV\ͫ?~ 6B6E޵?6FH?~ 6A=@6A ? 6A, 6AK 6AL 6AM 6A,6A?A@ 6!A2 6"AN 6#A$@A(@$ 7AO 7AP 7AO 7AQ 7AR 7A 7B) 7B* 7B+~ 7 B@P@ 7 BO 7 B3Bz 7 D&T 7D&T ?7Dp|Q7DhjaY ?7Bp7Bp?7B'?N7BZG?~ 7B7EGļF+>7F2x>~ 7AP@7A'0ד? 7A, 7A 7A  7A 7A,7A?A@ 7!A2 7"AS 7#A@A*@$ 8AT 8AU 8AT 8AV 8AW 8A 8B) 8B* 8B+~ 8 B$@ 8 BT 8 BCA8 BA8 D=f8D=f?8D[aB8D !?8B@ ܿ8B@ ?8B@/2:8Boi?~ 8B8E/UO?8F?OH?~ 8A"@8Ax2G? 8A, 8AX 8AY 8AZ 8AV~ 8A? 8 A[ 8!A2 8"A\ 8#A@A@$ 9A] 9A^ 9A] 9A_ 9A` 9A 9B) 9B* 9B+~ 9 B>@ 9 B] 9 B1B 9 Do=~?9Do=~?9Dk?9DT?9B U?9B U?9Bi}(A@9BXU[s?~ 9B9E @P?9Fd7W?~ 9A=@9AD? 9A, 9Aa 9Ab 9Ac 9A,9A?A@ 9!A2 9"Ad 9#A(@A*@$ :Ae :Af :Ae :Ag :Ah :A :B) :B* :B+~ : B.@ : Be : B@@: B@@: D4:D4?:DMpA:D ?:B)ۿ:B)?:BPd&9:B@O?~ :B:Ej}7v?:F^nˮl?~ :A,@:AȤ? :A, :Ai :A= :Aj :A,:A?A? :!A2 :"Ak :#A@A@$ ;Al ;Am ;Al ;An ;Ao ;A ;B) ;B* ;B+~ ; B>@ ; Bl ; B2B<# ; D\ ;D\ ?;D/FQ;D~"?;B?$;B?$?;Bn^F;BjHd?~ ;B;E`V ?;FFV?~ ;A=@;AD"s? ;A, ;Ap ;Aq ;AM ;A,;A?A? ;!A2 ;"Ar ;#A@A@$ <As <At <As <Au <Av <A <B) <B* <B+~ < B.@ < Bs < B@< B@/@< D>K<D>K?<DrOXl]J<D2s@?<B@,<B@,@<B#R<B]pf?~ <B<E>k=?<F>|?~ <A,@<AA.Or? <A, <Aw <Ax <A <A, <A < A  <!A2 <"Ay <#A@A@$ =Az =A{ =Az =A| =A} =A =B) =B* =B+~ = B$@ = Bz = B@= B`@= D1gۿ=D1g?=DQh:=D73?=B?A޿=B?A?=B;?A;=B|=p?~ =B=EլG?=F+t??~ =A"@=A[$? =A, =A~ =A =A= =A, =A = A  =!A2 ="A =#A@A@$ >A >A >A >A >A >A >B) >B* >B+~ > B.@ > B > B@T@> Bݨ@> Dj2?>Dj2?>Dp 0#@>D)BX톿>BX?>B&>Bǰ?~ >B>EN?>F/?~ >A,@>AlP? >A, >A >A >A >Ag >Ah > A  >!A2 >"A >#A@A@$ ?A ?A ?A ?A ?A ?A ?B) ?B* ?B+~ ? BD@ ? B ? B`B/A~ ? BNe+? D-}u?D-}u??Dgb>?DF~ 6??BT??BT??Bn7??B?~ ?B?EZĻ??F?~@?~ ?AC@?A2B? ?A, ?A ?A ?A ?A,?A?A@ ?!A2 ?"A ?#A"@A&@$DGl2,(22.222.(22.,(,(,2,,2,222@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A @A @A @A @A @A @B) @B* @B+~ @ B$@ @ B @ B `m@@ Bί@@ D{bŗ;?@D{bŗ;?@D>6H@@D9?@BMԿ@BM?@BM,˼3@B%?~ @B@EsF/H!?@F?~ @A"@@Atxr)? @A, @A @A @A @A,@A?A@ @!A2 @"A @#A@A@$ AA AA AA AA AA AA AB) AB* AB+~ A B@ A B A B ƣ@~ A B4@A DLADL?ADUSİJADukeu?AB @AB @AB%H-@AB@~ ABAE=A'?AF&9?~ AA@AA'@ AA, AA AA AA AA,AA?A@ A!A2 A"A A#A@A@$ BA BA BA BA BA BA BB) BB* BB+~ B B@ B B B B_@B BM@B D(gq?BD(gq?BDwvG@BD*?BBq BBq @BB[J-wJSBBEt;?~ BBBEtnk?BF:嫴?~ BA@BA/eT@ BA, BA BA BA BA~ BA? B A B!A2 B"A B#A?A?$ CA CA CA CA CA CA CB) CB* CB+~ C BQ@ C B C BAC BAC Dq׺ZӿCDq׺Z?CD<)2CDb?CB?CB?CB\?q[6@CB Ao?~ CBCEF`?CFQ?~ CA@Q@CAgw[? CA, CA CA CA CA, CA C A  C!A2 C"A C#A,@A1@$ DA DA DA DA DA DA DB) DB* DB+~ D B4@ D B D Bg@D B\@D D&CDD&C?DD}$LDD۳ @s?DB{DB{?DBVzDB<?~ DBDE(?DF#h2?~ DA3@DAW.? DA, DA DA DA DA,DA?A@ D!A2 D"A D#A @A$@$ EA EA EA EA EA EA EB) EB* EB+~ E B.@ E B ~ E B{,E Bk AE D +>?ED +>?EDpYN@EDxk?EB@gEB@g@EBmSEB{]7?~ EBEE]\]?EF1gN}H?~ EA,@EA-0? EA, EA EA EA EA,EA?A? E!A2 E"A E#A@A@$ FA FA FA FA FA FA FB) FB* FB+~ F BI@ F B F B+AF B@ 'AF D$y5-FͿFD$y5-F?FDŌQ-FD;.O?FBm7?FBm7?FBN -33@FB\m?~ FBFEF:&?FF?~ FAH@FA3$ ? FA, FA FA FA FA,FA?A? F!A2 F"A F#A3@A3@$ GA GA GA GA GA GA GB) GB* GB+~ G B$@ G B G BuB G DB̅)GDB̅)?GDp ?GD~L?GBfGBf?GBɽCGB*ra3?~ GBGE6`p?GF?~ GA"@GA=/ݽ? GA, GA GA GA GAV GA~ G A? G!A2 G"A G#A?A@$ HA HA HA HA HA HA HB) HB* HB+~ H B9@ H B H B`'A~ H B!]JH D-/ni@HD-/ni@HD9r@HDԺ,JX@HB?HB?HBW7P@HBk1-?~ HBHEH(PhU?HFm?~ HA8@HAE^i? HA, HAA HA HA,HA?A? H!A2 H"A H#A@A @$ IA IA IA IA IA IA IB) IB* IB+~ I BI@ I B I BG`7 BA I DڿID?IDZ9IDFi *?IBl3IBl3?IB'eeJ@IBw$JN?~ IBIE 5%l?IFRU1?~ IAH@IA«? IA, IA IA IA IA,IA?A@ I!A2 I"A I#A$@A(@$ JA JA JA JA JA JA JB) JB* JB+~ J BQ@ J B J B`Q4AJ B`6,AJ D" XJD" X?JD +ַR?JD?JBJB?JBSJBⲆwp>?~ JBJEa.?JFno3?~ JA@Q@JA7QD? JA, JA JA JA JA,JA?A? J!A2 J"A J#A(@A6@$ KA KA KA KA KA KA KB) KB* KB+~ K BN@ K B K B@pAK B@9AK D`KD`?KD{z?KDIUpW??KB`vKB`v?KB~IKBK^?~ KBKEJE3?KFf?~ KAM@KA'?? KA, KA KA KA KA,KA?A? K!A2 K"A K#A*@A1@$ LA LA LA LA LA LA LB) LB* LB+~ L B4@ L B L B;\@L Bx@L Dj      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghiklmnopqrstuvwxyz{|}~@?LDj@?LD}{u?3@LDNed?LB?LB?LB-@LB?~ LBLEnpH?LF)?~ LA3@LA1H? LA, LA LA" LA LA,LA?A@ L!A2 L"A L#A@A@$ MA MA MA MA MA MA MB) MB* MB+~ M B.@ M B M B@ (@M Bs@M DSi?MDSi?MD^|]@MD\2Ƽu@MBMB?MB^DMBS0?~ MBME&6?MF{?~ MA,@MA P0~? MA, MA MA MA MA,MA?A@ M!A2 M"A M#A,@A1@$ NA NA NA NA NA NA NB) NB* NB+~ N BK@ N B N B//B+S, N D |#6ND |#6?ND"6PhND!m0?NB_',ܿNB_',?NBVxSK:NBJtʕ?~ NBNEe|X?NFc5A?~ NAK@NA*y? NA, NA! NA! NA! NA, NA N A N!A2 N"A!N#A(@A0@$ OA! OA! OA! OA! OA!OA OB) OB* OB+~ O B4@ O B!O B@O B@'AO DxpO @ODxpO @ODs`먉@ODl"@OB?Sm?OB?Sm?OB1& a@OBΧa@~ OBOE\p>?OF-O$W?~ OA3@OAחU? OA, OA! OA OA} OA,OA@A? O!A2 O"A !O#A$@A(@$ PA ! PA ! PA ! PA ! PA !PA PB) PB* PB+~ P B@ P B !P Bn@P B`~@P DJPDJ?PDv"BPD(#;?PB ]PB ]?PB0fEb%KPB@?~ PBPEh˭?PFSr?~ PA@PA|$01@ PA, PA! PA! PA! PA,PA?A? P!A2 P"A!P#A@A@$ QA! QA! QA! QA! QA!QA QB) QB* QB+~ Q BD@ Q B!~ Q BAQ B`æAQ D.jY[LMQD.jY[LM?QDЭ?FQD2ΙU?QBQRQBQR?QB|r~BQB)?~ QBQE ]|?QF =Z _?~ QAC@QA.cEs? QA, QA! QA! QA! QA,QA?A@ Q!A2 Q"A!Q#A*@A.@$ RA! RA! RA! RA! RA!RA RB) RB* RB+~ R B>@ R B!R Bc)B R D{==RD{==?RDC&lHRDvi6^?RBLwRBLw?RB*62ERBn?~ RBRE~#RM?RF&j}?~ RA=@RAф@H? RA, RALRA RAM RAFRA?A? R!A2 R"A!R#A@A@$ SA! SA ! SA! SA!! SA"!SA SB) SB* SB+~ S B.@ S B!S B@S BjJ@S DXD]SSDXD]S?SD (EMSDvFT݇?SBdR?SBdR?SBi',@SB'Ͽo@?~ SBSEBP?SFJ ž'?~ SA,@SANX? SA, SA#! SA$! SA%! SASA?A? S!A2 S"A&!S#A@A@$ TA'! TA(! TA'! TA)! TA*!TA TB) TB* TB+~ T BA@ T B'!T BAT BAYAT Dd k?TDd k?TDwd@@TD&ITL?TB q?TB q?TBF8@TB{5?~ TBTE(Xߔ?TF ?~ TAA@TA =3}? TA, TA+! TA,! TA-! TA0~ TA? T A1 T!A2 T"A.!T#A*@A.@$ UA/! UA0! UA/! UA1! UA2!UA UB) UB* UB+~ U B$@ U B/!U B<~@BHX@ U D[11UD[11?UD^wOUDrx?UB?UB?UBgkTx@UBST?~ UBUE\~/?UFn#?~ UA"@UAw!f%? UA, UA3! UA4! UA5! UA UA U A U!A2 U"A6!U#A@A@$ VA7! VA8! VA7! VA9! VA:!VA VB) VB* VB+~ V B9@ V B7!V BB@V B BT@V D ,?VD ,?VDn:s M(@VD2o?VBߺVBߺ?VBBVB8`h?~ VBVE*qy?VFfc>?~ VA8@VAm? VA, VA;! VA!V#A @A&@$ WA?! WA@! WA?! WAA! WAB!WA WB) WB* WB+~ W B@ W B?!W B )@W B`@W Ds<WDs9˿]D>9?]D2`ڔj+]DW>?]B]B?]B;3V ]Bx ?~ ]B]E9+-aD¹$>-?aDWV@KaDqZJ?aBg?aBg?aBY@aBx$QH@~ aBaE}?aF֍~=?~ aAA@aAFs? aA, aAAA aAFaA?A@ a!A2 a"A!a#A@A @$ bA! bA! bA! bA! bA!bA bB) bB* bB+~ b B@ b B!b B @b B`.@b D@ꐉbD@ꐉ@bDA[fTbD چ?bB_4bB_4?bBd!NQbBb]?~ bBbEׯm$?bFw'o?~ bA@bA$? bA, bA! bA! bA! bA9 bA?A? b!A2 b"A!b#A?A?$ cA! cA! cA! cA! cA!cA cB) cB* cB+~ c B@ c B!c B@ݥ@c B^@c D]fC?cD]fC?cD܏Vuۥ;@cDɺul?cBz¿cBz?cB-* t#cBi 1?~ cBcE"?cFno3?~ cA@cA*6? cA, cA! cA! cA! cA~ cA? c A! c!A2 c"A!c#A?A?$ dA! dA! dA! dA! dA!dA dB) dB* dB+~ d B$@ d B!d Bf@d B)@d DjcaZdDjcaZ?dD2sdLMdD;T.?dBadBa?dB" z|QdBuF?~ dBdEr+R?dFzS][?~ dA"@dAu3w? dA, dA! dA! dA! dAg dAh d Ah d!A2 d"A!d#A@A@$ eA! eA! eA! eA! eA!eA eB) eB* eB+~ e B@ e B!e B D@e B^@e D.'m?eD.'m?eDJߛ^@eDA$\F@eB m?eB m?eB5md@eBV2y#@~ eBeERK-?eFY?~ eA@eAZ.|s? eA, eA! eA! eA! eA,eA?A? e!A2 e"A!e#A?A?$ fA! fA! fA! fA! fA!fA fB) fB* fB+~ f B@ f B!f B@~ f B|@f DͯG?fDͯG?fD>OJn/@fD䐯_?fB@vfB@v?fBVfB2_I?~ fBfE'&?fF7 ?~ fA@fA#k? fA, fA! fA! fA! fA, fA  f A f!A2 f"A!f#A@A@$ gA! gA! gA! gA! gA!gA gB) gB* gB+~ g B.@ g B!g Bk@g B y@g D w?gD w?gDKG@gDt T?gBgB?gBV+lW)DgB!J?~ gBgEG ?gFcL?~ gA,@gAw? gA, gA! gA! gA gA,gA?A@ g!A2 g"A!g#A@A@$ hA! hA! hA! hA! hA!hA hB) hB* hB+~ h BR@ h B!h B>B̸A h DhD?hDhO6 KhDa?hB hB ?hB61H\OhB1?~ hBhEmT>hF.t?~ hAR@hAQJl\\? hA, hA hA  hA hA,hA?A@ h!A2 h"A!h#A @A0@$ iA! iA! iA! iA! iA!iA iB) iB* iB+~ i B4@ i B!i BAi B`^Ai DUrprwiDUrprw?iD+cٿiD7?iB?o^iB?o^?iB IqiB u4?~ iBiEܙI_?iFj"A?~ iA3@iAac? iA, iA! iA! iA! iA,iA?A@ i!A2 i"A!i#A@A@$ jA! jA! jA! jA! jA!jA jB) jB* jB+~ j BD@ j B!j B EAj B` Aj DAԊ?jDAԊ?jDh(@jDSMZ?jB`#:ҿjB`#:?jBb1jBfI[tD?~ jBjE*`s?jFj?~ jAC@jA9jµ? jA, jA! jA! jA! jA,jA?A? j!A2 j"A!j#A @A$@$ kA! kA! kA! kA! kA!kA kB) kB* kB+~ k B@ k B!k Bx@k B `ή@k D޿kD?kDVB<kD?kB`{߿kB`{?kBaS\<kB *?~ kBkE^0?kF&9?~ kA@kA/f? kA, kAc kA! kA! kA,kA?A? k!A2 k"A!k#A?A?$ lA! lA! lA! lA! lA!lA lB) lB* lB+~ l B$@ l B!l B`@l Bu@l DI3UœۿlDI3Uœ?lD>9lD3׼?lB?lB?lB71SQ@lBOH ?~ lBlE lm?lF%h?mB?hؿmB?h?mBd~7mBelF{?~ mBmE@K ?mFo?~ mA,@mAe~?? mA, mA! mA! mA! mA,mA?A@ m!A2 m"A!m#A@A@$ nA! nA! nA! nA! nA!nA nB) nB* nB+~ n B.@ n B!n B An B An Dg$ۡnDg$ۡ?nD!0 nD?nB 8?nB 8?nBݍzY@nBWj"'@~ nBnE;4HJ?nFm-#?~ nA,@nAg^%? nA, nA! nA! nA! nA,nA?A@ n!A2 n"A!n#A*@A0@$ oA! oA! oA! oA! oA!oA oB) oB* oB+~ o B4@ o B!o B%4@o B`[@o D~DzPj߿oD~DzPj?oDE<oDj?oBԿoB?oBqg3oBf@E?~ oBoET4?oFm?~ oA3@oA `2eM? oA, oA! oA! oA! oA,oA?A@ o!A2 o"A!o#A*@A0@$ pA! pA! pA! pA! pA!pA pB) pB* pB+~ p B$@ p B!p B?@p B1K@p DM?pDM?pDOi@pD,cf#@pB/5?pB/5?pBD3=i@@pBXe@?~ pBpE|??pFЙ?~ pA"@pA Tp? pA, pA! pA! pA" pA pA p A p!A2 p"A"p#A@A@$ qA" qA" qA" qA" qA"qA qB) qB* qB+~ q BF@ q B"q B T$@ t B"~ t B2t B`?At D@ Q_tD@ Q_?tDLlTtDEb+?tB+?tB+?tB3s.@tBЧo?~ tBtE0?Į?tFzp/?~ tA=@tA:V=6? tA, tA" tA" tA " tA, tA t AR t!A2 t"A!"t#A @A(@$ uA"" uA#" uA"" uA$" uA%"uA uB) uB* uB+~ u B.@ u B""u B@w @u B`s(@u D3B-uD3B-?uD-!OuDJMr?uB?MuB?M?uB)84AuBܿ ?~ uBuE??uFh+a?~ uA,@uAm*۾-.? uA, uA&" uA'" uA(" uAV~ uA? u A u!A2 u"A)"u#A@A@$ vA*" vA+" vA*" vA," vA-"vA vB) vB* vB+~ v B$@ v B*"v Bӕ@v B,@v Dǯ̽vDǯ̽?vDvDx?vBvB?vB9.vBтS?~ vBvEݯ(?vF6^u?~ vA"@vA!:d1? vA, vA." vA/" vA0" vA,vA?A@ v!A2 v"A1"v#A@A$@$ wA2" wA3" wA2" wA4" wA5"wA wB) wB* wB+~ w B.@ w B2"w B\Aw B@ @w D\wD\?wDFVgQwD&AYq?wB`wB`?wB@wBv ]?~ wBwE#1?wF_i_V?~ wA,@wA܅Y? wA, wA6" wA7" wA8" wA9 ~ wA? w A[ w!A2 w"A9"w#A@A@$ xA:" xA;" xA:" xA<" xA="xA xB) xB* xB+~ x B9@ x B:"x B=@x B@x DRW?xDRW?xDFR@xD%<,$?xB e@xB e@xBuuU~@xB14A)j@~ xBxE/?7?xFx,?~ xA8@xAm? xA, xA>"xA xA? xA,xA?A? x!A2 x"A?"x#A@A@$ yA@" yAA" yA@" yAB" yAC"yA yB) yB* yB+~ y BA@ y B@"~ y BW<y B pAy D-26zڿyD-26z?yD[Ry:9yD 5.?yBRɿyBR?yBǠ)yBkyF?~ yByE#M~&@}BA ?~ }B}E[k|?}Fn#?~ }A@}A_賐 @ }A, }Ac" }Ad" }Ae" }A,}A?A@ }!A2 }"Af"}#A@A@$ ~Ag" ~Ah" ~Ag" ~Ai" ~Aj"~A ~B) ~B* ~B+~ ~ B4@ ~ Bg"~ B}MA~ B`m A~ DH$?~DH$?~DMg4@~D [kC?~B0?~B0?~B0?~B@J<5_G?~ ~B~E`O ?~FD$]?~ ~A3@~A`m? ~A, ~Ak" ~Al" ~Am" ~A,~A?A@ ~!A2 ~"An"~#A@A@$ Ao" Ap" Ao" Aq" Ar"A B) B* B+~  B9@  Bo"~  B7A B@A Do ?Do ?D!jU@D?BjBj?BŠp;CB?~ BE#io?~ BEIZ?Fn#?~ AA@AU? A,A A" A" A,A?A? !A2 "A"#A"@A&@$ A" A" A" A" A"A B) B* B+~  BA@  B" Bo@ B A D`s`?D`s`?DFxF@D++P?B+?B+?Bf-) EeK@B ??~ BE7?F`:?~ AA@AIu? A, A"A A" A,A?A? !A2 "A"#A@A @$ A" A" A" A" A"A B) B* B+~  B$@  B" B@|b@ B@ Di6a9?Di6a9?DշS@D-@  B" BA BA DѿD?DV+51Dj@wd?BB?B-֎B2'?~ BE!˿3?F[ݤ?~ A=@Av? A, A" A" A" A9 ~ A?  AR !A2 "A"#A @A @$ A" A" A" A" A"A B) B* B+~  B@  B" BomCB'ތ%  DnADnA?DH%'FDV?B@B@?BX:ABv?~ BEBT?FSP?~ A@ARdz? A, AC AD AE AFA?A@ !A2 "A"#A?A?$ A" A" A" A" A"A B) B* B+~  B.@  B" B?@ BH@ D-;m*RuD-;m*Ru?D9 ׿Dt?B@[t?B@[t?B0iE@B*?~ BEf?FPY#?~ A,@Aij? A, A" A" A" A A~  A" !A2 "A"#A@A@$ A" A" A" A" A"A B) B* B+~  B@  B" B`@ B@ M@ D`+fxڼD`+fxڼ?DADf#h?B@_B@_?BvABC9?~ BEH7?Fjq@  B" BB0J  D&V&5D&V&5?DA8RDWA?B`/B`/?BNBLT?~ BE‹.F?F9w?~ A=@At? A, AC AD AE AFA@A? !A2 "A"#A@A@$ A" A" A" A" A"A B) B* B+~  B.@  B" B`A BഊA DY4Y/l:DY4Y/l:?D"| kDPj?Bθ?Bθ?BOw N@Bۅ/?~ BEwF?F8,?~ A,@AP&?*? A, A# A# A# Ag Ah  Ai !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  B$@  B# BA B:y@ DR՛_DR՛_?D RD.p?B?DcB?Dc?Bn N=IPBANN?~ BEg"?F HOQ?~ A"@A7RNN1? A, A# A # A # Ar As  Am !A2 "A ##A@A@$ A # AP A # A # A;A B) B* B+~  B9@  B #~  B=i BA D9R- D9R- @Dk VDi(?B?f*B?f*?B%8ߞQB}*?~ BE`C|TS?FZp?~ A8@A5X? A, AAA AFA?A? !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  B.@  B# BT@ B@K?@ D8# A0A?A? !A2 "A?##A@A@$ A@# A A@# AA# AB#A B) B* B+~  B@  B@# B@ B@ DiDi?Da;+DD{@  BT# BBjB"  DfDf?DSn(BD>L?B`B`?Bۮ,PB5$,ٗ?~ BE&D ?Fe9sW?~ A=@A4=>P? A, A A  A A,A?A@ !A2 "AX##A@A@$DGl,22$(2222,,2,22222,222.(,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ AY# AZ# AY# A[# A\#A B) B* B+~  BD@  BY#~  B+J B@@,A D7*տD7*?D@˖x|4DTwq?BB?BA’H;BUV?~ BEI=q?FE?~ AC@AJ`촖U? A, A]# A^# A_# A,A?A@ !A2 "A`##A1@A2@$ Aa# Ab# Aa# Ac# Ad#A B) B* B+~  BF@  Ba# BA B @ Dw,Dw,?DT/DDjA?Bu?Bu?B͉cS@B\s+҅?~ BE ?F)9O"?~ AF@Avq? A, Ae# Af# Ag# A, A  AR !A2 "Ah##A*@A2@$ Ai# Aj# Ai# Ak# Al#A B) B* B+~  B@  Bi# B@ B@@ D1D1?D=D y/?BſB?BJeK+&Bs?~ BE?w?FѮ?~ A@AU'O? A, Am# An# Ao# A, Ap#  Aq# !A2 "Ar##A?A?$ As# At# As# Au# Av#A B) B* B+~  B>@  Bs# BB~  D3D3?D@.^RD6?B#OB#O?BADSFBPԟ?~ BEsڑ?F1ǪK?~ A=@A ,L? A, Aw# Ax# Ay# A,A?A@ !A2 "Az##A@A@$ A{# A|# A{# A}# A~#A B) B* B+~  B@P@  B{# B` A B@bZA DeN.tӿDeN.t?D'wt3D5 @?B_#MB_#M?B9BpBо?~ BEgɚ?FS=G?~ AP@A s"? A, A# A# A# A,A?A? !A2 "A##A*@A3@$ A# A# A# A# A#A B) B* B+~  B.@  B# B`@ B`g4@ Dvk ϿDvk ?DWd.DDlj ?B`mĿB`m?B#{,%B?~ BE?F|:4p?~ A,@Aĵi? A, A# A# A# A, A  A !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  B.@  B# B`_@ B`@ DTS)޿DTS)?D;Dff?BKBK?B/EFBB́vM?~ BEY?Fil?~ A,@A~^?? A, A# A# A# A,A?A@ !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  B9@  B# B@h6A B@|A Dna`?Dna`?DELhm@B~ui @~ BEXS?FO `?~ A"@A`$a? A, A# A# A# A,A?A? !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  BD@  B# B`Z4A B`C%A D.2D.2?DF1foGD;@B's?~ BE*H`?Fj"A?~ A@Ax^'? A, A# A# A# A, A  AR !A2 "A##A?A?$ A# A# A# A# A#A B) B* B+~  B>@  B# BZh@ B@o@ DŕDŕ?D1RDN.ǵ?B gB g?BHHMBr[~?~ BE"$?F1gN}H?~ A=@ATh? A, A# A# A# A, A  A !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  B@  B# B@D@ Bz@ DڿD?D8DfaI#?B@0B@0?Bf:[B n{?~ BE2dRԌ?F0pI?~ A@Ae@ ? A, A#A Ao A,A?A? !A2 "A##A@A@$ A# A# A# A# A#A B) B* B+~  B9@  B# B##A Blr$A Dm+k?Dm+k?Dd?W@Dͧ?B,tB,t?BV֚GBcY@@?~ BEl"g?F|e?~ A8@A 9!=K7? A, AA A A,A@A? !A2 "A##A"@A$@$ A# A# A# A# A#A B) B* B+~  B$@  B# B@`Z@ B@ D{qѿD{q?DJ 1D01N`?B B ?BVB[?~ BE/2?Fno3?~ A"@A|&? A, A# A# A# A# A#  A# !A2 "A$#A@A@$ A$ A$ A$ A$ A$A B) B* B+~  B$@  B$ BH@ B i@ D1D1@D)wTDSvS4?B?B?Bkp@@B.>hV?~ BE6ZJn?F./M?~ A"@A3@@ A, A$ A$ A$ Ag Ah  A  !A2 "A$#A@A@$ A $ A $ A $ A $ A $A B) B* B+~  B.@  B $ B:EB[H;t  D_{tD_{t?Dwc!D57?BB?Bqy{B=.t[?~ BE cU3?FVR?~ A,@A[ -? A, A $ A$ A$ A,A?A? !A2 "A$#A?A@$ A$ A$ A$ A$ A$A B) B* B+~  B$@  B$ B@ B@Y@ D^U޿D^U?D5?ȗ<D-R&4 ?BڿB?B>æ 9B.f?~ BEPG?FOM?~ A"@AJ? A, A$ A$ A$ A,A?A? !A2 "A$#A@A@$ A$ A$ A$ A$ A$A B) B* B+~  B$@  B$ B E@ B=@ D cD c?DdcſDBO?B?B?BY@B!S?~ BEX<?FvF_`?~ A"@ASS_P? A, A$ A$ A$ A; A  A $ !A2 "A!$#A@A@$ A"$ A#$ A"$ A$$ A%$A B) B* B+~  B$@  B"$ Bg @ BsA D::?D::?D6 ڥW@Dw"?B?B?B@,8P@B{?~ BE+0jOv?FG0tG?~ A"@A͊zx? A, A A A&$ Ag A   Ah !A2 "A'$#A@A@$ A($ A)$ A($ A*$ A+$A B) B* B+~  B@Z@  B($ B`6pAB"  D5 D5 ?DhP+D+-jw?BB?BT 7GB߭5?~ BEuh?F5q?~ AZ@A!,i? A, A A A A,A?A? !A2 "A,$#A$@A5@$ A-$ A.$ A-$ A/$ A0$A B) B* B+~  B>@  B-$ B;N9A~  Bg) DwiDwi@DfS(>xSDxFP?B!ؿB!?BHXdz7Bh|?~ BEO%?Fm?~ A=@A?kV? A, A1$ A A2$ A A  A !A2 "A3$#A"@A$@$ A4$ A5$ A4$ A6$ A7$A B) B* B+~  B9@  B4$ B`0A~  BO Di۠N?Di۠N?D_0@DuKܾ?B?B?B//OI+@B.?~ BE'?F@Ѝ?~ A8@AӖ}? A, A8$ A9$ A:$ A0~ A?  A1 !A2 "A;$#A@A@$ A<$ A=$ A<$ A>$ A?$A B) B* B+~  BR@  B<$ B4bB  D_ۿD_?D0$v:D`'}?BB?B/&@ABR=?~ BEv?FYCW?~ AR@AG? A, A A A A,A@A? !A2 "A@$#A@A3@$ AA$ AB$ AA$ AC$ AD$A B) B* B+~  B.@  BA$ B}@ B`@ Dݣ{bDݣ{b?DTOD Q<=?B?B??B˾W3@B\8M?~ BEng?F ?~ A,@AZlP? A, Ac Ac AE$ AVA?A? !A2 "AF$#A?A@$ AG$ A  AG$ AH$ AI$A B) B* B+~  B.@  BG$ B @ B@!@ DSV8DSV8?D-mBD*5?B.B.?B Yt&PB΄˧?~ BE+?F)2 ?~ A,@Auݐ? A, A A A AF~ A?  A !A2 "AJ$#A@A@$DHl(22,2,22222,2,222(22,22..,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ AK$ AL$ AK$ AM$ AN$A B) B* B+~  B$@  BK$ B*o@ BU^@ D!0ot?D!0ot?DI~B^@D~e@B??B??BO?By"??~ BEt?Fw=I?BB?B`\^ B28 ya?~ BE-#A?Fk@#a?~ A"@A"=A.? A, Ag$ Ah$ Ai$ A Aj$  Ak$ !A2 "Al$#A@A@$ Am$ A Am$ A An$A B) B* B+~  B@  Bm$ B@ B "@ D?+?D?+?D١&$<@D\.Hl~?B bB b?B;pB߳&k?~ BELy6H?F7 ?~ A@A? A, AAA A, AA !A2 "Ao$#A?A?$ Ap$ Aq$ Ap$ Ar$ As$A B) B* B+~  B9@  Bp$ B@A B A Du-ԿDu-?DzS_3Dp?BB?B"qHBR4m?~ BEThty?FdȚ?~ A8@AX? A, At$ Au$ Av$ A, A  A !A2 "Aw$#A"@A$@$ Ax$ Ay$ Ax$ Az$ A{$A B) B* B+~  B4@  Bx$ B5O.A B@I5A DdDd@Dw)6TDP+)@?B~B~?Blg?Dmvd>?DCAXs@D6Q7?Bz+ǿBz+?BR9?_'B:]r=:?~ BEUE<?FVi?~ AA@A kN? A, A$ A A$ A,A?A@ !A2 "A$#A.@A2@$ A$ A$ A$ A$ A$A B) B* B+~  B4@  B$ BwA B*@ DAIccDAIcc?D=%AD+IMp?B]B]?B MABBI?~ BE2R?FYa?~ A3@A}[ȕ? A, A; A A$ A; A<  A$ !A2 "A$#A$@A(@$ A$ A$ A$ A$ A$A B) B* B+~  B@  B$ B`@ B 9@ D0:?D0:?DrJ&A@D1v|?Be?Be?BʘP@B/9?~ BEi?F8VO?~ A@A`Z'N=? A, A$ A$ A$ A= A>  A$ !A2 "A$#A@A@$ A$ A$ A$ A$ A$A B) B* B+~  B$@  B$ BI@ BE@ D7uUAʿD7uUA?D1Gխ*D2J?B??B??BKZIR@By?~ BEF ?Fvkb?~ A"@AT9%? A, A$ A% A% A A  A} !A2 "A%#A@A@$ A% A% A% A% A!A B) B* B+~  B.@  B% B3B'  D,CY1D,CY1?DUQ -EDSN[?B_B_?B]L@B>T[^?~ BE%yPɤ+?Fq˒A?~ A,@AU? A, A  A  Az A,A@A? !A2 "A%#A@A@$ A% A% A% A % A %A B) B* B+~  B.@  B% B CA B*?!A Da+?Da+?D<»CB@DDPF?B @_6?B @_6?B0$!/@B?T?~ BE?Fx[?~ A,@A #6? A, A A A % Ag Ah  A  !A2 "A %#A@A@$ A % A% A % A% A%A B) B* B+~  B$@  B % B`@ B:@ Dm@I߿Dm@I?D~,<DNo?B `B `?BG}aIBɡ?~ BEfxP?F^?~ A"@A!8? A, A% A% A% Ag Ah  A  !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B@  B%~  Blv@ B@ Do ?Do ?D#S_@D4S@B }?B }?B?46![@B̾w@~ BEAO?Fiz?~ A@Aj| $Gc@ A, A% A% A% A; A<  A# !A2 "A%#A?A?$ A% A% A% A% A %A B) B* B+~  B@  B% B @ B`U@ DJ`?DJ`?DsS3@Dm,?B?B?Bx\bv$8@B?~ BE68?FfYU~j?~ A@A`? A, A!% A"% A#% Ag Ah  Ah !A2 "A$%#A?A?$ A%% A&% A%% A'% A(%A B) B* B+~  B@  B%% B`@ B`Ǿ@ DYU 2DYU 2?Di^eDD ?B ſB ?Br^%BkS?~ BE]zM<?F[?~ A@AoX ? A, A)% A*% A+% A9 ~ A?  AR !A2 "A,%#A?A?$ A-% A.% A-% A/% A0%A B) B* B+~  B$@  B-% B`6z@ B@ D߄KD߄K?D}_PD4?BKBK?B;;ØSLB0?~ BEPpۉ?F /bQ?~ A"@AW(? A, A1% A2% A3% A= A>  A4% !A2 "A5%#A@A@$ A6% A7% A6% A8% A9%A B) B* B+~  B@  B6% B@ BD@ DpRjĬؿDpRjĬ?D/aXus7DQ}~?BB?Bh>Bp:?~ BEZ3~?F^P\?~ A@AbJ{ P? A, A:% A;% A<% A A  A !A2 "A=%#A?A@$DDHl2222 2,2222.2,22,,,,22222.222%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A>% A?% A>% A@% AA%A B) B* B+~  B.@  B>% Br@ B2@ DFxw>~ AF@Aab ? A, A A  A A,A?A@ !A2 "AZ%#A@A"@$ A[% A\% A[% A]% A^%A B) B* B+~  B.@  B[% BA B*A DZu?DZu?D+J#@D +?B'B'?B}V@OBݩ?~ BEe?FD$]?~ A,@A(B|? A, A_% A`% Aa% Aw A  A !A2 "Ab%#A@A@$ Ac% Ad% Ac% Ae% Af%A B) B* B+~  BD@  Bc% Bw A Bq A DQڙ?DQڙ?D>B'@DrGWh?B^Q?B^Q?B݉0@BԦ?~ BEt7?Fm?~ AC@AY 2? A, Ag% Ah% Ai% A,A?A@ !A2 "Aj%#A$@A*@$ Ak% Al% Ak% Am% An%A B) B* B+~  B.@  Bk% B6@ B@ DNQZ?DNQZ?DE ^o5@DZ^ǚ?B?B?B/"+R@BO%?~ BE:~C?F`r-V?~ A,@A†}? A, Ao% Ap% Aq% A,A?A@ !A2 "Ar%#A$@A&@$ As% At% As% Au% Av%A B) B* B+~  B.@  Bs% B!A BA DHyDHy?Du|JD!E?BB?B`6-CB[/hk?~ BEۗ?F <,?~ A,@A? A, Aw% Ax% Ay% A,A?A@ !A2 "Az%#A@A@$ A{% A|% A{% A}% A~%A B) B* B+~  B9@  B{% B`A BaA D@T*D@T*?D!D,?BֿB?BD^zC5BQ>R52?~ BE;''?Fi<&X4a?~ A8@A\=9? A, A% A% A% A,A?A? !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B@  B% B`@ Bx@ Ds9)^DݿDs9)^D?Dp*;Dwp@  B% B8A~  BG  D'㩻P?D'㩻P?D_"Br@D꒦@BY?BY?BkF8@B5m[b?~ BE+=?F{?~ A=@AUU@ ? A, A% A% A% A,A?A@ !A2 "A%#A"@A(@$ A% A% A% A% A%A B) B* B+~  B.@  B% B @ B"@ DޡJ |?DޡJ |?DԈO1@DI?B@οB@?BS%Q^i.B$?~ BE=)DcVё;M?B B ?B= BPt?~ BE=ګ?FM$QN?~ AC@A%? A, A% A% A% A; A<  A$ !A2 "A%#A@A"@$ A% A% A% A% A%A B) B* B+~  B@  B% B@ Bw@ DDj1#?DDj1#?D< t b@DEJpv@BTBT?B!jĉBk ?~ BE4M?Fn<7H?~ A@Ac ? A, A% A% A% A,A?A@ !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B.@  B% Br@ B@ DF+?DF+?Dn~@Dw'?B?B?BU5e@Bx'@~ BEv3̀?F֍~=?~ A,@AE? A, A% A% A% A,A?A? !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B$@  B% B Z|@ B@ D܄k8?D܄k8?D .;%@DpL?B??B??B?B|:?~ BEx#5?Fn#?~ A"@A}t? A, A% A% A% A,A?A@ !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B@  B% B@ B T@ DJ7@DJ7@D辈[@D @BoBo?BަzBQ:2q?~ BEtd?Fn#?~ A@Ahh? A, A% A+ A% A,A@A@ !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B$@  B% B@g@ BJ@ D jw?D jw?Dt4D@Dߕߣh?B?JCٿB?JC?B~7B?* W?~ BE?!A?FhKw_?~ A"@AhxB? A, A% A% A% A,A?A? !A2 "A%#A@A@$ A% A% A% A% A%A B) B* B+~  B.@  B% B@|C@ B@=@ D@R?]??D@R?]??D%D)@DQ?k ?B pn?B pn?BAd+@BzY!;?~ BE?F?ȓQ?~ A,@A,|gĶ? A, A% A% A% A,A?A@ !A2 "A%#A@A@$ A% G% A% A% A%A B) B* B+~  B@  B% B@@ B@ DD?D0 =zBD3|?B`r?B`r?BA'c@Be_rBB@~ BEU?F>'?~ A@A@ A, A% A% A% A% A%  A% !A2 "A%#A?A?$ A% A% A% A% A&A B) B* B+~  B9@  B% B@ Bj@ D,<.ɿD,<.?D:w6*D3gF?B yοB y?Bc im.Bky!?~ BEB?Fоl?~ A8@AW*'? A, A& A& A& A, A  A  !A2 "A&#A$@A$@$ A& A& A& A& A&A B) B* B+~  B$@  B& B/7@ B=@ DZbo~DZbo~?DFە@ADb?B#B#?Bm& !A2 "A?&#A?A?$ A@& AA& A@& AB& AC&A B) B* B+~  B@  B@& B皾@ B8@ D;lp}ٿD;lp}?D&I8DamG?B?B?B ynaȶ7@BBS?~ BEqxA?F ꉶ?~ A@AU? A, AD& AE& AF& Ar As  Am !A2 "AG&#A?A?$ AH& AI& AH& AJ& AK&A B) B* B+~  B@  BH& B @ Be@ D3PX⹻D3PX⹻?DMeRD#b ?BB?BDn>BWPv1?~ BEi?F`X?~ A@A$?? A, AL& AM& AN& A0A?A? !A2 "AO&#A@A@$ AP& AQ& AP& AR& AS&A B) B* B+~  B@  BP& B@-@ B굷@ Dd.uDd.u@D`/4^TDC?B.B.?B;]QQBi?ז?~ BE)`?F!t&?~ A@ApK ? A, A; A; AT& A= A>  AU& !A2 "AV&#A?A?$ AW& AX& AW& AY& AZ&A B) B* B+~  B$@  BW& B @ Ba@ D#*J׿D#*J?D5Y56D5Kr?B@B@?B»{AB[Zsq?~ BE|Q+Y?FU`?~ A"@AD9xS? A, A[& A\& A]& A,A?A? !A2 "A^&#A@A@$ A_& A`& A_& Aa& Ab&A B) B* B+~  BN@  B_& B8 B&  DQJDQJ@DkSSDk@c ?Bo6Bo6?B_@=B癶?~ BE t ?Fq/?~ AM@AKy? A, A A  A A,A?A@ !A2 "Ac&#A@A,@$ Ad& Ae& Ad& Af& Ag&A B) B* B+~  B@  Bd& B@ B@:n@ D"D"?D.$E3?DP??BDJӿBDJ?BgK2B{?~ BEn+?Fjq@  Bu& B06A BϊA DPRdDPRd@DM3pTD0q~Y?B?B?B9Z@Bd[cy?~ BE}}?Fno3?~ A=@A? A, A Ac Ay& A, A  A !A2 "Az&#A@A@$ A{& A|& A{& A}& A~& A B) B* B+~  B.@  B{&  B <@  BKm@  D:;? D:;? D &@ DwHK? B@\? B@\? Bx ?@ B'{l?~ B E$C(? FͥD6?~ A,@ A5\? A, A& A& A& A, A  A !A2 "A& #A@A@$ A& A& A& A& A& A B) B* B+~  B.@  B&  B*@  B A  DIڹ* @ DIڹ* @ Dph9 @ D#@ B {E? B {E? BKrb@ B@~ B E+ /tϵ? Fl?~ A,@ A# jk? A, A& A& A& A, A  A  !A2 "A& #A@A@$ A& A& A& A& A& A B) B* B+~  BI@  B&  B%A  B`i+A  Dj? Dj? D[69@ D<\? B^d? B^d? BJJR0@ BĆpi?~ B ER|g? FJR`?~ AH@ A9? A, A& A& A& A, A?A@ !A2 "A& #A@A(@$ A& A& A& A& A& A B) B* B+~  B$@  B&  B़@  B@  D3y? D3y? DxM}\S@ DTW;'d? Br? Br? B7~BNT@ B#?~ B EF-A? Fr9?~ A"@ A0t5? A, A& A& A& A, A?A@ !A2 "A& #A?A@$ A& A& A& A& A& A B) B* B+~  B$@  B&  Bj@  B@;@  D)H? D)H? DP@ DeխF? B ? B ? BŎ@@ B=*BZ?~ B E2;H? F5C$C`?~ A"@ A]\? A, A& A& A& A, A  A  !A2 "A& #A@A@$ A& A& A& A& A&A B) B* B+~  B$@  B& BI<@ B`3@ Dp?Dp?D@DA{?BZ?BZ?B-_**@B_?~ BE3L?F{V?F(ݧo?~ AC@Ag? A, A& A& A& A,A?A? !A2 "A&#A"@A"@$ A& A& A& A& A&A B) B* B+~  B>@  B& By%?B  D,TÿD,T?D #D^k?BkڿBk?BcRx9BP-!?~ BE$H?F~ ?~ A=@Aʑ? A, A A A A, A  A1 !A2 "A&#A@A@$ A& G& A& A& A&A B) B* B+~  B$@  B& Bz@ By@ D گD گ?D<+D9?B <3B <3?BLHAJ@B!8V% ?~ BEw~?F ?~ A"@A >:C? A, A& A& A& A9 ~ A?  AR !A2 "A&#A@A@$ A& A& A& A& A&A B) B* B+~  B.@  B& B`@ B@X@ D 򌛔?D 򌛔?DjnyWO@D ?B_?B_?B(Q@B2.U?~ BE1߉% #?Fw'o?~ A,@AV|j ? A, A& A& A Ag Ah  A !A2 "A&#A@A@$ A& A& A& A& A&A B) B* B+~  BD@  B& BB  D;"qQDֿD;"qQD?DIam5D1G$?B?B??BBλ{B6?~ BEIYg}?F'Z ?~ AC@A1Ƀ? A, AC AD AE AFA?A? !A2 "A&#A@A @$ A& A& A& A& A&A B) B* B+~  B@  B& Bϩ@ B @ DQ%EDQ%E?DO{)yDYA{X?B1B1?BI5)BUG?~ BE("1?Fno3?~ A@AY? A, A; A; A& A& A&  A& !A2 "A&#A?A?$ A& AP A& A& A;A B) B* B+~  B$@  B&~  BA B@A D|LܒӿD|Lܒ?D:;R3D?B?B?BJ[@B" nÍ@~ BE?FKh?~ A"@A?? A, AC AD AE AFA@A? !A2 "A&#A?A@$ A& A& A& A& A&A B) B* B+~  B@  B& B A@ Bm7@ De7?De7?DfC@@Dc rd?B.ߥ?B.ߥ?BL, @B{?~ BEkL>?F& }?~ A@A5Ӕ ? A, A& A& A& A9 A?A? !A2 "A&#A?A?$ A& A& A& A& A&A B) B* B+~  B9@  B& BO A BA D{AKٿD{AK?Dx~O7DfT?BEBE?BlߦEB p?~ BE)Uvz?F)_?~ A8@AG? A, A& A& A& A0~ A?  A1 !A2 "A&#A@A@$ A& A& A& A& A&A B) B* B+~  B@  B& B@@ B Ы@ D?D?D~S@Dbs?BB?Bd~B*+ש?~ BEvaū-?Fn#?~ A@Aj2T? A, A& A& A& A& A'  A' !A2 "A'#A?A?$ A' A' A' A' A'A B) B* B+~  B9@  B' BbA B`A DUF- ?DUF- ?D/Ng0@D!?B_'?B_'?Bκ@Bc?~ BEJ)u?F͋?~ A8@AP*E5? A, A' A' A ' A0~ A?  A !A2 "A '#A*@A.@$ A ' A ' A ' A ' A'A B) B* B+~  B.@  B '~  BA B @ D!0D!0@Dj*TD Z2?B\B\?B+X=QB@֝?~ BE\?F HOQ?~ A,@A! )9? A, Ac Ac Ac A0 A  A !A2 "A'#A@A@$ A' A' A' A' A'A B) B* B+~  B@  B' BF{@ B;g@ DFJ?DFJ?D- j!C@Ds Z?B@s?B@s?B| HOA@BP-?~ BE>yX?Fȱ`xv?~ A@ASoF? A, A' A' A' A0A?A? !A2 "A'#A?A?$ A' A' A' A' A'A B) B* B+~  B$@  B' B@ B@L@ D` 3D` 3?D#wD%GDJn/?B`}B`}?Bb>B?a?~ BEQ?FSP?~ A"@A]p? A, A A A Ag Ah  Ah !A2 "A'#A@A@$D Hl22,2,2,222,,222(,$222(,222., %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A' A' A' A' A ' A B) B* B+~  B$@  B'  BqK@  B@0@  D&U}S D&U}S? D7C DU<6? BM׿ BM? B.PqN6 B~L^?~ B E#+? F#$C?~ A"@ AJ? A, A!' A"' A#' A, A?A? !A2 "A$' #A@A@$ !A%' !A&' !A%' !A'' !A('!A !B) !B* !B+~ ! B>@ ! B%'~ ! B?@TM! B`Lb=A! Dgi!Dgi?!DwؤGPD!D/%?!Bt!Bt?!B6%H!Bhl2?~ !B!EKsOYQ?!F!J?~ !A=@!AloK_? !A, !A  !A  !A !A,!A@A@ !!A2 !"A)'!#A@A@$ "A*' "A+' "A*' "A,' "A-'"A "B) "B* "B+~ " B$@ " B*'" B@@" BH@" D]/{S?"D]/{S?"DdfO@"DE:#T?"B ?"B ?"Ba©^U@"B/?~ "B"E|u?"F#ܱi/?~ "A"@"Adcݦ3? "A, "A.' "A/' "A0' "A, "A " A "!A2 ""A1'"#A@A@$ #A2' #A3' #A2' #A4' #A5'#A #B) #B* #B+~ # B@ # B2'# B @# B`@# DC`)#DC`)?#D'4>#D;ᮆ"+?#B#B?#B90Ю@#Bzm?~ #B#E ?#Fo:?~ #A@#Ab@dF? #A, #A6' #A7' #A8' #A,#A?A@ #!A2 #"A9'##A@A@$ $A:' $A;' $A:' $A<' $A='$A $B) $B* $B+~ $ B@ $ B:'$ B ڦ@$ B `lI@$ D$J?$D$J?$Dd47@$Dnt?$BU?$BU?$BNC[K@$B ' $A?' $A $A, $A $ A@' $!A2 $"AA'$#A@A@$ %AB' %AC' %AB' %AD' %AE'%A %B) %B* %B+~ % B.@ % BB'% B A@% B @% D#sp/?%D#sp/?%DPE@%D?%BG%BG?%B5l9?%BOK?~ %B%E jlqq?%F`:?~ %A,@%AZ̸?? %A, %AF' %AG' %AH' %A,%A?A@ %!A2 %"AI'%#A@A @$ &AJ' &AK' &AJ' &AL' &AM'&A &B) &B* &B+~ & B$@ & BJ'& B W@& B@& D;?&D;?&Dh".B@&D R?&B??&B??&B}f1 SJ@&Bk_?~ &B&E]RQ?&Fp˕G?~ &A"@&AAPa? &A, &AN' &AO' &Ao &A,&A?A@ &!A2 &"AP'&#A@A @$ 'AQ' 'AR' 'AQ' 'AS' 'AT''A 'B) 'B* 'B+~ ' B@ ' BQ'' BR^@' B;@' D*.]'D*.]?'D\}J'D5#8?'Bϫ'Bϫ?'B3(fI'BM??~ 'B'Ew~5ު?'Fa$ ?~ 'A@'AP? 'A, 'AU' 'A 'AV' 'A, 'A ' A '!A2 '"AW''#A?A?$ (AX' (AY' (AX' (AZ' (A['(A (B) (B* (B+~ ( B$@ ( BX'( BZ@( B@( Dob?(Dob?(D@?(D(7%su/?(B~(B~?(BߢGO (B?~ (B(E+?(FͥD6?~ (A"@(A+! ? (A, (A\' (A]' (A^' (A, (A ( A (!A2 ("A_'(#A@A@$ )A`' )Aa' )A`' )Ab' )Ac')A )B) )B* )B+~ ) B4@ ) B`') B@ !@~ ) BA) DG拶@)DG拶@)D v@)Dpqg@)Bൣ?)Bൣ?)BQ=1\@)BCTe-@~ )B)EkG?)F!t&?~ )A3@)A + ? )A, )Ad' )Ae' )Af' )A,)A?A@ )!A2 )"Ag')#A @A"@$ *Ah' *Ai' *Ah' *Aj' *Ak'*A *B) *B* *B+~ * BA@ * Bh'* B9HA~ * B * D_p?*D_p?*Dv:8@*D1 !y5?*BkB?*BkB?*B^"8@*B:b?~ *B*E_N(2?*FEkE5?~ *AA@*A',? *A, *Al' *Am' *An' *A,*A?A@ *!A2 *"Ao'*#A @A"@$ +Ap' +Aq' +Ap' +Ar' +As'+A +B) +B* +B+~ + B[@ + Bp'+ B @TA~ + B`P+ DHhHGg?+DHhHGg?+D#6 "?+Dm9?+B 9+B 9?+Btv +BqIIN?~ +B+EO]?+F60?~ +A@[@+AEd? +A, +At' +Au' +Av' +A,+A?A? +!A2 +"Aw'+#A @A<@$ ,Ax' ,Ay' ,Ax' ,Az' ,A{',A ,B) ,B* ,B+~ , B4@ , Bx', B@, B;A, D( ?,D( ?,D|d5@,D*RNl?,B?,B??,Bh"Q ,Bvl?~ ,B,E ص~?,FUvC?~ ,A3@,Aky? ,A, ,A|' ,A}' ,A~' ,A, ,A , A9 ,!A2 ,"A',#A"@A$@$ -A' -A' -A' -A' -A'-A -B) -B* -B+~ - B@ - B'- B >@- B@=@- DzDz?-DzDz?-D|{Ou?-Dxz@/?-BL?-BL?-B͌3@-Brh#?~ -B-E8€?-FbÉ?~ -A@-AJF? -A, -A' -A' -A' -A, -A' - A( -!A2 -"A'-#A?A?$ .A' .A' .A' .A' .A'.A .B) .B* .B+~ . B.@ . B'. B KKA. B @. D) .D) ?.DXwB.D|?.B ؿ.B ?.B@R6.B%=?~ .B.E{R?.Fm?~ .A,@.Arܞ;W? .A, .A' .A' .A' .A,.A?A@ .!A2 ."A'.#A@A      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijkmnopqrstuvwxyz{|}~@$ /A' /A' /A' /A' /A'/A /B) /B* /B+~ / B@ / B'/ B L@/ B>e@/ Dcb?/Dcb?/DpyW0@/Dquf ?0B Jh?0B Jh?0B:`VE@0Bo%$?~ 0B0E-ʬ?0FrH#?~ 0A@0A"n/t?~ 2B2E`Ts?2F{ C~?7Fn#?~ 7A"@7A+? 7A, 7AC 7AD 7AE 7AF7A@A? 7!A2 7"A'7#A@A@$ 8A' 8A' 8A' 8A' 8A'8A 8B) 8B* 8B+~ 8 B@ 8 B'8 B@8 B@7@8 D8U!8D8U!?8DWm,=@8DMrh?8B@f8B@f?8BPK(E8B5Vu?~ 8B8EL=$A-?8Frd5J?~ 8A@8A[~? 8A, 8A' 8A' 8A' 8A9 8A?A? 8!A2 8"A'8#A?A?$ 9A' 9A' 9A' 9A' 9A'9A 9B) 9B* 9B+~ 9 B4@ 9 B'~ 9 B`A@9 B` A9 D嬇]]?9D嬇]]?9DJ.Z@9D,V@9B@?9B@?9ByBliG@9B*χ?~ 9B9E?9FS?~ 9A3@9A#UK? 9A, 9A' 9A' 9A' 9Ag 9Ah 9 A  9!A2 9"A'9#A@A@$ :A' :A' :A' :A' :A':A :B) :B* :B+~ : B@P@ : B': B* BJ9 : Dj :Dj ?:DiRkhtF:D#F?:B?I:B?I?:Bq7D:B'M؊'?~ :B:E'?:Fjvc j\?~ :AP@:A$g? :A, :A :A :A :A,:A@A? :!A2 :"A':#A@A.@$ ;A' ;A' ;A' ;A' ;A';A ;B) ;B* ;B+~ ; B@ ; B'; B N@; BQ@; DA' >A' >A' >A' >A'>A >B) >B* >B+~ > B@ > B'> B@{@> BKV@> DU'?>DU'?>D+J@>DW1?>B<>BBЉ0>Bqm?~ >B>Er?>Fw=IA@>A$)E? >A, >A >A >A' >Ar >As > A' >!A2 >"A(>#A@A@$ ?A( ?A( ?A( ?A( ?A(?A ?B) ?B* ?B+~ ? B$@ ? B(? B@? Bk@? D~݁Ͽ?D~݁??D;#k_/?D"??B@m??B@m??B"Qsu9@?BՙZ3@DS?@B ̿@B ?@B$>j,@B\?~ @B@E?@Fzmѯ?~ @A,@@A׿? @A, @A ( @A ( @A ( @A,@A?A? @!A2 @"A(@#A@A@$ AA( AA( AA( AA( AA(AA AB) AB* AB+~ A BQ@ A B(A B GxXA~ A Bo8MA Dsw%OADsw%O?AD HADM0{J(?AB AB ?ABl @ABLSٚ)?~ ABAE:sVoKV?AF~J?~ AA@Q@AA #? AA, AA AA  AA AA,AA?A@ A!A2 A"A(A#A@A1@$ BA( BA( BA( BA( BA(BA BB) BB* BB+~ B BQ@ B B(B BB;  B DxBDx?BDQ,~EBD^$>?BB ~ٿBB ~?BB[| 8BBiG?~ BBBE?BF!;?~ BA@Q@BA\?? BA, BA( BA* BA- BA,BA?A@ B!A2 B"A(B#A@A.@$ CA( CA( CA( CA( CA(CA CB) CB* CB+~ C BI@ C B(C BJ6B& C DtmCDtm?CD]JCD߸?CB_CB_?CB,:3 j CBRr_?~ CBCE璘?CFJ?~ CAH@CAͺ^=\? CA, CA( CA( CA ( CAV~ CA? C A C!A2 C"A!(C#A@A,@$ DA"( DA#( DA"( DA$( DA%(DA DB) DB* DB+~ D B@ D B"(~ D B@D BH@D DNGTѿDDNGT?DD̄- 1DD:(G#A@A@$ HA?( HA@( HA?( HAA( HAB(HA HB) HB* HB+~ H B$@ H B?(H B@H B@H Ddp?HDdp?HD0>*\"@HDc}?HBYHBY?HB줵F HBjQe?~ HBHE\?HFi?~ HA"@HA ? HA, HAC( HAD( HAE( HA, HA H A H!A2 H"AF(H#A@A@$ IAG( IAH( IAG( IAI( IAJ(IA IB) IB* IB+~ I B@ I BG(I Bդ@I B`@I Db ˃*I?IDb ˃*I?IDm0A@IDk-J?IB6?IB6?IBPQ2C@IBJ.xT?~ IBIER Ia?IFH}H?~ IA@IA55? IA, IA% IAK( IAL( IA,IA@A@ I!A2 I"AM(I#A@A@$ JAN( JAO( JAN( JAP( JAQ(JA JB) JB* JB+~ J B@ J BN(J Bԯ@J B @J DӮKJDӮK?JDdod>JDC.?JB_-ܿJB_-?JB7jTOSM:JB/U?~ JBJEW*@eJFR@MD@<~t?MB??MB??MBqpvR@MB) ?~ MBMEB1?MFOM?~ MA"@MAg` ? MA, MAg( MAh( MAi( MA,MA?A? M!A2 M"Aj(M#A@A@$ NAk( NAl( NAk( NAm( NAn(NA NB) NB* NB+~ N B$@ N Bk(N B@ $AN BAN DD1 ۿNDD1 ?ND[?$b9ND J?NB NB ?NBzLBNBu3 ?~ NBNE.3+?NFil?~ NA"@NA̒ ? NA, NALNA NAM NAFNA@A@ N!A2 N"Ao(N#A?A@$ OAp( OAq( OAp( OAr( OAs(OA OB) OB* OB+~ O B4@ O Bp(O B@X^AO B@AO D~?OD~?ODs.R@ODR3?OBK?OBK?OBye=7@OB~F?~ OBOE*==d?OF%?~ OA3@OA ? OA, OAt( OAu( OAv( OAw( OAx( O Ay( O!A2 O"Az(O#A@A@$ PA{( PA|( PA{( PA}( PA~(PA PB) PB* PB+~ P B$@ P B{(P B AP B AP Dw'ܿPDw'?PD-Q'G:PD`\?PB?PB??PBą~.PBFeo?~ PBPEguګ?PFU8?~ PA"@PAg;? PA, PA( PA( PA( PA( PA( P A( P!A2 P"A(P#A@A@$ QA( QA  QA( QA( QA(QA QB) QB* QB+~ Q B$@ Q B(Q B,5A~ Q BͳCQ DRo^?QDRo^?QDv'Z@QDM^@QB?QB?QB&^Nh@QB`'i@~ QBQE-> ?QFDj?~ QA"@QA֋? QA, QA QA QA QA~ QA? Q A Q!A2 Q"A(Q#A@A@$ RA( RA( RA( RA( RA(RA RB) RB* RB+~ R B@ R B(R B @R B ɦ@R D, ͿRD, ?RD!#Cq-RD3X?RB0?RB0?RB]Ze,C@RB"?~ RBRE˴zH1`?RF(ݧo?~ RA@RAy)? RA, RA( RA( RA( RA0RA?A? R!A2 R"A(R#A@A@$ SA( SA( SA( SA( SA(SA SB) SB* SB+~ S B4@ S B(S B4BLM S D,7zJCSD,7zJC?SD?pEYASDB\b?SBSB?SBDxFSBH{q?~ SBSEC) jA,jA?A@ j!A2 j"A?)j#A@A@$ kA@) kAA) kA@) kAB) kAC)kA kB) kB* kB+~ k B@ k B@)k B @k B@k DkD?kDY;OkDx?kB_:kB_:?kBxJkB鯵?~ kBkE'Q?kF)2 ?~ kA@kArY!? kA, kAD) kAE) kAF) kAg kAh k Ah k!A2 k"AG)k#A?A?$ lAH) lAI) lAH) lAJ) lAK)lA lB) lB* lB+~ l B@ l BH)l B9@l BcA@l DI+EGlDI+EG?lD-ClDiS?lB_HlB_H?lBw?eNIlBh=?~ lBlEcY?lF(?~ lA@lALrty@ lA, lAL) lAM) lAN) lA,lA?A@ l!A2 l"AO)l#A?A?$ mAP) mAQ) mAP) mAR) mAS)mA mB) mB* mB+~ m B@ m BP)m Bdߠ@m B )@m Dץ5zmDץ5z?mDi'GmDH.?mBmB?mBd;62FmB ib?~ mBmED.x?mFm?~ mA@mA6nh? mA, mAe mA~ mAT) mA,mA?A@ m!A2 m"AU)m#A@A@$ nAV) nAW) nAV) nAX) nAY)nA nB) nB* nB+~ n B$@ n BV)n B@n B@n D'r?nD'r?nDtgpG@nD !?nB#?nB#?nB *1@nBiX4&?~ nBnE>T?nF6':?~ nA"@nACR? nA, nAZ) nA[) nA nA,nA?A? n!A2 n"A\)n#A@A@$ oA]) oA^) oA]) oA_) oA`)oA oB) oB* oB+~ o B.@ o B])o B@o BY?@o D~[ٿoD~[?oDXK-f8oD8/91?oB_uпoB_u?oBJ20oB`=D?~ oBoEg!G?oF?ȓQ?~ oA,@oA =⡑? oA, oAa) oAb) oAc) oA, oA o A o!A2 o"Ad)o#A@A@$ pAe) pAf) pAe) pAg) pAh)pA pB) pB* pB+~ p B@ p Be)p B`wg@~ p B@p D3?pD3?pD{_bHo@pD2i/ @pB m[?pB m[?pBOw@W@pB#D?~ pBpEL8?pF=d?~ pA@pA#4 ? pA, pAi) pAj) pAk) pA,pA?A@ p!A2 p"Al)p#A?A?$ qAm) qAn) qAm) qAo) qAp)qA qB) qB* qB+~ q B@ q Bm)q B @~ q BN@q DA6pwqDA6pw?qD3aM"qDE?qB_?qB_?qBb~4kb,@qB_"MPE?~ qBqE@\ ?qFno3?~ qA@qA7tݽ? qA, qAq) qAr) qAs) qA qAt) q Au) q!A2 q"Av)q#A?A?$ rAw) rAx) rAw) rAy) rAz)rA rB) rB* rB+~ r B@ r Bw)r Bz@r B@r Dߤ?rDߤ?rDoF5zfI@rD ?rB@?rB@?rBE2@rB&?~ rBrEݢ{'?rFe.?~ rA@rABO? rA, rA{) rA|) rA}) rA= rA> r A> r!A2 r"A~)r#A?A?$ sA) sA) sA) sA) sA)sA sB) sB* sB+~ s BR@ s B)s BB+R s DpmhosDpmho?sDṔJsD3,?sB OsB O?sBbh\AsB܎?~ sBsE@SZhM?sFfk3}?~ sAR@sA0$? sA, sA sA sA sA,sA@A? s!A2 s"A)s#A"@A3@$ tA) tA) tA) tA) tA)tA tB) tB* tB+~ t BK@ t B)t B<B/)Q t D\K?tD\K?tD_j'4@tDӍ9?tB?;ӿtB?;?tB'2tB(Ԃ?~ tBtEƖEʄ?tFU9?~ tAK@tA6H? tA, tA tA tA tA,tA@A? t!A2 t"A)t#A@A(@$ uA) uA) uA) uA) uA)uA uB) uB* uB+~ u B@ u B)u B`:O@~ u B|@u D^*ൈuD^*ൈ?uD dH JTNuD<-?uBuB?uBvbPuBLA?~ uBuEj?uFjC_?~ uA@uA/K ? uA, uA) uA) uA) uA)uA?A? u!A2 u"A)u#A?A?$ vA) vA vA) vA) vAvA vB) vB* vB+~ v B>@ v B)v Bx7Av BI:Av DM?vDM?vD/66(@vD<^?vBL?vBL?vB+~A@vB#?~ vBvE/x?vFVL?~ vA=@vAL?`Q? vA, vAAA vAFvA?A? v!A2 v"A)v#A@A@$ wA) wA) wA) wA) wA)wA wB) wB* wB+~ w B@ w B)w B `"@w B @w Dm-0f?wDm-0f?wD?AL@wDzP ?wB'h?wB'h?wB2\X@wB󶐥k?~ wBwE%d?wFgd%?~ wA@wA1? wA, wA) wA) wA) wA) wA) w A) w!A2 w"A)w#A?A?$ xA) xA xA) xA) xA%xA xB) xB* xB+~ x B@ x B)x B @x B˾@x DS?xDS?xD)[r@xD9@xB@xB@xB'_k~{@xBd2@~ xBxEOՐQ=?xFȱ`xv?~ xA@xA*)P@ xA, xAAA xAFxA?A? x!A2 x"A)x#A?A?$ yA) yA) yA) yA) yA)yA yB) yB* yB+~ y B$@ y B)y BOBwRvT y D!oy׿yD!oy?yD 4G6yD2ƫ?yBFIݿyBFI?yBe1!.;yBۉeM?~ yByE=?yFϒx%?~ yA"@yAs? yA, yA) yA) yA) yA; yA< y A< y!A2 y"A)y#A@A@$ zA) zA) zA) zA) zA)zA zB) zB* zB+~ z B@ z B)z B=@@z B3@z D]5P5?zD]5P5?zDɃW(@zDoIl?zB˿zB?zB?,+zB4?~ zBzEѮ?zF1gC?~ zA@zA_? zA, zA) zA) zA) zA,zA?A? z!A2 z"A)z#A@A@$ {A) {A) {A) {A) {A){A {B) {B* {B+~ { B$@ { B){ B@^R@{ BW@{ D{?{B ?{B ?{BzH9Q@{BXs?~ {B{E{L?{FW#~/?~ {A"@{A^$*U? {A, {A) {A) {A) {A, {A { A  {!A2 {"A){#A@A @$ |A) |A) |A) |A) |A)|A |B) |B* |B+~ | B@ | B)| B@| B@| Dzqt?|Dzqt?|D&YT@|Dbe?|B ?|B ?|BEsI@|B-+?~ |B|ES?|FG?~ |A@|A?&+*? |A, |A) |A) |A) |A, |A | A |!A2 |"A)|#A?A?$ }A) }A) }A) }A) }A)}A }B) }B* }B+~ } B@ } B)} Bu@} Bx@} DWzp}DWzp?}D˭I}DN?}B }B ?}BhGAL}B F ?~ }B}Ezvr?}F cf?~ }A@}A"נZ? }A, }A) }A) }A) }A, }A } A }!A2 }"A)}#A@A@$ ~A) ~A) ~A) ~A) ~A)~A ~B) ~B* ~B+~ ~ B@ ~ B)~ BiU@~ B2ё@~ D6"uܿ~D6"u?~D,;:~D6n?~B ÿ~B ?~B]d#~BŽP?~ ~B~ErY?~FU8?~ ~A@~AnZ) 2? ~A, ~A) ~A) ~A) ~A, ~A ~ A ~!A2 ~"A)~#A@A@$ A) A) A) A) A)A B) B* B+~  B.@  B) B@$ !A B A D}epD}ep?DDmܟ?B οB ?B/V.B ?~ BE5x?FH/w˶ ?~ A,@ACs? A, A) A) A) AFA@A@ !A2 "A)#A?A@$DGl222,2(2,(2,,,2(.2(2$,2222%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A) A) A) A) A)A B) B* B+~  B$@  B) BA B>VA D؅* ?D؅* ?D a5C$@Drޝ?BߓbBߓb?Bl@BBX|?~ BEMRa?FO0?~ A"@Ad7? A, A) A) A) A A  A !A2 "A)#A@A@$ A) A) A) A) A)A B) B* B+~  B$@  B) B@ @ B%@ D A7?D A7?Dqk@D @B?6?B?6?BM;`@Bc@~ BE榈Tϲ?Fm?~ A"@AQ? A, A) A) A) A0~ A?  A !A2 "A)#A@A@$ A) A) A) A) A)A B) B* B+~  B$@  B)~  B@ B !%@ DTMg<DTMg#O?~ BE'?F&HǴ?~ A"@Aˤ"=H? A, A* A* A* A, A  A  !A2 "A*#A@A@$ A* A* A* A* A*A B) B* B+~  B@  B* B% @ B X@ D D ?DgGdrAD/M4cp?ByοBy?BW.B#%?~ BE"߯?FIA8 ?~ A@Aߜ!u? A, A* A * A * A, A  A !A2 "A *#A@A@$ A * AO A * AP A *A B) B* B+~  B$@  B * B '8@~  B@ D>FrD>Fr?DR,Ãx?DC?BYBY?B&R\GB( 9 ?~ BEUp$?F&-?~ A"@A,pH? A, AAA A, AA !A2 "A*#A@A@$ A* A A* A* AA B) B* B+~  B$@  B* B@ B`%@ DPR?DPR?D&zVI@DP?B?B?BU#bU@B9Rh?~ BEs?F,.q?~ A"@Ad*? A, AAA AFA?A? !A2 "A*#A@A@$ A* A* A* A* A*A B) B* B+~  B$@  B* BJ{=A B`¿#A DVݝ?DVݝ??D:dPD Xo?B`B`?B:prKB'?~ BEsF?F1gN}H?~ A"@A4E<? A, A  A  Az A,A@A? !A2 "A*#A@A@$ A* Ai A* A* A*A B) B* B+~  B@  B* B@ B`6n@ D* A?* A>* A@* AA*A B) B* B+~  B$@  B>* Bd@ B@ DkBDkB?D4|tv]AD1?B=ɿB=?Bi*Ba'?~ BE'?F=d?~ A"@ApDU2? A, AB* AC* AD* A,A?A? !A2 "AE*#A@A@$ AF* AG* AF* AH* AI*A B) B* B+~  B@  BF* Bٵ@ B@R@ DUѿDU?D}r1D 0Vd?BrѿBr?BRU81BtzEi}?~ BE7wӲ(?FE?~ A@A5 k? A, AJ* AK* AL* A0~ A?  A !A2 "AM*#A?A?$ AN* AO* AN* AP* AQ*A B) B* B+~  B@  BN* B@ Br@ D")D")?DID9?BB?BuS MHBcWr?~ BE)|?F`:?~ A@A? A, AR* AS* AT* A,A?A? !A2 "AU*#A?A?$ AV* AW* AV* AX* AY*A B) B* B+~  B$@  BV* B`4@ B H|@ D YD Y?DێIDU7?B@BaB@Ba?BS(CB0H?~ BE?F(B$,?~ A"@Ac/? A, AZ* A[* A\* A A  A !A2 "A]*#A@A@$ A^* A_* A^* A`* Aa*A B) B* B+~  B@  B^* BS@ B@s@ DU?DU?DPNEGp@D/| @Bn?Bn?B\E4z`@BʒZQ@~ BEc؃?Fm-#?~ A@AXo? A, Ac Ac Ab* A, A  A !A2 "Ac*#A@A@$ Ad* Ae* Ad* Af* Ag*A B) B* B+~  B@  Bd* BR7@ B@ DF?DF?DϾx@DxG?B lB l?Bmd |B9f?~ BEǙ֟3?F 뭞Al?~ A@ABN? A, Ah* A Ai* A, A  A  !A2 "Aj*#A?A?$ Ak* Al* Ak* Am* An*A B) B* B+~  B$@  Bk* B A B`A D 6EaD 6Ea?D,PÿDg?B7?B7?Bp(9@Bµ-"?~ BEnl?FV?~ A"@ALT^? A, Ao* A& Ap* A,A?A? !A2 "Aq*#A@A@$ Ar* As* Ar* At* Au*A B) B* B+~  B>@  Br* BB'ȭG  D7SM޿D7SM?Dv*4I<DKk?B 4B 4?BovvCFBg/?~ BE D8?F>|?~ A=@A6? A, A A A AFA?A? !A2 "Av*#A@A@$ Aw* Ax* Aw* Ay* Az*A B) B* B+~  B@  Bw* B`@ B .@ Du?Du?D)t>B@Dϭ?BA?BA?Bo.E1@B֠c)?~ BE& ?F!V~)?~ A@A\? A, A{* A|* A}* A~* A*  A* !A2 "A*#A?A?$ A* A* A* A* A*A B) B* B+~  B@  B* B;Bw  D?),D?),?D5[ED(&?BB?B&bU5CBA't?~ BEGU0?F6G>? ?~ A@Au? A, A* A* A* A, A  A* !A2 "A*#A?A?$ A* A* A* A* A*A B) B* B+~  B@  B* B i@~  B@ DhJܿDhJ?DnJd:DB&?B2޿B2?B-[;BW?~ BEX?FQ,?~ A@AGA? A, A* A* A* A,A?A? !A2 "A*#A@A@$ A* A* A* A* A*A B) B* B+~  B@  B* B '?F%?~ A@A|"w? A, A* A* A* A, A  A  !A2 "A*#A?A?$ A* A* A* A* A*A B) B* B+~  B@  B* BVy A B@LA DA/?DA/?DsaI@DM>?B |?B |?Bca@BOjTn@~ BEw?Fc`?~ A@A2j? A, A* A* A* Ag A*  Ah !A2 "A*#A?A?$ A* A* A* A* A*A B) B* B+~  B@  B* Bo@ B0p@ D[3x?D[3x?DYO@D^#rM?B@-p?B@-p?B5M@B1t?~ BE?FSP?~ A@AzJGv? A, A* A* A* A, A  A !A2 "A*#A?A?$ A* A* A* A* A*A B) B* B+~  B@  B* B 3@ B @ D!?D!?DtIuUU@DRN+1|?B)?B)?B?p@B=TJ @~ BEXY뎑?F Hg?~ A@Aʚ@ A, A* A* A* A, A  A !A2 "A*#A?A@$ A* A* A* A* A*A B) B* B+~  B@  B* B@R@ B@ D"}8=?D"}8=?D=+|Z@D0y@B?B?BF d@B\DjrD@~ BEƱ1?Fz{De?~ A@Ae ? A, A* A* A* A,A?A? !A2 "A*#A@A@$DGl22.2.2,2,2,,2,222,2$(,2222%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A* A* A* A* A*A B) B* B+~  B@  B* BH@ B=ʷ@ D9C[D9C[?Dn1_ OD,)p ?B OB O?BсTWLBdOn-?~ BEs?F+?~ A@A3? A, A* A A* A~ A?  A* !A2 "A*#A?A?$ A* A* A* A* A*A B) B* B+~  B@  B* B @ B|@ D:oȫrD:oȫr?D4Lщ0ԿD#ZE(?B_20?B_20?BLY%@B+7?~ BE 7F?F(?~ A@Ahb? A, AAA AFA@A? !A2 "A*#A?A?$ A* A A* A* AA B) B* B+~  B$@  B* B`GA BأA D`, ?D`, ?D Џ2?DJ?B Z¿B Z?B^|"B:u ?~ BE3gh?F'Z ?~ A"@Adž~_? A, AAA AFA?A? !A2 "A*#A?A@$ A* A* A* A* A*A B) B* B+~  B.@  B* B@A B{A DplDpl?D9\OFD#!Hpj?BݿB?B.;ByF*?~ BE ,?FbGh?~ A,@Ar.(D? A, A* A* A* A* A*  A* !A2 "A*#A@A@$ A* A* A* A* A*A B) B* B+~  B@  B* B`ݷ@ B `W@ D-ïD-ï?DLDLD-F?B?l B?l ?Bs&7MBr{?~ BE 6P?FV?~ A@AoG? A, A* A* A* A# A#  A* !A2 "A*#A@A@$ A* A* A* A* A*A B) B* B+~  B@  B* Bܚ@ B Hy@ DIXu?DIXu?DE@D6z!\?BG?BG?B,V4@B0A?~ BEvp?FKh?~ A@Aw)$:? A, A* A* A* Ag Ah  Ah !A2 "A*#A@A@$ A* A* A* A* A*A B) B* B+~  B$@  B* B "A B`1A D]?D]?D,/`V@DTQ?B_?B_?B5R+@B[m}8?~ BESIM?Ftp8:?~ A"@A`dj? A, A* A* A* A,A?A? !A2 "A*#A @A(@$ A* A* A* A* A*A B) B* B+~  B@  B* B`|@ BJ@ D0ŒпD0Œ?D!h0DrE?Bd?Bd?B%{yM@B.Ǎn?~ BEiW?FUIp ?~ A@A3,? A, A* A* A* A= A>  A !A2 "A*#A?A?$ A* A+ A* A+ A+A B) B* B+~  B.@  B* B@&4@ B@ Dy#a̿Dy#a?D,W(,D~o~?B?ʿB??B\vOW+B b?~ BEJ K?FO `?~ A,@AH? A, AT" A A+ A,A?A@ !A2 "A+#A@A@$ A+ A+ A+ A+ A+A B) B* B+~  B@  B+ B @ B%@ D|^$Ʌ?D|^$Ʌ?Db9 @DVT?B cB c?Bas@Byu?~ BE.~T?FJ?~ A@A `*>? A, A + A + A + A0~ A?  A1 !A2 "A +#A?A?$ A + A+ A + A+ A+A B) B* B+~  B@  B + BrJ@ B@ DaųQοDaųQ?D"ɜ.DAo?B@&B@&?B *o5[B\wwȦ?~ BEDȨt?F'Z ?~ A@A1ʸ8? A, A+ A+ A+ A,A?A? !A2 "A+#A@A@$ A+ A+ A+ A+ A+A B) B* B+~  B$@  B+~  B? BͰ A DaQLƿDaQL?D>6&Dx46\?BB?B.D\e`{ABE}N?~ BEϕ?F 9y?~ A"@A"? A, A+ A) A+ AF~ A?  A+ !A2 "A+#A?A@$ A+ A+ A+ A+ A +A B) B* B+~  B@  B+ B A B`4A DqѿDq?Dnr0DH?B c?B c?B J@B>Y?~ BEG  ?FPJudm?~ A"@AOl? A, A1+ A2+ A3+ Aa A4+  A5+ !A2 "A6+#A@A@$ A7+ Aa A7+ A8+ AcA B) B* B+~  B.@  B7+ BBf  Db<g?Db<g?D0?DR *&?B?G?B?G?BR#@B4ɑ?~ BE[9?F(?~ A,@A ? A, AAA AFA?A? !A2 "A9+#A?A@$ A:+ A;+ A:+ A<+ A=+A B) B* B+~  B$@  B:+ B@H)@ B +@ D|xݙE?D|xݙE?Dz sf?DUg<?B?B?Bi<k@@BP±Q?~ BE'A?FQ,?~ A"@AytC? A, A>+ A?+ A@+ A9 A?A? !A2 "AA+#A@A@$ AB+ AC+ AB+ AD+ AE+A B) B* B+~  B@  BB+ B@ B :k@ DnTDnT?D0ZIDo'?B߰B߰?Bu2XXD/>XX@DARTDͮ~?B%DB%D?B&)PwVKBWyGg?~ BEU&9?F9B|: ?~ A"@Aٙo? A, AAA AFA?A? !A2 "Ak+#A@A@$ Al+ Am+ Al+ An+ Ao+A B) B* B+~  B@  Bl+ B@A@ B@@ DD) ڿDD) ?DQ{.8DѹB$#?B_B_?BCkBd4?~ BE|?F[ݤ?~ A@Ato? A, A Ap+ Aq+ Ar As  As !A2 "Ar+#A?A?$ As+ A As+ At+ Au+A B) B* B+~  B@  Bs+ Bଦ@ B \@ D(.?D(.?DI2=^R@D r?B`?B`?B*ϓI@B:0"L/?~ BE;H~*?F 4ϝ?~ A@A[A? A, AAA AFA?A? !A2 "Av+#A?A?$ Aw+ Ax+ Aw+ Ay+ Az+A B) B* B+~  B@  Bw+ Bs@ BT@ D!-пD!-?Db0DD2Ӧ?BVzؿBVz?BfI7BI?~ BE"K?FVi?~ A@A#)? A, A{+ A|+ A}+ A,A?A@ !A2 "A~+#A@A@$ A+ A+ A+ A+ A+A B) B* B+~  B.@  B+ B`²@ Bs@ DIX?DIX?DOsS@D2`r?BQ?BQ?Bei=f@B_UW;@~ BE@G7?F^Z?~ A,@AZ0? A, A+ A+ A+ A,A?A@ !A2 "A+#A@A@$ A+ A+ A+ A+ A+A B) B* B+~  B$@  B+ B@`@ B@ D"Ȗ_D"Ȗ_?DڌxED465B?BB?B⏑&CBu?~ BEA2?Fr9?~ A"@A*γ~? A, A+ A~ A+ A,A@A@ !A2 "A+#A@A@$ A+ A+ A+ A+ A+A B) B* B+~  B$@  B+ B@1@ B@k@ DYM~DYM~@DaTD<*ʭ?BXBX@B_@WBN!W?~ BENwRYr?FZ]?B?B?B(?@BTA?~ BEi[!?F^mh ?~ A@ATפ? A, A+ A+ A} A,A?A@ !A2 "A+#A?A?$ A+ A+ A+ A+ A+A B) B* B+~  B@  B+ B ౰@ B )#@ D!29.ڿD!29.?DA118DQ.$?BB?BWJBfԕ?~ BEߤA?F-D3{?~ A@An ? A, A+ A+ A+ Ar As  Am !A2 "A+#A?A?$ A+ A+ A+ A+ A+A B) B* B+~  B$@  B+~  B BA DknDkn?D| tLD&-o?BB?BTFBr?~ BE(GJZa?F|[?~ A"@AW^ ? A, A A A AFA@A? !A2 "A+#A@A@$DGl2222,2,2,.22$,2,,.2,,,2,2%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A+ A+ A+ A+ A+A B) B* B+~  B@  B+ B@6@ B@R@ D3 wRD3 wR?D/JDp؝?B?B?BNKJ8@BՀW??~ BEXi?F=d?~ A@AXM? A, A+ A+ A+ A A  A+ !A2 "A+#A?A?$ A+ A+ A+ A+ A+A B) B* B+~  B@  B+ B`"@ Bm@ D0pҿD0p?D$K2D\PǕ5?BTڿBT?B2onY9B&-a?~ BEN?F!V~)?~ A@A-&? A, A+ A" A+ Ar As  Am !A2 "A+#A?A?$ A+ A+ A+ A+ A+A B) B* B+~  B@  B+ B@ B`J@ Dc)?Dc)?DַJ>@DՊ?B`?B`?BYP@Brj >?~ BE+?F s?~ A@A{? A, A+ A+ A+ At Au  A+ !A2 "A+#A?A?$ A+ A+ A+ A+ A+A B) B* B+~  B@  B+ B A B@-.A DٍDٍ?D 487DD3?B`B`?BB`Xrݞ?~ BETR?FM$QN?~ A@AN? A, A, A, A, A,A?A? !A2 "A,#A@A@$ A, A, A, A , A ,A B) B* B+~  BI@  B,~  Bvl B WA D5`.C?D5`.C?DT*@DG{?B@P?B@P?B6ן?Bw?~ BE/Om4?Fn#?~ AH@AhV?#? A, A A A AFA?A? !A2 "A ,#A@A$@$ A , A , A , A, A,A B) B* B+~  BA@  B , B`OVA~  BK D :5D :5?D[#FD=1Zm?B_B_?B-Ϲ'KB~>fY?~ BEw;+-(?F2Y0<^?~ AA@A_8ˮ? A, A A A A,A?A? !A2 "A,#A@A$@$ A, A, A, A, A,A B) B* B+~  B4@  B, BdB-  DQQ((ȩDQQ((ȩ?D2D\>"D}[?BnBn?BJk=B9j?~ BElƳ?FYCW?~ A3@A\*.&? A, A, A, A, A0 AV  A1 !A2 "A,#A@A@$ A, A, A, A, A,A B) B* B+~  B$@  B, BA B A D ;?D ;?D|BmG@DkT-?Bo?Bo?B"8Ґ=@Boa?~ BEA?Fm?~ A"@AE#p? A, A, A, A, A A  A , !A2 "A!,#A@A@$ A", A#, A", A$, A%,A B) B* B+~  B@  B", B@H@ B@ D3)UD3)U?D:ED}K?B`B`?BL$]EBA,?~ BESoQژ?FF/S?~ A@AB,u? A, A&, A', A(, A9 ~ A?  AR !A2 "A),#A?A?$ A*, A+, A*, A,, A-,A B) B* B+~  BK@  B*, BEkeBfd  D22I ݿD22I ?D, ;DCW?BXܿBX?B*:B d?~ BE7+?F(B$,?~ AK@Aq? A, A A  A A,A?A@ !A2 "A.,#A@A&@$ A/, A0, A/, A1, A2,A B) B* B+~  B@  B/, Bzi@ B`yb@ DTeIsDTeIs?DD?=DĨ=h?BڿB?Bf/Ϡ8B^Ov?~ BEJh~?FKh?~ A@AӥYAE? A, A3, A4, A5, A,A?A@ !A2 "A6,#A@A@$ A7, A8, A7, A9, A:,A B) B* B+~  B$@  B7, B @ BaA Dwi?Dwi?D+x S@D̳̕?B v ?B v ?B:khR@B$Y^Ҳ?~ BE8t3m?F8zY?~ A"@AS? A, A;, A<, A=, A, Aj  A>, !A2 "A?,#A@A@$ A@, AA, A@, AB, AC,A B) B* B+~  B@  B@, B@ Bǿ@ Doy?Doy?D B@DlEg?Bh?Bh?BSh@@B w7@n?~ BE+?F⅛?~ A@Afp+? A, AD, AE, AF, Ar As  A !A2 "AG,#A?A?$ AH, AI, AH, AJ, AK,A B) B* B+~  B.@  BH, BmBx=  DTrJqSDTrJqS?D OFD~3?B^B^?BHcP>pKBG›?~ BE\؞Fd?FK`IQ?~ A,@A4DW? A, A A  A A,A?A@ !A2 "AL,#A?A@$ AM, AN, AM, AO, AP,A B) B* B+~  BA@  BM, B+ږzBKge  DGq&ѿDGq&?DG1DRumx?B Q,̿B Q,?B,L,BI>_x?~ BEy:5'?Fm?~ AA@A^B? A, A A  A A,A?A@ !A2 "AQ,#A@A @$ AR, Ai AR, AS, AT,A B) B* B+~  B@  BR, Bഇ@ Bj@ DQtF޶?DQtF޶?D">@Dn?Bq?Bq?B|34j:@B{g?~ BEf1?FUvC?~ A@A? A, AAA A,A?A? !A2 "AU,#A?A?$ AV, AW, AV, AX, AY,A B) B* B+~  B9@  BV,~  BW3A B` 0A Dl"˿Dl"?D%T+DI?BcܿBc?B;8'x:B`2?~ BEn?FBl?~ A8@A ? A, AC AD AE AFA?A@ !A2 "AZ,#A@A@$ A[, A\, A[, A], A^,A B) B* B+~  B$@  B[, BA BA D`q?JD`q?J?Dcǯ't\KDHL?BB?BEB$C?~ BESמ?FRpp?~ A"@AGJ? A, A A  A A,A?A@ !A2 "A_,#A@A@$ A`, Aa, A`, Ab, Ac,A B) B* B+~  B@  B`,~  BB BnVA D%mD%m?D&R KDS*wa?B`ZB`Z?BvIWlKByR?~ BEG-w?Fu?~ A@ARn? A, A) A* A A,A@A? !A2 "Ad,#A@A@$ Ae, A! Ae, A" Af,A B) B* B+~  B.@  Be, BW,BK7+  DՍM=DՍM=?D4IDsA0?Bhj?Bhj?BI6IA@BJ_9Y ?~ BE̅w?F )XO?~ A,@A?D׼>?DdX|y?DqgC?BB?B/qB:ZКy?~ BENB\?F? ?~ A"@A5d? A, Aq, Ar, As, A)A?A? !A2 "At,#A@A@$ Au, Av, Au, Aw, Ax,A B) B* B+~  B@  Bu, BA BA DyP_?DyP_?DZ6-J@D=FW?B?R?B?R?BǨR@B ߛC#?~ BE2 ~y?Fm?~ A@AWhB? A, Ay, Az, A{, A A  A|, !A2 "A},#A?A?$ A~, A, A~, A, A,A B) B* B+~  B@  B~, B l@ BT@ DgDg?Dw'dyDcQ\?B?'?B?'?BcE8@B2H]?~ BEׅ5?FO?~ A@AZD? A, A, A, A, Ag Ah  Ah !A2 "A,#A?A?$DGl2222(,2222,(($22,22(,(((2%;@%;@%;@ A, A, A, A, A,A B) B* B+~  B@  B, B`@ B`W@ D@UlD@Ul?D1DP@ABmggD ZO Q)W)ɟ)I).*u**+[M+O+Y+{%,Ml,!,C,D-U--C.Cd...;///!0 \00031=|1Y1; 2T222,3{u33 45N4494S5  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} m} } $(} I(} } } m } I } } } I} I } } } I }  } I } } } } 3} "} ##} $$} %mQ%%h%,%,%,%J@%,%,%,%, %, %, %, %, %,%,%,%,%,%,%,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ >8N?????@??@@@@@@@@@@@@@@@???HHH?????@?$ A8NAAAAAIAABBBBIIIBBBBBBBBAAAJJJAAAAAIA$PAAAAAAIAABBBBIIIBBBBBBBBAAAJJJAAAAAIA$PAAAAAAIAABBBBIIIBBBBBBBBAAAJJJAAAAAIA$ p q q q q q q q q  q  q  q  q  q q q q q q q q q q q q q q q q q q q  q !q! "q" #q# $K$ A% A& A% A' A(A I) A* A+~  Bd@  B% D`2!A~  D  D*N?D*N?DJT1Q@DRC?D 0D 0?D/.DzdRJZ?~ BE1\?FTh=?~ Ad@A$? A, J- J. J/ A0~ A?  A1 !A2 "A3#I?@AF@$ A4 A5 A4 A6 A7A I) A* A+~  B9@  B4 DA DxA D:g??D:g??DJlUN@D^~?D?I̿D?I?D?;,g,DE !t?~ BE|?F ?~ A8@A%CE? A, J8 J9 J: A; A<  A= !A2 "A>#I"@A$@$ A? A@ A? AA ABA I) A* A+~  BA@  B? Dz D  D색7D색7?DtBD ?DD?D+{ BD?~ BE4gnOʧ?F$r?~ AA@AV w4? A, JC JD JE AFA?A@ !A2 "AG#I@A@$ AH AI AH AJ AKA I) A* A+~  BQ@  BH D:fD*m  DrrDrr?D3NPAD?D?IǿD?I?D6@.r['D5 6b5?~ BE2߅?FKh?~ A@Q@AΆc!? A, JLJ JM AFA?A? !A2 "AN#I@A,@$ AO AP AO AQ AR A I) A* A+~ Bp@ BO D`|A D A DQi DQi? D%>΢{J Dt?? Du. Du.? DbeB DA|9?~ B E5ȳ? FYЍ^G?~ Ap@ A(? A, JS JT JU A0 AV~ A? !A2 "AW #I5@AK@$ AX AY AX AZ A[ A I) A* A+~ B`c@ BX D\ A D a/A D]D'? D]D'? DO'庌V@ DزIn? Dߎh? Dߎh? D1'H<@ DH?~ B Els? F!t&?~ A@c@ A ^1? A, J\ J] J^ A0~ A? A1 !A2 "A_ #IG@AM@$ A` Aa A` Ab Ac A I) A* A+~ B|@ B` D 5A D A D)̿ D)? DhVFJ, D+ m{?D5>{?DY(0@DY?D5?D5?D=\(@DVg?~ BE0,B`?F&-?~ Ae@Af? A, J J JM AFA@A? !A2 "A#I1@AC@$ A A A A AA I) A* A+~  B@P@  B~  Dg D !A D@z(@?D@z(@?D,ԎP@DQ?D_EڿD_E?D 99Da>IC?~ BE:'9?Fm?~ AP@AKI!ں? A, J J J A0~ A?  A !A2 "A#I.@A1@$ A A A A AA I) A* A+~  Bd@  B D NYDzՁ  D70?D70?DrYC"Q@Dk]?D@?D@?D_R?C@D#=V?~ BEŕ]=F^o=~ A`@Ay`)Ұ? A, J J J A0~ A?  A !A2 "A#Ic@At@$ A A A A AA I) A* A+~  B|@  B D-GD L  DWJMi?DWJMi?DYqU@D?D,?D,?DʥAP7@D@ ?~ BEĠls!?FOM?~ A|@AJ@d? A, J J J A0A?A? !A2 "A#ID@A@Z@$ A A A A AA I) A* A+~  B4@  B DA D6)A D%O?D%O?DKHEOl@DuA @D?D?D(US@D∨?~ BE:^f?FcMo"?~ A3@A;pv/? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  Bh@  B D@.A~  DC/ DXPA?DXPA?D]"X@D ?DQ?DQ?D@ mP@D $Ճ?~ BEmvXC<F3<~ A`@AŽ д? A, J J J A0~ A?  A !A2 "A#Ia@Ak@$ A A A A AA I) A* A+~  Bo@  B DM`D#<  D>VF>]D>VF>]?D-[tBDW*/%?D ]ԿD ]?DgNF^3Dנ?~ BE[-Y?F ?~ Ao@A2s? A, JJJ AFA?A@ !A2 "A#I1@AL@$ A A A A AA I) A* A+~  BQ@  B~  DZ'  D@&MA D33|ۿD33|?DC44ܾ9D<?D?D?D5X@Dz?~ BE,?FZ Gk ?~ A@Q@ALTX? A, J J J A A  A !A2 "A#I4@A;@$ A A A A AA I) A* A+~  Bu@  B D^)Dw'A  DQDQ?DůYKDM \?DvDv?DTr5@DG?~ BEOz]:?F#m?~ Au@Al$8? A, J J J A0~ A?  A1 !A2 "A#IA@AU@$ A A A A AA I) A* A+~  B g@  B DD#  D=R(3D=R(3?D!ǨLDFP?DWDW?DU>gEDls{?~ BEO_>FA)?~ Ag@A=@? A, J J J AFA?A? !A2 "A#I1@AE@$ A A A A AA I) A* A+~  Ba@  B D2fDi  Dw/ϻ;Dw/ϻ;?D|CQD1 ?DϯDϯ?DFmHDT?~ BE&?}>F>~ A`a@A,? A, J J J AFA?A? !A2 "A#I$@A=@$ A A A A AA I) A* A+~  B@`@  B D<A DPA DPYտDPY?D D\4D*N?DNDN?D8xD$e}M?~ BEyr?Fp ?~ A `@Am&? A, J J J A0~ A?  A1 !A2 "A#I>@AC@$ A A A A AA I) A* A+~  BN@  B D hA D`2A D!RpD!Rp?D3GD6a}&?DߘDߘ?Dzy^ GD??~ BEDLZid?~ BE`b6?FڤAg%;@?%;@ A A A A A A I) A* A+~ BF@ B DA D A DV? DV? DY/:}I@ D|(? D? D? D?ze ,@ D~2K?~ B EP#Ot? F%@ $ B6$ D@@$ Dii@$ D?$D?$DD<#@$D?$D-v?$D-v?$D(Yc@$DׂUy?~ $B$Ea<7?$F6^u?~ $A=@$Al4ܼ? $A, $J: $J; $J< $A= $A> $ A> $!A2 $"A?$#I@A$@$ %A@ %AA %A@ %AB %AC%A %I) %A* %A+~ % B@ % B@% DBID % D{\U%D{\U?%Dc7a4G%D'f8.(&?%D2`%D2`?%D 7[=%DTf*q?~ %B%EQ@H=%Fh>~ %A@%ArkoQ? %A, %JJJ %AF%A?A? %!A2 %"AD%#IT@Aj@$ &AE &AF &AE &AG &AH&A &I) &A* &A+~ & B9@ & BE~ & DA& D@& D 7Iֿ&D 7I?&D#0Q6&Dzs5?&Dڿ&D?&D|%W,9&D1?~ &B&E|$,?&Foـ?~ &A8@&AO=c? &A, &JI &JJ &JK &AL~ &A? & AM &!A2 &"AN&#I@A"@$ 'AO 'AP 'AO 'AQ 'AR'A 'I) 'A* 'A+~ ' BȄ@ ' BO' Dˢ(A~ ' D_*lI' D?'D?'Dyrq@'D-@'D?'D?'DYZ4_@'D(@~ 'B'Erlf)<'FAW<1<~ 'A@'Aׇ? 'A, 'JS 'JT'J 'AF'A?A? '!A2 '"AU'#IW@A@c@$ (AV (AW (AV (AX (AY(A (I) (A* (A+~ ( BK@ ( BV( DA( D Y A( DZ?(DZ?(DIGE@(D?~ /B/Eف?/Fk@#a?~ /AC@/A^p+? /A, /J /J /J /A/A?A? /!A2 /"A/#I @A$@$ 0A 0A 0A 0A 0A0A 0I) 0A* 0A+~ 0 BK@ 0 B~ 0 D@0 D@A0 D16Dw?0D16Dw?0DF1F@0D>)ٽ[?0Diȿ0Di?0D`1g(0D ?~ 0B0E)8x?0F7ك?~ 0AK@0A+? 0A, 0J 0J 0J 0A0~ 0A? 0 A 0!A2 0"A0#I:@A=@$ 1A 1A 1A 1A 1A1A 1I) 1A* 1A+~ 1 B.@ 1 B1 D@A1 D@      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmopqrstuvwxyz{|}~A1 D2 ut?1D2 ut?1DV?1DL?1DO1DO?1Dd׶ 1Di9=r?~ 1B1EME?1Fn³?~ 1A,@1A@2? 1A, 1J 1J 1J 1A 1A 1 A 1!A2 1"A1#I@A@$ 2A 2A 2A 2A 2A2A 2I) 2A* 2A+~ 2 BK@ 2 B2 D@~mA2 DA2 DВ(gʿ2DВ(g?2DYP*2D0K?2D?2D?2DM!:@2De $aA?~ 2B2Ee?2Fz D?~ 2AK@2ATR? 2A, 2J 2J 2J 2A0 2A 2 A 2!A2 2"A2#I&@A.@$ 3A 3A 3A 3A 3A3A 3I) 3A* 3A+~ 3 Bb@ 3 B3 D^zA3 D],A3 D#ʬ?3D#ʬ?3DRg@3D6*iL@3D?3D?3DA2@3DAM?~ 3B3EΙpL?3F+`?~ 3Ab@3AtcSP? 3A, 3J 3J 3J 3A03A?A? 3!A2 3"A3#I7@AC@$ 4A 4A 4A 4A 4A4A 4I) 4A* 4A+~ 4 B@ 4 B~ 4 D!,4 D`$A4 DQ麿4DQ?4D<94DC?4D_̓4D_̓?4D̆4D`u?~ 4B4Eax?4FG0tG?~ 4A؀@4A0Uغ? 4A, 4J 4J 4J 4A0~ 4A? 4 A1 4!A2 4"A4#IU@Ab@$ 5A 5A 5A 5A 5A5A 5I) 5A* 5A+~ 5 BF@ 5 B5 D @5 D`SA5 D4?5D4?5D؁R\@5D>.s0@5DM?5DM?5DEc\U@5D ū?~ 5B5E+钴?5Fކ?~ 5AF@5AeZ#? 5A, 5J 5J 5J 5A 5A 5 A 5!A2 5"A5#I&@A(@$ 6A 6A 6A 6A 6A6A 6I) 6A* 6A+~ 6 By@ 6 B6 DZ^5DJ( 6 Dx# 6Dx# ?6Dh-HC6DF>j?6D`?6D`?6DbǑ8@6DzW]?~ 6B6E/?6F*U?~ 6Ay@6AA9~? 6A, 6J 6J 6J 6A06A?A? 6!A2 6"A6#IK@AX@$ 7A 7A 7A 7A 7A7A 7I) 7A* 7A+~ 7 B4@ 7 B7 DA7 D\ A7 Dީ[?7Dީ[?7D^jH@7DM?7D-7D-?7DInC1Q7Dƹ%p?~ 7B7E(a0~o?7F凗9_?~ 7A3@7A092oo? 7A, 7J 7J 7J 7Ag 7A 7 A 7!A2 7"A7#I@A@$ 8A 8A 8A 8A 8A8A 8I) 8A* 8A+~ 8 B4@ 8 B8 D^QA8 D'a@8 Dm 8Dm ?8D~5K$P8DLS?8D?V8D?V?8D owB8DQ{Y?~ 8B8E.[?8Fn#?~ 8A3@8AC?6!? 8A, 8J 8J 8J 8A; 8A< 8 A< 8!A2 8"A8#I@A@$ 9A 9A 9A 9A 9A9A 9I) 9A* 9A+~ 9 BPy@ 9 B9 DA9 D=/A9 D ?9D ?9D%H[@9D5@9D1~ 9A@y@9AJ흺z? 9A, 9J 9J 9J 9A 9A 9 A 9!A2 9"A9#I@S@A[@$ :A :A :A :A :A:A :I) :A* :A+~ : Bo@ : B: DnA: DxA: Dx?:Dx?:D(2꫾`@:D8[Dx@:D?:D?:Dar~W@:D㩇 ?~ :B:Exع̩>:FU8ΎK>~ :Ao@:A+5|? :A, :JJJ :AF:A?A? :!A2 :"A:#I2@AJ@$ ;A ;A ;A ;A ;A;A ;I) ;A* ;A+~ ; Bq@ ; B; D[AD ; D%󕱿;D%?;D,;D ?;D;D?;D^;DEOs.?~ ;B;EgL?;F:嫴?~ ;Aq@;AU&Y? ;A, ;J ;J ;J ;A,;A?A@ ;!A2 ;"A;#IF@A@S@$ <A <A  <A <A  <A <A <I) <A* <A+~ < B4@ < B< DRA< D@< D n<D n?<DfWB*D<Dv'?<DB<DB?<D ?f<DZͺ$-?~ <B<Eg&ϝ?<F3I?~ <A3@<Aso4? <A, <J  <J  <J <A,<A?A@ <!A2 <"A<#I@A@$ =A =A =A =A =A=A =I) =A* =A+~ = B\@ = B~ = D[ = D aA= D}=D}?=D;_@=Ds)6C^?=D_ѿ=D_?=D(30=D'7?~ =B=Eԗ ?=Fc7Dg?~ =A\@=Abh? =A, =J =J =J =A,=A?A@ =!A2 ="A=#I3@A:@$ >A >A >A >A >A>A >I) >A* >A+~ > BT@ > B> D8A~ > Dr> DseMNۿ>DseMN?>D7449>DI|?>D`gտ>D`g?>DGme4>Dx?~ >B>Ec҇?>Fn?~ >AS@>A|R? >A, >J >J >J >A, >A > A  >!A2 >"A!>#I"@A0@$ ?A" ?A# ?A" ?A$ ?A%?A ?I) ?A* ?A+~ ? Bd@ ? B"? D`>.A? DX>#A? DFo?DFo??DD'/B?DU88\??D2ٿ?D2??DdQY7?D_?c?~ ?B?ElN??F;H?~ ?Ac@?AgY ? ?A, ?J& ?J' ?J( ?A,?A?A@ ?!A2 ?"A)?#I7@AC@$DGl2,2.$22222(2,.22,.2222,(.@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A* @A+ @A* @A, @A-@A @I) @A* @A+~ @ BQ@ @ B*@ D`*A@ D > A@ DƖI@DƖI?@D6!~BA BI) BA* BA+~ B B@`@ B B;~ B D B D`AB D:~xwBD:~xw?BDP>GBDz/3?BD@[ަ?BD@[ަ?BD' @BD[2ˀ?~ BBBE [?BFtYQ?~ BA `@BA&ώ0? BA, BJ? BJ@ BJA BA,BA?A@ B!A2 B"ABB#I4@A?@$ CAC CAD CAC CAE CAFCA CI) CA* CA+~ C B@U@ C BCC D AC D AC DVrCDVr?CDUpKCDo>?CD_?CD_?CDi`YG@CDsx?~ CBCEQw [6?CFb' ?~ CAU@CA3b? CA, CJG CJH CJI CA,CA?A? C!A2 C"AJC#I1@A:@$ DAK DAL DAK DAM DANDA DI) DA* DA+~ D B.@ D BKD D@D D@D D(DWBDD(DWB?DD3apDDDը0 ?DD; DD; ?DD@DDChL.?~ DBDE7;H!?DF8zY?~ DA,@DAq5'? DA, DJO DJP DJQ DA, DA D AR D!A2 D"ASD#I$@A&@$ EAT EAU EAT EAV EAWEA EI) EA* EA+~ E B@P@ E BTE D,kAE D'AE D5ނ[?ED5ނ[?EDzC2LR@EDIG?ED?ED?EDA%1h@EDv~|@~ EBEE<Y`f?EFH> Α?~ EAP@EAq+? EA, EJX EJY EJZ EA,~ EA? E A1 E!A2 E"A[E#I&@A.@$ FA\ FA] FA\ FA^ FA_FA FI) FA* FA+~ F B@@ F B\F DA~ F DnsF DfGFDfG?FDOLFDɏ?FD FD ?FDYKz[CFDqj@~?~ FBFEqHX>FF`>~ FA8@FA$vtDп? FA, FJ` FJa FJb FA,FA?A? F!A2 F"AcF#IE@A[@$ GAd GAe GAd GAf GAgGA GI) GA* GA+~ G Bq@ G BdG D%AG DAG D1ܿGD1?GD]LT :GDMƪw?GDߣU?GDߣU?GD:T$@GDۋ?~ GBGEQ0)I?GF?~ GApq@GAx_? GA, GJh GJi GJj GA,GA?A@ G!A2 G"AkG#IE@A@R@$ HAl HAm HAl HAn HAoHA HI) HA* HA+~ H B`m@ H BlH D AH DAH DltȝHDltȝ?HDထHD`\?HDM޿HDM?HDgUA<HD46?~ HBHELc?HFDž?~ HA@m@HAnΟ,hu? HA, HJp HJq HJr HA,HA?A@ H!A2 H"AsH#IK@A@R@$ IAt IAu IAt IAv IAwIA II) IA* IA+~ I B g@ I BtI D4 AI D:AI Dwɿ]L?IDwɿ]L?ID>ۏB@IDV?IDߏ?IDߏ?ID!< @ID?s|uI?~ IBIEH?IFKh?~ IAg@IA줳6? IA, IJx IJy IJz IA, IA I A  I!A2 I"A{I#IC@AM@$ JA| JA} JA| JA~ JAJA JI) JA* JA+~ J B@o@ J B|J D D2 J D B ?JD B ?JDGk9̱=@JD#ɢI?JD?JD?JD)9G;8@JD%F?~ JBJE߂?JFɉ?~ JA o@JAW~? JA, JJ JJ JJ JA,JA?A@ J!A2 J"AJ#I7@AJ@$ KA KA KA KA KAKA KI) KA* KA+~ K BA@ K BK D@K D`]@K D<D?KD<D?KDX8@KD{~?KD˾KD˾?KDξy. KDm gp?~ KBKE`N;?KF ?~ KAA@KA4a^so? KA, KJ KJ KJ KA, KA K A K!A2 K"AK#I$@A,@$ LA LA LA LA LALA LI) LA* LA+~ L BH@ L BL DZD L Dҍ0?LDҍ0?LD e@LDb@LD`f?LD`f?LD3L@LDMUGX3?~ LBLE.y } h=LF gW?>~ LA@@LA? LA, LJ LJ LJ LA,LA?A? L!A2 L"AL#IU@Ah@$ MA MA MA MA MAMA MI) MA* MA+~ M Bz@ M BM D AM D ߙAM D#|$?MD#|$?MDVBA@MDqcq?MD}?MD}?MDUL@MD{2?~ MBMEr^ѝ>MF+3i4M>~ MAz@MAThT? MA, MJ MJ MJ MA,MA?A? M!A2 M"AM#IU@A`@$ NA NA NA NA NANA NI) NA* NA+~ N B@z@ N BN DÈ M@PDP v?~ PBPE&\& >PF]`>~ PA@PAN? PA, PJ PJ PJ PA,PA?A@ P!A2 P"AP#I@V@A g@$ QA QA QA QA QAQA QI) QA* QA+~ Q B`c@ Q BQ DeD[! Q D'CZ#?QD'CZ#?QDmxz1@QD:`?QDG͂QDG͂?QD4ĩoLQD@ ?~ QBQEc?QFw=IRFc }>~ RA0u@RAƊ? RA, RJ RJ RJ RA,RA?A? R!A2 R"AR#IF@A@V@$ SA SA SA SA SASA SI) SA* SA+~ S B@@ S BS DpADBB S D }w ?SD }w ?SDU@SDC<?SD?SD?SD]kDC@SD gU?~ SBSE/+Щl>SFƢƐ>~ SA8@SAtW^? SA, SJ SJ SJ SA,SA?A@ S!A2 S"AS#IK@Ac@$ TA TA TA TA TATA TI) TA* TA+~ T B@o@ T BT D )YA~ T D"ZT Dќ?TDќ?TDq:^H@TDr~?TD?TD?TDC2:@TDO}D?~ TBTESb?TFs5 .?~ TA o@TAqP? TA, TJ TJ TJ TA,TA?A@ T!A2 T"AT#I<@AN@$ UA UA UA UA UAUA UI) UA* UA+~ U Bԧ@ U BU D`FFAU D@WxAU D9fs 2ѿUD9fs 2?UD}0(0UDV&?UDUD?UD\sA UDJKO?~ UBUE ?UF#X9i?~ UAҧ@UA6 ? UA, UJ UJ UJ UA,UA?A@ U!A2 U"AU#Ii@AX@$ VA VA VA VA VAVA VI) VA* VA+~ V B4@ V BV DB# DR V D:g?VD:g?VD )F1@VDD?VD &_?VD &_?VD̪&@VD$"?~ VBVEff;#)S?VFĠIf?~ VA2@VAEէ? VA, VJ VJ VJ VA,VA?A@ V!A2 V"AV#Il@A`@$ WA WA WA WA WAWA WI) WA* WA+~ W B@ W BW DjD" W D_up?WD_up?WDuH1@WD?WD_͢?WD_͢?WDsU骟@WDIi?~ WBWE 4,`?WF z}?~ WA@WA"i?? WA, WJ WJ WJ WA,WA?A@ W!A2 W"AW#IX@Ad@$ XA XA XA XA XAXA XI) XA* XA+~ X B@@ X BX D/D 1 X D 5a?XD 5a?XDdQ@XDkG+!?XD_ ?XD_ ?XDK]A@XD2?~ XBXEgm{?XFYЍ^G?~ XA0@XAmwAS? XA, XJ XJ XJ XA,XA?A@ X!A2 X"AX#IL@A\@$ YA YA YA YA YAYA YI) YA* YA+~ Y B@Z@ Y BY DdcAY D`WAY D&9?YD&9?YDA10@YDe ]ϫ?YDF?YDF?YD-D;C@YD.lGS?~ YBYERH?YF16?~ YAZ@YAg_P? YA, YJ YJ YJ YA,YA?A@ Y!A2 Y"AY#I2@A>@$ ZA ZA ZA ZA ZAZA ZI) ZA* ZA+~ Z Bn@ Z BZ DtDd3 Z D^*UZD^*U?ZD KZDWtK?ZDZD?ZD`DBޔe>ZDߘE?~ ZBZE@T?ZFx)D?~ ZAm@ZA'vx? ZA, ZJ ZJ ZJ ZA,ZA?A@ Z!A2 Z"AZ#I6@AL@$ [A [A [A [A [A [A [I) [A* [A+~ [ BN@ [ B[ D=*DP [ D-S[D-S?[DЫXQ[D3P?[Dt[Dt?[D0%u!'O[DU+?~ [B[Ervz>[Ftp>~ [AM@[Aa8$t? [A, [J  [J  [J  [A,[A?A@ [!A2 ["A [#I@A*@$ \A \A \A \A \A\A \I) \A* \A+~ \ BR@ \ B\ DrLD1 \ Db*\Db*?\Dt|Q\DJ(";?\DDm\DDm?\D l7O\D.>+A2?~ \B\E8vb=\FY4P>~ \AR@\A%? \A, \J \J  \J \A,\A?A@ \!A2 \"A\#I@A.@$ ]A ]A ]A ]A ]A]A ]I) ]A* ]A+~ ] BK@ ] B] DZ΄D{-F ] D1m"P]D1m"P?]Dŷ{Q]D3U?]D]D?]Dy!ci~Q]D D7?~ ]B]E xf?]FrP@*9?~ ]AK@]Aw bO? ]A, ]J ]J  ]J ]A,]A?A@ ]!A2 ]"A]#I@A(@$ ^A ^A ^A ^A ^A^A ^I) ^A* ^A+~ ^ B@Z@ ^ B^ DF@Df ^ D[C^D[C?^DHP^DA?^D N{^D N{?^Dz)I^DaXV?~ ^B^Efu.>^F.Դ>~ ^AZ@^Aurx'? ^A, ^J ^J  ^J ^A,^A?A@ ^!A2 ^"A^#I @A5@$ _A  _A! _A  _A" _A#_A _I) _A* _A+~ _ BN@ _ B _ DjzeDHj _ DÁP_DÁP?_Drf yD_D[@?_D B_D B?_DL=E_D 7ί?~ _B_E! ?_Fo(?~ _AM@_A_;(? _A, _J _J  _J _A,_A?A@ _!A2 _"A$_#I@A,@$D8Gl,$(,22(,,22,,(((,,`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A% `A& `A% `A' `A(`A `I) `A* `A+~ ` B l@ ` B%` DBf?DH ` D?T`D?T?`D+w&P`D))?`D`D?`D-(C`D|rB?~ `B`EVS>`Fu#>~ `Al@`A9PԤ[6? `A, `J `J  `J `A,`A?A@ `!A2 `"A)`#I1@AH@$ aA* aA+ aA* aA, aA-aA aI) aA* aA+~ a B@e@ a B*a DB8 DR a DVaDV?aḎĪZQaDKr?aDaD?aD؊n\HaD`Lh?~ aBaE#>aFW2p>~ aA e@aA@-ɸX? aA, aJ aJ  aJ aA,aA?A@ a!A2 a"A.a#I*@AA@$ bA/ bA0 bA/ bA1 bA2bA bI) bA* bA+~ b B0{@ b B/b D&D9 b DFbDF?bDBbDSk?bDbD?bDµ <>bDz65.S?~ bBbE5Bk)?bF"1j^9^?~ bA {@bAW? bA, bJ3 bJ4 bJ5 bA,bA?A@ b!A2 b"A6b#IM@AY@$ cA7 cA8 cA7 cA9 cA:cA cI) cA* cA+~ c Bp@ c B7c DBJ"D6 c D]U?cD]U?cD%sL@cD2X;?cDs?cDs?cDpJD@cDgka~?~ cBcE762?cF`~nC?e?~ cAp@cAY%? cA, cJ; cJ< cJ= cA,cA?A@ c!A2 c"A>c#I6@AJ@$ dA? dA@ dA? dAA dABdA dI) dA* dA+~ d B8@ d B?d DBz@d DAd D40ݩ?dD40ݩ?dD'RU{n@dD% @dD?dD?dDxKS@dD ~n?~ dBdEB8<dFD~M`=~ dA0@dA;]$? dA, dJC dJD dJE dA,dA?A@ d!A2 d"AFd#I@d@A p@$ eAG eAH eAG eAI eAJeA eI) eA* eA+~ e B@@ e BGe DOAe DgAe D2ro?eD2ro?eDB-JKR@eDul:?eD?eD?eDR@eD(?~ eBeE,ޤ.́9eFѳ[\:~ eA<@eA0S? eA, eJK eJL eJM eA,eA?A? e!A2 e"ANe#IS@Ak@$ fAO fAP fAO fAQ fARfA fI) fA* fA+~ f B g@ f BOf D8 Dr f D aO[fD aO[?fDKZfD$z"C?fDW?fDW?fDSi@fDҕ"Y?fFG0tG?~ fAg@fA*'? fA, fJS fJT fJU fAVfA?A? f!A2 f"AWf#I2@AD@$ gAX gAY gAX gAZ gA[gA gI) gA* gA+~ g BT@ g BXg D`|pAg D9Ag D ?gD ?gDǿ%@gD\ ?gD?gD?gD"(8:=@gDA?~ gBgE]IT$>gF>{vs>~ gAR@gAX}? gA, gJ\ gJ] gJ^ gA,gA?A@ g!A2 g"A_g#Ia@A|@$ hA` hAa hA` hAb hAchA hI) hA* hA+~ h BL@ h B`h DBXAh D 4Ah DN?hDN?hDk?'@hD&K"?hDR?hDR?hD@|{"@hDD z?~ hBhE0h?hFDJ?~ hAH@hA u? hA, hJd hJe hJ^ hA,hA?A@ h!A2 h"Afh#IV@Au@$ iAg iAh iAg iAi iAjiA iI) iA* iA+~ i BL@ i Bgi DAi D6Ai Djo>0?iDjo>0?iD_ @iDAq)k?iD߆?iD߆?iDW @iD Ww[?~ iBiE:ʥ?iF]g#t?~ iAH@iA%8Y? iA, iJk iJl iJm iA,iA?A@ i!A2 i"Ani#I@T@A q@$ jAo jAp jAo jAq jArjA jI) jA* jA+~ j B`h@ j Boj D DR] j D&JjD&J?jD.9PPIjD,F2?jD޿jD?jDR<jDyQ?~ jBjEue>jFqn>~ jA@h@jAc$4? jA, jJs jJt jJu jA,jA?A@ j!A2 j"Avj#I0@AJ@$ kAw kAx kAw kAy kAzkA kI) kA* kA+~ k Bl@ k Bwk D;dD6 k D#U8kD#U8?kD`FkD`V?kDt%kDt%?kDz0@@kD z?~ kBkE>kFԾ0?~ kAl@kAI? kA, kJ{ kJT kJ| kA,kA?A@ k!A2 k"A}k#I5@AH@$ lA~ lA lA~ lA lAlA lI) lA* lA+~ l Bl@ l B~l D/A*,D : l D9o?lD9o?lDxe#U@@lD drV?lD6?lD6?lDn\b[D@lD'gyo?~ lBlEr>'֋?lF^EZǰ?~ lAl@lAP ? lA, lJlJ lJ lA,lA?A@ l!A2 l"Al#ID@AM@$ mA mA mA mA mAmA mI) mA* mA+~ m B@o@ m B~ m DKIm D \Am D'vJ?mD'vJ?mDxda@mDB69z@mD?mD?mD$^Y\@mDg[@~ mBmEwjۯs >mFH)K_>~ mA o@mA~? mA, mJ mJ mJ mA,mA?A@ m!A2 m"Am#I<@AM@$ nA nA nA nA nAnA nI) nA* nA+~ n B[@ n Bn DD A~ n D'n DZ?nDZ?nDĝPp@nD.x @nD?nD?nDf@nDPJK(@~ nBnEUD::?nF#m?~ nA@[@nAl? nA, nJ nJ nJ nA,nA?A@ n!A2 n"An#I2@A:@$ oA oA oA oA oAoA oI) oA* oA+~ o B@ o Bo D_D!k o D1?oD1?oDTi*@oDow;!?oD?oD?oD(_@oD ?~ oBoE%m>?oF#PP[?~ oA@oAP-C? oA, oJ oJ oJ oA,oA?A@ o!A2 o"Ao#Ih@A@$ pA pA pA pA pApA pI) pA* pA+~ p B[@ p Bp D .Ap D)Ap Dբ5?pDբ5?pDKQl0W@pD:gG?~ wBwESwj?wF}?~ wA@wAʥ? wA, wJ wJ wJ wA,wA?A@ w!A2 w"Aw#IX@Aq@$ xA xA xA xA xAxA xI) xA* xA+~ x Bo@ x B~ x D؃x DU$Ax Dg>[xDg>[?xDkFxrxD8?xD+y?xD+y?xD1*s2@xDOɡ?~ xBxEg?xF<?~ xAo@xAX呷=? xA, xJ xJ xJ xA,xA?A@ x!A2 x"Ax#IB@AO@$ yA yA yA yA yAyA yI) yA* yA+~ y B@ y By D`RAy DAy D>d̿yD>d?yDM`Sˀ,yDNp?yDyD?yDc]uC"yD8E?~ yByE$>yF>{vs>~ yA@yA0kȰ? yA, yJ yJ yJ yA,yA?A@ y!A2 y"Ay#I@A@$ zA zA zA zA zAzA zI) zA* zA+~ z Bw@ z B~ z DH{\Az D_Az D1;`Q?zD1;`Q?zDh}C!@zD.Bzj?zD/?zD/?zDSt1$#@zDK?~ zBzEH2?zF-It<?~ zAw@zA? zA, zJ zJ zJ zA,zA?A? z!A2 z"Az#ID@AU@$ {A {AP {A {A {A{A {I) {A* {A+~ { B@ { B~ { D$SB{ D1A{ DR{DR?{DV>RdJ{DDY7?{D`{D`?{DE{D38;?~ {B{E7دܘ;{FjyM <~ {A@{A ? {A,{J {JD {J {A,{A?A? {!A2 {"A{#IG@A c@$ |A |A |A |A |A|A |I) |A* |A+~ | B @ | B| D D | DM?|DM?|D$ |L@|Dl\%?|D?|D?|D޸E@|D"d<?~ |B|Ea|;|F(x ;~ |A@|AٸJـ? |A, |J |J |J |A,|A?A@ |!A2 |"A|#Ii@A@$ }A }A }A }A }A}A }I) }A* }A+~ } Bn@ } B} DlX7AD } D̹Ŀ}D̹?}D21%}Dڛ?}D?}D?}Dsu`*)@}Dd2c?~ }B}E vI?}FOM?~ }Am@}A7? }A, }J }J }J  }A,}A?A@ }!A2 }"A }#I@@AQ@$ ~A  ~A  ~A  ~A  ~A~A ~I) ~A* ~A+~ ~ BF@ ~ B ~ D TD; ~ D,ӛ~D,ӛ?~DF5۟>~ Ar@Ae]G? A, J6 J7 J8 A, A A  !A2 "A9#I?@AQ@$ A: A; A: A< A=A I) A* A+~ Bv@ B: DŸD_7  DHR$ĿDHR$?D݀$D}\q?DRDR?D -DpVD5?~ BE?FZ v?~ Apv@A܇7OC? A, J>J J? A,A?A@ !A2 "A@#II@AV@$ AA AB AA AC ADA I) A* A+~ B`m@ BA D #A D`A DNvDNv?DH=Dε:g?DڿD?Dex#8D ?~ BEn:?F4?~ A@m@Aӫ? A, JE JF JG A,A?A@ !A2 "AH#IB@AN@$ AI AJ AI AK ALA I) A* A+~ B[@ BI DClD+  DvݞĿDvݞ?D?P:8%DNآ?D lҿD l?D:l72D-+?~ BE_J?F/,?~ A@[@A˚U? A, JM JN JO A,A?A? !A2 "AP#I4@A=@$ AQ AR AQ AS ATA I) A* A+~ BP~@ BQ DkHD?T  D̗S?D̗S?Di}0@D練?DC?DC?D)@D7R5?~ BE| ?F?~ A@~@AI? A, JU JV JW A,A?A? !A2 "AX#IP@A`@$ AY AR AY AS AZA I) A* A+~ B$@ BY D@@ D ԋA Dא.X?Dא.X?DYZ@D/&~@DFĿDF?Dƪf%DfOh?~ BEf4?Fno3?~ A"@ASsr? A, JJJ A, AA !A2 "A[#I@A@$ A\ A] A\ A^ A_A I) A* A+~ BA@ B\ Dff A Dw~A D<%#?D<%#?D#nP D@Duj?D_ٰ?D_ٰ?DX+NT@D'M%?~ BElyނ?FO `?~ AA@AqG? A, J` Ja J A,A?A@ !A2 "Ab#I@A$@$ Ac Ad Ac Ae AfA I) A* A+~ B@ Bc DfDB  DR?DR?DKGKN@Dv?D_?D_?D/gB@Dia?~ BEu%/C>F d?~ A@A6kfA? A, Jg Jh Ji A,A?A@ !A2 "Aj#IT@Af@$ Ak Al Ak Am AnA I) A* A+~ B@`@ Bk D`; A DyA D|ʿD|?D꛶*D5lSI?D_MտD_M?D@R4Df]rh?~ BEDB?F@AE@$ As At As Au AvA I) A* A+~ Bȉ@ Bs Df|>DXH  D`($ ?D`($ ?D-2/Hh/@DsjtM1?Dx?Dx?DN 4@Dr-XBU?~ BEK,,?F%.`?~ A@A\ɲ? A, Jw Jx Jy A,A?A? !A2 "Az#IS@Ag@$ A{ A| A{ A} A~A I) A* A+~ B`h@ B{ D+A DƓA D*TkɿD*Tk?D"B)Dr?DY¿DY?Drt}"D]ׁ?~ BEd`R?FA s?~ A@h@A% ? A, J J J A,A?A@ !A2 "A#IA@AI@$ A A A A AA I) A* A+~ B g@ B D`>3A D`T0A D#b XοD#b X?D6aN.D+7kd&?D@?D@?D:N@DEp?~ BEŽl?F$ݡ ѕ?~ Ag@A^a`? A, J J J A,A?A@ !A2 "A#I@@AL@$ A A A A AA I) A* A+~ Bn@ B D N/%A D OK+A DXie?DXie?DU `Ҭ<@D_:?D{?D{?D-R;@D~c3y?~ BEdf'{?F]g#t?~ Am@As7?? A, J J J A,A?A@ !A2 "A#IB@AN@$ A A A A AA I) A* A+~ B@ B DrDiK  Dp'hcS?Dp'hcS?D!&_r@DP+@D@2&?D@2&?Dm'`@DQ߹V@~ BEs0zP7F7~ A@A{ 6ӟ? A, J J J A,A?A? !A2 "A#IW@Ap@$ A A A A AA I) A* A+~ B@ B DB2Do   Dq M?Dq M?D$C@Dd >F?Dq?Dq?DmO 5@D]n?~ BEtPs?F Hg?~ A@AD՟? A, J J J A,A?A@ !A2 "A#I^@Ap@$ A A A A AA I) A* A+~ B g@ B DpAADH@  D7_?D7_?D,@DnyzM?D@^?D@^?Dѥ8i(@D?~ BEӾ?FG3p@?~ Ag@ALb? A, J J J A,A?A@ !A2 "A#I:@AI@$ A A A A AA I) A* A+~ BD@ B DpA DJA DRXo`?DRXo`?D*\vA@D?D@BD@B?D;qFDit|?~ BE7N ?F2{?~ AC@Ajcc? A, J J J A A A !A2 "A#I@A @$ A A A A AA I) A* A+~ B@ B DB^D  D}c!6D}c!6?Dr"ED)#?DL DL ?DM6-@D?C?~ BE > F=F:=~ A@A`;? A, J J J A,A?A? !A2 "A#IQ@Ah@$ A A A A AA I) A* A+~ Bt@ B D2DR2x  D(EuzӿD(Euz?D #0K3DZ>?D_2w?D_2w?DU"@D}?~ BEL#Ԣ?FdS?~ Ap@AUh1? A, J J J A,A?A@ !A2 "A#Id@Au@$ A A A A AA I) A* A+~ B>@ B~ D3" D`Q2A D}EsпD}Es?Dx-R0Dj?D qD q?D(f3;ADCbJ?~ BEs8Qb?F ?~ A=@A? A, J J J A,A?A@ !A2 "A#I@A"@$ A A A A AA I) A* A+~ Bs@ B~ D 3 Dʲ0A DH;+?DH;+?DaL7@DB*?D!K?D!K?Dx!@D1e?~ BEPN ?F-3Wm?~ As@AKdxP? A, JJ J A,A?A@ !A2 "A#IK@AW@$ A A A A AA I) A* A+~ B@U@ B DZDDJ  DQq?DQq?Dq͕<@D??DпD?DcS~0DyA?~ BEϙ?F??~ AU@A{ :]~? A, J J J A,A?A? !A2 "A#I0@A7@$ A A A A AA I) A* A+~ B@ B Dy"DB  DDz |ϿDDz |?Do{/DDh?D?D?DE3@D 6ޗ?~ BE7洺?F_?~ A@A`/? A, J J J A, A A !A2 "A#IG@A\@$ A A A A AA I) A* A+~ B@u@ B D`*A~ D1 Db6CDb6C?D\!D-dLv$?D_ȿD_?DDb(D\&$?~ BE I3y.?Fw'o?~ A0u@Ac? A, J J J A,A?A@ !A2 "A#IH@AV@$ A A A A AA I) A* A+~ BK@ B~ DE  DoA Do:+:Do:+:?DbDT*M?D2D2?DL^*OaD :?~ BE[lP?F(?~ AK@A8c? A, J J J A,A?A? !A2 "A#I @A(@$ A A A A AA I) A* A+~ Be@ B DvA D ?A DKNꏂ?DKNꏂ?D`*?DߤJ?Dߙ?Dߙ?D =@DޯKҺ?~ BEHi?Fu݁?~ Ae@AԪAQ? A, J J J A A A !A2 "A#I@@AH@$ A A A A AA I) A* A+~ Bd@ B DD  D/5"eD/5"e?D=zY8CDx4?DcDc?D;DD،6?~ BER 7V?F~J?~ Ad@Aϰ"? A, J J J A,A?A@ !A2 "A#I5@AB@$ A A A A  A A I) A* A+~ B@ B D CA D wF(A D'\?D'\?D 6U@D1FR7>~ A@A"&̹? A, JJJ A, AA !A2 "A #Ic@A o@$ A  A  A  A AA I) A* A+~ BV@ B  D A D`A D׿D?DK#6DF Ю?DfDf?D Dt(i=?~ BEYm?Fh=m6?~ A@V@Aлe? A, J J J A, A A !A2 "A#I6@A;@$DGl2.($, ,,,,,2($$((2 %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~ Bt@ B~ D. D9k;A DqzDqz?D'^DL;?DG棿DG?DWتCDܭ@&?~ BE0?F@Ѝ?~ At@Atо? A, J J J A,A?A@ !A2 "A#IF@A@S@$ A A A A A A I) A* A+~ Bp@ B D Ʀ5A~ DK D=ϿD=?D:2 /Dn?D+?D+?D{|,@D^ M?~ BE?FU\?~ Ap@A꓂ ? A, J! J" J# A,A?A@ !A2 "A$#IC@AQ@$ A% A& A% A' A(A I) A* A+~ Bl@ B% DD  DBteDBte?DW9!D*t{?D`.D`.?D{s(DR)&c?~ BE&?Fc-s:?~ Ah@Ad*>\? A, J) J* J+ A,A?A@ !A2 "A,#I@f@Aq@$ A- A. A- A/ A0A I) A* A+~ B@P@ B- DrFD0CAA  D=w[l5+ٿD=w[l5+?D6_7DKfp]?D_ =?D_ =?D_$@D )3?~ BE#?F1V^IT?~ AP@Al!? A, J1 J2 J3 A, A A !A2 "A4#I"@A*@$ A5 A6 A5 A7 A8A I) A* A+~ B`m@ B5 D`n %A DZ6"A Dh>&ڟʿDh>&ڟ?D c*D֨7?DtDt?D3\sD x?~ BE"?Fw=I J? J@ A,A?A@ !A2 "AA#IE@AL@$ AB AC AB AD AEA I) A* A+~ Ba@ BB D@Q#A D@ A DfDf?Dq7ODAs?DCDC?DIIDؐq?~ BE2p`<$>Fv9[?~ A`a@AWUm_h? A, JF JG JH A,A?A@ !A2 "AI#I>@AD@$ AJ AK AJ AL AMA I) A* A+~ Bt@ BJ D$3D+b  Dq8Kg?Dq8Kg?DXɶAD@Dr{?D_y0?D_y0?D-θ9@DFs ?~ BElb?FXO?~ At@A_st? A, JN J" J A,A?A@ !A2 "AO#IK@AU@$ AP AQ AP AR ASA I) A* A+~ Bv@ BP D X0A D`s.A Dce Dce ?D''DRQ:?DYDY?D0y[D~b ?~ BEv Z?F~?~ Apv@AJO¾? A, JT JU JV A,A?A@ !A2 "AW#IO@A@X@$ AX AY AX AZ A[A I) A* A+~ Bu@ BX D` +A D A DoRݩDoRݩ?Dca>LDM?D0CֿD0C?D9hl5Di|$?~ BE6Cނ?FTLO?~ Au@AJ? A, J\ J] J^ A,A?A@ !A2 "A_#II@AT@$ A` Aa A` Ab AcA I) A* A+~ BR@ B` D̏#AD?$  DDtDDt?D&$7D DC?D@|D@|?DQu8Dbt)C?~ BEZ\/?FIA8 ?~ AR@ALՀ? A, Jd Je Jf A, A A !A2 "Ag#I"@A.@$ Ah Ai Ah Aj AkA I) A* A+~ BK@ Bh D @ DY@ D1뗸D1뗸?DC(^D D?DaHDaH?Ds HD&YZ:?~ BE/?F r?~ AK@As_77? A, Jl Jm Jn A,A?A@ !A2 "Ao#I3@A3@$ Ap Aq Ap Ar AsA I) A* A+~ B@`@ Bp D`s;A~ D)/ D{I?D{I?D{w&@Do2?DD?D)n<$PD6d`?~ BEmF(?F[ݤ?~ A `@A+? A, Jt Ju Jv AV~ A? A !A2 "Aw#I6@A@@$ Ax Ay Ax Az A{A I) A* A+~ Bp@ Bx D@ DQ[A Di?Di?Dc/j@D> @D`'?D`'?DUl'HP@D+6Zk?~ BE>!>FFo&q>~ Ah@A"N`? A, J| J} J~ A, A A !A2 "A#IS@A`a@$ A A A A AA I) A* A+~ Bi@ B D@"A~ D  D`D`?D/Di֭?D?D?Dd0&@D4U?~ BE5?Frd5J?~ Ah@A_]K$? A, J J J A, A A !A2 "A#IC@AM@$ A A A A AA I) A* A+~ Ba@ B D@>A DA D,ק^?D,ק^?D$ذK@DP?D ?D ?Dw~R@D:ke?~ BETΉ?FPS?~ A`a@A? A, J J J A, A A !A2 "A#I7@A?@$ A A A A AA I) A* A+~ B b@ B D A DnA DIq͓;DIq͓;?D60_CD?D2D2?Dmk3ED h$?~ BEs?Fl0'ኜ?~ Ab@A\R"C? A, J J J A,A?A? !A2 "A#I;@AB@$ A A A A AA I) A* A+~ B@Z@ B D A D@sA D ֊sԿD ֊s?Dpy>3D|f?Dߝ翿Dߝ?Dǫ*H DZ?~ BEf.?Fn?~ AZ@AMc? A, J J J A,A?A? !A2 "A#I9@A?@$ A A A A AA I) A* A+~ BW@ B DwA D@ c@ D1~{^D1~{^?D!+BD'z$?D@ڿD@?D@19D?~ BE̽'?F9jR9?~ AW@A[\*? A, J J J A,A?A@ !A2 "A#I7@A@@$ A A A A AA I) A* A+~ B@@ B D U0A D&A DxDx?DtyѴ5>D`fU?D]ɿD]?D+S)D,ow\?~ BEQl㟥?F}n?~ A8@AHkߢ? A, J J J A, A A !A2 "A#IV@Ad@$ A A A A AA I) A* A+~ B`h@ B~ D?r.2 D|&;A D3uJϿD3uJ?D.DQ[ ?D@D@?D/ ΘCDp"|j?~ BE| ?FfBB?~ A@h@A.0X2? A, J J J A,A?A@ !A2 "A#I8@AG@$ A A A A AA I) A* A+~ B@e@ B DD~  DikHDikH?DiJ_IDNg:?D D ?D*Ҏ6CD1>9o?~ BEwWeP?F7ŽۮB?~ A e@Ak? A, JJ J A,A?A@ !A2 "A#I(@AB@$ A A A A AA I) A* A+~ B~@ B DXA~ D*6 D(z0(?D(z0(?D|D@DlT?DM?DM?DKh5@Dt޾Kq?~ BE&-~S?FM)O?~ A}@Aa? A, J J J AV~ A? A !A2 "A#II@AZ@$ A A A A AA I) A* A+~ Bx@ B D8D?  Drn#?Drn#?DY6DҲ*@D<$"?Du?Du?D _ @D=[O?~ BEdS?F|e?~ Ax@A7/? A, J J J A, A A !A2 "A#I9@A\@$ A A A A AA I) A* A+~ B@ B DbDeU  D<&˿D<&?DQX+D;ߟ?DD?DyUv Dk)Q?~ BE(m?FRU1?~ A@A?>נ? A, J J J A, A A !A2 "A#I l@A0{@$ A A A A AA I) A* A+~ BT@ B D A DPmA DzښB˞?DzښB˞?D¿D>?D[/gs#D~:?~ BEroI5?F 4ϝ?~ AS@AD k? A, J J J A,A?A@ !A2 "A#I2@A:@$ A A A A AA I) A* A+~ BD@ B~ D(A DQh@ DUTDUT?D+{GD+o?DD?D(ƜGDN7X?~ BE=CM?FMt?~ AC@A@=Is? A, J J J A, A AR !A2 "A#I"@A&@$ A A A A AA I) A* A+~ B\@ B DlQADpJ  DRK4DRK4?D1U5@Dy/(3?DΒDΒ?D]/GAD(?~ BEu|/2,>Fy ?~ A\@ATO? A, J J J A,A?A@ !A2 "A#I0@A;@$ A A A A AA I) A* A+~ By@ B~ D:i D,A DtDt?Dɓy؝FDj ?D KĿD K?D7 `S%DĀQ?~ BE$çu=|?F~ ?~ Ax@Aib? A, J J J A, A A !A2 "A#IO@AY@$ A A A A AA I) A* A+~ BI@ B D A~ D@ D4h8D4h8?DStIJD)Y?D_?D_?DDb @D#揄?~ BED7 ~?F|gG?~ AH@Afk? A, J J J A,A?A@ !A2 "A#I,@A2@$ A A A A AA I) A* A+~ Bn@ B D2A DdA D׳5qĿD׳5q?D¤!A%D LBk?DmҿDm?D1D\NkL?~ BE0'?F?~ Am@Aj#i? A, JJJ A, AA !A2 "A#IP@A@T@$ A A  A A  A A I) A* A+~ BT@ B D@Zh!A D@.&A DqgO޿DqgO?D&8;DU0}?DժDժ?DVE DUD?~ BEAoa?F@Ѝ?~ AS@A*? A, J  J  J A, A A !A2 "A#I1@A9@$DrGl(($ ,,,,$,.2.2,,,2(.$$,..( %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~ Bi@ B~ D6 D 1o+t?~ BE ލ?Ff`?~ Ai@A.? A, J J J A,A?A@ !A2 "A#I3@AG@$ A A A A AA I) A* A+~ Bh@ B D \--A D@@.A DTVAٱ?DTVAٱ?D}@DF?D1?D1?D"{l~7@Dڡz?~ BE:G>FaW5?~ Ad@A$d*? A, J J J A,A?A@ !A2 "A#Ie@Aq@$ A  A! A  A" A#A I) A* A+~ B@ B  D_xq_D[?  D$zD$z?Dd@D7c@L?D,fֿD,f?Drtt5DL_?~ BE~0p >FXa%>~ A@AEo>? A, J$ J% J& A,A?A@ !A2 "A'#I]@A`j@$ A( A) A( A* A+A I) A* A+~ Bg@ B( D A D3A D~s:;?D~s:;?DERa@D08@D@t?D@t?D)vQ@D*Q,?~ BE;ZaX@?F@$r?~ Ag@A? A, J, J- J. A,A?A@ !A2 "A/#I9@AF@$ A0 A1 A0 A2 A3A I) A* A+~ B$@ B0 D_@ D@@ DѩFDѩF?Do LDtP?DD?DogOCDcMG?~ BEMci6?Fm?~ A"@A^S1|? A, J4 J5 J6 A,A?A@ !A2 "A7#I@A@$ A8 A9 A8 A: A;A I) A* A+~ BD@ B8 D$A D "A Dh3wDh3w?D/trMDpN?D2޿D2?D34}1;DRd?~ BEBc?Fކ?~ AC@Ab:q? A, J< J= J> A, A A !A2 "A?#I @A,@$ A@ AA A@ AB ACA I) A* A+~ Bw@ B@ D@+A DR&A DWxѿDWx?Di8=1Dޗ\{?D_?D_?Dz0)@D9e?~ BEN` ?FA}V?~ Aw@AG.O? A, JD JE JF A,A?A@ !A2 "AG#II@AW@$ AH AI AH AJ AKA I) A* A+~ BK@ BH DA D pA D&P&ɴD&P&ɴ?DAJDx??DP?DP?DO@@DX ?~ BEˈ?Fm?~ AK@A2~? A, JL JM JN A,A?A? !A2 "AO#I @A,@$ AP AQ AP AR ASA I) A* A+~ BK@ BP D DA DW A Dez^9?Dez^9?Da,APz!@D_a/e?D˿D?D9+Du>)0?~ BEt"?F:)?~ AK@An5!a=-? A, JT JU JV A,A?A? !A2 "AW#I&@A.@$ AX AY AX AZ A[A I) A* A+~ B9@ BX D`eA D`b@ DìESDìES?DRRGRD]4?DߣDߣ?DP]RD4?!?~ BE-˭b?Fs5 .?~ A8@Aki? A, J\ J] J^ A, A AR !A2 "A_#I"@A"@$ A` Aa A` Ab AcA I) A* A+~ B@p@ B` D@qA~ D9 DZ5X&U?DZ5X&U?DXߖ?D0?D?D?D]'@Dٖ?~ BE[GӶ?FM(/vU?~ A0p@As+9M? A, Jd Je Jf A,A?A@ !A2 "Ag#IL@AT@$ Ah Ai Ah Aj AkA I) A* A+~ Bg@ Bh D`Ɏ1A D`$/A Dj8¿Dj8?Di{@5#D˅,?D׿D?Dp&6D Y?~ BE\:?FnMm?~ Ag@At? A, JJJ A,A?A? !A2 "Al#I6@AE@$ Am An Am Ao ApA I) A* A+~ B@P@ Bm DsA D A D{%̿D{%?D`zF,D3a\y?D`ڭ?D`ڭ?Dh@DIn?~ BEo?F)?~ AP@AV˜G\? A, Jq Jr Js A,A?A@ !A2 "At#I.@A3@$ Au Av Au Aw AxA I) A* A+~ Bd@ Bu~ DS D`h-A D[D@ƿD[D@?D6Ӑ&DR%R?D?lD?l?DVH}$D{o?~ BE[Ǒu?F r.5:?~ Ad@Ax߰9? A, Jy Jz J{ A, A A !A2 "A|#I<@AG@$ A} A~ A} A AA I) A* A+~ B4@ B}~ D(8 DA D[_@ D[_@ @DVDe3~#?D'D'?D ֩ED?2(?~ BE;.D>.?Ddݓ]~QD\b7?D?ڿD??D 68DDc6 ?~ BEt0?F^mh ?~ AF@A՘D\ ? A, J J J A,A?A@ !A2 "A#I$@A*@$ A A A A AA I) A* A+~ B@U@ B D@+a&A D9t,A D ;,?D ;,?D庸$;@DkeW?D ^?D ^?D>S/G@D_A?~ BEQc܌q?F?~ AU@A僧~? A, J J J A, A A !A2 "A#I1@A6@$ A A A A AA I) A* A+~ B`x@ B D f A D`A1A D؜,?D؜,?Dl[@D(c@D?D?DNޛS@DƢ޴?~ BEt}kW>F`>~ APx@A"? A, J J J A,A?A? !A2 "A#IN@A@Y@$ A A A A AA I) A* A+~ B\@ B D kA D A D@οD@?Do緡.D7S?DIDI?D9OID-?~ BEKU?Fց'_:?~ A\@A? A, J J J A,A?A@ !A2 "A#I6@AA@$ A A A A AA I) A* A+~ B@p@ B DXQ.A~ D DeN:?DeN:?DEa@D5 ?DY¿DY?Dz"#D*q 5?~ BEB}?F_i_V?~ A0p@AV?2S? A, J J J A,A?A@ !A2 "A#I?@AO@$ A A A A AA I) A* A+~ B@P@ B DA D8A DYډ?DYډ?Dlg?DW-=#?D@@D<M?~ BE?FG?~ AP@AQ A,A?A? !A2 "A?#I2@A@@$ A@ AA A@ AB ACA I) A* A+~ B@U@ B@ D?+A D +A DxȬ?DxȬ?D3! @D?̃$?D8?D8?DOjZ(@D>/?~ BEBj?FG0tG?~ AU@A~dXd? A, JD JE JF A,A?A? !A2 "AG#I"@A4@$ AH AI AH AJ AKA I) A* A+~ B4@ BH D vA D )@ DD$DD$?DoTFDcd?D_F}ٿD_F}?D-8D;bG?~ BE2J+?Fm?~ A3@A2H7? A, JL JM JN A A A !A2 "AO#I@A@$ AP AQ AP AR ASA I) A* A+~ BR@ BP D A DA Djj?Djj?Di@Ds?Dl?Dl?D`| aB@Dp?~ BEЭu?FXwz#?~ AR@AT? A, JT JU JV A,A?A? !A2 "AW#I(@A3@$ AX AY AX AZ A[A I) A* A+~ B@o@ BX D&wD  Dr)Dr)?D6QBD-^G?D?P?D?P?D)+@DiK 3?~ BEҀM?F?~ A o@A/e;!? A, J\ J] J^ A,A?A? !A2 "A_#I?@AM@$ A` Aa A` Ab AcA I) A* A+~ B@ B` D@ Dk@ D?5׿D?5?D196D P?D_?ֿD_??D"i5Dfz8%?~ BEJ'?Fd/J%?~ A@A #? A, Jd Je Jf AV~ A? A1 !A2 "Ag#I@A@$ Ah Ai Ah Aj AkA I) A* A+~ B b@ Bh D@0$A D`A DֶDֶ?D.?BD$al?DৼӿDৼ?Dy>3D!'c?~ BEʩ>?F.?~ Ab@A=? A, Jl Jm Jn A,A?A@ !A2 "Ao#I7@AC@$ Ap Aq Ap Ar AsA I) A* A+~ B r@ Bp D!QD @  DoտDo?D .5DkW>?D)?D)?Daz@DZA?~ BEޒ*?Fоl?~ Ar@Al? A, Jt Ju Jv A,A?A? !A2 "Aw#I>@AS@$ Ax Ay Ax Az A{A I) A* A+~ B@_@ Bx D$A D@7A DriJ?DriJ?DU`@DJs@Dt0?Dt0?D6Ewp8@DՁ?~ BEuG3?FRU1?~ A_@A)? A, J; J| J} A,A?A@ !A2 "A~#I.@A@@$ A A A A AA I) A* A+~ B`}@ B D4D[  D^3~?D^3~?DUhLm>mR@Dc; ?Dk?Dk?D)%U@D~?~ BEHP=FhJl}p=~ AP}@AVNͼ? A, J J J A,A?A@ !A2 "A#I;@A@Z@$ A A A A AA I) A* A+~ BW@ B Dd-A D@G A D|D|?DHj>,r!DEi5?D?%?D?%?D EW @DUϤ%Y?~ BElSl?F6':?~ AW@A갑Cy? A, J J J A,A?A@ !A2 "A#I.@A6@$ A A A A AA I) A* A+~ Bi@ B Dp2A~ D DVP DVP ?DICDLD)l?D%0D%0?Dp?Dr ?~ BEGʧZ?F\ׇ?~ Ah@At? A, J J J A,A?A@ !A2 "A#IB@AL@$ A A A A AA I) A* A+~ BA@ B D)DcH  D |75D |75?D1X|BDǏr ?D@k?D@k?D#.@DP*v?~ BE4#j?FRPA0?~ AA@A?uvF#? A, J J  J  A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~ B>@ B~ D3\& Dm2A DRxEzڿDRxEz?DR% 8Dk`?DYA?DYA?Dn @D]lM?~ BE房%3?F^Ŷ?~ A=@AD ? A, J J J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~ Bs@ B DA D`A D3sy{?D3sy{?DbH@D^n?DԼ?DԼ?D x< @Ḋg֎L?~ BE,a?FZ\s?~ As@A>? A, J J J A,A?A@ !A2 "A#IS@AX@$ A A A A AA I) A* A+~ Bg@ B D mA D@ A DR 2?DR 2?D\EA@Dܰ?D`D`?DXD)¡?~ BEz?F=d?~ Ag@A? A, J J J A, A AR !A2 "A#IH@AM@$ A A A A AA I) A* A+~ B4@ B DZ@ D`@ DEJ@DEJ@?DqED̋9?D?D?D"?GG?D'x?~ BE8??F0pI?~ A3@A;ǶK^+? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~ B@p@ B D^ D#  Dd7d8~¿Dd7d8~?Dg##DP,6?Di˿Di?D32,D?V?~ BEĜ?Fh$r?~ A0p@A:{i? A, J J J A, A A9 !A2 "A#ID@AR@$ A A A A AA I) A* A+~ B^@ B D @ D y@ D=)R[D=)R[?DoJDD|?D@(}߿D@(}?DO<Dl8?~ BE`3dk?F \~?~ A]@Atoa? A, J J J A,A?A@ !A2 "A#I=@AB@$ A A A A AA I) A* A+~ B@j@ B Dg!nD^,  DukүDukү?DKMD}怮?D fD f?D;jrSf'ADj"F?~ BEJ/UA^?F^9B?~ A j@AO? A, J J J A,A?A@ !A2 "A#I@@AM@$ A A A A AA I) A* A+~ B`c@ B D Dm+E?~ BEd t?Fno3?~ A@c@A6”? A, JS J J A,A?A? !A2 "A#I6@AC@$ A A A A AA I) A* A+~ Bs@ B D 2A D i:A D{?D{?D# }G@DF6[?Dߓ)?Dߓ)?Dh1Q@D pw?~ BEh>FR8%?~ As@AR,? A, J J J A, A A  !A2 "A#IE@A@U@$ A A A A AA I) A* A+~ B@ B DCDu  D %?D %?D L#T?DL /?DؙDؙ?D0D!kq?~ BE 0?Fso?~ A@Atw? A, J J J A,A?A@ !A2 "A#Ij@Av@$ A A A A AA I) A* A+~ B$@ B D`@ D@z@ DZ9zӿDZ9z?Dg6Φ^3D!C;?D`D`?DR犨j!DUUU.?~ BED F?F[?~ A"@A%H? A, J J J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~ B$@ B D\@ D`@ D[|KD[|K?DF0&CD ?DD?D7Q%@D8bT?~ BEIJvv?F%?~ A"@AklM=? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~ Bh@ B D]MD+  DaR]>DaR]>?DQǞuIFDf{Z?DD?DR0 Q=D^Y\?~ BELY>F2x>~ A`@A/M? A, J Ja J A,A?A? !A2 "A#II@A]@$ A A A A AA I) A* A+~ B@Z@ B DVA D A D&3?D&3?D NsB@DmKLu?D!d¹?D!d¹?D)@D)'?~ BE^@$DGl,,,,,,2,2,,,((,2,$,(2,,%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A  A  A  A  A A I) A* A+~  Bo@  B  D aDk 2  D>q?D>q?DСTk7?@Dx?D_2i?D_2i?D]@D~G;?~ BE1< F ?Fb;I?~ Ao@AШ)Iվ? A, J  J J A,A?A? !A2 "A#I@@AR@$ A A A A AA I) A* A+~  B@  B D+D*  D%{2?D%{2?DЎ%E@Dk9?D[?D[?DK('Q@D}:W?~ BENmو!=F,{`v6>~ A@A8 T\? A, J J J A,A?A@ !A2 "A#I@S@Aa@$ A A A A AA I) A* A+~  BR@  B D`A DA DC1%?DC1%?D練grD@Df?D^пD^?Dޥ0D?~ BEnӄ?F=d?~ AR@A6H'1c? A, J J J A,A?A@ !A2 "A #I6@A9@$ A! A" A! A# A$A I) A* A+~  B@Z@  B! D *A DA Dx,Dx,?DW6dPD"n?D? ſD? ?DAu%D. ō?~ BEOb ?F쨇?~ AZ@Aq? A, J J J A, AA !A2 "A%#I.@A8@$ A& A' A& A( A)A I) A* A+~  B$@  B& D #@~  D42@ D/həD/hə?D"mbID?D:D:?Dʄ~b?PDad]g?~ BEon?F%?~ A"@AFu? A, J* J+ J, A, A  A !A2 "A-#I@A@$ A. A/ A. A0 A1A I) A* A+~  BT@  B. DcA D 9A Do كg?Do كg?DBu|B@DDg'?D S&?D S&?D j1@DUb?~ BEl.?FT4?~ AS@A{ ? A, J2 J3 J4 A,A?A@ !A2 "A5#I8@A<@$ A6 A7 A6 A8 A9A I) A* A+~  BK@  B6 D A D6@ DXDX?DhZhVe@DM{?D?D?Db04lR@DU&?~ BEVD?Fm?~ AK@A? A, J: J; J< A,A?A? !A2 "A=#I,@A1@$ A> A? A> A@ AAA I) A* A+~  B@@  B>~  D1E DQ[A DdjmٿDdjm?D<7DW74ac?D>x?D>x?DVG?@Dּ(S?~ BE089?FmRl?~ A8@A{bT? A, JB JC JD A,A?A@ !A2 "AE#IR@A d@$ AF AG AF AH AIA I) A* A+~  B`h@  BF D A~  Dk0  D R?D R?D@Dac;?D?I<пD?I@AG@$ A[ A\ A[ A] A^ A I) A* A+~  B@P@  B[  D@Y&A  DA  DǷ4E? DǷ4E? Dӫ0TL@ D 6/j? Dk Dk? DҠ6! DS ?~ B E-$(~L? F16?~ AP@ A(|l:? A, J_ J` Ja A, A?A@ !A2 "Ab #I9@A?@$ Ac Ad Ac Ae Af A I) A* A+~  B w@  Bc  DcA  DA  Dnx Dnx? D&E D܍і ? D`Z? D`Z? D? DҒ?~ B E6"0? FK?~ Aw@ An? A, Jg Jh Ji A, Aj  Ak !A2 "Al #IZ@A@_@$ Am An Am Ao Ap A I) A* A+~  B@U@  Bm~  DҔ  D`i?A  D÷Ϳ D÷? Da$͗- D`-C? Dܽ Dܽ? D; o D ƒ?~ B E?~ BEPʫ?F)wM_?~ AF@ACӔ#5? A, J J J A, A  A !A2 "A#I&@A*@$ A A A A AA I) A* A+~  Bg@  B Df^D  D&~D&~?D;!ADDQ_[ ?DD?DeL!D7pt;?~ BEΐ~?F{?~ Ag@Aiz&? A, J J J A, A  A !A2 "A#IM@AP@$ A A A A AA I) A* A+~  B.@  B D6h@ D`@ D)NR]?D)NR]?D5,@D8ۼA?DDE?DDE?D %I@Doø ?~ BE[Օx`?FѾ'?~ A,@A"}J? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B@Z@  B D@>,A~  Dz1A Dw)&?Dw)&?D.6b8@DVF?D͸D͸?D9 Dհ?~ BE?FJ?~ AZ@AUuc? A, J J J A, A  A  !A2 "A#ID@AH@$ A A A A AA I) A* A+~  BN@  B D"oA D"A DL1?DL1?DbD@D?D?D?Di H+@D׳5?~ BEF'v?FJR`?~ AM@AdS? A, J J J A,A?A@ !A2 "A#I8@A<@$ A A A A AA I) A* A+~  BT@  B D8A DA DNAqDNAq?D?r@D=@H?D`$g?D`$g?D\~JL@DxK?~ BEKҿ?FULc?~ AS@AvGw? A, J J J A,A?A? !A2 "A#I7@A<@$ A A A A AA I) A* A+~  BW@  B DA D?A Dk~Dk~?DL)TCDvu4P?F 뭞Al?~ AW@AuHx? A, J J J A, A  A !A2 "A#I0@A9@$ A A A A AA      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrstuvwxyz{|}~ I) A* A+~  B>@  B~  D D bA DwƃuۿDwƃu?Dyd59D6oџ?Di?Di?D/0F@D?~ BETr?F,RUi?~ A=@A9C`J? A, J J J A, A  A  !A2 "A#I@A @$ A A A A AA I) A* A+~  Bw@  B DwB&D  DY: ߿DY: ?DF(J<D3Z?D>?D>?DQo2@DGBi?~ BErBC]?FO `?~ Aw@A5? A, J J J A, A  A !A2 "A#IJ@AX@$ A A A A AA I) A* A+~  Bn@  B D:A D@)A Du?ԿDu??DOJ4DkRY?Dt>?Dt>?DLu?D>u?%#?~ BE+\?FM$QN?~ An@A?nSI? A, J J J A,A@A@ !A2 "A#IP@AS@$ A A A A AA I) A* A+~  BI@  B~  DtT  D@}A D-p*ܿD-p*?Dj9J:D::?D @D @?Dz!RJD\N1O?~ BE&M^?Fě)R?~ AH@A`+? A, J J J A,A?A@ !A2 "A#I0@A4@$ A A A A AA I) A* A+~  B>@  B D@ DU@ D0J?D0J?DfJ%OH@Dg?Df?Df?Dqz@DEљ?~ BEe8u?Frl?~ A=@AKO@? A, J J J A,A?A@ !A2 "A#I @A @$ A A A A AA I) A* A+~  Bn@  B~  D\ D5)A D9D9?DmRz0#5DJtwހ?D ^?D ^?D}4ޙ@DIc/?~ BEeG?F=d?~ An@Ar? A, J J J A,A?A@ !A2 "A#I@@AM@$ A A A A AA I) A* A+~  B@  B D`A DbA DJ-ȿDJ-?DyȊ(DR.?DhȿDh?Dw_(}(Dq?~ BE/Kt"?F^sYi?~ A@A{"l? A, J J J A,A@A@ !A2 "A#I@e@A@m@$ A A A A AA I) A* A+~  Bs@  B D_Do'P  Dڪ7ϿDڪ7?D8a/D$`%;@?%;@ A A A A A  A I) A* A+~  BA@  B   D`,-A  D@A  D,% D,%? DSDP DI? Dj Dj? DWٖ@ D~vD?~ B Exw%z? FXwz#?~ AA@ A}ǰ? A, J J J A, A  A !A2 "A  #I@A"@$ !A !A !A !A !A! !A !I) !A* !A+~ ! B@_@ ! B ! DPA! D @! DM>)!DM>)?!DNT}M!DRVU(.?!D!D?!DqyD!DfA?~ !B!Ed0?!F~N-~D@?~ !A_@!A^>/@ " B& " DQ8@" D<{@" Dޡ?"Dޡ?"D>C@"D[̦C?"DA=?"DA=?"D@QVqF@"DBv8>?~ "B"EWP?"F,Kv?~ "A=@"A~X q? "A, "J* "J "J+ "A, "A " A "!A2 ""A, "#I"@A$@$ #A- #A. #A- #A/ #A0 #A #I) #A* #A+~ # BX@ # B- # D A~ # D# D\Gm?#D\Gm?#D2s!IE2@#D]?#D 1?#D 1?#Dw(j$@#DJ?~ #B#Esj|?#Fɷ$?~ #AT@#A,)(? #A, #J1 #J2 #J3 #A, #A # A  #!A2 #"A4 ##I f@A0p@$ $A5 $A6 $A5 $A7 $A8 $A $I) $A* $A+~ $ BI@ $ B5 $ DخA$ D !2@$ DT4ۿ$DT4?$D9$D#޳?$D[ܿ$D[?$DGln:$DMb`?~ $B$E\%l`?$Fm?~ $AH@$Aآ? $A, $J9 $J: $J; $A0~ $A? $ A1 $!A2 $"A< $#I"@A&@$ %A= %A> %A= %A? %A@ %A %I) %A* %A+~ % BR@ % B= % D`ϭA% D!A% DJ?%DJ?%D51υq@%Ducm@%Du?%Du?%D >.@%DLEw?~ %B%Eby?%FJ?~ %AR@%Aُy? %A, %JA %JB %JC %A,%A?A@ %!A2 %"AD %#I2@A6@$ &AE &AF &AE &AG &AH &A &I) &A* &A+~ & B4@ & BE & D հ@& D@& DT^ݿ&DT^?&DYI _;&D}D=?&D`Ŀ&D`?&DlU /%&D=Z+?~ &B&E` ?&F}?~ &A3@&Ae? &A, &JI &JJ &JK &A,&A?A? &!A2 &"AL &#I@A@$ 'AM 'AN 'AM 'AO 'AP 'A 'I) 'A* 'A+~ ' B@U@ ' BM ' D[/D ' DPտ,?'DPտ,?'D}"?@'D?'D?'D?'Dz 7@'DHW?~ 'B'E0a?'F?~ 'AU@'A{1? 'A, 'JJ 'J? 'A,'A@A? '!A2 '"AQ '#I&@A4@$ (AR (AS (AR (AT (AU (A (I) (A* (A+~ ( Bi@ ( BR ( D_FZA~ ( D q|( D Y=ٿ(D Y=?(DZAKz8(D&*?(D?&ο(D?&?(D.(D2l?~ (B(ELq?)F;j9:?~ )A@[@)AF? )A, )J_ )J` )Ja )A,)A?A@ )!A2 )"Ab )#I5@A?@$ *Ac *Ad *Ac *Ae *Af *A *I) *A* *A+~ * B@U@ * Bc ~ * D(* DA* D=7ѿ*D=7?*D1*D?f?*D?*D?*D[zq@*DTp?~ *B*E^ꣂ?*F'Z ?~ *AU@*A#Ĺ? *A, *Jg *Jh *Ji *A,*A?A? *!A2 *"Aj *#I2@A;@$ +Ak +Al +Ak +Am +An +A +I) +A* +A+~ + BR@ + Bk + D5F A+ DA+ D\4Aܿ+D\4A?+DC\:+D%R?+D_ix¿+D_ix?+D_EJ #+Do0E?~ +B+EՆ(-?+F#$C?~ +AR@+A-Vb? +A, +Jo +J2 +Jp +A, +A  + AR +!A2 +"Aq +#I0@A5@$ ,Ar ,As ,Ar ,At ,Au ,A ,I) ,A* ,A+~ , BA@ , Br , DU(A, D`A, D$,D$?,DkD,DpuIӥ?,Dݿ,D?,D%Iaд;,DvL"?~ ,B,E|/w?,Fh$r?~ ,AA@,Afh? ,A, ,Jc ,Jc ,Jv ,A, ,A , A ,!A2 ,"Aw ,#I"@A$@$ -Ax -Ay -Ax -Az -A{ -A -I) -A* -A+~ - B@P@ - Bx - D k? A- D@vA- DN4Rzȿ-DN4Rz?-Dʶi(-Do*YK?-Dſ-D?-D}&-D Hpu?~ -B-E;(-?-F 4ϝ?~ -AP@-A#5϶? -A, -J| -JT -J} -A,-A?A@ -!A2 -"A~ -#I.@A6@$ .A .A .A .A .A .A .I) .A* .A+~ . B$@ . B . D,@~ . D@. DU)$:?.DU)$:?.DW}c&@.DT?.D .D ?.DJBM.D%k_?~ .B.EՁC2?.FSP?~ .A"@.A93~? .A, .J .J .J .A .A . A .!A2 ."A .#I@A@$ /A /A /A /A /A /A /I) /A* /A+~ / By@ / B / D^UA~ / DW/ DTotd/DTotd?/DATyA/Dտ?/D"T/D"T?/D($K?/DZ^H?~ /B/Ev]t>/F>|8 >~ /Ay@/AVN? /A, /J /J /J /A,/A?A@ /!A2 /"A /#IB@AY@$ 0A 0A 0A 0A 0A 0A 0I) 0A* 0A+~ 0 B`c@ 0 B 0 D#A0 D`GA0 D:ѿ0D:?0DWij10DwIX?0D 00D 0?0DG0D .3?~ 0B0Ea5 !P?0FXzdYw(?~ 0A@c@0AȾ? 0A, 0J 0J 0J 0A, 0A 0 A 0!A2 0"A 0#I:@AC@$ 1A 1A 1A 1A 1A 1A 1I) 1A* 1A+~ 1 BD@ 1 B ~ 1 D{w1 DಀA1 Dg(1Dg(@1D#պDS1Drj\lX?1D 1D ?1DY[E1Dȗ T?~ 1B1EqQ n?1F+e `?~ 1AC@1AG}n? 1A, 1J 1J 1J 1A0~ 1A? 1 A1 1!A2 1"A 1#I @A"@$ 2A 2A 2A 2A 2A 2A 2I) 2A* 2A+~ 2 BH@ 2 B ~ 2 D2 D Ia:A2 D`3w2D`3w?2D:J2D۵b?2D 刺2D ?2DK 2D ,?~ 2B2ELO{?2F7ك?~ 2AD@2A>O˰? 2A, 2J 2J 2J 2A,2A?A@ 2!A2 2"A 2#Ij@Az@$ 3A 3A 3A 3A 3A 3A 3I) 3A* 3A+~ 3 B@ 3 B 3 DB'&D 3 DeO3DeO?3D;ag@3D,V?3D?ؿ3D??3Dal}{73DR,|?~ 3B3Ei *G<3F,E=~ 3A@3Ay.֑? 3A,3J 3J" 3J 3A,3A?A@ 3!A2 3"A 3#Ik@AX@$ 4A 4A 4A 4A 4A 4A 4I) 4A* 4A+~ 4 Bf@ 4 B 4 DKFD6 4 DRv׿4DRv?4DG;^64DEf; ?4D_޿4D_?4D\(G1<4DmE?~ 4B4ENj\,`?4FmIe w?~ 4A`f@4Ambdl? 4A, 4J 4J 4J 4A,4A@A@ 4!A2 4"A 4#I4@AH@$ 5A 5A 5A 5A 5A 5A 5I) 5A* 5A+~ 5 B4@ 5 B 5 DrA~ 5 D,5 D!@?5D!@?5DӀ5q@5DpRP@5DL5DL?5Da N5D[#Po?~ 5B5E?5F͝j?~ 5A3@5A? 5A, 5J 5J 5J 5A0~ 5A? 5 A1 5!A2 5"A 5#I @A"@$ 6A 6A 6A 6A 6A 6A 6I) 6A* 6A+~ 6 BQ@ 6 B 6 D" D~ 6 Dc~J6Dc~J?6DגN6Dm{2]?6DE?6DE?6DB@6DhAq?~ 6B6E~GJ?6F16?~ 6A@Q@6A=f ? 6A, 6J 6J 6J 6AF6A?A@ 6!A2 6"A 6#I"@A0@$ 7A 7A 7A 7A 7A 7A 7I) 7A* 7A+~ 7 B`@ 7 B 7 DY DF 7 Da?7Da?7D<] Z@7Deh̝@7D *?7D *?7DuVA@7Dfm0y?~ 7B7E\kF)?7F]÷?~ 7A`@7Auuŏ? 7A, 7J 7J 7J 7A0~ 7A? 7 A 7!A2 7"A 7#I:@AD@$ 8A 8A 8A 8A 8A 8A 8I) 8A* 8A+~ 8 By@ 8 B 8 D,jA8 D  A8 D2,%?8D2,%?8D6'8@8D{^?8D@j?8D@j?8DF|^ȉ+@8D.ȭ3?~ 8B8EzL T?8F\!1%?~ 8Ay@8A>z8? 8A, 8J 8J 8J 8A0~ 8A? 8 A1 8!A2 8"A 8#IX@A`@$ 9A 9A 9A 9A 9A 9A 9I) 9A* 9A+~ 9 B\@ 9 B ~ 9 D~iD9 DF$A9 Dyֺ9Dyֺ?9DdwCC9D`ޔs?9D䦖?9D䦖?9DKFSظ?9DmI??~ 9B9EL T?9F 뭞Al?~ 9A\@9Aj&^x? 9A, 9J 9J 9J 9AF~ 9A? 9 A 9!A2 9"A 9#I:@A@@$ :A :A :A :A :A :A :I) :A* :A+~ : B>@ : B : D>&A~ : DV`X: D(n@:D(n@:DDݛx@:D-#@:D 9Ͽ:D 9?:Dm;/:D(?~ :B:E!,r?:F2?~ :A=@:A |? :A, :J :J :J :A,:A@A? :!A2 :"A :#I@A@$ ;A ;A ;A ;A ;A ;A ;I) ;A* ;A+~ ; B.@ ; B ~ ; D; D@OA; DBW& ?;DBW& ?;D1J\R@;Dd?;Dx?;Dx?;D%3-@;DT!?R?~ ;B;E)}i?;Fh=m6?~ ;A,@;A}ӄ7C? ;A, ;J ;J ;J ;A ;A ; A ;!A2 ;"A ;#I@A@$ <A <A <A <A <A <A <I) <A* <A+~ < B4@ < B < D@/ A< D໌@< D<D?<DKdGI<DӲR?<D.<D.?<D$aF"G<DyT&z1?~ <B<EjI(Ї?<F%?~ <A3@<A? <A, <J <J <J <Ag <Ah < Ah <!A2 <"A <#I@A@$ =A =A =A =A =A =A =I) =A* =A+~ = B\@ = B = D^ *D)X = DR߭\jҿ=DR߭\j?=Dlr2=DLbۿ6?=D`=D`?=Dm=D4?~ =B=Ex?=F?~ =A\@=A\?? =A, =J =J =J =A0~ =A? = A1 =!A2 ="A =#I4@A>@$ >A >A >A >A >A >A >I) >A* >A+~ > BF@ > B ~ > DZ > DW^A> D#p>D#p?>DFJ>DS8?>D>D?>D}ȉF>DvCV?~ >B>Eb?xkM?>FB4e?~ >AF@>A鑭? >A, >J >J >J >AF>A?A? >!A2 >"A >#I@A"@$ ?A ?A ?A ?A ?A ?A ?I) ?A* ?A+~ ? B@U@ ? B ? DByD ? DtaV|?DtaV|??DT-ynO?DCg??D?D??D4mmM?D6ͯ?~ ?B?ET-{>?FڨW ?~ ?AU@?A;u? ?A, ?J ?J ?J ?AF?A?A? ?!A2 ?"A ?#I"@A6@$DGl2,2.2,,.,(22,.(2.(.$2.(.2$(@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A @A @A @A @A @A @I) @A* @A+~ @ B9@ @ B ~ @ DT7@ D`A=A@ DmD ѿ@DmD ?@D 0Q1@D{Gpu?@Dl@Dl?@Dy59:ҐG@D?~ @B@Eh@J?@FMt?~ @A8@@A98uM[? @A, @JC @JD @JE @AF@A?A? @!A2 @"A @#I@A@$ AA AA AA AA AA AA AI) AA* AA+~ A Bb@ A B A D AA D@AA D&AۿAD&A?ADRn:ADZЬW?AD sjϿAD sj?AD jI/AD s?~ ABAEy?AF+?~ AAb@AAG1+? AA, AJ AJ AJ AAgAA?A? A!A2 A"A A#I;@AD@$ BA BA BA BA BA BA BI) BA* BA+~ B B[@ B B B D`GA~ B D_xzB Ds5~%?BDs5~%?BD/Q]@@BDuaCF%>~ CAPx@CA ? CA, CJJJ CAFCA?A? C!A2 C"A$ C#I>@AU@$ DA% DA& DA% DA' DA( DA DI) DA* DA+~ D B@ D B% D DD  D D?DD?DD}95@DDge?DD4Q?DD4Q?DD6X!>@DD"?~ DBDE-c>DF%R6?~ DA@DA`? DA, DJc DJc DJc DA0 DA D A D!A2 D"A) D#IT@A@g@$ EA* EA+ EA* EA, EA- EA EI) EA* EA+~ E B`c@ E B* ~ E D^E D@KAE Dsמ6?EDsמ6?EDth@EDb?ot@@ED_q$?ED_q$?ED.LU%`@ED0yOUU@~ EBEE#"uE>EFnRG4_>~ EA@c@EAJ[!/? EA, EJ. EJ/ EJ0 EA0EA?A? E!A2 E"A1 E#I(@A@@$ FA2 FA3 FA2 FA4 FA5 FA FI) FA* FA+~ F B@ F B2 ~ F D@F D @F DXYFDXY?FD~InQFDr`?FDlFDl?FDp*oGFDQ,=?~ FBFEr္?FFЙ?~ FA@FAt( \? FA, FJ6 FJ7 FJ8 FA9 FA?A? F!A2 F"A: F#I@A@$ GA; GG< GA; GA= GA> GA GI) GA* GA+~ G B@P@ G B; ~ G D.G D "AG D_Ӯ;ӿGD_Ӯ;?GD}Q2GD+@B?GDp̿GDp?GD6&;,GDn?~ GBGEFI?GFm?~ GAP@GA͏? GA, GJ? GJ@ GJA GAg GAh G Ah G!A2 G"AB G#I*@A1@$ HAC HAD HAC HAE HAF HA HI) HA* HA+~ H BV@ H BC H D,A~ H D:|H D^Mn?HD^Mn?HD"^@HDR9@HD2T?HD2T?HDde@HDƣO"?~ HBHE ?HFhKw_?~ HA@V@HA42? HA, HJG HJH HJI HA0HA?A? H!A2 H"AJ H#I.@A7@$ IAK IGL IAK IAM IAN IA II) IA* IA+~ I BT@ I BK I D AI D *AI D9.P?ID9.P?ID~WY#?ID1=?ID?HsID?Hs?ID;WHIDw}1?~ IBIE/h䀏b?IF?~ IAS@IA5\Ɗ9? IA, IJO IJP IJQ IA9 ~ IA? I AR I!A2 I"AS I#I2@A4@$ JAT JAU JAT JAV JAW JA JI) JA* JA+~ J B@_@ J BT J D`ZAJ DR8AJ D ?JD ?JD.2@JD¿>?JD}%?JD}%?JDȇ?JDKy?~ JBJEW?JF!B?~ JA_@JAVUS|{? JA, JJX JJY JJZ JA9 ~ JA? J A[ J!A2 J"A\ J#I:@AC@$ KA] KA^ KA] KA_ KA` KA KI) KA* KA+~ K Ba@ K B] ~ K D_K D AK Dz[JοKDz[J?KDE8T.KDe]ƪ?KD ?KD ?KDNg1@KD?~ KBKElFò?KF )XO?~ KA`a@KA$>? KA, KJa KJb KJc KAr KAs K Ad K!A2 K"Ae K#I=@AD@$ LAf LAg LAf LAh LAi LA LI) LA* LA+~ L Be@ L Bf L D "A~ L DL Dր?LDր?LDu6GZ@LD@LD@?LD@?LD=8x=@@LDc2?~ LBLE]mPFޢ?LFdS?~ LAe@LAɞ? LA, LJj LJk LJl LA9 ~ LA? L A[ L!A2 L"Am L#I>@AH@$ MAw MAx MAw MAy MAz MA MI) MA* MA+~ M BD@ M Bw M D A~ M D_ M DЖ.?MDЖ.?MD0'@MD?MDhk?MDhk?MDLu#@MD\F0?~ MBMEtPZ\?MF(ݧo?~ MAC@MA&YA? MA, MJ{ MJ| MJ} MA MA~ M A~ M!A2 M"A M#I@A @$ NA NA NA NA NA NA NI) NA* NA+~ N B.@ N B N D{AN D`@N DTr6NDTr6?NDmJND ?ND ND ?NDm&\p|HNDh92T?~ NBNE5z466\?NFy?~ NA,@NAXa_'? NA, NJ NJ NJ NAt NAu N A N!A2 N"A N#I@A@$ OA OA OA OA OA OA OI) OA* OA+~ O B9@ O B O D y*AO D` AO D=rOD=r?OD1ҟFOD?OD$OD$?ODOD?-f?~ OBOEU?OFO?~ OA8@OAnI? OA, OJ OJ OJ OA0OA?A? O!A2 O"A O#I"@A&@$ PA PA PA PA PA PA PI) PA* PA+~ P B@Z@ P B P D@/AP D@MLAP D.x ڿPD.x ?PD7%:8PD^*$?PDi?PDi?PDfn$@PDp|?~ PBPEm??PF60?~ PAZ@PA(Դ%? PA, PJ PJ PJ PA0~ PA? P A1 P!A2 P"A P#I<@AC@$ QA QA QA QA QA QA QI) QA* QA+~ Q BD@ Q B Q DEA~ Q DQ D(J޿QD(J?QD_+}<QD\/?QD8?QD8?QDGDe6@QD3j?~ QBQE3?QFź?~ QAC@QAoJa? QA, QJ QJ QJ QA9 ~ QA? Q A[ Q!A2 Q"A Q#I@A @$ RA RA RA RA RA RA RI) RA* RA+~ R Bk@ R B R D"'AR D.AR D[=?RD[=?RD1:n=@RD-;C?RDI?RDI?RDv>9@RDdP_y&?~ RBREX~މ?RFPS?~ RA`k@RA+nj? RA, RJ RJ RJ RAr RAs R As R!A2 R"A R#I@@AK@$ SA SA SA SA SA SA SI) SA* SA+~ S BF@ S B S D-AS D` "AS DZy?SDZy?SD ҂^b@SDҕ@SD(:?SD(:?SD963@SD?~ SBSED|?SFG0tG?~ SAF@SAr}u? SA, SJ SJ SJ SAg SAh S A  S!A2 S"A S#I"@A&@$ TA TA TA TA TA TA TI) TA* TA+~ T B@_@ T B T D ?\A~ T D2T Dig?TDig?TD\aF6@TD Bi?TD??TD??TDH,|C@TD??~ TBTE[xq؎?TFFV?~ TA_@TAAE(? TA, TJ TJc TJ TA0TA?A? T!A2 T"A T#I.@A;@$ UA UA UA UA UA UA UI) UA* UA+~ U BA@ U B U D@AU D`AU DH(UDH(?UDj];PUDϟa?UD9ƿUD9?UDV7k'UD@?~ UBUEhU{8?UF Hg?~ UAA@UA/]? UA, UJ UJ UJ UA9 ~ UA? U A U!A2 U"A U#I@A @$ VA VA VA VA VA VA VI) VA* VA+~ V BI@ V B V D@# AV DAV D7QVD7Q?VDVҌxB VD&1f?VD!@VD!@?VD;z-?VDSl?~ VBVEUH6p?VF ;eD?~ VAH@VAHݦ? VA, VJ VJ VJ VA0~ VA? V A V!A2 V"A V#I"@A*@$ WA WA WA WA WA WA WI) WA* WA+~ W B>@ W B W D@i@W D@7@W DRM5?WDRM5?WDqWm$@WDw1o?WD#?WD#?WDb#@WD=?~ WBWEKʝБ?WF Hg?~ WA=@WA[? WA, WJ WJ WJ WA0~ WA? W A W!A2 W"A W#I@A$@$ XA XA XA XA XA XA XI) XA* XA+~ X B$@ X B X D@@X DuM@X DвۖѿXDвۖ?XD9jX1XDNLs?XD_^?XD_^?XDӐ'f@XDv7})}-@~ XBXEz^?XFȱ`xv?~ XA"@XAg? XA, XJ XJ XJ XAXA?A? X!A2 X"A X#I@A@$ YA YA YA YA YA YA YI) YA* YA+~ Y B4@ Y B Y DBc@Y D`@Y DTaڿYDTa?YDQ9YDm+?YDϿYD?YDnFY/YD i]D$?]Dߡ ۿ]Dߡ ?]DN_c9]D/aZ83?~ ]B]E.?{zj?]FDž?~ ]A\@]A=m? ]A, ]J ]J ]J ]A,]A?A@ ]!A2 ]"A ]#I9@AA@$ ^A ^A ^A ^A ^A ^A ^I) ^A* ^A+~ ^ B b@ ^ B ~ ^ D^k^ Di4A^ D,ؿ^D,?^DYAw7^D'v?^D?Kۿ^D?K?^D.U9^DK?~ ^B^Eiq?^Ft+1?~ ^Ab@^Aëő? ^A,^J ^J ^J ^A,^A?A@ ^!A2 ^"A ^#I8@AB@$ _A _A _A _A _A _A _I) _A* _A+~ _ Bd@ _ B _ D 0A_ DnA_ DFP8{?_DFP8{?_DݠyܳtE@_Dp2?_D`W?_D`W?_D!8:@_DkF")?~ _B_EbD?_Fj3?~ _Ac@_A>ze? _A, _J _J _J _A,_A?A@ _!A2 _"A! _#I=@AF@$DGl(,($((.(22...2,2.22(222,,,($`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A" `A# `A" `A$ `A% `A `I) `A* `A+~ ` Bt@ ` B" ` DϘ!D!K ` D?`D?`D` _@`DFV\:@`D_v?`D_v?`D/jU>@`Djcw?~ `B`EbVm?`F O"?~ `At@`Ar`JcƦ? `A, `J& `J' `J( `A,`A?A@ `!A2 `"A) `#IF@AU@$ aA* aA+ aA* aA, aA- aA aI) aA* aA+~ a BR@ a B* a DTAa Db3Aa D)Pv0aD)Pv0@aD 3ǂSaD??aDʗǿaDʗ?aDvPG'aD#{)?~ aBaEB{?aF=d?~ aAR@aAl"? aA, aJ. aJ/ aJ0 aA,aA?A@ a!A2 a"A1 a#I*@A2@$ bA2 bA bA2 bA bA3 bA bI) bA* bA+~ b BA@ b B2 b D^\D b D>?bD>?bD}X@bDɽyl?bDQP?bDQP?bD"I+Z׊?@bDy* ?~ bBbE П>?bFa瑶?~ bAA@bA/ n[? bA, bJJJ bA, bAA b!A2 b"A4 b#I@A@$ cA5 cA6 cA5 cA7 cA8 cA cI) cA* cA+~ c BY@ c B5 c DADRT c DRڶ2fcDRڶ2f?cD{ PPcD߮L=?cDO'cDO'?cDjzNcD%Ԙ?~ cBcE˨|7>cF d?~ cAX@cA5p8V? cA, cJ cJ  cJ cA,cA?A@ c!A2 c"A9 c#I@A4@$ dA: dA; dA: dA< dA= dA dI) dA* dA+~ d BK@ d B: d D3uDz d D пdD ?dDVy0dD >~?dD_$ĿdD_$?dDp{$dD?~N?~ dBdE) Z?dF7ك?~ dAK@dA? dA, dJ dJ  dJ dA,dA?A@ d!A2 d"A> d#I@A*@$ eA? eA@ eA? eAA eAB eA eI) eA* eA+~ e B@U@ e B? e DҸDږ e DfeDf?eDKeD&Ye6?eD UԿeD U?eD?L3eDQkf?~ eBeE-Q?eFb?~ eAU@eA_:aT? eA, eJ eJ  eJ eA,eA?A@ e!A2 e"AC e#I"@A2@$ fAD fAE fAD fAF fAG fA fI) fA* fA+~ f Bb@ f BD ~ f D{P^f D.~ hA~@hA {? hA, hJW hJX hJY hA,hA?A@ h!A2 h"AZ h#IA@AZ@$ iA[ iA\ iA[ iA] iA^ iA iI) iA* iA+~ i Be@ i B[ i D`#Ai D@*Ai Dɣ?iDɣ?iDܗSQ@iD!R?iD?iD?iD7)L@iDhT!?~ iBiEzr>߉?iFPS?~ iAe@iA>O!~? iA, iJ_ iJ` iJa iA,iA?A@ i!A2 i"Ab i#I<@AD@$ jAc jAd jAc jAe jAf jA jI) jA* jA+~ j B@ j Bc j D pAj DaiAj D  jD  ?jDESYBjD/A?jD`#jD`#?jDEj>@jD C?~ jBjEt5=jF_ >~ jA@jA3^6? jA, jJg jJh jJi jA,jA?A? j!A2 j"Aj j#IQ@A`h@$ kAk kAl kAk kAm kAn kA kI) kA* kA+~ k Bi@ k Bk k DB)DLA k D?kD?kDA:_b@kD⾩ @kD?kD?kDT%d@kD줜B@~ kBkE A,5>kFɃJ>~ kAh@kAwt? kA, kJo kJp kJq kA,kA?A? k!A2 k"Ar k#I0@AE@$ lAs lAt lAs lAu lAv lA lI) lA* lA+~ l B l@ l Bs l D?ip!DaNA l D[?lD[?lDJf@lD cL@lD?=?lD?=?lD:H@lDxb?~ lBlE`Jh?lFDJ?~ lAl@lAd:E? lA, lJw lJx lJy lA,lA?A@ l!A2 l"Az l#I8@AH@$ mA{ mA| mA{ mA} mA~ mA mI) mA* mA+~ m B@j@ m B{ m DD** m D>#?mD>#?mDvRL@mDە2+?mDd?mDd?mDf:@mDvt+?~ mBmEv?mF1gN}H?~ mA j@mA)J3? mA, mJ mJ" mJ mA,mA?A? m!A2 m"A m#I5@AH@$ nA nA nA nA nA nA nI) nA* nA+~ n Be@ n B n DD n D N,?nD N,?nD0PO@nDAtaY?nDe?nDe?nD>R@nD**U?~ nBnEhS?nFM)O?~ nAe@nA?ˋq8? nA, nJ nJ nJ nA,nA?A? n!A2 n"A n#I1@AD@$ oA oA oA oA oA oA oI) oA* oA+~ o B9@ o B o D`{2@o DhO@o D?oD??oD%1HoDB?oDyoDy?oDY:|WPoDSG*?~ oBoEc?oF?~ oA8@oA6"O? oA, oJ oJ oJ oA,oA?A@ o!A2 o"A o#I"@A*@$ pA pA pA pA pA pA pI) pA* pA+~ p Bi@ p B p Dp+ A~ p DFL'p D&嘉?pD&嘉?pD@0Vh5@pD_Xq?pDw?pDw?pD@z*@pD#Xrg?~ pBpEVA?pFoـ?~ pAi@pAܖe? pA, pJ pJ pJ pA,pA?A@ p!A2 p"A p#IB@AL@$ qA qA qA qA qA qA qI) qA* qA+~ q BD@ q B q DPm6A~ q D kZq Dl2ð(K?qDl2ð(K?qD@@ S?qD]k ?qDU?qDU?qDr $@qDr?~ qBqE<9?qF ꉶ?~ qAC@qAa a? qA, qJ qJ qJ qA,qA?A@ q!A2 q"A q#I(@A1@$ rA rA rA rA rA rA rI) rA* rA+~ r Bk@ r B r D Dh)A r DL@P3?rDL@P3?rDڊ!1@rD4-??rD_?rD_?rDj[@rDQ?~ rBrE %R?rF?~ rA`k@rAL+? rA, rJ rJ rJ rA,rA?A? r!A2 r"A r#I2@AG@$ sA sA sA sA sA sA sI) sA* sA+~ s B@ s B s D"rUD[`5 s D@$1 sD@$1 ?sD*?BsDG?sD8zsD8z?sD&} sD;?~ sBsEMܴc?sFj"A?~ sA@sAZ^%]? sA, sJ sJ sJ sA,sA?A@ s!A2 s"A s#IN@A@_@$ tA tA tA tA tA tA tI) tA* tA+~ t B@P@ t B t DAt D At D# ?tD# ?tD]D@tD̿?tD`<տtD`uFv,з>~ uAW@uAZ#iB? uA, uJ uJ  uJ  uA,uA@A@ u!A2 u"A u#I$@A4@$ vA vA vA vA vA vA vI) vA* vA+~ v B@Z@ v B v DDD" v D:mʑvD:mʑ?vDAf`PvDvit?vD_wvD_w?vD ՃIvD5[?~ vBvE&y4>vF^*>~ vAZ@vA"8? vA, vJ  vJ  vJ vA,vA?A? v!A2 v"A v#I"@A6@$ wA wA wA wA wA wA wI) wA* wA+~ w BV@ w B w DZ!A~ w Df w DOV;?wDOV;?wD5V@wDZ]?wD?wD?wDj=@wDzŹ?~ wBwEۭJG>?wFgh~??~ wA@V@wAw_ұ? wA, wJ wJ wJ wA,wA?A? w!A2 w"A w#I&@A4@$ xA xA xA xA xA xA xI) xA* xA+~ x B l@ x B ~ x DqT x D = -Ax DVlt[xDVlt[?xDٚ=xDths?xD?xD?xD*c!()@xD5?~ xBxE(BNʣ?xF&^?~ xAl@xAܹË? xA, xJJJ xA, xAA x!A2 x"A x#I@@AK@$ yA yA yA yA yA yA yI) yA* yA+~ y B b@ y B y D5ӻ4{DA{B~]?{D?{D?{Dj[7#@{D`ޑ?~ {B{EB~?{FV22?~ {A@{AC>`? {A, {J {J {J {A,{A?A@ {!A2 {"A {#I@U@Af@$ |A |A |A |A |A |A |I) |A* |A+~ | B@P@ | B | D@A| D%A| Dڂ$¿|Dڂ$?|D1"|Dh?|D]޿|D]?|Ds,<|D 7/?~ |B|E&JV? A, J J J A,A?A@ !A2 "A #I @A @$DFl,(,,,,(( ( ,,2%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A A A I) A* A+~  B@P@  B ~  Dp  D`fe A DMQDMQ?D,4CD}Y.v?D"D"?D z@DrT?~ BE@Aۥ?F]g#t?~ AP@A\? A, J J J A,A?A@ !A2 "A #I0@A5@$ A A A A A A I) A* A+~  BV@  B  D ,0A D Fq.A DepDep?D'{D~[)!?DÿD?D0" i$D67?~ BE_?FKh?~ A8@Ay` p? A, J8 J9 J: A,A?A@ !A2 "A; #I@A@$ A< A= A< A> A? A I) A* A+~  By@  B<  D|A D A Dg|Dg|?D3PPCD+h"?~ Ay@Alj⪔? A, J@ JA JB A, A  A !A2 "AC #IL@AY@$ AD AE AD AF AG A I) A* A+~  B9@  BD  DO7FD  D>etwD>etw@DoɜTD:;?D \{?D \{?DJ 0@D0 C?~ BE@P)O?F)J?~ A8@Alw ? A, JH JI JJ A,A?A@ !A2 "AK #I@A"@$ AL AM AL AN AO A I) A* A+~  B@P@  BL  D?ED{{  DпPX?DпPX?DU L@Db1?D?D?DyAwF72@D;2)?~ BEJeyo?F[T?~ AP@A΀? A, JP JQ JR A,A?A@ !A2 "AS #I1@A4@$ AT AU AT AV AW A I) A* A+~  Br@  BT ~  D& D`W.A DN_zyDN_zy?DR-2CDl>?D??D??DS*cU4@DJ[?~ BEq=?FD?~ Ar@A=p? A, JX JY JZ A,A?A@ !A2 "A[ #IH@AR@$ A\ A] A\ A^ A_ A I) A* A+~  BW@  B\  D@xA DA D$*W/ᢿD$*W/?D$70DIyE1?D?D?DX{}5@D7_Ae`?~ BE2~~?F`:?~ AW@A}? A, J` Ja Jb A,A?A? !A2 "Ac #I4@A:@$ Ad Ae Ad Af Ag A I) A* A+~  BF@  Bd ~  Dy DA DzG+f˽DzG+f˽?Da_Dh?DĿD?D{5}B&O%D4-?~ BE6D 4|?F%?~ AF@AwC{? A, Jh Ji Jj A,A?A@ !A2 "Ak #I@A$@$ Al Am Al An Ao A I) A* A+~  BW@  Bl ~  DbA DA DA&$ſDA&$?D%Da։?D¿D?D$a4N#D*;?~ BE`H?Fm?~ AW@A7? A, Jp Jq Jr A, A  A !A2 "As #I7@A=@$ At Au At Av Aw A I) A* A+~  B0{@  Bt  Do.D@  D6G?D6G?DegC@D2jU5?D_?D_?Dec`G@D Z{?~ BE(z>F}.I"?~ A {@A,༿? A, Jx Jy J A,A?A@ !A2 "Az #IK@A\@$ A{ A| A{ A} A~ A I) A* A+~  B9@  B{  D}A D@'o A DTwZ}cпDTwZ}c?DKlpxC0Dc?D (ٿD (?DЦw7D=@^?~ BENjJT?F>?~ A8@Ao$? A, J J J A,A?A@ !A2 "A #I@A"@$ A A A A A A I) A* A+~  B@  B  DD$$IA  D[-:D[-:?DX#QDG) P?D`#D`#?D.R.LD]r}?~ BE;G̴:F9+.;~ A@Af? A, J J J A,A?A@ !A2 "A #IQ@A a@$ A A A A A A I) A* A+~  B@U@  B  D)r$A Dv&A Dn-5b?Dn-5b?D9#@DY\?DD?DD?DX$&@De\Q?~ BE([@i ?F쨇?~ AU@Apc? A, Jc Jc Jc AV A  A !A2 "A #I&@A2@$ A A A A A A I) A* A+~  BA@  B  DA DA D*'9=4y?D*'9=4y?D2qz?DJ>?D`TD`T?Dn,QDCH?~ BE#?Fdl"Z?~ AA@A? A, J J J A,A?A@ !A2 "A #I@A"@$ A A A A A A I) A* A+~  B4@  B  D @ DR@ D'#u?D'#u?DcA@Dt}?D?D?DaeaJ=@DWؤ?~ BE d?F`X?~ A3@A*? A, J J J A, A  A  !A2 "A #I @A"@$ A A A A A A I) A* A+~  BN@  B  D|1A~  Do DocпDoc?DW-kC0DK?D@пD@?D@Ư0Dn?~ BE]1E?FrH#?~ AM@A2? A, JJJ A, AA !A2 "A #I @A.@$ A A A A A A I) A* A+~  BA@  B  DA D0A D VU?D VU?De^M@Dɥ e?Dγ?Dγ?D>,t @Dߺ*?~ BE^ǫ?Fno3?~ AA@APWBK? A, J J J A, A  AR !A2 "A #I@A @$ A A A A A A I) A* A+~  B@j@  B  DR D  Dy]ٿDy]?D-8D-_SC?D⏺D⏺?DtuD?~ BEJ?Fnb'v?~ A j@Aln4? A, J J J A,A?A@ !A2 "A #I7@AK@$ A A A A A A I) A* A+~  BQ@  B  D@ DS@ DuzUܿDuzU?D#=l:D >?DD?Dw);ihDЁ5k?~ BEf)*[a?F Xȍ?~ A@Q@A%%s? A, J J J A, A  AR !A2 "A #I,@A1@$ A A A A A A I) A* A+~  B@e@  B  Dt&(A~  D *A DF?DF?D˿5!f$@DLԡ?D?D?D5+F@D{ڪ9?~ BEj:S?FM)O?~ A e@Aձ(? A, J J* J A,A?A@ !A2 "A #I:@AE@$ A A A A A A I) A* A+~  BY@  B  D JA D`KP A Di0>Di0>?D&33BD:9E?D#?D#?D!{<@DV?~ BEݢ?Fei{C"?~ AX@A P'? A, J J J A,A?A@ !A2 "A #I1@A7@$ A A A A A A I) A* A+~  B9@  B  DF@ D2@ Ds,3?Ds,3?Db/@Dxd0鰆?D?$?D?$?D2g4@DWFC?~ BE~.?F-It<?~ A8@ALd? A, J J J A,A?A@ !A2 "A #I@A@$ A A A A A A I) A* A+~  B.@  B ~  D@ D _@ D@,?D@,?DTs@D;U#lv?DF@?DF@?DmO%S@DK;@?~ BEpgMjx?FG0tG?~ A,@A&Y~? A, J J J A,A?A@ !A2 "A #I@A@$ A A A A A A I) A* A+~  Bs@  B ~  D7~E D,A DTShDTSh?DQDv0?DD?DJrlCDtP9zt?~ BE0ե>Fbc>~ As@AGs?F闋#ua?~ A_@A%e? A, J J J A,A?A@ !A2 "A #I7@A?@$ A A A A A A I) A* A+~  B@Z@  B  D A DGA D4O/̿D4O/?DPO,D{pM&Wx?D4?D4?DXx @D+(q?~ BEr匚?F@Ѝ?~ AZ@A+P? A, J J J A,A?A@ !A2 "A #I2@A:@$DGl(,,(.,2(,(.,2,222(,,((,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A A A I) A* A+~  B^@  B  D_A D@%A D혊D혊?D0 CD=m]?DQ?DQ?D)JAK!@D9f?~ BE s?F=d?~ A]@A<{{^? A, J J" J A,A?A? !A2 "A #I3@A>@$ A A A A A A I) A* A+~  B@  B ~  DY D ^YA Dg$!&ֿDg$!&?D"5D ?D?ͿD??Dh(ַ8-D刪g9?~ BE51sl?F<Ň?~ A@A=kP? A, J J J A,A?A@ !A2 "A #IL@Aa@$ A A A A A A I) A* A+~  BW@  B  DA DA DοD?D_rc:,.DCq?DٴDٴ?D'YD%9_R>?~ BExF?FhKw_?~ AW@ACݸ$? A, J J J A,A?A@ !A2 "A #I7@A@@$ A A A A A A I) A* A+~  B@U@  B  D@WA D@A Db{?Db{?D믝@Dv{?DD?D\vۛlADTJ?~ BE,HJH?FI?~ AU@A? A, J J J A,A?A@ !A2 "A #I5@A9@$ A A A A A A I) A* A+~  Bd@  B  DP@ D>A D:7 ?D:7 ?D}T@Dd:F?DD?DDG?~ BERth?F ~~?~ Ac@AXt? A, J J J A, A  AR !A2 "A #I>@A@@$ A A A A! A" A I) A* A+~  BD@  B  DR_<D2J  DM&.?DM&.?D2u-2`@D6΍]@Dc?Dc?DQ\.Y@DZ7E@~ BE Im>F d?~ AC@AkwOW? A, J# J J$ A,A?A? !A2 "A% #I@A"@$ A& A' A& A( A) A I) A* A+~  B@  B&  D2DR  DBMj,GڿDBMj,G?D"8DK"?DV?DV?D8_V@D /?~ BE1Fu?F%?~ A@A(qB? A, J* J+ J, A,A?A? !A2 "A- #ID@A `@$ A. A/ A. A0 A1 A I) A* A+~  B9@  B.  D@pK@ D@ D.ͫD.ͫ?DF0Dȟ۰?D@LſD@L?D̸G9%DH꤃?~ BElĽ?FS=G?~ A8@A/LG~? A, J2 J3 J4 A,A?A? !A2 "A5 #I@A@$ A6 A7 A6 A8 A9 A I) A* A+~  B>@  B6  D`wi6A D E>A DrK?DrK?DZ%rGA@D?D@?D@?D%]cN@D ?~ BEZB?FV]?~ A=@AM? A, J: J; J< A,A?A? !A2 "A= #I@A&@$ A> A? A> A@ AA A I) A* A+~  B@P@  B>  D1 A DRA DWP?DWP?D9M'}@@D"1-F?DCDC?Dc˗ =Dl?~ BEw-aw?FOZ}?~ AP@Ab? A, JB JC JD A,A?A? !A2 "AE #I,@A5@$ AF AG AF AH AI A I) A* A+~  B4@  BF  D@ D @ D'D]oҿD'D]o?Dxf@2D9(?D@sD@s?DV,PD+xQ?~ BE{zt?Ffc>?~ A3@Aq>3? A, JJ JK JL Ag Ah  Ah !A2 "AM #I@A@$ AN AO AN AP AQ A I) A* A+~  B@U@  BN  DǑ-DDg9  DcpϻDcpϻ?DD T>ȭ?D;?D;?Df@DXW?~ BE!OP:?Foـ?~ Ab@A&? A, Jb Jc Jd A,A?A@ !A2 "Ae #I.@A@@$ Af Ag Af Ah Ai A I) A* A+~  B>@  Bf  D`A D@ DqܿDq?D(K \:D/Ym?DqݿDq?DI0O;DN/?~ BEJ(h L?F>|?~ A=@A|? A, Jj Jk Jl A,A?A@ !A2 "Am #I@A"@$ An Ao An Ap Aq A I) A* A+~  B.@  Bn  D`>@ D @ DaIDaI?DpDR@?D`?D`?D@k1@Dc?~ BEIo?FJ?~ A,@AJ~? A, Jr Js Jt A, A  A !A2 "Au #I@A@$ Av Aw Av Ax Ay A I) A* A+~  BI@  Bv  DѡA DA Dqo1?Dqo1?D^[1@D68A?D$Ϻ?D$Ϻ?DK0@D0_??~ BE]cƵ?F?[a΢?~ AH@A09"? A, Jz J{ J| A, A ~  A? !A2 "A} #I&@A1@$ A~ A A~ A A A I) A* A+~  B0v@  B~  D[;D`D  Dya_XS?Dya_XS?DTq/@DkA?D?4?D?4?DQ^+C%@D2t?~ BE s?Fm?~ A v@A_? A, J J J A,A?A? !A2 "A #ID@AU@$ A A A A A A I) A* A+~  B g@  B  DXvA D pA Dց$?Dց$?D[]BS@D}1Iզ?D ?D ?D"C@DyÅPN?~ BEn0i?FI?~ Ag@AG v? A, J J J A,A?A@ !A2 "A #IC@AL@$ A A A A A A I) A* A+~  BV@  B  Dk A DA DCdZݿDCdZ?D[`;;D " H?DԿD?Dl3D\G?~ BEȮ I?FH?~ A@V@AYh? A, J J J A,A?A@ !A2 "A #I2@A8@$ A A A A A A I) A* A+~  BI@  B  D,A D`(A D $ݛͿD $ݛ?DLH-DxX?D?D?Dc9N@Dce4?~ BE&<b?Fs5 .?~ AH@A}S0? A, J J J A, A  AR !A2 "A #I"@A$@$ A A A A A A I) A* A+~  B.@  B  D@ D`'5@ D{Фo?D{Фo?DKUW@Dd]0 ?Dk?Dk?D[{C:@Doc3?~ BE{r}Nh?F7ك?~ A,@A Y? A, J J J A,A?A@ !A2 "A #I@A @$ A A A A A A I) A* A+~  B9@  B  D @ D@$@ DX !?DX !?Dd[? A, J J J A, A  A !A2 "A #I1@A6@$ A A A A A A I) A* A+~  B>@  B ~  Dk D@7'A D;|ӿD;|?Dp62DT ?DD?D ACDu2f?~ BEamtl?Fow8U?~ A=@A#+o? A, J J J A,A?A@ !A2 "A #I@A&@$ A A A A A A I) A* A+~  B^@  B  DJA D A DESl!ٿDESl!?DŸ7L7DfI_?D@^z?D@^z?DyWV@D gv|L?~ BEKvpY^?F^9B?~ A]@AKv? A, J J J A,A?A@ !A2 "A #IG@AI@$ A A A A A A I) A* A+~  B`@  B  D A D`X "A D-p1?D-p1?D=MJT@D81?D?D?D Z?dA@DaQR͐?~ BEyaZ?F-O$W?~ A`@A!? A, J J J A, A  A !A2 "A #I9@AD@$ A A A A A A I) A* A+~  B.@  B ~  D1 D-A D?D?Djy5@Dk,w?D5ȯ?D5ȯ?Dt!@Dg?~ BE7 p?FM$QN?~ A,@AdުtF? A, J J JE A,A?A@ !A2 "A #I"@A$@$ A A A A A A I) A* A+~  B$@  B  D `9;@ D4@ D@  B DN#@ D)J@ D*3ֿD*3?DC5DlP?DbpDbp?DrDDb֊?~ BE4z(E?FYt?~ A=@AP°? A, J\ J  J  A, A  A !A2 "A #I"@A$@$ A  A  A  A AA I) A* A+~  Be@  B ~  DfR D 4A DCɉ?BDCɉ?B?D tDBTF?D綿D?D]P D|c?~ BE؊izc?Fh$r?~ Ae@A? A,J J" J A,A?A? !A2 "A#I8@AB@$ A A A A AA I) A* A+~  BK@  B D hA D!A D;Oe?D;Oe?D't;@D#N}d?DD?Dk=X >Dsa?~ BE>I?F9jR9?~ AK@A?wی? A, J J J A, A  A !A2 "A#I$@A(@$ A A A A AA I) A* A+~  BQ@  B~  D  D,A D3?D3?D(F} @D Z?D@aпD@a?Dw0Da%š?~ BEd?F{?~ A@Q@A? A, J J J  A, A  AR !A2 "A!#I*@A1@$ A" A# A" A$ A%A I) A* A+~  B$@  B" DM@ DB@ Dv5}ɿDv5}?D3Sy*D0C?D`D`?DJHNDq4?~ BE ?FSP?~ A"@A9m~-? A, J& J* JM A,A@A@ !A2 "A'#I@A@$ A( A) A( A* A+A I) A* A+~  B.@  B( D @ D@ D8飗ҿD8飗?Dsv =2D`+)?DN?DN?DrrSM@Dbzb?~ BES?q?FG0tG?~ A,@A? A, J, J" J- A,A?A@ !A2 "A.#I@A@$ A/ A0 A/ A1 A2A I) A* A+~  Bd@  B/ D ;A D N.A DؓDؓ?Dj>DSN-?DX]ٿDX]?Dl1MO8DNu8P?~ BE>] [S?FB4e?~ Ac@A1_ S? A, J3 J4 J5 A, A  AR !A2 "A6#I8@AD@$ A7 A8 A7 A9 A:A I) A* A+~  BK@  B7 DA D@@ DqDq?DUO/EDp?DDDD?D D6j'?~ BEPǵu?F'Z ?~ AK@A,q=? A, J; J< J= A, A  A  !A2 "A>#I.@A1@$ A? A@ A? AA ABA I) A* A+~  BK@  B? D`@ D@@ D7?D7?D{W`7@DqnBS?D_?D_?D;D@D;#{y?~ BEI4\?FaQAU?~ AK@AŠDM-? A, JC JD JE A,A?A@ !A2 "AF#I(@A,@$ AG AH AG AI AJA I) A* A+~  B$@  BG D/&@ D @ D 2?D 2?D O @Dc?D_ؿD$r>?D;7D?|*5?D (D (?DQw ?DH?~ BE\|i?FU`?~ AH@Ay39e? A, JS JT JU A, A  AV !A2 "AW#I0@A2@$ AX AY AX AZ A[A I) A* A+~  B.@  BX D@ D:@ D@>X?D@>X?D; l%@D|FHt?D?D?DZ?D{ 8?~ BE.?yP?Fn#?~ A,@Abh-!5? A, J\ J] J^ A,A?A@ !A2 "A_#I @A"@$ A` Aa A` Ab AcA I) A* A+~  BT@  B` DY7A DyA D`fD`f?D\gX#nIDA>s?D οD ?D .Dz;1?~ BE!b?FS*?~ AS@Av]m? A, Jd Je Jf A,A?A@ !A2 "Ag#I2@A8@$ Ah Ai Ah Aj AkA I) A* A+~  BK@  Bh D`qA D`LEA Ds Ds ?DDV@eGD n)?D?D??D؁׫LDު?~ BEx61?F`~nC?e?~ AK@AlU? A, JJJ A, AA !A2 "Al#I@A*@$ Am An Am Ao ApA I) A* A+~  BA@  Bm D+m@ D@OA D?D?DX+@D֒I 5?D D ?Dk8wq!D| /?~ BE-;G?F#?~ AA@Aj#I? A, Jq Jr Js A, A  AR !A2 "At#I @A&@$ Au Av Au Aw AxA I) A* A+~  Bx@  Bu D`A D A D27?D27?D,Ok2@DHρi?D^׿D^?D%\6DG ?~ BEC6t0]?Fj=?~ Ax@AH? A, Jy J" Jz A,A?A@ !A2 "A{#IP@AW@$ A| A} A| A~ AA I) A* A+~  B@`@  B| D@f&A D ].A D>?D>?D6FaN@@Da57m?D @V6?D @V6?D@?au5#A@D`%{?~ BEEpF?F@t?~ A `@A汳? A, J J J A,A?A@ !A2 "A#I8@AB@$ A A A A AA I) A* A+~  B.@  B D@@ D@ D_1b\Z?D_1b\Z?Dq5[8D@D/Rx?Dm>;пD >m>;?D!2}0D-3d7?DH?DH?Dfp@Dߍ?~ BEvh?Fe.?~ Ae@A 76? A, J J J A,A?A@ !A2 "A#ID@AM@$ A A A A AA I) A* A+~  B@  B D @ D `uB@ DrLtRDrLtR?D[]+CD7I?D `CD `C@D6ɏSDؽ"؛?~ BE_y?F:!M?~ A@AOKk6@ A, J Jc J A, A  A  !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B DA D`!uA D\tD\t?Da,D]o+#?D޿D?DtaD<DF?~ BE;?FjqFPC]?~ A`a@Aշch ~? A, J J J Ar As  Am !A2 "A#I5@AA@$ A A A A AA I) A* A+~  BY@  B DB\D*z  D^jaD^ja?D+ OD2|F?E?DD?DDD"5)?~ BE,>FQJ6?~ AX@A JZ+? A, JJJ AFA?A? !A2 "A#I$@A6@$ A A A A AA I) A* A+~  BR@  B D`N3A D 02A DD?D_DPJ&?D_7D_7?DT DX~3?~ BEʩ?F=d?~ AR@AIy(? A, J  J  J A0~ A?  A1 !A2 "A #I(@A5@$ A  A  A  A AA I) A* A+~  BI@  B  D`lA~  D  DmEDmE?DD4[?Dȏ?Dȏ?D7+@D<ٛAk-?~ BE,F๎?FJ?~ AH@A>$:? A, J J J Ar As  A !A2 "A#I4@A8@$ A A A A AA I) A* A+~  B[@  B D XA~  Ď Dި Dި ?D0So -PDن?D+D+?Dg 4PDG7?~ BEpZ=FY4P>~ A@[@A.;*? A, J J J A,A@A? !A2 "A#I&@A8@$ A A A A AA I) A* A+~  Ba@  B Ds#D  Dt6wDt6w?D[/PD5=?D/:D/:?DEDjxF5!?~ BEfte[>F&4{2?~ A`a@A?(m? A, J J J AFA?A? !A2 "A#I&@A@@$ A A  A A! A"A I) A* A+~  BQ@  B D6D?(  Dݮe9;ڿDݮe9;?Dub8D;?D`D`?D 3 ePD ?~ BE_w >F;/?~ A@Q@A?/3? A, JC JD JE AFA?A? !A2 "A##I @A,@$ A$ A% A$ A& A'A I) A* A+~  B@U@  B$ D jA~  DX DOƮhDOƮh?Dˋj[*OD8?DkDk?D)N?yOD! RP?~ BErrwi>Fp>~ AU@A%˜?? A, J( J) J* A0 A1  A1 !A2 "A+#I @A2@$ A, A- A, A. A/A I) A* A+~  Bb@  B, D`A D@A DQ5?DQ5?Daj C@DtXVH?D?D?D}r6@D?G?~ BEWSJÂ?F[~rn?~ Ab@AsYp? A, J0 J1 J2 Ag Ah  A  !A2 "A3#I?@AG@$ A4 A5 A4 A6 A7A I) A* A+~  BA@  B4 D`K.A~  D" DFf?DFf?DnE@D?"kT?D ̿D ?D,a*A,Ditz?~ BE^s?F7,??~ AA@A~OQ? A, J J J A,A@A? !A2 "A8#I@A"@$ A9 AP A9 A: A;A I) A* A+~  Bb@  B9 D.HDZy  DX8|-?DX8|-?D!@va@DP N,@DӿD?Dٴ&3DS3A?~ BE%P?F\!1%?~ Ab@AG^? A, J J J AFA?A? !A2 "A<#I.@AD@$ A= A> A= A? A@A I) A* A+~  Be@  B= DxA DCA D 0"{̿D 0"{?Dq 5,Dn=m?D?D?Dn".@D*}f?~ BER?F?OH?~ Ae@A3? A, JA JB JC A; A<  A= !A2 "AD#I@@AF@$ AE AP AE AF A;A I) A* A+~  BV@  BE DzȔD:?  D?~ BE2A$?F?~ AM@A@c*? A, J J J Ag A  A !A2 "AU#I @A*@$ AV AW AV AX AYA I) A* A+~  B>@  BV D\@ DX@ Di')?Di')?D9B/n;@Dc:T?D۴ͿD۴?D'/ -D/>?~ BEdr5L?F)wM_?~ AM@A5$? A, J` Ja Jb A9 ~ A?  Ac !A2 "Ad#I @A,@$ Ae Af Ae Ag AhA I) A* A+~  BD@  Be D A D0A DI0X,ֿDI0X,?D.J5DjaҪ?D n?D n?D M0Z4@DxhA?~ BE(?FZFM?~ AC@Atid? A, Ji Jj Jk A A~  Al !A2 "Am#I@A"@$ An Ao An Ap AqA I) A* A+~  BA@  Bn DF@~  DlT D1f?D1f?DEb]1Q@DH|?D?D?Dn>c;@Ds?~ BE(rM?F2{?~ AA@Ayxz? A, Jr Js Jt A,A?A@ !A2 "Au#I*@A,@$ Av Gw Av Ax AyA I) A* A+~  BD@  Bv D@A Du A DE6oDE6o?DIv,c>DO6/2@1?DD?D6\PD}$?~ BEb@I?Fh=?~ AC@A$ӽ(? A, Jz J{ J| A A  A} !A2 "A~#I @A(@$ A A A A AA I) A* A+~  BA@  B D@ D`#A Dq(?Dq(?D^뿚Xa@Deɣ@D2?D2?DZ c?D;K?~ BEƷ{z?Fw=I@~ BEߥ?FIN?~ A"@AܶA? A, J J J A9 A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B D RA DA DX \Է?DX \Է?DD@Dx?DE˿DE?D\,DVA?~ BE&3z?F ~?~ A8@AmУ[*? A, J J J Ar Am  As !A2 "A#I@A@$ A A A A AA I) A* A+~  BW@  B DA DA D|?D|?D:M>@D?D?D?DE"hZ@D}[4 ?~ BEdI?F(?~ AW@A ? A, J J J A A  A !A2 "A#I2@A8@$ A A A A AA I) A* A+~  B.@  B D`\NA D@ D36`wD36`w?Da(O?Df.k?DֿD?D͵ɹ5D!?: ?~ BE“AH?F`r-V?~ A,@Ak? A, J J J A= A>  A !A2 "A#I@A@$ A A A A AA I) A      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqstuvwxyz{|}~* A+~  B9@  B DM@ D@ DſD?Dpr $\&Dh 1#l?DE?DE?DT%x E@D،?~ BE`n.V?Fm?~ A8@Axxᖰ? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BT@  B DA D@vA Du9⺜Du9⺜?D֨8>D6NT?D -?D -?DKX*@D.#?~ BE^Z0?F 4ϝ?~ AS@Ao? A, JJJ A, AA !A2 "A#I2@A5@$ A A A A AA I) A* A+~  BA@  B D'e@ D1_@ DdxĿDdx?DT_K%DNyǗ?DōۿDō?Dg 9DZzb?~ BE o?F凗9_?~ AA@A2K+? A, J J J A,A?A@ !A2 "A#I$@A$@$ A A A A AA I) A* A+~  BW@  B DVDn  DQK?DQK?DїLW$@D C?D@ĶD@Ķ?D3ʲD!]?~ BE:Dj~D?Fоl?~ AW@Aɀ? A, JJJ A, AA !A2 "A#I3@A<@$ A A A A AA I) A* A+~  B4@  B DzA D@@ D?ް͆D?ް͆@DČ/SDZkY?Dj?Dj?Dz{2@@Dz'.?~ BE@,ة?F?~ A3@A}? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BD@  B D@A~  DwW D%pA{xҿD%pA{x?D9`n!2D{t2?DٿD?D]("=8Dc0>?~ BE,P?FvxE ?~ AC@A1@A? A, J J J A,A?A? !A2 "A#I$@A,@$D|Gl$2.(.2(2222.2(222,2222 ,2%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  BT@  B D@P@ D @ DWx?DWx?D:d5@DGl?D`Ls?D`Ls?DVЃ*4@DȰT?~ BE-Νi?FH}H?~ AS@AߴT? A, Jc Jc Jc A, AA !A2 "A#I1@A3@$ A A A A AA I) A* A+~  B>@  B D# @ D 1@ DěPǿDěP?D 'DD9P4?Df_ſDf_?D_(%D%?~ BEFt?F%?~ A=@An#:C? A, J J J A, A  A  !A2 "A#I"@A&@$ A A A A AA I) A* A+~  BQ@  B D@[A DA Dki ?Dki ?D:dC@Dq]9J?D$ͿD$?D]502-DT?~ BEtZh&?Fm?~ A@Q@AN? A, J J J A, A  A !A2 "A#I*@A0@$ A A A A AA I) A* A+~  B>@  B D@ D@m@ DƁԿDƁ?DM-/ 4DblTa?DD?DW/BDV?~ BEE%@?Fm?~ A=@A\0? A, J J J A,A?A@ !A2 "A#I3@A:@$ A A A A A A I) A* A+~  B.@  B D W@ D W{@ D 0ƙ?D 0ƙ?D1ƮP@D+|_K?D?D?DO~JD?~ BEK%R=FG=~ Au@A\D? A, J" J# J$ A,A@A@ !A2 "A%#I<@A@S@$ A& A' A& A( A)A I) A* A+~  BK@  B& DFA D A D*Ux"D*Ux"?D}~=D ˿?D?D?DlW7 L@DMsY?~ BEBҰ?F )XO?~ AK@AA? A, J* J+ J, A,A?A@ !A2 "A-#I&@A*@$ A. A/ A. A0 A1 A I) A* A+~  B@e@  B.  D.Dx$   D, D,? D/sO6L D1Wq? D@vW D@vW? Dc%*N D#.c?~ B EάC3К= F9=~ A e@ AH? A, J2 J3 J4 A, A?A? !A2 "A5 #I3@AA@$ A6 A7 A6 A8 A9 A I) A* A+~  B9@  B6  D@)MA  D A  DIx4? DIx4? Dd05@ D c? D`п D`? DW@0 D?~ B EE].? FJ?c?~ A8@ A,X? A, J: J; J< A, A  A !A2 "A= #I@A@$ A> A? A> A@ AA A I) A* A+~  B>@  B>  D>9DO   D D? DAL Dxl;? DEu  DEu @ DxuyV Dk^ܹ?~ B E P? FS?~ A=@ AZ?}? A, J J  J A, A?A@ !A2 "AB #I@A@$ AC AD AC AE AF A I) A* A+~  B@j@  BC  DCD    D>l4 D>l4? DU axID DY^-? D{̿ D{? Dy1, DR(}?~ B E[{E? FRU1?~ A j@ A*f? A, JG J* JQ A, A?A@ !A2 "AH #I3@AG@$ AI AJ AI AK AL A I) A* A+~  B g@  BI  D DJ^A~  DRp  D1Ôh? D1Ôh? DXDNW@ D/.i? Dnk? Dnk? Dk^@ DmK4@~ B E5և ? F=B?~ Ag@ AKX? A, JM JN JO A, A?A? !A2 "AP #I2@AD@$ AQ AR AQ AS ATA I) A* A+~  BP~@  BQ DԩDzp@  Db8d߻Db8d߻?DyD򍄬?D!?D!?D+jW@D*5?~ BE0>FS[:~>~ A@~@AsT? A, JU JV JW A, A  A !A2 "AX#IL@A^@$ AY AZ AY A[ A\A I) A* A+~  BN@  BY D`װ*A~  D^X DՄ@DՄ@D>Ls@DZ@D`Ֆ?D`Ֆ?DrQpE@D!8?~ BE" p?FS?~ AM@Ahr&? A, J] J^ J_ A,A?A@ !A2 "A`#I@A*@$ Aa Ab Aa Ac AdA I) A* A+~  BF@  Ba DG;D  D߶ D߶ @DyHRDxx?D?D??DD`_1ODQf?~ BE,OeI`?F򮳌t?~ AF@AؖZS? A, Je Jf Jg A,A?A@ !A2 "Ah#I@A"@$ Ai Aj Ai Ak AlA I) A* A+~  BI@  Bi D@!A D`g+"A Dg#N5?Dg#N5?D!{í @D?D?D?D7[G>@DI?~ BE'o/?F ~?~ AH@A ? A, Jm Jn Jo A,A?A? !A2 "Ap#I @A,@$ Aq Ar Aq As AtA I) A* A+~  Br@  Bq D2 D  DdGpƿDdGp?DވT.&DmF5k3}>~ A@m@A[\Z? A, J} J~ J A,A?A@ !A2 "A#I@@AM@$ A A A A AA I) A* A+~  B|@  B DZD?\G  D[rvD[rv?DQLd4RD2g?D r/D r/?D HDnH?~ BE\S}Tm<F^ɏ<~ A|@AF ? A, J J J A,A?A@ !A2 "A#IM@A@[@$ A A A A AA I) A* A+~  B9@  B D #@ D@ D˾J?D˾J?DγZ3A@Dl1?D?D?D1J`@DцqXL@~ BEWCz&?F>|?~ A8@AXFpC|? A, J J J A,A?A@ !A2 "A#I @A&@$ A A A A AA I) A* A+~  BR@  B D و@ Dɠ A D~?D~?Dj3w+Y@D,/m @DM@?DM@?D"9zB@D闵?~ BETg=?F h{?~ AR@Ad(ö? A, J J J A, A  A !A2 "A#I2@A8@$ A A A A AA I) A* A+~  B`c@  B D(ADS  DKX&$?DKX&$?Dn=eN@D=(?D_X?D_X?DEC6@DH?~ BE1Tx?F- V?~ A@c@A&? A, J J J A,A?A@ !A2 "A#I=@AF@$ A A A A AA I) A* A+~  BD@  B Ds"ADp  D4WڹD4Wڹ?D]Չ Di2?D@ڿD@?D]dCJ8D1@$?~ BEqȳ?F[ȮW4?~ AC@A$Z ? A, J J J A A  A !A2 "A#I@A&@$ A A A A AA I) A* A+~  B^@  B D3A D`IJ A D[tD[t?DOtPEDɭ ?D¿D?D39P#DC?~ BEsnA?Fl ?~ A]@A&S? A, J J J A,A?A? !A2 "A#I=@AA@$ A A A A AA I) A* A+~  B@`@  B DqCA Dख़A DOX6DOX6?DJ*DD/Я?DTDT?D>|Dx ?~ BEMf3?F&HǴ?~ A `@A,hL+? A, J J J A, A  A9 !A2 "A#I8@AB@$ A A A A AA I) A* A+~  BT@  B D  A D@}*A D\Wt)@D\Wt)@Dh)ns@D$g9@D ?D ?DT`@D[ A@~ BE:΅?F!l۫?~ AS@AxRT ? A, J J J A,A?A@ !A2 "A#I0@A7@$ A A A A AA I) A* A+~  B |@  B DLyDkJ  DY{DY{?DccGDc?D}SD}S?D%;@?%;@ A A A A A A I) A* A+~  BA@  B  D A  DA  DlqN꯹? DlqN꯹? D5@ Dl[5'? D`m޿ D`m? DG9[< D%ŵ ?~ B EPֱ? FS?~ AA@ A5? A, J J J A, A  A !A2 "A #I@A @$ !A !A !A !A !A!A !I) !A* !A+~ ! B9@ ! B~ ! D7-J! D, ,J? ,J@ ,A,,A?A? ,!A2 ,"AA,#I@A@$ -AB -AC -AB -AD -AE-A -I) -A* -A+~ - B@P@ - BB- D`A~ - DA- D@7--D@7-?-DTU=-DTj3?-D`&տ-D`&?-DbAy4-D~[r?~ -B-EU?-F'?~ -AP@-AA)? -A, -JF -JG -JH -A, -A - AR -!A2 -"AI-#I&@A,@$ .AJ .AK .AJ .AL .AM.A .I) .A* .A+~ . B$@ . BJ. D@. D @. D/m͐.D/m͐?.D\v)L.D Z?.D.D?.DC.D4e9?~ .B.E,r?.FO `?~ .A"@.A;(? .A, .JN .JO .JP .A,.A?A@ .!A2 ."AQ.#I@A@$ /AR /AS /AR /AT /AU/A /I) /A* /A+~ / BD@ / BR/ DQA/ DuA/ D *Pݿ/D *P?/Dl-? 4A, 4J| 4J} 4J~ 4A, 4A 4 A 4!A2 4"A4#I@A@$ 5A 5A 5A 5A 5A5A 5I) 5A* 5A+~ 5 Bd@ 5 B5 DOOJD|G 5 Dbzk=5Dbzk=?5DR|>5DzJd?5D q?5D q?5DԚdû"@5D?;}?~ 5B5E·h?5FKh?~ 5Ac@5Aye? 5A, 5J 5J 5J 5A,5A?A@ 5!A2 5"A5#I,@AB@$ 6A 6A 6A 6A 6A6A 6I) 6A* 6A+~ 6 B@P@ 6 B6 D` A6 D A6 D6D?6DU@6DCD7T?6DHz6DHz?6DN5ũ6D"9?~ 6B6Ed ?6Fh=m6?~ 6AP@6A0 Er? 6A, 6J 6J 6J 6A,6A?A? 6!A2 6"A6#I(@A.@$ 7A 7A 7A 7A 7A7A 7I) 7A* 7A+~ 7 B b@ 7 B~ 7 Dʛ7 DWA7 D s>7D s>?7D1|7SzE7DskA?7D7D?7DaXFD7D+u?~ 7B7E'ܭ|=j>7F E>~ 7Ab@7A2R5JT? 7A, 7J7J 7J 7A,7A?A@ 7!A2 7"A7#I2@A@@$ 8A 8A 8A 8A 8A8A 8I) 8A* 8A+~ 8 B$@ 8 B8 D@@8 D@A8 D%t@8D%t@8DE @8D1H@8D`n?8D`n?8D^ƑJ@8D?~ 8B8E17?8F&9?~ 8A"@8AчQ[? 8A, 8J 8J 8J 8A,8A?A@ 8!A2 8"A8#I@A@$ 9A 9A 9A 9A 9A9A 9I) 9A* 9A+~ 9 Bd@ 9 B9 D` A9 D@#A9 Dq8?9Dq8?9DP&ßU@9DC߸K?9D峪9D峪?9DRXg 9DTm%?~ 9B9EacJ?9FS=G?~ 9Ad@9AڸY? 9A, 9J 9J 9J 9A,9A?A@ 9!A2 9"A9#IA@AG@$ :A :A :A :A :A:A :I) :A* :A+~ : B4@ : B: D@A: D`{TA: D'?:D'?:D H.:P@:DWaSc?:D:D?:DqgK:Dqy?~ :B:E~fm?:Fqc`?~ :A3@:Ar)? :A, :J :J :J :A~ :A? : A :!A2 :"A:#I@A@$ ;A ;A ;A ;A ;A;A ;I) ;A* ;A+~ ; B9@ ; B; D@; D@@; Dyl;Dyl?;D VGQ;D"e?;D;D?;D%pJG;D\`m?~ ;B;E=?;F%p6X?~ ;A8@;AS? ;A, ;J ;J ;J ;A, ;A ; A  ;!A2 ;"A;#I"@A&@$ <A <A <A <A <A<A <I) <A* <A+~ < BY@ < B< D\A~ < DiA< D<*Yο<D<*Y?<D;O.<D˅&?<D.ѿ<D.?<DR^0<Da̎d)?~ <B<Ea?<Fzp/?~ <AX@<Az!? <A, <J <J <J <A,<A?A@ <!A2 <"A<#I4@A;@$ =A =A =A =A =A=A =I) =A* =A+~ = BD@ = B~ = D.O= D33A= DWz=DWz?=D{ܿ=DnaA >A >A >A >A>A >I) >A* >A+~ > B[@ > B> DA> D`*A> Db?>Db?>DBPT@>D|0?>D@= ?>D@= ?>DGL%?@>D7?~ >B>E?>FZDh?~ >A@[@>AR1? >A, >J >J >J >A,>A?A@ >!A2 >"A>#I.@A9@$ ?A ?A ?A ?A ?A?A ?I) ?A* ?A+~ ? B9@ ? B? D;( A? D`qA? Dnm??Dnm??Ds)J@?D[x _??D~??D~??DxE@?D=?~ ?B?Eڰl71??F-Ou?~ ?A8@?A ю? ?A, ?J ?J ?J ?A,?A?A? ?!A2 ?"A?#I(@A(@$DGl2.((,2 2,(2.(.,22222,$,,22((,@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A @A @A @A @A@A @I) @A* @A+~ @ BK@ @ B@ D@;A@ D #A@ DXӈ)?@DXӈ)?@De@@D<`m?@D6Qƿ@D6Q?@Dub _&@Du[?~ @B@EFK;#?@F²Bm?~ @AK@@A{1? @A, @J @J @J @A,@A?A@ @!A2 @"A@#I,@A1@$ AA AA AA AA AAAA AI) AA* AA+~ A B9@ A BA DAA D~AA DrADr?AD=A$ADǸD?AD mֿAD m?AD%EH5AD1C?~ ABAEP1t?AFKh?~ AA8@AA{N? AA, AJ AJ AJ AAVAA?A? A!A2 A"AA#I@A @$ BA BA BA BA BABA BI) BA* BA+~ B BF@ B BB D`#A~ B D B D5ų?BD5ų?BD$R@?@BD: ?BD`qտBD`q?BD:h4BD5EQ?~ BBBEY?BF]6?~ BAF@BAqP? BA, BJ BJ BJ BA,BA?A? B!A2 B"AB#I.@A0@$ CA CA CA CA CACA CI) CA* CA+~ C BT@ C BC D`+A~ C DC DpֿCDp?CD $ L5CDԃ7?CDE׿CDE?CD }6CDpF ?~ CBCEy?CF-D3{?~ CAS@CAɮێ? CA, CJ CJ CJ CA,CA?A@ C!A2 C"AC#I1@A7@$ DA DA DA DA DADA DI) DA* DA+~ D BR@ D BD D D: D D"=^̿DD"=^?DDovz,DD rq?DDI?DDI?DDlOR?DDqGXU?~ DBDEtg?DF?~ DAR@DAG}? DA, DJ DJ DJ DA,DA?A@ D!A2 D"AD#I2@A8@$ EA EA EA EA EAEA EI) EA* EA+~ E BY@ E BE DsAE D`"AE D տED ?EDS.'6)5ED-~:?ED ?ED ?ED%a2D-@EDue?~ EBEEV?EF^mh ?~ EAX@EA ? EA, EJ EJ EJ EA, EA E A E!A2 E"AE#I2@A7@$ FA FA FA FA FAFA FI) FA* FA+~ F BY@ F BF Dp AF D00AF DՈ[U?FDՈ[U?FDSX;Y@FDcI;@FD J?FD J?FDSݱ/~W@FDH ?~ FBFEG]Ҕ>FFHQa?~ FAX@FA/@? FA, FJ FJ  FJ  FA,FA?A@ F!A2 F"A F#I*@A5@$ GA  GA  GA  GA GAGA GI) GA* GA+~ G BD@ G B G D`@A~ G DQG D9x]?GD9x]?GDl3(BW@GD֫?GDz?GDz?GDBv0n[@GD@~ GBGEu=j?GF!p?~ GAC@GA|;? GA, GJ GJ GJ GA,GA?A@ G!A2 G"AG#I$@A&@$ HA HA HA HA HAHA HI) HA* HA+~ H B@P@ H BH D@AH D@j"AH D#+̿HD#+?HD:4,HDmg?HDSHDS?HDnInAHDbK4?~ HBHEƨ3?HF>|?~ HAP@HA0aںX? HA, HJ HJ HJ HA0~ HA? H A H!A2 H"AH#I&@A0@$ IA IA IA IA IAIA II) IA* IA+~ I Ba@ I BI D DBk I DZ?IDZ?ID6X@ID֝e?ID_; ?ID_; ?IDje-K@ID6]?~ IBIE0Wyz`?IFh FЋ?~ IA`a@IAQ&y4_? IA, IJ  IJ! IJ" IA,IA?A? I!A2 I"A#I#I&@A<@$ JA$ JA% JA$ JA& JA'JA JI) JA* JA+~ J B\@ J B$J D7A~ J D=&J DC?JDC?JDFϡ@JD x?JDпJD?JD\ud0JDα=?~ JBJEzO?JF.?~ JA\@JAiHبE? JA, JJ( JJ) JJ* JA,JA?A? J!A2 J"A+J#I0@A=@$ KA, KA- KA, KA. KA/KA KI) KA* KA+~ K BD@ K B,K DvGAK D AK D"?KD"?KDOVQ@KD jc?KD)i?KD)i?KD"W _p4@KD,Q?~ KBKE$Ju?KF Hg?~ KAC@KAcwNv? KA, KJ0 KJ1 KJ2 KA,KA?A? K!A2 K"A3K#I&@A(@$ LA4 LA5 LA4 LA6 LA7LA LI) LA* LA+~ L BF@ L B4L D`-AL DAL Dhl.EwLDhl.Ew?LD*ILDcO\?LD?,?LD?,?LD84N@LDM됁?~ LBLEhTst?LF`:?~ LAF@LA:q? LA, LJ8 LJ9 LJ: LA,LA?A@ L!A2 L"A;L#I"@A&@$ MA< MA= MA< MA> MA?MA MI) MA* MA+~ M BK@ M B<M DY AM D׏AM D/5MD/5?MD35 ?MDƣb?MDؿMD?MD[R7MDk=I?~ MBMEmH:?MF!t&?~ MAK@MA? MA, MJ@ MJA MJB MA,MA?A? M!A2 M"ACM#I @A*@$ NAD NAE NAD NAF NAGNA NI) NA* NA+~ N B[@ N BDN DW4Dn\ N D@8-K?ND@8-K?ND[No5@ND;} ?ND??ND??NDha @ND;V?~ NBNE7@$ OAL OAM OAL OAN OAOOA OI) OA* OA+~ O BW@ O BLO D 'A~ O D('AO D2^OD2^?ODqVOD@6{?ODP˷ODP˷?ODž!ODǓ?~ OBOEa;?OFso?~ OAW@OA4=P? OA, OJP OJQ OJR OA,OA?A? O!A2 O"ASO#I3@A=@$ PAY PAZ PAY PA[ PA\PA PI) PA* PA+~ P B9@ P BYP DD~@P DG@P DWT1PPDWT1P?PDWFPD ]T?PDȿPD?PDm̾ )PDA?~ PBPEEQij?PF=d?~ PA8@PA@P$? PA, PJ] PJ^ PJ_ PA,PA?A@ P!A2 P"A`P#I@A@$ QAa QAb QAa QAc QAdQA QI) QA* QA+~ Q B$@ Q Ba~ Q D @Q D@Q DNIQDNI?QDx2)QDQXm3?QD_5QD_5?QDMA1@QDy'?~ QBQEGi?QFU`?~ QA"@QAxT}4? QA, QJe QJf QJg QA,QA?A@ Q!A2 Q"AhQ#I@A@$ RAi RAj RAi RAk RAlRA RI) RA* RA+~ R B9@ R BiR D@R D-v@R DrQRDrQ?RDARDrLCJ?RD?RD?RDˉd9 @RDy}Kc?~ RBREM\?RF 뭞Al?~ RA8@RA}P? RA, RJm RJn RJo RA,RA?A@ R!A2 R"ApR#I @A"@$ SAq SAr SAq SAs SAtSA SI) SA* SA+~ S BA@ S Bq~ S DoQBS D`lAS DY ?SDY ?SDY6R&@SD L%?SDSD?SDV"SDM_?~ SBSE |?SF쨇?~ SAA@SAqJuQ? SA, SJu SJv SJw SA, SA S A  S!A2 S"AxS#I&@A(@$ TAy TAz TAy TA{ TA|TA TI) TA* TA+~ T B.@ T ByT D.b@T D(@T Dv|?TDv|?TD!$ k@TD͞JcO @TD3?TD3?TDatI@TDAɠ@?~ TBTEY7?TF z?~ TA,@TAkx"? TA, TJc TJc TJ} TA, TA T A  T!A2 T"A~T#I@A@$ UA UA UA UA UAUA UI) UA* UA+~ U BN@ U BU D`AU DAU Dn?UDn?UDfK2@UDzgn?UD)?UD)?UD: )$@UD#B\?~ UBUE,y>?UF`M?~ UAM@UA!!J? UA, UJ UJ UJ UA,UA?A@ U!A2 U"AU#I,@A5@$ VA VA VA VA VAVA VI) VA* VA+~ V B9@ V BV DR-@V D @V Daᯱ)?VDaᯱ)?VD'%N1@VD ?VD?C?VD?C?VD `[@VD ׶@~ VBVE@?VFO `?~ VA8@VAii4? VA, VJ VJ VJ VA, VA V A  V!A2 V"AV#I"@A"@$ WA WA WA WA WAWA WI) WA* WA+~ W B4@ W BW D,@W D`#@W D&XWD&X?WDf1bBWD?WDWD?WD}9WD@ [ B[ D{vA[ DA[ Dn"4?[Dn"4?[D@[Dbס ?[D?[D?[Dl+ jB@[D_P~?~ [B[Eg ?[F Hg?~ [A=@[AfR:? [A, [J [J [J [A, [A [ A  [!A2 ["A[#I&@A,@$ \A \A \A \A \A\A \I) \A* \A+~ \ B`c@ \ B\ D`z A~ \ D_d\ DI?\DI?\DPFcP@\DeA^Z?\D@P?\D@P?\Dte\?\D-ݹ*?~ \B\EhӇ?\F e}?~ \A@c@\AQ? \A, \J \J \J \A,\A?A@ \!A2 \"A\#IA@AF@$ ]A ]A ]A ]A ]A]A ]I) ]A* ]A+~ ] BI@ ] B] D`2 A] D v%A] D"?]D"?]DrΫ@@]DiV?]D}?]D}?]DKyP1@]Dؘ??~ ]B]E9zV?aD)aD)?aD=k @aDnU?~ aBaEn?aF IL?~ aA\@aAr V4? aA, aJ aJ aJ aA,aA?A@ a!A2 a"Aa#I5@A>@$ bA bA bA bA bAbA bI) bA* bA+~ b Bb@ b Bb DLAb D!Ab DL?bDL?bDS B@bD冱?bD 5bD 5?bDL5v#bD:r?~ bBbE$ ?bF& }?~ bAb@bA? bA, bJ bJ bJ bA,bA?A@ b!A2 b"Ab#I<@AE@$ cA cA cA cA cAcA cI) cA* cA+~ c Ba@ c Bc D0#Ac D`%&Ac D)W\z?cD)W\z?cDLc+@cD@$ iA iA iA iA iAiA iI) iA* iA+~ i B@P@ i B~ i Di D Ai D XiD X?iD BGiD(5?iDAҿiDA?iDـ41iDy~B?~ iBiEG?iF/k?~ iAP@iA\@^?a? iA, iJ iJ iJ  iA,iA?A? i!A2 i"A!i#I,@A4@$ jA" jA# jA" jA$ jA%jA jI) jA* jA+~ j BT@ j B"j D{,D j D`T?jD`T?jDHlO@jDE@Q?jD&?jD&?jDCi S@jD|gW1?~ jBjEx??jF=@/?~ jAS@jA{? jA, jJ& jJ' jJ( jA, jA j AR j!A2 j"A)j#I.@A8@$ kA4 kA5 kA4 kA6 kA7kA kI) kA* kA+~ k B`c@ k B4~ k D Ik D 7Ak Dgf%?kDgf%?kD氬 @@kDv-Ad?kD~H?kD~H?kDs3thC@kD5?~ kBkEt*M?kF8 wK?~ kA@c@kAɋҽ? kA, kJ8 kJ9 kJ: kA, kA k A k!A2 k"A;k#I1@AA@$ lA< lA= lA< lA> lA?lA lI) lA* lA+~ l B9@ l B<l Ds@l D&@l D?ϿlD??lD*k/lD_?lD@ӿlD@?lDPб2lD#?~ lBlEye?lFow8U?~ lA8@lA? lA, lJ@ lJA lJB lA,lA@A? l!A2 l"ACl#I$@A&@$ mAD mAE mAD mAF mAGmA mI) mA* mA+~ m BN@ m BDm D UKAm D`α'Am D8_9?mD8_9?mDCѪ$P@mDRm@?mD?b ?mD?b ?mDð>FWF@mDg*&?~ mBmEeM ހ?mFw@~?~ mAM@mA4Ӏ? mA,mJ mJH mJM mA,mA?A? m!A2 m"AIm#I"@A0@$ nAJ nAK nAJ nAL nAMnA nI) nA* nA+~ n Bv@ n BJn D_*fJD(F n Dۻ@nDۻ@?nD20nDQ6-?nD ^o?nD ^o?nDΔ?nDTI) ?~ nBnEF7ZM?nFn#?~ nApv@nA8Ozz? nA, nJN nJO nJP nA,nA?A? n!A2 n"AQn#I@@AV@$ oAR oAS oAR oAT oAUoA oI) oA* oA+~ o BF@ o BR~ o D,o D`oAo Dz oDz ?oD߽JoD?oD?oD?oDi4SD@oD]Xy)?~ oBoEuи?oF_i_V?~ oAF@oAك\? oA, oJV oJW oJX oA,oA?A@ o!A2 o"AYo#I*@A2@$ pAZ pA[ pAZ pA\ pA]pA pI) pA* pA+~ p BI@ p BZp D4Ap D Ap Dr wEpDr wE?pDm "CpD?pD?pD?pD1Ҫ~6@pDc?~ pBpE2|P?pFtp8:?~ pAH@pA(*LP? pA, pJ^ pJ_ pJ` pA,pA?A? p!A2 p"Aap#I(@A.@$ qAb qAc qAb qAd qAeqA qI) qA* qA+~ q BA@ q Bbq D Aq D Aq DL?qDL?qD:>Ñ%@qD ?qDm?qDm?qD[5J?qDu ?~ qBqE~c?qF?~ qAA@qA2&b? qA, qJf qJ qJg qA,qA?A? q!A2 q"Ahq#I&@A*@$ rAr rAs rAr rAt rAurA rI) rA* rA+~ r B@j@ r Brr D D/1 r D\ L.οrD\ L.?rD-'.rDX,?rD@Š?rD@Š?rDmM>!@rD(ya?~ rBrE?rFm?~ rA j@rAȋbT? rA, rJv rJ rJw rA,rA?A@ r!A2 r"Axr#I@@AK@$ sA sA sA sA sAsA sI) sA* sA+~ s B9@ s Bs D@ڏ@s D H@s D=Wn' sD=Wn' ?sD_)BKsD©xL?sDVsDV?sD q fHsDGrb?~ sBsE ?sF-O$W?~ sA8@sAxL? sA, sJ sJ sJ sA, sA s A s!A2 s"As#I@A@$ tA tA tA tA tAtA tI) tA* tA+~ t BW@ t Bt Dy D ) t D FtD F@tD[`TtDI?tDtD?tD%TVPtD Z?~ tBtEM½[p>tFUgeg >~ tAW@tAFW? tA, tJC tJD tJE tAFtA?A? t!A2 t"At#I@A3@$ uA uA uA uA uAuA uI) uA* uA+~ u B4@ u Bu DOKRD}B( u D0RԀuD0RԀ?uDYIuDoUO?uDgSuDgS?uD,NEuD}}?~ uBuEMTUI?uFzCl?~ uA3@uA^? uA, uJC uJD uJE uAFuA?A? u!A2 u"Au#I@A@$ vA vA vA vA vAvA vI) vA* vA+~ v B.@ v Bv D`4Av DP Av DVvDV?vD_uF4@vDe\MԠ?vD vD ?vDc_WPvD<>Iɤ?~ vBvEF#)?vFm?~ vA,@vA..w? vA, vJC vJD vJE vAFvA?A? v!A2 v"Av#I@A@$ wA wA wA wA wAwA wI) wA* wA+~ w BT@ w Bw D Dp%rA w DG-EYwDG-EY?wD-.PwDyv?wD gwD g?wDtoݠnIwDWq_Ker?~ wBwEZiŷ?wFyY ??~ wAS@wA< ? wA, wJLwJ wJM wAFwA@A? w!A2 w"Aw#I@A1@$ xA xA xA xA xAxA xI) xA* xA+~ x BI@ x Bx DڞDJ7 x DjRxDjR?xD\_OxD7G?xDdxDd?xDYFxD(L?~ xBxEm;?xF'K0A?~ xAH@xA0/? xA, xJ xJ xJ xAFxA?A? x!A2 x"Ax#I@A$@$ yA yA yA yA yAyA yI) yA* yA+~ y BD@ y By D; ooD6 y DGyDG?yD:HyD '?yD yD ?yD#VEyDW?~ yByEYme?yFU&?~ yAC@yAׇ? yA, yJ yJ yJ yAFyA?A? y!A2 y"Ay#I@A$@$ zA zAI zA zA zAzA zI) zA* zA+~ z B.@ z B~ z Dz DEAz D<zD@ ~ B~ D A~ D mA~ DŰuFn?~DŰuFn?~DqP3@~DDX?~Dt~Dt?~Dcz@~Dvt?~ ~B~Ea ?~F7%?~ ~A=@~Ar? ~A, ~J ~J ~J ~A= ~A> ~ A ~!A2 ~"A~#I@A@$ A A A A AA I) A* A+~  BW@  B D0DUg  DlDl?DcR̫NDɠV.6?DD?D(\IFDC|q?~ BE fz>F%R6?~ AW@AKTR? A, J J J AFA?A? !A2 "A#I&@A3@$D^Gl(,,2(,,,($.,((,,2,2,,2%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  B[@  B DDy  DXpDXp?D_ED*C ?DD?DIA՚FDǘe m?~ BE)>F0 ?~ A@[@A[T? A, J J J AFA?A? !A2 "A#I"@A8@$ A A A A AA I) A* A+~  B9@  B D@W A D+(A DfmV >DfmV >?Dr8qBDhk2?D@(ٿD@(?D"7D`7&^?~ BEH p?F>-I?~ A8@A>O*? A, J J J AA?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  BW@  B DD~1   Dq0A]Dq0A]?Da)QDWYw?DE1DE1?D x89 ND(u<ˍ?~ BE#MH">F؍r>~ AW@AR1v? A, J J J AFA?A? !A2 "A#I@A5@$ A A A A AA I) A* A+~  BF@  B DRD  DK6]DK6]?DFŨVED]CmW?D`D`?D-9 FED:b?~ BEuH=i?Fq2P?~ AF@AR]? A, J J J A, A  A1 !A2 "A#I@A"@$ A A A A AA I) A* A+~  BW@  B D`=A D`?A D~?D~?Dښw@D(9G?D?7D?7?Dg|lD?~ BE7S1 ?F7,??~ AW@AB׋R? A, J J J A0~ A?  A !A2 "A#I*@A5@$ A A A A AA I) A* A+~  B4@  B D@Ce@ D@U@ Dg]?Dg]?DoQ@D_&#|?D_?D_?DxjV@DE?~ BETm ?F!t&?~ A3@AĽ? A, J J J A~ A?  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BA@  B~  DR D@FA D0˿D0?DdU,D2L㋩?D@wѿD@w?D_T<1D]C |?~ BEe?F-D3{?~ AA@AZ>? A, J J J A A  A !A2 "A#I @A"@$ A  A  A  A AA I) A* A+~  B4@  B  D8@ D:%@ D<]ND<]N?DF-~D/ׄ?DWB?DWB?D&;@DQw?~ BEݢ̮?F?~ A3@A4K? A, J J J A0A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  BF@  B~  DY DA DRDR?DuhB>DDP.?D?=D?=?D:GRQ@D7n0?~ BEI>Yb^?F>?~ AF@Axe9B? A, J J J A0A?A? !A2 "A#I,@A3@$ A G A A AA I) A* A+~  BN@  B DMA D A Di8Di8?Dĝ DvRO?D]D]?DԘ?=DA+Wr?~ BE]p`J!?FOM?~ AM@As; ? A, JJJ AFA?A? !A2 "A #I(@A.@$ A! A" A! A# A$A I) A* A+~  BK@  B! D7KDf  D8?D8?Dm-@D L1f?D?D?DB H1@D㌸b?~ BEv@  B) D @ D@|@ D-:8D-:8?D5H~XEDOjV"?D D ?DMSlDD>5?~ BE@?F|e?~ A=@Aۍ:? A, J- J. J/ Ag Ah  A  !A2 "A0#I$@A&@$ A1 A2 A1 A3 A4A I) A* A+~  B4@  B1 D bb!A D`Q-A D3;+?D3;+?DWZQ@D4bY?D ?D ?D Ch6@D5^{ݨ?~ BE_?F.gC?~ A3@A^VC? A, J5 J6 J7 A0~ A?  A !A2 "A8#I@A @$ A9 A: A9 A; A<A I) A* A+~  B$@  B9 D@ DY@ DH6DH6?D{ζGD?DxDDxD?D+ADw J? A0A?A? !A2 "A@#I@A@$ AA AB AA AC ADA I) A* A+~  BN@  BA D| A~  Dg. DmЁ@DmЁ@Db7@D{Ie!@D?D?DRR@Dg,?~ BEuA+e?FW{w?~ AM@AHA? A, Jc JE JF A0~ A?  A1 !A2 "AG#I*@A.@$ AH AI AH AJ AKA I) A* A+~  BN@  BH DpA DA D<8iD<8i?D]pN@D7ׇU?D_*{ԿD_*{?D*3DًI?~ BEOj '?F;}?~ AM@Aq8lL? A, JL JM JN A0~ A?  A !A2 "AO#I,@A0@$ AP AQ AP AR ASA I) A* A+~  B.@  BP D@x@ D}\A DWF?DWF?D"Nsf@D n@Do?Do?D36@D @??~ BEw?F`X?~ A,@A{N6? A, JT JU JV A A  AW !A2 "AX#I@A@$ AY AZ AY A[ A\A I) A* A+~  B$@  BY D @ D@ D.D.?D%#!DzA?D ?D ?Dc2ֆ@DIN'?~ BEF2?F[ݤ?~ A"@AW? A, J] J^ J_ A A  A` !A2 "Aa#I@A@$ Ab Ac Ab Ad AeA I) A* A+~  BA@  Bb D`umA D@]A DPYDPY?DZ=DkA?D [aݿD [a?D\'A;D|RG?~ BE0ֈ?F`X?~ AA@AQ|? A, Jf Jg Jh A,A?A? !A2 "Ai#I"@A&@$ Aj Ak Aj Al AmA I) A* A+~  B@_@  Bj DI$A D@L#A D/PuD/Pu?D@)Dfp?D_ ?D_ ?D6I@D}?~ BE)o?Fg,?~ A_@Aj$? A, Jn Jo Jp A A  Aq !A2 "Ar#I9@A<@$ As At As Au AvA I) A* A+~  BD@  Bs DA D %@ D̿^D̿^?D}QDQDL?D@߿D@?D$W<DvM\?~ BEu@?F/k?~ AC@Ap8E? A,J JwJ A,A?A@ !A2 "Ax#I3@A3@$ Ay Az Ay A{ A|A I) A* A+~  B9@  By D.@~  D`"A DP0?DP0?DZ—U@D d?D`?D`?DT+@DFX[ɻ3?~ BE T!V?F`X?~ A8@A?b? A, J} J~ J A, A  AR !A2 "A#I&@A*@$ A A A A AA I) A* A+~  B9@  B D@ D`hA D`@D`@D&jVa|@Dp)@D\?D\?Djp { J@Da;V?~ BE^l?FVL?~ A8@A_4W? A, J J J A,A?A@ !A2 "A#I @A&@$ A A A A AA I) A* A+~  B@  B D @ DG@ D V]?D V]?Du#m@D~L @D@9@D@9@Dٟ@De^©>@~ BEz+;?F C?~ A@A@ A, J J" J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B DDjȭ  Dku@Dku@DӺ@Dh~hU@DsDs?DADa5-?~ BE.Q-4?FĤ ?~ A8@AxbO%? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BA@  B D` A D@<{"A Due?Due?Df^8N@D?D"D"?D$cT?DOo?~ BEkH(%?FZFM?~ AA@A3? A, J J J A,A@A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B$@  B Dd@ Dͥ@ DvhU+DvhU+?DV3D~6+?DiؿDi?D73;7D"j?~ BEt?FKh?~ A"@AwUp? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  BA@  B~  Ds  D fA Dx6C߿Dx6C?D"=DV(?D~QڿD~Q?D.8D2C?~ BE]h?F\?~ AA@A#? A, J J J A,A?A@ !A2 "A#I@A @$ A A A A AA I) A* A+~  BR@  B D`4A~  D& D&?D&?Ddo@DmA @Do?Do?Df G@DpK?~ BEӾ&Τ?FJb%kU?~ AR@A$? A, J J J A,A?A@ !A2 "A#I2@A9@$ A A A A AA I) A* A+~  BA@  B DA D 'A DMtEz?DMtEz?DrFLUT@D d?D ?D ?DV -@DK>R?~ BEۣh?F?ȓQ?~ AA@Ah? A, J J J A, A  A !A2 "A#I@A&@$ A A A A AA I) A* A+~  BQ@  B D"qDb  D2D2?D|PDyn?D?uD?u?DQۑKDz,?~ BE)M>F%>~ A@Q@Ax? A, J J  J  A,A?A@ !A2 "A#I@A,@$ A A A A AA I) A* A+~  BF@  B D*`D  Ds;`Ds;`?DlA$ED;`;,@DO?=J?~ BET?`B>?FOM?~ A8@AdR? A, J J J A, A  AR !A2 "A#I@A@$ A A A A AA I) A* A+~  BT@  B D:ADkeS  D/t?D/t?DL><@DS?D9?D9?D3>s!@D>P]?~ BE 6"?FA?~ AS@Af4? A, J J J A,A?A@ !A2 "A#I*@A1@$ A A  A A AA I) A* A+~  BV@  B D A~  D6 D>M?D>M?D\?C1S@DfH?D/?D/?D_O8@D?~ BEU*?Fm?~ A@V@AԆ? A, J J J AA?A@ !A2 "A#I"@A5@$ A A A A AA I) A* A+~  BQ@  B D@ӬA Dz A DtCg?DtCg?DW2oq3@DOEf?Dt?Dt?DmĒQ@Dt?~ BEYޅҟ?Fgn2?~ A@Q@AA[^#? A, J J J A,A?A@ !A2 "A#I,@A1@$ A A A A AA I) A* A+~  BD@  B D @ Dݮ@ Du?Du?Dzüƃ/@D8?D?D?DC@Dѫ?~ BEt~?DL?DL?D7>.@D n?~ BE/ӠP?F 뭞Al?~ AC@A&@? A, J) J* J A,A?A? !A2 "A#I@A(@$ A A A A AA I) A* A+~  B[@  B D ;a_A~  D:O DD?DUiټDKv?D?K?D?K?DrV0@DlIKB?~ BEDwkCo?F7ك?~ A@[@A+⤫? A, J  J! J" A,A?A? !A2 "A##I(@A9@$ A$ A% A$ A& A'A I) A* A+~  BF@  B$ Dq0A Ds*A DKmԿDKm?Df4Dd~U?DDпDD?D0DCIHң?~ BEcB?FJ?~ AF@Aeɨ? A, J( J J) A,A?A? !A2 "A*#I@A(@$ A+ A, A+ A- A.A I) A* A+~  BR@  B+ D^A DA D4@G?D4@G?D՞G7?Dˮn;?DֿD?DQL%F45DǢ6?~ BEY.!?Ff箮?~ AR@A? A, J/ J0 J1 A,A?A@ !A2 "A2#I8@A<@$ A3 A4 A3 A5 A6A I) A* A+~  Bd@  B3 D`W>A D2A Dc"pDc"p?D秗vCD-k$?DuֿDu?Dr&֒5DEY?~ BErt&?FPS?~ Ad@A? A, J7 J8 J9 A,A?A? !A2 "A:#I8@AE@$ A; A< A; A= A>A I) A* A+~  B.@  B; D@ Dފ@ DۋDۋ?D0FFDWk?D`D`?DZήKDn4-h?~ BEpT?FOZ}?~ A,@AGR0? A, J? J@ JA A, A  A !A2 "AB#I@A@$ AC AD AC AE AFA I) A* A+~  B.@  BC D`@ D@ D Oo?D Oo?D["SqQ@DZO)?D&A D3͚?D3͚?DuLlP@D?DJDJ?D&g!D>7b?7?~ BEm ٚ?F@Ѝ?~ AM@AsD? A, Jh Ji Jj A,A?A@ !A2 "Ak#I$@A2@$ Al Am Al An AoA I) A* A+~  BR@  Bl D A DA D|oӿD|o?DRo3D[?Dޥ?Dޥ?D<$1<@Dݏ$]]?~ BE|G_?FO?~ AR@Ar~_? A, Jp Jq Jr A, A  A !A2 "As#I,@A2@$ At Au At Av AwA I) A* A+~  B>@  Bt Dm@ Dm-A Dwh0?Dwh0?Ds_>KN@Dg\t?D @`ѿD @`?DPS0Dxuޜ?~ BEf)w?F%?~ A=@A2F? A, Jx Jy Jz A, A  A !A2 "A{#I @A&@$ A| A} A| A~ AA I) A* A+~  Bt@  B|~  D̿MA D #A DлR-DлR-@DpևTTD: n?DA"DA"?DͦK CD9@?~ BE'^eKV>FÑ>~ At@AƓJ`? A, J J J A,A?A@ !A2 "A#IF@A@T@$ A A A A AA I) A* A+~  BK@  B D A DɨA Dr?Dr?DcG@DL?D\ ?D\ ?D)gVNUF@D%ǧ%?~ BE) ?F)2 ?~ AK@A nIp? A, J J J A,A?A@ !A2 "A#I.@A1@$ A A A A AA I) A* A+~  BW@  B~  D@JA D~^A D\}ĿD\}?DL%Dx硣?D?6t?D?6t?DĂ)4@DmRwMT?~ BE~?FTC^9u?~ AW@A5-Չ? A, JJJ A, AA !A2 "A#I6@A@@$ A A A A AA I) A* A+~  BQ@  B D @ D`A D 2X?D 2X?DNho\Q@Dla?D?D?DCRMiJ@DA}?~ BEUʵ?F#PP[?~ A@Q@AW? A, J J J A,A?A? !A2 "A#I4@A9@$ A A A A AA I) A* A+~  Bd@  B DB~:A DD3A DP#'ۿDP#'?Dݞez9D=?D2ʿD2?DX03+DJ ?~ BEG"?Fݓ?~ Ad@AioW? A, J J J A,A?A? !A2 "A#I6@AD@$ A A A A AA I) A* A+~  B^@  B DuA D A Dek?Dek?DfBI@DAHR2?D@9@  B D ;4A D@A DMD\?DMD\?D9+|$@D H?D?*C?D?*C?D/OLE@DhKˡ?~ BEK@/?Fq/?~ A=@Ajѝ3E? A, J J J A,A?A@ !A2 "A#I@A&@$ A A A A AA I) A* A+~  B@U@  B D@?A DH A D=]?D=]?D5@ D@@ D0iD0i?DI DDh^>?D?D?Dqj&@D=۝?~ BE%r?Fno3?~ A,@A:? A, J  J  J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B$@  B DG@ D`܀@ Dr͊8޿Dr͊8?D+;;D&CSNQ?DD?Dw7DcivD?~ BEkkQYv?Fe}#x?~ A"@A_? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B@U@  B DOh?Dc3  D}3y6ӿD}3y6?D f J3Dcӣ?D_ۿD_?D-:Dne?~ BE$rz- ?FcL^M?~ AU@AfJ? A, J J J  A,A?A? !A2 "A!#I1@A7@$ A" A# A" A$ A%A I) A* A+~  B@_@  B" D@ _A DIA D!bYo?D!bYo?D _C@Dn[B??DȿD?Dy)')D?~ BE10 ?F 4ϝ?~ A_@AHfa? A, J& J' J( A,A?A@ !A2 "A)#I@@AB@$ A* A+ A* A, A-A I) A* A+~  B$@  B* D@ D3@ D`{ͿD`{?D.-Dz+G?D@D@DXEZ@Dv/@~ BEn!?F J? J@ A, A  A  !A2 "AA#I0@A9@$ AB AC AB AD AEA I) A* A+~  B$@  BB D~@ D@ DS/FѠ?DS/FѠ?D1Gl@DRZS^?D1D1?D DpF?~ BE$7Ty?FUvC?~ A"@A ? A, JF JG JH A,A?A? !A2 "AI#I@A@$ AJ AK AJ AL AMA I) A* A+~  Bd@  BJ D? A D A DGtaR#ÿDGtaR#?Dbo$D? A, JN JO JP A,A?A@ !A2 "AQ#IA@AF@$ AR AS AR AT AUA I) A* A+~  BA@  BR D <@ D`"A D<ÅG @D<ÅG @D=g0 w@DP{@D_4R@D_4R@DtɦQx@D@j@~ BEc?FH!?~ AA@A(t? A, JV JW JX A, A  A  !A2 "AY#I @A$@$ AZ A[ AZ A\ A]A I) A* A+~  B9@  BZ D@~  Dh@ DG"aEDG"aE?D4=D}~?DD?DD8ABD['^#Q?~ BEvK] ?FEo];&?~ A8@A? A, J^ J_ J` A,A?A? !A2 "Aa#I@A @$ Ab Ac Ab Ad AeA I) A* A+~  B$@  Bb D@ Du@ Dm%?Dm%?D(r]@D?QΈ@D?D?Dy_U@D˭_2?~ BE#Wdr=?F ꉶ?~ A"@A?~,}? A, Jf Jg Jh A,A?A@ !A2 "Ai#I @A @$ Aj Ak Aj Al AmA I) A* A+~  BI@  Bj D@uA DY5A D/h'?D/h'?D?;RJ@DtGQl?D?D??DD-?~ BE/ us?FѮ?~ AH@Aޒ? A, Jn J Jo A, A  A !A2 "Ap#I&@A.@$ Aq Ar Aq As AtA I) A* A+~  B@P@  Bq D A D UA DR("QӿDR("Q?D2D"Ä?D_*uտD_*u?Dp񆜼4DvI#>]?~ BEN`?F6G>? ?~ AP@A _X? A, Ju Jv J A,A@A@ !A2 "Aw#I*@A0@$ Ax Ay Ax Az A{A I) A* A+~  BD@  Bx DE)A~  D?, D3I؟?D3I؟?D*nn@DDO@Y?D?D?DIEߟ;@D;k?~ BEJR6?FSP?~ AC@AA=? A, J| J} J~ A,A?A? !A2 "A#I @A&@$ A A A A AA I) A* A+~  BA@  B~  DOd  D+A D[ܹڿD[ܹ?Dv"{#9De]?DuпDu?DȽߪ,T0DՅ=X?~ BE;Rv?F%?~ BEx4?FtYQ?~ A@[@AD)c? A, J J J A,A?A@ !A2 "A#I@@AG@$ A A A A AA I) A* A+~  B`@  B D@%@~  D7 D{?D{?D [E S]@D"hb@Dl$?Dl$?D!?D0V-?~ BEwvY?F 뭞Al?~ A`@A:( ? A, J J J A,A?A? !A2 "A#I@@AG@$ A A A A AA I) A* A+~  B>@  B D@A D A DG !?DG !?D+lpL@D 7?D?D??Dl@D∫?~ BE.v?FSP?~ A=@A1 ? A, J J J A, A   A  !A2 "A#I@A$@$ A A A A AA I) A* A+~  BA@  B D@G3A D@A D7e?D7e?DT#ЋP@Dhc?DgDg?D %oID_q?~ BE)?F HOQ?~ AA@A~ѷ? A, J J J A,A?A? !A2 "A#I"@A$@$ A A A A AA I) A* A+~  B4@  B      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrsuvwxyz{|}~ DkA D `@ DӂDӂ?DJ=DI)-%?~ BEU?F;0?~ A8@AkY? A, J J J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  BN@  B D@@ D7A DLz\?DLz\?D,sK@D:ݞO?D R$?D R$?D^pƸ@DZ&?~ BE)?F(?~ AM@A>fC? A, J J J A,A?A? !A2 "A#I.@A5@$ A A A A AA I) A* A+~  B4@  B D.m@ D;]@ D!ЦͿD!Ц?Ds;-D);?DؿD?D,Gw7Dwm}?~ BEy\YM?F>?~ A3@AG>R? A, J J J A,A?A? !A2 "A#I"@A$@$ A A A A AA I) A* A+~  B>@  B D@ A~  DJ@ D:fD:f@Dߟ4/SD/쁭?D>?D>?DHN@D2.?~ BE xl?F./M?~ A=@AS? A, J J J A,A?A@ !A2 "A#I"@A&@$ A A A A AA I) A* A+~  B[@  B D#A D@EA DEJti׿DEJti?D-6D7c?DĿD?D:ҍ}$D4G{?~ BE ~v?F{?~ A@[@Awhm? A, J J J A, A  A !A2 "A#I.@A<@$ A A A A AA I) A* A+~  B>@  B D$'@~  D@ D[ ?D[ ?D/Ϧ@DO`Zp?DX?DX?DWi&L@DɌ .?~ BEBz[GL?F`r-V?~ A=@A1z? A, J J J A,A?A@ !A2 "A#I&@A&@$ A A A A AA I) A* A+~  B>@  B D2@ D@ DWʿDW?D1+D ?D窰?D窰?D_*w@D~ӆ?~ BEػb8?F16?~ A=@A!j]? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B>@  B De@ Dq@ DcCӿDcC?D dDc3Do'?DeⲿDe?DZ` @D? g?~ BEty ?F1gC?~ A=@A ? A, Je J~ J A,A@A@ !A2 "A#I$@A&@$ A A A A AA I) A* A+~  BY@  B~  DH D@P@ D iD i?D3`DD'q?D =ͿD =?D}I6J-D;IP?~ BEԛ?F:!M?~ AX@A~t :u? A, J J J A, A  AR !A2 "A#ID@AG@$ A A A A AA I) A* A+~  Bb@  B DWڡ DoX  Dt<S׿Dt<S?DqpR6DE?D?D?D@  B  DA D~.@ DfWDfW?Dj BDĜ'?DD?D5GD9z3%?~ BEֶ2R?F~ ?~ A=@AgY? A, J J J A, A  A !A2 "A#I"@A$@$ A A A A AA I) A* A+~  BK@  B~  D4A DA DͶ8[?DͶ8[?DavP@DVH?D?D?DJ-=Q@DzEA?~ BE -?F?~ AK@AbPa? A, J J J A,A?A@ !A2 "A#I"@A(@$ A A A A AA I) A* A+~  B b@  B~  D D@_A D'>D'>?DqD?D?D?D`m@DL?~ BEJz ?F}?~ Ab@AT? A, J J  J! A,A?A@ !A2 "A"#IA@AF@$ A# A$ A# A% A&A I) A* A+~  BF@  B# DҘDֿ  D` :D` :?D&"@D$E'J?D¼տD¼?DNx4DuCI?~ BE$[uG?F`r-V?~ AF@A['w!? A, J' J( J) A,A?A@ !A2 "A*#I*@A.@$ A+ A, A+ A- A.A I) A* A+~  B9@  B+ D+@ Da@ D.kD.k?D^Z?D`NReI?DD?Dx`SADx?~ BE͏?Fm?~ A8@A6i? A, J/ J J0 A, A  A !A2 "A1#I&@A(@$ A2 A3 A2 A4 A5A I) A* A+~  BI@  B2 DA@ D@ D@.?D@.?D#_a7@D-?DZD?DZD?D{IQ@D#x|?~ BEW?F(?~ AH@A5!? A, J6 J7 J8 A,A?A? !A2 "A9#I,@A5@$ A: A; A: A< A=A I) A* A+~  BR@  B:~  D6H D O8A DRްV?DRްV?DSN`@@DZ)?DvʿDv?D[аD*D%Wo ?~ BE[b?FJ?~ AR@AW˪5? A, J> J? J@ A,A?A@ !A2 "AA#I0@A5@$ AB AC AB AD AEA I) A* A+~  B$@  BB D"@ D`Y@ D6{D6{?DʺHD@}l1?~ BE S?F_|By ?~ A"@AAO@ A, JN JO JP A0~ A?  A !A2 "AQ#I@A@$ AR AS AR AT AUA I) A* A+~  B.@  BR D@8m@ D`h@ DrFN?DrFN?DsQkA7@DD ?D `\?D `\?D.&T7@D%j?~ BE &?FZ\s?~ A,@AA٢? A, JV JW JX A0~ A?  A1 !A2 "AY#I@A@$ Ae Af Ae Ag AhA I) A* A+~  B9@  Be D`@ Dh@ Dՙ!*6ۿDՙ!*6?D\F9Dt-S?D_׿D_?D" ډ6D=ɮ?~ BEo>?Fso?~ A8@At? A, Ji Jj Jk Ag Ah  A  !A2 "Al#I@A@$ Am An Am Ao ApA I) A* A+~  B$@  Bm D H@ Dڅ@ D?D?DBy>@D8 ?DYĿDY?DC_$DL)?~ BECUsx?F(w?~ A"@A;F);>~ AP@AŨ ? A, Jv JD J AFA?A? !A2 "Aw#I@A.@$ Ax AP Ax Ay A;A I) A* A+~  BD@  Bx D#fYD q  D/A&HD/A&H?DrMIDkfw?DD?DL9GD d?~ BEf7s?Fs?~ AC@Aw1u? A, JLJ JM AFA?A@ !A2 "Az#I@A"@$ A{ A| A{ A} A~A I) A* A+~  B>@  B{ DA DKA Dm@FDm@F?D:\Da$G?D?D?D1Լu@D\BT?~ BEjyj=`?FTh=?~ A=@A? A, J J J A A  A !A2 "A#I@A @$ A A A A AA I) A* A+~  BI@  B DA D`A D1)kD1)k?D&b"MDcw#?D?Tɫ?D?Tɫ?D2Fƪ@DV)?~ BEÛ?F? ?~ AH@A?? A, JJ J A,A?A@ !A2 "A#I1@A4@$ A A A A AA I) A* A+~  B.@  B Db@ DE@ D"-%?D"-%?D>+wW@D)C?Dx\?Dx\?D|,kH@DQ`?~ BEQ?FA}V?~ A,@Ak? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BA@  B D-'A DA DjcDjc?D$)/]CDn;7HH?D@D@?D?D^i?~ BE쯟?F޿Jpј?D @?D @?Dy_˨D@DE j?~ BE:;?F?~ BE .9|?Fi п?~ Aq@Aa3"߿? A, J J J A0~ A?  A1 !A2 "A#IC@A@Q@$DGl,,,(2(2,.2((2,(,.22,2(22$$2%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  B9@  B D`1A~  DOv DqjmֿDqjm?Dl˪ 5D/bN?D jD j?D(h0r@Dk[zy?~ BEr-d?Fz D?~ A8@As$? A, J J J A A  A !A2 "A#I$@A$@$ A A A A AA I) A* A+~  B@  B DФ@ D /@ DZ(?DZ(?D(;f@DIM3:@D`Z?D`Z?D4Ir@DX@~ BE iz?F kT?~ A@A? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B4@  B~  Dg D ]@ D D @Db ƯrWD_eȯ?DB@DB@?DBRDhB?~ BEifb?F5&?~ A3@A ? A, J J J A A  A !A2 "A#I @A @$ A A A A AA I) A* A+~  B g@  B~  D DA D+;]}ҿD+;]}?DbpV@%2D֨[1?D׿D?D5M6D_WȮ?~ BEI7 ?FpRd?~ Ag@Ab? A, J J J A,A?A? !A2 "A#I:@AF@$ A A A A AA I) A* A+~  BK@  B D௉ A D` A DcYDcY?DI'ёBD.Q?D;ſD;?D7|&D dvy?~ BE{5?F?~ AK@AN( C? A, J JH J A,A?A@ !A2 "A#I @A(@$ A A A A AA I) A* A+~  BW@  B D 3@ Dস@ D Ǎdq˿D Ǎdq?Dq~+D{?DѿD?D f1D`p$n?~ BEDZB?F <,?~ AW@Aq|? A, J J- J A,A?A @ !A2 "A#I<@A>@$ A A A A AA I) A* A+~  B>@  B D A D ?@ D ]4D ]4?DeK0>D99?D@E?D@E?DROf4@D޺J?~ BEo6z?F{?~ A=@A1D? A, J  J  J  A, A  A  !A2 "A #I"@A$@$ A  A A  A AA I) A* A+~  B4@  B  D@ DP A D.]f?D.]f?Dp@D* @D?D?D67CH@Dh0Uq?~ BEݘO?F/X?~ A3@A4ZV? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B>@  B D`sA~  D_ DUBDUB?DBC DiɯEke?D¿D?D3d"DΓ(?~ BEY?FVi?~ A=@AM&NJ? A, J J J A, A'  A !A2 "A#I@A@$ A A A A  A! A I) A* A+~  BN@  B  DODFd   D!\m D!\m? D-k~K DuiY? D D? DԳK Dٙ~?~ B E؏? FQn aJ?~ AM@ AYt? A, J J  J  A, A?A@ !A2 "A" #I@A*@$ A# A$ A# A% A& A I) A* A+~  B^@  B#  D69DOf_   D"4 D"4? DH D䀢#? Dhl Dhl? D˔Y= DUIk?~ B E5 s? Fl0'ኜ?~ A]@ AXe,? A, J J  J A, A?A@ !A2 "A' #I&@A>@$ A( A) A( A* A+ A I) A* A+~  Bp@  B(  DcA  D A  DI DI? D AՍ=E D!%g? D@$  D@$ ? DKZLB Df|J?~ B E1^a? F_(Q?~ Ap@ AaW? A, J, J* J- A, A?A? !A2 "A. #I5@AL@$ A/ A0 A/ A1 A2 A I) A* A+~  B`c@  B/~  D*  DMTA  DJN? DJN? Dg:Z1@ DN? Dr? Dr? DԓbR@ DĦ5?~ B E 0P^? F`'Q?~ A@c@ A Fd? A, JO J* JQ A, A?A? !A2 "A3 #I1@AD@$ A4 A5 A4 A6 A7 A I) A* A+~  B>@  B4  D3@~  Dl@  DԦG? DԦG? DwJ;@ D34&x]? D D? D L D $m?~ B E+? Fn#?~ A=@ A΅"? A, J8 J9 J A, A?A? !A2 "A: #I@A@$ A; A< A; A= A>A I) A* A+~  BF@  B; DrC D3  DEu[DEu[?D@*NDC?DD?D0KDA?FZhtp?~ AF@Ar? A, J J  J A,A@A@ !A2 "A?#I@A"@$ AI AJ AI AK ALA I) A* A+~  BW@  BI D @D,{D?~ BEnh?Fzg?~ AW@A? A, JM JN JO A,A?A@ !A2 "AP#I(@A6@$ AQ AR AQ AS ATA I) A* A+~  B4@  BQ DAA DA DDP?DDP?DqqK1E@Dl$?D i?D i?DƠC>@D`H?~ BE5v?F60?~ A3@A8a`J? A, JU JV JW A, A  A  !A2 "AX#I@A@$ AY AZ AY A[ A\A I) A* A+~  BF@  BY D^@ D A D?@D?@D~-!@D@DC?DC?D(G0@D?К?~ BEԶ?FJ?~ AF@AE ʼV? A, J] J^ J_ A,A?A@ !A2 "A`#I*@A*@$ Aa Ab Aa Ac AdA I) A* A+~  B>@  Ba D@/A~  D. DqBֿDqB?DdF6=5D &)?D߶׿D߶?D6DYQ`?~ BEMv?F)wM_?~ A=@ASkY!? A, Je Jf Jg A, A  A !A2 "Ah#I@A@$ Ai Aj Ai Ak AlA I) A* A+~  BI@  Bi~  D7[- D5X5A D cܿD c?D&&x:Dxsܥ?D?y?D?y?D9P`J@DAf?~ BEiKP?Fh+a?~ AH@At0=Ea? A, Jm J" Jn A,A?A@ !A2 "Ao#I@A$@$ Ap Aq Ap Ar AsA I) A* A+~  B4@  Bp D @ D`_8@ D/lD/l?D$GD0a?D>D>?D`7IDַ> ?~ BE/*?FWF?~ A3@AjΒj? A, Jt Ju Jv Aw A  Ax !A2 "Ay#I&@A&@$ Az A{ Az A| A}A I) A* A+~  B$@  Bz Df@ D@"@ DqObq8DqObq8?DvED.ztC?DfDf?DQD$L?~ BEw?FPS?~ A"@A:r? A, J~ J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BK@  B D MA Do A Dfb<DfbHͿD@>H?DS-DVeN?~ BE"E ?F1gC?~ A3@A+? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B4@  B DH@ DA D9W8@D9W8@DWM@Dm=m@Dt,?Dt,?D+V@DA?~ BE3#?F)_?~ A3@A&ΗX? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B D ^@ D e@ DD?D!^MD!y4?DHDH?D;1PDL]eYg?~ BEkIDM?FJXY?~ A8@A$Zc? A, J J J A,A?A@ !A2 "A#I@A @$ A A A A AA I) A* A+~  BV@  B D`A DA D?D?DAގ39@D;??D?D?D[*&'@Ds!J?~ BEgUA?FKh?~ A@V@AQ &Н? A, J J J A,A?A@ !A2 "A#I1@A8@$ A A A A AA I) A* A+~  B@  B D@ D@iR@ D}vYc?D}vYc?Dp( NE@Dk!V?D??D??D$ @D@@3W?~ BEڦ?F3I?~ A@A1}? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B$@  B D@@ D` @ D!VD!V?D;ED͋Qš?DͿD?D,P-D*Ō9?~ BE=?Fn?~ A"@Am? A, J Jc J A, A  A  !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B Dy@ Dr>@ D}0z?D}0z?DMQO\@D`0$@DZ@DZ@D5%Fu@DUV|@~ BEwf?F^nˮl?~ A,@AXz? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B D=A DA D'f  οD'f  ?Dh%;@?%;@ A A A A A A I) A* A+~  B4@  B  D,@  D`@  D|b? D|b?? DdyDI DaZ%ߧ? D D? D4+q= D$=f"?~ B E " ? Fob?~ A3@ AtFT5? A, Jc Jc Jc A, AA !A2 "A #I@A@$ !A !A !A !A !A!A !I) !A* !A+~ ! B.@ ! B! D`@! DK@! D@!D@?!D _pwXA!D3=?!D2!D2?!Dy.RA!Dt?~ !B!Er c?!F:ܓ?~ !A,@!AU:(\? !A, !J !J !J !A,!A?A? !!A2 !"A!#I@A@$ "A "A "A "A "A"A "I) "A* "A+~ " BF@ " B" D XA" Di A" D zg 0?"D zg 0?"D\?@"D?)?"D??"D??"D:&@"D`?~ "B"E̍|?"F?~ "AF@"A*? "A, "J "J "J "A,"A?A@ "!A2 ""A"#I,@A0@$ #A #A #A #A #A#A #I) #A* #A+~ # B4@ # B# D@# DM@# DnhR?#DnhR?#D> .?#D,E$?#D,#D,?#DoM0I#D|+?~ #B#E>?#F?~ #A3@#A} (g? #A, #J #J #J #A,#A?A@ #!A2 #"A##I@A"@$ $A $A $A $A $A$A $I) $A* $A+~ $ B.@ $ B$ D[D $ DC)[߽$DC)[߽?$D 8@O$D0C~?$D @<߿$D @@$ &A &A &A &A &A&A &I) &A* &A+~ & BD@ & B& D`"A& DjuA& Dq)*&Dq)*?&D ߳L4L&D|8?&D&D?&DEf0tѿ(D>0t?(D%W߃1(Do.(e?(D ?(D ?(D/+gl@(Dlm @~ (B(EZg?(F%p6X?~ (A3@(A[,#G!? (A, (J (J (J (A (A ( A (!A2 ("A(#I@A@$ )A )A )A )A )A)A )I) )A* )A+~ ) B^@ ) B) DG{2Dw7 ) DY>ܱ?)DY>ܱ?)D;_ό$@)DTx?)D_8)D_8?)D³+U!)DŜ&?~ )B)Eˤ?)F*?~ )A]@)Aza8? )A, )J )J )J )A,)A?A? )!A2 )"A)#I*@A:@$ *A  *A! *A  *A" *A#*A *I) *A* *A+~ * B$@ * B * DL@* D @* D CO?*D CO?*DXA@*Dxý?*D@΀?*D@΀?*D2@*DHm|?~ *B*Ey7AXA?*FA+ D @ - B7- D > A~ - DWR- D7.;G?-D7.;G?-DkzQ]#E@-D_Z?-D@%?-D@%?-D JnB@-Du G?~ -B-E6k۟?-Fgn2?~ -A=@-A$|-#I@A@$ .A? .A@ .A? .AA .AB.A .I) .A* .A+~ . B.@ . B?. D@. Ds@. D?.D?.Da78@.DeW?.D׿.D?.D(H]p2D*h>p?2Dy.A2Dۋ?2Dul2Dul?2DDgο2Dy(K?~ 2B2E!`W?2F?~@?~ 2A3@2Aj8,? 2A, 2J[ 2J\ 2J] 2A, 2A 2 A 2!A2 2"A^2#I@A@$ 3A_ 3A` 3A_ 3Aa 3Ab3A 3I) 3A* 3A+~ 3 B.@ 3 B_3 D8f@3 D {@3 Dt6a?3Dÿ3D?3D>ˣqc$3Daߓ?~ 3B3E~55d?3F(ݧo?~ 3A,@3A.n\? 3A, 3Jc 3Jd 3Je 3A,3A?A? 3!A2 3"Af3#I$@A$@$ 4Ag 4Ah 4Ag 4Ai 4Aj4A 4I) 4A* 4A+~ 4 BF@ 4 Bg4 D@@4 D f@4 DpT }4DpT }?4D$i-4DKX?4D?P?4D?P?4D. wC$@4D6sY?~ 4B4ES@ 5 Bn5 D+@5 D`@5 D#;\?5D#;\?5Dwf=:@5D{_a*?5D?5D?5D1B FC@5DWq*?~ 5B5EVEx ?5F)_?~ 5A=@5AlGxw? 5A, 5JJ 5Jr 5A,5A@A@ 5!A2 5"As5#I*@A,@$ 6At 6Au 6At 6Av 6Aw6A 6I) 6A* 6A+~ 6 Be@ 6 Bt6 DZN$A6 D`-*A6 DA_V?6DA_V?6DO*)m<@6Dp?6D!?6D!?6DVjn3@6DA ?~ 6B6E$C?6F#^9?~ 6Ae@6AB7? 6A, 6Jx 6Jy 6Jz 6A06A?A? 6!A2 6"A{6#I9@AC@$ 7A| 7A} 7A| 7A~ 7A7A 7I) 7A* 7A+~ 7 B@P@ 7 B|7 DkC@7 DA0@7 Dr*47Dr*4?7DsQ7Do6?7D߅1?7D߅1?7DotA@7D0lz?~ 7B7E#EJ%?7FYÚ?~ 7AP@7Az6 WY? 7A, 7J 7J 7J 7A,7A?A@ 7!A2 7"A7#I3@A8@$ 8A 8A 8A 8A 8A8A 8I) 8A* 8A+~ 8 B$@ 8 B8 D z@8 D@8 Duݿ8Du?8DSѷC;8D`&?8D޿8D?8DZ;l<8DT]f?~ 8B8E݆`?8F~ ?~ 8A"@8A30)? 8A, 8J 8J 8J 8A,8A?A? 8!A2 8"A8#I@A@$ 9A 9A 9A 9A 9A9A 9I) 9A* 9A+~ 9 BN@ 9 B9 D@9 D`z@9 DH?9DH?9D؜^M@9D02p?9DQ?9DQ?9DQY*@9DN'?~ 9B9E{oh>?9F`r-V?~ 9AM@9AB? W? 9A, 9J 9J 9J 9A,9A?A@ 9!A2 9"A9#I*@A0@$ :A :A :A :A :A:A :I) :A* :A+~ : B@_@ : B: D@' A: D VA: Dz@ ; B; D0gA; D%A; DSu=ҿ;DSu=?;DlU/2;Dv.?;D@;D@?;D+1!;Dfnwb?~ ;B;E1"OO?;Fiz?~ ;A=@;Aï?/? ;A, ;J ;J ;J ;A,;A?A@ ;!A2 ;"A;#I@A"@$ <A <A <A <A <A<A <I) <A* <A+~ < B9@ < B< D A< D @< D:ݿ<D:?<D;<D?ɐ9#?<D`8?<D`8?<DO-53@<DpTa?~ <B<EEƒ?<FJ ž'?~ <A8@<A۵ԓi? <A, <J <Jc <J <A, <A < A  <!A2 <"A<#I@A@$ =A =A =A =A =A=A =I) =A* =A+~ = BD@ = B= Dy A= D A= DR%(p?=DR%(p?=D?=D̽2 ?=D!=D!?=D,H=D:nh ?~ =B=Ek%?=Fc%,b?~ =AC@=A{l0? =A, =J =J =J =A,=A?A@ =!A2 ="A=#I"@A(@$ >A >A >A >A >A>A >I) >A* >A+~ > BR@ > B> D@A> D:A> Dܿ>D?>Dc;-:>Dy[|b?>D>D?>DjUA>D}Q1{ ?~ >B>E:ϩ?>F˸ ?~ >AR@>A3xD? >A, >J >J >J >A, >A > A  >!A2 >"A>#I:@A@@$ ?A ?A ?A ?A ?A?A ?I) ?A* ?A+~ ? BQ@ ? B? D ;A~ ? D`5A? D+sؿ?D+s??D D`7?DЄ??D?D??D3~ZJ?D:T?~ ?B?Ej9rCA??FJr?~ ?A@Q@?A8pT? ?A, ?JC ?JD ?JE ?AF?A@A? ?!A2 ?"A?#I @A1@$DGl$,,,$,(22(2(22.,2,,,,,,2,2@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A @A! @A @A @A# @A @I) @A* @A+~ @ B[@ @ B@ D^xD" @ DPChFſ@DPChF?@D.So%@D)i!{?@DF@DF?@DўI@D(r ?~ @B@EL(I.4?@F盲9g?~ @A@[@@A2$? @A, @JJJ @AF@A?A? @!A2 @"A@#I@A9@$ AA AA AA AA AAAA AI) AA* AA+~ A B\@ A BA DB%D2| A DF1 ADF1 ?ADEs9PADE9 ?AD`AD`?AD#w!FAD;n ?~ ABAEt />AFUgeg >~ AA\@AA[=3? AA, AJ AJ AJ AA,AA@A? A!A2 A"AA#I"@A;@$ BA BA BA BA BABA BI) BA* BA+~ B B$@ B BB D @B D@5@B D-qBD-q?BDdBDhb?BD^K?BD^K?BD^#@BDm#?~ BBBEeu1?BF(?~ BA"@BA}^? BA, BJ BJ BJ BA9 ~ BA? B Ac B!A2 B"AB#I@A@$ CA CA CA CA CACA CI) CA* CA+~ C B$@ C BC D@O@C D@C D{ȉ?CD{ȉ?CD.O@CDی;?CDۿCD?CD#:CDpo ?~ CBCE]rb6?CF 4ϝ?~ CA"@CA7j3f? CA, CJ CJ CJ CA CA C A C!A2 C"AC#I@A@$ DA DA DA DA DADA DI) DA* DA+~ D BF@ D B~ D DK D D3AD D\W<ֿDD\W~ EA `@EA y? EA, EJ EJ EJ EA,EA@A? E!A2 E"AE#I$@A>@$ FA FA FA FA FAFA FI) FA* FA+~ F BF@ F B~ F D;F D*ѿFD|>?FD.) 1FDm?~ FBFEЧ]#?FF:!M?~ FAF@FAʭM? FA, FJ FJ FJ FAFFA?A? F!A2 F"AF#I@A$@$ GA GA GA GA GAGA GI) GA* GA+~ G BF@ G BG DAG D@@G DE3GDE3?GD\UbCGDT;\?GD್пGD್?GD%ҷi0GDAs?~ GBGEN?GFШU?~ GAF@GAJB!? GA, GJ GJ GJ GAr GAs G Am G!A2 G"AG#I(@A(@$ HA HA HA HA HAHA HI) HA* HA+~ H B$@ H BH D`c@H D`@H Dox?HDox?HD kN@HDEl'?HDUT?HDUT?HDcG*]M@HD qe?~ HBHEQ s,?HF ?~ HA"@HA{~@)? HA, HJ HJ HJ HA9 ~ HA? H AR H!A2 H"AH#I@A @$ IA IA IA IA IAIA II) IA* IA+~ I BK@ I B~ I DuI D[AI D;dBID;dB?ID1G@DIDq ?ID5ID5?ID4L@IDQڑ?~ IBIEiyѥ?IF]g#t?~ IAK@IA>.`? IA, IJJJ IAFIA?A? I!A2 I"AI#I"@A,@$ JA JA JA JA JAJA JI) JA* JA+~ J B$@ J BJ D7 @J D@@J Dy3eAֿJDy3eA?JD8撝-k5JD61 b%?JD $?JD $?JD?Hja@JDF L%@~ JBJEX?JFT4?~ JA"@JAO5X,? JA, JJJJ JAFJA?A? J!A2 J"AJ#I@A@$ KA KA KA KA KA KA KI) KA* KA+~ K BF@ K BK D35AK D AK D|CTN?KD|CTN?KD_ؑ &@KD$g?KDKD?KD%#i!KDn76?~ KBKE~6@LDRFSR?LD6?LD6?LD`\I@LDQDA?~ LBLE}vyY?LFC?~ LAF@LA`,*? LA, LJ LJ LJ LA0~ LA? L A L!A2 L"AL#I&@A&@$ MA MAh MA MA MAMA MI) MA* MA+~ M B4@ M B~ M Dv8M D ?AM DAȿMDA?MD-FYqf(MDF?MDġMDġ?MDmMDrI=?~ MBME}F?MFѾ'?~ MA3@MA!<]? MA, MJJJ MAFMA?A? M!A2 M"AM#I@A@$ NA NA NA NA  NA!NA NI) NA* NA+~ N B$@ N BN D@/@N Ds@N DtTNDtT?ND$O.PND̛?ND_VND_V?ND@]IND2ˬO?~ NBNE8X?NF|[?~ NA"@NAԃ? NA, NJ" NJ# NJ$ NA9 ~ NA? N A[ N!A2 N"A%N#I@A@$ OA& OA' OA& OA( OA)OA OI) OA* OA+~ O B4@ O B&O D @O Dh@O DKӇ?ODKӇ?ODs@ODY?ODH?ODH?ODHz5;-S@ODdE?~ OBOE O?OFH?~ OA3@OA,u? OA, OJ* OJ+ OJ, OAg OAh O Ah O!A2 O"A-O#I@A @$ PA. PA/ PA. PA0 PA1PA PI) PA* PA+~ P B$@ P B.P D`H[@P D`Y[@P DlŠ=ֿPDlŠ=?PD@6g5PDh&?PDPD@PD{xdtRPDX0?~ PBPE짲?PF\] ?~ PA"@PA-? PA, PJ2 PJ3 PJ4 PA9 ~ PA? P A5 P!A2 P"A6P#I@A@$ QA7 QA8 QA7 QA9 QA:QA QI) QA* QA+~ Q BI@ Q B7Q D@[@Q Dգ@Q Dj#^?QDj#^?QDiX7@QDPo?QD ;?QD ;?QD^h@QDRh6W?~ QBQEs?QFUT+?~ QAH@QAU)? QA, QJ; QJ< QJ= QA; QA< Q A< Q!A2 Q"A>Q#I(@A*@$ RA? RA@ RA? RAA RABRA RI) RA* RA+~ R B.@ R B?R DPh@R D @R D)BNԿRD)BN?RDY3RDicY?RD{RD{?RDߚ+GRD*~m?~ RBREqUDw?RFXwz#?~ RA,@RAp? RA, RJC RJD RJE RA9 ~ RA? R A[ R!A2 R"AFR#I@A@$ SAG SAH SAG SAI SAJSA SI) SA* SA+~ S B.@ S BGS D`_u&AS D%AS D[_F?SD[_F??SDkigSD44 ?SDLi?SDLi?SD]3d@SD%^:[@~ SBSE>&?SFN-I?~ SA,@SAjz? SA, SJK SJ. SJL SAg SAh S A  S!A2 S"AMS#I@A@$ TAN TAO TAN TAP TAQTA TI) TA* TA+~ T B$@ T BNT Dx̶@T D@T DE*a\?TDE*a\?TD/ZK@TDyj?TDI?TDI?TDbƉM@TDW!!?~ TBTEMDN?TF`X?~ TA"@TA >)? TA, TJR TJS TJT TA, TA T A T!A2 T"AUT#I@A@$ UAV UAW UAV UAX UAYUA UI) UA* UA+~ U BN@ U BV~ U D` -AU D-AU D>?UD>?UD{HYF%R6?~ YA\@YAZųo? YA, YJ YJ  YJz YA,YA?A@ Y!A2 Y"A{Y#I @A8@$ ZA| ZA} ZA| ZA~ ZAZA ZI) ZA* ZA+~ Z BV@ Z B|Z DꢕD  Z D%ZpbZD%Zpb?ZDd {tKZD?Au?ZD-޿ZD-?ZD͵FF<ZDeJ?~ ZBZE ӑ?ZF1ǪK?~ ZA@V@ZAlYE/? ZA, ZJ ZJ  ZJ ZA,ZA?A@ Z!A2 Z"AZ#I"@A7@$ [A [A [A [A [A[A [I) [A* [A+~ [ B4@ [ B[ D 9A[ DmfA[ D8'?[D8'?[DMãKM@[D]4L?[Di?[Di?[Dኙ"J@[DR\?~ [B[En3?[F)2 ?~ [A3@[ArŸ? [A, [J [J [J [A,[A?A@ [!A2 ["A[#I@A@$ \A \A \A \A \A\A \I) \A* \A+~ \ BK@ \ B\ DA\ DlA\ D ˰¿\D ˰?\DEbC#\D?\DIƿ\DI?\D"Ƃ'\D5[O?~ \B\EK1?\FRGz?~ \AK@\AgDP? \A, \J \J \J \A,\A?A? \!A2 \"A\#I*@A0@$ ]A ]A ]A ]A ]A]A ]I) ]A* ]A+~ ] BR@ ] B] DTA] DA] D1?]D1?]DMhk&@]DM1E?]D]D?]D}h]DnQ!?~ ]B]E Q%s?]Fw=Iren?bF'Z ?~ bAS@bA]N+? bA, bJ bJ bJ bA,bA?A@ b!A2 b"Ab#I6@A:@$ cA cA  cA cA cAcA cI) cA* cA+~ c B>@ c Bc D@Ac D`wAc DJDcDJD?cD @ocDQ4?cDBؿcDB?cDQ47cDX"?~ cBcENjH?cFXZ?~ cA=@cAM܆? cA, cJJJ cA,cA?A? c!A2 c"Ac#I@A@$ dA dA dA dA dAdA dI) dA* dA+~ d BV@ d Bd D&ADFe d DlbdDlb?dDktPFdDik?dDdD?dDE3BdDA?~ dBdEe2(?dFFV?~ dA@V@dAaTZ? dA, dJ dJ  dJ dA,dA?A@ d!A2 d"Ad#I@A3@$ eA eA eA eA eAeA eI) eA* eA+~ e B.@ e Be D@'@e DM@e D M?eD M?eD~%6O@eD{z ~?eD?eD?eDd3Q@eD; sd?~ eBeElq>?eF r?~ eA,@eA^*ȸ? eA, eJ eJ eJ eAV~ eA? e A e!A2 e"Ae#I@A@$ fA fA fA fA fAfA fI) fA* fA+~ f B>@ f Bf D@eAf DJ@f D&QH!fD&QH!?fDޱ}MfDO?fD?fD??fDIfDPC?~ fBfE?撸Ɉ?fF ?~ fA=@fAdgL? fA, fJ fJ fJ fA, fA f A  f!A2 f"Af#I@A"@$ gA gA gA gA gAgA gI) gA* gA+~ g B.@ g Bg DAg Dm@g D4gD4@gDl9VgDi?gDgD?gDlRgD0<7F?~ gBgEX?gF4,?~ gA,@gA(SH m? gA, gJ gJ gJ gA gA g A g!A2 g"Ag#I@A@$ hA hA hA hA hAhA hI) hA* hA+~ h BN@ h Bh D@Ah DAh DdhDd?hDϱ1?hFF6?~ hAM@hA>? hA, hJ hJ hJ hA, hA h A h!A2 h"Ah#I.@A0@$ iA iA iA iA iAiA iI) iA* iA+~ i B9@ i Bi D&@i D`@i D2=ÿiD2=?iDY"xbK$iDX ?iD`?iD`?iDqkx% @iD {?~ iBiE5 ?iFtYQ?~ iA8@iAa'? iA, iJ iJ iJ iA,iA?A@ i!A2 i"Ai#I@A@$ jA jAi jA jA jAjA jI) jA* jA+~ j BN@ j B~ j DGG j D'#Aj D!)?jD!)?jDl.v/@jD1U?jD3?jD3?jDSqq9@jDb\+?~ jBjE;Ճ?jF1?~ jAM@jAjvg? jA, jJJJ jA,jA?A? j!A2 j"Aj#I$@A3@$ kA kA kA kA kAkA kI) kA* kA+~ k BR@ k Bk D@A~ k DWk D.껎?kD.껎?kDfAQ@kDqZRtA tI) tA* tA+~ t BD@ t B;t D At D#At D}?tD}?tD3lY$G@tD&&?tDȿtD?tD4!)tDor\?~ tBtE?tF?~ tAC@tA` \ ? tA, tJ? tJ@ tJA tA, tA t A  t!A2 t"ABt#I @A$@$ uAC uAD uAC uAE uAFuA uI) uA* uA+~ u BF@ u BC~ u Dg3 u DAu DڿuD?uDǨ 8uDPF9:#?uD>ÿuD>?uD F#uD)Yy?wD?A>?wDˉ_;3@wD@h?~ wBwEPMdDk?wF[T?~ wA@Q@wAu]? wA, wJW wJX wJY wA,wA?A? w!A2 w"AZw#I(@A0@$ xA[ xA\ xA[ xA] xA^xA xI) xA* xA+~ x Bn@ x B[x D7+D6G x D T?xD T?xDy`˜O@xD=;Bg?xDuf?xDuf?xD&aF@xD]^S?~ xBxE%VLfx>xFIV?~ xAn@xA—? xA, xJ_ xJ` xJa xA,xA?A@ x!A2 x"Abx#I0@AJ@$ yAc yAd yAc yAe yAfyA yI) yA* yA+~ y B>@ y Bcy D)u@y D@y D6 yD6 ?yD@cyD.?yDaֿyDa?yDLjņ5yDYY?~ yByEjv?yF2{?~ yA=@yAqiXR2? yA, yJg yJh yJi yA yA y A y!A2 y"Ajy#I@A@$ zAk zAl zAk zAm zAnzA zI) zA* zA+~ z B9@ z Bkz D` }Az D` Az D`"zD`"?zD?~ {B{Edk?{Fn?~ {A3@{A=4? {A, {Jw {Jx {Jy {A,{A?A? {!A2 {"Az{#I@A@$ |A{ |A| |A{ |A} |A~|A |I) |A* |A+~ | BD@ | B{| D@A~ | D?n| DEKx?|DEKx?|DIkU@|DE#?|DͿ|D?|D~-|D942E?~ |B|EȕC' ?|F?~ |AC@|AU C? |A, |J |J |J |A,|A?A@ |!A2 |"A|#I@A"@$ }A }A }A }A }A}A }I) }A* }A+~ } BY@ } B} D*D7 } DtP¿}DtP?}Db*W"}Di?}Dҿ}D?}Dɂj{2}D]:w?~ }B}Eċ6?}Fm?~ }AX@}A٬<5? }A, }J }J }J }A,}A?A? }!A2 }"A}#I3@A:@$ ~A ~A ~A ~A ~A~A ~I) ~A* ~A+~ ~ B9@ ~ B~ D"A~ DA~ D_fxU~D_fxU?~DQ,[I~D-&׊?~Dk?~Dk?~D4_@~D90~?~ ~B~E}j?~Fk@#a?~ ~A8@~Aý-? ~A, ~J ~J ~J ~A0~A?A? ~!A2 ~"A~#I@A @$ A A A A AA I) A* A+~  B.@  B D@ D A DJm^x5?DJm^x5?DsOm@D? F=' @DX?DX?D\Y@D\P=@~ BEP~5?Fq/?~ A,@A#? A, J J J AA?A? !A2 "A#I@A@$DGl22222,(,,.2,,,2(,,2,((,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  B$@  B DP@ Dv@ DTjVDTjV?Dw?JD@\hü?D ڿD ?D,U9D'4e?~ BEw?FJ?~ A"@Aaãg/? A, J J J A, A  AR !A2 "A#I@A@$ A A A A AA I) A* A+~  B4@  B Dwb@ D@ Dh8zp?Dh8zp?D"@Dh*\}?DClDCl?DRzo?D@ۈ?~ BE+K?Fc%,b?~ A3@AXj? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B DHA DOA DwȚݿDwȚ?D#:DLX_?D ÿD ?DS9$+$Dw[?~ BEw`?FEڕ0?~ A,@A%c? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BK@  B DK@ D``A D{ tT?D{ tT?D$0O@D8hr?D?\ƿD?\?DbBb'D$B?~ BEc?w|?FJ?~ AK@AE0? A, J J J A,A?A@ !A2 "A#I&@A,@$ A A A A AA I) A* A+~  B4@  B DA DA D?D?DbI>C@Dp}]?D?-?D?-?D1mV@@Dl7FYQ?~ BE\1&?F&ED?~ A3@Al/? A, J J J A, A  A !A2 "A#I$@A&@$ A A A A AA I) A* A+~  B@  B D @ Dtf@ Dvk?Dvk?D}Ii2@DH?D`6?D`6?DnR*M@D*FWJU?~ BEL"?Fm?~ A@Aq? A, J J J A, A  A  !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B D`+@ DQ@ DD?Dj2wIHDj'A u?D﴿D?DOS D mtU? A, J J  J  A0A?A? !A2 "A #I@A@$ A  A  A  A AA I) A* A+~  B.@  B  D@A~  D/w DqGJݡZDqGJݡZ?D |lKDK?DD?D28ڤ@DzF Y?~ BE?1v?F^nˮl?~ A,@AF.l ? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B4@  B D@ D @ D#p?D#p?DCD@D] ?D?D?D Il@Dt9k @~ BEaU?F{ %?~ A3@A !b? A, J J J A; A<  A= !A2 "A#I@A@$ A AP A A  A;A I) A* A+~  B@P@  B~  D D IUA DYDY?DY;1KDx=n0?D@$D@$?D D̃BDuE}O?~ BEW7mBp?F?~ AP@AH2? A, JJJ AFA?A? !A2 "A!#I@A,@$ A- A. A- A/ A0A I) A* A+~  B>@  B- D%A D`KZA D}K ^R׿D}K ^R?D6(R6D6x?D 9D 9?DէDA) ?~ BEK?F}!K*?~ A=@A"[b? A, J1 J2 J3 A0A?A? !A2 "A4#I@A@$ A5 AR A5 A6 A7A I) A* A+~  B9@  B5 D֪%A D`?A Ddh?Ddh?De%Uh@Daƻ0/@D`?D`?DP0rG@DǮ?~ BE)ZC?FiU?~ A8@AW? A, JJJ AFA?A? !A2 "A8#I@A@$ AD AE AD AF AGA I) A* A+~  BN@  BD DV@ D$@ D͡?D͡?DmźV@DK c?Dܧ?Dܧ?D8&cR@D5)?~ BEV}J-s?Fj=?~ AM@ANu? A, JH JI JJ Ag Ah  AK !A2 "AL#I0@A2@$ AM AN AM AO APA I) A* A+~  BF@  BM DA D@o!A D!D5OCF?~ BE+?F&9?~ A3@AH? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  BQ@  B D@  B D}# A~  Db  D%??D%??DJ8M@DoY?DD?D @DU ?~ BE?F|k|?~ A=@A>? A, J J J A,A?A? !A2 "A#I.@A1@$ A A A A AA I) A* A+~  B.@  B D@A D}@ DvCgDvCg?Ds:BD ?DzDԿDzD?Dl[3D3|?~ BE\D?F_TA?~ A,@Ag>? A, J J J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  BT@  B D@ A DA D~?D~?D^@DS@Do?Do?DSTĿPK@D@>?~ BE2 /T?F!%G?~ AS@A8C? A, J J J A,A?A@ !A2 "A#I3@A7@$ A A A A AA I) A* A+~  B>@  B Dp A D A De~0..?De~0..?DA0-5@Dcc{?DkaDka?De$ADb\?~ BE̟]?FL?z?~ A=@Ae? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B@  B D ʑ@ DMM@ DYDY?D!VDD+|x?DWDW?D+CDL?~ BE3tU?FZ{xa?~ A@A? A, J J J A,A?A@ !A2 "A#I@A@$DGl2,2,222,2,2..,.2,2,,(,,,(,,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  BV@  B D :A~  Dg?9 D+ ?D+ ?D{ॺC@Df5P?D@W?D@W?Daޱ@D"{1?~ BEH?Fi?~ A@V@A*6@k? A, J J J A, A  AR !A2 "A#I2@A;@$ A A A A AA I) A* A+~  B9@  B D@@ D`@ D0?D0?De0@Dד?D,]?D,]?Dj/<@D3c?~ BEu4?F )XO?~ A8@AoQ? A, J J J A,A?A@ !A2 "A#I"@A&@$ A A A A AA I) A* A+~  BD@  B D2A D@6(A DS!PbDS!Pb?D ÿD3!\P?D j㓿D j?DWJDeDdt?~ BE+A}_?FM$QN?~ AC@AO? A, J J J A, A  A !A2 "A#I @A$@$ A A A A AA I) A* A+~  B$@  B D@ Dp@ Dѵ(;Dѵ(;?D>WY EDц?D?D??D.eRDBm ?~ BE]?Fȱ`xv?~ A"@A !? A, J J" J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  B@U@  B DHA DTA D+̏⦿D+̏?D=gD?DD?D"D@ D< >nؿD< >n?D[&@7D޾O?D`&ۿD`&?D5X":D?~ BEWz?F;?~ AX@A5.W"? A, J J J A, A  A !A2 "A#I7@A<@$ A A A A AA I) A* A+~  B>@  B D@ D@ DA}R?DA}R?Dĉ?D/>I?D]?D]?D|{g@DG[@~ BE ?F;?~ A3@AFm? A, J J J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  B@  B Dhd@ D g@ DD@D6KvUD $i?D-D-@D>@{XDŏ?~ BEж?F~rr?~ A@A3ZY? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B>@  B D@4A D@j2A DrǾ6?DrǾ6?D%.登@D}q&j?D p?D p?Dކ۹""@D &^}?~ BEFSe?Fb?~ A=@A^`p? A, J  J  J  A0~ A?  A !A2 "A #I@A@$ A  A A  A AA I) A* A+~  B@P@  B  DbnDh  D,9)WɿD,9)W?D[%*Di ?DͿD?D޿-D螙6?~ BEVtr?Fc?~ AP@Amg? A, J J J A,A?A? !A2 "A#I*@A1@$ A A A A AA I) A* A+~  B.@  B D mA D@OA Dw)Dw)?D/LD Eq?D `jvD `jv?D@RD:?~ BE0?F )XO?~ A,@A^(? A, J J J A,A?A? !A2 "A#I@A@$ A A A A A A I) A* A+~  BA@  B D A Dr A D0IL?D0IL?D}3A@Dy'?D}B?D}B?DJI@DiH?~ BEKh;:d?Fz D?~ AA@AҤg&? A, J! J J" A,A?A? !A2 "A##I"@A*@$ A$ A% A$ A& A'A I) A* A+~  BD@  B$ D@A D"A DQ?DQ?D p3E@Dj]?DeDe?D_B>W BD' Ct?~ BEԀKF?FbZHA?~ AC@Al&J0? A, J( J) J* A,A?A@ !A2 "A+#I"@A,@$ A, A- A, A. A/A I) A* A+~  BA@  B, D@A Dt&A DЍ @?DЍ @?D1FQ@DH5?D_g:?D_g:?D*U@DO}?~ BE}"?FbGh?~ AA@Asj? A, J0 J1 J2 A,A?A@ !A2 "A3#I(@A,@$ A4 A5 A4 A6 A7A I) A* A+~  BK@  B4 D`qA D "H@ D;&D;&?DYÑDDz?D ԿD ?DeX\%4D}d[?~ BEHJ?F1?~ AK@As۰*? A, J8 J J A,A?A? !A2 "A9#I.@A5@$ AB AC AB AD AEA I) A* A+~  B>@  BB~  DpG A D.A DpQ3'DpQ3'?D5OѢNDm"j0?Dvm?Dvm?D Ϋ@Dt /?~ BEˆt?F$zd?~ A=@A!? A, JFJ JG A,A?A? !A2 "AH#I"@A$@$ AI AJ AI AK ALA I) A* A+~  B.@  BI D3@ Ds@ Dqu˿Dqu?DCQ,Dկ{ށ?DgؿDg?D?~:7D3{RjQDJ)@?DӿD?D5#5m3DՒ?~ BEKQ?F&HǴ?~ AH@AԵ|~? A, J]J J^ A,A?A@ !A2 "A_#I @A&@$ A` Aa A` Ab AcA I) A* A+~  BN@  B` DA D`T A D]ƩӿD]Ʃ?DDwc.3DSos?D@eD@e?D 닂nNDS?~ BE>Gi?Fۛjw?~ AM@A1Kl]? A, Jd Je Jf A, A  A !A2 "Ag#I"@A.@$ Ah Ai Ah Aj AkA I) A* A+~  BF@  Bh DjWD  DhiDhi?Dg_DD3?D?ޑD?ޑ?DV<Dd2?~ BEy?FUvC?~ AF@A}HX-? A, Jl Jm Jn A, Ah  A  !A2 "Ao#I$@A,@$ Ap Aq Ap Ar AsA I) A* A+~  B\@  Bp D -,A~  D D=hl.ʿD=hl.?Do*DG/?DտD?DӠ4DzO?~ BE맠@Y?FRU1?~ A\@AI1B8? A, Jt J Ju A,A?A@ !A2 "Av#I8@AA@$ Aw Ax Aw Ay AzA I) A* A+~  B9@  Bw D@@ D?@ Dt.p}ݿDt.p}?Du%:W;DKUZV?@?D_ne¿D_ne?DHj"D??~ BEa?Foـ?~ A8@AXpP$? A, J{ J| J} A,A?A? !A2 "A~#I @A$@$ A A A A AA I) A* A+~  BQ@  B D ,a A DA DОɿDО?Dk)D~?D x?D x?DtZs@@Dl1_?~ BEa)3?F_']?~ A@Q@AP? A, J J8 J A,A?A@ !A2 "A#I*@A1@$ A A A A AA I) A* A+~  BK@  B DA D`A Dȓ}&?Dȓ}&?DئD@D\ 6k?D_pD_p?Dp7WMCD x憊?~ BE+UIC?F[qx?~ AK@A;u,1? A, J J J Ag Ah  Ah !A2 "A#I"@A.@$ A A A A AA I) A* A+~  B9@  B D`EA D@ A D#l޿D#l?D gAL;D2?D ,ϿD ,?DUpP/DlN?x?~ BEQ\?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuwxyz{|}~DD?DlM2QD?~ BE+Iqy?F?~ A,@Ah-? A, J J J A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B D F@ D ?@ DxDx?DNWCAD||?DD?D7-@D^Ѭ*?~ BE0?F*U?~ A,@A ? A, J J J A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B DZ(@ DA @ Dx?Dx?D,+!E@Ds?D_`¿D_`?Di2"DW/?~ BEW?Fj"A?~ A,@A-ެ? A, J J J A0A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  BN@  B DoD  DzeDze?DvDIDiMrV'?D#D#?D9BDo2#?~ BE@d|H?F!kb?~ AM@A ? A, JC JD JE AFA?A? !A2 "A#I@A(@$ A A A A AA I) A* A+~  B$@  B D|@ Dɘ@ Dy?Dy?DbLJP @DE9?D ?D ?Dk&?D!6?D!6?DQrx8@DgO?~ BEb?FTb?~ A@Ai5? A, J J J Ag Ah  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BD@  B D A D@A Dp?Dp?DV. G@Dw⚿``?Dj?Dj?Dr}2L?DֱM?~ BEQM?FO?~ AC@AEN:? A, J J J Ag Ah  A  !A2 "A#I@A$@$ A A A A AA I) A* A+~  B9@  B D A D@ DD?D#\RD [$?D`\D`\?Dñ#*JRDa-?~ BE6j!6=?F4wBp?~ A8@A0IG? A, JC JD JE AFA?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  BF@  B D2OXA~  D+X D%KaD%Ka?DZDDz6?Du׿Du?Drh'p6DuY ?~ BEYƟ?FO `?~ AF@A)q'y? A, J J J AFA@A? !A2 "A#I@A&@$ A A A A AA I) A* A+~  BT@  B DkhDG  D }jD }j?Dm?DOq?D ߿D ?DB2Id<DLe?~ BEcX?F>?~ AS@A,B? A, J J J AFA?A? !A2 "A#I@A1@$ A A A A AA I) A* A+~  B.@  B~  D<A D@fA D??D??DjeAڢc@Dkw/@Dk鷱?~ BE{l]?FȬ?~ A"@A? A, J J J A9 A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B D@A D@A DtE?DtE?DI(:PL@D*!6?DU?DU?D3@Dowr#?~ BE[r?F Hg?~ A,@A%Wk)? A, J J J A0~ A?  A1 !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B DDW@ D@ DrX?DrX?DݻqQ@DHFO4b?D ?D ?Dn_B@Du ?~ BE 2>?FYt?~ A,@A? A, J; J; J; A; A  A !A2 "A#I @A @$ A A A A AA I) A* A+~  B.@  B D@ 8@ D™@ Djq|?Djq|?D<@(4@D̕V?D`D`?DBD?~ BEw?F7ك?~ A,@Ao;v? A, J J  J! A0~ A?  A !A2 "A"#I@A@$ A# A A# A$ A%A I) A* A+~  B4@  B# DD6-  DCr- ?DCr- ?D{@DG?DHy?DHy?D̫yB0c@DyYb H@~ BEA  D6apCпD6apC?DZF/D$?D_#D_#?Ds@4@DMO?~ BE$؞u:?FEkE5?~ AC@AZz? A, J+ J, J- Ag~ A?  A. !A2 "A/#I@A&@$ A0 A1 A0 A2 A3A I) A* A+~  B$@  B0 D @ D @ DkhF8޿DkhF8?D򝧾\<DLqxם?D0?D0?D1@Day؂?~ BEn7?F`MK?~ A"@A3? A, J4 J5 J6 Ag Ah  Ah !A2 "A7#I@A@$ A8 A9 A8 A: A;A I) A* A+~  BF@  B8 D`JIA~  DO2  D{gSu4?D{gSu4?D&qĶ/ '@Dj?DZĿDZ?D< $D՟?~ BE^?@?FOM?~ AF@Araңh? A, J< J= J> A,A?A@ !A2 "A?#I2@A4@$ A@ AA A@ AB ACA I) A* A+~  B$@  B@ Di`@ D@>@ Dn@._?Dn@._?D@A@D[ k?D[?D[?D4@D*r$8O?~ BEOτh?F`X?~ A"@A` ? A, JD JE JF A,A?A? !A2 "AG#I@A@$ AH AI AH AJ AKA I) A* A+~  B@  BH DD@ D `Oœ@ DzIC2?DzIC2?D([s @D\ɹP?D@`@D@`@Dov@Dz[@~ BE՛?Fm?~ A@A;u? A, JL JM JN A, AO  AP !A2 "AQ#I@A@$ AR AS AR AT AUA I) A* A+~  B.@  BR DS@ Dj@ Dݧ$ڿDݧ$?D1>IC8D?DKܿDK?DYJe:D|ɺ?~ BE ?FSP?~ A,@A x0!? A, JV JW JX A,A?A? !A2 "AY#I@A@$ AZ A[ AZ A\ A]A I) A* A+~  BN@  BZ D@w.A D G3A Dfc{?Dfc{?D8@D b E?D'?D'?DO:?@D7/?~ BE D u?FXa?~ AM@AEk? A, J^ J_ J` A,A?A? !A2 "Aa#I"@A,@$ Ae Af Ae Ag AhA I) A* A+~  B`c@  Be DתA~  D.Z DWp*DWp*?D GD|k?D pD p?Dtx /KBD`'+J?~ BEd2k>Fbþ?~ A@c@Am0)? A, Ji J Jj A,A?A@ !A2 "Ak#I*@A@@$ Al Am Al An AoA I) A* A+~  B@  Bl D>@ D@b@ D={hD={h?D 4KDRS?DiDi?D9@DYV?~ BEg?Fw?~ A@A ? A, Jp Jq Jr AVA?A? !A2 "As#I@A@$ At Au At Av AwA I) A* A+~  B4@  Bt D@ D@@ DytB?DytB?D݄$H@D+zS|5?Dߢ?Dߢ?D})uT@Di$*?~ BE[E?Fm?~ A3@AFo>? A, Jx Jy Jz A, A  A !A2 "A{#I&@A(@$ A| A} A| A~ AA I) A* A+~  BD@  B| D dA D@,A D'oJ8?D'oJ8?D(J@D!^0?D3?D3?D&6t:Q@D?~ BEEH?F4f?~ AC@A“zl? A, J J J Ag Ah  A  !A2 "A#I @A @$ A A A A AA I) A* A+~  B4@  B D@=@ D VA DaY?DaY?DF'J@D?D ~4?D ~4?D'@DC~?~ BE7*}?Fso?~ A3@A q? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B@  B D@ D"@ D隋տD隋?Dc4D >W?D `G?D `G?D\i3)@DͰ?~ BEh?F tA?~ A@AC? A, J J J A, A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  BD@  B D A D`%A DW*9?DW*9?Dk5 R@D1)#A?DIt?DIt?DK%Q,@D2_C?~ BEA-)?FE?~ AC@A4i\E>? A, J J J A,A@A@ !A2 "A#I*@A0@$ A A A A AA I) A* A+~  BD@  B D A D"A D~Ͻ-?D~Ͻ-?Dz4t4e@D_(6@D@?D@?DyZ@D]x0|@~ BEl\f?FTLO?~ AC@AA|~? A, J J J A,A?A@ !A2 "A#I @A"@$ A A A A AA I) A* A+~  BV@  B DD5A~  DB Dj5SٿDj5S?D"s7DR?Da?Da?DWF@D?~ BEt?F>'?~ A@V@A||? A, J J J A,A?A@ !A2 "A#I(@A6@$DGl,,,22,((,222$2(,2,,(,2222,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  B>@  B DM A D@H%A D?D?D+ >@DP*?D?D?Db+˝@Dv?~ BEkȔ?F)?~ A=@A,ke? A, J J J A,A?A@ !A2 "A#I"@A"@$ A A A A AA I) A* A+~  B4@  B DcA D&@ DԸ<߿DԸ@  B D 4@ Di<@ DP+MDP+M?D`sy D)+?D7D7?DoED d8?~ BE9}Y?FMt?~ A=@AYY? A, J J J A,A?A@ !A2 "A#I"@A&@$ A A A A AA I) A* A+~  BD@  B Dj>A~  Dغ D?D?DX^*D@Da(_?D ?D ?Dyۮ,IQ@D1?~ BEJdk?F(sr6?~ AC@Am W? A, J J J A,A?A@ !A2 "A#I"@A(@$ A A A A AA I) A* A+~  B4@  B DR@ D@$@ D32l?D32l?D{dx3@D{[?De|?De|?De4S\@DIW@~ BE=ytE>?FfH?~ A3@AoE? A, J J J A, A  A !A2 "A#I@A @$ A A A A AA I) A* A+~  B>@  B D'2 A DA DQ~-t?DQ~-t?D R5ҭcR@D" ?De$?De$?DIZJrE9@D?~ BE1jٴ|?F`X?~ A=@Ai{G? A, J J J AV~ A?  A !A2 "A#I@A&@$ A A A A AA I) A* A+~  B.@  B D`@ D*h@ DBMTDBMT?D})-5QDXX0?D,YD,Y?D"@n!kJD9f^1/?~ BEdF?F?ש?~ A,@AH;s? A, J J J A, A  AR !A2 "A#I@A@$ A A A A AA I) A* A+~  BD@  B DA D@ D A D@x?D@x?D* :"@D\Us?D D ?Dh DrS?~ BEC ?F[?~ AC@AjTM%? A, J J J A,A?A? !A2 "A#I&@A*@$ A A A A AA I) A* A+~  B$@  B D`@ D@#@ DjDj?DNBDf)?D?D?DA I) A* A+~  B4@  B; D@&A D@A Dd?yDd?y?D&}VGDO8 /?D۰D۰?D] <D.Ǫx?~ BEjN?F 뭞Al?~ A3@AR3? A, J J J? A,A@A@ !A2 "A@#I@A@$ AA AB AA AC ADA I) A* A+~  B$@  BA D@ @ D`@ D=B%D=B%?DD4FD,z?D ɿD ?DcV?[)D/pL?~ BEZ?F(?~ A"@Au? A, JE JF JG A0~ A?  A1 !A2 "AH#I@A@$ AI AJ AI AK ALA I) A* A+~  B4@  BI DwA D`A DAc:?DAc:?DLg@Dv' X@Dr\?Dr\?D =@D 1*ia?~ BE ѱ?FpC9?~ A3@Ag? A, JMJ JN A,A?A? !A2 "AO#I @A&@$ AP AQ AP AR ASA I) A* A+~  B.@  BP D@l@ Dj@ DY 4E?DY 4E?DΌMZ@DX@D?D?DsKcǻQ@DD^uY?~ BEi8Z?F:嫴?~ A,@A? A, JT JU JV A,A?A@ !A2 "AW#I@A@$ AX AY AX AZ A[A I) A* A+~  B@  BX D`@~  D ¸@ DsۿDs?D}Y:D5e^?D{D{?D&`6JJ>DPN?~ BEOxN?Fd7W?~ A@AQ*8? A, J\ J J A,A?A? !A2 "A]#I@A@$ A^ A_ A^ A` AaA I) A* A+~  B.@  B^ D@ Dԓ@ D=9*'D=9*'?DCEn1LDٲ?Da.Da.?DaOGDiF{?~ BE"C?FS?~ A,@A8[? A, JJJ A, AA !A2 "Ab#I @A @$ Ac Ad Ac Ae AfA I) A* A+~  BD@  Bc D K A~  DkG DƗ?DƗ?D5h@D/5je~@D?Η?D?Η?D?oJ@DY=su?~ BE{?FO `?~ AC@Aʴ? A, Jg Jh Ji A, A  A  !A2 "Aj#I$@A&@$ Ak Al Ak Am AnA I) A* A+~  B$@  Bk Dy[@ D<@ DF4~DF4~?D&HGD]a?D.D.?DRPLD*wx\2@D>E=?D? ٿD? ?DC9B77Dz<@`?~ BEbߥ?FF/S?~ A3@ASQ? A, Ju Jv Jw A, A  A !A2 "Ax#I@A@$ Ay Az Ay A{ A|A I) A* A+~  B$@  By D`HA D@ D2d#.D2d#.?DV2ODr?D LGD LG?D%_#ODZ{ȈX?~ BEW3Kf?FDЭ?~ A"@A=/? A, J} J J~ A,A?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B D`B@ Dj @ D9\vzϿD9\vz?Dac'/D?D_=D_=?DDuX^?~ BESbDQ?Fn#?~ A,@A7IG? A, JJJ A,A?A? !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B DA D@N%A Diu?Diu?DU5"q@DxY @D `!ٿD `!?D &8D9E?~ BEj+?F 4ϝ?~ A8@AaN+? A, J J J A, A  A  !A2 "A#I*@A*@$ A A A A AA I) A* A+~  B@U@  B D A D|A D7)l̿D7)l?DZ ,Dy`o?DǿD?DxH+A(D^QXo?~ BEU#[?Fm?~ AU@AyJf? A, J J J A,A?A? !A2 "A#I0@A8@$DGl,,,(222,,222 2,,(,2(,( .2,2%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A A A A AA I) A* A+~  B9@  B~  D[ш D  A DQƿDQ?D{VGa2'DI?D_D_?D,EM|HD/(e?~ BEAP?Fn#?~ A8@Api? A, J J J A,A?A@ !A2 "A#I$@A*@$ A A A A AA I) A* A+~  B4@  B D]@ DpE@ D8¯D8¯?DnKD|*Y?DܿD?Dz":DSr?~ BEH?F-D3{?~ A3@Ad"2? A, J J J Ag Ah  Ah !A2 "A#I@A@$ A A A A AA I) A* A+~  BT@  B D:A De-A D`^D`^?D9ZED a?DfԿDf?D#3D$?~ BEbeja?Ff?~ A8@A<<\r? A, JC JD JE AFA?A@ !A2 "A#I@A@$ A A A A AA I) A* A+~  B.@  B DN@ Dr@ DjYɌ?DjYɌ?D!8@D8q5?D >?D >?DRi,'@D9ė?~ BEjLQ ?FIA8 ?~ A,@Arb? A, J J J A A  A !A2 "A#I@A@$ A A A A AA I) A* A+~  B9@  B D>A D M:A Dz ̿Dz ?Dg|),D~Rk~?D ߿D ?Dͦ1=Dj?~ BEX4x#?F?~ A8@AE0? A, J J J A; A<  A= !A2 "A#I@A@$ A A A A AA I) A* A+~  BD@  B D@` A D8@ D_D_?Duzw]FD~ܛ?D%ʿD%?DgAg*Dli?~ BE ?F]{?~ AC@Aޞ? A, J J J Ag Ah  A  !A2 "A#I @A$@$ A A A A AA I) A* A+~  B9@  B~  D@ D@ DE宫DE宫?D\m D\?Di?Di?D1IA1@D 4R?~ BEr:i?Fc9?~ A8@A}? A, J J J A A  A !A2 "A#I(@A*@$ A A A A AA I) A* A+~  B@  B~  DȺ@ Dӷ@ D:GZqD:GZq?Dfz QD8Z?D@D@?Dj-QDr?~ BEgA>^?Fp˕G?~ A@Aa? A, J J J A0A?A? !A2 "A#I@A@$ A A A A A A I) A* A+~  B.@  B  Dŕ@  D:@  D3.3> D3.3>? D}z@ Dy|lm? D0f D0f? DuD Dtl?~ B E6Ӟ? F]D @?~ A,@ AX n? A, J J J A9 ~ A?  A !A2 "A  #I@A@$ A A A A A  A I) A* A+~  B$@  B   D@"A  D`@  De De? Dl^Q D[iNW? D? ~? D? ~? D :^@ DK1@~ B E.Pc? F^mh ?~ A"@ A!b? A, J J J A0~ A?  A !A2 "A  #I@A@$ A A A A A  A I) A* A+~  B.@  B   DC-A~  De?  DAt DAt? D3`ƃrB Dec? D@D D@D? D#Wy D Kd?~ B EJ? ? Fno3?~ A,@ AzG ? A, J J J Ag Ah  Ah !A2 "A  #I@A@$ A A A A A  A I) A* A+~  BA@  B   DpA  D _""A  D>V? D>V? D5e~.j@ D~@ De? De? D?6V:@ DT6?~ B Eh9t? FKh?~ AA@ ASl? A, J J J A, A?A@ !A2 "A  #I"@A*@$ A A A A A  A I) A* A+~  BA@  B ~  DkU  DA  Dhw  Dhw ? Dzō  D# ? Dؕ Dؕ? D\Zo DG?~ B E*1>? F(?~ AA@ A L? A, J J J A, A?A@ !A2 "A  #I0@A3@$ A! A" A! A# A$ A I) A* A+~  B>@  B!  Di A D(A D?D?DsϼRq@Dxv,@D..D..?DTF@Ddie?~ BE&>?FOM?~ A=@AFT? A, J% JH J& A,A?A@ !A2 "A' #I@A@$ A( A) A( A* A+ A I) A* A+~  B>@  B( ~  Dq D /A D9?3ɿD9?3?Dǃ)D~)C?DD?DW$D}?~ BEF?F^ld\?~ A=@A]? A, J, J- J. A,A?A? !A2 "A/ #I@A@$ A0 A1 A0 A2 A3 A I) A* A+~  B$@  B0  D}o@ D`i@ D#˿D#?D U+DzT?D)%D)%?Dk`fDnx_?~ BEa)=?F!B?~ A"@A+? A, J4 J5 J A,A?A@ !A2 "A6 #I@A@$ A7 A8 A7 A9 A: A I) A* A+~  B4@  B7  D@ A D A Dnj ?Dnj ?D@V7S@D\/-?D`?D`?DGcɐV@D۷$q?~ BExNm?F]6?~ A3@Aenk? A, J; J< J= AV~ A?  A !A2 "A> #I@A @$ A? A@ A? AA AB A I) A* A+~  B>@  B?  D@qA D@4 A DYy1p?DYy1p?D̸2a?@DFdk?D?D?D dA+@D~߉6?~ BEHwU?F*?~ A=@A``mx? A, JC JD JE A,A?A@ !A2 "AF #I*@A1@$ AG AH AG AI AJ A I) A* A+~  B>@  BG  D ' A D c A D@M1LD@M1L?D5?MD"C_?D SX?D SX?D/LD$@DV\ͫ?~ BE޵?FH?~ A=@A ? A, JK JL JM A,A?A@ !A2 "AN #I$@A(@$ AO AP AO AQ AR A I) A* A+~  B@P@  BO  D3Dz  D&T D&T ?Dp|QDhjaY ?DpDp?D'?NDZG?~ BEGļF+>F2x>~ AP@A'0ד? A, J J  J A,A?A@ !A2 "AS #I@A*@$ AT AU AT AV AW A I) A* A+~  B$@  BT  DCA DA D=fD=f?D[aBD !?D@ ܿD@ ?D@/2:Doi?~ BE/UO?F?OH?~ A"@Ax2G? A, JX JY JZ AV~ A?  A[ !A2 "A\ #I@A@$ A] A^ A] A_ A` A I) A* A+~  B>@  B]  D1D  Do=~?Do=~?Dk?DT?D U?D U?Di}(A@DXU[s?~ BE @P?Fd7W?~ A=@AD? A, Ja Jb Jc A,A?A@ !A2 "Ad #I(@A*@$ Ae Af Ae Ag Ah A I) A* A+~  B.@  Be  D@@ D@@ D4D4?DMpAD ?D)ۿD)?DPd&9D@O?~ BEj}7v?F^nˮl?~ A,@AȤ? A, Ji J= Jj A,A?A? !A2 "Ak #I@A@$ Al Am Al An Ao A I) A* A+~  B>@  Bl  D2D<#  D\ D\ ?D/FQD~"?D?$D?$?Dn^FDjHd?~ BE`V ?FFV?~ A=@AD"s? A, Jp Jq JM A,A?A? !A2 "Ar #I@A@$ As At As Au Av A I) A* A+~  B.@  Bs  D@ D@/@ D>KD>K?DrOXl]JD2s@?D@,D@,@D#RD]pf?~ BE>k=?F>|?~ A,@AA.Or? A, Jw Jx J A, A  A  !A2 "Ay #I@A@$ Az A{ Az A| A} A I) A* A+~  B$@  Bz  D@ D`@ D1gۿD1g?DQh:D73?D?A޿D?A?D;?A;D|=p?~ BEլG?F+t??~ A"@A[$? A, J~ J J= A, A  A  !A2 "A #I@A@$ A A A A A A I) A* A+~  B.@  B  D@T@ Dݨ@ Dj2?Dj2?Dp 0#@D)DF~ 6?DT?DT?Dn7?D?~ BEZĻ?F?~@?~ AC@A2B? A, J J J A,A?A@ !A2 "A #I"@A&@$ A A A A A A I) A* A+~  B$@  B  D `m@ Dί@ D{bŗ;?D{bŗ;?D>6H@D9?DMԿDM?DM,˼3D%?~ BEsF/H!?F?~ A"@Atxr)? A, J J J A,A?A@ !A2 "A #I@A@$ A A A A A A I) A* A+~  B@  B  D ƣ@~  D4@ DLDL?DUSİJDukeu?D @D @D%H-@D@~ BE=A'?F&9?~ A@A'@ A, J J J A,A?A@ !A2 "A #I@A@$ A A A A A A I) A* A+~  BQ@  B  DA DA Dq׺ZӿDq׺Z?D<)2Db?D?D?D\?q[6@D Ao?~ BEF`?FQ?~ A@Q@Agw[? A, J J J A, A  A  !A2 "A #I,@A1@$DHl(2,(222.(22.,(,(,2,,2,222(,( %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A A A A A  A I) A* A+~  B4@  B   Dg@  D\@  D&C D&C? D}$L D۳ @s? D{ D{? DVz D<?~ B E(? F#h2?~ A3@ AW.? A, J J J A, A?A@ !A2 "A  #I @A$@$ !A !A !A !A !A !A !I) !A* !A+~ ! B.@ ! B ~ ! D{,! Dk A! D +>?!D +>?!DpYN@!Dxk?!D@g!D@g@!DmS!D{]7?~ !B!E]\]?!F1gN}H?~ !A,@!A-0? !A, !J !J !J !A,!A?A? !!A2 !"A !#I@A@$ "A "A "A "A "A "A "I) "A* "A+~ " BI@ " B " D+A" D@ 'A" D$y5-FͿ"D$y5-F?"DŌQ-"D;.O?"Dm7?"Dm7?"DN -33@"D\m?~ "B"EF:&?"F?~ "AH@"A3$ ? "A, "J "J "J "A,"A?A? "!A2 ""A "#I3@A3@$ #A #A #A #A #A #A #I) #A* #A+~ # B9@ # B # D`'A~ # D!]J# D-/ni@#D-/ni@#D9r@#DԺ,JX@#D?#D?#DW7P@#Dk1-?~ #B#EH(PhU?#Fm?~ #A8@#AE^i? #A, #JJ #J #A,#A?A? #!A2 #"A ##I@A @$ $A $A $A $A $A $A $I) $A* $A+~ $ BI@ $ B $ DG`7 DA $ Dڿ$D?$DZ9$DFi *?$Dl3$Dl3?$D'eeJ@$Dw$JN?~ $B$E 5%l?$FRU1?~ $AH@$A«? $A, $J $J $J $A,$A?A@ $!A2 $"A $#I$@A(@$ %A %A %A %A %A %A %I) %A* %A+~ % BQ@ % B % D`Q4A% D`6,A% D" X%D" X?%D +ַR?%D?%D%D?%DS%DⲆwp>?~ %B%Ea.?%Fno3?~ %A@Q@%A7QD? %A, %J %J %J %A,%A?A? %!A2 %"A %#I(@A6@$ &A &A &A &A &A &A &I) &A* &A+~ & BN@ & B & D@pA& D@9A& D`&D`?&D{z?&DIUpW??&D`v&D`v?&D~I&DK^?~ &B&EJE3?&Ff?~ &AM@&A'?? &A, &J &J &J &A,&A?A? &!A2 &"A &#I*@A1@$ 'A 'A 'A 'A 'A 'A 'I) 'A* 'A+~ ' B4@ ' B ' D;\@' Dx@' Dj@?'Dj@?'D}{u?3@'DNed?'D?'D?'D-@'D?~ 'B'EnpH?'F)?~ 'A3@'A1H? 'A, 'J 'J" 'J 'A,'A?A@ '!A2 '"A '#I@A@$ (A (A (A (A (A (A (I) (A* (A+~ ( B.@ ( B ( D@ (@( Ds@( DSi?(DSi?(D^|]@(D\2Ƽu@(D(D?(D^D(DS0?~ (B(E&6?(F{?~ (A,@(A P0~? (A, (J (J (J (A,(A?A@ (!A2 ("A (#I,@A1@$ )A )A )A )A )A )A )I) )A* )A+~ ) BK@ ) B ) D//D+S, ) D |#6)D |#6?)D"6Ph)D!m0?)D_',ܿ)D_',?)DVxSK:)DJtʕ?~ )B)Ee|X?)Fc5A?~ )AK@)A*y? )A, )J! )J! )J! )A, )A ) A )!A2 )"A!)#I(@A0@$ *A! *A! *A! *A! *A!*A *I) *A* *A+~ * B4@ * B!* D@* D@'A* DxpO @*DxpO @*Ds`먉@*Dl"@*D?Sm?*D?Sm?*D1& a@*DΧa@~ *B*E\p>?*F-O$W?~ *A3@*AחU? *A, *J! *J *J} *A,*A@A? *!A2 *"A !*#I$@A(@$ +A ! +A ! +A ! +A ! +A !+A +I) +A* +A+~ + B@ + B !+ Dn@+ D`~@+ DJ+DJ?+Dv"B+D(#;?+D ]+D ]?+D0fEb%K+D@?~ +B+Eh˭?+FSr?~ +A@+A|$01@ +A, +J! +J! +J! +A,+A?A? +!A2 +"A!+#I@A@$ ,A! ,A! ,A! ,A! ,A!,A ,I) ,A* ,A+~ , BD@ , B!~ , DA, D`æA, D.jY[LM,D.jY[LM?,DЭ?F,D2ΙU?,DQR,DQR?,D|r~B,D)?~ ,B,E ]|?,F =Z _?~ ,AC@,A.cEs? ,A, ,J! ,J! ,J! ,A,,A?A@ ,!A2 ,"A!,#I*@A.@$ -A! -A! -A! -A! -A!-A -I) -A* -A+~ - B>@ - B!- Dc)D - D{==-D{==?-DC&lH-Dvi6^?-DLw-DLw?-D*62E-Dn?~ -B-E~#RM?-F&j}?~ -A=@-Aф@H? -A, -JL-J -JM -AF-A?A? -!A2 -"A!-#I@A@$ .A! .A ! .A! .A!! .A"!.A .I) .A* .A+~ . B.@ . B!. D@. DjJ@. DXD]S.DXD]S?.D (EM.DvFT݇?.DdR?.DdR?.Di',@.D'Ͽo@?~ .B.EBP?.FJ ž'?~ .A,@.ANX? .A, .J#! .J$! .J%! .A.A?A? .!A2 ."A&!.#I@A@$ /A'! /A(! /A'! /A)! /A*!/A /I) /A* /A+~ / BA@ / B'!/ DA/ DAYA/ Dd k?/Dd k?/Dwd@@/D&ITL?/D q?/D q?/DF8@/D{5?~ /B/E(Xߔ?/F ?~ /AA@/A =3}? /A, /J+! /J,! /J-! /A0~ /A? / A1 /!A2 /"A.!/#I*@A.@$ 0A/! 0A0! 0A/! 0A1! 0A2!0A 0I) 0A* 0A+~ 0 B$@ 0 B/!0 D<~@DHX@ 0 D[110D[11?0D^wO0Drx?0D?0D?0DgkTx@0DST?~ 0B0E\~/?0Fn#?~ 0A"@0Aw!f%? 0A, 0J3! 0J4! 0J5! 0A 0A 0 A 0!A2 0"A6!0#I@A@$ 1A7! 1A8! 1A7! 1A9! 1A:!1A 1I) 1A* 1A+~ 1 B9@ 1 B7!1 DB@1 D BT@1 D ,?1D ,?1Dn:s M(@1D2o?1Dߺ1Dߺ?1DB1D8`h?~ 1B1E*qy?1Ffc>?~ 1A8@1Am? 1A, 1J;! 1J!1#I @A&@$ 2AH! 2A  2AH! 2AI! 2AJ!2A 2I) 2A* 2A+~ 2 B$@ 2 BH!2 D@2 D`GF@2 DQ7-?2DQ7-?2Dw H@2D=\X?2D?2D?2D- и3@2DX'?~ 2B2E?2F ?~ 2A"@2AԢ? 2A, 2J; 2J; 2J; 2A=2A?A? 2!A2 2"AK!2#I@A@$ 3AL! 3AM! 3AL! 3AN! 3AO!3A 3I) 3A* 3A+~ 3 B$@ 3 BL!3 D`r@3 Dԋ@3 D~VG?0?3D~VG?0?3D2A1@3DؙF9q?3D_g?3D_g?3D/~?3DQ7Q?~ 3B3Ev*φ?3F e}?~ 3A"@3A4ҹ? 3A, 3JP! 3JQ! 3JR! 3A9 ~ 3A? 3 AR 3!A2 3"AS!3#I@A@$ 4AT! 4AU! 4AT! 4AV! 4AW!4A 4I) 4A* 4A+~ 4 B.@ 4 BT!4 D@4 D@4 D8|4D8|?4DzM*?4De9?4Da:ٿ4Da:?4Ddov74D( oY?~ 4B4Ev ?4F ;?~ 4A,@4A<@? 4A, 4JX! 4JY! 4JZ! 4A[! 4A\! 4 A]! 4!A2 4"A^!4#I@A@$ 5A_! 5A`! 5A_! 5Aa! 5Ab!5A 5I) 5A* 5A+~ 5 B@ 5 B_!5 D<@5 D @@5 DnѦe?5DnѦe?5DdQ/Z@5DIa@5D'?5D'?5D٨O@5D}m.?~ 5B5ElqO?5F(?~ 5A@5A'\߮3@ 5A, 5Jc! 5J 5Jd! 5A 5A 5 Ae! 5!A2 5"Af!5#I@A@$ 6Ag! 6Ah! 6Ag! 6Ai! 6Aj!6A 6I) 6A* 6A+~ 6 B$@ 6 Bg!6 D-A@6 DiF@6 D~YT6D~YT?6DM5,C6D^B(e?6Dik6Dik?6D0-:D¹$>-?:DWV@K:DqZJ?:Dg?:Dg?:DY@:Dx$QH@~ :B:E}?:F֍~=?~ :AA@:AFs? :A, :JJJ :AF:A?A@ :!A2 :"A!:#I@A @$ ;A! ;A! ;A! ;A! ;A!;A ;I) ;A* ;A+~ ; B$@ ; B!; Df@; D)@; DjcaZ;DjcaZ?;D2sdLM;D;T.?;Da;Da?;D" z|Q;DuF?~ ;B;Er+R?;FzS][?~ ;A"@;Au3w? ;A, ;J! ;J! ;J! ;Ag ;Ah ; Ah ;!A2 ;"A!;#I@A@$ <A! <A! <A! <A! <A!<A <I) <A* <A+~ < B@ < B!< D@~ < D|@< DͯG?<DͯG?<D>OJn/@<D䐯_?<D@v<D@v?<DV<D2_I?~ <B<E'&?<F7 ?~ <A@<A#k? <A, <J! <J! <J! <A, <A  < A <!A2 <"A!<#I@A@$ =A! =A! =A! =A! =A!=A =I) =A* =A+~ = B.@ = B!= Dk@= D y@= D w?=D w?=DKG@=Dt T?=D=D?=DV+lW)D=D!J?~ =B=EG ?=FcL?~ =A,@=Aw? =A, =J! =J! =J =A,=A?A@ =!A2 ="A!=#I@A@$ >A! >A! >A! >A! >A!>A >I) >A* >A+~ > BR@ > B!> D>D̸A > D>D?>DhO6 K>Da?>D >D ?>D61H\O>D1?~ >B>EmT>>F.t?~ >AR@>AQJl\\? >A, >J >J  >J >A,>A?A@ >!A2 >"A!>#I @A0@$ ?A! ?A! ?A! ?A! ?A!?A ?I) ?A* ?A+~ ? B4@ ? B!? DA? D`^A? DUrprw?DUrprw??D+cٿ?D7??D?o^?D?o^??D Iq?D u4?~ ?B?EܙI_??Fj"A?~ ?A3@?Aac? ?A, ?J! ?J! ?J! ?A,?A?A@ ?!A2 ?"A!?#I@A@$DGl,(,,,,,$,,(,2$2,2222..22.,@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A! @A! @A! @A! @A!@A @I) @A* @A+~ @ BD@ @ B!@ D EA@ D` A@ DAԊ?@DAԊ?@Dh(@@DSMZ?@D`#:ҿ@D`#:?@Db1@DfI[tD?~ @B@E*`s?@Fj?~ @AC@@A9jµ? @A, @J! @J! @J! @A,@A?A? @!A2 @"A!@#I @A$@$ AA! AA! AA! AA! AA!AA AI) AA* AA+~ A B$@ A B!A D`@A Du@A DI3UœۿADI3Uœ?AD>9AD3׼?AD?AD?AD71SQ@ADOH ?~ ABAE lm?AF%h?BD?hؿBD?h?BDd~7BDelF{?~ BBBE@K ?BFo?~ BA,@BAe~?? BA, BJ! BJ! BJ! BA,BA?A@ B!A2 B"A!B#I@A@$ CA! CA! CA! CA! CA!CA CI) CA* CA+~ C B.@ C B!C D AC D AC Dg$ۡCDg$ۡ?CD!0 CD?CD 8?CD 8?CDݍzY@CDWj"'@~ CBCE;4HJ?CFm-#?~ CA,@CAg^%? CA, CJ! CJ! CJ! CA,CA?A@ C!A2 C"A!C#I*@A0@$ DA! DA! DA! DA! DA!DA DI) DA* DA+~ D B4@ D B!D D%4@D D`[@D D~DzPj߿DD~DzPj?DDE<DDj?DDԿDD?DDqg3DDf@E?~ DBDET4?DFm?~ DA3@DA `2eM? DA, DJ! DJ! DJ! DA,DA?A@ D!A2 D"A!D#I*@A0@$ EA! EA! EA! EA! EA!EA EI) EA* EA+~ E B$@ E B!E D?@E D1K@E DM?EDM?EDOi@ED,cf#@ED/5?ED/5?EDD3=i@@EDXe@?~ EBEE|??EFЙ?~ EA"@EA Tp? EA, EJ! EJ! EJ" EA EA E A E!A2 E"A"E#I@A@$ FA" FA" FA" FA" FA"FA FI) FA* FA+~ F BF@ F B"F D T$@ I B"~ I D2I D`?AI D@ Q_ID@ Q_?IDLlTIDEb+?ID+?ID+?ID3s.@IDЧo?~ IBIE0?Į?IFzp/?~ IA=@IA:V=6? IA, IJ" IJ" IJ " IA, IA I AR I!A2 I"A!"I#I @A(@$ JA"" JA#" JA"" JA$" JA%"JA JI) JA* JA+~ J B.@ J B""J D@w @J D`s(@J D3B-JD3B-?JD-!OJDJMr?JD?MJD?M?JD)84AJDܿ ?~ JBJE??JFh+a?~ JA,@JAm*۾-.? JA, JJ&" JJ'" JJ(" JAV~ JA? J A J!A2 J"A)"J#I@A@$ KA*" KA+" KA*" KA," KA-"KA KI) KA* KA+~ K B$@ K B*"K Dӕ@K D,@K Dǯ̽KDǯ̽?KDKDx?KDKD?KD9.KDтS?~ KBKEݯ(?KF6^u?~ KA"@KA!:d1? KA, KJ." KJ/" KJ0" KA,KA?A@ K!A2 K"A1"K#I@A$@$ LA2" LA3" LA2" LA4" LA5"LA LI) LA* LA+~ L B.@ L B2"L D\AL D@ @L D\LD\?LDFVgQLD&AYq?LD`LD`?LD@LDv ]?~ LBLE#1?LF_i_V?~ LA,@LA܅Y? LA, LJ6" LJ7" LJ8" LA9 ~ LA? L A[ L!A2 L"A9"L#I@A@$ MA:" MA;" MA:" MA<" MA="MA MI) MA* MA+~ M B9@ M B:"M D=@M D@M DRW?MDRW?MDFR@MD%<,$?MD e@MD e@MDuuU~@MD14A)j@~ MBME/?7?MFx,?~ MA8@MAm? MA, MJ>"MJ MJ? MA,MA?A? M!A2 M"A?"M#I@A@$ NA@" NAA" NA@" NAB" NAC"NA NI) NA* NA+~ N BA@ N B@"~ N DW<N D pAN D-26zڿND-26z?ND[Ry:9ND 5.?NDRɿNDR?NDǠ)NDkyF?~ NBNE#M~&@RDA ?~ RBRE[k|?RFn#?~ RA@RA_賐 @ RA, RJc" RJd" RJe" RA,RA?A@ R!A2 R"Af"R#I@A@$ SAg" SAh" SAg" SAi" SAj"SA SI) SA* SA+~ S B4@ S Bg"S D}MAS D`m AS DH$?SDH$?SDMg4@SD [kC?SD0?SD0?SD0?SD@J<5_G?~ SBSE`O ?SFD$]?~ SA3@SA`m? SA, SJk" SJl" SJm" SA,SA?A@ S!A2 S"An"S#I@A@$ TAo" TAp" TAo" TAq" TAr"TA TI) TA* TA+~ T B9@ T Bo"~ T D7AT D@AT Do ?TDo ?TD!jU@TD?TDjTDj?TDŠp;CTD?~ TBTE#io?~ VBVEIZ?VFn#?~ VAA@VAU? VA,VJ VJ" VJ" VA,VA?A? V!A2 V"A"V#I"@A&@$ WA" WA" WA" WA" WA"WA WI) WA* WA+~ W BA@ W B"W Do@W D AW D`s`?WD`s`?WDFxF@WD++P?WD+?WD+?WDf-) EeK@WD ??~ WBWE7?WF`:?~ WAA@WAIu? WA, WJ"WJ WJ" WA,WA?A? W!A2 W"A"W#I@A @$ XA" XA" XA" XA" XA"XA XI) XA* XA+~ X B.@ X B"X Dp@X D k@X D=̿XD=?XD3yS-XDI4Y?XD]VXD]V?XD㋾7GXD1Ť.?~ XBXE['a?XF="d?~ XA,@XAMTA? XA, XJ" XJ" XJ" XA, XA X A X!A2 X"A"X#I@A@$ YA" YA" YA" YA" YA"YA YI) YA* YA+~ Y BF@ Y B"Y D`AY D@ AY DU9?YDU9?YDl"nE@YDF?YDU?YDU?YDm(HU&@YD=Fڳ?~ YBYEN-Dݞ?YF?~ YAF@YAKm6? YA, YJ" YJ" YJ" YA, YA Y A Y!A2 Y"A"Y#I.@A3@$ ZA" ZA" ZA" ZA" ZA"ZA ZI) ZA* ZA+~ Z B4@ Z B"Z D;jAZ DDKAZ D*q?ZD*q?ZD.-§Ie@ZDǟ@ZD ԿZD ?ZD(J3ZDd&c?~ ZBZEg3?ZFU21?~ ZA3@ZA8sy`? ZA, ZJ" ZJ" ZJ" ZA, ZA Z AR Z!A2 Z"A"Z#I@A@$ [A" [A" [A" [A" [A"[A [I) [A* [A+~ [ B.@ [ B"[ Dc@[ Do@[ Dz(9[Dz(9?[D"}lRG[D(&^?[D@2u[D@2u?[DkK[D!?~ [B[E*?[F+5& S?~ [A,@[A?? [A, [J" [J [J" [A,[A?A? [!A2 ["A"[#I@A@$ \A" \A" \A" \A" \A"\A \I) \A* \A+~ \ B.@ \ B"\ Db@\ DN\@\ D4x*׿\D4x*?\D =06\DF7?\D?\D??\DH섏3F\D|m?~ \B\Ey58?\F9B|: ?~ \A,@\A6vx? \A, \J" \J" \J" \A,\A?A? \!A2 \"A"\#I@A@$ ]A" ]A" ]A" ]A" ]A"]A ]I) ]A* ]A+~ ] B$@ ] B"] D @] D@] DhI x?]DhI x?]D;{)M1@]D~?]D?]D?]DK]z!@]Dx9e?~ ]B]Ewa1?]Fоl?~ ]A"@]AJ}? ]A, ]J" ]J" ]J" ]A,]A?A@ ]!A2 ]"A"]#I@A@$ ^A" ^A" ^A" ^A" ^A"^A ^I) ^A* ^A+~ ^ B>@ ^ B"^ DA^ DA^ Dѿ^D?^DV+51^Dj@wd?^D^D?^D-֎^D2'?~ ^B^E!˿3?^F[ݤ?~ ^A=@^Av? ^A, ^J" ^J" ^J" ^A9 ~ ^A? ^ AR ^!A2 ^"A"^#I @A @$ _A" _A" _A" _A" _A"_A _I) _A* _A+~ _ B.@ _ B"_ D?@_ DH@_ D-;m*Ru_D-;m*Ru?_D9 ׿_Dt?_D@[t?_D@[t?_D0iE@_D*?~ _B_Ef?_FPY#?~ _A,@_Aij? _A, _J" _J" _J" _A _A~ _ A" _!A2 _"A"_#I@A@$D Hl,,,,,22.,.2,2((,,((,.,$(222,,,2`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A" `A" `A" `A" `A"`A `I) `A* `A+~ ` B>@ ` B"` DD0J ` D&V&5`D&V&5?`DA8R`DWA?`D`/`D`/?`DN`DLT?~ `B`E‹.F?`F9w?~ `A=@`At? `A, `JC `JD `JE `AF`A@A? `!A2 `"A"`#I@A@$ aA" aA" aA" aA" aA"aA aI) aA* aA+~ a B.@ a B"a D`Aa DഊAa DY4Y/l:aDY4Y/l:?aD"| kaDPj?aDθ?aDθ?aDOw N@aDۅ/?~ aBaEwF?aF8,?~ aA,@aAP&?*? aA, aJ# aJ# aJ# aAg aAh a Ai a!A2 a"A#a#I@A@$ bA# bA# bA# bA# bA#bA bI) bA* bA+~ b B$@ b B#b DAb D:y@b DR՛_bDR՛_?bD RbD.p?bD?DcbD?Dc?bDn N=IPbDANN?~ bBbEg"?bF HOQ?~ bA"@bA7RNN1? bA, bJ# bJ # bJ # bAr bAs b Am b!A2 b"A #b#I@A@$ cA # cAP cA # cA # cA;cA cI) cA* cA+~ c B9@ c B #~ c D=ic DAc D9R- cD9R- @cDk VcDi(?cD?f*cD?f*?cD%8ߞQcD}*?~ cBcE`C|TS?cFZp?~ cA8@cA5X? cA, cJJJ cAFcA?A? c!A2 c"A#c#I@A@$ dA# dA# dA# dA# dA#dA dI) dA* dA+~ d B.@ d B#d DT@d D@K?@d D8# iA0iA?A? i!A2 i"A?#i#I@A@$ jA@# jA jA@# jAA# jAB#jA jI) jA* jA+~ j B@ j B@#j D@j D@j DijDi?jDa;+DjD{@ l BT#l DBjD" l DflDf?lDSn(BlD>L?lD`lD`?lDۮ,PlD5$,ٗ?~ lBlE&D ?lFe9sW?~ lA=@lA4=>P? lA, lJ lJ  lJ lA,lA?A@ l!A2 l"AX#l#I@A@$ mAY# mAZ# mAY# mA[# mA\#mA mI) mA* mA+~ m BD@ m BY#~ m D+Jm D@@,Am D7*տmD7*?mD@˖x|4mDTwq?mDmD?mDA’H;mDUV?~ mBmEI=q?mFE?~ mAC@mAJ`촖U? mA, mJ]# mJ^# mJ_# mA,mA?A@ m!A2 m"A`#m#I1@A2@$ nAa# nAb# nAa# nAc# nAd#nA nI) nA* nA+~ n BF@ n Ba#n DAn D @n Dw,nDw,?nDT/DnDjA?nDu?nDu?nD͉cS@nD\s+҅?~ nBnE ?nF)9O"?~ nAF@nAvq? nA, nJe# nJf# nJg# nA, nA n AR n!A2 n"Ah#n#I*@A2@$ oAs# oAt# oAs# oAu# oAv#oA oI) oA* oA+~ o B>@ o Bs#o DD~ o D3oD3?oD@.^RoD6?oD#OoD#O?oDADSFoDPԟ?~ oBoEsڑ?oF1ǪK?~ oA=@oA ,L? oA, oJw# oJx# oJy# oA,oA?A@ o!A2 o"Az#o#I@A@$ pA{# pA|# pA{# pA}# pA~#pA pI) pA* pA+~ p B@P@ p B{#p D` Ap D@bZAp DeN.tӿpDeN.t?pD'wt3pD5 @?pD_#MpD_#M?pD9BppDо?~ pBpEgɚ?pFS=G?~ pAP@pA s"? pA, pJ# pJ# pJ# pA,pA?A? p!A2 p"A#p#I*@A3@$ qA# qA# qA# qA# qA#qA qI) qA* qA+~ q B.@ q B#q D`@q D`g4@q Dvk ϿqDvk ?qDWd.qDDlj ?qD`mĿqD`m?qD#{,%qD?~ qBqE?qF|:4p?~ qA,@qAĵi? qA, qJ# qJ# qJ# qA, qA q A q!A2 q"A#q#I@A@$ rA# rA# rA# rA# rA#rA rI) rA* rA+~ r B.@ r B#r D`_@r D`@r DTS)޿rDTS)?rD;rDff?rDKrDK?rD/EFBrD́vM?~ rBrEY?rFil?~ rA,@rA~^?? rA, rJ# rJ# rJ# rA,rA?A@ r!A2 r"A#r#I@A@$ sA# sA# sA# sA# sA#sA sI) sA* sA+~ s B9@ s B#s D@h6As D@|As Dna`?sDna`?sDELhm@xD~ui @~ xBxEXS?xFO `?~ xA"@xA`$a? xA, xJ# xJ# xJ# xA,xA?A? x!A2 x"A#x#I@A@$ yA# yA# yA# yA# yA#yA yI) yA* yA+~ y BD@ y B#y D`Z4Ay D`C%Ay D.2yD.2?yDF1foGyD;@ { B#{ DZh@{ D@o@{ Dŕ{Dŕ?{D1R{DN.ǵ?{D g{D g?{DHHM{Dr[~?~ {B{E"$?{F1gN}H?~ {A=@{ATh? {A, {J# {J# {J# {A, {A { A {!A2 {"A#{#I@A@$ |A# |A# |A# |A# |A#|A |I) |A* |A+~ | B@ | B#| D@D@| Dz@| Dڿ|D?|D8|DfaI#?|D@0|D@0?|Df:[|D n{?~ |B|E2dRԌ?|F0pI?~ |A@|Ae@ ? |A, |J#|J |Jo |A,|A?A? |!A2 |"A#|#I@A@$ }A# }A# }A# }A# }A#}A }I) }A* }A+~ } B9@ } B#} D##A} Dlr$A} Dm+k?}Dm+k?}Dd?W@}Dͧ?}D,t}D,t?}DV֚G}DcY@@?~ }B}El"g?}F|e?~ }A8@}A 9!=K7? }A, }JJ }J }A,}A@A? }!A2 }"A#}#I"@A$@$ ~A# ~A# ~A# ~A# ~A#~A ~I) ~A* ~A+~ ~ B$@ ~ B#~ D@`Z@~ D@~ D{qѿ~D{q?~DJ 1~D01N`?~D ~D ?~DV~D[?~ ~B~E/2?~Fno3?~ ~A"@~A|&? ~A, ~J# ~J# ~J# ~A# ~A# ~ A# ~!A2 ~"A$~#I@A@$ A$ A$ A$ A$ A$A I) A* A+~  B$@  B$ DH@ D i@ D1D1@D)wTDSvS4?D?D?Dkp@@D.>hV?~ BE6ZJn?F./M?~ A"@A3@@ A, J$ J$ J$ Ag Ah  A  !A2 "A$#I@A@$DGl22,22.(,(2,2,22222,2,2(2%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A$ A$ A$ A$ A$A I) A* A+~  B$@  B$ D@ D@Y@ D^U޿D^U?D5?ȗ<D-R&4 ?DڿD?D>æ 9D.f?~ BEPG?FOM?~ A"@AJ? A, J$ J$ J$ A,A?A? !A2 "A$#I@A@$ A$ A$ A$ A$ A$A I) A* A+~  B$@  B$ D E@ D=@ D cD c?DdcſDBO?D?D?DY@D!S?~ BEX<?FvF_`?~ A"@ASS_P? A, J$ J$ J$ A; A  A $ !A2 "A!$#I@A@$ A"$ A#$ A"$ A$$ A%$A I) A* A+~  B$@  B"$ Dg @ DsA D::?D::?D6 ڥW@Dw"?D?D?D@,8P@D{?~ BE+0jOv?FG0tG?~ A"@A͊zx? A, J J J&$ Ag A   Ah !A2 "A'$#I@A@$ A($ A)$ A($ A*$ A+$A I) A* A+~  B@Z@  B($ D`6pAD"  D5 D5 ?DhP+D+-jw?DD?DT 7GD߭5?~ BEuh?F5q?~ AZ@A!,i? A, J J J A,A?A? !A2 "A,$#I$@A5@$ A-$ A.$ A-$ A/$ A0$A I) A* A+~  B>@  B-$ D;N9A~  Dg) DwiDwi@DfS(>xSDxFP?D!ؿD!?DHXdz7Dh|?~ BEO%?Fm?~ A=@A?kV? A, J1$ J J2$ A A  A !A2 "A3$#I"@A$@$ A4$ A5$ A4$ A6$ A7$A I) A* A+~  B9@  B4$ D`0A~  DO Di۠N?Di۠N?D_0@DuKܾ?D?D?D//OI+@D.?~ BE'?F@Ѝ?~ A8@AӖ}? A, J8$ J9$ J:$ A0~ A?  A1 !A2 "A;$#I@A@$ A<$ A=$ A<$ A>$ A?$A I) A* A+~  BR@  B<$ D4bD  D_ۿD_?D0$v:D`'}?DD?D/&@ADR=?~ BEv?FYCW?~ AR@AG? A, J J J A,A@A? !A2 "A@$#I@A3@$ AG$ A  AG$ AH$ AI$A I) A* A+~  B.@  BG$ D @ D@!@ DSV8DSV8?D-mBD*5?D.D.?D Yt&PD΄˧?~ BE+?F)2 ?~ A,@Auݐ? A, J J J AF~ A?  A !A2 "AJ$#I@A@$ AK$ AL$ AK$ AM$ AN$A I) A* A+~  B$@  BK$ D*o@ DU^@ D!0ot?D!0ot?DI~B^@D~e@D??D??DO?Dy"??~ BEt?Fw=I?DD?D`\^ D28 ya?~ BE-#A?Fk@#a?~ A"@A"=A.? A, Jg$ Jh$ Ji$ A Aj$  Ak$ !A2 "Al$#I@A@$ Ap$ Aq$ Ap$ Ar$ As$A I) A* A+~  B9@  Bp$ D@A D A Du-ԿDu-?DzS_3Dp?DD?D"qHDR4m?~ BEThty?FdȚ?~ A8@AX? A, Jt$ Ju$ Jv$ A, A  A !A2 "Aw$#I"@A$@$ Ax$ Ay$ Ax$ Az$ A{$A I) A* A+~  B4@  Bx$ D5O.A D@I5A DdDd@Dw)6TDP+)@?D~D~?Dlg?Dmvd>?DCAXs@D6Q7?Dz+ǿDz+?DR9?_'D:]r=:?~ BEUE<?FVi?~ AA@A kN? A, J$ J J$ A,A?A@ !A2 "A$#I.@A2@$ A$ A$ A$ A$ A$A I) A* A+~  B4@  B$ DwA D*@ DAIccDAIcc?D=%AD+IMp?D]D]?D MABDI?~ BE2R?FYa?~ A3@A}[ȕ? A, J; J J$ A; A<  A$ !A2 "A$#I$@A(@$ A$ A$ A$ A$ A$A I) A* A+~  B@  B$ D`@ D 9@ D0:?D0:?DrJ&A@D1v|?De?De?DʘP@D/9?~ BEi?F8VO?~ A@A`Z'N=? A, J$ J$ J$ A= A>  A$ !A2 "A$#I@A@$ A$ A$ A$ A$ A$A I) A* A+~  B$@  B$ DI@ DE@ D7uUAʿD7uUA?D1Gխ*D2J?D??D??DKZIR@Dy?~ BEF ?Fvkb?~ A"@AT9%? A, J$ J% J% A A  A} !A2 "A%#I@A@$ A% A% A% A% A!A I) A* A+~  B.@  B% D3D'  D,CY1D,CY1?DUQ -EDSN[?D_D_?D]L@D>T[^?~ BE%yPɤ+?Fq˒A?~ A,@AU? A, J  J  Jz A,A@A? !A2 "A%#I@A@$ A% A% A% A % A %A I) A* A+~  B.@  B% D CA D*?!A Da+?Da+?D<»CB@DDPF?D @_6?D @_6?D0$!/@D?T?~ BE?Fx[?~ A,@A #6? A, J J J % Ag Ah  A  !A2 "A %#I@A@$ A % A% A % A% A%A I) A* A+~  B$@  B % D`@ D:@ Dm@I߿Dm@I?D~,<DNo?D `D `?DG}aIDɡ?~ BEfxP?F^?~ A"@A!8? A, J% J% J% Ag Ah  A  !A2 "A%#I@A@$D:Hl,22..22222,222.2,22,,,,2222%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A-% A.% A-% A/% A0%A I) A* A+~  B$@  B-% D`6z@ D@ D߄KD߄K?D}_PD4?DKDK?D;;ØSLD0?~ BEPpۉ?F /bQ?~ A"@AW(? A, J1% J2% J3% A= A>  A4% !A2 "A5%#I@A@$ A>% A?% A>% A@% AA%A I) A* A+~  B.@  B>% Dr@ D2@ D?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwyz{|}~rDMDѹ?~ BEܬ ?Fdׅ:?~ AC@At*? A, JS% J JT% A, A~  A@ !A2 "AU%#I@A @$ AV% AW% AV% AX% AY%A I) A* A+~  BF@  BV% D/)Dz  DcC*HDcC*H?D7ODYg ?DD?DVNDS5p?~ BEc8P>Fxw>~ AF@Aab ? A, J J  J A,A?A@ !A2 "AZ%#I@A"@$ A[% A\% A[% A]% A^%A I) A* A+~  B.@  B[% DA D*A DZu?DZu?D+J#@D +?D'D'?D}V@ODݩ?~ BEe?FD$]?~ A,@A(B|? A, J_% J`% Ja% Aw A  A !A2 "Ab%#I@A@$ Ac% Ad% Ac% Ae% Af%A I) A* A+~  BD@  Bc% Dw A Dq A DQڙ?DQڙ?D>B'@DrGWh?D^Q?D^Q?D݉0@DԦ?~ BEt7?Fm?~ AC@AY 2? A, Jg% Jh% Ji% A,A?A@ !A2 "Aj%#I$@A*@$ Ak% Al% Ak% Am% An%A I) A* A+~  B.@  Bk% D6@ D@ DNQZ?DNQZ?DE ^o5@DZ^ǚ?D?D?D/"+R@DO%?~ BE:~C?F`r-V?~ A,@A†}? A, Jo% Jp% Jq% A,A?A@ !A2 "Ar%#I$@A&@$ As% At% As% Au% Av%A I) A* A+~  B.@  Bs% D!A DA DHyDHy?Du|JD!E?DD?D`6-CD[/hk?~ BEۗ?F <,?~ A,@A? A, Jw% Jx% Jy% A,A?A@ !A2 "Az%#I@A@$ A{% A|% A{% A}% A~%A I) A* A+~  B9@  B{% D`A DaA D@T*D@T*?D!D,?DֿD?DD^zC5DQ>R52?~ BE;''?Fi<&X4a?~ A8@A\=9? A, J% J% J% A,A?A? !A2 "A%#I@A@$ A% A% A% A% A%A I) A* A+~  B4@  B% D{@ D A DW?L`~?DW?L`~?D /Q@Ḓ2?D]?D]?D{ElM@D1?Dj?~ BE:̏?F޿J@  B% D8A~  DG  D'㩻P?D'㩻P?D_"Br@D꒦@DY?DY?DkF8@D5m[b?~ BE+=?F{?~ A=@AUU@ ? A, J% J% J% A,A?A@ !A2 "A%#I"@A(@$ A% A% A% A% A%A I) A* A+~  B.@  B% D @ D"@ DޡJ |?DޡJ |?DԈO1@DI?D@οD@?DS%Q^i.D$?~ BE=)DcVё;M?D D ?D= DPt?~ BE=ګ?FM$QN?~ AC@A%? A, J% J% J% A; A<  A$ !A2 "A%#I@A"@$ A% A% A% A% A%A I) A* A+~  B@  B% D@ Dw@ DDj1#?DDj1#?D< t b@DEJpv@DTDT?D!jĉDk ?~ BE4M?Fn<7H?~ A@Ac ? A, J% J% J% A,A?A@ !A2 "A%#I@A@$ A% A% A% A% A%A I) A* A+~  B.@  B% Dr@ D@ DF+?DF+?Dn~@Dw'?D?D?DU5e@Dx'@~ BEv3̀?F֍~=?~ A,@AE? A, J% J% J% A,A?A? !A2 "A%#I@A@$ A% A% A% A% A%A I) A* A+~  B$@  B% D Z|@ D@ D܄k8?D܄k8?D .;%@DpL?D??D??D?D|:?~ BEx#5?Fn#?~ A"@A}t? A, J% J% J% A,A?A@ !A2 "A%#I@A@$ A% A% A% A% A%A I) A* A+~  B@  B% D@ D T@ DJ7@DJ7@D辈[@D @DoDo?DަzDQ:2q?~ BEtd?Fn#?~ A@Ahh? A, J% J+ J% A,A@A@ !A2 "A%#I@A@$ A% A% A% A% A%A I) A* A+~  B$@  B% D@g@ DJ@ D jw?D jw?Dt4D@Dߕߣh?D?JCٿD?JC?D~7D?* W?~ BE?!A?FhKw_?~ A"@AhxB? A, J% J% J% A,A?A? !A2 "A%#I@A@$ A% A% A% A% A%A I) A* A+~  B.@  B% D@|C@ D@=@ D@R?]??D@R?]??D%D)@DQ?k ?D pn?D pn?DAd+@DzY!;?~ BE?F?ȓQ?~ A,@A,|gĶ? A, J% J% J% A,A?A@ !A2 "A%#I@A@$ A% A% A% A% A&A I) A* A+~  B9@  B% D@ Dj@ D,<.ɿD,<.?D:w6*D3gF?D yοD y?Dc im.Dky!?~ BEB?Fоl?~ A8@AW*'? A, J& J& J& A, A  A  !A2 "A&#I$@A$@$ A& A& A& A& A&A I) A* A+~  B$@  B& D/7@ D=@ DZbo~DZbo~?DFە@ADb?D#D#?DmDWPv1?~ BEi?F`X?~ A@A$?? A, JL& JM& JN& A0A?A? !A2 "AO&#I@A@$ AW& AX& AW& AY& AZ&A I) A* A+~  B$@  BW& D @ Da@ D#*J׿D#*J?D5Y56D5Kr?D@D@?D»{AD[Zsq?~ BE|Q+Y?FU`?~ A"@AD9xS? A, J[& J\& J]& A,A?A? !A2 "A^&#I@A@$ A_& A`& A_& Aa& Ab&A I) A* A+~  BN@  B_& D8 D&  DQJDQJ@DkSSDk@c ?Do6Do6?D_@=D癶?~ BE t ?Fq/?~ AM@AKy? A, J J  J A,A?A@ !A2 "Ac&#I@A,@$ Am& An& Am& Ao& Ap&A I) A* A+~  B4@  Bm& DzA D#_@ DkDk?D̽4jPDn?DͿD?Df3'3&-D `@?~ BE+d=?FG?~ A3@AN6? A, Jq& Jr& Js& A,A?A@ !A2 "At&#I@A@$DGl222$2,,,,2.2 (,.,,,,,,22222,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ Au& Av& Au& Aw& Ax&A I) A* A+~  B>@  Bu& D06A DϊA DPRdDPRd@DM3pTD0q~Y?D?D?D9Z@Dd[cy?~ BE}}?Fno3?~ A=@A? A, J Jc Jy& A, A  A !A2 "Az&#I@A@$ A{& A|& A{& A}& A~&A I) A* A+~  B.@  B{& D <@ DKm@ D:;?D:;?D &@DwHK?D@\?D@\?Dx ?@D'{l?~ BE$C(?FͥD6?~ A,@A5\? A, J& J& J& A, A  A !A2 "A&#I@A@$ A& A& A& A& A&A I) A* A+~  B.@  B& D*@ D A DIڹ* @DIڹ* @Dph9 @D#@D {E?D {E?DKrb@D@~ BE+ /tϵ?Fl?~ A,@A# jk? A, J& J& J& A, A  A  !A2 "A&#I@A@$ A& A& A& A& A&A I) A* A+~  BI@  B& D%A D`i+A Dj?Dj?D[69@D<\?D^d?D^d?DJJR0@DĆpi?~ BER|g?FJR`?~ AH@A9? A, J& J& J& A,A?A@ !A2 "A&#I@A(@$ A& A& A& A& A&A I) A* A+~  B$@  B& Dj@ D@;@ D)H?D)H?DP@DeխF?D ?D ?DŎ@@D=*BZ?~ BE2;H?F5C$C`?~ A"@A]\? A, J& J& J& A, A  A  !A2 "A&#I@A@$ A& A& A& A& A&A I) A* A+~  B$@  B& DI<@ D`3@ Dp?Dp?D@DA{?DZ?DZ?D-_**@D_?~ BE3L?F{V?F(ݧo?~ AC@Ag? A, J& J& J& A,A?A? !A2 "A&#I"@A"@$ A& A& A& A& A&A I) A* A+~  B>@  B& Dy%?D  D,TÿD,T?D #D^k?DkڿDk?DcRx9DP-!?~ BE$H?F~ ?~ A=@Aʑ? A, J J J A, A  A1 !A2 "A&#I@A@$ A& G& A& A& A&A I) A* A+~  B$@  B& Dz@ Dy@ D گD گ?D<+D9?D <3D <3?DLHAJ@D!8V% ?~ BEw~?F ?~ A"@A >:C? A, J& J& J& A9 ~ A?  AR !A2 "A&#I@A@$ A& A& A& A& A&A I) A* A+~  B.@  B& D`@ D@X@ D 򌛔?D 򌛔?DjnyWO@D ?D_?D_?D(Q@D2.U?~ BE1߉% #?Fw'o?~ A,@AV|j ? A, J& J& J Ag Ah  A !A2 "A&#I@A@$ A& A& A& A& A&A I) A* A+~  BD@  B& DD  D;"qQDֿD;"qQD?DIam5D1G$?D?D??DBλ{D6?~ BEIYg}?F'Z ?~ AC@A1Ƀ? A, JC JD JE AFA?A? !A2 "A&#I@A @$ A& A& A& A& A&A I) A* A+~  B9@  B& DO A DA D{AKٿD{AK?Dx~O7DfT?DEDE?DlߦED p?~ BE)Uvz?F)_?~ A8@AG? A, J& J& J& A0~ A?  A1 !A2 "A&#I@A@$ A' A' A' A' A'A I) A* A+~  B9@  B' DbA D`A DUF- ?DUF- ?D/Ng0@D!?D_'?D_'?Dκ@Dc?~ BEJ)u?F͋?~ A8@AP*E5? A, J' J' J ' A0~ A?  A !A2 "A '#I*@A.@$ A ' A ' A ' A ' A'A I) A* A+~  B.@  B '~  DA D @ D!0D!0@Dj*TD Z2?D\D\?D+X=QD@֝?~ BE\?F HOQ?~ A,@A! )9? A, Jc Jc Jc A0 A  A !A2 "A'#I@A@$ A' A' A' A' A'A I) A* A+~  B$@  B' D@ D@L@ D` 3D` 3?D#wD%GDJn/?D`}D`}?Db>D?a?~ BEQ?FSP?~ A"@A]p? A, J J J Ag Ah  Ah !A2 "A'#I@A@$ A' A' A' A' A 'A I) A* A+~  B$@  B' DqK@ D@0@ D&U}SD&U}S?D7CDU<6?DM׿DM?D.PqN6D~L^?~ BE#+?F#$C?~ A"@AJ? A, J!' J"' J#' A,A?A? !A2 "A$'#I@A@$ A%' A&' A%' A'' A('A I) A* A+~  B>@  B%'~  D?@TM D`Lb=A DgiDgi?DwؤGPDD/%?DtDt?D6%HDhl2?~ BEKsOYQ?F!J?~ A=@AloK_? A, J  J  J A,A@A@ !A2 "A)'#I@A@$ A*' A+' A*' A,' A-'A I) A* A+~  B$@  B*' D@@ DH@ D]/{S?D]/{S?DdfO@DE:#T?D ?D ?Da©^U@D/?~ BE|u?F#ܱi/?~ A"@Adcݦ3? A, J.' J/' J0' A, A  A !A2 "A1'#I@A@$ A2' A3' A2' A4' A5'A I) A* A+~  B@  B2' D @ D`@ DC`)DC`)?D'4>D;ᮆ"+?DD?D90Ю@Dzm?~ BE ?Fo:?~ A@Ab@dF? A, J6' J7' J8' A,A?A@ !A2 "A9'#I@A@$ A:' A;' A:' A<' A='A I) A* A+~  B@  B:' D ڦ@ D `lI@ D$J?D$J?Dd47@Dnt?DU?DU?DNC[K@D ' J?' J A, A  A@' !A2 "AA'#I@A@$ AB' AC' AB' AD' AE'A I) A* A+~  B.@  BB' D A@ D @ D#sp/?D#sp/?DPE@D?DGDG?D5l9?DOK?~ BE jlqq?F`:?~ A,@AZ̸?? A, JF' JG' JH' A,A?A@ !A2 "AI'#I@A @$ AJ' AK' AJ' AL' AM'A I) A* A+~  B$@  BJ' D W@ D@ D;?D;?Dh".B@D R?D??D??D}f1 SJ@Dk_?~ BE]RQ?Fp˕G?~ A"@AAPa? A, JN' JO' Jo A,A?A@ !A2 "AP'#I@A @$ AX' AY' AX' AZ' A['A I) A* A+~  B$@  BX' DZ@ D@ Dob?Dob?D@?D(7%su/?D~D~?DߢGO D?~ BE+?FͥD6?~ A"@A+! ? A, J\' J]' J^' A, A  A !A2 "A_'#I@A@$ A`' Aa' A`' Ab' Ac'A I) A* A+~  B4@  B`' D@ !@~  DA DG拶@DG拶@D v@Dpqg@Dൣ?Dൣ?DQ=1\@DCTe-@~ BEkG?F!t&?~ A3@A + ? A, Jd' Je' Jf' A,A?A@ !A2 "Ag'#I @A"@$ Ah' Ai' Ah' Aj' Ak'A I) A* A+~  BA@  Bh' D9HA~  D  D_p?D_p?Dv:8@D1 !y5?DkB?DkB?D^"8@D:b?~ BE_N(2?FEkE5?~ AA@A',? A, Jl' Jm' Jn' A,A?A@ !A2 "Ao'#I @A"@$ Ap' Aq' Ap' Ar' As'A I) A* A+~  B[@  Bp' D @TA~  D`P DHhHGg?DHhHGg?D#6 "?Dm9?D 9D 9?Dtv DqIIN?~ BEO]?F60?~ A@[@AEd? A, Jt' Ju' Jv' A,A?A? !A2 "Aw'#I @A<@$ Ax' Ay' Ax' Az' A{'A I) A* A+~  B4@  Bx' D@ D;A D( ?D( ?D|d5@D*RNl?D?D??Dh"Q Dvl?~ BE ص~?FUvC?~ A3@Aky? A, J|' J}' J~' A, A  A9 !A2 "A'#I"@A$@$ A' A' A' A' A'A I) A* A+~  B.@  B' D KKA D @ D) D) ?DXwBD|?D ؿD ?D@R6D%=?~ BE{R?Fm?~ A,@Arܞ;W? A, J' J' J' A,A?A@ !A2 "A'#I@A@$ A' A' A' A' A'A I) A* A+~  B$@  B' D@ D;@ DirDir?Do@CDO1?D_cD_c?DH BD>t?~ BE`Ts?F{ C~?Fn#?~ A"@A+? A, JC JD JE AFA@A? !A2 "A'#I@A@$ A' A' A' A' A'A I) A* A+~  B4@  B'~  D`A@ D` A D嬇]]?D嬇]]?DJ.Z@D,V@D@?D@?DyBliG@D*χ?~ BE?FS?~ A3@A#UK? A, J' J' J' Ag Ah  A  !A2 "A'#I@A@$ A' A' A' A' A'A I) A* A+~  B@P@  B' D* DJ9  Dj Dj ?DiRkhtFD#F?D?ID?I?Dq7DD'M؊'?~ BE'?Fjvc j\?~ AP@A$g? A, J J J A,A@A? !A2 "A'#I@A.@$ A' A' A' A' A'A I) A* A+~  B.@  B' D,@ D@ D&ND&N?D.wEED{#m?D:?D:?D:CV@D/?~ BEOHJ'?Frd5J?~ A,@A(IJ? A, J' J' J' A~ A?  A' !A2 "A'#I@A@$ A' A' A' A' A'A I) A* A+~  B@  B' D@{@ DKV@ DU'?DU'?D+J@DW1?D<DՙZ3DS?D ̿D ?D$>j,D\?~ BE?Fzmѯ?~ A,@A׿? A, J ( J ( J ( A,A?A? !A2 "A(#I@A@$ A( A( A( A( A(A I) A* A+~  BQ@  B( D GxXA~  Do8M Dsw%ODsw%O?D HDM0{J(?D D ?Dl @DLSٚ)?~ BE:sVoKV?F~J?~ A@Q@A #? A, J J  J A,A?A@ !A2 "A(#I@A1@$ A( A( A( A( A(A I) A* A+~  BQ@  B( DD;   DxDx?DQ,~ED^$>?D ~ٿD ~?D[| 8DiG?~ BE?F!;?~ A@Q@A\?? A, J( J* J- A,A?A@ !A2 "A(#I@A.@$ A( A( A( A( A(A I) A* A+~  BI@  B( DJ6D&  DtmDtm?D]JD߸?D_D_?D,:3 j DRr_?~ BE璘?FJ?~ AH@Aͺ^=\? A, J( J( J ( AV~ A?  A !A2 "A!(#I@A,@$ A,( A-( A,( A.( A/(A I) A* A+~  B.@  B,( D`cA D A D(p?D(p?D 9@D?DaDa?D\QAD앰!e?~ BE6?Fo!?~ A,@A7yT+? A, J0( J1( J2( A,A?A@ !A2 "A3(#I@A@$ A7( A8( A7( A9( A:(A I) A* A+~  B@  B7( Ds@ D;@ DnF?DnF?D~ݴ3pA@Dm?DD?D*foPD/A`R?~ BEV8'?F4\@?~ A@Aʿ'? A, J;( J<( J=( A,A?A@ !A2 "A>(#I@A@$ A?( A@( A?( AA( AB(A I) A* A+~  B$@  B?( D@ D@ Ddp?Ddp?D0>*\"@Dc}?DYDY?D줵F DjQe?~ BE\?Fi?~ A"@A ? A, JC( JD( JE( A, A  A !A2 "AF(#I@A@$ AG( AH( AG( AI( AJ(A I) A* A+~  B@  BG( Dդ@ D`@ Db ˃*I?Db ˃*I?Dm0A@Dk-J?D6?D6?DPQ2C@DJ.xT?~ BER Ia?FH}H?~ A@A55? A, J% JK( JL( A,A@A@ !A2 "AM(#I@A@$ AV( AW( AV( AX( AY(A I) A* A+~  B.@  BV( D-A DiA DcӿDc?D'3D?D?D?Djb1@D.?~ BER.?F&HǴ?~ A,@A4R? A, JZ( J[( J\( A,A?A@ !A2 "A](#I@A@$ A^( A_( A^( A`( Aa(A I) A* A+~  B@  B^( DR@ D@ D=1|?D=1|?DpS@D&q?D`?D`?D5P@Dil}?~ BEmV?FS?~ A@A(c)? A, JJJ A,A?A@ !A2 "Ab(#I@A@$ Ac( Ad( Ac( Ae( Af(A I) A* A+~  B$@  Bc( D@ D@ D s*?D s*?D2>eJFR@D@<~t?D??D??DqpvR@D) ?~ BEB1?FOM?~ A"@Ag` ? A, Jg( Jh( Ji( A,A?A? !A2 "Aj(#I@A@$ Ap( Aq( Ap( Ar( As(A I) A* A+~  B4@  Bp( D@X^A D@A D~?D~?Ds.R@DR3?DK?DK?Dye=7@D~F?~ BE*==d?F%?~ A3@A ? A, Jt( Ju( Jv( Aw( Ax(  Ay( !A2 "Az(#I@A@$ A{( A|( A{( A}( A~(A I) A* A+~  B$@  B{( D A D A Dw'ܿDw'?D-Q'G:D`\?D?D??Dą~.DFeo?~ BEguګ?FU8?~ A"@Ag;? A, J( J( J( A( A(  A( !A2 "A(#I@A@$ A( A  A( A( A(A I) A* A+~  B$@  B( D,5A~  DͳC DRo^?DRo^?Dv'Z@DM^@D?D?D&^Nh@D`'i@~ BE-> ?FDj?~ A"@A֋? A, J J J A~ A?  A !A2 "A(#I@A@$ A( A( A( A( A(A I) A* A+~  B@  B( D @ D ɦ@ D, ͿD, ?D!#Cq-D3X?D0?D0?D]Ze,C@D"?~ BE˴zH1`?F(ݧo?~ A@Ay)? A, J( J( J( A0A?A? !A2 "A(#I@A@$ A( A( A( A( A(A I) A* A+~  B4@  B( D4DLM  D,7zJCD,7zJC?D?pEYADB\b?DD?DDxFDH{q?~ BEC) A, A?A@ !A2 "A?) #I@A@$ AP) AQ) AP) AR) AS) A I) A* A+~  B@  BP)  Ddߠ@  D )@  Dץ5z Dץ5z? Di'G DH.? D D? Dd;62F D ib?~ B ED.x? Fm?~ A@ A6nh? A, Je J~ JT) A, A?A@ !A2 "AU) #I@A@$ AV) AW) AV) AX) AY) A I) A* A+~  B$@  BV)  D@  D@  D'r? D'r? DtgpG@ D !? D#? D#? D *1@ DiX4&?~ B E>T? F6':?~ A"@ ACR? A, JZ) J[) J A, A?A? !A2 "A\) #I@A@$ A]) A^) A]) A_) A`) A I) A* A+~  B.@  B])  D@  DY?@  D~[ٿ D~[? DXK-f8 D8/91? D_uп D_u? DJ20 D`=D?~ B Eg!G? F?ȓQ?~ A,@ A =⡑? A, Ja) Jb) Jc) A, A  A !A2 "Ad) #I@A@$ A) A) A) A) A)A I) A* A+~  BR@  B) DD+R  DpmhoDpmho?DṔJD3,?D OD O?Dbh\AD܎?~ BE@SZhM?Ffk3}?~ AR@A0$? A, J J J A,A@A? !A2 "A)#I"@A3@$ A) A) A) A) A)A I) A* A+~  BK@  B) D<D/)Q  D\K?D\K?D_j'4@DӍ9?D?;ӿD?;?D'2D(Ԃ?~ BEƖEʄ?FU9?~ AK@A6H? A, J J J A,A@A? !A2 "A)#I@A(@$ A) A A) A) AA I) A* A+~  B>@  B) Dx7A DI:A DM?DM?D/66(@D<^?DL?DL?D+~A@D#?~ BE/x?FVL?~ A=@AL?`Q? A, JJJ AFA?A? !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B$@  B) DODwRvT  D!oy׿D!oy?D 4G6D2ƫ?DFIݿDFI?De1!.;DۉeM?~ BE=?Fϒx%?~ A"@As? A, J) J) J) A; A<  A< !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B@  B) D=@@ D3@ D]5P5?D]5P5?DɃW(@DoIl?D˿D?D?,+D4?~ BEѮ?F1gC?~ A@A_? A, J) J) J) A,A?A? !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B$@  B) D@^R@ DW@ D{?D ?D ?DzH9Q@DXs?~ BE{L?FW#~/?~ A"@A^$*U? A, J) J) J) A, A  A  !A2 "A)#I@A @$ A) A) A) A) A)A I) A* A+~  B@  B) Du@ Dx@ DWzpDWzp?D˭IDN?D D ?DhGALD F ?~ BEzvr?F cf?~ A@A"נZ? A, J) J) J) A, A  A !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B@  B) DiU@ D2ё@ D6"uܿD6"u?D,;:D6n?D ÿD ?D]d#DŽP?~ BErY?FU8?~ A@AnZ) 2? A, J) J) J) A, A  A !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B$@  B) DA D>VA D؅* ?D؅* ?D a5C$@Drޝ?DߓbDߓb?Dl@DBX|?~ BEMRa?FO0?~ A"@Ad7? A, J) J) J) A A  A !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B$@  B) D@ @ D%@ D A7?D A7?Dqk@D @D?6?D?6?DM;`@Dc@~ BE榈Tϲ?Fm?~ A"@AQ? A, J) J) J) A0~ A?  A !A2 "A)#I@A@$ A) A) A) A) A)A I) A* A+~  B$@  B)~  D@ D !%@ DTMg<DTMg#O?~ BE'?F&HǴ?~ A"@Aˤ"=H? A, J* J* J* A, A  A  !A2 "A*#I@A@$ A* A* A* A* A*A I) A* A+~  B@  B* D% @ D X@ D D ?DgGdrAD/M4cp?DyοDy?DW.D#%?~ BE"߯?FIA8 ?~ A@Aߜ!u? A, J* J * J * A, A  A !A2 "A *#I@A@$ A * AO A * AP A *A I) A* A+~  B$@  B * D '8@~  D@ D>FrD>Fr?DR,Ãx?DC?DYDY?D&R\GD( 9 ?~ BEUp$?F&-?~ A"@A,pH? A, JJJ A, AA !A2 "A*#I@A@$ A* A A* A* AA I) A* A+~  B$@  B* D@ D`%@ DPR?DPR?D&zVI@DP?D?D?DU#bU@D9Rh?~ BEs?F,.q?~ A"@Ad*? A, JJJ AFA?A? !A2 "A*#I@A@$ A* A* A* A* A*A I) A* A+~  B$@  B* DJ{=A D`¿#A DVݝ?DVݝ??D:dPD Xo?D`D`?D:prKD'?~ BEsF?F1gN}H?~ A"@A4E<? A, J  J  Jz A,A@A? !A2 "A*#I@A@$ A* A* A* A* A*A I) A* A+~  B4@  B* D@A D`)A DtUԿDtU?DfY3D&TM?D9?D9?D-;_@D?~ BEt.?F)?~ A3@Aq? A, J* J * J!* A; A<  A"* !A2 "A#*#I@A@$ A$* A A$* A%* AA I) A* A+~  B$@  B$* D9@ D`@ DX2`DX2`?D N%^?D݊PZ?D ԿD ?De+3DAyAJ?~ BE ?F9jR9?~ A"@A*u؍? A, JJJ AFA?A? !A2 "A&*#I@A@$DrGl(2,2,2(2(,,2$,22222..2,2 %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A'* A(* A'* A)* A** A I) A* A+~  B.@  B'*  DA  D`<A  D+WX? D+WX? Dp9D(@ Dܓ^&? D f? D f? Dg<@ Dw* #A?* #A>* #A@* #AA*#A #I) #A* #A+~ # B$@ # B>*# Dd@# D@# DkB#DkB?#D4|tv]A#D1?#D=ɿ#D=?#Di*#Da'?~ #B#E'?#F=d?~ #A"@#ApDU2? #A, #JB* #JC* #JD* #A,#A?A? #!A2 #"AE*##I@A@$ $AV* $AW* $AV* $AX* $AY*$A $I) $A* $A+~ $ B$@ $ BV*$ D`4@$ D H|@$ D Y$D Y?$DێI$DU7?$D@Ba$D@Ba?$DS(C$D0H?~ $B$E?$F(B$,?~ $A"@$Ac/? $A, $JZ* $J[* $J\* $A $A $ A $!A2 $"A]*$#I@A@$ %A^* %A_* %A^* %A`* %Aa*%A %I) %A* %A+~ % B@ % B^*% DS@% D@s@% DU?%DU?%DPNEGp@%D/| @%Dn?%Dn?%D\E4z`@%DʒZQ@~ %B%Ec؃?%Fm-#?~ %A@%AXo? %A, %Jc %Jc %Jb* %A, %A % A %!A2 %"Ac*%#I@A@$ &Ak* &Al* &Ak* &Am* &An*&A &I) &A* &A+~ & B$@ & Bk*& D A& D`A& D 6Ea&D 6Ea?&D,Pÿ&Dg?&D7?&D7?&Dp(9@&Dµ-"?~ &B&Enl?&FV?~ &A"@&ALT^? &A, &Jo* &J& &Jp* &A,&A?A? &!A2 &"Aq*&#I@A@$ 'Ar* 'As* 'Ar* 'At* 'Au*'A 'I) 'A* 'A+~ ' B>@ ' Br*' DD'ȭG ' D7SM޿'D7SM?'Dv*4I<'DKk?'D 4'D 4?'DovvCF'Dg/?~ 'B'E D8?'F>|?~ 'A=@'A6? 'A, 'J 'J 'J 'AF'A?A? '!A2 '"Av*'#I@A@$ (A* (A* (A* (A* (A*(A (I) (A* (A+~ ( B@ ( B*( D i@~ ( D@( DhJܿ(DhJ?(DnJd:(DB&?(D2޿(D2?(D-[;(DW?~ (B(EX?(FQ,?~ (A@(AGA? (A, (J* (J* (J* (A,(A?A? (!A2 ("A*(#I@A@$ )A* )A* )A* )A* )A*)A )I) )A* )A+~ ) B@ ) B*) D 'dm?~ 2A"@2AOl? 2A, 2J1+ 2J2+ 2J3+ 2Aa 2A4+ 2 A5+ 2!A2 2"A6+2#I@A@$ 3A:+ 3A;+ 3A:+ 3A<+ 3A=+3A 3I) 3A* 3A+~ 3 B$@ 3 B:+3 D@H)@3 D +@3 D|xݙE?3D|xݙE?3Dz sf?3DUg<?3D?3D?3Di<k@@3DP±Q?~ 3B3E'A?3FQ,?~ 3A"@3AytC? 3A, 3J>+ 3J?+ 3J@+ 3A9 3A?A? 3!A2 3"AA+3#I@A@$ 4AB+ 4AC+ 4AB+ 4AD+ 4AE+4A 4I) 4A* 4A+~ 4 B@ 4 BB+4 D@4 D :k@4 DnT4DnT?4D0ZI4Do'?4D߰4D߰?4Du2XX8D/>XX@8DART8Dͮ~?8D%D8D%D?8D&)PwVK8DWyGg?~ 8B8EU&9?8F9B|: ?~ 8A"@8Aٙo? 8A, 8JJJ 8AF8A?A? 8!A2 8"Ak+8#I@A@$ 9Aw+ 9Ax+ 9Aw+ 9Ay+ 9Az+9A 9I) 9A* 9A+~ 9 B@ 9 Bw+9 Ds@9 DT@9 D!-п9D!-?9Db09DD2Ӧ?9DVzؿ9DVz?9DfI79DI?~ 9B9E"K?9FVi?~ 9A@9A#)? 9A, 9J{+ 9J|+ 9J}+ 9A,9A?A@ 9!A2 9"A~+9#I@A@$ :A+ :A+ :A+ :A+ :A+:A :I) :A* :A+~ : B.@ : B+: D`²@: Ds@: DIX?:DIX?:DOsS@:D2`r?:DQ?:DQ?:Dei=f@:D_UW;@~ :B:E@G7?:F^Z?~ :A,@:AZ0? :A, :J+ :J+ :J+ :A,:A?A@ :!A2 :"A+:#I@A@$ ;A+ ;A+ ;A+ ;A+ ;A+;A ;I) ;A* ;A+~ ; B$@ ; B+; D@`@; D@; D"Ȗ_;D"Ȗ_?;DڌxE;D465B?;D;D?;D⏑&C;Du?~ ;B;EA2?;Fr9?~ ;A"@;A*γ~? ;A, ;J+ ;J~ ;J+ ;A,;A@A@ ;!A2 ;"A+;#I@A@$ <A+ <A+ <A+ <A+ <A+<A <I) <A* <A+~ < B$@ < B+< D@1@< D@k@< DYM~<DYM~@<DaT<D<*ʭ?<DX<DX@<D_@W<DN!W?~ <B<ENwRYr?<FZA+ >A+ >A+ >A+ >A+>A >I) >A* >A+~ > B.@ > B+> D`C&A~ > D/V> DOͿ>DO?>D(mږ->DD_҇>D_҇?>DIO>Dxci?~ >B>EK͚?>Fg?~ >A,@>A1? >A, >J+ >J+ >J+ >A,>A?A@ >!A2 >"A+>#I@A@$ ?A+ ?A+ ?A+ ?A+ ?A+?A ?I) ?A* ?A+~ ? B@ ? B+? Dp@? Du@? D.ѿ?D.??Dx)1?D!A]??D /C?D /C??D: ?D mM?~ ?B?E:U ??F?~ ?A@?Anf,? ?A, ?J+ ?J+ ?J+ ?Ag ?Ah ? A ?!A2 ?"A+?#I@A@$DHl,2,,22,(,,222,,,2$,2,,.,,,2((@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@ @A+ @A+ @A+ @A+ @A+@A @I) @A* @A+~ @ BI@ @ B+@ D6qD!H @ Dbe@Dbe?@D2H@Da?@D_@D_?@D+/dC@D$+q?~ @B@Es]]2?@Fzsze?~ @AH@@A4:R? @A, @J @J  @J @A,@A?A@ @!A2 @"A+@#I@A(@$ AA+ AA, AA+ AA, AA,AA AI) AA* AA+~ A B@ A B+A D@A D`}@A D\AD\?AD/<#1CADº*?ADAD?AD~/>AD`Xrݞ?~ ABAETR?AFM$QN?~ AA@AAN? AA, AJ, AJ, AJ, AA,AA?A? A!A2 A"A,A#I@A@$ BA, BA, BA, BA , BA ,BA BI) BA* BA+~ B BI@ B B,~ B DvlB D WAB D5`.C?BD5`.C?BDT*@BDG{?BD@P?BD@P?BD6ן?BDw?~ BBBE/Om4?BFn#?~ BAH@BAhV?#? BA, BJ BJ BJ BAFBA?A? B!A2 B"A ,B#I@A$@$ CA , CA , CA , CA, CA,CA CI) CA* CA+~ C BA@ C B ,C D`OVA~ C DKC D :5CD :5?CD[#FCD=1Zm?CD_CD_?CD-Ϲ'KCD~>fY?~ CBCEw;+-(?CF2Y0<^?~ CAA@CA_8ˮ? CA, CJ CJ CJ CA,CA?A? C!A2 C"A,C#I@A$@$ DA, DA, DA, DA, DA,DA DI) DA* DA+~ D B4@ D B,D DdD- D DQQ((ȩDDQQ((ȩ?DD2D\>"DD}[?DDnDDn?DDJk=DD9j?~ DBDElƳ?DFYCW?~ DA3@DA\*.&? DA, DJ, DJ, DJ, DA0 DAV D A1 D!A2 D"A,D#I@A@$ EA, EA, EA, EA, EA,EA EI) EA* EA+~ E B$@ E B,E DAE D AE D ;?ED ;?ED|BmG@EDkT-?EDo?EDo?ED"8Ґ=@EDoa?~ EBEEA?EFm?~ EA"@EAE#p? EA, EJ, EJ, EJ, EA EA E A , E!A2 E"A!,E#I@A@$ FA*, FA+, FA*, FA,, FA-,FA FI) FA* FA+~ F BK@ F B*,F DEkeDfd F D22I ݿFD22I ?FD, ;FDCW?FDXܿFDX?FD*:FD d?~ FBFE7+?FF(B$,?~ FAK@FAq? FA, FJ FJ  FJ FA,FA?A@ F!A2 F"A.,F#I@A&@$ GA/, GA0, GA/, GA1, GA2,GA GI) GA* GA+~ G B@ G B/,G Dzi@G D`yb@G DTeIsGDTeIs?GDD?=GDĨ=h?GDڿGD?GDf/Ϡ8GD^Ov?~ GBGEJh~?GFKh?~ GA@GAӥYAE? GA, GJ3, GJ4, GJ5, GA,GA?A@ G!A2 G"A6,G#I@A@$ HA7, HA8, HA7, HA9, HA:,HA HI) HA* HA+~ H B$@ H B7,H D @H DaAH Dwi?HDwi?HD+x S@HD̳̕?HD v ?HD v ?HD:khR@HD$Y^Ҳ?~ HBHE8t3m?HF8zY?~ HA"@HAS? HA, HJ;, HJ<, HJ=, HA, HAj H A>, H!A2 H"A?,H#I@A@$ IAM, IAN, IAM, IAO, IAP,IA II) IA* IA+~ I BA@ I BM,I D+ږzDKge I DGq&ѿIDGq&?IDG1IDRumx?ID Q,̿ID Q,?ID,L,IDI>_x?~ IBIEy:5'?IFm?~ IAA@IA^B? IA, IJ IJ  IJ IA,IA?A@ I!A2 I"AQ,I#I@A @$ JAV, JAW, JAV, JAX, JAY,JA JI) JA* JA+~ J B9@ J BV,~ J DW3AJ D` 0AJ Dl"˿JDl"?JD%T+JDI?JDcܿJDc?JD;8'x:JD`2?~ JBJEn?JFBl?~ JA8@JA ? JA, JJC JJD JJE JAFJA?A@ J!A2 J"AZ,J#I@A@$ KA[, KA\, KA[, KA], KA^,KA KI) KA* KA+~ K B$@ K B[,K DAK DAK D`q?JKD`q?J?KDcǯ't\KKDHL?KDKD?KDEKD$C?~ KBKESמ?KFRpp?~ KA"@KAGJ? KA, KJ KJ  KJ KA,KA?A@ K!A2 K"A_,K#I@A@$ LA`, LAa, LA`, LAb, LAc,LA LI) LA* LA+~ L B@ L B`,~ L DBL DnVAL D%mLD%m?LD&R KLDS*wa?LD`ZLD`Z?LDvIWlKLDyR?~ LBLEG-w?LFu?~ LA@LARn? LA, LJ) LJ* LJ LA,LA@A? L!A2 L"Ad,L#I@A@$ MAe, MA! MAe, MA" MAf,MA MI) MA* MA+~ M B.@ M Be,M DW,DK7+ M DՍM=MDՍM=?MD4IMDsA0?MDhj?MDhj?MDI6IA@MDJ_9Y ?~ MBME̅w?MF )XO?~ MA,@MA?OD׼>?ODdX|y?ODqgC?ODOD?OD/qOD:ZКy?~ OBOENB\?OF? ?~ OA"@OA5d? OA, OJq, OJr, OJs, OA)OA?A? O!A2 O"At,O#I@A@$ PA, PA, PA, PA, PA,PA PI) PA* PA+~ P B@ P B,P D w=@P DM@P DP_$?PDP_$?PD{CG;@PDcG*m?PD_(?PD_(?PDڀ c_K@PDv P]?~ PBPEz ?PF^?~ PA@PA#D]P? PA, PJ, PJ, PJ, PA,PA?A@ P!A2 P"A,P#I@A@$&%@,(($2,2(,(((>@ABmggD ZO q5E5556Mb66Ǜ66W666/6w667O7 7-7';7oH7U7b7Gp7}7׊77g777?777  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} m} } )} !} '} } } m } I } } } I} I } } } I } } I } }  } } 2} "} ##} $$} %m%%h%,%,%,%; %h@ %,%,%, %, %, %, %, %,%,%,%,%,%,%,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ >8N????????@???@@@@??????L???????????@?$ A8NAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$N O,A A,HAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P O,LAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$ p q q q q q q q q  q  q  q  q  q q q q q q q q q q q q q q q q q q q  q !q! "q" #q# $K$ A # AP A # A # A;A B) A* A+~  B9@  A #~  Q=i QA R9R- D9R- @Dk VDi(?Q?f*Q?f*?Q%8ߞQQ}*?~ AS`C|TS?FZp?~ A8@A5X? A, AAA AFA?A? !A2 "A##I@A@$ A A A A AA B) A* A+~  B@  A Qhd@ Q g@ RD@D6KvUD $i?Q-Q-@Q>@{XQŏ?~ ASж?F~rr?~ A@A3ZY? A, A A A A,A?A@ !A2 "A#I@A@$ A| A} A| A~ AA B) A* A+~  Bt@  A|~  Q̿MA Q #A RлR-DлR-@DpևTTD: n?QA"QA"?QͦK CQ9@?~ AS'^eKV>FÑ>~ At@AƓJ`? A, A A A A,A?A@ !A2 "A#IF@A@T@$ A+ A+ A+ A+ A+ A B) A* A+~ B$@ A+ Q@1@ Q@k@ RYM~ DYM~@ DaT D<*ʭ? QX QX@ Q_@W QN!W?~ A SNwRYr? FZ FUgeg >~ AW@ AFW? A, AC AD AE AF A?A? !A2 "A #I@A3@$ A A A A A A B) A* A+~ Ba@ A QKDSMQ$  Rt Dt@ Dҫ]S DL͆? Q?P. Q?P.? QsLQ Qr!q?~ A Sؠ> FPC]?~ A`a@ Aշch ~? A, A A A Ar As Am !A2 "A #I5@AA@$ A A A A A  A B) A* A+~ BD@ A ~ Q{w QಀA Rg( Dg(@ D#պDS Drj\lX? Q  Q ? QY[E Qȗ T?~ A SqQ n? F+e `?~ AC@ AG}n? A, A A A A0~ A? A1 !A2 "A  #I @A"@$ A A  A A A A B) A* A+~ BD@ A Q`A QU@ R,d D,d? D =R Dqv#? QI QI? Q͎@UQ QT$?~ A S~c\? Fy?~ AC@ AiW1? A, AAA A, A?A@ !A2 "A #I@A(@$ A A A A AA B) A* A+~  B9@  A Q A Q@ RD?D#\RD [$?Q`\Q`\?Qñ#*JRQa-?~ AS6j!6=?F4wBp?~ A8@A0IG? A, AC AD AE AFA?A? !A2 "A#I@A@$ AX AY AX AZ A[A B) A* A+~  B9@  AX Q`eA Q`b@ RìESDìES?DRRGRD]4?QߣQߣ?QP]RQ4?!?~ AS-˭b?Fs5 .?~ A8@Aki? A, A\ A] A^ A, A  AR !A2 "A_#I"@A"@$ A" A" A" A" A"A B) A* A+~  B>@  A" QQ0J  R&V&5D&V&5?DA8RDWA?Q`/Q`/?QNQLT?~ AS‹.F?F9w?~ A=@At? A, AC AD AE AFA@A? !A2 "A"#I@A@$ A A A A AA B) A* A+~  B|@  A QZQ?\G  R[rvD[rv?DQLd4RD2g?Q r/Q r/?Q HQnH?~ AS\S}Tm<F^ɏ<~ A|@AF ? A, A A A A,A?A@ !A2 "A#IM@A@[@$ A A A A AA B) A* A+~  BK@  A QZ΄Q{-F  R1m"PD1m"P?Dŷ{QD3U?QQ?Qy!ci~QQ D7?~ AS xf?FrP@*9?~ AK@Aw bO? A, A A  A A,A?A@ !A2 "A#I@A(@$ A A A A AA B) A* A+~  Ba@  A Q2fQi  Rw/ϻ;Dw/ϻ;?D|CQD1 ?QϯQϯ?QFmHQT?~ AS&?}>F>~ A`a@A,? A, A A A AFA?A? !A2 "A#I$@A=@$ AO AP AO AQ AR A B) A* A+~  B@P@  AO  Q3Qz  R&T D&T ?Dp|QDhjaY ?QpQp?Q'?NQZG?~ ASGļF+>F2x>~ AP@A'0ד? A, A A  A A,A?A@ !A2 "AS #I@A*@$ A A A A A A B) A* A+~  B@  A  QQ$$IA  R[-:D[-:?DX#QDG) P?Q`#Q`#?Q.R.LQ]r}?~ AS;G̴:F9+.;~ A@Af? A, A A A A,A?A@ !A2 "A #IQ@A a@$ A A A A AA B) A* A+~  BW@  A QQ~1   Rq0A]Dq0A]?Da)QDWYw?QE1QE1?Q x89 NQ(u<ˍ?~ AS#MH">F؍r>~ AW@AR1v? A, A A A AFA?A? !A2 "A#I@A5@$ A% A& A% A' A(A B) A* A+~  B@U@  A% QoiQf  RW)DW)?D}QD[M:?Q Q ?Qp!LQ3a?~ ASy;yLQ?FbU؀?~ AU@A#c+? A, A) A* A+ A,A@A@ !A2 "A-#I"@A2@$ A A A A AA B) A* A+~  BR@  A QrLQ1  Rb*Db*?Dt|QDJ(";?QDmQDm?Q l7OQ.>+A2?~ AS8vb=FY4P>~ AR@A%? A, A A  A A,A?A@ !A2 "A#I@A.@$ A A A A A A B) A* A+~  BN@  A Q=*QP  R-SD-S?DЫXQD3P?QtQt?Q0%u!'OQU+?~ ASrvz>Ftp>~ AM@Aa8$t? A, A  A  A  A,A?A@ !A2 "A #I@A*@$ A A A A A A B) A* A+~  Bs@  A ~  Q7~E Q,A RTShDTSh?DQDv0?QQ?QJrlCQtP9zt?~ AS0ե>Fbc>~ As@AGFW2p>~ A e@A@-ɸX? A, A A  A A,A?A@ !A2 "A.#I*@AA@$ Av Aw Av Ax AyA B) A* A+~  B\@  Av QnQ  RCΣCDCΣC?DBPDWY?Qn5Qn5?QYmAQk?~ ASgc>F%R6?~ A\@AZųo? A, A A  Az A,A?A@ !A2 "A{#I @A8@$ AO% AP% AO% AQ% AR%A B) A* A+~  BD@  AO% Qj2Q  R'e[D'e[?DX$PD1OF?Q`RQ`R?QލrDMQѹ?~ ASܬ ?Fdׅ:?~ AC@At*? A, AS% A AT% A, A~  A@ !A2 "AU%#I@A @$ A$ A$ A$ A$ A$A B) A* A+~  BI@  A$ Q !QS~  RC1-DC1-?De8PD M?QQ?Q(IQw?~ AS+d?FSj!/5?~ AH@AK? A, A A  A A,A?A@ !A2 "A$#I@A$@$ A A A A AA B) A* A+~  B\@  A QB%Q2|  RF1 DF1 ?DEs9PDE9 ?Q`Q`?Q#w!FQ;n ?~ ASt />FUgeg >~ A\@A[=3? A, A A A A,A@A? !A2 "A#I"@A;@$D=l``|hT(2$.,2($ %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@ A A A A A A B) A* A+~ B@Z@ A QF@Qf  R[C D[C? DHP DA? Q N{ Q N{? Qz)I QaXV?~ A Sfu.> F.Դ>~ AZ@ Aurx'? A, A A  A A, A?A@ !A2 "A #I @A5@$ !A !A !A !A !A!A !B) !A* !A+~ ! BQ@ ! A! Q"qQb ! R2!D2?!D|P!Dyn?!Q?u!Q?u?!QQۑK!Qz,?~ !A!S)M>!F%>~ !A@Q@!Ax? !A, !A !A  !A  !A,!A?A@ !!A2 !"A!#I@A,@$ "A "A "A "A "A "A "B) "A* "A+~ " B@Z@ " A " QDQ" " R:mʑ"D:mʑ?"DAf`P"Dvit?"Q_w"Q_w?"Q ՃI"Q5[?~ "A"S&y4>"F^*>~ "AZ@"A"8? "A, "A  "A  "A "A,"A?A? "!A2 ""A "#I"@A6@$ #A5 #A6 #A5 #A7 #A8 #A #B) #A* #A+~ # BY@ # A5 # QAQRT # RRڶ2f#DRڶ2f?#D{ PP#D߮L=?#QO'#QO'?#QjzN#Q%Ԙ?~ #A#S˨|7>#F d?~ #AX@#A5p8V? #A, #A #A  #A #A,#A?A@ #!A2 #"A9 ##I@A4@$ $A& $A' $A& $A( $A)$A $B) $A* $A+~ $ Bq@ $ A&$ Q Z,VA~ $ Q+0$ Rk4$Dk4?$D~ 'A@[@'A.;*? 'A, 'A 'A 'A 'A,'A@A? '!A2 '"A'#I&@A8@$ (A% (A& (A% (A' (A((A (B) (A* (A+~ ( B l@ ( A%( QBf?QH ( R?T(D?T?(D+w&P(D))?(Q(Q?(Q-(C(Q|rB?~ (A(SVS>(Fu#>~ (Al@(A9PԤ[6? (A, (A (A  (A (A,(A?A@ (!A2 ("A)(#I1@AH@$ )A )A )A )A )A)A )B) )A* )A+~ ) BV@ ) A) QA) Q@) RBQ)DBQ?)D/;Fi%P)DTѪ?)Q@WO)Q@WO?)QUP)Q"& a?~ )A)Srrz]W?)FYTD ?~ )A@V@)Aj D? )A, )A )A )A )A,)A?A@ )!A2 )"A)#I3@A>@$ *A *A *A *A *A*A *B) *A* *A+~ * Ba@ * A* Qs#Q * Rt6w*Dt6w?*D[/P*D5=?*Q/:*Q/:?*QE*QjxF5!?~ *A*Sfte[>*F&4{2?~ *A`a@*A?(m? *A, *A *A *A *AF*A?A? *!A2 *"A*#I&@A@@$ +A: +A; +A: +A< +A=+A +B) +A* +A+~ + B l@ + A:+ Q;A+ Q`+r$A+ R ?42+D ?42?+D˺e(O+Dn?+Q4+Q4?+QFUH+Q5C]X?~ +A+S< @?+FoA?~ +Al@+A~B8(? +A, +A> +A? +A@ +A,+A?A@ +!A2 +"AA+#IE@AL@$ ,Ay ,Az ,Ay ,A{ ,A|,A ,B) ,A* ,A+~ , B$@ , Ay, Q`HA, Q@, R2d#.,D2d#.?,DV2O,Dr?,Q LG,Q LG?,Q%_#O,QZ{ȈX?~ ,A,SW3Kf?,FDЭ?~ ,A"@,A=/? ,A, ,A} ,A ,A~ ,A,,A?A@ ,!A2 ,"A,#I@A@$ -AB -AC -AB -AD -AE-A -B) -A* -A+~ - Ba@ - AB- Q@Q#A- Q@ A- Rf-Df?-Dq7O-DAs?-QC-QC?-QII-Qؐq?~ -A-S2p`<$>-Fv9[?~ -A`a@-AWUm_h? -A, -AF -AG -AH -A,-A?A@ -!A2 -"AI-#I>@AD@$ .AV% .AW% .AV% .AX% .AY%.A .B) .A* .A+~ . BF@ . AV%. Q/)Qz . RcC*H.DcC*H?.D7O.DYg ?.Q.Q?.QVN.QS5p?~ .A.Sc8P>.Fxw>~ .AF@.Aab ? .A, .A .A  .A .A,.A?A@ .!A2 ."AZ%.#I@A"@$ /A /A /A /A /A /A /B) /A* /A+~ / B@U@ / A / QByQ / RtaV|/DtaV|?/DT-ynO/DCg?/Q/Q?/Q4mmM/Q6ͯ?~ /A/ST-{>/FڨW ?~ /AU@/A;u? /A, /A /A /A /AF/A?A? /!A2 /"A /#I"@A6@$ 0A( 0A( 0A( 0A( 0A(0A 0B) 0A* 0A+~ 0 BF@ 0 A(0 Q˸YA~ 0 Q;0 R +0D +?0D6cO0DنLx?0Q_5 0Q_5 ?0Quϝ E0Q rs4?~ 0A0S R[?0FU-?~ 0AF@0A7h;? 0A, 0AC 0AD 0AE 0AF0A?A? 0!A2 0"A(0#I@A"@$ 1A 1A 1A 1A 1A1A 1B) 1A* 1A+~ 1 BI@ 1 A1 QڞQJ7 1 RjR1DjR?1D\_O1D7G?1Qd1Qd?1QYF1Q(L?~ 1A1Sm;?1F'K0A?~ 1AH@1A0/? 1A, 1A 1A 1A 1AF1A?A? 1!A2 1"A1#I@A$@$ 2A 2A 2A 2A  2A!2A 2B) 2A* 2A+~ 2 Bu@ 2 A2 QdQh% 2 Ru[b`2Du[b`?2DȞh.O2D)zS?2Q `\2Q `\?2QE>~J2Q?~ 2A2SK%R=2FG=~ 2Au@2A\D? 2A, 2A" 2A# 2A$ 2A,2A@A@ 2!A2 2"A%2#I<@A@S@$ 3A$ 3A% 3A$ 3A& 3A'3A 3B) 3A* 3A+~ 3 B@U@ 3 A$3 Q jA~ 3 QX3 ROƮh3DOƮh?3Dˋj[*O3D8?3Qk3Qk?3Q)N?yO3Q! RP?~ 3A3Srrwi>3Fp>~ 3AU@3A%˜?? 3A, 3A( 3A) 3A* 3A0 3A1 3 A1 3!A2 3"A+3#I @A2@$ 4A 4A 4A 4A 4A4A 4B) 4A* 4A+~ 4 BY@ 4 A4 QB\Q*z 4 R^ja4D^ja?4D+ O4D2|F?E?4Q4Q?4QD4Q"5)?~ 4A4S,>4FQJ6?~ 4AX@4A JZ+? 4A, 4AAA 4AF4A?A? 4!A2 4"A4#I$@A6@$ 5A; 5A< 5A; 5A= 5A>5A 5B) 5A* 5A+~ 5 BF@ 5 A;5 QrC Q3 5 REu[5DEu[?5D@*N5DC?5Q5Q?5Q0K5QA?5FZhtp?~ 5AF@5Ar? 5A, 5A 5A  5A 5A,5A@A@ 5!A2 5"A?5#I@A"@$ 6A 6A 6A 6A 6A6A 6B) 6A* 6A+~ 6 BW@ 6 A6 Q0QUg 6 Rl6Dl?6DcR̫N6DɠV.6?6Q6Q?6Q(\IF6QC|q?~ 6A6S fz>6F%R6?~ 6AW@6AKTR? 6A, 6A 6A 6A 6AF6A?A? 6!A2 6"A6#I&@A3@$ 7A 7A 7A 7A 7A7A 7B) 7A* 7A+~ 7 B@`@ 7 A7 Q8aQV 7 RɇB7DɇB?7D˼M7D="?7QF7QF?7Q&!;rXJ7Q5FG?~ 7A7S4aP=7FmA>~ 7A `@7A y? 7A, 7A 7A 7A 7A,7A@A? 7!A2 7"A7#I$@A>@$ 8A 8A 8A 8A 8A8A 8B) 8A* 8A+~ 8 B@j@ 8 A8 Qg!nQ^, 8 Rukү8Dukү?8DKM8D}怮?8Q f8Q f?8Q;jrSf'A8Qj"F?~ 8A8SJ/UA^?8F^9B?~ 8A j@8AO? 8A, 8A 8A 8A 8A,8A?A@ 8!A2 8"A8#I@@AM@$ 9A 9A 9A 9A 9A! 9A 9B) 9A* 9A+~ 9 B@_@ 9 A 9 QPA9 Q @9 RM>)9DM>)?9DNT}M9DRVU(.?9Q9Q?9QqyD9QfA?~ 9A9Sd0?9F~N-~D@?~ 9A_@9A^>/?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~!A2 9"A% 9#IB@AE@$ :A :A :A :A :A :A :B) :A* :A+~ : BW@ : A : QRr~Qfq| : Rly:Dly?:D %ѕzM:D,^D?:Q.:Q.?:Q`:aI:Q\֪?~ :A:SIy$B>:Fv,з>~ :AW@:AZ#iB? :A, :A :A  :A  :A,:A@A@ :!A2 :"A :#I$@A4@$ ;A> ;A? ;A> ;A@ ;AA;A ;B) ;A* ;A+~ ; B>@ ; A>; Q>9QO ; R;D?;DAL;Dxl;?;QEu ;QEu @;QxuyV;Qk^ܹ?~ ;A;S P?;FS?~ ;A=@;AZ?}? ;A, ;A ;A  ;A ;A,;A?A@ ;!A2 ;"AB;#I@A@$ <AX <AY <AX <AZ <A[<A <B) <A* <A+~ < Bu@ < AX< Q` +A< Q A< RoRݩ<DoRݩ?<Dca>L<DM?<Q0Cֿ<Q0C?<Q9hl5<Qi|$?~ <A<S6Cނ?<FTLO?~ <Au@<AJ? <A, <A\ <A] <A^ <A,<A?A@ <!A2 <"A_<#II@AT@$ =A =A =A =A =A=A =B) =A* =A+~ = B g@ = A= QQ# = R=R(3=D=R(3?=D!ǨL=DFP?=QW=QW?=QU>gE=Qls{?~ =A=SO_>=FA)?~ =Ag@=A=@? =A, =A =A =A =AF=A?A? =!A2 ="A=#I1@AE@$ >A >A >A >A >A>A >B) >A* >A+~ > B9@ > A> Q`M\A~ > Q*> Rш>Dш?>DQL>Dxt?>QOp>QOp?>Q}:luL>Q`-?~ >A>S.V_!>a?>Ff?~ >A8@>A<<\r? >A, >AC >AD >AE >AF>A?A@ >!A2 >"A>#I@A@$ ?A\ ?A] ?A\ ?A^ ?A_?A ?B) ?A* ?A+~ ? B@@ ? A\? QA~ ? Qns? RfG?DfG??DOL?Dɏ??Q ?Q ??QYKz[C?Qqj@~?~ ?A?SqHX>?F`>~ ?A8@?A$vtDп? ?A, ?A` ?Aa ?Ab ?A,?A?A? ?!A2 ?"Ac?#IE@A[@$DFl($(,,,,(.,,(@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@ @A. @A/ @A. @A0 @A1@A @B) @A* @A+~ @ B@e@ @ A.@ Q.Qx$ @ R,@D,?@D/sO6L@D1Wq?@Q@vW@Q@vW?@Qc%*N@Q#.c?~ @A@SάC3К=@F9=~ @A e@@AH? @A, @A2 @A3 @A4 @A,@A?A? @!A2 @"A5@#I3@AA@$ AA AA AA AA AAAA AB) AA* AA+~ A Bn@ A AA QtQd3 A R^*UAD^*U?AD KADWtK?AQAQ?AQ`DBޔe>AQߘE?~ AAAS@T?AFx)D?~ AAm@AA'vx? AA, AA AA AA AA,AA?A@ A!A2 A"AA#I6@AL@$ BA BA BA BA BABA BB) BA* BA+~ B Bu@ B AB Q^)Qw'A B RQBDQ?BDůYKBDM \?BQvBQv?BQTr5@BQG?~ BABSOz]:?BF#m?~ BAu@BAl$8? BA, BA BA BA BA0~ BA? B A1 B!A2 B"AB#IA@AU@$ CAr CAs CAr CAt CAuCA CB) CA* CA+~ C B@P@ C ArC QrOQ& C Rl`CDl`?CD^!OӽKCDnש}?CQCQ?CQl^LCQRdA k?~ CACSgk`>CF);>~ CAP@CAŨ ? CA, CAv CAD CA CAFCA?A? C!A2 C"AwC#I@A.@$ DA DA DA DA  DA!DA DB) DA* DA+~ D BN@ D AD QOQFd D R!\mDD!\m?DD-k~KDDuiY?DQDQ?DQԳKDQٙ~?~ DADS؏?DFQn aJ?~ DAM@DAYt? DA, DA DA  DA  DA,DA?A@ D!A2 D"A"D#I@A*@$ EA EAP EA EA  EA;EA EB) EA* EA+~ E B@P@ E A~ E QE Q IUAE RYEDY?EDY;1KEDx=n0?EQ@$EQ@$?EQ D̃BEQuE}O?~ EAESW7mBp?EF?~ EAP@EAH2? EA, EAAA EAFEA?A? E!A2 E"A!E#I@A,@$ FA! FA! FA! FA! FA!FA FB) FA* FA+~ F BR@ F A!F Q>Q̸A F RFD?FDhO6 KFDa?FQ FQ ?FQ61H\OFQ1?~ FAFSmT>FF.t?~ FAR@FAQJl\\? FA, FA FA  FA FA,FA?A@ F!A2 F"A!F#I @A0@$ GAS GAT GAS GAU GAV GA GB) GA* GA+~ G B~@ G AS G Q@9AG Q AG RҕGDҕ?GDRJGD@ %?GQhOGQhO?GQa xDGQT_?~ GAGSV0=GFhJ+>~ GA~@GA {? GA, GAW GAX GAY GA,GA?A@ G!A2 G"AZ G#IA@AZ@$ HA HA HA HA HA HA HB) HA* HA+~ H B.@ H A H Q{AH Q`@H RTr6HDTr6?HDmJHD ?HQ HQ ?HQm&\p|HHQh92T?~ HAHS5z466\?HFy?~ HA,@HAXa_'? HA, HA HA HA HAt HAu H A H!A2 H"A H#I@A@$ IA IA IA IA IA IA IB) IA* IA+~ I BF@ I A ~ I QZ I QW^AI R#pID#p?IDFJIDS8?IQIQ?IQ}ȉFIQvCV?~ IAISb?xkM?IFB4e?~ IAF@IA鑭? IA, IA IA IA IAFIA?A? I!A2 I"A I#I@A"@$ JA) JA) JA) JA) JA)JA JB) JA* JA+~ J BR@ J A)J QQ+R J RpmhoJDpmho?JDṔJJD3,?JQ OJQ O?JQbh\AJQ܎?~ JAJS@SZhM?JFfk3}?~ JAR@JA0$? JA, JA JA JA JA,JA@A? J!A2 J"A)J#I"@A3@$ KAO KAP KAO KAQ KARKA KB) KA* KA+~ K Bp@ K AOK Q`|AK Q AK RQiKDQi?KD%>΢{JKDt??KQu.KQu.?KQbeBKQA|9?~ KAKS5ȳ?KFYЍ^G?~ KAp@KA(? KA, KAS KAT KAU KA0 KAV~ K A? K!A2 K"AWK#I5@AK@$ LA LAP LA LA LALA LB) LA* LA+~ L B@ L A~ L Q$SBL Q1AL RRLDR?LDV>RdJLDDY7?LQ`LQ`?LQELQ38;?~ LALS7دܘ;LFjyM <~ LA@LA ? LA,LA LAD LA LA,LA?A? L!A2 L"AL#IG@A c@$ MAD MAE MAD MAF MAG MA MB) MA* MA+~ M Bb@ M AD ~ M Q{P^M Q.9o?~ NANSwWeP?NF7ŽۮB?~ NA e@NAk? NA, NANA NA NA,NA?A@ N!A2 N"AN#I(@AB@$ OAo OAp OAo OAq OArOA OB) OA* OA+~ O B`h@ O AoO Q QR] O R&JOD&J?OD.9PPIOD,F2?OQ޿OQ?OQR<OQyQ?~ OAOSue>OFqn>~ OA@h@OAc$4? OA, OAs OAt OAu OA,OA?A@ O!A2 O"AvO#I0@AJ@$ PAx PAP PAx PAy PA;PA PB) PA* PA+~ P BD@ P AxP Q#fYQ q P R/A&HPD/A&H?PDrMIPDkfw?PQPQ?PQL9GPQ d?~ PAPSf7s?PFs?~ PAC@PAw1u? PA, PALPA PAM PAFPA?A@ P!A2 P"AzP#I@A"@$ QA  QA! QA  QA" QA#QA QB) QA* QA+~ Q Bd@ Q A Q Q`_(A~ Q Q[g Q Rغ QDغ ?QDHܯHQDѲ ?QQQQQQ?QQݙZAQQ"yK?~ QAQS3%?QFK-?~ QAd@QAEy a? QA, QA$ QA% QA& QA, QA' Q A( Q!A2 Q"A)Q#I7@AF@$ RA+ RA+ RA+ RA+ RA+RA RB) RA* RA+~ R BI@ R A+R Q6qQ!H R RbeRDbe?RD2HRDa?RQ_RQ_?RQ+/dCRQ$+q?~ RARSs]]2?RFzsze?~ RAH@RA4:R? RA, RA RA  RA RA,RA?A@ R!A2 R"A+R#I@A(@$ SA# SA$ SA# SA% SA&SA SB) SA* SA+~ S B^@ S A#S Q69QOf_ S R"4SD"4?SDHSD䀢#?SQhlSQhl?SQ˔Y=SQUIk?~ SASS5 s?SFl0'ኜ?~ SA]@SAXe,? SA, SA SA  SA SA,SA?A@ S!A2 S"A'S#I&@A>@$ TA TA TA TA TATA TB) TA* TA+~ T BD@ T AT Q; ooQ6 T RGTDG?TD:HTD '?TQ TQ ?TQ#VETQW?~ TATSYme?TFU&?~ TAC@TAׇ? TA, TA TA TA TAFTA?A? T!A2 T"AT#I@A$@$ UA( UA( UA( UA( UA(UA UB) UA* UA+~ U BQ@ U A(U Q GxXA~ U Qo8MU Rsw%OUDsw%O?UD HUDM0{J(?UQ UQ ?UQl @UQLSٚ)?~ UAUS:sVoKV?UF~J?~ UA@Q@UA #? UA, UA UA  UA UA,UA?A@ U!A2 U"A(U#I@A1@$ VA VA VA VA VAVA VB) VA* VA+~ V BX@ V AV Q#QKQA V RVD?VDq44HVD ,?VQHĿVQH?VQ%%VQ#?~ VAVSYu#?VFxޗ\?~ VAV@VA nخ? VA, VA VA VA VA,VA?A@ V!A2 V"AV#IPr@A(@$ WA! WA! WA! WA! WA!WA WB) WA* WA+~ W B>@ W A!W Qc)Q W R{==WD{==?WDC&lHWDvi6^?WQLwWQLw?WQ*62EWQn?~ WAWS~#RM?WF&j}?~ WA=@WAф@H? WA, WALWA WAM WAFWA?A? W!A2 W"A!W#I@A@$ XAe XAf XAe XAg XAhXA XB) XA* XA+~ X B`c@ X AeX QתA~ X Q.ZX RWp*XDWp*?XD GXD|k?XQ pXQ p?XQtx /KBXQ`'+J?~ XAXSd2k>XFbþ?~ XA@c@XAm0)? XA, XAi XA XAj XA,XA?A@ X!A2 X"AkX#I*@A@@$ YA YA! YA YA" YA# YA YB) YA* YA+~ Y B`x@ Y A Y Q A~ Y Q}XY R q$$YD q$$?YD Bw(gGYDK?YQYQ?YQvAYQY?~ YAYS{H>YF%>~ YAPx@YA ? YA, YAAA YAFYA?A? Y!A2 Y"A$ Y#I>@AU@$ ZAh ZAi ZAh ZAj ZAkZA ZB) ZA* ZA+~ Z BK@ Z AhZ Q`qAZ Q`LEAZ Rs ZDs ?ZDDV@eGZD n)?ZQ?ZQ??ZQ؁׫LZQު?~ ZAZSx61?ZF`~nC?e?~ ZAK@ZAlU? ZA, ZAAA ZA, ZAA Z!A2 Z"AlZ#I@A*@$ [Av [Aw [Av [Ax [Ay[A [B) [A* [A+~ [ BR@ [ Av[ Q"XQn [ R(Ӑ[D(Ӑ?[D;1p6G[D"Q$?[Q[Q?[QOEA[QQX(?~ [A[SCX?[Fq2P?~ [AR@[A퐼? [A, [AAA [AF[A?A? [!A2 ["Az[#I@A1@$ \A@ \AA \A@ \AB \AC\A \B) \A* \A+~ \ B@ \ A@\ QBIQ \ R{\U\D{\U?\Dc7a4G\D'f8.(&?\Q2`\Q2`?\Q 7[=\QTf*q?~ \A\SQ@H=\Fh>~ \A@\ArkoQ? \A, \AAA \AF\A?A? \!A2 \"AD\#IT@Aj@$ ]A , ]A , ]A , ]A, ]A,]A ]B) ]A* ]A+~ ] BA@ ] A ,] Q`OVA~ ] QK] R :5]D :5?]D[#F]D=1Zm?]Q_]Q_?]Q-Ϲ'K]Q~>fY?~ ]A]Sw;+-(?]F2Y0<^?~ ]AA@]A_8ˮ? ]A, ]A ]A ]A ]A,]A?A? ]!A2 ]"A,]#I@A$@$ ^Aw ^Ax ^Aw ^Ay ^Az^A ^B) ^A* ^A+~ ^ Bl@ ^ Aw^ Q;dQ6 ^ R#U8^D#U8?^D`F^D`V?^Qt%^Qt%?^Qz0@@^Q z?~ ^A^S>^FԾ0?~ ^Al@^AI? ^A, ^A{ ^AT ^A| ^A,^A?A@ ^!A2 ^"A}^#I5@AH@$ _A' _A' _A' _A' _A'_A _B) _A* _A+~ _ B@P@ _ A'_ Q* QJ9 _ Rj _Dj ?_DiRkhtF_D#F?_Q?I_Q?I?_Qq7D_Q'M؊'?~ _A_S'?_Fjvc j\?~ _AP@_A$g? _A, _A _A _A _A,_A@A? _!A2 _"A'_#I@A.@$DPFl$,2(2$(.(( (`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@ `A `A `A `A `A`A `B) `A* `A+~ ` BT@ ` A` QHA` QK A` Rry?`Dry??`D$U JF`Dm?`Qa`Qa?`QjΚF`Q윟?~ `A`S$wPJ?`F {?~ `AS@`A6? `A, `A `A `A `A, `A ` A `!A2 `"A`#I6@A;@$ aA aA aA aA aAaA aB) aA* aA+~ a Bh@ a Aa Q]MQ+ a RaR]>aDaR]>?aDQǞuIFaDf{Z?aQaQ?aQR0 Q=aQ^Y\?~ aAaSLY>aF2x>~ aA`@aA/M? aA, aA aAa aA aA,aA?A? a!A2 a"Aa#II@A]@$ bAE bAP bAE bAF bA;bA bB) bA* bA+~ b BV@ b AEb QzȔQ:? b RcF0 ?~ cA@[@cA[T? cA, cA cA cA cAFcA?A? c!A2 c"Ac#I"@A8@$ dA dA dA dA dAdA dB) dA* dA+~ d B@ d Ad QB^Q d R}c!6dD}c!6?dDr"EdD)#?dQL dQL ?dQM6-@dQ?C?~ dAdS > F=dF:=~ dA@dA`;? dA, dA dA dA dA,dA?A? d!A2 d"Ad#IQ@Ah@$ eA eA eA eA eAeA eB) eA* eA+~ e B b@ e A~ e Qʛe QWAe R s>eD s>?eD1|7SzEeDskA?eQeQ?eQaXFDeQ+u?~ eAeS'ܭ|=j>eF E>~ eAb@eA2R5JT? eA, eAeA eA eA,eA?A@ e!A2 e"Ae#I2@A@@$ fA fA fA fA fAfA fB) fA* fA+~ f BF@ f Af QRQ f RK6]fDK6]?fDFŨVEfD]CmW?fQ`fQ`?fQ-9 FEfQ:b?~ fAfSuH=i?fFq2P?~ fAF@fAR]? fA, fA fA fA fA, fA f A1 f!A2 f"Af#I@A"@$ gA( gA) gA( gA* gA+gA gB) gA* gA+~ g Bp@ g A(g QcAg Q Ag RIgDI?gD AՍ=EgD!%g?gQ@$ gQ@$ ?gQKZLBgQf|J?~ gAgS1^a?gF_(Q?~ gAp@gAaW? gA, gA, gA* gA- gA,gA?A? g!A2 g"A.g#I5@AL@$ hAK hAL hAK hAM hANhA hB) hA* hA+~ h B@P@ h AKh Qp%Ah Q4Ah R:@ k A%'~ k Q?@TMk Q`Lb=Ak RgikDgi?kDwؤGPDkD/%?kQtkQt?kQ6%HkQhl2?~ kAkSKsOYQ?kF!J?~ kA=@kAloK_? kA, kA  kA  kA kA,kA@A@ k!A2 k"A)'k#I@A@$ lA lA lA lA lAlA lB) lA* lA+~ l B@_@ l A~ l Q߯l QdB&Al RElDE?lDt($DlD;kKއ?lQDlQD?lQM\UBlQ a?D?~ lAlSd:99?lF~rr?~ lA_@lA9-? lA, lA lA lA lA,lA?A@ l!A2 l"Al#I3@A@@$ mA mA mA mA mAmA mB) mA* mA+~ m Bs@ m Am Q EAm QAm RmD?mD5i DmD9?mQ mQ ?mQIWBmQVR|?~ mAmS(Q?mFjϳR?~ mAs@mA. ? mA, mA mA mA mA,mA?A@ m!A2 m"Am#IJ@AT@$ nA nA nA nA nAnA nB) nA* nA+~ n Bl@ n An Q An QAn R|\TnD|\T?nDW kCnD%?~?N?nQ`LnQ`L?nQmvYUCnQ+U?~ nAnSiE?nF#G?~ nAl@nA,7? nA, nA nA nA nA,nA?A@ n!A2 n"An#IE@AO@$ oA oA oA oA oAoA oB) oA* oA+~ o Bd@ o Ao Q`%Ao QAo RLE*oDLE*?oD;iCoD,Ḥ_?oQ 7oQ 7?oQBqqrGoQwoo?~ oAoSl;c˵=?oF!")p?~ oAd@oAYiF? oA, oA oA" oA oA,oA?A@ o!A2 o"Ao#I7@AD@$ pA pA pA pA pApA pB) pA* pA+~ p Bi@ p Ap Qp2A~ p Qp RVP pDVP ?pDICpDLD)l?pQ%0pQ%0?pQp?pQr ?~ pApSGʧZ?pF\ׇ?~ pAh@pAt? pA, pA pA pA pA,pA?A@ p!A2 p"Ap#IB@AL@$ qA< qA= qA< qA> qA? qA qB) qA* qA+~ q By@ q A< q Q|Aq Q Aq Rg|qDg|?qD3PPCqD+h"?~ qAy@qAlj⪔? qA, qA@ qAA qAB qA, qA q A q!A2 q"AC q#IL@AY@$ rA rA rA rA rArA rB) rA* rA+~ r B b@ r Ar Q Ar QnAr RIq͓;rDIq͓;?rD60_CrD?rQ2rQ2?rQmk3ErQ h$?~ rArSs?rFl0'ኜ?~ rAb@rA\R"C? rA, rA rA rA rA,rA?A? r!A2 r"Ar#I;@AB@$ sA sA sA sA sAsA sB) sA* sA+~ s Bd@ s As QQ s R/5"esD/5"e?sD=zY8CsDx4?sQcsQc?sQ;DsQ،6?~ sAsSR 7V?sF~J?~ sAd@sAϰ"? sA, sA sA sA sA,sA?A@ s!A2 s"As#I5@AB@$ tA/ tA0 tA/ tA1 tA2tA tB) tA* tA+~ t B0{@ t A/t Q&Q9 t RFtDF?tDBtDSk?tQtQ?tQµ <>tQz65.S?~ tAtS5Bk)?tF"1j^9^?~ tA {@tAW? tA, tA3 tA4 tA5 tA,tA?A@ t!A2 t"A6t#IM@AY@$ uA uA uA uA uAuA uB) uA* uA+~ u BQ@ u Au QdpQrY u RQuDQ?uD6=BuD`?uQuQ?uQև=DuQ..+$?~ uAuSb]6?uF~i?~ uA@Q@uA]XA? uA, uAC uAD uAE uAFuA?A? u!A2 u"Au#I @A.@$ vAc vAd vAc vAe vAf vA vB) vA* vA+~ v B@ v Ac v Q pAv QaiAv R  vD  ?vDESYBvD/A?vQ`#vQ`#?vQEj>@vQ C?~ vAvSt5=vF_ >~ vA@vA3^6? vA, vAg vAh vAi vA,vA?A? v!A2 v"Aj v#IQ@A`h@$ wA wA wA wA wA wA wB) wA* wA+~ w By@ w A w Q^UA~ w QWw RTotdwDTotd?wDATyAwDտ?wQ"TwQ"T?wQ($K?wQZ^H?~ wAwSv]t>wF>|8 >~ wAy@wAVN? wA, wA wA wA wA,wA?A@ w!A2 w"A w#IB@AY@$ xA xA xA xA xAxA xB) xA* xA+~ x B\@ x Ax QlQAQpJ x RRK4xDRK4?xD1U5@xDy/(3?xQΒxQΒ?xQ]/GAxQ(?~ xAxSu|/2,>xFy ?~ xA\@xATO? xA, xA xA xA xA,xA?A@ x!A2 x"Ax#I0@A;@$ yA  yA! yA  yA" yA#yA yB) yA* yA+~ y B@ y A y Q_xq_Q[? y R$zyD$z?yDd@yD7c@L?yQ,fֿyQ,f?yQrtt5yQL_?~ yAyS~0p >yFXa%>~ yA@yAEo>? yA, yA$ yA% yA& yA,yA?A@ y!A2 y"A'y#I]@A`j@$ zA zA zA zA zA zA zB) zA* zA+~ z B@ z A z QB'&Q z ReOzDeO?zD;ag@zD,V?zQ?ؿzQ??zQal}{7zQR,|?~ zAzSi *G<zF,E=~ zA@zAy.֑? zA,zA zA" zA zA,zA?A@ z!A2 z"A z#Ik@AX@$ {A {A {A {A {A{A {B) {A* {A+~ { B@o@ { A{ Q )YA~ { Q"Z{ Tќ?{Dќ?{Dq:^H@{Dr~?{Q?{Q?{QC2:@{QO}D?~ {A{SSb?{Fs5 .?~ {A o@{AqP? {A, {A {A {A {A,{A?A@ {!A2 {"A{#I<@AN@$ |A |A |A |A |A|A |B) |A* |A+~ | B @ | A| Q Q | TM?|DM?|D$ |L@|Dl\%?|Q?|Q?|Q޸E@|Q"d<?~ |A|Sa|;|F(x ;~ |A@|AٸJـ? |A, |A |A |A |A,|A?A@ |!A2 |"A|#Ii@A@$ }A7 }A8 }A7 }A9 }A:}A }B) }A* }A+~ } Bp@ } A7} QBJ"Q6 } T]U?}D]U?}D%sL@}D2X;?}Qs?}Qs?}QpJD@}Qgka~?~ }A}S762?}F`~nC?e?~ }Ap@}AY%? }A, }A; }A< }A= }A,}A?A@ }!A2 }"A>}#I6@AJ@$ ~A ~A ~A ~A ~A~A ~B) ~A* ~A+~ ~ Bt@ ~ A~ QXQz% ~ T|r ?~D|r ?~De:fdM@~DJSS?~Q?~Q?~QgI@~QN5/0!?~ ~A~Sp_s ?~F_eC?~ ~As@~A,4? ~A, ~A ~A ~A ~A,~A?A? ~!A2 ~"A~#IB@AR@$ Ac Ad Ac Ae AfA B) A* A+~  B@  Ac QfQB  TR?DR?DKGKN@Dv?Q_?Q_?Q/gB@Qia?~ ASu%/C>F d?~ A@A6kfA? A, Ag Ah Ai A,A?A@ !A2 "Aj#IT@Af@$DFl2$$,,,((,,,(2,,((%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ A*' A+' A*' A,' A-'A B) A* A+~ B$@ A*' Q@@ QH@ T]/{S?D]/{S?DdfO@DE:#T?Q ?Q ?Qa©^U@Q/?~ AS|u?F#ܱi/?~ A"@Adcݦ3? A, A.' A/' A0' A, A A !A2 "A1'#I@A@$ A" A# A" A$ A%A B) A* A+~ BT@ A" Q{,Q  T`T?D`T?DHlO@DE@Q?Q&?Q&?QCi S@Q|gW1?~ ASx??F=@/?~ AS@A{? A, A& A' A( A, A AR !A2 "A)#I.@A8@$ A[ A\ A[ A] A^A B) A* A+~ Bn@ A[ Q7+Q6G  T T?D T?Dy`˜O@D=;Bg?Quf?Quf?Q&aF@Q]^S?~ AS%VLfx>FIV?~ An@A—? A, A_ A` Aa A,A?A@ !A2 "Ab#I0@AJ@$ A A A A A A B) A* A+~ Be@ A  QQ  T N,?D N,?D0PO@DAtaY?Qe?Qe?Q>R@Q**U?~ AShS?FM)O?~ Ae@A?ˋq8? A, A A A A,A?A? !A2 "A #I1@AD@$ AD AE AD AF AGA B) A* A+~ BN@ AD Q UKA Q`α'A T8_9?D8_9?DCѪ$P@DRm@?Q?b ?Q?b ?Qð>FWF@Qg*&?~ ASeM ހ?Fw@~?~ AM@A4Ӏ? A,A AH AM A,A?A? !A2 "AI#I"@A0@$ A A A A AA B) A* A+~ Bd@ A Q NYQzՁ  T70?D70?DrYC"Q@Dk]?Q@?Q@?Q_R?C@Q#=V?~ ASŕ]=F^o=~ A`@Ay`)Ұ? A, A A A A0~ A? A !A2 "A#Ic@At@$ A A A A AA B) A* A+~ B@@ A Q/Q 1  T 5a?D 5a?DdQ@DkG+!?Q_ ?Q_ ?QK]A@Q2?~ ASgm{?FYЍ^G?~ A0@AmwAS? A, A A A A,A?A@ !A2 "A#IL@A\@$ A. A/ A. A0 A1A B) A* A+~ Bp|@ A. Q!Qf  Td'.V?Dd'.V?D?GR@DcQ?Q?Q?QѢ L@QH柭?~ AS?<F`0 =~ A`|@Aɏ#? A, A2 A3 A4 A,A?A@ !A2 "A5#IK@AY@$ AT AU AT AV AWA B) A* A+~ B@P@ AT Q,kA Q'A T5ނ[?D5ނ[?DzC2LR@DIG?Q?Q?QA%1h@Qv~|@~ AS<Y`f?FH> Α?~ AP@Aq+? A, AX AY AZ A,~ A? A1 !A2 "A[#I&@A.@$ A A A A AA B) A* A+~ B`}@ A Q4Q[  T^3~?D^3~?DUhLm>mR@Dc; ?Qk?Qk?Q)%U@Q~?~ ASHP=FhJl}p=~ AP}@AVNͼ? A, A A A A,A?A@ !A2 "A#I;@A@Z@$ AG AH AG AI AJA B) A* A+~ B@@ AG QOA QgA T2ro?D2ro?DB-JKR@Dul:?Q?Q?QR@Q(?~ AS,ޤ.́9Fѳ[\:~ A<@A0S? A, AK AL AM A,A?A? !A2 "AN#IS@Ak@$ A A A A AA B) A* A+~ BQ@ A Q`CA Q'A T _?D _?D GPR@Db)='?Q?Q?Q#j0X@QB+nD?~ AS>[J?Faٗc{?~ A@Q@AɃڕ? A, A A A} A,A?A? !A2 "A#I"@A0@$ A A A A A A B) A* A+~ B g@ A  QXvA Q pA Tց$?Dց$?D[]BS@D}1Iզ?Q ?Q ?Q"C@QyÅPN?~ ASn0i?FI?~ Ag@AG v? A, A A A A,A?A@ !A2 "A #IC@AL@$ A A A A AA B) A* A+~ BT@ A Q&A~ Q  TJY?DJY?DN9T@D+bu$U?Q_c?Q_c?QD@QG%JQ?~ AS< hv?FiL?~ AS@A~FR7>~ A@A"&̹? A, AAA A, AA !A2 "A #Ic@A o@$ A A A A AA B) A* A+~ B@@ A QpAQBB  T }w ?D }w ?DU@DC<?Q?Q?Q]kDC@Q gU?~ AS/+Щl>FƢƐ>~ A8@AtW^? A, A A A A,A?A@ !A2 "A#IK@Ac@$ AI AJ AI AK ALA B) A* A+~ B g@ AI Q DJ^A~ QRp T1Ôh?D1Ôh?DXDNW@D/.i?Qnk?Qnk?Qk^@QmK4@~ AS5և ?F=B?~ Ag@AKX? A, AM AN AO A,A?A? !A2 "AP#I2@AD@$ A A A A AA B) A* A+~ Ba@ A Q QBk  TZ?DZ?D6X@D֝e?Q_; ?Q_; ?Qje-K@Q6]?~ AS0Wyz`?Fh FЋ?~ A`a@AQ&y4_? A, A  A! A" A,A?A? !A2 "A##I&@A<@$ A A A A AA B) A* A+~ Bh@ A Q@.A~ QC/ TXPA?DXPA?D]"X@D ?QQ?QQ?Q@ mP@Q $Ճ?~ ASmvXC<F3<~ A`@AŽ д? A, A A A A0~ A? A !A2 "A#Ia@Ak@$ A A A A AA B) A* A+~ BY@ A Qp A Q00A TՈ[U?DՈ[U?DSX;Y@DcI;@Q J?Q J?QSݱ/~W@QH ?~ ASG]Ҕ>FHQa?~ AX@A/@? A, A A  A  A,A?A@ !A2 "A #I*@A5@$ A A A A AA B) A* A+~ B@ A Q4A~ Q Tgx?Dgx?DZ@DB@Qt?Qt?Q>È M@QP v?~ AS&\& >F]`>~ A@AN? A, A A A A,A?A@ !A2 "A#I@V@A g@$ A A A A AA B) A* A+~ BPy@ A QA Q=/A T ?D ?D%H[@D5@Q1~ A@y@AJ흺z? A, A A A A A A !A2 "A#I@S@A[@$ A A A A AA B) A* A+~ B`x@ A Q f A Q`A1A T؜,?D؜,?Dl[@D(c@Q?Q?QNޛS@QƢ޴?~ ASt}kW>F`>~ APx@A"? A, A A A A,A?A? !A2 "A#IN@A@Y@$ A A A A AA B) A* A+~ B@ A QwA Q ҦA T^?D^?DL^4\@DЎL&@Q{h?Q{h?QiG8^@QiٵHf@~ AS1#;F35?<~ A@AVUt޾? A, A A A A,A?A? !A2 "A#IP@Ah@$ A A A A AA B) A* A+~ BT@ A Q@ A QA T~?D~?D^@DS@Qo?Qo?QSTĿPK@Q@>?~ AS2 /T?F!%G?~ AS@A8C? A, A A A A,A?A@ !A2 "A#I3@A7@$ A2 A3 A2 A4 A5A B) A* A+~ Br@ A2 Q{3Q+e|s  TN7?DN7?D:;Z^@D<d@Q_?Q_?Qv" =X@QHc߮?~ ASw֕X>F5۟>~ Ar@Ae]G? A, A6 A7 A8 A, A A  !A2 "A9#I?@AQ@$ A" A# A" A$ A% A B) A* A+~ Bt@ A"  QϘ!Q!K  T?D?D` _@DFV\:@Q_v?Q_v?Q/jU>@Qjcw?~ ASbVm?F O"?~ At@Ar`JcƦ? A, A& A' A( A,A?A@ !A2 "A) #IF@AU@$ A A A A A A B) A* A+~ B@_@ A  QA Q@*&A T 8յ?D 8յ?Dط:_@DvԌYM@Q_r?Q_r?Q|/U@QتQc?~ ASD>s?F闋#ua?~ A_@A%e? A, A A A A,A?A@ !A2 "A #I7@A?@$ A A A A! A" A B) A* A+~ BD@ A  QR_<Q2J  TM&.?DM&.?D2u-2`@D6΍]@Qc?Qc?QQ\.Y@QZ7E@~ AS Im>F d?~ AC@AkwOW? A, A# A A$ A,A?A? !A2 "A% #I@A"@$ A A A A AA B) A* A+~ Bo@ A QnA QxA Tx?Dx?D(2꫾`@D8[Dx@Q?Q?Qar~W@Q㩇 ?~ ASxع̩>FU8ΎK>~ Ao@A+5|? A, AAA AFA?A? !A2 "A#I2@AJ@$ A( A) A( A* A+A B) A* A+~ Bg@ A( Q A Q3A T~s:;?D~s:;?DERa@D08@Q@t?Q@t?Q)vQ@Q*Q,?~ AS;ZaX@?F@$r?~ Ag@A? A, A, A- A. A,A?A@ !A2 "A/#I9@AF@$ A A A A AA B) A* A+~ B@o@ A~ QKI Q \A T'vJ?D'vJ?Dxda@DB69z@Q?Q?Q$^Y\@Qg[@~ ASwjۯs >FH)K_>~ A o@A~? A, A A A A,A?A@ !A2 "A#I<@AM@$D*Gl2$($2,,,( (.,(2,,,$,,%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@ Ak Al Ak Am An A B) A* A+~ Bi@ Ak  QB)QLA  T?D?DA:_b@D⾩ @Q?Q?QT%d@Q줜B@~ AS A,5>FɃJ>~ Ah@Awt? A, Ao Ap Aq A,A?A? !A2 "Ar #I0@AE@$ A A A A AA B) A* A+~ B@u@ A~ Qn1 Q_A T[ ?D[ ?D qՙb@Dm@Q_YP?Q_YP?Q%nO@QI~?~ AS:>Fc }>~ A0u@AƊ? A, A A A A,A?A? !A2 "A#IF@A@V@$ Ay Az Ay A{ A|A B) A* A+~ B`m@ Ay QyQ23  Tp`?Dp`?DIO~w.c@D%F2@Q`T?Q`T?Q Y@Qc@~ ASv@>F5k3}>~ A@m@A[\Z? A, A} A~ A A,A?A@ !A2 "A#I@@AM@$ A A A A AA B) A* A+~ BH@ A QZQ  Tҍ0?Dҍ0?D e@Db@Q`f?Q`f?Q3L@QMUGX3?~ AS.y } h=F gW?>~ A@@A? A, A A A A,A?A? !A2 "A#IU@Ah@$ A A A A AA B) A* A+~ BD@ A Q A Q"A T~Ͻ-?D~Ͻ-?Dz4t4e@D_(6@Q@?Q@?QyZ@Q]x0|@~ ASl\f?FTLO?~ AC@AA|~? A, A A A A,A?A@ !A2 "A#I @A"@$ A A A A AA B) A* A+~ B@ A QA~ Q,A TkM?DkM?DTf@DY@@Q ?Q ?Q#d@Qg@~ ASO2F2|3~ A@A&pdK? A, A A A A,A?A@ !A2 "A#Ia@Az@$ As At As Au Av A B) A* A+~ B l@ As  Q?ip!QaNA  T[?D[?DJf@D cL@Q?=?Q?=?Q:H@Qxb?~ AS`Jh?FDJ?~ Al@Ad:E? A, Aw Ax Ay A,A?A@ !A2 "Az #I8@AH@$ A A A A AA B) A* A+~ B@U@ A QMA Q2!A T+?D+?D)gh@D)/@Q`?Q`?Qf((1[@Qr9@~ AS䍔|`D?F͹ɒ~u?~ AU@ANw? A, A A A  A,A?A@ !A2 "A #I5@A9@$ A* A+ A* A, A- A B) A* A+~ B`c@ A* ~ Q^ Q@KA Tsמ6?Dsמ6?Dth@Db?ot@@Q_q$?Q_q$?Q.LU%`@Q0yOUU@~ AS#"uE>FnRG4_>~ A@c@AJ[!/? A, A. A/ A0 A0A?A? !A2 "A1 #I(@A@@$ Ax Ay Ax Az A{A B) A* A+~ Bp@ Ax Q@ QQ[A Ti?Di?Dc/j@D> @Q`'?Q`'?QUl'HP@Q+6Zk?~ AS>!>FFo&q>~ Ah@A"N`? A, A| A} A~ A, A A !A2 "A#IS@A`a@$ A? A@ A? AA ABA B) A* A+~ B8@ A? QBz@ QA T40ݩ?D40ݩ?D'RU{n@D% @Q?Q?QxKS@Q ~n?~ ASB8<FD~M`=~ A0@A;]$? A, AC AD AE A,A?A@ !A2 "AF#I@d@A p@$ A A A A AA B) A* A+~ Bx@ A QDLQ$  T\B?D\B?Dn"o@D/ @Q_?Q_?Q a@Q~'?@~ ASV^훤7F"-8~ At@A7e ? A, A A A A,A?A@ !A2 "A#IZ@A q@$ A A A A AA B) A* A+~ B[@ A QD A~ Q' TZ?DZ?DĝPp@D.x @Q?Q?Qf@QPJK(@~ ASUD::?F#m?~ A@[@Al? A, A A A A,A?A@ !A2 "A#I2@A:@$ AO AP AO AQ ARA B) A* A+~ BȄ@ AO Qˢ(A~ Q_*lI T?D?Dyrq@D-@Q?Q?QYZ4_@Q(@~ ASrlf)<FAW<1<~ A@Aׇ? A, AS ATA AFA?A? !A2 "AU#IW@A@c@$ A A A A AA B) A* A+~ B@ A QrQiK  Tp'hcS?Dp'hcS?D!&_r@DP+@Q@2&?Q@2&?Qm'`@QQ߹V@~ ASs0zP7F7~ A@A{ 6ӟ? A, A A A A,A?A? !A2 "A#IW@Ap@$ A A A A AA B) A* A+~ Bp|@ A Q(3Q O  TŐ8+@DŐ8+@Dؖ`ju@D3@Q`?Q`?Q)NSZ@Qͤ-l@~ ASڍX,=Fxd=~ A`|@A&c? A, A A A A,A?A@ !A2 "A#IG@AY@$ AR AS AR AT AUA B) A* A+~ BA@ AR Q <@ Q`"A T<ÅG @D<ÅG @D=g0 w@DP{@Q_4R@Q_4R@QtɦQx@Q@j@~ ASc?FH!?~ AA@A(t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l(,(,(2,($2TTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P!AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P"AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P#AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P$AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P%AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P&AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P'AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P(AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P)AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P*AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P+AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P,AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P-AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P.AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P/AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P0AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P1AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P2AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P3AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P4AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P5AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P6AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P7AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P8AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P9AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P:AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P;AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P<AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P=AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P>AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P?AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@P@AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PBAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PCAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PDAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PEAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PFAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PGAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PHAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PIAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PJAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PKAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PLAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PMAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PNAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$POAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PPAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PQAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PRAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PSAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PTAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PUAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PVAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PWAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PXAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PYAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PZAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P[AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P\AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P]AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P^AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P_AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@P`AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PaAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PbAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PcAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PdAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PeAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PfAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PgAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PhAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PiAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PjAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PkAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PlAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PmAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PnAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PoAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PpAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PqAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PrAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PsAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PtAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PuAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PvAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PwAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PxAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PyAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PzAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P{AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P|AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P}AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P~AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P!AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P"AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P#AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P$AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P%AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P&AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P'AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P(AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P)AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P*AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P+AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P,AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P-AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P.AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P/AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P0AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P1AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P2AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P3AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P4AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P5AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P6AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P7AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P8AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P9AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P:AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P;AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P<AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P=AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P>AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P?AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@P@AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PBAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PCAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PDAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PEAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PFAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PGAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PHAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PIAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PJAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PKAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PLAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PMAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PNAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$POAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PPAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PQAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PRAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PSAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PTAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PUAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PVAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PWAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PXAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PYAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PZAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P[AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P\AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P]AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P^AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P_AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@P`AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PaAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PbAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PcAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PdAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PeAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PfAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PgAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PhAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PiAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PjAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PkAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PlAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PmAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PnAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PoAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PpAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PqAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PrAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PsAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PtAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PuAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PvAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PwAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PxAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PyAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PzAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P{AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P|AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P}AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P~AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@ %;@ %;@ %;@ %;@ %;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{}~@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT %;@!%;@"%;@#%;@$%;@%%;@&%;@'%;@(%;@)%;@*%;@+%;@,%;@-%;@.%;@/%;@0%;@1%;@2%;@3%;@4%;@5%;@6%;@7%;@8%;@9%;@:%;@;%;@<%;@=%;@>%;@?%;@P AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P!AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P"AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P#AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P$AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P%AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P&AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P'AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P(AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P)AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P*AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P+AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P,AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P-AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P.AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P/AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P0AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P1AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P2AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P3AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P4AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P5AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P6AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P7AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P8AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P9AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P:AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P;AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P<AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P=AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P>AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P?AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT@%;@A%;@B%;@C%;@D%;@E%;@F%;@G%;@H%;@I%;@J%;@K%;@L%;@M%;@N%;@O%;@P%;@Q%;@R%;@S%;@T%;@U%;@V%;@W%;@X%;@Y%;@Z%;@[%;@\%;@]%;@^%;@_%;@P@AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PBAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PCAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PDAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PEAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PFAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PGAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PHAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PIAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PJAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PKAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PLAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PMAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PNAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$POAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PPAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PQAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PRAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PSAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PTAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PUAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PVAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PWAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PXAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PYAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PZAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P[AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P\AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P]AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P^AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P_AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT`%;@a%;@b%;@c%;@d%;@e%;@f%;@g%;@h%;@i%;@j%;@k%;@l%;@m%;@n%;@o%;@p%;@q%;@r%;@s%;@t%;@u%;@v%;@w%;@x%;@y%;@z%;@{%;@|%;@}%;@~%;@%;@P`AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PaAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PbAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PcAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PdAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PeAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PfAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PgAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PhAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PiAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PjAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PkAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PlAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PmAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PnAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PoAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PpAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PqAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PrAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PsAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PtAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PuAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PvAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PwAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PxAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PyAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PzAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P{AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P|AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P}AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$P~AAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$D lTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT%;@%;@%;@%;@%;@%;@%;@%;@PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$PAAAAAAAAABAAAIIIBAAAAAAMAAAAAAAAAAAIA$@TTTTTTT>@ABmy"yz z z z|zZ?U?y"y{ { { z|zZ??ggD ZO 77S8S;8WZ8=y8#8ݶ888929Q9Wp9E9/9/99o :]):GH: g:م:Ǥ::{:m;u ;_?;];|;;];a;5;<5<T<ss<5<#< << =c,=K=i==  dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?&<3U} } m} } } )} $!}  } } } I } ,} 0} $0} } h,; ; ,,,, , , , , ,,,,,,,,,,,,,,,,,,, i8 j5 p p p p p p p p p  p  p  p  p  p p# r% r& r% r' r( s)~ sd@t+oݿt+o? t2^(xo6? rJqEsv?  r-  r.  r/~ r@@ r4 r5 r4 r6 r7 s)~ s4@t-ҿt-? tH$w? r)?  r8  r9  r:~ r"@ r! r! r! r! r! s)~ s>@tOz]tOz]? tYy? r&?  rL r  rM~ r@ r? r@ r? rA rB s)~ s9@tJEtJE? t:v^? rDgw*?  rC  rD  rE~ r@ rH rI rH rJ rK s)~ sN@ tŔ tŔ? t0KES? r{>&? rL r rM~ r@ r r r r r s)~ sQ@ t)Ssп t)Ss? t? r7P N&? rC rD rE~ r"@ rO rP rO rQ rR s)~ s l@ tA tA? tqr? rD8v? rS rT rU~ r3@ r5 r& r5 r5 r, s)~ sK@ t4}  t4} ? t&@? r F,? rS rT r,~ r@ rX rY rX rZ r[ s)~ sb@ tb?tTc>b? tkm? uPy>  r  r  r~ r`b@ r r r r r s)~ sy@t'iO?t'iO? tre'? rq[R?  r  r  r~ rD@ r r r r r s)~ s@j@t Rmt Rm? tKt? uRfB5>  rrr ~ r1@ r r r r r s)~ sT@tY]?tY]? tzE쭾? r#9[?  r  r  r~ r9@ r r r r r s)~ ss@tRUtRU? tn? r M/?  r  r  r~ rA@ r r r r r s)~ s`c@t05ut05u? tHC4? rg-QX?  r  r  r~ r,@ r r r r r s)~ s\@to?[to?[? tuq? r\[P?  r  r  r~ r @ r r r r r s)~ s^@t[L1}?t[L1}? tE#vD? r3Ҕ!?  r  r  r~ r@@ r5 r r5 r5 r, s)~ sF@t(st(s? t!6? r,AR}f?  r,  r,  r,~ r @ r r r r r s)~ s$@t^0vFؿt^0vF? tB? r`R?  r  r  r~ r@BX ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r5 r r5 r rR- s)~ sI@ tr)ݿ tr)? t2? rf`~04? r r r~ r$@ !r% !r% !r% !r % !r % !s)~ !s4@!tY^1ӿ!tY^1?! t:jsh?! r#>:? ! r ! r ! r %~ !r@ "r "r "r "r "r "s)~ "sK@"t"ҿ"t"?" tR?" rwpn ? " r " r " r ~ "r$@ #r #r #r #r #r #s)~ #s>@#tzT6ֿ#tzT6?# tyR?# rd%(? # r # r # r~ #r.@ $r $r $r $r $r $s)~ $sA@$t?$t?$ tqj?$ r#9[? $ r  $ r! $ r"~ $r"@ %r. %r/ %r. %r0 %r1 %s)~ %sy@%t Βw3>?%t Βw3>?% t^\Y?% u%]fE%> % r2 % r3 % r4~ %rI@ &r6 &r7 &r6 &r8 &r9 &s)~ &s9@&t|7?&t|7?& tN@& r^ j? & r: & r; & r<~ &r@ 'r@ 'rA 'r@ 'rB 'rC 's)~ 'sP@'t_V't_V?' t@?' u k\> ' rrr ~ 'rT@ (rE (rF (rE (rG (rH (s)~ (sA@(tR9?(tR9?( t8 M?( rnK? ( rI ( rJ ( rK~ (r@ )rO )rP )rO )rQ )rR )s)~ )s@)tP?)tP?) tQwa`@) uW^R< ) rS ) rT) r~ )rT@ *rV *rW *rV *rX *rY *s)~ *sF@*t^9ڿ*t^9?* ty݃?* r<S? * rZ * r[ * r\~ *r,@ +r5 +r/ +r5 +r5 +r/ +s)~ +s4@+tm+tm?+ ttC^Su?+ rʄҵL? + r/ + r/ + r/~ +r @ ,r' ,r' ,r' ,r' ,r' ,s)~ ,s$@,t+5?,t+5?, t&bsS?, rM/Jx? , r' , r' , r'~ ,r@ -r -rh -r -r -r -s)~ -s.@-t|J˿-t|J?- t_?- roĝ'? - rrr ~ -r@ .rd. .re. .rd. .rf. .rg. .s)~ .s@.tNa6n?.tNa6n?. t967S?. rco? . rrr ~ .r? /r /r /r /r /r /s)~ /s.@/t7|' /t7|' ?/ tcAx+#?/ r+3? / r / r / r~ /r@ 0r5 0r. 0r5 0r5 0r. 0s)~ 0s@0t-_'0t-_'?0 tj25&?0 r? 0 r. 0 r . 0 r!.~ 0r@ 1rf 1rg 1rf 1rh 1ri 1s)~ 1sW@1tjLP1tjLP?1 t!L2?1 rXi? 1 rj 1 rk 1 rl~ 1r3@ 2ro 2rp 2ro 2rq 2rr 2s)~ 2sK@2tu޿2tu?2 t*b?2 rV&C? 2 rs 2 rt 2 ru~ 2r@ 3rw 3rx 3rw 3ry 3rz 3s)~ 3sQ@3t i~3t i~?3 tcZ*?3 rd&? 3 r{ 3 r| 3 r}~ 3r5@ 4r 4r 4r 4r 4r 4s)~ 4s^@4t 6z{p?4t 6z{p?4 tÄ?4 rY0\? 4 r 4 r 4 r~ 4r4@ 5r 5r 5r 5r 5r 5s)~ 5sN@5t?5t?5 tbv?5 r6c? 5 rc 5 r 5 r~ 5r(@ 6r  6r! 6r  6r" 6r# 6s)~ 6s`@6tV#G?6tV#G?6 tT?6 re(? 6 r$ 6 r% 6 r&~ 6rB@ 7r 7r 7r 7r 7r 7s)~ 7sD@7t 01?7t 01?7 teS@7 rcڥ? 7 r 7 r 7 r~ 7r @ 8r 8r 8r 8r 8r 8s)~ 8sQ@8t@d!?8t@d!?8 tˈ$T?8 rB C=? 8 r 8 r 8 r~ 8r<@ 9r 9r 9r 9r 9r 9s)~ 9s@9tחb~ٿ9tחb~?9 tշG?9 rXV!q? 9 r 9 r 9 r~ 9r? :r :r :r :r :r :s)~ :s.@:t %K?:t %K?: t7y?: rFa>? : r : r : r~ :r@ ;r ;r ;r ;r ;r ;s)~ ;sF@;t2՟H?;t2՟H?; thD?; rU7\? ; r ; r ; r~ ;r$@ <r <r <r <r <r <s)~ <s`@<t4}6<t4}6?< t/*?< rd%(? < r < r < r~ <r5@ =r =r =r =r =r =s)~ =s~@=t-t}Ŀ=t-t}?= t%3?= r? = r = r = r~ =rU@ >r >r >r >r >r >s)~ >sF@>t퇥?>t퇥?> tME.@> rl %)N? > r > r > r~ >r*@ ?r ?r ?r ?r ?r ?s)~ ?su@?t+c?t+c?? t%e/?? r5,? ? r ? r ? r~ ?rJ@Dnl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r1 @r2 @r1 @r3 @r4 @s)~ @s>@@t ?@t ?@ tޢL4?@ rZ`? @ r5 @ r6 @ r7~ @r @ Ar Ar Ar Ar Ar As)~ As9@At ?At ?A tˍ8W?A rw}}? A r A r A r~ Ar@ Br Br Br Br Br Bs)~ Bs.@Bt)O?Bt)O?B tnF@B rj谒:? B r B r B r~ Br@ Cr Cr Cr Cr Cr Cs)~ Csy@Cty?Cty?C toV;@C uuzߘk? C r C r C r~ Cr@T@ Dr Dr Dr Dr Dr Ds)~ Dsq@Dt߯ĻDt߯Ļ?D tm?D ry#? D r D r D r~ DrE@ Er Er  Er Er  Er  Es)~ Es4@Et%FUA?Et%FUA?E ta@E rUf.Z? E r  E r  E r~ Er@ Fr Fr Fr Fr Fr Fs)~ Fs^@Ft8Ft8?F t+#?F r*!e? F r F r F r~ Fr3@ Gr Gr Gr Gr Gr Gs)~ GsT@Gt~g܄ܿGt~g܄?G t-j?G r/*t;? G r G r G r~ Gr(@ Hr" Hr# Hr" Hr$ Hr% Hs)~ Hsb@Ht ?Ht ?H t7zL?H rBGYS? H r& H r' H r(~ Hr6@ Ir* Ir+ Ir* Ir, Ir- Is)~ IsN@Itvgi;ѿItvgi;?I t蠱P?I r 6? I r. I r/ I r0~ Ir,@ Jr2 Jr3 Jr2 Jr4 Jr5 Js)~ Js~@JtLSJtLS?J t(nYO?J u忮&: J r6 J r7 J r8~ JrI@ Kr; Kr< Kr; Kr= Kr> Ks)~ Ks^@Kt˦Kt˦?K tF`3?K rd%(? K r? K r@ K rA~ Kr6@ LrC LrD LrC LrE LrF Ls)~ Ls@P@Lt95?Lt95?L tg4x?L r|NtX>?N tr?N rT4V? N rO N rP N rQ~ Nr,@ OrT OrU OrT OrV OrW Os)~ OsI@Ot{r?Ot{r?O t/?O r`D? O rX O rY O rZ~ Or$@ Pr\ Pr] Pr\ Pr^ Pr_ Ps)~ Psp|@PtevPtev?P t'?P rFM(? P r` P ra P rb~ PrF@ Qrd Qre Qrd Qrf Qrg Qs)~ Qsn@Qt~,UܿQt~,U?Q tIR?Q r^? Q rh Q ri Q rj~ QrE@ Rr| Rr} Rr| Rr~ Rr Rs)~ Rs9@RtA3I?RtA3I?@R tHO?R rB C=? R r R r R r~ Rr@ Sr| Sr} Sr| Sr~ Sr Ss)~ Ssl@St!:>?St!:>?S tV3?S r^=$53? S r S r S r~ Sr4@ Tr Tr Tr Tr Tr Ts)~ Ts@TtRAL?TtRAL?T ti@T uWPp = T r T r T r~ TrT@ Ur Ur Ur Ur Ur Us)~ Usy@Ut6k?Ut6k?U tFc; ?U uE퐛> U r U r U r~ Ur@W@ Vr Vr Vr Vr Vr Vs)~ Vsv@VthFAǿVthFA?V t|!?V rކ ? V r V r V r~ VrI@ Wr Wr Wr Wr Wr Ws)~ Ws`@WteBWteB?W t?ƾ_?W rpt:{? W r W r W r ~ Wr;@ Xr Xr Xr Xr Xr Xs)~ Xs(@Xt3H?Xt3H?X tw%p@X uGYʿX< X r X r X r~ XrP@ Yr Yr Yr Yr Yr Ys)~ Ys@YtMy?YtMy?Y t?Y uW> Y r Y r Y r~ YrU@ Zr Zr Zr Zr Zr Zs)~ Zs b@Ztn!B?Ztn!B?Z t_J>_?Z r xP? Z r Z r Z r~ Zr<@ [r [r [r [r [r [s)~ [st@[t|0?[t|0?[ t@[ u52I> [ r [ r [ r~ [rF@ \r \r \r \r \r \s)~ \sp@\tYϩ?\tYϩ?\ tB|S?\ rm ? \ r \ r \ r~ \rJ@ ]r ]r ]r ]r ]r ]s)~ ]s`h@]t0_?]t0_?] t3=Έ?] r9? ? ] r ] r ] r~ ]r;@ ^r ^r ^r ^r ^r ^s)~ ^s@^tUҿ^tU?^ tDr?^ r>$%? ^ r ^ r ^ r~ ^rg@ _r _r _r _r _r _s)~ _sT@_t?_t?_ t@Wn?_ r/? _ r _ r _ r~ _rj@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `sP~@`tTUdq?`tTUdq?` tY7?` r#9[? ` r ` r ` r~ `rX@ ar ar ar ar ar as)~ as@z@at:`c?at:`c?a tan?a r㌜Ii? a r a r a r~ arJ@ br br br br br bs)~ bs^@btD5޿btD5?b tO@?b r4&͆? b r b r b r~ br5@ cr cr cr cr cr cs)~ csj@ct\wct\w?c t X*?c rj94? c r c r c r~ cr6@ dr dr dr dr dr  ds)~ dsF@dt0@#4dt0@#4?d ty4?d r}l? d r  d r  d r ~ dr@ er! er! er! er! er! es)~ esQ@et<et<?e t+N?e uג> e r e r  e r~ er@ fr fr fr fr fr fs)~ fsR@fteHgfteHg?f tZXK>?f u )q-> f r f r  f r~ fr@ gr gr gr gr gr gs)~ gsA@gt_gt_@g t҈}so?g rFKaa? g r g r  g r~ gr@ hr  hr! hr  hr" hr# hs)~ hsD@ht>ht>?h t%_$[?h rP b? h r h r  h r~ hr@ ir% ir& ir% ir' ir( is)~ is@j@it̕Ώit̕Ώ?i td~ X?i rR5*n8? i r i r  i r~ ir1@ jr* jr+ jr* jr, jr- js)~ jsW@jt(jt(?j tll5?j u>Q> j r j r  j r~ jr$@ kr/ kr0 kr/ kr1 kr2 ks)~ ksy@kt kt ?k tCqvY?k rx.2? k r3 k r4 k r5~ krL@ lr7 lr8 lr7 lr9 lr: ls)~ ls@j@lta!?lta!?l tqٜ?l r<S? l r; l r< l r=~ lr5@ mr mr mr mr mr ms)~ msi@mtomto?m tG7e?m uCTJ> m r m r m r~ mrD@ nr: nr; nr: nr< nr= ns)~ nsj@ntzQ1LntzQ1L?n t_?n ràC? n r> n r? n r@~ nrF@ or? or@ or? orA orB os)~ osx@ot?o?ot?o?o tZ鴀@o u0= o rC o rD o rE~ orc@ prG prH prG prI prJ ps)~ ps @pt_N3-?pt_N3-?p tVv,5?p uq kW p< p rK p rL p rM~ prR@ qrO qrP qrO qrQ qrR qs)~ qs`@qtP`q VqtP`q V?q t0+?q rH{u? q rS q rT q rU~ qr.@ rrX rrY rrX rrZ rr[ rs)~ rs@rt^A?rt^A?r tH ?r uି{2> r r\ r r] r r^~ rr@a@ sr` sra sr` srb src ss)~ ss@stH(?stH(?s t9* ?s rM@Jm? s rd s re s r^~ srV@ trg trh trg tri trj ts)~ ts @tt(}?tt(}?t t{XqA?t r? t rk t rl t rm~ tr@S@ uro urp uro urq urr us)~ usf@ut_xjvout_xjvo?u tzhg?u rD&[ś? u rs u rt u ru~ ur0@ vr~ vr vr~ vr vr vs)~ vs l@vtwJ=?vtwJ=?v t?v rC? v rv r v r~ vrD@ wr wr wr wr wr ws)~ ws l@wt+31Ÿ?wt+31Ÿ?w tp8@w rX+(? w r w r w r~ wr;@ xr xr xr xr xr xs)~ xs[@xtY;[?xtY;[?x tm58=i?x rovy? x r x r x r~ xr2@ yr yr yr yr yr ys)~ yst@ytH("}?ytH("}?y t?y r˚? y r y r y r~ yr h@ zr zr zr zr zr zs)~ zs@Z@zta?zta?z t':tD@z rEb? z r z r z r~ zr.@ {r {r {r {r {r {s)~ {sq@{t.?{t.?{ t?{ r\B? { r { r { r~ {rA@ |r |r |r |r |r |s)~ |s@|t ?|t ?| t_AB!@| uR5 | r | r | r~ |ra@ }r }r }r }r }r }s)~ }s(@}tX$J?}tX$J?} t @} uHR9 } r } r } r~ }rZ@ ~r ~r ~r ~r ~r ~s)~ ~sPy@~tWK@~tWK@~ t}4Su@~ ui(= ~ r ~ r ~ r~ ~rH@ r r r r r s)~ s@z@tܜitܜi? t@rn? r?  r  r  r~ rL@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s@tFj9?tFj9? tʝ? rS ʥ? r r r~ rX@ r r r r r s)~ s`m@tCL$ttCL$t? tY8^o? r8Yl7? r r r~ rA@ r r r r r s)~ s@tReοtRe? t-? uSC]> r r r~ rh@ r r r r r s)~ s`s@t ]Y2Z?t ]Y2Z? t)Y? rbC}? r r r~ rB@ r rP r r r s)~ s@t]r?t]r?? tK!~PP? u2W< r rD r~ rE@ r r r r r s)~ s@tp+3?tp+3? t~Cr? u1RX= r r r~ r`h@ r  r  r  r  r s)~ sF@t6_t6_? t-{N|? r.M&T? r r  r ~ r@ r5 r r5 r r. s)~ s@`@tYvtYv? t1& =? rFa>? r. r. r.~ r3@ r r r r r s)~ sT@t r r?~ rI@ rA rB rA rC rD s)~ s@j@tztz? t(w ? rӏa? rE rF rG~ r@@ rI rJ rI rK rL s)~ s@_@tS&`tS&`? t!>m? rB́C-? rM rN rO~ r4@ rQ rR rQ rS rT s)~ s`z@tŹw`?tŹw`? tsfY? r]e)r4? rU rV rW~ rP@ rY rR rY rS rZ s)~ s$@t;?t;? tFfl@ rQHH? rrr ~ r@ r\ r] r\ r^ r_ s)~ s9@t N6kt N6k? třǦ? r 6V? r` ra r~ r@ rc rd rc re rf s)~ s@t!@u?t!@u? tbw? re B? rg rh ri~ rS@ rk rl rk rm rn s)~ sY@toh}пtoh}? t.8P? rFa>? ro rp rq~ r=@ r r r r r s)~ sR@tG{BӶ?tG{BӶ? tr*: ? riD? r r r~ r*@ rs rt rs ru rv s)~ s @tr?tr? t-݀? r`M? rw rx ry~ rR@ r{ r| r{ r} r~ s)~ si@t2V3t2V3? tv`zK? rv"E ? r r r~ rC@ r r r r r s)~ sf@t> ?t> ? tr}? r 'LC? r r r~ r@@ r r r r r s)~ sl@tV_ͬ?tV_ͬ? t? rL2W? r r r~ rC@ r r r r r s)~ s@@tifL?tifL? t @ ur7 r r r~ rU@ r r r r r s)~ sc@t.t.? t`kc? r @%1IQ? r r r ~ r?@ r r r r r s)~ sh@t/ D?t/ D? t:_2? r$BӦ? r r r~ r]@ r r r r r s)~ s@b@t]y5cI?t]y5cI? tf ? rӨ? r r r~ r7@ r r r r r s)~ s @t0ptdt0ptd? teح? uWj$> r r r~ rP@ r r r r r s)~ sؔ@t=2ܿt=2? tVH:;}? rB́C-? r r r~ rb@ r r r r r s)~ s>@t^ROܿt^RO? t:v? rgD@? r r r~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ spr@t+/mM?t+/mM? tQ2NzJ? r#9[? r r r~ rL@ r r r r r s)~ sz@tEQӿtEQ? t1pL? r#9[? r r r~ rG@ r r r r r s)~ s`s@tK ྿tK ? tHo? r? r r r~ rG@ r r r r r s)~ sI@t<ai?t<ai? tB@ r˿t(->? t8)? rS"? r! r" r#~ rE@ r% r& r% r' r( s)~ s@t(,Qÿt(,Q? tt=? r^=$53? r) r* r+~ rg@ r- r. r- r/ r0 s)~ sN@tF2ڿtF2? t!? roĝ'? r1 r2 r3~ r"@ r5 r6 r5 r7 r8 s)~ s l@tɴ}$¿tɴ}$? tВ? rSUO3a)? rrr ~ rA@ r& r' r& r( r) s)~ sn@t-cBpt-cBp? t=#)j/? u>Q> r* r+ r,~ rB@ rB rC rB rD rE s)~ s_@tt? tA? r*LA4? rF rG rH~ r;@ rJ rK rJ rL rM s)~ sp@tס:j?tס:j? tgL? r'? rN r" r~ rG@ rP rQ rP rR rS s)~ sr@t^Qt^Q? t2L7? r#9[? rT rU rV~ rN@ rT rU rT rV rW s)~ so@t)?t)? tg6? rw﹬? rX rY rZ ~ rH@ r( r( r( r( r( s)~ s.@t~,Uпt~,U? t=? r& f? r( r( r(~ r@ rX rY rX rZ r[ s)~ s`s@tČtČ? t뱝3_? r 5? r\ r] r^~ rG@ rp rq rp rr rs s)~ s\@tw>" ?tw>" ? t ? r#? rt ru rv~ r6@ rx ry rx rz r{ s)~ s@tV6>?tV6>? t/戅? u+:> r| r} r~~ rR@ r r r r r s)~ s`h@tf9eoz޿tf9eoz? t)m? rf-? r r r~ r=@ r r r r r s)~ s@_@tzR7?tzR7? t? r6e ? r r r~ r5@ r r r r r s)~ s b@tbtb? tBt|? rL-m? r r r~ r<@ r r r r r s)~ sV@t^5o7Կt^5o7? t/B? ro? r r r~ r:@ r r r r r s)~ sW@t5ٺ>t5ٺ>? t ? r-J;? r r r~ r;@ r r r r r s)~ s`d@t-idt-id? t1 bvd? r5/1? r r r~ r6@ r r r r r s)~ sd@tYtY? t/ْ? r~oVl"R? r r r~ r&@ r r r r r s)~ sy@tg?tg? t ? r+4!? r r r~ rG@ rt ru rt rv rw s)~ sv@tTBq?tTBq? tDUN? r+_Lk? rx ry r~ rI@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r5 r r5 rz- r{- s)~ sK@tEҺtEҺ? tѬ!Y? r0ʃx-? r|- r}- r~-~ r$@ r r r r r s)~ s@@t}),.Ŀt}),.? tcК? rsB? r r r~ rl@ r r r r r s)~ sT@tz~Y?tz~Y? t$8a? rQHH? r r r~ r5@ r r r r r s)~ sD@t % @t % @ t'C !0@ rC .ގ? r r r~ r(@ r$ r$ r$ r$ r$ s)~ sD@t=%Pt=%P? t_? rP b? r$ r$ r$~ r"@ r r r r r s)~ s^@tZ(tZ(? t?i? r7Fs? r r r~ r0@ r r r r r s)~ su@t)L t)L ? t ? rA,Ґ$? r r r~ rN@ r r r r r s)~ sI@tkC?tkC? tɭ%? r? r_q帊? r| r} r~~ r@ r r r r r s)~ sd@t rrr ~ rW@ r( r) r( r* r+ s)~ se@tظ8Sd?tظ8Sd? t @t4" Ϳt4" ? t66? rZ`? r# r# r#~ r@ r8 r9 r8 r: r; s)~ sI@th#Nth#N? tJ|? rRP>? r< r= r>~ r$@ r@ rA r@ rB rC s)~ st@tWBAޕпtWBAޕ? t&'? rM? rD rE rF~ rG@ rH rI rH rJ rK s)~ sK@t"¿t"? t? r#9[? rL rM rN~ r @ rP rQ rP rR rS s)~ sK@tZۨ:z?tZۨ:z? tGK? ruS!? rT rU rV~ r$@ rX rY rX rZ r[ s)~ s4@t~Yt~Y? t;at? r)? r\ r] r^~ r"@ r` ra r` rb rc s)~ s@p@tV.h?tV.h? tVZR? rӨ? rd re rf~ rL@ r5 ri r5 r5 r5 s)~ sQ@tg1tg1? tY.z/? rwpn ? rrr ~ r$@ r5 r# r5 rx/ ry/ s)~ sA@t ;;c?t ;;c? t W? rɧJH{? rz/ r{/ r|/~ r0@ rm rn rm ro rp s)~ s@P@tGx`?tGx`? t[bW@ rӨ? rq rr rs~ r.@ ru rv ru rw rx s)~ se@tMm̿tMm? t:>Y? rL ? ry rz r{~ r@@ r r r r r s)~ sp@t8tb?t8tb? tlW? ryuX? r r r~ rE@ r r r r r s)~ s؁@tdGUl3?tdGUl3? t8hi? rӨ? r r r~ rX@ r r r r r s)~ sܣ@tf tf ? t51OAY? rQ> r r r~ rM@ r r r r r s)~ s@Z@to>̍;տto>̍;? t0rm? r<S? r r r~ r6@ r r r r r s)~ s`m@t~DBt~DB? t_%? r*L_? r r r~ r>@ r r r r r s)~ s@P@t^35ͼ?t^35ͼ? tA =L? r~ r3@ r@ rA r@ rB rC s)~ sT@tG4AtG4A? t4C)? rlHV6{? rD rE rF~ r"@ rH rI rH rJ rK s)~ s4@ts\^Fts\^F? t'A? rn(? rL rM rN~ r@ rP rQ rP rR rS s)~ sN@t/??t/?? t)Ga? rCa? rT rU rV~ r,@ r` ra r` rb rc s)~ sQ@t&ٻt&ٻ? t' 2? ry&;? rd re rf~ r"@ rX rY rX rZ r[ s)~ sj@t߯]t߯]? t@@%? r2hn? r\ r] r^~ r=@ rh ri rh rj rk s)~ sa@tC/WtC/W? tŠMU? ruAF? rl rm rn~ r7@ rp rq rp rr rs s)~ sp@thտth? t :w? rY? rt ru rv~ r>@ rx ry rx rz r{ s)~ s@Z@tߦ#IX?tߦ#IX? tCIVK? ru6'? r; r| r}~ r.@ r r r r r s)~ sz@t+?t+? tPAN? uc*⡙= r r r~ r:@ r r r r r s)~ sQ@tR0q9?tR0q9? tN36@ r !? r r r~ r,@ r r r r r s)~ sg@tip{qtip{q? t[OnN? r| {? r r r~ rB@ r r r r r s)~ sA@t)Yt)Y? tK'? rV&C? r r  r ~ r@ r r r r r s)~ s>@tRW?tRW? tt NGA? r'y(? r r r~ r@ r r r r r s)~ sq@tL<(?tL<(? tlw}A? r1)P? r r r~ r@T@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ sd@t!@c?t!@c? tjlݎ? rw 8Q?  r  r  r~ rH@ r r r r r s)~ sn@t;F t;F ? t6 ? rR ?  r  r  r~ rC@ r r r r r s)~ sY@tq؝3?tq؝3? twVgY? rf#^?  r  r  r~ r<@ r r r r r s)~ sb@t$ t$ ? t]Q%C7? rT?  rS  r  r~ r8@ r r r r r s)~ sq@txT|?txT|? tO6? r-6g]  r  ra  r~ rI@ r r r r r s)~ sY@tE~?tE~? tp1aO? r]e)r4?  r  r  r~ r3@ r" r# r" r$ r% s)~ s@Z@ t 紋 t 紋?  t?ھ?  r?  r&  r'  r(~ r@@ r  r  r  r  r  s)~ sk@ t0$~wz? t0$~wz?  tu*?  r]?  r   r  r~ r@@ r r r r r s)~ s0~@ tv: ? tv: ?  tإv|6?  urB_v>  r  r  r~ rR@ r r r r r s)~ s@P@ tgۧ? tgۧ?  t"B= ?  rn?  r  r  r~ r7@ r! r" r! r# r$ s)~ s@U@ tF&4 tF&4?  tZSg?  rpt:{?  r  r  r~ r.@ r& r' r& r( r) s)~ s$@t-f/t-f/@ t!? ry&;?  r*  r+  r,~ r@ r. r/ r. r0 r1 s)~ sW@tBzn?tBzn? t8j\@ rQHH?  r2  r3  r4~ r7@ r6 r7 r6 r8 r9 s)~ sN@t%%?t%%? tq? rT4V?  r:  r;  r<~ r.@ r> r? r> r@ rA s)~ s @teM%teM%? tJL«? r<Ƿ?  rB  rC  rD~ rQ@ rF rG rF rH rI s)~ sf@tc}r>tc}r>? t? r.M&T?  rJ  rK  rL~ r;@ rN rO rN rP rQ s)~ s r@t ?t ? t5~? uWwX ?  rR  rS  rT~ rI@ rV rW rV rX rY s)~ s g@trW[޿trW[? tm~"C? rHM"?  rrr ~ rB@ r[ r\ r[ r] r^ s)~ sT@tU>,?, r r r r r s)~ sY@ t<3? t<3?  tk ;@  rzk?  r  r  r~ rH@ !r !r !r !r !r !s)~ !sR@!tDYs!tDYs?! t ),`?! r+3? ! r ! r ! r~ !r:@ "r "r "r "r "r "s)~ "sW@"tJ0ѿ"tJ0?" tké^?" rXN? " r " r " r~ "r1@ #rt #ru #rt #rv #rw #s)~ #s@e@#tQ2KneUk#tQ2KneUk?# txa?# r5J? # rx # ry # rz~ #r8@ $r $r $r $r $r $s)~ $sA@$t=z?$t=z?$ t6V V@$ rc? $ r $ r $ r~ $r1@ %r %r %r %r %r %s)~ %st@%tBd%tBd?% tS0k?% r=? % r % r % r~ %rH@ &r &r &r &r &r &s)~ &s l@&t{C&t{C?& t}29 ?& r˸7 ? & r & r & r~ &rR@ 'r 'r 'r 'r 'r 's)~ 'sI@'t@;'t@;?' t`7OG?' rR? ' r ' r ' r~ 'r1@ (r-. (rk (r-. (rl (r.. (s)~ (sI@(t)^ ҿ(t)^ ?( t(?( r? ( r/. ( r" ( r0.~ (r(@ )r )r )r )r )r )s)~ )s4@)t[g{)t[g{?) tT# ?) rdJ#? ) r ) r ) r~ )r @ *r *r *r *r *r *s)~ *si@*t+\/D@*t+\/D@?* ta?* r:? * r * r * r~ *rA@ +r +r +r +r +r +s)~ +s8@+t1 l鯿+t1 l?+ t.m?+ rD~vc? + r + r + r~ +r`d@ ,r5 ,r. ,r5 ,r. ,r. ,s)~ ,s$@,tٹO?,tٹO?, tNZMb?, rӨ? , r. , r. , r.~ ,r@ -rq -rr -rq -rs -rt -s)~ -sN@-t4-t4?- t=k[O?- rL-m? - ru - rv - r~ -r,@ .r .r .r .r .r .s)~ .sp@.tAMп.tAM?. tC=?. rOmT? . r. r . r~ .r?@ /r^ /r_ /r^ /r` /ra /s)~ /s9@/t-tP#?/t-tP#?/ tR$3@/ r17~A? / rb / rc / rd~ /r@ 0r 0r 0r 0r 0r 0s)~ 0sK@0t8c(O?0t8c(O?0 t@a?0 rq-? 0 r 0 r 0 r ~ 0r*@ 1r 1r 1r 1r 1r 1s)~ 1sN@1t/?1t/?1 tJü;?1 r]? 1 r 1 r 1 r ~ 1r*@ 2r 2r 2r 2r 2r 2s)~ 2s4@2t=k@?2t=k@?2 th @2 r\-ǦJ? 2 r 2 r 2 rE~ 2r@ 3r 3r 3r 3r 3r 3s)~ 3s>@3t"[3t"[?3 tjbmQ?3 r5!? 3 r 3 r 3 r ~ 3r@ 4r 4r 4r 4r 4r! 4s)~ 4s@`@4t{4t{?4 t*TU?4 roUt? 4 r" 4 r# 4 r$ ~ 4rB@ 5r& 5r' 5r& 5r( 5r) 5s)~ 5s4@5t}0* ?5t}0* ?5 tPF?5 rFa>? 5 r* 5 r 5 r+ ~ 5r"@ 6r- 6r. 6r- 6r/ 6r0 6s)~ 6s@6t$ 6?6t$ 6?6 t]_=?6 rtw>? 6 r1 6 r2 6 r3 ~ 6re@ 7r5 7r6 7r5 7r7 7r8 7s)~ 7sD@7t;e37t;e3?7 t>쬗?7 r:"]? 7 r9 7 r: 7 r; ~ 7r @ 8r= 8r> 8r= 8r? 8r@ 8s)~ 8sT@8ttS4@8ttS4@8 tق=@8 rw﹬? 8 rA 8 rB 8 rC ~ 8r3@ 9rE 9rF 9rE 9rG 9rH 9s)~ 9s4@9t(߿9t(?9 t6:@[?9 rjJ? 9 rI 9 rJ 9 rK ~ 9r@ :rM :rN :rM :rO :rP :s)~ :sT@:toY0?:toY0?: t]2ؚ?: rS+f? : rr : r?~ :r&@ ;rR ;rS ;rR ;rT ;rU ;s)~ ;sg@;tտ;t?; tz8?; r@? ; rV ; rW ; rX ~ ;r2@ <r[ <r\ <r[ <r] <r^ <s)~ <s\@<tOY ?<tOY ?< t-׫ ?< r l? < r_ < r` < ra ~ <r7@ =rc =rd =rc =re =rf =s)~ =sR@=t\=t\?= tM (?= rHM"? = rg = rh = ri ~ =r3@ >r5 >r5 >r5 >r5 >r<- >s)~ >s@>t<˫>t<˫?> tK ?> rg3Qym? > r=- > r>- > r?-~ >r? ?rq- ?rd ?rq- ?re ?rr- ?s)~ ?sI@?t 6Y?t 6Y?? t]tL?? rSUO3a)? ? rs- ? rt- ? ru-~ ?r.@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rk @rl @rk @rm @rn @s)~ @sT@@t7 j@t7 j?@ t~_M?@ rF!5? @ ro @ r2 @ rp ~ @r0@ Arr Ars Arr Art Aru As)~ AsD@AtmJj?AtmJj?A tI@?A r]? A rc A rc A rv ~ Ar"@ Brx Bry Brx Brz Br{ Bs)~ BsQ@Bt*uٿBt*u?B tTtߙI?B r/*t;? B r| B rT B r} ~ Br0@ Cr Cr Cr Cr Cr Cs)~ Cs$@Ctk?Ctk?C tiCݩ?C r#9[? C r C r C r ~ Cr@ Dr Dr Dr Dr Dr Ds)~ Dst@DtFnODtFnO?D tp|?D r M/? D r D r D r ~ DrB@ Er Er Er Er Er Es)~ Es$@Etw/}ؿEtw/}?E ti?E rs17? E r E r E r ~ Er? Fr Fr Fr Fr Fr Fs)~ Fsa@FtRԿFtR?F tfļ?F r}O? F r F r F r ~ Fr:@ Gr Gr Gr Gr Gr Gs)~ Gs>@Gt~ۉwGt~ۉw?G tu?G r1]? G r G r G r ~ Gr@ Hr Hr Hr Hr Hr Hs)~ Hs@HtS5HtS5?H t4j?H rw? H r H r H r ~ Hr@j@ Ir Ir Ir Ir Ir Is)~ Is@It*`VZIt*`VZ?I te6 ?I u37=I r I r" I r ~ Ir`j@ Jr Jr Jr Jr Jr Js)~ Jsd@Jtҟ ֿJtҟ ?J teJ?J rR ? J r J r J r ~ Jr4@ Kr Kr Kr Kr Kr Ks)~ Ks4@KtJ1v4KtJ1v4@K tJ?K r{6)/? K r K r K r ~ Kr @ Lr Lr Lr Lr Lr Ls)~ LsN@Lt,Lt,?L t ?L r>g? L r L r L r~ Lr"@ Mr Mr Mr Mr Mr Ms)~ Ms`@Mt;!?Mt;!?M t/T@m?M rEI? M r M r M r ~ Mr9@ Nr Nr Nr Nr Nr Ns)~ Nsy@NtDT?NtDT?N tL ?N r:!Qȶ? N r N r N r ~ NrZ@ Or Or Or Or Or Os)~ Os@`@Ot7IqOt7Iq?O t54?O r3B? O r O r O r~ Or<@ Pr Pr Pr Pr Pr Ps)~ PsN@Pt Y?Pt Y?P tU"7?P r4&͆? P r P r P r~ Pr1@ Qr Qr Qr Qr Qr Qs)~ Qs9@QtAc?QtAc?Q tNз@Q rɅy? Q r Q r Q r~ Qr@ Rr Rr Rr Rr Rr Rs)~ Rs4@Rt^ .y?Rt^ .y?R tHh?R rϪ? R r R r R r ~ Rr@ Sr Sr Sr Sr Sr Ss)~ Ss.@St$St$?S t) M?S rϪ? S r S r S r ~ Sr@ Tr Tr Tr Tr Tr Ts)~ Ts[@TtZѿTtZ?T tl04g?T rft!? T r T r T r ~ Tr3@ Ur Ur Ur Ur Ur Us)~ UsR@UtN jUtN j?U t{&Ra?U rr,? U r U r U r~ Ur$@ Vr Vr Vr Vr Vr Vs)~ Vs>@Vt'?Vt'?V txҌ ?V rGu#? V rC V rD V rE~ Vr@ Wr= Wr> Wr= Wr? Wr@ Ws)~ Wse@Wt2(ԿWt2(?W tIlth?W rn? W rA W rB W rC~ WrB@ Xr Xr Xr Xr Xr Xs)~ Xsb@Xt4LMLO7ۿXt4LMLO7?X t֫x?X ry? X r X r X r ~ Xr<@ Yr Yr Yr Yr Yr Ys)~ Ys\@Ytɝ.'?Ytɝ.'?Y tH!A6Ʉ?Y rKev? Y rc Y rc Y rc~ Yr8@ Zr Zr! Zr Zr" Zr# Zs)~ Zst@Zt ͗|Zt ͗|?Z t4ODW?Z uE퐛> Z rrr ~ Zr:@ [r% [r& [r% [r' [r( [s)~ [sh@[td Wf?[td Wf?[ tIyHT?[ rG@2n? [ rc [ rc [ rc~ [rR@ \r\ \r] \r\ \r^ \r_ \s)~ \sN@\t+`Zf\t+`Zf?\ tOb?\ rft!? \ r` \ ra \ rb~ \r@ ]r* ]r+ ]r* ]r, ]r- ]s)~ ]s`@]tS9?]tS9?] t$6@] u M> ] r. ] r/ ] r0 ~ ]r(@ ^rv~ ^v<@ ^rv ^rx ^ry ^s)~ ^s9@^t#Eƨ^t#Eƨ?^ tx?^ rN ? ^ rz ^ r{ ^ r|~ ^r@ _r2 _r3 _r2 _r4 _r5 _s)~ _s$@_t״r_t״r@_ t»p-?_ r?j,? _ r6 _ r7 _ r8 ~ _r@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r5 `r `r5 `r5 `r `s)~ `s[@`tXIϱ?`tXIϱ?` ty[kf`?` rʄҵL? ` r/ ` r/ ` r/~ `r8@ arC arD arC arE arF as)~ asV@at)/,?at)/,?a tlZ?a rN ? a rG a rH a rI ~ ar*@ brK ~ bv@=@ brK brM brN bs)~ bsR@btؙξXebtؙξXe?b tPcu?b r)9? b rO b rP b rQ ~ br2@ cr5 cr- cr5 cr5 cr- cs)~ cs4@ctA{ ?ctA{ ?c t6+?c r@ =? c r- c r- c r-~ cr @ drT drU drT drV drW ds)~ ds^@dtjgÿdtjg?d tB?d rpt:{? d rX d rY d rZ ~ dr=@ er] er^ er] er_ er` es)~ esa@et*ƿet*?e tpք;I?e r\BP? e ra e rb e rc ~ er7@ frf frg frf frh fri fs)~ fsd@ftar^?ftar^?f tu?f r<$?k r_xx#? k r k r k r ~ kr@@ lr lr lr lr lr ls)~ ls.@ltQsL+ltQsL+?l tCK?l rpm.? l r l r l r ~ lr@ mr mr mr mr mr ms)~ ms$@mte0b(?mte0b(?m tێ2?m r'y(? m r m r m r ~ mr? nr nr nr nr nr ns)~ nsk@nt@IB?nt@IB?n tod?n rym? n r n r n r ~ nr@@ or or or or or os)~ os[@otze?otze?o taX,?o r/G? o r o rc o r ~ or,@ pr pr pr pr pr ps)~ psA@ptV`ptV`?p t*o98?p rT ? p r p r p r ~ pr@ qr qr qr qr qr qs)~ qsA@qtŨg?qtŨg?q t9Ȗ ?q rU7\? q r q r q r ~ qr@ rr rr rr rr rr rs)~ rs.@rtCș ?rtCș ?r t11?r rtzno? r r r r r r ~ rr@ sr sr sr sr sr ss)~ ss4@stA j@stA j@?s t?s r?j@|tpҟ?|tpҟ?| tf_?| r.)? | rrr ~ |r@ }r5 }r6 }r5 }r7 }r8 }s)~ }sY@}t:Y,m}t:Y,m?} tIZK?} uPl> } r } r  } r~ }r@ ~r ~r ~r ~r ~r ~s)~ ~sI@~tD:,LVj~tD:,LVj?~ t<H?~ r~ݬiMu? ~ r ~ r  ~ r~ ~r@ r: r; r: r< r= s)~ sI@tȈcѿtȈc? t̨ȁ? r+3?  r  r   r~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sD@t}qFt}qF? t? u$>  r  r   r ~ r@ r? r@ r? rA rB s)~ sK@tZaʔtZaʔ? t 0? rR ?  r  r   r~ r @ rD rE rD rF rG s)~ s\@t[ot[o? t?:3? r?"!?  rH  r  rI ~ r1@ rK rL rK rM rN s)~ sq@t U$?t U$? t1? rIx?  rO  rP  rQ ~ r;@ rS rT rS rU rV s)~ s`}@t{ ^Mt{ ^M? tO>? u H.y=  rW  rX  rY ~ r?@ r[ r\ r[ r] r^ s)~ s@e@t6ѶR?t6ѶR? t>J? rfGv?  r_  r`  ra ~ r=@ rc rd rc re rf s)~ sȉ@t1Î@t1Î@? th MW? uR_F6'>  rg  rh  ri ~ rQ@ rk rl rk rm rn s)~ sd@tF%?tF%? t;6@ ua|?>  ro  rp  rq ~ r1@ rs rt rs ru rv s)~ si@tRh?tRh? t5@ r!y +?  rw  rx  ry ~ r7@ rw rx rw ry rz s)~ s@e@tìutìu? tW? u>  r{  rT  r|~ r1@ r{ r| r{ r} r~ s)~ sd@t^?t^? tZ{!? r#?  r  r"  r ~ r5@ r r r r r s)~ se@ts7?ts7? t(zT+I? r^Io?  r  r  r ~ r0@ r r r r r s)~ spr@tZ=4tZ=4? te? r!c p;?  r  r  r~ rJ@ r r r r r s)~ s9@t+x`!Ϳt+x`!? t`PBB? rFL?  r  r  r ~ r"@ r r r r r s)~ s`h@tː|tː|? t\h? rJyH{?  r  r  r ~ rA@ r r r r r s)~ sA@tַۛQſtַۛQ? t̂? r#9[?  r  r  r ~ r(@ r5 r. r5 r. r. s)~ s.@tT?tT? t*Yd|? rSL?  r.  r.  r.~ r@ r r r r r s)~ s g@tt?tt? tWN? rIH2w?  r  r  r ~ r1@ r r r r r s)~ s|@t;̄ܿt;̄? tOy? rKhق?  r  r  r ~ rN@ r r r r r s)~ sI@trh?trh? tpH? rN~-?  rrr ~ r.@ r r r r r s)~ sT@t~@Vt~@V? tZ ? r@Sy?  r  r   r ~ r"@ r r r r r s)~ sQ@t:m|t:m|? tǥI晳? rUD*T?  r   r   r ~ r @ r r r r r s)~ sT@t 3tt 3t? t.K? rB C=?  r  r  r ~ r$@ r r r r r s)~ s@j@t,&LS߿t,&LS? tz? rP`?  rrr ~ r@@ r5 r r5 r3. r4. s)~ sI@t-\t-\? t'ʋ"? rS+f?  r5.  r6.  r7.~ r"@ r r r r r s)~ s`@t/Eyt/Ey? te[o? rKZўP?  r  r  r ~ r3@ r r r r r s)~ sV@t1w%U?t1w%U? tQ%T? rlM?  rrr ~ r5@ r r r r r s)~ s@tAF0׿tAF0? tCqG? r]?  r  r  r ~ rT@ r] r^ r] r_ r` s)~ s@U@t]t]? tNUB? r{r.t/?  ra  rb  rc ~ r7@ r r r r r s)~ s@U@t-?t-? te? rw﹬?  r  r  r~ r1@ r r r r r s)~ s@P@t͇lAt͇lA? tΧ? r8iY?  r  r  r ~ r1@ r r r r r s)~ sx@t;Mt;M? tλr>? rlM?  r  r  r~ rJ@Drl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s>@t~?t~? t85i? rpt:{?  r  r  r ~ r@ r5 r r5 r5 r. s)~ s4@t_H?t_H? tP+? rcڥ?  r.  r.  r.~ r@ r r r r r s)~ s@P@tDrj[ֿtDrj[? t L? r% ?  r  r  r ~ r.@ r r r r r s)~ sT@t"%*t"%*? t$̧? r2"?  r  r  r ~ r,@ r$ r% r$ r& r' s)~ sV@txK׏?txK׏? tq%? r\-ǦJ?  r(  r)  r* ~ r(@ r, r- r, r. r/ s)~ s@P@tt`tt`? t2+I? r Bž?  r0  r1  r2 ~ r"@ r4 r5 r4 r6 r7 s)~ s9@t Z&X?t Z&X? tWt@ rD2?  r8  r9  r: ~ r@ r  r  r  r  r s)~ sI@tB,f?tB,f? tex@ rSL?  r  r  r~ r"@ r< r= r< r> r? s)~ sx@tS@t8%t8%@ t XeZ4|? ran?  rH  rI  rJ ~ r@ rL rM rL rN rO s)~ sN@twjtwj? t`"Ҟ)? rD?  rP  rQ  rR ~ r0@ r\ r] r\ r^ r_ s)~ s@U@t$GC2ÿt$GC2? tã0? rFa>?  r`  ra  rb ~ r4@ rD- rt rD- ru r5 s)~ s9@tA ?tA ? tM;? rӁS.?  rE-  rF-  rG-~ r&@ r3 r4 r3 r5 r6 s)~ sb@teCteC? ty_? r{ {?  r7  r8  r9~ r5@ rh ri rh rj rk s)~ sQ@tf?ntf?n      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}? t:? r?  rl  rm  rn~ r5@ r r r r r s)~ s`@t[^aY't[^aY'? t!? r r?  r  r  r~ rV@ rd re rd rf rg s)~ sF@tt? t ? r`cm?  rh  ri  rj ~ r@ r{ r| r{ r} r~ s)~ s4@tGr ~tGr ~? tX*? r3 _?  r  r  r ~ r @ r r r r r s)~ s8@t´ i>t´ i>? ttVy? u`% 01;  r  r  r~ rQ@ r r r r r s)~ s9@tU?w9ӿtU?w9? td(1? rKhق?  r  r  r ~ r@ r r r r r s)~ s9@th8|Aֿth8|A? ty4@%? r3bL&?  r  r  r ~ r@ r r r r r s)~ sN@th3οth3? tBҙ+,? r>g?  rrr ~ r @ r r r r r s)~ sd@t4ԇڿt4ԇ? tm[T? rٔY?  r  r  r ~ r5@ r r r r r s)~ sQ@t|]t|]? tZM? rߣ^C*?  r  r  r ~ r,@ r r r r r s)~ s b@t;N~?t;N~? ti>g&? r"?  r  r*  r ~ r6@ r r r r r s)~ sV@t=t=? tV7? rOu?  r  r  r ~ r3@ r r r r r s)~ s4@t"7[ۿt"7[? t[ė? rZ?  r  r  r ~ r@ r r r r r s)~ s.@t(k|zft(k|zf? tSn? r&H?  r  r  r ~ r@ r r r r r s)~ ss@tFtF? tB? u\%>  r  r  r ~ rJ@ r r r r r s)~ s4@t?t? th? rU7\?  r  r  r ~ r@ r r r r r s)~ s@_@t6?t6? tC@ rhX?  r  r  r ~ r7@ r r r r r s)~ s@Z@tAYݿtAY? t*RY? rB C=?  r  r  r ~ r3@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r/ r r/ r/ r/ s)~ s4@t/ r5 r5 r?/ s)~ s@t?t? tC>? rF+?  r@/  rA/  rB/~ r? r r r r r s)~ sd@tp^?tp^? t+lː? rC .ގ?  r  r  r ~ r>@ r r r r r s)~ s@`@tR"C?tR"C? trUa? r|mn?  r   r!  r"~ r&@ r r r r! r" s)~ sA@t ?t ? t o]@ rvF?  r#  r  r$ ~ r@ r& r' r& r( r) s)~ sp}@tY!:տtY!:? tLIm? r>g?  r*  r+  r, ~ rC@ r. r/ r. r0 r1 s)~ s>@tzz?tzz? tZ=M7_? r@Y?  r2  r3  r4 ~ r@ r6 r7 r6 r8 r9 s)~ s4@tQd?tQd? t<w@ r2 ?  r:  r;  r< ~ r@ r> r? r> r@ rA s)~ s@P@t7t7? t6? r?  rB  rC  rD ~ r*@ rN rO rN rP rQ s)~ s@U@tѪB+tѪB+? tAw_? r]?  rR  rS  rT ~ r @ rV rW rV rX rY s)~ sT@tZJgǿtZJg? t(=? r Bž?  rZ  r[  r\ ~ r(@ r^ r_ r^ r` ra s)~ s`@tsRڿtsR? t.L)? r>g?  rb  rc  rd ~ r.@ rf rg rf rh ri s)~ sA@t0ӻc?t0ӻc? t%? r)@}?  rj  rk  rl ~ r@ rn ro rn rp rq s)~ s.@tD?tD? t ੘? rq-?  rr  rs  rt ~ r@ rv rw rv rx ry s)~ sI@tW 76?tW 76? tBSi? rU7\?  rz  r{  r| ~ r(@ r~ r r~ r r s)~ st@t$R?t$R? to? ro?  r  r  r ~ rC@ r r r r r s)~ sd@t,?t,? t+? r9 =?  r  r  r ~ rB@ r r r r r s)~ sR@th=Vؿth=V? tnu? r@OV~?  r  r  r ~ r3@ r r r r r s)~ sI@t!%KAշÿt!%KAշ? tM[? r&H?  r  r  r ~ r"@ r r r r r s)~ s4@tpU[?tpU[? t~M? r-z?  r  r  r ~ r@ r r r r r s)~ s>@tK)ve?tK)ve? t5{? r*/?  r  r  r ~ r @ r r r r r s)~ sR@ttۋ޵?ttۋ޵? t? r?  r  r  r ~ r0@ r r r r r s)~ s9@tBHAI?tBHAI? tI/O? rw?  r  r  r ~ r@ r r r r r s)~ s\@t XAh?t XAh? t ? r^,gWG?  r  r  r ~ rI@ r r r r r s)~ s`@tM?tM? t-꤭³? r>a?  r  r  r ~ r7@ r r r r r s)~ s.@tRhI(tRhI(? t0<ΤQ? r#9[?  r  r  rE~ r"@ rJ rK rJ rL rM s)~ s`c@to!?to!? tm#&X? r?  rN  rO  rP~ rB@ r r r r r s)~ s$@t<I@t<I@ t+w]@ r@t 8et 8e? tҬ;ސ? r%I+p~?  r\  r   r ~ r"@ r  r  r  r r s)~ sb@t=bmt=bm? t؛Ϯ? rSL? r  r"  r~ r7@ r r r r r s)~ sN@tk etk e? tHrlS? r:h?  r  r  r~ r&@ r r r r r s)~ sT@tc Fe?tc Fe? tzs/? rB C=?  r  r  r ~ r,@ r5 r) r5 r5 ra- s)~ s$@tb-"QDڿtb-"QD? tby? r]e)r4?  rb-  rc-  rd-~ r@ r/ r0 r/ r1 r2 s)~ sb@tiпti? tH?? r@ =?  r3  r4  r5~ r8@ r7 r8 r7 r9 r: s)~ sD@tmyC޿tmyC? tE? r?  r;  r<  r=~ r*@ r? r@ r? rA rB s)~ sN@t>+V9t>+V9? tiʸ? rOD?  rC  rD  rE~ r,@ r5 r/ r5 r/ r/ s)~ s@tq Wx׿tq Wx? tWsS? rS"?  r /  r!/  r"/~ r@ r` ra r` rb rc s)~ s@U@ti |ti |? t_c? rɅy?  rd  re  rf~ r2@ r5 rJ. r5 rK. rL. s)~ s4@t+5t+5? tEF? r57@?  r  r  rM.~ r@ r r r r r s)~ sa@tz)3?tz)3? tvS5ս^? r?  r  r"  r?~ r>@ rm rn rm ro rp s)~ sA@tY^?tY^? tgV? rlM?  rq  rr  rs~ r @ ru rv ru rw rx s)~ su@tfds?tfds? tew!T? r/?  ry  r"  rz~ rM@ r| r} r| r~ r s)~ s`@tlhd?tlhd? t5? rc?  r  r  r~ r9@ r r r r r s)~ s.@t&t&? t*@^? rT4V?  r  r  r~ r@ r r r r r s)~ s@t6GS?t6GS? ti^? rʄҵL?  rc  rc  r~ r@ r r r r r s)~ s$@tf6?tf6? tNZQ? rB C=?  r  r  r~ r@ r r r r r s)~ sK@taƃtaƃ? tu`}? r`T?  r  r  r~ r @ ri rj ri rk rl s)~ s.@tN1n@tN1n@ t%,+@ r$)E*?  rm  rn  ro~ r@ r r r r r s)~ sF@t˼ĚͿt˼Ě? trt2B? rZ`?  r  r  r~ r0@ r r r r r s)~ sV@t0C*t0C*? tHO? r@tQi`ֿtQi`? t[? rC .ގ?  r  r  r~ r$@ r r r r r s)~ s@P@tt? tNq4? rJU| ?  rC  rD  rE~ r @ r r r r r s)~ s4@t:?tt:?t? t09r? rR-?  r  r  r~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ s$@tVBO2?tVBO2? tB0ԕF? rjSx7e?  r  r  r~ r@ r5 r r5 r5 r, s)~ s`@tt? t ? r|ͅZ?  r,  r)  r,~ r6@ rp. rq. rp. rr. rs. s)~ sA@tY!,ݿtY!,? t94? r@?  rrr ~ r@ r r r r r s)~ sW@t4mt4m? tNwJ? rQnD?  rrr ~ r$@ r r r r r s)~ sQ@tj\tj\? t[MA? r#9[?  r   r   r ~ r&@ r  r  r  r r s)~ sD@tPqhtPqh? tx*? raJ6D?  r  r  r~ r2@ r r r r r s)~ sU@tbylEtbylE? tR6GR? r5(=?  r  r  r~ r$@ r r  r r! r" s)~ s@P@tLztLz? tLvV? rTK&T#S?  rC  rD  rE~ r @ r$ r% r$ r& r' s)~ sK@t}X 0}t}X 0}? tZ2.? u]~>  r(  r)  r*~ r@ r, r- r, r. r/ s)~ s b@ tx? tx?  t0D2 k]?  r&>dYx?  r0  r1  r2~ r>@ r4 r5 r4 r6 r7 s)~ s:@ tN[? tN[?  t3=o?  ro?  r  r  r~ r@ r9 rP r9 r: r; s)~ s b@ tGX tGX?  t8?  r?"!?  r  r  r~ r.@ rE rP rE rF r; s)~ sQ@ t![5 t![5?  tPU;[?  rA,Ґ$?  rrr ~ r @ r5 r9/ r5 r5 r:/ s)~ s$@ tv9? tv9?  tOz ?  ro?  r;/  r?  r,  r,  r,~ rU@ r%+ r&+ r%+ r'+ r(+ s)~ s.@tO'?tO'? tk@ r gs"?  r)+  r*+  r++~ r@ r  r  r  r r s)~ sV@t?U?t?U? t \@ rR ?  r  r  r~ r&@ r/ r  r/ r/ r5 s)~ sa@t.[t.[? t63]? rco?  rrr ~ r5@ r5 r5 r5 r5 r/ s)~ s@P@t?wr+t?wr+? t{d.9? rlM?  rc  rc  rc~ r$@ rV rW rV rX rY s)~ s4@tRj 揨tRj 揨? tA4Ϧ? r_q帊?  r  r  r~ r@ r-+ r.+ r-+ r/+ r0+ s)~ s$@trCo0?trCo0? t1}i? ru֭?  r1+  r2+  r3+~ r@ re rf re rg rh s)~ sA@t^=8?t^=8? tN? rlM?  ri  rj  rk~ r$@ rn ro rn rp rq s)~ sI@t 23?t 23? tM~? r?  rr  rs  rt~ r,@ r5 r/ r5 r5 r/ s)~ s@t?t? tkf? rlM?  r/  r/  r/~ r@ r r r r r s)~ sI@t#e?t#e? t\%O6@ r]`?  r  r  r~ r$@ r r r r r s)~ s@`@tSQtSQ? tk? rq{T?  r  r  r~ r7@ r r r r r s)~ sD@tVtV? t6? rc?  r  r  r~ r(@ r5 r- r5 r5 r- s)~ s@tP>?tP>? t&k5? rEj?  r-  r-  r-~ r@ r r r r r s)~ sW@tL+?tL+? tX8|? r)?  r  r  r~ r1@ r5 r, r5 r5 r, s)~ s@tv9tv9@ tp~,{? r l?  r,  r,  r,~ r? r5 r r5 r5 r/ s)~ s.@tr?tr? t@^XU]@ r]`?  r/  r/  r/~ r@ r5 r r5 r5 r<. s)~ s9@tlCp?tlCp? t.  r?.~ r@DXl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r r r r r s)~ s9@ tUNL߿ tUNL?  tϬ?  r'?  r  r  r~ r@ !r !r !r !r !r !s)~ !s4@!tRS!tRS?! t*2?! r3Ҕ!? ! r ! r ! r~ !r@ "r "r "r "r "r "s)~ "s.@"t~ؿ"t~?" tx ?" rq-? " r " r " r~ "r@ #r5 #r5 #r5 #r5 #r- #s)~ #s>@#t˜zٿ#t˜z?# tkCg?# roiU? # r. # r. # r.~ #r@ $r5 $r $r5 $r5 $r! $s)~ $sA@$txfO$txfO?$ tN?$ r\UhF? $ r/ $ r/ $ r/~ $r@ %r %r %r %r %r %s)~ %sk@%tQ;}?%tQ;}?% t3/@% uyY{N> % rrr ~ %r2@ &r &r &r &r &r &s)~ &sR@&tJv?&tJv?& t_V?& r՟? & rrr ~ &r1@ 'r 'r 'r 'r 'r 's)~ 's>@'tVS??'tVS??' t#i?' r]? ' r ' r ' r~ 'r$@ (rk/ (rW (rk/ (rX (rl/ (s)~ (sN@(tkD9?(tkD9?( t9 O?( r@? ( rrr ~ (r4@ )r )r )r )r )r )s)~ )sT@)tUʜ?)tUʜ?) th%?) r? ) rrr ~ )r3@ *r5 *r. *r5 *r. *r. *s)~ *s$@*thVi?*thVi?* t;?, rram? , r- , r- , r-~ ,r*@ -r -r -r -r -r -s)~ -s.@-tCW˿-tCW?- tWYsȉ?- rs17? - r - r - r~ -r@ .r .r .r .r .r .s)~ .sQ@.t^|r.t^|r?. t)W|?. r.N? . r . r . r~ .r*@ /r /r /r /r /r /s)~ /s9@/t.k)?/t.k)?/ tl?/ r.ꄸ? / r / r / r~ /r @ 0r 0r 0r 0r 0r 0s)~ 0s9@0tڿ0t?0 ty?0 r)!? 0 r 0 r 0 r~ 0r3@ 1r 1r 1r 1r 1r  1s)~ 1s.@1t@T9M?1t@T9M?1 tDF?1 rSL? 1 r  1 r  1 r ~ 1r@ 2r 2r 2r 2r 2r 2s)~ 2sA@2t ;2t ;?2 t*t4?2 r`R? 2 r 2 r 2 r~ 2r"@ 3r 3r 3r 3r 3r 3s)~ 3s@P@3tv}_ֿ3tv}_?3 tx55?3 r? 3 r 3 r 3 r~ 3r(@ 4r 4r 4r 4r  4r! 4s)~ 4sr@4tauiN4tauiN?4 t~?4 ri#? 4 r" 4 r# 4 r$~ 4r;@ 5r& 5r' 5r& 5r( 5r) 5s)~ 5s@P@5ts0L6cU?5ts0L6cU?5 t?v[9^|@5 ru-a? 5 r* 5 r+ 5 r,~ 5r(@ 6r. 6r/ 6r. 6r0 6r1 6s)~ 6sb@6tm6tm?6 tW%?6 u>Q> 6 r2 6 r3 6 r4~ 6r1@ 7r6 7r7 7r6 7r8 7r9 7s)~ 7s4@7tf n?7tf n?7 tO˖?7 rgc 8r? 8r> 8r@ 8rA 8s)~ 8s9@8tWS~8tWS~?8 tHO?8 rz? 8 r 8 r  8 r~ 8r@ 9rC 9rD 9rC 9rE 9rF 9s)~ 9s g@9te<jz9te<jz?9 t;l?9 rMc? 9 rG 9 r* 9 rQ ~ 9r2@ :rI :rJ :rI :rK :rL :s)~ :sf@:tA_?:tA_?: t7@: rA'bTS? : rM : rN : rO~ :r1@ ;rQ ;rR ;rQ ;rS ;rT ;s)~ ;s{@;tq?;tq?; t\ٓ@; uNzB:a> ; rU ; rV ; rW~ ;rK@ <rY <rZ <rY <r[ <r\ <s)~ <sK@<tRv?<tRv?< t_o @< rri >rj >ri >rk >rl >s)~ >sA@>tAlSֿ>tAlS?> tCSu?> rȔUD? > rm > rn > ro~ >r@ ?rq ?rr ?rq ?rs ?rt ?s)~ ?so@?tRGƿ?tRG?? t@A?? rOu? ? ru ? rv ? rw~ ?r@@DXl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @ry @rz @ry @r{ @r| @s)~ @sj@@t<?@t<?@ t+@@ uW> @ r} @ r~ @ r~ @r>@ Ar Ar Ar Ar Ar As)~ As`y@AtiA?e~AtiA?e~?A te,Bs?A u,t= A r A r A r~ ArM@ Br Br Br Br Br Bs)~ BsT@BtAjx?BtAjx?B t62u;J5?B rvS? B r B r B r~ Br3@ Cr Cr Cr Cr Cr Cs)~ Csb@Ct .?Ct .?C t3~sZ?C r#9[? C r C r C r~ Cr=@ DrO DrP DrO DrQ DrR Ds)~ Ds@P@Dt̒JDt̒J?D t5h?D u&= D r D r  D r~ Dr@ Er Er Er Er Er Es)~ EsA@Et9jEt9j?E tsU5?E rR:$? E r E r E r~ Er@ Fr Fr Fr Fr Fr Fs)~ FsY@Ft=DYտFt=DY?F td?F r4$DG? F r F r F r~ Fr<@ Gr Gr Gr Gr Gr Gs)~ Gs@P@GtqgGtqg?G tՖ8?G r&\Nn'? G r G r G r~ Gr3@ Hr Hr Hr Hr Hr Hs)~ HsK@HtA{Y\-?HtA{Y\-?H tOG?H r]Ag,i? H r H r H r~ Hr&@ Ir Ir Ir Ir Ir Is)~ IsA@ItNuξ?ItNuξ?I t@TNd?I r DK? I r I r I r~ Ir&@ Jr Jr Jr Jr Jr Js)~ JsD@Jt-2TnJt-2Tn?J t?J rwߞu? J r J r J r~ Jr@ Kr Kr Kr Kr Kr Ks)~ KsR@Ktkst-Ktkst-?K t g?K r*LA4? K r K r K r~ Kr0@ Lr5 Lr/ Lr5 Lr5 Lr/ Ls)~ Ls4@Lth)4޽Lth)4޽?L tpI?L rC .ގ? L r/ L r/ L r/~ Lr@ Mr Mr Mr Mr Mr Ms)~ Msz@Mtej.ĿMtej.?M tOG?M r+C`a? M r M r M r ~ Mr@U@ Nr Nr Nr Nr Nr Ns)~ Nsk@Nto.ÿNto.?N tO ?N r*I? N r N r N r~ NrB@ Or Or Or Or Or Os)~ Os[@Ot_Ot_?O tVQ?O r\p? O r O r O r~ Or3@ Pr Pr Pr Pr Pr Ps)~ PsQ@Pti,?Pti,?P t¶m2?P rM@Jm? P r P r P r ~ Pr2@ Qr Qr Qr Qr Qr Qs)~ Qs.@Qt^o^ٿQt^o^?Q tBU P?Q r3Ҕ!? Q rrr ~ Qr@ Rr5 Rr" Rr5 Rr5 Rrl. Rs)~ Rs9@Rt-@@IۿRt-@@I?R tqj?R r'C7? R rm. R rn. R ro.~ Rr@ Sr{# Sr|# Sr{# Sr}# Sr~# Ss)~ SsN@St~2l1PҿSt~2l1P?S tOj.>?S r)!? S r# S r# S r#~ Sr.@ Tr. Tr  Tr. Tr/ Tr0 Ts)~ Ts.@Tt2wc?Tt2wc?T tq?T rϪ? T rc T rc T rc~ Tr@ Ur2 Ur3 Ur2 Ur4 Ur5 Us)~ UsT@Ut?Ut?U t_?U r? U r6 U r7 U r8~ Ur*@ Vr Vr Vr Vr Vr Vs)~ VsW@VtbI7VtbI7?V t?V r? V r V r V r~ Vr7@ Wrl Wrm Wrl Wrn Wro Ws)~ WsV@WtH]`)ѿWtH]`)?W trL?W r57@? W rp W rq W rr ~ Wr.@ XrB XrC XrB XrD XrE Xs)~ XsN@Xt#V׿Xt#V?X t[⑮?X r>? X rF X rG X rH~ Xr&@ Yr Yr Yr Yr Yr Ys)~ Yspp@Yt?Yt?Y tz}1?Y r@ =? Y r Y r Y r~ Yr:@ ZrJ ZrK ZrJ ZrL ZrM Zs)~ Zs$@Zt']/>Zt']/>?Z tfS?Z r@]tu]tu@] tr?] rM/Jx? ] rf ] rg ] rh~ ]r@ ^rj ^r ^rj ^r ^rk ^s)~ ^si@^ta^ta?^ t:/?^ rN ? ^ rl ^ rm ^ rn~ ^r@@ _rp _rq _rp _rr _rs _s)~ _s.@_tQܴ?_tQܴ?_ tXۉ ?_ r? _ rt _ ru _ rv~ _r@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `s`c@`t\TS0`t\TS0?` t4??` rUC? ` r ` r ` r~ `r,@ ar ar ar ar ar as)~ as@P@atsNsRuatsNsRu?a t{B?a rjl? a r a r a r~ ar&@ br br br br br bs)~ bs b@btMDbtMD?b t ?b u`?F0> b rb r b r~ br3@ cr cr cr cr cr cs)~ cs$@ctfr ctfr ?c toqKh?c r]? c r c r c r~ cr@ drl drm drl drn dro ds)~ dsN@dt\W(dt\W(?d t_EE?d rC? d rp d rq d rr~ dr,@ er er er er er es)~ es b@etmD?etmD?e tH݃?e rjJ? e r e r e r~ erA@ fr5 fr fr5 fr, fr, fs)~ fs9@fti5@fti5@f t'Y@f r\BP? f r, f r, f r,~ fr@ gr/ gri gr/ gr/ gr5 gs)~ gs@Z@gt9=eؿgt9=e?g tX?g rU7\? g rrr ~ gr,@ hr hr hr hr hr hs)~ hs4@ht~ۣ?ht~ۣ?h t%?h r& f? h r h r h r~ hr@ ir ir ir ir ir is)~ is9@it\s丠it\s丠?i t`3?i r#? i r i r i r~ ir$@ jr jr jr jr jr js)~ jsF@jt퟉M?jt퟉M?j tk\Ej?j r? j r j r j r~ jr$@ kr kr kr kr kr ks)~ ks\@ktlx>L?ktlx>L?k t@k r7P N&? k r k r k r~ kr0@ lr- lr- lr- lr- lr- ls)~ ls$@ltPvͿltPv?l tΰV?@wt?wt?w t)]R j?w r:g? w r0 w r1 w r2~ wr&@ xr4 xr5 xr4 xr6 xr7 xs)~ xsF@xtNxtN?x t|?x r6 ? x r8 x r9 x r:~ xr"@ yrC yrD yrC yrE yrF ys)~ ysD@ytZ4׿ytZ4?y t шQ?y r'y(? y rG y rH y rI~ yr@ zrD zrE zrD zrF zrG zs)~ zsW@ztЌxּ?ztЌxּ?z tl\L?z rnK? z rH z rI z rJ~ zr5@ {rL {rM {rL {rN {rO {s)~ {s@U@{tl?{tl?{ tfP?{ r? { rP { rQ { rR~ {r3@ |rT |rU |rT |rV |rW |s)~ |s.@|tH<@|tH<@| t$@| r1ZO)? | r; | r| | r=~ |r? }ra }rb }ra }rc }rd }s)~ }s$@}t^ˍ1}t^ˍ1?} t.sk?} rT`I0G? } re } rf } rg~ }r@ ~ri ~rj ~ri ~rk ~rl ~s)~ ~s9@~tryV t~tryV t?~ t~CF?~ rϪ? ~ rm ~ rn ~ ro~ ~r$@ ry rz ry r{ r| s)~ s.@tF ?tF ? tHXP? rɅy?  rc  rc  r}~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sF@t_n[?t_n[? t}G:? r?$j*?  r  r  r~ r(@ r r r r r s)~ s4@t@gʿt@g? t`@1? rB C=?  r  r  r~ r"@ r r r r r s)~ s4@t?\ҿt?\? tBYP? rlM?  r  r  r~ r@ r r r r r s)~ sV@t{Jqαt{Jqα? t&#i~? rǷ ?  rr  r~ r4@ r/ r r/ r r5 s)~ sN@t)ye?t)ye? t=? rl %)N?  r/  r/  r/~ rA@ r- r r- r r- s)~ sD@tc܃tc܃? t\? rR ?  rrr ~ r*@ r r r r r s)~ sd@tt %?tt %? tdn@? r#9[?  r  r  r~ rB@ rg" rh" rg" ri" rj" s)~ s4@tc1waVtc1waV? t? rN~-?  rk"  rl"  rm"~ r@ r r r r r s)~ sK@to(p?to(p? tY~+? rco?  r  r  r~ r(@ ro" rp" ro" rq" rr" s)~ s>@t*?t*? tA[Ar#V@ r;ێo?  rs"  rt"  ru"~ r(@ r r r r r s)~ s`@t:9Xt:9X? t?/? rDF?  r  r"  r~ r5@ r r r r r s)~ s0q@tٿt? t#z A? rfGv?  r  r  r~ r>@ r~ v<@ r r r s)~ sR@tsmٿtsm? tS0K? r+Nc?  r  r  r~ r4@ r r r r r s)~ s b@t]$c?t]$c? tDMZ2? rʄҵL?  r  r  r~ r9@ r r r r r s)~ s`@tN.?tN.? t4"? rϪ?  r  r  r~ r:@ r3 r4 r3 r5 r6 s)~ sA@t_ف?t_ف? t`? r*/?  r7  r8  r9~ r2@ r r r r r s)~ sF@tM?tM? t x]s? rFa>?  r  r  r?~ r"@ r r r r r s)~ sK@tBdӿtBd? tG? r h?  r  r  r ~ r0@ r  r  r  r  r s)~ sI@tK*kStK*kS? tgw ? r-e&?  r  r  r~ r.@ r - r" r - r" r - s)~ s4@ty1ty1? t's~? ri'?  r -  r -  r-~ r@ r r r r r s)~ s@P@t[yGj#t[yGj#? tԘyv? r<Ո?  r  r  r~ r,@ r r r r r s)~ s@Z@tvӐtvӐ? t3O? r(.}q?  r  r  r~ rA@ r r r r r s)~ s@P@t"t"? tZ? r xP?  r  r  r ~ r,@ r" r# r" r$ r% s)~ sT@t>.t>.? tZ 6? rw]Nq?  r&  r'  r(~ r1@ r* r+ r* r, r- s)~ s@tYnd+tYnd+? t4V? r-hdB?  r.  r/  r0~ r? r. r r. r. r5 s)~ s4@t$n+@t$n+@ t[Cܴ@ roĝ'?  rrr ~ r@ r r r r r s)~ sR@tθZ}?tθZ}? tQo0? ry#?  r  r8  r~ r,@ r/ r/ r/ r/ r/ s)~ s@tr otr o? t"׮ r? s)~ s4@t]?t]? t ? r:g?  r@  rA  rB~ r$@ r5 r5 r5 r5 r9- s)~ sA@tlihtlih? t6xP? rqr-?  r:-  rC%  r;-~ r@ rD rE rD rF rG s)~ sI@tMCyY? r.|?  rf  r  rg~ r&@ r. r. r. r. r. s)~ s.@tc5tc5? t=$lm? r?z?  r.  r.  r .~ r@ r r r r r s)~ sI@tbtb? t}Hy? r io?  r  r  r~ r"@ rr rs rr rt ru s)~ sf@t.ҿt.? tFwN? r& f?  rv  r  rw~ r@@ r# r$ r# r% r& s)~ sF@t t ? tafu&? r"?  r'  r(  r)~ r,@ ry rz ry r{ r| s)~ s$@t _Tt _T? tF3L? rjl?  r}  r~  r~ r? r r r r r s)~ s4@t [ct [c? t#w? rV@?  r  r  r~ r@ r r r r r s)~ s9@t:d>ӿt:d>? tZyE? r/؍YK?  r  r  r~ r@ r r r r r s)~ s@U@tx&X+=tx&X+=@ ty[? u\1z>  rC  rD  rE~ r@ r r r r r s)~ s4@t_1Tt_1T? t ? rpt:{?  rC  rD  rE~ r@ r r r r r s)~ sR@tD.NtD.N? tIw#? r{֕ #ڰ?  rL r  rM~ r @ r. r. r. r. r. s)~ s@tB tB @ t2MOο? rc?  rrr ~ r? r r r r r s)~ sF@tن`tن`? t>? r0RMg?  r  r  r~ r@ r r r r r s)~ sA@t9{Řt9{Ř? tBU ? r-hdB?  r  r  r~ r@ r&/ r'/ r&/ r(/ r)/ s)~ s$@tpc?tpc? t K? rpt:{?  r  r  r~ r@ r rI r r r s)~ s.@t:bA9t:bA9? tf7{o? rڪS?  rrr ~ r@ r r r r r s)~ s.@tyſty? tAp>y? r$BӦ?  r  r  r~ r@ r5 r r5 r5 r s)~ s9@t!??t!?? tռ%l? r>g?  r-  r-  r-~ r@ r r r r r s)~ s>@t3>Iyտt3>Iy? tɦ[? ry#?  r  r  r~ r@ r r r r r s)~ sW@t0A t0A ? tCr ? r5HxO?  r  r  r~ r(@ r r r r r s)~ sW@tlKKbtlKKb? t(? rXg:T?  r  r  r~ r @ r r r r r s)~ s4@t^Q-2Nֻt^Q-2Nֻ? trUe?? r?  r  r  r~ r@ r r r r r s)~ sT@t+>t+>? tU2? u>  r  r  r~ r@ r r r r r s)~ sA@tt? txGL? r;c!?  r  r  r~ r@ r r r r r s)~ s@U@tC#Y?tC#Y? tgNXQ? r"X?  r  r  r~ r.@ r5 r5 r5 r5 r, s)~ s@t?t? t7B? rmL/?  r,  r,  r,~ r? r r r r r s)~ s4@tK}l?tK}l? t&vI-? rL-m?  r  r  r~ r@ r r r r r s)~ sA@t:t %ٿt:t %? ttt3_? rCa?  r  r  r~ r @Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r& r r  r  s)~ s$@t` t` ? t'? r xP?  rc  rc  rc~ r? r r r r r s)~ sI@ti8߿ti8? t;U? rF?  r  r  r~ r,@ r5 rx r5 r5 r`/ s)~ s>@tY?tY? t̛o? r&H?  ra/  rb/  rc/~ r@ r)# r*# r)# r+# r,# s)~ sA@tgu?tgu? t? rg3Qym?  r-#  r.#  r/#~ r.@ r  r  r  r r s)~ s.@tkS&me(tkS&me(? tA!'? rcڥ?  r  r  r~ r@ r5 r r5 r5 r, s)~ sD@teͿte? t>M8? r5J?  r-  r-  r-~ r@ r~ v<@ r r r s)~ sI@tn;ɿtn;? tČ? rX@D?  rrr ~ r$@ r5 r r5 r5 r#/ s)~ s@_@te|{zTte|{zT? t1PA? rB C=?  rc  rc  rc~ r1@ r! r" r! r# r$ s)~ sD@t?#(?t?#(? tD9ʿ? rFa>?  r%  r&  r'~ r @ r) r* r) r+ r, s)~ sA@th.wpth.wp? t? rYЍE?  r-  r.  r/~ r*@ r9 r: r9 r; r< s)~ s.@tzu?tzu? t S*I @ r?  r=  r>  r?~ r@ r5 r  r5 r  r/ s)~ sI@tWFÿtWF? t*? r8iY?  r  r  r~ r"@ rH rI rH rJ rK s)~ s@P@tDHTTտtDHTT? tsB? r?  rL  rM  rN~ r.@ r r r r r s)~ sI@trytry@ tƴ6? r^I|?  r  r  r ~ r&@ r5 rc r5 rd r- s)~ sA@toE ؿtoE ? t*? r/5rh?  r-  r-  r-~ r@ rj rk rj rl rm s)~ s b@tUV<tUV@t-oԅt-oԅ? t$?(? r7p?  r}  r~  r~ r&@ r r r r r s)~ s@t~dz\a?t~dz\a? toV.@ rXN?  r  r"  r~ r@ r5 r r5 r5 r- s)~ s9@tC e?tC e? t7&? rR ?  r-  r-  r-~ r@ r r r r r s)~ s@U@t6S?t6S? th2? r?  r  r  r ~ r7@ r r r r r s)~ sA@tzE;?tzE;? t9? r{xd?  r  r  r~ r @ r r r r r s)~ s$@t'>?t'>? t0|w@ rB C=?  r  r  r~ r@ r5 r. r5 r. r. s)~ s$@ti.ti.? trX0? rӨ?  r.  r.  r.~ r@ r r r r r s)~ s>@t=Mhƿt=Mh? tNC? rq-?  r  r  r~ r"@ r r r r r s)~ sF@tKͶ޿tKͶ? tq;}? rȔUD?  r  r  r~ r@ r r r r r s)~ sQ@t?'?t?'? t(P@ r]ib?  r  r  r~ r2@ r r r r r s)~ s9@tT1OʿtT1O? t&? r3 _?  r  r  r~ r@ r r r r r s)~ sN@t]ݹt]ݹ? t"z[? u22'?  r  r   r ~ r@ rV% rW% rV% rX% rY% s)~ sK@t&N t&N ? tWJ? r/uQ-!?  r  r   r~ r@ r/ r0 r/ r1 r2 s)~ sd@tx?tx? tb@ rS;!?  rO  r*  rQ ~ r1@ r r r r r s)~ s4@txM5&?txM5&? t? r'(x?  r  r  r~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sR@t^pg@ r r r r r s)~ sQ@t,Qu֭?t,Qu֭? t'-Lب? r?  r  r  r} ~ r0@ r r r r r s)~ sK@t]|78?t]|78? tb$B? rN?  r  r  r~ r*@ r r  r r r s)~ s>@t}t}@ t=? r,H?  rrr ~ r@ r r r r r s)~ sN@tEg?tEg? toɡ? rM?  r  r  r} ~ r$@ r r r r r s)~ s4@t?t? tϕq2@ rU7\?  r  r  r~ r@ r r r r r s)~ sD@tpƾtpƾ? tOq? rG칯?  r)  r*  r~ r@ r$ r% r$ r& r' s)~ sD@t8A f?t8A f? t6hb? r<S?  r(  r  r)~ r@ rY rZ rY r[ r\ s)~ s@P@tCb?tCb? t9=? r8b`?  r]  r^  r_~ r3@ r+ r, r+ r- r. s)~ sV@tQ.tQ.? t)=? rFa>?  r/  r0  r1~ r<@ r, r r, r r, s)~ s>@tO}?tO}? t?`s? roO?  r,  r,  r ~ r@ r r  r r r s)~ sR@t{ј2?t{ј2? tsr,s? ry#?  r  r  r~ r @ r; r< r; r= r> s)~ s.@ttq?ttq? tֵ|@ rD ?  r?  r@  rA~ r @ r: r; r: r< r= s)~ s.@t$$Dt$$D? tߦelQ? rB C=?  r>  r?  r@~ r@ rC rD rC rE rF s)~ s>@t@7Fݿt@7F? tRg+N? r]?  rG  rH  rI~ r@ rK rL rK rM rN s)~ s.@tRDtRD? t:g? rOu?  rO  rP  rQ~ r@ rS rT rS rU rV s)~ s.@t95+(2t95+(2? tB-15"? ry#?  rW  rX  rY~ r@ r[ r\ r[ r] r^ s)~ s>@tI{;ڍ@tI{;ڍ@ tJw@ rjJ?  r_  r`  ra~ r@ rm/ r rm/ r rn/ s)~ s9@tN?tN? tˆ=k @ rs?  ro/  rp/  rq/~ r@ rt ru rt rv rw s)~ s.@ta_ta_@ te.ς? rBo6?  rx  ry  rz~ r @ r r r r r s)~ sF@t|ONa)Կt|ONa)? tۑ;? rӨ?  r  r  r~ r,@ r| r} r| r~ r s)~ s@s@t8 {et8 {e@ t? u< ?  r  r  r~ rF@ r r r r r s)~ sI@t4P>t4P>? tueC? r?  r  r  r~ r,@ r&- r'- r&- r(- r)- s)~ s$@tt? t{O? rUe?  r*-  r  r+-~ r@ r, r r, r, r, s)~ s$@t :JVt :JV? tc) ? rL-m?  r,  r,  r,~ r@ r r r r r s)~ sV@tR0tR0? tq x? rjJ?  rrr ~ r5@ r r r r r s)~ sb@tպP!0ԿtպP!0? tj&? r 2?  r  r  r~ r8@ r r r r r s)~ s\@t^. _?t^. _? twB@ r?  r  r  r~ r"@ r6 r6 r6 r6 r@- s)~ s4@t #;t #;? t$? r(.}q?  rA-  rB-  rC-~ r@ r r r r r s)~ s@t?t? t9t87? r?  r  r  r~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ sA@t#lRt#lR? tV踷? r0.}?  r  r  r~ r$@ r r r r r s)~ s@P@tbimﵿtbim? tU '? r/5rh?  r  r  rM~ r(@ r r r r r s)~ s@P@tߒ6X?tߒ6X? t٬6?? rbڭ@6?  rrr ~ r0@ r< r= r< r> r? s)~ sI@ti ?ti ? tto? r]?  r@  rA  rB~ r @ rh' ri' rh' rj' rk' s)~ sI@t+uĿt+u? tӏ?  r  r  r~ r8@ r r r r r s)~ sT@ tGYu tGYu?  t*Nɼ?  rc?  r  r  r ~ r1@ rH/ rI/ rH/ rJ/ rK/ s)~ s@ tga&] tga&]?  tH?  rq-?  rL/  rM/  rN/~ r@ r6 rC/ r6 r6 rD/ s)~ s@ tV<ѿ tV  r?  r@~ r2@ rB rC rB rD rE s)~ s$@ti'`2ti'`2? th$? rL-m?  rF  rG  rH~ r@ rR rS rR rT rU s)~ s4@tRLQ?tRLQ? t7B? rH{u?  rV  rW  rX~ r@ rZ r[ rZ r\ r] s)~ s4@tazοtaz? tҼcK/? rÎ='?  r^  r_  r`~ r@ rb rc rb rd re s)~ s$@t ʎ^?t ʎ^? t!>TN? rG칯?  rf  rg  rh~ r @ r r r r r s)~ sT@t_a?t_a? tpf? r`R?  r  r  r~ r7@ r6 r6 r6 r6 r, s)~ s$@tIrtIr? t[~_? r Y?}?  r,  r,  r,~ r@ rn ro rn rp rq s)~ sF@t\J>?t\J>? tϰtn@ rs17?  rr  rr~ r*@ rx ry rx rz r{ s)~ sD@tHOtHO? tk<6? rpt:{?  r|  r}  r~~ r @ r r r r r s)~ s4@t$C5xֿt$C5x? t~έx? rFa>?  r  r  r~ r*@ r6 r r6 r r}. s)~ s`@t1sҿt1s? t@z'? r]?  r~.  r.  r.~ rB@ r r r r r s)~ s9@t0/2Y?t0/2Y? tP=? rQHH?  r  r  r~ r@ r r r r r s)~ sA@t?t? t8Ŕ? rL-m?  r  r  r~ r"@ r r r r r s)~ s.@t>zOt>zO? tOM;t? rFa>?  r  r  r~ r@ rO rP rO rQ rR s)~ sK@t78`Nt78`N? t4z? rȔUD?  rS  rT  rU~ r,@ r r r r r s)~ s.@tv"sοtv"s? t["? r]`?  r  r  r~ r@ r r r r r s)~ s@twm޿twm? t #e9? r3bL&?  r  r  r~ r? r r r r r s)~ s>@t: "ܿt: "? tso? r(,0?  r  r  r~ r @Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r r r r r s)~ s4@ t6# Eʿ t6# E?  t_sյ?  r h5?  r  r  r~ r @ !r !r !r !r !r !s)~ !sA@!tHT~?!tHT~?! t@! rh2? ! r ! r ! r~ !r(@ "r' "r' "r' "r' "r' "s)~ "s>@"t.+?"t.+?" t_/@" r=V? " r' " r' " r'~ "r"@ #r #r #r #r #r #s)~ #sY@#t8( #t8( ?# t;2'.?# rpt:{? # r # r # r~ #r.@ $r 6 $r $r 6 $r $rv- $s)~ $s>@$tnE?$tnE?$ t *?$ rNJ8t? $ rw- $ rx- $ ry-~ $r(@ %r %r %r %r %r %s)~ %sA@%t-E{ǚ%t-E{ǚ?% t%/?% rŢ V? % r % rc % r~ %r@ &r &r &r &r &r &s)~ &s\@&twT{׿&twT{?& t<)D?& rHM"? & r & r & r~ &rB@ 'r 'r 'r 'r 'r 's)~ 's@`@'tLS'tLS?' t?' r 5`@? ' r ' r ' r ~ 'r4@ (r  (r  (r  (r  (r (s)~ (s>@(tJѲݿ(tJѲ?( t 2?( rÞL? ( r ( r ( r~ (r"@ )r 6 )r - )r 6 )r!- )r"- )s)~ )s.@)t ЍRΗ)t ЍRΗ?) t&?) rWWl? ) r#- ) r$- ) r%-~ )r@ *r! *r! *r! *r! *r! *s)~ *sF@*tw0ȿ*tw0?* t(#R?* rC ? * r! * r * r} ~ *r,@ +r +r +r +r +r +s)~ +sD@+tLJt9?+tLJt9?+ t2ټ?+ rlM? + r + r + r~ +r"@ ,r ,r ,r ,r ,r ,s)~ ,sa@,tʿ,t?, t6B?, r$8? , r , r  , r!~ ,r?@ -r+ -r, -r+ -r- -r. -s)~ -s>@-tT"b1s?-tT"b1s?- t&0vS ?- r̭E? - r/ - r - r0~ -r(@ .rr/ .rs/ .rr/ .rt/ .ru/ .s)~ .s@.t .t ?. to!n?. rs? . rv/ . rw/ . r"~ .r@ /r2 /r3 /r2 /r4 /r5 /s)~ /sI@/tbW?/tbW?/ t]%?>?/ rN ? / r6 / r7 / r8~ /r1@ 0r: 0r; 0r: 0r< 0r= 0s)~ 0sR@0t@?0t@?0 t%Yri?0 r? 0 r> 0 r? 0 r@~ 0r3@ 1r$ 1r$ 1r$ 1r$ 1r$ 1s)~ 1sD@1tQH~?1tQH~?1 tj\"x?1 rq[R? 1 r$ 1 r 1 r$~ 1r.@ 2rB 2rC 2rB 2rD 2rE 2s)~ 2s$@2t_C#U2t_C#U?2 te?2 r l? 2 rF 2 rG 2 rH~ 2r@ 3r$ 3r$ 3r$ 3r$ 3r$ 3s)~ 3s>@3t:.Uۿ3t:.U?3 tO?3 rˋT? 3 r; 3 r 3 r$~ 3r(@ 4rR 4rS 4rR 4rT 4rU 4s)~ 4s.@4tIВο4tIВ?4 tZ)1?4 r#9[? 4 rV 4 rW 4 rX~ 4r@ 5rZ 5r[ 5rZ 5r\ 5r] 5s)~ 5s@5tJ-9P5tJ-9P@5 tcmIl?5 rs17? 5 r^ 5 r_ 5 r`~ 5r? 6re 6rf 6re 6rg 6rh 6s)~ 6s>@6tM6tM?6 tRY7,?6 rNTׄ:? 6 ri 6 rj 6 rk~ 6r @ 7rm 7rn 7rm 7ro 7rp 7s)~ 7s.@7tZsX7tZsX?7 t#p?7 r/*t;? 7 rC 7 rD 7 rE~ 7r@ 8r 8r 8r 8r 8r 8s)~ 8sA@8t<]S8t<]S?8 tF?8 rv"E ? 8 r 8 r 8 r~ 8r@ 9rr 9rs 9rr 9rt 9ru 9s)~ 9sI@9t`9t`?9 t| ͏?9 us? 9 rv 9 rD 9 r~ 9r@ :rx :rP :rx :ry :r; :s)~ :sA@:t N:t N?: tu+V3?: r,F? : rL: r : rM~ :r@ ;r{ ;r| ;r{ ;r} ;r~ ;s)~ ;s>@;t)&̘;t)&̘?; teYHs?; rU7\? ; r ; r ; r~ ;r@ <r, <r, <r, <r, <r, <s)~ <s.@<t߮E5?<t߮E5?< tB?< r2H:? < rr < r ~ <r@ =r =r =r =r =r =s)~ =sK@=tor=tor?= tv?= r :| ? = r= r = r~ =r3@ >r >r >r >r >r >s)~ >sA@>t6 ݿ>t6 ?> t.+]?> r@? > r > r > r~ >r@ ?r ?r ?r ?r ?r ?s)~ ?sN@?t}SQ??t}SQ?? ti ?? r? ? r ? r ? r~ ?r,@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rD @rE @rD @rF @rG @s)~ @s>@@t$F\?@t$F\?@ tRz?@ r[S~$$? @ rH @ rI @ rJ~ @r,@ Ar Ar Ar Ar Ar As)~ As@Atl?Atl?A t|?A r`)*k? A r A r A r~ Ar@ Br Br Br Br Br Bs)~ Bs9@Bt8:ĿBt8:?B t?B r? B r B r B r~ Br&@ Cr Cr Cr Cr Cr Cs)~ Cs@CtoA?CtoA?C tco@C r'? C r C r C r~ Cr? Dr 6 Dr- Dr 6 Dr 6 Dr- Ds)~ Ds.@Dt\2kڿDt\2k?D tZ?D r& f? D r- D r- D r-~ Dr@ Er 6 Er Er 6 Er6 Er/ Es)~ Es.@Et'?Et'?E ts'?E rF2? E r; E r; E r /~ Er@ Fr Fr Fr Fr Fr Fs)~ Fs$@FtտFt?F t# ;?F rIH2w? F r F r F r~ Fr? Gr/ Gr/ Gr/ Gr/ Gr/ Gs)~ Gs@Gt>yGt>y@G tOb E.?G rȔUD? G re G r/ G r/~ Gr@ Hr Hr Hr Hr Hr Hs)~ Hs`@HtϴHtϴ?H tP#??H r jPq? H r H r H r~ Hr3@ Ir Ir Ir Ir Ir Is)~ IsD@IttltIttlt?I t0?I r"I3? I r I rH I r~ Ir @ Jr Jr Jr Jr Jr Js)~ Js9@Jt|?Jt|?J t/z+?J r gs"? J r  J r  J r ~ Jr@ Kr  Kr Kr  Kr Kr Ks)~ Ks4@Kt{5Uт?Kt{5Uт?K tBzwo?K r)? K r K r K r~ Kr@ Lr Lr Lr Lr Lr Ls)~ LsA@LtG#LtG#?L t5?L r\? L r L r L r~ Lr@ Mr7 Mr8 Mr7 Mr9 Mr: Ms)~ Ms>@Mt(?Mt(?M t2"@M r+C`a? M r; M r< M r= ~ Mr"@ Nr Nr Nr Nr  Nr! Ns)~ Ns@P@NtKNtK?N tڦq?N rTK&T#S? N r N r  N r ~ Nr@ Or# Or$ Or# Or% Or& Os)~ Os\@OtrtެOtrtެ?O tپ?O rz? O r O r  O r~ Or&@ Pr( Pr) Pr( Pr* Pr+ Ps)~ Ps`m@PtgPtg?P tP?P rg]? P r, P r* P r-~ Pr3@ Qrp$ Qrq$ Qrp$ Qrr$ Qrs$ Qs)~ Qs9@Qt.4!yV?Qt.4!yV?Q tr3(?Q r3Ҕ!? Q rt$ Q ru$ Q rv$~ Qr&@ Rr; Rr< Rr; Rr= Rr> Rs)~ RsA@RtPfRtPf?R tUJDi2?R rfGv? R r R r  R r~ Rr@ SrY# SrZ# SrY# Sr[# Sr\# Ss)~ SsI@StiϿSti?S t*?S rdJ#? S r]# S r^# S r_#~ Sr2@ Tr@ TrA Tr@ TrB TrC Ts)~ Ts@TtKD@?TtKD@?T tB-3?T r? T rD T rE T rF~ Tr? Ur! Ur! Ur! Ur! Ur! Us)~ UsD@UtypR3?UtypR3?U t f|?U rbhFc? U r! U r! U r!~ Ur @ VrI VrJ VrI VrK VrL Vs)~ VsT@Vt 3?Vt 3?V t^GKc~?V r? V rM V rN V rO~ Vr(@ Wr Wr Wr Wr Wr Ws)~ WsQ@WtqМWtqМ?W t"?W rT? W r W r? W r~ Wr0@ XrQ XrR XrQ XrS XrT Xs)~ Xs4@Xt۲ 7 @Xt۲ 7 @X tN#@X r? X rU X rV X rW~ Xr @ Yr Yr Yr Yr Yr Ys)~ YsV@YtެXֿYtެX?Y t Ȏ?Y r#9[? Y r Y r Y r~ Yr @ Zr Zr Zr Zr Zr Zs)~ ZsY@Zt¿Zt?Z t?Z r!U? Z r  Z r! Z r"~ Zr(@ [ra [rb [ra [rc [rd [s)~ [s9@[t_[t_?[ tm<F?[ r_b? [ re [ rf [ rg~ [r@ \ri \rj \ri \rk \rl \s)~ \sI@\t6xqR2޿\t6xqR2?\ tOh.?\ r:"]? \ rm \ r" \ rn~ \r@ ]rp ]rq ]rp ]rr ]rs ]s)~ ]s4@]tJQPd]tJQPd?] t ¬Tv?] r? ] rt ] ru ] rv~ ]r@ ^rz ^r{ ^rz ^r| ^r} ^s)~ ^s.@^t!.SϿ^t!.S?^ t8u?^ r ? ^ r~ ^ r ^ r~ ^r@ _r _r _r _r _r _s)~ _sD@_t_t?_ t8#?_ rR:$? _ r _ r _ r~ _r2@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `s.@`tf?G `tf?G ?` tכ\?` r6a3Q? ` r ` r ` r~ `r@ ar ar ar ar ar as)~ as@Z@atrmq߿atrmq?a tkЩ?a r"X? a r a r a r~ ar5@ br br br br br bs)~ bs9@btX$btX$?b t8c/?b r&H? b r b r b r~ br@ cr cr cr cr cr cs)~ csY@ctH\|8˿ctH\|8?c th0K?c rc? c r c r c r~ cr1@ dr dr dr dr dr ds)~ ds.@dt&@?J?dt&@?J?d t#~T,?d r$BӦ? d r d r d r~ dr @ er er er er er es)~ es$@et`;sS\et`;sS\?e tNU4dJ?e r57@? e r e rc e r~ er@ fr6 fr- fr6 fr- fr- fs)~ fs.@ft 5 ӿft 5 ?f t޾l?f rs$,`? f r- f r- f r-~ fr@ gr gr gr gr gr gs)~ gsF@gt_0gt_0?g tf7?g rXN? g r  g r  g r ~ gr"@ hr hr hr hr hr hs)~ hs`@ht2l޽ht2l޽?h t"S?h r`cm? h r h r h r~ hr5@ ir ir ir ir ir is)~ isD@it it ?i tJh~?i rh]J? i rc i rc i rc~ ir$@ jr jr jr jr jr js)~ js.@jtuDjtuD?j tJc?j rOu? j r j r j r~ jr@ kr kr kr kr kr ks)~ ks4@kt#p({?kt#p({?k t;WRҒ?k r4G1? k r k r k r~ kr@ lr lr lr lr lr ls)~ ls4@ltBe =ltBe =?l ter?l r&H? l r l r l r~ lr@ mr6 mr mr6 mr6 mr/ ms)~ ms$@mt!Ϳmt!?m tT?m rD ? m r/ m r/ m r/~ mr@ nr nr nr nr nr ns)~ ns^@ntHFtԿntHFt?n trW?n r? n r n r n r~ nr5@ or or or or or os)~ osD@ot`;ot`;?o tw^ǔ?o r?$? o r o r o r~ or @ pr pr pr pr pr  ps)~ psT@pt ~?pt ~?p tD@AO?p rlM? p r  p r  p r ~ pr,@ qr- qr- qr- qr- qr- qs)~ qs$@qt`C6?qt`C6?q te$?q rU7\? q r- q r- q r-~ qr@ rr rr rr rr rr rs)~ rs9@rto/ٿrto/?r tm\?r r.7]B? r r r r r r~ rr@ sr sr sr sr sr ss)~ ss[@stqοstq?s tx0?s rgp? s r s r s r~ sr*@ tr  tr! tr  tr" tr# ts)~ ts$@tt?x@tt?x@t t;#@,@t rkX? t r$ t r% t r&~ tr@ ur) ur) ur) ur) ur) us)~ us$@ut?z%z?ut?z%z?u tH2?u rbqN? u r) u r) u r)~ ur @ vr6 vr vr6 vr vr/ vs)~ vsN@vtW3vtW3?v tiUX?v rN ? v r/ v r/ v r/~ vr(@ wr( wr) wr( wr* wr+ ws)~ ws@P@wt:%Oן?wt:%Oן?w t79ס?w r`? w r,w r w r-~ wr @ xr xr  xr xr  xr  xs)~ xs$@xtxe?xtxe?x t8$_?x rS"? x r  x r  x r~ xr@ yr/ yr0 yr/ yr1 yr2 ys)~ ys4@ytgytg?y tm#B?y r,$,? y r3 y r4 y r5~ yr@ zr7 zr8 zr7 zr9 zr: zs)~ zsF@ztۆ?ztۆ?z tt?z r?[IA? z r; z r< z r=~ zr@ {r? {r@ {r? {rA {rB {s)~ {s.@{t.U?{t.U?{ tSJ?{ rN? { rC { rD { rE~ {r$@ |r/ |r~" |r/ |r/ |r/ |s)~ |s$@|tWQ>  r  r  r~ r"@ r r r r r s)~ s@trğtrğ? tɟ? rz5?  r  r  r~ r@ r r r r r s)~ s@_@ttǩttǩ? twsA? u eb>  r  r  r~ r$@ r r r r r s)~ sa@t5+t5+? t ,3k? r<Ƿ?  r  r  r~ r*@ r r r r r s)~ sD@t1*PĿt1*P? tZLn ? rSUO3a)?  r  r  r~ r@ r r r r r s)~ sI@tE!tE!? tAgc? rɶ?  rrr ~ r @ r # rP r # r # r; s)~ s9@tv/h tv/h @ tTZص? r*L_?  rrr ~ r@ r% r% r% r% r% s)~ sF@t;BPt;BP? t? rcڥ?  r%  r%  r%~ r*@ r r? r r r s)~ s@t8W6J?t8W6J? tf? r^SH?  rrr ~ r? r6 r, r6 r6 r, s)~ s@tySZtySZ? t_SH? r@OV~?  r,  r,  r,~ r? r r r r  r! s)~ s$@tjtj? t?v5? rʄҵL?  r"  r#  r$~ r@ r& r' r& r( r) s)~ s9@t=Ռ?t=Ռ? td3淿? ruÕ?  r*  r+  r,~ r @ r r r r r s)~ s$@t;ͻgozt;ͻgoz? tr}m? r#9[?  r  r  r~ r@ r7 r8 r7 r9 r: s)~ sI@t, ?t, ? tk?B? rBo6?  r;  r<  r=~ r(@ r? r@ r? rA rB s)~ s@tPetPe? t@t'-t'-? t%? rZQf?  rj  rk  rl~ r$@ r r r r r s)~ sR@t)?t)? tS? rz1?  r  r  r~ r:@ rv rw rv rx ry s)~ s@Z@tItI? t&\? u9ue>  r  r   rz~ r @ r| r} r| r~ r s)~ sT@taͼ2taͼ2? tM&9{? rf?  r  r   r~ r"@ r, r, r, r, r, s)~ s$@t ~`Rڿt ~`R? t+? r9^ld?  r  r   r~ r@ r r r r r s)~ s9@t3st3s? t՛u? r& f?  r  r  r~ r@ r r r r r s)~ sK@t։{4@t։{4@ t;e@ rn?  r  r  r~ r*@ r r r r r s)~ s@P@t:?t:? tՙi? r:ɑTɠ?  r  r*  r~ r(@ rt ru rt rv rw s)~ sA@tvGӿtvG? tBg? r"X?  rx  ry  rz~ r,@ rT rU rT rV rW s)~ sK@t~:=ݿt~:=? t* 's/? rl %)N?  rX  rY  rZ ~ r$@ r!) r") r!) r#) r$) s)~ s.@t(H?t(H? tK8E? r?  r%)  r&)  r')~ r@ r r r r r s)~ s>@tg9ֿtg9? tF]X'? rlM?  r  r  r~ r1@ r r r r r s)~ sR@t2gt2g? tI،7? rn?  r  r   r~ r@ r r r r r s)~ s.@t7t>7? tް? r s)~ s>@t"$?t"$? tu? rlM?  r?  r@  rA~ r@ rK rL rK rM rN s)~ sK@tKړ tKړ ? t? rI'?  rO  rP  rQ~ r0@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r[ r\ r[ r] r^       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~s)~ sj@t*b(?t*b(? t7#*T)? u;wqJ->  r_  r`  ra~ r1@ rc rd rc re rf s)~ sA@t=汿t=? tqc|? rnK?  rg  rh  ri~ r@ rk rl rk rm rn s)~ s9@t#<_t#<_? tDܴ? r"D%?  ro  rp  rq~ r @ rs rt rs ru rv s)~ s4@t Ft F? tP? r h5?  rw  rx  ry~ r@ r{ r| r{ r} r~ s)~ sA@t R f?t R f? tga@ r$z'?  r  r  r~ r@ r r r r r s)~ s9@t޺QVt޺QV? t;띝? rD~vc?  r  r  r~ r@ r r r r r s)~ s$@tWtW? t|^N%? rD!L?  r  r  r~ r@ r6 r r6 r6 r s)~ s.@twx7gtwx7g? tgR? rZ<Ҍ?  r,  r'  r,~ r@ r" r" r" r" r" s)~ sD@tw}f?tw}f? t۠u? rȳ.?  r"  r"  r"~ r.@ r r r r r s)~ s4@t0{h?t0{h? t85P? rR ?  r  r  r~ r@ r6 r r6 r6 r6 s)~ s$@t(c?Q?t(c?Q? tZ{JF? r"X?  r  r  r~ r? r r r r r s)~ sF@tCqC?tCqC? tڄ&? r]?  r  r  r~ r$@ r 6 r- r 6 r- r- s)~ s$@tEh%tEh%? tWQ ? r4?  r-  r-  r-~ r@ r r r r r s)~ s4@tvBOe?tvBOe? tAj? rR ?  r  r  r~ r$@ r r r r r s)~ sN@t>_g4?t>_g4? tTr@ r?  r  r  r3~ r@ r r r r r s)~ s4@t?ڝyѿt?ڝy? tr{? r0 8?  r  r  r~ r@ r r r r r s)~ s$@tX~:tX~:? t#? r\BP?  rrr ~ r@ r r r r r s)~ sI@t;Wӿt;W? tE? rͦ?  r  r  r~ r @ r r r r r s)~ s$@t,j[t,j[? te%\E? r& f?  r  r  r~ r@ r r r r r s)~ s4@tW8?؋ʿtW8?؋? t|? r߇4?  r  r  r~ r@ r r r r r s)~ s.@t6t6@ t|HI? rTnB?  r  r   r ~ r@ r!6 r  r!6 r"6 r. s)~ s9@t*?t*? tfo? rϪ?  r.  r.  r.~ r@ r r r r r s)~ s4@t ?t ? t0>? rseO}?  r  r  r~ r@ r rP r r  r; s)~ sK@t?N`Dt?N`D? tos*T? r;IF?  rrr ~ r@ r r r r r  s)~ sA@t%?t%? t h? r4&͆?  r   r   r ~ r*@ r" r# r" r$ r% s)~ s@tSO?tSO? ts\7?? r8iY?  r&  r'  r(~ r? r#6~ v <@ r#6 r$6 r, s)~ sI@t-'ſt-'? t•Bwu? r/?  r,  r,  r,~ r@ r5 rR r5 r6 r7 s)~ s9@t7έd?t7έd? tp']?6 @ rI\H?  rrr ~ r@ r9 r: r9 r; r< s)~ s@tA tA @ tm'5? r"60?  r=  r>  r?~ r? rM rN rM rO rP s)~ sD@tR?tR? tS.? r-㏑?  rQ  rR  rS~ r@ rU r rU rV rW s)~ s@tJotJo? ty? r ?  rrr ~ r?DXl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rY r rY rZ r s)~ s$@t+aj?t+aj? tH ? r"60?  rrr ~ r? r\ r] r\ r^ r_ s)~ s.@t/Ƀ?t/Ƀ? tiFY? rkR=GI?  r`  ra  rb~ r@ r%6 r- r%6 r&6 r- s)~ s@t.2t.2? tQ6#'"(? r& f?  r-  r-  r-~ r? r'6 r- r'6 r(6 r)6 s)~ s@tJ 9@tJ 9@ tAq@ ry#?  r;  r;  r;~ r? r r r r r s)~ s$@t4NPt4NP@ t.? r?  r  r  r~ r@ rm rn rm ro rp s)~ s.@t9% t9% ? tuq? r?  rq r  rr~ r@ r r r r r s)~ sA@tE?tE? toW!s? rFa>?  r  r  r ~ r3@ rt ru rt rv rw s)~ s>@t1Y[t1Y[? t ? rw?  rx  ry  rz~ r"@ r*6 r_. r*6 r+6 r`. s)~ s@t[``iNt[``iN? ts+:? r ?8c:?  ra.  rb.  rc.~ r? r r r r r s)~ s9@tUtU? t#Lw? r51?  r  r  r~ r.@ r r r r r s)~ sQ@t:?t:? tl? rT̀?  r  r  r~ r2@ r r r r r s)~ s9@t t ? t6*/? r!-?  r  r  r~ r"@ rl rm rl rn ro s)~ s$@tw]tw]? tgt#r? rR ?  rp  rq  rr~ r@ r r r r r s)~ s@t’۵ǿt’۵? t')? rN ?  r  r  r~ r@ re rf re rg rh s)~ s4@tj btj b? t~p? rD!L?  ri  r=  rj ~ r@ r1. r r1. r r2. s)~ s$@tv#ϴ?tv#ϴ? t3ܾ? r?  rrr ~ r@ r,6 r/ r,6 r-6 r/ s)~ s.@t/Kt/K? t,$rp? rlM?  r/  r/  r/~ r@ r r r r r s)~ sT@tخtخ? t"2}? rU7\?  r  r  r~ r3@ r r r r r s)~ s9@tv)& Ϭ?tv)& Ϭ? t@jP_? rpt:{?  r  r  r~ r$@ r r r r r s)~ sD@tHƬtHƬ? t4? rXV!q?  r  r  r~ r @ r r r r r s)~ s@t~=t~=? t'YRx? r%Ɖ7J?  r  r"  r~ r? r r r r r s)~ sD@to?to? t@>? r5J?  r  r  r~ r"@ r r r r r s)~ sT@tnhu/?tnhu/? tE)? rs?  r  r  r~ r,@ r r r r r s)~ sV@tR'YsOtR'YsO? tmդA? r):0s?  r  r  r~ r6@ rJ' rK' rJ' rL' rM' s)~ s$@t%PSt%PS? taomw? rt@toto? tv? r12+/K?  r  r  r~ r @ r r r r r s)~ s.@t\ Q %?t\ Q %? tknV&@ rϪ?  r  r  r~ r@ r r r r r s)~ s@U@tܭ^tܭ^? tvP? rHM"?  r  r  r~ r3@ r  r r  r r s)~ sI@tުpn\tުpn\? tg;? rlM?  r  r  r~ r&@ r r r r r s)~ s.@tirN)ۿtirN)? tAE? rAj:?  r  r  r~ r@ r.6 rH- r.6 rI- rJ- s)~ s@thbz~?thbz~? tP65@ rdJ#?  rK-  rL-  rM-~ r@ r- r- r- r- r- s)~ s$@tu?tu? t' ? r?  r-  r-  r -~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r  s)~ s>@t*YNt*YN? t,/l@$? rN ?  r!  r  r"~ r&@ r$ r% r$ r& r' s)~ sD@tk?tk? tx!q@ rg?  r-  r-  r-~ r@ rO/ r; rO/ rP/ r= s)~ s$@ty>6n3ty>6n3? t**!k? rq-?  rQ/  rR/  rS/~ r@ rB rC rB rD rE s)~ s>@ tk tk?  tjȔ8U?  r'?  rF  r  rG~ r$@ rI rJ rI rK rL s)~ s.@ t&3MͿ t&3M?  tgG N?  rl %)N?  rM  rN  rO~ r@ rQ rR rQ rS rT s)~ s4@ t3?v? t3?v?  trG?  rU7\?  rU  rV  rW~ r@ r` ra r` rb rc s)~ sF@ t/g? t/g?  tǐ6?  r}Q?  rd  re  rf~ r@ r% r% r% r% r% s)~ s>@ tMs@ tMs@  tr@  rXN?  r%  r%  r%~ r$@ rG( rH( rG( rI( rJ( s)~ s$@tPtP? toS? rWE?  r%  rK(  rL(~ r@ rh ri rh rj rk s)~ s>@tX?tX? tɣc? rʄҵL?  rl  rm  rn~ r"@ rp rq rp rr rs s)~ s[@t ɿt ? t0&? r>?  rt  r  ru~ r7@ rw rx rw ry rz s)~ s4@tt? t?^W? r'y(?  r{  r|  r}~ r@ r06 rY r06 rZ r- s)~ s$@t'mp?t'mp? t+ؿ? rU7\?  r-  r-  r-~ r@ r# r# r# r# r# s)~ s4@tVŢֿtVŢ? t4 / 2? r3Ҕ!?  r#  r#  r#~ r@ r16 r r16 r26 r. s)~ sI@t~L?t~L? t3? rs?  r.  r.  r.~ r @ r r r r r s)~ s$@tfctfc? tv6? r,H;?  r  r  r~ r@ r r r r r s)~ s.@tZ%"ٿtZ%"? tR{_? rtzno?  r  rh  r~ r@ r36 r". r36 r#. r$. s)~ s@tUIv.$tUIv.$? t@=*? r?  r%.  r&.  r'.~ r? r r r r r s)~ s.@t\_NUct\_NUc? tْ? rYЍE?  r  r  r~ r@ r r r r r s)~ s.@t(R{[ɿt(R{[? t=s? r)@}?  r  r  r~ r @ r r r r r s)~ s.@t7!?t7!? t.j? r/L'?  r  r  r~ r@ r r r r r s)~ sI@tWj*AutWj*Au? tx _? r@c`?  rC  rD  rE~ r@ r46 r- r46 r56 r- s)~ s$@tʋYYtʋYY? t"&? r!-?  r-  r-  r-~ r@ r r r r r s)~ s9@tǟ&Rtǟ&R? t3P? r~ı?  rC  rD  rE~ r@ r r r r r s)~ sA@tT((tT((? t&? r+4!?  r  r  r~ r@ r r r r r s)~ sT@tD)6tD)6? t ? r l?  r  r  r~ r@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r  r  r  r  r  s)~ sD@ t%ߊ ? t%ߊ ?  t?  r}QIEf?  r   r  r~ r$@ !r !r !r !r  !r  !s)~ !s@!tw ?!tw ?! tD; @! r)? ! r ! r  ! r ~ !r? "r>% "r?% "r>% "r@% "rA% "s)~ "s4@"tf}/@"tf}/@" tiWF@" rڪS? " rB% " rC% " rD%~ "r @ #r66 #r #r66 #r76 #r86 #s)~ #s4@#tQ?#tQ?# t,?# rȔUD? # r # r # r~ #r&@ $rA $rB $rA $rC $rD $s)~ $sF@$tܽ&`?$tܽ&`?$ t8d?$ rpA;? $ rc $ rE $ rF~ $r&@ %r %r %r %r %r %s)~ %s$@%tePn.?%tePn.?% t@"٣V?% rB C=? % r % r  % r!~ %r@ &r' &r( &r' &r) &r* &s)~ &sD@&t-idܼ?&t-idܼ?& tc5L?& r)#B? & r+ & r, & r-~ &r@ 'r96 'r9 'r96 'r: 'r/ 's)~ 'sD@'t <ƿ't :? * r^ * r_ * r`~ *r"@ +rb +r} +rb +r~ +rc +s)~ +s@+tD.?+tD.?+ tN̛?+ rjO? + rrr ~ +r? ,r_& ,r`& ,r_& ,ra& ,rb& ,s)~ ,sK@,t^ۊ,t^ۊ@, tF:8?, rn? , r , r  , r~ ,r@ -re -rf -re -rg -rh -s)~ -s`@-t;a-t;a?- t1e7?- u{6> - ri - r - rj~ -r(@ .r .r .r .r .r .s)~ .sA@.tAR؜0?.tAR؜0?. t HTw?. rB C=? . r . r . r~ .r@ /r:6 /r} /r:6 /r, /r, /s)~ /sD@/tKX?/tKX?/ tsUa?/ r"{ij? / r, / r, / r,~ /r7@ 0r;6 0r 0r;6 0r 0r. 0s)~ 0s$@0t=*['ҿ0t=*['?0 tN ?0 r-e&? 0 r. 0 r. 0 r.~ 0r@ 1r 1r 1r 1r 1r 1s)~ 1sD@1tmÿ1tm?1 t&l?1 r`T? 1 r 1 r 1 r~ 1r(@ 2r 2r 2r 2r 2r 2s)~ 2s@Q@2tAP؈3ؿ2tAP؈3?2 t_Za#?2 r^|yd? 2 r 2 r 2 r~ 2r&@ 3r$ 3r$ 3r$ 3r$ 3r$ 3s)~ 3s.@3tyeͿ3tye?3 t,٭8?3 rIH2w? 3 r$ 3 r$ 3 r$~ 3r@ 4r 4r 4r 4r 4r 4s)~ 4s@P@4tr ֿ4tr ?4 th3?4 r`cm? 4 r 4 r 4 r~ 4r2@ 5r 5r 5r 5r 5r 5s)~ 5sD@5t;gݿ5t;g?5 tWxE?5 r՟? 5 r 5 r 5 r~ 5r,@ 6r 6r 6r 6r 6r 6s)~ 6s4@6tK06tK0?6 t<̇'n?6 r? 6 r 6 r 6 r~ 6r@ 7r 7r 7r 7r 7r 7s)~ 7s4@7tsѿ7ts?7 tx?7 rb ? 7 r 7 r 7 r~ 7r @ 8r 8r 8r 8r 8r 8s)~ 8s.@8ttCeKgt 8ttCeKgt @8 tE޸?8 rǼaSN? 8 r 8 r 8 r~ 8r@ 9r 9r 9r 9r 9r 9s)~ 9s@9tOu9tOu?9 t@ ?9 r}+">? 9 r 9 r 9 r~ 9r? :r<6 :r# :r<6 :r# :r. :s)~ :s$@:tVfǿ:tVf?: t&U?: rc? : r. : r. : r.~ :r@ ;r/ ;r/ ;r/ ;r/ ;r/ ;s)~ ;s$@;tH,;tH,?; tk9?; rD? ; r/ ; r/ ; r/~ ;r@ <r <r <r <r <r <s)~ <s9@<t(t߿<t(t?< tyè?< r xP? < r < r < r~ <r@ =r=6 =r, =r=6 =r>6 =r, =s)~ =s.@=tښTsc׿=tښTsc?= t?= rM? = r, = r, = r,~ =r@ >r >r >r >r >r >s)~ >s>@>t WܘM?>t WܘM?> t҇?> rw﹬? > r > r > r~ >r@ ?r ?rW ?r ?rX ?r ?s)~ ?s$@?t .?t .?? tiHGaF?? rC? ? rrr ~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r @r @r @r @r @s)~ @sA@@tϷ[?@tϷ[?@ t0"z@@ r? @ r  @ r! @ r"~ @r@ Ar$ Ar% Ar$ Ar& Ar' As)~ AsI@AttTUֺAttTUֺ?A tA/?A rlM? A r( A r) A r*~ Ar(@ Br, Br- Br, Br. Br/ Bs)~ Bs$@BtHI:TBtHI:T?B tQpRҳ?B r]e)r4? B r0 B r* B r1~ Br@ Cr) Cr) Cr) Cr) Cr) Cs)~ Cs$@CtkCtk?C t4n?C r#d@? C r) C r) C r)~ Cr@ DrA DrB DrA DrC DrD Ds)~ Ds@Dt]xk ?Dt]xk ?D tE5>?D rB́C-? D rE D rF D rG~ Dr? ErI ErJ ErI ErK ErL Es)~ Es4@Etp.koEtp.ko?E tP{9?E rm? E rME r E rN~ Er @ FrP FrQ FrP FrR FrS Fs)~ Fs.@FtV1$?FtV1$?F tR >?F rF %? F rT F rU F rV~ Fr@ Gr^ Gr_ Gr^ Gr` Gra Gs)~ Gs9@GtbvGtbv?G t48?G r.|? G rrr ~ Gr @ Hrk Hrl Hrk Hrm Hrn Hs)~ Hs$@HtĿHt?H t ͵?H rUe? H rr H ro~ Hr@ Ir Ir Ir Ir Ir Is)~ Is>@ItVL?ItVL?I tc;V ?I raJ6D? I r I r I r~ Ir @ Jrq Jrr Jrq Jrs Jrt Js)~ Js4@Jtui/@ ?Jtui/@ ?J tm쟴'?J rQw? J ru J rv J rw~ Jr@ Kr Kr Kr Kr Kr Ks)~ Ks4@KtC?KtC?K tE?K r\? K r K r K r ~ Kr*@ Lry Lrz Lry Lr{ Lr| Ls)~ Ls$@LtrT8LtrT8?L tsǺ?L r2H:? L r} L r L r~~ Lr@ Mr Mr Mr Mr Mr Ms)~ Ms$@Mtk5Mtk5@M tZtl?M r $_? M rrr ~ Mr@ Nr Nr Nr Nr Nr Ns)~ Ns9@NtZa@NtZa@N t!uSb@N r z? N r N r N r~ Nr&@ Or Or Or Or Or Os)~ OsT@Ot <ͿOt @[t]T8T[t]T8T?[ tC5 K?[ r-hdB? [ r [ r [ r~ [r(@ \r \r \r \r \r \s)~ \s@\t\ z?\t\ z?\ tӷk0?\ rlM? \ rrr ~ \r? ]r ]r ]r ]r ]r ]s)~ ]s>@]tu4]tu4?] t hu?] rB C=? ] r ] r ] r ~ ]r$@ ^r) ^r) ^r) ^r) ^r) ^s)~ ^s4@^tW?^tW?^ t)sR@^ r]? ^ r) ^ r) ^ r)~ ^r@ _r! _r" _r! _r# _r$ _s)~ _s>@_t0?_t0?_ t˙tp@_ r+@/? _ r% _ rH _ r& ~ _r@D`l`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r0 `r1 `r0 `r2 `r3 `s)~ `s$@`t:?`t:?` tHqf?` r9=? ` r4 ` r5 ` r~ `r@ arn aro arn arp arq as)~ asN@atAH4?atAH4?a t9jUO?a rlM? a rr a rs a rt~ ar,@ br? br@ br? brA brB bs)~ bs>@btHl-?btHl-?b t^?b r]? b rC b rD b rE ~ br(@ crG crH crG crI crJ cs)~ csA@ctD3ctD3?c t\l?c rD~vc? c rK c rL c rM ~ cr*@ dr dr dr dr dr ds)~ ds$@dt?dt?d tp+?d rˋT? d r d r d r~ dr@ er er er er er es)~ es.@etnMn?etnMn?e tr ?e r#9[? e r e r e r~ er@ fr fr fr fr  fr  fs)~ fs@ft>NЅ?ft>NЅ?f taT?f rv"E ? f rrr ~ fr@ grz gr{ grz gr| gr} gs)~ gs$@gt@jtQWo׿jtQWo?j tTQ*?j rlM? j r j r j r ~ jr$@ krF6 kr krF6 krG6 kr, ks)~ ks$@ktsvk?ktsvk?k tI<@k rwߞu? k r k r k r ~ kr@ lr lr lr lr lr ls)~ ls$@ltԃ};?ltԃ};?l tLw@l r9=? l r l r l r ~ lr@ mrS mrT mrS mrU mrV ms)~ ms.@mtcȿmtc?m t$e0.?m rnK? m rW m rX m rY~ mr@ nrH6 nrG nrH6 nr- nr- ns)~ ns4@nt("A,nt("A,?n t`a3?n rU7\? n r- n r- n r-~ nr@ or or or or or os)~ os.@ot[Ka?ot[Ka?o t5c@o r]? o r o r o r ~ or @ pr. pr. pr. pr. prI6 ps)~ ps@pt~E@pt~E@p tc@p rM? p r. p r p r.~ pr? qrY qrZ qrY qr[ qr\ qs)~ qsD@qtMWqtMW?q tg?q rQHH? q r]q r q r^~ qr@ rr rr rr rr rr rs)~ rs9@rtHk:A?rtHk:A?r t~'I@r r8iY? r rr r r ~ rr@ srJ6 sr srJ6 sr sr/ ss)~ ssQ@stnwH$֙?stnwH$֙?s tߏEH?s rN ? s r/ s r/ s r/~ sr&@ tr- tr- tr- tr- tr- ts)~ ts@tt+c[Gؿtt+c[G?t tx?t r:"]? t r- t r- t r-~ tr@ urG urH urG urI urJ us)~ us$@utxIOҿutxIO?u tp>?u r(?? u rK u rL u rM~ ur @ vr vr vr vr vr vs)~ vs9@vt92H?vt92H?v tM4?v rnK? v r v r" v r ~ vr@ wr[/ wr wr[/ wr wr\/ ws)~ wsF@wt|]?wt|]??w t#z?w r%? w r]/ w r^/ w r_/~ wr(@ xr ! xr ! xr ! xr ! xr ! xs)~ xs@xt``xt``?x tB|F?x rlM? x r! x r! x r!~ xr@ yr'! yr(! yr'! yr)! yr*! ys)~ ysD@ytyyty?y teSd?y r? y r+! y r,! y r-!~ yr(@ zrK6 zr0! zrK6 zrL6 zrh. zs)~ zs@ztȜztȜ?z t`AZE?z rV0? z ri. z rj. z rk.~ zr? {r?! {r@! {r?! {rA! {rB! {s)~ {s@{tY' >{tY' >?{ t/j?{ r?z? { rC! { rD! { rE!~ {r? |rH! |r  |rH! |rI! |rJ! |s)~ |s$@|tk&$?|tk&$?| t0LF @| r6L? | r; | r; | r;~ |r@ }rT! }rU! }rT! }rV! }rW! }s)~ }s.@}tHz#/Ϳ}tHz#/?} tۉ~iR?} rw? } rX! } rY! } rZ!~ }r@ ~rg! ~rh! ~rg! ~ri! ~rj! ~s)~ ~s$@~tGBп~tGB?~ ti e?~ rQHH? ~ rk! ~ rl! ~ rm!~ ~r@ ro! rp! ro! rq! rr! s)~ s@t0l!6<t0l!6ʆUot>ʆUo@ t.? rcOFn?  r!  r!  r!~ r? r! r! r! r! r! s)~ s@tu*V?tu*V? tGmI29? rOu?  r!  r!  r"~ r@ r! r! r! r! r! s)~ s@tG?tG? tOfC? rlM?  r!  r!  r!~ r? r! r! r! r! r! s)~ s@tq܎?tq܎? tyf;? rPey?  r!  r!  r!~ r? r / r / r / r / r / s)~ s.@t9% ?t9% ? t*9Ȫ &? r6c?  r/  r/  r/~ r@ r! r! r! r! r! s)~ s@tJv?tJv? t'-? r7d?  r!  r!  r!~ r@ r! r! r! r! r! s)~ s4@t .7t .7? t@->6? r`T?  r!  r!  r~ r@ r! r! r! r! r! s)~ s4@tx Bb?tx Bb? t? r/*t;?  r!  r!  r!~ r @ rm& rn& rm& ro& rp& s)~ s9@tY%ڿtY%? tF8^? rq-?  rq&  rr&  rs&~ r@ r! r! r! r! r! s)~ s@t%k%bt%k%b? tB ? rlM?  rc  r!  r!~ r? r! r! r! r! r! s)~ s@t!)D?t!)D? tɽ3U? rϪ?  r!  r!  r!~ r@ r! r! r! r! r! s)~ s.@tYDͿtYD? tŋ}A? rl?  r!  r!  r!~ r@ r! r! r! r! r! s)~ s>@t.?t.? th"*? r럈?  r!  r!  r!~ r.@ r" r" r" r" r" s)~ sF@tJ|3ڿtJ|3? t ? rsB?  r"  r"  r"~ r"@ rO6 r " rO6 r " r[. s)~ s4@t[Ut[U? t $}? ro?  r\.  r].  r^.~ r @ r" r" r" r" r" s)~ s.@tփov?tփov? t&OST? r" g?  r"  r"  r~ r@ r" r" r" r" r" s)~ sA@t6Qwпt6Qw? tA? r'y(?  r"  r"  r "~ r @ r"" r#" r"" r$" r%" s)~ s.@tL8tL8? t"!>? rIH2w?  r&"  r'"  r("~ r@ r r r r r s)~ s9@tiG4ÿtiG4? tc? r[R?  r  r  r~ r&@ r*" r+" r*" r," r-" s)~ s$@td޴?td޴? tꞠd? r/*t;?  r."  r/"  r0"~ r @ r2" r3" r2" r4" r5" s)~ s$@tbtb? ta"? rQHH?  r6"  r7"  r8"~ r@ r:" r;" r:" r<" r=" s)~ s4@tQ s?tQ s? t L? r42s?  r>" r  r?~ r@ r@" rA" r@" rB" rC" s)~ s9@t$S ?t$S ? ta!Z@ rU7\?  rD"  rE"  rF"~ r"@ rH" rI" rH" rJ" rK" s)~ s>@t@It@I? t@0? r _?  rL"  rM"  rN"~ r@ rP6 r. rP6 r. r. s)~ s4@tLYtLY? tz^yc? rϪ?  r.  r.  r.~ r"@ rP" rQ" rP" rR" rS" s)~ s9@tXT?tXT? tf;D6 @ r1ZO)?  rT"  r  rU"~ r@ rW" rX" rW" rY" rZ" s)~ sA@t~-޿t~-? tNJ? r r?  r["  r\"  r]"~ r0@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r_" r`" r_" ra" rb" s)~ s$@t;gﵿt;g? t޼'? rN~-?  rc"  rd"  re"~ r@ r" r" r" r" r" s)~ s@tve'Ds@tve'Ds@ t}@@ r@tQԿtQ? tA~G٭? r/0k?  r"  r"  r"~ r$@ r" r" r" r" r" s)~ s@t2G>Lt2G>L? t{? rs$,`?  rC  rD  rE~ r? r! r ! r! r!! r"! s)~ s$@tlm?tlm? tS"f@? r{?  r#!  r$!  r%!~ r@ rQ6 rR6 rQ6 rS6 r, s)~ s$@t/T2?t/T2? t_@ r/?  r,  r,  r,~ r@ r]+ r^+ r]+ r_+ r`+ s)~ s9@tHektHek? tLR? rC .ގ?  ra+  rb+  rc+~ r @ r" r" r" r" r" s)~ s>@tietie? t97+f? reP?  rC  rD  rE~ r@ rT6 r" rT6 rU6 rR. s)~ s$@t]t]? t&I`? rׇ?  rS.  rT.  rU.~ r@ rV6 r# rV6 rW6 r5- s)~ s@t@9t@9? tcwA? r͖?  r6-  r7-  r8-~ r? r# r# r# r# r# s)~ s.@tY1itY1i? t`? r l?  r#  r#  r#~ r@ rX6 rh rX6 ri rY6 s)~ s>@tr- @tr- @ t3mo!@ r]lށ?  rrr ~ r@ r r r r r s)~ s>@t_-?t_-? tk/? rȔUD?  r  r  r~ r@ r!# r"# r!# r## r$# s)~ s$@tLIJӿtLIJ? t]y? r?  r%#  r&#  r'#~ r@ r1# r2# r1# r3# r4# s)~ sI@t7@?t7@? t篍:? rʄҵL?  r5#  r6#  r7#~ r @ r:# r;# r:# r<# r=# s)~ s4@tCYgܿtCYg? tJC? rqdiS?  rc  rc  r>#~ r@ rZ6 r/ rZ6 r[6 r/ s)~ s.@t:Lih?t:Lih? t_O? rlM?  r/  r/  r/~ r@ r/* r0* r/* r1* r2* s)~ s$@tA?tA? tEK@ r+@/?  r3*  r4*  r5*~ r@ rD# rE# rD# rF# rG# s)~ s$@tM?tM? t}aC\)? r?z?  rH#  rI#  rJ#~ r? rL# rM# rL# rN# rO# s)~ s$@tbe-tbe-? t5WtN? r?  rP#  rQ#  rR#~ r@ rT# rU# rT# rV# rW# s)~ s>@t:1t:1? tclө? rOD?  r  r   r ~ r@ r\6 rb# r\6 r]6 r- s)~ sA@tٿt? t> M6? r _?  r-  r-  r-~ r@ rs# rt# rs# ru# rv# s)~ s>@t2t2? t:I? r1]?  rw#  rx#  ry#~ r@ r r r r r s)~ s.@tz&aĿtz&a? t其g ? r?z?  r  r  r~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r^6 r# r^6 r# r. s)~ s$@t}Կt}? t?c? rFa>?  r.  r.  r.~ r@ r# r# r# r# r# s)~ s4@t1?t1? tfD\? rm?  r#  r#  r#~ r@ r# r# r# r# r# s)~ s$@t-?t-? tһۤ? rw=p??  r#  r#  r#~ r@ r r r r r s)~ sD@tf$?tf$? t e? r3*?  r  r  r~ r"@ r- r- r- r- r- s)~ s@tu{tu{? t"꧳? rN~-?  rrr ~ r@ r r r r r s)~ s$@tUJ&=tUJ&=? t]\W? roĝ'?  r  r  r ~ r@ r# r# r# r# r# s)~ s@t;̿t;? ti? rs?  r#  r#  r~ r@ r# r# r# r# r# s)~ s$@tw2 ?tw2 ? t[,? rU7\?  r#  r#  r#~ r@ r r r r r s)~ s@t&<t& s)~ s.@t1k}"3t1k}"3? tm{? r$BӦ?  r  r  r?~ r@ r_6 ri r_6 r`6 ra6 s)~ s9@tϛ> ſtϛ> ? t|ލ? rӨ?  rrr ~ r@ r+ r+ r+ r+ r+ s)~ s$@t992)9t992)9? tO? rz'N[?  r+  r+  r+~ r@ r% r% r% r% r% s)~ s$@tXaf|tXaf|? to+Ռ? rK͚?  r%  r%  r%~ r@ r $ r $ r $ r $ r $ s)~ s.@t Z4«?t Z4«? tjFJC? rSKu?  r $  r$  r$~ r? r$ r$ r$ r$ r$ s)~ s$@t#5@t#5@ t$ r?$ s)~ sQ@tݭ?tݭ? tb? rL-m?  r  r   r~ r@ r$ r$ r$ r$ r$ s)~ s@tim!?tim!? t}۫? r-e&?  r$  r$  r$~ r? r$ r$ r$ r$ r$ s)~ s$@t{u-?t{u-? tFC ]@ r 5`@?  r$  r$  r$~ r@ r. r$ r. r$ re6 s)~ s9@t2Jt2J? tb%>? rc?  rrr ~ r@ rK$ rL$ rK$ rM$ rN$ s)~ s@t;yTut;yTu? t=1? r@t??t?? t 8? r-e&?  r.  r.  r.~ r@ rx' ry' rx' rz' r{' s)~ s4@t2#.?t2#.? t 2@ r-&?  r|'  r}'  r~'~ r(@ rW rX rW rY rZ s)~ s.@tTtT? t2]R? rHM"?  r[  r\  r]~ r@ r% r% r% r% r% s)~ s.@tfĿtf? ta|]+? rlM?  r%  r%  r%~ r @ r r r r r s)~ sD@t\|׿t\|? t13? r|?ʛ?  r  r  r ~ r"@ r$ r$ r$ r$ r$ s)~ sA@t|9бt|9б? t~? rco?  r$  r$  r$~ r@ r$ r$ r$ r$ r$ s)~ s$@tF]q_ tF]q_ ? tNۥ? r֡# ?  r$  r  r$~ r@ r$ r$ r$ r$ r$ s)~ s@t~Gf[?t~Gf[? t[K j? rϪ?  r$  r$  r$~ r@ rf6 r$ rf6 rg6 r}/ s)~ s@t"t"? tZ ? rgEUM?  r~/  r/  r/~ r? r% r% r% r% r! s)~ s$@tNʔuOtNʔuO? tNڵ? rrCؕ?  r   r   rz~ r@ rh6 r|% rh6 ri6 r~% s)~ s4@trKƿtrK? t#.?  rC  rD  rE~ r@ r& r& r& r& r& s)~ s$@tex?tex? tnt4I? r !?  r&  r&  r&~ r@ r& r& r& r& r & s)~ s@t#?t#? t8-? r+3?  r!&  r"&  r#&~ r? rt6 r. rt6 ru6 r. s)~ s@tF ԿtF ? t#^̳? r`cm?  r.  r.  r.~ r@ r%& r&& r%& r'& r(& s)~ s@tQY"?tQY"? tH4n? rn?  r)&  r  r*&~ r@ rv6 r-& rv6 rw6 r,- s)~ s@t6ax ?t6ax ? tW @ r]1H£?  r--  r.-  r/-~ r? r5& r6& r5& r7& r8& s)~ s@t9-t9-? t\? r/*t;?  r9&  r:&  r;&~ r? r@& rA& r@& rB& rC& s)~ s@t}@t}@? tX`Z? rʄҵL?  rD&  rE&  rF&~ r? rH& rI& rH& rJ& rK& s)~ s@tCbtCb@ t6;? rf 6?  rL&  rM&  rN&~ r@ rP& rQ& rP& rR& rS& s)~ s@trg 2Dtrg 2D? tq4+[? rz5?  r;  r;  rT&~ r? rW& rX& rW& rY& rZ& s)~ s$@tt? t?  rh&  ri&  rj&~ r@ r r r r r s)~ s4@t??t?? tJ~ډ? r$ ?  r  r  r~ r@ r r r r r s)~ s>@tvp?tvp? t|>+? r5bz?  r  r  r~ r*@ ru& rv& ru& rw& rx& s)~ s9@tMhP'|пtMhP'|? tv? r]?  r  rc  ry&~ r@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, rx6 r. rx6 ry6 r. s)~ s$@ t'D:Ӓ? t'D:Ӓ?  t^<4?  rϪ?  r.  r.  r.~ r@ !r{& !r|& !r{& !r}& !r~& !s)~ !s.@!t|b?!t|b?! tQ_?! rqdiS? ! r& ! r& ! r&~ !r@ "r "r "r "r "r "s)~ "s.@"t+?"t+?" tGrsn?" rq풓? " r " r " r~ "r@ #rz6 #r. #rz6 #r. #r. #s)~ #s@#tY8п#tY8?# tsS8?# rFa>? # r. # r. # r.~ #r@ $r& $r& $r& $r& $r& $s)~ $sF@$t0 ^$t0 ^?$ t x~?$ rqN? $ r& $ r& $ r&~ $r@ %r& %r& %r& %r& %r& %s)~ %s$@%tjqT?%tjqT?% tQ?% r#9[? % r& % r& % r&~ %r? &r& &r& &r& &r& &r& &s)~ &s$@&t~({?&t~({?& tR[?& rZ? & r& & r& & r&~ &r@ 'r{6 'r. 'r{6 'r|6 'r. 's)~ 's$@'tX;ӿ'tX;?' tv*>?' ry[? ' r. ' r. ' r.~ 'r@ (r& (r& (r& (r& (r& (s)~ (s@(tdRsɿ(tdRs?( tʃ:E?( rOmT? ( r& ( r ( r&~ (r@ )r}6 )r~6 )r}6 )r6 )r6 )s)~ )s@)t?t#Q;)t?t#Q;?) t3JD?) r&?}? ) r, ) r, ) r,~ )r? *r& *r& *r& *r& *r& *s)~ *sI@*t%侽?*t%侽?* tW?* rA'v g? * rrr ~ *r@ +r& +r& +r& +r& +r& +s)~ +s@+t&$c6+t&$c6?+ tY?xE]?+ rs?+ r + r& + r&~ +r@ ,r& ,r& ,r& ,r& ,r& ,s)~ ,sD@,tGcۿ,tGc?, tQ ,v0?, rʄҵL? , r& , r& , r&~ ,r$@ -r& -r& -r& -r& -r& -s)~ -s>@-tF}r-tF}r?- t7ni?- rKev? - r - r - r~ -r@ .r6 .r- .r6 .r6 .r- .s)~ .s@.tjyz?.tjyz?. tiGvZ?. r驮? . r- . r- . r-~ .r? /r& /r& /r& /r& /r& /s)~ /s$@/tW/tW?/ t4IQ?/ r 5`@? / r& / r& / r~ /r@ 0r& 0r& 0r& 0r& 0r& 0s)~ 0s@0tp}i޿0tp}i?0 t:?0 r?3 rѪ캌? 3 r 3 r 3 r~ 3r? 4r& 4r& 4r& 4r& 4r& 4s)~ 4s@4t/("?4t/("?4 tZ?4 r DK? 4 r& 4 r& 4 r&~ 4r? 5r& 5r& 5r& 5r& 5r& 5s)~ 5s@5tP%SMֿ5tP%SM?5 tt#1?5 rgEUM? 5 r& 5 r& 5 r&~ 5r? 6r6 6r6 6r6 6r6 6r- 6s)~ 6s@6t ]s?6t ]s?6 tw޳@6 r4? 6 r- 6 r- 6 r-~ 6r? 7r ' 7r ' 7r ' 7r ' 7r' 7s)~ 7s4@7tʹ?7tʹ??7 tZ5K?7 r^|yd? 7 rc 7 rc 7 rc~ 7r@ 8r' 8r' 8r' 8r' 8r' 8s)~ 8s@8tz}Tqߗ?8tz}Tqߗ?8 tg'B?8 r1]? 8 r' 8 r' 8 r'~ 8r? 9r' 9r' 9r' 9r' 9r' 9s)~ 9s@9tҭ! ?9tҭ! ?9 tݬY?9 rϪ? 9 r 9 r 9 r~ 9r@ :r6 :r6 :r6 :r6 :r/ :s)~ :s@:t.!?:t.!?: tt)P?: r*? : r/ : r/ : r/~ :r? ;r%' ;r&' ;r%' ;r'' ;r(' ;s)~ ;s>@;tf1;tf1?; t~U?; rŌ? ; r  ; r  ; r~ ;r@ <r*' <r+' <r*' <r,' <r-' <s)~ <s$@<t&T?<t&T?< tf.<@< rrB' >rC' >rB' >rD' >rE' >s)~ >s.@>ty`^!>ty`^!?> t 61?> r+4!? > rF' > rG' > rH'~ >r@ ?rQ' ?rR' ?rQ' ?rS' ?rT' ?s)~ ?s@?tۍ?tۍ?? t[?? r$;Iڿ@td>$;I?@ t׾5wj?@ rIH2w? @ r @ r @ r~ @r@ Ar`' Ara' Ar`' Arb' Arc' As)~ As4@At:Pt㣿At:Pt?A t7\&?A r-z? A rd' A re' A rf'~ Ar@ Brp' Brq' Brp' Brr' Brs' Bs)~ BsY@BtluBtlu?B teo?B r$BӦ? B rt' B ru' B rv'~ Br@ Cr' Cr' Cr' Cr' Cr' Cs)~ Cs@Ctɞ5X'ٿCtɞ5X'?C tւ_^?C rlM? C r' C r' C r'~ Cr? Dr' Dr' Dr' Dr' Dr' Ds)~ Ds.@Dt"EؿDt"E?D t)_7l?D rvS? D r' D r' D r'~ Dr@ Er' Er' Er' Er' Er' Es)~ Es@EtC?EtC?E twz?E r+3? E r' E r' E r'~ Er? Fr' Fr' Fr' Fr' Fr' Fs)~ Fs@Ft?tKКFt?tKК?F t ?F rh4? F r' F r' F r'~ Fr? Gr6 Gr Gr6 Gr6 Gr/ Gs)~ Gs$@GtkF?GtkF?G ty]?G r]`? G r/ G r/ G r/~ Gr@ Hr' Hr' Hr' Hr' Hr' Hs)~ Hs4@Ht*%Ht*%?H t{?H r.? H r' H r' H r'~ Hr@ Ir' Ir' Ir' Ir' Ir' Is)~ Is$@ItZH5^?ItZH5^?I t͓?3?I rSUO3a)? I r' I r" I r'~ Ir$@ Jr6 Jr*/ Jr6 Jr+/ Jr,/ Js)~ Js@Jt}Z?Jt}Z?J tw0oJ ?J rpt:{? J r-/ J r./ J r//~ Jr? Kr' Kr' Kr' Kr' Kr' Ks)~ Ks.@KtRLº,տKtRLº,?K tӜe,q?K r(ZN}? K rC K rD K rE~ Kr@ Lr6 Lr. Lr6 Lr6 Lr. Ls)~ Ls@Lt0M0DLt0M0D?L t @b?L r#9[? L r. L r. L r.~ Lr@ Mr' Mr' Mr' Mr' Mr' Ms)~ Ms@MtF(?_MtF(?_?M tx,?M r:/ch? M r' M r' M r'~ Mr? Nr6 Nr6 Nr6 Nr6 Nr/ Ns)~ Ns@NtJC?NtJC?N tfZ?N r3Ҕ!? N r/ N r/ N r/~ Nr? Or' Or' Or' Or' Or' Os)~ Os$@Ot Ot ?O t]7i?O r`? O r' O r' O r'~ Or@ Pr' Pr' Pr' Pr' Pr' Ps)~ PsH@Pt3{+8Pt3{+8?P t1;E?P rg-QX? P r P r P r~ Pr@ Qr6 Qrm- Qr6 Qr6 Qr6 Qs)~ Qs@Qtq?Qtq?Q tVFU?Q rjJ? Q rn- Q ro- Q rp-~ Qr? Rr& Rr& Rr& Rr& Rr& Rs)~ Rs4@RtAq?RtAq?R t#!C?R r/L'? R r& R r& R r&~ Rr@ Sr6 SrH Sr6 Sr6 Sr6 Ss)~ Ss@St?St?S tg @S rw 8Q? S rrr ~ Sr? Tr' Tr' Tr' Tr' Tr' Ts)~ Ts.@Ttk +6Ttk +6?T tAk?T rښ? T r' T r' T r'~ Tr@ Ur' UrP Ur' Ur' Ur; Us)~ Us@Ut$ThaY?Ut$ThaY?U t :r?U r܋? U rrr ~ Ur? Vr Vr Vr Vr Vr Vs)~ Vs$@Vt1?Vt1?V th.,?V rN ? V r V r V r ~ Vr@ Wr( Wr( Wr( Wr ( Wr ( Ws)~ Ws4@Wtח 3,Wtח 3,?W tġJ?W rq-? W r ( W r ( W r (~ Wr@ Xr( Xr( Xr( Xr( Xr( Xs)~ XsI@XtNmXtNm?X tA~k ?X r&`N? X r X r  X r~ Xr@ Yr. Yr( Yr. Yr. Yr( Ys)~ YsK@Yt%a?Yt%a?Y t{?Y rd? Y r. Y r. Y r.~ Yr@ Zr6 Zr(. Zr6 Zr6 Zr). Zs)~ Zs@ZtyX@0%ZtyX@0%?Z t2.?Z r? Z r*. Z r+. Z r,.~ Zr? [r4( [r [r4( [r [r5( [s)~ [s@[t$fXn@Ŀ[t$fXn@?[ t?[ r&H? [ rrr ~ [r? \r6 \r. \r6 \r. \r. \s)~ \s@\tΐq ?\tΐq ?\ tV$՛r[?\ r'y(? \ r. \ r. \ r.~ \r? ]r7( ]r8( ]r7( ]r9( ]r:( ]s)~ ]s@]tȖ#3]tȖ#3?] ti 1`?] rc? ] r;( ] r<( ] r=(~ ]r@ ^r?( ^r@( ^r?( ^rA( ^rB( ^s)~ ^s$@^t^t?^ th?^ rЃq? ^ rC( ^ rD( ^ rE(~ ^r@ _rN( _rO( _rN( _rP( _rQ( _s)~ _s@_t2t7_t2t7?_ t7~_?_ r`90? _ rR( _ rS( _ rT(~ _r?Drl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r& `r& `r& `r& `r& `s)~ `s@`tYN*?`tYN*?` tAD?` rڪS? ` r& ` r& ` r ~ `r? arV( arW( arV( arX( arY( as)~ as.@atgGzֿatgGz?a tK?a rE$N? a rZ( a r[( a r\(~ ar@ br^( br_( br^( br`( bra( bs)~ bs@btY㼂?btY㼂?b tֻ ?b r gs"? b rrr ~ br@ crk( crl( crk( crm( crn( cs)~ cs$@cticti@c tA0m?c rY? c rLc r c rM~ cr? dr{( dr|( dr{( dr}( dr~( ds)~ ds$@dtQo5ѿdtQo5?d t3&?d rSL? d r( d r( d r(~ dr@ er& er& er& er& er& es)~ es>@ets=Z:Wets=Z:W?e t-aD?e r܋? e rC e rD e rE~ er@ fr6 frP fr6 fr6 fr; fs)~ fs@ftY?ftY?f tO@f rT? f rc f rc f rc~ fr? gr( gr( gr( gr( gr( gs)~ gs@gt\8Wgt\8W@g t p L?g r NŽ? g r( g r( g r(~ gr@ hrB+ hrC+ hrB+ hrD+ hrE+ hs)~ hs$@htM5Ċ׿htM5Ċ?h th߬M?h r ^? h rF+ h rG+ h rH+~ hr@ ir( ir( ir( ir( ir( is)~ is9@it"ZXժit"ZXժ@i tQ̺e?i r<S? i r i r  i r~ ir@ jr( jr( jr( jr( jr( js)~ js4@jtOő̿jtOő?j tpv@Z?j r=? j r( j r( j r(~ jr@ kr( kr( kr( kr( kr( ks)~ ks.@ktEN׿ktEN?k t7t?k ro? k r( k r( k r(~ kr@ lr( lr( lr( lr( lr( ls)~ ls@ltPPltPP?l tۂOlO?l ri^? l r( l r( l r~ lr? mr$ mr$ mr$ mr$ mr$ ms)~ ms9@mtџT֥mtџT֥?m tp]?m rKev? m r$ m r$ m r$~ mr@ nr( nr( nr( nr( nr( ns)~ ns@ntM^b?ntM^b?n taw5?n r@ =? n r( n r( n r(~ nr@ or( or( or( or( or( os)~ os$@otH?otH?o t)q.0?o rtzno? o r( o r( o r(~ or@ pr pr pr pr pr ps)~ ps@pt@pt@?p tcK?p rFnѱ? p r  p r  p r ~ pr@ qr6 qr( qr6 qr6 qr8. qs)~ qs$@qti2JTԿqti2JT?q t7N-?q r:? q r9. q r:. q r;.~ qr@ rr( rr( rr( rr( rr( rs)~ rs@rtoHrtoH?r tvE?r r]`? r rc r r( r r(~ rr@ sr( sr( sr( sr( sr( ss)~ ssA@stmstm?s t(atZ2?s rxΰ(? s rC s rD s rE~ sr@ tr( tr tr( tr( tr( ts)~ ts$@ttܩttܩ?t tR?t r _? t rrr ~ tr? ur( ur( ur( ur( ur( us)~ us@ut~5ut~5?u tr/I! ?u r%? u r( u r( u r(~ ur@ vr( vrP vr( vr( vr; vs)~ vs>@vt Ct?vt Ct?v t\ϭ(@v r51? v rrr ~ vr@ wrx. wry. wrx. wrz. wr{. ws)~ ws@wt%}?wt%}?w t)0N?w r]?w r w r w r|.~ wr? xr. xr. xr. xr. xr. xs)~ xs@xt[=?xt[=?x t8Os?x r:g? x r. x r. x r.~ xr@ yr( yr( yr( yr( yr( ys)~ ys@yt#ݡٿyt#ݡ?y t4?y rZݧ#? y r( y r" y r(~ yr? zr( zr( zr( zr( zr( zs)~ zs@zt0?zt0?z t*'n?z r#>:? z r( z r( z r)~ zr? {r) {r) {r) {r) {r) {s)~ {s.@{tڪd{tڪd?{ t *?{ r޳5@t,t,? t֕? raƴ?  r5)  r  r6)~ r@Djl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r8) r9) r8) r:) r;) s)~ s4@t՘Ү¿t՘Ү? t5? rڪS?  r<)  r=)  r>)~ r@ r6 r. r6 r6 r. s)~ s@tv&tv&? t-? rFa>?  r.  r.  r.~ r? rH) rI) rH) rJ) rK) s)~ s@t|#@ r?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`acdefghijklmnopqrstuvwxyz{|}~) s)~ s$@twol,?twol,? t$Gq? rN?  r)  r)  r)~ r@ r( r( r( r( r( s)~ s@P@tD!QtD!Q? twL? rj4?  r(  r*  r-~ r@ r) r) r) r) r) s)~ s@t޿90 @t޿90 @ t@9!@ rs?  r*  r*  r*~ r@ r* r* r* r* r* s)~ s$@t[ 2=GͿt[ 2=G? t<5N? rs?  r*  r *  r *~ r@ r" r" r" r" r" s)~ s$@tJctJc? t\eJr? rq풓?  r"  r"  r"~ r@ r* r r* r* r s)~ s$@tXJtXJ? tfgP? r]e:u?  rrr ~ r@ r* r* r* r* r* s)~ s$@t4PX?t4PX? tNҎ ? r?  r   r   rz~ r@ r* r* r* r* r* s)~ s4@tiXdֿtiXd? tUS[? rӨ?  r*  r *  r!*~ r@ r'* r(* r'* r)* r** s)~ s.@t(x?t(x? tm@ r xP?  r+*  r,*  r-*~ r@ r>* r?* r>* r@* rA* s)~ s$@tt? t0m? rK=?  rB*  rC*  rD*~ r@ rF* rG* rF* rH* rI* s)~ s@t ePUt ePU? tI"? rw3?  rJ*  rK*  rL*~ r? rN* rO* rN* rP* rQ* s)~ s@t𩉸t𩉸? t;? r@؊_?  rR*  rS*  rT*~ r? rd* re* rd* rf* rg* s)~ s@tpU ?tpU ? t<Ws\? rUC?  rh*  r  ri*~ r?Drl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rk* rl* rk* rm* rn* s)~ s$@tBRtBR? t:E/? r h5?  ro*  r&  rp*~ r@ rr* rs* rr* rt* ru* s)~ s>@tR_P_tR_P_? tRhdg? r8b`?  r  r  r~ r@ rw* rx* rw* ry* rz* s)~ s@tF +=tF +=? tj;? r?z?  r{*  r|*  r}*~ r? r6 rZ# r6 r6 r6 s)~ s@tҿt? t)O? r/5rh?  rrr ~ r? r6 r. r6 r. r. s)~ s@t^׿t^? t~N'? rc?  r.  r.  r3~ r@ r* r* r* r* r* s)~ s@teirteir? t? r0ʃx-?  r*  r*  r*~ r? r* r* r* r* r* s)~ s@t=:)t=:)? tO? rB C=?  r*  r*  r*~ r@ r* r* r* r* r* s)~ s@tYʿtY? t8lJOc@ ry#?  r*  r*  r*~ r? r r r r r s)~ s$@t:Y?t:Y? tM? rlM?  r  r  r ~ r@ r* r* r* r* r* s)~ s@t;:?t;:? t0/&@ r)f?  r*  r*  r*~ r@ r* r* r* r* r* s)~ s$@tg ?tg ? t<$O? r/*t;?  r*  r  r*~ r@ r* r* r* r* r* s)~ s@t8pv?t8pv? t&F i@ rlHV6{?  rrr ~ r? r* r r* r* r s)~ s$@t;]A?t;]A? t/ƝM? rM/Jx?  rrr ~ r? r* r* r* r* r* s)~ s@t<|kt<|k? tǭz? r3*?  r*  r*  r*~ r@ r* r* r* r* r* s)~ s@txԿtx? t? rɅy?  r*  r*  r*~ r? r* r+ r* r+ r+ s)~ s.@t$-0t$-0? t95CQP? rFa>?  rT"  r  r+~ r@ r+ r+ r+ r+ r+ s)~ s@t/8e?t/8e? t? rttp>? tyuX[? rY.cS?  r>+  r?+  r@+~ r@ r*, r+, r*, r,, r-, s)~ sK@t?ڥt?ڥ? t1K]? rgD@?  r  r   r~ r@ r# r# r# r# r# s)~ s$@t "硿t "? t|p;? r& f?  r#  r#  r#~ r@ rJ+ rK+ rJ+ rL+ rM+ s)~ s$@t#Mt?t#Mt? t̙ݵr? rhUV?  rN+  rO+  rP+~ r@ rR+ rS+ rR+ rT+ rU+ s)~ s@t~w׿t~w? t8{? rR ?  rV+  rW+  rX+~ r@ r- r. r- r/ r0 s)~ s$@tLz;QǿtLz;Q? t$"8%? rFa>?  r1  r2  r3~ r@ r6 r* r6 r6 r- s)~ s@tH[EпtH[E? t٫]? r`R?  r-  r-  r-~ r? rs+ r rs+ rt+ ru+ s)~ s@t{c*?t{c*? tJS @ r?  rrr ~ r? rw+ rx+ rw+ ry+ rz+ s)~ s@tF! ?tF! ? tql? rʄҵL?  r{+  r|+  r}+~ r@ r+ r+ r+ r+ r+ s)~ s$@tyO޿tyO? tҖ0 ? rvS?  r+  r+  r+~ r@ r+ r+ r+ r+ r+ s)~ s$@t`"9׿t`"9? t^? rY?  r+  r~  r+~ r@DXl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r+ r+ r+ r+ r+ s)~ s@t(*?t(*? tC? rѡu?  r+  r+  r} ~ r? r+ r+ r+ r+ r+ s)~ s@t gt g? tv? r xP?  r+  r+  r+~ r? r+ r+ r+ r+ r+ s)~ s@t8f{?t8f{? td? rT4V?  r+  r+  r+~ r? r+ r+ r+ r+ r+ s)~ s@tҾ;ֿtҾ;? t8Q&? ruS!?  r+  r"  r+~ r? r+ r+ r+ r+ r+ s)~ s@tĠs¦?tĠs¦? t'ޮ1 @ r T?  r+  r+  r+~ r? r+ r+ r+ r+ r+ s)~ s.@tlStlS? t~? rgD@?  r+  r+  r+~ r@ r+ r+ r+ r+ r+ s)~ s@tRFtRF? tw6? r/*t;?  rc  rc  r+~ r? r+ r+ r+ r+ r+ s)~ s@t7(t3ݿt7(t3? tʗ^? rU7\?  r+  r+  r+~ r@ r+ r+ r+ r+ r+ s)~ s@t|o_t|o_? t^P? rR ?  r+  r+  r+~ r? r+ r+ r+ r+ r+ s)~ sF@t-ԯGt-ԯG? tW>? rw^)oI?  r  r   r~ r@ r( r  r( r( r( s)~ s@t`7W ?t`7W ? tX? rU7\?  r  r  r~ r? r+ r, r+ r, r, s)~ s@tjtj@ t*օ~? r9L>?  r,  r,  r,~ r@ r, r, r, r , r , s)~ s<@trh'\Otrh'\O? t_EWP? rKhق?  r  r  r~ r@ r5/ r6/ r5/ r7/ r8/ s)~ s$@tPZ?tPZ? tcNb? r Bž?  r  r  r~ r@ r/, r0, r/, r1, r2, s)~ s@tfdptfdp@ t"" ? r:"]?  r3,  r4,  r5,~ r? r7, r8, r7, r9, r:, s)~ s$@tTVtTV? t)K!? rKev?  r;,  r<,  r=,~ r@ r' r' r' r' r' s)~ s.@tntn? t&i? rw﹬?  rC  rD  rE~ r@ rH, rI, rH, rJ, rK, s)~ s.@t%st%s? t:j5? r*L_?  r  r   r~ r? rM, rN, rM, rO, rP, s)~ sA@t1?t1? t."Y:? r r?  r  r   r~ r@ r6 rD. r6 rE. rF. s)~ s@tS0?tS0? tW <? r/*t;?  rG.  rH.  rI.~ r? r[, r\, r[, r], r^, s)~ s.@tpU~tpU~? t`&}3? r@?  r  r   r~ r@ r`, ra, r`, rb, rc, s)~ s@t% pt% p? tB? r`M?  r)  r*  r~ r@ rh, ri, rh, rj, rk, s)~ s.@tT-s?tT-s? tO? r#pY?  r  r   r~ r@ r+ r+ r+ r+ r+ s)~ s@ttGۿttG? t!si? r)?  r  r  r~ r? rm, rn, rm, ro, rp, s)~ s$@t Jt J? t5P:Gf? r?  rq,  rr,  rs,~ r@ r~, r, r~, r, r, s)~ s@tb|͝?tb|͝? to!l? rP?  r,  r,  r,~ r@ r6 rW- r6 r6 rX- s)~ s@tiq]Ԍ?tiq]Ԍ? t#? r :| ?  rY-  rZ-  r[-~ r? rZ+ r rZ+ r[+ r s)~ s@tE݂u?tE݂u? ts ? rdR?  rrr ~ r? r, r, r, r, r, s)~ s@tgy?tgy? tjZD? rKev?  r,  r,  r,~ r? r, r, r, r, r, s)~ s$@tn1"?tn1"? tpL}_? r1v?  r,  r,  r,~ r? r6 r r6 r6 r6 s)~ s@tҔߺ;tҔߺ;? t3Ҏ? r aM?  rc  rc  rc~ r@BX>@MJggD ZO J='===>!>@>_>~>u>k>U>?>?7?V?u?#????@{.@iM@=l@7@)@1@@A%A_DAccAMAߠAAAcAQB!;BZBxBїBB  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} I} } } } I1} !} m } I} m} } I } *} I%} m%} } Jh,; ; ,,,, , , , , ,,,,,,,,,,,,,,,,,,, i8 j6 p p p p p p p p p  p  p  p  p  p p# r% r& r% r' r( s)~ sd@t+oݿt+o? t2^(xo6? rJqEsv?  r-  r.  r/~ r@@ r4 r5 r4 r6 r7 s)~ s4@t-ҿt-? tH$w? r)?  r8  r9  r:~ r"@ r! r! r! r! r! s)~ s>@tOz]tOz]? tYy? r&?  rL r  rM~ r@ r? r@ r? rA rB s)~ s9@tJEtJE? t:v^? rDgw*?  rC  rD  rE~ r@ rH rI rH rJ rK s)~ sN@ tŔ tŔ? t0KES? r{>&? rL r rM~ r@ r r r r r s)~ sQ@ t)Ssп t)Ss? t? r7P N&? rC rD rE~ r"@ rO rP rO rQ rR s)~ s l@ tA tA? tqr? rD8v? rS rT rU~ r3@ r5 r& r5 r5 r, s)~ sK@ t4}  t4} ? t&@? r F,? rS rT r,~ r@ rX rY rX rZ r[ s)~ sb@ tb?tTc>b? tkm? uPy>  r  r  r~ r`b@ r r r r r s)~ sy@t'iO?t'iO? tre'? rq[R?  r  r  r~ rD@ r r r r r s)~ s@j@t Rmt Rm? tKt? uRfB5>  rrr ~ r1@ r r r r r s)~ sT@tY]?tY]? tzE쭾? r#9[?  r  r  r~ r9@ r r r r r s)~ ss@tRUtRU? tn? r M/?  r  r  r~ rA@ r r r r r s)~ s`c@t05ut05u? tHC4? rg-QX?  r  r  r~ r,@ r r r r r s)~ s\@to?[to?[? tuq? r\[P?  r  r  r~ r @ r r r r r s)~ s^@t[L1}?t[L1}? tE#vD? r3Ҕ!?  r  r  r~ r@@ r5 r r5 r5 r, s)~ sF@t(st(s? t!6? r,AR}f?  r,  r,  r,~ r @ r r r r r s)~ s$@t^0vFؿt^0vF? tB? r`R?  r  r  r~ r@BX ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r5 r r5 r rR- s)~ sI@ tr)ݿ tr)? t2? rf`~04? r r r~ r$@ !r% !r% !r% !r % !r % !s)~ !s4@!tY^1ӿ!tY^1?! t:jsh?! r#>:? ! r ! r ! r %~ !r@ "r "r "r "r "r "s)~ "sK@"t"ҿ"t"?" tR?" rwpn ? " r " r " r ~ "r$@ #r #r #r #r #r #s)~ #s>@#tzT6ֿ#tzT6?# tyR?# rd%(? # r # r # r~ #r.@ $r $r $r $r $r $s)~ $sA@$t?$t?$ tqj?$ r#9[? $ r  $ r! $ r"~ $r"@ %r. %r/ %r. %r0 %r1 %s)~ %sy@%t Βw3>?%t Βw3>?% t^\Y?% u%]fE%> % r2 % r3 % r4~ %rI@ &r6 &r7 &r6 &r8 &r9 &s)~ &s9@&t|7?&t|7?& tN@& r^ j? & r: & r; & r<~ &r@ 'r@ 'rA 'r@ 'rB 'rC 's)~ 'sP@'t_V't_V?' t@?' u k\> ' rrr ~ 'rT@ (rE (rF (rE (rG (rH (s)~ (sA@(tR9?(tR9?( t8 M?( rnK? ( rI ( rJ ( rK~ (r@ )rO )rP )rO )rQ )rR )s)~ )s@)tP?)tP?) tQwa`@) uW^R< ) rS ) rT) r~ )rT@ *rV *rW *rV *rX *rY *s)~ *sF@*t^9ڿ*t^9?* ty݃?* r<S? * rZ * r[ * r\~ *r,@ +r5 +r/ +r5 +r5 +r/ +s)~ +s4@+tm+tm?+ ttC^Su?+ rʄҵL? + r/ + r/ + r/~ +r @ ,r' ,r' ,r' ,r' ,r' ,s)~ ,s$@,t+5?,t+5?, t&bsS?, rM/Jx? , r' , r' , r'~ ,r@ -r -rh -r -r -r -s)~ -s.@-t|J˿-t|J?- t_?- roĝ'? - rrr ~ -r@ .r .r .r .r .r .s)~ .s.@.t7|' .t7|' ?. tcAx+#?. r+3? . r . r . r~ .r@ /r5 /r. /r5 /r5 /r. /s)~ /s@/t-_'/t-_'?/ tj25&?/ r? / r. / r . / r!.~ /r@ 0rf 0rg 0rf 0rh 0ri 0s)~ 0sW@0tjLP0tjLP?0 t!L2?0 rXi? 0 rj 0 rk 0 rl~ 0r3@ 1ro 1rp 1ro 1rq 1rr 1s)~ 1sK@1tu޿1tu?1 t*b?1 rV&C? 1 rs 1 rt 1 ru~ 1r@ 2rw 2rx 2rw 2ry 2rz 2s)~ 2sQ@2t i~2t i~?2 tcZ*?2 rd&? 2 r{ 2 r| 2 r}~ 2r5@ 3r 3r 3r 3r 3r 3s)~ 3s^@3t 6z{p?3t 6z{p?3 tÄ?3 rY0\? 3 r 3 r 3 r~ 3r4@ 4r 4r 4r 4r 4r 4s)~ 4sN@4t?4t?4 tbv?4 r6c? 4 rc 4 r 4 r~ 4r(@ 5r  5r! 5r  5r" 5r# 5s)~ 5s`@5tV#G?5tV#G?5 tT?5 re(? 5 r$ 5 r% 5 r&~ 5rB@ 6r 6r 6r 6r 6r 6s)~ 6sD@6t 01?6t 01?6 teS@6 rcڥ? 6 r 6 r 6 r~ 6r @ 7r 7r 7r 7r 7r 7s)~ 7sQ@7t@d!?7t@d!?7 tˈ$T?7 rB C=? 7 r 7 r 7 r~ 7r<@ 8r 8r 8r 8r 8r 8s)~ 8s.@8t %K?8t %K?8 t7y?8 rFa>? 8 r 8 r 8 r~ 8r@ 9r 9r 9r 9r 9r 9s)~ 9sF@9t2՟H?9t2՟H?9 thD?9 rU7\? 9 r 9 r 9 r~ 9r$@ :r :r :r :r :r :s)~ :s`@:t4}6:t4}6?: t/*?: rd%(? : r : r : r~ :r5@ ;r ;r ;r ;r ;r ;s)~ ;s~@;t-t}Ŀ;t-t}?; t%3?; r? ; r ; r ; r~ ;rU@ <r <r <r <r <r <s)~ <sF@<t퇥?<t퇥?< tME.@< rl %)N? < r < r < r~ <r*@ =r =r =r =r =r =s)~ =su@=t+c=t+c?= t%e/?= r5,? = r = r = r~ =rJ@ >r1 >r2 >r1 >r3 >r4 >s)~ >s>@>t ?>t ?> tޢL4?> rZ`? > r5 > r6 > r7~ >r @ ?r ?r ?r ?r ?r ?s)~ ?s9@?t ??t ?? tˍ8W?? rw}}? ? r ? r ? r~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r @r @r @r @r @s)~ @s.@@t)O?@t)O?@ tnF@@ rj谒:? @ r @ r @ r~ @r@ Ar Ar Ar Ar Ar As)~ Asy@Aty?Aty?A toV;@A uuzߘk? A r A r A r~ Ar@T@ Br Br Br Br Br Bs)~ Bsq@Bt߯ĻBt߯Ļ?B tm?B ry#? B r B r B r~ BrE@ Cr Cr  Cr Cr  Cr  Cs)~ Cs4@Ct%FUA?Ct%FUA?C ta@C rUf.Z? C r  C r  C r~ Cr@ Dr Dr Dr Dr Dr Ds)~ Ds^@Dt8Dt8?D t+#?D r*!e? D r D r D r~ Dr3@ Er Er Er Er Er Es)~ EsT@Et~g܄ܿEt~g܄?E t-j?E r/*t;? E r E r E r~ Er(@ Fr" Fr# Fr" Fr$ Fr% Fs)~ Fsb@Ft ?Ft ?F t7zL?F rBGYS? F r& F r' F r(~ Fr6@ Gr* Gr+ Gr* Gr, Gr- Gs)~ GsN@Gtvgi;ѿGtvgi;?G t蠱P?G r 6? G r. G r/ G r0~ Gr,@ Hr2 Hr3 Hr2 Hr4 Hr5 Hs)~ Hs~@HtLSHtLS?H t(nYO?H u忮&: H r6 H r7 H r8~ HrI@ Ir; Ir< Ir; Ir= Ir> Is)~ Is^@It˦It˦?I tF`3?I rd%(? I r? I r@ I rA~ Ir6@ JrC JrD JrC JrE JrF Js)~ Js@P@Jt95?Jt95?J tg4x?J r|LtX>?L tr?L rT4V? L rO L rP L rQ~ Lr,@ MrT MrU MrT MrV MrW Ms)~ MsI@Mt{r?Mt{r?M t/?M r`D? M rX M rY M rZ~ Mr$@ Nr\ Nr] Nr\ Nr^ Nr_ Ns)~ Nsp|@NtevNtev?N t'?N rFM(? N r` N ra N rb~ NrF@ Ord Ore Ord Orf Org Os)~ Osn@Ot~,UܿOt~,U?O tIR?O r^? O rh O ri O rj~ OrE@ Pr| Pr} Pr| Pr~ Pr Ps)~ Ps9@PtA3I?PtA3I?@P tHO?P rB C=? P r P r P r~ Pr@ Qr| Qr} Qr| Qr~ Qr Qs)~ Qsl@Qt!:>?Qt!:>?Q tV3?Q r^=$53? Q r Q r Q r~ Qr4@ Rr Rr Rr Rr Rr Rs)~ Rs@RtRAL?RtRAL?R ti@R uWPp = R r R r R r~ RrT@ Sr Sr Sr Sr Sr Ss)~ Ssy@St6k?St6k?S tFc; ?S uE퐛> S r S r S r~ Sr@W@ Tr Tr Tr Tr Tr Ts)~ Tsv@TthFAǿTthFA?T t|!?T rކ ? T r T r T r~ TrI@ Ur Ur Ur Ur Ur Us)~ Us`@UteBUteB?U t?ƾ_?U rpt:{? U r U r U r ~ Ur;@ Vr Vr Vr Vr Vr Vs)~ Vs(@Vt3H?Vt3H?V tw%p@V uGYʿX< V r V r V r~ VrP@ Wr Wr Wr Wr Wr Ws)~ Ws@WtMy?WtMy?W t?W uW> W r W r W r~ WrU@ Xr Xr Xr Xr Xr Xs)~ Xs b@Xtn!B?Xtn!B?X t_J>_?X r xP? X r X r X r~ Xr<@ Yr Yr Yr Yr Yr Ys)~ Yst@Yt|0?Yt|0?Y t@Y u52I> Y r Y r Y r~ YrF@ Zr Zr Zr Zr Zr Zs)~ Zsp@ZtYϩ?ZtYϩ?Z tB|S?Z rm ? Z r Z r Z r~ ZrJ@ [r [r [r [r [r [s)~ [s`h@[t0_?[t0_?[ t3=Έ?[ r9? ? [ r [ r [ r~ [r;@ \r \r \r \r \r \s)~ \s@\tUҿ\tU?\ tDr?\ r>$%? \ r \ r \ r~ \rg@ ]r ]r ]r ]r ]r ]s)~ ]sT@]t?]t?] t@Wn?] r/? ] r ] r ] r~ ]rj@ ^r ^r ^r ^r ^r ^s)~ ^sP~@^tTUdq?^tTUdq?^ tY7?^ r#9[? ^ r ^ r ^ r~ ^rX@ _r _r _r _r _r _s)~ _s@z@_t:`c?_t:`c?_ tan?_ r㌜Ii? _ r _ r _ r~ _rJ@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `s^@`tD5޿`tD5?` tO@?` r4&͆? ` r ` r ` r~ `r5@ ar ar ar ar ar as)~ asj@at\wat\w?a t X*?a rj94? a r a r a r~ ar6@ br br br br br  bs)~ bsF@bt0@#4bt0@#4?b ty4?b r}l? b r  b r  b r ~ br@ cr! cr! cr! cr! cr! cs)~ csQ@ct<ct<?c t+N?c uג> c r c r  c r~ cr@ dr dr dr dr dr ds)~ dsR@dteHgdteHg?d tZXK>?d u )q-> d r d r  d r~ dr@ er er er er er es)~ esA@et_et_@e t҈}so?e rFKaa? e r e r  e r~ er@ fr  fr! fr  fr" fr# fs)~ fsD@ft>ft>?f t%_$[?f rP b? f r f r  f r~ fr@ gr% gr& gr% gr' gr( gs)~ gs@j@gt̕Ώgt̕Ώ?g td~ X?g rR5*n8? g r g r  g r~ gr1@ hr* hr+ hr* hr, hr- hs)~ hsW@ht(ht(?h tll5?h u>Q> h r h r  h r~ hr$@ ir/ ir0 ir/ ir1 ir2 is)~ isy@it it ?i tCqvY?i rx.2? i r3 i r4 i r5~ irL@ jr7 jr8 jr7 jr9 jr: js)~ js@j@jta!?jta!?j tqٜ?j r<S? j r; j r< j r=~ jr5@ kr kr kr kr kr ks)~ ksi@ktokto?k tG7e?k uCTJ> k r k r k r~ krD@ lr: lr; lr: lr< lr= ls)~ lsj@ltzQ1LltzQ1L?l t_?l ràC? l r> l r? l r@~ lrF@ mr? mr@ mr? mrA mrB ms)~ msx@mt?o?mt?o?m tZ鴀@m u0= m rC m rD m rE~ mrc@ nrG nrH nrG nrI nrJ ns)~ ns @nt_N3-?nt_N3-?n tVv,5?n uq kW p< n rK n rL n rM~ nrR@ orO orP orO orQ orR os)~ os`@otP`q VotP`q V?o t0+?o rH{u? o rS o rT o rU~ or.@ prX prY prX prZ pr[ ps)~ ps@pt^A?pt^A?p tH ?p uି{2> p r\ p r] p r^~ pr@a@ qr` qra qr` qrb qrc qs)~ qs@qtH(?qtH(?q t9* ?q rM@Jm? q rd q re q r^~ qrV@ rrg rrh rrg rri rrj rs)~ rs @rt(}?rt(}?r t{XqA?r r? r rk r rl r rm~ rr@S@ sro srp sro srq srr ss)~ ssf@st_xjvost_xjvo?s tzhg?s rD&[ś? s rs s rt s ru~ sr0@ tr~ tr tr~ tr tr ts)~ ts l@ttwJ=?ttwJ=?t t?t rC? t rt r t r~ trD@ ur ur ur ur ur us)~ us l@ut+31Ÿ?ut+31Ÿ?u tp8@u rX+(? u r u r u r~ ur;@ vr vr vr vr vr vs)~ vs[@vtY;[?vtY;[?v tm58=i?v rovy? v r v r v r~ vr2@ wr wr wr wr wr ws)~ wst@wtH("}?wtH("}?w t?w r˚? w r w r w r~ wr h@ xr xr xr xr xr xs)~ xs@Z@xta?xta?x t':tD@x rEb? x r x r x r~ xr.@ yr yr yr yr yr ys)~ ysq@yt.?yt.?y t?y r\B? y r y r y r~ yrA@ zr zr zr zr zr zs)~ zs@zt ?zt ?z t_AB!@z uR5 z r z r z r~ zra@ {r {r {r {r {r {s)~ {s(@{tX$J?{tX$J?{ t @{ uHR9 { r { r { r~ {rZ@ |r |r |r |r |r |s)~ |sPy@|tWK@|tWK@| t}4Su@| ui(= | r | r | r~ |rH@ }r }r }r }r }r }s)~ }s@z@}tܜi}tܜi?} t@rn?} r? } r } r } r~ }rL@ ~r ~r ~r ~r ~r ~s)~ ~s@~tFj9?~tFj9?~ tʝ?~ rS ʥ? ~ r ~ r ~ r~ ~rX@ r r r r r s)~ s`m@tCL$ttCL$t? tY8^o? r8Yl7?  r  r  r~ rA@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s@tReοtRe? t-? uSC]> r r r~ rh@ r r r r r s)~ s`s@t ]Y2Z?t ]Y2Z? t)Y? rbC}? r r r~ rB@ r rP r r r s)~ s@t]r?t]r?? tK!~PP? u2W< r rD r~ rE@ r r r r r s)~ s@tp+3?tp+3? t~Cr? u1RX= r r r~ r`h@ r  r  r  r  r s)~ sF@t6_t6_? t-{N|? r.M&T? r r  r ~ r@ r5 r r5 r r. s)~ s@`@tYvtYv? t1& =? rFa>? r. r. r.~ r3@ r r r r r s)~ sT@t r r?~ rI@ rA rB rA rC rD s)~ s@j@tztz? t(w ? rӏa? rE rF rG~ r@@ rI rJ rI rK rL s)~ s@_@tS&`tS&`? t!>m? rB́C-? rM rN rO~ r4@ rQ rR rQ rS rT s)~ s`z@tŹw`?tŹw`? tsfY? r]e)r4? rU rV rW~ rP@ rY rR rY rS rZ s)~ s$@t;?t;? tFfl@ rQHH? rrr ~ r@ r\ r] r\ r^ r_ s)~ s9@t N6kt N6k? třǦ? r 6V? r` ra r~ r@ rc rd rc re rf s)~ s@t!@u?t!@u? tbw? re B? rg rh ri~ rS@ rk rl rk rm rn s)~ sY@toh}пtoh}? t.8P? rFa>? ro rp rq~ r=@ r r r r r s)~ sR@tG{BӶ?tG{BӶ? tr*: ? riD? r r r~ r*@ rs rt rs ru rv s)~ s @tr?tr? t-݀? r`M? rw rx ry~ rR@ r{ r| r{ r} r~ s)~ si@t2V3t2V3? tv`zK? rv"E ? r r r~ rC@ r r r r r s)~ sf@t> ?t> ? tr}? r 'LC? r r r~ r@@ r r r r r s)~ sl@tV_ͬ?tV_ͬ? t? rL2W? r r r~ rC@ r r r r r s)~ s@@tifL?tifL? t @ ur7 r r r~ rU@ r r r r r s)~ sc@t.t.? t`kc? r @%1IQ? r r r ~ r?@ r r r r r s)~ sh@t/ D?t/ D? t:_2? r$BӦ? r r r~ r]@ r r r r r s)~ s@b@t]y5cI?t]y5cI? tf ? rӨ? r r r~ r7@ r r r r r s)~ s @t0ptdt0ptd? teح? uWj$> r r r~ rP@ r r r r r s)~ sؔ@t=2ܿt=2? tVH:;}? rB́C-? r r r~ rb@ r r r r r s)~ s>@t^ROܿt^RO? t:v? rgD@? r r r~ r@ r r r r r s)~ spr@t+/mM?t+/mM? tQ2NzJ? r#9[? r r r~ rL@ r r r r r s)~ sz@tEQӿtEQ? t1pL? r#9[? r r r~ rG@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s`s@tK ྿tK ? tHo? r? r r r~ rG@ r r r r r s)~ sI@t<ai?t<ai? tB@ r˿t(->? t8)? rS"? r! r" r#~ rE@ r% r& r% r' r( s)~ s@t(,Qÿt(,Q? tt=? r^=$53? r) r* r+~ rg@ r- r. r- r/ r0 s)~ sN@tF2ڿtF2? t!? roĝ'? r1 r2 r3~ r"@ r5 r6 r5 r7 r8 s)~ s l@tɴ}$¿tɴ}$? tВ? rSUO3a)? rrr ~ rA@ r& r' r& r( r) s)~ sn@t-cBpt-cBp? t=#)j/? u>Q> r* r+ r,~ rB@ rB rC rB rD rE s)~ s_@tt? tA? r*LA4? rF rG rH~ r;@ rJ rK rJ rL rM s)~ sp@tס:j?tס:j? tgL? r'? rN r" r~ rG@ rP rQ rP rR rS s)~ sr@t^Qt^Q? t2L7? r#9[? rT rU rV~ rN@ rT rU rT rV rW s)~ so@t)?t)? tg6? rw﹬? rX rY rZ ~ rH@ r( r( r( r( r( s)~ s.@t~,Uпt~,U? t=? r& f? r( r( r(~ r@ rX rY rX rZ r[ s)~ s`s@tČtČ? t뱝3_? r 5? r\ r] r^~ rG@ rp rq rp rr rs s)~ s\@tw>" ?tw>" ? t ? r#? rt ru rv~ r6@ rx ry rx rz r{ s)~ s@tV6>?tV6>? t/戅? u+:> r| r} r~~ rR@ r r r r r s)~ s`h@tf9eoz޿tf9eoz? t)m? rf-? r r r~ r=@ r r r r r s)~ s@_@tzR7?tzR7? t? r6e ? r r r~ r5@ r r r r r s)~ s b@tbtb? tBt|? rL-m? r r r~ r<@ r r r r r s)~ sV@t^5o7Կt^5o7? t/B? ro? r r r~ r:@ r r r r r s)~ sW@t5ٺ>t5ٺ>? t ? r-J;? r r r~ r;@ r r r r r s)~ s`d@t-idt-id? t1 bvd? r5/1? r r r~ r6@ r r r r r s)~ sd@tYtY? t/ْ? r~oVl"R? r r r~ r&@ r r r r r s)~ sy@tg?tg? t ? r+4!? r r r~ rG@ rt ru rt rv rw s)~ sv@tTBq?tTBq? tDUN? r+_Lk? rx ry r~ rI@ r5 r r5 rz- r{- s)~ sK@tEҺtEҺ? tѬ!Y? r0ʃx-? r|- r}- r~-~ r$@ r r r r r s)~ s@@t}),.Ŀt}),.? tcК? rsB? r r r~ rl@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sT@tz~Y?tz~Y? t$8a? rQHH? r r r~ r5@ r r r r r s)~ sD@t % @t % @ t'C !0@ rC .ގ? r r r~ r(@ r$ r$ r$ r$ r$ s)~ sD@t=%Pt=%P? t_? rP b? r$ r$ r$~ r"@ r r r r r s)~ s^@tZ(tZ(? t?i? r7Fs? r r r~ r0@ r r r r r s)~ su@t)L t)L ? t ? rA,Ґ$? r r r~ rN@ r r r r r s)~ sI@tkC?tkC? tɭ%? r? r_q帊? r| r} r~~ r@ r r r r r s)~ sd@t rrr ~ rW@ r( r) r( r* r+ s)~ se@tظ8Sd?tظ8Sd? t @t4" Ϳt4" ? t66? rZ`? r# r# r#~ r@ r8 r9 r8 r: r; s)~ sI@th#Nth#N? tJ|? rRP>? r< r= r>~ r$@ r@ rA r@ rB rC s)~ st@tWBAޕпtWBAޕ? t&'? rM? rD rE rF~ rG@ rH rI rH rJ rK s)~ sK@t"¿t"? t? r#9[? rL rM rN~ r @ rP rQ rP rR rS s)~ sK@tZۨ:z?tZۨ:z? tGK? ruS!? rT rU rV~ r$@ rX rY rX rZ r[ s)~ s4@t~Yt~Y? t;at? r)? r\ r] r^~ r"@ r` ra r` rb rc s)~ s@p@tV.h?tV.h? tVZR? rӨ? rd re rf~ rL@ r5 ri r5 r5 r5 s)~ sQ@tg1tg1? tY.z/? rwpn ? rrr ~ r$@ r5 r# r5 rx/ ry/ s)~ sA@t ;;c?t ;;c? t W? rɧJH{? rz/ r{/ r|/~ r0@ rm rn rm ro rp s)~ s@P@tGx`?tGx`? t[bW@ rӨ? rq rr rs~ r.@ ru rv ru rw rx s)~ se@tMm̿tMm? t:>Y? rL ? ry rz r{~ r@@ r r r r r s)~ sp@t8tb?t8tb? tlW? ryuX? r r r~ rE@ r r r r r s)~ s؁@tdGUl3?tdGUl3? t8hi? rӨ? r r r~ rX@ r r r r r s)~ sܣ@tf tf ? t51OAY? rQ> r r r~ rM@ r r r r r s)~ s@Z@to>̍;տto>̍;? t0rm? r<S? r r r~ r6@ r r r r r s)~ s`m@t~DBt~DB? t_%? r*L_? r r r~ r>@ r r r r r s)~ s@P@t^35ͼ?t^35ͼ? tA =L? r~ r3@ r@ rA r@ rB rC s)~ sT@tG4AtG4A? t4C)? rlHV6{? rD rE rF~ r"@ rH rI rH rJ rK s)~ s4@ts\^Fts\^F? t'A? rn(? rL rM rN~ r@ rP rQ rP rR rS s)~ sN@t/??t/?? t)Ga? rCa? rT rU rV~ r,@ r` ra r` rb rc s)~ sQ@t&ٻt&ٻ? t' 2? ry&;? rd re rf~ r"@ rX rY rX rZ r[ s)~ sj@t߯]t߯]? t@@%? r2hn? r\ r] r^~ r=@ rh ri rh rj rk s)~ sa@tC/WtC/W? tŠMU? ruAF? rl rm rn~ r7@ rp rq rp rr rs s)~ sp@thտth? t :w? rY? rt ru rv~ r>@ rx ry rx rz r{ s)~ s@Z@tߦ#IX?tߦ#IX? tCIVK? ru6'? r; r| r}~ r.@ r r r r r s)~ sz@t+?t+? tPAN? uc*⡙= r r r~ r:@ r r r r r s)~ sQ@tR0q9?tR0q9? tN36@ r !? r r r~ r,@ r r r r r s)~ sg@tip{qtip{q? t[OnN? r| {? r r r~ rB@ r r r r r s)~ sA@t)Yt)Y? tK'? rV&C? r r  r ~ r@ r r r r r s)~ s>@tRW?tRW? tt NGA? r'y(? r r r~ r@ r r r r r s)~ sq@tL<(?tL<(? tlw}A? r1)P? r r r~ r@T@ r r r r r s)~ sd@t!@c?t!@c? tjlݎ? rw 8Q? r r r~ rH@ r r r r r s)~ sn@t;F t;F ? t6 ? rR ? r r r~ rC@ r r r r r s)~ sY@tq؝3?tq؝3? twVgY? rf#^? r r r~ r<@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ sb@t$ t$ ? t]Q%C7? rT?  rS  r  r~ r8@ r r r r r s)~ sq@txT|?txT|? tO6? r-6g]  r  ra  r~ rI@ r r r r r s)~ sY@tE~?tE~? tp1aO? r]e)r4?  r  r  r~ r3@ r" r# r" r$ r% s)~ s@Z@t 紋t 紋? t?ھ? r?  r&  r'  r(~ r@@ r  r  r  r  r  s)~ sk@t0$~wz?t0$~wz? tu*? r]?  r   r  r~ r@@ r r r r r s)~ s0~@tv: ?tv: ? tإv|6? urB_v>  r  r  r~ rR@ r r r r r s)~ s@P@ tgۧ? tgۧ?  t"B= ?  rn?  r  r  r~ r7@ r! r" r! r# r$ s)~ s@U@ tF&4 tF&4?  tZSg?  rpt:{?  r  r  r~ r.@ r& r' r& r( r) s)~ s$@ t-f/ t-f/@  t!?  ry&;?  r*  r+  r,~ r@ r. r/ r. r0 r1 s)~ sW@ tBzn? tBzn?  t8j\@  rQHH?  r2  r3  r4~ r7@ r6 r7 r6 r8 r9 s)~ sN@ t%%? t%%?  tq?  rT4V?  r:  r;  r<~ r.@ r> r? r> r@ rA s)~ s @teM%teM%? tJL«? r<Ƿ?  rB  rC  rD~ rQ@ rF rG rF rH rI s)~ sf@tc}r>tc}r>? t? r.M&T?  rJ  rK  rL~ r;@ rN rO rN rP rQ s)~ s r@t ?t ? t5~? uWwX ?  rR  rS  rT~ rI@ rV rW rV rX rY s)~ s g@trW[޿trW[? tm~"C? rHM"?  rrr ~ rB@ r[ r\ r[ r] r^ s)~ sT@tU>,?, rt ru rt rv rw s)~ s@e@ tQ2KneUk tQ2KneUk?  txa?  r5J?  rx  ry  rz~ r8@ !r !r !r !r !r !s)~ !sA@!t=z?!t=z?! t6V V@! rc? ! r ! r ! r~ !r1@ "r "r "r "r "r "s)~ "st@"tBd"tBd?" tS0k?" r=? " r " r " r~ "rH@ #r #r #r #r #r #s)~ #s l@#t{C#t{C?# t}29 ?# r˸7 ? # r # r # r~ #rR@ $r $r $r $r $r $s)~ $sI@$t@;$t@;?$ t`7OG?$ rR? $ r $ r $ r~ $r1@ %r-. %rk %r-. %rl %r.. %s)~ %sI@%t)^ ҿ%t)^ ?% t(?% r? % r/. % r" % r0.~ %r(@ &r &r &r &r &r &s)~ &s4@&t[g{&t[g{?& tT# ?& rdJ#? & r & r & r~ &r @ 'r 'r 'r 'r 'r 's)~ 'si@'t+\/D@'t+\/D@?' ta?' r:? ' r ' r ' r~ 'rA@ (r (r (r (r (r (s)~ (s8@(t1 l鯿(t1 l?( t.m?( rD~vc? ( r ( r ( r~ (r`d@ )r5 )r. )r5 )r. )r. )s)~ )s$@)tٹO?)tٹO?) tNZMb?) rӨ? ) r. ) r. ) r.~ )r@ *rq *rr *rq *rs *rt *s)~ *sN@*t4*t4?* t=k[O?* rL-m? * ru * rv * r~ *r,@ +r +r +r +r +r +s)~ +sp@+tAMп+tAM?+ tC=?+ rOmT? + r+ r + r~ +r?@ ,r^ ,r_ ,r^ ,r` ,ra ,s)~ ,s9@,t-tP#?,t-tP#?, tR$3@, r17~A? , rb , rc , rd~ ,r@ -r -r -r -r -r -s)~ -sK@-t8c(O?-t8c(O?- t@a?- rq-? - r - r - r ~ -r*@ .r .r .r .r .r .s)~ .sN@.t/?.t/?. tJü;?. r]? . r . r . r ~ .r*@ /r /r /r /r /r /s)~ /s4@/t=k@?/t=k@?/ th @/ r\-ǦJ? / r / r / rE~ /r@ 0r 0r 0r 0r 0r 0s)~ 0s>@0t"[0t"[?0 tjbmQ?0 r5!? 0 r 0 r 0 r ~ 0r@ 1r 1r 1r 1r 1r! 1s)~ 1s@`@1t{1t{?1 t*TU?1 roUt? 1 r" 1 r# 1 r$ ~ 1rB@ 2r& 2r' 2r& 2r( 2r) 2s)~ 2s4@2t}0* ?2t}0* ?2 tPF?2 rFa>? 2 r* 2 r 2 r+ ~ 2r"@ 3r- 3r. 3r- 3r/ 3r0 3s)~ 3s@3t$ 6?3t$ 6?3 t]_=?3 rtw>? 3 r1 3 r2 3 r3 ~ 3re@ 4r5 4r6 4r5 4r7 4r8 4s)~ 4sD@4t;e34t;e3?4 t>쬗?4 r:"]? 4 r9 4 r: 4 r; ~ 4r @ 5r= 5r> 5r= 5r? 5r@ 5s)~ 5sT@5ttS4@5ttS4@5 tق=@5 rw﹬? 5 rA 5 rB 5 rC ~ 5r3@ 6rE 6rF 6rE 6rG 6rH 6s)~ 6s4@6t(߿6t(?6 t6:@[?6 rjJ? 6 rI 6 rJ 6 rK ~ 6r@ 7rM 7rN 7rM 7rO 7rP 7s)~ 7sT@7toY0?7toY0?7 t]2ؚ?7 rS+f? 7 rr 7 r?~ 7r&@ 8rR 8rS 8rR 8rT 8rU 8s)~ 8sg@8tտ8t?8 tz8?8 r@? 8 rV 8 rW 8 rX ~ 8r2@ 9r[ 9r\ 9r[ 9r] 9r^ 9s)~ 9s\@9tOY ?9tOY ?9 t-׫ ?9 r l? 9 r_ 9 r` 9 ra ~ 9r7@ :rc :rd :rc :re :rf :s)~ :sR@:t\:t\?: tM (?: rHM"? : rg : rh : ri ~ :r3@ ;rq- ;rd ;rq- ;re ;rr- ;s)~ ;sI@;t 6Y;t 6Y?; t]tL?; rSUO3a)? ; rs- ; rt- ; ru-~ ;r.@ <rk <rl <rk <rm <rn <s)~ <sT@<t7 j<t7 j?< t~_M?< rF!5? < ro < r2 < rp ~ <r0@ =rr =rs =rr =rt =ru =s)~ =sD@=tmJj?=tmJj?= tI@?= r]? = rc = rc = rv ~ =r"@ >rx >ry >rx >rz >r{ >s)~ >sQ@>t*uٿ>t*u?> tTtߙI?> r/*t;? > r| > rT > r} ~ >r0@ ?r ?r ?r ?r ?r ?s)~ ?s$@?tk??tk?? tiCݩ?? r#9[? ? r ? r ? r ~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r @r @r @r @r @s)~ @st@@tFnO@tFnO?@ tp|?@ r M/? @ r @ r @ r ~ @rB@ Ar Ar Ar Ar Ar As)~ Asa@AtRԿAtR?A tfļ?A r}O? A r A r A r ~ Ar:@ Br Br Br Br Br Bs)~ Bs>@Bt~ۉwBt~ۉw?B tu?B r1]? B r B r B r ~ Br@ Cr Cr Cr Cr Cr Cs)~ Cs@CtS5CtS5?C t4j?C rw? C r C r C r ~ Cr@j@ Dr Dr Dr Dr Dr Ds)~ Ds@Dt*`VZDt*`VZ?D te6 ?D u37=D r D r" D r ~ Dr`j@ Er Er Er Er Er Es)~ Esd@Etҟ ֿEtҟ ?E teJ?E rR ? E r E r E r ~ Er4@ Fr Fr Fr Fr Fr Fs)~ Fs4@FtJ1v4FtJ1v4@F tJ?F r{6)/? F r F r F r ~ Fr @ Gr Gr Gr Gr Gr Gs)~ GsN@Gt,Gt,?G t ?G r>g? G r G r G r~ Gr"@ Hr Hr Hr Hr Hr Hs)~ Hs`@Ht;!?Ht;!?H t/T@m?H rEI? H r H r H r ~ Hr9@ Ir Ir Ir Ir Ir Is)~ Isy@ItDT?ItDT?I tL ?I r:!Qȶ? I r I r I r ~ IrZ@ Jr Jr Jr Jr Jr Js)~ Js@`@Jt7IqJt7Iq?J t54?J r3B? J r J r J r~ Jr<@ Kr Kr Kr Kr Kr Ks)~ KsN@Kt Y?Kt Y?K tU"7?K r4&͆? K r K r K r~ Kr1@ Lr Lr Lr Lr Lr Ls)~ Ls9@LtAc?LtAc?L tNз@L rɅy? L r L r L r~ Lr@ Mr Mr Mr Mr Mr Ms)~ Ms4@Mt^ .y?Mt^ .y?M tHh?M rϪ? M r M r M r ~ Mr@ Nr Nr Nr Nr Nr Ns)~ Ns.@Nt$Nt$?N t) M?N rϪ? N r N r N r ~ Nr@ Or Or Or Or Or Os)~ Os[@OtZѿOtZ?O tl04g?O rft!? O r O r O r ~ Or3@ Pr Pr Pr Pr Pr Ps)~ PsR@PtN jPtN j?P t{&Ra?P rr,? P r P r P r~ Pr$@ Qr Qr Qr Qr Qr Qs)~ Qs>@Qt'?Qt'?Q txҌ ?Q rGu#? Q rC Q rD Q rE~ Qr@ Rr= Rr> Rr= Rr? Rr@ Rs)~ Rse@Rt2(ԿRt2(?R tIlth?R rn? R rA R rB R rC~ RrB@ Sr Sr Sr Sr Sr Ss)~ Ssb@St4LMLO7ۿSt4LMLO7?S t֫x?S ry? S r S r S r ~ Sr<@ Tr Tr Tr Tr Tr Ts)~ Ts\@Ttɝ.'?Ttɝ.'?T tH!A6Ʉ?T rKev? T rc T rc T rc~ Tr8@ Ur Ur! Ur Ur" Ur# Us)~ Ust@Ut ͗|Ut ͗|?U t4ODW?U uE퐛> U rrr ~ Ur:@ Vr% Vr& Vr% Vr' Vr( Vs)~ Vsh@Vtd Wf?Vtd Wf?V tIyHT?V rG@2n? V rc V rc V rc~ VrR@ Wr\ Wr] Wr\ Wr^ Wr_ Ws)~ WsN@Wt+`ZfWt+`Zf?W tOb?W rft!? W r` W ra W rb~ Wr@ Xr* Xr+ Xr* Xr, Xr- Xs)~ Xs`@XtS9?XtS9?X t$6@X u M> X r. X r/ X r0 ~ Xr(@ Yrv~ Yv<@ Yrv Yrx Yry Ys)~ Ys9@Yt#EƨYt#Eƨ?Y tx?Y rN ? Y rz Y r{ Y r|~ Yr@ Zr2 Zr3 Zr2 Zr4 Zr5 Zs)~ Zs$@Zt״rZt״r@Z t»p-?Z r?j,? Z r6 Z r7 Z r8 ~ Zr@ [r5 [r [r5 [r5 [r [s)~ [s[@[tXIϱ?[tXIϱ?[ ty[kf`?[ rʄҵL? [ r/ [ r/ [ r/~ [r8@ \rC \rD \rC \rE \rF \s)~ \sV@\t)/,?\t)/,?\ tlZ?\ rN ? \ rG \ rH \ rI ~ \r*@ ]rK ~ ]v@=@ ]rK ]rM ]rN ]s)~ ]sR@]tؙξXe]tؙξXe?] tPcu?] r)9? ] rO ] rP ] rQ ~ ]r2@ ^r5 ^r- ^r5 ^r5 ^r- ^s)~ ^s4@^tA{ ?^tA{ ?^ t6+?^ r@ =? ^ r- ^ r- ^ r-~ ^r @ _rT _rU _rT _rV _rW _s)~ _s^@_tjgÿ_tjg?_ tB?_ rpt:{? _ rX _ rY _ rZ ~ _r=@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r] `r^ `r] `r_ `r` `s)~ `sa@`t*ƿ`t*?` tpք;I?` r\BP? ` ra ` rb ` rc ~ `r7@ arf arg arf arh ari as)~ asd@atar^?atar^?a tu?a r<$?e r_xx#? e r e r e r ~ er@@ fr fr fr fr fr fs)~ fs.@ftQsL+ftQsL+?f tCK?f rpm.? f r f r f r ~ fr@ gr gr gr gr gr gs)~ gsk@gt@IB?gt@IB?g tod?g rym? g r g r g r ~ gr@@ hr hr hr hr hr hs)~ hs[@htze?htze?h taX,?h r/G? h r h rc h r ~ hr,@ ir ir ir ir ir is)~ isA@itV`itV`?i t*o98?i rT ? i r i r i r ~ ir@ jr jr jr jr jr js)~ jsA@jtŨg?jtŨg?j t9Ȗ ?j rU7\? j r j r j r ~ jr@ kr kr kr kr kr ks)~ ks.@ktCș ?ktCș ?k t11?k rtzno? k r k r k r ~ kr@ lr lr lr lr lr ls)~ ls4@ltA j@ltA j@?l t?l r?j@utpҟ?utpҟ?u tf_?u r.)? u rrr ~ ur@ vr5 vr6 vr5 vr7 vr8 vs)~ vsY@vt:Y,mvt:Y,m?v tIZK?v uPl> v r v r  v r~ vr@ wr wr wr wr wr ws)~ wsI@wtD:,LVjwtD:,LVj?w t<H?w r~ݬiMu? w r w r  w r~ wr@ xr: xr; xr: xr< xr= xs)~ xsI@xtȈcѿxtȈc?x t̨ȁ?x r+3? x r x r  x r~ xr@ yr yr yr yr yr ys)~ ysD@yt}qFyt}qF?y t?y u$> y r y r  y r ~ yr@ zr? zr@ zr? zrA zrB zs)~ zsK@ztZaʔztZaʔ?z t 0?z rR ? z r z r  z r~ zr @ {rD {rE {rD {rF {rG {s)~ {s\@{t[o{t[o?{ t?:3?{ r?"!? { rH { r { rI ~ {r1@ |rK |rL |rK |rM |rN |s)~ |sq@|t U$?|t U$?| t1?| rIx? | rO | rP | rQ ~ |r;@ }rS }rT }rS }rU }rV }s)~ }s`}@}t{ ^M}t{ ^M?} tO>?} u H.y= } rW } rX } rY ~ }r?@ ~r[ ~r\ ~r[ ~r] ~r^ ~s)~ ~s@e@~t6ѶR?~t6ѶR?~ t>J?~ rfGv? ~ r_ ~ r` ~ ra ~ ~r=@ rc rd rc re rf s)~ sȉ@t1Î@t1Î@? th MW? uR_F6'>  rg  rh  ri ~ rQ@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rk rl rk rm rn s)~ sd@tF%?tF%? t;6@ ua|?>  ro  rp  rq ~ r1@ rs rt rs ru rv s)~ si@tRh?tRh? t5@ r!y +?  rw  rx  ry ~ r7@ rw rx rw ry rz s)~ s@e@tìutìu? tW? u>  r{  rT  r|~ r1@ r{ r| r{ r} r~ s)~ sd@t^?t^? tZ{!? r#?  r  r"  r ~ r5@ r r r r r s)~ se@ts7?ts7? t(zT+I? r^Io?  r  r  r ~ r0@ r r r r r s)~ spr@tZ=4tZ=4? te? r!c p;?  r  r  r~ rJ@ r r r r r s)~ s9@t+x`!Ϳt+x`!? t`PBB? rFL?  r  r  r ~ r"@ r r r r r s)~ s`h@tː|tː|? t\h? rJyH{?  r  r  r ~ rA@ r r r r r s)~ sA@tַۛQſtַۛQ? t̂? r#9[?  r  r  r ~ r(@ r5 r. r5 r. r. s)~ s.@tT?tT? t*Yd|? rSL?  r.  r.  r.~ r@ r r r r r s)~ s g@tt?tt? tWN? rIH2w?  r  r  r ~ r1@ r r r r r s)~ s|@t;̄ܿt;̄? tOy? rKhق?  r  r  r ~ rN@ r r r r r s)~ sI@trh?trh? tpH? rN~-?  rrr ~ r.@ r r r r r s)~ sT@t~@Vt~@V? tZ ? r@Sy?  r  r   r ~ r"@ r r r r r s)~ sQ@t:m|t:m|? tǥI晳? rUD*T?  r   r   r ~ r @ r r r r r s)~ sT@t 3tt 3t? t.K? rB C=?  r  r  r ~ r$@ r r r r r s)~ s@j@t,&LS߿t,&LS? tz? rP`?  rrr ~ r@@ r5 r r5 r3. r4. s)~ sI@t-\t-\? t'ʋ"? rS+f?  r5.  r6.  r7.~ r"@ r r r r r s)~ s`@t/Eyt/Ey? te[o? rKZўP?  r  r  r ~ r3@ r r r r r s)~ sV@t1w%U?t1w%U? tQ%T? rlM?  rrr ~ r5@ r r r r r s)~ s@tAF0׿tAF0? tCqG? r]?  r  r  r ~ rT@ r] r^ r] r_ r` s)~ s@U@t]t]? tNUB? r{r.t/?  ra  rb  rc ~ r7@ r r r r r s)~ s@U@t-?t-? te? rw﹬?  r  r  r~ r1@ r r r r r s)~ s@P@t͇lAt͇lA? tΧ? r8iY?  r  r  r ~ r1@ r r r r r s)~ sx@t;Mt;M? tλr>? rlM?  r  r  r~ rJ@ r r r r r s)~ s>@t~?t~? t85i? rpt:{?  r  r  r ~ r@ r5 r r5 r5 r. s)~ s4@t_H?t_H? tP+? rcڥ?  r.  r.  r.~ r@ r r r r r s)~ s@P@tDrj[ֿtDrj[? t L? r% ?  r  r  r ~ r.@ r r r r r s)~ sT@t"%*t"%*? t$̧? r2"?  r  r  r ~ r,@ r$ r% r$ r& r' s)~ sV@txK׏?txK׏? tq%? r\-ǦJ?  r(  r)  r* ~ r(@ r, r- r, r. r/ s)~ s@P@tt`tt`? t2+I? r Bž?  r0  r1  r2 ~ r"@ r4 r5 r4 r6 r7 s)~ s9@t Z&X?t Z&X? tWt@ rD2?  r8  r9  r: ~ r@Drl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r  r  r  r  r s)~ sI@tB,f?tB,f? tex@ rSL?  r  r  r~ r"@ r< r= r< r> r? s)~ sx@tS@t8%t8%@ t XeZ4|? ran?  rH  rI  rJ ~ r@ rL rM rL rN rO s)~ sN@twjtwj? t`"Ҟ)? rD?  rP  rQ  rR ~ r0@ r\ r] r\ r^ r_ s)~ s@U@t$GC2ÿt$GC2? tã0? rFa>?  r`  ra  rb ~ r4@ rD- rt rD- ru r5 s)~ s9@tA ?tA ? tM;? rӁS.?  rE-  rF-  rG-~ r&@ r3 r4 r3 r5 r6 s)~ sb@teCteC? ty_? r{ {?  r7  r8  r9~ r5@ rh ri rh rj rk s)~ sQ@tf?ntf?n? t:? r?  rl  rm  rn~ r5@ r r r r r s)~ s`@t[^aY't[^aY'? t!? r r?  r  r  r~ rV@ rd re rd rf rg s)~ sF@tt? t ? r`cm?  rh  ri  rj ~ r@ r{ r| r{ r} r~ s)~ s4@tGr ~tGr ~? tX*? r3 _?  r  r  r ~ r @ r r r r r s)~ s8@t´ i>t´ i>? ttVy? u`% 01;  r  r  r~ rQ@ r r r r r s)~ s9@tU?w9ӿtU?w9? td(1? rKhق?  r  r  r ~ r@ r r r r r s)~ s9@th8|Aֿth8|A? ty4@%? r3bL&?  r  r  r ~ r@ r r r r r s)~ sN@th3οth3? tBҙ+,? r>g?  rrr ~ r @ r r r r r s)~ sd@t4ԇڿt4ԇ? tm[T? rٔY?  r  r  r ~ r5@ r r r r r s)~ sQ@t|]t|]? tZM? rߣ^C*?  r  r  r ~ r,@ r r r r r s)~ s b@t;N~?t;N~? ti>g&? r"?  r  r*  r ~ r6@ r r r r r s)~ sV@t=t=? tV7? rOu?  r  r  r ~ r3@ r r r r r s)~ s4@t"7[ۿt"7[? t[ė? rZ?  r  r  r ~ r@ r r r r r s)~ s.@t(k|zft(k|zf? tSn? r&H?  r  r  r ~ r@ r r r r r s)~ ss@tFtF? tB? u\%>  r  r  r ~ rJ@ r r r r r s)~ s4@t?t? th? rU7\?  r  r  r ~ r@ r r r r r s)~ s@_@t6?t6? tC@ rhX?  r  r  r ~ r7@ r r r r r s)~ s@Z@tAYݿtAY? t*RY? rB C=?  r  r  r ~ r3@ r/ r r/ r/ r/ s)~ s4@t@ r r r r r s)~ s@`@tR"C?tR"C? trUa? r|mn?  r   r!  r"~ r&@ r r r r! r" s)~ sA@t ?t ? t o]@ rvF?  r#  r  r$ ~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r& r' r& r( r) s)~ sp}@tY!:տtY!:? tLIm? r>g?  r*  r+  r, ~ rC@ r. r/ r. r0 r1 s)~ s>@tzz?tzz? tZ=M7_? r@Y?  r2  r3  r4 ~ r@ r6 r7 r6 r8 r9 s)~ s4@tQd?tQd? t<w@ r2 ?  r:  r;  r< ~ r@ r> r? r> r@ rA s)~ s@P@t7t7? t6? r?  rB  rC  rD ~ r*@ rN rO rN rP rQ s)~ s@U@tѪB+tѪB+? tAw_? r]?  rR  rS  rT ~ r @ rV rW rV rX rY s)~ sT@tZJgǿtZJg? t(=? r Bž?  rZ  r[  r\ ~ r(@ r^ r_                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c e f g h i j k l m n o p q r s t u v w x y z { | } ~  r^ r` ra s)~ s`@tsRڿtsR? t.L)? r>g?  rb  rc  rd ~ r.@ rf rg rf rh ri s)~ sA@t0ӻc?t0ӻc? t%? r)@}?  rj  rk  rl ~ r@ rn ro rn rp rq s)~ s.@tD?tD? t ੘? rq-?  rr  rs  rt ~ r@ rv rw rv rx ry s)~ sI@tW 76?tW 76? tBSi? rU7\?  rz  r{  r| ~ r(@ r~ r r~ r r s)~ st@t$R?t$R? to? ro?  r  r  r ~ rC@ r r r r r s)~ sd@t,?t,? t+? r9 =?  r  r  r ~ rB@ r r r r r s)~ sR@th=Vؿth=V? tnu? r@OV~?  r  r  r ~ r3@ r r r r r s)~ sI@t!%KAշÿt!%KAշ? tM[? r&H?  r  r  r ~ r"@ r r r r r s)~ s4@tpU[?tpU[? t~M? r-z?  r  r  r ~ r@ r r r r r s)~ s>@tK)ve?tK)ve? t5{? r*/?  r  r  r ~ r @ r r r r r s)~ sR@ttۋ޵?ttۋ޵? t? r?  r  r  r ~ r0@ r r r r r s)~ s9@tBHAI?tBHAI? tI/O? rw?  r  r  r ~ r@ r r r r r s)~ s\@t XAh?t XAh? t ? r^,gWG?  r  r  r ~ rI@ r r r r r s)~ s`@tM?tM? t-꤭³? r>a?  r  r  r ~ r7@ r r r r r s)~ s.@tRhI(tRhI(? t0<ΤQ? r#9[?  r  r  rE~ r"@ rJ rK rJ rL rM s)~ s`c@to!?to!? tm#&X? r?  rN  rO  rP~ rB@ r r r r r s)~ s$@t<I@t<I@ t+w]@ r@t 8et 8e? tҬ;ސ? r%I+p~?  r\  r   r ~ r"@ r  r  r  r r s)~ sb@t=bmt=bm? t؛Ϯ? rSL? r  r"  r~ r7@ r r r r r s)~ sN@tk etk e? tHrlS? r:h?  r  r  r~ r&@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sT@tc Fe?tc Fe? tzs/? rB C=?  r  r  r ~ r,@ r5 r) r5 r5 ra- s)~ s$@tb-"QDڿtb-"QD? tby? r]e)r4?  rb-  rc-  rd-~ r@ r/ r0 r/ r1 r2 s)~ sb@tiпti? tH?? r@ =?  r3  r4  r5~ r8@ r7 r8 r7 r9 r: s)~ sD@tmyC޿tmyC? tE? r?  r;  r<  r=~ r*@ r? r@ r? rA rB s)~ sN@t>+V9t>+V9? tiʸ? rOD?  rC  rD  rE~ r,@ r5 r/ r5 r/ r/ s)~ s@tq Wx׿tq Wx? tWsS? rS"?  r /  r!/  r"/~ r@ r` ra r` rb rc s)~ s@U@ti |ti |? t_c? rɅy?  rd  re  rf~ r2@ r5 rJ. r5 rK. rL. s)~ s4@t+5t+5? tEF? r57@?  r  r  rM.~ r@ r r r r r s)~ sa@tz)3?tz)3? tvS5ս^? r?  r  r"  r?~ r>@ rm rn rm ro rp s)~ sA@tY^?tY^? tgV? rlM?  rq  rr  rs~ r @ ru rv ru rw rx s)~ su@tfds?tfds? tew!T? r/?  ry  r"  rz~ rM@ r| r} r| r~ r s)~ s`@tlhd?tlhd? t5? rc?  r  r  r~ r9@ r r r r r s)~ s.@t&t&? t*@^? rT4V?  r  r  r~ r@ r r r r r s)~ s@t6GS?t6GS? ti^? rʄҵL?  rc  rc  r~ r@ r r r r r s)~ s$@tf6?tf6? tNZQ? rB C=?  r  r  r~ r@ r r r r r s)~ sK@taƃtaƃ? tu`}? r`T?  r  r  r~ r @ ri rj ri rk rl s)~ s.@tN1n@tN1n@ t%,+@ r$)E*?  rm  rn  ro~ r@ r r r r r s)~ sF@t˼ĚͿt˼Ě? trt2B? rZ`?  r  r  r~ r0@ r r r r r s)~ sV@t0C*t0C*? tHO? r@tQi`ֿtQi`? t[? rC .ގ?  r  r  r~ r$@ r r r r r s)~ s@P@tt? tNq4? rJU| ?  rC  rD  rE~ r @ r r r r r s)~ s4@t:?tt:?t? t09r? rR-?  r  r  r~ r@ r r r r r s)~ s$@tVBO2?tVBO2? tB0ԕF? rjSx7e?  r  r  r~ r@ r5 r r5 r5 r, s)~ s`@tt? t ? r|ͅZ?  r,  r)  r,~ r6@ rp. rq. rp. rr. rs. s)~ sA@tY!,ݿtY!,? t94? r@?  rrr ~ r@ r r r r r s)~ sW@t4mt4m? tNwJ? rQnD?  rrr ~ r$@ r r r r r s)~ sQ@tj\tj\? t[MA? r#9[?  r   r   r ~ r&@ r  r  r  r r s)~ sD@tPqhtPqh? tx*? raJ6D?  r  r  r~ r2@ r r r r r s)~ sU@tbylEtbylE? tR6GR? r5(=?  r  r  r~ r$@ r r  r r! r" s)~ s@P@tLztLz? tLvV? rTK&T#S?  rC  rD  rE~ r @Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r$ r% r$ r& r' s)~ sK@t}X 0}t}X 0}? tZ2.? u]~>  r(  r)  r*~ r@ r, r- r, r. r/ s)~ s b@tx?tx? t0D2 k]? r&>dYx?  r0  r1  r2~ r>@ r4 r5 r4 r6 r7 s)~ s:@tN[?tN[? t3=o? ro?  r  r  r~ r@ r9 rP r9 r: r; s)~ s b@tGXtGX? t8? r?"!?  r  r  r~ r.@ rE rP rE rF r; s)~ sQ@t![5t![5? tPU;[? rA,Ґ$?  rrr ~ r @ r5 r9/ r5 r5 r:/ s)~ s$@tv9?tv9? tOz ? ro?  r;/  r?  r,  r,  r,~ rU@ r%+ r&+ r%+ r'+ r(+ s)~ s.@tO'?tO'? tk@ r gs"?  r)+  r*+  r++~ r@ r  r  r  r r s)~ sV@t?U?t?U? t \@ rR ?  r  r  r~ r&@ r/ r  r/ r/ r5 s)~ sa@ t.[ t.[?  t63]?  rco?  rrr ~ r5@ r5 r5 r5 r5 r/ s)~ s@P@ t?wr+ t?wr+?  t{d.9?  rlM?  rc  rc  rc~ r$@ rV rW rV rX rY s)~ s4@ tRj 揨 tRj 揨?  tA4Ϧ?  r_q帊?  r  r  r~ r@ r-+ r.+ r-+ r/+ r0+ s)~ s$@ trCo0? trCo0?  t1}i?  ru֭?  r1+  r2+  r3+~ r@ re rf re rg rh s)~ sA@ t^=8? t^=8?  tN?  rlM?  ri  rj  rk~ r$@ rn ro rn rp rq s)~ sI@t 23?t 23? tM~? r?  rr  rs  rt~ r,@ r5 r/ r5 r5 r/ s)~ s@t?t? tkf? rlM?  r/  r/  r/~ r@ r r r r r s)~ sI@t#e?t#e? t\%O6@ r]`?  r  r  r~ r$@ r r r r r s)~ s@`@tSQtSQ? tk? rq{T?  r  r  r~ r7@ r r r r r s)~ sD@tVtV? t6? rc?  r  r  r~ r(@ r5 r- r5 r5 r- s)~ s@tP>?tP>? t&k5? rEj?  r-  r-  r-~ r@ r r r r r s)~ sW@tL+?tL+? tX8|? r)?  r  r  r~ r1@ r5 r r5 r5 r/ s)~ s.@tr?tr? t@^XU]@ r]`?  r/  r/  r/~ r@ r5 r r5 r5 r<. s)~ s9@tlCp?tlCp? t.  r?.~ r@ r r r r r s)~ s9@tUNL߿tUNL? tϬ? r'?  r  r  r~ r@ r r r r r s)~ s4@tRStRS? t*2? r3Ҕ!?  r  r  r~ r@ r r r r r s)~ s.@t~ؿt~? tx ? rq-?  r  r  r~ r@ r5 r5 r5 r5 r- s)~ s>@t˜zٿt˜z? tkCg? roiU?  r.  r.  r.~ r@ r5 r r5 r5 r! s)~ sA@txfOtxfO? tN? r\UhF?  r/  r/  r/~ r@ r r r r r s)~ sk@tQ;}?tQ;}? t3/@ uyY{N>  rrr ~ r2@ r r r r r s)~ sR@tJv?tJv? t_V? r՟?  rrr ~ r1@ r r r r r s)~ s>@tVS??tVS?? t#i? r]?  r  r  r~ r$@ rk/ rW rk/ rX rl/ s)~ sN@tkD9?tkD9? t9 O? r@?  rrr ~ r4@D>l ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r r r r r s)~ sT@ tUʜ? tUʜ?  th%?  r?  rrr ~ r3@ !r5 !r. !r5 !r. !r. !s)~ !s$@!thVi?!thVi?! t;?# rram? # r- # r- # r-~ #r*@ $r $r $r $r $r $s)~ $s.@$tCW˿$tCW?$ tWYsȉ?$ rs17? $ r $ r $ r~ $r@ %r %r %r %r %r %s)~ %sQ@%t^|r%t^|r?% t)W|?% r.N? % r % r % r~ %r*@ &r &r &r &r &r &s)~ &s9@&t.k)?&t.k)?& tl?& r.ꄸ? & r & r & r~ &r @ 'r 'r 'r 'r 'r 's)~ 's9@'tڿ't?' ty?' r)!? ' r ' r ' r~ 'r3@ (r (r (r (r (r  (s)~ (s.@(t@T9M?(t@T9M?( tDF?( rSL? ( r  ( r  ( r ~ (r@ )r )r )r )r )r )s)~ )sA@)t ;)t ;?) t*t4?) r`R? ) r ) r ) r~ )r"@ *r *r *r *r *r *s)~ *s@P@*tv}_ֿ*tv}_?* tx55?* r? * r * r * r~ *r(@ +r +r +r +r  +r! +s)~ +sr@+tauiN+tauiN?+ t~?+ ri#? + r" + r# + r$~ +r;@ ,r& ,r' ,r& ,r( ,r) ,s)~ ,s@P@,ts0L6cU?,ts0L6cU?, t?v[9^|@, ru-a? , r* , r+ , r,~ ,r(@ -r. -r/ -r. -r0 -r1 -s)~ -sb@-tm-tm?- tW%?- u>Q> - r2 - r3 - r4~ -r1@ .r6 .r7 .r6 .r8 .r9 .s)~ .s4@.tf n?.tf n?. tO˖?. rgc /r? /r> /r@ /rA /s)~ /s9@/tWS~/tWS~?/ tHO?/ rz? / r / r  / r~ /r@ 0rC 0rD 0rC 0rE 0rF 0s)~ 0s g@0te<jz0te<jz?0 t;l?0 rMc? 0 rG 0 r* 0 rQ ~ 0r2@ 1rI 1rJ 1rI 1rK 1rL 1s)~ 1sf@1tA_?1tA_?1 t7@1 rA'bTS? 1 rM 1 rN 1 rO~ 1r1@ 2rQ 2rR 2rQ 2rS 2rT 2s)~ 2s{@2tq?2tq?2 t\ٓ@2 uNzB:a> 2 rU 2 rV 2 rW~ 2rK@ 3rY 3rZ 3rY 3r[ 3r\ 3s)~ 3sK@3tRv?3tRv?3 t_o @3 r 7 r} 7 r~ 7 r~ 7r>@ 8r 8r 8r 8r 8r 8s)~ 8s`y@8tiA?e~8tiA?e~?8 te,Bs?8 u,t= 8 r 8 r 8 r~ 8rM@ 9r 9r 9r 9r 9r 9s)~ 9sT@9tAjx?9tAjx?9 t62u;J5?9 rvS? 9 r 9 r 9 r~ 9r3@ :r :r :r :r :r :s)~ :sb@:t .?:t .?: t3~sZ?: r#9[? : r : r : r~ :r=@ ;rO ;rP ;rO ;rQ ;rR ;s)~ ;s@P@;t̒J;t̒J?; t5h?; u&= ; r ; r  ; r~ ;r@ <r <r <r <r <r <s)~ <sA@<t9j<t9j?< tsU5?< rR:$? < r < r < r~ <r@ =r =r =r =r =r =s)~ =sY@=t=DYտ=t=DY?= td?= r4$DG? = r = r = r~ =r<@ >r >r >r >r >r >s)~ >s@P@>tqg>tqg?> tՖ8?> r&\Nn'? > r > r > r~ >r3@ ?r ?r ?r ?r ?r ?s)~ ?sK@?tA{Y\-??tA{Y\-?? tOG?? r]Ag,i? ? r ? r ? r~ ?r&@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r @r @r @r @r @s)~ @sA@@tNuξ?@tNuξ?@ t@TNd?@ r DK? @ r @ r @ r~ @r&@ Ar Ar Ar Ar Ar As)~ AsD@At-2TnAt-2Tn?A t?A rwߞu? A r A r A r~ Ar@ Br Br Br Br Br Bs)~ BsR@Btkst-Btkst-?B t g?B r*LA4? B r B r B r~ Br0@ Cr5 Cr/ Cr5 Cr5 Cr/ Cs)~ Cs4@Cth)4޽Cth)4޽?C tpI?C rC .ގ? C r/ C r/ C r/~ Cr@ Dr Dr Dr Dr Dr Ds)~ Dsz@Dtej.ĿDtej.?D tOG?D r+C`a? D r D r D r ~ Dr@U@ Er Er Er Er Er Es)~ Esk@Eto.ÿEto.?E tO ?E r*I? E r E r E r~ ErB@ Fr Fr Fr Fr Fr Fs)~ Fs[@Ft_Ft_?F tVQ?F r\p? F r F r F r~ Fr3@ Gr Gr Gr Gr Gr Gs)~ GsQ@Gti,?Gti,?G t¶m2?G rM@Jm? G r G r G r ~ Gr2@ Hr Hr Hr Hr Hr Hs)~ Hs.@Ht^o^ٿHt^o^?H tBU P?H r3Ҕ!? H rrr ~ Hr@ Ir5 Ir" Ir5 Ir5 Irl. Is)~ Is9@It-@@IۿIt-@@I?I tqj?I r'C7? I rm. I rn. I ro.~ Ir@ Jr{# Jr|# Jr{# Jr}# Jr~# Js)~ JsN@Jt~2l1PҿJt~2l1P?J tOj.>?J r)!? J r# J r# J r#~ Jr.@ Kr. Kr  Kr. Kr/ Kr0 Ks)~ Ks.@Kt2wc?Kt2wc?K tq?K rϪ? K rc K rc K rc~ Kr@ Lr2 Lr3 Lr2 Lr4 Lr5 Ls)~ LsT@Lt?Lt?L t_?L r? L r6 L r7 L r8~ Lr*@ Mr Mr Mr Mr Mr Ms)~ MsW@MtbI7MtbI7?M t?M r? M r M r M r~ Mr7@ Nrl Nrm Nrl Nrn Nro Ns)~ NsV@NtH]`)ѿNtH]`)?N trL?N r57@? N rp N rq N rr ~ Nr.@ OrB OrC OrB OrD OrE Os)~ OsN@Ot#V׿Ot#V?O t[⑮?O r>? O rF O rG O rH~ Or&@ Pr Pr Pr Pr Pr Ps)~ Pspp@Pt?Pt?P tz}1?P r@ =? P r P r P r~ Pr:@ QrJ QrK QrJ QrL QrM Qs)~ Qs$@Qt']/>Qt']/>?Q tfS?Q r@TtuTtu@T tr?T rM/Jx? T rf T rg T rh~ Tr@ Urj Ur Urj Ur Urk Us)~ Usi@UtaUta?U t:/?U rN ? U rl U rm U rn~ Ur@@ Vrp Vrq Vrp Vrr Vrs Vs)~ Vs.@VtQܴ?VtQܴ?V tXۉ ?V r? V rt V ru V rv~ Vr@ Wr Wr Wr Wr Wr Ws)~ Ws`c@Wt\TS0Wt\TS0?W t4??W rUC? W r W r W r~ Wr,@ Xr Xr Xr Xr Xr Xs)~ Xs@P@XtsNsRuXtsNsRu?X t{B?X rjl? X r X r X r~ Xr&@ Yr Yr Yr Yr Yr Ys)~ Ys b@YtMDYtMD?Y t ?Y u`?F0> Y rY r Y r~ Yr3@ Zr Zr Zr Zr Zr Zs)~ Zs$@Ztfr Ztfr ?Z toqKh?Z r]? Z r Z r Z r~ Zr@ [rl [rm [rl [rn [ro [s)~ [sN@[t\W([t\W(?[ t_EE?[ rC? [ rp [ rq [ rr~ [r,@ \r \r \r \r \r \s)~ \s b@\tmD?\tmD?\ tH݃?\ rjJ? \ r \ r \ r~ \rA@ ]r5 ]r ]r5 ]r, ]r, ]s)~ ]s9@]ti5@]ti5@] t'Y@] r\BP? ] r, ] r, ] r,~ ]r@ ^r/ ^ri ^r/ ^r/ ^r5 ^s)~ ^s@Z@^t9=eؿ^t9=e?^ tX?^ rU7\? ^ rrr ~ ^r,@ _r _r _r _r _r _s)~ _s4@_t~ۣ?_t~ۣ?_ t%?_ r& f? _ r _ r _ r~ _r@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `s9@`t\s丠`t\s丠?` t`3?` r#? ` r ` r ` r~ `r$@ ar ar ar ar ar as)~ asF@at퟉M?at퟉M?a tk\Ej?a r? a r a r a r~ ar$@ br br br br br bs)~ bs\@btlx>L?btlx>L?b t@b r7P N&? b r b r b r~ br0@ cr- cr- cr- cr- cr- cs)~ cs$@ctPvͿctPv?c tΰV?@mt?mt?m t)]R j?m r:g? m r0 m r1 m r2~ mr&@ nr4 nr5 nr4 nr6 nr7 ns)~ nsF@ntNntN?n t|?n r6 ? n r8 n r9 n r:~ nr"@ orC orD orC orE orF os)~ osD@otZ4׿otZ4?o t шQ?o r'y(? o rG o rH o rI~ or@ prD prE prD prF prG ps)~ psW@ptЌxּ?ptЌxּ?p tl\L?p rnK? p rH p rI p rJ~ pr5@ qrL qrM qrL qrN qrO qs)~ qs@U@qtl?qtl?q tfP?q r? q rP q rQ q rR~ qr3@ rra rrb rra rrc rrd rs)~ rs$@rt^ˍ1rt^ˍ1?r t.sk?r rT`I0G? r re r rf r rg~ rr@ sri srj sri srk srl ss)~ ss9@stryV tstryV t?s t~CF?s rϪ? s rm s rn s ro~ sr$@ try trz try tr{ tr| ts)~ ts.@ttF ?ttF ?t tHXP?t rɅy? t rc t rc t r}~ tr@ ur ur ur ur ur us)~ usF@ut_n[?ut_n[?u t}G:?u r?$j*? u r u r u r~ ur(@ vr vr vr vr vr vs)~ vs4@vt@gʿvt@g?v t`@1?v rB C=? v r v r v r~ vr"@ wr wr wr wr wr ws)~ ws4@wt?\ҿwt?\?w tBYP?w rlM? w r w r w r~ wr@ xr xr xr xr xr xs)~ xsV@xt{Jqαxt{Jqα?x t&#i~?x rǷ ? x rr x r~ xr4@ yr/ yr yr/ yr yr5 ys)~ ysN@yt)ye?yt)ye?y t=?y rl %)N? y r/ y r/ y r/~ yrA@ zr- zr zr- zr zr- zs)~ zsD@ztc܃ztc܃?z t\?z rR ? z rrr ~ zr*@ {r {r {r {r {r {s)~ {sd@{tt %?{tt %?{ tdn@?{ r#9[? { r { r { r~ {rB@ |rg" |rh" |rg" |ri" |rj" |s)~ |s4@|tc1waV|tc1waV?| t?| rN~-? | rk" | rl" | rm"~ |r@ }r }r }r }r }r }s)~ }sK@}to(p?}to(p?} tY~+?} rco? } r } r } r~ }r(@ ~ro" ~rp" ~ro" ~rq" ~rr" ~s)~ ~s>@~t*?~t*?~ tA[Ar#V@~ r;ێo? ~ rs" ~ rt" ~ ru"~ ~r(@ r r r r r s)~ s`@t:9Xt:9X? t?/? rDF?  r  r"  r~ r5@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s0q@tٿt? t#z A? rfGv?  r  r  r~ r>@ r~ v<@ r r r s)~ sR@tsmٿtsm? tS0K? r+Nc?  r  r  r~ r4@ r r r r r s)~ s b@t]$c?t]$c? tDMZ2? rʄҵL?  r  r  r~ r9@ r r r r r s)~ s`@tN.?tN.? t4"? rϪ?  r  r  r~ r:@ r3 r4 r3 r5 r6 s)~ sA@t_ف?t_ف? t`? r*/?  r7  r8  r9~ r2@ r r r r r s)~ sF@tM?tM? t x]s? rFa>?  r  r  r?~ r"@ r r r r r s)~ sK@tBdӿtBd? tG? r h?  r  r  r ~ r0@ r  r  r  r  r s)~ sI@tK*kStK*kS? tgw ? r-e&?  r  r  r~ r.@ r - r" r - r" r - s)~ s4@ty1ty1? t's~? ri'?  r -  r -  r-~ r@ r r r r r s)~ s@P@t[yGj#t[yGj#? tԘyv? r<Ո?  r  r  r~ r,@ r r r r r s)~ s@Z@tvӐtvӐ? t3O? r(.}q?  r  r  r~ rA@ r r r r r s)~ s@P@t"t"? tZ? r xP?  r  r  r ~ r,@ r" r# r" r$ r% s)~ sT@t>.t>.? tZ 6? rw]Nq?  r&  r'  r(~ r1@ r. r r. r. r5 s)~ s4@t$n+@t$n+@ t[Cܴ@ roĝ'?  rrr ~ r@ r r r r r s)~ sR@tθZ}?tθZ}? tQo0? ry#?  r  r8  r~ r,@ r4 r5 r4 r6 r7 s)~ s b@tZJF?tZJF? tVAoN? rC?  r8  r9  r:~ r1@ r< r= r< r> r? s)~ s4@t]?t]? t ? r:g?  r@  rA  rB~ r$@ r5 r5 r5 r5 r9- s)~ sA@tlihtlih? t6xP? rqr-?  r:-  rC%  r;-~ r@ rD rE rD rF rG s)~ sI@tMCyY? r.|?  rf  r  rg~ r&@ r. r. r. r. r. s)~ s.@tc5tc5? t=$lm? r?z?  r.  r.  r .~ r@ r r r r r s)~ sI@tbtb? t}Hy? r io?  r  r  r~ r"@ rr rs rr rt ru s)~ sf@t.ҿt.? tFwN? r& f?  rv  r  rw~ r@@ r# r$ r# r% r& s)~ sF@t t ? tafu&? r"?  r'  r(  r)~ r,@ r r r r r s)~ s4@t [ct [c? t#w? rV@?  r  r  r~ r@ r r r r r s)~ s9@t:d>ӿt:d>? tZyE? r/؍YK?  r  r  r~ r@ r r r r r s)~ s@U@tx&X+=tx&X+=@ ty[? u\1z>  rC  rD  rE~ r@ r r r r r s)~ s4@t_1Tt_1T? t ? rpt:{?  rC  rD  rE~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sR@tD.NtD.N? tIw#? r{֕ #ڰ?  rL r  rM~ r @ r r r r r s)~ sF@tن`tن`? t>? r0RMg?  r  r  r~ r@ r r r r r s)~ sA@t9{Řt9{Ř? tBU ? r-hdB?  r  r  r~ r@ r&/ r'/ r&/ r(/ r)/ s)~ s$@tpc?tpc? t K? rpt:{?  r  r  r~ r@ r rI r r r s)~ s.@t:bA9t:bA9? tf7{o? rڪS?  rrr ~ r@ r r r r r s)~ s.@tyſty? tAp>y? r$BӦ?  r  r  r~ r@ r5 r r5 r5 r s)~ s9@t!??t!?? tռ%l? r>g?  r-  r-  r-~ r@ r r r r r s)~ s>@t3>Iyտt3>Iy? tɦ[? ry#?  r  r  r~ r@ r r r r r s)~ sW@t0A t0A ? tCr ? r5HxO?  r  r  r~ r(@ r r r r r s)~ sW@tlKKbtlKKb? t(? rXg:T?  r  r  r~ r @ r r r r r s)~ s4@t^Q-2Nֻt^Q-2Nֻ? trUe?? r?  r  r  r~ r@ r r r r r s)~ sT@t+>t+>? tU2? u>  r  r  r~ r@ r r r r r s)~ sA@tt? txGL? r;c!?  r  r  r~ r@ r r r r r s)~ s@U@tC#Y?tC#Y? tgNXQ? r"X?  r  r  r~ r.@ r r r r r s)~ s4@tK}l?tK}l? t&vI-? rL-m?  r  r  r~ r@ r r r r r s)~ sA@t:t %ٿt:t %? ttt3_? rCa?  r  r  r~ r @ r r r r r s)~ sI@ti8߿ti8? t;U? rF?  r  r  r~ r,@ r5 rx r5 r5 r`/ s)~ s>@tY?tY? t̛o? r&H?  ra/  rb/  rc/~ r@ r)# r*# r)# r+# r,# s)~ sA@tgu?tgu? t? rg3Qym?  r-#  r.#  r/#~ r.@ r  r  r  r r s)~ s.@tkS&me(tkS&me(? tA!'? rcڥ?  r  r  r~ r@ r5 r r5 r5 r, s)~ sD@teͿte? t>M8? r5J?  r-  r-  r-~ r@ r~ v<@ r r r s)~ sI@tn;ɿtn;? tČ? rX@D?  rrr ~ r$@ r5 r r5 r5 r#/ s)~ s@_@te|{zTte|{zT? t1PA? rB C=?  rc  rc  rc~ r1@ r! r" r! r# r$ s)~ sD@t?#(?t?#(? tD9ʿ? rFa>?  r%  r&  r'~ r @ r) r* r) r+ r, s)~ sA@th.wpth.wp? t? rYЍE?  r-  r.  r/~ r*@ r9 r: r9 r; r< s)~ s.@tzu?tzu? t S*I @ r?  r=  r>  r?~ r@ r5 r  r5 r  r/ s)~ sI@tWFÿtWF? t*? r8iY?  r  r  r~ r"@ rH rI rH rJ rK s)~ s@P@tDHTTտtDHTT? tsB? r?  rL  rM  rN~ r.@ r r r r r s)~ sI@trytry@ tƴ6? r^I|?  r  r  r ~ r&@ r5 rc r5 rd r- s)~ sA@toE ؿtoE ? t*? r/5rh?  r-  r-  r-~ r@ rj rk rj rl rm s)~ s b@tUV<tUV@t-oԅt-oԅ? t$?(? r7p?  r}  r~  r~ r&@ r r r r r s)~ s@t~dz\a?t~dz\a? toV.@ rXN?  r  r"  r~ r@ r5 r r5 r5 r- s)~ s9@tC e?tC e? t7&? rR ?  r-  r-  r-~ r@ r r r r r s)~ s@U@t6S?t6S? th2? r?  r  r  r ~ r7@ r r r r r s)~ sA@tzE;?tzE;? t9? r{xd?  r  r  r~ r @ r r r r r s)~ s$@t'>?t'>? t0|w@ rB C=?  r  r  r~ r@ r5 r. r5 r. r. s)~ s$@ti.ti.? trX0? rӨ?  r.  r.  r.~ r@ r r r r r s)~ s>@t=Mhƿt=Mh? tNC? rq-?  r  r  r~ r"@ r r r r r s)~ sF@tKͶ޿tKͶ? tq;}? rȔUD?  r  r  r~ r@ r r r r r s)~ sQ@t?'?t?'? t(P@ r]ib?  r  r  r~ r2@ r r r r r s)~ s9@tT1OʿtT1O? t&? r3 _?  r  r  r~ r@ r r r r r s)~ sN@t]ݹt]ݹ? t"z[? u22'?  r  r   r ~ r@ rV% rW% rV% rX% rY% s)~ sK@t&N t&N ? tWJ? r/uQ-!?  r  r   r~ r@ r/ r0 r/ r1 r2 s)~ sd@tx?tx? tb@ rS;!?  rO  r*  rQ ~ r1@ r r r r r s)~ s4@txM5&?txM5&? t? r'(x?  r  r  r~ r@ r r r r r s)~ sR@t^pg@ r r r r r s)~ sQ@t,Qu֭?t,Qu֭? t'-Lب? r?  r  r  r} ~ r0@ r r r r r s)~ sK@t]|78?t]|78? tb$B? rN?  r  r  r~ r*@ r r  r r r s)~ s>@t}t}@ t=? r,H?  rrr ~ r@ r r r r r s)~ sN@tEg?tEg? toɡ? rM?  r  r  r} ~ r$@ r r r r r s)~ s4@t?t? tϕq2@ rU7\?  r  r  r~ r@ r r r r r s)~ sD@tpƾtpƾ? tOq? rG칯?  r)  r*  r~ r@ r$ r% r$ r& r' s)~ sD@t8A f?t8A f? t6hb? r<S?  r(  r  r)~ r@ rY rZ rY r[ r\ s)~ s@P@tCb?tCb? t9=? r8b`?  r]  r^  r_~ r3@ r+ r, r+ r- r. s)~ sV@tQ.tQ.? t)=? rFa>?  r/  r0  r1~ r<@ r, r r, r r, s)~ s>@tO}?tO}? t?`s? roO?  r,  r,  r ~ r@ r r  r r r s)~ sR@t{ј2?t{ј2? tsr,s? ry#?  r  r  r~ r @ r; r< r; r= r> s)~ s.@ttq?ttq? tֵ|@ rD ?  r?  r@  rA~ r @ r: r; r: r< r= s)~ s.@t$$Dt$$D? tߦelQ? rB C=?  r>  r?  r@~ r@ rC rD rC rE rF s)~ s>@t@7Fݿt@7F? tRg+N? r]?  rG  rH  rI~ r@ rK rL rK rM rN s)~ s.@tRDtRD? t:g? rOu?  rO  rP  rQ~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rS rT rS rU rV s)~ s.@t95+(2t95+(2? tB-15"? ry#?  rW  rX  rY~ r@ r[ r\ r[ r] r^ s)~ s>@tI{;ڍ@tI{;ڍ@ tJw@ rjJ?  r_  r`  ra~ r@ rm/ r rm/ r rn/ s)~ s9@tN?tN? tˆ=k @ rs?  ro/  rp/  rq/~ r@ rt ru rt rv rw s)~ s.@ta_ta_@ te.ς? rBo6?  rx  ry  rz~ r @ r r r r r s)~ sF@t|ONa)Կt|ONa)? tۑ;? rӨ?  r  r  r~ r,@ r| r} r| r~ r s)~ s@s@t8 {et8 {e@ t? u< ?  r  r  r~ rF@ r r r r r s)~ sI@t4P>t4P>? tueC? r?  r  r  r~ r,@ r&- r'- r&- r(- r)- s)~ s$@tt? t{O? rUe?  r*-  r  r+-~ r@ r, r r, r, r, s)~ s$@t :JVt :JV? tc) ? rL-m?  r,  r,  r,~ r@ r r r r r s)~ sV@tR0tR0? tq x? rjJ?  rrr ~ r5@ r r r r r s)~ sb@tպP!0ԿtպP!0? tj&? r 2?  r  r  r~ r8@ r r r r r s)~ s\@t^. _?t^. _? twB@ r?  r  r  r~ r"@ r6 r6 r6 r6 r@- s)~ s4@t #;t #;? t$? r(.}q?  rA-  rB-  rC-~ r@ r r r r r s)~ s@t?t? t9t87? r?  r  r  r~ r@ r r r r r s)~ sA@t#lRt#lR? tV踷? r0.}?  r  r  r~ r$@ r r r r r s)~ s@P@tbimﵿtbim? tU '? r/5rh?  r  r  rM~ r(@ r r r r r s)~ s@P@tߒ6X?tߒ6X? t٬6?? rbڭ@6?  rrr ~ r0@ r< r= r< r> r? s)~ sI@ti ?ti ? tto? r]?  r@  rA  rB~ r @ rh' ri' rh' rj' rk' s)~ sI@t+uĿt+u? tӏ?  r  r  r~ r8@ r r r r r s)~ sT@tGYutGYu? t*Nɼ? rc?  r  r  r ~ r1@ rH/ rI/ rH/ rJ/ rK/ s)~ s@tga&]tga&]? tH? rq-?  rL/  rM/  rN/~ r@ r6 rC/ r6 r6 rD/ s)~ s@tV<ѿtV  r?  r@~ r2@ rB rC rB rD rE s)~ s$@ti'`2ti'`2? th$? rL-m?  rF  rG  rH~ r@ rR rS rR rT rU s)~ s4@tRLQ?tRLQ? t7B? rH{u?  rV  rW  rX~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, rZ r[ rZ r\ r] s)~ s4@tazοtaz? tҼcK/? rÎ='?  r^  r_  r`~ r@ rb rc rb rd re s)~ s$@t ʎ^?t ʎ^? t!>TN? rG칯?  rf  rg  rh~ r @ r r r r r s)~ sT@t_a?t_a? tpf? r`R?  r  r  r~ r7@ r6 r6 r6 r6 r, s)~ s$@tIrtIr? t[~_? r Y?}?  r,  r,  r,~ r@ rn ro rn rp rq s)~ sF@t\J>?t\J>? tϰtn@ rs17?  rr  rr~ r*@ rx ry rx rz r{ s)~ sD@tHOtHO? tk<6? rpt:{?  r|  r}  r~~ r @ r r r r r s)~ s4@t$C5xֿt$C5x? t~έx? rFa>?  r  r  r~ r*@ r6 r r6 r r}. s)~ s`@t1sҿt1s? t@z'? r]?  r~.  r.  r.~ rB@ r r r r r s)~ s9@t0/2Y?t0/2Y? tP=? rQHH?  r  r  r~ r@ r r r r r s)~ sA@ t? t?  t8Ŕ?  rL-m?  r  r  r~ r"@ r r r r r s)~ s.@ t>zO t>zO?  tOM;t?  rFa>?  r  r  r~ r@ rO rP rO rQ rR s)~ sK@ t78`N t78`N?  t4z?  rȔUD?  rS  rT  rU~ r,@ r r r r r s)~ s.@ tv"sο tv"s?  t["?  r]`?  r  r  r~ r@ r r r r r s)~ s>@ t: "ܿ t: "?  tso?  r(,0?  r  r  r~ r @ r r r r r s)~ s4@t6# Eʿt6# E? t_sյ? r h5?  r  r  r~ r @ r r r r r s)~ sA@tHT~?tHT~? t@ rh2?  r  r  r~ r(@ r' r' r' r' r' s)~ s>@t.+?t.+? t_/@ r=V?  r'  r'  r'~ r"@ r r r r r s)~ sY@t8( t8( ? t;2'.? rpt:{?  r  r  r~ r.@ r 6 r r 6 r rv- s)~ s>@tnE?tnE? t *? rNJ8t?  rw-  rx-  ry-~ r(@ r r r r r s)~ sA@t-E{ǚt-E{ǚ? t%/? rŢ V?  r  rc  r~ r@ r r r r r s)~ s\@twT{׿twT{? t<)D? rHM"?  r  r  r~ rB@ r r r r r s)~ s@`@tLStLS? t? r 5`@?  r  r  r ~ r4@ r  r  r  r  r s)~ s>@tJѲݿtJѲ? t 2? rÞL?  r  r  r~ r"@ r 6 r - r 6 r!- r"- s)~ s.@t ЍRΗt ЍRΗ? t&? rWWl?  r#-  r$-  r%-~ r@ r! r! r! r! r! s)~ sF@tw0ȿtw0? t(#R? rC ?  r!  r  r} ~ r,@ r r r r r s)~ sD@tLJt9?tLJt9? t2ټ? rlM?  r  r  r~ r"@ r r r r r s)~ sa@tʿt? t6B? r$8?  r  r   r!~ r?@ r+ r, r+ r- r. s)~ s>@tT"b1s?tT"b1s? t&0vS ? r̭E?  r/  r  r0~ r(@ rr/ rs/ rr/ rt/ ru/ s)~ s@t t ? to!n? rs?  rv/  rw/  r"~ r@ r2 r3 r2 r4 r5 s)~ sI@tbW?tbW? t]%?>? rN ?  r6  r7  r8~ r1@ r: r; r: r< r= s)~ sR@t@?t@? t%Yri? r?  r>  r?  r@~ r3@ r$ r$ r$ r$ r$ s)~ sD@tQH~?tQH~? tj\"x? rq[R?  r$  r  r$~ r.@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, rB rC rB rD rE s)~ s$@ t_C#U t_C#U?  te?  r l?  rF  rG  rH~ r@ !r$ !r$ !r$ !r$ !r$ !s)~ !s>@!t:.Uۿ!t:.U?! tO?! rˋT? ! r; ! r ! r$~ !r(@ "rR "rS "rR "rT "rU "s)~ "s.@"tIВο"tIВ?" tZ)1?" r#9[? " rV " rW " rX~ "r@ #re #rf #re #rg #rh #s)~ #s>@#tM#tM?# tRY7,?# rNTׄ:? # ri # rj # rk~ #r @ $rm $rn $rm $ro $rp $s)~ $s.@$tZsX$tZsX?$ t#p?$ r/*t;? $ rC $ rD $ rE~ $r@ %r %r %r %r %r %s)~ %sA@%t<]S%t<]S?% tF?% rv"E ? % r % r % r~ %r@ &rr &rs &rr &rt &ru &s)~ &sI@&t`&t`?& t| ͏?& us? & rv & rD & r~ &r@ 'rx 'rP 'rx 'ry 'r; 's)~ 'sA@'t N't N?' tu+V3?' r,F? ' rL' r ' rM~ 'r@ (r{ (r| (r{ (r} (r~ (s)~ (s>@(t)&̘(t)&̘?( teYHs?( rU7\? ( r ( r ( r~ (r@ )r, )r, )r, )r, )r, )s)~ )s.@)t߮E5?)t߮E5?) tB?) r2H:? ) rr ) r ~ )r@ *r *r *r *r *r *s)~ *sK@*tor*tor?* tv?* r :| ? * r* r * r~ *r3@ +r +r +r +r +r +s)~ +sA@+t6 ݿ+t6 ?+ t.+]?+ r@? + r + r + r~ +r@ ,r ,r ,r ,r ,r ,s)~ ,sN@,t}SQ?,t}SQ?, ti ?, r? , r , r , r~ ,r,@ -rD -rE -rD -rF -rG -s)~ -s>@-t$F\?-t$F\?- tRz?- r[S~$$? - rH - rI - rJ~ -r,@ .r .r .r .r .r .s)~ .s@.tl?.tl?. t|?. r`)*k? . r . r . r~ .r@ /r /r /r /r /r /s)~ /s9@/t8:Ŀ/t8:?/ t?/ r? / r / r / r~ /r&@ 0r 6 0r- 0r 6 0r 6 0r- 0s)~ 0s.@0t\2kڿ0t\2k?0 tZ?0 r& f? 0 r- 0 r- 0 r-~ 0r@ 1r 6 1r 1r 6 1r6 1r/ 1s)~ 1s.@1t'?1t'?1 ts'?1 rF2? 1 r; 1 r; 1 r /~ 1r@ 2r/ 2r/ 2r/ 2r/ 2r/ 2s)~ 2s@2t>y2t>y@2 tOb E.?2 rȔUD? 2 re 2 r/ 2 r/~ 2r@ 3r 3r 3r 3r 3r 3s)~ 3s`@3tϴ3tϴ?3 tP#??3 r jPq? 3 r 3 r 3 r~ 3r3@ 4r 4r 4r 4r 4r 4s)~ 4sD@4ttlt4ttlt?4 t0?4 r"I3? 4 r 4 rH 4 r~ 4r @ 5r 5r 5r 5r 5r 5s)~ 5s9@5t|?5t|?5 t/z+?5 r gs"? 5 r  5 r  5 r ~ 5r@ 6r  6r 6r  6r 6r 6s)~ 6s4@6t{5Uт?6t{5Uт?6 tBzwo?6 r)? 6 r 6 r 6 r~ 6r@ 7r 7r 7r 7r 7r 7s)~ 7sA@7tG#7tG#?7 t5?7 r\? 7 r 7 r 7 r~ 7r@ 8r7 8r8 8r7 8r9 8r: 8s)~ 8s>@8t(?8t(?8 t2"@8 r+C`a? 8 r; 8 r< 8 r= ~ 8r"@ 9r 9r 9r 9r  9r! 9s)~ 9s@P@9tK9tK?9 tڦq?9 rTK&T#S? 9 r 9 r  9 r ~ 9r@ :r# :r$ :r# :r% :r& :s)~ :s\@:trtެ:trtެ?: tپ?: rz? : r : r  : r~ :r&@ ;r( ;r) ;r( ;r* ;r+ ;s)~ ;s`m@;tg;tg?; tP?; rg]? ; r, ; r* ; r-~ ;r3@ <rp$ <rq$ <rp$ <rr$ <rs$ <s)~ <s9@<t.4!yV?<t.4!yV?< tr3(?< r3Ҕ!? < rt$ < ru$ < rv$~ <r&@ =r; =r< =r; =r= =r> =s)~ =sA@=tPf=tPf?= tUJDi2?= rfGv? = r = r  = r~ =r@ >rY# >rZ# >rY# >r[# >r\# >s)~ >sI@>tiϿ>ti?> t*?> rdJ#? > r]# > r^# > r_#~ >r2@ ?r! ?r! ?r! ?r! ?r! ?s)~ ?sD@?typR3??typR3?? t f|?? rbhFc? ? r! ? r! ? r!~ ?r @Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rI @rJ @rI @rK @rL @s)~ @sT@@t 3?@t 3?@ t^GKc~?@ r? @ rM @ rN @ rO~ @r(@ Ar Ar Ar Ar Ar As)~ AsQ@AtqМAtqМ?A t"?A rT? A r A r? A r~ Ar0@ BrQ BrR BrQ BrS BrT Bs)~ Bs4@Bt۲ 7 @Bt۲ 7 @B tN#@B r? B rU B rV B rW~ Br @ Cr Cr Cr Cr Cr Cs)~ CsV@CtެXֿCtެX?C t Ȏ?C r#9[? C r C r C r~ Cr @ Dr Dr Dr Dr Dr Ds)~ DsY@Dt¿Dt?D t?D r!U? D r  D r! D r"~ Dr(@ Era Erb Era Erc Erd Es)~ Es9@Et_Et_?E tm<F?E r_b? E re E rf E rg~ Er@ Fri Frj Fri Frk Frl Fs)~ FsI@Ft6xqR2޿Ft6xqR2?F tOh.?F r:"]? F rm F r" F rn~ Fr@ Grp Grq Grp Grr Grs Gs)~ Gs4@GtJQPdGtJQPd?G t ¬Tv?G r? G rt G ru G rv~ Gr@ Hrz Hr{ Hrz Hr| Hr} Hs)~ Hs.@Ht!.SϿHt!.S?H t8u?H r ? H r~ H r H r~ Hr@ Ir Ir Ir Ir Ir Is)~ IsD@ItIt?I t8#?I rR:$? I r I r I r~ Ir2@ Jr Jr Jr Jr Jr Js)~ Js.@Jtf?G Jtf?G ?J tכ\?J r6a3Q? J r J r J r~ Jr@ Kr Kr Kr Kr Kr Ks)~ Ks@Z@Ktrmq߿Ktrmq?K tkЩ?K r"X? K r K r K r~ Kr5@ Lr Lr Lr Lr Lr Ls)~ Ls9@LtX$LtX$?L t8c/?L r&H? L r L r L r~ Lr@ Mr Mr Mr Mr Mr Ms)~ MsY@MtH\|8˿MtH\|8?M th0K?M rc? M r M r M r~ Mr1@ Nr Nr Nr Nr Nr Ns)~ Ns.@Nt&@?J?Nt&@?J?N t#~T,?N r$BӦ? N r N r N r~ Nr @ Or Or Or Or Or Os)~ Os$@Ot`;sS\Ot`;sS\?O tNU4dJ?O r57@? O r O rc O r~ Or@ Pr6 Pr- Pr6 Pr- Pr- Ps)~ Ps.@Pt 5 ӿPt 5 ?P t޾l?P rs$,`? P r- P r- P r-~ Pr@ Qr Qr Qr Qr Qr Qs)~ QsF@Qt_0Qt_0?Q tf7?Q rXN? Q r  Q r  Q r ~ Qr"@ Rr Rr Rr Rr Rr Rs)~ Rs`@Rt2l޽Rt2l޽?R t"S?R r`cm? R r R r R r~ Rr5@ Sr Sr Sr Sr Sr Ss)~ SsD@St St ?S tJh~?S rh]J? S rc S rc S rc~ Sr$@ Tr Tr Tr Tr Tr Ts)~ Ts.@TtuDTtuD?T tJc?T rOu? T r T r T r~ Tr@ Ur Ur Ur Ur Ur Us)~ Us4@Ut#p({?Ut#p({?U t;WRҒ?U r4G1? U r U r U r~ Ur@ Vr Vr Vr Vr Vr Vs)~ Vs4@VtBe =VtBe =?V ter?V r&H? V r V r V r~ Vr@ Wr6 Wr Wr6 Wr6 Wr/ Ws)~ Ws$@Wt!ͿWt!?W tT?W rD ? W r/ W r/ W r/~ Wr@ Xr Xr Xr Xr Xr Xs)~ Xs^@XtHFtԿXtHFt?X trW?X r? X r X r X r~ Xr5@ Yr Yr Yr Yr Yr Ys)~ YsD@Yt`;Yt`;?Y tw^ǔ?Y r?$? Y r Y r Y r~ Yr @ Zr Zr Zr Zr Zr  Zs)~ ZsT@Zt ~?Zt ~?Z tD@AO?Z rlM? Z r  Z r  Z r ~ Zr,@ [r- [r- [r- [r- [r- [s)~ [s$@[t`C6?[t`C6?[ te$?[ rU7\? [ r- [ r- [ r-~ [r@ \r \r \r \r \r \s)~ \s9@\to/ٿ\to/?\ tm\?\ r.7]B? \ r \ r \ r~ \r@ ]r ]r ]r ]r ]r ]s)~ ]s[@]tqο]tq?] tx0?] rgp? ] r ] r ] r~ ]r*@ ^r  ^r! ^r  ^r" ^r# ^s)~ ^s$@^t?x@^t?x@^ t;#@,@^ rkX? ^ r$ ^ r% ^ r&~ ^r@ _r) _r) _r) _r) _r) _s)~ _s$@_t?z%z?_t?z%z?_ tH2?_ rbqN? _ r) _ r) _ r)~ _r @Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r6 `r `r6 `r `r/ `s)~ `sN@`tW3`tW3?` tiUX?` rN ? ` r/ ` r/ ` r/~ `r(@ ar( ar) ar( ar* ar+ as)~ as@P@at:%Oן?at:%Oן?a t79ס?a r`? a r,a r a r-~ ar @ br br  br br  br  bs)~ bs$@btxe?btxe?b t8$_?b rS"? b r  b r  b r~ br@ cr/ cr0 cr/ cr1 cr2 cs)~ cs4@ctgctg?c tm#B?c r,$,? c r3 c r4 c r5~ cr@ dr7 dr8 dr7 dr9 dr: ds)~ dsF@dtۆ?dtۆ?d tt?d r?[IA? d r; d r< d r=~ dr@ er? er@ er? erA erB es)~ es.@et.U?et.U?e tSJ?e rN? e rC e rD e rE~ er$@ fr/ fr~" fr/ fr/ fr/ fs)~ fs$@ftWQ> u r u r u r~ ur"@ vr vr vr vr vr vs)~ vs@vtrğvtrğ?v tɟ?v rz5? v r v r v r~ vr@ wr wr wr wr wr ws)~ ws@_@wttǩwttǩ?w twsA?w u eb> w r w r w r~ wr$@ xr xr xr xr xr xs)~ xsa@xt5+xt5+?x t ,3k?x r<Ƿ? x r x r x r~ xr*@ yr yr yr yr yr ys)~ ysD@yt1*PĿyt1*P?y tZLn ?y rSUO3a)? y r y r y r~ yr@ zr zr zr zr zr zs)~ zsI@ztE!ztE!?z tAgc?z rɶ? z rrr ~ zr @ {r # {rP {r # {r # {r; {s)~ {s9@{tv/h {tv/h @{ tTZص?{ r*L_? { rrr ~ {r@ |r% |r% |r% |r% |r% |s)~ |sF@|t;BP|t;BP?| t?| rcڥ? | r% | r% | r%~ |r*@ }r }r }r }r  }r! }s)~ }s$@}tj}tj?} t?v5?} rʄҵL? } r" } r# } r$~ }r@ ~r& ~r' ~r& ~r( ~r) ~s)~ ~s9@~t=Ռ?~t=Ռ?~ td3淿?~ ruÕ? ~ r* ~ r+ ~ r,~ ~r @ r r r r r s)~ s$@t;ͻgozt;ͻgoz? tr}m? r#9[?  r  r  r~ r@DTl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r7 r8 r7 r9 r: s)~ sI@t, ?t, ? tk?B? rBo6?  r;  r<  r=~ r(@ r? r@ r? rA rB s)~ s@tPetPe? t@t'-t'-? t%? rZQf?  rj  rk  rl~ r$@ r r r r r s)~ sR@t)?t)? tS? rz1?  r  r  r~ r:@ rv rw rv rx ry s)~ s@Z@tItI? t&\? u9ue>  r  r   rz~ r @ r| r} r| r~ r s)~ sT@taͼ2taͼ2? tM&9{? rf?  r  r   r~ r"@ r, r, r, r, r, s)~ s$@t ~`Rڿt ~`R? t+? r9^ld?  r  r   r~ r@ r r r r r s)~ s9@t3st3s? t՛u? r& f?  r  r  r~ r@ r r r r r s)~ sK@t։{4@t։{4@ t;e@ rn?  r  r  r~ r*@ r r r r r s)~ s@P@t:?t:? tՙi? r:ɑTɠ?  r  r*  r~ r(@ rt ru rt rv rw s)~ sA@tvGӿtvG? tBg? r"X?  rx  ry  rz~ r,@ rT rU rT rV rW s)~ sK@t~:=ݿt~:=? t* 's/? rl %)N?  rX  rY  rZ ~ r$@ r!) r") r!) r#) r$) s)~ s.@t(H?t(H? tK8E? r?  r%)  r&)  r')~ r@ r r r r r s)~ s>@tg9ֿtg9? tF]X'? rlM?  r  r  r~ r1@ r r r r r s)~ sR@t2gt2g? tI،7? rn?  r  r   r~ r@ r r r r r s)~ s.@t7t>7? tް? r s)~ s>@t"$?t"$? tu? rlM?  r?  r@  rA~ r@ rK rL rK rM rN s)~ sK@tKړ tKړ ? t? rI'?  rO  rP  rQ~ r0@ r[ r\ r[ r] r^ s)~ sj@t*b(?t*b(? t7#*T)? u;wqJ->  r_  r`  ra~ r1@ rc rd rc re rf s)~ sA@t=汿t=? tqc|? rnK?  rg  rh  ri~ r@ rk rl rk rm rn s)~ s9@t#<_t#<_? tDܴ? r"D%?  ro  rp  rq~ r @ rs rt rs ru rv s)~ s4@t Ft F? tP? r h5?  rw  rx  ry~ r@ r{ r| r{ r} r~ s)~ sA@t R f?t R f? tga@ r$z'?  r  r  r~ r@ r r r r r s)~ s9@t޺QVt޺QV? t;띝? rD~vc?  r  r  r~ r@ r r r r r s)~ s$@tWtW? t|^N%? rD!L?  r  r  r~ r@ r6 r r6 r6 r s)~ s.@twx7gtwx7g? tgR? rZ<Ҍ?  r,  r'  r,~ r@ r" r" r" r" r" s)~ sD@tw}f?tw}f? t۠u? rȳ.?  r"  r"  r"~ r.@ r r r r r s)~ s4@t0{h?t0{h? t85P? rR ?  r  r  r~ r@ r r r r r s)~ sF@tCqC?tCqC? tڄ&? r]?  r  r  r~ r$@ r 6 r- r 6 r- r- s)~ s$@tEh%tEh%? tWQ ? r4?  r-  r-  r-~ r@ r r r r r s)~ s4@tvBOe?tvBOe? tAj? rR ?  r  r  r~ r$@ r r r r r s)~ sN@t>_g4?t>_g4? tTr@ r?  r  r  r3~ r@ r r r r r s)~ s4@t?ڝyѿt?ڝy? tr{? r0 8?  r  r  r~ r@ r r r r r s)~ s$@tX~:tX~:? t#? r\BP?  rrr ~ r@ r r r r r s)~ sI@t;Wӿt;W? tE? rͦ?  r  r  r~ r @ r r r r r s)~ s$@t,j[t,j[? te%\E? r& f?  r  r  r~ r@ r r r r r s)~ s4@tW8?؋ʿtW8?؋? t|? r߇4?  r  r  r~ r@ r r r r r s)~ s.@t6t6@ t|HI? rTnB?  r  r   r ~ r@ r!6 r  r!6 r"6 r. s)~ s9@t*?t*? tfo? rϪ?  r.  r.  r.~ r@ r r r r r s)~ s4@t ?t ? t0>? rseO}?  r  r  r~ r@ r rP r r  r; s)~ sK@t?N`Dt?N`D? tos*T? r;IF?  rrr ~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r  s)~ sA@t%?t%? t h? r4&͆?  r   r   r ~ r*@ r#6~ v <@ r#6 r$6 r, s)~ sI@t-'ſt-'? t•Bwu? r/?  r,  r,  r,~ r@ r5 rR r5 r6 r7 s)~ s9@t7έd?t7έd? tp']?6 @ rI\H?  rrr ~ r@ rM rN rM rO rP s)~ sD@tR?tR? tS.? r-㏑?  rQ  rR  rS~ r@ r\ r] r\ r^ r_ s)~ s.@t/Ƀ?t/Ƀ? tiFY? rkR=GI?  r`  ra  rb~ r@ r r r r r s)~ s$@t4NPt4NP@ t.? r?  r  r  r~ r@ rm rn rm ro rp s)~ s.@t9% t9% ? tuq? r?  rq r  rr~ r@ r r r r r s)~ sA@tE?tE? toW!s? rFa>?  r  r  r ~ r3@ rt ru rt rv rw s)~ s>@t1Y[t1Y[? t ? rw?  rx  ry  rz~ r"@ r r r r r s)~ s9@tUtU? t#Lw? r51?  r  r  r~ r.@ r r r r r s)~ sQ@t:?t:? tl? rT̀?  r  r  r~ r2@ r r r r r s)~ s9@t t ? t6*/? r!-?  r  r  r~ r"@ rl rm rl rn ro s)~ s$@tw]tw]? tgt#r? rR ?  rp  rq  rr~ r@ r r r r r s)~ s@t’۵ǿt’۵? t')? rN ?  r  r  r~ r@ re rf re rg rh s)~ s4@tj btj b? t~p? rD!L?  ri  r=  rj ~ r@ r1. r r1. r r2. s)~ s$@tv#ϴ?tv#ϴ? t3ܾ? r?  rrr ~ r@ r,6 r/ r,6 r-6 r/ s)~ s.@t/Kt/K? t,$rp? rlM?  r/  r/  r/~ r@ r r r r r s)~ sT@tخtخ? t"2}? rU7\?  r  r  r~ r3@ r r r r r s)~ s9@tv)& Ϭ?tv)& Ϭ? t@jP_? rpt:{?  r  r  r~ r$@ r r r r r s)~ sD@tHƬtHƬ? t4? rXV!q?  r  r  r~ r @ r r r r r s)~ sD@to?to? t@>? r5J?  r  r  r~ r"@ r r r r r s)~ sT@tnhu/?tnhu/? tE)? rs?  r  r  r~ r,@ r r r r r s)~ sV@tR'YsOtR'YsO? tmդA? r):0s?  r  r  r~ r6@ rJ' rK' rJ' rL' rM' s)~ s$@t%PSt%PS? taomw? rt@toto? tv? r12+/K?  r  r  r~ r @ r r r r r s)~ s.@t\ Q %?t\ Q %? tknV&@ rϪ?  r  r  r~ r@ r r r r r s)~ s@U@tܭ^tܭ^? tvP? rHM"?  r  r  r~ r3@ r !!!!!!!! ! ! ! ! !!!!!!!!!!!!!!!!!!! !!!"!#!$!%!&!'!(!)!*!+!,!-!.!/!0!1!2!3!4!5!6!7!8!9!:!;!!?!@!A!B!C!D!E!F!G!H!I!J!K!L!M!N!O!P!Q!R!S!T!U!V!W!X!Y!Z![!\!]!^!_!`!a!b!c!d!e!g!h!i!j!k!l!m!n!o!p!q!r!s!t!u!v!w!x!y!z!{!|!}!~!!! r r  r r s)~ sI@tުpn\tުpn\? tg;? rlM?  r  r  r~ r&@ r r r r r s)~ s.@tirN)ۿtirN)? tAE? rAj:?  r  r  r~ r@ r.6 rH- r.6 rI- rJ- s)~ s@thbz~?thbz~? tP65@ rdJ#?  rK-  rL-  rM-~ r@ r- r- r- r- r- s)~ s$@tu?tu? t' ? r?  r-  r-  r -~ r@ r r r r r  s)~ s>@t*YNt*YN? t,/l@$? rN ?  r!  r  r"~ r&@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r$ r% r$ r& r' s)~ sD@tk?tk? tx!q@ rg?  r-  r-  r-~ r@ rO/ r; rO/ rP/ r= s)~ s$@ty>6n3ty>6n3? t**!k? rq-?  rQ/  rR/  rS/~ r@ rB rC rB rD rE s)~ s>@tktk? tjȔ8U? r'?  rF r  rG~ r$@ rI rJ rI rK rL s)~ s.@t&3MͿt&3M? tgG N? rl %)N?  rM  rN  rO~ r@ rQ rR rQ rS rT s)~ s4@t3?v?t3?v? trG? rU7\?  rU  rV  rW~ r@ r` ra r` rb rc s)~ sF@t/g?t/g? tǐ6? r}Q?  rd  re  rf~ r@ r% r% r% r% r% s)~ s>@tMs@tMs@ tr@ rXN?  r%  r%  r%~ r$@ rG( rH( rG( rI( rJ( s)~ s$@tPtP? toS? rWE?  r%  rK(  rL(~ r@ rh ri rh rj rk s)~ s>@tX?tX? tɣc? rʄҵL?  rl  rm  rn~ r"@ rp rq rp rr rs s)~ s[@t ɿt ? t0&? r>?  rt  r  ru~ r7@ rw rx rw ry rz s)~ s4@tt? t?^W? r'y(?  r{  r|  r}~ r@ r06 rY r06 rZ r- s)~ s$@t'mp?t'mp? t+ؿ? rU7\?  r-  r-  r-~ r@ r# r# r# r# r# s)~ s4@tVŢֿtVŢ? t4 / 2? r3Ҕ!?  r#  r#  r#~ r@ r16 r r16 r26 r. s)~ sI@t~L?t~L? t3? rs?  r.  r.  r.~ r @ r r r r r s)~ s$@tfctfc? tv6? r,H;?  r  r  r~ r@ r r r r r s)~ s.@tZ%"ٿtZ%"? tR{_? rtzno?  r  rh  r~ r@ r r r r r s)~ s.@t\_NUct\_NUc? tْ? rYЍE?  r  r  r~ r@ r r r r r s)~ s.@t(R{[ɿt(R{[? t=s? r)@}?  r  r  r~ r @ r r r r r s)~ s.@t7!?t7!? t.j? r/L'?  r  r  r~ r@ r r r r r s)~ sI@tWj*AutWj*Au? tx _? r@c`?  rC  rD  rE~ r@ r46 r- r46 r56 r- s)~ s$@tʋYYtʋYY? t"&? r!-?  r-  r-  r-~ r@ r r r r r s)~ s9@tǟ&Rtǟ&R? t3P? r~ı?  rC  rD  rE~ r@ r r r r r s)~ sA@tT((tT((? t&? r+4!?  r  r  r~ r@ r r r r r s)~ sT@tD)6tD)6? t ? r l?  r  r  r~ r@ r  r  r  r  r  s)~ sD@t%ߊ ?t%ߊ ? t? r}QIEf?  r   r  r~ r$@ r>% r?% r>% r@% rA% s)~ s4@tf}/@tf}/@ tiWF@ rڪS?  rB%  rC%  rD%~ r @Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r66 r r66 r76 r86 s)~ s4@tQ?tQ? t,? rȔUD?  r  r  r~ r&@ rA rB rA rC rD s)~ sF@tܽ&`?tܽ&`? t8d? rpA;?  rc  rE  rF~ r&@ r r r r r s)~ s$@tePn.?tePn.? t@"٣V? rB C=?  r  r   r!~ r@ r' r( r' r) r* s)~ sD@t-idܼ?t-idܼ? tc5L? r)#B?  r+  r,  r-~ r@ r96 r9 r96 r: r/ s)~ sD@t <ƿt :?  r^  r_  r`~ r"@ r_& r`& r_& ra& rb& s)~ sK@t^ۊt^ۊ@ tF:8? rn?  r  r   r~ r@ re rf re rg rh s)~ s`@ t;a t;a?  t1e7?  u{6>  ri  r  rj~ r(@ r r r r r s)~ sA@ tAR؜0? tAR؜0?  t HTw?  rB C=?  r  r  r~ r@ r:6 r} r:6 r, r, s)~ sD@ tKX? tKX?  tsUa?  r"{ij?  r,  r,  r,~ r7@ r;6 r r;6 r r. s)~ s$@ t=*['ҿ t=*['?  tN ?  r-e&?  r.  r.  r.~ r@ r r r r r s)~ sD@ tmÿ tm?  t&l?  r`T?  r  r  r~ r(@ r r r r r s)~ s@Q@tAP؈3ؿtAP؈3? t_Za#? r^|yd?  r  r  r~ r&@ r$ r$ r$ r$ r$ s)~ s.@tyeͿtye? t,٭8? rIH2w?  r$  r$  r$~ r@ r r r r r s)~ s@P@tr ֿtr ? th3? r`cm?  r  r  r~ r2@ r r r r r s)~ sD@t;gݿt;g? tWxE? r՟?  r  r  r~ r,@ r r r r r s)~ s4@tK0tK0? t<̇'n? r?  r  r  r~ r@ r r r r r s)~ s4@tsѿts? tx? rb ?  r  r  r~ r @ r r r r r s)~ s.@ttCeKgt ttCeKgt @ tE޸? rǼaSN?  r  r  r~ r@ r<6 r# r<6 r# r. s)~ s$@tVfǿtVf? t&U? rc?  r.  r.  r.~ r@ r/ r/ r/ r/ r/ s)~ s$@tH,tH,? tk9? rD?  r/  r/  r/~ r@ r r r r r s)~ s9@t(t߿t(t? tyè? r xP?  r  r  r~ r@ r=6 r, r=6 r>6 r, s)~ s.@tښTsc׿tښTsc? t? rM?  r,  r,  r,~ r@ r r r r r s)~ s>@t WܘM?t WܘM? t҇? rw﹬?  r  r  r~ r@ r rW r rX r s)~ s$@t .t .? tiHGaF? rC?  rrr ~ r@ r r r r r s)~ sA@tϷ[?tϷ[? t0"z@ r?  r   r!  r"~ r@ r$ r% r$ r& r' s)~ sI@ttTUֺttTUֺ? tA/? rlM?  r(  r)  r*~ r(@ r, r- r, r. r/ s)~ s$@tHI:TtHI:T? tQpRҳ? r]e)r4?  r0  r*  r1~ r@ r) r) r) r) r) s)~ s$@tktk? t4n? r#d@?  r)  r)  r)~ r@ rI rJ rI rK rL s)~ s4@tp.kotp.ko? tP{9? rm?  rM r  rN~ r @Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, rP rQ rP rR rS s)~ s.@ tV1$? tV1$?  tR >?  rF %?  rT  rU  rV~ r@ !r^ !r_ !r^ !r` !ra !s)~ !s9@!tbv!tbv?! t48?! r.|? ! rrr ~ !r @ "rk "rl "rk "rm "rn "s)~ "s$@"tĿ"t?" t ͵?" rUe? " rr " ro~ "r@ #r #r #r #r #r #s)~ #s>@#tVL?#tVL?# tc;V ?# raJ6D? # r # r # r~ #r @ $rq $rr $rq $rs $rt $s)~ $s4@$tui/@ ?$tui/@ ?$ tm쟴'?$ rQw? $ ru $ rv $ rw~ $r@ %r %r %r %r %r %s)~ %s4@%tC?%tC?% tE?% r\? % r % r % r ~ %r*@ &ry &rz &ry &r{ &r| &s)~ &s$@&trT8&trT8?& tsǺ?& r2H:? & r} & r & r~~ &r@ 'r 'r 'r 'r 'r 's)~ 's$@'tk5'tk5@' tZtl?' r $_? ' rrr ~ 'r@ (r (r (r (r (r (s)~ (s9@(tZa@(tZa@( t!uSb@( r z? ( r ( r ( r~ (r&@ )r )r )r )r )r )s)~ )sT@)t <Ϳ)t @1t]T8T1t]T8T?1 tC5 K?1 r-hdB? 1 r 1 r 1 r~ 1r(@ 2r 2r 2r 2r 2r 2s)~ 2s>@2tu42tu4?2 t hu?2 rB C=? 2 r 2 r 2 r ~ 2r$@ 3r) 3r) 3r) 3r) 3r) 3s)~ 3s4@3tW?3tW?3 t)sR@3 r]? 3 r) 3 r) 3 r)~ 3r@ 4r! 4r" 4r! 4r# 4r$ 4s)~ 4s>@4t0?4t0?4 t˙tp@4 r+@/? 4 r% 4 rH 4 r& ~ 4r@ 5r0 5r1 5r0 5r2 5r3 5s)~ 5s$@5t:?5t:?5 tHqf?5 r9=? 5 r4 5 r5 5 r~ 5r@ 6rn 6ro 6rn 6rp 6rq 6s)~ 6sN@6tAH4?6tAH4?6 t9jUO?6 rlM? 6 rr 6 rs 6 rt~ 6r,@ 7r? 7r@ 7r? 7rA 7rB 7s)~ 7s>@7tHl-?7tHl-?7 t^?7 r]? 7 rC 7 rD 7 rE ~ 7r(@ 8rG 8rH 8rG 8rI 8rJ 8s)~ 8sA@8tD38tD3?8 t\l?8 rD~vc? 8 rK 8 rL 8 rM ~ 8r*@ 9r 9r 9r 9r 9r 9s)~ 9s$@9t?9t?9 tp+?9 rˋT? 9 r 9 r 9 r~ 9r@ :r :r :r :r :r :s)~ :s.@:tnMn?:tnMn?: tr ?: r#9[? : r : r : r~ :r@ ;r ;r ;r ;r  ;r  ;s)~ ;s@;t>NЅ?;t>NЅ?; taT?; rv"E ? ; rrr ~ ;r@ <rz <r{ <rz <r| <r} <s)~ <s$@<tr >ri >r >r >r >s)~ >s$@>t9bx?>t9bx?> tJgUL @> r'|F? > rrr ~ >r@ ?r ?r ?r ?r ?r ?s)~ ?s>@?tQWo׿?tQWo?? tTQ*?? rlM? ? r ? r ? r ~ ?r$@DJl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rF6 @r @rF6 @rG6 @r, @s)~ @s$@@tsvk?@tsvk?@ tI<@@ rwߞu? @ r @ r @ r ~ @r@ Ar Ar Ar Ar Ar As)~ As$@Atԃ};?Atԃ};?A tLw@A r9=? A r A r A r ~ Ar@ BrS BrT BrS BrU BrV Bs)~ Bs.@BtcȿBtc?B t$e0.?B rnK? B rW B rX B rY~ Br@ CrH6 CrG CrH6 Cr- Cr- Cs)~ Cs4@Ct("A,Ct("A,?C t`a3?C rU7\? C r- C r- C r-~ Cr@ Dr Dr Dr Dr Dr Ds)~ Ds.@Dt[Ka?Dt[Ka?D t5c@D r]? D r D r D r ~ Dr @ ErY ErZ ErY Er[ Er\ Es)~ EsD@EtMWEtMW?E tg?E rQHH? E r]E r E r^~ Er@ Fr Fr Fr Fr Fr Fs)~ Fs9@FtHk:A?FtHk:A?F t~'I@F r8iY? F rr F r ~ Fr@ GrJ6 Gr GrJ6 Gr Gr/ Gs)~ GsQ@GtnwH$֙?GtnwH$֙?G tߏEH?G rN ? G r/ G r/ G r/~ Gr&@ Hr- Hr- Hr- Hr- Hr- Hs)~ Hs@Ht+c[GؿHt+c[G?H tx?H r:"]? H r- H r- H r-~ Hr@ IrG IrH IrG IrI IrJ Is)~ Is$@ItxIOҿItxIO?I tp>?I r(?? I rK I rL I rM~ Ir @ Jr Jr Jr Jr Jr Js)~ Js9@Jt92H?Jt92H?J tM4?J rnK? J r J r" J r ~ Jr@ Kr[/ Kr Kr[/ Kr Kr\/ Ks)~ KsF@Kt|]?Kt|]??K t#z?K r%? K r]/ K r^/ K r_/~ Kr(@ Lr ! Lr ! Lr ! Lr ! Lr ! Ls)~ Ls@Lt``Lt``?L tB|F?L rlM? L r! L r! L r!~ Lr@ Mr'! Mr(! Mr'! Mr)! Mr*! Ms)~ MsD@MtyMty?M teSd?M r? M r+! M r,! M r-!~ Mr(@ NrH! Nr  NrH! NrI! NrJ! Ns)~ Ns$@Ntk&$?Ntk&$?N t0LF @N r6L? N r; N r; N r;~ Nr@ OrT! OrU! OrT! OrV! OrW! Os)~ Os.@OtHz#/ͿOtHz#/?O tۉ~iR?O rw? O rX! O rY! O rZ!~ Or@ Prg! Prh! Prg! Pri! Prj! Ps)~ Ps$@PtGBпPtGB?P ti e?P rQHH? P rk! P rl! P rm!~ Pr@ Qrt! Qru! Qrt! Qrv! Qrw! Qs)~ QsK@QtkA7?QtkA7?Q tNo?Q rf14? Q rx! Q ry! Q rz!~ Qr(@ Rr|! Rr}! Rr|! Rr~! Rr! Rs)~ Rs4@RtPwzJRtPwzJ?R tj!Me?R r*L_? R r! R r! R r!~ Rr"@ Sr! Sr! Sr! Sr! Sr! Ss)~ Ss$@StÈ YrStÈ Yr?S t?S r4&͆? S r! S ra S r!~ Sr@ Tr! Tr Tr! Tr! Tr Ts)~ TsA@Tt9Aj߿Tt9Aj?T tmRQTA?T r/? T rrr ~ Tr@ Ur! Ur! Ur! Ur! Ur! Us)~ Us@Utu*V?Utu*V?U tGmI29?U rOu? U r! U r! U r"~ Ur@ Vr / Vr / Vr / Vr / Vr / Vs)~ Vs.@Vt9% ?Vt9% ?V t*9Ȫ &?V r6c? V r/ V r/ V r/~ Vr@ Wr! Wr! Wr! Wr! Wr! Ws)~ Ws@WtJv?WtJv?W t'-?W r7d? W r! W r! W r!~ Wr@ Xr! Xr! Xr! Xr! Xr! Xs)~ Xs4@Xt .7Xt .7?X t@->6?X r`T? X r! X r! X r~ Xr@ Yr! Yr! Yr! Yr! Yr! Ys)~ Ys4@Ytx Bb?Ytx Bb?Y t?Y r/*t;? Y r! Y r! Y r!~ Yr @ Zrm& Zrn& Zrm& Zro& Zrp& Zs)~ Zs9@ZtY%ڿZtY%?Z tF8^?Z rq-? Z rq& Z rr& Z rs&~ Zr@ [r! [r! [r! [r! [r! [s)~ [s@[t!)D?[t!)D?[ tɽ3U?[ rϪ? [ r! [ r! [ r!~ [r@ \r! \r! \r! \r! \r! \s)~ \s.@\tYDͿ\tYD?\ tŋ}A?\ rl? \ r! \ r! \ r!~ \r@ ]r! ]r! ]r! ]r! ]r! ]s)~ ]s>@]t.?]t.?] th"*?] r럈? ] r! ] r! ] r!~ ]r.@ ^r" ^r" ^r" ^r" ^r" ^s)~ ^sF@^tJ|3ڿ^tJ|3?^ t ?^ rsB? ^ r" ^ r" ^ r"~ ^r"@ _rO6 _r " _rO6 _r " _r[. _s)~ _s4@_t[U_t[U?_ t $}?_ ro? _ r\. _ r]. _ r^.~ _r @Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r" `r" `r" `r" `r" `s)~ `s.@`tփov?`tփov?` t&OST?` r" g? ` r" ` r" ` r~ `r@ ar" ar" ar" ar" ar" as)~ asA@at6Qwпat6Qw?a tA?a r'y(? a r" a r" a r "~ ar @ br"" br#" br"" br$" br%" bs)~ bs.@btL8btL8?b t"!>?b rIH2w? b r&" b r'" b r("~ br@ cr cr cr cr cr cs)~ cs9@ctiG4ÿctiG4?c tc?c r[R? c r c r c r~ cr&@ dr*" dr+" dr*" dr," dr-" ds)~ ds$@dtd޴?dtd޴?d tꞠd?d r/*t;? d r." d r/" d r0"~ dr @ er2" er3" er2" er4" er5" es)~ es$@etbetb?e ta"?e rQHH? e r6" e r7" e r8"~ er@ fr:" fr;" fr:" fr<" fr=" fs)~ fs4@ftQ s?ftQ s?f t L?f r42s? f r>"f r f r?~ fr@ gr@" grA" gr@" grB" grC" gs)~ gs9@gt$S ?gt$S ?g ta!Z@g rU7\? g rD" g rE" g rF"~ gr"@ hrH" hrI" hrH" hrJ" hrK" hs)~ hs>@ht@Iht@I?h t@0?h r _? h rL" h rM" h rN"~ hr@ irP6 ir. irP6 ir. ir. is)~ is4@itLYitLY?i tz^yc?i rϪ? i r. i r. i r.~ ir"@ jrP" jrQ" jrP" jrR" jrS" js)~ js9@jtXT?jtXT?j tf;D6 @j r1ZO)? j rT" j r j rU"~ jr@ krW" krX" krW" krY" krZ" ks)~ ksA@kt~-޿kt~-?k tNJ?k r r? k r[" k r\" k r]"~ kr0@ lr_" lr`" lr_" lra" lrb" ls)~ ls$@lt;gﵿlt;g?l t޼'?l rN~-? l rc" l rd" l re"~ lr@ mr" mr" mr" mr" mr" ms)~ ms9@mtKqmtKq?m tۼ =?m r&F? m r"m r m r"~ mr@ nr" nr" nr" nr" nr" ns)~ ns.@nt]3@ٿnt]3@?n tW?n r 5`@? n r" n r" n r"~ nr@ or- or- or- or- or- os)~ os.@otuES$Y޿otuES$Y?o tt?o r'? o r- o r- o r-~ or@ pr" pr" pr" pr" pr" ps)~ ps.@pt+`"@pt+`"@?p t#p?p rf-? p r" p r p r"~ pr@ qr qr qr qr qr qs)~ qs4@qt^Kz?qt^Kz?q to^?q r*/? q r q r q r~ qr(@ rrc( rrd( rrc( rre( rrf( rs)~ rs4@rtUѬrtUѬ?r trGߐ?r r+3? r rg( r rh( r ri(~ rr @ sr" sr" sr" sr" sr" ss)~ ss$@st\i?st\i?s tRaf?s ro? s r" s r" s r"~ sr@ tr" tr" tr" tr" tr" ts)~ ts>@ttQԿttQ?t tA~G٭?t r/0k? t r" t r" t r"~ tr$@ ur! ur ! ur! ur!! ur"! us)~ us$@utlm?utlm?u tS"f@?u r{? u r#! u r$! u r%!~ ur@ vrQ6 vrR6 vrQ6 vrS6 vr, vs)~ vs$@vt/T2?vt/T2?v t_@v r/? v r, v r, v r,~ vr@ wr]+ wr^+ wr]+ wr_+ wr`+ ws)~ ws9@wtHekwtHek?w tLR?w rC .ގ? w ra+ w rb+ w rc+~ wr @ xr" xr" xr" xr" xr" xs)~ xs>@xtiextie?x t97+f?x reP? x rC x rD x rE~ xr@ yrT6 yr" yrT6 yrU6 yrR. ys)~ ys$@yt]yt]?y t&I`?y rׇ? y rS. y rT. y rU.~ yr@ zr# zr# zr# zr# zr# zs)~ zs.@ztY1iztY1i?z t`?z r l? z r# z r# z r#~ zr@ {rX6 {rh {rX6 {ri {rY6 {s)~ {s>@{tr- @{tr- @{ t3mo!@{ r]lށ? { rrr ~ {r@ |r |r |r |r |r |s)~ |s>@|t_-?|t_-?| tk/?| rȔUD? | r | r | r~ |r@ }r!# }r"# }r!# }r## }r$# }s)~ }s$@}tLIJӿ}tLIJ?} t]y?} r? } r%# } r&# } r'#~ }r@ ~r1# ~r2# ~r1# ~r3# ~r4# ~s)~ ~sI@~t7@?~t7@?~ t篍:?~ rʄҵL? ~ r5# ~ r6# ~ r7#~ ~r @ r:# r;# r:# r<# r=# s)~ s4@tCYgܿtCYg? tJC? rqdiS?  rc  rc  r>#~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rZ6 r/ rZ6 r[6 r/ s)~ s.@t:Lih?t:Lih? t_O? rlM?  r/  r/  r/~ r@ r/* r0* r/* r1* r2* s)~ s$@tA?tA? tEK@ r+@/?  r3*  r4*  r5*~ r@ rL# rM# rL# rN# rO# s)~ s$@tbe-tbe-? t5WtN? r?  rP#  rQ#  rR#~ r@ rT# rU# rT# rV# rW# s)~ s>@t:1t:1? tclө? rOD?  r  r   r ~ r@ r\6 rb# r\6 r]6 r- s)~ sA@tٿt? t> M6? r _?  r-  r-  r-~ r@ rs# rt# rs# ru# rv# s)~ s>@t2t2? t:I? r1]?  rw#  rx#  ry#~ r@ r r r r r s)~ s.@tz&aĿtz&a? t其g ? r?z?  r  r  r~ r@ r^6 r# r^6 r# r. s)~ s$@t}Կt}? t?c? rFa>?  r.  r.  r.~ r@ r# r# r# r# r# s)~ s4@t1?t1? tfD\? rm?  r#  r#  r#~ r@ r# r# r# r# r# s)~ s$@t-?t-? tһۤ? rw=p??  r#  r#  r#~ r@ r r r r r s)~ sD@tf$?tf$? t e? r3*?  r  r  r~ r"@ r- r- r- r- r- s)~ s@tu{tu{? t"꧳? rN~-?  rrr ~ r@ r r r r r s)~ s$@tUJ&=tUJ&=? t]\W? roĝ'?  r  r  r ~ r@ r# r# r# r# r# s)~ s@t;̿t;? ti? rs?  r#  r#  r~ r@ r# r# r# r# r# s)~ s$@tw2 ?tw2 ? t[,? rU7\?  r#  r#  r#~ r@ r r r r r s)~ s@t&<t& s)~ s.@t1k}"3t1k}"3? tm{? r$BӦ?  r  r  r?~ r@ r_6 ri r_6 r`6 ra6 s)~ s9@tϛ> ſtϛ> ? t|ލ? rӨ?  rrr ~ r@ r+ r+ r+ r+ r+ s)~ s$@t992)9t992)9? tO? rz'N[?  r+  r+  r+~ r@ r% r% r% r% r% s)~ s$@tXaf|tXaf|? to+Ռ? rK͚?  r%  r%  r%~ r@ r$ r$ r$ r$ r$ s)~ s$@t#5@t#5@ t$ r?$ s)~ sQ@tݭ?tݭ? tb? rL-m?  r  r   r~ r@ r$ r$ r$ r$ r$ s)~ s$@t{u-?t{u-? tFC ]@ r 5`@?  r$  r$  r$~ r@ r. r$ r. r$ re6 s)~ s9@t2Jt2J? tb%>? rc?  rrr ~ r@ r$ r$ r$ r$ r$ s)~ s@tӹ܅?tӹ܅? tN? r@?  r$  r$  r$~ r@ r$ r$ r$ r$ r$ s)~ s$@tЁtЁ? t/߭? rِC?  r$  r$  r$~ r@ r$ r$ r$ r$ r$ s)~ s$@t̽~׿t̽~? t6E;? roĝ'?  r$  r$  r$~ r@ r. r. r. r. r. s)~ s>@t??t?? t 8? r-e&?  r.  r.  r.~ r@ rx' ry' rx' rz' r{' s)~ s4@t2#.?t2#.? t 2@ r-&?  r|'  r}'  r~'~ r(@ rW rX rW rY rZ s)~ s.@tTtT? t2]R? rHM"?  r[  r\  r]~ r@ r% r% r% r% r% s)~ s.@tfĿtf? ta|]+? rlM?  r%  r%  r%~ r @ r r r r r s)~ sD@t\|׿t\|? t13? r|?ʛ?  r  r  r ~ r"@ r$ r$ r$ r$ r$ s)~ sA@t|9бt|9б? t~? rco?  r$  r$  r$~ r@ r$ r$ r$ r$ r$ s)~ s$@tF]q_ tF]q_ ? tNۥ? r֡# ?  r$  r  r$~ r@ r$ r$ r$ r$ r$ s)~ s@t~Gf[?t~Gf[? t[K j? rϪ?  r$  r$  r$~ r@ r% r% r% r% r! s)~ s$@tNʔuOtNʔuO? tNڵ? rrCؕ?  r   r   rz~ r@ rh6 r|% rh6 ri6 r~% s)~ s4@trKƿtrK? t#.?  rC  rD  rE~ r@ r& r& r& r& r& s)~ s$@tex?tex? tnt4I? r !?  r&  r&  r&~ r@ rt6 r. rt6 ru6 r. s)~ s@tF ԿtF ? t#^̳? r`cm?  r.  r.  r.~ r@ r%& r&& r%& r'& r(& s)~ s@tQY"?tQY"? tH4n? rn?  r)&  r  r*&~ r@ rH& rI& rH& rJ& rK& s)~ s@tCbtCb@ t6;? rf 6?  rL&  rM&  rN&~ r@ rW& rX& rW& rY& rZ& s)~ s$@tt? t?  rh&  ri&  rj&~ r@ r r r r r s)~ s4@t??t?? tJ~ډ? r$ ?  r  r  r~ r@ r r r r r s)~ s>@tvp?tvp? t|>+? r5bz?  r  r  r~ r*@ ru& rv& ru& rw& rx& s)~ s9@tMhP'|пtMhP'|? tv? r]?  r  rc  ry&~ r@ rx6 r. rx6 ry6 r. s)~ s$@t'D:Ӓ?t'D:Ӓ? t^<4? rϪ?  r.  r.  r.~ r@ r{& r|& r{& r}& r~& s)~ s.@t|b?t|b? tQ_? rqdiS?  r&  r&  r&~ r@ r r r r r s)~ s.@t+?t+? tGrsn? rq풓?  r  r  r~ r@ rz6 r. rz6 r. r. s)~ s@tY8пtY8? tsS8? rFa>?  r.  r.  r.~ r@ r& r& r& r& r& s)~ sF@t0 ^t0 ^? t x~? rqN?  r&  r&  r&~ r@ r& r& r& r& r& s)~ s$@t~({?t~({? tR[? rZ?  r&  r&  r&~ r@ r{6 r. r{6 r|6 r. s)~ s$@tX;ӿtX;? tv*>? ry[?  r.  r.  r.~ r@ r& r& r& r& r& s)~ s@tdRsɿtdRs? tʃ:E? rOmT?  r&  r  r&~ r@ r& r& r& r& r& s)~ sI@t%侽?t%侽? tW? rA'v g?  rrr ~ r@ r& r& r& r& r& s)~ s@t&$c6t&$c6? tY?xE]? rs? r  r&  r&~ r@ r& r& r& r& r& s)~ sD@tGcۿtGc? tQ ,v0? rʄҵL?  r&  r&  r&~ r$@ r& r& r& r& r& s)~ s>@tF}rtF}r? t7ni? rKev?  r  r  r~ r@ r& r& r& r& r& s)~ s$@tWtW? t4IQ? r 5`@?  r&  r&  r~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r ' r ' r ' r ' r' s)~ s4@tʹ?tʹ?? tZ5K? r^|yd?  rc  rc  rc~ r@ r' r' r' r' r' s)~ s@tҭ! ?tҭ! ? tݬY? rϪ?  r  r  r~ r@ r%' r&' r%' r'' r(' s)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"~ s>@tf1tf1? t~U? rŌ?  r   r   r~ r@ r*' r+' r*' r,' r-' s)~ s$@t&T?t&T? tf.<@ r$;Iڿtd>$;I? t׾5wj? rIH2w?  r  r  r~ r@ r`' ra' r`' rb' rc' s)~ s4@t:Pt㣿t:Pt? t7\&? r-z?  rd'  re'  rf'~ r@ rp' rq' rp' rr' rs' s)~ sY@tlutlu? teo? r$BӦ?  rt'  ru'  rv'~ r@ r' r' r' r' r' s)~ s.@t"Eؿt"E? t)_7l? rvS?  r'  r'  r'~ r@ r6 r r6 r6 r/ s)~ s$@tkF?tkF? ty]? r]`?  r/  r/  r/~ r@ r' r' r' r' r' s)~ s4@t*%t*%? t{? r.?  r'  r'  r'~ r@ r' r' r' r' r' s)~ s$@tZH5^?tZH5^? t͓?3? rSUO3a)?  r'  r"  r'~ r$@ r' r' r' r' r' s)~ s.@tRLº,տtRLº,? tӜe,q? r(ZN}?  rC  rD  rE~ r@ r6 r. r6 r6 r. s)~ s@t0M0Dt0M0D? t @b? r#9[?  r.  r.  r.~ r@ r' r' r' r' r' s)~ s$@t t ? t]7i? r`?  r'  r'  r'~ r@ r' r' r' r' r' s)~ sH@t3{+8t3{+8? t1;E? rg-QX?  r  r  r~ r@ r& r& r& r& r& s)~ s4@tAq?tAq? t#!C? r/L'?  r&  r&  r&~ r@ r' r' r' r' r' s)~ s.@tk +6tk +6? tAk? rښ?  r'  r'  r'~ r@ r r r r r s)~ s$@t1?t1? th.,? rN ?  r  r  r ~ r@ r( r( r( r ( r ( s)~ s4@tח 3,tח 3,? tġJ? rq-?  r (  r (  r (~ r@ r( r( r( r( r( s)~ sI@tNmtNm? tA~k ? r&`N?  r  r   r~ r@ r. r( r. r. r( s)~ sK@t%a?t%a? t{? rd?  r.  r.  r.~ r@ r7( r8( r7( r9( r:( s)~ s@tȖ#3tȖ#3? ti 1`? rc?  r;(  r<(  r=(~ r@ r?( r@( r?( rA( rB( s)~ s$@tt? th? rЃq?  rC(  rD(  rE(~ r@ rV( rW( rV( rX( rY( s)~ s.@tgGzֿtgGz? tK? rE$N?  rZ(  r[(  r\(~ r@ r^( r_( r^( r`( ra( s)~ s@tY㼂?tY㼂? tֻ ? r gs"?  rrr ~ r@ r{( r|( r{( r}( r~( s)~ s$@tQo5ѿtQo5? t3&? rSL?  r(  r(  r(~ r@ r& r& r& r& r& s)~ s>@ts=Z:Wts=Z:W? t-aD? r܋?  rC  rD  rE~ r@ r( r( r( r( r( s)~ s@t\8Wt\8W@ t p L? r NŽ?  r(  r(  r(~ r@ rB+ rC+ rB+ rD+ rE+ s)~ s$@tM5Ċ׿tM5Ċ? th߬M? r ^?  rF+  rG+  rH+~ r@ r( r( r( r( r( s)~ s9@t"ZXժt"ZXժ@ tQ̺e? r<S?  r  r   r~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r( r( r( r( r( s)~ s4@tOő̿tOő? tpv@Z? r=?  r(  r(  r(~ r@ r( r( r( r( r( s)~ s.@tEN׿tEN? t7t? ro?  r(  r(  r(~ r@ r$ r$ r$ r$ r$ s)~ s9@tџT֥tџT֥? tp]? rKev?  r$  r$  r$~ r@ r( r( r( r( r( s)~ s@tM^b?tM^b? taw5? r@ =?  r(  r(  r(~ r@ r( r( r( r( r( s)~ s$@tH?tH? t)q.0? rtzno?  r(  r(  r(~ r@ r r r r r s)~ s@t@t@? tcK? rFnѱ?  r   r   r ~ r@ r6 r( r6 r6 r8. s)~ s$@ti2JTԿti2JT? t7N-? r:?  r9.  r:.  r;.~ r@ r( r( r( r( r( s)~ s@toHtoH? tvE? r]`?  rc  r(  r(~ r@ r( r( r( r( r( s)~ sA@tmtm? t(atZ2? rxΰ(?  rC  rD  rE~ r@ r( r( r( r( r( s)~ s@ t~5 t~5?  tr/I! ?  r%?  r(  r(  r(~ r@ r( rP r( r( r; s)~ s>@ t Ct? t Ct?  t\ϭ(@  r51?  rrr ~ r@ r. r. r. r. r. s)~ s@ t[=? t[=?  t8Os?  r:g?  r.  r.  r.~ r@ r) r) r) r) r) s)~ s.@ tڪd tڪd?  t *?  r޳5@t,t,? t֕? raƴ?  r5)  r  r6)~ r@ r8) r9) r8) r:) r;) s)~ s4@t՘Ү¿t՘Ү? t5? rڪS?  r<)  r=)  r>)~ r@ rP) rQ) rP) rR) rS) s)~ s@tJSqtJSq? t(Kv? r"X?  re  r~  rT)~ r@ rT/ rU/ rT/ rV/ rW/ s)~ s@tO8tO8? ts@0? rq-?  rX/  rY/  rZ/~ r@ rV) rW) rV) rX) rY) s)~ s$@tc8?tc8? tW.G? r\UhF?  rZ)  r[)  r~ r@ r r r r r s)~ s@tCĝ?tCĝ? t%EH? rKev?  r  r  r~ r@ r) r) r) r) r) s)~ s@P@t ږt ږ? tSr$? rP:k?  r  r  r~ r@ r) r) r) r) r) s)~ sF@tt:?tt:? t#? r◬??  r  r  r~ r@ r) r r) r) r s)~ sA@t0?t0? t48xj? r[S~$$?  rrr ~ r@ r6 r^) r6 r6 r, s)~ s$@ts܆ts܆? t]R? r9^ld?  r,  r,  r,~ r@ r) r) r) r) r) s)~ s@tTzPEؿtTzPE? tYԦ{? rM/Jx?  r)  r)  r)~ r@ rV, rW, rV, rX, rY, s)~ s9@t㮢q-?t㮢q-? t&ʿ#? roCd\?  rC  rD  rE~ r@ r, r, r, r, r, s)~ s9@taӿta? tX ? r$z'?  r,  r,  r,~ r@ r) r) r) r) r) s)~ s$@twol,?twol,? t$Gq? rN?  r)  r)  r)~ r@ r( r( r( r( r( s)~ s@P@tD!QtD!Q? twL? rj4?  r(  r*  r-~ r@ r) r) r) r) r) s)~ s@t޿90 @t޿90 @ t@9!@ rs?  r*  r*  r*~ r@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r* r* r* r* r* s)~ s$@ t[ 2=GͿ t[ 2=G?  t<5N?  rs?  r*  r *  r *~ r@ !r" !r" !r" !r" !r" !s)~ !s$@!tJc!tJc?! t\eJr?! rq풓? ! r" ! r" ! r"~ !r@ "r* "r "r* "r* "r "s)~ "s$@"tXJ"tXJ?" tfgP?" r]e:u? " rrr ~ "r@ #r* #r* #r* #r* #r* #s)~ #s$@#t4PX?#t4PX?# tNҎ ?# r? # r  # r  # rz~ #r@ $r* $r* $r* $r* $r* $s)~ $s4@$tiXdֿ$tiXd?$ tUS[?$ rӨ? $ r* $ r * $ r!*~ $r@ %r'* %r(* %r'* %r)* %r** %s)~ %s.@%t(x?%t(x?% tm@% r xP? % r+* % r,* % r-*~ %r@ &r>* &r?* &r>* &r@* &rA* &s)~ &s$@&t&t?& t0m?& rK=? & rB* & rC* & rD*~ &r@ 'rk* 'rl* 'rk* 'rm* 'rn* 's)~ 's$@'tBR'tBR?' t:E/?' r h5? ' ro* ' r& ' rp*~ 'r@ (rr* (rs* (rr* (rt* (ru* (s)~ (s>@(tR_P_(tR_P_?( tRhdg?( r8b`? ( r ( r ( r~ (r@ )r6 )r. )r6 )r. )r. )s)~ )s@)t^׿)t^?) t~N'?) rc? ) r. ) r. ) r3~ )r@ *r* *r* *r* *r* *r* *s)~ *s@*t=:)*t=:)?* tO?* rB C=? * r* * r* * r*~ *r@ +r +r +r +r +r +s)~ +s$@+t:Y?+t:Y?+ tM?+ rlM? + r + r + r ~ +r@ ,r* ,r* ,r* ,r* ,r* ,s)~ ,s@,t;:?,t;:?, t0/&@, r)f? , r* , r* , r*~ ,r@ -r* -r* -r* -r* -r* -s)~ -s$@-tg ?-tg ?- t<$O?- r/*t;? - r* - r - r*~ -r@ .r* .r* .r* .r* .r* .s)~ .s@.t<|k.t<|k?. tǭz?. r3*? . r* . r* . r*~ .r@ /r* /r+ /r* /r+ /r+ /s)~ /s.@/t$-0/t$-0?/ t95CQP?/ rFa>? / rT" / r / r+~ /r@ 0r+ 0r+ 0r+ 0r+ 0r+ 0s)~ 0s.@0t}Կ0t}?0 t ߧ?0 rf#^? 0 r+ 0 r) 0 r+~ 0r@ 1r , 1r , 1r , 1r, 1r, 1s)~ 1sR@1t ׁ1t ׁ?1 txl'M?1 r8^X? 1 r 1 r 1 r~ 1r@ 2r:+ 2r;+ 2r:+ 2r<+ 2r=+ 2s)~ 2s$@2tp>2tp>?2 tyuX[?2 rY.cS? 2 r>+ 2 r?+ 2 r@+~ 2r@ 3r*, 3r+, 3r*, 3r,, 3r-, 3s)~ 3sK@3t?ڥ3t?ڥ?3 t1K]?3 rgD@? 3 r 3 r  3 r~ 3r@ 4r# 4r# 4r# 4r# 4r# 4s)~ 4s$@4t "硿4t "?4 t|p;?4 r& f? 4 r# 4 r# 4 r#~ 4r@ 5rJ+ 5rK+ 5rJ+ 5rL+ 5rM+ 5s)~ 5s$@5t#Mt?5t#Mt?5 t̙ݵr?5 rhUV? 5 rN+ 5 rO+ 5 rP+~ 5r@ 6rR+ 6rS+ 6rR+ 6rT+ 6rU+ 6s)~ 6s@6t~w׿6t~w?6 t8{?6 rR ? 6 rV+ 6 rW+ 6 rX+~ 6r@ 7r- 7r. 7r- 7r/ 7r0 7s)~ 7s$@7tLz;Qǿ7tLz;Q?7 t$"8%?7 rFa>? 7 r1 7 r2 7 r3~ 7r@ 8rw+ 8rx+ 8rw+ 8ry+ 8rz+ 8s)~ 8s@8tF! ?8tF! ?8 tql?8 rʄҵL? 8 r{+ 8 r|+ 8 r}+~ 8r@ 9r+ 9r+ 9r+ 9r+ 9r+ 9s)~ 9s$@9tyO޿9tyO?9 tҖ0 ?9 rvS? 9 r+ 9 r+ 9 r+~ 9r@ :r+ :r+ :r+ :r+ :r+ :s)~ :s$@:t`"9׿:t`"9?: t^?: rY? : r+ : r~ : r+~ :r@ ;r+ ;r+ ;r+ ;r+ ;r+ ;s)~ ;s.@;tlS;tlS?; t~?; rgD@? ; r+ ; r+ ; r+~ ;r@ <r+ <r+ <r+ <r+ <r+ <s)~ <s@<t7(t3ݿ<t7(t3?< tʗ^?< rU7\? < r+ < r+ < r+~ <r@ =r+ =r+ =r+ =r+ =r+ =s)~ =sF@=t-ԯG=t-ԯG?= tW>?= rw^)oI? = r = r  = r~ =r@ >r+ >r, >r+ >r, >r, >s)~ >s@>tj>tj@> t*օ~?> r9L>? > r, > r, > r,~ >r@ ?r, ?r, ?r, ?r , ?r , ?s)~ ?s<@?trh'\O?trh'\O?? t_EWP?? rKhق? ? r ? r ? r~ ?r@Dl@,A,B,C,D,E,F,G,H,I, @r5/ @r6/ @r5/ @r7/ @r8/ @s)~ @s$@@tPZ?@tPZ?@ tcNb?@ r Bž? @ r @ r @ r~ @r@ Ar7, Ar8, Ar7, Ar9, Ar:, As)~ As$@AtTVAtTV?A t)K!?A rKev? A r;, A r<, A r=,~ Ar@ Br' Br' Br' Br' Br' Bs)~ Bs.@BtnBtn?B t&i?B rw﹬? B rC B rD B rE~ Br@ CrM, CrN, CrM, CrO, CrP, Cs)~ CsA@Ct1?Ct1?C t."Y:?C r r? C r C r  C r~ Cr@ Dr[, Dr\, Dr[, Dr], Dr^, Ds)~ Ds.@DtpU~DtpU~?D t`&}3?D r@? D r D r  D r~ Dr@ Er`, Era, Er`, Erb, Erc, Es)~ Es@Et% pEt% p?E tB?E r`M? E r) E r* E r~ Er@ Frh, Fri, Frh, Frj, Frk, Fs)~ Fs.@FtT-s?FtT-s?F tO?F r#pY? F r F r  F r~ Fr@ Grm, Grn, Grm, Gro, Grp, Gs)~ Gs$@Gt JGt J?G t5P:Gf?G r? G rq, G rr, G rs,~ Gr@ Hr~, Hr, Hr~, Hr, Hr, Hs)~ Hs@Htb|͝?Htb|͝?H to!l?H rP? H r, H r, H r,~ Hr@ Ir6 Ir Ir6 Ir6 Ir6 Is)~ Is@ItҔߺ;ItҔߺ;?I t3Ҏ?I r aM? I rc I rc I rc~ Ir@ >@MJggD ZO $YB'BBBC0C  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} I} } m} I} I1} !} $ } I} m} } I } *} I%} m%} } h,,,,; ; ,, , , , , ,,,,,,,,,,,,,,,,,,, i8 kk j/ jjl m6jn m6jj p p p p p p p p p  p  p  p  p  p p# r r r r r s)~ s4@tJ1v4tJ1v4@ tJ? r{6)/?  r  r  r ~ r @ r r  r r r s)~ s>@t}t}@ t=? r,H?  rrr ~ r@ r( r( r( r( r( s)~ s9@ t"ZXժ t"ZXժ@ tQ̺e? r<S? r r  r~ r@ r| r} r| r~ r s)~ s@s@ t8 {e t8 {e@ t? u< ? r r r~ rF@ r r r r r s)~ s@U@ tx&X+= tx&X+=@ ty[? u\1z> rC rD rE~ r@ r r r r r s)~ sA@ t_ t_@ t҈}so? rFKaa? r r  r~ r@ rO rP rO rQ rR s)~ s@P@ t̒J t̒J? t5h? u&= r r  r~ r@ r r r r r s)~ s8@t´ i>t´ i>? ttVy? u`% 01;  r  r  r~ rQ@ r> r? r> r@ rA s)~ s9@tWS~tWS~? tHO? rz?  r  r   r~ r@ r" r" r" r" r" s)~ s>@tietie? t97+f? reP?  rC  rD  rE~ r@ r r r r r s)~ sT@t+>t+>? tU2? u>  r  r  r~ r@ r r r r r  s)~ sF@t0@#4t0@#4? ty4? r}l?  r   r   r ~ r@ r r r r r s)~ sR@tkst-tkst-? t g? r*LA4?  r  r  r~ r0@ r r r r r s)~ s`y@tiA?e~tiA?e~? te,Bs? u,t=  r  r  r~ rM@ r r r r r s)~ sR@teHgteHg? tZXK>? u )q->  r  r   r~ r@ r* r+ r* r, r- s)~ sW@t(t(? tll5? u>Q>  r  r   r~ r$@ r r r r r s)~ sR@tN jtN j? t{&Ra? rr,?  r  r  r~ r$@ r r r r r s)~ ss@tFtF? tB? u\%>  r  r  r ~ rJ@ rv rw rv rx ry s)~ sQ@ti[ti[? t?vǣ? rhX?  rrr ~ r@ r r r r r s)~ sI@tD:,LVjtD:,LVj? t<H? r~ݬiMu?  r  r   r~ r@ r| r} r| r~ r s)~ sT@taͼ2taͼ2? tM&9{? rf?  r  r   r~ r"@ r r r r r s)~ sQ@t:m|t:m|? tǥI晳? rUD*T?  r   r   r ~ r @ r5 r r5 r5 r, s)~ s`@tt? t ? r|ͅZ?  r,  r)  r,~ r6@ rv rw rv rx ry s)~ s@Z@tItI? t&\? u9ue>  r  r   rz~ r @ r2 r3 r2 r4 r5 s)~ s~@tLStLS? t(nYO? u忮&:  r6  r7  r8~ rI@Dl""  ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r' r' r' r' r' s)~ s4@ t*% t*%? t{? r.? r' r' r'~ r@ !r$ !r$ !r$ !r$ !r$ !s)~ !s$@!tF]q_ !tF]q_ ?! tNۥ?! r֡# ? ! r$ ! r ! r$~ !r@ "r "r "r "r "r "s)~ "sW@"t4m"t4m?" tNwJ?" rQnD? " rrr ~ "r$@ #r% #r& #r% #r' #r( #s)~ #s@j@#t̕Ώ#t̕Ώ?# td~ X?# rR5*n8? # r # r  # r~ #r1@ $r& $r' $r& $r( $r) $s)~ $sn@$t-cBp$t-cBp?$ t=#)j/?$ u>Q> $ r* $ r+ $ r,~ $rB@ %r %r %r %r %r %s)~ %sF@%tن`%tن`?% t>?% r0RMg? % r % r % r~ %r@ &r$ &r% &r$ &r& &r' &s)~ &sK@&t}X 0}&t}X 0}?& tZ2.?& u]~> & r( & r) & r*~ &r@ 'rX 'rY 'rX 'rZ 'r[ 's)~ 's`s@'tČ'tČ?' t뱝3_?' r 5? ' r\ ' r] ' r^~ 'rG@ (r (r (r (r  (r! (s)~ (sr@(tauiN(tauiN?( t~?( ri#? ( r" ( r# ( r$~ (r;@ )r )r )r )r )r )s)~ )s\@)to?[)to?[?) tuq?) r\[P? ) r ) r ) r~ )r @ *rB *rC *rB *rD *rE *s)~ *s_@*t*t?* tA?* r*LA4? * rF * rG * rH~ *r;@ +r +r +r +r +r +s)~ +sW@+t0A +t0A ?+ tCr ?+ r5HxO? + r + r + r~ +r(@ ,r ,r ,r ,r ,r ,s)~ ,sR@,t2g,t2g?, tI،7?, rn? , r , r  , r~ ,r@ -r -r -r -r -r -s)~ -sN@-t]ݹ-t]ݹ?- t"z[?- u22'? - r - r  - r ~ -r@ .r .r .r .r .r .s)~ .s`c@.t05u.t05u?. tHC4?. rg-QX? . r . r . r~ .r,@ /r5 /r6 /r5 /r7 /r8 /s)~ /sY@/t:Y,m/t:Y,m?/ tIZK?/ uPl> / r / r  / r~ /r@ 0r 0r 0r 0r 0r 0s)~ 0si@0to0to?0 tG7e?0 uCTJ> 0 r 0 r 0 r~ 0rD@ 1r 1r 1r 1r 1r 1s)~ 1s@_@1ttǩ1ttǩ?1 twsA?1 u eb> 1 r 1 r 1 r~ 1r$@ 2r: 2r; 2r: 2r< 2r= 2s)~ 2sj@2tzQ1L2tzQ1L?2 t_?2 ràC? 2 r> 2 r? 2 r@~ 2rF@ 3rV% 3rW% 3rV% 3rX% 3rY% 3s)~ 3sK@3t&N 3t&N ?3 tWJ?3 r/uQ-!? 3 r 3 r  3 r~ 3r@ 4rO 4rP 4rO 4rQ 4rR 4s)~ 4s l@4tA4tA?4 tqr?4 rD8v? 4 rS 4 rT 4 rU~ 4r3@ 5r 5r 5r 5r 5r 5s)~ 5s4@5t)5t)?5 tNZh ?5 roȨ? 5 rC 5 rD 5 rE~ 5r@ 6r. 6r/ 6r. 6r0 6r1 6s)~ 6sb@6tm6tm?6 tW%?6 u>Q> 6 r2 6 r3 6 r4~ 6r1@ 7r 7r 7r 7r 7r 7s)~ 7sX@7t787t78?7 tqm .?7 u>Q> 7 r 7 r 7 r~ 7r"@ 8r 8r 8r 8r  8r! 8s)~ 8s@P@8tK8tK?8 tڦq?8 rTK&T#S? 8 r 8 r  8 r ~ 8r@ 9r( 9r( 9r( 9r( 9r( 9s)~ 9sI@9tNm9tNm?9 tA~k ?9 r&`N? 9 r 9 r  9 r~ 9r@ :r! :r! :r! :r! :r! :s)~ :sQ@:t<:t<?: t+N?: uג> : r : r  : r~ :r@ ;r ;r ;r ;r ;r ;s)~ ;sj@;t\w;t\w?; t X*?; rj94? ; r ; r ; r~ ;r6@ <r <r <r <r <r <s)~ <ss@<tRU<tRU?< tn?< r M/? < r < r < r~ <rA@ =r =r =r =r =r =s)~ =sd@=tY=tY?= t/ْ?= r~oVl"R? = r= r = r~ =r&@ >r\ >r] >r\ >r^ >r_ >s)~ >sp|@>tev>tev?> t'?> rFM(? > r` > ra > rb~ >rF@ ?r ?r ?r ?r ?r ?s)~ ?sT@?t~@V?t~@V?? tZ ?? r@Sy? ? r ? r  ? r ~ ?r"@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rr @rs @rr @rt @ru @s)~ @sI@@t`@t`?@ t| ͏?@ us? @ rv @ rD @ r~ @r@ ArS ArT ArS ArU ArV As)~ As`}@At{ ^MAt{ ^M?A tO>?A u H.y= A rW A rX A rY ~ Ar?@ Br BrP Br Br Br Bs)~ Bs@Bt]r?Bt]r??B tK!~PP?B u2W<B r B rD B r~ BrE@ Cr( Cr) Cr( Cr* Cr+ Cs)~ Cs`m@CtgCtg?C tP?C rg]? C r, C r* C r-~ Cr3@ Dr Dr Dr Dr Dr! Ds)~ Ds@`@Dt{Dt{?D t*TU?D roUt? D r" D r# D r$ ~ DrB@ Ero Erp Ero Erq Err Es)~ Esf@Et_xjvoEt_xjvo?E tzhg?E rD&[ś? E rs E rt E ru~ Er0@ Fr+ Fr+ Fr+ Fr+ Fr+ Fs)~ FsF@Ft-ԯGFt-ԯG?F tW>?F rw^)oI? F r F r  F r~ Fr@ Gr Gr Gr Gr Gr Gs)~ GsU@GtbylEGtbylE?G tR6GR?G r5(=? G r G r G r~ Gr$@ Hre Hrf Hre Hrg Hrh Hs)~ Hs`@Ht;aHt;a?H t1e7?H u{6> H ri H r H rj~ Hr(@ Ir' Ir' Ir' Ir' Ir' Is)~ IsH@It3{+8It3{+8?I t1;E?I rg-QX? I r I r I r~ Ir@ Jr Jr  Jr Jr! Jr" Js)~ Js@P@JtLzJtLz?J tLvV?J rTK&T#S? J rC J rD J rE~ Jr @ Kr# Kr$ Kr# Kr% Kr& Ks)~ Ks\@KtrtެKtrtެ?K tپ?K rz? K r K r  K r~ Kr&@ Lr@ LrA Lr@ LrB LrC Ls)~ LsP@Lt_VLt_V?L t@?L u k\> L rrr ~ LrT@ Mr Mr Mr Mr Mr Ms)~ MsD@Mt}qFMt}qF?M t?M u$> M r M r  M r ~ Mr@ Nr Nr Nr Nr Nr Ns)~ Nsa@Nt5+Nt5+?N t ,3k?N r<Ƿ? N r N r N r~ Nr*@ Or Or Or Or Or Os)~ Os{@Otى̤Otى̤?O t7aVR?O u!Zc> O r O ra O r~ OrI@ Pr Pr Pr Pr Pr Ps)~ Ps @Pt0ptdPt0ptd?P teح?P uWj$> P r P r P r~ PrP@ Qr Qr Qr Qr Qr Qs)~ Qs b@QtMDQtMD?Q t ?Q u`?F0> Q rQ r Q r~ Qr3@ Rr Rr Rr Rr Rr Rs)~ Rspr@RtZ=4RtZ=4?R te?R r!c p;? R r R r R r~ RrJ@ Sr Sr Sr Sr Sr Ss)~ SsD@St St ?S tJh~?S rh]J? S rc S rc S rc~ Sr$@ Trw Trx Trw Try Trz Ts)~ Ts@e@TtìuTtìu?T tW?T u> T r{ T rT T r|~ Tr1@ Ur Ur Ur Ur Ur Us)~ UsW@UtlKKbUtlKKb?U t(?U rXg:T? U r U r U r~ Ur @ Vr Vr! Vr Vr" Vr# Vs)~ Vst@Vt ͗|Vt ͗|?V t4ODW?V uE퐛> V rrr ~ Vr:@ Wr Wr Wr Wr Wr Ws)~ Ws^@WtZ(WtZ(?W t?i?W r7Fs? W r W r W r~ Wr0@ Xr Xr Xr Xr Xr Xs)~ XsT@XtD)6XtD)6?X t ?X r l? X r X r X r~ Xr@ Yr Yr Yr Yr Yr Ys)~ Ys@j@Yt RmYt Rm?Y tKt?Y uRfB5> Y rrr ~ Yr1@ Zr Zr Zr Zr Zr Zs)~ Zs@P@ZtZt?Z tNq4?Z rJU| ? Z rC Z rD Z rE~ Zr @ [r [r [r [r [r [s)~ [st@[tFnO[tFnO?[ tp|?[ r M/? [ r [ r [ r ~ [rB@ \r \r \r \r \r \s)~ \s[@\t_\t_?\ tVQ?\ r\p? \ r \ r \ r~ \r3@ ]r, ]r! ]r, ]r" ]r, ]s)~ ]s@]t ]t ?] tAx;L?] utPAFQ> ] rrr ~ ]rW@ ^r , ^r , ^r , ^r, ^r, ^s)~ ^sR@^t ׁ^t ׁ?^ txl'M?^ r8^X? ^ r ^ r ^ r~ ^r@ _rc _rd _rc _re _rf _s)~ _sȉ@_t1Î@_t1Î@?_ th MW?_ uR_F6'> _ rg _ rh _ ri ~ _rQ@DPl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r/ `r0 `r/ `r1 `r2 `s)~ `sy@`t `t ?` tCqvY?` rx.2? ` r3 ` r4 ` r5~ `rL@ ar3 ar4 ar3 ar5 ar6 as)~ asb@ateCateC?a ty_?a r{ {? a r7 a r8 a r9~ ar5@ br br br br br bs)~ bs@bt*`VZbt*`VZ?b te6 ?b u37=b r b r" b r ~ br`j@ cr( cr) cr( cr* cr+ cs)~ cse@ctظ8Sd?ctظ8Sd?c t b?gtTc>b?g tkm?g uPy> g r g r g r~ gr`b@ hr hr hr hr hr hs)~ hsq@ht.?ht.?h t?h r\B? h r h r h r~ hrA@ ir ir ir ir ir is)~ is[@itY;[?itY;[?i tm58=i?i rovy? i r i r i r~ ir2@ jr jr jr jr jr js)~ js@z@jt:`c?jt:`c?j tan?j r㌜Ii? j r j r j r~ jrJ@ kr[ kr\ kr[ kr] kr^ ks)~ ksj@kt*b(?kt*b(?k t7#*T)?k u;wqJ-> k r_ k r` k ra~ kr1@ lr lr lr lr lr ls)~ lse@lts7?lts7?l t(zT+I?l r^Io? l r l r l r ~ lr0@ mr mr mr mr mr ms)~ msz@mt+?mt+?m tPAN?m uc*⡙= m r m r m r~ mr:@ nr nr nr nr nr ns)~ ns@ntp+3?ntp+3?n t~Cr?n u1RX= n r n r n r~ nr`h@ or& or' or& or( or) os)~ os9@ot=Ռ?ot=Ռ?o td3淿?o ruÕ? o r* o r+ o r,~ or @ prG prH prG prI prJ ps)~ ps @pt_N3-?pt_N3-?p tVv,5?p uq kW p< p rK p rL p rM~ prR@ qr qr qr qr qr qs)~ qs@P@qt:?qt:?q tՙi?q r:ɑTɠ? q r q r* q r~ qr(@ rr. rr/ rr. rr0 rr1 rs)~ rsy@rt Βw3>?rt Βw3>?r t^\Y?r u%]fE%> r r2 r r3 r r4~ rrI@ sr$ sr% sr$ sr& sr' ss)~ ssD@st8A f?st8A f?s t6hb?s r<S? s r( s r s r)~ sr@ tr tr tr tr tr ts)~ ts@`@ttR"C?ttR"C?t trUa?t r|mn? t r  t r! t r"~ tr&@ ur ur ur ur ur us)~ usp@utYϩ?utYϩ?u tB|S?u rm ? u r u r u r~ urJ@ vr vr vr vr vr vs)~ vs`@vt;!?vt;!?v t/T@m?v rEI? v r v r v r ~ vr9@ wrf wrg wrf wrh wri ws)~ wsd@wtar^?wtar^?w tu?w r<?ztV6>?z t/戅?z u+:> z r| z r} z r~~ zrR@ {r {r {r {r {r {s)~ {s@{tMy?{tMy?{ t?{ uW> { r { r { r~ {rU@ |r" |r# |r" |r$ |r% |s)~ |sq@|t `b?|t `b?| t.'@| rfzn@!? | r& | r' | r( ~ |rD@ }r? }r@ }r? }rA }rB }s)~ }sx@}t?o?}t?o?} tZ鴀@} u0= } rC } rD } rE~ }rc@ ~r2 ~r3 ~r2 ~r4 ~r5 ~s)~ ~s`p@~t%ͫAE?~t%ͫAE?~ ts eȐ@~ u&4LEl? ~ r6 ~ r7 ~ r8~ ~r?@ r r r r r s)~ s`@tm`:?tm`:? tIoJ@ u]9j=  r  r  r~ r[@Dl,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sy@ty?ty? toV;@ uuzߘk? r r r~ r@T@ r r r r r s)~ s(@t3H?t3H? tw%p@ uGYʿX< r r r~ rP@ rI rJ rI rK rL s)~ sf@tA_?tA_? t7@ rA'bTS? rM rN rO~ r1@ r r r r r s)~ sk@tQ;}?tQ;}? t3/@ uyY{N> rrr ~ r2@ r& r' r& r( r) s)~ s@P@ts0L6cU?ts0L6cU? t?v[9^|@ ru-a? r* r+ r,~ r(@ r r r r r s)~ s l@t+31Ÿ?t+31Ÿ? tp8@ rX+(? r r r~ r;@ rk rl rk rm rn s)~ sd@tF%?tF%? t;6@ ua|?> ro rp rq ~ r1@ r r r r! r" s)~ sA@t ?t ? t o]@ rvF? r#  r r$ ~ r@ r r r r r s)~ st@t|0?t|0? t@ u52I> r r r~ rF@ r r r r r s)~ sv@t~?o3?t~?o3? t^5 @ u>Q> r r r~ rM@ r* r+ r* r, r- s)~ s`@tS9?tS9? t$6@ u M> r. r/ r0 ~ r(@ ry rz ry r{ r| s)~ sj@t<?t<? t+@ uW> r} r~ r~ r>@ r, r r, r  r0 s)~ s@tѕӅD?tѕӅD? t;[@ r:JBPR? r, r, r,~ rc@ r r r r r s)~ s@tRAL?tRAL? ti@ uWPp = r r r~ rT@ rs rt rs ru rv s)~ si@tRh?tRh? t5@ r!y +? rw rx ry ~ r7@ r' r' r' r' r' s)~ s>@t.+?t.+? t_/@ r=V? r' r' r'~ r"@ rQ rR rQ rS rT s)~ s{@tq?tq? t\ٓ@ uNzB:a> rU rV rW~ rK@ r r r r r s)~ s@_@t6?t6? tC@ rhX? r r r ~ r7@ r r r r r s)~ s@t ?t ? t_AB!@ uR5 r r r~ ra@ r r r r r s)~ s(@tX$J?tX$J? t @ uHR9 r r r~ rZ@ rO rP rO rQ rR s)~ s@tP?tP? tQwa`@ uW^R< rS rT r~ rT@ r r r r r s)~ s@@tifL?tifL? t @ ur7 r r r~ rU@ r r r r r s)~ sPy@tWK@tWK@ t}4Su@ ui(= r r r~ rH@2>@y"yzz??X??ggD ZO 3COCnChCRC@C CD'DHFD6eDDDDDD^E2=E\EzEEExEEFv4FdSFrFАF–F  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} }  } I} m} m.} !} m o} } m} $ } m} ,} *} $,} } h,; ; ,,,, , , , , ,,,,,,,,,,,,,,,,,,, i8 j6 p p p p p p p p p  p  p  p  p  p p# r? r@ r? rA rB s)~ sA@tSZtSZ? t3? r~}K3?  rC  rD  rE~ r@ r r r r r s)~ s@P@t¢'ot¢'o? tjkS? r1f?  rC  rD  rE~ r@ rO rP rO rQ rR s)~ s@o@t]]t]]? tu)? r]"ęU?  rS  rT  rU~ r5@ r( r r( r( r( s)~ sd@tOo?ktOo?k? t|'.3? rWFs0?  rrr ~ r9@ r, r, r, r , r , s)~ s@P@ tк tк? tyNa? ry Ys@b? r r r~ r@ r` ra r` rb rc s)~ sp@ tPUп tPU? tҟC? r7? rd re rf~ rE@ r/ r r/ r/ r/ s)~ sf@ td!ns td!ns? tk߫=J? u, rrr ~ r.@ rv rw rv rx ry s)~ sI@ tWL| tWL|? t:#)t? r ^|? rrr ~ r@ r6 r6 r6 r6 r6 s)~ sA@ tAO? tAO? tsG? rWDW:h? r0 r0 r0~ r@ r"""""""" " " " " """"""""""""""""""" "!"""#"$"%"&"'"(")"*"+","-"."/"0"1"2"3"4"5"6"7"8"9":";"<"=">"?"@"A"B"C"D"E"F"G"H"I"J"K"L"M"N"O"P"Q"R"S"T"U"V"W"X"Y"Z"["\"]"^"_"`"a"b"c"d"e"f"g"i"j"k"l"m"n"o"p"q"r"s"t"u"v"w"x"y"z"{"|"}"~""" r r r r s)~ s@t(|?t(|? toH? u÷ mJ <  r  r  r~ r@_@ r6 r6 r6 r6 r6 s)~ s@ttW\"ttW\"? tTe? rI!R?  r0  r0  r0~ r? r% r& r% r' r( s)~ sR@tTtT? t:ݖ? r5""ْ?  r)  r*  r+~ r@ r. r/ r. r0 r1 s)~ s w@tO'6?tO'6? tj ? u>=  r2  r3  r4~ rG@ r@ rA r@ rB rC s)~ sH@tS/I tS/I ? t~? u oT=  rrr ~ rR@ rO rP rO rQ rR s)~ s~@t1-?t1-? tu @ u3uFA=  rS  rT r~ rO@ r rh r r r s)~ s9@t|Ϳt|? t^A? ro?  rrr ~ r@ r6 r r6 r6 r s)~ sd@t_.צɿt_.צ? tȼF~? r}q$f?  r20  r30  r40~ r9@ r r r r r s)~ sY@t.o?t.o? tr_? r/xS?  r  r  r~ r,@ r r r r r s)~ sA@tl!8῿tl!8? txzZ? ryܑ?  rc  r  r~ r@ r6 r9 r6 r6 r6 s)~ s.@tdz+tdz+? t n? rC7?  r0  r0  r0~ r@ r r r r r s)~ s>@tٿt? tKU7? r~^X?  r  r  r~ r@ r r r r r s)~ sQ@t^ǿt^? t\Q@? r!?  r  r  r~ r&@ r r r r r s)~ sv@t12t12? tœ/? r6Zp?  r  r  r~ rJ@ r r r r r s)~ st@tyty? tW] ? r C,?  r  r  r~ rF@ r r r r r s)~ su@t}B9?t}B9? t<$I? uC Q>  r  r  r~ rN@ r r r r r s)~ s@Z@tJݿtJ? tH.75? rk4?  r  r  r~ r0@ r r r r r s)~ sR@tͫ2׿tͫ2? t ˟? ro?  r  r  r~ r"@BX ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r" r# r" r$ r% s)~ sV@ t! t!? t88ڻ? rPv? r& r' r(~ r*@ !r2 !r3 !r2 !r4 !r5 !s)~ !s`}@!t0#!t0#?! tޅ?! u3ޑ; ! r6 ! r7 ! r8~ !rG@ "r\ "r] "r\ "r^ "r_ "s)~ "s~@"t5 "t5 ?" tٯ m?" u NV> " r` " ra " rb~ "rD@ #rd #re #rd #rf #rg #s)~ #sj@#tmM&LO#tmM&LO?# t9y?# rO? # rh # ri # rj~ #r=@ $r6 $ru $r6 $rv $r6 $s)~ $s[@$t@^"4?$t@^"4?$ tZȽ?$ r`7:5^? $ r0 $ r0 $ r0~ $r0@ %rb %r} %rb %r~ %rc %s)~ %sk@%t1Gd?%t1Gd?% tlZC?% rV? % rrr ~ %r4@ &r &r &r &r &r &s)~ &s@Z@&tʿ&t?& tϭ?& r8\x?& r & r & r ~ &r(@ 'r 'r 'r 'r 'r 's)~ 'sX@'t@]9G?'t@]9G?' tX/@' u-= ' r ' r ' r~ 'rR@ (r (r (r (r (r (s)~ (sg@(tDׂW?(tDׂW?( tQ3=گ?( r5Y ? ( r ( r ( r~ (r?@ )r )r )r )r )r )s)~ )s r@)t Ϳ)t ?) t&9F?) r? ) r ) r ) r~ )rC@ *r *r *r *r *r *s)~ *s`@*t輼ӑ?*t輼ӑ?* t( %@* us(= * r * r * r~ *rR@ +r +r +r +r +r +s)~ +sH@+tD-z?+tD-z?+ t<@a?+ rܡbi1? + r + r + r~ +rI@ ,r ,r ,r ,r ,r ,s)~ ,sk@,tkA?,tkA?, t & ?, r)m? , r , r , r~ ,r:@ -r -r -r -r -r -s)~ -s>@-t 6FԿ-t 6F?- t?- rNqC? - r - r - r~ -rg@ .r .r .r .r .r .s)~ .s`@.tctg?.tctg?. to*@?. r| O? . r . r . r~ .r i@ /r /r /r /r /r /s)~ /sy@/t(?/t(?/ tM(Q?/ rbi ? / r / r / r~ /rP@ 0r 0r 0r 0r 0r 0s)~ 0s~@0tbM>,y?0tbM>,y?0 t7/?0 ry,? 0 r 0 r 0 r~ 0rI@ 1r 1r 1r 1r 1r 1s)~ 1sI@1tuaz˿1tuaz?1 tʴ?1 r"&!? 1 r 1 r 1 r~ 1r @ 2r 2r 2r 2r 2r 2s)~ 2sk@2tf?9&2tf?9&?2 t܈Q:?2 rDnʔ {? 2 r 2 r 2 r~ 2r2@ 3r! 3r! 3r! 3r! 3r! 3s)~ 3sQ@3t fʦ3t fʦ?3 t4 hQ?3 u)U> 3 r 3 r  3 r~ 3r@ 4r 4r 4r 4r 4r 4s)~ 4sT@4t? R4t? R?4 t;] ?4 u؏*+> 4 r 4 r  4 r~ 4r@ 5r 5r 5r 5r 5r 5s)~ 5sN@5t715t71?5 tqe7#?5 r_A"R? 5 r 5 r  5 r~ 5r@ 6r 6r 6r 6r 6r 6s)~ 6sW@6trqc6trqc?6 t^vN?6 uC Q> 6 r 6 r  6 r~ 6r @ 7r% 7r& 7r% 7r' 7r( 7s)~ 7s g@7t5&[7t5&[?7 tfI4n?7 uإZKٺ> 7 r 7 r  7 r~ 7r.@ 8r* 8r+ 8r* 8r, 8r- 8s)~ 8s[@8t"U"8t"U"?8 t?8 u!j[> 8 r 8 r  8 r~ 8r$@ 9r/ 9r0 9r/ 9r1 9r2 9s)~ 9sv@9t O9t O?9 t_qb+?9 u^u> 9 r3 9 r4 9 r5~ 9rF@ :r7 :r8 :r7 :r9 :r: :s)~ :s@j@:tw1p W?:tw1p W?: tN7:FS?: uEӦt> : r; : r< : r=~ :r3@ ;r ;r ;r ;r ;r ;s)~ ;sd@;t`^m;t`^m?; t_D?; roP? ; r ; r ; r~ ;r7@ <r: <r; <r: <r< <r= <s)~ <s`h@<t < r? < r@~ <r?@ =r? =r@ =r? =rA =rB =s)~ =s0@=tSW˿=tSW?= t2Q?= u;3= = rC = rD = rE~ =rT@ >rG >rH >rG >rI >rJ >s)~ >sȍ@>t`l?>t`l?> t\$?> u9,%؈9 > rK > rL > rM~ >rQ@ ?rO ?rP ?rO ?rQ ?rR ?s)~ ?sb@?t ,n?t ,n?? tc{s?? rvv? ? rS ? rT ? rU~ ?r,@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rX @rY @rX @rZ @r[ @s)~ @s@@tX?@tX?@ t't?@ uUIN> @ r\ @ r] @ r^~ @ra@ Ar` Ara Ar` Arb Arc As)~ As@AtyA?AtyA?A tt2]6b?A rאˏ? A rd A re A r^~ Ar@U@ Brg Brh Brg Bri Brj Bs)~ Bs@BtxU?BtxU?B t-'?B rjs-<^? B rk B rl B rm~ BrS@ Cro Crp Cro Crq Crr Cs)~ Cs@e@Ct#e+ Ct#e+ ?C tyҢ?C u .`> C rs C rt C ru~ Cr.@ Dr~ Dr Dr~ Dr Dr Ds)~ Dsi@Dt9s?Dt9s?D t1P?D r. dұ? D rD r D r~ Dr?@ Er Er Er Er Er Es)~ Esk@Et[F2I4v?Et[F2I4v?E t RlE@E uY]x= E r E r E r~ Er6@ Fr Fr Fr Fr Fr Fs)~ FsT@FtvtG?FtvtG?F tx3@F ru? F r F r F r~ Fr(@ Gr Gr Gr Gr Gr Gs)~ Gsh@Gt4?Gt4?G tnBN?G rM? G r G r G r~ Gre@ Hr Hr Hr Hr Hr Hs)~ Hs@P@HtgL g?HtgL g?H tsw?H r%A? H r H r H r~ Hr @ Ir Ir Ir Ir Ir Is)~ Isp@It8 I r I r I r~ Ir>@ Jr Jr Jr Jr Jr Js)~ Js$@Jt p}?Jt p}?J t$="@J ue7o 5 J r J r J r~ Jr `@ Kr Kr Kr Kr Kr Ks)~ Ks@j@Kt(OgtKt(Ogt?K t] lj?K r}6:N? K r K r K r~ KrB@ Lr Lr Lr Lr Lr Ls)~ Lsd@LtEc?LtEc?L tX R @L utwL8 L r L r L r~ LrY@ Mr Mr Mr Mr Mr Ms)~ Msv@Mtz˽m?Mtz˽m?M tʹq{? @M uX:zy= M r M r M r~ MrB@ Nr Nr Nr Nr Nr Ns)~ Ns @Nt"[8|?Nt"[8|?N tCb?N r% ? N r N r N r~ NrV@ Or Or Or Or Or Os)~ Os b@Ot aňпOt aň?O tcz?O ri? O r O r O r~ Or4@ Pr Pr Pr Pr Pr Ps)~ PsL@PtwX* ϿPtwX* ?P tKqd ?P uұ7M> P r P r P r~ Pr@ Qr Qr Qr Qr Qr Qs)~ Qss@QtGLL*QtGLL*?Q tD?Q rt pd? Q r Q r Q r~ QrB@ Rr RrP Rr Rr Rr Rs)~ Rs@@Rt®`Rt®`?R t ޻?R ur=;R r R rD R r~ RrE@ Sr Sr Sr Sr Sr Ss)~ Ss@StP5Z?StP5Z?S t?S uhq4*< S r S r S r~ Sr`e@ Tr* Tr+ Tr* Tr, Tr- Ts)~ TsD@TtHl?TtHl?T t5?T rG+? T r. T r/ T r0~ Tr@ Ur6 Ur3 Ur6 Ur4 Ur6 Us)~ Us l@Ut4?Ut4?U tt8r@U u2vm> U r/ U r/ U r/~ Ur;@ Vr: Vr; Vr: Vr< Vr= Vs)~ Vsj@Vt[Kq¿Vt[Kq?V t:' X?V rZⰏi? V r>V r V r?~ Vr<@ WrA WrB WrA WrC WrD Ws)~ Wsf@Wt0AmWt0Am?W t4-Fe?W rQ,7t? W rE W rF W rG~ Wr<@ XrI XrJ XrI XrK XrL Xs)~ Xs@P@Xt4ws{Xt4ws{?X t[ V ?X ru? X rM X rN X rO~ Xr&@ YrQ YrR YrQ YrS YrT Ys)~ Ys0x@Yt:?Yt:?Y t?Y rDaR? Y rU Y rV Y rW~ YrI@ ZrY ZrR ZrY ZrS ZrZ Zs)~ Zs$@Zt]?Zt]?Z tG?Z ro? Z rrr ~ Zr? [r\ [r] [r\ [r^ [r_ [s)~ [s>@[tOoJ7?[tOoJ7?[ t!&@[ rM? [ r` [ ra [ r~ [r@ \rc \rd \rc \re \rf \s)~ \s@\tW#^?\tW#^?\ tBm0?\ uOya?> \ rg \ rh \ ri~ \rQ@ ]rk ]rl ]rk ]rm ]rn ]s)~ ]sW@]ty$?cп]ty$?c?] tgEk?] r+S.3? ] ro ] rp ] rq~ ]r.@ ^rs ^rt ^rs ^ru ^rv ^s)~ ^s8@^tx9?l r߃L-int>L-i?n tRM+?n ru? n r\ n r] n r^~ nr?@ or{% or|% or{% or}% or~% os)~ osN@ot!V Pot!V P?o t~?o rDvF? o r% o r% o r%~ or"@ pr6 pry pr6 prz pr6 ps)~ ps0v@ptʨڮ?ptʨڮ?p tzSJB@p uSK> p r/ p r/ p r/~ prI@ qr qr qr qr qr qs)~ qsR@qt\Ci|?qt\Ci|?q t9_x1?q rL ?? q r q r q r~ qr(@ rr rr rr rr rr rs)~ rsI@rtIӿؿrtIӿ?r tm ?r rWaj6? r r r r r r~ rr"@ sr sr sr sr sr ss)~ ss.@st 2l%?st 2l%?s tk@_5Ks?s r|L? s r s r s r~ sr@ tr tr tr tr tr ts)~ ts@tt}tt}?t t?Yg?t rdHڛT? t r t r t r~ trQ@ ur ur ur ur ur us)~ use@ut)Ra ut)Ra ?u toF ?u r%C p? u r u r u r~ ur6@ vr vr vr vr vr vs)~ vs@e@vtin vtin ?v t#ROX?v rzW]? v rv r v r~ vr(@ wr wr wr wr wr ws)~ wsx@wt*K?wt*K?w t}O?w r@zt>!?zt>!?z t]o_{?z r"&/? z r z r z r~ zr@ {r {r {r {r {r {s)~ {s@`@{t/F'!g{t/F'!g?{ t9mr?{ r$^nP? { r { r { r~ {r1@ |r |r |r |r |r |s)~ |ss@|t C4|t C4?| tC5?| rzό#? | r | r | r~ |rG@ }r }r }r }r }r }s)~ }sP@}tx)N(?}tx)N(?} t -?} rjs-<^? } r } r } r~ }r@[@ ~r, ~r! ~r, ~r" ~r, ~s)~ ~s@~ta.7~ta.7@~ t-ˤg?~ u`Z}> ~ rrr ~ ~r@W@ r( r) r( r* r+ s)~ s\@tiuvYZ?tiuvYZ? t\Wԑ@ rş5&?  r,  r-  r.~ r0@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r@ rA r@ rB rC s)~ ss@tӲeK?tӲeK? tj޹f? r2I? rD rE rF~ rF@ r` ra r` rb rc s)~ s@_@t[?t[? tFI^? r$uӃ? rd re rf~ r4@ r r r r r s)~ su@t.^vk?t.^vk? toNGf ? r|? r r r~ rL@ r r r r r s)~ sP@t@ Ot@ O? twyP? r!u䡺? r r r~ rn@ r r r r r s)~ s9@t֐﬙?t֐﬙? tvG? r'7 .? r r r~ r@ r r r r r s)~ sK@t쥚R?t쥚R? tQ? r+&:? r r r~ r"@ r r r r r s)~ s0q@tA)?tA)? t28@ uh;F? r r r~ rC@ r r r r r s)~ sF@t|ڿt|? tj? r҇>[? r r r~ r@ r r r r r s)~ sf@tYZtYZ? tdi@? ry2b@t6_t6_? tv? rMKu|? r r  r ~ r@ r6 rI" r6 rJ" r6 s)~ s9@t^Jt^J? t6^[Q? ry? r!0 r"0 r#0~ r@ r r r r r s)~ sR@t$sH#`˿t$sH#`? tz=O? rJı? r r r~ r0@ r r r r r s)~ s@Z@t^k#t^k#? t{-Q? r2_;ږ? rS r r~ r1@ r r r r r s)~ sd@tkT?tkT? t`J8? r|r8? r r r~ r6@ r r r r r s)~ s@t9%0? r$y 3? r r r~ r&@ r> r? r> r@ rA s)~ s@t vtt vt? t%"N? rsFX? rB rC rD~ rM@ rF rG rF rH rI s)~ s@P@t]쩿t]? tVx? r44`-? rJ rK rL~ r(@ rN rO rN rP rQ s)~ sl@t?t? tЈT3? r ə? rR rS rT~ rA@ r0 rW r0 rX r0 s)~ sQ@tZ.BtZ.B? tD.N? r. dұ? rrr ~ r*@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s l@t>^Nοt>^N? t:(? rB? r r r ~ r@@ r/ r r/ r/ r/ s)~ s@t}x?t}x? tҊf@ ugq[X; r/ r/ r/~ rU@ r r r r r s)~ s.@tKi=ٿtKi=? to/*? r/A2? r r r~ r@ r6 r r6 r r6 s)~ s.@tEZ?tEZ? tM9? rƐ#? r0 r0 r0~ r@ r r r r r s)~ sq@t7 t7 ? t: ? r;k? r r r~ rB@ r r r r r s)~ s0v@tr1맿tr1? tg[R? rd:? r r r~ rN@ r r r r r s)~ sn@tHutͿtHut? tj1H? r} ? r r r~ r?@ r- r. r- r/ r0 s)~ s@tq徭tq徭? t驼? rȝ^I? r1 r2 r3 ~ rY@ r6 r> r6 r? r6 s)~ s9@t@H?@t@H?@ tmѓ@ rt? r1 r1 r1~ r@ rR rS rR rT rU s)~ sg@tܫۿtܫ? t? rR^U? rV rW rX ~ r4@ rc rd rc re rf s)~ sI@tt<|]'ֿtt<|]'? tuwy,? rKmY? rg rh ri ~ r @ rx ry rx rz r{ s)~ sA@tt? tMa? rME+'? r| rT r} ~ r@ r r r r r s)~ s@t,ITft,ITf? tM&_? rR^U? rf- rg- rh-~ r@ r6 r r6 r6 r6 s)~ s@P@t&t&? t<`? r5tQ? r; r; r;~ r$@ r r r r r s)~ s4@txF#@txF#@ t+|؅A@ rWin? r r r~ r@ r r r r r s)~ sn@t:vt:v? tA40@? rH? rrr ~ r1@ r r r r r s)~ sn@t5c#t5c#? tW6;? r7HT? r r r~ r=@ r6 r r6 r6 r6 s)~ s4@tBˠkʿtBˠk? tS1? r-X&Z? r1 r1 r1~ r@ r r r r r s)~ sT@t[جĘ4ۿt[جĘ4? ty0[? rb"%/? r r r ~ r,@ r r r r r s)~ s>@t-ͯ t-ͯ ? tD? rOJݱ+? r r r~ r@ r r r r r s)~ sR@tคtค? t,pc? r ;? r r r~ r @ rH! r  rH! rI! rJ! s)~ s$@t0~?t0~? t9~Q^8@ r^}H? r; r; r;~ r@ r r! r r" r# s)~ s0v@tDtD? t'XՎ? u:k!}`> rrr ~ r8@ r* r+ r* r, r- s)~ s@`@tZ?tZ? tX }@ u^$ϟ> r. r/ r0 ~ r&@ rC rD rC rE rF s)~ sK@t:ʿt:? t(A? r@O ? rG rH rI ~ r&@ r6 r r6 r6 r6 s)~ sK@tCeѷLtCeѷL? tG@K? r%? r0 r0 r0~ r"@ r6~ v@=@ r6 r6 r6 s)~ s9@tv5/i?tv5/i? t[u?tAMK]>? t&J`@ u%8< r r r~ rM@ r r r r r s)~ s^@t]7?t]7? tH? rl ? r r r~ r1@ r r r r r s)~ s0p@t7"S?t7"S? tJ§@ uPJ> r r r~ r>@ r2 r r2 r r3 s)~ sD@t\VD՞?t\VD՞? t5 _? r$uӃ? rrr ~ r@ r5 r6 r5 r7 r8 s)~ sT@tIlbtIlb? tCv? u;_d> r r  r~ r@ r: r; r: r< r= s)~ sF@tΎ2~&ӿtΎ2~&? t e>? rejU? r r  r~ r@ r? r@ r? rA rB s)~ s@P@tktk? tA"? r%? r r  r~ r@ r# r$ r# r% r& s)~ sW@tt? tL6ӯ4? r%+1e? r r  r~ r"@ rD rE rD rF rG s)~ s@_@tSI=ΘtSI=Θ? t^#ʧx? rlJc? rH r rI ~ r2@ rK rL rK rM rN s)~ spr@t|Vr?t|Vr? tX%e? rC7? rO rP rQ ~ r;@ rS rT rS rU rV s)~ s{@t+qt+q? t+Um6? u#T= rW rX rY ~ r>@ rc rd rc re rf s)~ s@t*͏t*͏? tmqY? u1= rg rh ri ~ rO@ rk rl rk rm rn s)~ sf@tz {(W5?tz {(W5? tF t? uq.> ro rp rq ~ r.@ rs rt rs ru rv s)~ s g@t d?t d? to~5@ rt^{8? rw rx ry ~ r6@ rw rx rw ry rz s)~ s@j@te te ? tLK? r=+? r{ rT r|~ r3@ r{ r| r{ r} r~ s)~ si@tot@?tot@? t5% @ rekh? r r" r ~ r3@ r r r r r s)~ s b@tj,&Lg>?tj,&Lg>? tb:\CF? rRAgĀ? r r r ~ r,@ r r r r r s)~ s{@tZ[`UtZ[`U? twd? r'K;֣? r r r~ rI@ r r r r r s)~ s@U@t9Rb?t9Rb? tP? rF\]{? r r r ~ r*@ r  r! r  r" r# s)~ s@_@tilbtilb? tDa? ra? r$ r% r&~ r1@ r r r r r s)~ s`h@t'B?t'B? tN]L? r>O? r r r ~ r1@ r r r r r s)~ s{@tjf-tjf-? t$]? ro? r r r ~ rI@ r r r r r s)~ s@U@t ٌt ٌ? t,p? uEG? r r  r ~ r"@ r r r r r s)~ sY@tZI tZI ? tFKTD? u<%sm> r  r  r ~ r"@ r r r r r s)~ se@t;?jt;?j? tN`]ס? r9ũe? rrr ~ r8@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s^@t! 1ėt! 1ė? tuC? rPI=_& ? r r r ~ r.@ r6 r r6 r r6 s)~ sD@tD޾tD޾? tr=8+o? rUT? r0 r0 r0~ r@ r r r r r s)~ sp@tZ:ڿtZ:? tt n)? r$y 3? r r r ~ rS@ r r r r r s)~ s b@tt{tt{? t1A? rZ? r r r ~ r1@ r r r r r s)~ sA@tчDtчD? t1x? r'M;? r r r ~ r@ r r r r r s)~ s g@t9-,?t9-,? tfFW? rG>? r r r~ rA@ r r r r r s)~ sa@tŜ.I2tŜ.I2? tBɣDM? r|g,D{s? r r r~ r2@ r, r- r, r. r/ s)~ sA@tyty? t_+? rH.D? r0 r1 r2 ~ r@ r6 r r6 r  r6 s)~ s@t.?t.? t1m@ u' \> r0 r0 r0~ r@S@ r< r= r< r> r? s)~ sl@t0o|t0o|? tK~? r&EM| ? r@ rA rB ~ rB@ r6 rE r6 rF r6 s)~ s4@t4&Ufh?t4&Ufh? t ~p? r͍? re0 rf0 rg0~ r@ rT rU rT rV rW s)~ s@e@t+ ׿t+ ? t3? rЫ? rX rY rZ ~ r<@ r6 r6 r6 r6 r6 s)~ s.@t3t3? t? r% ? r<0 r=0 r>0~ r@ r r r r r s)~ s~@t+m˅vt+m˅v? tA5 ? u74ާ: r r r~ rO@ r r r r r s)~ sd@tܡݿtܡ? t|q؜,? ru? r r r~ r4@ r r r r r s)~ sj@tWٿtW? tR~uKc? r[֬? r r r ~ r6@ rP rQ rP rR rS s)~ s.@tWلJ?tWلJ? tN? rdݠ? rT rU rV~ r@ r r r r r s)~ s@_@tVMkE?tVMkE? t ? r 2 z? r r* r ~ r4@ r r r r r s)~ sN@t>ѿt>? tf Hf? r@6s ? r r r ~ r$@ rh ri rh rj rk s)~ sa@tXRltXRl? t u? r~^X? rrr ~ r3@ r r r r r s)~ sp@t\*,]t\*,]? t^ߙ? r D۲C? r r r ~ rD@ r r r r r s)~ sz@t;ڿt;? t? raM? r r r ~ rH@ r r r r r s)~ s@e@teE޿teE? tw(l? r2I? rrr ~ r2@ r r r r r s)~ sb@t6 f?t6 f? t] j? rIh? r  r! r"~ r(@ r r r r! r" s)~ sD@tÌP?tÌP? t #@ r}vv? r#  r r$ ~ r@ r& r' r& r( r) s)~ s@}@tՇtݿtՇt? tq9W? rDga? r* r+ r, ~ rC@ r6 r7 r6 r8 r9 s)~ s.@tj)Xkltj)Xkl? trt:Y? rG.z? r: r; r< ~ r@ rV rW rV rX rY s)~ sF@tDotDo? tg? r=? rZ r[ r\ ~ r@ r^ r_ r^ r` ra s)~ s^@t"u8t"u8? tmvЃ? r}/M? rb rc rd ~ r*@ r~ r r~ r r s)~ s0q@ttI+;̿ttI+;? t~ՔҨv? r4`? r r r ~ r@@ r r r r r s)~ sf@tXhٿtXh? tGb? r^? r r r~ r;@ r r r r r s)~ s\@tDNC ?tDNC ? tjK%? u77> r r r ~ r1@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ s.@tyֿty? tgoA? rH.D?  r  r  r ~ r@ r  r  r  r r s)~ sY@tftf? t/ d? r?Al? r  r"  r~ r,@ r6 r r6 r r6 s)~ s@P@t,gt,g? t4ÄZ? r~c~?  r0  r0  r0~ r(@ r r r r r s)~ sI@tm$ſtm$? teo? r+S.3?  r  r  r ~ r"@ r/ r0 r/ r1 r2 s)~ s@U@t+vؿt+v? txS7? rG.z?  r3  r4  r5~ r*@ r r r r r s)~ sd@t'Zt'Z? tO_? rsԷa?  r  r  r~ r4@ r r r r r! s)~ sA@t/~:at/~:a? t5:ZX? r:=X?  r"  r#  r$ ~ r@ r& r& r& r& r& s)~ sȇ@t#z?t#z? tl ۠D? r.NP?  rrr ~ rR@ r` ra r` rb rc s)~ sK@tY>GſtY>G? tme;]? rٗPk?  rd  re  rf~ r"@ rh ri rh rj rk s)~ sN@ t-鷫 t-鷫?  toۋ?  rSR0?  rrr ~ r@ r| r} r| r~ r s)~ sY@ t<6? t<6?  t ㆂ?  r?  r  r  r~ r*@ r r r r r s)~ sK@ txn| txn|?  tIC?  rME+'?  r  r  r~ r@ r r r r r s)~ s`q@ tg9.& tg9.&?  tti?  u >  r  r  r ~ r>@ r r r r r s)~ sV@ tC7u tC7u?  t,  r  r  r~ r"@ r r  r r! r" s)~ s@P@t~gEQܿt~gEQ? tSrQ? r)FwK?  rC  rD  rE~ r @ r$ r% r$ r& r' s)~ sT@t=Lt=L? t&8l? u}g8> """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""# r(  r)  r*~ r@ r4 r5 r4 r6 r7 s)~ s4@t ܿt ? tQf? r1hA؛?  r  r  r~ r@ r9 rP r9 r: r; s)~ s``@tz$tz$? thr}? rY?  r  r  r~ r,@ rE rP rE rF r; s)~ sQ@t0˭t0˭? t$? r/$b?  rrr ~ r"@ r6 rI r6 r6 rK s)~ so@t  ׾Ŀt  ׾? t<02j? rjDDdM?  rL  rM  rN~ rI@ r  r  r  r r s)~ s>@t=??t=?? tem@ r+S.3?  r  r  r~ r@ r\ r] r\ r^ r_ s)~ sD@teQNtteQNt? t`? rT $W?  r`  ra  rb~ r@ re rf re rg rh s)~ s9@tQ߽ ?tQ߽ ? t+Vn? rt pd?  ri  rj  rk~ r@DTl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, rv~ v<@ rv rx ry s)~ s>@ tȊor\ tȊor\?  t$6l}?  rOV?  rz  r{  r|~ r@ !r !r !r !r !r !s)~ !sN@!tO!J Oܿ!tO!J O?! t{?! rFV?? ! r ! r ! r~ !r&@ "r "r "r "r "r "s)~ "s9@"tD޻"tD޻?" t;D?" ra? " r " r " r~ "r@ #r6 #r #r6 #r6 #r6 #s)~ #s9@#tsmb[ÿ#tsmb[?# t?# rQ? # rH0 # rI0 # rJ0~ #r@ $r6 $r $r6 $r7 $r7 $s)~ $s\@$t_y?$t_y?$ t%?$ rrQD,? $ r0 $ r0 $ r 0~ $r3@ %r7 %r7 %r7 %r7 %r7 %s)~ %s4@%t8~r%t8~r?% t H?% r}]? % r1 % r1 % r1~ %r@ &r &r &r &r &r &s)~ &s l@&t jr?&t jr?& tΞyVē@& u> & rrr ~ &r1@ 'r7 'r 'r7 'r 'r7 's)~ 's9@'tɍ1?'tɍ1?' t5?' r_~>? ' r0 ' r0 ' r0~ 'r@ (r5 (r (r5 (r (r- (s)~ (s9@(tǀ擵ѿ(tǀ擵?( tHid?es?( rOCs7? ( r- ( r- ( r-~ (r@ )r )r )r )r )r )s)~ )s4@)tovؿ)tov?) t1^t?) rpM? ) r ) r ) r~ )r@ *r *r *r *r *r *s)~ *s4@*tNoB޿*tNoB?* t=W?* rs_? * r * r * r~ *r@ +r" +r# +r" +r$ +r% +s)~ +sn@+t0>]?+t0>]?+ tB]k1\?+ u00S> + r& + r' + r( ~ +r@@ ,r ,r ,r ,r  ,r! ,s)~ ,s`s@,tC&,tC&?, tP@Sy?, u+i= , r" , r# , r$~ ,r9@ -r& -r' -r& -r( -r) -s)~ -s4@-tֿ-t?- tӮ?- r 2? - r* - r+ - r,~ -r@ .r. .r/ .r. .r0 .r1 .s)~ .sd@.t2+Y.t2+Y?. t%?. u> . r2 . r3 . r4~ .r2@ /r> /r? /r> /r@ /rA /s)~ /s>@/tEJX;/tEJX;?/ tgNk&?/ rMʟ`? / r / r  / r~ /r@ 0rQ 0rR 0rQ 0rS 0rT 0s)~ 0sx@0t^!gv?0t^!gv?0 t. A@0 u2\B~> 0 rU 0 rV 0 rW~ 0rF@ 1ra 1rb 1ra 1rc 1rd 1s)~ 1sF@1t/me1t/me?1 tFڴ3?1 r? 1 re 1 rf 1 rg~ 1r@ 2ri 2rj 2ri 2rk 2rl 2s)~ 2s>@2tC6!?2tC6!?2 t2qn6?2 r*8? 2 rm 2 rn 2 ro~ 2r@ 3rq 3rr 3rq 3rs 3rt 3s)~ 3sn@3tp_3tp_?3 ttT4?3 r0H<(C? 3 ru 3 rv 3 rw~ 3r9@ 4ry 4rz 4ry 4r{ 4r| 4s)~ 4sf@4tV 4 r} 4 r~ 4 r~ 4r9@ 5r 5r 5r 5r 5r 5s)~ 5sy@5tlqar5tlqar?5 t_=?5 uI3SO= 5 r 5 r 5 r~ 5rF@ 6r 6r 6r 6r 6r 6s)~ 6sd@6t+Q6t+Q?6 t"?6 r0H<(C? 6 r 6 r 6 r ~ 6r6@ 7rO 7rP 7rO 7rQ 7rR 7s)~ 7sN@7tK7tK?7 tc%d ?7 u#̖= 7 r 7 r  7 r~ 7r@ 8r 8r 8r 8r 8r 8s)~ 8sA@8t է _?8t է _?8 t2gr?8 r14ho? 8 r 8 r 8 r~ 8r@ 9r 9r 9r 9r 9r 9s)~ 9sF@9tk͊C?9tk͊C?9 td?9 r`,? 9 r 9 r 9 r~ 9r @ :r :r :r :r :r :s)~ :s$@:t Q a߿:t Q a?: t酲س?: rz? : r : r : r~ :r@ ;r ;r ;r ;r ;r ;s)~ ;s@j@;tiG?;tiG?; t(|r?; rGA? ; r ; r ; r~ ;r>@ <r <r <r <r <r <s)~ <s@u@<t*)?<t*)?< tό%?< rks0,? < r < r < r ~ <rL@ =r =r =r =r =r =s)~ =sA@=tNٿ=tN?= tÅ0B?= rs? = r = r = r~ =r@ >r >r >r >r >r >s)~ >sV@>t"4l>t"4l?> t˂(?> rbF? > r > r > r~ >r(@ ?r ?r ?r ?r ?r ?s)~ ?s@P@?tg7v`??tg7v`?? t6@? r| O? ? r ? r ? r ~ ?r*@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r  @r  @r  @r  @r @s)~ @s4@@t[=@t[=?@ t#0?@ ri? @ r @ r @ r~ @r@ Ar Ar Ar Ar Ar As)~ As$@Atyx)tݿAtyx)t?A tB?A rl#Ef$? A rrr ~ Ar@ BrB BrC BrB BrD BrE Bs)~ BsN@BtHCݰBtHCݰ?B tʹ2?B rljc4? B rF B rG B rH~ Br$@ Cr. Cr  Cr. Cr/ Cr0 Cs)~ Cs$@CtSιzοCtSιz?C t#^?C r'7 .? C rc C rc C rc~ Cr? Dr2 Dr3 Dr2 Dr4 Dr5 Ds)~ DsQ@DtI?DtI?D tef?D r!h? D r6 D r7 D r8~ Dr"@ Er7 Erm Er7 Ern Er 7 Es)~ Es9@EtRȅEtRȅ?E tgor?E r!u䡺? E r$0 E r%0 E r&0~ Er@ Fr Fr Fr Fr Fr Fs)~ Fss@Ft$B?Ft$B?F t!Z-?F r{yp ? F r F r F r~ Fr6@ Grj Gr Grj Gr Grk Gs)~ Gsa@Gt^kƿGt^k?G t EfW?G rE? G rl G rm G rn~ Gr6@ HrH HrI HrH HrJ HrK Hs)~ Hs4@Ht?͙߿Ht?͙?H tN?H rs!)? H rL H rM H rN~ Hr@ Ir Ir Ir Ir Ir Is)~ IsY@Itr Itr ?I tիq(A?I rw=p? I r I r I r~ Ir$@ Jr Jr Jr Jr Jr Js)~ Js`c@Jt [:mJt [:m?J t0+b?J u?֊M> J rJ r J r~ Jr2@ Kr Kr Kr Kr Kr Ks)~ Ks@P@KtN0O?KtN0O?K t̥G [@K r1hA؛? K r K r K r~ Kr&@ Lr/ Lr  Lr/ Lr/ Lr5 Ls)~ Ls@U@Lt+8?Lt+8?L t-[5?L rR^U? L rrr ~ Lr(@ Mr Mr Mr Mr Mr Ms)~ Ms.@Mt凩WMt凩W?M tU7?M r& ? M r M r M r~ Mr@ Nr Nr Nr Nr Nr Ns)~ NsR@Nt|ʿNt|?N t=?N ru n? N r N r N r~ Nr(@ Or Or Or Or Or Os)~ Os>@Ot8dA:Ot8dA:?O twc?O r?}? O r O r O r~ Or@ Pr Pr Pr Pr Pr Ps)~ PsA@Pt$#۬ۿPt$#۬?P t$ e?P r/iVK? P r P r P r~ Pr@ Qr Qr Qr Qr Qr Qs)~ QsI@Qtdy?Qtdy?Q t[b@Q u1W> Q r Q r  Q r ~ Qr@ Rr$ Rr% Rr$ Rr& Rr' Rs)~ RsT@RtQw Ĥ?RtQw Ĥ?R t<ּt?R rh fz? R r( R r) R r*~ Rr(@ Srf Srg Srf Srh Sri Ss)~ Ss.@St'Ea,ԿSt'Ea,?S t31?S rpM? S rj S rk S rl ~ Sr@ Tr Tr Tr Tr Tr Ts)~ TsF@Ttf%3߿Ttf%3?T tK ?T r\iT? T r T r T r~ Tr@ Ur  Ur  Ur  Ur  Ur  Us)~ Us l@UtҐF?UtҐF?U ti0"?U r2!? U r  U r U r~ Ur=@ Vr! Vr" Vr! Vr# Vr$ Vs)~ VsI@Vt(;??Vt(;??V t6{?V rŰ5? V r V r V r~ Vr"@ Wrc Wrd Wrc Wre Wrf Ws)~ WsY@WtWt?W tUA?W ruT? W rg W rh W ri~ Wr3@ Xr Xr Xr Xr Xr Xs)~ XsF@Xt[?Cg?Xt[?Cg?X t- k?X ri? X r X r X r~ Xr"@ Yr Yr Yr Yr Yr Ys)~ Ys@Z@YthYth?Y tI]?Y r:QatP>?a t;?a r5楈? a r a r a r ~ ar @ br" br# br" br$ br% bs)~ bs@P@btm~?btm~?b tl5 @b r4Z=? b r& b r' b r(~ br$@ cr4 cr5 cr4 cr6 cr7 cs)~ cs^@ctW#º?ctW#º?c t q f?c rWBmY?1? c r8 c r9 c r:~ cr.@ drJ drK drJ drL drM ds)~ dsq@dt*}dt*}?d t _K?d rqP ? d rN d rO d rP~ dr=@ er 7 erS er 7 erT er 7 es)~ es@etw}~ܿetw}~?e tj?e r^}H? e r1 e r1 e r1~ er? fru frv fru frw frx fs)~ fsl@ft?ft?f tuv?f r4} Z? f ry f r" f rz~ frD@ grr grs grr grt gru gs)~ gs`c@gtO<տgtOl?g r2!? g rv g r g rw~ gr7@ hry hrz hry hr{ hr| hs)~ hs$@ht M?ht M?h th f/?h r f#? h r} h r~ h r~ hr@ ir ir ir ir ir is)~ is4@itS 9itS 9?i tohEY?i rgB+? i rC i rD i rE~ ir@ jrH jrI jrH jrJ jrK js)~ jsN@jth%jth%?j tdè?j r\? j rLj r j rM~ jr@ kr kr kr kr kr ks)~ ksR@ktSktS?k tub?k r'lV?? k rLk r k rM~ kr@ lr lr lr lr lr ls)~ lsD@lt=lmlt=lm?l t75?l rh/? l r l r l r~ lr@ mr mr mr mr mr ms)~ ms.@mt>mt>?m t79-gj?m r:N")? m r m r m r~ mr@ nr 7 nr# nr 7 nr 7 nr% ns)~ nsF@nt"> ֿnt"> ?n t<tB.?n r%cg6? n r1 n r1 n r1~ nr"@ or7 or or7 or7 or7 os)~ os`@otԷ-otԷ-@o ty?o rPLq? o rc o rc o rc~ or4@ pr7 prY pr7 pr7 pr7 ps)~ ps9@ptA&!?ptA&!?p tHuچ?p rC? p r)1 p r*1 p r+1~ pr@ qr7 qrm qr7 qr7 qr7 qs)~ qs9@qtB1ѿqtB1?q tO#d?q r% ? q r90 q r:0 q r;0~ qr@ rrk rrl rrk rrm rrn rs)~ rsQ@rtX1|]?rtX1|]?r t " L?r r% ? r ro r rp r rq~ rr$@ sr7 sr sr7 sr7 sr7 ss)~ ssY@st:hst:h?s tC?s rH.D? s r?1 s r@1 s rA1~ sr*@ tr tr tr tr tr ts)~ ts b@tt z=p?tt z=p?t t(C?t r7&z? t r t r t rM~ tr*@ ur ur ur ur ur us)~ us`x@ut \?ut \?u tfZ?u rH.D? u r u r u r~ urA@ vr vr vr vr vr vs)~ vsV@vtHiYNvtHiYN?v tWDa?v u/sa 0> v r v r v r~ vr&@ wr wr wr wr wr ws)~ wsY@wto&5chwto&5ch?w tX`?w r0 ? w r w r w r~ wr"@ xr xr xr xr xr xs)~ xs@U@xt-i_xt-i_?x tXyM?x u:z'j> x r x r x r~ xr@ yr7 yr> yr7 yr7 yr7 ys)~ ysV@yt9R;:?yt9R;:?y tBK?y r7? y r_0 y r`0 y ra0~ yr1@ zr7 zr zr7 zr7 zr7 zs)~ zsD@zt&zt&?z t:+?z r#12? z r0 z r0 z r0~ zr @ {r 7 {r {r 7 {r!7 {r"7 {s)~ {sF@{tKGCqpNϿ{tKGCqpN?{ tRZ?{ r3'ˆ:\? { r1 { r1 { r1~ {r@ |r |r |r |r |r |s)~ |s.@|t?|t?| t3K ]?| rejU? | r | r | r~ |r@ }r }r }r }r }r }s)~ }s4@}tճdÿ}tճd?} tW?} r0| ? } r } r } r~ }r@ ~r#7 ~r; ~r#7 ~r$7 ~r%7 ~s)~ ~s@~tup@]?~tup@]?~ tww2#?~ r,_|? ~ r1 ~ r1 ~ r1~ ~r? rT rU rT rV rW s)~ sA@t t ? tʮ? r&$c ?  rX  rY  rZ ~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r& r r  r  s)~ s$@tvߐϙtvߐϙ? tn] ? ry2b-Wt+>-W? t>? ry2b@tJI;?tJI;? t0"4@ ry5N74?  r71  r81  r91~ r@ r r r r r s)~ s`h@t\Imƾt\Imƾ? tg"q? r;C.V?  r  r  r~ r<@ r; r< r; r= r> s)~ sT@tmk%fտtmk%f? tdj4;? r1!"?  r?  r@  rA~ r&@ r17 r27 r17 r37 r47 s)~ s$@t;yW̕?t;yW̕? tҳ  r*  r+  r,~ rA@ r3 r4 r3 r5 r6 s)~ sd@t vVt vV? tЇ2? rN+_&?  r7  r8  r9~ r3@ rC rD rC rE rF s)~ s.@t:ٿt:? tW)? r'7 .?  rG  rH  rI~ r@ rK rL rK rM rN s)~ s@tn`tn`? t)=? r?  rO  rP  rQ~ r?Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r| r} r| r~ r s)~ sr@t>Řt>Ř@ t#|? u,IzK>  r  r  r~ rA@ r r r r r s)~ s`@tIQtIQ? t@? r?R?  r  r  r~ r7@ r r r r r s)~ s@P@tdwũ?tdwũ? tf@2bw@ r/$b?  r  r  r ~ r&@ r57 r r57 r r67 s)~ sD@t+!oYt+!oY? t ? r 8=?  r0  rC0  r0~ r @ r r r r r s)~ s\@tq tq ? txc7G? r1[(,44?  r  r  r~ r4@ r r r r r s)~ s>@tj1E\vtj1E\v? tjw6X? r?  r  r  rM~ r@ r< r= r< r> r? s)~ sA@t?i߿t?i? tC@? r0|Ek?  r@  rA  rB~ r@ rD rE rD rF rG s)~ sK@tro[tro[? t$=? rDga?  rH  rI  rJ~ r"@ r r r r r s)~ sI@t5>t5>? t)êE? rSjT?  r  r  r~ r@ r r r r r s)~ sQ@tnZtnZ? tw ? rf_?  r  r  r~ r&@ r r r r r s)~ s{@tHpȘ?tHpȘ? t(t? uX83g|k>  r  r  r~ rL@ r: r; r: r< r= s)~ s9@t?|6yϿt?|6y? tY6  r?  r@~ r@ r r r r r s)~ s@P@trZktrZk? tgx? r,E?  r  r  r~ r&@ r77 r r77 r r87 s)~ s@Z@ta)@?ta)@? tFd? rI!R?  r0  r0  r0~ r1@ r r r r r s)~ sD@tata? t? r%cg6?  r  r  r~ r @ r r r r r s)~ s>@tq5ֹѿtq5ֹ? tr i? r |"?  r  r  r~ r@ r6 r r6 r r}. s)~ s.@tجҿtج? tv?BP? r=?  r~.  r.  r.~ r@ r r r r r s)~ s4@t )_ѿt )_? ta~l? r1hA؛?  r  r  r~ r@ r r r r r s)~ s.@t}(j=t}(j=? tZq@? r͏9?  r  r  r~ r@ r r r r r s)~ s$@t+t+? t_h? rj?  r  r  r~ r@ rr rs rr rt ru s)~ s@t92t92? tW? r^?  rc  rc  rv ~ r? r r r r r s)~ sQ@t桅t桅? tx? rj(?  r  r  r ~ r(@ r r r r r s)~ sV@tQuĿtQu? tDo9? rlC?  r  r   r!~ r0@ r2 r3 r2 r4 r5 s)~ s.@tUW?tUW? t%E\:? r-8?  r6  r7  r8~ r@ rB rC rB rD rE s)~ s$@t}St}S? t>? r?j?  rF  rG  rH~ r@ r97 rg r97 r:7 r;7 s)~ s.@t\߮ѿt\߮? tmCY? rks0,?  r1  r 1  r 1~ r@ r r r r r s)~ s4@tMAwXtMAwX? t 2X? rq3ћ?  rC  rD  rE~ r@ r<7 rE1 r<7 r=7 r>7 s)~ s@t *q?t *q? t& ? r0|Ek?  rF1  rG1  rH1~ r@ r r r r r s)~ s4@ta7Cޣӿta7Cޣ? tpOT? rZⰏi?  rC  rD  rE~ r@ rx rP rx ry r; s)~ sD@tgK&NktgK&Nk? tGk? rn\,:?  rL r  rM~ r@ r?7 r@7 r?7 rA7 rB7 s)~ s.@tk8Qtk8Q? tNS* ? rG3`?  rr1  rs1  rt1~ r@ r r r r r s)~ sQ@t"RY?t"RY? t0$? rCwM?  r  r  r~ r&@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r, r, r, r, r, s)~ s.@tBa?tBa? tiĭ? rR^U?  rr  r ~ r@ r r r r r s)~ s4@t8Mt8M? tk? rƚ?  r  r  r~ r@ rC7 r rC7 rD7 rE7 s)~ s>@t{?t{? t=nX6@ rM?  r0  r0  r0~ r@ r r r r r s)~ s@t$C`l>t$C`l>? t?vnW? rJı?  r  r  r~ r? rt ru rt rv rw s)~ s@_@tJȿtJ? tpA/U? rn?  rx  ry  rz~ r4@ r  r! r  r" r# s)~ sA@tR2dOhtR2dOh? tF)\? r1p?  r$  r%  r&~ r @ rF7 r1 rF7 rG7 rH7 s)~ s@t+zYut+zYu? t? rw=p?  r1  r1  r1~ r? rI7 r rI7 rJ7 r s)~ s4@tU8tU8? tS? rb)w ?  rf1  rg1  rh1~ r@ rK7 r rK7 rL7 rM7 s)~ sV@t@B?t@B? t =OA? rKf^?  r1  r1  r1~ r1@ r r r r r s)~ s`l@t|c?t|c? t.? rH?  r  r  r~ r@@ rN7 r rN7 rO7 rP7 s)~ s9@ttM̌ttM̌? tvvܲ? ry2b s)~ sF@t.;`t.;`? tyv(8F? r`~#jS?  r  r   r~ r@ rI rJ rI rK rL s)~ sT@tk Y}пtk Y}? th X? ri?  rM  rN  rO~ r$@ r r r r r s)~ sN@tMmtMm? tg? rAɑ?  r  r?  r~ r$@ r r r r r s)~ sD@tum tum ? tEu? rKmY?  r  r  r~ r@ r r r r r  s)~ s@e@t5\ӿt5\? teL? rQRԯ?  r!  r"  r#~ r;@ rQ7 r6 rQ7 r7 rR7 s)~ s^@t);ֿt);? tMTf'? rin?  r&1  r'1  r(1~ r2@ rS7 rQ rS7 rR rT7 s)~ si@tn~Ŀtn~? t{b^? r㵢?  ri1  rj1  rk1~ rB@ ri rj ri rk rl s)~ sD@tc'ݿtc'? tKTV? rЫ?  rm  r"  rn~ r@ rU7 r rU7 r rV7 s)~ s9@t @tcG,?tcG,? tȹj,? r]H9?  r1  r1  r1~ r@ r( r) r( r* r+ s)~ sI@tK][?tK][? tc .? rJlF8?  r, r  r-~ r@ r7 r8 r7 r9 r: s)~ s>@tgE!?tgE!? tUsU? rB?  r;  r<  r=~ r@ r r r r r s)~ sF@t*wu؋?t*wu؋? tvp]A? rQR?  r  r  r ~ r@ rJ rK rJ rL rM s)~ sN@t ?t ? t?~? rt^{8?  rN  rO  rP~ r$@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rG ri rG rH rI s)~ sD@t Vu6޿t Vu6? t/? r'o?  rrr ~ r@ r r r r r s)~ s.@t#{wt#{w? tWK8*? rd:?  r  r  r~ r@ rS r rS rT rU s)~ s.@tsts? tj? rJdz?  rrr ~ r? rj rk rj rl rm s)~ sA@t]o#Lt]o#L? tv? rє?  rn  r  ro~ r@ r r r r r s)~ s.@t@oxt@ox? tvpI^2? r]Ox?  r  r  r~ r@ rM rN rM rO rP s)~ sI@t|AAK?t|AAK? tS? r%cg6?  rr  r?~ r@ r r r r r s)~ sF@t< H?t< H? t)y/? ro?  r  r"  r?~ r @ rD rE rD rF rG s)~ sA@t<1S?t<1S? t:] ? rb)w ? r  rH  rM~ r@ r r r r r s)~ s9@t[at[a? tA<#? rwV/?  r  r  r~ r@ r r! r r r# s)~ sZ@tꠃ7tꠃ7? tY@&? r;OM"?  rrr ~ r@ r]7 r r]7 r^7 r_7 s)~ s4@tptp? twu1Z^? rH}A?  rb0  rc0  rd0~ r@ r r r r r s)~ sA@t~h2 @t~h2 @ tU$@ r9?  r  r  r~ r@ r r r r r s)~ s@_@t Et E? t+}mZ? uGe>  r  r  r~ r"@ r r r r r s)~ s@Z@tNC=ktNC=k? tmoF? uk6 >  r  r  r~ r$@ r, r- r, r. r/ s)~ sQ@tx?tx? tH ? rtŇ?  r0  r1  r2~ r(@ r r r r r s)~ s9@tSn;3tSn;3? t$p?? rYP m?  r  r  r~ r@ r& rP r& r& r; s)~ sF@tޥ tޥ ? t-wЉ4? rAz?  rC  rD  rE~ r@ r # rP r # r # r; s)~ sA@tp-yctp-yc@ tHP]gN? ro?  rrr ~ r@ r% r& r% r' r( s)~ s9@t~:˿t~:? t+? r*8?  rc  rc  rc~ r@ r`7 r r`7 ra7 rb7 s)~ s@tz0 $^tz0 $^? tmOx? rv?  rl1  rm1  rn1~ r? r r? r r r s)~ s@t2&U?t2&U? t<{|@ rF#?  rrr ~ r? rc7 r rc7 rd7 r s)~ s4@tr宏ɿtr宏? tG ? rg8V?  r1  r1  r1~ r@ re7 r re7 rf7 rg7 s)~ s@t?t? tTd? rZⰏi?  r\0  r]0  r^0~ r? rh7 r rh7 ri7 rj7 s)~ sN@tcO{ пtcO{ ? tRmgw? r-8?  r 1  r 1  r 1~ r&@ rk7 rl7 rk7 rm7 rn7 s)~ s@tJӞ?tJӞ? t* :? rdHڛT?  r0  r0  r0~ r? ro7 r+ ro7 rp7 rq7 s)~ s$@tO;տtO;? t=CB? r%cg6?  r1  r1  r1~ r@ rn ro rn rp rq s)~ sF@t=@t=@ t<J@ rE?  rr  rs  rt~ r"@ r r r r  r! s)~ sN@to|to|? t.W? r\'4?  r  r   r ~ r@ rv rw rv rx ry s)~ s@U@tata? teI? u!j[>  r  r   rz~ r @ r, r, r, r, r, s)~ s$@tעtע@ t15I? rg?  r  r   r~ r@ rr7 r5 rr7 rs7 rt7 s)~ s$@t}JU*t}JU*? t-0!B? r()\.?  rn0  ro0  rp0~ r@ r r r r r s)~ sK@t 7?t 7? t^ؿ@ r9گ?  r  r  r} ~ r&@D,l,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ sK@tT;ٿtT;? the.5? rLK-??  r  r  r~ r$@ r r r r r s)~ sA@th«S?th«S? tY? r{?  r  r  r} ~ r@ ru7 r ru7 r rv7 s)~ sv@t^&Tt^&T? t0c @t7 ?t7 ? t7qb? r;9}?  r  r*  r~ r@ r r r r r s)~ s.@tGp:tGp:? tϰ? rd:?  r  r  r~ r@ r r r r r s)~ sI@ tЅ tЅ?  tF:ڼ?  rs?  r  r  r ~ r @ r r r r r s)~ sI@ t]#k t]#k?  th&?  r>L?  r  r  r~ r$@ r; r< r; r= r> s)~ s9@ tX3~ӿ tX3~?  tn>?  r?Al?  r?  r@  rA~ r@ rC rD rC rE rF s)~ s9@ tGW'߱ tGW'߱?  t!U}?  r'7 .?  rG  rH  rI~ r@ rS rT rS rU rV s)~ sN@ t Oɿ t O?  t6X?  rF~g?  rW  rX  rY~ r$@ ry7 rQ ry7 rR rz7 s)~ s.@tڿt? t+? r ?  rt0  ru0  rv0~ r@ rv rw rv rx ry s)~ s9@tcC4пtcC4? tP{`? r&$c ?  rz  r{  r| ~ r@ r[ r\ r[ r] r^ s)~ sk@t F?t F? t4㯇{? u4U!X>  r_  r`  ra~ r.@ rk rl rk rm rn s)~ s$@t֞%t֞%? tauc? rJ^n?  ro  rp  rq~ r@ r0 r0 r0 r0 r0 s)~ s$@t?t?@ t@tVt+_?tVt+_? t7era? rR^U?  r  r  r?~ r@ r{7 r r{7 r r|7 s)~ s$@tJtJ? tn]Au? rw=p?  r1  r1  r1~ r@ r r r r r s)~ s>@t7 A@t7 A@ tDz#@ rt 63?  r  r  r ~ r@ r r r r r s)~ s9@t3~ ֿt3~ ? t/$qQ? r+ o?  r  r  r~ r@ r r r r r s)~ s@t;Uxt;Ux@ t4"D? r2!?  r  r  r~ r? r}7 r r}7 r~7 r7 s)~ s@t.Jvt.Jv? t&&7? r!?  r0  r0  r0~ r? r7 r r7 r7 r7 s)~ sD@t6nt6n? tՆ(? r2!?  r1  r1  r1~ r@ r r r r r s)~ sF@tqLa?tqLa? t8U? rA&0?  r  r  r~ r@ r7 r r7 r7 r s)~ s@tUyѿtUy? taj? rF?  rk0  rl0  rm0~ r? r7 r r7 r7 r7 s)~ s.@tW?mw?tW?mw? tVS@ ri?  r1  r1  r1~ r@ r r r r r s)~ s@t8#-@t8#-@? t{/S{? rt 63?  r  r  r~ r? r rP r r  r; s)~ sK@t=?t=?? t(g? r_?  rrr ~ r@ r r r r r s)~ s$@tcF%&tcF%&? t*;? rƐ#?  r  r  r ~ r@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, ######## # # # # ################### #!#"###$#%#&#'#(#)#*#+#,#-#.#/#0#1#2#3#4#5#6#7#8#9#:#;#<#=#>#?#@#A#B#C#D#E#F#G#H#I#J#K#L#M#N#O#P#Q#R#S#T#U#V#W#X#Y#Z#[#\#]#^#_#`#a#b#c#d#e#f#g#h#i#k#l#m#n#o#p#q#r#s#t#u#v#w#x#y#z#{#|#}#~###r r r r r s)~ s.@ tQSQQ? tQSQQ?  tȚpœ?  r^?  r  r  r~ r@ !r7 !r  !r7 !r7 !r7 !s)~ !s.@!tTLLS?!tTLLS?! tAv*A?! r+ o? ! r; ! r; ! r;~ !r@ "r5 "rx "r5 "r5 "r`/ "s)~ "s>@"tj+̯?"tj+̯?" tV,?" r? " ra/ " rb/ " rc/~ "r@ #r7 #r #r7 #r7 #r #s)~ #sA@#tMٿ#tM?# t@?# r?}? # r#1 # r$1 # r%1~ #r@ $r5 $rR $r5 $r6 $r7 $s)~ $s9@$t/j@$t/j@$ t 7 t@$ rr4߁? $ rrr ~ $r@ %r %r %r %r %r %s)~ %s@%tZ%tZ?% t^^?% rejU? % r % r % r~ %r? &rM &rN &rM &rO &rP &s)~ &sD@&tz*t!?&tz*t!?& tpJ1=?& rM KH? & rQ & rR & rS~ &r@ 'r 'r 'r 'r 'r 's)~ 's4@'tKc:D'tKc:D?' t^?' r3'ˆ:\? ' r ' r ' r~ 'r@ (r7 (r (r7 (r7 (r7 (s)~ (s9@(tMw:_(tMw:_?( tV~U?( rR^U? ( r1 ( r1 ( r1~ (r@ )r? )r@ )r? )rA )rB )s)~ )s@)t eLjU)t eLjU?) t) 064?) r2!? ) rC ) rD ) rE~ )r? *r *r *r *r *r *s)~ *s>@*trt*trt?* t{biiz?* r8I+? * r * rH * r~ *r@ +r +r +r +r +r +s)~ +s4@+t%+t%?+ tf?+ r5楈? + r + r + r~ +r@ ,r ,r ,r ,r ,r ,s)~ ,s4@,t[w0?,t[w0?, te6@, rP3X? , r , r , r~ ,r@ -r -r -r -r -r -s)~ -sA@-tH0˿-tH0?- t9mΔ?- r~c~? - r - r - r~ -r@ .r] .r^ .r] .r_ .r` .s)~ .s>@.t.t?. t{?. rV>? . ra . rb . rc ~ .r@ /r$ /r% /r$ /r& /r' /s)~ /sI@/tH"Z v/tH"Z v?/ tp?/ rXF? / r( / r) / r* ~ /r@ 0r{# 0r|# 0r{# 0r}# 0r~# 0s)~ 0s>@0tCf|A0tCf|A?0 tHng?0 rq7? 0 r# 0 r# 0 r#~ 0r@ 1r 1r 1r 1r 1r 1s)~ 1s$@1t1XN+1t1XN+?1 t@2?1 r$uӃ? 1 r 1 r" 1 r~ 1r@ 2r 2r 2r 2r 2r 2s)~ 2s9@2t2t?2 tQJ2?2 r1e!Y? 2 r 2 r 2 r~ 2r@ 3r7 3r  3r7 3r  3r7 3s)~ 3s9@3t#!3t#!?3 tLGp;?3 rT $W? 3 rx1 3 ry1 3 rz1~ 3r@ 4r 4r 4r 4r 4r 4s)~ 4sA@4tJ+Rƿ4tJ+R?4 tJg?4 r룜D"? 4 r 4 r 4 r~ 4r@ 5rm 5rn 5rm 5ro 5rp 5s)~ 5sK@5tɤ#5tɤ#?5 to?5 r/iVK? 5 rq 5 rr 5 rs~ 5r$@ 6r& 6r' 6r& 6r( 6r) 6s)~ 6s9@6tϱf?6tϱf?6 t/z0?6 r+ o? 6 r 6 rW 6 r*~ 6r@ 7r 7r 7r 7r 7r 7s)~ 7sT@7t5RƠ?7t5RƠ?7 tuZ?7 r m? 7 r 7 r 7 r~ 7r"@ 8r7 8r 8r7 8r 8r7 8s)~ 8s@8t'$q8t'$q?8 t f?8 r% ? 8 r60 8 r70 8 r80~ 8r? 9r7 9r 9r7 9r 9r7 9s)~ 9sA@9t{?9t{?9 t|?9 rH.D? 9 r<1 9 r=1 9 r>1~ 9r@ :r :r :r :r :r :s)~ :s$@:tp:tp?: t|-?: r`,? : r : r : r~ :r? ;r ;r ;r ;r ;r ;s)~ ;s4@;t:?;t:?; t 1]]?; r~^X? ; r ; r ; r ~ ;r@ <r <r <r <r <r <s)~ <s4@<tV<tV?< t"?< r8q(? < r < r < r~ <r@ =r7 =r5 =r7 =r6 =r7 =s)~ =s$@=t:M=t:M?= t O?= rHkP*? = ro1 = rp1 = rq1~ =r@ >rB >rC >rB >rD >rE >s)~ >s@>tݿ>t?> t)?> r%cg6? > rF> r > rG~ >r? ?rQ ?rR ?rQ ?rS ?rT ?s)~ ?s@?tuƿ?tu?? to˴%H?? r2_;ږ? ? rU ? rV ? rW~ ?r?Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r7 @rZ @r7 @r[ @r7 @s)~ @s4@@tD &?@tD &?@ t(a6?@ rZⰏi? @ rZ0 @ rc @ r[0~ @r@ Ar Ar Ar Ar Ar As)~ As$@At/t?At/t?A tvg?A r2!? A r A r A r~ Ar@ Br Br Br Br Br Bs)~ Bs>@BtsEBtsE?B t#b 9?B r2~~(bJ? B r B r B r~ Br@ Crh Cri Crh Crj Crk Cs)~ Cs4@CtQ'տCtQ'?C t[ ! r?C rjDDdM? C rl C rm C rn~ Cr@ Drp Drq Drp Drr Drs Ds)~ Ds@U@Dti[ӿDti[?D tLb?D r.NP? D rt D r D ru~ Dr.@ ErO ErP ErO ErQ ErR Es)~ Es>@Et qB˿Et qB?E t˛?E rT $W? E rS E rT E rU~ Er@ Fr[ Fr\ Fr[ Fr] Fr^ Fs)~ FsA@FtTG?FtTG?F t?F r^}H? F r_ F r` F ra ~ Fr@ Gr & Gr& Gr & Gr& Gr& Gs)~ Gs.@Gte3?Gte3?G t"dr?G r,CթW? G rLG r G rM~ Gr@ Hr7 Hr7 Hr7 Hr7 Hr7 Hs)~ Hs@Ht~Ht~?H t?H rCT? H r0 H r0 H r0~ Hr? Ir Ir Ir Ir Ir Is)~ IsF@It_}It_}?I tt ?I r;C.V? I r I r I r~ Ir@ Jr  Jr  Jr  Jr  Jr  Js)~ Js4@Jt', ?Jt', ?J t?J rSȉ{? J r  J r J r~ Jr@ KrQ KrR KrQ KrS KrT Ks)~ Ks>@Kt5=0Kt5=0?K t)&?K r+S.3? K r K r K r~ Kr@ Lr7 Lr7 Lr7 Lr7 Lr9 Ls)~ Ls@Lt'\@Lt'\@L t'*t@L r)@OtK2hXпOtK2hX?O t0?O r? O rP1 O rQ1 O rR1~ Or@ Pr7 Pr+ Pr7 Pr, Pr7 Ps)~ Ps9@Pt #]g??Pt #]g??P t\?P ro? P r1 P r1 P r1~ Pr@ Qre Qrf Qre Qrg Qrh Qs)~ Qs[@QtØQtØ?Q tZ?Q uE[k> Q ri Q r Q rj~ Qr"@ Rr Rr Rr Rr Rr Rs)~ Rs$@Rtу/Rtу/?R t ?R rF~g? R r R r R r~ Rr@ Sr Sr Sr Sr Sr Ss)~ Ss>@StEOStEO?S t4?S rM~*u!? S r S r S r~ Sr@ Tr Tr Tr Tr Tr Ts)~ TsD@Tt Tt ?T t'Y?T r-Ε[? T rrr ~ Tr@ Ur4( Ur Ur4( Ur Ur5( Us)~ UsF@Ut{:Ut{:?U t!?U rs!)? U rrr ~ Ur@ Vr Vr Vr Vr Vr Vs)~ VsQ@Vtd?Vtd?V t$?V rt^{8? V r V r" V r ~ Vr&@ Wr7 Wr Wr7 Wr Wr7 Ws)~ Ws$@WtM87ֿWtM87?W t*?W rCҡ? W r1 W r1 W r1~ Wr@ Xr Xr Xr Xr Xr  Xs)~ XsK@XtG{5ȿXtG{5?X tj I?X rC? X r  X r  X r ~ Xr"@ Yr Yr Yr Yr Yr Ys)~ Ys4@YtLlYtLl?Y trWr?Y rK? Y r Y r Y r~ Yr@ Zr Zr Zr Zr Zr Zs)~ Zs>@ZtLP?ZtLP?Z t> w?Z rH.D? Z r Z r Z r~ Zr@ [r7 [r0 [r7 [r0 [r7 [s)~ [s$@[t+H[t+H?[ t%N ?[ rLK-?? [ r0 [ r0 [ r0~ [r@ \rw \rx \rw \ry \rz \s)~ \s$@\tQuBֿ\tQuB?\ tĔ?\ rejU? \ r{ \ r| \ r}~ \r@ ]r0 ]r0 ]r0 ]r0 ]r0 ]s)~ ]s@]tݙ{]tݙ{@] tH$m?] rՋ? ] r0 ] r0 ] r0~ ]r? ^r ^r ^r ^r ^r ^s)~ ^s9@^tNֿ^tN?^ tAB!?^ ro? ^ r ^ r ^ r~ ^r@ _rZ _r[ _rZ _r\ _r] _s)~ _s9@_tP#?_tP#?_ t\Q`I ?_ r9ݿ? _ r^ _ r_ _ r`~ _r@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `s@`tftRܿ`tftR?` tbD?` rKmY? ` r ` r ` r~ `r? ar ar ar ar ar as)~ as.@atsi,l?atsi,l?a t7T0[q?a ro? a r a r a r~ ar@ br br br br br bs)~ bsQ@btS{3ÿbtS{3?b tAc?b r]ϵ? b r b r b r~ br(@ cr cr cr cr cr cs)~ cs9@cto?cto?c twldf?c r҇>[? c r c r c r~ cr@ dr dr dr dr dr ds)~ dsQ@dt?i r. dұ? i r i r i r ~ ir@ jr7 jr7 jr7 jr7 jr7 js)~ js.@jtR&pjtR&p?j tl/(?j r f#? j r41 j r51 j r61~ jr@ kr7~ kv<@ kr7 kr7 kr7 ks)~ ks9@kt!8kt!8?k t"IZ?k r%cg6? k r1 k r1 k r1~ kr@ lr lr lr lr lr ls)~ ls$@ltfltf?l t )=#?l r0H<(C? l r l r l r~ lr@ mr7 mr mr7 mr7 mr7 ms)~ ms.@mt܁\mt܁\?m tT^|?m r f#? m r11 m r21 m r31~ mr@ nr nr nr nr nr ns)~ ns@ntS?ntS?n t> &a?n r. dұ? n rrr ~ nr? or5 or or5 or5 or#/ os)~ os[@otTS&fotTS&f?o tK?o rEtl? o rc o rc o rc~ or(@ pr7 pr pr7 pr7 pr7 ps)~ ps$@pt2Gpt2G?p tϊ?p r~=H? p r p r p r50~ pr@ qr qr qr qr qr qs)~ qs$@qt2[Gjx?qt2[Gjx?q tOu]G@q rGpb? q r q r q r~ qr@ rr7 rr rr7 rr7 rr7 rs)~ rs$@rt/U?rt/U?r taXq?r r;9}? r r0 r r0 r r0~ rr@ srY srZ srY sr[ sr\ ss)~ ss9@stƢFwlcڿstƢFwlc?s twK ?s r 2? s r] s r^ s r_~ sr@ tr tr tr tr tr ts)~ ts@tt0%eltt0%el?t toC?t r{H? t r t r t r~ tr? url urm url urn uro us)~ us>@utf*utf*?u t ?u r5? u rp u rq u rM~ ur@ vr vri vr vr vr vs)~ vs.@vtVJz?vtVJz?v t%nd?v rO6? v rrr ~ vr@ wr7 wr% wr7 wr7 wr7 ws)~ ws9@wt-A?wt-A?w tB@w r  rC  rD  rE~ r@ r r r r r s)~ sI@t`"tt`"t? t]!? ryo4}?  rC  rD  rE~ r@ r& r& r& r& r& s)~ sF@t9t9? t̶!? rKmY?  rC  rD  rE~ r@ r! r! r! r! r! s)~ s@t"?t"? t/ @ rq7?  r!  r!  r!~ r? r7 rW r7 r7 r7 s)~ s4@tjJG?tjJG? t90_#@ rR^U?  r1  r1  r1~ r@ r7 r r7 r7 r7 s)~ sA@t?t? tiLI @ r| O?  r0  r0  r0~ r@ r7 r' r7 r7 r7 s)~ s@t]J~x?t]J~x? t;G@ r{?  r 0  r 0  r 0~ r? r7 r% r7 r7 r7 s)~ s$@t4$fW?t4$fW? ts? ro?  r1  r1  r1~ r@ r7~ v<@ r7 r7 r7 s)~ sK@t Ǜҿt Ǜ? tn(? rP?  r0  r0  r0~ r"@ r" r" r" r" r" s)~ s.@tO'M -޿tO'M -? t"? rG>?  r"  r"  r"~ r@ rt! ru! rt! rv! rw! s)~ s4@tsΘ?tsΘ? tjκ@ rZH&?  rx!  ry!  rz!~ r@ r! r! r! r! r! s)~ s4@t:lt:l? tۀi)? rLXww?  r!  ra  r!~ r@ r7 r8 r7 r9 r: s)~ s$@tX?tX? t7} 7? rs!)?  r;  r<  r=~ r@ r7 r" r7 r7 r7 s)~ s@t& G?t& G? t5< ? ro?  r1  r1  r1~ r? r! r r! r! r s)~ s9@t &K?t &K? t.II@ r4D?  rrr ~ r@ r7 r3" r7 r7 r5" s)~ s@th (?th (? t}NLD? r,_|?  r1  r1  r1~ r? rZ r[ rZ r\ r] s)~ sD@tov [?tov [? tOi_? r'7 .?  r^  r_  r`~ r@ r r r r r s)~ sI@t:`?t:`? t9'? r4$=?  r  r  r ~ r@ r$ r% r$ r& r' s)~ s>@ttX?ttX? t w" r  r?~ r@ r r r r r s)~ sD@tM`u@ӿtM`u@? t\5R$? rks0,?  r  r  r~ r @ rw" rx" rw" ry" rx" s)~ s@tz|1˿tz|1? tVH? rb"%/?  rz"  r{"  r~ r? r" r" r" r" r" s)~ s.@tӍ+1ԿtӍ+1? t2=A? rq7?  r" r  r"~ r@ r" r" r" r" r" s)~ s$@th&N?th&N? tdѪ? rZⰏi?  r"  r"  r"~ r? rk rl rk rm rn s)~ s$@tuj/?tuj/? ti-͌? r~?  ro  r2  rp ~ r@ r" r" r" r" r" s)~ s@teMZqteMZq? tΗDfT? r 'c)?  rC  rD  rE~ r? r" r" r" r" r" s)~ s9@tP4 7QtP4 7Q? tC? r]"ęU?  rC  rD  rE~ r@ r# r# r# r# r# s)~ s$@t, t, ? tIU? rKmY?  r#  r#  r#~ r? r7 ra r7 r7 r7 s)~ s$@t?r"1t?r"1? tuWXS? rkdg?  r0  r 0  r 0~ r@ r\6 rb# r\6 r]6 r- s)~ s$@t;?t;? tJ[+? r]ZY?  r-  r-  r-~ r@ r7 r7 r7 r7 r7 s)~ s@tMB_tMB_? tXͭ? ro?  r1  r1  r1~ r?Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r7 r# r7 r7 r7 s)~ s@tN>tN>? t`[? rma?  r1  r1  r1~ r? r7 r r7 r7 r s)~ s@tr<5Iпtr<5I? tOŃY? r?}?  r 1  r!1  r"1~ r? rT# rU# rT# rV# rW# s)~ s>@tt? ts? rЫ?  r  r   r ~ r@ rX6 rh rX6 ri rY6 s)~ s>@t9C@t9C@ tt6XL3@ r={?  rrr ~ r@ rY# rZ# rY# r[# r\# s)~ s4@tNSSԿtNSS? t"FZ? rhʆe?  r]#  r^#  r_#~ r@ r! r! r! r! r! s)~ s$@t@= ~޿t@= ~? t1$? rT $W?  r!  r!  r!~ r@ r7 rq r7 r7 r7 s)~ s@U@tʈptʈp? t8? rJVx?  r1  r1  r1~ r*@ r r r r r s)~ sK@t 䰧oӿt 䰧o? tR? r"&/?  r  r  r~ r @ r7 r r7 r r7 s)~ s4@t*Pap?t*Pap? t.iΞ5? r& ?  rh0  ri0  rj0~ r@ r r r r r s)~ s9@t%(eɦt%(eɦ? tVC%? r$?Yf1?  r  r  r~ r@ rK rL rK rM rN s)~ s.@tPk+?tPk+? tFE? rt^{8?  rO  rP  rQ~ r@ rN rO rN rP rQ s)~ sN@tEտtE? t-Rj? r!u䡺?  rR  rS  rT ~ r@ r# r# r# r# r# s)~ s$@tDG?tDG? t2*K? ro?  rr  r ~ r@ rb rc rb rd re s)~ s@t wտt w? t|5F/;? rF#?  rf  r  rg~ r? r r r r r s)~ s.@t2<< ߿t2<< ? t"h? r;9}?  r  r  r~ r@ r: r; r: r< r= s)~ s$@t5yXt5yX? tm? ri?  r>  r?  r@~ r@ r7 r r7 r7 r7 s)~ s4@t!');Կt!');? t=? rzb?  rQ0  rR0  rS0~ r@ r($ r)$ r($ r*$ r+$ s)~ sT@tf_9ɿtf_9? t? u 7-v>  r  r  r~ r @ r7 r.$ r7 r7 r7 s)~ s@t3 mt3 m? t ;? r7,:A?  r:1  r;  r;1~ r? r<$ r=$ r<$ r>$ r?$ s)~ sN@tCm?tCm? ta_:? rSm?  r  r  r~ r@ rA$ rB$ rA$ rC$ rD$ s)~ s$@tz¿tz? t$&Z? rnD?  rc  rc  rE$~ r? r7 r7 r7 r7 r7 s)~ s$@tc. 5tc. 5? tG? rE?  r0  r0  r0~ r@ r r r r r  s)~ sK@tt? t\? uk>  r   r   r ~ r@ r7 rH r7 r7 r7 s)~ s@tnpHtnpH? t'K? rbM?  r1  r1  r1~ r? rx$ ry$ rx$ rz$ r{$ s)~ s.@tt@ tG? rSjT?  r|$  r?  r}$~ r@ r$ r$ r$ r$ r$ s)~ sF@tn?i tn?i ? t8? ? rIX$K+?  r  r   r~ r@ r r r r r s)~ s@tt? tY? rS?  r  r  r~ r? rd re rd rf rg s)~ s9@t}x#ڿt}x#? tD? rD L?  rh  ri  rj~ r@ r7 r r7 r r7 s)~ s$@twiv?twiv? t? r1e!Y?  r1  r1  r1~ r@ r' r' r' r' r' s)~ s9@t]1?t]1? tv? rH.D?  r'  r'  r'~ r@ r7 r r7 r7 r s)~ s$@tmHCtmHC? tvŐ? rs!)?  r1  r1  r1~ r@ r% r% r% r% r! s)~ s4@t8j t8j ? t"9? rDry;D?  r   r   rz~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r7 r r7 r7 r s)~ s@tk+|P?tk+|P? t]@ r=?  r  r(  r,1~ r? r7 r7 r7 r7 r8 s)~ s$@tJ&Y~0?tJ&Y~0? tx7? r0e?  r0  r0  r0~ r@ r8 r8 r8 r8 r8 s)~ s@t?54t?54? tZ#? rejU?  r0  r0  r0~ r? ri rj ri rk rl s)~ s@t7bw?t7bw? t{مD? r$y 3?  rm  rn  ro~ r? r8 r8 r8 r8 r8 s)~ s9@thMthM? tf? r?  r0  r0  r0~ r@ r 8 r r 8 r r 8 s)~ s$@tMFɿtMF? td? r0|Ek?  rI1  rJ1  rK1~ r@ r r r r r s)~ s$@t͵Q@t͵Q@ tH9WC@ r19 ?  r  r  r ~ r@ r" r" r" r" r" s)~ s4@tW|ſtW|? t kvv? rgN?  r"  r"  r "~ r@ r r r r r s)~ sD@tOL?tOL? t/ ? r𘐿_|?  r  r  r~ r@ rc% rd% rc% re% rf% s)~ s.@t vӿt v? t? rdHڛT?  rg%  rh%  ri%~ r@ rs% rt% rs% ru% rv% s)~ s$@tɧDtɧD? tes X? rR^U?  rw%  rx%  ry%~ r@ r r r r r s)~ s9@t 4j?t 4j? t9m? r_J=nt?  r  r  r~ r@ r 8 r$ r 8 r- r 8 s)~ s$@tƈzտtƈz? tKR? r1hA؛?  r$  r$  r$~ r@ r r r r r s)~ s.@tj$'tj$'? tl97Q? r!0?  r  r  r~ r@ r 8 r  r 8 r  r8 s)~ s@t:x?t:x? t˛g? r?Al?  r0  r0  r~ r? r" r" r" r" r" s)~ s@tl7tl7? t.UP? rK3@?  r"  r"  r"~ r? r% r% r% r% r% s)~ s$@t)=aÿt)=a? to? rH.D?  r%  r%  r%~ r@ r r r r r s)~ s.@t1ųt1ų? tj Q? ry2b? r?Al?  r0  r0  r0~ r? r! r" r! r# r$ s)~ s9@t_ ?t_ ? to]R@ rt pd?  r%  rH  r& ~ r@ r_& r`& r_& ra& rb& s)~ sK@tg}؟]tg}؟]@ t ? rhʆe?  r  r   r~ r@ r  r  r  r  r s)~ sD@tUitUi? tM$'7? rP3?  r  r   r ~ r@ rY rZ rY r[ r\ s)~ s$@t@' ?t@' ? t,B̳? rL?  rD"  rE"  rF"~ r@ r` ra r` rb rc s)~ s4@t/t/? t5tvL? r+r= ?  rd  re  rf~ r@ r8 r r8 r r 8 s)~ s@tyj I?tyj I? tbWF? rJı?  r1  r1  r1~ r? rI rJ rI rK rL s)~ s@t <t IѨt?>IѨ? tMV? r,_|?  r  r  r~ r@ r( r) r( r* r+ s)~ s>@tT`;?tT`;? tY5];D? r%cg6?  r,  r-  r.~ r@ rh' ri' rh' rj' rk' s)~ s9@t!Y51rt!Y51r? tb -/ۿ? r44`-?  rl'  rm'  rn'~ r@ r' r' r' r' r' s)~ s.@thdƽ(thdƽ(? tC? r[ !?  r'  r'  r'~ r@ r08 rd r08 re r18 s)~ s$@t 8,?t 8,? tYw? rz?  r0  r0  r0~ r@ r r r r r s)~ s@t4m߿t4m? tG{,? rC?  r  r  r ~ r? r' r' r' r' r' s)~ s$@tLNĿtLN? tL k? r 8=?  rC  rD  rE~ r@ r0 r r0 r0 r s)~ s.@taI+taI+? th]@? rejU?  rC  rD  rE~ r@ r r r r r s)~ s>@tБ tБ ? tc@? r,E?  r  r  r~ r@ r28 r38 r28 r48 r58 s)~ s@t^gnt^gn? tTR? r,_|?  r1  r1  r1~ r? r' r' r' r' r' s)~ sC@th'th'? t*nvP ? u<>  r  r  r~ r@ rr rs rr rt ru s)~ sK@tmmtmm? tq? u\\&>  rv  rD  r~ r@ r r r r r s)~ sA@tCrtCr? t۷dG? r~L4O}?  r  r  r~ r@ r r r r r s)~ sF@tv[߿tv[? tֈ/1? r'M;?  r  r  r ~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r r r r r s)~ s@t\?t\? tnn? re?  r  r  r~ r? r68 r r68 r78 r s)~ s@t/$$?t/$$? t&ˬw? rZⰏi?  rW0  rX0  rY0~ r? r1# r2# r1# r3# r4# s)~ s.@ttۋ+?ttۋ+? tiSw? r;C.V?  r5#  r6#  r7#~ r@ r88 r0 r88 r98 r:8 s)~ s@t?t? ty? r$*?  r0  r0  r0~ r? r0 r0 r0 r0 r0 s)~ s@tׇ3?tׇ3? tHo`? r~c~?  r0  r1  r1~ r? r( r( r( r( r( s)~ sF@tAa7tAa7? t|O? r~Wp?  r  r   r~ r@ r( r( r( r( r( s)~ sK@t[, 5bt[, 5b? tMNa=? rQ?  r(  r(  r (~ r@ r r r r r s)~ s$@tA-.tA-.? tf? rDga?  r  r  r~ r@ r6 r r6 r r/ s)~ s9@tuB+?tuB+? tBx݈#? rbM?  r/  r/  r/~ r@ r$ r$ r$ r$ r$ s)~ s$@ tAz*c tAz*c?  t1q1]?  r2P?  r$  r$  r$~ r@ r r r r r s)~ s@ t6HX? t6HX?  tb@  rq4H?  r   r!  r"~ r? r{( r|( r{( r}( r~( s)~ s.@ tlB߿ tlB?  tڀ8?  r8pIۺ?  r(  r(  r(~ r@ r;8 r r;8 r<8 r=8 s)~ s@ t*? t*?  tG(?  rlC?  r0  r0  r0~ r? r- r. r- r/ r0 s)~ s4@ tjd Կ tjd ?  tȖ?  r0| ?  r1  r2  r3~ r@ r r r r  r! s)~ s@t)t)? t 2M? rbM?  r"  r#  r$~ r? r6 r( r6 r6 r8. s)~ s$@tܯ?tܯ? tyA? rCwM?  r9.  r:.  r;.~ r@ r r r r r s)~ s.@thYLO9thYLO9? t24o? rJlF8?  r  r  r ~ r@ rV% rW% rV% rX% rY% s)~ sA@t( 8t( 8? t>qB? rI%pJ?  r  r   r~ r@ r( r( r( r( r( s)~ s4@tpei?tpei? tw ? rߕƦ?  r  r   r~ r@ r>8 r r>8 r?8 r@8 s)~ s@tzP?tzP? t@t"Xt"X? tW.z2Mu? r)l\?  rS%  r  r)~ r@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, rT rU rT rV rW s)~ s$@ t.C&@ t.C&@  thd5@  r+S.3?  r;  r|  r=~ r? !r7 !r8 !r7 !r9 !r: !s)~ !s$@!t~ݏ!t~ݏ?! tQZ?! rPc? ! r; ! r< ! r=~ !r@ "r]) "r^) "r]) "r_) "r`) "s)~ "s$@"t?"t?" tj}I?" r2!? " ra) " rb) " rc)~ "r@ #r! #r! #r! #r! #r! #s)~ #s@#tF#tF?# t\?# rKf^? # r! # r # r} ~ #r? $rD8 $r $rD8 $rE8 $rF8 $s)~ $s$@$to?$to?$ tZ?% rҢRD? % r % r % r~ %r@ &r) &r) &r) &r) &r) &s)~ &sA@&tŒ.jF?&tŒ.jF?& tmip@& rդ;? & r & r & r~ &r@ 'rG8 'r 'rG8 'rH8 'r 's)~ 's@'tLV ?'tLV ?' tP6?' rh? ' r1 ' r1 ' r1~ 'r? (rI8 (rJ8 (rI8 (rK8 (rL8 (s)~ (s@(tԅQ(tԅQ?( t7?( r ? ( rw0 ( rx0 ( ry0~ (r? )rO% )rP% )rO% )rQ% )rR% )s)~ )sA@)t |")t |"?) taV?) r|r8? ) rS% ) r ) r##############################################################################################################################$T%~ )r@ *r  *r! *r  *r" *r# *s)~ *s>@*tAK%*tAK%?* tR{ֻa?* r):? * r * r  * r~ *r@ +rs# +rt# +rs# +ru# +rv# +s)~ +s.@+tk uk+tk uk?+ t^~D?+ rC? + rw# + rx# + ry#~ +r@ ,r\ ,r] ,r\ ,r^ ,r_ ,s)~ ,s@,tylο,tyl?, tm,l#?, r~ͥ? , r` , ra , rb ~ ,r? -r1) -r2) -r1) -r3) -r4) -s)~ -s4@-tN.ӽW-tN.ӽW?- tҖ?- r&EM| ? - r5) - r - r6)~ -r@ .rx .ry .rx .rz .r{ .s)~ .s$@.t &{ؿ.t &{?. tM6?. r0| ? . r| . r} . r~~ .r@ /rM8 /r /rM8 /rN8 /rO8 /s)~ /s$@/t;`#/t;`#?/ t9o?/ ryܑ? / r0 / r0 / r0~ /r@ 0r 0r 0r 0r 0r 0s)~ 0s@0tvɘs?0tvɘs?0 tԖ?0 rN$qbs ? 0 r 0 r 0 r~ 0r? 1r) 1r) 1r) 1r) 1r) 1s)~ 1s@1tr& @1tr& @1 t h!@1 rYYk? 1 r) 1 r) 1 r)~ 1r? 2rP8 2r# 2rP8 2rQ8 2rR8 2s)~ 2s@2t0h2t0h?2 t7?2 r)m? 2 rE0 2 rF0 2 rG0~ 2r? 3rt 3ru 3rt 3rv 3rw 3s)~ 3s@3t߾53t߾5?3 tф?3 rf_? 3 rx 3 ry 3 rz~ 3r? 4rS8 4r 4rS8 4r 4rT8 4s)~ 4s@4tʲa׿4tʲa?4 tK&?4 rHi[? 4 r{1 4 r- 4 r|1~ 4r? 5rU8 5r 5rU8 5r 5rV8 5s)~ 5s@5t(>ګۿ5t(>ګ?5 t?5 r2!? 5 r1 5 r1 5 r1~ 5r? 6r# 6r# 6r# 6r# 6r# 6s)~ 6s@6tw6tw?6 tL4* <r?* <r>* <r@* <rA* <s)~ <s.@<tKg\_<tKg\_?< tDU?< r?Al? < rB* < rC* < rD*~ <r@ =rN* =rO* =rN* =rP* =rQ* =s)~ =s@=tXJ=tXJ?= tbE ?= r{w? = rR* = rS* = rT*~ =r? >rZ8 >r$ >rZ8 >r[8 >r$ >s)~ >s$@>t,Q>t,Q?> tPЖ;?> rb"%/? > r1 > r1 > r1~ >r@ ?rr* ?rs* ?rr* ?rt* ?ru* ?s)~ ?s9@?t.+?t.+?? tx?? r& ? ? r ? r ? r~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r' @r( @r' @r) @r* @s)~ @s.@@t`JJ@t`JJ?@ tl-R|?@ rbM? @ r+ @ r, @ r-~ @r@ Ar* Ar* Ar* Ar* Ar* As)~ As@Atե Atե ?A tY*J?A r44`-? A r* A r* A r*~ Ar? Brx' Bry' Brx' Brz' Br{' Bs)~ Bs@Bt;EmBt;Em?B tZ&j?B rZⰏi? B r|' B r}' B r~'~ Br? CrK0 CrL0 CrK0 CrM0 CrN0 Cs)~ Cs$@CtP]CtP]?C tL8?C rk&? C rO0 C rP0 C r} ~ Cr@ Dr! Dr! Dr! Dr! Dr! Ds)~ Ds$@DtDpXDtDpX?D t}i+?D rhH?? D rLD r D rM~ Dr@ Erm Ern Erm Ero Erp Es)~ Es@Et~%\Et~%\?E t ?E rꛡH? E rC E rD E rE~ Er? Fr* Fr* Fr* Fr* Fr* Fs)~ Fs@Ft׾ؿFt׾?F toQ遭m?F r^}H? F r* F r * F r!*~ Fr? Gr| Gr} Gr| Gr~ Gr Gs)~ GsI@GtJҩGtJҩ?G tv^?G rlS;? G r G r  G r~ Gr@ Hr Hr Hr Hr Hr Hs)~ Hs>@Ht#JHt#J?H tҹ`?H r(Ra? H r H r H r~ Hr@ Ir! Ir! Ir! Ir! Ir! Is)~ Is$@Itۑ.dܿItۑ.d?I tNNW?I rH.D? I r! I r! I r!~ Ir@ Jr* Jr+ Jr* Jr+ Jr+ Js)~ Js$@Jt(OJt(O?J t*+/d??J r4X? J rT" J r J r+~ Jr@ Kr+ Kr+ Kr+ Kr+ Kr+ Ks)~ Ks4@Kt,kиKt,kи?K t%x?K r):? K r+ K r+ K r+~ Kr@ Lr\8 Lr& Lr\8 Lr& Lr]8 Ls)~ Ls@Lt׻qyqw?Lt׻qyqw?L t6|?L rm언0? L r1 L r1 L r1~ Lr? Mr+ Mr+ Mr+ Mr+ Mr+ Ms)~ Ms.@Mtv/ÿMtv/?M tZ@?M rzb? M r+ M r) M r+~ Mr@ Nr+ Nr+ Nr+ Nr+ Nr + Ns)~ Ns@Nt>ԿNt>?N tV *#?N r^}H? N r!+ N r"+ N r#+~ Nr? Or , Or , Or , Or, Or, Os)~ OsN@OtlMOtlM?O t;4x=n?O rؽP? O r O r O r~ Or@ Pr:+ Pr;+ Pr:+ Pr<+ Pr=+ Ps)~ Ps@Ptk<6^Ptk<6^?P tJatk?P r]j? P r>+ P r?+ P r@+~ Pr? Qr^8 Qrz Qr^8 Qr{ Qr_8 Qs)~ Qs@QtFQ뜟?QtFQ뜟?Q tCS?Q r~^X? Q ru1 Q rv1 Q rw1~ Qr@ Rr( Rr( Rr( Rr( Rr( Rs)~ Rs.@RtP4̿RtP4?R t+_?R rP"? R r( R r( R r(~ Rr@ Sr`8 Sr Sr`8 Sra8 Sr Ss)~ Ss@St=St=?S t WH?S r@6s ? S rc S rc S rc~ Sr? Trh+ Tr2) Trh+ Tri+ Trj+ Ts)~ Ts$@TtkTtk?T tt /?T r}j8|M? T rrr ~ Tr@ Ur:# Ur;# Ur:# Ur<# Ur=# Us)~ Us@UtD/X?UtD/X?U tba8?U r\[Zu? U rc U rc U r>#~ Ur? Vrb8 Vrj Vrb8 Vrc8 Vrd8 Vs)~ Vs@Vt`&UVt`&U?V tl ?V r+ o? V r0 V r0 V r0~ Vr? Wrs+ Wr Wrs+ Wrt+ Wru+ Ws)~ Ws@WtjG?WtjG?W tE @W rOCs7? W rrr ~ Wr? Xre8 Xr Xre8 Xrf8 Xrg8 Xs)~ Xs@Xt:ؿXt:?X t`Bsߣ?X r2_;ږ? X rrr ~ Xr? Yr[ Yr\ Yr[ Yr] Yr^ Ys)~ Ys@Yt{ҋYt{ҋ?Y tS?Y r:u? Y r_ Y r` Y ra~ Yr? Zrh8 Zr Zrh8 Zri8 Zr Zs)~ Zs@Zt@%W#?Zt@%W#?Z tk$T?Z r%cg6? Z rrr ~ Zr? [r+ [r+ [r+ [r+ [r+ [s)~ [s@[t%:@{?[t%:@{?[ tbga~?[ r9q? [ r+ [ r+ [ r} ~ [r? \rj8 \rk8 \rj8 \rl8 \rm8 \s)~ \s@\t~ѹ\t~ѹ?\ t p?\ rO:? \ r( \ r) \ r}0~ \r? ]r ]r ]r ]r ]r ]s)~ ]s$@]tHC]tHC?] tE 2?] rJı? ] r ] r ] r~ ]r@ ^r+ ^r+ ^r+ ^r+ ^r+ ^s)~ ^s@^tw `$ֿ^tw `$?^ tfaJ-?^ rGpb? ^ r+ ^ r" ^ r+~ ^r? _r _r _r _r _r _s)~ _s@_t/K?_t/K?_ tIr({@_ r1hA؛? _ r _ r _ r~ _r?DTl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `rG `rH `rG `rI `rJ `s)~ `s@`t ە?`t ە?` t b'(?` rgi? ` rK ` r. ` rL~ `r? ar  ar  ar  ar ar as)~ as$@atfZƿatfZ?a tѹ: Z?a r"3P? a r a r a r~ ar@ br$ br$ br$ br$ br$ bs)~ bs@btYҷ|ȿbtYҷ|?b t?b r1e!Y? b r$ b r$ b r$~ br? cr% cr% cr% cr% cr% cs)~ cs@ctаwctаw?c t CL{o?c r f#? c r% c r% c r%~ cr? dr+ dr+ dr+ dr+ dr+ ds)~ ds@dtLdtL?d tpUWH?d r2_;ږ? d r+ d r+ d r+~ dr? er( er( er( er( er( es)~ esI@et%VXet%VX?e t*9ۅ?e ru? e r( e r* e r-~ er@ fr+ fr+ fr+ fr+ fr+ fs)~ fsF@ftdT ftdT ?f t<{/?f rd1]? f r f r  f r~ fr@ gr5/ gr6/ gr5/ gr7/ gr8/ gs)~ gs@gtz . gtz . ?g tw$?g r;9}? g r g r g r~ gr? hrn8 hr hrn8 hro8 hrp8 hs)~ hs@htÇĩ֎̿htÇĩ֎?h tK^":j?h r,_|? h r1 h r1 h r1~ hr? ir ir ir ir ir is)~ is$@itywDж?itywDж?i tVF?i rF~g? i r i r i r~ ir@ jr/, jr0, jr/, jr1, jr2, js)~ js@jt(Vڿjt(V?j t?j rb)w ? j r3, j r4, j r5,~ jr? kr_ kr` kr_ kra krb ks)~ ks@ktBds?ktBds?k t!T?k r? k rc k rd k re~ kr? lr7, lr8, lr7, lr9, lr:, ls)~ ls$@lt%QYͿlt%QY?l t$y@?l r;9}? l r;, l r<, l r=,~ lr@ mr' mr' mr' mr' mr' ms)~ ms4@mt}.:?mt}.:?m tq*p-?m rJı? m rC m rD m rE~ mr@ nrq8 nr/ nrq8 nrr8 nrV1 ns)~ ns$@nteɿnte?n t̃u?n r+S.3? n rW1 n rX1 n rY1~ nr@ or*, or+, or*, or,, or-, os)~ osD@ottnXAottnXA?o tيV?o rhH?? o r o r  o r~ or@ pr1 pr pr1 pr1 pr1 ps)~ ps@pt"'?pt"'?p t3݉[g?p r%cg6? p rrr ~ pr? qr| qr} qr| qr~ qr qs)~ qs.@qt%e9Y?qt%e9Y?q t.#?q r]ZY? q r q r q r~ qr@ rrH, rrI, rrH, rrJ, rrK, rs)~ rs.@rtMӛRrtMӛR?r tg?r r-(? r r r r  r r~ rr? sr7! sr8! sr7! sr9! sr:! ss)~ ss@st;?w r|w.? w r, w r, w r,~ wr@ xrv8 xrw8 xrv8 xrx8 xry8 xs)~ xs@xtJ}9?xtJ}9?x ty?x r\iT? x r1 x r1 x r1~ xr? yrh, yri, yrh, yrj, yrk, ys)~ ys.@ytc_crb˿ytc_crb?y tN?y rEm? y r y r  y r~ yr@ zrz8 zr0 zrz8 zr0 zr{8 zs)~ zs@zttO$JzttO$J?z t?z rI/lry? z r0 z r0 z r0~ zr? {r-1 {r.1 {r-1 {r/1 {r01 {s)~ {s@{t24 {t24 @{ t#e2?{ r[ !? { rL{ r { rM~ {r@ |r) |r) |r) |r) |r) |s)~ |s@|t@%x|t@%x?| t=DI?| r7? | r) | r) | r)~ |r? }ry }rz }ry }r{ }r| }s)~ }s@}t^}t^?} t?} r ιҼ? } r} } r } r~~ }r? ~rm, ~rn, ~rm, ~ro, ~rp, ~s)~ ~s$@~tE Σ~tE Σ?~ tBYx|?~ r~\u6? ~ rq, ~ rr, ~ rs,~ ~r@ ru, rv, ru, rw, rx, s)~ s@t;ܿt;? tؖc? r%cg6?  ry,  rz,  r{,~ r?Dl,,,,,, r, r, r, r, r, s)~ s@tsrK?tsrK? t[iT? rpX?  r,  r,  r,~ r? r|8 r}8 r|8 r~8 r8 s)~ s@t8d̿t8d? tpp? rp9?  rc1  rd1  re1~ r? r6 rH r6 r6 r6 s)~ s@thĩȞ?thĩȞ? t%n? rfk?  rrr ~ r? r, r, r, r, r, s)~ s$@t5t5? t}uߩ? rb"%/?  r,  r,  r,~ r? r r r r r s)~ s@tY=YAt׿tY=YAt? t6)Z? r2!?  r  r  r~ r? rM, rN, rM, rO, rP, s)~ s.@tN hۿtN h? t:M? r2i ?  r  r   r~ r@d>@ "ggD ZO pF\FDF@F*G0GNGmGG GGGH&HEH|dHPH$HHHHI rrr ~ r.@ rv rw rv rx ry s)~ sI@ tWL| tWL|? t:#)t? r ^|? rrr ~ r@ r6 r6 r6 r6 r6 s)~ sA@ tAO? tAO? tsG? rWDW:h? r0 r0 r0~ r@ r r r r r s)~ s@t(|?t(|? toH? u÷ mJ <  r  r  r~ r@_@ r% r& r% r' r( s)~ sR@tTtT? t:ݖ? r5""ْ?  r)  r*  r+~ r@ r. r/ r. r0 r1 s)~ s w@tO'6?tO'6? tj ? u>=  r2  r3  r4~ rG@ r@ rA r@ rB rC s)~ sH@tS/I tS/I ? t~? u oT=  rrr ~ rR@ rO rP rO rQ rR s)~ s~@t1-?t1-? tu @ u3uFA=  rS  rT r~ rO@ r rh r r r s)~ s9@t|Ϳt|? t^A? ro?  rrr ~ r@ r6 r r6 r6 r s)~ sd@t_.צɿt_.צ? tȼF~? r}q$f?  r20  r30  r40~ r9@ r r r r r s)~ sY@t.o?t.o? tr_? r/xS?  r  r  r~ r,@ r r r r r s)~ sA@tl!8῿tl!8? txzZ? ryܑ?  rc  r  r~ r@ r6 r9 r6 r6 r6 s)~ s.@tdz+tdz+? t n? rC7?  r0  r0  r0~ r@ r r r r r s)~ s>@tٿt? tKU7? r~^X?  r  r  r~ r@ r r r r r s)~ sQ@t^ǿt^? t\Q@? r!?  r  r  r~ r&@ r r r r r s)~ sv@t12t12? tœ/? r6Zp?  r  r  r~ rJ@ r r r r r s)~ st@tyty? tW] ? r C,?  r  r  r~ rF@ r r r r r s)~ su@t}B9?t}B9? t<$I? uC Q>  r  r  r~ rN@ r r r r r s)~ s@Z@tJݿtJ? tH.75? rk4?  r  r  r~ r0@ r r r r r s)~ sR@tͫ2׿tͫ2? t ˟? ro?  r  r  r~ r"@ r" r# r" r$ r% s)~ sV@t!t!? t88ڻ? rPv?  r&  r'  r(~ r*@BX ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r2 r3 r2 r4 r5 s)~ s`}@ t0# t0#? tޅ? u3ޑ; r6 r7 r8~ rG@ !r\ !r] !r\ !r^ !r_ !s)~ !s~@!t5 !t5 ?! tٯ m?! u NV> ! r` ! ra ! rb~ !rD@ "rd "re "rd "rf "rg "s)~ "sj@"tmM&LO"tmM&LO?" t9y?" rO? " rh " ri " rj~ "r=@ #r6 #ru #r6 #rv #r6 #s)~ #s[@#t@^"4?#t@^"4?# tZȽ?# r`7:5^? # r0 # r0 # r0~ #r0@ $rb $r} $rb $r~ $rc $s)~ $sk@$t1Gd?$t1Gd?$ tlZC?$ rV? $ rrr ~ $r4@ %r %r %r %r %r %s)~ %s@Z@%tʿ%t?% tϭ?% r8\x?% r % r % r ~ %r(@ &r &r &r &r &r &s)~ &sX@&t@]9G?&t@]9G?& tX/@& u-= & r & r & r~ &rR@ 'r 'r 'r 'r 'r 's)~ 'sg@'tDׂW?'tDׂW?' tQ3=گ?' r5Y ? ' r ' r ' r~ 'r?@ (r (r (r (r (r (s)~ (s r@(t Ϳ(t ?( t&9F?( r? ( r ( r ( r~ (rC@ )r )r )r )r )r )s)~ )s`@)t輼ӑ?)t輼ӑ?) t( %@) us(= ) r ) r ) r~ )rR@ *r *r *r *r *r *s)~ *sH@*tD-z?*tD-z?* t<@a?* rܡbi1? * r * r * r~ *rI@ +r +r +r +r +r +s)~ +sk@+tkA?+tkA?+ t & ?+ r)m? + r + r + r~ +r:@ ,r ,r ,r ,r ,r ,s)~ ,s>@,t 6FԿ,t 6F?, t?, rNqC? , r , r , r~ ,rg@ -r -r -r -r -r -s)~ -s`@-tctg?-tctg?- to*@?- r| O? - r - r - r~ -r i@ .r .r .r .r .r .s)~ .sy@.t(?.t(?. tM(Q?. rbi ? . r . r . r~ .rP@ /r /r /r /r /r /s)~ /s~@/tbM>,y?/tbM>,y?/ t7/?/ ry,? / r / r / r~ /rI@ 0r 0r 0r 0r 0r 0s)~ 0sI@0tuaz˿0tuaz?0 tʴ?0 r"&!? 0 r 0 r 0 r~ 0r @ 1r 1r 1r 1r 1r 1s)~ 1sk@1tf?9&1tf?9&?1 t܈Q:?1 rDnʔ {? 1 r 1 r 1 r~ 1r2@ 2r! 2r! 2r! 2r! 2r! 2s)~ 2sQ@2t fʦ2t fʦ?2 t4 hQ?2 u)U> 2 r 2 r  2 r~ 2r@ 3r 3r 3r 3r 3r 3s)~ 3sT@3t? R3t? R?3 t;] ?3 u؏*+> 3 r 3 r  3 r~ 3r@ 4r 4r 4r 4r 4r 4s)~ 4sN@4t714t71?4 tqe7#?4 r_A"R? 4 r 4 r  4 r~ 4r@ 5r 5r 5r 5r 5r 5s)~ 5sW@5trqc5trqc?5 t^vN?5 uC Q> 5 r 5 r  5 r~ 5r @ 6r% 6r& 6r% 6r' 6r( 6s)~ 6s g@6t5&[6t5&[?6 tfI4n?6 uإZKٺ> 6 r 6 r  6 r~ 6r.@ 7r* 7r+ 7r* 7r, 7r- 7s)~ 7s[@7t"U"7t"U"?7 t?7 u!j[> 7 r 7 r  7 r~ 7r$@ 8r/ 8r0 8r/ 8r1 8r2 8s)~ 8sv@8t O8t O?8 t_qb+?8 u^u> 8 r3 8 r4 8 r5~ 8rF@ 9r7 9r8 9r7 9r9 9r: 9s)~ 9s@j@9tw1p W?9tw1p W?9 tN7:FS?9 uEӦt> 9 r; 9 r< 9 r=~ 9r3@ :r :r :r :r :r :s)~ :sd@:t`^m:t`^m?: t_D?: roP? : r : r : r~ :r7@ ;r: ;r; ;r: ;r< ;r= ;s)~ ;s`h@;t ; r? ; r@~ ;r?@ <r? <r@ <r? <rA <rB <s)~ <s0@<tSW˿<tSW?< t2Q?< u;3= < rC < rD < rE~ <rT@ =rG =rH =rG =rI =rJ =s)~ =sȍ@=t`l?=t`l?= t\$?= u9,%؈9 = rK = rL = rM~ =rQ@ >rO >rP >rO >rQ >rR >s)~ >sb@>t ,n>t ,n?> tc{s?> rvv? > rS > rT > rU~ >r,@ ?rX ?rY ?rX ?rZ ?r[ ?s)~ ?s@?tX??tX?? t't?? uUIN> ? r\ ? r] ? r^~ ?ra@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r` @ra @r` @rb @rc @s)~ @s@@tyA?@tyA?@ tt2]6b?@ rאˏ? @ rd @ re @ r^~ @r@U@ Arg Arh Arg Ari Arj As)~ As@AtxU?AtxU?A t-'?A rjs-<^? A rk A rl A rm~ ArS@ Bro Brp Bro Brq Brr Bs)~ Bs@e@Bt#e+ Bt#e+ ?B tyҢ?B u .`> B rs B rt B ru~ Br.@ Cr~ Cr Cr~ Cr Cr Cs)~ Csi@Ct9s?Ct9s?C t1P?C r. dұ? C rC r C r~ Cr?@ Dr Dr Dr Dr Dr Ds)~ Dsk@Dt[F2I4v?Dt[F2I4v?D t RlE@D uY]x= D r D r D r~ Dr6@ Er Er Er Er Er Es)~ EsT@EtvtG?EtvtG?E tx3@E ru? E r E r E r~ Er(@ Fr Fr Fr Fr Fr Fs)~ Fsh@Ft4?Ft4?F tnBN?F rM? F r F r F r~ Fre@ Gr Gr Gr Gr Gr Gs)~ Gs@P@GtgL g?GtgL g?G tsw?G r%A? G r G r G r~ Gr @ Hr Hr Hr Hr Hr Hs)~ Hsp@Ht8 H r H r H r~ Hr>@ Ir Ir Ir Ir Ir Is)~ Is$@It p}?It p}?I t$="@I ue7o 5 I r I r I r~ Ir `@ Jr Jr Jr Jr Jr Js)~ Js@j@Jt(OgtJt(Ogt?J t] lj?J r}6:N? J r J r J r~ JrB@ Kr Kr Kr Kr Kr Ks)~ Ksd@KtEc?KtEc?K tX R @K utwL8 K r K r K r~ KrY@ Lr Lr Lr Lr Lr Ls)~ Lsv@Ltz˽m?Ltz˽m?L tʹq{? @L uX:zy= L r L r L r~ LrB@ Mr Mr Mr Mr Mr Ms)~ Ms @Mt"[8|?Mt"[8|?M tCb?M r% ? M r M r M r~ MrV@ Nr Nr Nr Nr Nr Ns)~ Ns b@Nt aňпNt aň?N tcz?N ri? N r N r N r~ Nr4@ Or Or Or Or Or Os)~ OsL@OtwX* ϿOtwX* ?O tKqd ?O uұ7M> O r O r O r~ Or@ Pr Pr Pr Pr Pr Ps)~ Pss@PtGLL*PtGLL*?P tD?P rt pd? P r P r P r~ PrB@ Qr QrP Qr Qr Qr Qs)~ Qs@@Qt®`Qt®`?Q t ޻?Q ur=;Q r Q rD Q r~ QrE@ Rr Rr Rr Rr Rr Rs)~ Rs@RtP5Z?RtP5Z?R t?R uhq4*< R r R r R r~ Rr`e@ Sr* Sr+ Sr* Sr, Sr- Ss)~ SsD@StHl?StHl?S t5?S rG+? S r. S r/ S r0~ Sr@ Tr6 Tr3 Tr6 Tr4 Tr6 Ts)~ Ts l@Tt4?Tt4?T tt8r@T u2vm> T r/ T r/ T r/~ Tr;@ Ur: Ur; Ur: Ur< Ur= Us)~ Usj@Ut[Kq¿Ut[Kq?U t:' X?U rZⰏi? U r>U r U r?~ Ur<@ VrA VrB VrA VrC VrD Vs)~ Vsf@Vt0AmVt0Am?V t4-Fe?V rQ,7t? V rE V rF V rG~ Vr<@ WrI WrJ WrI WrK WrL Ws)~ Ws@P@Wt4ws{Wt4ws{?W t[ V ?W ru? W rM W rN W rO~ Wr&@ XrQ XrR XrQ XrS XrT Xs)~ Xs0x@Xt:?Xt:?X t?X rDaR? X rU X rV X rW~ XrI@ Yr\ Yr] Yr\ Yr^ Yr_ Ys)~ Ys>@YtOoJ7?YtOoJ7?Y t!&@Y rM? Y r` Y ra Y r~ Yr@ Zrc Zrd Zrc Zre Zrf Zs)~ Zs@ZtW#^?ZtW#^?Z tBm0?Z uOya?> Z rg Z rh Z ri~ ZrQ@ [rk [rl [rk [rm [rn [s)~ [sW@[ty$?cп[ty$?c?[ tgEk?[ r+S.3? [ ro [ rp [ rq~ [r.@ \rs \rt \rs \ru \rv \s)~ \s8@\tx9?j r߃L-ilt>L-i?l tRM+?l ru? l r\ l r] l r^~ lr?@ mr{% mr|% mr{% mr}% mr~% ms)~ msN@mt!V Pmt!V P?m t~?m rDvF? m r% m r% m r%~ mr"@ nr6 nry nr6 nrz nr6 ns)~ ns0v@ntʨڮ?ntʨڮ?n tzSJB@n uSK> n r/ n r/ n r/~ nrI@ or or or or or os)~ osR@ot\Ci|?ot\Ci|?o t9_x1?o rL ?? o r o r o r~ or(@ pr pr pr pr pr ps)~ psI@ptIӿؿptIӿ?p tm ?p rWaj6? p r p r p r~ pr"@ qr qr qr qr qr qs)~ qs.@qt 2l%?qt 2l%?q tk@_5Ks?q r|L? q r q r q r~ qr@ rr rr rr rr rr rs)~ rs@rt}rt}?r t?Yg?r rdHڛT? r r r r r r~ rrQ@ sr sr sr sr sr ss)~ sse@st)Ra st)Ra ?s toF ?s r%C p? s r s r s r~ sr6@ tr tr tr tr tr ts)~ ts@e@ttin ttin ?t t#ROX?t rzW]? t rt r t r~ tr(@ ur ur ur ur ur us)~ usx@ut*K?ut*K?u t}O?u r@xt>!?xt>!?x t]o_{?x r"&/? x r x r x r~ xr@ yr yr yr yr yr ys)~ ys@`@yt/F'!gyt/F'!g?y t9mr?y r$^nP? y r y r y r~ yr1@ zr zr zr zr zr zs)~ zss@zt C4zt C4?z tC5?z rzό#? z r z r z r~ zrG@ {r {r {r {r {r {s)~ {sP@{tx)N(?{tx)N(?{ t -?{ rjs-<^? { r { r { r~ {r@[@ |r, |r! |r, |r" |r, |s)~ |s@|ta.7|ta.7@| t-ˤg?| u`Z}> | rrr ~ |r@W@ }r( }r) }r( }r* }r+ }s)~ }s\@}tiuvYZ?}tiuvYZ?} t\Wԑ@} rş5&? } r, } r- } r.~ }r0@ ~r@ ~rA ~r@ ~rB ~rC ~s)~ ~ss@~tӲeK?~tӲeK?~ tj޹f?~ r2I? ~ rD ~ rE ~ rF~ ~rF@ r` ra r` rb rc s)~ s@_@t[?t[? tFI^? r$uӃ?  rd  re  rf~ r4@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ su@t.^vk?t.^vk? toNGf ? r|? r r r~ rL@ r r r r r s)~ sP@t@ Ot@ O? twyP? r!u䡺? r r r~ rn@ r r r r r s)~ s9@t֐﬙?t֐﬙? tvG? r'7 .? r r r~ r@ r r r r r s)~ sK@t쥚R?t쥚R? tQ? r+&:? r r r~ r"@ r r r r r s)~ s0q@tA)?tA)? t28@ uh;F? r r r~ rC@ r r r r r s)~ sF@t|ڿt|? tj? r҇>[? r r r~ r@ r r r r r s)~ sf@tYZtYZ? tdi@? ry2b@t6_t6_? tv? rMKu|? r r  r ~ r@ r6 rI" r6 rJ" r6 s)~ s9@t^Jt^J? t6^[Q? ry? r!0 r"0 r#0~ r@ r r r r r s)~ sR@t$sH#`˿t$sH#`? tz=O? rJı? r r r~ r0@ r r r r r s)~ s@Z@t^k#t^k#? t{-Q? r2_;ږ? rS r r~ r1@ r r r r r s)~ sd@tkT?tkT? t`J8? r|r8? r r r~ r6@ r r r r r s)~ s@t9%0? r$y 3? r r r~ r&@ r> r? r> r@ rA s)~ s@t vtt vt? t%"N? rsFX? rB rC rD~ rM@ rF rG rF rH rI s)~ s@P@t]쩿t]? tVx? r44`-? rJ rK rL~ r(@ rN rO rN rP rQ s)~ sl@t?t? tЈT3? r ə? rR rS rT~ rA@ r0 rW r0 rX r0 s)~ sQ@tZ.BtZ.B? tD.N? r. dұ? rrr ~ r*@ r r r r r s)~ s l@t>^Nοt>^N? t:(? rB? r r r ~ r@@ r/ r r/ r/ r/ s)~ s@t}x?t}x? tҊf@ ugq[X; r/ r/ r/~ rU@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s.@tKi=ٿtKi=? to/*? r/A2? r r r~ r@ r6 r r6 r r6 s)~ s.@tEZ?tEZ? tM9? rƐ#? r0 r0 r0~ r@ r r r r r s)~ sq@t7 t7 ? t: ? r;k? r r r~ rB@ r r r r r s)~ s0v@tr1맿tr1? tg[R? rd:? r r r~ rN@ r r r r r s)~ sn@tHutͿtHut? tj1H? r} ? r r r~ r?@ r- r. r- r/ r0 s)~ s@tq徭tq徭? t驼? rȝ^I? r1 r2 r3 ~ rY@ r6 r> r6 r? r6 s)~ s9@t@H?@t@H?@ tmѓ@ rt? r1 r1 r1~ r@ rR rS rR rT rU s)~ sg@tܫۿtܫ? t? rR^U? rV rW rX ~ r4@ rc rd rc re rf s)~ sI@tt<|]'ֿtt<|]'? tuwy,? rKmY? rg rh ri ~ r @ rx ry rx rz r{ s)~ sA@tt? tMa? rME+'? r| rT r} ~ r@ r r r r r s)~ s@t,ITft,ITf? tM$?$@$A$B$C$D$E$F$G$H$I$J$K$L$M$N$O$P$Q$R$S$T$U$V$W$X$Y$Z$[$\$]$^$_$`$a$b$c$d$e$f$g$h$i$j$k$m$n$o$p$q$r$s$t$u$v$w$x$y$z${$|$}$~$$$ r ~ r5@ r5 r| r5 r5 re- s)~ s4@t. ֭/?t. ֭/? ti>&_? rR^U? rf- rg- rh-~ r@ r6 r r6 r6 r6 s)~ s@P@t&t&? t<`? r5tQ? r; r; r;~ r$@ r r r r r s)~ s4@txF#@txF#@ t+|؅A@ rWin? r r r~ r@ r r r r r s)~ sn@t:vt:v? tA40@? rH? rrr ~ r1@ r r r r r s)~ sn@t5c#t5c#? tW6;? r7HT? r r r~ r=@ r6 r r6 r6 r6 s)~ s4@tBˠkʿtBˠk? tS1? r-X&Z? r1 r1 r1~ r@ r r r r r s)~ sT@t[جĘ4ۿt[جĘ4? ty0[? rb"%/? r r r ~ r,@ r r r r r s)~ s>@t-ͯ t-ͯ ? tD? rOJݱ+? r r r~ r@ r r r r r s)~ sR@tคtค? t,pc? r ;? r r r~ r @ rH! r  rH! rI! rJ! s)~ s$@t0~?t0~? t9~Q^8@ r^}H? r; r; r;~ r@ r r! r r" r# s)~ s0v@tDtD? t'XՎ? u:k!}`> rrr ~ r8@ r* r+ r* r, r- s)~ s@`@tZ?tZ? tX }@ u^$ϟ> r. r/ r0 ~ r&@ rC rD rC rE rF s)~ sK@t:ʿt:? t(A? r@O ? rG rH rI ~ r&@ r6 r r6 r6 r6 s)~ sK@tCeѷLtCeѷL? tG@K? r%? r0 r0 r0~ r"@ r6~ v@=@ r6 r6 r6 s)~ s9@tv5/i?tv5/i? t[u?tAMK]>? t&J`@ u%8< r r r~ rM@ r r r r r s)~ s^@t]7?t]7? tH? rl ? r r r~ r1@ r r r r r s)~ s0p@t7"S?t7"S? tJ§@ uPJ> r r r~ r>@ r2 r r2 r r3 s)~ sD@t\VD՞?t\VD՞? t5 _? r$uӃ? rrr ~ r@ r5 r6 r5 r7 r8 s)~ sT@tIlbtIlb? tCv? u;_d> r r  r~ r@ r: r; r: r< r= s)~ sF@tΎ2~&ӿtΎ2~&? t e>? rejU? r r  r~ r@ r? r@ r? rA rB s)~ s@P@tktk? tA"? r%? r r  r~ r@ r# r$ r# r% r& s)~ sW@tt? tL6ӯ4? r%+1e? r r  r~ r"@ rD rE rD rF rG s)~ s@_@tSI=ΘtSI=Θ? t^#ʧx? rlJc? rH r rI ~ r2@ rK rL rK rM rN s)~ spr@t|Vr?t|Vr? tX%e? rC7? rO rP rQ ~ r;@ rS rT rS rU rV s)~ s{@t+qt+q? t+Um6? u#T= rW rX rY ~ r>@ rc rd rc re rf s)~ s@t*͏t*͏? tmqY? u1= rg rh ri ~ rO@ rk rl rk rm rn s)~ sf@tz {(W5?tz {(W5? tF t? uq.> ro rp rq ~ r.@ rs rt rs ru rv s)~ s g@t d?t d? to~5@ rt^{8? rw rx ry ~ r6@ rw rx rw ry rz s)~ s@j@te te ? tLK? r=+? r{ rT r|~ r3@ r{ r| r{ r} r~ s)~ si@tot@?tot@? t5% @ rekh? r r" r ~ r3@ r r r r r s)~ s b@tj,&Lg>?tj,&Lg>? tb:\CF? rRAgĀ? r r r ~ r,@ r r r r r s)~ s{@tZ[`UtZ[`U? twd? r'K;֣? r r r~ rI@ r r r r r s)~ s@U@t9Rb?t9Rb? tP? rF\]{? r r r ~ r*@ r  r! r  r" r# s)~ s@_@tilbtilb? tDa? ra? r$ r% r&~ r1@ r r r r r s)~ s`h@t'B?t'B? tN]L? r>O? r r r ~ r1@ r r r r r s)~ s{@tjf-tjf-? t$]? ro? r r r ~ rI@ r r r r r s)~ s@U@t ٌt ٌ? t,p? uEG? r r  r ~ r"@ r r r r r s)~ sY@tZI tZI ? tFKTD? u<%sm> r  r  r ~ r"@ r r r r r s)~ se@t;?jt;?j? tN`]ס? r9ũe? rrr ~ r8@ r r r r r s)~ s^@t! 1ėt! 1ė? tuC? rPI=_& ? r r r ~ r.@ r6 r r6 r r6 s)~ sD@tD޾tD޾? tr=8+o? rUT? r0 r0 r0~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sp@tZ:ڿtZ:? tt n)? r$y 3? r r r ~ rS@ r r r r r s)~ s b@tt{tt{? t1A? rZ? r r r ~ r1@ r r r r r s)~ sA@tчDtчD? t1x? r'M;? r r r ~ r@ r r r r r s)~ s g@t9-,?t9-,? tfFW? rG>? r r r~ rA@ r r r r r s)~ sa@tŜ.I2tŜ.I2? tBɣDM? r|g,D{s? r r r~ r2@ r, r- r, r. r/ s)~ sA@tyty? t_+? rH.D? r0 r1 r2 ~ r@ r6 r r6 r  r6 s)~ s@t.?t.? t1m@ u' \> r0 r0 r0~ r@S@ r< r= r< r> r? s)~ sl@t0o|t0o|? tK~? r&EM| ? r@ rA rB ~ rB@ r6 rE r6 rF r6 s)~ s4@t4&Ufh?t4&Ufh? t ~p? r͍? re0 rf0 rg0~ r@ rT rU rT rV rW s)~ s@e@t+ ׿t+ ? t3? rЫ? rX rY rZ ~ r<@ r6 r6 r6 r6 r6 s)~ s.@t3t3? t? r% ? r<0 r=0 r>0~ r@ r r r r r s)~ s~@t+m˅vt+m˅v? tA5 ? u74ާ: r r r~ rO@ r r r r r s)~ sd@tܡݿtܡ? t|q؜,? ru? r r r~ r4@ r r r r r s)~ sj@tWٿtW? tR~uKc? r[֬? r r r ~ r6@ rP rQ rP rR rS s)~ s.@tWلJ?tWلJ? tN? rdݠ? rT rU rV~ r@ r r r r r s)~ s@_@tVMkE?tVMkE? t ? r 2 z? r r* r ~ r4@ r r r r r s)~ sN@t>ѿt>? tf Hf? r@6s ? r r r ~ r$@ rh ri rh rj rk s)~ sa@tXRltXRl? t u? r~^X? rrr ~ r3@ r r r r r s)~ sp@t\*,]t\*,]? t^ߙ? r D۲C? r r r ~ rD@ r r r r r s)~ sz@t;ڿt;? t? raM? r r r ~ rH@ r r r r r s)~ s@e@teE޿teE? tw(l? r2I? rrr ~ r2@ r r r r r s)~ sb@t6 f?t6 f? t] j? rIh? r  r! r"~ r(@ r r r r! r" s)~ sD@tÌP?tÌP? t #@ r}vv? r#  r r$ ~ r@ r& r' r& r( r) s)~ s@}@tՇtݿtՇt? tq9W? rDga? r* r+ r, ~ rC@ r6 r7 r6 r8 r9 s)~ s.@tj)Xkltj)Xkl? trt:Y? rG.z? r: r; r< ~ r@ rV rW rV rX rY s)~ sF@tDotDo? tg? r=? rZ r[ r\ ~ r@ r^ r_ r^ r` ra s)~ s^@t"u8t"u8? tmvЃ? r}/M? rb rc rd ~ r*@ r~ r r~ r r s)~ s0q@ttI+;̿ttI+;? t~ՔҨv? r4`? r r r ~ r@@ r r r r r s)~ sf@tXhٿtXh? tGb? r^? r r r~ r;@ r r r r r s)~ s\@tDNC ?tDNC ? tjK%? u77> r r r ~ r1@ r r r r r s)~ s.@tyֿty? tgoA? rH.D? r r r ~ r@ r  r  r  r r s)~ sY@tftf? t/ d? r?Al? r r" r~ r,@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r6 r r6 r r6 s)~ s@P@t,gt,g? t4ÄZ? r~c~?  r0  r0  r0~ r(@ r r r r r s)~ sI@tm$ſtm$? teo? r+S.3?  r  r  r ~ r"@ r/ r0 r/ r1 r2 s)~ s@U@t+vؿt+v? txS7? rG.z?  r3  r4  r5~ r*@ r r r r r s)~ sd@t'Zt'Z? tO_? rsԷa?  r  r  r~ r4@ r r r r r! s)~ sA@t/~:at/~:a? t5:ZX? r:=X?  r"  r#  r$ ~ r@ r& r& r& r& r& s)~ sȇ@t#z?t#z? tl ۠D? r.NP?  rrr ~ rR@ r` ra r` rb rc s)~ sK@tY>GſtY>G? tme;]? rٗPk?  rd  re  rf~ r"@ rh ri rh rj rk s)~ sN@t-鷫t-鷫? toۋ? rSR0?  rrr ~ r@ r| r} r| r~ r s)~ sY@t<6?t<6? t ㆂ? r?  r  r  r~ r*@ r r r r r s)~ sK@ txn| txn|?  tIC?  rME+'?  r  r  r~ r@ r r r r r s)~ s`q@ tg9.& tg9.&?  tti?  u >  r  r  r ~ r>@ r r r r r s)~ sV@ tC7u tC7u?  t,  r  r  r~ r"@ r r  r r! r" s)~ s@P@t~gEQܿt~gEQ? tSrQ? r)FwK?  rC  rD  rE~ r @ r$ r% r$ r& r' s)~ sT@t=Lt=L? t&8l? u}g8>  r(  r)  r*~ r@ r4 r5 r4 r6 r7 s)~ s4@t ܿt ? tQf? r1hA؛?  r  r  r~ r@ r9 rP r9 r: r; s)~ s``@tz$tz$? thr}? rY?  r  r  r~ r,@ rE rP rE rF r; s)~ sQ@t0˭t0˭? t$? r/$b?  rrr ~ r"@ r6 rI r6 r6 rK s)~ so@t  ׾Ŀt  ׾? t<02j? rjDDdM?  rL  rM  rN~ rI@ r  r  r  r r s)~ s>@t=??t=?? tem@ r+S.3?  r  r  r~ r@ r\ r] r\ r^ r_ s)~ sD@teQNtteQNt? t`? rT $W?  r`  ra  rb~ r@ re rf re rg rh s)~ s9@tQ߽ ?tQ߽ ? t+Vn? rt pd?  ri  rj  rk~ r@ rv~ v<@ rv rx ry s)~ s>@tȊor\tȊor\? t$6l}? rOV?  rz  r{  r|~ r@ r r r r r s)~ sN@tO!J OܿtO!J O? t{? rFV??  r  r  r~ r&@DXl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r r r r r s)~ s9@ tD޻ tD޻?  t;D?  ra?  r  r  r~ r@ !r6 !r !r6 !r6 !r6 !s)~ !s9@!tsmb[ÿ!tsmb[?! t?! rQ? ! rH0 ! rI0 ! rJ0~ !r@ "r6 "r "r6 "r7 "r7 "s)~ "s\@"t_y?"t_y?" t%?" rrQD,? " r0 " r0 " r 0~ "r3@ #r7 #r7 #r7 #r7 #r7 #s)~ #s4@#t8~r#t8~r?# t H?# r}]? # r1 # r1 # r1~ #r@ $r $r $r $r $r $s)~ $s l@$t jr?$t jr?$ tΞyVē@$ u> $ rrr ~ $r1@ %r7 %r %r7 %r %r7 %s)~ %s9@%tɍ1?%tɍ1?% t5?% r_~>? % r0 % r0 % r0~ %r@ &r5 &r &r5 &r &r- &s)~ &s9@&tǀ擵ѿ&tǀ擵?& tHid?es?& rOCs7? & r- & r- & r-~ &r@ 'r 'r 'r 'r 'r 's)~ 's4@'tovؿ'tov?' t1^t?' rpM? ' r ' r ' r~ 'r@ (r (r (r (r (r (s)~ (s4@(tNoB޿(tNoB?( t=W?( rs_? ( r ( r ( r~ (r@ )r" )r# )r" )r$ )r% )s)~ )sn@)t0>]?)t0>]?) tB]k1\?) u00S> ) r& ) r' ) r( ~ )r@@ *r *r *r *r  *r! *s)~ *s`s@*tC&*tC&?* tP@Sy?* u+i= * r" * r# * r$~ *r9@ +r& +r' +r& +r( +r) +s)~ +s4@+tֿ+t?+ tӮ?+ r 2? + r* + r+ + r,~ +r@ ,r. ,r/ ,r. ,r0 ,r1 ,s)~ ,sd@,t2+Y,t2+Y?, t%?, u> , r2 , r3 , r4~ ,r2@ -r> -r? -r> -r@ -rA -s)~ -s>@-tEJX;-tEJX;?- tgNk&?- rMʟ`? - r - r  - r~ -r@ .rQ .rR .rQ .rS .rT .s)~ .sx@.t^!gv?.t^!gv?. t. A@. u2\B~> . rU . rV . rW~ .rF@ /ra /rb /ra /rc /rd /s)~ /sF@/t/me/t/me?/ tFڴ3?/ r? / re / rf / rg~ /r@ 0ri 0rj 0ri 0rk 0rl 0s)~ 0s>@0tC6!?0tC6!?0 t2qn6?0 r*8? 0 rm 0 rn 0 ro~ 0r@ 1rq 1rr 1rq 1rs 1rt 1s)~ 1sn@1tp_1tp_?1 ttT4?1 r0H<(C? 1 ru 1 rv 1 rw~ 1r9@ 2ry 2rz 2ry 2r{ 2r| 2s)~ 2sf@2tV 2 r} 2 r~ 2 r~ 2r9@ 3r 3r 3r 3r 3r 3s)~ 3sy@3tlqar3tlqar?3 t_=?3 uI3SO= 3 r 3 r 3 r~ 3rF@ 4r 4r 4r 4r 4r 4s)~ 4sd@4t+Q4t+Q?4 t"?4 r0H<(C? 4 r 4 r 4 r ~ 4r6@ 5rO 5rP 5rO 5rQ 5rR 5s)~ 5sN@5tK5tK?5 tc%d ?5 u#̖= 5 r 5 r  5 r~ 5r@ 6r 6r 6r 6r 6r 6s)~ 6sA@6t է _?6t է _?6 t2gr?6 r14ho? 6 r 6 r 6 r~ 6r@ 7r 7r 7r 7r 7r 7s)~ 7sF@7tk͊C?7tk͊C?7 td?7 r`,? 7 r 7 r 7 r~ 7r @ 8r 8r 8r 8r 8r 8s)~ 8s$@8t Q a߿8t Q a?8 t酲س?8 rz? 8 r 8 r 8 r~ 8r@ 9r 9r 9r 9r 9r 9s)~ 9s@j@9tiG?9tiG?9 t(|r?9 rGA? 9 r 9 r 9 r~ 9r>@ :r :r :r :r :r :s)~ :s@u@:t*)?:t*)?: tό%?: rks0,? : r : r : r ~ :rL@ ;r ;r ;r ;r ;r ;s)~ ;sA@;tNٿ;tN?; tÅ0B?; rs? ; r ; r ; r~ ;r@ <r <r <r <r <r <s)~ <sV@<t"4l<t"4l?< t˂(?< rbF? < r < r < r~ <r(@ =r =r =r =r =r =s)~ =s@P@=tg7v`?=tg7v`?= t6@= r| O? = r = r = r ~ =r*@ >r  >r  >r  >r  >r >s)~ >s4@>t[=>t[=?> t#0?> ri? > r > r > r~ >r@ ?r ?r ?r ?r ?r ?s)~ ?s$@?tyx)tݿ?tyx)t?? tB?? rl#Ef$? ? rrr ~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @rB @rC @rB @rD @rE @s)~ @sN@@tHCݰ@tHCݰ?@ tʹ2?@ rljc4? @ rF @ rG @ rH~ @r$@ Ar2 Ar3 Ar2 Ar4 Ar5 As)~ AsQ@AtI?AtI?A tef?A r!h? A r6 A r7 A r8~ Ar"@ Br7 Brm Br7 Brn Br 7 Bs)~ Bs9@BtRȅBtRȅ?B tgor?B r!u䡺? B r$0 B r%0 B r&0~ Br@ Cr Cr Cr Cr Cr Cs)~ Css@Ct$B?Ct$B?C t!Z-?C r{yp ? C r C r C r~ Cr6@ Drj Dr Drj Dr Drk Ds)~ Dsa@Dt^kƿDt^k?D t EfW?D rE? D rl D rm D rn~ Dr6@ ErH ErI ErH ErJ ErK Es)~ Es4@Et?͙߿Et?͙?E tN?E rs!)? E rL E rM E rN~ Er@ Fr Fr Fr Fr Fr Fs)~ FsY@Ftr Ftr ?F tիq(A?F rw=p? F r F r F r~ Fr$@ Gr Gr Gr Gr Gr Gs)~ Gs`c@Gt [:mGt [:m?G t0+b?G u?֊M> G rG r G r~ Gr2@ Hr Hr Hr Hr Hr Hs)~ Hs@P@HtN0O?HtN0O?H t̥G [@H r1hA؛? H r H r H r~ Hr&@ Ir/ Ir  Ir/ Ir/ Ir5 Is)~ Is@U@It+8?It+8?I t-[5?I rR^U? I rrr ~ Ir(@ Jr Jr Jr Jr Jr Js)~ Js.@Jt凩WJt凩W?J tU7?J r& ? J r J r J r~ Jr@ Kr Kr Kr Kr Kr Ks)~ KsR@Kt|ʿKt|?K t=?K ru n? K r K r K r~ Kr(@ Lr Lr Lr Lr Lr Ls)~ Ls>@Lt8dA:Lt8dA:?L twc?L r?}? L r L r L r~ Lr@ Mr Mr Mr Mr Mr Ms)~ MsA@Mt$#۬ۿMt$#۬?M t$ e?M r/iVK? M r M r M r~ Mr@ Nr Nr Nr Nr Nr Ns)~ NsI@Ntdy?Ntdy?N t[b@N u1W> N r N r  N r ~ Nr@ Or$ Or% Or$ Or& Or' Os)~ OsT@OtQw Ĥ?OtQw Ĥ?O t<ּt?O rh fz? O r( O r) O r*~ Or(@ Prf Prg Prf Prh Pri Ps)~ Ps.@Pt'Ea,ԿPt'Ea,?P t31?P rpM? P rj P rk P rl ~ Pr@ Qr Qr Qr Qr Qr Qs)~ QsF@Qtf%3߿Qtf%3?Q tK ?Q r\iT? Q r Q r Q r~ Qr@ Rr  Rr  Rr  Rr  Rr  Rs)~ Rs l@RtҐF?RtҐF?R ti0"?R r2!? R r  R r R r~ Rr=@ Sr! Sr" Sr! Sr# Sr$ Ss)~ SsI@St(;??St(;??S t6{?S rŰ5? S r S r S r~ Sr"@ Trc Trd Trc Tre Trf Ts)~ TsY@TtTt?T tUA?T ruT? T rg T rh T ri~ Tr3@ Ur Ur Ur Ur Ur Us)~ UsF@Ut[?Cg?Ut[?Cg?U t- k?U ri? U r U r U r~ Ur"@ Vr Vr Vr Vr Vr Vs)~ Vs@Z@VthVth?V tI]?V r:Q^tP>?^ t;?^ r5楈? ^ r ^ r ^ r ~ ^r @ _r" _r# _r" _r$ _r% _s)~ _s@P@_tm~?_tm~?_ tl5 @_ r4Z=? _ r& _ r' _ r(~ _r$@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r4 `r5 `r4 `r6 `r7 `s)~ `s^@`tW#º?`tW#º?` t q f?` rWBmY?1? ` r8 ` r9 ` r:~ `r.@ arJ arK arJ arL arM as)~ asq@at*}at*}?a t _K?a rqP ? a rN a rO a rP~ ar=@ bru brv bru brw brx bs)~ bsl@bt?bt?b tuv?b r4} Z? b ry b r" b rz~ brD@ crr crs crr crt cru cs)~ cs`c@ctO<տctOl?c r2!? c rv c r c rw~ cr7@ dry drz dry dr{ dr| ds)~ ds$@dt M?dt M?d th f/?d r f#? d r} d r~ d r~ dr@ er er er er er es)~ es4@etS 9etS 9?e tohEY?e rgB+? e rC e rD e rE~ er@ frH frI frH frJ frK fs)~ fsN@fth%fth%?f tdè?f r\? f rLf r f rM~ fr@ gr gr gr gr gr gs)~ gsR@gtSgtS?g tub?g r'lV?? g rLg r g rM~ gr@ hr hr hr hr hr hs)~ hsD@ht=lmht=lm?h t75?h rh/? h r h r h r~ hr@ ir ir ir ir ir is)~ is.@it>it>?i t79-gj?i r:N")? i r i r i r~ ir@ jr 7 jr# jr 7 jr 7 jr% js)~ jsF@jt"> ֿjt"> ?j t<tB.?j r%cg6? j r1 j r1 j r1~ jr"@ kr7 kr kr7 kr7 kr7 ks)~ ks`@ktԷ-ktԷ-@k ty?k rPLq? k rc k rc k rc~ kr4@ lr7 lrY lr7 lr7 lr7 ls)~ ls9@ltA&!?ltA&!?l tHuچ?l rC? l r)1 l r*1 l r+1~ lr@ mr7 mrm mr7 mr7 mr7 ms)~ ms9@mtB1ѿmtB1?m tO#d?m r% ? m r90 m r:0 m r;0~ mr@ nrk nrl nrk nrm nrn ns)~ nsQ@ntX1|]?ntX1|]?n t " L?n r% ? n ro n rp n rq~ nr$@ or7 or or7 or7 or7 os)~ osY@ot:hot:h?o tC?o rH.D? o r?1 o r@1 o rA1~ or*@ pr pr pr pr pr ps)~ ps b@pt z=p?pt z=p?p t(C?p r7&z? p r p r p rM~ pr*@ qr qr qr qr qr qs)~ qs`x@qt \?qt \?q tfZ?q rH.D? q r q r q r~ qrA@ rr rr rr rr rr rs)~ rsV@rtHiYNrtHiYN?r tWDa?r u/sa 0> r r r r r r~ rr&@ sr sr sr sr sr ss)~ ssY@sto&5chsto&5ch?s tX`?s r0 ? s r s r s r~ sr"@ tr tr tr tr tr ts)~ ts@U@tt-i_tt-i_?t tXyM?t u:z'j> t r t r t r~ tr@ ur7 ur> ur7 ur7 ur7 us)~ usV@ut9R;:?ut9R;:?u tBK?u r7? u r_0 u r`0 u ra0~ ur1@ vr7 vr vr7 vr7 vr7 vs)~ vsD@vt&vt&?v t:+?v r#12? v r0 v r0 v r0~ vr @ wr 7 wr wr 7 wr!7 wr"7 ws)~ wsF@wtKGCqpNϿwtKGCqpN?w tRZ?w r3'ˆ:\? w r1 w r1 w r1~ wr@ xr xr xr xr xr xs)~ xs.@xt?xt?x t3K ]?x rejU? x r x r x r~ xr@ yr yr yr yr yr ys)~ ys4@ytճdÿytճd?y tW?y r0| ? y r y r y r~ yr@ zrT zrU zrT zrV zrW zs)~ zsA@zt zt ?z tʮ?z r&$c ? z rX z rY z rZ ~ zr@ {r] {r^ {r] {r_ {r` {s)~ {sK@{t+>-W{t+>-W?{ t>?{ ry2b@tJI;?tJI;? t0"4@ ry5N74?  r71  r81  r91~ r@ r r r r r s)~ s`h@t\Imƾt\Imƾ? tg"q? r;C.V?  r  r  r~ r<@ r; r< r; r= r> s)~ sT@tmk%fտtmk%f? tdj4;? r1!"?  r?  r@  rA~ r&@ r17 r27 r17 r37 r47 s)~ s$@t;yW̕?t;yW̕? tҳ  r*  r+  r,~ rA@ r3 r4 r3 r5 r6 s)~ sd@t vVt vV? tЇ2? rN+_&?  r7  r8  r9~ r3@ rC rD rC rE rF s)~ s.@t:ٿt:? tW)? r'7 .?  rG  rH  rI~ r@ r| r} r| r~ r s)~ sr@t>Řt>Ř@ t#|? u,IzK>  r  r  r~ rA@ r r r r r s)~ s`@tIQtIQ? t@? r?R?  r  r  r~ r7@ r r r r r s)~ s@P@tdwũ?tdwũ? tf@2bw@ r/$b?  r  r  r ~ r&@ r57 r r57 r r67 s)~ sD@t+!oYt+!oY? t ? r 8=?  r0  rC0  r0~ r @ r r r r r s)~ s\@tq tq ? txc7G? r1[(,44?  r  r  r~ r4@ r r r r r s)~ s>@tj1E\vtj1E\v? tjw6X? r?  r  r  rM~ r@ r< r= r< r> r? s)~ sA@t?i߿t?i? tC@? r0|Ek?  r@  rA  rB~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rD rE rD rF rG s)~ sK@tro[tro[? t$=? rDga?  rH  rI  rJ~ r"@ r r r r r s)~ sI@t5>t5>? t)êE? rSjT?  r  r  r~ r@ r r r r r s)~ sQ@tnZtnZ? tw ? rf_?  r  r  r~ r&@ r r r r r s)~ s{@tHpȘ?tHpȘ? t(t? uX83g|k>  r  r  r~ rL@ r: r; r: r< r= s)~ s9@t?|6yϿt?|6y? tY6  r?  r@~ r@ r r r r r s)~ s@P@trZktrZk? tgx? r,E?  r  r  r~ r&@ r77 r r77 r r87 s)~ s@Z@ta)@?ta)@? tFd? rI!R?  r0  r0  r0~ r1@ r r r r r s)~ sD@tata? t? r%cg6?  r  r  r~ r @ r r r r r s)~ s>@tq5ֹѿtq5ֹ? tr i? r |"?  r  r  r~ r@ r6 r r6 r r}. s)~ s.@tجҿtج? tv?BP? r=?  r~.  r.  r.~ r@ r r r r r s)~ s4@t )_ѿt )_? ta~l? r1hA؛?  r  r  r~ r@ r r r r r s)~ s.@t}(j=t}(j=? tZq@? r͏9?  r  r  r~ r@ r r r r r s)~ s$@t+t+? t_h? rj?  r  r  r~ r@ r r r r r s)~ sQ@t桅t桅? tx? rj(?  r  r  r ~ r(@ r r r r r s)~ sV@tQuĿtQu? tDo9? rlC?  r  r   r!~ r0@ r2 r3 r2 r4 r5 s)~ s.@tUW?tUW? t%E\:? r-8?  r6  r7  r8~ r@ rB rC rB rD rE s)~ s$@t}St}S? t>? r?j?  rF  rG  rH~ r@ r97 rg r97 r:7 r;7 s)~ s.@t\߮ѿt\߮? tmCY? rks0,?  r1  r 1  r 1~ r@ r r r r r s)~ s4@tMAwXtMAwX? t 2X? rq3ћ?  rC  rD  rE~ r@ r<7 rE1 r<7 r=7 r>7 s)~ s@t *q?t *q? t& ? r0|Ek?  rF1  rG1  rH1~ r@ r r r r r s)~ s4@ta7Cޣӿta7Cޣ? tpOT? rZⰏi?  rC  rD  rE~ r@ rx rP rx ry r; s)~ sD@tgK&NktgK&Nk? tGk? rn\,:?  rL r  rM~ r@ r?7 r@7 r?7 rA7 rB7 s)~ s.@tk8Qtk8Q? tNS* ? rG3`?  rr1  rs1  rt1~ r@ r r r r r s)~ sQ@t"RY?t"RY? t0$? rCwM?  r  r  r~ r&@ r, r, r, r, r, s)~ s.@tBa?tBa? tiĭ? rR^U?  rr  r ~ r@ r r r r r s)~ s4@t8M$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$%t8M? tk? rƚ?  r  r  r~ r@ rC7 r rC7 rD7 rE7 s)~ s>@t{?t{? t=nX6@ rM?  r0  r0  r0~ r@ rt ru rt rv rw s)~ s@_@tJȿtJ? tpA/U? rn?  rx  ry  rz~ r4@ r  r! r  r" r# s)~ sA@tR2dOhtR2dOh? tF)\? r1p?  r$  r%  r&~ r @ rI7 r rI7 rJ7 r s)~ s4@tU8tU8? tS? rb)w ?  rf1  rg1  rh1~ r@ rK7 r rK7 rL7 rM7 s)~ sV@t@B?t@B? t =OA? rKf^?  r1  r1  r1~ r1@ r r r r r s)~ s`l@t|c?t|c? t.? rH?  r  r  r~ r@@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rN7 r rN7 rO7 rP7 s)~ s9@ttM̌ttM̌? tvvܲ? ry2b s)~ sF@t.;`t.;`? tyv(8F? r`~#jS?  r  r   r~ r@ rI rJ rI rK rL s)~ sT@tk Y}пtk Y}? th X? ri?  rM  rN  rO~ r$@ r r r r r s)~ sN@tMmtMm? tg? rAɑ?  r  r?  r~ r$@ r r r r r s)~ sD@tum tum ? tEu? rKmY?  r  r  r~ r@ r r r r r  s)~ s@e@t5\ӿt5\? teL? rQRԯ?  r!  r"  r#~ r;@ rQ7 r6 rQ7 r7 rR7 s)~ s^@t);ֿt);? tMTf'? rin?  r&1  r'1  r(1~ r2@ rS7 rQ rS7 rR rT7 s)~ si@tn~Ŀtn~? t{b^? r㵢?  ri1  rj1  rk1~ rB@ ri rj ri rk rl s)~ sD@tc'ݿtc'? tKTV? rЫ?  rm  r"  rn~ r@ rU7 r rU7 r rV7 s)~ s9@t @tcG,?tcG,? tȹj,? r]H9?  r1  r1  r1~ r@ r( r) r( r* r+ s)~ sI@tK][?tK][? tc .? rJlF8?  r, r  r-~ r@ r7 r8 r7 r9 r: s)~ s>@tgE!?tgE!? tUsU? rB?  r;  r<  r=~ r@ r r r r r s)~ sF@t*wu؋?t*wu؋? tvp]A? rQR?  r  r  r ~ r@ rJ rK rJ rL rM s)~ sN@t ?t ? t?~? rt^{8?  rN  rO  rP~ r$@ rG ri rG rH rI s)~ sD@t Vu6޿t Vu6? t/? r'o?  rrr ~ r@ r r r r r s)~ s.@t#{wt#{w? tWK8*? rd:?  r  r  r~ r@ rj rk rj rl rm s)~ sA@t]o#Lt]o#L? tv? rє?  rn  r  ro~ r@ r r r r r s)~ s.@t@oxt@ox? tvpI^2? r]Ox?  r  r  r~ r@ rM rN rM rO rP s)~ sI@t|AAK?t|AAK? tS? r%cg6?  rr  r?~ r@ r r r r r s)~ sF@t< H?t< H? t)y/? ro?  r  r"  r?~ r @ rD rE rD rF rG s)~ sA@t<1S?t<1S? t:] ? rb)w ? r  rH  rM~ r@ r r r r r s)~ s9@t[at[a? tA<#? rwV/?  r  r  r~ r@ r r! r r r# s)~ sZ@tꠃ7tꠃ7? tY@&? r;OM"?  rrr ~ r@ r]7 r r]7 r^7 r_7 s)~ s4@tptp? twu1Z^? rH}A?  rb0  rc0  rd0~ r@Dvl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ sA@t~h2 @t~h2 @ tU$@ r9?  r  r  r~ r@ r r r r r s)~ s@_@t Et E? t+}mZ? uGe>  r  r  r~ r"@ r r r r r s)~ s@Z@tNC=ktNC=k? tmoF? uk6 >  r  r  r~ r$@ r, r- r, r. r/ s)~ sQ@tx?tx? tH ? rtŇ?  r0  r1  r2~ r(@ r r r r r s)~ s9@tSn;3tSn;3? t$p?? rYP m?  r  r  r~ r@ r& rP r& r& r; s)~ sF@tޥ tޥ ? t-wЉ4? rAz?  rC  rD  rE~ r@ r # rP r # r # r; s)~ sA@tp-yctp-yc@ tHP]gN? ro?  rrr ~ r@ r% r& r% r' r( s)~ s9@t~:˿t~:? t+? r*8?  rc  rc  rc~ r@ rc7 r rc7 rd7 r s)~ s4@tr宏ɿtr宏? tG ? rg8V?  r1  r1  r1~ r@ rh7 r rh7 ri7 rj7 s)~ sN@tcO{ пtcO{ ? tRmgw? r-8?  r 1  r 1  r 1~ r&@ ro7 r+ ro7 rp7 rq7 s)~ s$@tO;տtO;? t=CB? r%cg6?  r1  r1  r1~ r@ rn ro rn rp rq s)~ sF@t=@t=@ t<J@ rE?  rr  rs  rt~ r"@ r r r r  r! s)~ sN@to|to|? t.W? r\'4?  r  r   r ~ r@ rv rw rv rx ry s)~ s@U@tata? teI? u!j[>  r  r   rz~ r @ r, r, r, r, r, s)~ s$@tעtע@ t15I? rg?  r  r   r~ r@ rr7 r5 rr7 rs7 rt7 s)~ s$@t}JU*t}JU*? t-0!B? r()\.?  rn0  ro0  rp0~ r@ r r r r r s)~ sK@t 7?t 7? t^ؿ@ r9گ?  r  r  r} ~ r&@ r r r r r s)~ sK@tT;ٿtT;? the.5? rLK-??  r  r  r~ r$@ r r r r r s)~ sA@th«S?th«S? tY? r{?  r  r  r} ~ r@ ru7 r ru7 r rv7 s)~ sv@t^&Tt^&T? t0c @t7 ?t7 ? t7qb? r;9}?  r  r*  r~ r@ r r r r r s)~ s.@tGp:tGp:? tϰ? rd:?  r  r  r~ r@ r r r r r s)~ sI@tЅtЅ? tF:ڼ? rs?  r  r  r ~ r @ r r r r r s)~ sI@t]#kt]#k? th&? r>L?  r  r  r~ r$@ r; r< r; r= r> s)~ s9@tX3~ӿtX3~? tn>? r?Al?  r?  r@  rA~ r@ rC rD rC rE rF s)~ s9@tGW'߱tGW'߱? t!U}? r'7 .?  rG  rH  rI~ r@ rS rT rS rU rV s)~ sN@t Oɿt O? t6X? rF~g?  rW  rX  rY~ r$@ ry7 rQ ry7 rR rz7 s)~ s.@tڿt? t+? r ?  rt0  ru0  rv0~ r@ rv rw rv rx ry s)~ s9@tcC4пtcC4? tP{`? r&$c ?  rz  r{  r| ~ r@Dl,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, r[ r\ r[ r] r^ s)~ sk@t F?t F? t4㯇{? u4U!X>  r_  r`  ra~ r.@ rk rl rk rm rn s)~ s$@t֞%t֞%? tauc? rJ^n?  ro  rp  rq~ r@ r r r r r s)~ s>@tVt+_?tVt+_? t7era? rR^U?  r  r  r?~ r@ r{7 r r{7 r r|7 s)~ s$@tJtJ? tn]Au? rw=p?  r1  r1  r1~ r@ r r r r r s)~ s>@t7 A@t7 A@ tDz#@ rt 63?  r  r  r ~ r@ r r r r r s)~ s9@t3~ ֿt3~ ? t/$qQ? r+ o?  r  r  r~ r@ r7 r r7 r7 r7 s)~ sD@t6nt6n? tՆ(? r2!?  r1  r1  r1~ r@ r r r r r s)~ sF@tqLa?tqLa? t8U? rA&0?  r  r  r~ r@ r7 r r7 r7 r7 s)~ s.@tW?mw?tW?mw? tVS@ ri?  r1  r1  r1~ r@ r rP r r  r; s)~ sK@ t=? t=??  t(g?  r_?  rrr ~ r@ r r r r r s)~ s$@ tcF%& tcF%&?  t*;?  rƐ#?  r  r  r ~ r@ r r r r r s)~ s.@ tQSQQ? tQSQQ?  tȚpœ?  r^?  r  r  r~ r@ r7 r  r7 r7 r7 s)~ s.@ tTLLS? tTLLS?  tAv*A?  r+ o?  r;  r;  r;~ r@ r5 rx r5 r5 r`/ s)~ s>@ tj+̯? tj+̯?  tV,?  r?  ra/  rb/  rc/~ r@ r7 r r7 r7 r s)~ sA@tMٿtM? t@? r?}?  r#1  r$1  r%1~ r@ r5 rR r5 r6 r7 s)~ s9@t/j@t/j@ t 7 t@ rr4߁?  rrr ~ r@ rM rN rM rO rP s)~ sD@tz*t!?tz*t!? tpJ1=? rM KH?  rQ  rR  rS~ r@ r r r r r s)~ s4@tKc:DtKc:D? t^? r3'ˆ:\?  r  r  r~ r@ r7 r r7 r7 r7 s)~ s9@tMw:_tMw:_? tV~U? rR^U?  r1  r1  r1~ r@ r r r r r s)~ s>@trttrt? t{biiz? r8I+?  r  rH  r~ r@ r r r r r s)~ s4@t%t%? tf? r5楈?  r  r  r~ r@ r r r r r s)~ s4@t[w0?t[w0? te6@ rP3X?  r  r  r~ r@ r r r r r s)~ sA@tH0˿tH0? t9mΔ? r~c~?  r  r  r~ r@ r] r^ r] r_ r` s)~ s>@tt? t{? rV>?  ra  rb  rc ~ r@ r$ r% r$ r& r' s)~ sI@tH"Z vtH"Z v? tp? rXF?  r(  r)  r* ~ r@ r{# r|# r{# r}# r~# s)~ s>@tCf|AtCf|A? tHng? rq7?  r#  r#  r#~ r@ r r r r r s)~ s$@t1XN+t1XN+? t@2? r$uӃ?  r  r"  r~ r@ r r r r r s)~ s9@tt? tQJ2? r1e!Y?  r  r  r~ r@ r7 r  r7 r  r7 s)~ s9@t#!t#!? tLGp;? rT $W?  rx1  ry1  rz1~ r@ r r r r r s)~ sA@tJ+RƿtJ+R? tJg? r룜D"?  r  r  r~ r@ rm rn rm ro rp s)~ sK@tɤ#tɤ#? to? r/iVK?  rq  rr  rs~ r$@ r& r' r& r( r) s)~ s9@tϱf?tϱf? t/z0? r+ o?  r  rW  r*~ r@Dl ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r r r r r s)~ sT@ t5RƠ? t5RƠ?  tuZ?  r m?  r  r  r~ r"@ !r7 !r !r7 !r !r7 !s)~ !sA@!t{?!t{?! t|?! rH.D? ! r<1 ! r=1 ! r>1~ !r@ "r "r "r "r "r "s)~ "s4@"t:?"t:?" t 1]]?" r~^X? " r " r " r ~ "r@ #r #r #r #r #r #s)~ #s4@#tV#tV?# t"?# r8q(? # r # r # r~ #r@ $r7 $r5 $r7 $r6 $r7 $s)~ $s$@$t:M$t:M?$ t O?$ rHkP*? $ ro1 $ rp1 $ rq1~ $r@ %r7 %rZ %r7 %r[ %r7 %s)~ %s4@%tD &?%tD &?% t(a6?% rZⰏi? % rZ0 % rc % r[0~ %r@ &r &r &r &r &r &s)~ &s$@&t/t?&t/t?& tvg?& r2!? & r & r & r~ &r@ 'r 'r 'r 'r 'r 's)~ 's>@'tsE'tsE?' t#b 9?' r2~~(bJ? ' r ' r ' r~ 'r@ (rh (ri (rh (rj (rk (s)~ (s4@(tQ'տ(tQ'?( t[ ! r?( rjDDdM? ( rl ( rm ( rn~ (r@ )rp )rq )rp )rr )rs )s)~ )s@U@)ti[ӿ)ti[?) tLb?) r.NP? ) rt ) r ) ru~ )r.@ *rO *rP *rO *rQ *rR *s)~ *s>@*t qB˿*t qB?* t˛?* rT $W? * rS * rT * rU~ *r@ +r[ +r\ +r[ +r] +r^ +s)~ +sA@+tTG?+tTG?+ t?+ r^}H? + r_ + r` + ra ~ +r@ ,r & ,r& ,r & ,r& ,r& ,s)~ ,s.@,te3?,te3?, t"dr?, r,CթW? , rL, r , rM~ ,r@ -r -r -r -r -r -s)~ -sF@-t_}-t_}?- tt ?- r;C.V? - r - r - r~ -r@ .r  .r  .r  .r  .r  .s)~ .s4@.t', ?.t', ?. t?. rSȉ{? . r  . r . r~ .r@ /rQ /rR /rQ /rS /rT /s)~ /s>@/t5=0/t5=0?/ t)&?/ r+S.3? / r / r / r~ /r@ 0r7 0r7 0r7 0r7 0r7 0s)~ 0s$@0t62?0t62?0 t5\ߏ?0 r @2tK2hXп2tK2hX?2 t0?2 r? 2 rP1 2 rQ1 2 rR1~ 2r@ 3r7 3r+ 3r7 3r, 3r7 3s)~ 3s9@3t #]g??3t #]g??3 t\?3 ro? 3 r1 3 r1 3 r1~ 3r@ 4re 4rf 4re 4rg 4rh 4s)~ 4s[@4tØ4tØ?4 tZ?4 uE[k> 4 ri 4 r 4 rj~ 4r"@ 5r 5r 5r 5r 5r 5s)~ 5s$@5tу/5tу/?5 t ?5 rF~g? 5 r 5 r 5 r~ 5r@ 6r 6r 6r 6r 6r 6s)~ 6s>@6tEO6tEO?6 t4?6 rM~*u!? 6 r 6 r 6 r~ 6r@ 7r 7r 7r 7r 7r 7s)~ 7sD@7t 7t ?7 t'Y?7 r-Ε[? 7 rrr ~ 7r@ 8r4( 8r 8r4( 8r 8r5( 8s)~ 8sF@8t{:8t{:?8 t!?8 rs!)? 8 rrr ~ 8r@ 9r 9r 9r 9r 9r 9s)~ 9sQ@9td?9td?9 t$?9 rt^{8? 9 r 9 r" 9 r ~ 9r&@ :r7 :r :r7 :r :r7 :s)~ :s$@:tM87ֿ:tM87?: t*?: rCҡ? : r1 : r1 : r1~ :r@ ;r ;r ;r ;r ;r  ;s)~ ;sK@;tG{5ȿ;tG{5?; tj I?; rC? ; r  ; r  ; r ~ ;r"@ <r <r <r <r <r <s)~ <s4@<tLl<tLl?< trWr?< rK? < r < r < r~ <r@ =r =r =r =r =r =s)~ =s>@=tLP?=tLP?= t> w?= rH.D? = r = r = r~ =r@ >r7 >r0 >r7 >r0 >r7 >s)~ >s$@>t+H>t+H?> t%N ?> rLK-?? > r0 > r0 > r0~ >r@ ?rw ?rx ?rw ?ry ?rz ?s)~ ?s$@?tQuBֿ?tQuB?? tĔ?? rejU? ? r{ ? r| ? r}~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r @r @r @r @r @s)~ @s9@@tNֿ@tN?@ tAB!?@ ro? @ r @ r @ r~ @r@ ArZ Ar[ ArZ Ar\ Ar] As)~ As9@AtP#?AtP#?A t\Q`I ?A r9ݿ? A r^ A r_ A r`~ Ar@ Br Br Br Br Br Bs)~ Bs.@Btsi,l?Btsi,l?B t7T0[q?B ro? B r B r B r~ Br@ Cr Cr Cr Cr Cr Cs)~ CsQ@CtS{3ÿCtS{3?C tAc?C r]ϵ? C r C r C r~ Cr(@ Dr Dr Dr Dr Dr Ds)~ Ds9@Dto?Dto?D twldf?D r҇>[? D r D r D r~ Dr@ Er Er Er Er Er Es)~ EsQ@Et?I r. dұ? I r I r I r ~ Ir@ Jr7 Jr7 Jr7 Jr7 Jr7 Js)~ Js.@JtR&pJtR&p?J tl/(?J r f#? J r41 J r51 J r61~ Jr@ Kr7~ Kv<@ Kr7 Kr7 Kr7 Ks)~ Ks9@Kt!8Kt!8?K t"IZ?K r%cg6? K r1 K r1 K r1~ Kr@ Lr Lr Lr Lr Lr Ls)~ Ls$@LtfLtf?L t )=#?L r0H<(C? L r L r L r~ Lr@ Mr7 Mr Mr7 Mr7 Mr7 Ms)~ Ms.@Mt܁\Mt܁\?M tT^|?M r f#? M r11 M r21 M r31~ Mr@ Nr5 Nr Nr5 Nr5 Nr#/ Ns)~ Ns[@NtTS&fNtTS&f?N tK?N rEtl? N rc N rc N rc~ Nr(@ Or7 Or Or7 Or7 Or7 Os)~ Os$@Ot2GOt2G?O tϊ?O r~=H? O r O r O r50~ Or@ Pr Pr Pr Pr Pr Ps)~ Ps$@Pt2[Gjx?Pt2[Gjx?P tOu]G@P rGpb? P r P r P r~ Pr@ Qr7 Qr Qr7 Qr7 Qr7 Qs)~ Qs$@Qt/U?Qt/U?Q taXq?Q r;9}? Q r0 Q r0 Q r0~ Qr@ RrY RrZ RrY Rr[ Rr\ Rs)~ Rs9@RtƢFwlcڿRtƢFwlc?R twK ?R r 2? R r] R r^ R r_~ Rr@ Srl Srm Srl Srn Sro Ss)~ Ss>@Stf*Stf*?S t ?S r5? S rp S rq S rM~ Sr@ Tr Tri Tr Tr Tr Ts)~ Ts.@TtVJz?TtVJz?T t%nd?T rO6? T rrr ~ Tr@ Ur7 Ur% Ur7 Ur7 Ur7 Us)~ Us9@Ut-A?Ut-A?U tB@U r ^ rC ^ rD ^ rE~ ^r@ _r _r _r _r _r _s)~ _sI@_t`"t_t`"t?_ t]!?_ ryo4}? _ rC _ rD _ rE~ _r@Dl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r& `r& `r& `r& `r& `s)~ `sF@`t9`t9?` t̶!?` rKmY? ` rC ` rD ` rE~ `r@ ar7 arW ar7 ar7 ar7 as)~ as4@atjJG?atjJG?a t90_#@a rR^U? a r1 a r1 a r1~ ar@ br7 br br7 br7 br7 bs)~ bsA@bt?bt?b tiLI @b r| O? b r0 b r0 b r0~ br@ cr7 cr% cr7 cr7 cr7 cs)~ cs$@ct4$fW?ct4$fW?c ts?c ro? c r1 c r1 c r1~ cr@ dr7~ dv<@ dr7 dr7 dr7 ds)~ dsK@dt Ǜҿdt Ǜ?d tn(?d rP? d r0 d r0 d r0~ dr"@ er" er" er" er" er" es)~ es.@etO'M -޿etO'M -?e t"?e rG>? e r" e r" e r"~ er@ frt! fru! frt! frv! frw! fs)~ fs4@ftsΘ?ftsΘ?f tjκ@f rZH&? f rx! f ry! f rz!~ fr@ gr! gr! gr! gr! gr! gs)~ gs4@gt:lgt:l?g tۀi)?g rLXww? g r! g ra g r!~ gr@ hr7 hr8 hr7 hr9 hr: hs)~ hs$@htX?htX?h t7} 7?h rs!)? h r; h r< h r=~ hr@ ir! ir ir! ir! ir is)~ is9@it &K?it &K?i t.II@i r4D? i rrr ~ ir@ jrZ jr[ jrZ jr\ jr] js)~ jsD@jtov [?jtov [?j tOi_?j r'7 .? j r^ j r_ j r`~ jr@ kr kr kr kr kr ks)~ ksI@kt:`?kt:`?k t9'?k r4$=? k r k r k r ~ kr@ lr$ lr% lr$ lr& lr' ls)~ ls>@lttX?lttX?l t w"n r n r?~ nr@ or or or or or os)~ osD@otM`u@ӿotM`u@?o t\5R$?o rks0,? o r o r o r~ or @ pr" pr" pr" pr" pr" ps)~ ps.@ptӍ+1ԿptӍ+1?p t2=A?p rq7? p r"p r p r"~ pr@ qrk qrl qrk qrm qrn qs)~ qs$@qtuj/?qtuj/?q ti-͌?q r~? q ro q r2 q rp ~ qr@ rr" rr" rr" rr" rr" rs)~ rs9@rtP4 7QrtP4 7Q?r tC?r r]"ęU? r rC r rD r rE~ rr@ sr7 sra sr7 sr7 sr7 ss)~ ss$@st?r"1st?r"1?s tuWXS?s rkdg? s r0 s r 0 s r 0~ sr@ tr\6 trb# tr\6 tr]6 tr- ts)~ ts$@tt;?tt;?t tJ[+?t r]ZY? t r- t r- t r-~ tr@ urT# urU# urT# urV# urW# us)~ us>@utut?u ts?u rЫ? u r u r  u r ~ ur@ vrX6 vrh vrX6 vri vrY6 vs)~ vs>@vt9C@vt9C@v tt6XL3@v r={? v rrr ~ vr@ wrY# wrZ# wrY# wr[# wr\# ws)~ ws4@wtNSSԿwtNSS?w t"FZ?w rhʆe? w r]# w r^# w r_#~ wr@ xr! xr! xr! xr! xr! xs)~ xs$@xt@= ~޿xt@= ~?x t1$?x rT $W? x r! x r! x r!~ xr@ yr7 yrq yr7 yr7 yr7 ys)~ ys@U@ytʈpytʈp?y t8?y rJVx? y r1 y r1 y r1~ yr*@ zr zr zr zr zr zs)~ zsK@zt 䰧oӿzt 䰧o?z tR?z r"&/? z r z r z r~ zr @ {r7 {r {r7 {r {r7 {s)~ {s4@{t*Pap?{t*Pap?{ t.iΞ5?{ r& ? { rh0 { ri0 { rj0~ {r@ |r |r |r |r |r |s)~ |s9@|t%(eɦ|t%(eɦ?| tVC%?| r$?Yf1? | r | r | r~ |r@ }rK }rL }rK }rM }rN }s)~ }s.@}tPk+?}tPk+?} tFE?} rt^{8? } rO } rP } rQ~ }r@ ~rN ~rO ~rN ~rP ~rQ ~s)~ ~sN@~tEտ~tE?~ t-Rj?~ r!u䡺? ~ rR ~ rS ~ rT ~ ~r@ r# r# r# r# r# s)~ s$@tDG?tDG? t2*K? ro?  rr  r ~ r@Dvl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s.@t2<< ߿t2<< ? t"h? r;9}?  r  r  r~ r@ r: r; r: r< r= s)~ s$@t5yXt5yX? tm? ri?  r>  r?  r@~ r@ r7 r r7 r7 r7 s)~ s4@t!');Կt!');? t=? rzb?  rQ0  rR0  rS0~ r@ r($ r)$ r($ r*$ r+$ s)~ sT@tf_9ɿtf_9? t? u 7-v>  r  r  r~ r @ r<$ r=$ r<$ r>$ r?$ s)~ sN@tCm?tCm? ta_:? rSm?  r  r  r~ r@ r7 r7 r7 r7 r7 s)~ s$@tc. 5tc. 5? tG? rE?  r0  r0  r0~ r@ r r r r r  s)~ sK@tt? t\? uk>  r   r   r ~ r@ rx$ ry$ rx$ rz$ r{$ s)~ s.@tt@ tG? rSjT?  r|$  r?  r}$~ r@ r$ r$ r$ r$ r$ s)~ sF@tn?i tn?i ? t8? ? rIX$K+?  r  r   r~ r@ rd re rd rf rg s)~ s9@t}x#ڿt}x#? tD? rD L?  rh  ri  rj~ r@ r7 r r7 r r7 s)~ s$@twiv?twiv? t? r1e!Y?  r1  r1  r1~ r@ r' r' r' r' r' s)~ s9@t]1?t]1? tv? rH.D?  r'  r'  r'~ r@ r7 r r7 r7 r s)~ s$@tmHCtmHC? tvŐ? rs!)?  r1  r1  r1~ r@ r% r% r% r% r! s)~ s4@t8j t8j ? t"9? rDry;D?  r   r   rz~ r@ r7 r7 r7 r7 r8 s)~ s$@tJ&Y~0?tJ&Y~0? tx7? r0e?  r0  r0  r0~ r@ r8 r8 r8 r8 r8 s)~ s9@thMthM? tf? r?  r0  r0  r0~ r@ r 8 r r 8 r r 8 s)~ s$@tMFɿtMF? td? r0|Ek?  rI1  rJ1  rK1~ r@ r r r r r s)~ s$@t͵Q@t͵Q@ tH9WC@ r19 ?  r  r  r ~ r@ r" r" r" r" r" s)~ s4@tW|ſtW|? t kvv? rgN?  r"  r"  r "~ r@ r r r r r s)~ sD@tOL?tOL? t/ ? r𘐿_|?  r  r  r~ r@ rc% rd% rc% re% rf% s)~ s.@t vӿt v? t? rdHڛT?  rg%  rh%  ri%~ r@ rs% rt% rs% ru% rv% s)~ s$@tɧDtɧD? tes X? rR^U?  rw%  rx%  ry%~ r@ r r r r r s)~ s9@t 4j?t 4j? t9m? r_J=nt?  r  r  r~ r@ r 8 r$ r 8 r- r 8 s)~ s$@tƈzտtƈz? tKR? r1hA؛?  r$  r$  r$~ r@ r r r r r s)~ s.@tj$'tj$'? tl97Q? r!0?  r  r  r~ r@ r% r% r% r% r% s)~ s$@t)=aÿt)=a? to? rH.D?  r%  r%  r%~ r@ r r r r r s)~ s.@t1ųt1ų? tj Q? ry2bL?  rD"  rE"  rF"~ r@ r` ra r` rb rc s)~ s4@t/t/? t5tvL? r+r= ?  rd  re  rf~ r@ r!8 rn r!8 ro r"8 s)~ s.@tqFKѿtqFK? t=JXc? rR^U?  r1  r1  r1~ r@ r& r& r& r& r& s)~ s9@t1ɿt1? tZ,? rksu?  r  r  r~ r@ r&8 r r&8 r'8 r(8 s)~ s.@t/?t/? tFA+Y? r%cg6?  r1  r1  r1~ r@ r)8 rc r)8 r*8 r+8 s)~ s.@t?Ubؿt?Ub? tJ? r,E?  r0  r0  r0~ r@ r,8 r-8 r,8 r.8 r/8 s)~ s$@tkOàtkOà? tߍ;? r6- ?  rq0  rr0  rs0~ r@ r%' r&' r%' r'' r(' s)~ s9@t0B4hIt0B4hI? tYݚ? rZ+y?  r   r   r~ r@ r r r r r s)~ s4@trH?trH? tp@N{? rejU?  r  r  r ~ r@ r r r r r s)~ s$@t?>IѨt?>IѨ? tMV? r,_|?  r  r  r~ r@ r( r) r( r* r+ s)~ s>@tT`;?tT`;? tY5];D? r%cg6?  r,  r-  r.~ r@ rh' ri' rh' rj' rk' s)~ s9@t!Y51rt!Y51r? tb -/ۿ? r44`-?  rl'  rm'  rn'~ r@ r' r' r' r' r' s)~ s.@thdƽ(thdƽ(? tC? r[ !?  r'  r'  r'~ r@ r08 rd r08 re r18 s)~ s$@t 8,?t 8,? tYw? rz?  r0  r0  r0~ r@ r' r' r' r' r' s)~ s$@tLNĿtLN? tL k? r 8=?  rC  rD  rE~ r@ r0 r r0 r0 r s)~ s.@taI+taI+? th]@? rejU?  rC  rD  rE~ r@ r r r r r s)~ s>@tБ tБ ? tc@? r,E?  r  r  r~ r@ r' r' r' r' r' s)~ sC@th'th'? t*nvP ? u<>  r  r  r~ r@ rr rs rr rt ru s)~ sK@tmmtmm? tq? u\\&>  rv  rD  r~ r@ r r r r r s)~ sA@tCrtCr? t۷dG? r~L4O}?  r  r  r~ r@ r r r r r s)~ sF@tv[߿tv[? tֈ/1? r'M;?  r  r  r ~ r@ r1# r2# r1# r3# r4# s)~ s.@ttۋ+?ttۋ+? tiSw? r;C.V?  r5#  r6#  r7#~ r@ r( r( r( r( r( s)~ sF@tAa7tAa7? t|O? r~Wp?  r  r   r~ r@ r( r( r( r( r( s)~ sK@t[, 5bt[, 5b? tMNa=? rQ?  r(  r(  r (~ r@ r r r r r s)~ s$@tA-.tA-.? tf? rDga?  r  r  r~ r@ r6 r r6 r r/ s)~ s9@tuB+?tuB+? tBx݈#? rbM?  r/  r/  r/~ r@ r$ r$ r$ r$ r$ s)~ s$@tAz*ctAz*c? t1q1]? r2P?  r$  r$  r$~ r@ r{( r|( r{( r}( r~( s)~ s.@tlB߿tlB? tڀ8? r8pIۺ?  r(  r(  r(~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r- r. r- r/ r0 s)~ s4@tjd Կtjd ? tȖ%%%%%%%% % % % % %%%%%%%%%%%%%%%%%%% %!%"%#%$%%%&%'%(%)%*%+%,%-%.%/%0%1%2%3%4%5%6%7%8%9%:%;%<%=%>%?%@%A%B%C%D%E%F%G%H%I%J%K%L%M%N%O%P%Q%R%S%T%U%V%W%X%Y%Z%[%\%]%^%_%`%a%b%c%d%e%f%g%h%i%j%k%l%m%o%p%q%r%s%t%u%v%w%x%y%z%{%|%}%~%%%? r0| ?  r1  r2  r3~ r@ r6 r( r6 r6 r8. s)~ s$@tܯ?tܯ? tyA? rCwM?  r9.  r:.  r;.~ r@ r r r r r s)~ s.@thYLO9thYLO9? t24o? rJlF8?  r  r  r ~ r@ rV% rW% rV% rX% rY% s)~ sA@t( 8t( 8? t>qB? rI%pJ?  r  r   r~ r@ r( r( r( r( r( s)~ s4@tpei?tpei? tw ? rߕƦ?  r  r   r~ r@ r/ r( r/ r( rL1 s)~ s$@tO @tO @? tExO? r%\'n?  r  rM1  r ~ r@ r r r r r s)~ s9@tg`:tg`:? tk~? rx!?  r  r  r~ r@ rp' rq' rp' rr' rs' s)~ sT@tu]k̿tu]k? t=~o? r 7?  rt'  ru'  rv'~ r@ rm rn rm ro rp s)~ sI@tX&oӿtX&o? t? rt^{8?  rq  rr  rs~ r@ r r r r r s)~ s@t 3zݿt 3z? t(‚@? r 2?  r  r  r~ r@ r r r r r s)~ sK@tl$tl$? tBe? rIX$K+?  r  r  r~ r@ r( r( r( r( r( s)~ sF@t8袑et8袑e? ts? rAɑ?  rC  rD  rE~ r@ r( rP r( r( r; s)~ s4@t|?t|? tk:kp? rR^U?  rrr ~ r@ r) r) r) r) r) s)~ s>@t"Xt"X? tW.z2Mu? r)l\?  rS%  r  r)~ r@ r7 r8 r7 r9 r: s)~ s$@t~ݏt~ݏ? tQZ? rPc?  r;  r<  r=~ r@ r]) r^) r]) r_) r`) s)~ s$@t?t? tj}I? r2!?  ra)  rb)  rc)~ r@ r) r) r) r) r) s)~ sI@tFtF? t>? rҢRD?  r  r  r~ r@ r) r) r) r) r) s)~ sA@tŒ.jF?tŒ.jF? tmip@ rդ;?  r  r  r~ r@ rO% rP% rO% rQ% rR% s)~ sA@t |"t |"? taV? r|r8?  rS%  r  rT%~ r@ r  r! r  r" r# s)~ s>@tAK%tAK%? tR{ֻa? r):?  r  r   r~ r@ rs# rt# rs# ru# rv# s)~ s.@tk uktk uk? t^~D? rC?  rw#  rx#  ry#~ r@ r1) r2) r1) r3) r4) s)~ s4@tN.ӽWtN.ӽW? tҖ? r&EM| ?  r5)  r  r6)~ r@ rx ry rx rz r{ s)~ s$@t &{ؿt &{? tM6? r0| ?  r|  r}  r~~ r@ rM8 r rM8 rN8 rO8 s)~ s$@t;`#t;`#? t9o? ryܑ?  r0  r0  r0~ r@ r# r# r# r# r# s)~ s@twtw? tL4* r?* r>* r@* rA* s)~ s.@tKg\_tKg\_? tDU? r?Al?  rB*  rC*  rD*~ r@ rZ8 r$ rZ8 r[8 r$ s)~ s$@t,Qt,Q? tPЖ;? rb"%/?  r1  r1  r1~ r@ rr* rs* rr* rt* ru* s)~ s9@t.+t.+? tx? r& ?  r  r  r~ r@ r' r( r' r) r* s)~ s.@t`JJt`JJ? tl-R|? rbM?  r+  r,  r-~ r@Dl,,,,,,,,,,,,,,,,,,,,,,,,,,,,, rK0 rL0 rK0 rM0 rN0 s)~ s$@tP]tP]? tL8? rk&?  rO0  rP0  r} ~ r@ r! r! r! r! r! s)~ s$@tDpXtDpX? t}i+? rhH??  rL r  rM~ r@ r| r} r| r~ r s)~ sI@tJҩtJҩ? tv^? rlS;?  r  r   r~ r@ r r r r r s)~ s>@t#Jt#J? tҹ`? r(Ra?  r  r  r~ r@ r! r! r! r! r! s)~ s$@tۑ.dܿtۑ.d? tNNW? rH.D?  r!  r!  r!~ r@ r* r+ r* r+ r+ s)~ s$@t(Ot(O? t*+/d?? r4X?  rT"  r  r+~ r@ r+ r+ r+ r+ r+ s)~ s4@t,kиt,kи? t%x? r):?  r+  r+  r+~ r@ r+ r+ r+ r+ r+ s)~ s.@tv/ÿtv/? tZ@? rzb?  r+  r)  r+~ r@ r , r , r , r, r, s)~ sN@tlMtlM? t;4x=n? rؽP?  r  r  r~ r@ r^8 rz r^8 r{ r_8 s)~ s@tFQ뜟?tFQ뜟? tCS? r~^X?  ru1  rv1  rw1~ r@ r( r( r( r( r( s)~ s.@tP4̿tP4? t+_? rP"?  r(  r(  r(~ r@ rh+ r2) rh+ ri+ rj+ s)~ s$@tktk? tt /? r}j8|M?  rrr ~ r@ r r r r r s)~ s$@tHCtHC? tE 2? rJı?  r  r  r~ r@ r  r  r  r r s)~ s$@tfZƿtfZ? tѹ: Z? r"3P?  r  r  r~ r@ r( r( r( r( r( s)~ sI@t%VXt%VX? t*9ۅ? ru?  r(  r*  r-~ r@ r+ r+ r+ r+ r+ s)~ sF@tdT tdT ? t<{/? rd1]?  r  r   r~ r@ r r r r r s)~ s$@tywDж?tywDж? tVF? rF~g?  r  r  r~ r@ r7, r8, r7, r9, r:, s)~ s$@t%QYͿt%QY? t$y@? r;9}?  r;,  r<,  r=,~ r@ r' r' r' r' r' s)~ s4@t}.:?t}.:? tq*p-? rJı?  rC  rD  rE~ r@ rq8 r/ rq8 rr8 rV1 s)~ s$@teɿte? t̃u? r+S.3?  rW1  rX1  rY1~ r@ r*, r+, r*, r,, r-, s)~ sD@ttnXAttnXA? tيV? rhH??  r  r   r~ r@ r| r} r| r~ r s)~ s.@t%e9Y?t%e9Y? t.#? r]ZY?  r  r  r~ r@ rV, rW, rV, rX, rY, s)~ s4@tS1ΨM޿tS1ΨM? tP ? rS4Ao?  rC  rD  rE~ r@ r[, r\, r[, r], r^, s)~ s$@tD&&ZԿtD&&Z? th3u? rpX?  r  r   r~ r@ r, r, r, r, r, s)~ s.@tGF?tGF? t@'9>? r|w.?  r,  r,  r,~ r@ rh, ri, rh, rj, rk, s)~ s.@tc_crb˿tc_crb? tN? rEm?  r  r   r~ r@ r-1 r.1 r-1 r/1 r01 s)~ s@t24 t24 @ t#e2? r[ !?  rL r  rM~ r@ rm, rn, rm, ro, rp, s)~ s$@tE ΣtE Σ? tBYx|? r~\u6?  rq,  rr,  rs,~ r@ rM, rN, rM, rO, rP, s)~ s.@tN hۿtN h? t:M? r2i ?  r  r   r~ r@>0>@ "ggD ZO (HyIIIIDIJ"J  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} } m} m} $$} !}  } } m} } m} m%} &} } h,,,,; ; ,, , , , , ,,,,,,,,,,,,,,,,,,, i8 kk j8 jjl m8jn m8jj p p p p p p p p p  p  p  p  p  p p# r, r, r, r, r, s)~ s$@tעtע@ t15I? rg?  r  r   r~ r@ r| r} r| r~ r s)~ sr@t>Řt>Ř@ t#|? u,IzK>  r  r  r~ rA@ r r r r r s)~ sV@ t[X t[X@ tݿz? u 7-v> rC rD rE~ r@ r7 r r7 r7 r7 s)~ s`@ tԷ- tԷ-@ ty? rPLq? rc rc rc~ r4@ r, r! r, r" r, s)~ s@ ta.7 ta.7@ t-ˤg? u`Z}> rrr ~ r@W@ r r r r r s)~ sT@ t{^' t{^'? t{6? re9Qa4? r r  r~ r@ r$ r$ r$ r$ r$ s)~ sF@ tn?i  tn?i ? t8? ? rIX$K+? r r  r~ r@ ra rb ra rc rd s)~ sF@t/met/me? tFڴ3? r?  re  rf  rg~ r@ rO rP rO rQ rR s)~ sN@tKtK? tc%d ? u#̖=  r  r   r~ r@ r r r r r  s)~ sK@tt? t\? uk>  r   r   r ~ r@ r" r" r" r" r" s)~ s9@tP4 7QtP4 7Q? tC? r]"ęU?  rC  rD  rE~ r@ r r r r r s)~ s@U@t-i_t-i_? tXyM? u:z'j>  r  r  r~ r@ rl rm rl rn ro s)~ s>@tf*tf*? t ? r5?  rp  rq  rM~ r@ r> r? r> r@ rA s)~ s>@tEJX;tEJX;? tgNk&? rMʟ`?  r  r   r~ r@ r r r r r s)~ s~@t+m˅vt+m˅v? tA5 ? u74ާ:  r  r  r~ rO@ r r r r r s)~ sy@tlqartlqar? t_=? uI3SO=  r  r  r~ rF@ r* r+ r* r, r- s)~ s[@t"U"t"U"? t? u!j[>  r  r   r~ r$@ r r r r r s)~ sT@t? Rt? R? t;] ? u؏*+>  r  r   r~ r@ r| r} r| r~ r s)~ sI@tJҩtJҩ? tv^? rlS;?  r  r   r~ r@ rv rw rv rx ry s)~ s@U@tata? teI? u!j[>  r  r   rz~ r @ r r r r r s)~ sp@t\*,]t\*,]? t^ߙ? r D۲C?  r  r  r ~ rD@ r r r r r s)~ sN@t71t71? tqe7#? r_A"R?  r  r   r~ r@ r9 rP r9 r: r; s)~ s``@tz$tz$? thr}? rY?  r  r  r~ r,@ r$ r% r$ r& r' s)~ sT@t=Lt=L? t&8l? u}g8>  r(  r)  r*~ r@ r5 r6 r5 r7 r8 s)~ sT@tIlbtIlb? tCv? u;_d>  r  r   r~ r@Dl""  ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?, r r r r r s)~ sK@ tl$ tl$? tBe? rIX$K+? r r r~ r@ !r !r !r !r !r !s)~ !sY@!tZI !tZI ?! tFKTD?! u<%sm> ! r  ! r  ! r ~ !r"@ "r% "r& "r% "r' "r( "s)~ "s g@"t5&["t5&[?" tfI4n?" uإZKٺ> " r " r  " r~ "r.@ #r: #r; #r: #r< #r= #s)~ #s`h@#t # r? # r@~ #r?@ $r $r $r $r $r $s)~ $sN@$tАQ$tАQ?$ tY`?$ r)(BH*? $ r $ r  $ r ~ $r@ %r %r %r %r %r %s)~ %sT@%t.%t.?% t)?% r tVDP? % rrr ~ %r"@ &r &r &r &r &r &s)~ &s>@&t-ͯ &t-ͯ ?& tD?& rOJݱ+? & r & r & r~ &r@ 'r 'r 'r 'r 'r 's)~ 'sW@'trqc'trqc?' t^vN?' uC Q> ' r ' r  ' r~ 'r @ (r (r (r (r (r (s)~ (sV@(tHiYN(tHiYN?( tWDa?( u/sa 0> ( r ( r ( r~ (r&@ )rO% )rP% )rO% )rQ% )rR% )s)~ )sA@)t |")t |"?) taV?) r|r8? ) rS% ) r ) rT%~ )r@ *r *r *r *r *r *s)~ *sR@*tค*tค?* t,pc?* r ;? * r * r * r~ *r @ +r, +r, +r, +r , +r , +s)~ +s@P@+tк+tк?+ tyNa?+ ry Ys@b? + r + r + r~ +r@ ,r ,r ,r ,r ,r ,s)~ ,sD@,t=lm,t=lm?, t75?, rh/? , r , r , r~ ,r@ -r -r -r -r -r! -s)~ -sA@-t/~:a-t/~:a?- t5:ZX?- r:=X? - r" - r# - r$ ~ -r@ .r& .r' .r& .r( .r) .s)~ .sp@.t\*.t\*?. t x"s?. uJd=> . r* . r+ . r,~ .rA@ /r /r /r /r /r /s)~ /s@_@/t E/t E?/ t+}mZ?/ uGe> / r / r / r~ /r"@ 0r 0r 0r 0r  0r! 0s)~ 0s`s@0tC&0tC&?0 tP@Sy?0 u+i= 0 r" 0 r# 0 r$~ 0r9@ 1r 1r 1r 1r 1r 1s)~ 1s@Z@1tNC=k1tNC=k?1 tmoF?1 uk6 > 1 r 1 r 1 r~ 1r$@ 2r2 2r3 2r2 2r4 2r5 2s)~ 2s`}@2t0#2t0#?2 tޅ?2 u3ޑ; 2 r6 2 r7 2 r8~ 2rG@ 3r( 3r( 3r( 3r( 3r( 3s)~ 3sF@3tAa73tAa7?3 t|O?3 r~Wp? 3 r 3 r  3 r~ 3r@ 4r) 4r) 4r) 4r) 4r) 4s)~ 4sI@4tF4tF?4 t>?4 rҢRD? 4 r 4 r 4 r~ 4r@ 5r 5r 5r 5r  5r! 5s)~ 5sN@5to|5to|?5 t.W?5 r\'4? 5 r 5 r  5 r ~ 5r@ 6r 6r 6r 6r 6r 6s)~ 6sR@6tDy^t6tDy^t?6 t@|'1?6 ur( {> 6 r 6 r 6 r~ 6r"@ 7r; 7r< 7r; 7r= 7r> 7s)~ 7sF@7t.;`7t.;`?7 tyv(8F?7 r`~#jS? 7 r 7 r  7 r~ 7r@ 8r 8r 8r 8r 8r 8s)~ 8sd@8t`^m8t`^m?8 t_D?8 roP? 8 r 8 r 8 r~ 8r7@ 9rX 9rY 9rX 9rZ 9r[ 9s)~ 9s`h@9t>L-i9t>L-i?9 tRM+?9 ru? 9 r\ 9 r] 9 r^~ 9r?@ :rB :rC :rB :rD :rE :s)~ :sN@:tHCݰ:tHCݰ?: tʹ2?: rljc4? : rF : rG : rH~ :r$@ ;r/ ;r ;r/ ;r/ ;r/ ;s)~ ;sf@;td!ns;td!ns?; tk߫=J?; u, ; rrr ~ ;r.@ <r( <r( <r( <r( <r( <s)~ <sF@<t8袑e<t8袑e?< ts?< rAɑ? < rC < rD < rE~ <r@ =rv~ =v<@ =rv =rx =ry =s)~ =s>@=tȊor\=tȊor\?= t$6l}?= rOV? = rz = r{ = r|~ =r@ >r >r >r >r >r >s)~ >sn@>t5c#>t5c#?> tW6;?> r7HT? > r > r > r~ >r=@ ?r! ?r! ?r! ?r! ?r! ?s)~ ?sQ@?t fʦ?t fʦ?? t4 hQ?? u)U> ? r ? r  ? r~ ?r@Dl@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_, @r6 @r @r6 @r6 @r6 @s)~ @s@P@@t&@t&?@ t<`?@ r5tQ? @ r; @ r; @ r;~ @r$@ Ar\ Ar] Ar\ Ar^ Ar_ As)~ As~@At5 At5 ?A tٯ m?A u NV> A r` A ra A rb~ ArD@ Br Br Br Br Br Bs)~ Bs@U@Bt ٌBt ٌ?B t,p?B uEG? B r B r  B r ~ Br"@ Cr. Cr/ Cr. Cr0 Cr1 Cs)~ Csd@Ct2+YCt2+Y?C t%?C u> C r2 C r3 C r4~ Cr2@ Dr Dr Dr Dr Dr Ds)~ Dsk@Dtf?9&Dtf?9&?D t܈Q:?D rDnʔ {? D r D r D r~ Dr2@ Er Er Er Er Er Es)~ Es9@Et(Et(?E t^:?E r+? E rC E rD E rE~ Er@ Fr Fr Fr Fr Fr Fs)~ FsI@Ft`"tFt`"t?F t]!?F ryo4}? F rC F rD F rE~ Fr@ GrS GrT GrS GrU GrV Gs)~ Gs{@Gt+qGt+q?G t+Um6?G u#T= G rW G rX G rY ~ Gr>@ Hr HrP Hr Hr Hr Hs)~ Hs@@Ht®`Ht®`?H t ޻?H ur=;H r H rD H r~ HrE@ Irr Irs Irr Irt Iru Is)~ IsK@ItmmItmm?I tq?I u\\&> I rv I rD I r~ Ir@ Jr Jr Jr Jr Jr Js)~ Js@P@Jt\9zB6Jt\9zB6?J t"EH&o?J rq? J r J r J r~ Jr*@ Kr Kr Kr Kr Kr Ks)~ KsD@KtZn%KtZn%?K tT V rs V rt V ru~ Vr.@ Wr' Wr' Wr' Wr' Wr' Ws)~ WsC@Wth'Wth'?W t*nvP ?W u<> W r W r W r~ Wr@ Xre Xrf Xre Xrg Xrh Xs)~ Xs[@XtØXtØ?X tZ?X uE[k> X ri X r X rj~ Xr"@ Yr( Yr) Yr( Yr* Yr+ Ys)~ Ys@o@YtcEhCYtcEhC?Y t1A?Y r tVDP? Y r, Y r* Y r-~ Yr3@ Zrv Zrw Zrv Zrx Zry Zs)~ ZsI@ZtWL|ZtWL|?Z t:#)t?Z r ^|? Z rrr ~ Zr@ [rD [rE [rD [rF [rG [s)~ [s@_@[tSI=Θ[tSI=Θ?[ t^#ʧx?[ rlJc? [ rH [ r [ rI ~ [r2@ \r7 \ra \r7 \r7 \r7 \s)~ \s$@\t?r"1\t?r"1?\ tuWXS?\ rkdg? \ r0 \ r 0 \ r 0~ \r@ ]rw ]rx ]rw ]ry ]rz ]s)~ ]s@j@]te ]te ?] tLK?] r=+? ] r{ ] rT ] r|~ ]r3@ ^r ^r! ^r ^r" ^r# ^s)~ ^s0v@^tD^tD?^ t'XՎ?^ u:k!}`> ^ rrr ~ ^r8@ _r _r _r _r _r _s)~ _sN@_tMm_tMm?_ tg?_ rAɑ? _ r _ r? _ r~ _r$@Dfl`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,, `r `r `r `r `r `s)~ `s4@`tMAwX`tMAwX?` t 2X?` rq3ћ? ` rC ` rD ` rE~ `r@ ar@ arA ar@ arB arC as)~ asH@atS/I atS/I ?a t~?a u oT= a rrr ~ arR@ br br br br br bs)~ bsY@bto&5chbto&5ch?b tX`?b r0 ? b r b r b r~ br"@ cr cr cr cr cr cs)~ cs}@ctd:ectd:e?c tZ|?c ufe-? c r c ra c r~ crD@ dr dr dr dr dr ds)~ ds>@dtsEdtsE?d t#b 9?d r2~~(bJ? d r d r d r~ dr@ er% er% er% er% er! es)~ es4@et8j et8j ?e t"9?e rDry;D? e r  e r  e rz~ er@ fr fr fr fr fr fs)~ fsA@ftCrftCr?f t۷dG?f r~L4O}? f r f r f r~ fr@ gr gr gr gr gr gs)~ gs0@gtH.cIgtH.cI?g triV?g uҎ%CG= g r g r g r~ grM@ hrE hrP hrE hrF hr; hs)~ hsQ@ht0˭ht0˭?h t$?h r/$b? h rrr ~ hr"@ ir ir ir ir ir is)~ isV@itC7uitC7u?i t, m rm r m r~ mr2@ nr nr nr nr nr ns)~ ns\@ntq ntq ?n txc7G?n r1[(,44? n r n r n r~ nr4@ or? or@ or? orA orB os)~ osA@otSZotSZ?o t3?o r~}K3? o rC o rD o rE~ or@ pr pr pr pr pr ps)~ psV@pt"4lpt"4l?p t˂(?p rbF? p r p r p r~ pr(@ qr qr qr qr qr qs)~ qsn@qt:vqt:v?q tA40@?q rH? q rrr ~ qr1@ rr rr rr rr rr rs)~ rsQ@rtX2rtX2?r tE'h\?r r:(C0? r rC r rD r rE~ rr @ sr6 srD sr6 sr6 sr6 ss)~ ssb@stObfTstObfT?s t$P?s r {D? s r0 s rT s r~ sr*@ tr tr tr tr tr ts)~ tst@ttP6?pttP6?p?t te?t u;3=t r t r" t r ~ trg@ ur ur ur ur ur us)~ us9@ut[aut[a?u tA<#?u rwV/? u r u r u r~ ur@ vr/ vr0 vr/ vr1 vr2 vs)~ vsv@vt Ovt O?v t_qb+?v u^u> v r3 v r4 v r5~ vrF@ wr wr wr wr wr ws)~ ws@e@wtf .5wtf .5?w t߱6?w r)#? w r w r w r~ wr<@ xrc xrd xrc xre xrf xs)~ xs@xt*͏xt*͏?x tmqY?x u1= x rg x rh x ri ~ xrO@ yr , yr , yr , yr, yr, ys)~ ysN@ytlMytlM?y t;4x=n?y rؽP? y r y r y r~ yr@ zr zr zr zr zr zs)~ zs@`@zt/F'!gzt/F'!g?z t9mr?z r$^nP? z r z r z r~ zr1@ {r {r {r {r {r {s)~ {sa@{tŜ.I2{tŜ.I2?{ tBɣDM?{ r|g,D{s? { r { r { r~ {r2@ |r |r |r |r |r |s)~ |se@|t)Ra |t)Ra ?| toF ?| r%C p? | r | r | r~ |r6@ }r> }r? }r> }r@ }rA }s)~ }s@}t vt}t vt?} t%"N?} rsFX? } rB } rC } rD~ }rM@ ~r3 ~r4 ~r3 ~r5 ~r6 ~s)~ ~sd@~t vV~t vV?~ tЇ2?~ rN+_&? ~ r7 ~ r8 ~ r9~ ~r3@ rc rd rc re rf s)~ s@tW#^?tW#^? tBm0? uOya?>  rg  rh  ri~ rQ@Djl,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s b@tj,&Lg>?tj,&Lg>? tb:\CF? rRAgĀ? r r r ~ r,@ r7 r8 r7 r9 r: s)~ s@j@tw1p W?tw1p W? tN7:FS? uEӦt> r; r< r=~ r3@ r[ r\ r[ r] r^ s)~ sk@t F?t F? t4㯇{? u4U!X> r_ r` ra~ r.@ r r r r r s)~ s`@t̔:#o?t̔:#o? t"? rC7? r r r~ r5@ r r r r r s)~ s@t(|?t(|? toH? u÷ mJ < r r r~ r@_@ r r r r r s)~ sg@tDׂW?tDׂW? tQ3=گ? r5Y ? r r r~ r?@ r r r r r s)~ s@tP5Z?tP5Z? t? uhq4*< r r r~ r`e@ r r r r r s)~ sw@tbMȈq?tbMȈq? tÑj? u1= r r r~ r6@ r r r r r s)~ sb@t6 f?t6 f? t] j? rIh? r  r! r"~ r(@ r r r r r s)~ s\@tDNC ?tDNC ? tjK%? u77> r r r ~ r1@ r r r r r s)~ s~@tbM>,y?tbM>,y? t7/? ry,? r r r~ rI@ r r r r r s)~ sR@t\Ci|?t\Ci|? t9_x1? rL ?? r r r~ r(@ r ri r r r s)~ s.@tVJz?tVJz? t%nd? rO6? rrr ~ r@ rG rH rG rI rJ s)~ sȍ@t`l?t`l? t\$? u9,%؈9 rK rL rM~ rQ@ r. r/ r. r0 r1 s)~ s w@tO'6?tO'6? tj ? u>= r2 r3 r4~ rG@ r" r# r" r$ r% s)~ sn@t0>]?t0>]? tB]k1\? u00S> r& r' r( ~ r@@ r r r r r s)~ sH@tD-z?tD-z? t<@a? rܡbi1? r r r~ rI@ r r r r r s)~ su@t}B9?t}B9? t<$I? uC Q> r r r~ rN@ rk rl rk rm rn s)~ sf@tz {(W5?tz {(W5? tF t? uq.> ro rp rq ~ r.@ r r r r r s)~ s@P@tgL g?tgL g? tsw? r%A? r r r~ r @ rf rg rf rh ri s)~ sa@tryfw?tryfw? tCS@ r r/ r/ r/~ r;@ r/ r0 r/ r1 r2 s)~ s\@tC7?tC7? t@ $O@ rPX|? rO r* rQ ~ r&@ rI rJ rI rK rL s)~ sd@tB3_9?tB3_9? tPze@ ruȧwX? rM rN rO~ r0@ r r r r r s)~ s l@t jr?t jr? tΞyVē@ u> rrr ~ r1@Dl,,,,,,,,,,,,,,,,,,,, r r r r r s)~ s0p@t7"S?t7"S? tJ§@ uPJ> r r r~ r>@ r6 ry r6 rz r6 s)~ s0v@tʨڮ?tʨڮ? tzSJB@ uSK> r/ r/ r/~ rI@ r6 r r6 r  r6 s)~ s@t.?t.? t1m@ u' \> r0 r0 r0~ r@S@ r r r r r s)~ sk@t[F2I4v?t[F2I4v? t RlE@ uY]x= r r r~ r6@ r r r r r s)~ sI@tdy?tdy? t[b@ u1W> r r  r ~ r@ rQ rR rQ rS rT s)~ sx@t^!gv?t^!gv? t. A@ u2\B~> rU rV rW~ rF@ r r r r r s)~ s@tAMK]>?tAMK]>? t&J`@ u%8< r r r~ rM@ r r r r r s)~ sT@tvtG?tvtG? tx3@ ru? r r r~ r(@ r{ r| r{ r} r~ s)~ si@tot@?tot@? t5% @ rekh? r r" r ~ r3@ r r r r r s)~ sX@t@]9G?t@]9G? tX/@ u-= r r r~ rR@ r( r) r( r* r+ s)~ s\@tiuvYZ?tiuvYZ? t\Wԑ@ rş5&? r, r- r.~ r0@ ry rz ry r{ r| s)~ sf@tV r} r~ r~ r9@ r r r r r s)~ s`@t輼ӑ?t輼ӑ? t( %@ us(= r r r~ rR@ r* r+ r* r, r- s)~ s@`@tZ?tZ? tX }@ u^$ϟ> r. r/ r0 ~ r&@ r r r r r s)~ s$@t p}?t p}? t$="@ ue7o 5 r r r~ r `@ r r r r r s)~ sv@tz˽m?tz˽m? tʹq{? @ uX:zy= r r r~ rB@ rO rP rO rQ rR s)~ s~@t1-?t1-? tu @ u3uFA= rS rT r~ rO@ r r r r r s)~ sd@tEc?tEc? tX R @ utwL8 r r r~ rY@ r r r r r s)~ s@ti„?ti„? tvr@@ uj 8 r r r~ rU@ rA rB rA rC rD s)~ sK@tj R @tj R @ tZ{5#@ rHqp{? rc rE rF~ r$@,4|>@{{y"yzz??X??ggD ZO %J>JYJtJEJOJWJ_JgJoJwJJJJJJJJJJJJKK K KKKKK"K&KW'K  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} } I} $} I} m} &} %} I#} } I} } m} m } } mw,,,;;,,, , , , , ,,,,,,,;@;@;@;@;@;@;@;@;@;@;@;@ W8<XXXXYXXXXXXXXXXXXXXXXXXXXXX [1<XXXXYXXXXXXXXXXXXXXXXXXXXXX<XXXXYXXXXXXXXXXXXXXXXXXXXXX>ZXXXXYXXXXXXXXXXXXXXXXXXXXXX w1"xxxxxxxxxxxyXX \1 ]1 ]1 ]1 ]1 ]1 ]1 ]1 ]1  ]1  ]1  ]2  ^2$ __`````````````aY#:kO<a[w;= U2 U2~ U@ b2 b2 b2Ub@U[@U6@  co0E>? c镱^?  XXdR:Њ=dL̔s> V2 V2~ V@ e 2 e 2 e 2V@V@V6@  fDVlq? f/M?  XXdብ>d%گng> V 2 V2~ V@ e 2 e 2 e 2Vq@V@V6@  fN8q? f?  XX dڿFS> d^L> V2 V2~ V@ e2 e2 e2 V`w@V e@V3@  fw? fBǼ? XX dW){> dӋ5> V2 V2~ V@ e2 e2 e2 V@u@V@g@V2@  f? fc1Ƹ? XX dW){> d2_w> V2 V2~ V@ e2 e2 e2 V0u@V@g@V2@  f4A/? fc1Ƹ? XX dߒMU~> d[> V2 V2~ V@ e2 e2 e2 V@V`g@V3@  f4M4M? fw? XX d{f> d( 0> V2 V2~ V@ e2 e2 e2 V&@V@V@  fF]tE? f$I$I? XXd{f>d > V2 V2~ V@ e 2 e!2 e"2VC@V@V@  f(? f$I$I?  XXd  N?duHUs? V#2 V2~ V@ e$2 e%2 e&2V@V@V@  fUUUUUU?~  f?  XXdu%bGlB>d18*? V'2 V2~ V@ e(2 e)2 e*2VY@V<@V@  fQ?~  f?  XXd*#&,>d8*5{? V+2 V2~ V@ e,2 e-2 e.2V2@V,@V@  fUUUUUU? f۶m۶m?  XXdM7܉>d]/M? V/2 V2~ V@ e e02 e12VPs@V@[@V,@  f. 2? f p?  XXd!+lěN>d F? V22 V2~ V@ e32 e42 e52V3@V.@V@  fy 5? fUUUUUU?  XXdY#>dM(/? V62 V2~ V@ e72 e)2 e*2V@[@V@@V@  f p?~  f?  XXd T>da&? V82 V2~ V@ e92 e:2 e;2V<@V7@V@f?  f8Moz?  XXd  N?dcD[&@? V<2 V2~ V@ e=2 e>2 e?2$V @V@V@f?f?  XXdWQIxf?d5? V@2 V2~ V@ eA2 eB2 eC2V@V@V@  fUUUUUU? fUUUUUU?  XXd ʧ#>drC? VD2 V2~ V@ eE2 eF2 eG2V`u@V]@V,@  fXOa=? fW 'u_?  XXd ʧ#>dۧ%? VH2 V2~ V@ e> eF2 eG2V u@V]@V,@  fg\5? fW 'u_?  XXd{f>d~ʑ:? VI2 V2~ V@ eJ2 eK2 eL2V3@V@V@  f(? f$I$I?  XXd@?dQ8l? VM2 V2~ V@ eN2 eO2 eP2$V@V@V@f?f?  XXd T>dm2? VQ2 V2~ V@ eR2 eS2 eT2V,@V@V@  f۶m۶m?~  f?  XXd T>d8؀,? VU2 V2~ V@ eV2 eS2 eT2$V$@V@V@f>@f?  XXd  N?dcD[&@? VW2 V2~ V@ eX2 eY2 e $V@V@V?f?f?  XXd{;ӕ>di:w? VZ2 V2~ V@ e[2 e\2 e]2VC@V<@V@  foo?~  f?  XXDLlNN@B4 ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%&+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ d{;ӕ> di:w? V^2 V2~ V@ e_2 e\2 e]2 VD@V<@V@  fە]?~ f? XX!d{;ӕ>!dwF%? !V`2 !V2~ !V@ !ea2 !e\2 !e]2!VC@V<@V@ ! foo?~ ! f? ! XX"d  N?"dcD[&@? "Vb2 "V2~ "V@ "ec2 "eY2 "e "V@V@V? " fUUUUUU?~ " f? " XX#dﭣ>#d|/A? #Vd2 #V2~ #V@ #ee2 #ef2 #eg2#VS@VD@V @ # fAA?# f? # XX$d?v?$dG+.^? $Vh2 $V2~ $V@ $ei2 $ej2 $ek2$V"@V@V@ $ fqq?~ $ f? $ XX%d T>%d[&0@F? %Vl2 %V2~ %V@ %em2 %eS2 %eT2$%V.@V@V@f4@f? % XX&dBrEL?&d$? &Vn2 &V2~ &V@ &eo2 &ep2 &eq2&V$@V@V@f>@ & f۶m۶m? & XX'dBrEL?'d$? 'Vr2 'V2~ 'V@ 'es2 'et2 'eu2'VB@V@V@ ' fLϺ?' f۶m۶m? ' XX(dBrEL?(d$? (Vv2 (V2~ (V@ (ew2 (et2 (eu2(VM@V@V@ ( f/?( f۶m۶m? ( XX)d_4?)dh-3'? )Vx2 )V2~ )V@ )ey2 )ez2 )e{2)V&@V@V@ ) fF]tE?~ ) fD@ ) XX*d΋n>*d XPA? *V|2 *V2~ *V@ *e}2 *eF2 *eG2*V`@V`@V,@ * fɎ?* fzrv ? * XX+d'v~>+dkV 0? +V~2 +V2~ +V@ +e2 +e2 +e2+V;@V5@V@ + fqq?+ f$I$I? + XX,d_4?,dQ$թ? ,V2 ,V2~ ,V@ ,e2 ,e2 ,e2,VA@V@V@ , fAA?~ , fD@ , XX-d^W*^>-dp#? -V2 -V2~ -V@ -e2 -eS2 -eT2-V(@V@V@f? - f۶m۶m? - XX.d_4?.dh-3'? .V2 .V2~ .V@ .e .e2 .e2.VC@V@V@ . f(?~ . fD@ . XX/d3ۃ?/dbN9$? /V2 /V2~ /V@ /e2 /e2 /e2/V@Vx@V6@ / fRKq?/ f`F_? / XX0d3ۃ?0d>j0? 0V2 0V2~ 0V@ 0e2 0e2 0e20V@Vx@V6@ 0 fRKq?0 f`F_? 0 XX1d_4?1dQ$թ? 1V2 1V2~ 1V@ 1e2 1e2 1e21VQ@V@V@ 1 fAA?~ 1 fD@ 1 XX2dV?2d? 2V2 2V2~ 2V@ 2e2 2eO2 2eP22V&@V @V@ 2 ftE]t?~ 2 f? 2 XX3d-`儔5?3dPq? 3V2 3V2~ 3V@ 3e2 3e2 3e23V1@V(@V@ 3 f?3 fUUUUUU? 3 XX4d6o]`?4d %@4? 4V2 4V2~ 4V@ 4e2 4eO2 4eP24V,@V"@V@ 4 f۶m۶m?4 fUUUUUU? 4 XX5d() ?5dCN.? 5V2 5V2~ 5V@ 5eM 5e2 5e25V&@V@V6@ 5 foWz?5 f.(=? 5 XX6d/D4 ?6dZv8? 6V2 6V2~ 6V@ 6e2 6e2 6e26V4@V.@V@f? 6 fUUUUUU? 6 XX7d/D4 ?7do?sD? 7V2 7V2~ 7V@ 7e2 7e2 7e27V4@V.@V@f? 7 fUUUUUU? 7 XX8d6o]`?8d %@4? 8V2 8V2~ 8V@ 8e2 8ep2 8eq28V,@V"@V@ 8 f۶m۶m?8 fUUUUUU? 8 XX9dmg?9d|C? 9V2 9V2~ 9V@ 9e2 9e2 9e29Vk@VO@V"@ 9 fO橤?9 fRJ)? 9 XX:dI?:d_T? :V2 :V2~ :V@ :e2 :e2 :e2:VG@V9@V@ : f YB?~ : f8@ : XX;dWQIxf?;d5? ;V2 ;V2~ ;V@ ;e2 ;eY2 ;e ;V$@V@V?f$@ ; fUUUUUU? ; XX<dr?<d|C? <V2 <V2~ <V@ <e2 <e2 <e2<V`@V0@V@ < ft:W?~ < f? < XX=dr?=d|C? =V2 =V2~ =V@ =e2 =e2 =e2=V b@V0@V@ = f??~ = f? = XX>du>>d[&0@F? >V2 >V2~ >V@ >e2 >e2 >e2$>V@@V0@V@f?f? > XX?dr]畡??dS$V? ?V2 ?V2~ ?V@ ?e2 ?e2 ?e2?V@V`@V6@ ? fyXw?? f ? ? XXDl@;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@@dnI ?@dxJO5C? @V2 @V2~ @V@ @e2 @e2 @e2@Vw@V@T@V$@ @ fmw6;?@ fX <ݚ? @ XXAd#\N?AdxJO5C? AV2 AV2~ AV@ Ae# Ae2 Ae2AV@V@V@ A f۶m۶m?~ A f? A XXBd?e=?Bd*ߜM? BV2 BV2~ BV@ Be2 BeK2 BeL2BVk@V,@V@ B fh/?B f$I$I? B XXCdIas!?Cdwݹ-Z? CV2 CV2~ CV@ Ce Ce2 Ce2CV`@Vc@V,@ C f#[?C foo? C XXDdسD?Ddޣց? DV2 DV2~ DV@ De2 De2 De2DV@@V,@V@f? D f$I$I? D XXEdpy/"?EdXnۊ Q? EV2 EV2~ EV@ Ee2 Ee2 Ee2EV t@V f@V,@ E fd! YB?E f^o?? E XXFd20?Fddžr? FV2 FV2~ FV@ Fe2 Fe2 Fe2FV=@V4@V@ F f|a?~ F f? F XXGd-`儔5?Gd)t? GV2 GV2~ GV@ Ge2 Ge2 Ge2GV2@V(@V@ G fUUUUUU?~ G f? G XXHdD.,?Hdك{+3q? HV2 HV2~ HV@ He2 He2 He2HV@VV@V"@ H fp}?H f/袋.? H XXId٨\(p-?Id#ĘzQ? IV2 IV2~ IV@ Ie2 Ie2 Ie2IVa@V&@V@ I f V؜?I fF]tE? I XXJd٨\(p-?JdkLKVU? JV2 JV2~ JV@ Je2 Je2 Je2JV,@V&@V@ J f$I$I?J fF]tE? J XXKd20?KdrqLm? KV2 KV2~ KV@ Ke2 Ke2 Ke2KV?@V4@V@ K fRJ)?~ K f? K XXLd20?Ldك{+3q? LV2 LV2~ LV@ Le2 Le2 Le2LV=@V4@V@ L f|a?~ L f? L XXMdC,{>MdjO>? MV2 MV2~ MV@ Me2 Me2 Me2MVQ@V8@V@ M f?~ M f? M XXNdV?NdyY׉? NV2 NV2~ NV@ Ne2 Ne2 Ne2NV:@V @V@ N f;;?~ N f? N XXOd?v?OdG+.^? OV2 OV2~ OV@ Oe2 OeY2 Oe OV3@V@V? O f(?~ O f? O XXPdHN1?Pdك{+3q? PV2 PV2~ PV@ Pe2 Pe2 Pe2PV"@V@V@ P fUUUUUU?~ P fN@ P XXQdHN1?QdU? QV2 QV2~ QV@ Qe2 Qe2 Qe2QV"@V@V@ Q fUUUUUU?~ Q fN@ Q XXRd?v?Rd¾`k? RV2 RV2~ RV@ Re2 ReY2 Re RVN@V@V? R f?~ R f? R XXSdI?Sd/4S1Z? SV3 SV2~ SV@ Se3 Se2 Se2$SVI@V9@V@f(@f8@ S XXTd'v~>Td(ЀlK? TV3 TV2~ TV@ Te3 Te2 Te2TVL@V5@V@ T fm۶m۶?T fyy? T XXUd%~{>Ud%bPpG? UV3 UV2~ UV@ Ue3 Ue3 Ue3UVJ@V>@V@ U f;;?U f? U XXVd%~{>Vdb0yJ? VV3 VV2~ VV@ Ve 3 Ve3 Ve3VVJ@V>@V@ V f [?V f? V XXWdNԉ;?Wdlex? WV 3 WV2~ WV@ We 3 WeF2 WeG2WV@Ve@V,@ W f[?W f+}? W XXXd%~{>Xd%bPpG? XV 3 XV2~ XV@ Xe 3 Xe3 Xe3XVK@V>@V@ X f{ %?X f? X XXYdكUd@?YdV$Ҝy? YV3 YV2~ YV@ Ye3 Ye3 Ye3YVS@V7@V@ Y f3?Y fd! YB? Y XXZdNrn@?ZdV$Ҝy? ZV3 ZV2~ ZV@ Ze3 Ze2 Ze2ZVV@VA@V@ Z ftE]t?Z f__? Z XX[d{y?[dh? [V3 [V2~ [V@ [e3 [eO2 [eP2[VZ@V*@V@ [ f؉؉?[ f؉؉? [ XX\d{Ŀ:D?\d%A v? \V3 \V2~ \V@ \e3 \e3 \e3\VY@V8@V@ \ f,?\ fUUUUUU? \ XX]dسD?]dD~@5}? ]V3 ]V2~ ]V@ ]e3 ]e2 ]e2]V<@V,@V@ ] f$I$I?] f$I$I? ] XX^dKc?^d*ߜM? ^V3 ^V2~ ^V@ ^e3 ^e2 ^e2^VN@V6@V@ ^ fUUUUUU?^ f]tE? ^ XX_d6o]`?_dl? _V3 _V2~ _V@ _e3 _e2 _e2_VB@V"@V@ _ fк?_ fqq? _ XXDl`;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@`d?+zG?`dZD~? `V 3 `V2~ `V@ `e!3 `e"3 `e#3`V d@VB@V@ ` f6͟?` fL? ` XXadŷ?ad_[S? aV$3 aV2~ aV@ ae%3 ae3 ae3aV@U@V@@V@ a f?a f'l&? a XXbdÎxFg?bd/ү? bV&3 bV2~ bV@ be'3 be(3 be)3bV,@V$@V@ b f$I$I?~ b f4@ b XXcd'Ƀ?cd ̾t? cV*3 cV2~ cV@ ce+3 cep2 ceq2cV:@V.@V@ c f؉؉?~ c f4@ c XXdd'Ƀ?dd*2? dV,3 dV2~ dV@ de-3 dep2 deq2dV:@V.@V@ d f؉؉?~ d f4@ d XXed'Ƀ?ed*2? eV.3 eV2~ eV@ ee/3 eep2 eeq2eV;@V.@V@ e fqq?~ e f4@ e XXfd20?fdrqLm? fV03 fV2~ fV@ fe13 fe3 fe3fVR@V4@V@ f fO贁N?~ f f4@ f XXgd_4?gdQ$թ? gV23 gV2~ gV@ ge33 geY2 ge gV;@V@V? g fh/?~ g f4@ g XXhd'Ƀ?hd*2? hV43 hV2~ hV@ he53 he63 he73hV[@V.@V@ h f־a?~ h f4@ h XXid2ձz"P?idlf,t? iV83 iV2~ iV@ ie93 ie02 ie12iVH@Vg@V,@ i fR#9( ?i fL &W? i XXjd+ZnP?jds|? jV:3 jV2~ jV@ je;3 je<3 je=3jV@V p@V1@ j f}e)?j f8 yCް? j XXkdx9xhPR?kdHQԊP? kV>3 kV2~ kV@ ke?3 keS2 keT2kVJ@V0@V@ k f؉؉?~ k f? k XXldOGT?ld&gu? lV@3 lV2~ lV@ leA3 leB3 leC3lVl@VD@V@ l fm۶mۖ?l f818? l XXmdS\T?md'?+.cJ? mVD3 mV2~ mV@ meE3 meF3 meG3mVx@VV@V"@ m fȤxL?~ m f$@ m XXnd'Ƀ?nd ̾t? nVH3 nV2~ nV@ neI3 ne63 ne73nV `@V.@V@ n f}A_З?~ n f4@ n XXodﭣ>odb0yJ? oVJ3 oV2~ oV@ oeK3 oef2 oeg2oV@S@VD@V @ o fcj`?o f? o XXpd$W %W?pd Ouu? pVL3 pV2~ pV@ peM3 peS2 peT2pVL@V1@V@ p f۶m۶m?p f? p XXqdTW?qd@G? qVN3 qV2~ qV@ qe qeO3 qeP3qV@V@V6@ q f?q fSB1? q XXrdfĔW?rd,? rVQ3 rV2~ rV@ reR3 reS3 reT3rV@VW@V @ r f}?r fd! YB? r XXsdaFq+Y?sd<w}? sVU3 sV2~ sV@ seV3 seO3 seP3sV@V@V6@ s fvs|҄?s f? s XXtdZpZ?td3Dy? tVW3 tV2~ tV@ teX3 teO3 teP3tV@V@V6@ t f-̈́?t f? t XXudﭣ>udb0yJ? uVY3 uV2~ uV@ ueZ3 uef2 ueg2uVT@VD@V @f$@ u f? u XXvd6o]`?vdd1h#Α? vV[3 vV2~ vV@ ve\3 ve2 ve2vVD@V"@V@f@ v fqq? v XXwdslj?wdUL+ߚ? wV]3 wV2~ wV@ we^3 we_3 we`3wV@a@V5@V@ w fہv`?w faa? w XXxd8a˵?xd^%_c? xVa3 xV2~ xV@ xeb3 xe2 xe2xVa@V;@V@ x fL[?x fB{ %? x XXydDė>yd[&0@F? yVc3 yV2~ yV@ yed3 yee3 yef3yV|@VC@V@ y f 赙?y fCy 5? y XXzdo<VOo?zdb2? zVg3 zV2~ zV@ zeh3 zei3 zej3zVF@V&@V@ z fll?z fF]tE? z XX{d>Wa?{dd1h#Α? {Vk3 {V2~ {V@ {el3 {em3 {en3{V`p@VN@V@ { fձ6Ls?{ fXG).? { XX|dJ3?o?|dgIM? |Vo3 |V2~ |V@ |ep3 |e2 |e2|V^@V6@V@ | fh ?| fF]tE? | XX}d=b?}d#o? }Vq3 }V2~ }V@ }er3 }es3 }et3}V@VX@V @ } f[,'?} f9/? } XX~d+| e?~d(ї? ~Vu3 ~V2~ ~V@ ~ev3 ~ew3 ~ex3~V@VG@V@ ~ fC-?~ fmw6;? ~ XXd:Xe?dש;? Vy3 V2~ V@ ez3 e{3 e|3V @Vh@V6@  fRf\v? fs#?  XXDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@dJ3?o?db2? V}3 V2~ V@ e~3 e2 e2V_@V6@V@  fB!? fF]tE? XXdp"?dV#Qdc? V3 V2~ V@ e3 e"3 e#3V[@V<@V@  fq$? fm۶m? XXdZQf>d ? V3 V2~ V@ e< e2 e2V@f@VJ@V"@  fgdz=KP3? V3 V2~ V@ e . e2 e2V g@VK@V"@  fy? fUUUUUU? XXdDZ{Lh?d̚Ŗ? V3 V2~ V@ e3 e3 e3V{@V@P@V@  fqq? fzz?$ XXXXXXXXXXXXXXXdU5i?d̚Ŗ? V3 V2~ V@ e3 e3 e3V@Vd@V(@  f? f)A?$ XXXXXXXXXXXXXXXdslj?dvנ? V3 V2~ V@ e3 e2 e2VO@V5@V@  fc1ƨ? f$I$I?$ XXXXXXXXXXXXXXXdMP?d5v=\? V3 V2~ V@ e3 ef2 eg2V@c@VH@V @  fcj`? f9/?$ XXXXXXXXXXXXXXXdyʬp.a?d %@4? V3 V2~ V@ e3 e3 e3V h@V?@V@  f1K? fRJ)?$ XXXXXXXXXXXXXXXdo<VOo?dER!? V3 V2~ V@ e3 e3 e3VU@V&@V@  f$I$I? ftE]t?$ XXXXXXXXXXXXXXXdmO>dz=KP3? V3 V2~ V@ e3 e2 e2V g@VL@V"@  fy? f%I$I?$ XXXXXXXXXXXXXXXdJ3?o?dER!? V3 V2~ V@ e3 e3 e3V@Y@V6@V@  fbeF? fF]tE?$ XXXXXXXXXXXXXXXd%H?d!ރ? V3 V2~ V@ e3 e3 e3V``@V9@V@  fqBJeD?~ f0@$ XXXXXXXXXXXXXXXd \ ??d*ߜM? V3 V2~ V@ e3 e)2 e*2Vl@VF@V@  faܯK*? f]tE]?$ XXXXXXXXXXXXXXXdinV#?dV#Qdc? V3 V2~ V@ e3 e3 e3V k@VD@V@  f@q8P?~ f.@$ XXXXXXXXXXXXXXXdp0s?dp#ӗ? V3 V2~ V@ e) e3 e3V0@V@[@V"@  ff7I׈? f4R1:#?$ XXXXXXXXXXXXXXXd?v?d2u =? V3 V2~ V@ e3 ej2 ek2V"@V@V@  fqq?~ f?$ XXXXXXXXXXXXXXXd?v?d2u =? V3 V2~ V@ e3 eY2 e $V4@V@V?f@f? $ XXXXXXXXXXXXXXXdŕ1 ?d󕠼W? V3 V2~ V@ e3 ee3 ef3V@VG@V@  f ? fL &W?$ XXXXXXXXXXXXXXXd 8djO>? V3 V2~ V@ e3 eF2 eG2Vpu@V]@V,@  f9/? f?$ XXXXXXXXXXXXXXXd c/?ddžr? V3 V2~ V@ e3 e2 e2V|@V@V@V$@  fm۶mۖ? fasü?$ XXXXXXXXXXXXXXXd)Py?d&ђ? V3 V2~ V@ e3 e3 e3V`d@VL@V@  f\wآ? f۶m۶m?$ XXXXXXXXXXXXXXXd΍w?d16? V3 V2~ V@ e3 e3 e3V`u@VK@V@  fp}? f־a?$ XXXXXXXXXXXXXXXd[o{?d? V3 V2~ V@ e3 e3 e3V@y@Va@V$@  fz~X? fҲ?$ XXXXXXXXXXXXXXXd"'|?dRnj;? V3 V2~ V@ e3 eF3 eG3V8@V\@V"@  fY? fAV?$ XXXXXXXXXXXXXXXd%/(\?df\6g? V3 V2~ V@ e3 e3 e3Vȃ@VS@V @  f _}? f(?$ XXXXXXXXXXXXXXXDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@dk-?do54c? V3 V2~ V@ e3 e3 e3VW@V,@V@  fAL &W? f۶m۶m?$ XXXXXXXXXXXXXXXdR`?dl? V3 V2~ V@ e3 e3 e3V(@VS@V @  flf? fAA?$ XXXXXXXXXXXXXXXd_4?dkId~? V3 V2~ V@ e3 eB2 eC2V"@V@V@  fqq?~ fD@$ XXXXXXXXXXXXXXXd_4?dkId~? V3 V2~ V@ e3 e3 e3V>@V@V@  f?~ fD@$ XXXXXXXXXXXXXXXdv5Y}?dhaAͧ? V3 V2~ V@ e3 e3 e3V`w@VS@V@  f*Ap*? fCy 5?$ XXXXXXXXXXXXXXXd w%̢:?dX_yt? V3 V2~ V@ e3 e3 e3V@@V`@V(@  f tT? fF]tE?$ XXXXXXXXXXXXXXXdIas!?dV#Qdc? V3 V2~ V@ e3 eF2 eG2V@Vc@V,@  f@(NSZ5? foo?$ XXXXXXXXXXXXXXXdC[wy?dh? V3 V2~ V@ e3 e3 e3V@V@W@V @  f? fX`?$ XXXXXXXXXXXXXXXdm~ep?dƺA? V3 V2~ V@ e3 e3 e3Vđ@Vb@V&@  f`rDЃ? fo0E>?$ XXXXXXXXXXXXXXXd_(-?d! wð? V3 V2~ V@ e3 e3 e3V0@V@V6@  fPZs? fvs|Ҥ?$ XXXXXXXXXXXXXXXdgc?d! wð? V3 V2~ V@ e3 e3 e3V^@Vz@V4@  f~ Յ? f?$ XXXXXXXXXXXXXXXdCk,?d-7KUΫ? V3 V2~ V@ e3 e3 e3Vw@VN@V@  fAL &W? fXG).?$ XXXXXXXXXXXXXXXdkM9f?d5? V3 V2~ V@ e3 e3 e3V@Va@V$@  fx? fI8y'?$ XXXXXXXXXXXXXXXd!w?dEf[? V3 V2~ V@ e3 e3 e3VX@V@f@V(@  f{? fE(B?$ XXXXXXXXXXXXXXXdlx?diÙ?? V4 V2~ V@ e4 e4 e4V^@Vt@V1@  f3uy? fJt?$ XXXXXXXXXXXXXXXdAKFf?dh-3'? V4 V2~ V@ e4 e4 e4Vx@Vx@V3@  fU߇? fS| ?$ XXXXXXXXXXXXXXXd 5?dPq? V4 V2~ V@ e 4 e 4 e 4V@V`@V6@  fή)>3? fĕ (?$ XXXXXXXXXXXXXXXd~Ŗ̓?d2N? V 4 V2~ V@ e 4 e4 e4Vr@VT@V@  fLϺ?~ f@$ XXXXXXXXXXXXXXXYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYY Y Y Y Y YYYYYYYYYYYYYYYYYYYDl  ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ Y!Y"Y#Y$Y%Y&Y'Y(Y)Y*Y+Y,Y-Y.Y/Y0Y1Y2Y3Y4Y5Y6Y7Y8Y9Y:Y;Y<Y=Y>Y?YDl @;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@@YAYBYCYDYEYFYGYHYIYJYKYLYMYNYOYPYQYRYSYTYUYVYWYXYYYZY[Y\Y]Y^Y_YDl `;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@`YaYbYcYdYeYfYgYhYiYjYkYlYmYnYoYpYqYrYsYtYuYvYwYxYyYzY{Y|Y}Y~YYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYY Y Y Y Y YYYYYYYYYYYYYYYYYYYDl  ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ Y!Y"Y#Y$Y%Y&Y'Y(Y)Y*Y+Y,Y-Y.Y/Y0Y1Y2Y3Y4Y5Y6Y7Y8Y9Y:Y;Y<Y=Y>Y?YDl @;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@@YAYBYCYDYEYFYGYHYIYJYKYLYMYNYOYPYQYRYSYTYUYVYWYXYYYZY[Y\Y]Y^Y_YDl `;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@`YaYbYcYdYeYfYgYhYiYjYkYlYmYnYoYpYqYrYsYtYuYvYwYxYyYzY{Y|Y}Y~YYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYY Y Y Y Y YYYYYYYYYYYYYYYYYYYDl  ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ Y!Y"Y#Y$Y%Y&Y'Y(Y)Y*Y+Y,Y-Y.Y/Y0Y1Y2Y3Y4Y5Y6Y7Y8Y9Y:Y;Y<Y=Y>Y?YDl @;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@@YAYBYCYDYEYFYGYHYIYJYKYLYMYNYOYPYQYRYSYTYUYVYWYXYYYZY[Y\Y]Y^Y_YDl `;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@`YaYbYcYdYeYfYgYhYiYjYkYlYmYnYoYpYqYrYsYtYuYvYwYxYyYzY{Y|Y}Y~YYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYDl ;@;@;@;@;@;@;@;@YYYYYYYY >@ m  ggD ZO q)K@KZKUtKQKUKKKKuK=KKͶKK]K%KKK}KEK KKKeK-KKKKMLL LL L  dMbP?_*+%,&ffffff?'ffffff?(?)?"dXX& U} } $} } I} I} +} m } I#} } m} } $} m } } mw,,,;;,,, , , , , ,,, , , , , ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ W8 YYY [4 YYY YYYZ YYY z4xxxxxxxxxxxy \1 ]1 ]1 ]1 ]1 ]1 ]1 ]1 ]1  ]1  ]1  ]2  ^2  XXXXXXXXXXXXXaYY}RE8aDŔ8 U4 U2~ U@ bD g4 g4Uk@U]@UH@  cj3? c/?da͘9dp5 9 V4 V2~ V@ e, h4 h4Vh@V``@VG@  fUUUUUU? fˈ>:?dJ^o!9dp5 9 V4 V2~ V@ ev h4 h4V@Vf@VH@  f@+? f? d_iV? d2ȇ>? V4 V2~ V@ e4 h4 h4 V6@V@V@  ftE]t?~ fN@ dD\pr? d飇? V4 V2~ V@ e 4 h!4 h"4 V4@V@V@f.@  f۶m۶m? dD\pr? dkϞ? V#4 V2~ V@ e$4 h!4 h"4 V3@V@V@  f^Cy 5? f۶m۶m? dxғ9 d:&5: V%4 V2~ V@ e&4 h4 h4 Vk@Vb@VG@  f? fOק? d"יN9 dT}7: V'4 V2~ V@ e(4 h)4 h*4 Vw@V@e@VH@  fAA? f?dc9dوf9 V+4 V2~ V@ e,4 h-4 h.4Vc@V[@VE@  f&j? fyJ?d,G{9d|9 V/4 V2~ V@ e04 h-4 h.4V`e@V@\@VE@  f? f驅Z?d3קM#2;dOZс; V14 V2~ V@ e24 h34 h44VV@VK@V;@  f.?~  f?dOZA;dOZс; V54 V2~ V@ e64 h34 h44VW@VK@V;@  f-d! Y? fk߰ k?d۸cGې9d TԐ: V74 V2~ V@ e84 h94 h:4Vm@V@^@VF@  fG" >? fF]tE?d 9 Y~;d j; V;4 V2~ V@ e<4 h=4 h>4VW@VK@V:@  f! YB? f %?d[V|<dHN>rt< V?4 V2~ V@ e@4 hA4 hB4Va@VQ@V9@  f9 2ܫ`? fm۶m?dDz("`;do\; VC4 V2~ V@ eD4 h4 h4V@@Vl@VG@  f? fm۶m?d^)t;diW< VE4 V2~ V@ eF4 hG4 hH4V]@V@V@V?@  f{? fe%+YJ?d{=M+<d"\=M+< VI4 V2~ V@ eJ4 hK4 hB4Vb@VR@V9@  fTb*1? f88?d'qz?;d: Q< VL4 V2~ V@ eM4 hN4 hH4V@]@VV@V?@  fQP? f` ` ?dOu;d]3">+< VO4 V2~ V@ eP4 hG4 hH4V`@VW@V?@  fHֹd? fYB?d{k<dA)< VQ4 V2~ V@ eR4 hS4 hT4Vt@VS@V:@  f;6? fUUUUUU?dq:;d~'XU@< VU4 V2~ V@ eV4 hA4 hB4VY@VL@V9@f?  f}?d;K6<duu'<:L< VW4 V2~ V@ e# hX4 hY4VȚ@V`w@VH@  f<=kA? fnʄm?d8ܫZ <dQQsje< VZ4 V2~ V@ e[4 h\4 h]4V@V f@VD@  fh *3? fk2?dt c9t<<d Z:< V^4 V2~ V@ e h_4 h`4&&&&&&&& & & & & &&&&&&&&&&&&&&&&&&& &!&"&#&$&%&&&'&(&)&*&+&,&-&.&/&0&1&2&3&4&5&6&7&8&9&:&;&<&=&>&?&@&A&B&C&D&E&F&G&H&I&J&K&L&M&N&O&P&Q&R&S&T&U&V&W&X&Y&\&n&^&_&`&a&b&c&d&e&f&g&h&i&j&k&l&m&o&p&q&V@V@VH@  f[? fe?d)O<dS< Va4 V2~ V@ eb4 hc4 hd4V@Vf@VC@  f YB? f]tE]?Dl0 ;@! ;@" ;@# ;@$ ;@% ;@& ;@' ;@( ;@) ;@* ;@+ ;@, ;@- ;@. ;@/ ;@0 ;@1 ;@2 ;@3 ;@4 ;@5 ;@6 ;@7 ;@8 ;@9 ;@: ;@; ;@< ;@= ;@> ;@? ;@ d`q9 dzq[: Ve4 V2~ V@ ef4 hg4 hh4 Vw@Va@VF@  fWQe? f%I$I?!dn<!d<x= !Vi4 !V2~ !V@ !ej4 !hA4 !hB4!Vpq@VS@V9@ ! f[f?! f5H4H?"dʅiޗ15:"ducʏ: "Vk4 "V2~ "V@ "el4 "hg4 "hh4"V w@V`b@VF@ " f*Y7"?" f?#d8Wcݻ<#d[(^< #Vm4 #V2~ #V@ #en4 #ho4 #hp4#Vu@VY@V=@ # f|COE?# f222222?$dgݒ-?$d߱Y? $Vq4 $V2~ $V@ $er4 $hs4 $ht4$V@\@V9@V@ $ fx!?$ fQ?%d<%d͎Bً< %Vu4 %V2~ %V@ %eT %hv4 %hw4%V0p@VZ@V>@ % fqa ?% f5x+?&dhm3<&d]|< &Vx4 &V2~ &V@ &ey4 &hz4 &hw4&Vq@VZ@V>@ & fmw6;?& f_?'d\YF='d@ ( fxgں?( frq?)dP]j;)d4q; )V4 )V2~ )V@ )e4 )h4 )h]4)V}@V`b@VD@ ) fpR屵?) f[5;j?*dVz;*d``; *V4 *V2~ *V@ *e4 *h4 *hd4*Vp{@V@b@VC@ * f>?* f#F?+do"g<+dt< +V4 +V2~ +V@ +e4 +h4 +h4+V@Vw@VH@ + fӳڞ?+ fh ?,d?9Z=,d^~O= ,V4 ,V2~ ,V@ ,e4 ,h4 ,h~4,Vb@VV@V8@ , fLϺ?, f?-d{<-dLz< -V4 -V2~ -V@ -e4 -h4 -h4-V(@Vv@VH@ - f׵F?- f?.dkO{?.dզ߭Ĥ? .V4 .V2~ .V@ .e4 .h4 .h4.VI@V.@V@f @ . f?/dQ\</d7mz< /V4 /V2~ /V@ /e4 /h4 /h4/Vk@V_@V@@ / f?/ f!B?0d駋P<0d ѡ&= 0V4 0V2~ 0V@ 0e4 0hA4 0hB40Vl@V@T@V9@ 0 fn?0 fE?1d'紀<1d4&= 1V4 1V2~ 1V@ 1e4 1h4 1h41V@V0z@VH@ 1 fXw?1 f =S?2dXBÊ =2diD= 2V4 2V2~ 2V@ 2e4 2ho4 2hp42Vp@V]@V=@ 2 fx*?2 fV 'u?3du!{x<3d\\$= 3V4 3V2~ 3V@ 3e4 3hG4 3hH43Vpt@V@`@V?@ 3 fNqD?3 f_^?4d9e =4dB#IC= 4V4 4V2~ 4V@ 4e4 4h4 4h44Vi@V@P@V7@ 4 fѸ?4 fWjVj?5dN*w<5dl=< 5V4 5V2~ 5V@ 5e4 5h4 5h45V|@V`b@VA@ 5 fh/?5 fgG-B?6d.Ƕ#=6d.ǶS= 6V4 6V2~ 6V@ 6e4 6h4 6h46V@@V@e@VA@ 6 f9as?~ 6 f4@7dԱ!8=7d~_EYҘb= 7V4 7V2~ 7V@ 7e4 7h4 7h47V@V b@V?@ 7 f>?7 f)ٵ]?8dǣB=8d[ᵱ= 8V4 8V2~ 8V@ 8e; 8h4 8h48V@V f@VA@ 8 f1?8 fL;k?9d4:VD=9d9{= 9V2 9V2~ 9V@ 9e2 9h4 9h49Vb@V[@V<@ 9 fv)Y7?9 fNq$?:d\YF=:d;g~= :V4 :V2~ :V@ :e4 :h4 :h~4:Va@VU@V8@ : f-)D{?: f{a?;d-2=;dD= ;V4 ;V2~ ;V@ ;e4 ;h4 ;hT4;V@x@V@\@V:@ ; fin'?; f81s?<dRi|J=<d@ȱ2= <V4 <V2~ <V@ <e4 <h4 <h4<Vpr@VT@V8@ < f.& Ӵ?~ < f>@=dk==d(B= =V4 =V2~ =V@ =e4 =h4 =h4=V~@V]@V;@ = f1?= fAI?>dɘu<>dLR= >V4 >V2~ >V@ >e4 >h4 >h4>V@{@Vb@VA@ > fj?Y?> f6i??d`=?dB$8= ?V4 ?V2~ ?V@ ?e4 ?h4 ?hT4?Vy@V@]@V:@f@ ? fqq?D`l@ ;@A ;@B ;@C ;@D ;@E ;@F ;@G ;@H ;@I ;@J ;@K ;@L ;@M ;@N ;@O ;@P ;@Q ;@R ;@S ;@T ;@U ;@V ;@W ;@X ;@Y ;@Z ;@[ ;@\ ;@] ;@^ ;@_ ;@@dX$+xr=@d4U輨= @V3 @V2~ @V@ @e3 @h4 @h4@V^@Vz@VH@ @ f1B1ӓ?@ fP?AdEjnu=AdW-O*= AV4 AV2~ AV@ Ae4 Ah4 Ah4AVw@V^@V;@ A fkLGU?~ A f6@Bd"]t =Bd ŮRY= BV4 BV2~ BV@ Be4 BhN4 BhH4BVx@Va@V?@ B f9?B f|W|W?Cd2& -$=CdAi+8= CV4 CV2~ CV@ Ce4 Ch4 Ch4CV@V`@V;@ C fM.hj ?C f?Dd4 ɮ;DdDur< DV4 DV2~ DV@ De4 Dh4 Dh4DVЊ@V o@VH@ D f^?D fk?EdYH q=EdNT{&> EV4 EV2~ EV@ Ee4 Eh4 Eh4EV@Vb@V;@ E f ?E fu)Y?Fd>2 h=FdSV V.> FV4 FV2~ FV@ Fe4 Fh4 Fh4FV @Vb@V;@ F f?~ F f2@Gd뼽=GdM4ՌK> GV4 GV2~ GV@ Ge4 Gh4 Ghp4GV@@Vc@V=@ G fNmjSڤ?G f7a~?HdFH26r?HdkϞ? HV4 HV2~ HV@ He4 Hhs4 Hht4HV@v@VD@V@ H fBP"?~ H f1@Id) 4=Id C 4> IV2 IV2~ IV@ IeM Ih4 Ih4IV&@V@VH@ I fll^?I fxB?Jdt͐b=JdeZu> JV4 JV2~ JV@ Je4 Jh4 Jh4JV@Vk@VA@ J fA+?J f ?Kdp<9j<Kd+—< KV4 KV2~ KV@ Ke4 Kh4 Kh4KV@Vp@VG@ K fqq?K fq8?Ld=&ky<LdnGN< LV4 LV2~ LV@ Le4 Lh4 Lh4LV@V q@VG@ L f[4}?L f΂j?MdE9ʹ>Md/@B> MV4 MV2~ MV@ Me4 Mh4 Mh4MV@Vg@V>@ M f?M fR٨l?NdE9ʹ>Nd͊B> NV4 NV2~ NV@ Ne4 Nh4 Nh4NV@Vg@V>@ N f?N fR٨l?Od>Od/@B> OVy3 OV2~ OV@ Oez3 Oh4 Oh4OV @Vh@VH@ O f LA6?O f{ɳ?PdluH>PdȒ.sK> PV4 PV2~ PV@ Pe4 Ph4 Ph4PVt@Vh@V>@ P fҁr},?~ P f?Qd3?>Qd3dI> QV4 QV2~ QV@ Qe4 Qh4 Qh4QV@V@e@V<@ Q f;Sب?Q f?Rd\U6>Rd?H c> RV4 RV2~ RV@ Re5 Rh5 Rh5RV~@Vd@V;@ R f־a?R f%?SduGt;Sdk< SV5 SV2~ SV@ Se5 Sh5 Sh5SV@Vq@VH@ S f]ke?S fTDza?TdĀbB`=Td<ح= TV5 TV2~ TV@ Te5 Th 5 Th 5TV@V k@VB@ T fжD ?T fLW+?Ud | >Ud,> UV 5 UV2~ UV@ Ue 5 Uh 5 Uh5UV@VH@VH@ U f6A?U fPP?Vd$&>VdL3l> VV5 VV2~ VV@ Ve5 Vh5 Vh5VV@Vk@V=@ V fǠ?V f*5O?Wda|>WdO`+> WV5 WV2~ WV@ We5 Wh4 WhT4WVx@V`g@V:@ W fnI?W f)?Xd]6ǻjW>XdGm> XV5 XV2~ XV@ Xe5 Xh4 Xh4XV΢@Vpr@VA@ X fw[#?X fc;M?Yd|>Yd-%~-> YV5 YV2~ YV@ Ye5 Yh5 Yh5YV@V|@VF@ Y fx6;?Y faa?Zd@=Zd:BRi= ZV5 ZV2~ ZV@ Ze5 Zh4 Zh4ZV@Vi@VA@ Z f(?~ Z f1@[d.i0>[d"4Kƕ> [V5 [V2~ [V@ [e5 [h5 [h 5[V@V@@VH@ [ f| (?[ fE(B?\d1KKƕ>\d"4Kƕ> \V!5 \V2~ \V@ \e"5 \h#5 \h$5\Va@V@VH@ \ f^=(?\ f\nð?]d0Ү>]dPc9? ]V%5 ]V2~ ]V@ ]e&5 ]h'5 ]h(5]V@VP@VH@ ] fF>?] f}'x?^dM9>^dg`)? ^V)5 ^V2~ ^V@ ^e*5 ^h+5 ^h,5^V(@Vq@V>@ ^ fgIY?^ fZas ?_d\{B>_dV߀-? _V-5 _V2~ _V@ _e.5 _h/5 _h05_V@Vy@VC@ _ fa>Ҍ?_ fiAXȷ?Dll` ;@a ;@b ;@c ;@d ;@e ;@f ;@g ;@h ;@i ;@j ;@k ;@l ;@m ;@n ;@o ;@p ;@q ;@r ;@s ;@t ;@u ;@v ;@w ;@x ;@y ;@z ;@{ ;@| ;@} ;@~ ;@ ;@`d*FJ=?`d /N-? `V15 `V2~ `V@ `e25 `h35 `h45`V@Vu@VA@ ` fg?` fLwZ޸?adį ?ad;3? aV55 aV2~ aV@ ae65 ah75 ah85aV@V@VH@ a f9  ?a f ?bdqe<bdyUy< bV95 bV2~ bV@ be:5 bh;5 bh4bV@Vr@VH@ b fZk?b f`Q(X?cdȑ@$1 ?cd7R? cV<5 cV2~ cV@ ce=5 chs4 cht4cVj@V7@V@ c f;;?c f8Moz?dd_ #?ddRCNh)[? dV>5 dV2~ dV@ de?5 dh!4 dh"4$dV@V@V@f?f? ed_ #?edRCNh)[? eV@5 eV2~ eV@ eeA5 ehB5 ehC5$eV@V@V@f?f? fd_ #?fd@ܸAէK? fVD5 fV2~ fV@ feE5 fh!4 fh"4$fV@V@V@f?f? gd_ #?gd@ܸAէK? gVF5 gV2~ gV@ geG5 gh!4 gh"4$gV@V@V@f?f? hd_ #?hd@ܸAէK? hVH5 hV2~ hV@ heI5 hh!4 hh"4$hV@V@V@f?f? id_ #?id@ܸAէK? iVJ5 iV2~ iV@ ieK5 ihB5 ihC5$iV@V@V@f?f? jd_ #?jd@ܸAէK? jVL5 jV2~ jV@ jeM5 jhB5 jhC5$jV@V@V@f?f? kd6Z;|=kd]F\t> kVN5 kV2~ kV@ keO5 khP5 kh4kV@V`k@VA@ k fEAJ8\?k f=D?ldmd=d4> mVS5 mV2~ mV@ meT5 mhP5 mh4mVȖ@V q@VA@ m fT?m f8R4Ŀ?nd,! 6?ndO!_? nVU5 nV2~ nV@ neV5 nhW5 nhX5nVl@V0y@VA@ n f?n f) P;?odhe8?odi!՛b? oV2 oV2~ oV@ oe 2 ohY5 ohZ5oV@V@VH@ o f3 7?o f8߮?pd1Al8?pd>&w`? pV[5 pV2~ pV@ pe\5 phs4 pht4pV`l@V;@V@ p f{U?p f{ %?qd` 1G*??qdlzc? qV 2 qV2~ qV@ qe 2 qhY5 qhZ5qVq@V@VH@ q fU7ɂ?q fN?rd:T|=rdgڽ= rV]5 rV2~ rV@ re^5 rh_5 rh`5rV@V z@VH@ r fd ?r f$Be?sd>z $F?sd Iglh? sVa5 sV2~ sV@ seb5 shc5 shd5sV\@Vu@V>@ s f=嗋?s fPʶ?td>z $F?td Iglh? tVe5 tV2~ tV@ tef5 thc5 thd5tV\@Vu@V>@ t f=嗋?t fPʶ?ud%>ud괊> uVg5 uV2~ uV@ ueS uhh5 uhi5uV@Vv@VB@ u f= [?u fSNd6պ?vdHw?vdNlwE? vVj5 vV2~ vV@ vek5 vhl5 vhm5vV@Vu@V@@ v f0N@~?v fiF?wd9{V?wdTȲu? wVn5 wV2~ wV@ weo5 whp5 whq5wVr@V @VH@ w fg{t?w f@q8P?xds]Z?xd!4v? xVr5 xV2~ xV@ xes5 xht5 xhu5xV@V@@VH@ x f \|?x fA.?ydZ\RaUd?ydSӺK? yVv5 yV2~ yV@ yew5 yhx5 yhy5yV]@V3@V@ y f|a?y fy 5?zd*yg?zdMb? zVz5 zV2~ zV@ ze{5 zh|5 zh}5$zV@V@V@f?f? {dc?yUq?{d^? {V~5 {V2~ {V@ {e5 {h5 {h5{V@Vx@VH@ { f~,'=?{ ft?;?|dX p3?|dpN`? |V5 |V2~ |V@ |e5 |h5 |hd5|V@V0t@V>@ | f*?| f3@%[Ʒ?}dD\pr?}dATB)? }V5 }V2~ }V@ }e+ }h5 }h5}V0@V@V@f? } f۶m۶m?~dGC?~dybUr? ~V5 ~V2~ ~V@ ~e5 ~h5 ~h5~V@Vy@VA@ ~ fe03?~ fD{?d_;B#U?d2wH~? V5 V2~ V@ e5 h5 hm5V@@Vx@V@@  fx? fT᪓G?Dl ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@dr t>d1I > V4 V2~ V@ e 4 h5 h5V@V`@VH@  fUJs^!? f9/?d",]{?d*S\? V5 V2~ V@ e5 hc5 hd5V>@Vx@V>@  f5v{? fO?dUK]?d_R? V5 V2~ V@ e5 h5 h5Vx@Vx@V>@  fi\? fxT ~?d's?d){,? V5 V2~ V@ e5 h4 h4VH@V"@V@f?  fUUUUUU?d's?d 4j? V5 V2~ V@ e5 h4 h4VG@V"@V@  fAL &W? fUUUUUU? YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ YYY !YYY "YYY #YYY $YYY %YYY &YYY 'YYY (YYY )YYY *YYY +YYY ,YYY -YYY .YYY /YYY 0YYY 1YYY 2YYY 3YYY 4YYY 5YYY 6YYY 7YYY 8YYY 9YYY :YYY ;YYY <YYY =YYY >YYY ?YYYDl@;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@ @YYY AYYY BYYY CYYY DYYY EYYY FYYY GYYY HYYY IYYY JYYY KYYY LYYY MYYY NYYY OYYY PYYY QYYY RYYY SYYY TYYY UYYY VYYY WYYY XYYY YYYY ZYYY [YYY \YYY ]YYY ^YYY _YYYDl`;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@ `YYY aYYY bYYY cYYY dYYY eYYY fYYY gYYY hYYY iYYY jYYY kYYY lYYY mYYY nYYY oYYY pYYY qYYY rYYY sYYY tYYY uYYY vYYY wYYY xYYY yYYY zYYY {YYY |YYY }YYY ~YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ YYY !YYY "YYY #YYY $YYY %YYY &YYY 'YYY (YYY )YYY *YYY +YYY ,YYY -YYY .YYY /YYY 0YYY 1YYY 2YYY 3YYY 4YYY 5YYY 6YYY 7YYY 8YYY 9YYY :YYY ;YYY <YYY =YYY >YYY ?YYYDl@;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@ @YYY AYYY BYYY CYYY DYYY EYYY FYYY GYYY HYYY IYYY JYYY KYYY LYYY MYYY NYYY OYYY PYYY QYYY RYYY SYYY TYYY UYYY VYYY WYYY XYYY YYYY ZYYY [YYY \YYY ]YYY ^YYY _YYYDl`;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@ `YYY aYYY bYYY cYYY dYYY eYYY fYYY gYYY hYYY iYYY jYYY kYYY lYYY mYYY nYYY oYYY pYYY qYYY rYYY sYYY tYYY uYYY vYYY wYYY xYYY yYYY zYYY {YYY |YYY }YYY ~YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@ ;@ ;@ ;@ ;@ ;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl ;@!;@";@#;@$;@%;@&;@';@(;@);@*;@+;@,;@-;@.;@/;@0;@1;@2;@3;@4;@5;@6;@7;@8;@9;@:;@;;@<;@=;@>;@?;@ YYY !YYY "YYY #YYY $YYY %YYY &YYY 'YYY (YYY )YYY *YYY +YYY ,YYY -YYY .YYY /YYY 0YYY 1YYY 2YYY 3YYY 4YYY 5YYY 6YYY 7YYY 8YYY 9YYY :YYY ;YYY <YYY =YYY >YYY ?YYYDl@;@A;@B;@C;@D;@E;@F;@G;@H;@I;@J;@K;@L;@M;@N;@O;@P;@Q;@R;@S;@T;@U;@V;@W;@X;@Y;@Z;@[;@\;@];@^;@_;@ @YYY AYYY BYYY CYYY DYYY EYYY FYYY GYYY HYYY IYYY JYYY KYYY LYYY MYYY NYYY OYYY PYYY QYYY RYYY SYYY TYYY UYYY VYYY WYYY XYYY YYYY ZYYY [YYY \YYY ]YYY ^YYY _YYYDl`;@a;@b;@c;@d;@e;@f;@g;@h;@i;@j;@k;@l;@m;@n;@o;@p;@q;@r;@s;@t;@u;@v;@w;@x;@y;@z;@{;@|;@};@~;@;@ `YYY aYYY bYYY cYYY dYYY eYYY fYYY gYYY hYYY iYYY jYYY kYYY lYYY mYYY nYYY oYYY pYYY qYYY rYYY sYYY tYYY uYYY vYYY wYYY xYYY yYYY zYYY {YYY |YYY }YYY ~YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYY YYYDl;@;@;@;@;@;@;@;@ YYY YYY YYY YYY YYY YYY YYY YYY >@m  ggD   !"#$%&(DocumentLibraryFormDocumentLibraryFormDocumentLibraryForm This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. metaAttributes"/> Oh+'0@H\h  Joanna BonsQCMicrosoft Macintosh Excel@: @o ՜.+,D՜.+,@HP X`hp x   Table S4a Table S4b Table S4c Table S4d Table S4e Table S4f Table S4g Table S4h Table S4i Table S4j Table S4k  Worksheets x :BContentTypeId,0x01010086DF1D1AC43A7044A055675E9E9FAD1D F Microsoft Excel 2003 WorksheetBiff8Excel.Sheet.89q